{"meta":{"query_hash":"e496dea6c581","filters":{"topic":"Pharmacogenetics and Drug Metabolism"},"cohort_total":1519,"direct_labels_cover":3,"predictions_cover":1519,"exported":1519,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e496dea6c581","api":"https://metacan.xera.ac/api/v1/cohort?topic=Pharmacogenetics+and+Drug+Metabolism"},"results":[{"id":"W1015548331","doi":"10.1016/j.bmc.2015.07.025","title":"A P450 fusion library of heme domains from Rhodococcus jostii RHA1 and its evaluation for the biotransformation of drug molecules","year":2015,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"FP7 People: Marie-Curie Actions; European Commission","keywords":"Rhodococcus; Chemistry; Biotransformation; Cytochrome P450; Biochemistry; Hydroxylation; Demethylation; Escherichia coli; Heme; Monooxygenase; Enzyme; Gene; Gene expression","score_opus":0.11187130459542524,"score_gpt":0.3972669808825699,"score_spread":0.2853956762871447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1015548331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96505886,0.030722218,0.000374176,0.0014568598,0.0003794431,0.0006056884,0.00036888936,0.000023201392,0.0010106862],"genre_scores_gemma":[0.9968474,0.0019150515,0.00021352585,0.00035041088,0.00039216876,0.000037846603,0.0001351165,0.00001917071,0.00008932203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867684,0.00014433256,0.00044355437,0.00020321524,0.0003372985,0.00019479175],"domain_scores_gemma":[0.99876994,0.00040597175,0.00026129154,0.00015380773,0.00020869373,0.00020030915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010396051,0.00017291005,0.00026701353,0.000034432873,0.000088029155,0.0000068805684,0.00025085502,0.00018752717,0.0007277934],"category_scores_gemma":[0.0002221243,0.00012857918,0.000066454995,0.00016036359,0.00016822545,0.00009135028,0.000072918396,0.00023571802,0.000004001276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041832263,0.00009642554,0.0003148535,0.00016834332,0.00012244395,0.0000011418458,0.0017064479,0.000032833028,0.98234385,0.000045793164,0.0023334802,0.012416039],"study_design_scores_gemma":[0.0035881284,0.000040393035,0.0009992677,0.00003868876,0.000704136,0.000007401071,0.00070153613,0.017459879,0.96039873,0.00051596237,0.015418369,0.00012750408],"about_ca_topic_score_codex":0.000014286602,"about_ca_topic_score_gemma":0.000001072094,"teacher_disagreement_score":0.03178855,"about_ca_system_score_codex":0.00002222181,"about_ca_system_score_gemma":0.00027486868,"threshold_uncertainty_score":0.7968827},"labels":[],"label_agreement":null},{"id":"W1125187349","doi":"10.1007/978-3-319-16009-2_5","title":"Regioselective Versatility of Monooxygenase Reactions Catalyzed by CYP2B6 and CYP3A4: Examples with Single Substrates","year":2015,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Hydroxylation; Monooxygenase; Regioselectivity; CYP2B6; Cytochrome P450; Substrate (aquarium); Enzyme; Stereochemistry; Organic chemistry; Biochemistry; Catalysis; CYP1A2","score_opus":0.2506256391629043,"score_gpt":0.5149566931814417,"score_spread":0.26433105401853735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1125187349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029878603,0.9679113,0.00000568348,0.000042095282,0.00035195966,0.0005788659,0.00020122978,0.000016263544,0.0010139779],"genre_scores_gemma":[0.06110194,0.9381936,0.00010340317,0.00008194044,0.00012453148,0.00011644822,0.0002298532,0.000021402748,0.000026878553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796915,0.0005117171,0.000593661,0.00052816473,0.00007489127,0.00032241514],"domain_scores_gemma":[0.9986242,0.00054443534,0.00039820638,0.00015623483,0.00006307482,0.00021385333],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004298493,0.00040736326,0.0013929926,0.00017556544,0.00007420869,0.000003308421,0.00015503538,0.00034719185,0.00007234297],"category_scores_gemma":[0.000056257395,0.0002763021,0.000048262307,0.00024861927,0.0013975516,0.00010453717,0.00007985265,0.00048037793,0.0000012528021],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005104692,0.00066268665,0.00039011773,0.001886297,0.00034964338,0.000020933525,0.0015832431,0.00000150522,0.065695,0.00038457342,0.00035059376,0.92816496],"study_design_scores_gemma":[0.0018314115,0.0007174155,0.0000066622924,0.00047519535,0.00038114877,0.000072196926,0.0009386414,0.000007013146,0.020290473,0.00024967422,0.9747462,0.00028393613],"about_ca_topic_score_codex":0.000149477,"about_ca_topic_score_gemma":0.000042262494,"teacher_disagreement_score":0.97439563,"about_ca_system_score_codex":0.00006583112,"about_ca_system_score_gemma":0.00009129049,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W1167902140","doi":"10.1096/fasebj.29.1_supplement.616.14","title":"Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D Central Activation of Codeine to Morphine","year":2015,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"Morphine; Codeine; Nicotine; Pharmacology; Chemistry; Analgesic; Anesthesia; Medicine; Internal medicine","score_opus":0.1374100508209678,"score_gpt":0.410338380369313,"score_spread":0.2729283295483452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1167902140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824344,0.0010077475,0.0016293803,0.012802354,0.00088976853,0.00031981186,0.0000829301,0.000014181059,0.0008194056],"genre_scores_gemma":[0.9954404,0.0003823455,0.00025420135,0.0026583876,0.0009979549,0.0000073938004,0.000017810886,0.000019568324,0.00022190537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976794,0.000849662,0.0005889499,0.00014418627,0.00038019108,0.00035756873],"domain_scores_gemma":[0.99823594,0.00036030833,0.00051965954,0.00023152262,0.00037498432,0.00027758512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001884197,0.00019139548,0.00031504862,0.000099899305,0.00022984688,0.000017870008,0.0004849662,0.00011421301,0.00038703758],"category_scores_gemma":[0.0003862893,0.00011383164,0.00012118565,0.0004531579,0.0002446989,0.00015356681,0.00010894467,0.00074460986,0.000010936474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012855289,0.0003941264,0.0019115045,0.000013766454,0.00030565902,0.000004453127,0.002253669,0.022558894,0.9407473,0.0009712931,0.021527117,0.008026643],"study_design_scores_gemma":[0.002674799,0.00025151772,0.005901034,0.000025113204,0.00030528064,0.0001692055,0.0005720137,0.0021271808,0.9570432,0.0018321176,0.028951677,0.00014687714],"about_ca_topic_score_codex":0.00017227142,"about_ca_topic_score_gemma":0.000012488669,"teacher_disagreement_score":0.020431714,"about_ca_system_score_codex":0.00005384027,"about_ca_system_score_gemma":0.00020133157,"threshold_uncertainty_score":0.46419194},"labels":[],"label_agreement":null},{"id":"W117007957","doi":"10.1096/fasebj.27.1_supplement.670.2","title":"Decreased Nuclear Receptor Activity Mediates Down‐ Regulation of Drug Metabolizing Enzymes in Chronic Kidney Disease Through Epigenetic Modulation.","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Chromatin immunoprecipitation; Pregnane X receptor; Nuclear receptor; Histone; Epigenetics; CYP3A; Internal medicine; Endocrinology; Messenger RNA; Kidney disease; Chemistry; Gene expression; Biology; Promoter; Medicine; Cytochrome P450; Transcription factor; Gene; Biochemistry; Metabolism","score_opus":0.048942508447225204,"score_gpt":0.35110058253044235,"score_spread":0.30215807408321715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W117007957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98669815,0.008663831,0.00014689506,0.0024236902,0.001047739,0.00052296865,0.000069579044,0.000028372706,0.00039879486],"genre_scores_gemma":[0.9941549,0.0037005192,0.00030966822,0.0008361232,0.0007632163,0.000031936408,0.000018590714,0.00003724757,0.00014783868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710196,0.001265826,0.00056638656,0.00024256033,0.00033533422,0.00048790956],"domain_scores_gemma":[0.9982239,0.00033700388,0.00045533731,0.0002638839,0.00017306286,0.0005468097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011218985,0.00026010617,0.0003597966,0.0001542174,0.00037824846,0.000054945504,0.00044275876,0.00012739218,0.0071773008],"category_scores_gemma":[0.00022587014,0.00019556555,0.00018609114,0.00031570013,0.0002526469,0.00040327312,0.00009704633,0.0007891357,0.00013864005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032175225,0.00023841298,0.0037500318,0.0000409018,0.00016667145,0.000004477272,0.0013607751,0.018504806,0.95867205,0.00090182945,0.0032008637,0.012837443],"study_design_scores_gemma":[0.003974711,0.000041998723,0.112221286,0.000065267835,0.0004303926,0.000015555734,0.00012460024,0.076049134,0.77253854,0.01001023,0.024123468,0.0004048381],"about_ca_topic_score_codex":0.00010062542,"about_ca_topic_score_gemma":0.000007613157,"teacher_disagreement_score":0.18613352,"about_ca_system_score_codex":0.00013687465,"about_ca_system_score_gemma":0.0004038691,"threshold_uncertainty_score":0.99373025},"labels":[],"label_agreement":null},{"id":"W1186355623","doi":"10.1007/978-3-319-16009-2_8","title":"Use of Chemical Auxiliaries to Control P450 Enzymes for Predictable Oxidations at Unactivated C-H Bonds of Substrates","year":2015,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Oxidizing agent; Substrate (aquarium); Chemistry; Enzyme; Cytochrome P450; Selectivity; Combinatorial chemistry; Small molecule; Molecule; Stereochemistry; Biochemistry; Organic chemistry; Catalysis; Biology","score_opus":0.2972921616078985,"score_gpt":0.5411258675475317,"score_spread":0.24383370593963316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1186355623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018505473,0.97871596,0.000023981274,0.00007821877,0.0005771574,0.0011787189,0.0007253801,0.0000130725975,0.0001820497],"genre_scores_gemma":[0.05023077,0.9481092,0.00031144294,0.00026190077,0.00020777782,0.0003963679,0.0003872371,0.000023756547,0.00007154026],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804413,0.00026829526,0.0008814073,0.0003875605,0.00007805079,0.0003405553],"domain_scores_gemma":[0.99788946,0.0012283043,0.00040817173,0.0001515168,0.0001188814,0.00020364276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003889121,0.0003495832,0.0017649157,0.00022686858,0.00004311956,0.0000021938076,0.00020854185,0.0004267249,0.00011334411],"category_scores_gemma":[0.00023658614,0.0002532728,0.00009510322,0.00023835822,0.00080311793,0.00009241691,0.0001169015,0.00025348685,0.0000013263522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016329687,0.0007487093,0.0005167666,0.0033697912,0.0006142618,0.000005027033,0.0010039504,0.000037878377,0.5950811,0.0074009835,0.002555293,0.38703328],"study_design_scores_gemma":[0.0018179605,0.00054729794,0.0000017990643,0.00041134498,0.0004109004,0.000010320468,0.0001059052,0.00004794832,0.17045388,0.00015984579,0.8258477,0.00018509732],"about_ca_topic_score_codex":0.000025714955,"about_ca_topic_score_gemma":0.000005384422,"teacher_disagreement_score":0.82329243,"about_ca_system_score_codex":0.000062057225,"about_ca_system_score_gemma":0.00010879023,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W120726635","doi":"10.1139/jpn.0260","title":"Chirality and drugs used to treat psychiatric disorders","year":2002,"lang":"en","type":"editorial","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Chirality (physics); Psychiatry; Medicine; Psychology; Physics","score_opus":0.054989534377641765,"score_gpt":0.41003581676261414,"score_spread":0.3550462823849724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W120726635","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17307924,0.0110322675,0.000042767424,0.004249624,0.81027275,0.00028779966,0.00017990368,0.000019359111,0.00083627726],"genre_scores_gemma":[0.120897375,0.07559969,0.0012287912,0.0058740145,0.7940014,0.000020539443,0.0000071472355,0.00012453416,0.0022464818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968194,0.0004789824,0.00084022834,0.00060992263,0.0006988852,0.0005526056],"domain_scores_gemma":[0.9975735,0.0004220652,0.0007477467,0.00023266877,0.0001367988,0.0008872471],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013136972,0.00047126584,0.00068844075,0.00045869045,0.00046039376,0.000115818526,0.0006753839,0.0006067169,0.00007765193],"category_scores_gemma":[0.00029385136,0.00040014237,0.00020808837,0.000556298,0.00035963533,0.00021569847,0.00016982517,0.0022118117,0.000008384936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039629434,0.0006059424,0.004426728,0.00022051929,0.000033471082,0.000015955347,0.00056122226,0.00009024152,0.0038998595,0.00014633854,0.97732866,0.012274766],"study_design_scores_gemma":[0.0022448103,0.0005914198,0.0016478376,0.000035699344,0.00046171213,0.000049240494,0.00003771741,0.000108670814,0.00021710282,0.0010026433,0.9931635,0.0004395923],"about_ca_topic_score_codex":0.000008670667,"about_ca_topic_score_gemma":0.000013790675,"teacher_disagreement_score":0.064567424,"about_ca_system_score_codex":0.000022478043,"about_ca_system_score_gemma":0.0003008277,"threshold_uncertainty_score":0.999845},"labels":[],"label_agreement":null},{"id":"W125357068","doi":"10.2174/187569212800626430","title":"Editorials (Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?)","year":2012,"lang":"en","type":"article","venue":"Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Pharmacogenomics; Personalized medicine; Genomics; Primary care; Medicine; Point of care; Genomic medicine; Pharmacology; Computational biology; Bioinformatics; Family medicine; Genetics; Nursing; Biology; Genome; Gene","score_opus":0.14352934575995357,"score_gpt":0.4615633252755062,"score_spread":0.3180339795155526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W125357068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42692325,0.50937116,0.0006633011,0.005680724,0.044471845,0.004815388,0.006671056,0.00023396357,0.0011693157],"genre_scores_gemma":[0.26345807,0.61770993,0.0010079194,0.014369118,0.09165099,0.0011341086,0.009549727,0.0005916754,0.0005284776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98533744,0.0017317659,0.0041847606,0.0029895362,0.0017493324,0.004007147],"domain_scores_gemma":[0.989433,0.002147702,0.0019246058,0.000740961,0.0010282194,0.0047255196],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts"],"category_scores_codex":[0.0061675813,0.0030579525,0.0045864666,0.0012567416,0.0013081682,0.00010264119,0.0015772178,0.00096331886,0.0025724103],"category_scores_gemma":[0.00062687666,0.0027218563,0.0008487731,0.0013116007,0.004835264,0.00072342885,0.00081979594,0.0035435257,0.000029525449],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021824189,0.0047972337,0.02113292,0.008151274,0.0031478768,0.00013106957,0.051373567,0.00009747145,0.27766898,0.0099851135,0.08653911,0.5151512],"study_design_scores_gemma":[0.08012092,0.0006189958,0.0011030228,0.0010716342,0.00606949,0.00034206943,0.0041756737,0.0032566148,0.0009651039,0.0009519599,0.8987269,0.0025976468],"about_ca_topic_score_codex":0.00019392051,"about_ca_topic_score_gemma":0.00002665408,"teacher_disagreement_score":0.81218773,"about_ca_system_score_codex":0.0016021003,"about_ca_system_score_gemma":0.0011323905,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W126253151","doi":"10.1096/fasebj.23.1_supplement.lb400","title":"Effect of altered lipid homeostasis on cytochrome P450 2A5 expression","year":2009,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Lipid metabolism; Cytochrome P450; Homeostasis; Chemistry; Drug metabolism; Biology; Biochemistry; Pharmacology; Endocrinology; Metabolism; Gene","score_opus":0.06080914244997124,"score_gpt":0.4159904782549048,"score_spread":0.3551813358049336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W126253151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919281,0.002147028,0.00006365269,0.0009386541,0.0013663972,0.00030165148,0.000048478556,0.000028357312,0.0031776526],"genre_scores_gemma":[0.9948439,0.0016244102,0.000052355397,0.0017333009,0.0015263305,0.0000069865405,0.000005153925,0.000018991948,0.00018859736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970307,0.0015398996,0.0004448272,0.00018984397,0.00033053342,0.00046423657],"domain_scores_gemma":[0.9984223,0.00059305073,0.00032770488,0.00026539073,0.000077429155,0.00031412698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022021402,0.0002641224,0.00039193017,0.00015575333,0.00043508832,0.000031540752,0.0005586929,0.00017072326,0.0011981034],"category_scores_gemma":[0.00009834082,0.00015789134,0.000249859,0.00018531705,0.00013506273,0.000078843856,0.000056398665,0.0012495405,0.00011229579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015092816,0.00018388385,0.00009706773,0.000013171817,0.00008525363,0.000031585972,0.00032778902,0.0007894181,0.87205744,0.00006204066,0.0049637845,0.11987926],"study_design_scores_gemma":[0.003024462,0.0011944883,0.0017924628,0.000041409177,0.00024287113,0.00016456404,0.00002019336,0.00036334057,0.9732037,0.00035706576,0.019426744,0.00016869899],"about_ca_topic_score_codex":0.0000010709393,"about_ca_topic_score_gemma":1.4402758e-7,"teacher_disagreement_score":0.119710565,"about_ca_system_score_codex":0.00003598799,"about_ca_system_score_gemma":0.000054736767,"threshold_uncertainty_score":0.9997149},"labels":[],"label_agreement":null},{"id":"W137013804","doi":"10.1385/1-59259-957-5:003","title":"Pharmacogenomics: Historical Perspective and Current Status","year":2005,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Personalized medicine; Drug; Computational biology; Precision medicine; Genomics; Human genetics; Action (physics); Gene; Biology; Genetics; Bioinformatics; Medicine; Genome; Pharmacology","score_opus":0.3022909805118992,"score_gpt":0.5323538594758448,"score_spread":0.23006287896394562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W137013804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016106706,0.9806418,0.000045671815,0.00018832163,0.009956275,0.0024794545,0.00190029,0.00031864078,0.004308518],"genre_scores_gemma":[0.00006439475,0.98903006,0.00043006113,0.0009649848,0.0071500354,0.0005079459,0.0002696698,0.0004568192,0.0011260543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913625,0.0015034716,0.0021445388,0.0021389625,0.00049789966,0.0023526095],"domain_scores_gemma":[0.9945342,0.0008708184,0.00124713,0.00067234255,0.00034860056,0.0023269276],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0013715572,0.0021052111,0.003732988,0.00097088463,0.0006857841,0.0001538403,0.0013165064,0.0010880182,0.0019247042],"category_scores_gemma":[0.0001189061,0.0020927116,0.0013792046,0.00070278824,0.0004256801,0.0002728884,0.0010126358,0.005030622,0.0011717002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014594471,0.0006607282,0.000011286521,0.0026841876,0.0015070722,0.00008053736,0.0006581151,0.000034187742,0.00021376433,0.0007258633,0.011337366,0.9819409],"study_design_scores_gemma":[0.0026248847,0.0000519282,0.0000010845838,0.00032362848,0.009776354,0.00025946336,0.000047352085,0.0004738354,0.000111392954,0.00021492621,0.9840567,0.0020584196],"about_ca_topic_score_codex":0.0000628958,"about_ca_topic_score_gemma":0.0000062138406,"teacher_disagreement_score":0.97988254,"about_ca_system_score_codex":0.004758981,"about_ca_system_score_gemma":0.001465901,"threshold_uncertainty_score":0.999606},"labels":[],"label_agreement":null},{"id":"W1461815855","doi":"10.1016/j.abb.2015.09.002","title":"Kinetic analysis of electron flux in cytochrome P450 reductases reveals differences in rate-determining steps in plant and mammalian enzymes","year":2015,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Electron transfer; Chemistry; Electron transport chain; Flux (metallurgy); Hydride; Cytochrome c; Dehydrogenase; Cofactor; Enzyme; Photochemistry; Cytochrome; Reaction rate constant; Kinetics; Coenzyme Q – cytochrome c reductase; Stereochemistry; Biochemistry; Mitochondrion; Organic chemistry; Hydrogen; Physics","score_opus":0.06410435662737599,"score_gpt":0.35940323191205326,"score_spread":0.29529887528467724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1461815855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686104,0.00239451,0.0000019962467,0.00005262172,0.000027518297,0.000116363895,0.00017873081,0.0000041074486,0.0003631153],"genre_scores_gemma":[0.9985945,0.0010771804,0.00011504124,0.000043282067,0.000035998786,0.00001170942,0.00007307318,0.0000066142543,0.000042548887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987128,0.00021703576,0.00043232186,0.0002898083,0.00008159851,0.00026644138],"domain_scores_gemma":[0.999268,0.00030479446,0.00016925085,0.000117542906,0.000015631023,0.00012477285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028857755,0.0001796589,0.0005229193,0.00026643949,0.000019296756,0.000007054171,0.0001517493,0.00010286711,0.0000073754177],"category_scores_gemma":[0.00004639972,0.00016848095,0.00005218144,0.00044563864,0.0003313246,0.000034636752,0.00009251599,0.00025848622,1.8074284e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003307683,0.0002239518,0.078544654,0.00013376771,0.00011454471,0.00001993172,0.0013727935,0.00009649394,0.9165765,0.000095585936,0.000007046377,0.0024839772],"study_design_scores_gemma":[0.0012151476,0.00008502516,0.1789802,0.000058222355,0.00019135531,0.0000033366548,0.00036017926,0.00238815,0.81557584,0.0009515534,0.000029088918,0.00016187831],"about_ca_topic_score_codex":0.000060231814,"about_ca_topic_score_gemma":0.000019631489,"teacher_disagreement_score":0.10100062,"about_ca_system_score_codex":0.000008330614,"about_ca_system_score_gemma":0.00005770516,"threshold_uncertainty_score":0.6870454},"labels":[],"label_agreement":null},{"id":"W1481769216","doi":"10.18433/j3ng6z","title":"Cranberry Juice Ingestion and Clinical Drug-Drug Interaction Potentials; Review of Case Studies and Perspectives","year":2013,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Grapefruit juice; In vivo; CRANBERRY JUICE; Pharmacodynamics; Bioavailability; Drug interaction; Chemistry; Pharmacokinetics; Drug; Medicine; Biology; Biotechnology; Internal medicine","score_opus":0.47715001903308973,"score_gpt":0.6240484845981872,"score_spread":0.14689846556509745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481769216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010363042,0.98228794,0.000011134101,0.0017313232,0.004034541,0.0012043829,0.000054698085,0.000025678497,0.00028727495],"genre_scores_gemma":[0.0073176976,0.9892279,0.0006421623,0.0011962813,0.0014257454,0.000036838886,0.0000030674503,0.000046499183,0.00010380548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98993343,0.0043220716,0.003471322,0.00082200224,0.000761098,0.00069006596],"domain_scores_gemma":[0.99072725,0.0038804584,0.0031632388,0.0001952556,0.0010287531,0.0010050365],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010718088,0.0008223261,0.0033765256,0.000624651,0.00050277106,0.000099443125,0.0007279626,0.00024930917,0.0007520295],"category_scores_gemma":[0.0012166234,0.00058119796,0.000918722,0.000817298,0.0028235626,0.00083297637,0.00054838107,0.0031572618,0.000023775252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001291949,0.00044052844,0.00009599319,0.03531206,0.0015913296,0.0005881931,0.00057653757,0.000004118505,0.00010521968,0.000110708716,0.0057807006,0.9552654],"study_design_scores_gemma":[0.0017489713,0.00013491203,0.000005305202,0.014779811,0.013269457,0.010474837,0.0008271907,0.00041318816,0.00036213786,0.00010700969,0.95731634,0.0005608257],"about_ca_topic_score_codex":0.000023865121,"about_ca_topic_score_gemma":0.0000030582348,"teacher_disagreement_score":0.9547046,"about_ca_system_score_codex":0.00012421932,"about_ca_system_score_gemma":0.0005673921,"threshold_uncertainty_score":0.9998902},"labels":[],"label_agreement":null},{"id":"W1482946335","doi":"10.1038/sj.bjp.0706787","title":"Phenobarbital increases monkey<i>in vivo</i>nicotine disposition and induces liver and brain CYP2B6 protein","year":2006,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health","keywords":"Phenobarbital; Nicotine; CYP2B6; Pharmacology; In vivo; Endocrinology; Internal medicine; Medicine; Chemistry; Biology; Metabolism; Cytochrome P450; CYP1A2","score_opus":0.025937868684479972,"score_gpt":0.34153468592392944,"score_spread":0.3155968172394495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1482946335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96355337,0.033440318,0.000026759179,0.0011681719,0.00066288176,0.00044791543,0.00012211868,0.000022051792,0.00055639824],"genre_scores_gemma":[0.99033785,0.0057142973,0.00032372054,0.002138331,0.0011830488,0.00002957449,0.000008052266,0.00003424755,0.00023089242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971814,0.0009134251,0.0008227602,0.00033341895,0.00021057508,0.00053837756],"domain_scores_gemma":[0.99864393,0.00038349334,0.00044987845,0.000047490288,0.00017307606,0.00030214697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011489424,0.00028107216,0.00055414886,0.00024456097,0.00021267383,0.00006771658,0.00023338661,0.00028710478,0.00076219445],"category_scores_gemma":[0.00007434128,0.00032332688,0.00009822931,0.00022626741,0.0004103775,0.0003524612,0.00014820261,0.0010862828,0.0000053506096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061348436,0.0010141736,0.002459007,0.0000804113,0.00014286196,0.0018910472,0.00012280067,0.00016062913,0.9361076,0.00022204862,0.013210125,0.043975838],"study_design_scores_gemma":[0.021522284,0.00074060296,0.044816542,0.0002267027,0.0008976987,0.013225011,0.00015772707,0.0034356397,0.83202285,0.0027676413,0.07915866,0.0010286556],"about_ca_topic_score_codex":0.0006498673,"about_ca_topic_score_gemma":0.00013860168,"teacher_disagreement_score":0.10408473,"about_ca_system_score_codex":0.00005249912,"about_ca_system_score_gemma":0.00010779438,"threshold_uncertainty_score":0.99992186},"labels":[],"label_agreement":null},{"id":"W1495793224","doi":"10.1111/j.1476-5381.2009.00168.x","title":"The hepoxilins and some analogues: a review of their biology","year":2009,"lang":"en","type":"review","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Chemistry; Inflammation; Biological activity; Pharmacology; Biochemistry; In vitro; Biology; Immunology; Biotechnology","score_opus":0.13116060194753823,"score_gpt":0.4822046214859074,"score_spread":0.35104401953836917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1495793224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017483323,0.99252933,0.000008554684,0.00067565736,0.004698834,0.0010043645,0.0005092121,0.000018861334,0.0003803263],"genre_scores_gemma":[0.00012014349,0.9924932,0.00007503016,0.0048271576,0.0021955825,0.000046877467,0.000046768015,0.00006598594,0.00012925922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910924,0.004263586,0.0030962892,0.00046320353,0.00024663188,0.00083792635],"domain_scores_gemma":[0.99285775,0.002354969,0.0035171874,0.00019885725,0.00060967513,0.00046157345],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005056828,0.0006784579,0.003913162,0.0003446911,0.00039530723,0.000037988037,0.0014605619,0.00084354077,0.00042033827],"category_scores_gemma":[0.00034329054,0.000507653,0.001258544,0.00048386998,0.0010515524,0.00014165572,0.00029079447,0.0033179761,0.000016350456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005847951,0.00026707954,0.0000017077534,0.013802562,0.0016308442,0.00034974917,0.000030380566,9.644258e-7,0.0003856392,0.00026330748,0.036993425,0.94621587],"study_design_scores_gemma":[0.0013808846,0.00030087167,0.0000042584825,0.0133887185,0.005793181,0.0078170635,0.000011589043,0.000009506868,0.00029239466,0.00083986815,0.9697515,0.00041021343],"about_ca_topic_score_codex":0.000008963182,"about_ca_topic_score_gemma":0.0000043489704,"teacher_disagreement_score":0.94580567,"about_ca_system_score_codex":0.00008401216,"about_ca_system_score_gemma":0.0009317416,"threshold_uncertainty_score":0.9997375},"labels":[],"label_agreement":null},{"id":"W1499157913","doi":"10.1111/bcp.12308","title":"Characterizing variability in warfarin dose requirements in children using modelling and simulation","year":2013,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Uppsala Universitet; Hospital for Sick Children; Vetenskapsrådet; Baxter International","keywords":"VKORC1; Warfarin; CYP2C9; Dosing; Medicine; Maintenance dose; Vitamin K epoxide reductase; Therapeutic index; Pharmacogenetics; Internal medicine; Genotype; Pharmacology; Biology; Drug; Atrial fibrillation","score_opus":0.25253721412720814,"score_gpt":0.5135829619349581,"score_spread":0.26104574780775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499157913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427444,0.0013658138,0.00088483887,0.00027586642,0.0023655535,0.0006473344,0.000015331498,0.000011531833,0.00015931226],"genre_scores_gemma":[0.99109626,0.003968052,0.0013651936,0.002468247,0.0010439834,0.000012786898,0.00000460386,0.00002740874,0.000013464805],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9932594,0.0030049537,0.0025501,0.00040272204,0.00021400712,0.0005688212],"domain_scores_gemma":[0.9969422,0.0014348511,0.00086596725,0.00009116462,0.00024773864,0.0004180846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008175561,0.00022839909,0.00088092143,0.0002689904,0.000106258245,0.000049144506,0.00032474915,0.00045679417,0.0008479872],"category_scores_gemma":[0.00047759808,0.00026820603,0.00016511294,0.0002695334,0.0002523758,0.00055191637,0.00017335956,0.0021758755,0.000011206306],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006407723,0.001635265,0.4790744,0.00003789372,0.00025794667,0.00024624594,0.00020508286,0.29877087,0.025209947,0.000010264252,0.00014670167,0.19376464],"study_design_scores_gemma":[0.010192002,0.000101071666,0.39007384,0.00006558438,0.00019861307,0.00035499694,0.000020054838,0.5943403,0.0011632371,0.0014259875,0.0017631515,0.00030113466],"about_ca_topic_score_codex":0.00022692601,"about_ca_topic_score_gemma":0.0000073822403,"teacher_disagreement_score":0.29556948,"about_ca_system_score_codex":0.00008000882,"about_ca_system_score_gemma":0.0001733871,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W1502772866","doi":"10.18433/j3n30w","title":"Inhibition of Human Cytochrome P450 Metabolism by Blended Herbal Products and Vitamins","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Agriculture and Agri-Food Canada; Health Canada; University of Ottawa","funders":"Canadian Institutes of Health Research; Health Canada; Fondation pour la Recherche Médicale; Canadian Patient Safety Institute","keywords":"Cytochrome P450; Metabolism; Chemistry; Traditional medicine; Pharmacology; Biochemistry; Medicine","score_opus":0.18943000124686743,"score_gpt":0.45411292785520996,"score_spread":0.26468292660834253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502772866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758426,0.016061964,0.00007520907,0.0009237618,0.0012025563,0.00044481683,0.00009825573,0.000038032835,0.0053127804],"genre_scores_gemma":[0.991651,0.0050183767,0.0010168056,0.0014844927,0.0006540703,0.000013456234,0.000004499137,0.00003313087,0.00012415033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953316,0.00085000804,0.0015115164,0.0005478881,0.0008870437,0.0008719497],"domain_scores_gemma":[0.9971252,0.00025388607,0.0009978411,0.0001672932,0.00054037705,0.00091541634],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037346175,0.0004668744,0.0008186585,0.0004353416,0.0004934647,0.0000524242,0.00075974787,0.00017301946,0.0027238282],"category_scores_gemma":[0.00016474718,0.0003841516,0.0002434815,0.00091096613,0.0019838756,0.0008176591,0.0002569496,0.0012445844,0.00002031413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049341144,0.0011543666,0.0021570884,0.0001183737,0.00025041818,0.000075645265,0.00137136,0.000012882213,0.9580896,0.0015492601,0.0028263514,0.03190126],"study_design_scores_gemma":[0.0048554833,0.00031574836,0.0026423729,0.000030540956,0.0007697016,0.00023678795,0.00019501391,0.000560176,0.847116,0.0010801235,0.1418108,0.00038724812],"about_ca_topic_score_codex":0.000035055626,"about_ca_topic_score_gemma":0.0000013792467,"teacher_disagreement_score":0.13898444,"about_ca_system_score_codex":0.000050415063,"about_ca_system_score_gemma":0.00032816967,"threshold_uncertainty_score":0.99986106},"labels":[],"label_agreement":null},{"id":"W1505082577","doi":"10.1002/9780470409107.ch8","title":"Nuclear Receptors and Drug–Drug Interactions with Prescription and Herbal Medicines","year":2008,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Pharmacology; Medical prescription; Medicine; Receptor; Internal medicine","score_opus":0.04598741843625072,"score_gpt":0.37146988967384537,"score_spread":0.32548247123759466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505082577","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03826287,0.025114281,0.000028839338,0.0026837033,0.0047332663,0.0009480015,0.0001176639,0.00045740663,0.92765397],"genre_scores_gemma":[0.022860184,0.053254724,0.00076404464,0.0034610892,0.0015208327,0.0000415224,0.000048954014,0.00039821194,0.91765046],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986125,0.00023710301,0.00024272742,0.00044773822,0.00015631388,0.00030362236],"domain_scores_gemma":[0.99919885,0.000091118665,0.00017801738,0.00015522937,0.000042961008,0.00033379515],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017927865,0.0003807741,0.00040336174,0.0002444467,0.00018973232,0.0000225851,0.00013196887,0.00019529037,0.012098726],"category_scores_gemma":[0.000012522376,0.00029469226,0.000042958178,0.00011264494,0.00045897652,0.0000678454,0.0000951495,0.0007521855,0.000091965056],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014546429,0.00010934577,0.0012153115,0.00008128448,0.00033215064,0.000025132947,0.00087883824,0.0000033145238,0.0013093604,0.00020956602,0.98170996,0.013980253],"study_design_scores_gemma":[0.0014161261,0.000028279224,0.00018922125,0.00006603558,0.00038436742,0.00014475915,0.00023039222,0.000232481,0.0005166946,0.000028243592,0.99641585,0.00034754866],"about_ca_topic_score_codex":0.00024775803,"about_ca_topic_score_gemma":0.0003605557,"teacher_disagreement_score":0.028140442,"about_ca_system_score_codex":0.000017227423,"about_ca_system_score_gemma":0.000039525643,"threshold_uncertainty_score":0.9999505},"labels":[],"label_agreement":null},{"id":"W1507721581","doi":"10.1016/j.phrs.2015.07.031","title":"3-Hydroxyflavone and structural analogues differentially activate pregnane X receptor: Implication for inflammatory bowel disease","year":2015,"lang":"en","type":"article","venue":"Pharmacological Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Pregnane X receptor; Inflammatory bowel disease; Pregnane; Medicine; Pharmacology; Receptor; Disease; Internal medicine; Chemistry; Stereochemistry; Nuclear receptor; Biochemistry","score_opus":0.3355986465387274,"score_gpt":0.5316364873347571,"score_spread":0.1960378407960297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1507721581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879206,0.0044992766,0.00015037446,0.0028577535,0.0010780632,0.002057733,0.00033821436,0.00015323427,0.0009447679],"genre_scores_gemma":[0.9935398,0.0025399907,0.00035814056,0.00065140286,0.00090196636,0.000908047,0.00018621083,0.00004843555,0.0008659709],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99533,0.0014124544,0.00052711775,0.0008238917,0.0006753741,0.0012311647],"domain_scores_gemma":[0.9955445,0.0012413457,0.00015138695,0.00025925194,0.00072280224,0.0020807355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029179594,0.00037930795,0.00038779242,0.00027207713,0.00064741576,0.00010925263,0.00064964994,0.00033670594,0.00074368523],"category_scores_gemma":[0.00086379255,0.00031430487,0.00013918185,0.00031875647,0.0007739884,0.00025134496,0.00054482045,0.00136076,0.00013480826],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061882683,0.00056900573,0.012037269,0.00019029698,0.00040285123,0.000041148876,0.00061163027,0.0006781229,0.9128108,0.004059846,0.029123168,0.0332876],"study_design_scores_gemma":[0.015906023,0.00084815826,0.056551043,0.000044098146,0.0007072854,0.000019502913,0.000262405,0.073430605,0.3764699,0.03675771,0.43758577,0.0014175156],"about_ca_topic_score_codex":0.000011349445,"about_ca_topic_score_gemma":0.0000025490601,"teacher_disagreement_score":0.5363409,"about_ca_system_score_codex":0.0001694854,"about_ca_system_score_gemma":0.00033066046,"threshold_uncertainty_score":0.9999309},"labels":[],"label_agreement":null},{"id":"W1508047865","doi":"","title":"Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Drug response; Drug; Personalized medicine; Affect (linguistics); Pharmacogenomics; Human genetics; Medicine; Genetics; Gene; Bioinformatics; Psychology; Pharmacology; Biology; Genotype","score_opus":0.12459068733492117,"score_gpt":0.4157381700249984,"score_spread":0.29114748269007723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508047865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992891,0.0009487463,0.00012079702,0.0005077402,0.0022197557,0.002883878,0.0001799212,0.000061618106,0.00018654423],"genre_scores_gemma":[0.99187154,0.00044141035,0.0012734301,0.00093576143,0.0002990155,0.0041078003,0.000008069002,0.000050185237,0.0010127907],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975183,0.0003582125,0.0004518544,0.0006001581,0.00016441362,0.0009070778],"domain_scores_gemma":[0.99812984,0.000855783,0.00010046642,0.00024487977,0.00007434342,0.0005947115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013267256,0.00034625464,0.00034815283,0.00034614067,0.00020955667,0.00007143497,0.00032946872,0.00020247069,0.0001330712],"category_scores_gemma":[0.00031627648,0.00033021608,0.00010786816,0.0002703499,0.00010958599,0.0000997621,0.00012380001,0.00043249383,0.000019859957],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024094286,0.00038058308,0.12857205,0.00004071572,0.0001519064,0.000051870687,0.0026022776,0.00024786798,0.49174958,0.0000772434,0.00040720176,0.37330928],"study_design_scores_gemma":[0.0040632496,0.000041075415,0.49827608,0.0000027277513,0.00019362169,0.000018796902,0.0000813324,0.0004838292,0.31238624,0.00033893294,0.18368436,0.00042975933],"about_ca_topic_score_codex":0.000056073477,"about_ca_topic_score_gemma":0.00022175229,"teacher_disagreement_score":0.37287953,"about_ca_system_score_codex":0.00007329454,"about_ca_system_score_gemma":0.000084178995,"threshold_uncertainty_score":0.999915},"labels":[],"label_agreement":null},{"id":"W1508284217","doi":"10.1111/j.1365-2125.2011.03905.x","title":"Impact of <i>CYP2D6</i>, <i>CYP3A5</i>, <i>CYP2C9</i> and <i>CYP2C19</i> polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Medical Research Council; Medical Research Council","keywords":"CYP2C19; Tamoxifen; CYP2D6; CYP2C9; Pharmacokinetics; Breast cancer; CYP3A5; Genotype; Pharmacogenetics; Pharmacology; Medicine; Metabolite; Internal medicine; Active metabolite; Pharmacogenomics; Oncology; Cancer; Biology; Genetics; Cytochrome P450; Gene; Metabolism","score_opus":0.12015916823421677,"score_gpt":0.4751685171169909,"score_spread":0.35500934888277413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508284217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98194957,0.004976056,0.00001334981,0.00046953995,0.0075430023,0.00067646295,0.0010174963,0.000029866234,0.0033246488],"genre_scores_gemma":[0.9584517,0.03343146,0.00023932486,0.0058658635,0.0017883555,0.00003180163,0.0000125728675,0.00009852784,0.000080427046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99145967,0.002260337,0.0038132535,0.000715874,0.0006244918,0.0011263646],"domain_scores_gemma":[0.9941143,0.0009596897,0.0024321352,0.00022662111,0.00093720265,0.0013300499],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032843708,0.0006493493,0.0020287517,0.00052502524,0.00016040262,0.000030549756,0.0010314524,0.0007798911,0.0034174249],"category_scores_gemma":[0.00025854114,0.0006530977,0.00091126596,0.00063581433,0.0010863198,0.0003625005,0.0003009338,0.0028561514,0.000026016547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010526959,0.01140152,0.55877835,0.0000859903,0.0018720981,0.0014050755,0.0007763058,0.00041185174,0.021598963,0.00003788963,0.042801622,0.3503034],"study_design_scores_gemma":[0.033220332,0.0025712482,0.9224954,0.00022213947,0.0014663896,0.0012640209,0.00003911147,0.0004454659,0.018002061,0.0004912403,0.018853862,0.0009287236],"about_ca_topic_score_codex":0.00031089003,"about_ca_topic_score_gemma":0.000035012974,"teacher_disagreement_score":0.36371708,"about_ca_system_score_codex":0.000119991055,"about_ca_system_score_gemma":0.00060374907,"threshold_uncertainty_score":0.999592},"labels":[],"label_agreement":null},{"id":"W1508488371","doi":"10.1111/cge.12392","title":"The emerging era of pharmacogenomics: current successes, future potential, and challenges","year":2014,"lang":"en","type":"review","venue":"Clinical Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Child and Family Research Institute; University of British Columbia","funders":"University of British Columbia; Child and Family Research Institute; Genome British Columbia; Michael Smith Health Research BC; C17 Council; Canadian Institutes of Health Research; Faculty of Medicine, University of British Columbia","keywords":"Pharmacogenomics; Medicine; Precision medicine; Drug; Clinical Practice; Diversity (politics); Drug response; Drug reaction; Bioinformatics; Intensive care medicine; Biology; Pharmacology; Family medicine; Political science; Pathology","score_opus":0.31150394762817457,"score_gpt":0.5519255687042839,"score_spread":0.24042162107610932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508488371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003030421,0.98211646,0.000032750304,0.0007991512,0.015227831,0.0009703226,0.0002166905,0.000042573894,0.0002912063],"genre_scores_gemma":[0.00019099531,0.99165833,0.00015669684,0.00026183037,0.0074023553,0.000084274376,0.000055516666,0.00012241707,0.00006759712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926339,0.0027021149,0.0026550272,0.0009043546,0.0003220251,0.00078257004],"domain_scores_gemma":[0.994512,0.0023425727,0.0015384245,0.0007290106,0.00025107397,0.00062687666],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0037225452,0.00079962093,0.0025137807,0.000103499166,0.00044482594,0.000056274643,0.0013313126,0.0010742011,0.00012338052],"category_scores_gemma":[0.00018110315,0.0005681157,0.0009967441,0.00021894815,0.0009150995,0.000030750325,0.0007277969,0.0036305517,0.00007196026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040620744,0.00023395345,0.000017429467,0.0068199374,0.0007802578,0.000008192686,0.000055038727,0.00001717551,0.000006626903,0.00043128507,0.0016187597,0.98997074],"study_design_scores_gemma":[0.0009504276,0.00008998304,0.000021563275,0.00058594166,0.0046094568,0.000027629087,0.000027087248,0.00040389117,0.00002962102,0.0002530659,0.9924294,0.0005719834],"about_ca_topic_score_codex":0.0000012770042,"about_ca_topic_score_gemma":0.0000040652894,"teacher_disagreement_score":0.9908106,"about_ca_system_score_codex":0.000024883782,"about_ca_system_score_gemma":0.00041795135,"threshold_uncertainty_score":0.999677},"labels":[],"label_agreement":null},{"id":"W1508732282","doi":"10.1002/9781119959601.ch1","title":"Pharmacogenomics Principles: Introduction to Personalized Medicine","year":2012,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pharmacogenomics; Personalized medicine; Drug response; Pharmacogenetics; Precision medicine; Medicine; Data science; Computational biology; Bioinformatics; Drug; Computer science; Pharmacology; Biology; Genetics; Gene; Genotype","score_opus":0.15670766884655996,"score_gpt":0.4495417510369221,"score_spread":0.29283408219036217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508732282","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002846594,0.021486169,0.0007092665,0.008109139,0.01783924,0.0015135437,0.0002865044,0.0006743191,0.94909716],"genre_scores_gemma":[0.00034020183,0.0076453504,0.0019382633,0.0111253895,0.04187497,0.00016583277,0.0002347854,0.0008206918,0.9358545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967267,0.00044234635,0.0006086477,0.0008200292,0.0003632808,0.0010390015],"domain_scores_gemma":[0.997799,0.000099086195,0.0003461303,0.0005047696,0.00009680157,0.0011542403],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011876445,0.0007441683,0.00087205047,0.0006869069,0.00016838475,0.000015715725,0.00063521194,0.0008203826,0.26713562],"category_scores_gemma":[0.00008634287,0.000648121,0.0001834845,0.0004000625,0.0003414517,0.000046042984,0.00025123797,0.0010789755,0.005974417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016595765,0.00020392523,0.00006671907,0.00009543918,0.0005707976,0.0000095495125,0.00052993296,0.000036668614,0.036256194,0.005385367,0.923434,0.03324542],"study_design_scores_gemma":[0.0022339127,0.000049461414,0.000011581082,0.000027209333,0.00093387463,0.000029287961,0.00006970269,0.000108469234,0.007980877,0.000041569776,0.98779804,0.00071601826],"about_ca_topic_score_codex":0.00007132027,"about_ca_topic_score_gemma":0.000015242154,"teacher_disagreement_score":0.2611612,"about_ca_system_score_codex":0.000115918396,"about_ca_system_score_gemma":0.00010309047,"threshold_uncertainty_score":0.999597},"labels":[],"label_agreement":null},{"id":"W1510956999","doi":"10.1023/a:1015341726183","title":"In Vitro Characterization of Hepatic Flavopiridol Metabolism Using Human Liver Microsomes and Recombinant UGT Enzymes","year":2002,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"In vitro; Microsome; Enzyme; Recombinant DNA; Biochemistry; Chemistry; Metabolism; Human liver; Liver enzyme; Pharmacology; Biology; Endocrinology; Gene","score_opus":0.41966555515645854,"score_gpt":0.5384143441943517,"score_spread":0.11874878903789321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1510956999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842278,0.012547015,0.000030210475,0.00082993007,0.000744231,0.00080977747,0.000077576005,0.000030337838,0.0007031418],"genre_scores_gemma":[0.9867439,0.011122502,0.00021161359,0.00079104054,0.00033018537,0.000066783774,0.000018402081,0.000051791398,0.0006637466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949314,0.0019676893,0.0007752372,0.0005976435,0.0005971526,0.0011308773],"domain_scores_gemma":[0.9981386,0.0006976108,0.00013893229,0.00026831173,0.0002922972,0.00046424937],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027750116,0.00032459575,0.0006145115,0.0007121379,0.00040466088,0.000053640444,0.00044067707,0.00031470886,0.0032236767],"category_scores_gemma":[0.00023543903,0.0003180852,0.000113683695,0.0008394016,0.0008583435,0.00030433584,0.00039706964,0.0016921747,0.00011090184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030298298,0.0008106571,0.0012641458,0.00022636085,0.00009036282,0.00008313707,0.0010396373,0.000009540319,0.9746698,0.0016831894,0.00026235645,0.01955781],"study_design_scores_gemma":[0.0027306173,0.00004300402,0.0020785278,0.00002880747,0.00012227437,0.000027962451,0.000030537438,0.05657361,0.85987735,0.00066914206,0.077526346,0.00029179826],"about_ca_topic_score_codex":0.000090047644,"about_ca_topic_score_gemma":0.0000037985487,"teacher_disagreement_score":0.11479245,"about_ca_system_score_codex":0.00009446059,"about_ca_system_score_gemma":0.00006000241,"threshold_uncertainty_score":0.9999271},"labels":[],"label_agreement":null},{"id":"W1514900303","doi":"10.1186/bcr936","title":"Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview","year":2004,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Metabolic pathway; Enzyme; Chemistry; Breast cancer; Glucuronosyltransferase; Aromatase; Biochemistry; Metabolism; Glucuronic acid; Hydroxylation; Estrogen; Cancer; Biology; Internal medicine; Medicine; Endocrinology; Microsome","score_opus":0.3416129515924802,"score_gpt":0.5837350972914798,"score_spread":0.2421221456989996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514900303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018248718,0.98562187,0.000009841914,0.00033956938,0.0005916286,0.0020720551,0.009248226,0.00004452256,0.00024743387],"genre_scores_gemma":[0.005017176,0.9921515,0.000027021604,0.00012579869,0.00063456903,0.0011403931,0.0005544911,0.00017055692,0.00017848086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913651,0.0038062225,0.001363115,0.0011017036,0.0009337154,0.0014301481],"domain_scores_gemma":[0.9972588,0.00043709858,0.00036480467,0.00069022656,0.00050050527,0.00074857555],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029211668,0.00080081855,0.0024028895,0.0010871962,0.00023062398,0.000055448127,0.0012839594,0.0010050671,0.0033357504],"category_scores_gemma":[0.00003400832,0.0007433051,0.000395615,0.002257719,0.0005093968,0.00029199544,0.00022882062,0.003284024,0.00011747157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021627027,0.0012709503,0.000073706906,0.010473164,0.00046532243,0.00004888953,0.00025176234,0.000055216973,0.0043969257,0.001875219,0.0006332543,0.98023933],"study_design_scores_gemma":[0.0018157753,0.00006480781,0.00017843091,0.0033066862,0.0008365614,0.00020141751,0.00003768426,0.00002631585,0.0063166884,0.00016411438,0.98640144,0.00065005384],"about_ca_topic_score_codex":0.0028363583,"about_ca_topic_score_gemma":0.00013930854,"teacher_disagreement_score":0.9857682,"about_ca_system_score_codex":0.00058401405,"about_ca_system_score_gemma":0.0030082387,"threshold_uncertainty_score":0.9995018},"labels":[],"label_agreement":null},{"id":"W1519070625","doi":"10.1016/s0076-6879(05)00033-9","title":"Pregnane X Receptor‐Mediated Transcription","year":2005,"lang":"en","type":"article","venue":"Methods in enzymology on CD-ROM/Methods in enzymology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Pregnane X receptor; Nuclear receptor; Transcription factor; Xenobiotic; Cell biology; Drug metabolism; Constitutive androstane receptor; Gastrointestinal tract; Biology; Pregnane; Receptor; Reporter gene; Transcription (linguistics); Endogeny; Chemistry; Biochemistry; Pharmacology; Gene expression; Gene; Drug; Genetics; Enzyme","score_opus":0.16979546615555738,"score_gpt":0.5290633822734421,"score_spread":0.35926791611788467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1519070625","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8814851,0.018478815,0.04400378,0.006956617,0.01941774,0.0029934717,0.00022188052,0.0006625024,0.025780069],"genre_scores_gemma":[0.18245226,0.0041212435,0.7968249,0.012170329,0.0011684322,0.00083871355,0.00012525766,0.00021139605,0.0020874725],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9591371,0.033462763,0.0024800037,0.0020471793,0.00035776154,0.0025152129],"domain_scores_gemma":[0.9876398,0.009807468,0.00064601016,0.0010719264,0.00019321551,0.00064159033],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01885686,0.0011968985,0.0022268144,0.0020041496,0.0002990515,0.00003081926,0.001511994,0.003146428,0.006099612],"category_scores_gemma":[0.003046736,0.0012524426,0.00043315164,0.0017960274,0.0013175623,0.0002580953,0.00032551656,0.005330388,0.00060265017],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013539068,0.0018572366,0.0044955625,0.000060750135,0.00019780327,0.00019513586,0.0020039934,0.0035308728,0.6717065,0.004749699,0.0020531733,0.30779538],"study_design_scores_gemma":[0.010695203,0.0009031713,0.03723884,0.00007670861,0.0002467053,0.0003785355,0.00024939424,0.003560108,0.25220814,0.011885037,0.6808888,0.0016693886],"about_ca_topic_score_codex":0.00010774448,"about_ca_topic_score_gemma":0.00044881916,"teacher_disagreement_score":0.7528211,"about_ca_system_score_codex":0.00054706197,"about_ca_system_score_gemma":0.00026576794,"threshold_uncertainty_score":0.99899256},"labels":[],"label_agreement":null},{"id":"W1520464148","doi":"10.1038/nrcardio.2015.64","title":"Genotype-based clinical trials in cardiovascular disease","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre","funders":"National Institute of General Medical Sciences","keywords":"Pharmacogenomics; Clinical trial; Medicine; Randomized controlled trial; Intensive care medicine; Adverse effect; Pharmacogenetics; Population; Drug development; Disease; Psychological intervention; Clinical study design; Drug; Pharmacology; Internal medicine; Psychiatry; Genotype","score_opus":0.5735216600164936,"score_gpt":0.6214075842620781,"score_spread":0.047885924245584466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1520464148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003392276,0.977253,0.00009099028,0.00008842013,0.012596834,0.005986087,0.0007207736,0.000087331355,0.0031731676],"genre_scores_gemma":[0.000015814632,0.9881629,0.0002395039,0.0022742865,0.0067036054,0.001402861,0.00085111184,0.00016036791,0.00018955297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9095898,0.08160779,0.005493607,0.0017324787,0.0004674941,0.0011088087],"domain_scores_gemma":[0.98934895,0.005254516,0.0017547123,0.0019405312,0.00027652964,0.0014247521],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.092688024,0.0014340903,0.023274014,0.00067912816,0.00011211771,0.000029378401,0.0014801994,0.006429088,0.0003188805],"category_scores_gemma":[0.014950497,0.0010411083,0.013181923,0.0010059262,0.00043892674,0.000056017812,0.0003320043,0.010463716,0.0013968557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012855155,0.0001239537,0.000099463796,0.0071366685,0.0029886505,0.0005175815,0.0000057312527,0.00021535599,3.3030597e-7,0.0001774977,0.033651832,0.9549544],"study_design_scores_gemma":[0.0020671953,0.000042486885,0.000018960049,0.0015384658,0.02413729,0.000062224615,0.0000010961896,0.000051628376,4.0925633e-7,0.0001942664,0.97093993,0.0009460711],"about_ca_topic_score_codex":0.0000034767909,"about_ca_topic_score_gemma":0.000001823205,"teacher_disagreement_score":0.95400834,"about_ca_system_score_codex":0.00028642258,"about_ca_system_score_gemma":0.002742977,"threshold_uncertainty_score":0.9998409},"labels":[],"label_agreement":null},{"id":"W1520559074","doi":"10.4212/cjhp.v54i1.610","title":"2001: A Pharmacogenomics Odyssey","year":2001,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacology","score_opus":0.11412947460189349,"score_gpt":0.4096154040626059,"score_spread":0.2954859294607124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1520559074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9450175,0.011748067,0.000059236045,0.016154576,0.010035726,0.00045173964,0.0000997827,0.000027302187,0.016406072],"genre_scores_gemma":[0.98404855,0.0039240853,0.00012342575,0.00790091,0.0027385778,0.000011681301,0.000006799777,0.000065090644,0.0011808818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687403,0.0004883476,0.00085966353,0.00025259465,0.00034617184,0.0011791694],"domain_scores_gemma":[0.9962296,0.00023753793,0.00055402325,0.0002778153,0.0005372735,0.0021637527],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020814538,0.0003957835,0.00045335793,0.00036674505,0.00091519405,0.00013879151,0.001477658,0.00014405733,0.005491632],"category_scores_gemma":[0.00015783728,0.00030494647,0.00037787322,0.000545948,0.0005317582,0.0003346683,0.000067474946,0.0017754177,0.00039663434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014967822,0.0011034684,0.09945259,0.00006137405,0.0031372318,0.007637822,0.009384777,0.0072280923,0.068480104,0.0031646802,0.58749944,0.21135361],"study_design_scores_gemma":[0.0034434204,0.00015277659,0.0012269136,0.000011575763,0.0005232915,0.0007867206,0.00014668048,0.0010755358,0.014916306,0.0013003921,0.97600883,0.00040754626],"about_ca_topic_score_codex":0.002408128,"about_ca_topic_score_gemma":0.0026651772,"teacher_disagreement_score":0.3885094,"about_ca_system_score_codex":0.00025876064,"about_ca_system_score_gemma":0.0020474168,"threshold_uncertainty_score":0.9999403},"labels":[],"label_agreement":null},{"id":"W1521587409","doi":"10.4212/cjhp.v54i3.658","title":"Ethics and Pharmacogenomic Research","year":2001,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Engineering ethics; Medicine; Pharmacology; Engineering","score_opus":0.31842451852268117,"score_gpt":0.5168916819269885,"score_spread":0.19846716340430737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1521587409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93372965,0.021425018,0.000013185042,0.03272528,0.0043235444,0.0003748214,0.00004809549,0.000013091169,0.007347345],"genre_scores_gemma":[0.98424226,0.008748608,0.000059712205,0.0044483333,0.0017792345,0.000009827304,0.0000028371169,0.00004497766,0.00066422566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574494,0.0019154669,0.00061021646,0.00024467547,0.0004886713,0.0009960345],"domain_scores_gemma":[0.99575144,0.0011591288,0.0002664418,0.00021249556,0.00087511743,0.0017353736],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009164402,0.00026519355,0.00032751597,0.00046910538,0.0020447467,0.00016229619,0.0010170273,0.00019119478,0.0013820054],"category_scores_gemma":[0.0005408247,0.00020189532,0.00015769717,0.00054297614,0.0012254778,0.00025361616,0.00010154136,0.005786283,0.00014836526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020240375,0.001013876,0.16190954,0.00018200744,0.0030766714,0.008411418,0.06740036,0.0016437884,0.14116926,0.015354074,0.2151873,0.38262767],"study_design_scores_gemma":[0.0026044867,0.00017708603,0.0019752833,0.000014428572,0.00023924184,0.00066595466,0.00046546894,0.00046490182,0.013743307,0.0036862548,0.97568536,0.00027823393],"about_ca_topic_score_codex":0.0031344718,"about_ca_topic_score_gemma":0.0019278728,"teacher_disagreement_score":0.76049805,"about_ca_system_score_codex":0.00018091529,"about_ca_system_score_gemma":0.0022431235,"threshold_uncertainty_score":0.99953085},"labels":[],"label_agreement":null},{"id":"W1522657433","doi":"10.1111/bph.12284","title":"Indirect activation of the <scp>SV23</scp> and <scp>SV24</scp> splice variants of human constitutive androstane receptor: analysis with 3‐hydroxyflavone and its analogues","year":2013,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Galangin; Transactivation; Chemistry; Isorhamnetin; Proto-oncogene tyrosine-protein kinase Src; Pharmacology; Receptor; Biochemistry; Quercetin; Biology; Kaempferol; Transcription factor","score_opus":0.03708963950374107,"score_gpt":0.3400379426722101,"score_spread":0.30294830316846905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522657433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98608893,0.010980331,0.000058052756,0.00016935314,0.0006317943,0.0006530904,0.00023154996,0.000014917045,0.0011719733],"genre_scores_gemma":[0.98918974,0.009381714,0.00017897412,0.000689933,0.0002623213,0.000025628733,0.000017274859,0.000030249434,0.00022417745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964548,0.0011738525,0.0010710632,0.00038964694,0.00037533246,0.0005353408],"domain_scores_gemma":[0.99555403,0.0012652857,0.0017356168,0.0001209574,0.0009530483,0.00037103964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012755552,0.0003450323,0.0011128158,0.00050308957,0.0003873156,0.000038295653,0.0004794516,0.00034683538,0.00027757912],"category_scores_gemma":[0.0003129172,0.0003044284,0.0002099288,0.0009863911,0.0010437815,0.00040387176,0.00019971376,0.0011197852,0.000004644637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006213883,0.0005845919,0.020896168,0.00012508647,0.004315543,0.00007260481,0.0015079305,0.0004234784,0.9597635,0.00013792224,0.0081229,0.0039880835],"study_design_scores_gemma":[0.006411666,0.00046579153,0.11043047,0.00011850281,0.0047910656,0.001066413,0.00086119183,0.0010464856,0.8661673,0.00030832866,0.008202477,0.0001302808],"about_ca_topic_score_codex":0.00013751845,"about_ca_topic_score_gemma":0.00003889162,"teacher_disagreement_score":0.09359623,"about_ca_system_score_codex":0.000046815872,"about_ca_system_score_gemma":0.00022235363,"threshold_uncertainty_score":0.99994075},"labels":[],"label_agreement":null},{"id":"W1522709944","doi":"10.1046/j.1432-1033.2003.03508.x","title":"Assessment of porcine and human 16‐ene‐synthase, a third activity of P450c17, in the formation of an androstenol precursor","year":2003,"lang":"en","type":"article","venue":"European Journal of Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Constitutive androstane receptor; Pregnenolone; Cytochrome P450; Lyase; Enzyme; Reductase; Dehydrogenase; Biochemistry; Steroid; CYP17A1; Chemistry; ATP synthase; Biology; Stereochemistry; Nuclear receptor; Gene","score_opus":0.06675817575336082,"score_gpt":0.4065634164008719,"score_spread":0.33980524064751105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522709944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499084,0.0008656802,0.00011781375,0.00006188772,0.00009782354,0.000111075344,0.00004241736,0.0000019995912,0.013710495],"genre_scores_gemma":[0.9992034,0.00026751298,0.00034667674,0.00007082961,0.00006457761,9.338963e-7,0.000004345944,0.000010432065,0.000031312593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979224,0.0010086915,0.0006263739,0.00010296867,0.00019892889,0.00014058767],"domain_scores_gemma":[0.99858296,0.000103878185,0.00090421014,0.00015759903,0.00015494722,0.00009642059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002747519,0.00012730752,0.00030122575,0.00008227083,0.00004622021,0.000006654425,0.0002536962,0.000059084035,0.000045619498],"category_scores_gemma":[0.000073090276,0.000096982774,0.00008108316,0.00013098674,0.00016173255,0.00009752307,0.000034801174,0.00043431128,1.8074256e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013666607,0.00064604986,0.0030821664,0.00017786848,0.000057026606,0.000028015651,0.00052573794,0.00007599295,0.9913862,0.00009031602,0.0001668003,0.0036272104],"study_design_scores_gemma":[0.0022830425,0.00030409597,0.017789308,0.000055500597,0.0001433755,0.00013954031,0.0002790681,0.00011051615,0.9773201,0.00007449165,0.0014136309,0.00008735186],"about_ca_topic_score_codex":0.0000022200722,"about_ca_topic_score_gemma":8.8840176e-7,"teacher_disagreement_score":0.014707141,"about_ca_system_score_codex":0.00001658996,"about_ca_system_score_gemma":0.000072199175,"threshold_uncertainty_score":0.39548427},"labels":[],"label_agreement":null},{"id":"W1523241089","doi":"10.1002/9780470929353.ch16","title":"Discovery and Development of BILN 2061 and Follow‐Up BI 201335","year":2011,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Clinical trial; Cardiotoxicity; In vivo; Potency; Drug discovery; Computational biology; Medicine; In vitro; Biology; Bioinformatics; Internal medicine; Genetics; Chemotherapy","score_opus":0.13599458584910953,"score_gpt":0.4034073842049368,"score_spread":0.2674127983558273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1523241089","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035158053,0.05256502,0.00040911476,0.0000877528,0.0042870548,0.00095987075,0.00037769848,0.00014686194,0.9060086],"genre_scores_gemma":[0.016054245,0.021185096,0.0039278753,0.0008328409,0.00036419905,0.0000539886,0.000052138814,0.00031008825,0.95721954],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985194,0.00013869464,0.0004051213,0.00043910585,0.00013517046,0.00036250768],"domain_scores_gemma":[0.9991898,0.00007955839,0.00025643178,0.00019631127,0.000034165376,0.00024376645],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035027327,0.00039970703,0.0005654874,0.0002875051,0.00008361733,0.000017247274,0.0002105175,0.0005803286,0.007982083],"category_scores_gemma":[0.0000128022075,0.0003305123,0.000059456688,0.000085190215,0.0002924127,0.00005277859,0.00027652507,0.00039783597,0.00010873742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025251615,0.0003724364,0.0046158577,0.0005603673,0.0015791897,0.000019560348,0.0016012477,5.3871565e-7,0.019507203,0.0019510017,0.83207613,0.13746397],"study_design_scores_gemma":[0.0017986189,0.000025124245,0.00067794777,0.000035222973,0.00025595428,0.000007463147,0.000045519977,0.00001406923,0.027301012,0.00013268487,0.9693002,0.00040619148],"about_ca_topic_score_codex":0.00009142354,"about_ca_topic_score_gemma":0.000116170006,"teacher_disagreement_score":0.1372241,"about_ca_system_score_codex":0.000009398915,"about_ca_system_score_gemma":0.00016061313,"threshold_uncertainty_score":0.9999147},"labels":[],"label_agreement":null},{"id":"W1528478735","doi":"10.1139/jpn.0312","title":"Interactions between the cytochrome P450 system and the second-generation antipsychotics","year":2003,"lang":"en","type":"article","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Olanzapine; Quetiapine; Ziprasidone; CYP1A2; CYP2D6; Pharmacology; Risperidone; Cytochrome P450; CYP3A4; Clozapine; Sertindole; CYP2C19; Atypical antipsychotic; Medicine; Drug; Antipsychotic; Metabolism; Psychiatry; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.09750897274758721,"score_gpt":0.4072555498554237,"score_spread":0.3097465771078365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1528478735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838212,0.0032007662,0.0008349106,0.004431866,0.006312646,0.00017665526,0.000015842676,0.000006904423,0.0011991946],"genre_scores_gemma":[0.9951965,0.0009596198,0.00016502831,0.0027486482,0.0007359862,0.00000292214,1.783134e-7,0.0000067133133,0.00018438455],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824697,0.000869436,0.0003956476,0.00014947349,0.00015589959,0.00018257461],"domain_scores_gemma":[0.99899584,0.00032769432,0.00034085938,0.00011575201,0.00007186221,0.00014797003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021559962,0.00011951555,0.00018907228,0.00006771292,0.0006989366,0.00008298889,0.00023510205,0.00005551123,0.000038649185],"category_scores_gemma":[0.000084726555,0.00006488112,0.0000719849,0.00020389396,0.00046917985,0.00016153752,0.000029266977,0.00066151965,0.0000020303873],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007635586,0.00040866566,0.04661972,0.0001726259,0.00021599296,0.00003107856,0.0018600695,0.00078215916,0.7933203,0.13588883,0.012053085,0.007883903],"study_design_scores_gemma":[0.009059115,0.00042475844,0.16013092,0.000064354615,0.0010209158,0.0048520095,0.0009914043,0.009251933,0.034179162,0.0053692525,0.7741509,0.00050528784],"about_ca_topic_score_codex":4.62248e-7,"about_ca_topic_score_gemma":0.0000043145747,"teacher_disagreement_score":0.7620978,"about_ca_system_score_codex":0.0000073640404,"about_ca_system_score_gemma":0.00008334576,"threshold_uncertainty_score":0.53757256},"labels":[],"label_agreement":null},{"id":"W1533588120","doi":"10.1111/j.1742-7843.2011.00807.x","title":"Distribution of <i>CYP2C</i> Polymorphisms in an Amerindian Population of Brazil","year":2011,"lang":"en","type":"article","venue":"Basic & Clinical Pharmacology & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; CYP2C19; CYP2C9; SLCO1B1; CYP2C8; International HapMap Project; Pharmacogenetics; Genetics; Population; Haplotype; Allele; Gene; Demography; Genotype","score_opus":0.1955070297897911,"score_gpt":0.49072393867907893,"score_spread":0.29521690888928787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533588120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932433,0.000746422,0.000097914,0.00039482236,0.006230761,0.0008786206,0.00032807447,0.00007569514,0.0019233582],"genre_scores_gemma":[0.9932794,0.00088982965,0.00033815796,0.004413824,0.0006262533,0.000106300926,0.00022909818,0.000053460113,0.000063697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920621,0.0032133083,0.002635689,0.00086916145,0.0002476977,0.000972048],"domain_scores_gemma":[0.9964426,0.0010328243,0.0011919979,0.00045661454,0.00025922566,0.00061673636],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030115978,0.00047412683,0.0014368744,0.00037935335,0.00012296518,0.0000043093914,0.00088695314,0.0012280082,0.004245343],"category_scores_gemma":[0.00023193963,0.0004994143,0.00039407314,0.0006919599,0.0014721224,0.00025435348,0.00026490728,0.0015596107,0.000072775896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035107925,0.0070963716,0.72029626,0.00006317774,0.0003719052,0.00012110508,0.00067025993,0.00023618886,0.22066715,0.002234436,0.0021553254,0.04257701],"study_design_scores_gemma":[0.007334604,0.001539928,0.8529247,0.00001409191,0.0006062559,0.000027562628,0.000054366446,0.0010338147,0.122565165,0.002015585,0.011396966,0.0004869745],"about_ca_topic_score_codex":0.0002646619,"about_ca_topic_score_gemma":0.0001691043,"teacher_disagreement_score":0.13262841,"about_ca_system_score_codex":0.000086616405,"about_ca_system_score_gemma":0.00027598368,"threshold_uncertainty_score":0.9997457},"labels":[],"label_agreement":null},{"id":"W153956865","doi":"10.1007/978-1-4615-0667-6_34","title":"Hydrogen Peroxide Supports Hepatocyte P450 Catalysed Xenobiotic/Drug Metabolic Activation to form Cytotoxic Reactive Intermediates","year":2001,"lang":"en","type":"article","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hydrogen peroxide; Reactive intermediate; Chemistry; Xenobiotic; Drug metabolism; Drug; Cytotoxic T cell; Biochemistry; Combinatorial chemistry; Catalysis; Metabolism; Enzyme; Pharmacology; In vitro; Biology","score_opus":0.07447922132691032,"score_gpt":0.4584507806443641,"score_spread":0.3839715593174538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W153956865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693362,0.025726786,0.000039063114,0.0010912673,0.0009002144,0.00067078264,0.000022963522,0.00004801785,0.0021647103],"genre_scores_gemma":[0.9823117,0.011774038,0.00012999495,0.004797854,0.0005404333,0.0001882877,0.00011333722,0.000025908032,0.000118400574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979333,0.00025093168,0.00053126365,0.00057139166,0.00010804973,0.0006050297],"domain_scores_gemma":[0.99894166,0.00029407957,0.00016962505,0.00018538864,0.00004810659,0.00036112394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046350725,0.00036043077,0.0005969788,0.00033955192,0.00014507693,0.000006502572,0.00024409084,0.00019392517,0.00042563854],"category_scores_gemma":[0.000102877195,0.00028653577,0.000060557086,0.000347432,0.00044919088,0.00028263216,0.0001694506,0.00041500342,0.000028536624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067958183,0.0002527618,0.018934172,0.000011168058,0.00007143456,0.000037114572,0.004461848,0.000016226753,0.94718635,0.00039790338,0.00013504115,0.027816424],"study_design_scores_gemma":[0.0024282562,0.00031273195,0.0018501843,0.000026922788,0.000058558042,0.00006045372,0.0014887074,0.00012867867,0.78875476,0.00076296355,0.20384878,0.00027900105],"about_ca_topic_score_codex":0.00017922255,"about_ca_topic_score_gemma":0.00008171162,"teacher_disagreement_score":0.20371373,"about_ca_system_score_codex":0.00007684581,"about_ca_system_score_gemma":0.000037080325,"threshold_uncertainty_score":0.9999587},"labels":[],"label_agreement":null},{"id":"W1546874842","doi":"10.1111/jphp.12053","title":"Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmacy and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"U.S. National Library of Medicine; Norges Idrettshøgskole; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Glucuronidation; CpG site; DNA methylation; Methylation; Epigenetics; Biology; Genotype; Bilirubin; Molecular biology; Biochemistry; DNA; Gene expression; Endocrinology; Enzyme; Gene","score_opus":0.17176134005573554,"score_gpt":0.4711815161530852,"score_spread":0.2994201760973496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546874842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879266,0.00610417,0.0015013494,0.0017628765,0.00091375335,0.0016905795,0.00002884704,0.000014031138,0.000057773104],"genre_scores_gemma":[0.994209,0.003701868,0.00068572024,0.0007297186,0.00047874628,0.00012427133,0.000004912663,0.000028669074,0.00003710531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966956,0.0012304533,0.0010245189,0.00035525713,0.00022518836,0.00046900567],"domain_scores_gemma":[0.9972896,0.0009612004,0.00084584294,0.000097933735,0.00037636308,0.00042907547],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020605486,0.000316416,0.0006572899,0.00046595148,0.00024088025,0.000021057707,0.0002467444,0.00022080376,0.0010830561],"category_scores_gemma":[0.00008269548,0.00029726757,0.00014454125,0.00023976686,0.00028448302,0.0008299362,0.00007698672,0.0008583636,0.000003003604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004945623,0.0004884913,0.0032859563,0.00041023866,0.00012519502,0.000009121303,0.00090538745,0.00046872458,0.9332643,0.00005497728,0.00054243644,0.055499516],"study_design_scores_gemma":[0.012678084,0.000750371,0.009128973,0.00008596122,0.00038719512,0.000043578508,0.00004207083,0.011626917,0.95717263,0.0013556676,0.006452143,0.00027638144],"about_ca_topic_score_codex":0.00007626012,"about_ca_topic_score_gemma":0.000007377999,"teacher_disagreement_score":0.055223133,"about_ca_system_score_codex":0.00007289614,"about_ca_system_score_gemma":0.0001570864,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W1550316448","doi":"10.4212/cjhp.v56i4.516","title":"Pharmacogenetics of Psychotropic Drugs","year":2003,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Medicine; Pharmacology; Biology; Genetics; Genotype","score_opus":0.07234523791836048,"score_gpt":0.4016761146159177,"score_spread":0.32933087669755723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550316448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561152,0.016371245,0.00005743296,0.0025603327,0.00864248,0.0003781593,0.000090862035,0.000010490038,0.015773797],"genre_scores_gemma":[0.99484116,0.0017519402,0.00025742696,0.002096986,0.0006209933,0.00000721309,0.0000024543626,0.000048306287,0.0003735484],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969882,0.0007263063,0.0009592926,0.00020389266,0.00038230114,0.00074005686],"domain_scores_gemma":[0.99691665,0.00023341987,0.0007185678,0.00027807578,0.0006085379,0.0012447529],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016519448,0.00032932934,0.0004728548,0.000324753,0.00043293886,0.000046275196,0.0010209653,0.00012479468,0.0028313703],"category_scores_gemma":[0.00016830115,0.0002539619,0.000364518,0.00048424234,0.00062906026,0.00015932566,0.000026402187,0.0012183844,0.00007388076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014306351,0.00293504,0.24844511,0.00040214998,0.0074508665,0.0015210585,0.0358594,0.011794625,0.1773976,0.04911187,0.24575143,0.21790023],"study_design_scores_gemma":[0.004097379,0.00021225506,0.0015137538,0.000017743734,0.00061958306,0.00013440018,0.00024334455,0.00016123755,0.1522807,0.0029924612,0.83738625,0.00034088225],"about_ca_topic_score_codex":0.00058094563,"about_ca_topic_score_gemma":0.0003171316,"teacher_disagreement_score":0.5916348,"about_ca_system_score_codex":0.00010382274,"about_ca_system_score_gemma":0.0017363174,"threshold_uncertainty_score":0.99999124},"labels":[],"label_agreement":null},{"id":"W1557320473","doi":"10.1007/978-3-642-27841-9_4501-2","title":"Pharmacokinetics and Pharmacodynamics in Drug Development","year":2015,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Pharmacology; Drug; Drug development; Medicine","score_opus":0.1605324733345047,"score_gpt":0.42770011563535176,"score_spread":0.26716764230084705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1557320473","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01086958,0.025670094,0.000038853308,0.00045106836,0.002864119,0.001056435,0.00019426085,0.00018452395,0.9586711],"genre_scores_gemma":[0.04089838,0.020381002,0.0014529561,0.0038012853,0.0009126235,0.00008442834,0.00024997682,0.00028074527,0.9319386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964786,0.00016425685,0.0011038368,0.00091422186,0.0005107027,0.00082836696],"domain_scores_gemma":[0.9979789,0.00022236902,0.0003397101,0.00029445725,0.00024654227,0.0009179832],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015111703,0.000961763,0.00093852996,0.0005891209,0.0001535886,0.000042975156,0.00054749777,0.00081381376,0.00534528],"category_scores_gemma":[0.000022810562,0.0009852228,0.00012690414,0.000097579104,0.0003333943,0.00010149022,0.0005467184,0.0024286946,0.00057950785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010280355,0.0007481789,0.0007356208,0.00064131577,0.0016657154,0.0012554895,0.0037503014,0.0015545585,0.009098817,0.11669392,0.18877813,0.6740499],"study_design_scores_gemma":[0.003741324,0.000020258543,0.000036689733,0.00004838971,0.0003746839,0.00004803842,0.000024167977,0.0030123466,0.003626001,0.005649791,0.9823164,0.0011019622],"about_ca_topic_score_codex":0.00001558103,"about_ca_topic_score_gemma":0.00009042297,"teacher_disagreement_score":0.7935382,"about_ca_system_score_codex":0.00025757533,"about_ca_system_score_gemma":0.0005355219,"threshold_uncertainty_score":0.99987274},"labels":[],"label_agreement":null},{"id":"W1558516295","doi":"10.1023/a:1022531403741","title":"Reassessing Models of Hepatic Extraction","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Physics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Mitacs; Alberta Heritage Foundation for Medical Research","keywords":"IVIVC; Context (archaeology); Dispersion (optics); In vivo; Computer science; Biological system; Chemistry; Pharmacokinetics; Bioinformatics; Physics; Biology; Biopharmaceutics Classification System","score_opus":0.2862650852246321,"score_gpt":0.47788207886282735,"score_spread":0.19161699363819523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558516295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97653204,0.00201055,0.013546871,0.00006606253,0.0011265038,0.000083986255,0.00000945428,0.000008950984,0.0066155638],"genre_scores_gemma":[0.9946634,0.0019315096,0.0026726848,0.00034963884,0.00034201215,0.0000015118865,0.0000014716035,0.000008827169,0.000028907638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837303,0.00056930346,0.0005715539,0.00011156868,0.00015925926,0.00021530851],"domain_scores_gemma":[0.99851084,0.0003341392,0.0006554987,0.00008806173,0.00025294066,0.00015853228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009759062,0.00013756086,0.0003760123,0.000049429542,0.00007559738,0.000008311524,0.00016828133,0.00018992338,0.00016406238],"category_scores_gemma":[0.00013941723,0.00009860226,0.00021193596,0.0001704526,0.00013670015,0.0001571243,0.000021720225,0.0005927747,0.00000646755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027591788,0.0010990088,0.00436419,0.000030390627,0.00021981225,0.000034872217,0.00020082034,0.012282361,0.89915746,0.01962943,0.0005177591,0.06218797],"study_design_scores_gemma":[0.002622415,0.00052024535,0.0024138188,0.000040775667,0.00040214887,0.00017944262,0.00015267893,0.010641863,0.71713626,0.2261275,0.039407942,0.00035492328],"about_ca_topic_score_codex":0.0000012616225,"about_ca_topic_score_gemma":8.572717e-8,"teacher_disagreement_score":0.20649807,"about_ca_system_score_codex":0.00002535098,"about_ca_system_score_gemma":0.000088094384,"threshold_uncertainty_score":0.40208834},"labels":[],"label_agreement":null},{"id":"W156857027","doi":"10.1385/0-89603-519-0:141","title":"CYP2D6-Dependent Bufuralol 1 '-Hydroxylation Assayed by Reversed-Phase Ion-Pair High-Performance Liquid Chromatography with Fluorescence Detection","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Chromatography; Hydroxylation; Fluorescence; Chemistry; High-performance liquid chromatography; Phase (matter); Ion; Biochemistry; Organic chemistry; Enzyme; Physics; Optics","score_opus":0.06249636428874318,"score_gpt":0.3546729366023792,"score_spread":0.29217657231363603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W156857027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837657,0.0028561659,0.0009751837,0.000026678781,0.0012483407,0.0009868719,0.00009128878,0.0002760295,0.009773748],"genre_scores_gemma":[0.9966895,0.00082304317,0.00019976425,0.0004975602,0.00022207545,0.000253483,0.000043086297,0.00006841879,0.0012030808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971178,0.00062686857,0.0005104245,0.0006242619,0.00043417906,0.00068643305],"domain_scores_gemma":[0.99865186,0.000099851415,0.00031934143,0.0004196052,0.00016622497,0.0003431439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006960719,0.0004572353,0.00038120055,0.00019257427,0.000621792,0.000054643766,0.0003490528,0.00033117837,0.00024189829],"category_scores_gemma":[0.000022080232,0.000427424,0.00010483271,0.00010940912,0.00030934523,0.00020905757,0.00006212257,0.0007800101,0.000041630312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002007807,0.00064388243,0.0001257223,0.00014732072,0.00048664803,0.000050776696,0.0008391342,0.0013279143,0.94396085,0.0020283621,0.002079933,0.046301637],"study_design_scores_gemma":[0.0048699873,0.0005121108,0.00008657649,0.00002609661,0.0003101486,0.000029879855,0.000032802873,0.0024329282,0.83719575,0.00008906695,0.15391952,0.00049511605],"about_ca_topic_score_codex":0.00009113828,"about_ca_topic_score_gemma":0.000020763013,"teacher_disagreement_score":0.15183958,"about_ca_system_score_codex":0.00006573745,"about_ca_system_score_gemma":0.0000611042,"threshold_uncertainty_score":0.9998177},"labels":[],"label_agreement":null},{"id":"W1578691566","doi":"10.1002/9780470285251.ch9","title":"Structure, Mechanism, and Regulation of Cytochromes P450","year":2007,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytochrome P450; Mechanism (biology); SUPERFAMILY; Cytochrome P450 reductase; Cytochrome; Reading (process); Chemistry; Biology; Gene; Biochemistry; Cytochrome b; Enzyme; Political science; Philosophy","score_opus":0.0694987296364962,"score_gpt":0.42152029678911856,"score_spread":0.35202156715262234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578691566","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008190473,0.008370027,0.00089468824,0.000061670915,0.001734927,0.0007213588,0.00053632667,0.00018437352,0.97930616],"genre_scores_gemma":[0.14997995,0.004008085,0.003463825,0.00123318,0.0010534617,0.000010771926,0.00012497687,0.00042880615,0.83969694],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873614,0.00012887933,0.00032979998,0.00032540807,0.00018397509,0.00029581456],"domain_scores_gemma":[0.9991817,0.000085176864,0.0002976863,0.00020170426,0.00004954927,0.00018417567],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029708678,0.00030992838,0.00045305,0.0005034579,0.000046206467,0.0000072477706,0.00017743366,0.00084811583,0.035112966],"category_scores_gemma":[0.000013683039,0.0002778625,0.00007232686,0.00017070083,0.00017467383,0.000020683707,0.0000950541,0.00041578733,0.000039488677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014633643,0.00014651737,0.00018433343,0.0004108646,0.0007885791,0.0000150569085,0.00016477944,0.000019302955,0.45381752,0.13838436,0.35945022,0.046472147],"study_design_scores_gemma":[0.00097207556,0.000029080904,0.0003206217,0.00002040279,0.00029277947,0.0000131029465,0.000010738048,0.00025389684,0.17292985,0.006205585,0.8186678,0.0002840124],"about_ca_topic_score_codex":0.00003928809,"about_ca_topic_score_gemma":0.000032274955,"teacher_disagreement_score":0.45921764,"about_ca_system_score_codex":0.000010557676,"about_ca_system_score_gemma":0.000053237705,"threshold_uncertainty_score":0.99996734},"labels":[],"label_agreement":null},{"id":"W1581862317","doi":"10.4212/cjhp.v58i1.285","title":"Warfarin Dosing after Initiation of Fenofibrate","year":2005,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital","funders":"","keywords":"Fenofibrate; Warfarin; Medicine; Dosing; Therapeutic index; Oral anticoagulant; Anticoagulant; Anticoagulant therapy; Drug; Intensive care medicine; Internal medicine; Pharmacology; Atrial fibrillation","score_opus":0.07397626367806759,"score_gpt":0.3879808281621054,"score_spread":0.3140045644840378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1581862317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97856414,0.007284789,0.000025681742,0.007571164,0.0025228602,0.00021054098,0.00007103642,0.000007638291,0.0037421368],"genre_scores_gemma":[0.99486744,0.0004598523,0.0002606162,0.0029175477,0.0013052722,0.000006064956,0.000003276224,0.00002856874,0.00015138394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817526,0.0003198973,0.00068017276,0.00012837723,0.00022594046,0.00047035233],"domain_scores_gemma":[0.9981824,0.00013192848,0.00049975724,0.000149895,0.00035783474,0.000678193],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011124284,0.0002049803,0.0002921715,0.0002512971,0.0002763473,0.000049871,0.00052787835,0.00009216105,0.0019488216],"category_scores_gemma":[0.000069272806,0.00015879607,0.00019981981,0.0002540322,0.00030808614,0.00034863426,0.000036274727,0.0007947097,0.00007165252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003043139,0.0014787855,0.15443128,0.00024679577,0.0031557756,0.0014336575,0.04191785,0.021537421,0.20566066,0.0058723544,0.059214775,0.5020075],"study_design_scores_gemma":[0.004243505,0.00021840943,0.013703903,0.000042251526,0.0006509543,0.00014869806,0.0001510033,0.0017510899,0.2778542,0.0013802759,0.69942385,0.0004318439],"about_ca_topic_score_codex":0.0007125753,"about_ca_topic_score_gemma":0.0014643191,"teacher_disagreement_score":0.6402091,"about_ca_system_score_codex":0.00012260363,"about_ca_system_score_gemma":0.00090914423,"threshold_uncertainty_score":0.99896353},"labels":[],"label_agreement":null},{"id":"W1589835327","doi":"10.1002/bdd.1847","title":"Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity","year":2013,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nebivolol; Bioavailability; Stereoselectivity; Pharmacokinetics; Chemistry; Pharmacology; First pass effect; Atenolol; Enantiomer; Oral administration; Internal medicine; Biochemistry; Medicine; Stereochemistry","score_opus":0.04616879704448408,"score_gpt":0.3783021071795566,"score_spread":0.3321333101350725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589835327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886067,0.0049887663,0.00006319728,0.002401048,0.0009075733,0.0021415967,0.000086550106,0.000033724158,0.0005169001],"genre_scores_gemma":[0.9907624,0.0042241765,0.000048656326,0.004188588,0.0002709419,0.0003612212,0.000043517295,0.000034381406,0.000066083434],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9950736,0.002423834,0.0008666343,0.00047598354,0.00045900032,0.00070095214],"domain_scores_gemma":[0.99828607,0.0006726039,0.00033024105,0.00035829764,0.00018802598,0.00016475646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026681856,0.00043244063,0.0004602855,0.0003035696,0.00022818675,0.0000919109,0.00076128234,0.0002505381,0.00023336303],"category_scores_gemma":[0.000040496205,0.00030686866,0.0001273162,0.00088859117,0.0004290695,0.0002926059,0.00012377164,0.0012390801,0.00006105758],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007072928,0.002438608,0.07298713,0.0006705124,0.00017695953,0.000117516356,0.014178386,0.0017438027,0.8667507,0.001611154,0.00428226,0.03433565],"study_design_scores_gemma":[0.02582184,0.00038219112,0.42969385,0.0004296046,0.002009749,0.0009773393,0.0060634175,0.11694459,0.36040512,0.0043339618,0.050428927,0.0025094263],"about_ca_topic_score_codex":0.00016741542,"about_ca_topic_score_gemma":0.000048315316,"teacher_disagreement_score":0.5063456,"about_ca_system_score_codex":0.00007787241,"about_ca_system_score_gemma":0.00007784384,"threshold_uncertainty_score":0.99993837},"labels":[],"label_agreement":null},{"id":"W1589912390","doi":"10.1016/s0076-6879(02)57666-7","title":"Genotyping human CYP2A6 variants","year":2002,"lang":"en","type":"article","venue":"Methods in enzymology on CD-ROM/Methods in enzymology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"CYP2A6; Cotinine; Genotyping; Nicotine; Biology; Allele; Genotype; Genetics; Phenotype; Genetic variability; Cytochrome P450; Enzyme; Gene; Biochemistry; CYP3A4","score_opus":0.27073021257073043,"score_gpt":0.5537021702957196,"score_spread":0.2829719577249891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589912390","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8260692,0.016098892,0.043806113,0.0026808616,0.020188566,0.0025787924,0.00012444796,0.0006028886,0.08785025],"genre_scores_gemma":[0.31632066,0.0018991159,0.6649434,0.0122121,0.0010599828,0.0005898001,0.00003456735,0.00024702403,0.0026933122],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9573814,0.03445538,0.002573431,0.0023022438,0.00034979472,0.0029377067],"domain_scores_gemma":[0.9878104,0.009165307,0.00076225866,0.0014142247,0.00018073019,0.0006670914],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.01893708,0.0012880373,0.0025029634,0.0022666908,0.0005790306,0.000044338256,0.0019792188,0.0029844493,0.010088666],"category_scores_gemma":[0.0030578582,0.001380652,0.00044617592,0.0018709847,0.0014535085,0.00020180349,0.00076592574,0.0058494527,0.00050862494],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005287517,0.0026099482,0.011506203,0.00009380329,0.00037639638,0.0014861628,0.002876601,0.002559679,0.66261935,0.027551686,0.0027051966,0.28508624],"study_design_scores_gemma":[0.020685868,0.0019252789,0.230246,0.0001417904,0.00073760696,0.0018443675,0.0004875379,0.011997614,0.15013526,0.13568507,0.44169015,0.0044234535],"about_ca_topic_score_codex":0.0001971085,"about_ca_topic_score_gemma":0.0002996749,"teacher_disagreement_score":0.6211373,"about_ca_system_score_codex":0.0004317093,"about_ca_system_score_gemma":0.00011630217,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W1593851516","doi":"","title":"Abstract 11847: Genotype-Guided Vitamin K Antagonist Dosing Algorithms Improve Time in Therapeutic Range: A Systematic Review and Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Circulation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dosing; Medicine; Vitamin K antagonist; VKORC1; Meta-analysis; Genotype; Internal medicine; Algorithm; Randomized controlled trial; Warfarin; Gastroenterology; CYP2C9; Atrial fibrillation; Biology; Genetics","score_opus":0.18892035522802744,"score_gpt":0.4617229990521668,"score_spread":0.2728026438241393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593851516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023950142,0.99455553,0.00027909115,0.00009160973,0.00026397363,0.0041965544,0.00022904904,0.000055871413,0.00030437717],"genre_scores_gemma":[0.0037123817,0.9936532,0.00006702224,0.0011495824,0.0001484027,0.00068343483,0.00031129352,0.00008836134,0.0001863481],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99403286,0.0021921468,0.0020840866,0.00085451995,0.00031641588,0.00051996484],"domain_scores_gemma":[0.996837,0.00072072813,0.0014351825,0.00062721735,0.00014721385,0.00023261338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038332914,0.0008053194,0.0074039013,0.0006245831,0.00019357777,0.00009323207,0.00040806725,0.0007077603,0.00084353785],"category_scores_gemma":[0.000114602684,0.000631676,0.0019100212,0.0010849083,0.00011054604,0.0001123475,0.000087054534,0.0009539216,0.0002608608],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000082086435,0.00019684604,0.000022248041,0.814807,0.1259478,0.00003377846,0.0001258451,0.00017934667,0.00023000824,0.00012342742,0.00007489302,0.05825058],"study_design_scores_gemma":[0.0005183483,0.00000789845,0.00008082298,0.003298119,0.9339706,0.00003946017,0.0000027998133,0.0029319008,0.000007978989,0.00008406651,0.05829731,0.00076074887],"about_ca_topic_score_codex":0.000024770627,"about_ca_topic_score_gemma":0.0000053082863,"teacher_disagreement_score":0.8115089,"about_ca_system_score_codex":0.00018457732,"about_ca_system_score_gemma":0.0001519199,"threshold_uncertainty_score":0.99961346},"labels":[],"label_agreement":null},{"id":"W1594081613","doi":"10.1002/9780470686263.ch4","title":"Physiologically Based Modeling of Pharmacokinetic Interactions in Chemical Mixtures","year":2010,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Chemistry; Computer science; Computational biology; Biochemical engineering; Data science; Pharmacology; Biology; Engineering","score_opus":0.11394734142969953,"score_gpt":0.4488184450313272,"score_spread":0.33487110360162764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594081613","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02698619,0.0027172759,0.00083569647,0.00031910703,0.0034533946,0.0008669848,0.00030113335,0.00025997154,0.9642602],"genre_scores_gemma":[0.90787745,0.0012479589,0.004252006,0.0031247893,0.0013494798,0.0001612511,0.00017674663,0.00044765204,0.08136266],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800485,0.0002646903,0.0005812086,0.00050003646,0.00018504552,0.0004641652],"domain_scores_gemma":[0.99895805,0.00020494605,0.00025978527,0.00028571626,0.00006803123,0.00022344713],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028877115,0.00044561405,0.0006810078,0.00047464707,0.000029551229,0.000007955176,0.0005348111,0.0007192799,0.04041776],"category_scores_gemma":[0.00006139067,0.0003882497,0.00023124601,0.00024850018,0.00019383893,0.00002286881,0.00012532744,0.0021739376,0.00010590355],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020465543,0.00087133836,0.000087851404,0.00014140522,0.00016256879,0.000019588735,0.000042068998,0.005842958,0.913837,0.00017313562,0.06542453,0.013192906],"study_design_scores_gemma":[0.0021874069,0.00001754694,0.0000114222985,0.000059946466,0.00022866779,0.0000039737665,0.000007157134,0.21511184,0.1451561,0.00026706533,0.6364814,0.00046748534],"about_ca_topic_score_codex":0.00014176614,"about_ca_topic_score_gemma":0.00007691115,"teacher_disagreement_score":0.8828976,"about_ca_system_score_codex":0.000020748224,"about_ca_system_score_gemma":0.000113130576,"threshold_uncertainty_score":0.99985695},"labels":[],"label_agreement":null},{"id":"W1594588311","doi":"","title":"Lack of association of CYP11B2-344C/T polymorphism with essential hypertension: a meta-analysis.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Polymorphism (computer science); Essential hypertension; Internal medicine; Aldosterone synthase; Genetic model; Genotype; Genetics; Blood pressure; Gene; Biology","score_opus":0.3647916287318141,"score_gpt":0.4129102436769624,"score_spread":0.0481186149451483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594588311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97503316,0.0102432035,0.00022605831,0.0030254766,0.0009880353,0.0009616898,0.00026955298,0.000053261378,0.00919955],"genre_scores_gemma":[0.9961245,0.0001509712,0.00020423601,0.0010291684,0.00016791918,0.00026039538,0.000021428315,0.000019252126,0.0020221022],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99763435,0.0005699366,0.0005792497,0.00028530348,0.00050243695,0.00042870335],"domain_scores_gemma":[0.99792814,0.00024194358,0.0006745599,0.00026215165,0.0005402115,0.00035299308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002118237,0.00021030834,0.0011465817,0.00026302622,0.000047054305,0.00000891881,0.0002542251,0.00022804299,0.0003835351],"category_scores_gemma":[0.00015474168,0.00016000758,0.0005794128,0.00077819143,0.00012296368,0.00008303037,0.00007900535,0.0002888682,0.000013369099],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041252137,0.0043828688,0.110428885,0.00019134032,0.7592843,0.00014982099,0.0022133593,0.017550016,0.034507506,0.0025037369,0.037209366,0.027453573],"study_design_scores_gemma":[0.008052337,0.00010492638,0.080772705,0.0000014713454,0.5693436,0.000020788259,0.00012079634,0.001991249,0.2632642,0.00069142686,0.07498893,0.00064752897],"about_ca_topic_score_codex":0.00008056935,"about_ca_topic_score_gemma":0.000028305396,"teacher_disagreement_score":0.22875671,"about_ca_system_score_codex":0.000043698907,"about_ca_system_score_gemma":0.00009639225,"threshold_uncertainty_score":0.6524919},"labels":[],"label_agreement":null},{"id":"W1596914918","doi":"10.18433/j3dw3s","title":"Pharmacokinetics of a Cytochrome P450 2E1 Probe, Chlorzoxazone, and its 6-Hydroxy Metabolite in Poloxamer 407-Induced Hyperlipidemic Rats","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Research Foundation of Korea; Catholic University of Korea; National Research Foundation","keywords":"Chlorzoxazone; CYP2E1; Pharmacokinetics; Chemistry; Metabolite; Pharmacology; Cytochrome P450; In vivo; Active metabolite; Metabolism; Biochemistry; Medicine; Biology","score_opus":0.16617667059064845,"score_gpt":0.46487871189829116,"score_spread":0.2987020413076427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596914918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604978,0.03048374,0.000042408217,0.004000442,0.0018004075,0.0012677534,0.00005520957,0.000044086108,0.0018081588],"genre_scores_gemma":[0.9753484,0.01880499,0.0008249783,0.0038286855,0.0009413319,0.00007068084,0.000002860057,0.000058734124,0.00011929869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99229866,0.0014204638,0.0026244598,0.00079998974,0.001255814,0.0016006397],"domain_scores_gemma":[0.99511194,0.0010822455,0.0013093442,0.00022951492,0.0007576355,0.0015093242],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0049769967,0.00077325245,0.0014915268,0.0011215348,0.000342305,0.00011896676,0.0015283005,0.00029729606,0.0027791313],"category_scores_gemma":[0.00043415013,0.00063550426,0.00040861775,0.0018856508,0.0011350714,0.0013869281,0.0004547423,0.0024655387,0.00011131453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004959672,0.0009308499,0.009701405,0.0001781145,0.00028829952,0.00008524912,0.0006338771,0.0005282464,0.92820925,0.0007727035,0.0005169825,0.057659075],"study_design_scores_gemma":[0.008756434,0.0003469096,0.012693135,0.00008382091,0.0008227139,0.00041267407,0.00018551073,0.04385451,0.83890265,0.0008243272,0.09234639,0.0007709234],"about_ca_topic_score_codex":0.00007683384,"about_ca_topic_score_gemma":0.0000028968782,"teacher_disagreement_score":0.09182941,"about_ca_system_score_codex":0.00011458777,"about_ca_system_score_gemma":0.0005833019,"threshold_uncertainty_score":0.9998358},"labels":[],"label_agreement":null},{"id":"W1599477728","doi":"10.18433/j3p599","title":"Antimicrobial and P450 Inhibitory Properties of Common Functional Foods","year":2014,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada; Carleton University; University of Ottawa","funders":"Agriculture and Agri-Food Canada","keywords":"Apiaceae; Antimicrobial; Lamiaceae; Biology; Fabaceae; Traditional medicine; Botany; Microbiology; Medicine","score_opus":0.20349943375077628,"score_gpt":0.44450062773635757,"score_spread":0.24100119398558129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1599477728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982963,0.009003432,0.00024321744,0.0022800327,0.0027933093,0.00023205942,0.000018620454,0.000027049373,0.0024392295],"genre_scores_gemma":[0.9919382,0.0029894842,0.0005224451,0.003369033,0.0010887563,0.0000052022297,0.0000011020492,0.000022223761,0.00006359241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99612194,0.0009847996,0.0011760187,0.0003587486,0.00072472385,0.00063373917],"domain_scores_gemma":[0.99769974,0.00047711583,0.00067485595,0.00011663584,0.00036267034,0.00066896074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004282885,0.00034312092,0.0006570374,0.00028934175,0.00044178372,0.00006415193,0.00063258724,0.00013950536,0.0005621245],"category_scores_gemma":[0.00020233373,0.00026327503,0.00025008168,0.0004887785,0.001994221,0.0004904456,0.00024644518,0.0011263242,0.000017550652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007478723,0.0006134363,0.012343681,0.00014299694,0.00015355552,0.000014042869,0.0003192302,0.0006756152,0.87764245,0.00095991074,0.0022723645,0.10411484],"study_design_scores_gemma":[0.0038337014,0.0001616569,0.001471143,0.0000507852,0.0003661536,0.00027595984,0.00007096182,0.011063989,0.6690105,0.00025396975,0.31317052,0.00027062217],"about_ca_topic_score_codex":0.000012165057,"about_ca_topic_score_gemma":0.0000018540692,"teacher_disagreement_score":0.31089815,"about_ca_system_score_codex":0.00003797491,"about_ca_system_score_gemma":0.00027145937,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W1599887186","doi":"10.18433/j3288c","title":"Reversible, Time-Dependent Inhibition of CYP3A-Mediated Metabolism of Midazolam and Tacrolimus by Telaprevir in Human Liver Microsomes","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institutes of Health; University of Washington","keywords":"CYP3A; Telaprevir; Midazolam; Microsome; Pharmacology; Tacrolimus; CYP3A4; Chemistry; Non-competitive inhibition; IC50; Metabolite; Drug interaction; Cytochrome P450; Pharmacokinetics; Metabolism; Biochemistry; Biology; In vitro; Medicine; Enzyme; Internal medicine; Transplantation","score_opus":0.11859135691760876,"score_gpt":0.4371306430822569,"score_spread":0.31853928616464816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1599887186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552068,0.041304898,0.000030612016,0.0008056174,0.000803016,0.00040399734,0.0001596022,0.000016684891,0.0012687348],"genre_scores_gemma":[0.9865261,0.0117170755,0.00035723503,0.0009773622,0.0002664411,0.0000071578615,0.0000072895273,0.000024512083,0.00011685679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950966,0.0011110969,0.0016882815,0.00042301728,0.0009814319,0.0006995728],"domain_scores_gemma":[0.9967393,0.00059665396,0.0011073269,0.00013478006,0.00052163616,0.0009002777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00555351,0.00039305896,0.0009716681,0.00064439804,0.00016586075,0.00004094041,0.0006941031,0.00019622523,0.00078529783],"category_scores_gemma":[0.00028367143,0.00033342556,0.00022445033,0.0009873896,0.0014735579,0.0006844276,0.0002819707,0.0011184596,0.00002071065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075418595,0.0009968755,0.01192303,0.00012659848,0.00016679928,0.00009049786,0.000884743,0.0004466088,0.96734184,0.00013589858,0.0043987646,0.012734167],"study_design_scores_gemma":[0.009789897,0.0002284915,0.0007762692,0.00006650481,0.00052527763,0.00014317053,0.00019439343,0.0037456676,0.85109705,0.00035650592,0.13273008,0.00034669874],"about_ca_topic_score_codex":0.000060361715,"about_ca_topic_score_gemma":0.000002989013,"teacher_disagreement_score":0.12833132,"about_ca_system_score_codex":0.000079722704,"about_ca_system_score_gemma":0.00036609566,"threshold_uncertainty_score":0.9999118},"labels":[],"label_agreement":null},{"id":"W1600350812","doi":"10.1046/j.1471-4159.2002.01069.x","title":"Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics","year":2002,"lang":"en","type":"article","venue":"Journal of Neurochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; Canada Research Chairs","keywords":"Dentate gyrus; Blot; Cerebellum; Human brain; Immunocytochemistry; CYP2D6; Hippocampus; Northern blot; Biology; Messenger RNA; Molecular biology; Endocrinology; Internal medicine; Neuroscience; Cytochrome P450; Medicine; Biochemistry; Gene; Metabolism","score_opus":0.1892853364846411,"score_gpt":0.4162120425284196,"score_spread":0.2269267060437785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600350812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931739,0.0038231984,0.000003547624,0.0010457292,0.00024277616,0.000054217267,0.0000087192175,0.0000031593695,0.0016447804],"genre_scores_gemma":[0.9974811,0.0006798333,0.000064562504,0.0010640081,0.00027770796,0.0000017347039,0.0000011214795,0.000014022766,0.00041588757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867034,0.00016588248,0.000603459,0.00015233373,0.00019033089,0.00021768021],"domain_scores_gemma":[0.99911517,0.00017766663,0.00036803744,0.00010041716,0.000075048614,0.00016363457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039136107,0.00014559441,0.0003085344,0.00013598282,0.000036287856,0.000006820001,0.00022819107,0.0002038997,0.0005530995],"category_scores_gemma":[0.00005268488,0.00013972483,0.000077801255,0.00014852673,0.00011459644,0.00007070605,0.00006613101,0.00086107064,0.0000013290456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006061719,0.00031533142,0.005903974,0.000058435566,0.000013711271,0.0002375188,0.00034032905,0.00018692279,0.98881596,0.000023183755,0.0031982241,0.0008457882],"study_design_scores_gemma":[0.003226141,0.000049637118,0.023389108,0.00006450617,0.000032892047,0.00011899665,0.00003227475,0.00022825882,0.9298697,0.00038732548,0.04245524,0.00014591099],"about_ca_topic_score_codex":0.0000014444561,"about_ca_topic_score_gemma":2.8658133e-7,"teacher_disagreement_score":0.058946256,"about_ca_system_score_codex":0.00002002414,"about_ca_system_score_gemma":0.000022809507,"threshold_uncertainty_score":0.6056052},"labels":[],"label_agreement":null},{"id":"W1601283237","doi":"10.1111/j.1360-0443.2010.03353.x","title":"Associations of<i>CYP2A6</i>genotype with smoking behaviors in southern China","year":2010,"lang":"en","type":"article","venue":"Addiction","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Odds ratio; Medicine; Confidence interval; Smoking cessation; Internal medicine; Demography; Genotype; Allele; Genetics; Biology; Cytochrome P450; Gene; Pathology","score_opus":0.04572874333085353,"score_gpt":0.38117364762121364,"score_spread":0.3354449042903601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601283237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934413,0.00018063502,0.00004780375,0.00011060271,0.0011712034,0.00018687833,0.00020715082,0.000044981804,0.0046094395],"genre_scores_gemma":[0.99909025,0.00004999021,0.0001873145,0.00017124302,0.00019188065,0.000024639337,0.00005760914,0.0000204472,0.00020663494],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99907094,0.000119914344,0.00025805476,0.00017461077,0.00014172962,0.00023475068],"domain_scores_gemma":[0.99948305,0.0000648776,0.00016762242,0.000126455,0.000067742614,0.000090226946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047763693,0.00012263916,0.00017073828,0.00013817144,0.000117504474,0.000007822295,0.0001236432,0.00022112309,0.00093558914],"category_scores_gemma":[0.00003134499,0.00011392041,0.000048477385,0.0002798464,0.00007712482,0.0000694038,0.000025602072,0.00077769894,0.00003334843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013169777,0.00047538945,0.45103654,0.0000059839326,0.00013435702,0.000010567212,0.003272503,0.00096618256,0.4992646,0.00074744155,0.00040853932,0.0435462],"study_design_scores_gemma":[0.0033429626,0.00011320735,0.82373554,0.000012986396,0.0005661613,0.000014830102,0.00019884206,0.001516964,0.12692869,0.00044759738,0.04274424,0.00037801053],"about_ca_topic_score_codex":0.00030712373,"about_ca_topic_score_gemma":0.0006107964,"teacher_disagreement_score":0.372699,"about_ca_system_score_codex":0.00002240455,"about_ca_system_score_gemma":0.000059959522,"threshold_uncertainty_score":0.9999777},"labels":[],"label_agreement":null},{"id":"W1601862985","doi":"10.26443/mjm.v10i1.625","title":"Personalized Medicine and the Practice of Medicine in the 21st Century","year":2020,"lang":"en","type":"article","venue":"McGill Journal of Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Alternative medicine; Personalized medicine; Family medicine; Traditional medicine; Medical education; Bioinformatics; Pathology","score_opus":0.13826939995475213,"score_gpt":0.4482426661609605,"score_spread":0.30997326620620835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601862985","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017884541,0.10014113,0.000032169813,0.84636116,0.0016977731,0.0004720627,0.000017781062,0.000008033301,0.033385374],"genre_scores_gemma":[0.75970095,0.0772094,0.000061686726,0.16072658,0.00224881,0.000004836054,0.000002672237,0.00001560953,0.000029477325],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954326,0.002179812,0.001172435,0.00017798902,0.0007597546,0.0002773671],"domain_scores_gemma":[0.9939318,0.0042321566,0.0009922937,0.00015539318,0.00038127528,0.00030711616],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008297647,0.00023648104,0.00090268534,0.00016231462,0.00016813012,0.0000026210787,0.000613032,0.0001259521,0.0010415039],"category_scores_gemma":[0.0047039646,0.00010190472,0.00008554976,0.0005183979,0.0026263383,0.000097812335,0.00007232895,0.0014154441,0.000003153494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030448003,0.00086605723,0.001064711,0.0006539403,0.0023757555,0.0016066636,0.1620562,0.00025480942,0.17929642,0.1637623,0.27328926,0.18432589],"study_design_scores_gemma":[0.034361,0.0007883066,0.00028354189,0.00016103454,0.0013540882,0.0007233521,0.01902627,0.0003257695,0.00049648853,0.000870817,0.94151247,0.00009684373],"about_ca_topic_score_codex":0.000059871425,"about_ca_topic_score_gemma":0.0000020006892,"teacher_disagreement_score":0.7418164,"about_ca_system_score_codex":0.000018660512,"about_ca_system_score_gemma":0.000042573487,"threshold_uncertainty_score":0.9998717},"labels":[],"label_agreement":null},{"id":"W1603258755","doi":"10.1002/ptr.3371","title":"The Effects of Commercial Preparations of Herbal Supplements Commonly Used by Women on the Biotransformation of Fluorogenic Substrates by Human Cytochromes P450","year":2011,"lang":"en","type":"article","venue":"Phytotherapy Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"CYP3A4; Traditional medicine; Black cohosh; CYP1A2; Pharmacology; Enzyme; Cytochrome P450; Chemistry; Biochemistry; Medicine","score_opus":0.2161939200423032,"score_gpt":0.492616864114315,"score_spread":0.2764229440720118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603258755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941582,0.0023846938,0.000010074619,0.00030564028,0.0001290174,0.0012287218,0.000459644,0.000010438587,0.0013135367],"genre_scores_gemma":[0.99708146,0.0022482555,0.000008969846,0.000114758484,0.00004101982,0.0002790774,0.000040437877,0.000021644746,0.00016439662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967343,0.0015875036,0.00054171105,0.0001671957,0.00048032583,0.0004889386],"domain_scores_gemma":[0.997642,0.0014993553,0.0002146336,0.00032275362,0.00021396478,0.0001073255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023535816,0.000166414,0.00028961056,0.00009637426,0.00050017773,0.000013968841,0.0006686069,0.00012709359,0.00070435955],"category_scores_gemma":[0.00003508687,0.00010938211,0.000106060215,0.00034309487,0.00080165925,0.00006770417,0.000043353568,0.00049349724,0.000007719545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007626361,0.000998107,0.003496395,0.000095866875,0.00042879392,3.4278582e-7,0.010572716,0.000003166265,0.96557295,0.0021251277,0.012119863,0.0038240182],"study_design_scores_gemma":[0.0019301022,0.00080206065,0.0031289894,0.00001372488,0.000030314488,3.7220974e-7,0.00036217706,0.00007697437,0.975535,0.0012111358,0.016814679,0.00009449761],"about_ca_topic_score_codex":0.0001365092,"about_ca_topic_score_gemma":0.000050840932,"teacher_disagreement_score":0.010210538,"about_ca_system_score_codex":0.00003697077,"about_ca_system_score_gemma":0.00009132859,"threshold_uncertainty_score":0.7712243},"labels":[],"label_agreement":null},{"id":"W1603362850","doi":"10.1002/9780470921920.edm004","title":"Sex Differences in Drug Metabolism","year":2012,"lang":"en","type":"other","venue":"Encyclopedia of Drug Metabolism and Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Drug metabolism; Cytochrome P450; Internal medicine; Endocrinology; Sexual dimorphism; Metabolism; Medicine","score_opus":0.04545445368411434,"score_gpt":0.37217458191443276,"score_spread":0.32672012823031843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603362850","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03866715,0.09838531,0.000018234014,0.00038298004,0.013374078,0.0007966232,0.00092120195,0.00015801944,0.8472964],"genre_scores_gemma":[0.1135903,0.123352,0.000621408,0.00056186074,0.0039623636,0.00024078583,0.00011587878,0.0004253862,0.75713],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961728,0.000896257,0.0010140006,0.00070931006,0.00035224954,0.0008553812],"domain_scores_gemma":[0.9977076,0.00047616384,0.00071767694,0.00048091647,0.00007881751,0.00053884025],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007527437,0.00080483104,0.0015895931,0.0011760786,0.00014337225,0.000032269643,0.0005893288,0.00047648614,0.013732941],"category_scores_gemma":[0.00009776025,0.00073657726,0.0002903764,0.00046346922,0.00039377366,0.00027288173,0.0003042665,0.0018267676,0.00023237418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001694825,0.0019306149,0.009318469,0.00043702187,0.0013315963,0.000029500188,0.009808726,0.000009394125,0.002647872,0.008226347,0.8765007,0.08959024],"study_design_scores_gemma":[0.0014752534,0.0000051542443,0.0054484475,0.00008149586,0.0009902015,0.000014764476,0.00048391166,0.000051034527,0.002018809,0.00037773055,0.9883601,0.00069308246],"about_ca_topic_score_codex":0.0012443372,"about_ca_topic_score_gemma":0.0005602516,"teacher_disagreement_score":0.111859374,"about_ca_system_score_codex":0.000022594333,"about_ca_system_score_gemma":0.000133337,"threshold_uncertainty_score":0.9995085},"labels":[],"label_agreement":null},{"id":"W1603529942","doi":"10.18433/j3sg66","title":"The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole","year":2008,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Ketoconazole; CYP1A2; In vivo; Chemistry; Isozyme; Cytochrome P450; CYP3A; Pharmacology; Microsome; CYP3A4; Gene isoform; Pharmacokinetics; Metabolism; Metabolite; Inhibitory postsynaptic potential; In vitro; Enzyme; Biochemistry; Endocrinology; Biology","score_opus":0.08183137636494679,"score_gpt":0.4338577602700514,"score_spread":0.3520263839051046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603529942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9183356,0.07782026,0.000016833626,0.0021247019,0.00062899,0.00044461075,0.00004660848,0.0000080659975,0.0005743361],"genre_scores_gemma":[0.96289945,0.03570843,0.00009651934,0.0009466267,0.00022770131,0.000012405884,5.878514e-7,0.000015285466,0.00009300206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99539506,0.0012469944,0.0016419882,0.0002965507,0.00086806796,0.0005513623],"domain_scores_gemma":[0.99536544,0.0020975408,0.0014217345,0.0001732139,0.0005098716,0.0004321892],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.005394419,0.00032938845,0.0008777477,0.00018957257,0.0008757453,0.00003066361,0.0010193513,0.000109078275,0.00011709738],"category_scores_gemma":[0.00029539745,0.00018957966,0.00024160578,0.00056142773,0.010346852,0.0003812091,0.00032816918,0.0010409579,0.0000012922578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013505557,0.0004650491,0.0139651615,0.00011195658,0.00042070387,0.000017694914,0.0019520512,0.00043200518,0.9567214,0.0039803423,0.0037224316,0.01686064],"study_design_scores_gemma":[0.009425452,0.0001837694,0.0031290834,0.00003070681,0.0007248551,0.0002563597,0.00022159766,0.0020185155,0.7683754,0.0009779553,0.21443152,0.0002247972],"about_ca_topic_score_codex":0.0000689021,"about_ca_topic_score_gemma":0.000002656705,"teacher_disagreement_score":0.2107091,"about_ca_system_score_codex":0.000017528155,"about_ca_system_score_gemma":0.0003089103,"threshold_uncertainty_score":0.9923464},"labels":[],"label_agreement":null},{"id":"W1608447397","doi":"10.1002/9780470571224.pse048","title":"Cytochrome<scp>P</scp>450 Enzymes","year":2010,"lang":"en","type":"other","venue":"Pharmaceutical Sciences Encyclopedia","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biotransformation; Cytochrome P450; Enzyme; Xenobiotic; Mixed Function Oxidase; Cytochrome; Biochemistry; Microsome; Function (biology); Chemistry; Oxidase test; Biology; Cell biology","score_opus":0.09840464064716335,"score_gpt":0.4422971645448059,"score_spread":0.3438925238976425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608447397","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027162854,0.027718991,0.00008625497,0.0005609398,0.01135327,0.0012369626,0.0005600933,0.0008796515,0.95488757],"genre_scores_gemma":[0.0063109193,0.055707365,0.0024206752,0.008967473,0.010707705,0.00038343007,0.00012057234,0.00097193295,0.91440994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99293935,0.0007811158,0.0009047802,0.0017779286,0.0012197339,0.0023771017],"domain_scores_gemma":[0.99522656,0.0015739752,0.0005441645,0.0006232421,0.000111781825,0.0019202651],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0021323257,0.0012305963,0.0011141659,0.00078093493,0.0006856049,0.00017288051,0.0025565873,0.0019974953,0.035184227],"category_scores_gemma":[0.0007788547,0.0010821893,0.00044207522,0.0012303556,0.002842292,0.00019262485,0.00073701865,0.0043944665,0.00486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017939308,0.00055028446,0.00063963595,0.00014401019,0.0003274174,0.00014370446,0.00029496194,0.000026047459,0.012796517,0.005446225,0.9221247,0.057488542],"study_design_scores_gemma":[0.0015410404,0.0000776575,0.00013043194,0.00003972413,0.00067123346,0.00006129608,0.000059611477,0.0009587404,0.012712024,0.00075841375,0.9823867,0.0006031123],"about_ca_topic_score_codex":0.000089866415,"about_ca_topic_score_gemma":0.000084984196,"teacher_disagreement_score":0.060262002,"about_ca_system_score_codex":0.000068108,"about_ca_system_score_gemma":0.0005812008,"threshold_uncertainty_score":0.9998714},"labels":[],"label_agreement":null},{"id":"W1622313911","doi":"10.1002/hup.2383","title":"Positive perception of pharmacogenetic testing for psychotropic medications","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; Centre for Addiction and Mental Health; Western University","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacogenetics; Medicine; Perception; Psychology; Pharmacology; Biology; Genetics; Neuroscience; Genotype; Gene","score_opus":0.1763177381488729,"score_gpt":0.5428489992395906,"score_spread":0.36653126109071776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1622313911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886736,0.0015538041,0.0004596099,0.0007335217,0.0030103542,0.00088927534,0.0000930852,0.00007627041,0.0045104558],"genre_scores_gemma":[0.98963237,0.00027861728,0.0020905153,0.005871002,0.0015045822,0.0002832534,0.000051573017,0.00004387007,0.000244217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676776,0.0007859264,0.001105429,0.0006853123,0.00016477406,0.00049078604],"domain_scores_gemma":[0.9976151,0.0011411652,0.00037652336,0.00019989381,0.00016190429,0.00050543575],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012985639,0.00033170715,0.0005915019,0.00015040638,0.0004846523,0.000013763422,0.0003484286,0.00036740178,0.0014795014],"category_scores_gemma":[0.000072610244,0.00032640743,0.00023312077,0.00015243204,0.0011525714,0.000076787815,0.00010089045,0.00058874115,0.000046805173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00119968,0.0014877305,0.013520987,0.000044253018,0.00035662323,0.0000018970478,0.00064485776,0.000028209482,0.91959965,0.0009967615,0.0074738082,0.054645568],"study_design_scores_gemma":[0.11720138,0.008285607,0.09681841,0.00010398753,0.003697312,0.0001360416,0.0015255663,0.02573957,0.45845264,0.012130544,0.27332935,0.00257959],"about_ca_topic_score_codex":0.0000055745454,"about_ca_topic_score_gemma":7.9594014e-7,"teacher_disagreement_score":0.46114698,"about_ca_system_score_codex":0.00001968068,"about_ca_system_score_gemma":0.000044335553,"threshold_uncertainty_score":0.9999188},"labels":[],"label_agreement":null},{"id":"W162868904","doi":"10.1007/978-3-319-10527-7_3","title":"Drug Interaction Potential of Antimalarial Drugs Based on Known Metabolic Properties of Antimalarials","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amodiaquine; Mefloquine; Primaquine; Atovaquone; Sulfadoxine; Artemether; Artemisinin; Chloroquine; Proguanil; Artesunate; Pharmacology; Quinine; Malaria; Drug; Medicine; Pyrimethamine; Plasmodium falciparum; Immunology","score_opus":0.07299654881167561,"score_gpt":0.3629240715735569,"score_spread":0.2899275227618813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W162868904","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060869552,0.0053773187,0.0007256688,0.00092270155,0.016181963,0.0023712018,0.00086549605,0.00019532125,0.9124908],"genre_scores_gemma":[0.9044979,0.0014774355,0.00033490453,0.0010790902,0.0016727417,0.000024489851,0.000098810524,0.00013463595,0.09067996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961507,0.0005380349,0.0015117886,0.0006798553,0.00063717755,0.00048246997],"domain_scores_gemma":[0.99704,0.0002655285,0.001345163,0.00055974926,0.00053988956,0.00024967693],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015658425,0.0007701873,0.0017118494,0.0006846124,0.00014050548,0.000022727801,0.0006090805,0.0009296236,0.007002885],"category_scores_gemma":[0.00008305576,0.00065528153,0.0007550569,0.00008175202,0.00051151897,0.00008367288,0.00019056554,0.001304594,0.00018889668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007543253,0.0010906033,0.000048125275,0.0010198902,0.0024158922,0.000024129477,0.00052072725,0.010624129,0.77610373,0.121919096,0.011188868,0.067501545],"study_design_scores_gemma":[0.0029889091,0.0001376004,0.000028056871,0.00017604855,0.0017571758,0.000004595911,0.000013127263,0.011167106,0.5366571,0.0004934099,0.44602627,0.00055062864],"about_ca_topic_score_codex":0.000049563117,"about_ca_topic_score_gemma":0.0000033584267,"teacher_disagreement_score":0.8436284,"about_ca_system_score_codex":0.000028069624,"about_ca_system_score_gemma":0.00029653683,"threshold_uncertainty_score":0.99958986},"labels":[],"label_agreement":null},{"id":"W1633107772","doi":"","title":"The Hurdled Race Toward Personalized Medicine: the Study of Pharmacogenomics. An interview with Dr. Stan Bardal","year":2013,"lang":"en","type":"article","venue":"UBC Faculty of Medicine medical journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Human genome; Personalized medicine; Medicine; Drug response; Genome; Drug; Pharmacology; Bioinformatics; Genetics; Gene; Biology","score_opus":0.16514966518091748,"score_gpt":0.46528561356999615,"score_spread":0.30013594838907864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1633107772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8838608,0.008902173,0.00042108796,0.102338135,0.0020717992,0.0012887727,0.000025373229,0.000029388993,0.0010624592],"genre_scores_gemma":[0.98254323,0.007591177,0.0000862565,0.0069608176,0.002157793,0.000070437454,0.000015872156,0.000049268583,0.0005251727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918427,0.0030678227,0.0017185454,0.0003880445,0.0022580219,0.000724869],"domain_scores_gemma":[0.9950176,0.0013052725,0.0010325682,0.000407588,0.000930108,0.001306893],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009521032,0.00048171665,0.0011438342,0.00015883357,0.0006678782,0.000026504802,0.0020369398,0.00023386725,0.011791368],"category_scores_gemma":[0.0009146167,0.00020540896,0.00017685698,0.00041895133,0.0036653406,0.00015327136,0.00021803178,0.0025852711,0.000022517403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030151687,0.0028938677,0.0050813816,0.00021825652,0.004176884,0.0003025315,0.0666253,0.00017792502,0.036520224,0.00045506997,0.20587336,0.67466],"study_design_scores_gemma":[0.061655298,0.007214961,0.009345907,0.00053218607,0.0037643395,0.0015291141,0.08405025,0.008473786,0.003593324,0.0012935803,0.81783754,0.00070969923],"about_ca_topic_score_codex":0.00021235837,"about_ca_topic_score_gemma":0.00004323541,"teacher_disagreement_score":0.6739503,"about_ca_system_score_codex":0.000057849786,"about_ca_system_score_gemma":0.00040717976,"threshold_uncertainty_score":0.9997158},"labels":[],"label_agreement":null},{"id":"W165664982","doi":"10.1096/fasebj.22.1_supplement.184.1","title":"Expression of the Human <i>UGT1</i> Locus in Transgenic Mice by WY‐14643 and Implications on Drug Metabolism Through Peroxisome Proliferator‐Activated Receptor (PPAR) α Activation","year":2008,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"U.S. Public Health Service","keywords":"Fibrate; Glucuronidation; Peroxisome proliferator-activated receptor; Genetically modified mouse; Drug metabolism; Glucuronosyltransferase; Receptor; Endocrinology; Lithocholic acid; Biology; Internal medicine; Peroxisome; Transgene; Chemistry; Metabolism; Biochemistry; Gene; Enzyme; Bile acid; Medicine; Microsome","score_opus":0.0687287760682565,"score_gpt":0.3657578713079008,"score_spread":0.29702909523964427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W165664982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993097,0.0018525135,0.00004122193,0.0032465495,0.00051448494,0.00054363156,0.00011193057,0.000019459436,0.00057321583],"genre_scores_gemma":[0.99511683,0.0023414367,0.000046030906,0.001765846,0.00035986764,0.000047090674,0.00001200257,0.000030919495,0.00027997795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974239,0.0011066182,0.0005586883,0.00025552424,0.00027385043,0.0003814514],"domain_scores_gemma":[0.9988169,0.0002592392,0.00040115966,0.00024775893,0.00011917231,0.00015575206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007339078,0.00026157315,0.00031945555,0.000090375754,0.0010584774,0.000023145245,0.00051871786,0.00017507198,0.00021984948],"category_scores_gemma":[0.000041175048,0.00016233548,0.00013596863,0.00036241702,0.000338562,0.00021727566,0.000068065856,0.0014366182,0.000008319271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023762707,0.0003821563,0.002097337,0.000009977743,0.00006977498,7.759328e-7,0.003929573,0.00020212925,0.98527277,0.00020906268,0.0068811867,0.00070761587],"study_design_scores_gemma":[0.0023482223,0.000030233547,0.0052295933,0.000031202897,0.00009933169,0.00004789322,0.00014929492,0.000023648077,0.9654803,0.0007324969,0.025651304,0.00017646409],"about_ca_topic_score_codex":0.00002476493,"about_ca_topic_score_gemma":0.000003816427,"teacher_disagreement_score":0.019792467,"about_ca_system_score_codex":0.000051889863,"about_ca_system_score_gemma":0.0001153136,"threshold_uncertainty_score":0.814106},"labels":[],"label_agreement":null},{"id":"W17089399","doi":"10.1007/978-3-642-37393-0_226-1","title":"Pharmacogenomics and Personalized Medicine: Bridging Genetic Knowledge and Clinical Practice","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacogenomics; Personalized medicine; Precision medicine; Bridging (networking); Medicine; Clinical Practice; Data science; Bioinformatics; Computer science; Pharmacology; Family medicine; Biology; Pathology","score_opus":0.14594088462330077,"score_gpt":0.4852945158635577,"score_spread":0.33935363124025697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W17089399","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041090157,0.133945,0.0008735587,0.0026413403,0.0042943466,0.0009600512,0.00010147371,0.00016285334,0.85291237],"genre_scores_gemma":[0.017391844,0.32801348,0.0034423186,0.026218677,0.00960165,0.000037017857,0.00008481382,0.00035160827,0.61485857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959813,0.00063528045,0.0013100951,0.0011567962,0.00029108848,0.0006254777],"domain_scores_gemma":[0.99503607,0.0025403777,0.0006536746,0.00035027871,0.00034227318,0.0010773427],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028057222,0.0008615112,0.0013000689,0.00026307604,0.0003684767,0.000046876812,0.00037588313,0.0011559083,0.003971926],"category_scores_gemma":[0.0003195607,0.0007921623,0.00022654957,0.000047911693,0.0016484997,0.000076196055,0.0004705126,0.0023389752,0.0003045633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007750121,0.00017602011,0.00044968663,0.00034918523,0.002519983,0.00022462892,0.0008945157,0.000007400678,0.002236193,0.08032772,0.09176997,0.8202697],"study_design_scores_gemma":[0.0051806923,0.0001660359,0.00016002153,0.00006328625,0.0043487847,0.00046090758,0.000028650416,0.004444904,0.00012455715,0.0019699135,0.98221076,0.00084149494],"about_ca_topic_score_codex":0.00001426862,"about_ca_topic_score_gemma":0.000006609786,"teacher_disagreement_score":0.89044076,"about_ca_system_score_codex":0.00005051671,"about_ca_system_score_gemma":0.00019881206,"threshold_uncertainty_score":0.9999627},"labels":[],"label_agreement":null},{"id":"W1740551684","doi":"10.1517/14656566.2015.1088829","title":"Will personalized drugs for cardiovascular disease become an option? – Defining ‘Evidence-based personalized medicine’ for its implementation and future use","year":2015,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Personalized medicine; Precision medicine; Disease; Intensive care medicine; Bioinformatics; Internal medicine; Pathology","score_opus":0.20933489707651082,"score_gpt":0.5118279032799685,"score_spread":0.3024930062034577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740551684","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012195987,0.3765244,0.0022979635,0.0059890887,0.6001949,0.005877121,0.0076150224,0.00026503205,0.000016924625],"genre_scores_gemma":[0.0006247565,0.2885138,0.0017019007,0.01055511,0.6835056,0.00536736,0.008769014,0.00043560876,0.0005268499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99309576,0.0016182825,0.0010163349,0.0017309634,0.0015058202,0.0010328396],"domain_scores_gemma":[0.9929396,0.0030424118,0.0006230667,0.0005791602,0.0013613045,0.0014544376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034775736,0.0012281508,0.0014947203,0.00049646245,0.0008989361,0.00017579814,0.00068515574,0.0010243045,0.0011053097],"category_scores_gemma":[0.0003384026,0.0011319248,0.0010915798,0.00025809804,0.00036197738,0.0009744714,0.000055696597,0.0010668138,0.000011027822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016370894,0.00041977825,0.000014038808,0.0003888952,0.0026611974,0.000007317278,0.004640339,0.00039130123,0.005518607,0.0020193455,0.89860046,0.068967834],"study_design_scores_gemma":[0.036586728,0.00077385746,0.0000033978488,0.00019494379,0.00087409787,0.0000017259129,0.00067367917,0.006959477,0.0020011428,0.00028023412,0.95044714,0.0012035926],"about_ca_topic_score_codex":0.000054761145,"about_ca_topic_score_gemma":0.0000012919043,"teacher_disagreement_score":0.0880106,"about_ca_system_score_codex":0.00034102568,"about_ca_system_score_gemma":0.0010467329,"threshold_uncertainty_score":0.99980783},"labels":[],"label_agreement":null},{"id":"W1748017913","doi":"10.1002/dta.1863","title":"Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements","year":2015,"lang":"en","type":"article","venue":"Drug Testing and Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"CYP3A4; Pharmacology; CYP2D6; Chemistry; Enzyme; Cytochrome P450; CYP1A2; Drug; Dietary supplement; In vivo; Biochemistry; Medicine; Biology; Food science; Biotechnology","score_opus":0.13737968176286192,"score_gpt":0.4142317591891828,"score_spread":0.2768520774263209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1748017913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481386,0.0037164583,0.000051764742,0.00035937692,0.00007866755,0.00015341277,0.00029753495,0.000049620357,0.0004793172],"genre_scores_gemma":[0.9974782,0.00046128515,0.0006030231,0.00076386024,0.00010912234,0.000021989843,0.00025631004,0.000016238328,0.00028996996],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99827534,0.00031739724,0.00039579626,0.0004268561,0.00018389573,0.0004007415],"domain_scores_gemma":[0.9989004,0.0003595833,0.00013048903,0.0001287567,0.00008783045,0.00039294158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010427516,0.00023401188,0.00042289187,0.00034185793,0.00015135494,0.00003990785,0.00009378252,0.00011205697,0.000095934825],"category_scores_gemma":[0.0002154379,0.00022654556,0.000056604975,0.00082983373,0.00011958013,0.00010519954,0.00013339709,0.00035121932,0.000010537844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016630667,0.00064824853,0.7034582,0.00007821307,0.0010971234,0.00015962534,0.0021893946,0.0062017855,0.23952718,0.000019194973,0.009928765,0.036525972],"study_design_scores_gemma":[0.016879203,0.00029226017,0.29577407,0.000092683425,0.0079032695,0.00006852498,0.0011352055,0.58990526,0.047973953,0.002418598,0.03559373,0.0019632385],"about_ca_topic_score_codex":0.00034585193,"about_ca_topic_score_gemma":0.00006969119,"teacher_disagreement_score":0.58370346,"about_ca_system_score_codex":0.000028602233,"about_ca_system_score_gemma":0.000032150434,"threshold_uncertainty_score":0.9238259},"labels":[],"label_agreement":null},{"id":"W1765975574","doi":"10.1155/2007/976804","title":"<i>N</i>-acetyltransferase 2 Slow Acetylator Genotype Associated with Adverse Effects of Sulfasalazine in the Treatment of Inflammatory Bowel Disease","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Education of the People's Republic of China","keywords":"Sulfasalazine; Genotype; Medicine; Inflammatory bowel disease; Gastroenterology; Adverse effect; Internal medicine; Allele; Ulcerative colitis; Sulfapyridine; Arylamine N-acetyltransferase; Rash; Polymorphism (computer science); Disease; Biology; Gene; Genetics","score_opus":0.02099568495005241,"score_gpt":0.30343337229438405,"score_spread":0.28243768734433167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1765975574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963689,0.0018537937,0.0000920386,0.00042131325,0.0007018019,0.00037228948,0.00009773955,0.000003041257,0.00008908501],"genre_scores_gemma":[0.99824727,0.0004920038,0.00004513296,0.0010209819,0.00013488744,0.000007397776,0.000010286028,0.000020515725,0.0000215517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780333,0.000601335,0.0006869242,0.0001432912,0.000164624,0.00060051144],"domain_scores_gemma":[0.9980751,0.00036099847,0.00042294778,0.00017143975,0.00020667349,0.0007627906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009826025,0.00022582317,0.00048278132,0.00040025703,0.00006691413,0.0000035359933,0.00033289648,0.00014219231,0.00008268345],"category_scores_gemma":[0.00008922854,0.00016234096,0.00017943089,0.00018524454,0.00041345146,0.00005902697,0.0000062494723,0.00039471933,0.0000017530551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059128553,0.00082180364,0.9619686,0.00007623167,0.0006632322,0.0025249969,0.0027058,0.0015931075,0.022042667,0.000072289906,0.00029623846,0.001322205],"study_design_scores_gemma":[0.013567219,0.0043382705,0.9506532,0.000069939786,0.00085508055,0.00010754663,0.00016419991,0.00008795565,0.0200001,0.000042766,0.009966265,0.00014743721],"about_ca_topic_score_codex":0.00014691536,"about_ca_topic_score_gemma":0.009403323,"teacher_disagreement_score":0.011315351,"about_ca_system_score_codex":0.00013280132,"about_ca_system_score_gemma":0.00056530786,"threshold_uncertainty_score":0.6620073},"labels":[],"label_agreement":null},{"id":"W1779232898","doi":"10.3109/00498254.2015.1060374","title":"Characterization of ligand-dependent activation of bovine and pig constitutive androstane (CAR) and pregnane X receptors (PXR) with interspecies comparisons","year":2015,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Pregnane X receptor; Constitutive androstane receptor; Xenobiotic; Nuclear receptor; Receptor; Ligand (biochemistry); Biology; Biochemistry; Drug metabolism; Transporter; Steroid; Chemistry; Pharmacology; Metabolism; Enzyme; Gene; Transcription factor; Hormone","score_opus":0.08548819046845897,"score_gpt":0.3596491832988352,"score_spread":0.27416099283037626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1779232898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631023,0.0005346974,0.00048396247,0.00043044979,0.00030740077,0.00036960916,0.00014858496,0.000018849134,0.001396231],"genre_scores_gemma":[0.99852276,0.0008498388,0.000258978,0.00013146792,0.00005514795,0.000005670427,0.000049686914,0.000010687989,0.00011576872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901384,0.000148307,0.00030176537,0.00021548064,0.000145211,0.00017540633],"domain_scores_gemma":[0.99910444,0.00011443215,0.00024594905,0.000105458115,0.00024310467,0.00018662724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029279958,0.00016286699,0.000341964,0.00010484796,0.000063363,0.000012589153,0.00008336875,0.00013480673,0.000051199568],"category_scores_gemma":[0.00005854141,0.00013745023,0.000019924857,0.00013749732,0.0006335608,0.00011207781,0.00008286164,0.00022398475,0.0000017993915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012634253,0.00036207156,0.0252816,0.00009808293,0.00019982802,0.0000037213595,0.0026634205,0.00003443272,0.96543044,0.002439754,0.00015646532,0.0020667552],"study_design_scores_gemma":[0.002643563,0.0005649598,0.0080408715,0.000087176835,0.00024315758,0.000023353752,0.00061501615,0.0004358571,0.9759402,0.000055888875,0.011170012,0.00017990165],"about_ca_topic_score_codex":0.000016162354,"about_ca_topic_score_gemma":0.0000085033325,"teacher_disagreement_score":0.01724073,"about_ca_system_score_codex":0.000021383983,"about_ca_system_score_gemma":0.00009095446,"threshold_uncertainty_score":0.56050575},"labels":[],"label_agreement":null},{"id":"W1781334389","doi":"10.1007/978-1-60327-362-6_10","title":"Grapefruit and Other Fruit Juices Interactions with Medicines","year":2009,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"","keywords":"Grapefruit juice; CYP3A4; Pharmacology; Drug; Pharmacokinetics; Adverse effect; Medicine; Pharmacokinetic interaction; Drug metabolism; Efflux; Drug interaction; Chemistry; Metabolism; Cytochrome P450; Internal medicine; Biochemistry","score_opus":0.22116545925945827,"score_gpt":0.43162243608362943,"score_spread":0.21045697682417117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1781334389","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057751674,0.027601257,0.000015151683,0.0001480938,0.00087359047,0.00066319935,0.00016798257,0.00014473635,0.96980846],"genre_scores_gemma":[0.012429485,0.0052926466,0.00014082686,0.0086382,0.001843453,0.00009153853,0.00003594095,0.0001666461,0.9713613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981575,0.00009743888,0.00044977554,0.00059790193,0.0002711045,0.00042628933],"domain_scores_gemma":[0.99865323,0.00017800908,0.00035576924,0.00035587925,0.000116919255,0.0003401992],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024536203,0.00061614456,0.00062266964,0.0002323429,0.0003221695,0.00005776523,0.00035975457,0.00045602454,0.0017077309],"category_scores_gemma":[0.0000057401035,0.00050767744,0.00012595576,0.000009035941,0.0005214759,0.00005297487,0.00012392196,0.0013554061,0.000043550306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006625701,0.00013009984,0.000023021224,0.00026075557,0.0021235542,0.00026998232,0.002318408,0.00003471329,0.0015532103,0.27130738,0.031647984,0.6896683],"study_design_scores_gemma":[0.0013505251,0.00011713906,0.000023326842,0.0001246319,0.0013865978,0.000071347735,0.000012365283,0.00006506792,0.0016561768,0.0075018643,0.98712516,0.00056577334],"about_ca_topic_score_codex":0.00004699765,"about_ca_topic_score_gemma":0.00016117867,"teacher_disagreement_score":0.9554772,"about_ca_system_score_codex":0.000023227574,"about_ca_system_score_gemma":0.000053376865,"threshold_uncertainty_score":0.9997375},"labels":[],"label_agreement":null},{"id":"W1789580053","doi":"","title":"Lesion scoring and P450 Isoenzyme activity in liver of hepatocarcinogenesis rats treated with Strobilanthes Crispus","year":2008,"lang":"en","type":"article","venue":"Iranian Journal of Cancer Prevention","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Glycyrrhizin; Hepatocellular carcinoma; 2-Acetylaminofluorene; Lesion; Liver cancer; Internal medicine; Gastroenterology; Carcinogen; Pathology; Microsome; Enzyme; Biochemistry; Chemistry","score_opus":0.15563776951044508,"score_gpt":0.4211681005919032,"score_spread":0.26553033108145807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1789580053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889499,0.01027613,0.00021051301,0.00006645698,0.00019301171,0.00020485444,0.000016303364,0.0000055595615,0.00007729802],"genre_scores_gemma":[0.98604083,0.013514505,0.00018842124,0.000038871,0.00011632154,0.000007986824,6.870101e-7,0.000015368585,0.00007699504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986831,0.0004109713,0.00038149455,0.00014827422,0.00017693527,0.0001992013],"domain_scores_gemma":[0.9991436,0.000066338514,0.0004438915,0.000073740135,0.00014317236,0.00012923662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047753347,0.00015116775,0.00035979575,0.00021137323,0.00008534422,0.0000058160367,0.000110733745,0.000103989834,0.00012469146],"category_scores_gemma":[0.000010270676,0.00012492412,0.000087703724,0.00018830285,0.00011683415,0.00019942291,0.00002399423,0.00032216538,7.8328e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002127358,0.00029586113,0.382735,0.00008369823,0.0001641372,0.00015400314,0.0006058629,0.0010421097,0.5517452,0.000007999337,0.000043255124,0.060995556],"study_design_scores_gemma":[0.0028135017,0.0002929746,0.46732783,0.00014931208,0.0002617175,0.00015005498,0.000035913046,0.00065245485,0.5275679,0.000034517878,0.00059162313,0.00012216432],"about_ca_topic_score_codex":0.00010486235,"about_ca_topic_score_gemma":0.00010656976,"teacher_disagreement_score":0.08459282,"about_ca_system_score_codex":0.000049022994,"about_ca_system_score_gemma":0.00014142806,"threshold_uncertainty_score":0.50942576},"labels":[],"label_agreement":null},{"id":"W1811805154","doi":"","title":"Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP3A4; Flunitrazepam; Chemistry; CYP1A2; Mephenytoin; Microsome; Cytochrome P450; Ketoconazole; Pharmacology; Metabolite; Metabolism; Pharmacokinetics; Biochemistry; CYP2C19; Enzyme; Biology; Receptor; Benzodiazepine","score_opus":0.09584527878852,"score_gpt":0.37546103379237056,"score_spread":0.27961575500385055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1811805154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495005,0.020086521,0.000059125687,0.0017700404,0.0014758299,0.0010120986,0.00017777504,0.00018011224,0.025738018],"genre_scores_gemma":[0.97882724,0.0083298255,0.000087451575,0.005914652,0.000655096,0.0011360027,0.00003796586,0.000051479463,0.0049602864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975372,0.00035371783,0.0003918367,0.00049191195,0.00023017736,0.0009951507],"domain_scores_gemma":[0.9985597,0.00019404766,0.00012222174,0.0002552534,0.000081392915,0.0007873774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009101686,0.00034488004,0.00041871917,0.0001618471,0.0002905461,0.000057267906,0.0003542855,0.0003269194,0.00082215737],"category_scores_gemma":[0.00008039031,0.00033251807,0.0001108402,0.0003515772,0.000260944,0.00017144706,0.00015926684,0.0006967385,0.00010610445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004608187,0.000647568,0.009310569,0.000045081815,0.00062669336,0.00014345432,0.00045756038,0.00004574622,0.09153266,0.0019437528,0.053592104,0.841194],"study_design_scores_gemma":[0.0022043416,0.0000103986395,0.110538065,0.0000012600128,0.00031399727,0.00008760084,0.000025205652,0.0002438789,0.021848178,0.0008280687,0.8635207,0.00037831484],"about_ca_topic_score_codex":0.000035779627,"about_ca_topic_score_gemma":0.0000051067964,"teacher_disagreement_score":0.84081566,"about_ca_system_score_codex":0.00003110435,"about_ca_system_score_gemma":0.000030598272,"threshold_uncertainty_score":0.9999127},"labels":[],"label_agreement":null},{"id":"W1817947240","doi":"10.3934/genet.2015.4.250","title":"Associations of CYP1A1 gene polymorphisms and risk of breast cancer in Indian women: a meta-analysis","year":2015,"lang":"en","type":"article","venue":"AIMS Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of the Environment, Conservation and Parks","funders":"","keywords":"Meta-analysis; Breast cancer; Medicine; Oncology; Subgroup analysis; Internal medicine; Epidemiology; Case-control study; Demography; Publication bias; Gynecology; Cancer","score_opus":0.16305378488181962,"score_gpt":0.4273417605252685,"score_spread":0.26428797564344886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1817947240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710404,0.02331,0.000037345002,0.00027877753,0.00021587177,0.00021675156,0.004698856,0.000009563941,0.00019242536],"genre_scores_gemma":[0.99175566,0.007164965,0.0004435623,0.0003513296,0.00007576005,0.00005961786,0.000023098082,0.000020295223,0.00010568869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783355,0.00058004004,0.00064953166,0.00028168826,0.0002655655,0.00038960608],"domain_scores_gemma":[0.99844974,0.00017681778,0.00051575125,0.0002523302,0.00025036323,0.0003549929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012987205,0.0002162565,0.0009585706,0.00041142842,0.00005505384,0.000008207617,0.0002409563,0.00024268878,0.0006461748],"category_scores_gemma":[0.00004568037,0.0002002462,0.00029143548,0.00093787,0.00019932022,0.00003936009,0.00012064214,0.00033528052,0.00000455763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013356864,0.00060030643,0.83426183,0.000020561763,0.08122184,0.000012751247,0.009053207,0.034217544,0.03114904,0.00009981028,0.00021950333,0.009010005],"study_design_scores_gemma":[0.0038123764,0.00013588624,0.72149336,0.00000206671,0.15398195,0.000011639934,0.00047991902,0.0070993653,0.10694299,0.0017744541,0.003678025,0.00058795593],"about_ca_topic_score_codex":0.0006831378,"about_ca_topic_score_gemma":0.0004979084,"teacher_disagreement_score":0.112768486,"about_ca_system_score_codex":0.00006288836,"about_ca_system_score_gemma":0.00020561149,"threshold_uncertainty_score":0.8165803},"labels":[],"label_agreement":null},{"id":"W1829431903","doi":"10.1016/s0022-2275(20)33464-7","title":"Comparison of deuterium incorporation and mass isotopomer distribution analysis for measurement of human cholesterol biosynthesis","year":2000,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Isotopomers; Biosynthesis; Deuterium; Chemistry; Cholesterol; Biochemistry; Physics; Organic chemistry; Enzyme; Nuclear physics; Molecule","score_opus":0.3802398926867185,"score_gpt":0.5481562739329916,"score_spread":0.16791638124627312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829431903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614394,0.0011299653,0.0014524678,0.0004928913,0.00017093269,0.00029200217,0.00012305782,0.0000025952627,0.00019216038],"genre_scores_gemma":[0.9986193,0.00069678976,0.00026429078,0.000024044408,0.0003006837,0.000011139172,0.0000138647,0.000009023407,0.00006086749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972815,0.0008007142,0.0008703407,0.00013826476,0.00065730023,0.00025188812],"domain_scores_gemma":[0.99768275,0.00025426134,0.0004970004,0.0001229376,0.0012679482,0.00017510483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005582578,0.0001096578,0.0005289581,0.00042222952,0.00016396728,0.00001772415,0.0002303599,0.00014804254,0.00038000685],"category_scores_gemma":[0.000107323205,0.00009341205,0.0002009976,0.00052553037,0.00023494531,0.000093552924,0.000030802723,0.00043954258,0.000001774398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008823043,0.0006427379,0.09874297,0.00012975249,0.0010863252,0.0000011723106,0.00036051843,0.0010918665,0.87201685,0.00006537763,0.0011333514,0.023846755],"study_design_scores_gemma":[0.0019074245,0.0005960385,0.05575538,0.000030091118,0.0009028611,0.0000031747725,0.00013023833,0.0050435425,0.8982726,0.0002886548,0.0369636,0.00010644358],"about_ca_topic_score_codex":0.000009110464,"about_ca_topic_score_gemma":0.0000062407335,"teacher_disagreement_score":0.042987593,"about_ca_system_score_codex":0.000060409526,"about_ca_system_score_gemma":0.000089503184,"threshold_uncertainty_score":0.41608086},"labels":[],"label_agreement":null},{"id":"W1838732593","doi":"10.1124/mol.58.4.747","title":"Duplications and Defects in the<i>CYP2A6</i>Gene: Identification, Genotyping, and In Vivo Effects on Smoking","year":2000,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse","keywords":"CYP2A6; Allele; Genotyping; Nicotine; Cotinine; Genotype; Genetics; Biology; Gene","score_opus":0.028214784637219735,"score_gpt":0.3774294290619727,"score_spread":0.349214644424753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1838732593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877643,0.0064941063,0.00003986193,0.0018905463,0.00045887835,0.000953292,0.000020446909,0.000037058562,0.0023414844],"genre_scores_gemma":[0.9794073,0.003165412,0.000049858558,0.01663227,0.00014858342,0.00041537406,0.00001109659,0.000031311276,0.00013879078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707955,0.001238332,0.00042066688,0.0005669939,0.00015395465,0.0005405056],"domain_scores_gemma":[0.99894565,0.0005279784,0.000094978575,0.0002283861,0.000034835393,0.0001681965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010822978,0.0002840764,0.00029174198,0.00028804687,0.00022106136,0.000037664573,0.00033550712,0.00025514234,0.0005071797],"category_scores_gemma":[0.000041835538,0.00026819715,0.00005393857,0.00046763316,0.0002044296,0.000070352355,0.0000660767,0.0007959488,0.000043642463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021948676,0.0003547591,0.008793759,0.000055612978,0.00008200543,0.0002642075,0.001144136,0.0015223313,0.950938,0.0009294019,0.001391081,0.03430521],"study_design_scores_gemma":[0.0047423365,0.0000840389,0.055260077,0.000015363583,0.00029011164,0.00009992456,0.0000360664,0.0024639305,0.79855394,0.0015909588,0.13643365,0.0004295846],"about_ca_topic_score_codex":0.000026204632,"about_ca_topic_score_gemma":0.000020304095,"teacher_disagreement_score":0.15238404,"about_ca_system_score_codex":0.00004273389,"about_ca_system_score_gemma":0.000045306046,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W1839698594","doi":"10.1111/j.1369-1600.2010.00287.x","title":"Pharmacogenetics of alcohol, nicotine and drug addiction treatments","year":2011,"lang":"en","type":"review","venue":"Addiction Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Addiction; Medicine; Drug; Pharmacotherapy; Naltrexone; Pharmacology; Nicotine; Psychiatry; Internal medicine; Opioid; Genetics; Biology; Gene; Genotype","score_opus":0.21330391609195812,"score_gpt":0.4835784193924277,"score_spread":0.27027450330046954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1839698594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009752735,0.9878553,0.000022538681,0.000016680358,0.0038852405,0.00096913276,0.0014925308,0.000107217136,0.0046760584],"genre_scores_gemma":[0.002074924,0.9946879,0.00014118172,0.00021961727,0.0006873668,0.00024018038,0.00080596795,0.00009139911,0.0010514362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959492,0.0013317637,0.0012301152,0.00078490056,0.000104438564,0.0005995442],"domain_scores_gemma":[0.9977178,0.00038990745,0.0010090733,0.0003582258,0.00014970844,0.00037525967],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061986415,0.00075517525,0.0018238024,0.00050533476,0.00032090404,0.000007523118,0.00039284962,0.0010940039,0.0033182965],"category_scores_gemma":[0.000040632363,0.00064757816,0.0004738589,0.00038932313,0.0004989147,0.0000656063,0.00034199608,0.0009998615,0.00016158016],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082358434,0.0003572988,0.0003212492,0.0005992185,0.0024671922,0.000004466084,0.0001512922,0.0000017472543,0.00034881863,0.0005838822,0.003618947,0.99146354],"study_design_scores_gemma":[0.0016412787,0.00015530626,0.000087158405,0.00028437458,0.008557948,0.00008548906,0.000005173311,0.00004648438,0.0011071314,0.00016460723,0.9873944,0.000470662],"about_ca_topic_score_codex":0.00006310086,"about_ca_topic_score_gemma":0.000004297305,"teacher_disagreement_score":0.99099284,"about_ca_system_score_codex":0.00006858859,"about_ca_system_score_gemma":0.00015821912,"threshold_uncertainty_score":0.99959755},"labels":[],"label_agreement":null},{"id":"W1842977100","doi":"10.1002/9780470921920.edm119","title":"Current and Future Tools for Predicting Clinical Drug–Drug Interactions","year":2012,"lang":"en","type":"other","venue":"Encyclopedia of Drug Metabolism and Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Intertek (Canada)","funders":"","keywords":"Drug; Computer science; Drug development; Field (mathematics); Data science; Risk analysis (engineering); Computational biology; Medicine; Pharmacology; Biology; Mathematics","score_opus":0.07688309488247434,"score_gpt":0.4458639384986488,"score_spread":0.36898084361617445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1842977100","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03831362,0.2893543,0.0002447801,0.0028529002,0.110430315,0.0033029988,0.006279472,0.000399995,0.5488216],"genre_scores_gemma":[0.01646514,0.5395634,0.0031544298,0.0009145047,0.050205383,0.0008094891,0.00065956323,0.00072572025,0.38750234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648154,0.0006689913,0.0012311405,0.00073993334,0.0002245277,0.0006538447],"domain_scores_gemma":[0.99613816,0.0016261,0.0010028611,0.00039213165,0.00018660826,0.00065413123],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010702601,0.00067171006,0.00116331,0.00053028256,0.00033141577,0.00006727114,0.00035047552,0.00026804305,0.0035664134],"category_scores_gemma":[0.00024455355,0.0006245378,0.00042968316,0.00020926897,0.00035306276,0.00049194886,0.0002735275,0.0020555775,0.000053240008],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013679083,0.0006486314,0.002418509,0.00031108558,0.00069520355,0.000001446312,0.0016736971,0.0000018425916,0.00013738636,0.0015482915,0.6217588,0.37066832],"study_design_scores_gemma":[0.0017396837,0.00001093503,0.002088621,0.0001234126,0.0022779792,0.000021668462,0.0006879905,0.00015505466,0.00026317278,0.00018082769,0.99189603,0.00055461674],"about_ca_topic_score_codex":0.0000862916,"about_ca_topic_score_gemma":0.00017505797,"teacher_disagreement_score":0.37013724,"about_ca_system_score_codex":0.000019717945,"about_ca_system_score_gemma":0.00014033534,"threshold_uncertainty_score":0.9996206},"labels":[],"label_agreement":null},{"id":"W1861932861","doi":"10.1093/pch/15.9.571","title":"Baby boy blue – why is this newborn lethargic?","year":2010,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Children's Hospital of Western Ontario; University of Toronto","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.05129371163290666,"score_gpt":0.396338296081426,"score_spread":0.3450445844485194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1861932861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5867133,0.052297853,0.0012008046,0.21664344,0.03981974,0.0033354214,0.0023336047,0.0010106375,0.096645184],"genre_scores_gemma":[0.65818095,0.036730938,0.004354987,0.28653958,0.011314841,0.00011842431,0.00019575734,0.00020378157,0.0023607737],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958687,0.00054595404,0.0008626646,0.00079453504,0.0004888792,0.0014392722],"domain_scores_gemma":[0.9969594,0.00034082108,0.00045963383,0.0006187611,0.00019767645,0.0014237404],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002344964,0.00051637087,0.00064309867,0.0003585916,0.0010186887,0.000062084146,0.00079957256,0.0006721161,0.0055720196],"category_scores_gemma":[0.00016490665,0.00050958997,0.00029778943,0.00077912514,0.00015458667,0.00014830506,0.00024705494,0.0037954869,0.0014163321],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001522762,0.0008353841,0.01624007,0.00017662256,0.00017319288,0.00003357907,0.0036630102,0.000076157936,0.00400533,0.0037859122,0.8196364,0.15122207],"study_design_scores_gemma":[0.0022400215,0.00008521894,0.0029685847,0.000005288339,0.00015282964,0.00004118806,0.00005024902,0.0009422192,0.0047256285,0.000730721,0.9875688,0.0004892476],"about_ca_topic_score_codex":0.0002289956,"about_ca_topic_score_gemma":0.00010861052,"teacher_disagreement_score":0.1679324,"about_ca_system_score_codex":0.00007288727,"about_ca_system_score_gemma":0.00058314565,"threshold_uncertainty_score":0.9997356},"labels":[],"label_agreement":null},{"id":"W1867975073","doi":"10.1007/978-1-4614-3055-1_6","title":"Physiologically-Based Pharmacokinetic (PBPK) Models in Toxicity Testing and Risk Assessment","year":2012,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; In silico; Pharmacology; Biochemical engineering; Computational biology; Computer science; Chemistry; Medicine; Biology; Engineering","score_opus":0.34442742621845124,"score_gpt":0.558341622173602,"score_spread":0.2139141959551507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1867975073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017000662,0.9785625,0.00003857782,0.000047367,0.0010469193,0.0009735632,0.000074518895,0.0000347921,0.0022211515],"genre_scores_gemma":[0.096184835,0.9010639,0.000990578,0.00077261234,0.00050444534,0.00037787532,0.00006537674,0.00003269069,0.000007694514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958731,0.0015105938,0.000970708,0.0007891165,0.00010153379,0.0007549287],"domain_scores_gemma":[0.9972246,0.0017869519,0.0004715846,0.00017764112,0.000032636617,0.00030654334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010651065,0.0006774768,0.0019047499,0.0003611559,0.00012710066,0.0000069088087,0.0002940008,0.00058129727,0.00021367389],"category_scores_gemma":[0.00010359003,0.00047769636,0.00009297008,0.00038834472,0.000878418,0.00015305931,0.00026385716,0.0015038039,0.0000041226335],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006777315,0.0004661984,0.0026839946,0.0010740525,0.00006681702,0.000022436278,0.00014876809,0.0001112554,0.0043978123,0.0002859823,0.000011865545,0.99066305],"study_design_scores_gemma":[0.0043512806,0.0007172268,0.00020764979,0.001305246,0.0008159271,0.000047954658,0.00013045063,0.004876551,0.0006790856,0.0017918929,0.9842384,0.0008383761],"about_ca_topic_score_codex":0.00006183902,"about_ca_topic_score_gemma":0.000010933691,"teacher_disagreement_score":0.98982465,"about_ca_system_score_codex":0.000101517406,"about_ca_system_score_gemma":0.00008102924,"threshold_uncertainty_score":0.9997675},"labels":[],"label_agreement":null},{"id":"W1877341189","doi":"10.1002/jps.24495","title":"Use of a Physiologically Based Pharmacokinetic Model for Quantitative Prediction of Drug–Drug Interactions via CYP3A4 and Estimation of the Intestinal Availability of CYP3A4 Substrates","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Physiologically based pharmacokinetic modelling; CYP3A4; In vivo; Pharmacokinetics; Pharmacology; Drug-drug interaction; Chemistry; Drug; Drug metabolism; Medicine; Enzyme; Cytochrome P450; Biology; Biochemistry","score_opus":0.37766360271369076,"score_gpt":0.4895583486762489,"score_spread":0.11189474596255816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1877341189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844129,0.0008395589,0.012702549,0.0006315855,0.0006445743,0.0004570557,0.00023313175,0.000006289139,0.00007233237],"genre_scores_gemma":[0.9864791,0.00018597432,0.013082052,0.0001611776,0.000053641146,0.000010374633,0.0000024204264,0.000007651184,0.000017619359],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99702686,0.00069275853,0.0012955394,0.0002230823,0.0005065109,0.00025526914],"domain_scores_gemma":[0.99485636,0.002113421,0.0014551796,0.000109953944,0.001206501,0.0002586053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031512964,0.00019623486,0.000535597,0.00019274969,0.00011397946,0.000012133918,0.00044411226,0.00006435463,0.00007656617],"category_scores_gemma":[0.0011504096,0.00012910603,0.00023980813,0.00050060684,0.0019601015,0.0003676866,0.000097861426,0.0004710994,3.8140885e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016170983,0.00095519715,0.009696233,0.00022945795,0.00012590106,6.992699e-7,0.0009357614,0.3154028,0.66541827,0.00046269008,0.00033300882,0.004822864],"study_design_scores_gemma":[0.0012512533,0.00023927985,0.0032506932,0.000060097806,0.0003863288,0.00001083043,0.00012412075,0.6114985,0.38107428,0.0018317201,0.00020615656,0.0000667518],"about_ca_topic_score_codex":0.000019659932,"about_ca_topic_score_gemma":0.000004719703,"teacher_disagreement_score":0.2960957,"about_ca_system_score_codex":0.00003376792,"about_ca_system_score_gemma":0.00041351383,"threshold_uncertainty_score":0.72220755},"labels":[],"label_agreement":null},{"id":"W1884752701","doi":"10.1002/pbc.24932","title":"<i>VKORC1</i> and <i>CYP2C9</i> genotypes are predictors of warfarin‐related outcomes in children","year":2014,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; CYP2C9; Warfarin; Medicine; Dosing; Pharmacogenetics; Vitamin K epoxide reductase; Genotype; Cohort; Internal medicine; Atrial fibrillation; Genetics; Biology; Gene","score_opus":0.021630411946716905,"score_gpt":0.34129829576818566,"score_spread":0.31966788382146877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1884752701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723859,0.024504818,0.0000039234137,0.00030262538,0.0011754803,0.00038495808,0.00020571939,0.000057062734,0.0009795468],"genre_scores_gemma":[0.9832406,0.014648008,0.000063327716,0.0010690811,0.00065107265,0.00006876592,0.000010404805,0.000037105663,0.00021160168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804145,0.00027990036,0.00056872464,0.00041724608,0.00020965,0.00048304562],"domain_scores_gemma":[0.9989205,0.00022873103,0.0003242693,0.00020391915,0.0000761866,0.0002464209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055293785,0.00029530565,0.00055757654,0.00022623646,0.00009292793,0.0000108502,0.00028282686,0.00031693015,0.00030138606],"category_scores_gemma":[0.00007150036,0.0002693876,0.00010153231,0.0004064175,0.00013435939,0.00007598663,0.00014233789,0.00061714184,0.000016125008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004854556,0.00034783685,0.9930305,0.00007169386,0.00033764556,0.0000028996853,0.0002846389,0.0005156875,0.0018147498,0.00014548085,0.00061955786,0.0027807704],"study_design_scores_gemma":[0.005138334,0.000064882195,0.9754578,0.000008628415,0.0018451097,0.000009519382,0.000010652145,0.000309171,0.0085914675,0.0003944807,0.007797035,0.00037294265],"about_ca_topic_score_codex":0.00021436854,"about_ca_topic_score_gemma":0.00004545441,"teacher_disagreement_score":0.017572716,"about_ca_system_score_codex":0.0000144967435,"about_ca_system_score_gemma":0.00008145798,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W1890529144","doi":"10.1111/jgh.12361","title":"Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short‐term remission in patients with ulcerative colitis treated with tacrolimus","year":2013,"lang":"en","type":"article","venue":"Journal of Gastroenterology and Hepatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mitsubishi Tanabe Pharma Corporation; Eisai Canada; Eisai","keywords":"CYP3A5; Ulcerative colitis; Pharmacokinetics; Gastroenterology; Medicine; Internal medicine; Tacrolimus; Trough level; Trough Concentration; CYP3A4; Pharmacology; Genotype; Cytochrome P450; Biology; Transplantation; Disease; Genetics; Metabolism","score_opus":0.02794258075012768,"score_gpt":0.33465730866329807,"score_spread":0.3067147279131704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1890529144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983129,0.0002798214,0.000026629403,0.0007013113,0.00012333764,0.0004322388,0.00003853716,0.000004645114,0.00008057311],"genre_scores_gemma":[0.997939,0.00084847317,0.00012489806,0.0009735204,0.000060298982,0.000016979795,0.0000046917053,0.000020489642,0.000011650831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977813,0.00080084853,0.0005763194,0.00022921662,0.00014662535,0.00046574202],"domain_scores_gemma":[0.9986705,0.00024412532,0.00042317653,0.00012651864,0.0002667621,0.0002688718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002992043,0.0002917765,0.0006499881,0.0002531627,0.00010577069,0.000012444992,0.00018818286,0.00019662273,0.0003216688],"category_scores_gemma":[0.000020259686,0.00016100398,0.00007241594,0.00011548509,0.00064678513,0.000083877254,0.00005957776,0.0007796037,0.0000015901064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015006622,0.00051434233,0.9760901,0.000012069501,0.00048102485,0.0000919663,0.0003046324,0.00015289361,0.0034007365,0.000021860282,0.00029362197,0.0036301594],"study_design_scores_gemma":[0.007305673,0.007784065,0.9818817,0.00003036249,0.00026761842,0.0004603197,0.000025062885,0.00052427035,0.0014344525,0.0000688973,0.000107174325,0.000110443216],"about_ca_topic_score_codex":0.000033508433,"about_ca_topic_score_gemma":0.000034758203,"teacher_disagreement_score":0.00770095,"about_ca_system_score_codex":0.00003756422,"about_ca_system_score_gemma":0.00006515018,"threshold_uncertainty_score":0.6565551},"labels":[],"label_agreement":null},{"id":"W1895335686","doi":"10.4212/cjhp.v55i3.578","title":"Formulary Considerations Related to Warfarin Interchangeability","year":2002,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Warfarin; Formulary; Medicine; Therapeutic index; Warfarin Sodium; Antithrombotic; Generic drug; Drug; Pharmacology; Internal medicine; Atrial fibrillation","score_opus":0.15438704824613905,"score_gpt":0.40715268901986434,"score_spread":0.2527656407737253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895335686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.934259,0.0047945566,0.00002149607,0.046333924,0.0052561015,0.00052832963,0.00009344946,0.0000203285,0.008692808],"genre_scores_gemma":[0.99031794,0.00024725933,0.00014817002,0.008194791,0.00041026494,0.000013961715,0.000002476508,0.00002936382,0.00063575426],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785095,0.00044905453,0.00069042004,0.00019072827,0.00021318626,0.0006056805],"domain_scores_gemma":[0.99734664,0.00029358998,0.00024097608,0.00023808143,0.00040239067,0.0014783309],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013152342,0.00023641123,0.00030571627,0.0002770702,0.0007105057,0.000087961045,0.00056867895,0.00010816341,0.009819557],"category_scores_gemma":[0.00039596838,0.00018309371,0.00022046345,0.000328785,0.00029966387,0.00022985779,0.000061403836,0.0012810744,0.00042859794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030877613,0.001288552,0.041113026,0.00007243974,0.0023880163,0.0027304415,0.06863578,0.0069400175,0.023643827,0.015553186,0.67643976,0.16088615],"study_design_scores_gemma":[0.0034178982,0.00040104665,0.0031918706,0.000023759449,0.0004704964,0.0005454686,0.0002839614,0.0034879476,0.021054616,0.013751949,0.95282626,0.0005447246],"about_ca_topic_score_codex":0.0010955757,"about_ca_topic_score_gemma":0.0027338373,"teacher_disagreement_score":0.27638647,"about_ca_system_score_codex":0.00018867424,"about_ca_system_score_gemma":0.00039201806,"threshold_uncertainty_score":0.9910856},"labels":[],"label_agreement":null},{"id":"W1904768480","doi":"10.1111/j.1365-2125.2010.03772.x","title":"Repaglinide‐gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism","year":2010,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Repaglinide; Gemfibrozil; Glucuronidation; Chemistry; Pharmacology; Glucuronide; Microsome; Metabolite; Drug interaction; Nateglinide; Pharmacokinetics; Biochemistry; Endocrinology; Medicine; Enzyme; Metformin; Cholesterol","score_opus":0.07043696450870818,"score_gpt":0.4751353786480097,"score_spread":0.4046984141393015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1904768480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650093,0.0007700293,0.0004744431,0.0017997547,0.028532814,0.00044100598,0.0009245101,0.00005483375,0.0019933374],"genre_scores_gemma":[0.98119986,0.0028372572,0.0017295503,0.0044189105,0.009195367,0.000028099968,0.0002026763,0.000051558505,0.00033674028],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99180585,0.0023558955,0.004027003,0.0005286223,0.0005971483,0.0006854614],"domain_scores_gemma":[0.9902111,0.0033616945,0.0036954603,0.00018826456,0.0018072646,0.0007361979],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008591873,0.00034018583,0.0012004878,0.0002968013,0.00037347755,0.00005428746,0.0005211041,0.00074535626,0.034865588],"category_scores_gemma":[0.0038074965,0.0003987364,0.0009049538,0.0003107768,0.00062345056,0.00051692844,0.00024429907,0.004724074,0.0001325711],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061102733,0.003811509,0.00096521195,0.000107417145,0.0017298248,0.0033312982,0.00019105092,0.00093629205,0.58254397,0.0023674397,0.25070885,0.14719686],"study_design_scores_gemma":[0.021280333,0.0009684001,0.004479507,0.00020008985,0.0019689682,0.010623069,0.00022319412,0.0046281717,0.33967182,0.016650788,0.5985164,0.0007892421],"about_ca_topic_score_codex":0.00003407757,"about_ca_topic_score_gemma":0.000025757487,"teacher_disagreement_score":0.3478076,"about_ca_system_score_codex":0.000045648798,"about_ca_system_score_gemma":0.00076910487,"threshold_uncertainty_score":0.99984646},"labels":[],"label_agreement":null},{"id":"W1910111405","doi":"10.1002/pds.3571","title":"Validation of patient‐reported warfarin dose in a prospective incident cohort study","year":2014,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Warfarin; Medicine; Concordance; Dosing; Observational study; CYP2C9; Prospective cohort study; Internal medicine; Cohort study; Cohort; Population; Atrial fibrillation","score_opus":0.06433469346619204,"score_gpt":0.42044968127288473,"score_spread":0.3561149878066927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1910111405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066156,0.0010267766,0.00018914352,0.0005440851,0.0011906641,0.0019843676,0.000030442949,0.00007192481,0.004301053],"genre_scores_gemma":[0.99663454,0.0010889841,0.00018684425,0.0014826977,0.00017163322,0.00026924192,0.000032499884,0.00003116604,0.000102399375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909266,0.0057536894,0.0016322099,0.0008165517,0.00023211111,0.0006387892],"domain_scores_gemma":[0.995994,0.0024571023,0.00071672274,0.0003249827,0.00018528858,0.00032195795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009771057,0.0004145766,0.0010515851,0.00031488016,0.00022267898,0.000007144227,0.00027931767,0.00026421796,0.00040620097],"category_scores_gemma":[0.0013053777,0.00038508154,0.00012706197,0.00041608585,0.0003482895,0.0001604552,0.00028162272,0.0010473311,0.000023560538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013213359,0.0011130618,0.9640577,0.000040265335,0.00036136448,0.000026662035,0.002677419,0.0024130885,0.009366375,0.00083616475,0.00031572132,0.017470835],"study_design_scores_gemma":[0.0072207265,0.00019851727,0.9319311,0.000014475001,0.0005344332,0.000030837542,0.00030960687,0.005785998,0.037797406,0.002697934,0.013026332,0.00045267472],"about_ca_topic_score_codex":0.00037560583,"about_ca_topic_score_gemma":0.000048051097,"teacher_disagreement_score":0.032126646,"about_ca_system_score_codex":0.000080807426,"about_ca_system_score_gemma":0.00007997316,"threshold_uncertainty_score":0.9998601},"labels":[],"label_agreement":null},{"id":"W1916407220","doi":"10.1002/bdd.1934","title":"Dealing with the complex drug–drug interactions: Towards mechanistic models","year":2014,"lang":"en","type":"review","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Drug; Pharmacokinetics; Pharmacology; Drug metabolism; Disposition; Transporter; Drug development; Medicine; Computational biology; Chemistry; Psychology; Biology","score_opus":0.22091946795104653,"score_gpt":0.4804788298779997,"score_spread":0.25955936192695317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1916407220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031019893,0.9821897,0.0029118315,0.0014081147,0.0036653068,0.0030994427,0.0011888378,0.00036679802,0.004859765],"genre_scores_gemma":[0.021673266,0.96830857,0.0005363225,0.0033235757,0.0019870491,0.00079351413,0.0012220807,0.0003192425,0.001836384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99255157,0.0024545493,0.0015591811,0.0012989672,0.0008177746,0.0013179549],"domain_scores_gemma":[0.9954565,0.0010596181,0.0013774763,0.0008921181,0.0004322545,0.0007820224],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0022531152,0.0016148109,0.0023028487,0.000527297,0.0014380872,0.00026548083,0.0015777157,0.00037835378,0.0010906599],"category_scores_gemma":[0.000027695989,0.0011489409,0.001005008,0.0007995048,0.00051742705,0.00029910804,0.00046477283,0.0033888896,0.000607342],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004053854,0.000653916,0.0000015255653,0.0075592855,0.002286633,0.00011490904,0.0010799513,0.0026556002,0.0008090934,0.010398386,0.014359163,0.95967615],"study_design_scores_gemma":[0.0013482831,0.00002512052,0.0000012244902,0.0014937156,0.010821794,0.00021506376,0.00012312745,0.027563987,0.0008943003,0.000672977,0.9555115,0.0013289235],"about_ca_topic_score_codex":0.00006997734,"about_ca_topic_score_gemma":0.000055180524,"teacher_disagreement_score":0.9583472,"about_ca_system_score_codex":0.00037486744,"about_ca_system_score_gemma":0.0004381094,"threshold_uncertainty_score":0.9998619},"labels":[],"label_agreement":null},{"id":"W1918770470","doi":"10.1111/bph.12997","title":"Differential activation of human constitutive androstane receptor and its<scp>SV23</scp>and<scp>SV24</scp>splice variants by rilpivirine and etravirine","year":2014,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Etravirine; Rilpivirine; Constitutive androstane receptor; Transactivation; Efavirenz; Chemistry; Pharmacology; Nevirapine; Biology; Nuclear receptor; Gene expression; Biochemistry; Reverse transcriptase; Virology; Gene; Transcription factor; Human immunodeficiency virus (HIV); RNA","score_opus":0.03422792534136944,"score_gpt":0.35901022668496707,"score_spread":0.32478230134359765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918770470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832758,0.012604869,0.00028882208,0.00026909183,0.0017004927,0.0004628624,0.00032339015,0.000026911777,0.0010477706],"genre_scores_gemma":[0.97175735,0.025602698,0.00014073393,0.001158109,0.00085015624,0.000018079694,0.00003584854,0.00004593367,0.00039106124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964537,0.0010552241,0.0010534873,0.000489297,0.0003015894,0.0006467242],"domain_scores_gemma":[0.99614316,0.0016411123,0.0010329819,0.000084855434,0.0004763451,0.0006215585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012042378,0.0004137643,0.0009802801,0.000276733,0.0004447933,0.000054442193,0.00033528326,0.00044553026,0.00032185277],"category_scores_gemma":[0.0005442389,0.000468299,0.00011492991,0.00022349322,0.0008324366,0.0003412659,0.000252485,0.0014038223,0.000006316163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119017066,0.00058558513,0.0015276124,0.00015841829,0.00062280544,0.00008030502,0.00048430797,0.000015285848,0.9504103,0.00050557277,0.024381572,0.021109197],"study_design_scores_gemma":[0.013496956,0.0007490468,0.011443058,0.000102474936,0.0010312645,0.0022985027,0.00021575998,0.0010130472,0.8066134,0.00048434295,0.16235594,0.00019622875],"about_ca_topic_score_codex":0.0000388259,"about_ca_topic_score_gemma":0.000006954491,"teacher_disagreement_score":0.14379694,"about_ca_system_score_codex":0.000039284405,"about_ca_system_score_gemma":0.00010474386,"threshold_uncertainty_score":0.9997769},"labels":[],"label_agreement":null},{"id":"W1919247819","doi":"10.1016/j.clpt.2005.12.124","title":"OV-A-3Genetic determinants of the hepatic expression of the phase II conjugating UGT1A3 enzyme","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Enzyme; Chemistry; Phase (matter); Biochemistry; Pharmacology; Medicine; Organic chemistry","score_opus":0.16431138991915625,"score_gpt":0.5032590767554878,"score_spread":0.3389476868363315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919247819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842836,0.003777336,0.00004617815,0.0016421739,0.008359363,0.0011128183,0.00015719981,0.00004496435,0.00057633675],"genre_scores_gemma":[0.98015,0.0010299816,0.00018142168,0.017054686,0.0009314363,0.000060422157,0.000005684777,0.00006244448,0.00052396435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9930461,0.0029944074,0.0022083619,0.00056193693,0.00043537913,0.00075379974],"domain_scores_gemma":[0.99536556,0.0018283727,0.0015703471,0.00071054464,0.00032534622,0.00019983182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019030861,0.0004777634,0.0009401242,0.00008716196,0.0007395875,0.000010006321,0.0016797129,0.00066257117,0.00068702316],"category_scores_gemma":[0.00008382619,0.0003066006,0.00073340064,0.00052325276,0.0022326028,0.00006714457,0.00086155446,0.001596104,0.000017621462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006231856,0.0035487209,0.07365469,0.0000853142,0.00032919212,0.000007166689,0.00041991883,0.00090167474,0.90075856,0.00004815831,0.005408853,0.014214567],"study_design_scores_gemma":[0.008250563,0.00039879052,0.01834903,0.000053266525,0.002118582,0.00001430322,0.00004741376,0.008053745,0.89441174,0.00072414335,0.06725529,0.00032310913],"about_ca_topic_score_codex":0.000020384785,"about_ca_topic_score_gemma":0.000012856925,"teacher_disagreement_score":0.061846435,"about_ca_system_score_codex":0.00004036417,"about_ca_system_score_gemma":0.00033997482,"threshold_uncertainty_score":0.9999386},"labels":[],"label_agreement":null},{"id":"W1932022242","doi":"10.1016/s0022-3565(24)35325-x","title":"Potentiation of Oxygen-Induced Lung Injury in Rats by the Mechanism-Based Cytochrome P-450 Inhibitor, 1-Aminobenzotriazole","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences","keywords":"Hyperoxia; Lung; Cytochrome P450; Microsome; Oxygen toxicity; Pharmacology; Cytochrome; Internal medicine; Chemistry; Endocrinology; Enzyme; Biology; Medicine; Biochemistry","score_opus":0.04850392889263474,"score_gpt":0.4055658496335674,"score_spread":0.3570619207409327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1932022242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984791,0.011515675,0.000039882045,0.0013270248,0.0015594314,0.00044749395,0.000048973143,0.000012711625,0.00025783377],"genre_scores_gemma":[0.9900412,0.0022806134,0.00008363958,0.0070549618,0.0003712536,0.000024777344,0.0000071265176,0.00003195008,0.0001045065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99718606,0.00088172307,0.0009688774,0.00023515058,0.00029242033,0.00043576251],"domain_scores_gemma":[0.99883264,0.0002231473,0.0005402466,0.000117968,0.00012073645,0.00016524736],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011846258,0.00031529166,0.00051573996,0.00021903732,0.00021294404,0.000019956695,0.00039819782,0.00034465283,0.0020730572],"category_scores_gemma":[0.0000054855814,0.00025055354,0.00017525004,0.00029951544,0.0002416793,0.00018283624,0.000055054785,0.0009514125,0.000008526339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002506702,0.001130127,0.00025895613,0.000020439764,0.00035005723,0.000025407366,0.0009551933,0.00039247356,0.97885454,0.000085504194,0.002053562,0.013367054],"study_design_scores_gemma":[0.0060116462,0.00054227666,0.00035916377,0.00001369867,0.00037487398,0.000056235633,0.00020978924,0.0056368383,0.9660671,0.00022715845,0.02026695,0.0002343066],"about_ca_topic_score_codex":0.000009350272,"about_ca_topic_score_gemma":7.4677945e-7,"teacher_disagreement_score":0.018213388,"about_ca_system_score_codex":0.00010478637,"about_ca_system_score_gemma":0.00017811704,"threshold_uncertainty_score":0.9999947},"labels":[],"label_agreement":null},{"id":"W1933983447","doi":"10.1139/cjpp-2012-0334","title":"Prediction of hepatic plasma clearance in vivo from gel-entrapped rat and human hepatocytes","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"In vivo; In vitro; Chemistry; Human plasma; Metabolic clearance rate; Plasma; Dispersion (optics); Distribution (mathematics); Pharmacokinetics; Chromatography; Biophysics; Biochemistry; Pharmacology; Biology; Mathematics","score_opus":0.06402301019181372,"score_gpt":0.3495859931400059,"score_spread":0.28556298294819216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933983447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98700565,0.009128135,0.0000051811803,0.00024151051,0.0029457589,0.0002178495,0.00021559124,0.00000599778,0.00023430705],"genre_scores_gemma":[0.99613565,0.0019627935,0.00006659972,0.0009890202,0.00077075517,0.000011508009,0.000009849634,0.000018978748,0.000034860717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976518,0.0007824411,0.0006650657,0.00020886684,0.00007363966,0.00061816844],"domain_scores_gemma":[0.998211,0.00037922623,0.0003875096,0.00008510654,0.00010395604,0.00083318946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007162807,0.0002360354,0.000592875,0.00034453557,0.00019524073,0.0000062138674,0.0002109107,0.00036024748,0.0029569366],"category_scores_gemma":[0.000031624684,0.00023090636,0.00008035331,0.0001501212,0.00065563165,0.00020076342,0.000038312,0.00085109385,0.000005404653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039391004,0.00012512309,0.17344503,0.00006512418,0.00021800934,0.000030146439,0.0013190559,0.00010847844,0.82114714,0.0003176136,0.0016409913,0.001189378],"study_design_scores_gemma":[0.0053512147,0.00030778497,0.15845999,0.00003114536,0.0004876555,0.00011223971,0.00013541908,0.0011060918,0.78081363,0.0015999537,0.0513307,0.000264154],"about_ca_topic_score_codex":0.00087445404,"about_ca_topic_score_gemma":0.0005410772,"teacher_disagreement_score":0.04968971,"about_ca_system_score_codex":0.000048511614,"about_ca_system_score_gemma":0.00024125105,"threshold_uncertainty_score":0.9979545},"labels":[],"label_agreement":null},{"id":"W1947995207","doi":"10.4212/cjhp.v61i2.129","title":"Stockley’s Drug Interactions Pocket Companion, 2007","year":2008,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Drug; Pharmacology","score_opus":0.10031288708434959,"score_gpt":0.40080807988973066,"score_spread":0.30049519280538106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1947995207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95207727,0.009609182,0.00004517679,0.012813961,0.014713759,0.0003580782,0.00012755215,0.000024193347,0.0102308225],"genre_scores_gemma":[0.98797524,0.000914216,0.00009538272,0.00664767,0.0022483985,0.000009386369,0.000008168368,0.00004220327,0.0020593526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975981,0.00048502194,0.00071218197,0.00019277346,0.00030087735,0.0007110555],"domain_scores_gemma":[0.9969995,0.00026212636,0.00047043327,0.00023012687,0.00055101776,0.0014868123],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009918517,0.00030072252,0.000377764,0.00031921008,0.0013849403,0.000055682016,0.00096948526,0.00005780934,0.0064158896],"category_scores_gemma":[0.00011208539,0.00023332181,0.00030380028,0.00033078794,0.0005969257,0.0003371683,0.00005281634,0.0018210288,0.00038051564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019122871,0.00038702844,0.039166022,0.000014913383,0.0007629183,0.0012597213,0.0073455893,0.0023032422,0.0030365656,0.0007835632,0.93447554,0.010273675],"study_design_scores_gemma":[0.0022690182,0.000063208296,0.007307661,0.000013306649,0.00027556493,0.0009877555,0.00021741352,0.00054557587,0.009639756,0.00057545747,0.97778875,0.0003165402],"about_ca_topic_score_codex":0.003708399,"about_ca_topic_score_gemma":0.002618689,"teacher_disagreement_score":0.04331321,"about_ca_system_score_codex":0.00020302835,"about_ca_system_score_gemma":0.0016115826,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W1958070321","doi":"10.1002/clc.22200","title":"Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization","year":2013,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Pharmacogenetics; Precision medicine; Personalized medicine; Pharmacogenomics; Intensive care medicine; Disease; Pharmacodynamics; Clinical pharmacology; Pharmacology; Bioinformatics; Internal medicine; Pharmacokinetics; Genotype; Pathology","score_opus":0.19093092557257357,"score_gpt":0.46416457451257137,"score_spread":0.2732336489399978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1958070321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676513,0.020813458,0.0008182724,0.002635941,0.0027218559,0.0015924595,0.00015360929,0.000044565506,0.0035685222],"genre_scores_gemma":[0.98799473,0.007806654,0.00014228278,0.0022952042,0.001304523,0.00031724392,0.000041183433,0.000034486075,0.00006372119],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950095,0.0026003541,0.0010451416,0.00061949744,0.0002276609,0.00049784285],"domain_scores_gemma":[0.99725354,0.0011726691,0.00017085795,0.0007040403,0.00021265716,0.00048622413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023459566,0.00025630507,0.0008927419,0.000101883226,0.000092669536,0.000011007662,0.0006151065,0.00036138223,0.0005690636],"category_scores_gemma":[0.0007131396,0.00019927314,0.0005589792,0.0002848471,0.00034558188,0.00005145897,0.00031103767,0.0007627976,0.0002661332],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009603495,0.0007330061,0.4694001,0.00010009226,0.0039049631,0.00017269465,0.0011417065,0.10264712,0.011267892,0.001412372,0.012004815,0.3962549],"study_design_scores_gemma":[0.0041978676,0.00016094188,0.47079152,0.000024973851,0.0014219026,0.000004437673,0.00010206852,0.010411755,0.0016915353,0.00829433,0.5023602,0.0005384778],"about_ca_topic_score_codex":0.00016571015,"about_ca_topic_score_gemma":0.000008470584,"teacher_disagreement_score":0.49035537,"about_ca_system_score_codex":0.000028400324,"about_ca_system_score_gemma":0.00011608975,"threshold_uncertainty_score":0.8126123},"labels":[],"label_agreement":null},{"id":"W1963797800","doi":"10.1002/jbt.20103","title":"Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT–PCR","year":2006,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"CYP1A2; Gene isoform; Cytochrome P450; Real-time polymerase chain reaction; Messenger RNA; Inducer; Molecular biology; Gene expression; Biology; CYP2E1; Chemistry; Biochemistry; Gene; Enzyme","score_opus":0.04918967283824594,"score_gpt":0.37894300831280103,"score_spread":0.3297533354745551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963797800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070793,0.0072614867,0.0006579925,0.0007416849,0.00024926336,0.00019243672,0.000045096323,0.0000029897235,0.00014112516],"genre_scores_gemma":[0.9984719,0.000540868,0.00054621877,0.00034303858,0.00004769855,0.000004181611,0.0000059103454,0.000009154487,0.00003103721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983954,0.0003667771,0.000678596,0.00019825279,0.00016651992,0.00019445522],"domain_scores_gemma":[0.99867207,0.00021221214,0.0006661025,0.0001442104,0.00018682914,0.00011854837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007195965,0.0001504384,0.00039649886,0.00007478046,0.00007079808,0.000005712897,0.00020541604,0.00031398775,0.000041145926],"category_scores_gemma":[0.00017205637,0.00010069687,0.00012338409,0.000121769044,0.0006323075,0.000050418337,0.00009816507,0.00045463207,4.1144273e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037905815,0.00042706603,0.0011876047,0.00005969858,0.00006328878,0.00000404289,0.000118720156,0.000028054761,0.9943282,0.0007232313,0.0018116275,0.0008693989],"study_design_scores_gemma":[0.0014110396,0.00022575812,0.004776582,0.000021667925,0.00015340824,0.000051156683,0.000055556808,0.000108548644,0.9868014,0.0022554707,0.004038623,0.00010079538],"about_ca_topic_score_codex":0.000007618405,"about_ca_topic_score_gemma":0.000001145085,"teacher_disagreement_score":0.007763968,"about_ca_system_score_codex":0.00001559853,"about_ca_system_score_gemma":0.000066843975,"threshold_uncertainty_score":0.4106299},"labels":[],"label_agreement":null},{"id":"W1964281506","doi":"10.4155/bio.09.168","title":"Opinion: Microdosing: Safer Clinical Trials and Fewer Animal Tests","year":2010,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Dr Hadwen Trust for Humane Research","keywords":"SAFER; Clinical trial; Animal testing; Pharmacology; Medicine; Computer science; Biology; Internal medicine; Computer security","score_opus":0.36628675302535707,"score_gpt":0.5806299406802352,"score_spread":0.21434318765487814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964281506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97526336,0.011491316,0.00004329051,0.0033644077,0.0055299075,0.0003226727,0.00012939806,0.000083436564,0.0037722026],"genre_scores_gemma":[0.98882365,0.0043370402,0.0012495535,0.0025129768,0.0023118288,0.000019787647,0.000030082394,0.000028639462,0.00068643916],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611396,0.0015924226,0.0011129699,0.0005638118,0.00018387617,0.00043297332],"domain_scores_gemma":[0.9970794,0.0015038538,0.0003545291,0.00034011327,0.00015666524,0.0005654426],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0077661043,0.0002834806,0.0009041016,0.00020584096,0.00026816243,0.00006657609,0.0003041626,0.00055376004,0.0033266721],"category_scores_gemma":[0.0013487206,0.00023626107,0.0004650891,0.0003604956,0.00042157734,0.00007878304,0.00016448967,0.0011285343,0.00019821845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053590874,0.00068620517,0.15690348,0.000025980247,0.001947526,0.00003017124,0.00019250854,0.0000077179775,0.5090003,0.0012710568,0.0106158955,0.31878328],"study_design_scores_gemma":[0.0021691355,0.000057588863,0.04210044,0.0000031622326,0.0015262347,0.00001948369,0.000026749547,0.0016133891,0.019512061,0.00023851183,0.9323899,0.000343302],"about_ca_topic_score_codex":0.000017756623,"about_ca_topic_score_gemma":0.000020591822,"teacher_disagreement_score":0.921774,"about_ca_system_score_codex":0.000009464148,"about_ca_system_score_gemma":0.00009194792,"threshold_uncertainty_score":0.9975844},"labels":[],"label_agreement":null},{"id":"W1964371322","doi":"10.1139/y08-088","title":"Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Universidade de São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Ketoconazole; Chemistry; Quinidine; Fluvoxamine; Pharmacology; Pharmacokinetics; Drug interaction; Metabolism; CYP3A4; CYP2D6; CYP3A; Citalopram; Endocrinology; Cytochrome P450; Receptor; Biochemistry; Medicine; Fluoxetine","score_opus":0.05422045697016994,"score_gpt":0.35323263445877995,"score_spread":0.29901217748861003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964371322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401844,0.0035773853,0.0000019706386,0.0008108864,0.00066507125,0.00036352887,0.00009020216,0.0000033007127,0.00046924746],"genre_scores_gemma":[0.99313253,0.004247603,0.000030277193,0.0023079515,0.00020658509,0.000016321808,0.0000028560696,0.000017536797,0.00003831218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751353,0.0008627027,0.0007823706,0.00024164726,0.00011077291,0.00048897],"domain_scores_gemma":[0.9973351,0.0011805053,0.00057685934,0.00011192173,0.0003525306,0.0004431127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008739744,0.00026487967,0.0006606577,0.00048582282,0.00020054157,0.000002916139,0.00037276538,0.00026987618,0.0005198817],"category_scores_gemma":[0.00013613843,0.00020700184,0.00009390368,0.00038051803,0.001668667,0.0000984647,0.000049962633,0.0010902999,0.000003160252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005887709,0.00016125343,0.016791493,0.00007812461,0.00027769402,0.000114677154,0.0015886757,0.0041390597,0.97261333,0.000978219,0.0017333864,0.0009353404],"study_design_scores_gemma":[0.0029864963,0.0005670569,0.10406763,0.000027132937,0.00019384702,0.00023518041,0.00008887498,0.0004711758,0.87944967,0.0012162203,0.010487929,0.0002087826],"about_ca_topic_score_codex":0.00023381936,"about_ca_topic_score_gemma":0.00014604513,"teacher_disagreement_score":0.09316363,"about_ca_system_score_codex":0.00003195102,"about_ca_system_score_gemma":0.000687754,"threshold_uncertainty_score":0.844129},"labels":[],"label_agreement":null},{"id":"W1964571784","doi":"10.1016/s1040-0486(01)70007-5","title":"Drug interactions/P450","year":2001,"lang":"en","type":"article","venue":"Current Problems in Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Drug; Medicine; Pharmacology","score_opus":0.15149489478162362,"score_gpt":0.4669930212480249,"score_spread":0.3154981264664013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964571784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404884,0.02092486,0.00053169404,0.003377973,0.0096096145,0.00071827485,0.00002455578,0.00018859515,0.024136014],"genre_scores_gemma":[0.99010074,0.0074321576,0.00009210562,0.0010897184,0.0002895152,0.00021714324,0.000038265993,0.000030859937,0.0007095144],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997385,0.00059707946,0.00068032235,0.00045340433,0.00013234417,0.00075180776],"domain_scores_gemma":[0.9989508,0.00026812847,0.00017457096,0.0002668896,0.000086164866,0.0002534913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00041721863,0.0002951135,0.00041132147,0.00038852493,0.00016245162,0.000021050206,0.00045831743,0.00014393136,0.0018971965],"category_scores_gemma":[0.0000614471,0.00029875324,0.00011307253,0.00046942275,0.00020979463,0.00018802109,0.00018587252,0.0013842905,0.0008052211],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025871088,0.0028808508,0.49851337,0.0003328852,0.0002028429,0.00044063554,0.003601828,0.0040077018,0.023509169,0.009672266,0.072935656,0.3836441],"study_design_scores_gemma":[0.00197744,0.000006810766,0.003821604,0.000029981971,0.00005505214,0.0006599875,0.00004933411,0.0044230376,0.0049364106,0.0044967323,0.97922003,0.00032356122],"about_ca_topic_score_codex":0.000017795628,"about_ca_topic_score_gemma":0.000112178735,"teacher_disagreement_score":0.9062844,"about_ca_system_score_codex":0.0000634428,"about_ca_system_score_gemma":0.00008065406,"threshold_uncertainty_score":0.99997276},"labels":[],"label_agreement":null},{"id":"W1964732626","doi":"10.1021/tx800177k","title":"Demonstration of the Metabolic Pathway Responsible for Nevirapine-Induced Skin Rash","year":2008,"lang":"en","type":"article","venue":"Chemical Research in Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chemistry; Quinone methide; Metabolite; Rash; Hydroxylation; Pharmacology; Stereochemistry; Metabolic pathway; Metabolism; Quinone; Biochemistry; Enzyme; Medicine; Dermatology","score_opus":0.4167828139448221,"score_gpt":0.529682845843989,"score_spread":0.11290003189916686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964732626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885591,0.0016003448,0.000022676153,0.003110731,0.00072781293,0.0012115575,0.000056146757,0.000021647202,0.004689951],"genre_scores_gemma":[0.996643,0.0009859789,0.0004130125,0.00068240805,0.0003439941,0.00041494667,0.000010862719,0.00002901075,0.00047680794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995801,0.0017141799,0.0006519566,0.00046383866,0.00041057362,0.0009584879],"domain_scores_gemma":[0.99629,0.00253847,0.00014363012,0.00039687127,0.00036056404,0.0002704406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003526458,0.00020919509,0.00047184946,0.0003309085,0.0002428265,0.0000073103683,0.0008307302,0.0006234349,0.00020757956],"category_scores_gemma":[0.0014066525,0.00016786135,0.00020499255,0.0010413862,0.0009839865,0.00007178848,0.00031472926,0.0015069301,0.00002717144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063311635,0.0005206414,0.0027599533,0.00003540426,0.00005191179,0.000014700822,0.00031565918,0.000058036254,0.96923745,0.008504091,0.0021278872,0.01574118],"study_design_scores_gemma":[0.00241187,0.000089114576,0.003797866,0.000009412025,0.000023165381,0.000030418378,0.000041690942,0.0013938275,0.89997655,0.003231297,0.08884864,0.00014616433],"about_ca_topic_score_codex":0.000018493432,"about_ca_topic_score_gemma":0.000022225908,"teacher_disagreement_score":0.08672075,"about_ca_system_score_codex":0.00008365645,"about_ca_system_score_gemma":0.0009707569,"threshold_uncertainty_score":0.6845187},"labels":[],"label_agreement":null},{"id":"W1964983051","doi":"10.1124/dmd.31.2.202","title":"Comparison of the Formation of N-Alkylprotoporphyrin IX after Interaction of Porphyrinogenic Xenobiotics with Single cDNA-Expressed Human P450 Enzymes in Microsomes Prepared from Baculovirus-Infected Insect Cells and Human Lymphoblastoid Cell Lines+","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Microsome; Xenobiotic; CYP1A2; Cytochrome P450; Complementary DNA; Enzyme; Biochemistry; CYP3A4; Biology; CYP2B6; Isozyme; Molecular biology; Chemistry; Gene","score_opus":0.034886315928599025,"score_gpt":0.33663304785152715,"score_spread":0.3017467319229281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964983051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942472,0.003946436,0.00006944898,0.00001509498,0.00023326423,0.00081507803,0.00036856867,0.0000141965365,0.0002907313],"genre_scores_gemma":[0.9992223,0.00023295608,0.00023654809,0.00006163624,0.00005029867,0.000049312686,0.00009654754,0.00002410164,0.00002635004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978539,0.0006080187,0.0008014293,0.00030452144,0.00019348992,0.00023867637],"domain_scores_gemma":[0.9986847,0.0001231224,0.0007129524,0.00023554878,0.00014932468,0.000094319395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030185515,0.00028318027,0.0005772389,0.0002092375,0.00013228538,0.000020959624,0.00014065662,0.00017787317,0.00008892213],"category_scores_gemma":[0.000012156498,0.00022778354,0.000104483275,0.0002709588,0.00027151583,0.0002503183,0.0000782404,0.00025859274,8.801294e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059623807,0.0010731788,0.027972957,0.00022354755,0.00006344926,0.0000010625108,0.0037821194,0.00040678016,0.9652093,0.0002823611,0.000031151267,0.0003578534],"study_design_scores_gemma":[0.0033409104,0.0000861787,0.081453845,0.000076719334,0.0003962847,0.0000029751593,0.0003604404,0.00027427514,0.912435,0.0002200369,0.0011456732,0.00020768934],"about_ca_topic_score_codex":0.00020952648,"about_ca_topic_score_gemma":0.00014083029,"teacher_disagreement_score":0.053480886,"about_ca_system_score_codex":0.000025195346,"about_ca_system_score_gemma":0.000039893257,"threshold_uncertainty_score":0.9288743},"labels":[],"label_agreement":null},{"id":"W1965061440","doi":"10.1002/cbic.201200524","title":"Type II Ligands as Chemical Auxiliaries To Favor Enzymatic Transformations by P450 2E1","year":2012,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Biocatalysis; Enzyme; Combinatorial chemistry; Substrate (aquarium); Active site; Stereochemistry; Biochemistry; Catalysis; Biology; Reaction mechanism","score_opus":0.07344985078902708,"score_gpt":0.424801213434592,"score_spread":0.3513513626455649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965061440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706394,0.004147894,0.000099469224,0.0020223178,0.0012240998,0.00041200846,0.00010796451,0.00013918798,0.021207668],"genre_scores_gemma":[0.9887824,0.0003348959,0.00028340105,0.0058355904,0.0005923161,0.00009447855,0.00013657505,0.00004155887,0.0038988022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982162,0.000055164284,0.00042280817,0.00027301902,0.00022184152,0.00081096555],"domain_scores_gemma":[0.9985677,0.00011780858,0.00008139736,0.000259193,0.00011845275,0.0008554548],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004875207,0.00032276832,0.0003390253,0.00008430052,0.00034580042,0.000028293713,0.00038352932,0.00037083516,0.0019151563],"category_scores_gemma":[0.00014679901,0.00031798246,0.00012532237,0.00040062226,0.0001410286,0.00017766179,0.00014357585,0.0005300679,0.0012717798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011334517,0.00048038058,0.00018175249,0.00004775884,0.00011588167,0.0000011378377,0.0038866512,0.000005721999,0.90273815,0.0010488549,0.086565174,0.004815208],"study_design_scores_gemma":[0.00067784585,0.000035142373,0.000046245314,0.0000058821934,0.00013538533,0.000013360488,0.00010543418,0.00009298019,0.65136254,0.00010792324,0.3471599,0.00025733607],"about_ca_topic_score_codex":0.0000055294768,"about_ca_topic_score_gemma":3.5187722e-7,"teacher_disagreement_score":0.26059473,"about_ca_system_score_codex":0.00006338888,"about_ca_system_score_gemma":0.00009942316,"threshold_uncertainty_score":0.9999272},"labels":[],"label_agreement":null},{"id":"W1965844669","doi":"10.1529/biophysj.105.069369","title":"Structural Motif-Based Homology Modeling of CYP27A1 and Site-Directed Mutational Analyses Affecting Vitamin D Hydroxylation","year":2006,"lang":"en","type":"article","venue":"Biophysical Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Homology modeling; Biochemistry; Hydroxylation; Active site; Binding site; Cytochrome P450; Stereochemistry; Site-directed mutagenesis; Chemistry; Docking (animal); Mutagenesis; CYP27A1; Biology; Protein structure; Enzyme; Mutation; Gene; Mutant","score_opus":0.0925468959742783,"score_gpt":0.42036459296474304,"score_spread":0.32781769699046476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965844669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966147,0.00029402005,0.0020955573,0.00014812601,0.00045844264,0.00010694945,0.000050972143,0.00003798376,0.00019325719],"genre_scores_gemma":[0.9973347,0.000022215221,0.0016251394,0.00014308079,0.00079296465,0.0000030539709,0.000045910005,0.000017375109,0.000015538724],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983877,0.0004264887,0.00045005945,0.00021530627,0.00021487655,0.00030560078],"domain_scores_gemma":[0.99898195,0.0003212699,0.00027056626,0.00007081143,0.00019529031,0.00016012124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000329411,0.00019495466,0.00031985383,0.00019417777,0.00029323608,0.000030582447,0.0001144773,0.00016307726,0.00013501882],"category_scores_gemma":[0.00005363622,0.0001739711,0.00014334948,0.00023382987,0.0001639824,0.000104047045,0.000037481477,0.0005448831,0.000006206895],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013832099,0.00012020406,0.005266562,0.000017392946,0.00007606039,0.000027812297,0.00008288228,0.18808095,0.80285925,0.00019397582,0.00003406696,0.0031025521],"study_design_scores_gemma":[0.0014841126,0.000058432357,0.014323596,0.000007739424,0.00022876816,0.00007647644,0.000016134632,0.7967443,0.18558577,0.001269253,0.00004718457,0.0001582586],"about_ca_topic_score_codex":0.000036090263,"about_ca_topic_score_gemma":0.000004381014,"teacher_disagreement_score":0.61727345,"about_ca_system_score_codex":0.000030916763,"about_ca_system_score_gemma":0.000067319255,"threshold_uncertainty_score":0.70943356},"labels":[],"label_agreement":null},{"id":"W1966988028","doi":"10.3109/03602532.2012.751992","title":"Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGT","year":2013,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Glucuronidation; Chemistry; Glucuronosyltransferase; Receptor; Uridine diphosphate; Nuclear receptor; Biochemistry; Enzyme; Cell biology; Gene; Biology; Transcription factor","score_opus":0.12628961848727616,"score_gpt":0.42306576512738975,"score_spread":0.2967761466401136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966988028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053977634,0.9810908,0.0000051167194,0.0031118458,0.0049944534,0.006938826,0.00010221094,0.000056475346,0.0036462813],"genre_scores_gemma":[0.000019582149,0.9872666,0.000133037,0.005759612,0.0022724716,0.00095217,0.00005026334,0.00014047803,0.0034058075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98639363,0.009728632,0.001810755,0.0008597313,0.00037860963,0.0008286138],"domain_scores_gemma":[0.9940935,0.0026994667,0.0014463288,0.0012575381,0.00012924841,0.00037395733],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.007995022,0.0011766432,0.0033081898,0.00012344739,0.0015420528,0.00035199182,0.0018224311,0.0005506381,0.0015954899],"category_scores_gemma":[0.00048653092,0.00047529643,0.00095680234,0.0006473007,0.0020160794,0.00016682499,0.0009225836,0.0031439397,0.0010434757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001676997,0.000043540997,0.0000017808703,0.0015948977,0.00044959714,0.000001928038,0.00096072274,9.951151e-7,0.0000040991204,0.018009288,0.048466686,0.93044966],"study_design_scores_gemma":[0.0011799262,0.000006695669,0.0000059125487,0.00043178903,0.008536082,0.00010824825,0.000099844445,0.00008926301,0.000010385415,0.00040731544,0.9885667,0.0005578193],"about_ca_topic_score_codex":0.000036739057,"about_ca_topic_score_gemma":0.000006785874,"teacher_disagreement_score":0.9401,"about_ca_system_score_codex":0.0000341005,"about_ca_system_score_gemma":0.000152306,"threshold_uncertainty_score":0.99976987},"labels":[],"label_agreement":null},{"id":"W1967723196","doi":"10.1002/jps.10182","title":"The Influence of Lipids on Stereoselective Pharmacokinetics of Halofantrine: Important Implications in Food‐Effect Studies Involving Drugs That Bind to Lipoproteins","year":2002,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Halofantrine; Bioavailability; Pharmacokinetics; Chemistry; Pharmacology; Volume of distribution; Enantiomer; Oral administration; Peanut oil; Free fraction; Distribution (mathematics); Stereochemistry; Medicine; Chloroquine","score_opus":0.18110921458844792,"score_gpt":0.47230847675474874,"score_spread":0.2911992621663008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967723196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789992,0.01552236,0.000009252841,0.0033523303,0.0008975615,0.0006787042,0.000041521016,0.000009922164,0.00048914226],"genre_scores_gemma":[0.97986406,0.018575996,0.00017659823,0.0010700042,0.00023099552,0.000033320262,2.287137e-7,0.000015783784,0.000033018856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99587786,0.00087721494,0.0014180121,0.0003387369,0.00079871324,0.0006894668],"domain_scores_gemma":[0.9948162,0.0030400255,0.000980303,0.00019848473,0.0005315485,0.00043346704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050330153,0.00032173377,0.00069729815,0.00050743105,0.00037828216,0.000036679805,0.0011308147,0.00012724444,0.00009919385],"category_scores_gemma":[0.0009571378,0.00020662189,0.0002233931,0.0015774677,0.0011794092,0.00022316408,0.00022725397,0.001033507,0.00000757118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014265338,0.0015973124,0.09833822,0.00025294846,0.0009873443,0.000033338798,0.0063273674,0.02026276,0.7504291,0.0044195596,0.0015615918,0.114363946],"study_design_scores_gemma":[0.0037276659,0.0028971978,0.024985934,0.00022206162,0.00039382535,0.000056272183,0.0005974288,0.003642048,0.93055683,0.0015432115,0.030969217,0.00040830657],"about_ca_topic_score_codex":0.000009328122,"about_ca_topic_score_gemma":0.000011665552,"teacher_disagreement_score":0.18012775,"about_ca_system_score_codex":0.00010201209,"about_ca_system_score_gemma":0.00013210338,"threshold_uncertainty_score":0.8425796},"labels":[],"label_agreement":null},{"id":"W1967788840","doi":"10.1111/j.1365-2125.2006.02796.x","title":"The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension","year":2006,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Université Laval","funders":"","keywords":"Nebivolol; CYP2D6; Pharmacology; Tolerability; Medicine; Blood pressure; Atenolol; Adverse effect; Essential hypertension; Internal medicine; Cytochrome P450; Metabolism","score_opus":0.08047983882801567,"score_gpt":0.4496756294067638,"score_spread":0.36919579057874813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967788840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928417,0.0012765843,0.000007756845,0.0017621324,0.003371795,0.0005046239,0.000049268507,0.0000068977665,0.00017922773],"genre_scores_gemma":[0.9932661,0.002521476,0.000079544196,0.0030904212,0.00095287245,0.000008549623,0.0000027181668,0.000027364493,0.0000509706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9886536,0.0066028824,0.003447166,0.00030335202,0.0005169697,0.00047600566],"domain_scores_gemma":[0.9829899,0.013190458,0.002282982,0.00021655044,0.0010956721,0.00022445392],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011562622,0.00023485794,0.0010353825,0.0001240377,0.00020386097,0.000016342177,0.0008844432,0.00040873862,0.00020985221],"category_scores_gemma":[0.002201598,0.0001543286,0.00040331742,0.00035424845,0.0017512513,0.0001031278,0.00015186095,0.002488363,0.000010989705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17431757,0.015646862,0.5934326,0.000068314905,0.0016415558,0.0010954592,0.00013105512,0.027669828,0.034689184,0.00055490655,0.06321121,0.08754143],"study_design_scores_gemma":[0.015132339,0.0017793899,0.94779557,0.00008320643,0.0004664884,0.000066592234,0.000022039001,0.0002789818,0.0056269947,0.00043837243,0.028124461,0.00018554783],"about_ca_topic_score_codex":0.00004431449,"about_ca_topic_score_gemma":0.000025180176,"teacher_disagreement_score":0.35436296,"about_ca_system_score_codex":0.000023120121,"about_ca_system_score_gemma":0.0004715502,"threshold_uncertainty_score":0.99981296},"labels":[],"label_agreement":null},{"id":"W1968172143","doi":"10.1038/npp.2008.110","title":"Brain Drug-Metabolizing Cytochrome P450 Enzymes are Active In Vivo, Demonstrated by Mechanism-Based Enzyme Inhibition","year":2008,"lang":"en","type":"article","venue":"Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health","keywords":"Cytochrome P450; In vivo; Enzyme; Drug metabolism; Biochemistry; Prodrug; Pharmacology; Biology; Endogeny; Xenobiotic; Isozyme; Chemistry","score_opus":0.055646538220043444,"score_gpt":0.37160034617687415,"score_spread":0.3159538079568307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968172143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840733,0.0024646013,0.00023154926,0.0044066454,0.0030146092,0.0013891398,0.00069397764,0.0003744179,0.0033517652],"genre_scores_gemma":[0.96293485,0.0017228479,0.00016114725,0.033012543,0.0006136771,0.00041976853,0.00008096171,0.00015204729,0.00090213434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9927169,0.0027166987,0.00113569,0.0013643336,0.00047063568,0.0015957041],"domain_scores_gemma":[0.99700046,0.0009831155,0.00061492,0.00039718303,0.00024508542,0.00075922534],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000841562,0.00087919645,0.0010332372,0.0008174442,0.00062617,0.000031547974,0.0006477013,0.00069282175,0.004539473],"category_scores_gemma":[0.00014232442,0.0009779863,0.0002958073,0.0013799756,0.0006342082,0.00032145402,0.00015862311,0.0024263111,0.00031079698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001587029,0.0013268442,0.0007734137,0.000040243413,0.00013661361,0.0012350151,0.00043057252,0.0011136088,0.90643615,0.000296159,0.08470553,0.0019188523],"study_design_scores_gemma":[0.0127772335,0.00014916633,0.004758489,0.000019365578,0.00018834231,0.00020707365,0.000090560054,0.004676152,0.8215768,0.00033136396,0.15439409,0.000831411],"about_ca_topic_score_codex":0.000047888032,"about_ca_topic_score_gemma":0.000029861281,"teacher_disagreement_score":0.08485937,"about_ca_system_score_codex":0.00016666757,"about_ca_system_score_gemma":0.00033799544,"threshold_uncertainty_score":0.9998751},"labels":[],"label_agreement":null},{"id":"W1968319279","doi":"10.1097/fpc.0000000000000031","title":"Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Monooxygenase; Metabolite; Metabolism; Chemistry; Cotinine; Cytochrome P450; Drug metabolism; Biochemistry; Pharmacology; Biology; Internal medicine; CYP1A2; Medicine","score_opus":0.04835469404427228,"score_gpt":0.3456313863337212,"score_spread":0.2972766922894489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968319279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320036,0.003218956,0.00030447415,0.00097231276,0.0006307709,0.00081488886,0.00067658175,0.000041829,0.0001398018],"genre_scores_gemma":[0.9878309,0.0060803825,0.0007281385,0.0045003584,0.00037140716,0.0001212513,0.00013762877,0.000073577314,0.00015635723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99664944,0.000645167,0.00087827176,0.0008210876,0.00023667439,0.00076937233],"domain_scores_gemma":[0.9984326,0.00033529958,0.00037095687,0.00025379757,0.000153208,0.00045415736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014662584,0.00054120575,0.00065352506,0.00040404746,0.00028377617,0.00011884659,0.00023636986,0.00031728353,0.00018601649],"category_scores_gemma":[0.0000705941,0.0004948029,0.00007398347,0.00025894874,0.00024000194,0.0001791674,0.0001658045,0.000778919,0.000009826352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010243051,0.00047136762,0.02012468,0.000068402725,0.00038224936,0.000038882645,0.004790022,0.0026659607,0.9558686,0.00052676216,0.000056536155,0.013982216],"study_design_scores_gemma":[0.016316565,0.000196569,0.14098479,0.00005629374,0.0012185806,0.000053802407,0.00020762527,0.18129043,0.646312,0.0008595849,0.011135498,0.0013682626],"about_ca_topic_score_codex":0.00021394838,"about_ca_topic_score_gemma":0.00036630547,"teacher_disagreement_score":0.3095566,"about_ca_system_score_codex":0.00013586036,"about_ca_system_score_gemma":0.00011721173,"threshold_uncertainty_score":0.9997504},"labels":[],"label_agreement":null},{"id":"W1968349511","doi":"10.2174/187231210791292717","title":"Assessment of Competitive and Mechanism-Based Inhibition by Clarithromycin: Use of Domperidone as a CYP3A Probe-Drug Substrate and Various Enzymatic Sources Including a New Cell-Based Assay with Freshly Isolated Human Hepatocytes","year":2010,"lang":"en","type":"article","venue":"Drug Metabolism Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Heart And Stroke Foundation Of Quebec; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Clarithromycin; CYP3A4; CYP3A; Microsome; Non-competitive inhibition; Pharmacology; Potency; Cytochrome P450; Drug metabolism; Biology; Chemistry; Drug; Biochemistry; Enzyme; In vitro; Antibiotics","score_opus":0.033419530124974436,"score_gpt":0.33336855677661625,"score_spread":0.2999490266516418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968349511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067134,0.0009975438,0.0050450047,0.0014254974,0.00032844528,0.0011326346,0.00025228786,0.00007448256,0.000072763505],"genre_scores_gemma":[0.98819745,0.0001324401,0.0077213966,0.0035164151,0.00010547231,0.00007922201,0.00012731997,0.00007425224,0.00004600705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966113,0.0009372944,0.0008025588,0.0006389398,0.00045009993,0.0005598168],"domain_scores_gemma":[0.9975356,0.00072605134,0.00078778394,0.0003099351,0.00020426027,0.00043636558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011590369,0.0005746078,0.0009735697,0.0003528076,0.0003636555,0.00009590254,0.00023097653,0.00025834076,0.00020658612],"category_scores_gemma":[0.00003490088,0.0005209227,0.00012366242,0.0003364535,0.00065256795,0.00026986044,0.00011645413,0.0011309439,0.0000025434297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003037378,0.00052589085,0.0047920085,0.00025711616,0.0002610034,0.000029616436,0.0012145325,0.0013841102,0.987712,0.0029564383,0.0003810928,0.0001824333],"study_design_scores_gemma":[0.007898707,0.00011496369,0.004014308,0.0000963026,0.0010192274,0.00001625361,0.00014654752,0.012529491,0.9706141,0.00045325057,0.0025064952,0.00059037004],"about_ca_topic_score_codex":0.00061948056,"about_ca_topic_score_gemma":0.00015103281,"teacher_disagreement_score":0.017097937,"about_ca_system_score_codex":0.000024022389,"about_ca_system_score_gemma":0.00026309848,"threshold_uncertainty_score":0.9997242},"labels":[],"label_agreement":null},{"id":"W1968413239","doi":"10.1097/fpc.0b013e32801a3c10","title":"CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6–serotonin–dopamine crosstalk revisited","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Alliance for Research on Schizophrenia and Depression","keywords":"Perphenazine; Internal medicine; Endocrinology; CYP2D6; Dopaminergic; Serotonergic; Pharmacology; Prolactin; Dopamine; Pharmacodynamics; Medicine; Antipsychotic; Serotonin; Pharmacokinetics; Schizophrenia (object-oriented programming); Cytochrome P450; Psychiatry; Receptor; Hormone","score_opus":0.03873708750571099,"score_gpt":0.3915192264568302,"score_spread":0.3527821389511192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968413239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98376036,0.010227297,0.0014854277,0.0007087201,0.0007353644,0.0018328176,0.00028505325,0.00005085408,0.0009141076],"genre_scores_gemma":[0.98272943,0.012234084,0.0016674129,0.0025496746,0.0004143209,0.00004815991,0.00015973259,0.00007736028,0.00011980601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963677,0.00041218134,0.0010327992,0.0008913138,0.00025842,0.0010376065],"domain_scores_gemma":[0.99834967,0.00033195104,0.00022300683,0.00023566096,0.00015934053,0.0007003539],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026939898,0.00055643945,0.0006113102,0.00036493037,0.00024611544,0.00007106885,0.00019534418,0.00035772834,0.00017380607],"category_scores_gemma":[0.000070325,0.0006428755,0.00006329932,0.000670203,0.00022470635,0.00017927242,0.00024928906,0.000944598,0.000039803064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009837413,0.0002876428,0.057234265,0.00009592101,0.0000850711,0.00032069022,0.0021580579,0.005917323,0.8421355,0.00022296119,0.00008400823,0.09047483],"study_design_scores_gemma":[0.011968144,0.00030810694,0.35247853,0.00007671956,0.00045515798,0.0002463562,0.0003318937,0.109038964,0.3828484,0.0005963044,0.13996723,0.0016841647],"about_ca_topic_score_codex":0.00011914578,"about_ca_topic_score_gemma":0.00038979313,"teacher_disagreement_score":0.45928708,"about_ca_system_score_codex":0.0002382768,"about_ca_system_score_gemma":0.00011809525,"threshold_uncertainty_score":0.99960226},"labels":[],"label_agreement":null},{"id":"W1968595695","doi":"10.1007/s002280100298","title":"Study of the drug-drug interaction between simvastatin and cisapride in man","year":2001,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Dalton Pharma Services (Canada); Université Laval; Université de Montréal","funders":"Medical Research Council; Heart And Stroke Foundation Of Quebec","keywords":"Simvastatin; Cisapride; Pharmacology; Drug interaction; Medicine; Concomitant; Pharmacokinetics; Drug; Internal medicine","score_opus":0.27510572726083704,"score_gpt":0.5407515798846579,"score_spread":0.2656458526238209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968595695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876442,0.00056634675,0.000016348691,0.0021929112,0.0058893366,0.00042119715,0.000010495645,0.000010423866,0.0032487735],"genre_scores_gemma":[0.9937473,0.0014151136,0.00006680844,0.002565996,0.0018530214,0.0000028741854,9.0106994e-7,0.00003528503,0.00031272534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9863673,0.010079216,0.002604368,0.00030144193,0.00027346463,0.0003742357],"domain_scores_gemma":[0.99532104,0.0023225842,0.0016119112,0.00017743779,0.00021320111,0.00035382115],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008804705,0.00024970606,0.00083311094,0.00022971253,0.00012128041,0.000013564325,0.0007370143,0.00007704139,0.0005043389],"category_scores_gemma":[0.00038460584,0.00018440608,0.00024327823,0.00032067669,0.00035695027,0.00014316695,0.00035417007,0.0024523258,0.000028574426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023596382,0.0033449465,0.84809303,0.000030583706,0.0007260819,0.0011413897,0.003922201,0.0020079804,0.008879135,0.000014413477,0.01592831,0.11355227],"study_design_scores_gemma":[0.02084374,0.0008376875,0.7778576,0.000043427815,0.0010885076,0.00020087165,0.0017987235,0.0003779387,0.0059592472,0.00020592399,0.19046621,0.00032014205],"about_ca_topic_score_codex":0.000008597834,"about_ca_topic_score_gemma":0.000014633325,"teacher_disagreement_score":0.17453791,"about_ca_system_score_codex":0.000025252719,"about_ca_system_score_gemma":0.00009481174,"threshold_uncertainty_score":0.9998491},"labels":[],"label_agreement":null},{"id":"W1968996495","doi":"10.1097/ftd.0b013e31816b918f","title":"Herbal Supplements and Therapeutic Drug Monitoring: Focus on Digoxin Immunoassays and Interactions With St. John's Wort","year":2008,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacology; Carbamazepine; Medicine; Drug interaction; Drug; Ginseng; Digoxin; Pharmacokinetics; Therapeutic drug monitoring; Traditional medicine","score_opus":0.13787733445137268,"score_gpt":0.4444780486792382,"score_spread":0.3066007142278655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968996495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01732574,0.9736409,0.000013243557,0.00019144481,0.005518301,0.001636581,0.00020398358,0.00020809751,0.0012616602],"genre_scores_gemma":[0.120904334,0.87452453,0.00012985313,0.000112255526,0.0021114817,0.00049762835,0.000038774433,0.00026187263,0.0014192413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99444395,0.0012453655,0.001149629,0.0012506691,0.00061628956,0.0012940704],"domain_scores_gemma":[0.9966401,0.0012013322,0.0006955359,0.000720933,0.0001349259,0.0006071582],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00078358856,0.0015053062,0.00208429,0.0005371205,0.0010423361,0.00019630564,0.00073632714,0.0004631402,0.00016610735],"category_scores_gemma":[0.000013041393,0.0012348648,0.00037681227,0.0005231393,0.00043434135,0.00021227506,0.00034229457,0.003066464,0.00006552662],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002547741,0.00043964124,0.0032125134,0.0009585683,0.0026685449,0.00012160299,0.0016109912,0.00001992591,0.00023324152,0.000106263484,0.000191472,0.99018246],"study_design_scores_gemma":[0.0022479738,0.00013024925,0.00062844856,0.0021600877,0.0029517172,0.00032148385,0.00034648392,0.00003587572,0.001913362,0.00019957722,0.9877571,0.0013076355],"about_ca_topic_score_codex":0.00007892474,"about_ca_topic_score_gemma":0.0000066612283,"teacher_disagreement_score":0.98887485,"about_ca_system_score_codex":0.00029529963,"about_ca_system_score_gemma":0.0002891233,"threshold_uncertainty_score":0.99976957},"labels":[],"label_agreement":null},{"id":"W1969752754","doi":"10.1124/dmd.108.023499","title":"Identification of Ginkgo biloba as a Novel Activator of Pregnane X Receptor","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Killam Trusts; National Institutes of Health; Michael Smith Health Research BC; GlaxoSmithKline","keywords":"Pregnane X receptor; Ginkgo biloba; CYP3A4; Pharmacology; Ginkgoales; Activator (genetics); Chemistry; Gene expression; Nuclear receptor; Receptor; Biology; Cytochrome P450; In vitro; Biochemistry; Transcription factor; Biological activity; Gene; Metabolism; Pharmacognosy","score_opus":0.05127372640614435,"score_gpt":0.36863628135205867,"score_spread":0.3173625549459143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969752754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903003,0.0062442087,0.00043640292,0.00027059612,0.0009707438,0.00040917518,0.0004940507,0.000035401044,0.00083914364],"genre_scores_gemma":[0.99376494,0.0047886698,0.0003057372,0.00026466322,0.00021853462,0.00004501011,0.00010237891,0.000022669137,0.00048738407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998308,0.0002191076,0.00063435663,0.00032308733,0.00025714425,0.0002583143],"domain_scores_gemma":[0.99878484,0.00012658205,0.00044688178,0.0002264172,0.00021150956,0.00020378246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050161104,0.00021783506,0.00042349065,0.00019579941,0.00018531753,0.000008195849,0.00019110974,0.00017615856,0.00023495629],"category_scores_gemma":[0.0000679216,0.00020735919,0.00012530868,0.00031592385,0.00034320392,0.00023405103,0.00007076624,0.0002434725,0.000027195847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003867033,0.0006296749,0.00091396354,0.00009759487,0.000116189316,0.0000020869836,0.0017443916,0.00006205287,0.98180056,0.0063609704,0.0005618166,0.007324029],"study_design_scores_gemma":[0.0020624455,0.000027428976,0.016979737,0.000019639623,0.0003113106,0.000028014423,0.00012001581,0.00044474629,0.9576243,0.0005542487,0.02161604,0.00021205629],"about_ca_topic_score_codex":0.000052483436,"about_ca_topic_score_gemma":8.816065e-7,"teacher_disagreement_score":0.024176208,"about_ca_system_score_codex":0.00001149781,"about_ca_system_score_gemma":0.000079978105,"threshold_uncertainty_score":0.84558624},"labels":[],"label_agreement":null},{"id":"W1970010625","doi":"10.1016/j.bmcl.2010.07.030","title":"Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study","year":2010,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Chemistry; CYP3A4; Renin inhibitor; Moiety; Stereochemistry; Renin–angiotensin system; Amide; Drug; Pharmacology; Biochemistry; Combinatorial chemistry; Cytochrome P450; Enzyme; Internal medicine","score_opus":0.12045615350016277,"score_gpt":0.3734272187967631,"score_spread":0.25297106529660035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970010625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965921,0.00029733207,0.000021572117,0.0012755751,0.0008797285,0.00065463077,0.00008183439,0.00008062929,0.00011658013],"genre_scores_gemma":[0.99829894,0.000021241362,0.00014490109,0.00053846644,0.00072780007,0.000059269816,0.000059574006,0.00004654627,0.000103249266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974029,0.00017291101,0.00086848735,0.0005707188,0.00043036783,0.00055460155],"domain_scores_gemma":[0.99866843,0.0001334514,0.0003883462,0.00035199258,0.00012988703,0.00032787607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011835895,0.0004083284,0.0005450553,0.00013088626,0.00017155978,0.000024032426,0.00029047293,0.0003538788,0.0007144955],"category_scores_gemma":[0.00023019525,0.0003975656,0.000094579686,0.00045601674,0.0004571886,0.0001533103,0.00015789225,0.0015423126,0.00001578429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031920045,0.0010191246,0.009289418,0.00014738773,0.000119299635,0.0037308317,0.0019645505,0.000026550495,0.98235387,0.0000016136053,0.00030277652,0.00072535535],"study_design_scores_gemma":[0.00521569,0.00004707001,0.002104183,0.000073844116,0.00032336108,0.0023920066,0.0009228998,0.00025903352,0.98739153,0.000004796283,0.00088088296,0.0003846994],"about_ca_topic_score_codex":0.00031719333,"about_ca_topic_score_gemma":0.00017177469,"teacher_disagreement_score":0.0071852356,"about_ca_system_score_codex":0.00011443228,"about_ca_system_score_gemma":0.00028337073,"threshold_uncertainty_score":0.99984765},"labels":[],"label_agreement":null},{"id":"W1970033257","doi":"10.1016/s0731-7085(00)00244-2","title":"Stability and enzymatic hydrolysis of quaternary ammonium-linked glucuronide metabolites of drugs with an aliphatic tertiary amine-implications for analysis","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Medical Research Council Canada","keywords":"Chemistry; Tertiary amine; Enzymatic hydrolysis; Ammonium; Hydrolysis; Organic chemistry; Enzyme; Amine gas treating; Chromatography","score_opus":0.0739053531599121,"score_gpt":0.41673094086368556,"score_spread":0.34282558770377347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970033257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867859,0.0072134594,0.0031218005,0.0020752854,0.00006031042,0.00029871284,0.00039149495,0.000012733945,0.00004028547],"genre_scores_gemma":[0.9910554,0.005186697,0.002940293,0.00052496616,0.000149276,0.000021786185,0.00006540217,0.00001778754,0.000038360202],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9961618,0.000720583,0.0017406846,0.000429532,0.0004960552,0.00045133973],"domain_scores_gemma":[0.99638057,0.0011182746,0.0007890935,0.00028494542,0.00042941252,0.0009976776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022103651,0.00034778836,0.0016217169,0.00093847146,0.00015319894,0.000027002157,0.00040665164,0.00022769916,0.0013890349],"category_scores_gemma":[0.0000872527,0.00023872023,0.0007054963,0.0022493936,0.0011709908,0.00022327145,0.00006896453,0.00045889674,9.156873e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005676154,0.0054354817,0.29345584,0.0007993652,0.057706594,0.000025856078,0.0021633608,0.001241942,0.34806043,0.00034763434,0.000059716953,0.28502762],"study_design_scores_gemma":[0.011512771,0.0016457732,0.16244465,0.000060706665,0.2516765,0.00009696075,0.0006219155,0.35006833,0.20044571,0.002792174,0.0176036,0.0010308985],"about_ca_topic_score_codex":0.000049596,"about_ca_topic_score_gemma":0.000015405134,"teacher_disagreement_score":0.34882638,"about_ca_system_score_codex":0.000023889412,"about_ca_system_score_gemma":0.000105169864,"threshold_uncertainty_score":0.9995238},"labels":[],"label_agreement":null},{"id":"W1970064806","doi":"10.1038/sj.tpj.6500361","title":"Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine","year":2006,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Personalized medicine; Precision medicine; Medicine; Disease; Drug; Ethnic group; Drug response; Bioinformatics; Gene; Pharmacology; Genetics; Biology; Internal medicine; Genotype; Pathology; Political science","score_opus":0.09054567564092775,"score_gpt":0.4204349707298063,"score_spread":0.32988929508887854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970064806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8170495,0.15016864,0.001987416,0.020587957,0.0047502606,0.002654368,0.00045943336,0.00009971274,0.002242724],"genre_scores_gemma":[0.83958757,0.13395508,0.0006899919,0.014880541,0.008068712,0.00024299117,0.00005057252,0.00018419334,0.0023403796],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946716,0.0013927148,0.0013187167,0.00067063206,0.00045760165,0.0014887333],"domain_scores_gemma":[0.9954794,0.0021497111,0.0007989184,0.00033337527,0.00042404988,0.0008145327],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.005922575,0.0008009776,0.00090870826,0.00025340903,0.0025691413,0.00024551857,0.0010021037,0.00023034247,0.00083077967],"category_scores_gemma":[0.00012403667,0.00048544945,0.0003403002,0.00032526115,0.003305616,0.00019925418,0.00035857374,0.0018605866,0.000027165259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017495397,0.000609273,0.005679016,0.00025102764,0.004095404,0.000116405026,0.008161003,0.0040654624,0.6313423,0.06609626,0.09374123,0.16834721],"study_design_scores_gemma":[0.035637494,0.00009614515,0.0002803164,0.000014907374,0.0031256094,0.0011291603,0.00037183828,0.018448103,0.01238758,0.014765471,0.9131042,0.000639205],"about_ca_topic_score_codex":0.000097945056,"about_ca_topic_score_gemma":0.000010546057,"teacher_disagreement_score":0.81936294,"about_ca_system_score_codex":0.00015347356,"about_ca_system_score_gemma":0.00026374773,"threshold_uncertainty_score":0.99975973},"labels":[],"label_agreement":null},{"id":"W1970093780","doi":"10.2165/00129784-200404050-00002","title":"Interactions Between Grapefruit Juice and Cardiovascular Drugs","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"","keywords":"Grapefruit juice; Pharmacology; Bioavailability; Felodipine; Medicine; Fluvastatin; Nisoldipine; Repaglinide; Nitrendipine; Verapamil; Oral administration; Cisapride; Pharmacokinetics; Chemistry; Nifedipine; Metformin; Endocrinology; Internal medicine; Simvastatin; Insulin; Calcium","score_opus":0.08993227723574834,"score_gpt":0.42836363717711545,"score_spread":0.3384313599413671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970093780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005969114,0.99281174,0.00067316735,0.000068654015,0.0031974753,0.0007618366,0.00016172971,0.000051699146,0.0016767797],"genre_scores_gemma":[0.0042645754,0.9914216,0.00062394276,0.00019693002,0.0030730108,0.000059194786,0.000037684546,0.00020631617,0.00011679443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913803,0.003427236,0.0020688716,0.0008635446,0.0013095504,0.0009505361],"domain_scores_gemma":[0.99481106,0.00085747126,0.0015905435,0.0010930297,0.0005414247,0.0011064953],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00491992,0.0011478055,0.0074255797,0.001022551,0.00036789704,0.000110379515,0.0011762847,0.0004781983,0.0001182746],"category_scores_gemma":[0.00012750873,0.000999247,0.011393434,0.0012224928,0.0009946333,0.0002847546,0.00035452616,0.0039136466,0.000101964375],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028763361,0.000085548534,0.00000995079,0.0018710534,0.059921652,0.00021555476,0.0006952396,0.00059932686,0.0000012173095,0.0000311062,0.00030634872,0.93623424],"study_design_scores_gemma":[0.0016740586,0.00013414616,0.000009428446,0.0018321049,0.06750425,0.0014658266,0.0003718124,0.000003538419,0.000028859795,0.00009214339,0.9260075,0.0008763079],"about_ca_topic_score_codex":0.0000948248,"about_ca_topic_score_gemma":4.6302213e-7,"teacher_disagreement_score":0.9353579,"about_ca_system_score_codex":0.00029470472,"about_ca_system_score_gemma":0.0010427006,"threshold_uncertainty_score":0.9992458},"labels":[],"label_agreement":null},{"id":"W1970461091","doi":"10.1002/humu.20698","title":"Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent","year":2008,"lang":"en","type":"article","venue":"Human Mutation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"CYP2A6; Nicotine; Biology; Allele; Cotinine; Population; Genetics; Genotype; Gene; Medicine; CYP1A2; In vitro","score_opus":0.09492972198041459,"score_gpt":0.39175397157669206,"score_spread":0.29682424959627746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970461091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775386,0.00073273416,0.000073558534,0.000095808624,0.0001701221,0.00041547779,0.000036159934,0.000024220284,0.00069807144],"genre_scores_gemma":[0.9987964,0.00037660493,0.00039217432,0.00017034449,0.00009051832,0.000028501747,0.000053021315,0.000020381316,0.00007202565],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984543,0.0002522711,0.00056422414,0.00027662245,0.00016315302,0.00028944892],"domain_scores_gemma":[0.9993896,0.00009959958,0.00021739285,0.00010851685,0.00007453021,0.00011039229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005699191,0.0001813535,0.00033642017,0.000400349,0.00009221341,0.000009438669,0.00011283557,0.00015520306,0.00021208747],"category_scores_gemma":[0.000055540524,0.00019199013,0.00004831947,0.00035394653,0.0001577368,0.00016612292,0.000047508227,0.00030426445,0.0000033174194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003791522,0.0012406661,0.19535178,0.0001101092,0.000067310684,0.000031078718,0.013664295,0.008739281,0.77308536,0.0027437296,0.0002201167,0.004367114],"study_design_scores_gemma":[0.0050633503,0.000046861787,0.92986137,0.000016695953,0.00007219603,0.000021436203,0.00024012878,0.011190312,0.05058623,0.00092959235,0.0017322566,0.00023956275],"about_ca_topic_score_codex":0.00052118907,"about_ca_topic_score_gemma":0.0005560342,"teacher_disagreement_score":0.7345096,"about_ca_system_score_codex":0.000048427577,"about_ca_system_score_gemma":0.000039744325,"threshold_uncertainty_score":0.782913},"labels":[],"label_agreement":null},{"id":"W1970801600","doi":"10.2174/1568026043387728","title":"Preface [Hot Topic: Pharmacogenomics (Guest Editor: Amadeo M. Parissenti)]","year":2004,"lang":"en","type":"article","venue":"Current Topics in Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacology","score_opus":0.09419277259503857,"score_gpt":0.4482717134690607,"score_spread":0.35407894087402214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970801600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9289407,0.020192629,0.00018818295,0.002103307,0.038218647,0.00045570786,0.00007188931,0.00012690721,0.009701989],"genre_scores_gemma":[0.94454193,0.009255576,0.00026899204,0.0011586776,0.04343592,0.00010115316,0.00013290446,0.000054166107,0.001050671],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745655,0.00010981332,0.0006820304,0.00058700604,0.00039923322,0.00076538126],"domain_scores_gemma":[0.9987438,0.00009721998,0.00019115944,0.00034072093,0.00010555137,0.00052157114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006192198,0.00041115397,0.00044771898,0.00007801759,0.00016585347,0.000027663065,0.00065739034,0.00038982148,0.00094351306],"category_scores_gemma":[0.00012676694,0.00041730836,0.00014490868,0.00026257423,0.0002884233,0.00008925371,0.00019484122,0.0020598043,0.00009787567],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087151007,0.0043059234,0.03635138,0.0020883433,0.0004486743,0.0005533578,0.004197138,0.0038115585,0.7092554,0.0016401939,0.08186025,0.15461625],"study_design_scores_gemma":[0.003214712,0.000018193956,0.00050775736,0.00006230503,0.00013027056,0.000028504184,0.00008320559,0.00017373763,0.29202384,0.0006977875,0.7027167,0.00034301417],"about_ca_topic_score_codex":0.00001595557,"about_ca_topic_score_gemma":0.000004739203,"teacher_disagreement_score":0.62085646,"about_ca_system_score_codex":0.00025236304,"about_ca_system_score_gemma":0.00029104948,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W1970977102","doi":"10.1002/jps.23502","title":"Toward a new paradigm for the efficient in vitro–in vivo extrapolation of metabolic clearance in humans from hepatocyte data","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In vivo; Hepatocyte; In vitro; Extrapolation; Metabolic clearance rate; Chemistry; Cell biology; Biology; Computational biology; Pharmacology; Biochemistry; Pharmacokinetics; Genetics; Mathematics","score_opus":0.3159447964285114,"score_gpt":0.4846943504884899,"score_spread":0.1687495540599785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970977102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965544,0.02609356,0.0013860381,0.0045345314,0.0012423302,0.0007906234,0.00009301853,0.000004930097,0.00031096494],"genre_scores_gemma":[0.9943428,0.0031614972,0.0011205476,0.00095891685,0.00036538858,0.000020315252,0.0000019734612,0.000009949375,0.000018591667],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99703246,0.000495385,0.0011043708,0.00034756112,0.00045720328,0.0005629981],"domain_scores_gemma":[0.9975877,0.001440421,0.00042492786,0.00020412082,0.000074518066,0.00026832815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038563523,0.0002005843,0.0005156213,0.0003316536,0.00010190308,0.000048950234,0.001458713,0.00013344416,0.0007423321],"category_scores_gemma":[0.00023675433,0.0001382575,0.00012497518,0.0008107675,0.0004516977,0.00037196447,0.00015808137,0.0007801298,0.000008979769],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027336627,0.0015295515,0.039719667,0.000062457606,0.00018114538,0.000038586644,0.0041982927,0.05209205,0.74863225,0.0037057665,0.0015245001,0.14558206],"study_design_scores_gemma":[0.0067038676,0.000089799214,0.054983452,0.00005766062,0.00021808634,0.000011664947,0.00034220712,0.6188105,0.20735781,0.004771894,0.10636624,0.0002868561],"about_ca_topic_score_codex":0.00050380034,"about_ca_topic_score_gemma":0.0000611199,"teacher_disagreement_score":0.5667184,"about_ca_system_score_codex":0.000037686,"about_ca_system_score_gemma":0.00031114204,"threshold_uncertainty_score":0.81280154},"labels":[],"label_agreement":null},{"id":"W1971839077","doi":"10.1016/j.jss.2010.06.040","title":"Drug Metabolism in Hemorrhagic Shock: Pharmacokinetics of Selective Markers of Cytochrome-P450 2C9, 2D6, and 3A4 Enzyme Activities in a Porcine Model","year":2010,"lang":"en","type":"article","venue":"Journal of Surgical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Office of Naval Research; Naval Group; University of Minnesota","keywords":"Pharmacokinetics; Pharmacology; Cytochrome P450; Hemorrhagic shock; Drug metabolism; CYP2C9; CYP3A4; Drug; Medicine; Chemistry; Enzyme; Shock (circulatory); Biochemistry; Internal medicine","score_opus":0.10067116599379468,"score_gpt":0.46486015174310136,"score_spread":0.3641889857493067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971839077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900172,0.0055176145,0.000013169591,0.001220171,0.0003059383,0.0003815893,0.000058853973,0.0000047669278,0.0024807286],"genre_scores_gemma":[0.98519325,0.013592789,0.00053905154,0.00008039651,0.0002716494,0.000015404665,0.000001997957,0.000031663945,0.00027378756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99536604,0.0013207211,0.0012608111,0.00030995978,0.00096801686,0.0007744774],"domain_scores_gemma":[0.9960656,0.0020866701,0.0004676006,0.00017998299,0.00072064647,0.00047947993],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00813855,0.00027576226,0.0010212595,0.0014054497,0.000077639736,0.000018714169,0.00054148934,0.00032353032,0.0005231804],"category_scores_gemma":[0.0003760042,0.00023668085,0.00019295477,0.0010975936,0.0007918952,0.00023218487,0.00027107407,0.004339995,0.0000019779918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007218425,0.0014725153,0.0080740005,0.00018629726,0.00022804936,0.00054306834,0.0017906544,0.0057179374,0.9595246,0.00093378226,0.0012700809,0.013040595],"study_design_scores_gemma":[0.020813394,0.0004581972,0.029876431,0.00013242468,0.0002368531,0.0004918036,0.00088503025,0.098244235,0.8186079,0.006284178,0.023425015,0.000544533],"about_ca_topic_score_codex":0.00005726204,"about_ca_topic_score_gemma":0.00004783805,"teacher_disagreement_score":0.14091669,"about_ca_system_score_codex":0.0000667329,"about_ca_system_score_gemma":0.00060710066,"threshold_uncertainty_score":0.99795705},"labels":[],"label_agreement":null},{"id":"W1972310204","doi":"10.1016/j.jchromb.2005.07.016","title":"Assessment of 3-nitrobenzanthrone reductase activity in mammalian tissues by normal-phase HPLC with fluorescence detection","year":2005,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Carleton University","funders":"Health Canada; National Institutes of Health; Cancer Research Institute","keywords":"Chemistry; Chromatography; Fluorescence; High-performance liquid chromatography","score_opus":0.03501206374497128,"score_gpt":0.4152515355554261,"score_spread":0.3802394718104548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972310204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995324,0.0021500685,0.000824256,0.00032405675,0.00040744647,0.00022389648,0.00006803292,0.000013674474,0.0006645349],"genre_scores_gemma":[0.9948978,0.0015107705,0.0031330304,0.0001268013,0.0002752773,0.000009588769,0.0000036124063,0.000022451019,0.000020682164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979907,0.00039104748,0.0006906283,0.00019445179,0.00036274054,0.00037042043],"domain_scores_gemma":[0.9984736,0.00009426347,0.00079906936,0.00015853305,0.00019349549,0.0002810717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009237623,0.00024068198,0.00050851144,0.0005159786,0.00009683753,0.000018156945,0.00027853774,0.000170773,0.00036902912],"category_scores_gemma":[0.000014111622,0.00020522394,0.00017481245,0.00058014714,0.00026302828,0.00036140726,0.000033931756,0.0008206456,0.0000023850998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081281894,0.0022480811,0.011018481,0.000060635863,0.0002208687,0.00007285064,0.0002100631,0.0004741665,0.9187784,0.000040037656,0.000918622,0.06514495],"study_design_scores_gemma":[0.0066313306,0.0007877684,0.018470341,0.000051513645,0.00024750252,0.00019114342,0.00007001734,0.0019648275,0.9400067,0.00004047217,0.031305682,0.00023275489],"about_ca_topic_score_codex":0.000030916064,"about_ca_topic_score_gemma":0.000027201397,"teacher_disagreement_score":0.06491219,"about_ca_system_score_codex":0.00005512376,"about_ca_system_score_gemma":0.00013953462,"threshold_uncertainty_score":0.83687896},"labels":[],"label_agreement":null},{"id":"W1972504152","doi":"10.1006/jmbi.1999.3374","title":"Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4 1 1Edited by J. Karn","year":2000,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Pseudogene; Biology; Gene; Genetics; Exon; Gene cluster; Homology (biology); Tandem exon duplication; Promoter; Genome; Gene expression","score_opus":0.03060425396471708,"score_gpt":0.36310026061990214,"score_spread":0.3324960066551851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972504152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565804,0.002692157,0.00036182694,0.00054360507,0.00040212265,0.00019295432,0.000081605016,0.0000036358551,0.00006403986],"genre_scores_gemma":[0.9962216,0.0021278935,0.00017708122,0.0012328451,0.0001415574,0.0000034406112,0.000021739852,0.000015196321,0.000058666497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998247,0.0007023977,0.00062634767,0.00015430199,0.00011245614,0.00015746924],"domain_scores_gemma":[0.9989496,0.000064480446,0.00063478056,0.0001152706,0.00013968452,0.00009619442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054806215,0.00015970739,0.00037020445,0.00011143984,0.00008630423,0.0000064149185,0.00017119326,0.00025045205,0.00012337293],"category_scores_gemma":[0.000025835043,0.00011372571,0.00009267014,0.00013009435,0.00029161826,0.000040604864,0.00004658699,0.00027334402,8.4321914e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038963207,0.00013103845,0.004584634,0.000023646704,0.00018763692,0.000003839056,0.00019467981,0.0002654847,0.9867989,0.00012107872,0.00006552781,0.007233905],"study_design_scores_gemma":[0.0027418125,0.0003499361,0.004951741,0.00002019519,0.00024500894,0.000093767245,0.000008082514,0.0015729498,0.9789172,0.00039988526,0.010578432,0.000121000856],"about_ca_topic_score_codex":0.0000047597555,"about_ca_topic_score_gemma":6.879107e-7,"teacher_disagreement_score":0.010512904,"about_ca_system_score_codex":0.000009830847,"about_ca_system_score_gemma":0.000039844428,"threshold_uncertainty_score":0.46376002},"labels":[],"label_agreement":null},{"id":"W1972812665","doi":"10.1016/j.bcp.2013.04.014","title":"First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo","year":2013,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health; National Institutes of Health; Ontario Ministry of Research and Innovation; National Institute on Drug Abuse; Ontario Ministry of Research, Innovation and Science","keywords":"Opiate; In vivo; Neuroscience; Pharmacology; Chemistry; Medicine; Anesthesia; Psychology; Biology; Internal medicine; Receptor","score_opus":0.0615965428876762,"score_gpt":0.3782378347088845,"score_spread":0.3166412918212083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972812665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981532,0.0021643538,0.00019781175,0.010215504,0.001781136,0.0012981512,0.00007266269,0.00016630122,0.0025720927],"genre_scores_gemma":[0.98127764,0.0013652454,0.00027530955,0.015355391,0.0006648618,0.000540792,0.00011383144,0.000056710116,0.0003502315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99645495,0.0006967955,0.000741296,0.0007565339,0.00028368266,0.0010667199],"domain_scores_gemma":[0.997872,0.00085980474,0.00030286782,0.00022815652,0.0001416106,0.0005955592],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006841557,0.0005107475,0.0005988918,0.00043241488,0.00021655233,0.000044186883,0.0005542506,0.0007159183,0.008502198],"category_scores_gemma":[0.00015730126,0.0005173084,0.00017858364,0.0006970147,0.0003974201,0.00035181871,0.00017094974,0.0011361036,0.00054855016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021147312,0.00042430416,0.0022683577,0.00003360227,0.00016912511,0.00001618249,0.00020046673,0.00041965605,0.8070703,0.00026000862,0.1877029,0.0012236206],"study_design_scores_gemma":[0.0040195617,0.000044828757,0.007203896,0.00001037167,0.00015453095,0.000013841112,0.000050814793,0.014484582,0.790386,0.0005275523,0.18260849,0.00049548165],"about_ca_topic_score_codex":0.00015548653,"about_ca_topic_score_gemma":0.0000056300096,"teacher_disagreement_score":0.016684258,"about_ca_system_score_codex":0.00013483888,"about_ca_system_score_gemma":0.00013624212,"threshold_uncertainty_score":0.99972785},"labels":[],"label_agreement":null},{"id":"W1973165085","doi":"10.1080/15376520490429382","title":"Incorporation of Pharmacokinetic and Pharmacodynamic Data into Risk Assessments","year":2004,"lang":"en","type":"article","venue":"Toxicology Mechanisms and Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Physiologically based pharmacokinetic modelling; In silico; Pharmacokinetics; Pharmacology; Pharmacodynamics; Risk assessment; Computational biology; Medicine; Chemistry; Biology; Computer science; Biochemistry","score_opus":0.1472903305135723,"score_gpt":0.5406335177628201,"score_spread":0.39334318724924777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973165085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7057921,0.0062503256,0.28319585,0.00044659807,0.0021386018,0.0007904938,0.00019362412,0.000089118126,0.0011032782],"genre_scores_gemma":[0.68062437,0.009362879,0.3084322,0.0011840323,0.00014411406,0.000055630655,0.00007214194,0.000040767176,0.00008388418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996195,0.0017074868,0.00066801725,0.0007839428,0.00018182599,0.00046370112],"domain_scores_gemma":[0.99802274,0.0004980352,0.0005030797,0.000451373,0.000111711066,0.00041307815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035150445,0.00038215166,0.00062066043,0.0002714387,0.00033571175,0.00002043639,0.0005393539,0.00042005678,0.00028039314],"category_scores_gemma":[0.00016488823,0.0003693765,0.00005903835,0.00029523548,0.00042773192,0.0002543306,0.00078618614,0.0008277355,0.000008727002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017168172,0.0002447143,0.00018418748,0.00006253718,0.0002205191,0.000012575896,0.00034151482,0.00046489766,0.6522912,0.009976117,0.000037855698,0.33599222],"study_design_scores_gemma":[0.00930626,0.00061957573,0.0019409332,0.000021457166,0.0018244985,0.00010639923,0.00027103102,0.055027466,0.7171878,0.18272588,0.030291403,0.00067725364],"about_ca_topic_score_codex":0.000073149466,"about_ca_topic_score_gemma":0.000020531674,"teacher_disagreement_score":0.33531496,"about_ca_system_score_codex":0.000048678674,"about_ca_system_score_gemma":0.00017370193,"threshold_uncertainty_score":0.99987584},"labels":[],"label_agreement":null},{"id":"W1973438638","doi":"10.1006/bbrc.2000.2795","title":"Isolation and Characterization of the Human UGT2B7 Gene","year":2000,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé; Medical Research Council Canada","keywords":"Gene; Biology; UGT2B7; Promoter; Exon; Molecular biology; Genetics; Biochemistry; Gene expression; Glucuronidation; Enzyme; Microsome","score_opus":0.20915214843550145,"score_gpt":0.491323296417168,"score_spread":0.28217114798166654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973438638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942465,0.0006232571,0.0000047732037,0.0032408217,0.000025884012,0.00022061214,0.00006804186,0.000011608949,0.001558547],"genre_scores_gemma":[0.99541056,0.0036329417,0.00012482009,0.00020453235,0.00009368466,0.00003083808,0.00005262417,0.000006992018,0.00044298044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880576,0.0004777534,0.00019139628,0.0001597575,0.00017110856,0.00019422882],"domain_scores_gemma":[0.9990547,0.00022810303,0.000040455416,0.00041388464,0.00012661584,0.00013627418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042755358,0.00008151964,0.00011559671,0.000038195176,0.00051306473,0.000018429013,0.00043811463,0.00011853069,0.00015868901],"category_scores_gemma":[0.000045167144,0.000059477796,0.000039418228,0.00028819052,0.0011374251,0.00004385718,0.00029869957,0.0005314927,0.000011694389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023377062,0.00021609887,0.0006443438,0.000012413647,0.000017413739,8.4987875e-8,0.00012917073,1.9497152e-7,0.9761878,0.0029522588,0.000119538905,0.019697284],"study_design_scores_gemma":[0.00043512616,0.00003399228,0.041502234,0.000011842538,0.00003845561,0.0000022467939,0.000013005828,0.002438478,0.9048659,0.0020082693,0.048554048,0.00009635314],"about_ca_topic_score_codex":0.000020168723,"about_ca_topic_score_gemma":9.549851e-7,"teacher_disagreement_score":0.071321875,"about_ca_system_score_codex":0.0000103802895,"about_ca_system_score_gemma":0.000026463314,"threshold_uncertainty_score":0.41908902},"labels":[],"label_agreement":null},{"id":"W1974750430","doi":"10.1016/s0924-977x(02)00005-6","title":"Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes","year":2002,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nefazodone; CYP3A4; Enzyme; Microsome; Cytochrome P450; Metabolism; Drug metabolism; CYP2B6; Chemistry; Metabolic pathway; Pharmacology; Biochemistry; Biology; Receptor; Fluoxetine","score_opus":0.05361579510543714,"score_gpt":0.3455406473337206,"score_spread":0.29192485222828346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974750430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93154085,0.06041034,0.000006309391,0.0018418246,0.0008365538,0.0007359728,0.00011842643,0.0001519025,0.0043578153],"genre_scores_gemma":[0.9678315,0.02055775,0.00005087817,0.009528891,0.00044539483,0.000042680695,0.000009689285,0.00014785126,0.0013854018],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934672,0.003768206,0.0008748756,0.0009248372,0.00021225637,0.0007525885],"domain_scores_gemma":[0.9979936,0.0005659933,0.0004750277,0.00039332607,0.000097295844,0.0004747494],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0012922595,0.0006127083,0.00087572966,0.00022611793,0.00071078556,0.0000689803,0.0005969122,0.00020886713,0.00070200564],"category_scores_gemma":[0.00005394828,0.0004979151,0.00013743209,0.00022707942,0.0031259882,0.00016210933,0.00059771334,0.0011813504,0.00003283705],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042795352,0.00038420415,0.0005821169,0.00007128322,0.0003299262,0.00013150428,0.0017161209,0.000011781636,0.95693195,0.001025767,0.02885758,0.009529829],"study_design_scores_gemma":[0.05394514,0.00069685536,0.042669296,0.0000266827,0.0022564929,0.00065192697,0.000112891146,0.0029056103,0.11946521,0.0006933731,0.7750816,0.0014949255],"about_ca_topic_score_codex":0.000026935657,"about_ca_topic_score_gemma":0.0000025286424,"teacher_disagreement_score":0.8374667,"about_ca_system_score_codex":0.000007949386,"about_ca_system_score_gemma":0.00000681525,"threshold_uncertainty_score":0.9997473},"labels":[],"label_agreement":null},{"id":"W1974807717","doi":"10.1016/j.bmc.2014.09.026","title":"Chemical synthesis, cytotoxicity, selectivity and bioavailability of 5α-androstane-3α,17β-diol derivatives","year":2014,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Androstane; Bioavailability; Cytotoxicity; Stereochemistry; CYP3A4; In vivo; Pharmacokinetics; IC50; Pharmacology; Cell growth; Cell culture; In vitro; Biochemistry; Enzyme; Cytochrome P450","score_opus":0.049740435153245215,"score_gpt":0.3665065988968841,"score_spread":0.31676616374363886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974807717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931643,0.0020840988,0.00016811992,0.0005438113,0.00022067616,0.00022331094,0.000093465496,0.000073965384,0.0034282748],"genre_scores_gemma":[0.99808437,0.0005222316,0.00021904045,0.00044608154,0.0005490072,0.000025845815,0.000014254972,0.000032643347,0.000106519976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773073,0.00030869365,0.00053728616,0.00059169036,0.00032186654,0.0005097241],"domain_scores_gemma":[0.99785984,0.00090974156,0.00026082978,0.00033691034,0.00015769483,0.0004749708],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013326375,0.00036950994,0.00065610826,0.00004352144,0.00014405845,0.000011830609,0.00037723506,0.00047452154,0.001489935],"category_scores_gemma":[0.0012691492,0.0003371424,0.0001055201,0.0002814801,0.0009844649,0.000057193396,0.00021759566,0.0007643074,0.000015434936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002158849,0.0003152785,0.011820606,0.0003410774,0.0001371664,0.0000062268036,0.0002358226,9.764459e-7,0.9799112,0.000049844948,0.0005520463,0.0064138384],"study_design_scores_gemma":[0.0011999862,0.00003971404,0.0051115337,0.00003694274,0.0002771188,0.000085528176,0.00008633818,0.00039732634,0.9840277,0.00028523756,0.00813287,0.0003197192],"about_ca_topic_score_codex":0.000023298515,"about_ca_topic_score_gemma":0.0000017989898,"teacher_disagreement_score":0.0075808237,"about_ca_system_score_codex":0.000063930034,"about_ca_system_score_gemma":0.00015428195,"threshold_uncertainty_score":0.9999081},"labels":[],"label_agreement":null},{"id":"W1975032319","doi":"10.1016/s0006-2952(00)00249-5","title":"Transcriptional suppression of cytochrome P450 2C11 gene expression by 3-methylcholanthrene","year":2000,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Methylcholanthrene; Cytochrome P450; Transcription (linguistics); Gene expression; Biology; In vivo; Messenger RNA; Enzyme inducer; Gene; Carcinogen; Molecular biology; Internal medicine; Chemistry; Endocrinology; Enzyme; Metabolism; Biochemistry; Genetics; Medicine","score_opus":0.055565309597907016,"score_gpt":0.4018804836958368,"score_spread":0.3463151740979298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975032319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97696567,0.016202865,0.00014762081,0.0008709785,0.0012771337,0.00054578413,0.0010043334,0.00012564627,0.0028599577],"genre_scores_gemma":[0.9886981,0.0049884934,0.00088389136,0.0027878047,0.0007788186,0.00013667966,0.00040699105,0.00006061095,0.001258562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964917,0.00066068326,0.00086400297,0.00074571,0.00039118287,0.0008467292],"domain_scores_gemma":[0.9984392,0.00030112037,0.00021209523,0.00027196805,0.00013933396,0.00063627993],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057000446,0.000477476,0.0006571763,0.00015229962,0.0002223821,0.000012024263,0.0007199025,0.00076668145,0.045930974],"category_scores_gemma":[0.000026888665,0.00045187832,0.00028484082,0.0003265719,0.0006310451,0.00014031706,0.00011550129,0.0010403304,0.00028503445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011958977,0.0008802949,0.000062824794,0.0000403732,0.00012651666,0.000015460972,0.00011046296,0.00008797,0.6935971,0.000019961484,0.29986235,0.004000818],"study_design_scores_gemma":[0.0034081975,0.00007986665,0.0003678523,0.0000099685585,0.0002129095,0.000028417933,0.000007135653,0.00032762834,0.6777393,0.00015597856,0.31734687,0.00031583602],"about_ca_topic_score_codex":0.000010789698,"about_ca_topic_score_gemma":8.063981e-8,"teacher_disagreement_score":0.045645937,"about_ca_system_score_codex":0.000060328577,"about_ca_system_score_gemma":0.00009999824,"threshold_uncertainty_score":0.9997933},"labels":[],"label_agreement":null},{"id":"W1975781755","doi":"10.1021/bi000779p","title":"N-Glycosylation and Residue 96 Are Involved in the Functional Properties of UDP-Glucuronosyltransferase Enzymes<sup>,</sup>","year":2000,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Glycosylation; Biochemistry; Enzyme; Chemistry; Asparagine; Biology","score_opus":0.08207284842191288,"score_gpt":0.33037291651102374,"score_spread":0.24830006808911087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975781755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888405,0.008325691,0.0000044627996,0.0009571993,0.00008090276,0.00022434714,0.0000740913,0.000020724241,0.0014720707],"genre_scores_gemma":[0.99706966,0.0012338366,0.000020479867,0.00092225743,0.00026689647,0.00004778554,0.000037262434,0.000013764659,0.00038806058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987657,0.0002195849,0.0003230139,0.00027095003,0.0001723833,0.0002483684],"domain_scores_gemma":[0.99949807,0.00009617153,0.0000652593,0.0001826233,0.00006142551,0.00009642585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047301585,0.00018575876,0.00019493182,0.00004443814,0.00012192192,0.00001612692,0.00019416393,0.00022719744,0.00093763246],"category_scores_gemma":[0.000043780925,0.00014553024,0.000060875096,0.0001638435,0.00021781198,0.000055929147,0.000022844299,0.00041908034,0.000016594438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010825774,0.0005223118,0.04150773,0.0002744004,0.00010098335,0.000021580032,0.0018027049,0.0023057007,0.93786967,0.00014259592,0.0032203814,0.011149343],"study_design_scores_gemma":[0.0016060487,0.0000212331,0.011735225,0.000031854357,0.00008367964,0.000014865321,0.0003504071,0.0027156651,0.96496344,0.0001272179,0.018160228,0.00019016626],"about_ca_topic_score_codex":0.000024436886,"about_ca_topic_score_gemma":0.000007590575,"teacher_disagreement_score":0.029772501,"about_ca_system_score_codex":0.000018595425,"about_ca_system_score_gemma":0.000083690225,"threshold_uncertainty_score":0.9999756},"labels":[],"label_agreement":null},{"id":"W1976009585","doi":"10.1111/j.1365-2885.2007.00893.x","title":"Comparative oxidative metabolic profiles of clomipramine in cats, rats and dogs: preliminary results from an <i>in vitro</i> study","year":2007,"lang":"en","type":"article","venue":"Journal of Veterinary Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Université de Montréal","keywords":"Microsome; Clomipramine; CATS; Internal medicine; Endocrinology; Nicotinamide adenine dinucleotide phosphate; Metabolism; Chemistry; In vitro; Pharmacology; Biology; Biochemistry; Medicine; Oxidase test; Enzyme","score_opus":0.1446500564530649,"score_gpt":0.4667937058876791,"score_spread":0.3221436494346142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976009585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98134816,0.016233148,0.000020353926,0.00026102806,0.0010619594,0.0007338425,0.00018426374,0.000009645664,0.00014761793],"genre_scores_gemma":[0.991905,0.00604409,0.00064783165,0.0010222832,0.00030959316,0.00001442845,0.0000175279,0.000024494044,0.000014789799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99564236,0.0017782922,0.0014816935,0.00039674644,0.00021512857,0.00048574992],"domain_scores_gemma":[0.99714947,0.0013395338,0.0008760912,0.00015093807,0.00020049229,0.00028349116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032656381,0.00038034143,0.0010668676,0.00054415874,0.000107648164,0.0000140109905,0.00034556948,0.0002970259,0.000043277094],"category_scores_gemma":[0.000020592724,0.00033924644,0.000078467085,0.000353151,0.00047197836,0.00031731374,0.00016535654,0.0013066232,0.0000012885249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050834723,0.0042486717,0.010847338,0.00002484405,0.00075322884,0.0007737656,0.016684758,0.00015151192,0.89619815,0.000020898477,0.00002762066,0.019434495],"study_design_scores_gemma":[0.021803055,0.006691122,0.13569672,0.000031488024,0.0010963683,0.00028802658,0.00432277,0.0019340311,0.8167692,0.0003751809,0.010546821,0.00044522795],"about_ca_topic_score_codex":0.00005590069,"about_ca_topic_score_gemma":0.0000240554,"teacher_disagreement_score":0.12484938,"about_ca_system_score_codex":0.00003629697,"about_ca_system_score_gemma":0.00011496309,"threshold_uncertainty_score":0.99990594},"labels":[],"label_agreement":null},{"id":"W1976967080","doi":"10.3109/00498254.2010.529178","title":"The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat","year":2010,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ketoconazole; Pharmacokinetics; Pharmacology; Enantiomer; Lipoprotein; Medicine; Endocrinology; Biology; Internal medicine; Chemistry; Cholesterol; Antifungal; Microbiology; Stereochemistry","score_opus":0.05158699698607702,"score_gpt":0.397180062483188,"score_spread":0.345593065497111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976967080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862537,0.0005098815,0.0000050913804,0.0029435845,0.0014098014,0.0016169394,0.00009202135,0.000015787678,0.007153196],"genre_scores_gemma":[0.99784774,0.00024252661,0.000020600384,0.00136639,0.00025085165,0.000106829546,0.00000480771,0.000024766208,0.00013548767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647474,0.001855179,0.0005655911,0.0002474204,0.00036425536,0.00049282337],"domain_scores_gemma":[0.9938578,0.0051141283,0.00027969695,0.00054821116,0.00009101424,0.00010916777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003747504,0.00028159592,0.00035730188,0.00010052243,0.00031137545,0.000024922061,0.001146547,0.00023035728,0.000500868],"category_scores_gemma":[0.0005248988,0.00013094931,0.0001834885,0.00046380315,0.00088471815,0.00003115006,0.000117342126,0.0015989756,0.000045678902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065924803,0.00022790415,0.0019049199,0.000052678297,0.00013497722,0.00000834371,0.00042011676,0.000121786645,0.9682037,0.0053835115,0.0021336193,0.020749148],"study_design_scores_gemma":[0.002113754,0.00022656909,0.005251051,0.000013662578,0.00019674898,0.000007799364,0.00006887229,0.000817597,0.86084706,0.00031207877,0.13000207,0.00014275465],"about_ca_topic_score_codex":0.000049719692,"about_ca_topic_score_gemma":0.000033618202,"teacher_disagreement_score":0.12786844,"about_ca_system_score_codex":0.000010983764,"about_ca_system_score_gemma":0.00008405907,"threshold_uncertainty_score":0.6946842},"labels":[],"label_agreement":null},{"id":"W1976992742","doi":"10.1016/j.jpba.2009.07.004","title":"Validation of a new HPLC method for determination of midazolam and its metabolites: Application to determine its pharmacokinetics in human and measure hepatic CYP3A activity in rabbits","year":2009,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Chemistry; Chromatography; Midazolam; Pharmacokinetics; High-performance liquid chromatography; Analyte; Coefficient of variation; CYP3A; Correlation coefficient; Calibration curve; Extraction (chemistry); Cytochrome P450; Detection limit; Enzyme; Pharmacology; Biochemistry","score_opus":0.09434307390800653,"score_gpt":0.4639736425141439,"score_spread":0.3696305686061374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976992742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781528,0.0027114463,0.016948342,0.0014831837,0.000104098006,0.000524124,0.000056548353,0.0000044515327,0.000014985408],"genre_scores_gemma":[0.99384767,0.0013669105,0.0041851765,0.000411797,0.00013807137,0.000010576704,0.0000060414445,0.00000958789,0.00002416498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740815,0.0004850307,0.0010906953,0.0003154421,0.00039981696,0.00030085028],"domain_scores_gemma":[0.99809086,0.00038073148,0.00056579575,0.000081848695,0.00029203153,0.00058873306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002107151,0.00023656154,0.00091954885,0.0010466976,0.000052706524,0.000012982377,0.00019113447,0.00024085278,0.000042289226],"category_scores_gemma":[0.00032748954,0.00020124266,0.00018827347,0.0013909901,0.00008993553,0.00015469524,0.00007664224,0.00044489905,1.9528068e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049718085,0.0005585911,0.0048914403,0.00017090997,0.000197509,0.000004394445,0.00030572223,0.00012550116,0.76457685,0.00007474415,0.000009296893,0.22858787],"study_design_scores_gemma":[0.004900805,0.000258388,0.028869778,0.0000588573,0.0028914236,0.000017663951,0.000014945756,0.16008236,0.8003767,0.0007115933,0.0016219734,0.00019549535],"about_ca_topic_score_codex":0.000011426004,"about_ca_topic_score_gemma":0.000007442112,"teacher_disagreement_score":0.22839238,"about_ca_system_score_codex":0.00003547105,"about_ca_system_score_gemma":0.00007752367,"threshold_uncertainty_score":0.8206437},"labels":[],"label_agreement":null},{"id":"W1977032972","doi":"10.1007/s12160-011-9318-5","title":"Relationship Between Amounts of Daily Cigarette Consumption and Abdominal Obesity Moderated by CYP2A6 Genotypes in Chinese Male Current Smokers","year":2011,"lang":"en","type":"article","venue":"Annals of Behavioral Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Institutes of Health; Canadian Institutes of Health Research; Sun Yat-sen University","keywords":"CYP2A6; Abdominal obesity; Obesity; Medicine; Genotype; Cigarette smoking; Abdominal fat; Health psychology; Environmental health; Consumption (sociology); Risk factor; Demography; Internal medicine; Public health; Biology; Genetics; Gene; Pathology; Metabolic syndrome","score_opus":0.42569123688865657,"score_gpt":0.5116186034948406,"score_spread":0.085927366606184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977032972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906419,0.008028697,0.00003359409,0.0002104253,0.00034348178,0.000313539,0.00021741622,0.000012859063,0.00019806533],"genre_scores_gemma":[0.9981135,0.001412145,0.000051706076,0.00017546403,0.00008011045,0.000015286443,0.00009461288,0.000014238096,0.00004295238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832755,0.00030053506,0.000637226,0.0002501051,0.00020752891,0.00027702888],"domain_scores_gemma":[0.9990051,0.00016353352,0.00030262428,0.00014590695,0.00016614722,0.00021672306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008728631,0.00020988718,0.0004938784,0.00020559273,0.00006860858,0.00000228094,0.00016263222,0.00020116128,0.00058162207],"category_scores_gemma":[0.000057616187,0.00018327082,0.00004918931,0.00021131786,0.0005083956,0.00010681308,0.00005661323,0.0005115901,0.0000044992994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037602693,0.00042212373,0.9635818,0.00008196088,0.00003120216,0.000006669006,0.0020955172,0.000003573577,0.018080031,0.000057098943,0.000985815,0.014278196],"study_design_scores_gemma":[0.0021852176,0.00021374166,0.96829337,0.000054960245,0.00031970956,0.000004429308,0.000062607454,0.00010880536,0.027318938,0.00060452253,0.00066699553,0.00016668433],"about_ca_topic_score_codex":0.0002801883,"about_ca_topic_score_gemma":0.000023321765,"teacher_disagreement_score":0.014111511,"about_ca_system_score_codex":0.000010093293,"about_ca_system_score_gemma":0.000034032008,"threshold_uncertainty_score":0.7473567},"labels":[],"label_agreement":null},{"id":"W1977079922","doi":"10.1006/abbi.2000.2115","title":"The Human Cytochrome P450 1A1 mRNA Is Rapidly Degraded In HepG2 Cells","year":2000,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council Canada","keywords":"Messenger RNA; CYP1A2; Glyceraldehyde 3-phosphate dehydrogenase; Cytochrome P450; Biology; Molecular biology; P-bodies; Gene expression; Cell biology; Gene; Biochemistry; Enzyme; Translation (biology)","score_opus":0.03520420764586936,"score_gpt":0.3557035254223258,"score_spread":0.32049931777645646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977079922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862726,0.0021892118,0.0000020620507,0.00041475467,0.00007797893,0.00016406878,0.0001291844,0.000016941627,0.010733231],"genre_scores_gemma":[0.99161017,0.005842013,0.000109884204,0.0005355178,0.0002160777,0.000015767058,0.000020758698,0.000015235696,0.0016345837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987157,0.0001223087,0.00035036684,0.00031185697,0.00011515466,0.00038463995],"domain_scores_gemma":[0.9991928,0.00026539952,0.000110893656,0.00024972198,0.000016518603,0.00016471122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017164496,0.00022863137,0.00025481498,0.000032751606,0.00028775298,0.000020620142,0.00037119782,0.00013548203,0.00020176261],"category_scores_gemma":[0.000005845438,0.00018253605,0.00012328672,0.00015712481,0.0007259585,0.00003462794,0.000085430365,0.00046208696,0.000014160654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013711359,0.00021535507,0.00026290677,0.000058010704,0.000074055686,0.000008092738,0.0005437893,0.000013154026,0.9269213,0.00018016018,0.0002911302,0.07129491],"study_design_scores_gemma":[0.0011473969,0.000040227853,0.002911124,0.000019129442,0.000060590133,0.000005207999,0.00007044718,0.00041123477,0.9685732,0.003801362,0.022746535,0.00021351354],"about_ca_topic_score_codex":0.000016255315,"about_ca_topic_score_gemma":0.0000012568311,"teacher_disagreement_score":0.0710814,"about_ca_system_score_codex":0.000006028911,"about_ca_system_score_gemma":0.000042978543,"threshold_uncertainty_score":0.7443604},"labels":[],"label_agreement":null},{"id":"W1978042645","doi":"10.1111/j.1349-7006.2011.02143.x","title":"Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Prostate cancer; CYP3A4; Xenobiotic; Steroid; Cancer research; Cancer; Gene; Clinical significance; Receptor; Oncology; Medicine; Biology; Internal medicine; Cytochrome P450; Genetics; Hormone; Biochemistry; Metabolism; Enzyme","score_opus":0.2063154794774133,"score_gpt":0.48248698710334703,"score_spread":0.27617150762593373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978042645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97931206,0.018219758,0.000004250478,0.00013895765,0.0013075405,0.00047095594,0.00012245831,0.00001661179,0.00040738276],"genre_scores_gemma":[0.98541737,0.013254637,0.00026061697,0.00063321524,0.00012266194,0.00008552831,0.0000013038471,0.000013163233,0.00021153368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810207,0.00020461745,0.00048609794,0.0005642024,0.00017225368,0.00047076368],"domain_scores_gemma":[0.99905324,0.00007548536,0.00021580937,0.00014940625,0.00016717627,0.00033887516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014385359,0.00017723878,0.00033043802,0.00014666114,0.00018539974,0.000014653772,0.00037026164,0.00012375957,0.0004414857],"category_scores_gemma":[0.00005557554,0.00016380912,0.000030179966,0.00049514417,0.001292401,0.00019181019,0.00017935419,0.00039958602,0.000003952351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001298843,0.00012261493,0.13115607,0.000055321027,0.000022750755,0.0000052703904,0.002057917,0.0000415127,0.84282464,0.00022748364,0.00008499491,0.023271529],"study_design_scores_gemma":[0.0016374534,0.000112657595,0.17900936,0.000033423785,0.000059477683,0.0000022783897,0.00006406098,0.0013795355,0.812107,0.0001999017,0.0051392126,0.00025560334],"about_ca_topic_score_codex":0.0001568037,"about_ca_topic_score_gemma":0.00006081235,"teacher_disagreement_score":0.047853284,"about_ca_system_score_codex":0.000046814832,"about_ca_system_score_gemma":0.0003437681,"threshold_uncertainty_score":0.6679942},"labels":[],"label_agreement":null},{"id":"W1978118879","doi":"10.1016/j.toxlet.2005.08.006","title":"Role for mitogen-activated protein kinases in phenobarbital-induced expression of cytochrome P450 2B in primary cultures of rat hepatocytes","year":2005,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Ligue Contre le Cancer","keywords":"p38 mitogen-activated protein kinases; Kinase; MAPK/ERK pathway; Enhancer; Protein kinase A; Molecular biology; Cell biology; Mitogen-activated protein kinase; Biology; Signal transduction; Chemistry; Gene expression; Gene; Biochemistry","score_opus":0.05281194561271687,"score_gpt":0.37646414984549437,"score_spread":0.3236522042327775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978118879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434835,0.0013271256,0.000024902987,0.0016288089,0.00035407217,0.0018839784,0.00008189297,0.00003653703,0.00031434876],"genre_scores_gemma":[0.99445903,0.00008439477,0.00096404785,0.0035492259,0.00021083056,0.0005707435,0.000048787344,0.00003960168,0.000073343224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723285,0.00059576874,0.0008751041,0.0004715917,0.00017638973,0.0006483071],"domain_scores_gemma":[0.9987547,0.00037380442,0.00039967976,0.00024824345,0.00008237245,0.00014124218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006091545,0.00034789363,0.0007655279,0.00039028886,0.00007286292,0.000006127691,0.00042571605,0.00047700104,0.0002375762],"category_scores_gemma":[0.00011406196,0.00033493136,0.00016238363,0.00032257164,0.00026691784,0.00016228661,0.00013281523,0.0006010105,0.000007155828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017436675,0.00094436586,0.0030970336,0.00014764069,0.0000662769,0.000016044005,0.0012662216,0.0015588371,0.9864826,0.000076428885,0.001142003,0.0034588769],"study_design_scores_gemma":[0.005792234,0.00019067156,0.0102567645,0.000058757298,0.000060155468,0.00000597554,0.000090390095,0.0004621186,0.9749203,0.00012815141,0.0077248747,0.0003096561],"about_ca_topic_score_codex":0.000033332217,"about_ca_topic_score_gemma":0.000050023045,"teacher_disagreement_score":0.011562353,"about_ca_system_score_codex":0.00014328586,"about_ca_system_score_gemma":0.00012902044,"threshold_uncertainty_score":0.9999103},"labels":[],"label_agreement":null},{"id":"W1978188597","doi":"10.1007/s00253-012-4654-3","title":"Heterologous expression of CYP102A5 variant from Bacillus cereus CYPPB-1: Validation of model for predicting drug metabolism of human P450 probe substrates","year":2013,"lang":"en","type":"article","venue":"Applied Microbiology and Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Council of Scientific and Industrial Research, India","keywords":"Bacillus cereus; In silico; Biochemistry; Chemistry; Drug metabolism; Docking (animal); Homology modeling; Biology; Metabolism; Enzyme; Bacteria; Genetics","score_opus":0.04365088839581922,"score_gpt":0.32288330347463606,"score_spread":0.27923241507881685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978188597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930355,0.0019433317,0.0021040349,0.0002475698,0.00025000868,0.0011409685,0.0011249649,0.00006578696,0.00008785827],"genre_scores_gemma":[0.99350464,0.00051030976,0.0051668407,0.00016961839,0.00006286062,0.00015665127,0.0003720262,0.000026823333,0.000030200099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978837,0.00017007648,0.0009095951,0.00053156534,0.000049819373,0.00045528926],"domain_scores_gemma":[0.99833196,0.00034768877,0.0007529684,0.00031619295,0.00016979604,0.00008138356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044675698,0.0003231936,0.00083420327,0.00024127126,0.00015364733,0.000004487362,0.00043728648,0.0012557959,0.00012323643],"category_scores_gemma":[0.000043029777,0.00028024684,0.00011884676,0.00014800807,0.0009819889,0.00005543312,0.00026801982,0.0005436925,0.0000033251554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027791908,0.00036403662,0.00047708157,0.00010858061,0.0002336731,7.8462625e-7,0.0006380851,0.00037169506,0.98991764,0.0035513716,0.00016915915,0.003889965],"study_design_scores_gemma":[0.0024708828,0.00012170031,0.00035526376,0.00001548443,0.0002929811,0.000012269375,0.00017825438,0.002406409,0.9820189,0.011281784,0.00062057417,0.0002254888],"about_ca_topic_score_codex":0.0000889662,"about_ca_topic_score_gemma":0.000013925072,"teacher_disagreement_score":0.0078987405,"about_ca_system_score_codex":0.000010400635,"about_ca_system_score_gemma":0.000048692105,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W1978196851","doi":"10.1002/jcb.10177","title":"Displacement of histamine from liver cells and cell components by ligands for cytochromes P450","year":2002,"lang":"en","type":"article","venue":"Journal of Cellular Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Histamine; Displacement (psychology); Chemistry; Cell; Cell biology; Pharmacology; Biochemistry; Biology; Psychology","score_opus":0.05369761102648932,"score_gpt":0.32754899030868406,"score_spread":0.2738513792821947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978196851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614095,0.036557753,0.0004582005,0.00015012245,0.0004427139,0.00014664208,0.0005237798,0.0000046745454,0.00030659873],"genre_scores_gemma":[0.9925789,0.0047261114,0.00049923273,0.000248898,0.0003726461,0.0000044091794,0.000044580625,0.000021689639,0.0015035202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871844,0.000041305215,0.0005907728,0.00018728066,0.00021338821,0.00024880457],"domain_scores_gemma":[0.9986586,0.00018846769,0.0005822923,0.00013173633,0.00015291355,0.0002860122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003226759,0.0002109146,0.00040180236,0.000051583153,0.00007494016,0.0000136707085,0.0002558556,0.00022378772,0.00069663755],"category_scores_gemma":[0.000016985428,0.00019489901,0.00017186858,0.000058355068,0.00014304213,0.000041941134,0.00006677058,0.00033506984,0.0000049299106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002272613,0.00065566314,0.0002434633,0.00016454361,0.0001961926,0.000024758383,0.00021063707,0.000017039356,0.971996,0.0000016702243,0.024931658,0.0013311071],"study_design_scores_gemma":[0.0034248051,0.00011065472,0.000032886597,0.000023735623,0.00037936578,0.000010183511,0.000041188898,0.0017992087,0.9148254,0.000025704692,0.07915388,0.00017302652],"about_ca_topic_score_codex":0.0000037485065,"about_ca_topic_score_gemma":7.201347e-8,"teacher_disagreement_score":0.057170648,"about_ca_system_score_codex":0.00003352801,"about_ca_system_score_gemma":0.000024639963,"threshold_uncertainty_score":0.79477507},"labels":[],"label_agreement":null},{"id":"W1978862031","doi":"10.1007/s11095-006-9217-9","title":"The Evolving Role of Drug Metabolism in Drug Discovery and Development","year":2007,"lang":"en","type":"review","venue":"Pharmaceutical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"ADME; Drug metabolism; Drug discovery; Pharmacology; Pharmacogenomics; Drug; Computational biology; Drug development; Pharmacogenetics; Biology; Bioinformatics; Genetics","score_opus":0.3889439312688324,"score_gpt":0.5860510311367881,"score_spread":0.19710709986795572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978862031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016680376,0.98879534,0.0000068820673,0.00014394625,0.0009686747,0.001934207,0.000081367994,0.000033632004,0.0063679256],"genre_scores_gemma":[0.0048815147,0.9920257,0.00016074369,0.0001337851,0.00053349906,0.00039890513,0.0000307525,0.00011809101,0.0017170382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886732,0.0046446263,0.0019681365,0.0010182032,0.0014265435,0.0022692638],"domain_scores_gemma":[0.9872874,0.010547613,0.00033940794,0.00054064713,0.00039747293,0.0008874697],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.019989455,0.00076237164,0.0019281711,0.0010339624,0.0008180592,0.00018778552,0.0016322889,0.0005772037,0.0003248943],"category_scores_gemma":[0.0008705823,0.00053828355,0.0003432088,0.0014586713,0.0015628068,0.00022994702,0.0016497304,0.0066461987,0.00016991445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001686536,0.0003579747,0.00008236564,0.0033814579,0.00040719722,0.00005702223,0.0009151128,0.0000027423378,0.00022498888,0.0032109602,0.0010974557,0.99009407],"study_design_scores_gemma":[0.0010469519,0.0000086958735,0.00005592439,0.00081272156,0.00040779126,0.000022686309,0.0002949933,0.000227838,0.003964765,0.0005620099,0.99208033,0.0005153026],"about_ca_topic_score_codex":0.00007511687,"about_ca_topic_score_gemma":0.0000740964,"teacher_disagreement_score":0.9909829,"about_ca_system_score_codex":0.00027356547,"about_ca_system_score_gemma":0.0014927518,"threshold_uncertainty_score":0.99970686},"labels":[],"label_agreement":null},{"id":"W1979401973","doi":"10.1016/j.tox.2009.10.025","title":"Characterization of a new cytochrome P450 enzyme, CYP2S1, in rats: Its regulation by aryl hydrocarbon receptor agonists","year":2009,"lang":"en","type":"article","venue":"Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Aryl hydrocarbon receptor; Messenger RNA; CYP1B1; Internal medicine; Gene expression; Cytochrome P450; Endocrinology; Molecular biology; Biochemistry; Biology; Gene; Enzyme; Medicine","score_opus":0.05629017069368933,"score_gpt":0.37886978297206236,"score_spread":0.32257961227837306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979401973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918195,0.0013131393,0.00021806206,0.0025809584,0.0008248529,0.00076102914,0.00011191187,0.000081188395,0.0022893425],"genre_scores_gemma":[0.99228865,0.0011265696,0.00014033941,0.0035269205,0.00043692716,0.000039213177,0.0003239192,0.000031253112,0.0020862299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747294,0.00040735508,0.00081200374,0.0004943995,0.00019932177,0.0006139989],"domain_scores_gemma":[0.9988192,0.00012561373,0.00041138896,0.00024557923,0.00009099924,0.0003072231],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006002691,0.00033117924,0.00059809507,0.0003113101,0.000096747535,0.00001453376,0.00035042016,0.000662325,0.0019403944],"category_scores_gemma":[0.000086292406,0.00036367896,0.000102872706,0.00055031147,0.00011163584,0.0001834161,0.000059991973,0.00058787403,0.00013489365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005250608,0.00057357334,0.00027339082,0.00002061221,0.000048908016,0.000009964547,0.0005826974,0.0002034539,0.96868783,0.00092700904,0.004161584,0.023985887],"study_design_scores_gemma":[0.0024594653,0.00031860967,0.018720226,0.0000145308895,0.00007416289,0.0000125908455,0.000010566301,0.002188694,0.8492095,0.000669607,0.12601386,0.00030821335],"about_ca_topic_score_codex":0.000011701308,"about_ca_topic_score_gemma":0.000010334402,"teacher_disagreement_score":0.12185227,"about_ca_system_score_codex":0.000111390604,"about_ca_system_score_gemma":0.00020295798,"threshold_uncertainty_score":0.9998815},"labels":[],"label_agreement":null},{"id":"W1979729122","doi":"10.1016/s0024-3205(01)01241-3","title":"L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction","year":2001,"lang":"en","type":"article","venue":"Life Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Novartis Pharma","keywords":"In vivo; Cytochrome P450; Pharmacology; Chemistry; Cytochrome; Medicine; Biochemistry; Biology; Enzyme","score_opus":0.0739610474471642,"score_gpt":0.3999660705482856,"score_spread":0.3260050231011214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979729122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630916,0.00027938304,0.000056530756,0.0015169986,0.0004723832,0.000504414,0.000031146916,0.000023530922,0.0008064417],"genre_scores_gemma":[0.9975177,0.0007084759,0.000020598653,0.0012276978,0.00016731254,0.00006049076,0.00000790138,0.000007893292,0.0002819056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798363,0.0006991523,0.00040142727,0.00026022832,0.00036482414,0.0002907183],"domain_scores_gemma":[0.99904954,0.0002877657,0.00030742967,0.00019363019,0.00006132736,0.000100280595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019064209,0.0001462169,0.00017067324,0.00011341985,0.0004198235,0.000025605275,0.0004694902,0.0001246791,0.00022905461],"category_scores_gemma":[0.0000859227,0.000092135284,0.00004666652,0.00052877655,0.00050610735,0.00041574443,0.000057667334,0.00030695292,0.000012083558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095178955,0.00013025808,0.008919223,0.000007054269,0.00003624408,0.0000012502635,0.0010833486,0.00147437,0.98404294,0.0002629458,0.00041692413,0.0035302306],"study_design_scores_gemma":[0.0012338979,0.00015277005,0.2767014,0.000016042175,0.00015521438,0.000009550299,0.00056863244,0.03578689,0.6608242,0.0013699933,0.022945652,0.00023580558],"about_ca_topic_score_codex":0.00014064717,"about_ca_topic_score_gemma":0.000050427214,"teacher_disagreement_score":0.3232188,"about_ca_system_score_codex":0.000042163203,"about_ca_system_score_gemma":0.00013888151,"threshold_uncertainty_score":0.37571678},"labels":[],"label_agreement":null},{"id":"W1979836228","doi":"10.1023/b:pham.0000041458.81836.c4","title":"Tamoxifen Alters Hepatic Cytochrome P450 Enzyme Expression and Circulating Growth Hormone Levels in Intact Male Rats","year":2004,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Medical Research Council Canada","keywords":"Endocrinology; Internal medicine; Tamoxifen; Triiodothyronine; Testosterone (patch); Cytochrome P450; Hormone; Biology; Medicine; Chemistry; Metabolism; Cancer; Breast cancer","score_opus":0.3261665139244788,"score_gpt":0.5312953775401043,"score_spread":0.20512886361562543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979836228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98592114,0.0063443123,0.00029646824,0.002204946,0.00031203008,0.0012341251,0.00007926218,0.000087085726,0.0035206357],"genre_scores_gemma":[0.99400645,0.002883843,0.000595805,0.0015519855,0.00045264987,0.00023381319,0.00002068408,0.000079436184,0.00017534774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9933482,0.0018796646,0.0008175079,0.0009816348,0.0010350301,0.001937966],"domain_scores_gemma":[0.99642766,0.0015086425,0.000110430155,0.00034298803,0.00029311155,0.0013171445],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004985901,0.00047323832,0.00060186523,0.00068180636,0.0005909363,0.000119572585,0.00066969375,0.00044557118,0.0011716601],"category_scores_gemma":[0.00086029596,0.00045695942,0.0001266074,0.0010735216,0.000791336,0.00037019208,0.00075898744,0.0034937938,0.00030950544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005319257,0.00062149,0.0033484506,0.00016463203,0.0000786096,0.0005178195,0.0014132924,0.00056946947,0.9825645,0.001589975,0.00043943833,0.008160413],"study_design_scores_gemma":[0.009982639,0.00023089873,0.021539371,0.00013263599,0.00010740806,0.00020640767,0.00024376309,0.01202262,0.9320468,0.010055162,0.012638202,0.0007941162],"about_ca_topic_score_codex":0.00011364307,"about_ca_topic_score_gemma":0.0000113267615,"teacher_disagreement_score":0.050517708,"about_ca_system_score_codex":0.0003597185,"about_ca_system_score_gemma":0.00033153172,"threshold_uncertainty_score":0.9997882},"labels":[],"label_agreement":null},{"id":"W1979838277","doi":"10.1016/j.resmic.2008.08.006","title":"Characterization of a mycothiol ligase mutant of Rhodococcus jostii RHA1","year":2008,"lang":"en","type":"article","venue":"Research in Microbiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Biology; Mutant; Rhodococcus; Biochemistry; DNA ligase; Rhodococcus rhodochrous; Microbiology; Enzyme; Gene","score_opus":0.2825787198897924,"score_gpt":0.5010948488247937,"score_spread":0.21851612893500133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979838277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960902,0.0010104502,0.000033140142,0.00031931294,0.00039918083,0.0005733866,0.00036868936,0.000013818795,0.0011918666],"genre_scores_gemma":[0.99457866,0.0046877395,0.00008949061,0.00018356902,0.000121970734,0.000045542194,0.00009951732,0.000019904974,0.00017359755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963224,0.0018466023,0.000686654,0.00033931682,0.00012460808,0.0006804077],"domain_scores_gemma":[0.9984058,0.0006204219,0.00019748649,0.00025793503,0.00035988507,0.00015844787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023760598,0.00016822777,0.00049427245,0.00060641114,0.00011800482,0.000002450929,0.00044186617,0.00039178436,0.00067132624],"category_scores_gemma":[0.00020393234,0.00015869513,0.000094666204,0.000702538,0.000982719,0.000050936836,0.00022193846,0.00095279375,0.00007594477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005047564,0.0005374656,0.0091402745,0.000089001056,0.00006347919,0.000089396,0.0008343712,0.000050221777,0.98429275,0.00049131905,0.00020650482,0.0037004787],"study_design_scores_gemma":[0.0017166013,0.00017292419,0.005362402,0.000025390116,0.000015974829,0.00010864804,0.000028493061,0.00022772646,0.94186735,0.0002493645,0.050094295,0.00013083206],"about_ca_topic_score_codex":0.000047809226,"about_ca_topic_score_gemma":0.000007675261,"teacher_disagreement_score":0.04988779,"about_ca_system_score_codex":0.00004828348,"about_ca_system_score_gemma":0.00030721675,"threshold_uncertainty_score":0.73505515},"labels":[],"label_agreement":null},{"id":"W1979845492","doi":"10.1038/446975a","title":"When good drugs go bad","year":2007,"lang":"en","type":"article","venue":"Nature","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":282,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Drug reaction; Business; Adverse effect; Scale (ratio); Medicine; Drug; Geography; Psychiatry; Pharmacology","score_opus":0.0409152139193354,"score_gpt":0.4231492329399157,"score_spread":0.3822340190205803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979845492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6357941,0.022336537,0.00021095242,0.004659307,0.008961026,0.0004941241,0.00013057899,0.00027188763,0.3271415],"genre_scores_gemma":[0.96324706,0.00043781428,0.00082570675,0.024656171,0.0015885532,0.000010234447,0.000033745764,0.000039408133,0.009161326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981787,0.00015904734,0.00031237662,0.00036813525,0.0002881243,0.00069358107],"domain_scores_gemma":[0.9988097,0.0002810241,0.00010655945,0.00025467586,0.00013212614,0.00041590983],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014437357,0.00026185033,0.00025072027,0.00014426206,0.0002175969,0.00002201585,0.00046163754,0.002495322,0.0027716393],"category_scores_gemma":[0.00006903296,0.00024091268,0.0001460176,0.000249178,0.00011071126,0.00008641741,0.00011935288,0.0056614596,0.00069977564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080281345,0.0008054404,0.013162099,0.00006681737,0.0005160214,0.0002930657,0.0038142442,0.000082136605,0.20854865,0.03261649,0.37186623,0.367426],"study_design_scores_gemma":[0.0013972217,0.000022177821,0.003902221,0.000004134615,0.00011611741,0.000018696592,0.000056862154,0.0001299162,0.12112581,0.0025471963,0.87042004,0.0002596365],"about_ca_topic_score_codex":0.000005240852,"about_ca_topic_score_gemma":0.000010475739,"teacher_disagreement_score":0.49855378,"about_ca_system_score_codex":0.000045339635,"about_ca_system_score_gemma":0.00006646596,"threshold_uncertainty_score":0.9987996},"labels":[],"label_agreement":null},{"id":"W1979995329","doi":"10.1016/s0960-0760(01)00057-7","title":"Comparative biosynthetic pathway of androstenol and androgens","year":2001,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"","keywords":"Pregnane X receptor; Constitutive androstane receptor; Cytochrome P450; Biology; Nuclear receptor; Biochemistry; Dehydrogenase; Pheromone; Androgen receptor; Enzyme; Gene; Transcription factor; Genetics","score_opus":0.05564122880844084,"score_gpt":0.39505953266151783,"score_spread":0.339418303853077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979995329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97646224,0.02189168,0.00021101799,0.00049226766,0.00015830093,0.00009120081,0.00004008673,0.0000033157864,0.0006498814],"genre_scores_gemma":[0.9939897,0.005290634,0.00009633646,0.00049712916,0.00007418963,0.000001280319,0.000003032759,0.0000066854063,0.000041009527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989442,0.00031369604,0.00036186673,0.00011853293,0.000064640226,0.00019701189],"domain_scores_gemma":[0.99915,0.00014970163,0.00032071967,0.00011154499,0.000120657154,0.00014740585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005926635,0.00015458236,0.0003439226,0.000048220958,0.00009421906,0.000005767137,0.00018833218,0.0001730874,0.000044203065],"category_scores_gemma":[0.000027273516,0.00010194985,0.00006408387,0.0000822234,0.00063643145,0.000019704252,0.00009807463,0.00032755325,9.345434e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042094884,0.000081485996,0.00094790716,0.000022948936,0.00020981414,0.00002896544,0.00042935912,0.0000099916015,0.992536,0.000087842476,0.00004249445,0.0051822388],"study_design_scores_gemma":[0.0012227576,0.0002421812,0.00018782554,0.000014171907,0.00022128185,0.0013938427,0.00028319826,0.000071748196,0.985262,0.00058164017,0.010410532,0.0001088289],"about_ca_topic_score_codex":0.000001874303,"about_ca_topic_score_gemma":3.964538e-7,"teacher_disagreement_score":0.017527454,"about_ca_system_score_codex":0.0000057518937,"about_ca_system_score_gemma":0.00004170512,"threshold_uncertainty_score":0.41573945},"labels":[],"label_agreement":null},{"id":"W1980440732","doi":"10.1124/jpet.104.076141","title":"The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in Mice","year":2005,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnane X receptor; Inflammation; Pregnane; Gene; Receptor; Biology; Pharmacology; Internal medicine; Endocrinology; Nuclear receptor; Immunology; Medicine; Genetics; Transcription factor","score_opus":0.05142888166797033,"score_gpt":0.39064532776775296,"score_spread":0.33921644609978263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980440732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97833985,0.017007379,0.000004535137,0.0028282595,0.0013478665,0.0003710546,0.0000043448035,0.0000038904814,0.000092808594],"genre_scores_gemma":[0.9926738,0.0057302155,0.00014736496,0.0009185299,0.00039917004,0.000021273256,0.0000011211614,0.000013616118,0.0000948809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997846,0.0007023196,0.00085596065,0.00012778328,0.00019147509,0.00027643394],"domain_scores_gemma":[0.9989795,0.00023169321,0.00056421943,0.000080776685,0.00008057171,0.00006322385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001093915,0.00016701783,0.0002572375,0.0001374054,0.0001837312,0.000011410442,0.0003049634,0.00015407067,0.0001313101],"category_scores_gemma":[0.000010832663,0.00011274211,0.00008550144,0.00022004943,0.00025624014,0.00015321656,0.00009892823,0.0005969871,0.000002625878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000971419,0.0003419183,0.005804421,0.000019166844,0.00013351199,0.0000034118416,0.003138984,0.0034769902,0.97852105,0.00010344598,0.00008567712,0.0073999995],"study_design_scores_gemma":[0.0043589035,0.00009017727,0.008387919,0.000024526942,0.00009339819,0.000028865335,0.00034588983,0.0031027107,0.9659618,0.00015562316,0.017342044,0.00010810642],"about_ca_topic_score_codex":0.0000054429315,"about_ca_topic_score_gemma":0.000019063134,"teacher_disagreement_score":0.017256368,"about_ca_system_score_codex":0.00016765333,"about_ca_system_score_gemma":0.000090067755,"threshold_uncertainty_score":0.45974898},"labels":[],"label_agreement":null},{"id":"W1981252527","doi":"10.1139/y00-130","title":"Effect of<i>trans</i>-resveratrol on 7-benzyloxy-4-trifluoromethylcoumarin<i>O</i>-dealkylation catalyzed by human recombinant CYP3A4 and CYP3A5","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CYP3A4; Recombinant DNA; Alkylation; Chemistry; Resveratrol; Stereochemistry; Pharmacology; Catalysis; Biology; Biochemistry; Enzyme; Cytochrome P450; Gene","score_opus":0.02938001970215018,"score_gpt":0.3681678513950691,"score_spread":0.33878783169291893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981252527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859913,0.00918747,0.000022463017,0.0008098755,0.0027504966,0.00042966203,0.00013665165,0.000012825634,0.0006592496],"genre_scores_gemma":[0.99354357,0.0039192326,0.000021527692,0.0017769363,0.000479521,0.000021422278,0.00004152851,0.000037815345,0.00015842143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99609226,0.0018066152,0.0008171855,0.00041069207,0.00013301693,0.00074025337],"domain_scores_gemma":[0.9970796,0.0009535147,0.0005509123,0.00015543628,0.00018854802,0.0010719999],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001740177,0.00043469862,0.000963784,0.00052625284,0.0004928456,0.000015569625,0.0003625248,0.0005485562,0.0020775858],"category_scores_gemma":[0.0000537106,0.0003852463,0.00018622632,0.0002630678,0.0007709895,0.00015172723,0.00004036698,0.0013229018,0.000009404928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014879754,0.00013377248,0.006048142,0.00014787563,0.00050250354,0.00013243295,0.00036947534,0.00016620604,0.9670861,0.00020220014,0.007868614,0.015854718],"study_design_scores_gemma":[0.0090975035,0.002364324,0.0037926217,0.000024487428,0.00094402314,0.00030369763,0.000021055303,0.00024557675,0.85182154,0.0012839409,0.12967654,0.00042469005],"about_ca_topic_score_codex":0.00036332206,"about_ca_topic_score_gemma":0.00017126181,"teacher_disagreement_score":0.121807925,"about_ca_system_score_codex":0.000066328364,"about_ca_system_score_gemma":0.00028216644,"threshold_uncertainty_score":0.9998599},"labels":[],"label_agreement":null},{"id":"W1981397813","doi":"10.2217/pme.14.66","title":"Fast And Frugal Trees: Translating Population-Based Pharmacogenomics to Medication Prioritization","year":2015,"lang":"en","type":"article","venue":"Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Alberta","funders":"","keywords":"Pharmacogenomics; Prioritization; Population; Medicine; Pharmacogenetics; Computer science; Pharmacology; Biology; Genetics; Management science; Engineering; Environmental health; Gene","score_opus":0.1442892469105504,"score_gpt":0.4509678658964886,"score_spread":0.3066786189859382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981397813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9320107,0.009525093,0.021787774,0.02645555,0.0028144019,0.0012953149,0.00013196195,0.0002350112,0.005744193],"genre_scores_gemma":[0.98511535,0.00030233228,0.0027053135,0.009847843,0.0012878402,0.00007144605,0.0002640848,0.000042216154,0.00036357756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980028,0.0003212658,0.00047776257,0.00040572556,0.00041158436,0.00038080802],"domain_scores_gemma":[0.99835557,0.00021786484,0.00014956981,0.00013565716,0.00019042534,0.0009508908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013409541,0.00026367983,0.00037960816,0.00023535683,0.00019499181,0.000012338365,0.00016000109,0.00014337475,0.00071724894],"category_scores_gemma":[0.0002988514,0.00024271288,0.000049275168,0.00033092516,0.00016821544,0.00008548569,0.000028045994,0.0003499495,0.000034403423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002538423,0.0005394061,0.11663129,0.00024935164,0.00040930792,0.000054837506,0.036978185,0.0117872115,0.3047314,0.0042810338,0.016488599,0.50531095],"study_design_scores_gemma":[0.03434614,0.00042598305,0.021529974,0.00016205916,0.001471673,0.00006243889,0.0023839585,0.21589997,0.0129833035,0.0014406627,0.70816594,0.0011278862],"about_ca_topic_score_codex":0.00016329503,"about_ca_topic_score_gemma":0.00003833237,"teacher_disagreement_score":0.69167733,"about_ca_system_score_codex":0.000096359516,"about_ca_system_score_gemma":0.00017205195,"threshold_uncertainty_score":0.98975444},"labels":[],"label_agreement":null},{"id":"W1982052181","doi":"10.1124/dmd.108.022483","title":"Disparity in Intestine Disposition between Formed and Preformed Metabolites and Implications: A Theoretical Study","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Metabolite; Chemistry; Pharmacokinetics; Area under the curve; Oral administration; Metabolism; Pharmacology; Active metabolite; Enterocyte; Small intestine; Biochemistry; Biology","score_opus":0.05574559710314367,"score_gpt":0.3849257242669349,"score_spread":0.3291801271637912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982052181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875723,0.00913387,0.0002813333,0.0009310924,0.00018510604,0.0011399835,0.0002331616,0.00006905721,0.00045406193],"genre_scores_gemma":[0.99365854,0.004776975,0.00030821873,0.00050815416,0.00026698265,0.00026879626,0.00015076947,0.000028141734,0.00003338989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975334,0.0006112369,0.00057773245,0.0005995772,0.00018889814,0.00048916414],"domain_scores_gemma":[0.9986731,0.0004437128,0.00014462048,0.00020914065,0.00009116548,0.00043828704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094147446,0.0003657181,0.00059204025,0.00027502634,0.0005052098,0.000054350003,0.00014303613,0.00018121905,0.000049345967],"category_scores_gemma":[0.0001215437,0.00031462623,0.000057054283,0.00034122032,0.00067872985,0.0004171299,0.00020389757,0.0005411568,0.000005186256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000743625,0.0015930159,0.84061134,0.00012219547,0.00023135745,0.000046541398,0.007984203,0.000009632155,0.028366672,0.059370514,0.000099593766,0.060821325],"study_design_scores_gemma":[0.004005456,0.00006455123,0.9714646,0.000016552207,0.0006091204,0.00011506313,0.00036232584,0.00076280604,0.004590557,0.016277492,0.0013592067,0.0003722669],"about_ca_topic_score_codex":0.0000862615,"about_ca_topic_score_gemma":0.000030484702,"teacher_disagreement_score":0.13085328,"about_ca_system_score_codex":0.000021092523,"about_ca_system_score_gemma":0.00003865419,"threshold_uncertainty_score":0.99993056},"labels":[],"label_agreement":null},{"id":"W1982264959","doi":"10.1097/fpc.0b013e3283331637","title":"A pharmacogenetics study of the human glucuronosyltransferase UGT1A4","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Biology; Genetics; Coding region; Promoter; Linkage disequilibrium; Gene; Genetic variation; Haplotype; Allele; Gene expression","score_opus":0.0951563878583701,"score_gpt":0.42852828229794054,"score_spread":0.33337189443957044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982264959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98830366,0.006103343,0.00006179876,0.0005609429,0.0014703111,0.0015894396,0.00017032417,0.000060673883,0.0016794982],"genre_scores_gemma":[0.9917742,0.004268087,0.00016434197,0.0029531163,0.0004882186,0.00003939651,0.000011060029,0.00006234257,0.00023923705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99645776,0.00062561233,0.0010203633,0.0006962038,0.0004188077,0.0007812538],"domain_scores_gemma":[0.99819356,0.00013083198,0.00034446365,0.0005746086,0.00021103704,0.0005454875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077975786,0.00058962376,0.0006098645,0.0001845466,0.00071942585,0.00005204214,0.0009899815,0.00023175488,0.00030254902],"category_scores_gemma":[0.000022922139,0.00050040544,0.00023739263,0.00048151103,0.00032722903,0.00006608939,0.0002713909,0.00090687576,0.000013856318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021945497,0.0026557867,0.023697194,0.0000548213,0.00040900352,0.000024048888,0.003449842,0.0036380275,0.89861333,0.0003759803,0.000755623,0.06610686],"study_design_scores_gemma":[0.013562412,0.0010010577,0.050535697,0.000017303779,0.002376581,0.000071787275,0.0006301975,0.00570463,0.71619797,0.0019836565,0.20672166,0.0011970433],"about_ca_topic_score_codex":0.000026613548,"about_ca_topic_score_gemma":0.000013736426,"teacher_disagreement_score":0.20596604,"about_ca_system_score_codex":0.000048703736,"about_ca_system_score_gemma":0.00012425346,"threshold_uncertainty_score":0.9997448},"labels":[],"label_agreement":null},{"id":"W1983101272","doi":"10.1111/j.1399-0004.2006.0627a.x","title":"Pharmacogenetics of antidepressants: serotonin 2A receptor genotype strongly associated with treatment outcome","year":2006,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Citation; Medicine; Pharmacogenomics; Genotype; Psychiatry; Psychology; Family medicine; Library science; Genetics; Pharmacology; Biology; Computer science; Gene","score_opus":0.22834278485750384,"score_gpt":0.49838857943981363,"score_spread":0.2700457945823098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983101272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879221,0.004787567,0.00022378509,0.00017814961,0.001712785,0.0009898534,0.00068188907,0.00011449947,0.003389394],"genre_scores_gemma":[0.9900984,0.003995516,0.00222395,0.0005537865,0.00088253646,0.00006690303,0.0001900565,0.00010706037,0.0018817878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950076,0.0010141386,0.0019225283,0.00074214506,0.0004373024,0.00087629835],"domain_scores_gemma":[0.99673384,0.00095305784,0.0008321886,0.00055793935,0.00043657148,0.00048640178],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011639689,0.0005852067,0.0010738623,0.00013397489,0.00019943899,0.000027851895,0.0005961956,0.0006465217,0.0010353893],"category_scores_gemma":[0.0001515657,0.0004892355,0.00038698275,0.00041859018,0.00072539545,0.000048756014,0.00015817642,0.0007480569,0.00012839274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007222512,0.003282598,0.9258954,0.00003334015,0.0009466212,0.00004336517,0.00008103989,0.010936494,0.028591609,0.00014835483,0.0023394178,0.026979545],"study_design_scores_gemma":[0.016574303,0.0020697187,0.36334154,0.000039903887,0.0025115057,0.000012027894,0.000049698418,0.00806941,0.24853703,0.0002532998,0.35736206,0.0011795142],"about_ca_topic_score_codex":0.00003404603,"about_ca_topic_score_gemma":0.000043016145,"teacher_disagreement_score":0.5625538,"about_ca_system_score_codex":0.00008514663,"about_ca_system_score_gemma":0.0002626911,"threshold_uncertainty_score":0.9998778},"labels":[],"label_agreement":null},{"id":"W1983119579","doi":"10.1124/dmd.31.6.768","title":"INTERACTION OF BUPRENORPHINE AND ITS METABOLITE NORBUPRENORPHINE WITH CYTOCHROMES P450 IN VITRO","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institute on Drug Abuse","keywords":"Chemistry; Pharmacology; CYP2A6; Metabolite; Dextrorphan; CYP3A4; Dextromethorphan; Microsome; Buprenorphine; Cytochrome P450; Biochemistry; Opioid; In vitro; Metabolism; Biology","score_opus":0.03156261028565863,"score_gpt":0.34412999770526287,"score_spread":0.3125673874196042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983119579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676215,0.029450592,0.00011042247,0.00021959096,0.00037255898,0.0004600207,0.00019358695,0.000032517106,0.0015391858],"genre_scores_gemma":[0.9929387,0.0057339114,0.00047242895,0.00040033297,0.00012089543,0.000065785,0.00008351382,0.00003087725,0.00015354708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979833,0.0004917021,0.00048848573,0.0004451324,0.0001987382,0.00039265092],"domain_scores_gemma":[0.999062,0.00016426097,0.00022664419,0.00016047046,0.0001259235,0.00026068313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070343283,0.00033638635,0.0005826924,0.000353861,0.00013872213,0.000030091182,0.00010978716,0.00015300338,0.00015981309],"category_scores_gemma":[0.000048998132,0.00028587008,0.00006348542,0.00039554297,0.00015291534,0.0003998918,0.000058169455,0.00044161512,0.0000073256606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012673595,0.00041522933,0.0014318938,0.00012913768,0.00014602928,0.00002269467,0.0013383636,0.00026343937,0.97176576,0.010002927,0.000034408604,0.013182734],"study_design_scores_gemma":[0.005777238,0.000047992882,0.046868753,0.000032633692,0.0006680731,0.000105603445,0.0002750257,0.0019934527,0.91554415,0.0011850757,0.027034732,0.0004672759],"about_ca_topic_score_codex":0.00005815997,"about_ca_topic_score_gemma":0.000017770562,"teacher_disagreement_score":0.056221638,"about_ca_system_score_codex":0.000015010868,"about_ca_system_score_gemma":0.0000421257,"threshold_uncertainty_score":0.99995935},"labels":[],"label_agreement":null},{"id":"W1983986186","doi":"10.1016/j.tips.2011.08.005","title":"Cytochrome P450 enzymes in the brain: emerging evidence of biological significance","year":2011,"lang":"en","type":"review","venue":"Trends in Pharmacological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Cytochrome P450; Drug metabolism; Biology; Central nervous system; Endogeny; Metabolism; Enzyme; Neuroscience; Pharmacology; Drug; Biochemistry","score_opus":0.6210428183400608,"score_gpt":0.5809706546204215,"score_spread":0.04007216371963929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983986186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035217346,0.9861522,0.0000043354535,0.0005955701,0.00090049964,0.0010182547,0.00007117231,0.000054473257,0.007681767],"genre_scores_gemma":[0.07030418,0.92700696,0.00012791135,0.0014250553,0.00035011995,0.0005952406,0.000012334747,0.000021380862,0.00015682675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98940533,0.0055075297,0.0018487565,0.0013158931,0.0005524113,0.0013700628],"domain_scores_gemma":[0.99267757,0.0057843686,0.0008838478,0.0003283522,0.000060479688,0.0002654071],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008835943,0.0008357638,0.0022406632,0.0010116382,0.00030830884,0.000046600882,0.003923923,0.0008894036,0.0058706165],"category_scores_gemma":[0.00046474754,0.00047176742,0.0006495915,0.0045326995,0.0026392417,0.00022612845,0.0005230833,0.0025619795,0.00007560177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010973315,0.0008828448,0.00027345662,0.00070567767,0.00009954002,0.00018703168,0.00069501,0.000085400556,0.0010280885,0.0037447473,0.0022323874,0.9899561],"study_design_scores_gemma":[0.0007670743,0.00044115022,0.0010132099,0.0010392272,0.00051915634,0.0000542823,0.00010965811,0.0001675987,0.00050551374,0.0007470901,0.99388874,0.0007472772],"about_ca_topic_score_codex":0.000060829123,"about_ca_topic_score_gemma":0.000025263336,"teacher_disagreement_score":0.99165636,"about_ca_system_score_codex":0.00011604822,"about_ca_system_score_gemma":0.00031835816,"threshold_uncertainty_score":0.9997734},"labels":[],"label_agreement":null},{"id":"W1984061511","doi":"10.1002/bdd.517","title":"Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics","year":2006,"lang":"en","type":"review","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Enantiomer; Bioequivalence; Pharmacology; Pharmacodynamics; Chemistry; Drug; Stereoselectivity; In vivo; Distribution (mathematics); Medicine; Stereochemistry; Biology; Biochemistry; Mathematics","score_opus":0.12001963851674498,"score_gpt":0.4615586697855712,"score_spread":0.34153903126882623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984061511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07921989,0.9087423,0.00006519067,0.00026527565,0.004144433,0.004518097,0.0018088659,0.00029402116,0.000941905],"genre_scores_gemma":[0.09323718,0.89950776,0.00013742516,0.0015250201,0.0012324901,0.00085628644,0.0029628982,0.0003329644,0.00020795323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98833954,0.003974507,0.002620092,0.002161194,0.00089293113,0.0020117543],"domain_scores_gemma":[0.99608034,0.00077083136,0.0011341468,0.00095562066,0.0002001225,0.0008589615],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002698862,0.0020362502,0.0028853223,0.0021417646,0.0004624386,0.00018390892,0.0012791409,0.0012828296,0.0003796428],"category_scores_gemma":[0.000040483836,0.002054579,0.0008032687,0.0022848917,0.00036205593,0.00057263015,0.0003919287,0.005006307,0.00051727204],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012497702,0.008369535,0.00078128476,0.005744861,0.0004888503,0.00093270995,0.00045203528,0.0029060417,0.0030140034,0.0019179336,0.0022777885,0.9718652],"study_design_scores_gemma":[0.006049364,0.00013581045,0.000616684,0.0031253072,0.003457976,0.00007796515,0.00002923655,0.011179719,0.0039755553,0.0012731021,0.9673647,0.0027145615],"about_ca_topic_score_codex":0.00018807055,"about_ca_topic_score_gemma":0.00065657,"teacher_disagreement_score":0.9691506,"about_ca_system_score_codex":0.0011401919,"about_ca_system_score_gemma":0.00045796178,"threshold_uncertainty_score":0.99923795},"labels":[],"label_agreement":null},{"id":"W1984122156","doi":"10.1007/s00213-015-3898-x","title":"Exploring the role of drug-metabolising enzymes in antidepressant side effects","year":2015,"lang":"en","type":"article","venue":"Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Dalhousie University","funders":"Medical Research Council; H. Lundbeck A/S; Lundbeckfonden; European Commission; National Institute for Health and Care Research; Canada Research Chairs; South London and Maudsley NHS Foundation Trust; GlaxoSmithKline","keywords":"Antidepressant; Drug; Pharmacology; Medicine; Psychology; Psychiatry; Anxiety","score_opus":0.14755125303168887,"score_gpt":0.42150140560046895,"score_spread":0.2739501525687801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984122156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385797,0.037345577,0.000021193166,0.00087798794,0.007873348,0.0007888278,0.000025716201,0.00007957969,0.014408096],"genre_scores_gemma":[0.99235094,0.003921974,0.00018576595,0.002044755,0.0009511485,0.00035329376,0.000006177614,0.000056092755,0.00012985543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99572104,0.0017085058,0.0008045699,0.0005423067,0.00032847296,0.00089509896],"domain_scores_gemma":[0.9975455,0.0011632752,0.00030585553,0.00036913122,0.00017699998,0.0004392653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021496653,0.00040413416,0.0006829398,0.00039920758,0.00015365824,0.000019390962,0.00082344876,0.00017146324,0.00013963941],"category_scores_gemma":[0.00019627794,0.00032826225,0.0001812795,0.00071906776,0.0003986033,0.00026901014,0.00024830183,0.0011744242,0.000117822376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024950553,0.0013942004,0.046265792,0.00013025918,0.0005508129,0.00017614658,0.010121632,0.006317951,0.65569305,0.0064771944,0.0048640296,0.2655139],"study_design_scores_gemma":[0.007510448,0.00006381807,0.019915814,0.000021702397,0.00033417952,0.000032777374,0.0007841885,0.0024537304,0.651809,0.003314929,0.3133529,0.00040650152],"about_ca_topic_score_codex":0.00013378344,"about_ca_topic_score_gemma":0.000024842184,"teacher_disagreement_score":0.3084889,"about_ca_system_score_codex":0.000055374097,"about_ca_system_score_gemma":0.00015771925,"threshold_uncertainty_score":0.999917},"labels":[],"label_agreement":null},{"id":"W1984441096","doi":"10.1016/s0163-7258(01)00165-6","title":"Alteration of drug biotransformation and elimination during infection and inflammation","year":2001,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Inflammation; Mediator; Cytochrome P450; Biotransformation; Endogeny; Signal transduction; Biology; Drug; Drug metabolism; Immunology; Pharmacology; Cell biology; Enzyme; Endocrinology; Biochemistry","score_opus":0.14086341103683375,"score_gpt":0.46719198610173945,"score_spread":0.3263285750649057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984441096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061535433,0.93437177,0.00015988735,0.00029308847,0.0016357986,0.0015020717,0.00008940794,0.0000923257,0.00032019312],"genre_scores_gemma":[0.014186265,0.98419493,0.000098912074,0.00033941967,0.0006434495,0.00018039193,0.00018483728,0.00006727386,0.000104530736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663556,0.0011267086,0.0011320998,0.00047355067,0.0002004276,0.0004316314],"domain_scores_gemma":[0.9982628,0.00035965935,0.0008474007,0.00015458759,0.00019360824,0.000181894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089749834,0.00058110803,0.0011129605,0.0006391429,0.0003390462,0.000038102327,0.00016794416,0.0007183955,0.00018604484],"category_scores_gemma":[0.0000077344885,0.0005644452,0.00018874725,0.0004630316,0.0003419674,0.00033404338,0.000100760015,0.0010120961,0.000018752398],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010832581,0.00013208312,0.00009439167,0.0065874406,0.00092016376,0.000005970658,0.001097388,0.000046576377,0.013622192,0.00022351155,0.000049405382,0.97711253],"study_design_scores_gemma":[0.0018976944,0.00006770164,0.00020293023,0.0003688138,0.008504823,0.00014551672,0.000022123426,0.0018525898,0.016312376,0.0002097579,0.9698848,0.0005308821],"about_ca_topic_score_codex":0.000014337824,"about_ca_topic_score_gemma":0.000007039858,"teacher_disagreement_score":0.9765817,"about_ca_system_score_codex":0.00010249523,"about_ca_system_score_gemma":0.00011649152,"threshold_uncertainty_score":0.9996807},"labels":[],"label_agreement":null},{"id":"W1985406339","doi":"10.1124/dmd.109.029991","title":"Down-Regulation of Liver Drug-Metabolizing Enzymes in a Murine Model of Chronic Renal Failure","year":2009,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"CYP1A2; Cytochrome P450; Drug metabolism; CYP3A; Endocrinology; Internal medicine; Messenger RNA; Biology; Isozyme; Gene expression; Enzyme; Metabolism; Gene; Medicine; Biochemistry","score_opus":0.031937619041561345,"score_gpt":0.33781999480115205,"score_spread":0.3058823757595907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985406339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95926934,0.03791227,0.00074035034,0.0004295186,0.00020428174,0.0004291458,0.00017612716,0.000032176347,0.0008067829],"genre_scores_gemma":[0.99387646,0.0042733005,0.0009467656,0.00032088158,0.0002917475,0.000021747643,0.00008723123,0.000018554318,0.00016332598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979341,0.0003411696,0.00069735036,0.0003735447,0.00026169405,0.00039213165],"domain_scores_gemma":[0.9990529,0.00008850504,0.00033086695,0.00021070798,0.00013974724,0.00017727313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073595956,0.00029534925,0.0005977051,0.000402163,0.00010653847,0.000014474257,0.00019239259,0.00018645082,0.00015835803],"category_scores_gemma":[0.000022181814,0.00028429957,0.00014520137,0.0003844664,0.00016834874,0.00032102334,0.00006522345,0.0003772426,0.0000049504374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039178412,0.00055271265,0.00030355153,0.000116229545,0.00006010459,0.000004347788,0.0019354777,0.017871182,0.8917729,0.03609386,0.0004146261,0.050483216],"study_design_scores_gemma":[0.0044282405,0.00003883895,0.07788951,0.00007336587,0.0005425275,0.000009905914,0.00008260899,0.1439039,0.76035386,0.0059370454,0.0063384986,0.00040171598],"about_ca_topic_score_codex":0.000069413596,"about_ca_topic_score_gemma":0.00005489994,"teacher_disagreement_score":0.13141905,"about_ca_system_score_codex":0.000025524518,"about_ca_system_score_gemma":0.000089187044,"threshold_uncertainty_score":0.9999609},"labels":[],"label_agreement":null},{"id":"W1985410301","doi":"10.1016/j.pharmthera.2004.10.013","title":"UDP-glucuronosyltransferases and clinical drug-drug interactions","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":546,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Glucuronidation; Diflunisal; Glucuronosyltransferase; Temazepam; Enzyme; Drug; Chemistry; Pharmacology; CYP2B6; Drug metabolism; Xenobiotic; Biochemistry; Cytochrome P450; Biology; Microsome; CYP1A2; Receptor","score_opus":0.3361456151830802,"score_gpt":0.5765719802520972,"score_spread":0.240426365069017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985410301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010026108,0.97701705,0.000035521007,0.0017990038,0.0144477375,0.0021811603,0.0007416372,0.000357395,0.0024178901],"genre_scores_gemma":[0.0005654811,0.97152436,0.000274229,0.017367357,0.005722101,0.00043868995,0.00021982861,0.00030228824,0.0035856862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892006,0.004719939,0.0025892574,0.001609726,0.00033735935,0.0015431058],"domain_scores_gemma":[0.993311,0.0039015792,0.00090300775,0.00060437864,0.00022925113,0.0010508165],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0020830913,0.0016503303,0.0035182356,0.00063618436,0.0007276375,0.00009480973,0.0013352028,0.00094780495,0.0045687687],"category_scores_gemma":[0.000018916215,0.0015141334,0.0014500354,0.0005937699,0.0012954538,0.00025552366,0.00046823325,0.0061781113,0.0010727143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001528717,0.0012835461,0.00009237011,0.001238696,0.0058620223,0.000088964436,0.00033634552,0.000012752026,0.00012063143,0.000101405625,0.019648666,0.9710617],"study_design_scores_gemma":[0.002467937,0.00006218804,0.00001316673,0.00032197448,0.033234812,0.0002559539,0.000041407216,0.0003865389,0.00026770157,0.00006561581,0.96156746,0.0013152148],"about_ca_topic_score_codex":0.000016457918,"about_ca_topic_score_gemma":0.000046345638,"teacher_disagreement_score":0.96974653,"about_ca_system_score_codex":0.0002079876,"about_ca_system_score_gemma":0.00075538276,"threshold_uncertainty_score":0.9997051},"labels":[],"label_agreement":null},{"id":"W1985851151","doi":"10.1016/j.bcp.2005.10.040","title":"The 21-aminosteroid U74389G prevents the down-regulation and decrease in activity of CYP1A1, 1A2 and 3A6 induced by an inflammatory reaction","year":2005,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Merck Canada","keywords":"Chemistry; Pharmacology; Internal medicine; Endocrinology; Medicine","score_opus":0.04714237804707585,"score_gpt":0.3874188025204056,"score_spread":0.3402764244733298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985851151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204624,0.0044975025,0.0000048338616,0.0020528235,0.000509894,0.00067332754,0.000040817773,0.000027791022,0.00014676503],"genre_scores_gemma":[0.996249,0.0019070582,0.000026590964,0.00125454,0.00035997128,0.000099944584,0.000019468178,0.000021394995,0.000062024985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975894,0.0009456272,0.00045529907,0.00040551703,0.00016561444,0.00043853922],"domain_scores_gemma":[0.99851537,0.0006145792,0.00026403146,0.00019228226,0.00006743799,0.0003462946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001103363,0.00026363286,0.0002807245,0.000082830134,0.0002555059,0.00001879782,0.00028651595,0.00037720913,0.0000990503],"category_scores_gemma":[0.00008976414,0.00019353161,0.00005108985,0.00016250688,0.0005338551,0.00018600342,0.00019067418,0.00075596425,0.0000058597893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000869432,0.000369205,0.0014040082,0.000020254092,0.00008197547,0.0000017216136,0.00028108663,0.000014837094,0.9511182,0.00006037506,0.0053584306,0.040420488],"study_design_scores_gemma":[0.002837933,0.00007962897,0.023706615,0.0000053683298,0.00018114859,0.000017710263,0.000036341266,0.0058841216,0.914334,0.00022479818,0.052483592,0.00020877067],"about_ca_topic_score_codex":0.000045890407,"about_ca_topic_score_gemma":0.000012461954,"teacher_disagreement_score":0.04712516,"about_ca_system_score_codex":0.000079329664,"about_ca_system_score_gemma":0.00008221544,"threshold_uncertainty_score":0.789199},"labels":[],"label_agreement":null},{"id":"W1985978909","doi":"10.1016/j.tiv.2014.03.004","title":"Modulation of trichloroethylene in vitro metabolism by different drugs in human","year":2014,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"","keywords":"Mefenamic acid; Chemistry; Naproxen; Microsome; Salicylic acid; Metabolite; Pharmacology; Glucuronidation; Acetaminophen; Carbamazepine; Metabolism; Ibuprofen; Biochemistry; In vitro; Chromatography","score_opus":0.044262208007041226,"score_gpt":0.38232666997655274,"score_spread":0.3380644619695115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985978909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403596,0.0016161888,0.00006925625,0.0006262303,0.001038167,0.00063330465,0.00008951067,0.000037282483,0.0018540898],"genre_scores_gemma":[0.99748397,0.0003291047,0.00015001209,0.0012839256,0.00019559037,0.00019414129,0.00011182021,0.000042965326,0.00020849683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953355,0.0017650273,0.0011842747,0.00059863663,0.00023903948,0.0008775321],"domain_scores_gemma":[0.9984664,0.00061182765,0.00033354867,0.00032411492,0.000056139714,0.00020801405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017861247,0.00041242622,0.0010700439,0.00086492597,0.00007728009,0.000009370181,0.00050198555,0.000698795,0.0003287915],"category_scores_gemma":[0.00013522561,0.00042323495,0.00013673506,0.0006323242,0.00027155768,0.00011260932,0.00016750734,0.0012623575,0.00001902166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011234093,0.0014616487,0.005403272,0.00003694253,0.0000439902,0.000009332936,0.0009452139,0.0010739785,0.96561974,0.0006984172,0.00020010142,0.023383943],"study_design_scores_gemma":[0.008544121,0.00007152288,0.06411058,0.000007892267,0.00007052725,0.0000030607277,0.000059784517,0.014009955,0.9019882,0.0031128465,0.007653391,0.00036809928],"about_ca_topic_score_codex":0.00014490983,"about_ca_topic_score_gemma":0.00007869866,"teacher_disagreement_score":0.06363153,"about_ca_system_score_codex":0.00015357597,"about_ca_system_score_gemma":0.000049490325,"threshold_uncertainty_score":0.99982196},"labels":[],"label_agreement":null},{"id":"W1986311009","doi":"10.1016/j.clpt.2004.12.026","title":"Effect of St. John's Wort administration on CYP2C8 mediated rosiglitazone metabolism","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosiglitazone; Pharmacokinetics; CYP2C8; Pharmacology; Medicine; Internal medicine; Metabolism; Receptor; CYP3A4; Cytochrome P450","score_opus":0.13527301971220893,"score_gpt":0.516411642202892,"score_spread":0.3811386224906831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986311009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714834,0.00514075,0.000097838136,0.009106953,0.00887088,0.0014199052,0.00037821665,0.00025306345,0.0032489628],"genre_scores_gemma":[0.9238235,0.006908279,0.00027297033,0.0646083,0.0034920021,0.00015475757,0.00013116507,0.000107172265,0.00050186005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99083394,0.004596909,0.0020389052,0.0009375609,0.00052780705,0.0010648998],"domain_scores_gemma":[0.99178326,0.005761305,0.0008413214,0.0005405472,0.00031717285,0.0007563717],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0050783455,0.0007718794,0.0014750926,0.00030250897,0.00030099886,0.000024638097,0.00096654834,0.0012059312,0.0031657966],"category_scores_gemma":[0.00015750667,0.0006678371,0.00068566017,0.00056190597,0.0011378217,0.00017150806,0.0001904437,0.0026487703,0.0006851286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026014488,0.009425512,0.010483329,0.00021528613,0.007381479,0.00017386534,0.00066874025,0.0023163569,0.435251,0.00065203465,0.06698462,0.4404333],"study_design_scores_gemma":[0.009221068,0.0018909888,0.0022331749,0.000011201185,0.0031704106,0.000015082525,0.000011555138,0.003991573,0.36799136,0.0000678247,0.61091304,0.00048270856],"about_ca_topic_score_codex":0.000002578538,"about_ca_topic_score_gemma":0.0000046023024,"teacher_disagreement_score":0.54392844,"about_ca_system_score_codex":0.00008608516,"about_ca_system_score_gemma":0.00030971842,"threshold_uncertainty_score":0.99965215},"labels":[],"label_agreement":null},{"id":"W1986577071","doi":"10.1097/fjc.0b013e3182163b82","title":"Pharmacogenomics of Cardiovascular Drugs and Adverse Effects in Pediatrics","year":2011,"lang":"en","type":"review","venue":"Journal of Cardiovascular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Medicine; Adverse effect; Intensive care medicine; Pediatrics; Pharmacology","score_opus":0.08207730166137694,"score_gpt":0.39963533610348984,"score_spread":0.3175580344421129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986577071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038204682,0.9835963,0.00021461824,0.000010436091,0.009444679,0.0018802347,0.00013198615,0.000027156144,0.000874067],"genre_scores_gemma":[0.0019359291,0.9942165,0.0004779252,0.00019569456,0.0027887302,0.00011186563,0.000017580773,0.0002118545,0.000043932363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98799074,0.0056932373,0.0033802162,0.0009064695,0.0008489241,0.0011804051],"domain_scores_gemma":[0.9941975,0.0012999568,0.0022771691,0.0007102286,0.00062609726,0.0008890871],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.008281632,0.0013053825,0.008529241,0.002150643,0.00013456924,0.000016716313,0.0014625961,0.0016142164,0.00026154603],"category_scores_gemma":[0.00018580981,0.0011966242,0.008349807,0.001185332,0.00059381215,0.0002686434,0.0005956997,0.004149672,0.00004065692],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032062616,0.00059930177,0.00003545332,0.017537514,0.041863542,0.0017318277,0.000650866,0.0028585,0.00011171136,0.00006778124,0.0010507163,0.93317217],"study_design_scores_gemma":[0.0073682657,0.00019642134,0.0000097595685,0.0006161087,0.08758693,0.0011538322,0.000037171198,0.000061384,0.0008475456,0.000084564745,0.90118426,0.00085378316],"about_ca_topic_score_codex":0.000031932526,"about_ca_topic_score_gemma":4.978725e-7,"teacher_disagreement_score":0.9323184,"about_ca_system_score_codex":0.00031079832,"about_ca_system_score_gemma":0.0012054262,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W1987148753","doi":"10.1177/0091270005284389","title":"Use of Omeprazole as a CYP3A Probe Drug: Effect of Sex and Menstrual Cycle Phase on CYP3A Activity in Healthy Caucasian Adults","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Luteal phase; Omeprazole; Follicular phase; Menstrual cycle; CYP3A; Medicine; Endocrinology; Internal medicine; Metabolism; Hormone","score_opus":0.1143286373631692,"score_gpt":0.5257836796528554,"score_spread":0.4114550422896862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987148753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926769,0.0009225338,0.000014894956,0.0022424688,0.002756475,0.00084177655,0.00009071679,0.000012332968,0.00044188517],"genre_scores_gemma":[0.9940689,0.0028000663,0.00007462651,0.001971146,0.00095750537,0.000014196825,0.0000030542133,0.000034456,0.00007603742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9899412,0.006444614,0.0022964128,0.0003294935,0.00039123156,0.0005970682],"domain_scores_gemma":[0.9889556,0.008139488,0.0020295025,0.00022929646,0.00022827182,0.00041784393],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007927431,0.00037986567,0.0015554668,0.0003222857,0.00012520241,0.000008642484,0.000497844,0.00039227298,0.00029266317],"category_scores_gemma":[0.00042176995,0.00026844183,0.0003333635,0.00035312522,0.0009132993,0.0001821058,0.00017314065,0.0023836957,0.000010893346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24033174,0.01591721,0.05705198,0.0006734016,0.001574359,0.00053322973,0.0023398132,0.008420501,0.46311072,0.0002465379,0.012230462,0.19757006],"study_design_scores_gemma":[0.08664086,0.016367892,0.030173795,0.00015207137,0.0022909034,0.00042504095,0.00016703882,0.008513331,0.81070155,0.0009869704,0.04292091,0.00065961893],"about_ca_topic_score_codex":0.00017481521,"about_ca_topic_score_gemma":0.000030564002,"teacher_disagreement_score":0.34759086,"about_ca_system_score_codex":0.000046674457,"about_ca_system_score_gemma":0.00032430887,"threshold_uncertainty_score":0.99997675},"labels":[],"label_agreement":null},{"id":"W1987843098","doi":"10.1038/sj.tpj.6500364","title":"Pharmacogenomics and regulatory decision making: an international perspective","year":2006,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Pharmacogenomics; Perspective (graphical); Regulatory science; Clinical decision making; Medicine; Computer science; Family medicine; Pharmacology; Artificial intelligence; Pathology","score_opus":0.07374768435680266,"score_gpt":0.44596075582684136,"score_spread":0.3722130714700387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987843098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97284514,0.0077347774,0.0012613522,0.0016911629,0.006218394,0.00044433327,0.00016529685,0.00009037929,0.00954918],"genre_scores_gemma":[0.9815882,0.0067792893,0.0014784526,0.004063218,0.005618011,0.000020748437,0.000015301644,0.00009637803,0.00034043702],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663806,0.00067806605,0.0008439306,0.00057539635,0.00046186746,0.00080269366],"domain_scores_gemma":[0.99778736,0.00039913983,0.00051351107,0.0003429881,0.00044834884,0.0005086562],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026294484,0.0004999179,0.00038877458,0.00032447802,0.0012780009,0.00029779098,0.0013330644,0.00022715355,0.0014833909],"category_scores_gemma":[0.000054930446,0.0004080258,0.00023764798,0.00023110118,0.00049605645,0.0005387573,0.00036421462,0.0018426001,0.000099111116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034036378,0.001076673,0.006183142,0.0000143976395,0.0011623426,0.00038599843,0.0024039214,0.019740114,0.67652506,0.024350155,0.012638593,0.25211594],"study_design_scores_gemma":[0.009358239,0.00014078009,0.010761316,0.000026088946,0.0013326862,0.005435698,0.00090577704,0.055756867,0.045891892,0.06360661,0.8054875,0.0012965248],"about_ca_topic_score_codex":0.00002345062,"about_ca_topic_score_gemma":0.000009750239,"teacher_disagreement_score":0.79284894,"about_ca_system_score_codex":0.00041327192,"about_ca_system_score_gemma":0.00021397858,"threshold_uncertainty_score":0.99983716},"labels":[],"label_agreement":null},{"id":"W1988144987","doi":"10.1007/s002280000116","title":"Genotype and phenotype of cytochrome P 450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome","year":2000,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Genotype; CYP2D6; Dextromethorphan; Phenotype; Biology; Immunology; Virology; Internal medicine; Medicine; Genetics; Pharmacology; Gene","score_opus":0.05406232218643753,"score_gpt":0.40537479072086907,"score_spread":0.35131246853443154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988144987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914955,0.0030000661,0.000012653352,0.00011875406,0.0010779384,0.00047366155,0.000094636816,0.000013919809,0.003712901],"genre_scores_gemma":[0.9954502,0.0026461792,0.00017800559,0.001391794,0.0001788307,0.000003253175,0.00001551543,0.000056956313,0.00007928231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99318147,0.0030848098,0.002326701,0.00046745554,0.0003575305,0.00058201316],"domain_scores_gemma":[0.9971856,0.0006172619,0.0011762152,0.000176518,0.0004547855,0.00038962488],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031939268,0.00039183735,0.0010981971,0.00030233676,0.00021766443,0.000021153555,0.0005705092,0.0001804648,0.0014999909],"category_scores_gemma":[0.00011452568,0.00032538344,0.00016510797,0.00035104065,0.001059712,0.00025312166,0.00020336107,0.0011495681,0.00003382067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022268357,0.016791206,0.4795557,0.0002157072,0.0019173712,0.0015113631,0.003976025,0.001516549,0.17265053,0.00019739184,0.0012958886,0.29810393],"study_design_scores_gemma":[0.020458927,0.0039675743,0.9651612,0.000051323816,0.00054422667,0.000057716494,0.000026026779,0.00012473343,0.002020997,0.000089568115,0.0071134614,0.0003842506],"about_ca_topic_score_codex":0.000008926985,"about_ca_topic_score_gemma":0.000001301995,"teacher_disagreement_score":0.4856055,"about_ca_system_score_codex":0.000034325876,"about_ca_system_score_gemma":0.00011819714,"threshold_uncertainty_score":0.99991983},"labels":[],"label_agreement":null},{"id":"W1988257729","doi":"10.1016/j.bmc.2014.06.034","title":"Controlling substrate specificity and product regio- and stereo-selectivities of P450 enzymes without mutagenesis","year":2014,"lang":"en","type":"review","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Substrate (aquarium); Protein engineering; Directed evolution; Combinatorial chemistry; Molecular engineering; Enzyme; Mutagenesis; Selectivity; Covalent bond; Substrate specificity; Stereochemistry; Stereoselectivity; Saturated mutagenesis; Small molecule; Natural product; Biochemistry; Organic chemistry; Mutation; Catalysis; Gene","score_opus":0.12670602946013323,"score_gpt":0.42012914460428574,"score_spread":0.29342311514415254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988257729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042857528,0.95496655,0.000021330663,0.00006999322,0.000439002,0.0005757402,0.00013144061,0.000051937743,0.0008864626],"genre_scores_gemma":[0.12292523,0.87467307,0.000047706362,0.000099208,0.0014969056,0.000038681803,0.000042479725,0.00007451347,0.0006022067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695337,0.0004313747,0.00095926557,0.0008212769,0.00029090943,0.00054380274],"domain_scores_gemma":[0.99774534,0.0005115906,0.0008198763,0.00037079563,0.00013750551,0.00041489233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012702771,0.0007314286,0.0024789795,0.00010375075,0.00017557363,0.000028651424,0.0003661428,0.0006472638,0.00037731987],"category_scores_gemma":[0.0001953153,0.0006076277,0.00020603655,0.00023747119,0.0007787164,0.000044589975,0.00014891979,0.0011206438,0.0000063768093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037429045,0.00034333684,0.0009777016,0.06922311,0.0023146996,0.00012127672,0.00067239447,0.0000011800674,0.178535,0.00010451723,0.0014123542,0.7459201],"study_design_scores_gemma":[0.0015499444,0.000054746844,0.00006738917,0.0016475108,0.0043956744,0.0005264779,0.00010882692,0.000040829647,0.147802,0.000046215133,0.843088,0.000672413],"about_ca_topic_score_codex":0.000016759132,"about_ca_topic_score_gemma":0.00000233094,"teacher_disagreement_score":0.84167564,"about_ca_system_score_codex":0.000051393155,"about_ca_system_score_gemma":0.00036200185,"threshold_uncertainty_score":0.9996375},"labels":[],"label_agreement":null},{"id":"W1988416386","doi":"10.1016/j.ijcard.2015.02.025","title":"Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice","year":2015,"lang":"en","type":"review","venue":"International Journal of Cardiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Pharmacogenomics; Current (fluid); State (computer science); Intensive care medicine; Pharmacology","score_opus":0.20496760891612423,"score_gpt":0.5668869890262286,"score_spread":0.3619193801101044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988416386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001020435,0.98926455,0.0001771365,0.00003828177,0.007936714,0.00040712627,0.00031119553,0.000004377921,0.00084017107],"genre_scores_gemma":[0.0036855713,0.9943748,0.00010865482,0.00005260223,0.0016637648,0.00002332895,0.000048270846,0.00003355321,0.000009433795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951808,0.0022864945,0.0016156075,0.00026691257,0.0003727513,0.0002774569],"domain_scores_gemma":[0.9963131,0.0006038741,0.0014289458,0.0001386172,0.0013003281,0.00021516357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043979506,0.0003331281,0.0020943738,0.000767069,0.000022178803,0.000014590612,0.0006292512,0.00022659157,0.000027524466],"category_scores_gemma":[0.0001724916,0.00029567312,0.0008186114,0.00017738192,0.0001522876,0.0001609148,0.00025176926,0.0012295161,0.000013345986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017227218,0.000084949155,0.00010256315,0.00054456206,0.0064567006,0.00022253522,0.000322673,0.0005853898,0.000038945596,0.00010298788,0.0011129468,0.99025345],"study_design_scores_gemma":[0.0024417322,0.00006783377,0.00002268054,0.00030363194,0.004046183,0.0014423428,0.000042467324,0.000018568095,0.0000718877,0.00022307922,0.99110425,0.00021534665],"about_ca_topic_score_codex":0.0000072418,"about_ca_topic_score_gemma":0.0000019496522,"teacher_disagreement_score":0.99003816,"about_ca_system_score_codex":0.0002550226,"about_ca_system_score_gemma":0.0009761974,"threshold_uncertainty_score":0.9999495},"labels":[],"label_agreement":null},{"id":"W1988463445","doi":"10.1007/s00228-002-0487-9","title":"Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression","year":2002,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Medical Research Council Canada","keywords":"CYP3A4; Chemistry; Microsome; Population; Internal medicine; Biology; Molecular biology; Endocrinology; Enzyme; Cytochrome P450; Biochemistry","score_opus":0.17140802209131079,"score_gpt":0.4408356935308331,"score_spread":0.2694276714395223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988463445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891904,0.004932997,0.0023638122,0.000623274,0.0018750282,0.00037357557,0.00010257754,0.00002040432,0.00051794975],"genre_scores_gemma":[0.9928846,0.0033618843,0.0009602997,0.0008599314,0.0017957787,0.0000068031322,0.000044828525,0.00004479324,0.00004111113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9910885,0.004687551,0.0030186283,0.00040371245,0.0003191273,0.00048249203],"domain_scores_gemma":[0.9968587,0.0006203893,0.0015601302,0.00015946469,0.0003032332,0.00049805746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004164154,0.0003275814,0.0009293463,0.00024103612,0.00013837198,0.00001943331,0.0005464738,0.0002663321,0.0011129498],"category_scores_gemma":[0.00046268714,0.00030153323,0.00024171335,0.0002194503,0.00038108998,0.00020996165,0.00024699868,0.0018034212,0.000035517678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000917023,0.0018192203,0.017568508,0.00005540013,0.00027215722,0.00034272124,0.0005584985,0.008721365,0.9490127,0.000028165805,0.0017920315,0.018912185],"study_design_scores_gemma":[0.021732707,0.0017705681,0.031432003,0.00018992153,0.0010631643,0.00008371935,0.00009066975,0.14399412,0.7838001,0.00079544535,0.014299911,0.0007476299],"about_ca_topic_score_codex":0.000010699004,"about_ca_topic_score_gemma":0.0000024818505,"teacher_disagreement_score":0.16521259,"about_ca_system_score_codex":0.000042781372,"about_ca_system_score_gemma":0.000048186153,"threshold_uncertainty_score":0.9999437},"labels":[],"label_agreement":null},{"id":"W1988551553","doi":"10.1016/j.vascn.2003.10.005","title":"Evaluation of a real-time polymerase chain reaction method for the quantification of CYP1B1 gene expression in MCF-7 human breast carcinoma cells","year":2003,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CYP1B1; Amplicon; Molecular biology; Complementary DNA; Melting curve analysis; Real-time polymerase chain reaction; Agarose gel electrophoresis; SYBR Green I; Biology; Gene expression; MCF-7; Messenger RNA; Polymerase chain reaction; Breast carcinoma; Chemistry; Gene; Breast cancer; Cancer; Cytochrome P450; Biochemistry; Enzyme; Genetics; Human breast","score_opus":0.24174978708953548,"score_gpt":0.5317668371579236,"score_spread":0.2900170500683881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988551553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97702855,0.003684575,0.016152414,0.00041701196,0.0009610999,0.0012179848,0.0000699,0.000012007699,0.00045643398],"genre_scores_gemma":[0.93480587,0.0014640185,0.063094094,0.00022935594,0.00023607542,0.00010827105,0.0000042405322,0.000017413024,0.000040646722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9868236,0.010300453,0.0015351626,0.00037763675,0.00054745254,0.00041566353],"domain_scores_gemma":[0.99278134,0.0044527245,0.0014728141,0.0001635043,0.0008498175,0.00027978275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02798624,0.00030773052,0.0008741212,0.0002702732,0.00022455094,0.0000138916985,0.000371916,0.0004903326,0.00061501673],"category_scores_gemma":[0.00097430043,0.00019160549,0.000327188,0.00043021614,0.0003330158,0.00012138602,0.00008088393,0.00080185017,0.0000011126726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009318888,0.0024403648,0.00038612285,0.00003311159,0.00020100514,0.0000075146286,0.00017850116,0.0010333803,0.89785886,0.000511597,0.00013100388,0.096286654],"study_design_scores_gemma":[0.008743698,0.0006129135,0.01077405,0.00001683918,0.0018033996,0.00010479604,0.00012977971,0.01762893,0.95456505,0.0039331256,0.0014836779,0.00020372486],"about_ca_topic_score_codex":0.000010828074,"about_ca_topic_score_gemma":0.000001007277,"teacher_disagreement_score":0.09608293,"about_ca_system_score_codex":0.00010319936,"about_ca_system_score_gemma":0.00018283466,"threshold_uncertainty_score":0.9699528},"labels":[],"label_agreement":null},{"id":"W1989040972","doi":"10.1124/jpet.110.175927","title":"Differential Effect of Meclizine on the Activity of Human Pregnane X Receptor and Constitutive Androstane Receptor","year":2010,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Constitutive androstane receptor; Coactivator; CYP3A4; Agonist; Reporter gene; Receptor; Pharmacology; Nuclear receptor; Inverse agonist; CYP2B6; Biology; Transfection; Chemistry; Gene expression; Endocrinology; Cytochrome P450; Gene; Transcription factor; Biochemistry","score_opus":0.059989985206199775,"score_gpt":0.43189578480434937,"score_spread":0.3719057995981496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989040972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245787,0.0029677707,0.000006782761,0.00066357764,0.002929189,0.0004263563,0.00008582707,0.000007692847,0.00045491272],"genre_scores_gemma":[0.9970837,0.0017343549,0.00005008797,0.0006586294,0.00037671125,0.000013608409,0.0000029265098,0.00001989687,0.000060077124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793655,0.00081580743,0.00055554725,0.00019943455,0.00021350593,0.00027918065],"domain_scores_gemma":[0.9979445,0.0009302628,0.0007095385,0.000111273395,0.0001345575,0.00016991296],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085809635,0.00029837748,0.00064982614,0.0001335092,0.0002467902,0.000010890595,0.00026845452,0.00028870726,0.0017009991],"category_scores_gemma":[0.00002319111,0.00019574596,0.00015139062,0.00010855758,0.0014734176,0.000092217735,0.00011307453,0.0012338335,0.000002618738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047048368,0.0008304862,0.0013098952,0.00004820208,0.0008654225,0.000007885854,0.0009822914,0.000005021717,0.984106,0.001138426,0.00063916994,0.0053623854],"study_design_scores_gemma":[0.0056804507,0.0025020798,0.00032827893,0.00002227337,0.0005873073,0.00006480707,0.000105853265,0.0001045648,0.9787589,0.00008417463,0.011594237,0.00016707697],"about_ca_topic_score_codex":0.0000034195286,"about_ca_topic_score_gemma":6.9386095e-7,"teacher_disagreement_score":0.010955066,"about_ca_system_score_codex":0.00002109014,"about_ca_system_score_gemma":0.00006621092,"threshold_uncertainty_score":0.9992116},"labels":[],"label_agreement":null},{"id":"W1989226681","doi":"10.1517/17425255.2011.586630","title":"The effect and clinical consequences of hypoxia on cytochrome P450, membrane carrier proteins activity and expression","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Université de Montréal","funders":"","keywords":"Hypoxia (environmental); Pharmacology; Cytochrome P450; Gene isoform; Biology; Drug; Drug action; Cell biology; Chemistry; Biochemistry; Enzyme; Gene","score_opus":0.1443570859063354,"score_gpt":0.4785649180725097,"score_spread":0.33420783216617433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989226681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02110595,0.9665467,0.000004286593,0.00035593237,0.0066938084,0.0037073048,0.00034232644,0.000083049126,0.0011606307],"genre_scores_gemma":[0.0070614032,0.9892459,0.00009033381,0.00060625846,0.0014632253,0.0010876996,0.000031244326,0.00012478505,0.000289131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9856186,0.009853775,0.0016574761,0.0014691172,0.000409538,0.0009914736],"domain_scores_gemma":[0.99041706,0.0063775233,0.0014518525,0.00088889553,0.00012028275,0.0007444066],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0039577144,0.0012642479,0.0038385242,0.0003935782,0.00076951715,0.000056172365,0.00096419896,0.001780439,0.00029924457],"category_scores_gemma":[0.0007405391,0.0007990795,0.00075474865,0.0003194666,0.0028300907,0.00012184975,0.00056908716,0.002910174,0.000045743578],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013491118,0.0005366132,0.000010019012,0.0010547041,0.00088044174,0.000023236596,0.00042684152,0.0000016608765,0.021855382,0.002200522,0.001841654,0.9698198],"study_design_scores_gemma":[0.002421997,0.00077871,0.00021863136,0.0007844969,0.0005234725,0.00007625347,0.000021574724,0.000015897831,0.040682785,0.00013530825,0.95362633,0.00071451784],"about_ca_topic_score_codex":0.000041476957,"about_ca_topic_score_gemma":0.0000075046682,"teacher_disagreement_score":0.9691053,"about_ca_system_score_codex":0.000055539804,"about_ca_system_score_gemma":0.00041747885,"threshold_uncertainty_score":0.99988365},"labels":[],"label_agreement":null},{"id":"W1989512634","doi":"10.1038/sj.clpt.6100033","title":"Cytochrome P4502D6 (CYP2D6) Gene Locus Heterogeneity: Characterization of Gene Duplication Events","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Gene duplication; Gene; Locus (genetics); Genetics; Biology; CYP2D6; Allele; Polymerase chain reaction; Copy-number variation; Genotype; Genome","score_opus":0.20364432140957647,"score_gpt":0.5107263157474201,"score_spread":0.30708199433784367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989512634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97982544,0.001622519,0.007991991,0.0017525089,0.006736845,0.0012509979,0.00027046815,0.00017245574,0.0003767873],"genre_scores_gemma":[0.94841635,0.0066902456,0.00088075397,0.0409203,0.0023332601,0.00007732267,0.00028495395,0.00011300799,0.00028381354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9939475,0.0012952329,0.0022877692,0.0009243737,0.00043197465,0.0011131648],"domain_scores_gemma":[0.9960444,0.0009766412,0.0011440943,0.0005746651,0.000570129,0.00069007033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003972315,0.0005988547,0.0010110918,0.0003216594,0.0003174034,0.000015018882,0.00094854576,0.0011333455,0.00079580856],"category_scores_gemma":[0.000037146016,0.00060904084,0.00051073346,0.0006419306,0.00077192974,0.00017202494,0.00023723242,0.0014963874,0.0002752748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014172572,0.00194122,0.015733173,0.0000434092,0.0014913367,0.000039443647,0.00023491212,0.00010229878,0.93820107,0.000039809212,0.00028229685,0.040473767],"study_design_scores_gemma":[0.0049788523,0.00034435547,0.0684465,0.000008049766,0.0017305971,0.000043346765,0.000012476851,0.0013406313,0.8395912,0.00028526777,0.08268771,0.0005310117],"about_ca_topic_score_codex":0.0000039631727,"about_ca_topic_score_gemma":0.0000035327548,"teacher_disagreement_score":0.09860988,"about_ca_system_score_codex":0.00011146778,"about_ca_system_score_gemma":0.00020636956,"threshold_uncertainty_score":0.9996361},"labels":[],"label_agreement":null},{"id":"W1990239543","doi":"10.1097/00004714-200002000-00008","title":"Cytochrome P450 2D6 and Treatment of Codeine Dependence","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; Toronto Public Health","funders":"National Institute on Drug Abuse","keywords":"Codeine; Opiate; Morphine; CYP2D6; Fluoxetine; Pharmacology; Opioid; Medicine; Cytochrome P450; Anesthesia; Internal medicine; Serotonin; Receptor; Metabolism","score_opus":0.21482331721826947,"score_gpt":0.5619404381075592,"score_spread":0.34711712088928975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990239543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815703,0.008324133,0.000031864474,0.0016862391,0.002974553,0.00032910446,0.000052676067,0.000016751137,0.005014381],"genre_scores_gemma":[0.92746526,0.0659012,0.0007385058,0.0027694986,0.0019554403,0.000010638951,0.000002309514,0.000029089131,0.0011280864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951654,0.001218767,0.0024886986,0.00036332887,0.00028802405,0.0004757587],"domain_scores_gemma":[0.99596417,0.0016510723,0.001104739,0.00020480285,0.00030444414,0.0007707766],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002116964,0.00032717636,0.0013473618,0.00020042477,0.00010713068,0.000010789584,0.0004403731,0.00050504046,0.010217934],"category_scores_gemma":[0.00012660219,0.00026150208,0.00048854103,0.00023656951,0.0006697242,0.00014020683,0.00003822041,0.0009389822,0.00009068106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014450728,0.004296374,0.012407078,0.000040035702,0.0015801943,0.00047894803,0.00040391833,0.0008118037,0.16286622,0.00012953312,0.008379182,0.79415596],"study_design_scores_gemma":[0.032602306,0.004158874,0.060817383,0.000022893157,0.0014612207,0.0006631335,0.000034340886,0.0009943309,0.014641122,0.0011621255,0.88306355,0.0003786953],"about_ca_topic_score_codex":0.0000066169546,"about_ca_topic_score_gemma":0.0000033329425,"teacher_disagreement_score":0.8746844,"about_ca_system_score_codex":0.000033674667,"about_ca_system_score_gemma":0.00023565427,"threshold_uncertainty_score":0.9999837},"labels":[],"label_agreement":null},{"id":"W1990643506","doi":"10.1515/labm.2001.25.11-12.477","title":"Arzneimittelnebenwirkungen vermeiden: Möglichkeiten der pharmakogenetischen Diagnostik. Prevention of Adverse Drug Reactions: Potential of Pharmacogenetic Diagnostics","year":2001,"lang":"de","type":"article","venue":"LaboratoriumsMedizin","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lockheed Martin (Canada)","funders":"","keywords":"Medicine; Pharmacogenetics; Drug reaction; Gynecology; Drug; Pharmacology; Genotype; Biology; Genetics","score_opus":0.04177313621223318,"score_gpt":0.38162602412996494,"score_spread":0.33985288791773177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990643506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76640034,0.20677537,0.0003077297,0.0009611411,0.019538738,0.0022440213,0.002489473,0.00012697115,0.0011562025],"genre_scores_gemma":[0.7488228,0.2427655,0.0008376307,0.0012232261,0.0045631244,0.00023011105,0.00040439473,0.00021112882,0.00094208395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9889511,0.0034062422,0.0032326996,0.0013478725,0.0013980393,0.001664073],"domain_scores_gemma":[0.99152,0.0018264871,0.002384699,0.0010485395,0.0019304132,0.001289876],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0028465062,0.0012785831,0.0017687682,0.0007838732,0.00041855735,0.000033919783,0.0014592189,0.0010930282,0.0049918573],"category_scores_gemma":[0.0010744092,0.0014498373,0.0007672708,0.002350151,0.0010288545,0.00044250378,0.00060690223,0.0018888923,0.00052418385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043535605,0.007409548,0.052941717,0.0015737697,0.008741308,0.0010661844,0.002837315,0.011342853,0.8418658,0.0002481996,0.039581694,0.028038064],"study_design_scores_gemma":[0.00814445,0.00029088027,0.007473662,0.0002678394,0.006759891,0.00004438578,0.00039813606,0.0020127133,0.4965815,0.0002902414,0.4766462,0.0010901082],"about_ca_topic_score_codex":0.00012972143,"about_ca_topic_score_gemma":0.000018980712,"teacher_disagreement_score":0.4370645,"about_ca_system_score_codex":0.00017076438,"about_ca_system_score_gemma":0.001440061,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W1991072079","doi":"10.1002/jps.21802","title":"Physiologically Based Predictions of the Impact of Inhibition of Intestinal and Hepatic Metabolism on Human Pharmacokinetics of CYP3A Substrates","year":2009,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Ketoconazole; Pharmacology; Triazolam; CYP3A; Chemistry; Midazolam; Oral administration; First pass effect; Medicine; Cytochrome P450; Metabolism","score_opus":0.1606504098242696,"score_gpt":0.4841378396146311,"score_spread":0.3234874297903615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991072079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661106,0.0014799673,0.00008939798,0.00042855216,0.000331261,0.00024794985,0.000091560636,0.000005969826,0.0007142548],"genre_scores_gemma":[0.99846107,0.0007113502,0.0004060092,0.00026595528,0.00014224068,0.0000018386705,0.0000011129965,0.0000065008367,0.0000039454326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970009,0.0006554929,0.0012421327,0.00019625571,0.0005876982,0.00031753158],"domain_scores_gemma":[0.99702185,0.00068025274,0.0013889748,0.00012217926,0.0005319516,0.00025479426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018589367,0.00023461693,0.0006544228,0.0002692399,0.0001563783,0.000009638073,0.0005072244,0.0001282972,0.0003182053],"category_scores_gemma":[0.00028851896,0.00013930179,0.00040562317,0.0007275752,0.0018078884,0.00013105276,0.00006558181,0.0006662289,4.1663694e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004112201,0.0013602994,0.011280391,0.00006867573,0.0001300205,0.0000035047208,0.0001592022,0.017663574,0.96330374,0.000984267,0.00013067448,0.0045044287],"study_design_scores_gemma":[0.0020904674,0.0015270881,0.15277101,0.00011632208,0.0005104224,0.000022537724,0.000040572537,0.013463778,0.826718,0.0024758636,0.00014953125,0.00011446133],"about_ca_topic_score_codex":0.000013069486,"about_ca_topic_score_gemma":4.4138736e-7,"teacher_disagreement_score":0.14149061,"about_ca_system_score_codex":0.000022912041,"about_ca_system_score_gemma":0.0002416799,"threshold_uncertainty_score":0.66612405},"labels":[],"label_agreement":null},{"id":"W1991279188","doi":"10.1097/01.pra.0000341891.43501.6b","title":"Effect of Desvenlafaxine on the Cytochrome P450 2D6 Enzyme System","year":2008,"lang":"en","type":"review","venue":"Journal of Psychiatric Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"CYP2D6; Desipramine; Concomitant; Venlafaxine; Pharmacology; Paroxetine; Duloxetine; Area under the curve; Medicine; Internal medicine; Chemistry; Cytochrome P450; Metabolism; Antidepressant","score_opus":0.11581923016131854,"score_gpt":0.4986463035760674,"score_spread":0.38282707341474886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991279188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027019045,0.9826988,0.000048194473,0.000503297,0.006072175,0.0012700489,0.00008792067,0.00002235422,0.009027029],"genre_scores_gemma":[0.0013003402,0.9939291,0.0002689859,0.0005714186,0.0036109951,0.00005990478,0.000005501871,0.00009378295,0.00015996842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9869616,0.008912179,0.0023873365,0.00035844446,0.0008495149,0.0005309237],"domain_scores_gemma":[0.9783628,0.013507385,0.0067475704,0.0005471997,0.00045546514,0.0003796048],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007491098,0.0007555207,0.0028323657,0.0006992139,0.0003200886,0.00003235295,0.0014164975,0.00078127184,0.00025264669],"category_scores_gemma":[0.0016729527,0.00043067755,0.0016824021,0.0011007789,0.00017521,0.0002047004,0.00012466418,0.004372387,0.00023895508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019653556,0.001095366,0.0000042308166,0.012711619,0.004622551,0.00075654127,0.00013735991,0.0001276531,0.00013302328,0.0013942012,0.061935633,0.9151165],"study_design_scores_gemma":[0.00178879,0.0013402603,0.000002521306,0.0014202413,0.012434168,0.008027664,0.00002533349,0.000030304172,0.0002217453,0.000010756321,0.9743654,0.00033279756],"about_ca_topic_score_codex":0.000004451228,"about_ca_topic_score_gemma":1.6074863e-7,"teacher_disagreement_score":0.91478366,"about_ca_system_score_codex":0.00020505671,"about_ca_system_score_gemma":0.0009027898,"threshold_uncertainty_score":0.9998145},"labels":[],"label_agreement":null},{"id":"W1991435125","doi":"10.1038/tpj.2009.64","title":"Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines","year":2009,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Glucuronidation; Exon; Alternative splicing; Gene isoform; Gene knockdown; Biology; RNA splicing; Gene; Gene expression; Endogeny; Biochemistry; Cell biology; RNA; Molecular biology; Enzyme","score_opus":0.08082405094282673,"score_gpt":0.4104322238664293,"score_spread":0.32960817292360256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991435125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920643,0.0024754521,0.000403378,0.0018904746,0.0012386183,0.0007063808,0.00009499389,0.000020570884,0.0011058048],"genre_scores_gemma":[0.9951395,0.00086774974,0.00020114794,0.0024113436,0.0010773878,0.000009561631,0.000011821886,0.00004391774,0.00023759177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965881,0.0008225174,0.0011887868,0.0003350942,0.00034519724,0.00072031905],"domain_scores_gemma":[0.9977988,0.00019878568,0.0011972032,0.00030267442,0.0002460366,0.00025648726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023408087,0.00041176777,0.0004738766,0.00022534629,0.0012149909,0.00005690059,0.0012208768,0.00015199867,0.00024041196],"category_scores_gemma":[0.000043421816,0.00027756905,0.0002941042,0.00043911824,0.00027081024,0.00022884771,0.00027076737,0.0017284128,0.000008165729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044745475,0.0005610024,0.0005482422,0.000016082433,0.00012941698,0.000026116353,0.0035446885,0.012362928,0.9547812,0.00055916747,0.00016904096,0.026854688],"study_design_scores_gemma":[0.010045322,0.00024158215,0.0011235888,0.000024055696,0.0003973766,0.00015490463,0.00013514826,0.043627966,0.9316045,0.007987181,0.004341294,0.00031709086],"about_ca_topic_score_codex":0.00003556032,"about_ca_topic_score_gemma":0.000008592398,"teacher_disagreement_score":0.03126504,"about_ca_system_score_codex":0.0001876764,"about_ca_system_score_gemma":0.00018079586,"threshold_uncertainty_score":0.99996763},"labels":[],"label_agreement":null},{"id":"W1991546902","doi":"10.1097/fpc.0b013e32833bba25","title":"Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia; Child and Family Research Institute","funders":"","keywords":"Biology; Locus (genetics); Genetic variation; Genetics; Allele; Population; Genetic diversity; Confounding; Evolutionary biology; Gene; Demography","score_opus":0.0648848010729666,"score_gpt":0.3244512909148713,"score_spread":0.25956648984190467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991546902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9501829,0.048199985,0.000034746397,0.000023322704,0.00078818237,0.00045537628,0.000062977844,0.000008299308,0.00024417616],"genre_scores_gemma":[0.99403226,0.005482843,0.0001741467,0.000078757475,0.00014105477,0.000016053755,0.000009017667,0.000022720122,0.00004314146],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984615,0.00021817395,0.00052954355,0.00031633402,0.00017427228,0.00030018762],"domain_scores_gemma":[0.99914515,0.000112710324,0.00034115865,0.00019087478,0.0000462942,0.00016382211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067238335,0.00021698001,0.00030896126,0.00015109342,0.00029616297,0.000007307381,0.00023817985,0.00018901176,0.000103888306],"category_scores_gemma":[0.000011112002,0.00020867986,0.00006063671,0.00006890163,0.0003480933,0.000038837374,0.0005950768,0.0004318973,0.0000023551634],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006601143,0.00007867428,0.28207076,0.00006562319,0.000057603564,0.0000021346673,0.0011402839,0.0048864824,0.70515484,0.0005115095,0.000017321967,0.0059487266],"study_design_scores_gemma":[0.004574224,0.0001337867,0.5310057,0.000028503879,0.0010545132,0.00006649567,0.00059043267,0.114815354,0.23273914,0.0026786611,0.11150154,0.00081169215],"about_ca_topic_score_codex":0.00048324082,"about_ca_topic_score_gemma":0.00008766265,"teacher_disagreement_score":0.47241572,"about_ca_system_score_codex":0.00019370385,"about_ca_system_score_gemma":0.000040628172,"threshold_uncertainty_score":0.8509718},"labels":[],"label_agreement":null},{"id":"W1991715552","doi":"10.1111/j.1365-2125.2005.02519.x","title":"Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition","year":2005,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"National Center for Research Resources; National Institute of General Medical Sciences","keywords":"Grapefruit juice; Ciclosporin; Crossover study; Chemistry; Pharmacokinetics; CYP3A4; Orange juice; Fluorescence polarization immunoassay; Oral administration; Daucus carota; Pharmacology; Food science; Medicine; Internal medicine; Chromatography; Transplantation; Biochemistry; Cytochrome P450; Botany; Metabolism; Biology","score_opus":0.1507275346383384,"score_gpt":0.5474249559089603,"score_spread":0.3966974212706219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991715552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858465,0.00225789,0.00042637912,0.0017992451,0.005881642,0.000513989,0.00020595659,0.000031603224,0.003036752],"genre_scores_gemma":[0.98285043,0.0033776904,0.000878485,0.0075147673,0.0048888796,0.000016488922,0.000010211305,0.000052755917,0.00041031395],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99355483,0.0019340223,0.0028388025,0.00046544438,0.00047782922,0.0007290505],"domain_scores_gemma":[0.9939317,0.0022371078,0.001629032,0.00017633065,0.0007970596,0.0012287888],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032963306,0.0003758622,0.0013484512,0.00035655868,0.00019234278,0.000025808375,0.0007683677,0.00063031295,0.0035091701],"category_scores_gemma":[0.00072602043,0.00038578874,0.001181684,0.00047435818,0.0004102087,0.00031495406,0.00015861342,0.0031497155,0.00019802255],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011250047,0.0066673476,0.026946284,0.00004084934,0.0031430402,0.0011973468,0.0004308073,0.023430813,0.072751336,0.000288741,0.09467623,0.75917715],"study_design_scores_gemma":[0.027900822,0.0074980487,0.5487206,0.00022188073,0.002758031,0.0022430238,0.000046574052,0.0025520315,0.04767605,0.0018536857,0.35734695,0.0011823006],"about_ca_topic_score_codex":0.000028798231,"about_ca_topic_score_gemma":0.000011566738,"teacher_disagreement_score":0.7579949,"about_ca_system_score_codex":0.00013537162,"about_ca_system_score_gemma":0.00042063833,"threshold_uncertainty_score":0.9998594},"labels":[],"label_agreement":null},{"id":"W1991720659","doi":"10.1002/rcm.4507","title":"Improved detection of reactive metabolites with a bromine‐containing glutathione analog using mass defect and isotope pattern matching","year":2010,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Glutathione; Chromatography; Metabolite; Mass spectrometry; Electrospray ionization; Electrospray; Liquid chromatography–mass spectrometry; Adduct; Tandem mass spectrometry; Biochemistry; Organic chemistry; Enzyme","score_opus":0.057041847258660475,"score_gpt":0.38388406912848116,"score_spread":0.3268422218698207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991720659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803264,0.00438287,0.013393364,0.0001782757,0.0002439044,0.00044774936,0.000048849844,0.00004686339,0.0009317364],"genre_scores_gemma":[0.96260905,0.0016955048,0.035348836,0.00013918531,0.00008047292,0.000061550825,0.000016731712,0.000039050636,0.000009594488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794996,0.0006404946,0.00051331386,0.0003483767,0.0001435232,0.00040432648],"domain_scores_gemma":[0.99778867,0.0007413908,0.0003826015,0.0008106419,0.00013312603,0.00014356818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013071115,0.0002717002,0.00047215782,0.0006421402,0.00029753745,0.000036859452,0.00059137144,0.00023711771,0.00010335061],"category_scores_gemma":[0.00010373185,0.00026410102,0.000100849225,0.0008349742,0.00034083123,0.0002038318,0.000215183,0.0017293278,0.0000022395332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017009617,0.00017742164,0.015554731,0.000028534387,0.0002584737,0.0000039464844,0.00081037555,0.00008377443,0.96474814,0.0004861368,3.2054106e-7,0.017678041],"study_design_scores_gemma":[0.004505521,0.00032272705,0.039031185,0.00005257072,0.0008512737,0.00014000385,0.0017219778,0.08474405,0.86209327,0.0042467504,0.0015688841,0.00072177825],"about_ca_topic_score_codex":0.00027018556,"about_ca_topic_score_gemma":0.00028269168,"teacher_disagreement_score":0.10265487,"about_ca_system_score_codex":0.00006162671,"about_ca_system_score_gemma":0.00008177141,"threshold_uncertainty_score":0.9999811},"labels":[],"label_agreement":null},{"id":"W1991738315","doi":"10.1002/hep.21481","title":"The role of chrysin and the Ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice","year":2007,"lang":"en","type":"article","venue":"Hepatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; U.S. Public Health Service; Karolinska Institutet; Virginia Commonwealth University","keywords":"Chrysin; Pharmacology; Receptor; Chemistry; Agonist; Endocrinology; Biology; Biochemistry; Flavonoid","score_opus":0.03975550666566725,"score_gpt":0.37205727623956386,"score_spread":0.3323017695738966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991738315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986462,0.011168697,0.0000028293598,0.00110712,0.00037507154,0.00042160676,0.0000140205475,0.0000037931243,0.00044487728],"genre_scores_gemma":[0.9963322,0.003171128,0.000027140743,0.0003553525,0.000050762254,0.000026451238,0.0000023919733,0.000010162931,0.000024404431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788886,0.00097296934,0.00053791946,0.0001968727,0.00008194892,0.0003214088],"domain_scores_gemma":[0.99904,0.0005680509,0.00016401023,0.00015145975,0.000031376916,0.00004507887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002184655,0.00013262784,0.00032801076,0.00013277293,0.00011124856,0.0000036188947,0.00023615702,0.00024269774,0.000025680112],"category_scores_gemma":[0.0000521277,0.000081354825,0.0000501583,0.00032133012,0.00083387207,0.000029156416,0.00007981404,0.00064133684,9.0349073e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011027473,0.00012274462,0.12394901,0.000015960144,0.00003243936,0.000002333785,0.0021561,0.000019107041,0.85364985,0.0014911359,0.000015576787,0.017442973],"study_design_scores_gemma":[0.0046361093,0.000021580563,0.07140312,0.0000067261094,0.000055296503,0.000022143902,0.00039411933,0.0011316577,0.9049992,0.0032310942,0.013997192,0.000101748454],"about_ca_topic_score_codex":0.00037370637,"about_ca_topic_score_gemma":0.0018101938,"teacher_disagreement_score":0.05254589,"about_ca_system_score_codex":0.000022877015,"about_ca_system_score_gemma":0.000046847963,"threshold_uncertainty_score":0.33175534},"labels":[],"label_agreement":null},{"id":"W19917450","doi":"10.5588/ijtld.11.0404","title":"&lt;I&gt;UGT1A1&lt;/I&gt; polymorphisms associated with risk of induced liver disorders by anti-tuberculosis medications [Short communication]","year":2012,"lang":"en","type":"article","venue":"The International Journal of Tuberculosis and Lung Disease","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Taipei Medical University","keywords":"Medicine; Tuberculosis; Incidence (geometry); Drug; Internal medicine; Pharmacology; Pathology","score_opus":0.02793072421740166,"score_gpt":0.34330120234629374,"score_spread":0.3153704781288921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19917450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96429664,0.027796825,0.000076194185,0.005770983,0.0006261128,0.00023163026,0.0005924596,0.000013952953,0.00059519836],"genre_scores_gemma":[0.9688198,0.029657274,0.000052791464,0.0010229085,0.00024751134,0.000022467899,0.000089244146,0.000028024186,0.000059982794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974587,0.0007318867,0.0006445334,0.00016034304,0.00069240655,0.0003121211],"domain_scores_gemma":[0.99731255,0.0006625958,0.0006761796,0.0002651808,0.00053550827,0.0005479671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015818079,0.0002429621,0.0003385324,0.000184206,0.0003095275,0.000041771353,0.0008421989,0.00013133565,0.00043110136],"category_scores_gemma":[0.0002302521,0.00016622427,0.00022074813,0.00020715971,0.0003713753,0.00031858752,0.00017822455,0.00056913565,0.0000049439923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014223758,0.0056482623,0.76010066,0.000048235426,0.01458799,0.000016335018,0.004962451,0.0010464606,0.13883671,0.0025184094,0.0374623,0.03334978],"study_design_scores_gemma":[0.0036783668,0.00011976295,0.9218366,0.00017581135,0.008521768,0.000052398438,0.00019583479,0.008086548,0.0119870175,0.0005064503,0.044254556,0.0005848807],"about_ca_topic_score_codex":0.000036011956,"about_ca_topic_score_gemma":0.00003163372,"teacher_disagreement_score":0.16173592,"about_ca_system_score_codex":0.00008292074,"about_ca_system_score_gemma":0.00013162395,"threshold_uncertainty_score":0.6778429},"labels":[],"label_agreement":null},{"id":"W1991912173","doi":"10.1016/s0006-2952(01)00744-4","title":"Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain22Abbreviations: CYP, cytochrome P450; C8 xanthate, potassium octylxanthate; NCO, nicotine C-oxidation; NDMA, N-nitrosodimethylamine; NMA, N-nitroso-N-methylaniline; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; and SSC, saline-sodium citrate buffer.","year":2001,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research; Medical Research Council Canada","keywords":"Nicotine; Chemistry; Microsome; Endocrinology; Internal medicine; Ethanol; Cytochrome P450; Toxicity; Saline; Pharmacology; Metabolism; Biochemistry; Biology; Enzyme; Medicine","score_opus":0.04710211895602214,"score_gpt":0.3553460143880339,"score_spread":0.3082438954320118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991912173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551473,0.035731994,0.000305853,0.0026244086,0.0027831679,0.0019883518,0.00095924747,0.00019443425,0.0002652037],"genre_scores_gemma":[0.9631248,0.028280621,0.0011092856,0.003964183,0.0013523937,0.00035566065,0.0008176829,0.00016504899,0.00083030027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9908452,0.002298998,0.0024095448,0.0019284554,0.0006867808,0.0018310337],"domain_scores_gemma":[0.9947781,0.0017768695,0.0011515423,0.0005812441,0.0006525738,0.0010597005],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0025208946,0.0013818314,0.0020900364,0.00096521655,0.0004310113,0.00009605594,0.00087778183,0.0016265425,0.0015962329],"category_scores_gemma":[0.0005824868,0.0014047895,0.00033813666,0.001526477,0.0016468475,0.00059484027,0.00069885113,0.0026548174,0.00007870743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024498685,0.0015300534,0.0014383605,0.00028499536,0.00047585057,0.000085120395,0.00035652172,0.00005540859,0.97464895,0.00014596464,0.016010685,0.0025182434],"study_design_scores_gemma":[0.011733923,0.00030111164,0.0030012028,0.0000422005,0.0012020342,0.0002702852,0.00012788984,0.0026889162,0.94549257,0.00029205042,0.03359036,0.0012574439],"about_ca_topic_score_codex":0.00025599063,"about_ca_topic_score_gemma":0.0000145738595,"teacher_disagreement_score":0.029156346,"about_ca_system_score_codex":0.00020229451,"about_ca_system_score_gemma":0.0003266554,"threshold_uncertainty_score":0.99989325},"labels":[],"label_agreement":null},{"id":"W1992234430","doi":"10.1097/ftd.0b013e3182557325","title":"Is There a Role for Therapeutic Drug Monitoring With Codeine?","year":2012,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Codeine; Analgesic; Prodrug; Pharmacogenetics; Morphine; Drug; Pharmacology; CYP2D6; Medicine; Therapeutic drug monitoring; Adverse effect; Pharmacogenomics; Cytochrome P450; Chemistry; Internal medicine; Genotype; Metabolism","score_opus":0.2301740048227166,"score_gpt":0.47048771687925633,"score_spread":0.24031371205653973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992234430","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015375308,0.98378474,0.00012018468,0.00018741727,0.008860225,0.003230497,0.00029592827,0.0003839699,0.0015994996],"genre_scores_gemma":[0.034916263,0.9482681,0.0004846827,0.00026082745,0.008713995,0.0019889898,0.000050066425,0.00060911186,0.004707971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99318695,0.0011339884,0.0013815503,0.0013045447,0.0007047296,0.0022882274],"domain_scores_gemma":[0.9953235,0.001427638,0.0010247194,0.0011164994,0.00029703847,0.00081062067],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019339162,0.001897887,0.0029327453,0.00044817402,0.00090145273,0.00019360032,0.0016943758,0.00095015316,0.00038362213],"category_scores_gemma":[0.00001017806,0.0015011651,0.0011354985,0.00069587847,0.00028587814,0.00030781535,0.00027347772,0.0026703614,0.00034108764],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021025115,0.0004217901,0.0021024263,0.0047777905,0.0035555006,0.000015654987,0.0026475121,0.00003160915,0.00036630195,0.00017242234,0.0001192499,0.9855795],"study_design_scores_gemma":[0.0019130028,0.00006672455,0.00011304389,0.0021966537,0.01088323,0.00005657751,0.00042917678,0.000083753526,0.0064558024,0.00041020112,0.97570795,0.0016838831],"about_ca_topic_score_codex":0.000035674253,"about_ca_topic_score_gemma":0.0000020470577,"teacher_disagreement_score":0.9838956,"about_ca_system_score_codex":0.00034350433,"about_ca_system_score_gemma":0.0004942144,"threshold_uncertainty_score":0.9996305},"labels":[],"label_agreement":null},{"id":"W1992259971","doi":"10.1038/sj.clpt.6100434","title":"Combination of Phenotype Assessments and CYP2C9-VKORC1 Polymorphisms in the Determination of Warfarin Dose Requirements in Heavily Medicated Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep Saint-Jean-sur-Richelieu; Institut universitaire de cardiologie et de pneumologie de Québec; Montreal Heart Institute; Bausch Health (Canada); Centre Integre de Sante et de Services Sociaux de Laval; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; Warfarin; Vitamin K epoxide reductase; CYP2C9; Medicine; Internal medicine; Pharmacology; Genotype; Losartan; Biology; Genetics; Gene; Atrial fibrillation; Cytochrome P450; Renin–angiotensin system","score_opus":0.24618215903103102,"score_gpt":0.5471762856085234,"score_spread":0.30099412657749236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992259971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938775,0.00095262897,0.00020029364,0.0011379155,0.002129898,0.0009595372,0.000030925825,0.00001574852,0.00069556554],"genre_scores_gemma":[0.9841516,0.002035253,0.00028986819,0.013287379,0.000116435695,0.000029804733,0.00004190001,0.000025335998,0.00002244312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99515206,0.0017466078,0.001780871,0.000403944,0.00039280587,0.0005236889],"domain_scores_gemma":[0.99674463,0.0019117284,0.0007331959,0.00021849464,0.00023787918,0.0001540589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059119253,0.00027646005,0.00059676816,0.0003498511,0.00008333494,0.0000065749427,0.0005628023,0.0005120131,0.00014723028],"category_scores_gemma":[0.000068727386,0.00023483689,0.00010777975,0.0005993094,0.0007751295,0.00012079285,0.00015261678,0.0010880262,0.0000059503855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026462341,0.008395287,0.69863564,0.00007278642,0.00032324466,0.000038181093,0.0018319496,0.000027579703,0.09506414,0.00023472717,0.00032843137,0.1924018],"study_design_scores_gemma":[0.017990762,0.0008849435,0.93327534,0.000029211993,0.00072935526,0.0000034209008,0.00014774439,0.004679838,0.03370674,0.0014273783,0.006821848,0.00030338793],"about_ca_topic_score_codex":0.000029400058,"about_ca_topic_score_gemma":0.000027314405,"teacher_disagreement_score":0.23463973,"about_ca_system_score_codex":0.000066168715,"about_ca_system_score_gemma":0.00011907978,"threshold_uncertainty_score":0.957637},"labels":[],"label_agreement":null},{"id":"W1992320105","doi":"10.1097/00004714-200104000-00009","title":"Diphenhydramine Alters the Disposition of Venlafaxine Through Inhibition of CYP2D6 Activity in Humans","year":2001,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Medical Research Council; Heart and Stroke Foundation of Canada","keywords":"Diphenhydramine; Venlafaxine; Pharmacology; CYP2D6; Antihistamine; Venlafaxine Hydrochloride; Drug interaction; Concomitant; Pharmacokinetics; Oral administration; Diphenhydramine hydrochloride; Medicine; Chemistry; Endocrinology; Internal medicine; Antidepressant; Histamine; Cytochrome P450; Metabolism","score_opus":0.19000529920427853,"score_gpt":0.5480024974528064,"score_spread":0.3579971982485278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992320105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859466,0.001495855,0.00055136514,0.0040887888,0.0053803814,0.00037878987,0.000038505823,0.000007727013,0.0021119784],"genre_scores_gemma":[0.98662406,0.009143446,0.00018054612,0.0026879918,0.0012572964,0.000011047921,0.0000043227765,0.000023358916,0.000067898996],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99431014,0.0021047005,0.002568039,0.00027007074,0.00034648733,0.00040057095],"domain_scores_gemma":[0.99484277,0.0019969917,0.0023532219,0.00021906837,0.00038360484,0.00020435044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042883703,0.00025184537,0.0010728219,0.0002197538,0.00008142796,0.000005548399,0.0004692876,0.00041504303,0.00085104554],"category_scores_gemma":[0.00029396926,0.00018738229,0.0005369085,0.0005210988,0.00075098476,0.0002353788,0.00008529255,0.0018802587,0.000010574219],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02201625,0.006837138,0.056686714,0.0001163563,0.0008847337,0.00026395541,0.0011748995,0.0039047792,0.8381147,0.0005438501,0.0063770954,0.063079536],"study_design_scores_gemma":[0.06386398,0.0042333035,0.3728041,0.00022996754,0.0025017972,0.00026756842,0.00033765956,0.0032087346,0.32536373,0.012349273,0.21401078,0.00082911085],"about_ca_topic_score_codex":0.000019247964,"about_ca_topic_score_gemma":0.000015132848,"teacher_disagreement_score":0.512751,"about_ca_system_score_codex":0.000040879248,"about_ca_system_score_gemma":0.00015275543,"threshold_uncertainty_score":0.9318352},"labels":[],"label_agreement":null},{"id":"W1992520141","doi":"10.1080/13651500410005559","title":"High-dose venlafaxine treatment in a depressed patient with a genetic CYP2D6 deficiency","year":2004,"lang":"en","type":"article","venue":"International Journal of Psychiatry in Clinical Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ven; CYP2D6; Venlafaxine; Metabolite; Pharmacogenetics; Lithium (medication); Depression (economics); Antidepressant; Genotyping; Internal medicine; Nortriptyline; Medicine; Venlafaxine Hydrochloride; Psychology; Pharmacology; Psychiatry; Genotype; Metabolism; Anxiety; Cytochrome P450; Biology; Genetics","score_opus":0.09506915189284447,"score_gpt":0.5073594227501658,"score_spread":0.4122902708573213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992520141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733715,0.003091127,0.00037129925,0.0135711795,0.008216659,0.00026821325,0.00002153032,0.000007828434,0.001080646],"genre_scores_gemma":[0.969343,0.0024872292,0.02279067,0.0043630316,0.00096381677,0.000016621298,0.00000321466,0.000020204672,0.000012209784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966033,0.00066638883,0.0016480193,0.00028564024,0.000505103,0.00029151633],"domain_scores_gemma":[0.996995,0.0011336668,0.0010767151,0.00015439844,0.00040774196,0.00023249656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013574393,0.00021388428,0.00039248727,0.00030191426,0.00003993319,0.000031981403,0.00048459973,0.0001997553,0.00015259064],"category_scores_gemma":[0.000733119,0.00016776445,0.00016777303,0.00025039943,0.00011685776,0.0002688251,0.000056059136,0.0011559309,0.000036285302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029897213,0.043987103,0.34350172,0.00003258844,0.0017780327,0.010608086,0.0027606233,0.31807205,0.0015903206,0.007956247,0.00058473565,0.23923127],"study_design_scores_gemma":[0.12763776,0.011675646,0.5061397,0.00054293615,0.0018154414,0.007712236,0.002014524,0.0019039721,0.0038234177,0.03285544,0.30238897,0.0014899852],"about_ca_topic_score_codex":0.00018280407,"about_ca_topic_score_gemma":0.00021084819,"teacher_disagreement_score":0.31616807,"about_ca_system_score_codex":0.00021968524,"about_ca_system_score_gemma":0.0008582632,"threshold_uncertainty_score":0.6841236},"labels":[],"label_agreement":null},{"id":"W1992617863","doi":"10.1016/j.tiv.2007.07.002","title":"Constitutive expression and inducibility of CYP1A1 in the H9c2 rat cardiomyoblast cells","year":2007,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Inducer; In vitro; Cell culture; Embryonic stem cell; Cell biology; Messenger RNA; Gene expression; Biology; RNA; Molecular biology; Gene; Chemistry; Biochemistry; Genetics","score_opus":0.07969788146826398,"score_gpt":0.4170768668416165,"score_spread":0.33737898537335254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992617863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890551,0.0015393292,0.000073920935,0.0002996875,0.0011668002,0.0006547176,0.00005247909,0.000015579228,0.0071424064],"genre_scores_gemma":[0.9974321,0.0002759746,0.00026211565,0.0017857623,0.0001364476,0.00004165629,0.0000068424592,0.000011179844,0.000047914742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971081,0.0011179377,0.0006141609,0.00042757302,0.0001590338,0.00057321036],"domain_scores_gemma":[0.9979937,0.0013563441,0.00016982005,0.00028744835,0.000057255696,0.00013545027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004377892,0.00023012428,0.0004818505,0.00026332735,0.00010383622,0.0000073529127,0.0003507137,0.0004735422,0.00011364567],"category_scores_gemma":[0.0001495329,0.00018310007,0.00007504373,0.00038031326,0.00093325885,0.00005935968,0.00016278437,0.0010789884,0.00001044553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092870556,0.0004988243,0.010054465,0.000028000197,0.000027341712,0.00011518351,0.0023024888,0.00016458414,0.9772057,0.00046092217,0.00024217376,0.007971615],"study_design_scores_gemma":[0.0026386522,0.000076524135,0.021494789,0.00000916444,0.00005391736,0.000030316618,0.0006589571,0.00013313361,0.9609605,0.00075492484,0.0130134635,0.0001756745],"about_ca_topic_score_codex":0.0000399383,"about_ca_topic_score_gemma":0.000087764005,"teacher_disagreement_score":0.016245214,"about_ca_system_score_codex":0.00005576525,"about_ca_system_score_gemma":0.00011195696,"threshold_uncertainty_score":0.7466604},"labels":[],"label_agreement":null},{"id":"W1992854159","doi":"10.1007/s10822-010-9336-6","title":"Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism","year":2010,"lang":"en","type":"article","venue":"Journal of Computer-Aided Molecular Design","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Docking (animal); Homology modeling; Ligand (biochemistry); Homology (biology); Chemistry; Stereochemistry; Binding site; Cytochrome P450; Crystallography; Enzyme; Receptor; Biochemistry; Amino acid; Medicine","score_opus":0.13860884713725702,"score_gpt":0.4108136456716016,"score_spread":0.2722047985343446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992854159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5624073,0.0006648393,0.43568066,0.00008458741,0.0007949508,0.0002583121,0.00003589545,0.000008863633,0.00006459897],"genre_scores_gemma":[0.8287528,0.00012446016,0.16999075,0.00072137424,0.0003504656,0.0000044392195,0.0000019635806,0.00004127853,0.000012426336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99661547,0.00078934856,0.0013655382,0.00028510793,0.0004441653,0.0005003454],"domain_scores_gemma":[0.9969009,0.00026459177,0.001137665,0.0003428005,0.0008279639,0.00052604097],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020271346,0.00034920563,0.0010257632,0.0006037188,0.000079591926,0.000019540843,0.0006772914,0.00037754016,0.00009218835],"category_scores_gemma":[0.00008189225,0.00033081145,0.00041900197,0.00039853578,0.00022891218,0.00013850028,0.00016972832,0.0011304312,0.0000060099783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004157126,0.00028778633,0.000059516533,0.000032965585,0.00036982956,0.00012762207,0.000321548,0.34180838,0.65361387,0.00063306524,0.00017799709,0.002151693],"study_design_scores_gemma":[0.0022816998,0.00031523313,0.0006679413,0.000027708042,0.0007172091,0.00035246793,0.0000053185013,0.29073042,0.7015265,0.0021606493,0.000982655,0.00023217865],"about_ca_topic_score_codex":0.0000067620613,"about_ca_topic_score_gemma":0.000001057254,"teacher_disagreement_score":0.26634556,"about_ca_system_score_codex":0.000022422859,"about_ca_system_score_gemma":0.00051632524,"threshold_uncertainty_score":0.9999144},"labels":[],"label_agreement":null},{"id":"W1992917631","doi":"10.5414/cp201845","title":"Approvable generic carbamazepine formulations may not be bioequivalent in target patient populations","year":2013,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Pharmacokinetics; Cmax; Pharmacology; Carbamazepine; Medicine; Population","score_opus":0.3202860587396284,"score_gpt":0.5351534356356845,"score_spread":0.21486737689605612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992917631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614806,0.0020423152,0.00036697128,0.022872034,0.011805801,0.00041538352,0.00006913931,0.000018397117,0.00092935225],"genre_scores_gemma":[0.966936,0.00448125,0.0027628432,0.024131244,0.0014305874,0.0000324395,0.00002029069,0.000024676001,0.0001806567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964197,0.00071729,0.0018380167,0.00026686874,0.00037197667,0.0003861315],"domain_scores_gemma":[0.9973372,0.00072833215,0.00082188856,0.00010859994,0.0006714327,0.00033252325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001349295,0.00024809607,0.0005375916,0.00034536477,0.000116556446,0.000038938757,0.000489588,0.00035235944,0.001983138],"category_scores_gemma":[0.00010796938,0.00021559988,0.0002494468,0.00018768733,0.000293767,0.00029900245,0.00015981,0.0012415886,0.00003223526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034391535,0.0067887064,0.30121198,0.000052256353,0.004718351,0.00038310353,0.0025039339,0.018544089,0.14059648,0.01055719,0.020563457,0.4906413],"study_design_scores_gemma":[0.009287045,0.0004995986,0.10490586,0.00002029148,0.00051753165,0.00016831851,0.00015803809,0.029135706,0.013448626,0.007882796,0.8335124,0.00046378002],"about_ca_topic_score_codex":0.000026074771,"about_ca_topic_score_gemma":0.0000062713148,"teacher_disagreement_score":0.81294894,"about_ca_system_score_codex":0.000058537393,"about_ca_system_score_gemma":0.00018010198,"threshold_uncertainty_score":0.9989292},"labels":[],"label_agreement":null},{"id":"W1993351059","doi":"10.1167/tvst.2.6.1","title":"Translating Drugs From Animals to Humans: Do We Need to Prove Efficacy?","year":2013,"lang":"en","type":"article","venue":"Translational Vision Science & Technology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Allergan; Fidelity Biosciences; Akebia Therapeutics; Astellas Pharma; Concert Pharmaceuticals; Astellas Pharma Global Development; Shire; Aerie Pharmaceuticals; Santen; Innovent Biologics; Astex Pharmaceuticals; Wells Fargo; Valeant Pharmaceuticals International; Omeros Corporation; Alexion Pharmaceuticals; Teva Pharmaceutical Industries","keywords":"Medicine; Clinical trial; Drug development; Food and drug administration; Publication; Drug; Drug approval; Pharmacology; Family medicine; Pathology; Business","score_opus":0.07029417089914052,"score_gpt":0.44588606372034995,"score_spread":0.3755918928212094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993351059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9148953,0.0016086664,0.0047971522,0.07289572,0.00077726686,0.0017096469,0.00013820025,0.00031761127,0.0028604607],"genre_scores_gemma":[0.9848706,0.00007119888,0.011926701,0.0025775107,0.0001854928,0.00020536341,0.000007549758,0.000033084274,0.00012249147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647224,0.00013170812,0.0007044321,0.0010332611,0.00072530657,0.0009330454],"domain_scores_gemma":[0.9980851,0.00033248554,0.0001229072,0.00042576384,0.00040631188,0.0006274326],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011201979,0.00035700528,0.0004174553,0.0014982928,0.00078835594,0.00012581951,0.0013598696,0.00038859108,0.0029439526],"category_scores_gemma":[0.00014291066,0.0003350022,0.00011432351,0.003349189,0.0007503389,0.00034627857,0.00016254176,0.00071750244,0.0019061246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008045815,0.00014020439,0.00072056265,0.0000043351283,0.000021436535,0.000002980691,0.0027241847,0.0018366507,0.6898349,0.0051238528,0.00038428648,0.29912618],"study_design_scores_gemma":[0.0042540096,0.0005227923,0.014946634,0.00008696782,0.00014573065,0.000012364069,0.0013474901,0.013230927,0.4618715,0.06052208,0.4418285,0.0012310054],"about_ca_topic_score_codex":0.000039352104,"about_ca_topic_score_gemma":0.000008719587,"teacher_disagreement_score":0.44144422,"about_ca_system_score_codex":0.000057457484,"about_ca_system_score_gemma":0.00023102846,"threshold_uncertainty_score":0.9999102},"labels":[],"label_agreement":null},{"id":"W1994315871","doi":"10.1359/jbmr.060902","title":"CYP1A1: Ethnic and Population Differences in Allelic Frequencies and Interpretation of Bone Biology Studies","year":2006,"lang":"en","type":"letter","venue":"Journal of Bone and Mineral Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôpital Saint-François d'Assise","funders":"","keywords":"Allele frequency; Allele; Genotype; Osteoporosis; Genetics; Breast cancer; Population; Internal medicine; Demography; Medicine; Biology; Oncology; Endocrinology; Cancer; Gene","score_opus":0.3653082482145677,"score_gpt":0.540954819672869,"score_spread":0.17564657145830126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994315871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8438874,0.129545,0.000004202862,0.025963867,0.00029074837,0.00017093483,0.000032185308,0.0000022563434,0.00010344338],"genre_scores_gemma":[0.92792815,0.06370721,0.00012638,0.0068879067,0.00074585946,0.000010355435,0.000024463508,0.000014670275,0.0005549754],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970722,0.0011641504,0.0008723759,0.00023098824,0.00029055943,0.00036972092],"domain_scores_gemma":[0.9978681,0.00110352,0.00045257894,0.00007353534,0.00041005792,0.00009216056],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002653289,0.00020804348,0.00088174973,0.0009448581,0.00008797898,0.000020120951,0.00009231944,0.00055467384,0.000019414405],"category_scores_gemma":[0.00031301586,0.00015925348,0.00007195757,0.00019968482,0.0006035143,0.00010584198,0.00014230412,0.0024627636,4.5271779e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014587624,0.00042472876,0.13508344,0.002685955,0.0014625614,0.0011553203,0.008553485,0.000055915723,0.36183476,0.00045917608,0.27166387,0.21516204],"study_design_scores_gemma":[0.016013283,0.0045125163,0.58604276,0.0019171997,0.0016697982,0.0011882543,0.0024531973,0.005877681,0.0072529824,0.07153124,0.29967535,0.0018657292],"about_ca_topic_score_codex":0.00033158608,"about_ca_topic_score_gemma":0.00018217719,"teacher_disagreement_score":0.45095932,"about_ca_system_score_codex":0.00003760907,"about_ca_system_score_gemma":0.000079047866,"threshold_uncertainty_score":0.9998386},"labels":[],"label_agreement":null},{"id":"W1994438706","doi":"10.2165/00003088-200241080-00001","title":"Impact of Stereoselectivity on the Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs","year":2002,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Propafenone; Mexiletine; Flecainide; Stereoselectivity; Chemistry; Pharmacology; Debrisoquine; Verapamil; Pharmacokinetics; Quinidine; Disopyramide; Procainamide; Antiarrhythmic agent; Enantiomer; CYP2D6; Metabolism; Medicine; Internal medicine; Stereochemistry; Cytochrome P450; Biochemistry; Calcium","score_opus":0.29272726509544517,"score_gpt":0.5554188054718815,"score_spread":0.2626915403764363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994438706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03914014,0.9483514,0.00003451677,0.000119682096,0.003603026,0.002955485,0.0024949003,0.00009628056,0.0032046014],"genre_scores_gemma":[0.049942914,0.94705206,0.000099909324,0.00056088757,0.0014965285,0.000121910925,0.000084860214,0.00026571253,0.00037518892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98725605,0.0047577773,0.00446516,0.0014043106,0.0008407372,0.0012759505],"domain_scores_gemma":[0.9846331,0.009274603,0.0034791508,0.0011430979,0.000543099,0.0009269713],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0039648693,0.0017450365,0.0050342614,0.00062208675,0.00026937787,0.000045662382,0.0018289838,0.001428585,0.002528336],"category_scores_gemma":[0.00057121576,0.0012083624,0.003017697,0.0013761239,0.0022100266,0.000104559156,0.0008040101,0.005496875,0.00011810736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039130784,0.002315743,0.000346763,0.004793521,0.0042711915,0.00004367333,0.00017841438,0.00022217995,0.0004412854,0.0002285942,0.010853188,0.9759141],"study_design_scores_gemma":[0.0041406425,0.00084727595,0.00015780823,0.0013337698,0.010950298,0.00008008509,0.000011404317,0.008415483,0.0007987333,0.00015249634,0.9718636,0.0012483803],"about_ca_topic_score_codex":0.000013287065,"about_ca_topic_score_gemma":5.266087e-7,"teacher_disagreement_score":0.97466576,"about_ca_system_score_codex":0.00013895592,"about_ca_system_score_gemma":0.0005342328,"threshold_uncertainty_score":0.9998678},"labels":[],"label_agreement":null},{"id":"W1994627863","doi":"10.1007/s10928-010-9185-x","title":"Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion","year":2010,"lang":"en","type":"review","venue":"Journal of Pharmacokinetics and Pharmacodynamics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pharmacokinetics; Excretion; Metabolism; Absorption (acoustics); Physiologically based pharmacokinetic modelling; Pharmacology; Chemistry; Metabolic clearance rate; Medicine; Biochemistry; Physics","score_opus":0.13243371621155753,"score_gpt":0.4536219995116794,"score_spread":0.3211882833001219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994627863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008380465,0.9750286,0.007076538,0.0002188446,0.0055222963,0.0021795153,0.0013611757,0.000076434306,0.000156143],"genre_scores_gemma":[0.0066678436,0.9842694,0.0037490984,0.001144776,0.003330664,0.00019312114,0.00027392592,0.0002744204,0.000096759235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933482,0.0008222522,0.0030848235,0.0009964744,0.000616126,0.0011321354],"domain_scores_gemma":[0.99389106,0.0010804195,0.002409029,0.0003331612,0.000956117,0.0013302187],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0028011093,0.0015634036,0.0035951121,0.0010107966,0.0004666158,0.000115315,0.0009970447,0.0013935332,0.00031896788],"category_scores_gemma":[0.00010809437,0.0013168964,0.0013836568,0.00053948234,0.0005264475,0.00027146205,0.00017706706,0.004514902,0.000006976826],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007484244,0.0005913082,0.0000066444104,0.008603105,0.0012362896,0.00007777548,0.00014954842,0.005350031,0.016631357,0.00035441917,0.00047516855,0.9657759],"study_design_scores_gemma":[0.0055916845,0.00018028595,0.000003356205,0.00065675715,0.013082642,0.00030829143,0.000011417464,0.20222902,0.00044722698,0.00050057546,0.77593666,0.0010520926],"about_ca_topic_score_codex":0.0000038617386,"about_ca_topic_score_gemma":0.0000013986978,"teacher_disagreement_score":0.9647238,"about_ca_system_score_codex":0.000086770044,"about_ca_system_score_gemma":0.0005746371,"threshold_uncertainty_score":0.99990284},"labels":[],"label_agreement":null},{"id":"W1994925836","doi":"10.1089/gtmb.2011.0327","title":"The AmpliChip <sup>®</sup> CYP450 Test and Response to Treatment in Schizophrenia and Obsessive Compulsive Disorder: A Pilot Study and Focus on Cases with Abnormal CYP2D6 Drug Metabolism","year":2012,"lang":"en","type":"article","venue":"Genetic Testing and Molecular Biomarkers","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"CYP2D6; CYP2C19; Genotyping; Pharmacogenetics; Medicine; Schizophrenia (object-oriented programming); Analysis of variance; Drug; Internal medicine; Prospective cohort study; Psychiatry; Pharmacology; Genotype; Biology; Genetics; Cytochrome P450","score_opus":0.04705397687062119,"score_gpt":0.34476096420026775,"score_spread":0.29770698732964657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994925836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798603,0.018039795,0.000019565721,0.00040476612,0.00006868852,0.0013548865,0.00006373976,0.000036185596,0.00015203819],"genre_scores_gemma":[0.9972915,0.000529621,0.0014865675,0.00033708074,0.000059652477,0.00019053575,0.0000023737723,0.0000535953,0.00004906847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975604,0.00087592885,0.00028681676,0.0005190634,0.00015151242,0.00060627796],"domain_scores_gemma":[0.99678755,0.0023000496,0.00011190768,0.00021518994,0.00004742822,0.0005378772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006946247,0.00041697276,0.00034872457,0.0001904583,0.0004921099,0.000084423664,0.00011022295,0.00006544171,0.000004129628],"category_scores_gemma":[0.0004234298,0.00029649617,0.000021257103,0.00028724206,0.0003567915,0.00003521851,0.00017807972,0.00022147721,0.0000024668989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010927866,0.0018511798,0.51480746,0.000031085554,0.0007568409,0.00055603264,0.0071108355,0.0005550017,0.056590714,0.00006852365,0.000058756836,0.4066857],"study_design_scores_gemma":[0.011592319,0.0040011182,0.9696422,0.000047762176,0.0007715095,0.0005429272,0.0022660452,0.0018296496,0.0055579143,0.00011117165,0.002961228,0.0006761601],"about_ca_topic_score_codex":0.00050894497,"about_ca_topic_score_gemma":0.00017135672,"teacher_disagreement_score":0.45483473,"about_ca_system_score_codex":0.000022747578,"about_ca_system_score_gemma":0.00006388928,"threshold_uncertainty_score":0.99994874},"labels":[],"label_agreement":null},{"id":"W1995164644","doi":"10.1016/s0028-3908(03)00136-9","title":"Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain","year":2003,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Nicotine; CYP2B6; Hippocampus; Hippocampal formation; Cerebellum; Genotype; Medicine; Putamen; Internal medicine; Pharmacology; Biology; Endocrinology; Genetics","score_opus":0.10946275119032528,"score_gpt":0.42519202655195837,"score_spread":0.3157292753616331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995164644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98310536,0.0032939757,0.0000343563,0.0016884998,0.0034162237,0.0006846295,0.000056900273,0.00011339667,0.007606673],"genre_scores_gemma":[0.9702186,0.0007370506,0.0001717305,0.0269203,0.00046418206,0.0001277623,0.0000073256997,0.0001006602,0.0012524101],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944568,0.0022593348,0.0008155573,0.00096580625,0.00024299034,0.0012594997],"domain_scores_gemma":[0.9980563,0.0007035482,0.00022823933,0.0003220432,0.00007909819,0.00061075727],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008373045,0.00056632387,0.00064339925,0.00051278266,0.00037025794,0.00004133589,0.00047921468,0.00049400615,0.004580835],"category_scores_gemma":[0.00019139692,0.0006089626,0.00013267648,0.00046951254,0.0005119684,0.00012787025,0.0002159089,0.0016042833,0.00011704709],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009398049,0.000407095,0.028471,0.000030038871,0.00011623605,0.0011806092,0.00045284294,0.00045284175,0.95244217,0.0030346655,0.0054362374,0.0078823045],"study_design_scores_gemma":[0.011839975,0.00025212512,0.15623553,0.000009659541,0.00033052362,0.0006916758,0.000027536795,0.0008259804,0.29457396,0.0022949334,0.53194344,0.0009746479],"about_ca_topic_score_codex":0.000034812023,"about_ca_topic_score_gemma":0.000013889403,"teacher_disagreement_score":0.6578682,"about_ca_system_score_codex":0.00007209129,"about_ca_system_score_gemma":0.00012528726,"threshold_uncertainty_score":0.9996362},"labels":[],"label_agreement":null},{"id":"W1995307921","doi":"10.1016/j.jmb.2010.01.075","title":"Structural Basis of Human CYP51 Inhibition by Antifungal Azoles","year":2010,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Structural Genomics Consortium; University of Toronto","funders":"Knut och Alice Wallenbergs Stiftelse; Ontario Ministry of Research and Innovation; Stiftelsen för Strategisk Forskning; Karolinska Institutet; Stiftelsen för Strategisk Forskning; Ontario Genomics Institute; Canadian Institutes of Health Research; Genome Canada; Ontario Innovation Trust; Wellcome Trust; GlaxoSmithKline","keywords":"Azole; Sterol; Ergosterol; Lanosterol; Active site; Ketoconazole; Demethylase; Chemistry; Ligand (biochemistry); Econazole; Biochemistry; Enzyme; Stereochemistry; Binding site; Biology; Receptor; Antifungal; Cholesterol; Gene","score_opus":0.04465020308208338,"score_gpt":0.43135881597979575,"score_spread":0.38670861289771236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995307921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483174,0.0017062009,0.00029844747,0.00042161817,0.0018242428,0.0000944837,0.00009859132,0.000007998855,0.0007166935],"genre_scores_gemma":[0.9980949,0.00020028435,0.00051037,0.0007835351,0.00033738374,0.0000017924084,0.000025995623,0.000017126205,0.000028611727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983863,0.00039744453,0.0006464791,0.00015516706,0.00012969685,0.00028491212],"domain_scores_gemma":[0.99870723,0.00008304065,0.0006119474,0.0001306207,0.00027018646,0.00019699006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007313902,0.00017789521,0.00039591023,0.00018591773,0.00009990433,0.000008182498,0.00027349635,0.00038097854,0.0008277257],"category_scores_gemma":[0.00008022582,0.00015042434,0.00021770872,0.00012328352,0.00032425916,0.00006858209,0.00006930629,0.0010502388,0.0000062041954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113188646,0.00010873919,0.005706529,0.000013772397,0.00017874881,0.000041776188,0.00007360094,0.000027818958,0.98254937,0.00288032,0.0013948362,0.0069112764],"study_design_scores_gemma":[0.001674558,0.00023300498,0.0016357172,0.000005464191,0.00018004506,0.00017396129,0.000018245157,0.000075529984,0.9746371,0.003532948,0.017685322,0.00014809571],"about_ca_topic_score_codex":0.000007543541,"about_ca_topic_score_gemma":0.0000031693485,"teacher_disagreement_score":0.016290486,"about_ca_system_score_codex":0.000010333178,"about_ca_system_score_gemma":0.000067694906,"threshold_uncertainty_score":0.9063016},"labels":[],"label_agreement":null},{"id":"W1995565483","doi":"10.1097/01213011-200502000-00007","title":"Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP2A6; Cotinine; Zygosity; Nicotine; Pharmacogenetics; Metabolite; Heritability; Genotype; Genetic variation; Biology; Drug metabolism; Pharmacokinetics; Pharmacology; Genetics; Metabolism; Internal medicine; Medicine; Endocrinology; Gene; CYP1A2; Cytochrome P450","score_opus":0.052108970261283416,"score_gpt":0.4206246086507744,"score_spread":0.368515638389491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995565483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824297,0.014405668,0.00008067121,0.00024114588,0.0003162029,0.0005836463,0.00087861327,0.000023673145,0.0010406718],"genre_scores_gemma":[0.97954226,0.017705578,0.0014538864,0.0007064002,0.00043139324,0.000038127866,0.00001981076,0.000054483156,0.00004804329],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762934,0.00026799488,0.0008386929,0.00043059667,0.00025736034,0.0005760182],"domain_scores_gemma":[0.9978328,0.0006176476,0.00052015623,0.00037350666,0.0003100649,0.00034584905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005916487,0.00046238347,0.00061413174,0.00018517338,0.00020736801,0.00002217101,0.0005963961,0.00018894502,0.0005001611],"category_scores_gemma":[0.0000808066,0.00034133604,0.00029285642,0.00030270818,0.00063768023,0.000063731706,0.00023680754,0.0005585935,0.00003318533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005797887,0.0005524622,0.0071435547,0.000042376603,0.0008604041,0.000003357693,0.0012074148,0.15083852,0.69811004,0.00047238005,0.00072128454,0.1394684],"study_design_scores_gemma":[0.0026189971,0.00024388121,0.050424185,0.000014187955,0.000779006,0.00003242749,0.000051156494,0.042592634,0.857483,0.00076027063,0.044580728,0.00041949007],"about_ca_topic_score_codex":0.00006182058,"about_ca_topic_score_gemma":0.0000046621903,"teacher_disagreement_score":0.15937299,"about_ca_system_score_codex":0.000045587192,"about_ca_system_score_gemma":0.00018718449,"threshold_uncertainty_score":0.99990386},"labels":[],"label_agreement":null},{"id":"W1996069708","doi":"10.1038/jhg.2010.73","title":"Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements","year":2010,"lang":"en","type":"article","venue":"Journal of Human Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"VKORC1; Pharmacogenomics; Allele frequency; Single-nucleotide polymorphism; Biology; Genetics; Allele; SNP; 1000 Genomes Project; CYP2C9; Warfarin; Evolutionary biology; Medicine; Genotype; Gene; Internal medicine","score_opus":0.10880308868572869,"score_gpt":0.40596740656787644,"score_spread":0.29716431788214775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996069708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957493,0.0011057793,0.00019412745,0.0002483075,0.0012191144,0.00019992793,0.0001002637,0.000014694358,0.001168478],"genre_scores_gemma":[0.9975379,0.00028592898,0.0009872011,0.00028124062,0.0004835964,0.0000042670686,0.000047349527,0.000035332705,0.00033718417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976307,0.00028737387,0.0009615997,0.00018900087,0.0004921881,0.0004391038],"domain_scores_gemma":[0.9974396,0.00012582343,0.0012120495,0.00023789723,0.0006433252,0.0003413108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001278958,0.00026046424,0.00047201957,0.00016617763,0.00021383238,0.000023500947,0.0005354427,0.00027780258,0.00073361833],"category_scores_gemma":[0.00012913907,0.00022043154,0.00018022221,0.00025028992,0.00029134104,0.000099545454,0.000083192055,0.0012233035,0.0000087809485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021490757,0.00078511954,0.061024606,0.00001736577,0.00058976706,0.00011262003,0.0003294083,0.0003597087,0.927753,0.0009053675,0.0023150665,0.0055930903],"study_design_scores_gemma":[0.012121917,0.0016740591,0.32327747,0.00008277825,0.0018555553,0.00023991831,0.00008899402,0.0006825206,0.61471283,0.009111048,0.035342816,0.00081005535],"about_ca_topic_score_codex":0.000009306925,"about_ca_topic_score_gemma":0.00006610823,"teacher_disagreement_score":0.3130401,"about_ca_system_score_codex":0.000058041955,"about_ca_system_score_gemma":0.00020269226,"threshold_uncertainty_score":0.8988937},"labels":[],"label_agreement":null},{"id":"W1996237457","doi":"10.1089/omi.2014.0029","title":"Bernard Lerer: Recipient of the 2014 Inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics)","year":2014,"lang":"en","type":"article","venue":"OMICS A Journal of Integrative Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Personalized medicine; Pharmacogenetics; Precision medicine; Sociology; History; Medicine; Bioinformatics; Biology; Genetics","score_opus":0.11148479628998831,"score_gpt":0.48257665518281617,"score_spread":0.37109185889282786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996237457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98333293,0.0027942588,0.0013774874,0.006955249,0.0039042633,0.00047550793,0.00021332128,0.0000049728765,0.00094198674],"genre_scores_gemma":[0.9849907,0.010778678,0.0015196765,0.0015631136,0.000748462,0.000015531052,0.000022076689,0.000018157596,0.00034361123],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99544346,0.0021758846,0.0015841803,0.00027443233,0.00018181966,0.00034021836],"domain_scores_gemma":[0.99464756,0.0019409275,0.0019676704,0.00013837518,0.0011808411,0.00012463293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072422368,0.00026538,0.00083452906,0.00023943742,0.000108933,0.000010868797,0.00040329978,0.00046015382,0.000068041794],"category_scores_gemma":[0.0031593398,0.00016701205,0.00021606279,0.00042057454,0.000610622,0.00006332089,0.0000994068,0.0009170017,0.0000019985412],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008214709,0.00052853295,0.5141823,0.00004118137,0.0008917465,0.00000276666,0.0016027282,0.00011971248,0.3533923,0.05806193,0.017594213,0.045367833],"study_design_scores_gemma":[0.027850332,0.0024718328,0.09046187,0.00014508869,0.00096265506,0.000090931535,0.00090125686,0.008570701,0.1004259,0.037907273,0.72964823,0.0005639159],"about_ca_topic_score_codex":0.000015366773,"about_ca_topic_score_gemma":0.000024979287,"teacher_disagreement_score":0.712054,"about_ca_system_score_codex":0.00024098414,"about_ca_system_score_gemma":0.0003309882,"threshold_uncertainty_score":0.6810554},"labels":[],"label_agreement":null},{"id":"W1996603307","doi":"10.1517/17425255.2015.1028355","title":"Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Uridine diphosphate; Allosteric regulation; Biochemistry; Glycosylation; Enzyme; Ribosome; Uridine; Chemistry; Function (biology); Phosphorylation; Biology; Cell biology; RNA; Gene","score_opus":0.2114949152708257,"score_gpt":0.4791306733333917,"score_spread":0.267635758062566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996603307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022484155,0.9731416,0.00006333534,0.0007133333,0.01952871,0.002078272,0.0014854186,0.00019077433,0.002573706],"genre_scores_gemma":[0.0005112671,0.99108696,0.00033337987,0.001629377,0.003361564,0.0006511261,0.0013589637,0.00023519203,0.0008321915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99075,0.0033365483,0.0024577538,0.0014156243,0.00083612313,0.0012039506],"domain_scores_gemma":[0.99559325,0.000977134,0.0011396197,0.00088968925,0.00050402596,0.0008962672],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020628935,0.001501382,0.004376624,0.0010065559,0.0003066853,0.000037766866,0.0013117165,0.0016889625,0.0036231722],"category_scores_gemma":[0.00018680563,0.0013344432,0.001387431,0.0008832954,0.0006533371,0.00022448803,0.00020490562,0.001997155,0.00049718225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065783743,0.0017154886,0.0000027973927,0.0015389362,0.001194833,0.000020229336,0.0008792592,0.00023921355,0.003391703,0.016774561,0.03455793,0.9390272],"study_design_scores_gemma":[0.0027243774,0.00018973374,0.000023695105,0.00067742803,0.00072343496,0.000070614966,0.000031361586,0.000089149544,0.005565947,0.0005856304,0.98820215,0.0011164825],"about_ca_topic_score_codex":0.000027166292,"about_ca_topic_score_gemma":0.0000032628986,"teacher_disagreement_score":0.9536442,"about_ca_system_score_codex":0.00020479146,"about_ca_system_score_gemma":0.001181748,"threshold_uncertainty_score":0.9997735},"labels":[],"label_agreement":null},{"id":"W1997075839","doi":"10.1016/j.jmb.2008.03.065","title":"Structural Analysis of CYP2R1 in Complex with Vitamin D3","year":2008,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Structural Genomics Consortium; University of Toronto","funders":"Wellcome Trust","keywords":"Stereochemistry; Active site; Chemistry; Vitamin; Rickets; Vitamin D and neurology; Enzyme; Biology; Biochemistry; Endocrinology","score_opus":0.105146290333826,"score_gpt":0.44204101325358064,"score_spread":0.33689472291975464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997075839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965785,0.001554794,0.0007827333,0.00023898068,0.00022829698,0.00008462449,0.00003801568,0.0000036938036,0.00049033336],"genre_scores_gemma":[0.99712884,0.00045060038,0.0015142087,0.00079234305,0.000066356304,0.0000017169033,0.000017969218,0.000010778542,0.000017192815],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99820834,0.0005928281,0.00063411304,0.00015187143,0.00013306271,0.00027977506],"domain_scores_gemma":[0.998879,0.00012242615,0.0005103551,0.00012803753,0.0002130528,0.00014710173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051142875,0.00016217117,0.00067973556,0.00067946175,0.00004810601,0.0000022906734,0.00030388302,0.00018849425,0.0004112997],"category_scores_gemma":[0.000043839776,0.0001220836,0.00023060956,0.0007220166,0.00032451574,0.000033121643,0.00004864266,0.00050188694,0.0000022437594],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005697773,0.00014304767,0.13852288,0.000008238038,0.0019912485,0.00048518772,0.00035291922,0.011044652,0.8435188,0.0005179396,0.00012463091,0.002720691],"study_design_scores_gemma":[0.009541914,0.001180718,0.5230865,0.000013452727,0.004068493,0.0011113592,0.00013390536,0.010132968,0.42723453,0.00093550526,0.021994676,0.0005659702],"about_ca_topic_score_codex":0.00001860369,"about_ca_topic_score_gemma":0.000016635622,"teacher_disagreement_score":0.41628426,"about_ca_system_score_codex":0.000027599612,"about_ca_system_score_gemma":0.00010730268,"threshold_uncertainty_score":0.49784243},"labels":[],"label_agreement":null},{"id":"W1997849419","doi":"10.1191/096032700678827717","title":"In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms","year":2000,"lang":"en","type":"article","venue":"Human & Experimental Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Cytochrome P450; Cilostazol; CYP2D6; In vitro; Metabolism; Drug metabolism; Gene isoform; Pharmacology; Chemistry; Biochemistry; Medicine; Aspirin","score_opus":0.07079417858071473,"score_gpt":0.4295074177035331,"score_spread":0.3587132391228184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997849419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687804,0.0014109868,0.0000027181757,0.00012222568,0.0002487138,0.0006518097,0.000022187924,0.000043828662,0.010619481],"genre_scores_gemma":[0.99684143,0.00018252344,0.00016109865,0.0014653624,0.00020782689,0.00018835202,0.00003826128,0.00004601307,0.0008691563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977146,0.00036819853,0.0006483904,0.00050097465,0.00018134085,0.00058653334],"domain_scores_gemma":[0.9991901,0.00009101212,0.00020364318,0.00023557043,0.00003989686,0.0002398041],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003362926,0.0003740542,0.0006616303,0.00029369706,0.00026682328,0.000019532667,0.00026177385,0.00028774494,0.013715978],"category_scores_gemma":[0.0000056556128,0.00034025538,0.000088918336,0.00021026345,0.000564497,0.00025875066,0.00010614579,0.000508773,0.000094406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011081187,0.0012503491,0.0003398191,0.00002976311,0.00012921897,0.00006587756,0.00234739,0.00006342596,0.9882805,0.0013952651,0.00011779263,0.004872515],"study_design_scores_gemma":[0.005273943,0.0005760391,0.0060771164,0.00001268248,0.0001118365,0.00010343646,0.00038992337,0.00023543875,0.96011615,0.0005033734,0.026225293,0.00037475312],"about_ca_topic_score_codex":0.00009118783,"about_ca_topic_score_gemma":0.000034470562,"teacher_disagreement_score":0.028164301,"about_ca_system_score_codex":0.000095620715,"about_ca_system_score_gemma":0.000038599745,"threshold_uncertainty_score":0.99990493},"labels":[],"label_agreement":null},{"id":"W1997979175","doi":"10.1080/004982500406408","title":"Identification of enzymes responsible for rifalazil metabolism in human liver microsomes","year":2000,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto","keywords":"Microsome; Hydroxylation; CYP3A4; Enzyme; Biochemistry; Metabolism; Chemistry; Cytochrome P450; Biotransformation; Microsoma; Metabolite; Drug metabolism","score_opus":0.07261191469656943,"score_gpt":0.42408075111964194,"score_spread":0.35146883642307253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997979175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98703325,0.0071257604,0.000040451883,0.0005239708,0.00053204765,0.00070489844,0.00026240372,0.000044194378,0.003733042],"genre_scores_gemma":[0.9925292,0.0015211322,0.00041493916,0.000597971,0.00020968434,0.000057279747,0.000034681943,0.000031438623,0.004603654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980428,0.00034647487,0.0006800094,0.00035947122,0.00013254197,0.00043870788],"domain_scores_gemma":[0.99901336,0.00030770997,0.00015631231,0.00027235012,0.000114671435,0.00013556452],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011227558,0.00020696847,0.00038019358,0.00023485244,0.00017397509,0.000020369705,0.00034980648,0.0002777257,0.00262046],"category_scores_gemma":[0.000073053365,0.00021199924,0.00014642,0.00030429856,0.0002356842,0.00009934208,0.000040146468,0.00033340906,0.00011130863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045138432,0.0004783847,0.0004903409,0.000074462005,0.00008363892,0.0000060368384,0.0007618979,0.00030775246,0.9654211,0.012830522,0.0019233981,0.017171126],"study_design_scores_gemma":[0.0019144117,0.000033505337,0.008583317,0.000008394942,0.00016044307,0.0000041969865,0.000028054515,0.0009099189,0.7822522,0.002025853,0.20388757,0.00019213506],"about_ca_topic_score_codex":0.000024052975,"about_ca_topic_score_gemma":0.000015847256,"teacher_disagreement_score":0.20196417,"about_ca_system_score_codex":0.000023848794,"about_ca_system_score_gemma":0.00009497083,"threshold_uncertainty_score":0.99829125},"labels":[],"label_agreement":null},{"id":"W1998221260","doi":"10.1517/14622416.5.5.513","title":"Pharmacogenomic Data Submissions to the FDA: Clinical Pharmacology Case Studies","year":2004,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacogenetics; Medicine; Pharmacology; Library science; Biology; Computer science; Genetics","score_opus":0.5619068180930767,"score_gpt":0.6062603981433838,"score_spread":0.044353580050307095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998221260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9183073,0.021470636,0.00089930784,0.021582317,0.030881887,0.0029522763,0.0022240994,0.00042665872,0.0012554866],"genre_scores_gemma":[0.903702,0.021953747,0.0022232304,0.060315963,0.010473575,0.00034643614,0.00018024755,0.00021828171,0.0005864923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917606,0.001758369,0.0020561935,0.001984076,0.00048219884,0.0019585632],"domain_scores_gemma":[0.9936806,0.0014948726,0.000561209,0.0017549273,0.00047412983,0.0020342364],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.006277939,0.0010352758,0.001191828,0.00037467058,0.0018701518,0.000108238084,0.004010057,0.00045083667,0.0014535083],"category_scores_gemma":[0.00044794098,0.00082920067,0.00047245098,0.0010242957,0.0008878544,0.0004104827,0.003389254,0.0028043461,0.0031762565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024371962,0.0038849434,0.0015728343,0.00016733268,0.00819274,0.014242055,0.006359757,0.038597025,0.28117752,0.0010149837,0.46499923,0.17735437],"study_design_scores_gemma":[0.009911119,0.0001355,0.00005528403,0.000013054583,0.0027101596,0.0047990703,0.00068963517,0.0040313015,0.05896478,0.00047960292,0.9171553,0.0010551865],"about_ca_topic_score_codex":0.00006427851,"about_ca_topic_score_gemma":0.00004974881,"teacher_disagreement_score":0.45215607,"about_ca_system_score_codex":0.00039078156,"about_ca_system_score_gemma":0.00086699944,"threshold_uncertainty_score":0.9994962},"labels":[],"label_agreement":null},{"id":"W1998664238","doi":"10.1016/j.clinbiochem.2006.01.023","title":"Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort","year":2006,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"CYP2C9; Warfarin; Genotype; Genotyping; Internal medicine; Allele frequency; Allele; Gastroenterology; Genotype frequency; Medicine; Restriction fragment length polymorphism; Cohort; Anticoagulant; Biology; Genetics; Gene; Atrial fibrillation","score_opus":0.08773732555880336,"score_gpt":0.4538236815173983,"score_spread":0.36608635595859496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998664238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982558,0.0060818205,0.00005395684,0.00026984783,0.0017343728,0.00038070272,0.0001891077,0.00007151054,0.008660649],"genre_scores_gemma":[0.99565625,0.00085338135,0.00048361334,0.00084800937,0.0010796612,0.000030909756,0.0000995626,0.00004161729,0.00090698],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956518,0.0005847898,0.0019156353,0.0007746837,0.00027246375,0.00080065103],"domain_scores_gemma":[0.9974508,0.0010184378,0.00057569076,0.00051407295,0.0001243094,0.0003166507],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003795708,0.00037643543,0.0009983884,0.0001139237,0.00011089703,0.00001480299,0.00055405044,0.0008937108,0.001398475],"category_scores_gemma":[0.0006242678,0.00037020424,0.00045203953,0.00041704968,0.00043233525,0.00005633815,0.00023901193,0.0015215438,0.00012573219],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010633232,0.0015295825,0.61166775,0.00006728424,0.00014187877,0.00007308144,0.000028247492,0.000013558931,0.382554,0.00026330506,0.0012352717,0.0023196996],"study_design_scores_gemma":[0.0053407243,0.000036976355,0.34795183,0.000037772745,0.00041545648,0.00002191937,0.000036831745,0.0004372132,0.6359755,0.0016404579,0.007591718,0.0005136006],"about_ca_topic_score_codex":0.00012665903,"about_ca_topic_score_gemma":0.000015131537,"teacher_disagreement_score":0.26371592,"about_ca_system_score_codex":0.000035690988,"about_ca_system_score_gemma":0.00022022697,"threshold_uncertainty_score":0.999875},"labels":[],"label_agreement":null},{"id":"W2000070385","doi":"10.1002/jps.21607","title":"The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (±)-halofantrine","year":2008,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Adipose tissue; Chemistry; Biodistribution; Internal medicine; Endocrinology; Chylomicron; Kidney; Microsome; Hyperlipidemia; Lipoprotein; Pharmacokinetics; Spleen; Enantiomer; Triglyceride; Pharmacology; Very low-density lipoprotein; Cholesterol; Biochemistry; In vitro; Biology; Medicine","score_opus":0.06516465357576305,"score_gpt":0.42667827674217795,"score_spread":0.3615136231664149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000070385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834196,0.012551336,0.000024776999,0.0021138478,0.000987216,0.00035513143,0.000050141163,0.000005245432,0.0004926923],"genre_scores_gemma":[0.99666303,0.00253707,0.00004453776,0.0002883628,0.00037415556,0.000010594896,8.216249e-7,0.0000072584326,0.00007415552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966033,0.0014570488,0.00071681576,0.00017918689,0.0006495264,0.00039409907],"domain_scores_gemma":[0.9952969,0.0033492076,0.00081324374,0.00009077833,0.00024670365,0.00020316211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005228403,0.0001968744,0.0004491926,0.00006825359,0.00070681755,0.000023104778,0.00050707406,0.0001292356,0.00012698391],"category_scores_gemma":[0.0008372285,0.00009978894,0.00015417718,0.00041244365,0.0012613136,0.00012934598,0.000103216036,0.0007387911,0.0000041632625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014572038,0.0002816336,0.017612776,0.000021890102,0.0003415313,0.000013812949,0.000540781,0.000116838695,0.95456713,0.0024991115,0.0021757623,0.020371545],"study_design_scores_gemma":[0.0017275697,0.000749609,0.008833165,0.000013895167,0.000207699,0.00008798321,0.00007189784,0.00049257634,0.92851245,0.00013555626,0.05906812,0.00009948445],"about_ca_topic_score_codex":0.000012307074,"about_ca_topic_score_gemma":8.993078e-7,"teacher_disagreement_score":0.056892358,"about_ca_system_score_codex":0.000065215565,"about_ca_system_score_gemma":0.000116021794,"threshold_uncertainty_score":0.54363406},"labels":[],"label_agreement":null},{"id":"W2000172206","doi":"10.1196/annals.1423.020","title":"Genotypic Approaches to Therapy in Children","year":2007,"lang":"en","type":"article","venue":"Annals of the New York Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's & Women's Health Centre of British Columbia; Child and Family Research Institute; University of British Columbia","funders":"Health Canada","keywords":"Pharmacogenomics; Medicine; Drug reaction; Dosing; Drug; Incidence (geometry); Pharmacotherapy; Pharmacogenetics; Precision medicine; Genomics; Intensive care medicine; Pediatrics; Bioinformatics; Genotype; Pharmacology; Internal medicine; Genetics; Biology; Genome; Pathology","score_opus":0.46781501088935706,"score_gpt":0.47042429044790346,"score_spread":0.0026092795585463957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000172206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770193,0.008096335,0.000017818007,0.011787713,0.00020574841,0.00039008303,0.000010695276,0.0000093366425,0.002462958],"genre_scores_gemma":[0.9901801,0.0010167396,0.00043369015,0.0079048285,0.0002117251,0.0000036192705,2.451722e-7,0.000006938075,0.00024215759],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836457,0.00017726897,0.00043136504,0.0002620167,0.00031173558,0.00045302798],"domain_scores_gemma":[0.9993125,0.00018347983,0.00021402945,0.00008112159,0.000016477932,0.00019237811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034533215,0.00014244941,0.00024530434,0.00021509253,0.00013963442,0.000007201406,0.0012275719,0.00017779565,0.000087327426],"category_scores_gemma":[0.000051167284,0.000096687785,0.00011410919,0.0010052703,0.0005481582,0.00006720021,0.0001444445,0.00040025954,0.000011086856],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048611173,0.00048305598,0.28371134,0.000015796422,0.00017679886,3.0634195e-7,0.0036816776,0.008469895,0.20875448,0.014499106,0.014916234,0.4648052],"study_design_scores_gemma":[0.00042381816,0.00005858681,0.29223564,0.00001015098,0.000011952693,0.0000022816732,0.0000554696,0.00008273908,0.6698016,0.0065599643,0.03064917,0.00010861721],"about_ca_topic_score_codex":0.000062150684,"about_ca_topic_score_gemma":0.0000040841273,"teacher_disagreement_score":0.46469656,"about_ca_system_score_codex":0.000004580444,"about_ca_system_score_gemma":0.0000736667,"threshold_uncertainty_score":0.39428136},"labels":[],"label_agreement":null},{"id":"W2001064598","doi":"10.1016/j.phymed.2006.12.004","title":"In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato","year":2007,"lang":"en","type":"article","venue":"Phytomedicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine; University of Ottawa","funders":"","keywords":"Aglycone; Hypericin; Pharmacology; Chemistry; CYP3A4; Biochemistry; Cytochrome P450; In vitro; In vivo; Drug metabolism; Metabolism; Biology; Glycoside","score_opus":0.09117782702004557,"score_gpt":0.45052397743014594,"score_spread":0.3593461504101004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001064598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959094,0.008504816,0.00001716487,0.00020568914,0.000107666,0.000803625,0.00007325083,0.000007054343,0.00068977743],"genre_scores_gemma":[0.99889976,0.0004752678,0.00021343771,0.00017996052,0.00013507342,0.000041347048,0.00003043027,0.000015648815,0.0000091063375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979448,0.00020467432,0.000908463,0.00023977301,0.0003867324,0.00031556212],"domain_scores_gemma":[0.9986315,0.00042239175,0.00040797365,0.00014775344,0.0002239668,0.00016646432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031609086,0.0001805182,0.0006441246,0.00060196506,0.000028874509,0.0000015829087,0.000112893664,0.00016855264,0.000109089386],"category_scores_gemma":[0.00027057968,0.00017172298,0.000040646228,0.0005581492,0.00037536066,0.00012797306,0.000059835675,0.00033881757,6.1418024e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040754248,0.00040449458,0.0018647138,0.00014086884,0.000056639878,0.0000059524295,0.0017043863,0.000031179836,0.9878685,0.00022123045,0.000015405407,0.007279081],"study_design_scores_gemma":[0.00644583,0.00006483683,0.1703988,0.000043513977,0.00021892191,0.0000049644796,0.0001460434,0.0012438919,0.8171985,0.0037617174,0.00035370968,0.00011926593],"about_ca_topic_score_codex":0.00009516422,"about_ca_topic_score_gemma":0.000022904464,"teacher_disagreement_score":0.17067,"about_ca_system_score_codex":0.000030984545,"about_ca_system_score_gemma":0.000070944145,"threshold_uncertainty_score":0.70026594},"labels":[],"label_agreement":null},{"id":"W2001314811","doi":"10.1038/nchembio0709-436","title":"Open access chemical and clinical probes to support drug discovery","year":2009,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Drug discovery; Pharmaceutical industry; Productivity; Data science; Business; Drug industry; Computational biology; Computer science; Biology; Biotechnology; Bioinformatics; Economics","score_opus":0.134351923613858,"score_gpt":0.5619974727123195,"score_spread":0.4276455490984615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001314811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97673607,0.0014142409,0.000020798663,0.011104146,0.0014591358,0.0007347016,0.00014969145,0.00007400609,0.008307201],"genre_scores_gemma":[0.9497935,0.00067669264,0.0007257066,0.04703065,0.0010946447,0.000039061095,0.00014420274,0.00002081119,0.00047473394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973547,0.00030243213,0.00061134,0.0009277374,0.000113437054,0.0006903628],"domain_scores_gemma":[0.99825627,0.00048582736,0.00013693304,0.00030975696,0.00010485581,0.00070633437],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009726431,0.00035238377,0.0006642779,0.000089461566,0.00010079432,0.00018131359,0.0022431097,0.0013897349,0.00044668195],"category_scores_gemma":[0.00048708054,0.00028851736,0.0001467608,0.00028156763,0.00034601564,0.00030647984,0.0019163983,0.002484904,0.00007566068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009919782,0.00070463703,0.014167578,0.000015226823,0.0001395384,0.000028577635,0.000073297604,0.0000010186244,0.78736293,0.005056832,0.05536571,0.13609266],"study_design_scores_gemma":[0.0020054644,0.00011503565,0.0027292243,0.000006801678,0.0001322516,0.00003150999,0.000006475084,0.000033438617,0.5688101,0.0071957447,0.41853917,0.00039476462],"about_ca_topic_score_codex":0.000006378462,"about_ca_topic_score_gemma":0.0000019468036,"teacher_disagreement_score":0.36317345,"about_ca_system_score_codex":0.000035423986,"about_ca_system_score_gemma":0.00013338674,"threshold_uncertainty_score":0.9999567},"labels":[{"model":"gemma","categories":["open_science"],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["open_science","scholarly_communication"],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2001637088","doi":"10.1159/000064040","title":"Presence on human chromosome 10 of omeprazole-sensitivity gene whose product mediates CYP1A1 induction","year":2002,"lang":"en","type":"article","venue":"Cytogenetic and Genome Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Biology; Molecular biology; Cell culture; Gene expression; Fluorescence in situ hybridization; Signal transduction; Locus (genetics); Gene; In situ hybridization; Gene product; Chromosome; Cell biology; Genetics","score_opus":0.3781055115440178,"score_gpt":0.49505363337501984,"score_spread":0.11694812183100206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001637088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794785,0.014398771,0.0000069039784,0.0006593912,0.00035788486,0.0007418655,0.00011527839,0.00003575264,0.0042056823],"genre_scores_gemma":[0.9875923,0.008410481,0.000090008354,0.00012373469,0.0008428985,0.00007764894,0.000027901193,0.0000403214,0.0027947314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959087,0.0013707015,0.00046345082,0.0007352523,0.00065604376,0.0008658766],"domain_scores_gemma":[0.99797237,0.000505534,0.00013286268,0.00048935524,0.00041512706,0.0004847274],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027656555,0.0002931297,0.00042563034,0.00044917542,0.0005844876,0.000036680714,0.0003384483,0.00026475618,0.002537201],"category_scores_gemma":[0.0002590273,0.0002771326,0.00008707091,0.00062407827,0.0010001428,0.00007771473,0.00031654307,0.0010223874,0.0003309552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013246674,0.00057733763,0.0018434131,0.0001021103,0.00012099239,0.00005068336,0.0009904121,0.00034758067,0.9666116,0.00021950502,0.0008966309,0.028107224],"study_design_scores_gemma":[0.0016858635,0.0005325212,0.029196672,0.000021276011,0.00009262802,0.00006150989,0.00010337306,0.0012153125,0.8873945,0.00071111013,0.07857516,0.0004100991],"about_ca_topic_score_codex":0.00003027524,"about_ca_topic_score_gemma":0.000006503631,"teacher_disagreement_score":0.07921717,"about_ca_system_score_codex":0.00005138646,"about_ca_system_score_gemma":0.00006471911,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W2001989326","doi":"10.1080/03602530500251220","title":"“Phase I and Phase II” Drug Metabolism: Terminology that we Should Phase Out?","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Phase (matter); Drug metabolism; Drug; Terminology; Chemistry; Pharmacology; Medicine; Philosophy","score_opus":0.21912137132643994,"score_gpt":0.4792411872007885,"score_spread":0.26011981587434857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001989326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43315887,0.5431773,0.00024711477,0.010123645,0.00585485,0.002623081,0.00092842185,0.00031034078,0.0035763711],"genre_scores_gemma":[0.4017579,0.5457784,0.0035393755,0.025912283,0.006396173,0.0011041617,0.00035001643,0.00029803318,0.014863674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99017966,0.0029683916,0.0023233755,0.001798858,0.0006457291,0.0020839584],"domain_scores_gemma":[0.99518365,0.0004337353,0.0011494625,0.0013245199,0.00022582809,0.0016828143],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.004559952,0.0016026904,0.0032748743,0.0007187784,0.0011431426,0.00015041101,0.0014467761,0.000671046,0.004971372],"category_scores_gemma":[0.00028355766,0.001369615,0.00089923386,0.00067442725,0.0008568711,0.0008582003,0.0008214214,0.0024939405,0.0012937511],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006625704,0.006820537,0.00002430284,0.00019324536,0.00043023683,0.00008504273,0.005410137,0.000016143356,0.063234165,0.0021847906,0.09528813,0.8256507],"study_design_scores_gemma":[0.032692872,0.00011752902,0.000018808763,0.00004881234,0.0027726756,0.00011101939,0.00014596802,0.0016003409,0.094982035,0.00058062485,0.86567855,0.0012507905],"about_ca_topic_score_codex":0.000024587687,"about_ca_topic_score_gemma":0.000041226867,"teacher_disagreement_score":0.8243999,"about_ca_system_score_codex":0.000063788335,"about_ca_system_score_gemma":0.00020807066,"threshold_uncertainty_score":0.99980736},"labels":[],"label_agreement":null},{"id":"W2002040298","doi":"10.1038/nrg1559","title":"Pharmacogenetics and geographical ancestry: implications for drug development and global health","year":2005,"lang":"en","type":"review","venue":"Nature Reviews Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; University of Toronto","funders":"Hospital for Sick Children; Drugs for Neglected Diseases initiative; Ontario Genomics; Genome Canada; McGill University","keywords":"Pharmacogenetics; Nexus (standard); Personalized medicine; Genomics; Precision medicine; Biology; Developing country; Genotyping; Data science; Biotechnology; Genome; Bioinformatics; Genetics; Computer science; Genotype; Ecology","score_opus":0.2425314229493519,"score_gpt":0.5693222252738795,"score_spread":0.3267908023245276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002040298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007364423,0.99075,0.00020120485,0.0009703562,0.001290298,0.005001016,0.0014640545,0.00006897764,0.00018043644],"genre_scores_gemma":[0.000020718684,0.9744952,0.01816242,0.0041136853,0.001420371,0.0010838385,0.0004464441,0.0001029602,0.00015441567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994707,0.00091864855,0.0018680007,0.0012416443,0.00021575807,0.0010489597],"domain_scores_gemma":[0.9967771,0.0003972096,0.0010648239,0.00050722295,0.00017122373,0.0010824124],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018946569,0.0011286793,0.0028950928,0.00020660146,0.0006118239,0.000084530846,0.00068978977,0.0015223678,0.00003825331],"category_scores_gemma":[0.000084138235,0.000971569,0.000512872,0.000650628,0.00032209692,0.00004331421,0.00037367677,0.002178619,0.000022189874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010373958,0.0001392327,0.00013822557,0.008608628,0.0003361787,0.0000011138882,0.00005320322,0.0000023805687,0.0000023549374,0.0008366529,0.011091813,0.97877985],"study_design_scores_gemma":[0.00084668933,0.00003918644,0.0001282414,0.0010073653,0.0023317842,0.0001335714,0.0000033949884,0.00003270701,0.000011489806,0.0002116597,0.9944044,0.00084950944],"about_ca_topic_score_codex":0.0000011292972,"about_ca_topic_score_gemma":0.000020510677,"teacher_disagreement_score":0.9833126,"about_ca_system_score_codex":0.00018161548,"about_ca_system_score_gemma":0.0009957704,"threshold_uncertainty_score":0.99977386},"labels":[],"label_agreement":null},{"id":"W2002225487","doi":"10.1023/b:cemn.0000012725.31108.4a","title":"Inhibitory Effects of the Monoamine Oxidase Inhibitor Tranylcypromine on the Cytochrome P450 Enzymes CYP2C19, CYP2C9, and CYP2D6","year":2004,"lang":"en","type":"article","venue":"Cellular and Molecular Neurobiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Tranylcypromine; Monoamine oxidase inhibitor; Pharmacology; CYP2C9; CYP2C19; Monoamine oxidase; CYP3A4; CYP2D6; Cytochrome P450; Non-competitive inhibition; Dextromethorphan; Enzyme; CYP1A2; Chemistry; Selegiline; Biochemistry; Biology; Internal medicine; Medicine","score_opus":0.02254054429114349,"score_gpt":0.3001204972931966,"score_spread":0.2775799530020531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002225487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872545,0.008305962,0.00010900731,0.002099339,0.00086720753,0.00093100703,0.000042126,0.000031141502,0.0003597289],"genre_scores_gemma":[0.9931523,0.0010122524,0.000031073774,0.0054163146,0.00018510282,0.00006507525,0.000011040294,0.000040434345,0.00008641133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773866,0.0007998169,0.0003772369,0.0004999425,0.00012917495,0.0004551528],"domain_scores_gemma":[0.9987779,0.0004117775,0.00017147313,0.0003824829,0.00005863283,0.00019772914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037263992,0.00037412232,0.0004173636,0.000097478056,0.00028201268,0.000015958392,0.00033086143,0.0003192667,0.000028435863],"category_scores_gemma":[0.00012739586,0.00023684042,0.0001713758,0.00018818089,0.0008858407,0.000031992276,0.00024709676,0.0007617601,0.000009627898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014223965,0.00023733788,0.000078041536,0.00008255104,0.00011474282,0.00009811074,0.00031196716,0.00013315899,0.99162996,0.005861963,0.00016372334,0.0011462269],"study_design_scores_gemma":[0.0028103837,0.00035077662,0.0017498228,0.000029638057,0.00025459813,0.000060313312,0.000020611405,0.00007171656,0.9805153,0.0009246915,0.012974047,0.00023810139],"about_ca_topic_score_codex":0.00001236643,"about_ca_topic_score_gemma":0.000002677912,"teacher_disagreement_score":0.012810323,"about_ca_system_score_codex":0.000016548693,"about_ca_system_score_gemma":0.0000675199,"threshold_uncertainty_score":0.96580726},"labels":[],"label_agreement":null},{"id":"W2002367289","doi":"10.1016/s0960-0760(02)00044-4","title":"Structural specificity of steroids in stimulating DNA synthesis and protooncogene expression in primary rat hepatocyte cultures","year":2002,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"Flinders University","keywords":"DNA synthesis; Stimulation; Anabolism; Mechanism of action; Steroid; Biology; Pregnenolone; Hepatocyte; Endocrinology; Internal medicine; DNA; Steroid hormone; Biochemistry; Chemistry; Hormone; In vitro","score_opus":0.046627104563193,"score_gpt":0.3605423213105825,"score_spread":0.3139152167473895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002367289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986362,0.012912767,0.000033516317,0.00019008461,0.00011464942,0.00022222903,0.000018251882,0.000002566239,0.0001439296],"genre_scores_gemma":[0.99713266,0.0022578856,0.00026295567,0.00023721727,0.00007833747,0.0000068292384,0.0000021184603,0.000008602431,0.000013374938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984544,0.0005324352,0.0005428567,0.00015864875,0.00008639226,0.00022526801],"domain_scores_gemma":[0.9992192,0.00019544449,0.00032335415,0.000110144414,0.000055438253,0.000096449585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006911724,0.00017856104,0.00037120792,0.00007685453,0.00006235263,0.0000073476044,0.0002094025,0.00022217078,0.000048002996],"category_scores_gemma":[0.000073514784,0.00012017595,0.000051938794,0.000094450574,0.00030056862,0.000037928858,0.00013535749,0.00048181543,2.2180507e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049349805,0.0000681445,0.014314392,0.00007947823,0.000038835053,0.00003184739,0.0004629259,0.00011969752,0.9754978,0.0000039029787,0.000018087383,0.008871433],"study_design_scores_gemma":[0.0015365687,0.00010184825,0.002771642,0.00006138956,0.00006182193,0.000165058,0.000113647635,0.00059275876,0.994071,0.00014374455,0.0002564027,0.00012411746],"about_ca_topic_score_codex":0.0000030087197,"about_ca_topic_score_gemma":0.0000010509111,"teacher_disagreement_score":0.018573243,"about_ca_system_score_codex":0.000022265458,"about_ca_system_score_gemma":0.000018858438,"threshold_uncertainty_score":0.4900633},"labels":[],"label_agreement":null},{"id":"W2002417408","doi":"10.2174/138920009790820138","title":"Expression, Function and Regulation of Mouse Cytochrome P450 Enzymes: Comparison With Human Cytochrome P450 Enzymes","year":2009,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Cytochrome P450; Aryl hydrocarbon receptor; Constitutive androstane receptor; Biology; Enzyme; Function (biology); Gene; Biochemistry; Receptor; Isozyme; Nuclear receptor; Cell biology; Transcription factor","score_opus":0.1498512899212153,"score_gpt":0.4583765530236701,"score_spread":0.30852526310245476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002417408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006252385,0.9883474,0.00022574517,0.00003067267,0.0014095131,0.0024784743,0.0005742972,0.00020641883,0.00047509276],"genre_scores_gemma":[0.011049796,0.9840639,0.00023724519,0.000112133624,0.0017992618,0.00038560413,0.0010806442,0.00019122493,0.0010801753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99240506,0.0019730744,0.0023094423,0.0014375095,0.0008328111,0.0010420992],"domain_scores_gemma":[0.99528915,0.0003989672,0.00226165,0.00093819696,0.00038252855,0.00072950096],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013675629,0.00156209,0.0043436824,0.00096277747,0.0006068168,0.00010336111,0.0008604151,0.0009361001,0.0006930322],"category_scores_gemma":[0.000058251633,0.0012532461,0.00068597216,0.0007790247,0.0005852207,0.00037236037,0.00032179028,0.0024367364,0.00008025728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031124905,0.0017332726,0.000029748468,0.010086754,0.0010734167,0.000011592496,0.00073606457,0.00014284247,0.03684474,0.006281509,0.015284662,0.9274641],"study_design_scores_gemma":[0.0028811002,0.0001029303,0.0008969035,0.002307547,0.007112585,0.000037869126,0.000041190982,0.000085095984,0.010293391,0.00045753273,0.9745118,0.0012720692],"about_ca_topic_score_codex":0.0000116697565,"about_ca_topic_score_gemma":0.0000056915533,"teacher_disagreement_score":0.95922714,"about_ca_system_score_codex":0.00009076811,"about_ca_system_score_gemma":0.000414719,"threshold_uncertainty_score":0.9998647},"labels":[],"label_agreement":null},{"id":"W2002702566","doi":"10.1016/j.amjopharm.2011.09.006","title":"Detection and Prevention of Drug–Drug Interactions in the Hospitalized Elderly: Utility of New Cytochrome P450–Based Software","year":2011,"lang":"en","type":"article","venue":"˜The œAmerican journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Gériatrie de Montréal; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Polypharmacy; Medicine; Drug; CYP2D6; Prospective cohort study; Internal medicine; Drug interaction; Pharmacology; Cytochrome P450","score_opus":0.0715310687299459,"score_gpt":0.3993760881135736,"score_spread":0.3278450193836277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002702566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902923,0.003069589,0.0048858216,0.00040143862,0.00068104296,0.00051450904,0.000028439272,0.000013061469,0.00011380989],"genre_scores_gemma":[0.9952388,0.0024069885,0.0011026503,0.00085691904,0.00029379086,0.00001931816,0.0000013412925,0.000026595748,0.000053607673],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99652255,0.0015961326,0.001043781,0.00020907419,0.0003239071,0.00030457057],"domain_scores_gemma":[0.99702805,0.0005140092,0.0018280462,0.00022470775,0.00022764306,0.00017752235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021997797,0.0002599167,0.0006098139,0.00037957326,0.00013748025,0.000013734081,0.00058239774,0.000040006118,0.0005594646],"category_scores_gemma":[0.000029991656,0.00017787749,0.00032508714,0.0008871071,0.00040614422,0.00017211544,0.000033825643,0.0007966251,0.0000016842793],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068489173,0.0013993271,0.014657618,0.00007482136,0.0006966924,0.000021231797,0.012644864,0.00018359553,0.36832374,0.000008838814,0.0017531232,0.5933872],"study_design_scores_gemma":[0.025448676,0.0022420129,0.37212858,0.00011809626,0.002724742,0.00037912393,0.0038246375,0.004801839,0.5218065,0.006162834,0.05939153,0.0009714697],"about_ca_topic_score_codex":0.000325235,"about_ca_topic_score_gemma":0.00004713586,"teacher_disagreement_score":0.59241575,"about_ca_system_score_codex":0.00003295667,"about_ca_system_score_gemma":0.00023463825,"threshold_uncertainty_score":0.7253633},"labels":[],"label_agreement":null},{"id":"W2003017820","doi":"10.1067/mcp.2000.106464","title":"Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Metoprolol; Pharmacology; Diphenhydramine; Antihistamine; CYP2D6; Drug interaction; Debrisoquine; Medicine; Pharmacokinetics; Chemistry; In vivo; Histamine; Endocrinology; Internal medicine; Cytochrome P450; Biology; Metabolism","score_opus":0.15374140742723044,"score_gpt":0.46811064952311976,"score_spread":0.31436924209588935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003017820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96921396,0.0011824861,0.00008968982,0.024788607,0.0014874196,0.002130651,0.00009901811,0.000091666916,0.00091647625],"genre_scores_gemma":[0.9449418,0.015190858,0.0000670089,0.037455842,0.0013463815,0.00026249728,0.000030875795,0.00006590517,0.0006387938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918072,0.004814406,0.0012480165,0.00086250145,0.00032216494,0.0009457089],"domain_scores_gemma":[0.99380636,0.0047001042,0.00052644627,0.00044946076,0.00015117598,0.00036644642],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003987715,0.00059582444,0.0010601392,0.0001281499,0.00059247407,0.0000694412,0.0007334815,0.0005849196,0.0013119741],"category_scores_gemma":[0.000032224187,0.00032516097,0.00019494662,0.0005539975,0.0025490164,0.00022863233,0.00014071557,0.0032708058,0.00007999193],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2642797,0.007439859,0.07638313,0.00025263676,0.0085934065,0.00038939368,0.0048592933,0.0051975213,0.07010399,0.00036255355,0.007569688,0.5545688],"study_design_scores_gemma":[0.10003263,0.005000893,0.34003496,0.00007523522,0.011169413,0.0001669272,0.00063305453,0.072368056,0.059871815,0.0012803962,0.40719527,0.0021713644],"about_ca_topic_score_codex":0.00013927402,"about_ca_topic_score_gemma":0.000080039834,"teacher_disagreement_score":0.5523975,"about_ca_system_score_codex":0.000100295125,"about_ca_system_score_gemma":0.00023333891,"threshold_uncertainty_score":0.99992007},"labels":[],"label_agreement":null},{"id":"W2003227063","doi":"10.1097/fpc.0b013e3283527c1c","title":"CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people","year":2012,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Cotinine; Nicotine; CYP2B6; Population; Medicine; Nicotine replacement therapy; Genotype; Demography; Physiology; Metabolism; Pharmacology; Internal medicine; Genetics; Biology; Environmental health; Gene; Cytochrome P450","score_opus":0.042490101905294606,"score_gpt":0.34686930900466045,"score_spread":0.30437920709936583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003227063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644821,0.033169553,0.00014276106,0.00035167058,0.00069691864,0.0007062682,0.00019092733,0.0000347546,0.00022500091],"genre_scores_gemma":[0.97886026,0.018383179,0.0007416004,0.0010669768,0.0005855399,0.00007427537,0.000023201032,0.00006655665,0.00019840364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744743,0.00041747995,0.0005224872,0.0005255566,0.0002547133,0.00083231524],"domain_scores_gemma":[0.9984976,0.00027472313,0.0003506239,0.00013249982,0.00015377866,0.0005907909],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010633761,0.00045086953,0.000525344,0.00024244869,0.00025662192,0.0000768095,0.00015643753,0.00029978633,0.00007106363],"category_scores_gemma":[0.000049134273,0.00043948536,0.00004435377,0.00028386878,0.00008469921,0.00019390436,0.00023082922,0.0006156103,0.000016233122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000355208,0.0003327791,0.8506995,0.00011222304,0.00046986295,0.0000070685373,0.024311302,0.00081749127,0.11179586,0.00022789229,0.000041934978,0.010828886],"study_design_scores_gemma":[0.0065568667,0.00008988719,0.8988674,0.000012925295,0.0010876585,0.000051687606,0.00028255116,0.0121005755,0.05285352,0.00018232125,0.027115813,0.0007987868],"about_ca_topic_score_codex":0.000020292493,"about_ca_topic_score_gemma":0.000035172747,"teacher_disagreement_score":0.058942333,"about_ca_system_score_codex":0.000087373126,"about_ca_system_score_gemma":0.00007753025,"threshold_uncertainty_score":0.9998057},"labels":[],"label_agreement":null},{"id":"W2003392791","doi":"10.2310/6650.2007.06042","title":"Asymmetry in Scientific Method and Limits to Cross-Disciplinary Dialogue: Toward a Shared Language and Science Policy in Pharmacogenomics and Human Disease Genetics","year":2007,"lang":"en","type":"article","venue":"Journal of Investigative Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacogenomics; Observational study; Medical genetics; Engineering ethics; Genetics; Biology; Medicine; Engineering; Pathology","score_opus":0.1830591389252305,"score_gpt":0.5265354442479359,"score_spread":0.34347630532270534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003392791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980872,0.013998913,0.0001544547,0.0038652865,0.00052557123,0.0003373176,0.000042436786,0.0000063271254,0.0001977199],"genre_scores_gemma":[0.9936553,0.00077067746,0.0025278765,0.0024061385,0.0005623074,0.000004824952,0.0000041066405,0.00001892261,0.00004983758],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99753106,0.0003236904,0.0008051237,0.00042181002,0.00037991191,0.0005383987],"domain_scores_gemma":[0.9973582,0.00040797002,0.00032046926,0.00012325917,0.00023387547,0.0015562064],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.007536521,0.0002535574,0.0004864218,0.001737944,0.000284228,0.0000679803,0.0003267024,0.00009936024,0.000023595594],"category_scores_gemma":[0.0012675171,0.00021203898,0.00003097555,0.0013761444,0.0037639728,0.00022358855,0.00030629826,0.0007877231,9.865189e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000327148,0.000121375684,0.17149927,0.00009836643,0.00003064096,0.0003790168,0.019653283,0.00017837447,0.79485387,0.0005817726,0.00010946731,0.0121674435],"study_design_scores_gemma":[0.0055011087,0.00032878772,0.83959883,0.00020990513,0.00013866423,0.0001253488,0.001285461,0.001100893,0.14298826,0.006553647,0.0018711396,0.00029795003],"about_ca_topic_score_codex":0.00003780857,"about_ca_topic_score_gemma":0.000049521794,"teacher_disagreement_score":0.6680996,"about_ca_system_score_codex":0.00012542166,"about_ca_system_score_gemma":0.00039636792,"threshold_uncertainty_score":0.9989472},"labels":[],"label_agreement":null},{"id":"W2003705423","doi":"10.1016/j.lfs.2004.03.032","title":"The comparative interaction of human and bovine serum albumins with CYP2C9 in human liver microsomes","year":2004,"lang":"en","type":"article","venue":"Life Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs","funders":"","keywords":"Microsome; Bovine serum albumin; Chemistry; Biochemistry; Human liver; Biology; Enzyme","score_opus":0.1651852111968331,"score_gpt":0.4732791834806386,"score_spread":0.3080939722838055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003705423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934497,0.0023901905,0.00000555673,0.00074443,0.00023953727,0.00018472929,0.000012382032,0.000010419396,0.0029630691],"genre_scores_gemma":[0.9986861,0.00051009224,0.00008087011,0.0005053729,0.00007399795,0.000010694794,0.0000015061225,0.0000039877955,0.00012740747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902487,0.00015451534,0.00023017358,0.00021166529,0.00013467304,0.0002440909],"domain_scores_gemma":[0.9994966,0.00014342717,0.0001395504,0.00007516846,0.000044552387,0.000100745965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005850805,0.00011762818,0.00017720586,0.00009399957,0.00060227595,0.000028320268,0.00024163118,0.000052894866,0.000059710383],"category_scores_gemma":[0.000013162702,0.000075006246,0.000023881501,0.00026715308,0.0012411053,0.00014137778,0.00007042437,0.0002619558,0.0000051189822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032977722,0.0006539835,0.122174345,0.000052319378,0.0001471716,0.000021532422,0.015763806,0.0034232482,0.83189815,0.02102024,0.0006842677,0.003831176],"study_design_scores_gemma":[0.0042269635,0.0009879362,0.16414644,0.000062688036,0.00011222058,0.000027871265,0.004688327,0.0010180044,0.7914573,0.0031083545,0.029762829,0.00040106438],"about_ca_topic_score_codex":0.00014087907,"about_ca_topic_score_gemma":0.0006411323,"teacher_disagreement_score":0.041972093,"about_ca_system_score_codex":0.000015068558,"about_ca_system_score_gemma":0.00007553301,"threshold_uncertainty_score":0.46322805},"labels":[],"label_agreement":null},{"id":"W2003959180","doi":"10.4155/tde.10.59","title":"An Innovative Software Solution for Personalized Pharmacotherapy","year":2010,"lang":"en","type":"article","venue":"Therapeutic Delivery","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Drug; Polypharmacy; Medicine; Drug metabolism; Pharmacology; Pharmacotherapy; Prodrug; Adverse effect; Intensive care medicine; Internal medicine","score_opus":0.12050780089051928,"score_gpt":0.45457124555016315,"score_spread":0.3340634446596439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003959180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97015333,0.0023111533,0.019343361,0.00078530266,0.0048168693,0.0011538352,0.0003259241,0.00034822576,0.00076201896],"genre_scores_gemma":[0.9705758,0.0007278428,0.009903693,0.015586611,0.00149942,0.00032128626,0.00014253666,0.00010049396,0.0011423245],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787766,0.0003223147,0.00039680116,0.00049947837,0.00021857863,0.00068514457],"domain_scores_gemma":[0.9983053,0.0003575899,0.00018591645,0.0003113458,0.0005294253,0.000310394],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010704951,0.00036748315,0.00035405197,0.00018312356,0.00048558114,0.000047471603,0.0005237125,0.0003773194,0.0028734554],"category_scores_gemma":[0.000029443196,0.00035307952,0.00016620275,0.00036437047,0.00037519773,0.00025613946,0.000035846973,0.0009300575,0.00010996774],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009045352,0.0003721128,0.0011144008,0.000015518706,0.00024577705,0.0000033220965,0.0010326701,0.00002818586,0.65689397,0.0020894934,0.0008299127,0.33647013],"study_design_scores_gemma":[0.0060073924,0.00020876295,0.0010968647,0.0000038372636,0.00025703115,0.000020311936,0.00007069656,0.014012152,0.19663069,0.0024226333,0.7787253,0.00054432836],"about_ca_topic_score_codex":0.000013396897,"about_ca_topic_score_gemma":0.000007917208,"teacher_disagreement_score":0.7778954,"about_ca_system_score_codex":0.00003435259,"about_ca_system_score_gemma":0.00019962716,"threshold_uncertainty_score":0.9998921},"labels":[],"label_agreement":null},{"id":"W2004256112","doi":"10.1097/01213011-200503000-00008","title":"Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Alcohol Abuse and Alcoholism; University of Toronto","keywords":"CYP2A6; Haplotype; Allele; Genetics; Single-nucleotide polymorphism; Biology; Allele frequency; SNP; Genotype; Gene","score_opus":0.1199717370528832,"score_gpt":0.45728655851368316,"score_spread":0.33731482146079994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004256112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97420585,0.014057373,0.0056542875,0.001566727,0.00052759785,0.0009777409,0.00019101829,0.00012117258,0.0026982343],"genre_scores_gemma":[0.94242233,0.01796997,0.03223832,0.005537666,0.00083487236,0.0001310405,0.000040857565,0.0001422747,0.00068264967],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.996616,0.00042164957,0.00078305556,0.00094977045,0.0002922571,0.00093727844],"domain_scores_gemma":[0.9980675,0.0004757749,0.00032056074,0.00030102296,0.00018282044,0.0006523234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016944269,0.0006268652,0.00064401387,0.00038193242,0.00033635233,0.00011008208,0.00036698044,0.000415203,0.0005587358],"category_scores_gemma":[0.00005815123,0.0006263922,0.00009104546,0.00048548728,0.00022903824,0.00020697451,0.0002891629,0.0010066566,0.000055697463],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010485508,0.0007631343,0.002525756,0.00011602616,0.00046611187,0.0000449362,0.0032473572,0.019100478,0.8044362,0.0013332942,0.00026340896,0.16665474],"study_design_scores_gemma":[0.016855147,0.00031589228,0.03800338,0.000048878843,0.0013467942,0.0003986023,0.00024688212,0.37749285,0.1693103,0.0012651241,0.39288124,0.0018349226],"about_ca_topic_score_codex":0.00008792436,"about_ca_topic_score_gemma":0.00010260343,"teacher_disagreement_score":0.63512594,"about_ca_system_score_codex":0.00012152385,"about_ca_system_score_gemma":0.00026327488,"threshold_uncertainty_score":0.99961877},"labels":[],"label_agreement":null},{"id":"W2005113813","doi":"10.1016/j.bmc.2012.05.042","title":"Functional characterization of recombinant hyoscyamine 6β-hydroxylase from Atropa belladonna","year":2012,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hyoscyamine; Atropa belladonna; Tropane; Chemistry; Datura; Scopolamine; Stereochemistry; Biochemistry; Solanaceae; Biology; Botany; Pharmacology","score_opus":0.08144738520202573,"score_gpt":0.3575645116783777,"score_spread":0.276117126476352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005113813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907088,0.0035629368,0.00024725078,0.0005270646,0.003437154,0.00016200676,0.0001849329,0.00005635364,0.0011135001],"genre_scores_gemma":[0.99315244,0.0010621373,0.000061654275,0.00075023685,0.0028385168,0.000016376738,0.0005939928,0.0000382994,0.001486367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819463,0.00012850124,0.00053680985,0.00030580483,0.0003258311,0.00050842616],"domain_scores_gemma":[0.9987083,0.00013978926,0.00031659723,0.00021932156,0.00011794678,0.00049802137],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053453125,0.00028710155,0.0003798853,0.00004635226,0.00013118368,0.000005783731,0.0002561716,0.00034085193,0.011524671],"category_scores_gemma":[0.00009529295,0.00026851858,0.00010925218,0.00022561407,0.00020715813,0.00009754929,0.0001148555,0.0005543509,0.00016959627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025719852,0.0005489485,0.0060922108,0.00008328654,0.00015314341,0.000009239354,0.00023344086,0.000001467193,0.9847382,0.00002253703,0.0017324989,0.0061278767],"study_design_scores_gemma":[0.0018536117,0.000025054636,0.027884908,0.000020960195,0.000450346,0.00003561147,0.000053798656,0.00014567793,0.8819247,0.00005139725,0.08731694,0.00023699457],"about_ca_topic_score_codex":0.000020994428,"about_ca_topic_score_gemma":3.4146925e-7,"teacher_disagreement_score":0.10281345,"about_ca_system_score_codex":0.00006733665,"about_ca_system_score_gemma":0.00011827013,"threshold_uncertainty_score":0.9999767},"labels":[],"label_agreement":null},{"id":"W2005328285","doi":"10.2165/00003088-200038010-00003","title":"Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":907,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Pharmacology; Drug interaction; Ritonavir; CYP3A4; Ketoconazole; Triazolam; Pharmacokinetics; Dextromethorphan; Medicine; Chemistry; Benzodiazepine; Cytochrome P450; Internal medicine","score_opus":0.2913135195647739,"score_gpt":0.5702358397399223,"score_spread":0.2789223201751484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005328285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006089405,0.9767166,0.00005013891,0.00026825487,0.0060423864,0.0033004167,0.0021567002,0.00029747744,0.0050786315],"genre_scores_gemma":[0.0036456683,0.9872383,0.00066299096,0.0023154016,0.003970219,0.00023356416,0.0004393148,0.00035280953,0.0011417588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97963136,0.006635923,0.008560146,0.0025573946,0.00090522785,0.0017099362],"domain_scores_gemma":[0.9856516,0.0072808997,0.0035054549,0.001064398,0.0004903994,0.0020072144],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0058700712,0.002085371,0.006860445,0.0007183107,0.0003738953,0.00008692648,0.0016321352,0.002788246,0.0049633123],"category_scores_gemma":[0.0008468408,0.0019310478,0.00266761,0.0012573928,0.0068409694,0.00026085318,0.0008243652,0.0073650447,0.0006516532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005062792,0.0017243288,0.00009375693,0.0067375368,0.0023055866,0.00035588368,0.00004630492,0.00005086628,0.00071415986,0.00016691658,0.0102929305,0.9770054],"study_design_scores_gemma":[0.0064515,0.00048088585,0.000088755056,0.0023230738,0.0153845465,0.00028706805,0.000009714678,0.0013937037,0.00048870785,0.0005204145,0.97077703,0.0017946151],"about_ca_topic_score_codex":0.000011263573,"about_ca_topic_score_gemma":0.000002778233,"teacher_disagreement_score":0.97521085,"about_ca_system_score_codex":0.00012437094,"about_ca_system_score_gemma":0.001087233,"threshold_uncertainty_score":0.9991888},"labels":[],"label_agreement":null},{"id":"W2005384924","doi":"10.1053/jlts.2003.50216","title":"Pharmacogenomics in liver transplantation","year":2003,"lang":"en","type":"review","venue":"Liver Transplantation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenomics; Medicine; Library science; Citation; Liver transplantation; Transplantation; Internal medicine; Pharmacology; Computer science","score_opus":0.17056409262798156,"score_gpt":0.446579544662701,"score_spread":0.27601545203471944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005384924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074337726,0.9858117,0.0005216986,0.000010446796,0.0022794274,0.0017346938,0.0014082334,0.00009564306,0.007394742],"genre_scores_gemma":[0.00035365246,0.99559706,0.0003443534,0.00055629597,0.00037590516,0.00031586504,0.0018720739,0.00013422329,0.00045053853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99509424,0.0016944986,0.0012451833,0.00085728616,0.00031090985,0.00079787243],"domain_scores_gemma":[0.99840707,0.0005111426,0.0004364895,0.00025035648,0.000071804934,0.00032314862],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008903895,0.0008707215,0.0014231593,0.00068364653,0.0001933093,0.000046485187,0.0005131568,0.0010989702,0.0015375994],"category_scores_gemma":[0.0000067418587,0.0008865413,0.0005451434,0.0006320201,0.00012909432,0.0002490345,0.000016834829,0.0017393113,0.0007732871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023718596,0.00036701246,0.000018189354,0.030461408,0.00032673433,0.003076798,0.001774861,0.00022259571,0.0001416681,0.000520691,0.000258994,0.96259385],"study_design_scores_gemma":[0.0026177282,0.00003579661,0.000035316203,0.0011189573,0.006768321,0.0009504731,0.000012932216,0.00041531207,0.0006585163,0.000052428626,0.9863885,0.0009456851],"about_ca_topic_score_codex":0.000055923072,"about_ca_topic_score_gemma":0.00006294255,"teacher_disagreement_score":0.9861295,"about_ca_system_score_codex":0.00018632825,"about_ca_system_score_gemma":0.0003250995,"threshold_uncertainty_score":0.9993751},"labels":[],"label_agreement":null},{"id":"W2005685849","doi":"10.1002/jps.22675","title":"Effect of hyperlipidemia on ketoconazole–midazolam drug–drug interaction in rat","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Ketoconazole; Pharmacokinetics; Midazolam; CYP3A; Pharmacology; Hyperlipidemia; Chemistry; Drug interaction; Volume of distribution; Jugular vein; Free fraction; Drug; Medicine; Endocrinology; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.15947094308959447,"score_gpt":0.4887370155521109,"score_spread":0.32926607246251643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005685849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802311,0.0017201069,0.000013878485,0.000591621,0.004426109,0.00035253828,0.0000073205883,0.000014112653,0.012643235],"genre_scores_gemma":[0.99704534,0.0010591033,0.0001859691,0.0011398417,0.00045334903,0.000012197624,5.149756e-7,0.000015029784,0.00008866561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99561244,0.0017658758,0.0011336331,0.00031043572,0.00059325335,0.0005843365],"domain_scores_gemma":[0.9968103,0.0017774394,0.0006650973,0.00012113103,0.00015483797,0.00047114928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008141667,0.00030319238,0.0006633173,0.0005411962,0.00015364683,0.000021690981,0.0007915752,0.00014595604,0.0017958061],"category_scores_gemma":[0.00036790333,0.00021539952,0.0002908439,0.0006703537,0.0006825156,0.00037758538,0.0001045582,0.0015462068,0.00005888451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011402527,0.0026413999,0.13327843,0.00032960693,0.00036054387,0.00034769514,0.0041322773,0.004361293,0.5029167,0.0032338884,0.0063900384,0.3306056],"study_design_scores_gemma":[0.003833391,0.0007904574,0.0022822267,0.00009877027,0.00026072186,0.00009878109,0.0001704317,0.0043218187,0.93399346,0.0005277514,0.0533667,0.00025548777],"about_ca_topic_score_codex":0.00001838679,"about_ca_topic_score_gemma":0.0000055518585,"teacher_disagreement_score":0.43107677,"about_ca_system_score_codex":0.00008359501,"about_ca_system_score_gemma":0.0001586174,"threshold_uncertainty_score":0.99911666},"labels":[],"label_agreement":null},{"id":"W2005818996","doi":"10.1038/clpt.2008.50","title":"Mice as Clinically Relevant Models for the Study of Cytochrome P450-dependent Metabolism","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Research Nova Scotia","keywords":"Drug metabolism; Cytochrome P450; Biology; Computational biology; Drug; Xenobiotic; Drug discovery; Function (biology); Gene; Metabolism; Drug development; Pharmacology; Bioinformatics; Genetics; Biochemistry; Enzyme","score_opus":0.46419484390673466,"score_gpt":0.5847167342678442,"score_spread":0.12052189036110955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005818996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020066514,0.96916634,0.00034503697,0.00085357315,0.0141565725,0.011869054,0.0009639662,0.00017975067,0.00045905457],"genre_scores_gemma":[0.0013990655,0.9642879,0.0002991181,0.025397193,0.0047493894,0.002343028,0.000110077344,0.00038921527,0.0010250328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9801907,0.007867345,0.0072288327,0.0021159328,0.00085447426,0.001742739],"domain_scores_gemma":[0.9685193,0.024291206,0.0039170627,0.0014817652,0.00093772606,0.00085299823],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.006252494,0.0018642854,0.006844502,0.00042573496,0.0009747518,0.00004744412,0.0043002726,0.0030673202,0.000787337],"category_scores_gemma":[0.00023689077,0.0013165058,0.003552846,0.00080577104,0.0020654383,0.0001578369,0.0010829523,0.0068189655,0.00031853328],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029541368,0.014346153,0.000020961174,0.0018698716,0.031853545,0.00019770906,0.0013532605,0.0012683506,0.00036044253,0.00016191941,0.02152896,0.92408466],"study_design_scores_gemma":[0.010022847,0.0016385621,0.000021342657,0.00017136893,0.053318072,0.00016550161,0.00017655983,0.0024785039,0.00008589188,0.0005595074,0.9301996,0.0011621965],"about_ca_topic_score_codex":0.000022958446,"about_ca_topic_score_gemma":0.000007710907,"teacher_disagreement_score":0.9229225,"about_ca_system_score_codex":0.0001342508,"about_ca_system_score_gemma":0.0019533,"threshold_uncertainty_score":0.99941015},"labels":[],"label_agreement":null},{"id":"W2006615927","doi":"10.1124/dmd.105.005488","title":"HUMAN CYP2D6 AND MOUSE CYP2DS: ORGAN DISTRIBUTION IN A HUMANIZED MOUSE MODEL","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs","funders":"Canadian Institutes of Health Research","keywords":"Genetically modified mouse; Biology; Transgene; Humanized mouse; Kidney; CYP2D6; Cytochrome P450; Molecular biology; Enzyme; In vivo; Biochemistry; Gene; Endocrinology; Genetics","score_opus":0.04104609317897825,"score_gpt":0.3710906995961201,"score_spread":0.3300446064171419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006615927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921255,0.004622854,0.0004840497,0.00069345377,0.00018086027,0.00049034815,0.00061129493,0.000105507905,0.0006860919],"genre_scores_gemma":[0.99362785,0.002326858,0.00033676872,0.0014928106,0.00039384994,0.00008251748,0.000438475,0.000040906052,0.0012599664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978525,0.00035532616,0.00051789853,0.0005385933,0.00019942594,0.0005362712],"domain_scores_gemma":[0.99913746,0.000053834778,0.00015020261,0.00020774518,0.00008416128,0.0003666071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073679956,0.00036568134,0.00045651954,0.00019461155,0.00044740856,0.00008079177,0.0001688137,0.0002599483,0.0001345409],"category_scores_gemma":[0.00002585186,0.0003661076,0.00007689084,0.00020681365,0.00021052046,0.00041740277,0.00014102348,0.0005805407,0.000027046935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004170481,0.0009943151,0.0019538016,0.00008378248,0.00010800591,0.000012521372,0.0041443794,0.0026360785,0.92384386,0.03496782,0.0018041229,0.02903427],"study_design_scores_gemma":[0.022555267,0.00007052365,0.032176357,0.00004204911,0.0012219273,0.000048386508,0.0006786238,0.16503352,0.6722746,0.0070278947,0.09681259,0.002058289],"about_ca_topic_score_codex":0.00006869368,"about_ca_topic_score_gemma":0.00009900228,"teacher_disagreement_score":0.25156927,"about_ca_system_score_codex":0.000049962226,"about_ca_system_score_gemma":0.000035914556,"threshold_uncertainty_score":0.99987906},"labels":[],"label_agreement":null},{"id":"W2006793732","doi":"10.1067/mcp.2002.126409","title":"Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Felodipine; Ascorbyl palmitate; Chemistry; Bioavailability; Grapefruit juice; Pharmacokinetics; Pharmacology; Nifedipine; Food science; Chromatography; Ascorbic acid; Calcium; Endocrinology; Medicine","score_opus":0.2868937453360573,"score_gpt":0.5101501110644951,"score_spread":0.22325636572843782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006793732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858888,0.0089052385,0.0000021845824,0.0020914497,0.0011930602,0.00042439223,0.00006895597,0.000019538717,0.0014064292],"genre_scores_gemma":[0.97062016,0.024090962,0.00007943715,0.004774859,0.0002102454,0.00007217026,0.0000029649216,0.000034133667,0.00011508856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99397504,0.0032054028,0.0012821608,0.0005877617,0.00041415356,0.0005355023],"domain_scores_gemma":[0.99708724,0.0016338348,0.00051575014,0.00021052832,0.00028800775,0.00026462457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0054856776,0.00035369568,0.0009288999,0.0003434458,0.000071485025,0.000007756342,0.00026664557,0.0006056038,0.00084112317],"category_scores_gemma":[0.00013041255,0.00035509732,0.00014841389,0.00040983016,0.0011866271,0.00012561207,0.0002054738,0.001277949,0.000010926254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012416772,0.001784702,0.01147588,0.00007658332,0.000398547,0.000024943996,0.0009386088,0.00026578506,0.7717671,0.000008198006,0.0002488246,0.21176918],"study_design_scores_gemma":[0.021387404,0.00055539707,0.044633586,0.000042517942,0.0030106655,0.000036828766,0.00015936107,0.09038463,0.81894124,0.00092044525,0.019313361,0.000614563],"about_ca_topic_score_codex":0.000023960198,"about_ca_topic_score_gemma":0.00002170205,"teacher_disagreement_score":0.21115462,"about_ca_system_score_codex":0.000072800525,"about_ca_system_score_gemma":0.00015516918,"threshold_uncertainty_score":0.9998901},"labels":[],"label_agreement":null},{"id":"W2006820999","doi":"10.1038/sj.bjp.0703486","title":"Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine‐induced inflammation: the role of cytokines","year":2000,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cytochrome P450; Turpentine; Inflammation; Incubation; Chemistry; Antibody; Endocrinology; Internal medicine; Blood proteins; Pharmacology; Metabolism; Immunology; Biology; Biochemistry; Medicine","score_opus":0.01902833250098119,"score_gpt":0.315713561138266,"score_spread":0.2966852286372848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006820999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344486,0.0038972916,0.00005409765,0.00085253344,0.0003860533,0.00048366285,0.00039422055,0.000026751837,0.0004605205],"genre_scores_gemma":[0.99424833,0.0034128968,0.0001324901,0.0008322685,0.001166232,0.000034885637,0.000042370182,0.00004024881,0.00009025781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973952,0.00080587197,0.0007576164,0.00031793476,0.00032762488,0.00039572205],"domain_scores_gemma":[0.9980611,0.00032609576,0.000947514,0.000098804114,0.00036296528,0.00020350855],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005666308,0.0003054566,0.00057178375,0.00013128195,0.00034217,0.00006417077,0.00030837845,0.00025795007,0.003004284],"category_scores_gemma":[0.000024279674,0.00025251549,0.00009780603,0.0002782853,0.0003141873,0.00045340916,0.000058218197,0.0011114345,0.000009203241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019406584,0.00030148888,0.010331697,0.000017016273,0.00086653116,0.0001204112,0.00072976935,0.0005520593,0.87047535,0.000012747952,0.0010952477,0.11355699],"study_design_scores_gemma":[0.009358299,0.00058598927,0.15343916,0.00008313536,0.0011769852,0.00072379014,0.00013114422,0.00082438195,0.78134465,0.000558815,0.051434387,0.0003392618],"about_ca_topic_score_codex":0.00059295713,"about_ca_topic_score_gemma":0.00017618302,"teacher_disagreement_score":0.14310747,"about_ca_system_score_codex":0.000053393233,"about_ca_system_score_gemma":0.00015850483,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W2006946795","doi":"10.1371/journal.pone.0083898","title":"A Large-Scale Allosteric Transition in Cytochrome P450 3A4 Revealed by Luminescence Resonance Energy Transfer (LRET)","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Allosteric regulation; Chemistry; Förster resonance energy transfer; Biophysics; Allosteric enzyme; Stereochemistry; Biochemistry; Enzyme; Fluorescence; Biology","score_opus":0.06415620133064288,"score_gpt":0.3189187530538429,"score_spread":0.2547625517232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006946795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98907787,0.0057108696,0.00053699577,0.0018633911,0.00012892757,0.00070203474,0.00023724201,0.0000926134,0.0016500892],"genre_scores_gemma":[0.9864432,0.004059041,0.0003613934,0.0064097038,0.00024367901,0.0005321022,0.00010402103,0.000052653686,0.0017941735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727774,0.0005000361,0.00055530627,0.0005420484,0.0003295021,0.00079538766],"domain_scores_gemma":[0.99908996,0.00012126157,0.00006266932,0.00026317945,0.0001317659,0.0003311501],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004200175,0.00033261866,0.0005265478,0.00014742842,0.0001427143,0.000028773657,0.00036064975,0.0003585842,0.003003705],"category_scores_gemma":[0.000020191206,0.00035048363,0.000103463324,0.00044670593,0.00013343565,0.00024218738,0.00004414254,0.0006212102,0.00024207693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020969381,0.003241393,0.0011799361,0.00010556567,0.00011082323,0.000024429317,0.0017606444,0.000016141881,0.9877042,0.00008119798,0.00287891,0.0026870389],"study_design_scores_gemma":[0.009372316,0.00026608672,0.019754691,0.00022105758,0.0005598522,0.000016875994,0.00020340653,0.026095321,0.86681086,0.0006165524,0.074916214,0.0011667649],"about_ca_topic_score_codex":0.00007514861,"about_ca_topic_score_gemma":0.00005980305,"teacher_disagreement_score":0.12089337,"about_ca_system_score_codex":0.000059621594,"about_ca_system_score_gemma":0.000053210333,"threshold_uncertainty_score":0.99989474},"labels":[],"label_agreement":null},{"id":"W2007404873","doi":"10.1177/0269881110370504","title":"<i>CYP2D6</i> genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype–phenotype association study design in translational pharmacogenetics","year":2010,"lang":"en","type":"article","venue":"Journal of Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Fluvoxamine; CYP2D6; Pharmacology; Pharmacogenetics; Genotype; Serotonin reuptake inhibitor; Psychology; Reuptake inhibitor; Internal medicine; Antidepressant; Medicine; Cytochrome P450; Serotonin; Psychiatry; Fluoxetine; Anxiety; Biology; Genetics; Metabolism","score_opus":0.04800565763787678,"score_gpt":0.4051272772895266,"score_spread":0.3571216196516498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007404873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989228,0.001792358,0.00027589503,0.00096574915,0.0056578927,0.0018790357,0.0000922722,0.000016919337,0.000091854265],"genre_scores_gemma":[0.9947761,0.001481162,0.00136425,0.0015522401,0.0006288584,0.0000935573,0.00001457036,0.000051645005,0.00003760784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955807,0.0012141861,0.0015818217,0.0004679768,0.00043207657,0.0007232847],"domain_scores_gemma":[0.9963485,0.0013007751,0.0011191443,0.00013546707,0.0007660209,0.00033010574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037659353,0.00040026946,0.00066737423,0.0005832449,0.00018351022,0.00004330352,0.0004256574,0.0004208856,0.00020052781],"category_scores_gemma":[0.0002703098,0.00041077167,0.00012660219,0.0006738298,0.00011333129,0.00032249896,0.000043831296,0.0018859316,0.000006953925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063354773,0.003671046,0.53685206,0.00006709217,0.0004898495,0.000047967416,0.007880249,0.022954497,0.40295148,0.000048921174,0.00096848654,0.017732862],"study_design_scores_gemma":[0.06534582,0.001552801,0.8976829,0.000020668478,0.0012709707,0.000031890937,0.00036640628,0.008588353,0.011079943,0.0017552135,0.011416185,0.0008888356],"about_ca_topic_score_codex":0.000025208361,"about_ca_topic_score_gemma":0.00013795293,"teacher_disagreement_score":0.39187154,"about_ca_system_score_codex":0.00015004222,"about_ca_system_score_gemma":0.00031420775,"threshold_uncertainty_score":0.9998344},"labels":[],"label_agreement":null},{"id":"W2007411634","doi":"10.1016/s0958-1669(00)00142-7","title":"Enzymatic hydroxylation reactions","year":2000,"lang":"en","type":"review","venue":"Current Opinion in Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Hydroxylation; Regioselectivity; Stereoselectivity; Enzyme; Chemistry; Cytochrome P450; Substrate (aquarium); Context (archaeology); Biocatalysis; Stereochemistry; Biochemistry; Biology; Catalysis; Reaction mechanism","score_opus":0.33006365873134347,"score_gpt":0.5400877479652982,"score_spread":0.21002408923395477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007411634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019832896,0.97901523,0.000050835726,0.0002421694,0.017789306,0.0012260749,0.000177668,0.00028747958,0.0011913764],"genre_scores_gemma":[0.000027425354,0.9977162,0.00007133133,0.000034478187,0.0009420567,0.00046695973,0.0004964853,0.00007352778,0.0001715309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607825,0.0008267673,0.0014156385,0.00077769347,0.00017860098,0.0007230186],"domain_scores_gemma":[0.9982835,0.0003491442,0.0005604981,0.0005943764,0.00003210208,0.00018037831],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0006771069,0.0006518318,0.0015466079,0.0014637455,0.00017084324,0.000021002712,0.00076387567,0.0024084975,0.0015744161],"category_scores_gemma":[0.00010274143,0.000624911,0.00040570967,0.0012248353,0.00030422377,0.00007826856,0.00018690138,0.0037076203,0.0015510261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000105960835,0.00031807355,0.000003685916,0.006074545,0.00008456096,0.000002495684,0.000032216674,0.000029286213,0.0000102151735,0.002860723,0.0033134853,0.9872601],"study_design_scores_gemma":[0.00058586313,0.000028861934,0.0000018331784,0.002930942,0.00031743804,0.000070632814,0.0000051566803,0.00038097196,0.000045225832,0.0010126058,0.99407065,0.0005498314],"about_ca_topic_score_codex":0.00000635368,"about_ca_topic_score_gemma":0.0000011965058,"teacher_disagreement_score":0.99075717,"about_ca_system_score_codex":0.00020603753,"about_ca_system_score_gemma":0.00026567007,"threshold_uncertainty_score":0.9996202},"labels":[],"label_agreement":null},{"id":"W2007600177","doi":"10.1016/s0300-483x(02)00292-5","title":"Genetically-engineered bacteria expressing human enzymes and their use in the study of mutagens and mutagenesis","year":2002,"lang":"en","type":"review","venue":"Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Mutagenesis; Biotransformation; Enzyme; Mutagen; Biology; Xenobiotic; Biochemistry; Bacteria; Function (biology); Metabolite; Carcinogen; Computational biology; Chemistry; Genetics; Mutation; Gene","score_opus":0.27410794615285267,"score_gpt":0.45363944452622457,"score_spread":0.1795314983733719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007600177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32749686,0.67049646,0.000004072876,0.000021448928,0.00033141134,0.0013936879,0.00011275606,0.000022040353,0.00012126274],"genre_scores_gemma":[0.13481764,0.8641211,0.00008574368,0.00023511676,0.00024576313,0.00028011738,0.00002458599,0.000069193535,0.00012077917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99414366,0.003331923,0.0010818589,0.0006938887,0.0001342478,0.0006144399],"domain_scores_gemma":[0.99709016,0.0017765685,0.0004042614,0.0004760378,0.00005047655,0.00020250681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010984329,0.000693372,0.0020034458,0.00041449073,0.00024271428,0.00006214508,0.0005835049,0.0008292927,0.00045834773],"category_scores_gemma":[0.000089778274,0.0004783717,0.00017264673,0.00032568947,0.00043402423,0.00006795564,0.00035547442,0.0011796518,0.000006838364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044138058,0.0016268449,0.00036415228,0.0023055677,0.0007991526,0.00017247541,0.007379174,0.00002205243,0.009206447,0.0002383913,0.00033195727,0.9775097],"study_design_scores_gemma":[0.0020050611,0.00044047396,0.0011312107,0.00022676616,0.0018838574,0.00019159481,0.0005962257,0.00012944307,0.0005812564,0.000043216744,0.9921687,0.0006021744],"about_ca_topic_score_codex":0.000024085239,"about_ca_topic_score_gemma":0.00005677445,"teacher_disagreement_score":0.9918368,"about_ca_system_score_codex":0.000028340117,"about_ca_system_score_gemma":0.000055456265,"threshold_uncertainty_score":0.99976677},"labels":[],"label_agreement":null},{"id":"W2007657277","doi":"10.1074/jbc.275.12.8895","title":"Identification and Functional Characterization of a Conserved, Nuclear Factor 1-like Element in the Proximal Promoter Region ofCYP1A2 Gene Specifically Expressed in the Liver and Olfactory Mucosa","year":2000,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; National Institute on Deafness and Other Communication Disorders; University of Illinois at Urbana-Champaign; National Institutes of Health; National Institute of Environmental Health Sciences; University of Illinois at Chicago","keywords":"Gene; Identification (biology); Biology; Olfactory mucosa; Computational biology; Promoter; Genetics; Molecular biology; Olfactory system; Gene expression; Neuroscience","score_opus":0.1284334063191823,"score_gpt":0.32703745739549883,"score_spread":0.19860405107631654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007657277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981262,0.0005480884,0.000017144654,0.00092368835,0.00006489306,0.0002169814,0.00003503365,0.000002818223,0.000065124565],"genre_scores_gemma":[0.99575484,0.0033369306,0.000026781909,0.0006526108,0.00017169044,0.000008869092,0.000014570927,0.0000044948324,0.000029225826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986697,0.00038918748,0.00049663224,0.00015163093,0.00015132071,0.0001415675],"domain_scores_gemma":[0.99937224,0.00014975283,0.00027381314,0.000086356304,0.00006278969,0.00005502622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007906401,0.00011653698,0.00018388042,0.000029763567,0.00005820877,0.000023110073,0.00018008525,0.00017847237,0.0005299496],"category_scores_gemma":[0.000036842932,0.00006609901,0.00005124979,0.00008392917,0.00019007755,0.00006480863,0.000024890121,0.0004847385,0.000001306939],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062255154,0.00038019937,0.006921993,0.000030845244,0.000023275008,0.000034622542,0.00090428744,0.0000048324714,0.9833492,0.000010380819,0.00007673204,0.007641086],"study_design_scores_gemma":[0.0022047292,0.0001376226,0.59088653,0.000023294297,0.000056862606,0.00028503308,0.00024329829,0.000588116,0.37298656,0.00015513852,0.032276995,0.00015583032],"about_ca_topic_score_codex":0.0000010851658,"about_ca_topic_score_gemma":2.5146383e-7,"teacher_disagreement_score":0.61036265,"about_ca_system_score_codex":0.000016006577,"about_ca_system_score_gemma":0.000024862995,"threshold_uncertainty_score":0.58025765},"labels":[],"label_agreement":null},{"id":"W2008263103","doi":"10.1097/fpc.0000000000000008","title":"Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Exon; UGT2B7; Biology; Promoter; Alternative splicing; Glucuronidation; Molecular biology; Kidney; Gene expression; Gene; Genetics; Enzyme; Biochemistry","score_opus":0.05437189203628639,"score_gpt":0.40985482682499225,"score_spread":0.35548293478870585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008263103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889277,0.008384491,0.0001121401,0.0003888819,0.00033131812,0.0009165609,0.00018831628,0.000019724604,0.00073087064],"genre_scores_gemma":[0.9870379,0.010024548,0.0010071297,0.001355857,0.00019815059,0.00007217128,0.000028520351,0.00005218276,0.0002235605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978778,0.0002457066,0.0006263228,0.0005546183,0.00017267482,0.0005229233],"domain_scores_gemma":[0.9989276,0.00011275069,0.00029322665,0.00018084345,0.00010228299,0.000383288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030382536,0.00037783437,0.00047690378,0.00019587786,0.00020122735,0.00004660199,0.00030824807,0.00017128173,0.00045308925],"category_scores_gemma":[0.000009971868,0.0003826471,0.00006395113,0.00014189545,0.0003180828,0.00011680768,0.00039259891,0.00047901255,0.000010689254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046394875,0.00018681721,0.0118020335,0.000067143956,0.00009713447,0.000009263389,0.0047500837,0.0005341709,0.9533579,0.00007478247,0.00077725714,0.02829706],"study_design_scores_gemma":[0.0037786618,0.000105644904,0.0018096905,0.000029711355,0.0001473481,0.000012599726,0.00022575883,0.018556617,0.95610934,0.0018279703,0.016965557,0.00043109964],"about_ca_topic_score_codex":0.00012204012,"about_ca_topic_score_gemma":0.0000055258265,"teacher_disagreement_score":0.02786596,"about_ca_system_score_codex":0.000031259307,"about_ca_system_score_gemma":0.000039150364,"threshold_uncertainty_score":0.99986255},"labels":[],"label_agreement":null},{"id":"W2008423993","doi":"10.1177/0091270003261078","title":"Effects of St. John's Wort (<i>Hypericum perforatum</i>) on Tacrolimus Pharmacokinetics in Healthy Volunteers","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Pharmacokinetics; Hypericum perforatum; Tacrolimus; Pharmacology; CYP3A; Volume of distribution; Medicine; Pharmacokinetic interaction; Oral administration; Dosing; Drug interaction; Chemistry; Transplantation; Metabolism; Internal medicine; Cytochrome P450","score_opus":0.09962250996604795,"score_gpt":0.4859302468162513,"score_spread":0.38630773685020336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008423993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96792626,0.0077083693,0.00008217316,0.0023318504,0.01842721,0.0008276531,0.000029346795,0.000020651561,0.002646497],"genre_scores_gemma":[0.9563897,0.022112042,0.00019699444,0.019234253,0.001785718,0.000020818467,0.0000019953927,0.00006245154,0.00019597675],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98722976,0.0075961733,0.003208016,0.00038896877,0.0005833754,0.0009937291],"domain_scores_gemma":[0.9887505,0.007982261,0.0017544997,0.00028437443,0.00048725883,0.0007411151],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010565989,0.00050940615,0.0016184363,0.000439139,0.00019094156,0.00001116156,0.0011417877,0.00056687446,0.0012670975],"category_scores_gemma":[0.001187901,0.000369657,0.0005689119,0.0007719733,0.00085755694,0.00013123927,0.00013363353,0.004480775,0.000065606735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07968273,0.021269156,0.04709026,0.0009936339,0.0045365496,0.0019805296,0.0029039506,0.05265424,0.49373904,0.0018336778,0.22834696,0.06496928],"study_design_scores_gemma":[0.037993655,0.0049438896,0.013688426,0.00008119456,0.002659868,0.00030815657,0.00020075336,0.00290845,0.23080823,0.00088850566,0.70481694,0.000701944],"about_ca_topic_score_codex":0.000009477145,"about_ca_topic_score_gemma":0.0000046595715,"teacher_disagreement_score":0.47646996,"about_ca_system_score_codex":0.00009048108,"about_ca_system_score_gemma":0.00068322255,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W2008616614","doi":"10.2165/00003088-200342150-00004","title":"Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stereoselectivity; Chemistry; Pharmacology; Pharmacokinetics; Enantiomer; Primaquine; Mefloquine; Plasmodium falciparum; Chloroquine; Stereochemistry; Medicine; Biochemistry; Malaria","score_opus":0.2544438096591189,"score_gpt":0.5451954329062285,"score_spread":0.2907516232471096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008616614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007128352,0.9714599,0.000025604131,0.00036379322,0.010881707,0.0039312313,0.000802272,0.00005956021,0.0053475657],"genre_scores_gemma":[0.008552659,0.9845306,0.00015062682,0.0039148866,0.0018504825,0.00020120003,0.00006184904,0.00019538288,0.0005422991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9816342,0.010628044,0.003994854,0.0014057964,0.0009256698,0.0014114629],"domain_scores_gemma":[0.99113166,0.0048386236,0.0021052342,0.0011396908,0.00025154126,0.000533253],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0076345997,0.0014977913,0.0035585747,0.00037922166,0.00041062618,0.00009626475,0.0030791005,0.00149407,0.00043723703],"category_scores_gemma":[0.0004862931,0.0009575601,0.0017177331,0.0019181181,0.002005239,0.00013164866,0.0009662195,0.008034522,0.000044121494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002194836,0.0020374632,0.00074730493,0.004466463,0.0010419434,0.000058746464,0.0004489559,0.000095392454,0.00011594409,0.00067077024,0.008023738,0.9820738],"study_design_scores_gemma":[0.0051144124,0.00012226263,0.00017622081,0.00060156424,0.007425477,0.00012262903,0.000034379173,0.0017271863,0.00018868363,0.00038704582,0.9831204,0.0009797289],"about_ca_topic_score_codex":0.000010297154,"about_ca_topic_score_gemma":0.0000045473266,"teacher_disagreement_score":0.98109406,"about_ca_system_score_codex":0.000103639715,"about_ca_system_score_gemma":0.0007451358,"threshold_uncertainty_score":0.9998022},"labels":[],"label_agreement":null},{"id":"W2008730180","doi":"10.1080/00498250400015301","title":"Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone","year":2004,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; AstraZeneca (Canada); Université de Montréal","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec","keywords":"CYP3A4; Domperidone; Cytochrome P450; Metabolite; Chemistry; Microsome; Enzyme; Metabolism; Biochemistry; Drug metabolism; Pharmacology; Biology; Endocrinology; Dopamine","score_opus":0.06427480296366353,"score_gpt":0.3887474671002587,"score_spread":0.32447266413659515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008730180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911588,0.0036733467,0.000054602788,0.0025020444,0.0006631459,0.00057916914,0.000086006716,0.000013912515,0.0012690005],"genre_scores_gemma":[0.99812484,0.00044899702,0.00007308345,0.0010953448,0.0001426128,0.00002502475,0.000005646743,0.000014910373,0.00006954284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980321,0.00053210644,0.0006550001,0.00021796025,0.00027384868,0.00028897088],"domain_scores_gemma":[0.998855,0.00022146638,0.00030769268,0.00044143395,0.000113278584,0.00006113816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013038949,0.00017033776,0.00031438505,0.0001055639,0.000121776065,0.000011577957,0.00080079545,0.00018365296,0.00014857449],"category_scores_gemma":[0.00013064028,0.00010667667,0.00015802418,0.0005638877,0.00049001956,0.00006190094,0.00011433709,0.0005070727,0.00002381527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007609148,0.0004680754,0.00047568404,0.00004771023,0.00007664071,0.0000027175288,0.0025025029,0.001324468,0.96511304,0.029110113,0.00017618098,0.0006267661],"study_design_scores_gemma":[0.0018646924,0.00002086405,0.06922872,0.000015577927,0.00022527076,0.0000062999075,0.0002731215,0.00014916835,0.9097669,0.004319532,0.014004959,0.00012489574],"about_ca_topic_score_codex":0.000045388602,"about_ca_topic_score_gemma":0.000024446195,"teacher_disagreement_score":0.068753034,"about_ca_system_score_codex":0.000023423632,"about_ca_system_score_gemma":0.0001349377,"threshold_uncertainty_score":0.43501484},"labels":[],"label_agreement":null},{"id":"W2008837673","doi":"10.1016/j.bcp.2014.09.005","title":"Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole","year":2014,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; Institute of Aging; Universidad de Extremadura; Federación Española de Enfermedades Raras","keywords":"Metamizole; CYP2C19; Metabolite; Pharmacogenetics; Phenacetin; Allele; Biology; Pharmacology; Genotype; Genetics; Analgesic; Endocrinology; Gene","score_opus":0.08188882132745803,"score_gpt":0.3732399314390883,"score_spread":0.2913511101116303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008837673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639068,0.030263469,0.00021296517,0.001031987,0.0015166134,0.00045756495,0.000087450695,0.000051322833,0.0024718198],"genre_scores_gemma":[0.9907535,0.002050431,0.00038287614,0.0055469424,0.0008063207,0.00011012771,0.000024074418,0.00003277018,0.00029300922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976891,0.0006107493,0.00048774807,0.0004885268,0.00020180376,0.0005220307],"domain_scores_gemma":[0.9984165,0.0007003984,0.00021191195,0.00018690542,0.00012383325,0.00036047908],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009416626,0.00032858594,0.00050124864,0.00012816479,0.00023239708,0.000013843945,0.00026970153,0.00032126703,0.0015714127],"category_scores_gemma":[0.00009436762,0.0002459619,0.000113949856,0.00021136281,0.0010272948,0.000067641646,0.00033125505,0.00065802765,0.000030798677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003312573,0.0001972511,0.0007805205,0.000041405885,0.00035422723,0.0000037127852,0.00016366929,0.000019207106,0.95432466,0.002834229,0.031628117,0.009321709],"study_design_scores_gemma":[0.0028321473,0.000057808717,0.007806358,0.0000021815358,0.00080958166,0.00008841053,0.000023104407,0.006076093,0.7463882,0.00087429176,0.23477793,0.0002639125],"about_ca_topic_score_codex":0.0000092087175,"about_ca_topic_score_gemma":2.2607954e-7,"teacher_disagreement_score":0.2079365,"about_ca_system_score_codex":0.000011579859,"about_ca_system_score_gemma":0.00006438618,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W2009145411","doi":"10.1080/10256010208033314","title":"[<sup>13</sup>C]Aminopyrine and [<sup>13</sup>C]Caffeine Breath Test: Influence of Gender, Cigarette Smoking and Oral Contraceptives Intake","year":2002,"lang":"en","type":"article","venue":"Isotopes in Environmental and Health Studies","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Breath test; Medicine; Caffeine; CYP1A2; Cigarette smoking; Physiology; Oral dose; Internal medicine; Cytochrome P450; Oral administration; Metabolism","score_opus":0.10628741146972744,"score_gpt":0.39087320827697264,"score_spread":0.2845857968072452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009145411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8831454,0.1142442,0.0000026431862,0.0013683225,0.0000762449,0.000634211,0.0002531544,0.000024736713,0.00025109132],"genre_scores_gemma":[0.8417842,0.1545685,0.0001268505,0.003082118,0.00010995106,0.00007036856,0.000010627063,0.000025803314,0.00022159281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974409,0.0002832884,0.00074319384,0.0006177604,0.00023363502,0.0006812379],"domain_scores_gemma":[0.998788,0.0004486244,0.00024674664,0.00017004064,0.000019370515,0.00032720334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076608645,0.00045798343,0.00086066185,0.00015977377,0.00039197292,0.000019103216,0.00015902004,0.00019238185,0.00019185262],"category_scores_gemma":[0.000047864854,0.00041311744,0.000053307278,0.000113053095,0.0013081898,0.00019043883,0.00046215628,0.000650384,0.0000056109047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001633581,0.0007935145,0.8650618,0.0005398258,0.0005115016,0.00006401387,0.02523363,0.0027799422,0.0032704726,0.00011580511,0.0008447291,0.100621395],"study_design_scores_gemma":[0.008178434,0.000802933,0.9317735,0.00015440765,0.0003708738,0.00013691932,0.0067982823,0.01613467,0.0016500682,0.0005596191,0.032637764,0.0008025265],"about_ca_topic_score_codex":0.00009033585,"about_ca_topic_score_gemma":0.000032888496,"teacher_disagreement_score":0.09981886,"about_ca_system_score_codex":0.00008158133,"about_ca_system_score_gemma":0.000015357613,"threshold_uncertainty_score":0.9998321},"labels":[],"label_agreement":null},{"id":"W2009236753","doi":"10.1177/00912700222011418","title":"Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Midazolam; Reproducibility; Mean squared error; CYP3A; Sampling (signal processing); Linear regression; Pharmacokinetics; Mathematics; Statistics; Medicine; Anesthesia; Pharmacology; Internal medicine; Computer science","score_opus":0.17446470495559757,"score_gpt":0.48976398802201493,"score_spread":0.31529928306641736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009236753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97415966,0.0014323831,0.008176035,0.009089692,0.0035437678,0.0020780356,0.000043880507,0.000044620043,0.001431929],"genre_scores_gemma":[0.9827401,0.0018242694,0.0014861642,0.012033715,0.0017288546,0.00005825935,0.0000013480275,0.000038742335,0.00008854621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931392,0.0030261949,0.0025333536,0.0003239664,0.00038088998,0.0005963799],"domain_scores_gemma":[0.9947375,0.002672703,0.0012971296,0.00033997142,0.00049274525,0.00045993514],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008267464,0.00030997721,0.00085885805,0.00028089515,0.00018760828,0.000012957507,0.0015252626,0.00042766082,0.0004751277],"category_scores_gemma":[0.00082425354,0.00020272868,0.00030702306,0.00086534384,0.0003008307,0.00010419782,0.00034340643,0.0024573195,0.000042928867],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006333851,0.0031616653,0.017363897,0.00014052962,0.0007200886,0.000027352718,0.0032136282,0.031287357,0.41752282,0.0003151491,0.019278731,0.5006349],"study_design_scores_gemma":[0.015040762,0.0031944935,0.062192187,0.000434005,0.0025959117,0.0002582813,0.00043177302,0.055252112,0.29530948,0.0034555518,0.56067395,0.0011614988],"about_ca_topic_score_codex":0.000021374984,"about_ca_topic_score_gemma":0.000020203564,"teacher_disagreement_score":0.5413952,"about_ca_system_score_codex":0.00007765539,"about_ca_system_score_gemma":0.00017221525,"threshold_uncertainty_score":0.9998441},"labels":[],"label_agreement":null},{"id":"W2009830490","doi":"10.2165/00002018-200124020-00001","title":"What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Canada Research Chairs; University of Toronto","funders":"","keywords":"Pharmacogenetics; Medicine; Drug; Drug development; Pharmacology; Precision medicine; Bioinformatics; Computational biology; Intensive care medicine; Genetics; Gene; Biology; Genotype","score_opus":0.09356849628257248,"score_gpt":0.4601029387777244,"score_spread":0.36653444249515194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009830490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003955954,0.9864924,0.000009461357,0.00034384232,0.0033748045,0.0027469194,0.00033854495,0.000054105523,0.0026839846],"genre_scores_gemma":[0.0016956032,0.99520296,0.00018536617,0.0009441351,0.00068909995,0.00014033397,0.00016296252,0.00015639633,0.0008231671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99023736,0.0048334575,0.002209375,0.0010187379,0.00060592394,0.0010951703],"domain_scores_gemma":[0.9929321,0.004538058,0.0012403715,0.0006787154,0.00017640305,0.00043437834],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005423076,0.0011155054,0.0026371886,0.00040744437,0.00048091737,0.000059306658,0.0010693981,0.0006497306,0.00058998924],"category_scores_gemma":[0.00025093742,0.0008787229,0.000712628,0.0010190626,0.0005786258,0.00032278037,0.00067980506,0.0024795209,0.0000339717],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026547344,0.00029451595,0.00010729844,0.0039751246,0.0005927348,0.000047653975,0.002647899,0.00049451174,0.0002617982,0.00014422149,0.00020476739,0.990964],"study_design_scores_gemma":[0.0026723207,0.00002981932,0.000047491078,0.0029051756,0.003736619,0.000072568015,0.00070813415,0.0026174411,0.0010473226,0.00021832621,0.98511934,0.0008254206],"about_ca_topic_score_codex":0.00004516687,"about_ca_topic_score_gemma":0.000028918803,"teacher_disagreement_score":0.9901386,"about_ca_system_score_codex":0.00019539241,"about_ca_system_score_gemma":0.00048559296,"threshold_uncertainty_score":0.9998218},"labels":[],"label_agreement":null},{"id":"W2010082382","doi":"10.1139/cjc-2012-0537","title":"Modification of the anticancer drug tamoxifen to avoid CYP2D6 polymorphism","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Göteborgs Universitet","keywords":"Prodrug; Chemistry; CYP2D6; Tamoxifen; Drug; CYP3A; Adduct; Stereochemistry; Pharmacology; Cytochrome P450; Breast cancer; Combinatorial chemistry; Biochemistry; Enzyme; Cancer; Genetics; Organic chemistry","score_opus":0.05366901459742366,"score_gpt":0.354078313607545,"score_spread":0.3004092990101213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010082382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985136,0.0017211437,0.000021692531,0.006239164,0.0009926927,0.00015751913,0.00006156358,0.0000030778106,0.005667203],"genre_scores_gemma":[0.99545324,0.00007773233,0.000084309875,0.0022180509,0.0004663533,0.000008255984,0.000001635878,0.000015332094,0.0016750993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988942,0.000090390764,0.00042336964,0.00011506236,0.00015795,0.00031902106],"domain_scores_gemma":[0.99819195,0.000064440435,0.00030490212,0.00020719481,0.00033922557,0.00089230377],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036196742,0.00013170262,0.0002147844,0.00006430844,0.00012929417,0.00001996882,0.00060440414,0.00012824233,0.003025545],"category_scores_gemma":[0.00012115037,0.00010433412,0.00013296663,0.00020363911,0.00018365453,0.00006804631,0.000027487627,0.0005333503,0.000041277694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020155767,0.000033380893,0.0072874073,0.000039514412,0.00009660048,0.000009617305,0.0011359524,0.0007527447,0.9472537,0.000039593575,0.03825157,0.0050797393],"study_design_scores_gemma":[0.00056469283,0.000007353786,0.00907529,0.000030508034,0.00008841932,0.000054805056,0.00012997228,0.00021686334,0.89552003,0.00058572803,0.093588285,0.00013807477],"about_ca_topic_score_codex":0.0008996206,"about_ca_topic_score_gemma":0.00013729678,"teacher_disagreement_score":0.055336714,"about_ca_system_score_codex":0.0000877017,"about_ca_system_score_gemma":0.0009733226,"threshold_uncertainty_score":0.9978858},"labels":[],"label_agreement":null},{"id":"W2010152279","doi":"10.1002/jps.23090","title":"Advancing Prediction of Tissue Distribution and Volume of Distribution of Highly Lipophilic Compounds from a Simplified Tissue-Composition-Based Model as a Mechanistic Animal Alternative Method","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lipophilicity; Partition coefficient; Physiologically based pharmacokinetic modelling; Chemistry; Distribution (mathematics); Octanol; Volume of distribution; Volume (thermodynamics); Chromatography; Distribution Volume; Composition (language); Pharmacokinetics; Biological system; Thermodynamics; Stereochemistry; Pharmacology; Mathematics","score_opus":0.08519529832141709,"score_gpt":0.45123076288169545,"score_spread":0.36603546456027836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010152279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86047596,0.0019449185,0.13422994,0.00050846883,0.00067708036,0.00025766785,0.0018092582,0.00001024715,0.00008648599],"genre_scores_gemma":[0.99478865,0.0003734153,0.0042870953,0.00013293183,0.00032858085,0.000005819196,0.00006683374,0.0000102238655,0.0000064707965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99695367,0.00065593974,0.0010718639,0.00023463584,0.0006487984,0.00043509805],"domain_scores_gemma":[0.99707144,0.0008371853,0.0010624259,0.00009337388,0.0004713217,0.00046427225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002773732,0.0002270235,0.0006054823,0.00013102998,0.00023294236,0.000019732217,0.00033915,0.00017307063,0.00021029961],"category_scores_gemma":[0.0002383102,0.00019641568,0.00012745503,0.000420462,0.00065722957,0.00036724753,0.000092486436,0.0004828057,0.0000021027652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089949596,0.0007677813,0.0025557554,0.00009367151,0.00014636562,0.000003987703,0.00030498338,0.0136324745,0.97194475,0.002521104,0.00018224526,0.006947371],"study_design_scores_gemma":[0.0014950299,0.00059134443,0.0022134448,0.00004922261,0.0006026575,0.000028511546,0.00006153877,0.2985686,0.6913369,0.0026338664,0.0022986312,0.000120219156],"about_ca_topic_score_codex":0.00006879972,"about_ca_topic_score_gemma":0.0000013141394,"teacher_disagreement_score":0.28493613,"about_ca_system_score_codex":0.0000905315,"about_ca_system_score_gemma":0.00020693365,"threshold_uncertainty_score":0.8009599},"labels":[],"label_agreement":null},{"id":"W2010642193","doi":"10.1159/000139121","title":"Effect of Acute and Chronic Moderate Hypoxia on Diltiazem Kinetics and Metabolism in the Dog","year":2008,"lang":"en","type":"article","venue":"Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Diltiazem; Hypoxia (environmental); Metabolite; Chemistry; Medicine; Internal medicine; Pharmacology; Anesthesia; Endocrinology; Oxygen; Calcium","score_opus":0.05352348994147575,"score_gpt":0.40642327329426214,"score_spread":0.3528997833527864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010642193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841093,0.010844973,0.000015930324,0.0011803478,0.0012648349,0.0008702679,0.00008904936,0.00003311415,0.0015921965],"genre_scores_gemma":[0.9786167,0.017021678,0.000048419643,0.0035306439,0.00045473973,0.00016077119,0.000011199393,0.000034515262,0.00012129445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962442,0.0019329737,0.00049384043,0.00048157008,0.00021088267,0.00063653523],"domain_scores_gemma":[0.9980256,0.0013096023,0.000186363,0.00020260374,0.0000546765,0.00022116648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012212013,0.00041027227,0.0006756784,0.00024381206,0.00023764113,0.000011829375,0.000388638,0.00028490642,0.00027294955],"category_scores_gemma":[0.000031464802,0.00029794365,0.000096390315,0.00029931444,0.00076046574,0.00008150717,0.00017825217,0.00101836,0.000022189195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018613315,0.0005419974,0.0020621435,0.0001353384,0.00063307735,0.00034907056,0.0019516936,0.0006927933,0.95976174,0.0008353069,0.0033269885,0.02784853],"study_design_scores_gemma":[0.012778989,0.0012206453,0.016582817,0.000010138479,0.0016265082,0.0004421836,0.000017948805,0.012180261,0.8827078,0.00033962433,0.07163047,0.00046263234],"about_ca_topic_score_codex":0.000013137054,"about_ca_topic_score_gemma":0.000003507554,"teacher_disagreement_score":0.07705395,"about_ca_system_score_codex":0.000032645505,"about_ca_system_score_gemma":0.000062265004,"threshold_uncertainty_score":0.99994725},"labels":[],"label_agreement":null},{"id":"W2010953472","doi":"10.1124/dmd.30.12.1478","title":"Microsomal N-Glucuronidation of Nicotine and Cotinine: Human Hepatic Interindividual, Human Intertissue, and Interspecies Hepatic Variation","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Glucuronidation; Microsome; Nicotine; Cotinine; Microsoma; Chemistry; Internal medicine; Duodenum; Drug metabolism; Endocrinology; Jejunum; Metabolism; Biochemistry; Biology; Enzyme; Medicine","score_opus":0.049332615267348986,"score_gpt":0.3639251113968429,"score_spread":0.3145924961294939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010953472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885106,0.009177483,0.00016795642,0.0004136302,0.00046769716,0.00037846479,0.00012628175,0.000045689903,0.0007121767],"genre_scores_gemma":[0.9957363,0.0029350163,0.00022333776,0.00037678034,0.00022828544,0.00003335,0.00012118795,0.00002741228,0.00031834535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998144,0.00039314205,0.0005944144,0.00040920314,0.00016264594,0.00029662743],"domain_scores_gemma":[0.9991118,0.00011523503,0.00030901353,0.00015757784,0.00010235596,0.00020401886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046445944,0.00029929128,0.00045,0.00025685987,0.00034909722,0.000081921484,0.0001310732,0.00015050198,0.0004725413],"category_scores_gemma":[0.000036756708,0.00029509762,0.00005908788,0.00016314967,0.000353343,0.0003118783,0.000190125,0.00030758054,0.00000844619],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009744722,0.00042815148,0.010871466,0.00023884235,0.00017990997,0.0000040803225,0.0101236645,0.000007722503,0.9538346,0.007870404,0.00050268037,0.015841022],"study_design_scores_gemma":[0.010380826,0.00039942656,0.52190715,0.00022487556,0.0024694132,0.00011819213,0.0010639366,0.010349746,0.42674765,0.0036358763,0.021471035,0.0012318878],"about_ca_topic_score_codex":0.000096193195,"about_ca_topic_score_gemma":0.0000300462,"teacher_disagreement_score":0.527087,"about_ca_system_score_codex":0.000015142106,"about_ca_system_score_gemma":0.000006349278,"threshold_uncertainty_score":0.9999501},"labels":[],"label_agreement":null},{"id":"W2011586410","doi":"10.1067/mcp.2002.126174","title":"Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"CYP2C19; Omeprazole; Menstrual cycle; Medicine; Internal medicine; Endocrinology; Cytochrome P450; Physiology; Hormone; Metabolism","score_opus":0.18530976811129077,"score_gpt":0.5257971988813166,"score_spread":0.34048743077002586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011586410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905106,0.0014822196,0.000037632788,0.002321997,0.0014760677,0.0012575277,0.00015536397,0.00014201255,0.0026165864],"genre_scores_gemma":[0.9787159,0.0033491016,0.00006663458,0.016735619,0.0005244116,0.000115026705,0.000011327346,0.000093957664,0.00038800677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9926437,0.0041403654,0.0009356019,0.000943923,0.00040578272,0.00093063834],"domain_scores_gemma":[0.992801,0.005380222,0.0005416466,0.0004455727,0.00013145896,0.00070006814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028571002,0.0007065596,0.0012930204,0.000234713,0.0003814338,0.000025981415,0.00053369236,0.0007944289,0.0030765727],"category_scores_gemma":[0.00005361006,0.0005646751,0.000311055,0.0004243952,0.0018042497,0.00013607228,0.00020535418,0.002192624,0.00023257555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0110880295,0.005445416,0.0032746329,0.00011858022,0.0035162978,0.00021632451,0.00078010064,0.00013347522,0.7214809,0.000025349453,0.0038197732,0.25010112],"study_design_scores_gemma":[0.05729628,0.013713719,0.0033845962,0.000031610052,0.005494733,0.00015688606,0.00005615481,0.043304995,0.7198809,0.00011534025,0.15547688,0.0010879363],"about_ca_topic_score_codex":0.0000059597487,"about_ca_topic_score_gemma":0.000001473241,"teacher_disagreement_score":0.24901319,"about_ca_system_score_codex":0.0000520295,"about_ca_system_score_gemma":0.00008693167,"threshold_uncertainty_score":0.99968046},"labels":[],"label_agreement":null},{"id":"W2012012982","doi":"10.1093/chrsci/49.2.108","title":"Determination of Pharmacokinetics of Flurbiprofen in Pakistani Population Using Modified HPLC Method","year":2011,"lang":"en","type":"article","venue":"Journal of Chromatographic Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Flurbiprofen; Pharmacokinetics; Chemistry; Disposition; Pharmacology; Population; Chromatography; Medicine; Psychology","score_opus":0.20000171334017872,"score_gpt":0.4842981408414823,"score_spread":0.2842964275013036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012012982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996717,0.0006483796,0.0075861784,0.000015633666,0.0009462737,0.00018099028,0.000009384157,0.0000057148377,0.0006402941],"genre_scores_gemma":[0.96004343,0.00034272697,0.03946705,0.00006530748,0.00006522974,0.0000016384629,5.299277e-7,0.000011000862,0.000003057543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99746126,0.00037212324,0.0011421987,0.00018184134,0.00054051453,0.0003020491],"domain_scores_gemma":[0.9976231,0.00015767549,0.0013212507,0.00015149848,0.00057138834,0.00017510202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004095874,0.00015366508,0.00043342327,0.001305106,0.00008292989,0.00000833075,0.00059530523,0.00012992494,0.00012009136],"category_scores_gemma":[0.00014093152,0.00013933521,0.00015059637,0.0017673936,0.00048809955,0.00035161484,0.00007605612,0.00038721313,3.437793e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021965646,0.00036791127,0.054442838,0.00007489505,0.00003346545,0.000018453838,0.002013073,0.0012265837,0.9270971,0.0010966923,0.0000057053912,0.013403619],"study_design_scores_gemma":[0.002069456,0.0001541541,0.09866676,0.00007927064,0.00024011488,0.00011320971,0.00029217376,0.08826055,0.80586404,0.003991556,0.00009040221,0.0001783246],"about_ca_topic_score_codex":0.00010866526,"about_ca_topic_score_gemma":0.000004338084,"teacher_disagreement_score":0.12123307,"about_ca_system_score_codex":0.000035557045,"about_ca_system_score_gemma":0.00021654999,"threshold_uncertainty_score":0.56819254},"labels":[],"label_agreement":null},{"id":"W2012225071","doi":"10.2174/1389200043335531","title":"Cytochrome P450 and Liver Diseases","year":2004,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CYP2E1; Alcoholic liver disease; Cytochrome P450; Drug metabolism; Liver disease; Pharmacology; Pathogenesis; Liver injury; Steatohepatitis; Acetaminophen; Fatty liver; Metabolite; Cirrhosis; Chemistry; Biology; Biochemistry; Medicine; Immunology; Metabolism; Internal medicine; Disease; Drug","score_opus":0.17439992346561517,"score_gpt":0.48166391284223137,"score_spread":0.3072639893766162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012225071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011948631,0.98786074,0.000022314869,0.000044084463,0.007212324,0.0018295186,0.002054594,0.00023704772,0.00061990845],"genre_scores_gemma":[0.00012250553,0.9945843,0.000083522325,0.00024095815,0.0031334814,0.0005174765,0.00047411563,0.00019727484,0.00064635585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942955,0.0013806903,0.0012720745,0.0013498219,0.00048533123,0.0012165766],"domain_scores_gemma":[0.99666303,0.0004965552,0.00071263534,0.00068250485,0.00014080922,0.0013044475],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00073760684,0.0014533156,0.003357321,0.0006149612,0.0004667053,0.00012839043,0.001011779,0.00069782126,0.0012803042],"category_scores_gemma":[0.00011853446,0.0012312352,0.0010927519,0.0005686406,0.0005846284,0.00021799245,0.00069375423,0.0026842034,0.0010264384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001919446,0.0004644319,0.0000027163117,0.015000426,0.00054094853,0.00007618167,0.00022491369,0.0000059312356,0.000015035237,0.0029409477,0.004122888,0.9765864],"study_design_scores_gemma":[0.0015091746,0.000008809747,0.00007693594,0.002379765,0.011168754,0.00009454861,0.000007887263,0.00002629648,0.00002715435,0.0008201871,0.982616,0.0012644578],"about_ca_topic_score_codex":0.000012574791,"about_ca_topic_score_gemma":0.0000016895802,"teacher_disagreement_score":0.97849315,"about_ca_system_score_codex":0.00012570042,"about_ca_system_score_gemma":0.0008263306,"threshold_uncertainty_score":0.99982166},"labels":[],"label_agreement":null},{"id":"W2013199340","doi":"10.1016/j.msard.2012.11.003","title":"The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Child and Family Research Institute; University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Pharmacogenomics; Multiple sclerosis; Drug; Drug reaction; Adverse effect; Intensive care medicine; Pharmacology; Immunology","score_opus":0.0915563427425296,"score_gpt":0.3518274075304867,"score_spread":0.2602710647879571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013199340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.122495145,0.8733454,0.0000023460666,0.00011498199,0.0009045278,0.002606847,0.000205197,0.000019531319,0.0003060685],"genre_scores_gemma":[0.27620623,0.7231227,0.000030100584,0.000027519745,0.000039446608,0.00035178429,0.00007138825,0.000047775433,0.00010305249],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99504673,0.0018255076,0.0017546966,0.00052025233,0.0002667106,0.00058607454],"domain_scores_gemma":[0.99717796,0.001127867,0.0010776095,0.00039961416,0.00008128976,0.00013565089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017104872,0.00054196507,0.0011569703,0.0003633092,0.0003971875,0.000028425804,0.00070353586,0.00065978605,0.000116426614],"category_scores_gemma":[0.00012923173,0.00036279875,0.00063286425,0.0007936587,0.0005541165,0.00013086939,0.00020276864,0.0016115456,0.000020180021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013002308,0.0009078467,0.00054085656,0.00095462566,0.0005233834,0.0000015642987,0.0012733454,0.0020140873,0.0069219926,0.000053885484,0.00016890597,0.9865095],"study_design_scores_gemma":[0.008187059,0.000080651465,0.003458437,0.0021283175,0.00249693,0.0000137885945,0.0024979794,0.011117265,0.0008306225,0.00060434523,0.96777236,0.0008122111],"about_ca_topic_score_codex":0.00066960126,"about_ca_topic_score_gemma":0.00042889,"teacher_disagreement_score":0.98569727,"about_ca_system_score_codex":0.00006160136,"about_ca_system_score_gemma":0.00015319436,"threshold_uncertainty_score":0.9998824},"labels":[],"label_agreement":null},{"id":"W2013249805","doi":"10.4088/jcp.08r04856blu","title":"Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6","year":2009,"lang":"en","type":"review","venue":"The Journal of Clinical Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tamoxifen; CYP2D6; Bupropion; Venlafaxine; Antidepressant; Paroxetine; Breast cancer; Medicine; Pharmacology; Fluoxetine; Oncology; Internal medicine; Psychiatry; Cytochrome P450; Cancer; Metabolism; Receptor","score_opus":0.41565225308262443,"score_gpt":0.6227604105954995,"score_spread":0.20710815751287504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013249805","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002070023,0.98626274,0.00013179654,0.001137774,0.007607881,0.0004997902,0.000110640874,0.000020679194,0.00215868],"genre_scores_gemma":[0.0025590581,0.9849793,0.00040445616,0.0017227374,0.010007002,0.0000041741323,0.000010527611,0.000059771424,0.00025302827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912461,0.0038119364,0.0037833138,0.000326541,0.00035452997,0.0004775623],"domain_scores_gemma":[0.99131525,0.0039194766,0.0034679617,0.00043739492,0.00018653889,0.0006733913],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006604427,0.0005587859,0.0031570005,0.00025274485,0.00029295177,0.000038547736,0.0012044177,0.0008443546,0.00044107696],"category_scores_gemma":[0.00031153575,0.00034314013,0.0013052514,0.00030009693,0.00041684337,0.00014553864,0.00020763327,0.006131071,0.00011966404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016749071,0.00038974453,0.00053784373,0.0006959142,0.0016480647,0.000018530247,0.000044398872,0.0000050410126,0.000012774511,0.000027232803,0.015840441,0.9806125],"study_design_scores_gemma":[0.001406482,0.00024034597,0.0025762063,0.0013799523,0.0106878765,0.0005848629,0.000007478067,0.000015688058,0.000004298353,0.0026461354,0.9801025,0.00034821645],"about_ca_topic_score_codex":0.0000026834227,"about_ca_topic_score_gemma":0.000002031379,"teacher_disagreement_score":0.9802643,"about_ca_system_score_codex":0.000023242661,"about_ca_system_score_gemma":0.0005939174,"threshold_uncertainty_score":0.99990207},"labels":[],"label_agreement":null},{"id":"W2013380575","doi":"10.1371/journal.pone.0015666","title":"Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism","year":2010,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Microsome; Verapamil; Messenger RNA; Pharmacology; Drug metabolism; CYP2C9; Biology; Drug; Cytochrome P450; Heart failure; Internal medicine; Endocrinology; Medicine; Metabolism; Enzyme; Biochemistry; Gene; Calcium","score_opus":0.14834241397453862,"score_gpt":0.38685983842399435,"score_spread":0.23851742444945573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013380575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034375,0.005002223,0.000001527519,0.00041169082,0.0006676428,0.00056435633,0.0002934435,0.000052427687,0.002662935],"genre_scores_gemma":[0.9963788,0.001638263,0.0006359051,0.00041325018,0.00045106528,0.00007746953,0.000009074546,0.000043619737,0.00035260123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975915,0.00060820376,0.00047745268,0.00045107468,0.00033103937,0.000540733],"domain_scores_gemma":[0.998628,0.0002781815,0.00023344376,0.00036641996,0.00014969405,0.00034425626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014636888,0.00032537646,0.0009589888,0.00030101836,0.00016074552,0.000020155909,0.00035180518,0.00032862186,0.00059608195],"category_scores_gemma":[0.0001251305,0.00033130872,0.00013278295,0.00034670503,0.0003551122,0.00018236937,0.00022370872,0.0015642011,0.000024999947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082608596,0.001747205,0.02544053,0.000085878186,0.00056215905,0.0000059625427,0.00086810935,0.0000027691788,0.9615576,0.0040796767,0.0000714447,0.005496023],"study_design_scores_gemma":[0.0017405417,0.00001553866,0.15544175,0.000012460743,0.000754909,6.0404466e-7,0.000031669795,0.00024128205,0.8326175,0.0012713063,0.007582926,0.00028950896],"about_ca_topic_score_codex":0.00020196661,"about_ca_topic_score_gemma":0.00022100343,"teacher_disagreement_score":0.13000122,"about_ca_system_score_codex":0.000010307687,"about_ca_system_score_gemma":0.000082793675,"threshold_uncertainty_score":0.9999139},"labels":[],"label_agreement":null},{"id":"W2013899794","doi":"10.1016/s0149-2918(02)80102-3","title":"An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme a reductase inhibitors on health care utilization: A Canadian population-based study","year":2002,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Toronto Metropolitan University; University of Toronto; Bristol-Myers Squibb (Canada); PharmIdeas (Canada)","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Medicine; Statin; Medical prescription; Atorvastatin; Drug; Drug interaction; Health care; Pharmacology; Population; Adverse effect; Internal medicine; Environmental health","score_opus":0.19452395590427193,"score_gpt":0.5057903588286968,"score_spread":0.31126640292442487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013899794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524236,0.0011789623,0.000014271653,0.0006300478,0.0011741924,0.0012697389,0.00028314863,0.000019229623,0.00018802636],"genre_scores_gemma":[0.9982708,0.00013318678,0.000052770036,0.0012084821,0.00019606747,0.000030525956,0.00005695503,0.00002996099,0.000021240337],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944878,0.0034368297,0.0011876685,0.00031815522,0.00029690785,0.00027261474],"domain_scores_gemma":[0.99698746,0.0012912479,0.00070874,0.0005175998,0.00021629798,0.00027867814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017273113,0.00023097993,0.0005705624,0.00023459615,0.00021434757,0.0000068671875,0.00038636368,0.0001530514,0.0002678075],"category_scores_gemma":[0.00015518005,0.00018169994,0.00024125271,0.00053834217,0.00020777773,0.000056328518,0.000030002477,0.00063817005,0.0000037675134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011566731,0.007822573,0.424453,0.0004673234,0.0011871109,0.00000933613,0.0153162265,0.01912801,0.014750995,0.00026470213,0.0009593085,0.51448476],"study_design_scores_gemma":[0.010538197,0.0060638827,0.7474264,0.00017095133,0.0015266072,0.000003597696,0.0012691437,0.053139996,0.1630053,0.000091115675,0.016150767,0.0006140451],"about_ca_topic_score_codex":0.0017528684,"about_ca_topic_score_gemma":0.0033949197,"teacher_disagreement_score":0.5138707,"about_ca_system_score_codex":0.00011288065,"about_ca_system_score_gemma":0.00018650094,"threshold_uncertainty_score":0.7409509},"labels":[],"label_agreement":null},{"id":"W2014023051","doi":"10.2217/pgs.10.124","title":"Pharmacogenomic Testing for Angiotensin-Converting Enzyme Inhibitors: Getting Ready for Prime Time","year":2010,"lang":"en","type":"letter","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Pharmacogenomics; Pharmacology; Angiotensin-converting enzyme; Prime (order theory); Chemistry; Medicine; Internal medicine; Mathematics","score_opus":0.15434368504479087,"score_gpt":0.4108588781251313,"score_spread":0.25651519308034043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014023051","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1834755,0.03206879,0.0047415034,0.57856226,0.09204856,0.04622887,0.049635835,0.0046002916,0.008638369],"genre_scores_gemma":[0.0077157975,0.0006032502,0.02494101,0.845661,0.10242688,0.0027310858,0.0070317932,0.0018348368,0.007054337],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98958427,0.0007002353,0.0027462454,0.0025916956,0.0005978751,0.003779683],"domain_scores_gemma":[0.98878735,0.0055098888,0.0023444255,0.0009529295,0.0014937344,0.00091167394],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.003938993,0.0022567569,0.0022842467,0.0008152182,0.0016724927,0.00028189312,0.002146302,0.0051683057,0.0008297474],"category_scores_gemma":[0.0009243872,0.0025666698,0.0014654364,0.00051504263,0.0005161911,0.0003460392,0.0006203182,0.011384592,0.00072638696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039404866,0.00013929755,0.000043000975,0.00037584346,0.000954746,0.00009068523,0.00020544346,0.00015963704,0.511217,0.0000075252906,0.4510409,0.03537187],"study_design_scores_gemma":[0.0048997677,0.00012111872,0.0000019055866,0.000047527643,0.0028155157,0.00013028044,0.000008138094,0.033514302,0.35317972,0.00030375842,0.6031812,0.0017967824],"about_ca_topic_score_codex":0.0000368172,"about_ca_topic_score_gemma":0.0000018802104,"teacher_disagreement_score":0.26709872,"about_ca_system_score_codex":0.00049842923,"about_ca_system_score_gemma":0.0011668641,"threshold_uncertainty_score":0.9996272},"labels":[],"label_agreement":null},{"id":"W2014144507","doi":"10.1038/clpt.2011.18","title":"Pharmacogenetic Testing: Time for Clinical Practice Guidelines","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute; BC Children's Hospital","funders":"","keywords":"Pharmacogenetics; Clinical pharmacology; Clinical Practice; Drug; Medicine; Genetic testing; Drug reaction; Pharmacology; Drug response; Adverse effect; Intensive care medicine; Medical physics; Internal medicine; Family medicine; Biology; Gene; Genetics; Genotype","score_opus":0.806811082690761,"score_gpt":0.6867118532933741,"score_spread":0.12009922939738682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014144507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035179226,0.9502405,0.00027768832,0.0028462776,0.03469459,0.00639405,0.0011245146,0.0006228617,0.0037643223],"genre_scores_gemma":[7.0685e-7,0.7963672,0.016151866,0.16613255,0.01605206,0.0012162046,0.00030715295,0.000574212,0.0031980416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97381413,0.010285639,0.009687733,0.0030791613,0.00054323016,0.002590083],"domain_scores_gemma":[0.95823264,0.029840203,0.004672022,0.001327096,0.0039701564,0.0019578582],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.015881486,0.0025332845,0.007242541,0.0005369956,0.0008115683,0.000099572804,0.003709307,0.005306634,0.0031125606],"category_scores_gemma":[0.0030584875,0.0022525932,0.0044369893,0.001164474,0.0022068536,0.00026047998,0.0010517518,0.007522948,0.004515315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000664176,0.0024545297,0.000021077092,0.0013500976,0.007917409,0.00009748219,0.00003801364,0.00000704255,0.00006755299,0.000018667786,0.32812098,0.659243],"study_design_scores_gemma":[0.00617771,0.0010007395,0.0000047484323,0.0005333445,0.078379236,0.00026822838,0.000011730312,0.0013203012,0.00007812856,0.0002001856,0.909969,0.0020566897],"about_ca_topic_score_codex":0.0000027053459,"about_ca_topic_score_gemma":4.3006068e-7,"teacher_disagreement_score":0.65718627,"about_ca_system_score_codex":0.0001732188,"about_ca_system_score_gemma":0.0028306926,"threshold_uncertainty_score":0.9987403},"labels":[],"label_agreement":null},{"id":"W2014305717","doi":"10.1371/journal.pone.0061897","title":"Water Oxidation by a Cytochrome P450: Mechanism and Function of the Reaction","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; Simon Fraser University","keywords":"Chemistry; Borneol; Camphor; Hydrogen peroxide; Catalysis; Monooxygenase; Redox; Cytochrome; Catalytic cycle; Reaction mechanism; Biocatalysis; Photochemistry; Cytochrome P450; Medicinal chemistry; Organic chemistry; Enzyme","score_opus":0.08968631440100855,"score_gpt":0.3215443455690774,"score_spread":0.23185803116806886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014305717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996924,0.00028327183,0.000056585122,0.0010536009,0.00020060722,0.0005151528,0.00001702202,0.000028741088,0.0009210148],"genre_scores_gemma":[0.9974277,0.00038534563,0.00007048751,0.0009540406,0.00012014151,0.0000909527,0.000021165351,0.000014161282,0.0009160196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990904,0.00018396453,0.00020207572,0.00016505593,0.0001640538,0.00019449713],"domain_scores_gemma":[0.99954623,0.000043408505,0.00008775463,0.00013342811,0.000105005274,0.00008416642],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025165567,0.0001105856,0.00015250182,0.000043012828,0.00013635207,0.000012283536,0.00009955281,0.00014779285,0.0009988898],"category_scores_gemma":[0.000017816843,0.000073871975,0.000035296383,0.00007168173,0.00007042743,0.00012566542,0.00006839998,0.0002611106,0.00012627676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004136578,0.0004646717,0.00025238606,0.000037147205,0.0001750754,1.316989e-7,0.00017840965,0.000001530836,0.995418,0.0004090346,0.0006232529,0.0023990052],"study_design_scores_gemma":[0.00069009874,0.000050404367,0.00787397,0.0000095067735,0.0003700479,0.0000013694628,0.00002181629,0.00064319774,0.98209447,0.0047960896,0.0033537513,0.000095282834],"about_ca_topic_score_codex":0.000036774505,"about_ca_topic_score_gemma":0.0000014454113,"teacher_disagreement_score":0.013323524,"about_ca_system_score_codex":0.00001565846,"about_ca_system_score_gemma":0.000010883564,"threshold_uncertainty_score":0.99991435},"labels":[],"label_agreement":null},{"id":"W2014467774","doi":"10.1071/rd11159","title":"Ontogenesis of phase I hepatic drug metabolic enzymes in sheep","year":2011,"lang":"en","type":"article","venue":"Reproduction Fertility and Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"U.S. National Library of Medicine; Canadian Institutes of Health Research","keywords":"Biology; CYP3A4; Fetus; Endocrinology; Internal medicine; Cytochrome P450; Messenger RNA; Enzyme; Drug metabolism; CYP2A6; CYP3A; Complementary DNA; Ontogeny; Metabolism; Gene; Biochemistry; Pregnancy; Genetics; Medicine","score_opus":0.17477960085153482,"score_gpt":0.4065292542753175,"score_spread":0.23174965342378268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014467774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816527,0.015773471,0.00008879249,0.000099590885,0.0007405943,0.0003603394,0.000009305787,0.00003928496,0.001235919],"genre_scores_gemma":[0.9964125,0.001160611,0.0018437237,0.00015825243,0.00005001312,0.00006747912,0.000009136488,0.000012697387,0.00028557552],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980006,0.00033233615,0.0006613915,0.00054311985,0.00015956769,0.00030294296],"domain_scores_gemma":[0.99924785,0.000046996745,0.00015087992,0.00027718328,0.000107271946,0.00016982408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016865063,0.00020135596,0.00037592973,0.00019623709,0.00012412075,0.0000058352616,0.00013548258,0.0001117157,0.0007642552],"category_scores_gemma":[0.00009467959,0.0001929154,0.000049188242,0.00025386206,0.00015477423,0.00011162658,0.00009049203,0.00023827735,0.000024696628],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031389373,0.0050294255,0.18292955,0.00036056503,0.00042468103,0.000019524115,0.029465294,0.000063885076,0.065061495,0.00095784885,0.0002458863,0.7123029],"study_design_scores_gemma":[0.001525237,0.00001906073,0.26519316,0.000006666942,0.00005886493,0.000004316069,0.00017171876,0.00010627223,0.67265445,0.00026646408,0.05982823,0.00016558556],"about_ca_topic_score_codex":0.00012844475,"about_ca_topic_score_gemma":0.00004835038,"teacher_disagreement_score":0.71213734,"about_ca_system_score_codex":0.000029061339,"about_ca_system_score_gemma":0.00014220607,"threshold_uncertainty_score":0.8368059},"labels":[],"label_agreement":null},{"id":"W2014927292","doi":"10.1182/blood-2011-08-372722","title":"VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"VKORC1; Warfarin; CYP2C9; Pharmacogenetics; Dosing; Medicine; Vitamin K epoxide reductase; Pharmacogenomics; Maintenance dose; Cohort; Internal medicine; Pharmacology; Genotype; Biology; Atrial fibrillation; Genetics","score_opus":0.055999133099533804,"score_gpt":0.32894300954047917,"score_spread":0.27294387644094537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014927292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785155,0.00048306884,0.00001381959,0.000041988576,0.0002688214,0.00073124043,0.00011893966,0.000013578846,0.00047700084],"genre_scores_gemma":[0.99909014,0.000409109,0.00014057918,0.00023802802,0.00004353227,0.00004246146,0.000011064352,0.00001262745,0.000012463438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841017,0.00047845946,0.0004299579,0.00027364786,0.00013057514,0.00027718657],"domain_scores_gemma":[0.999351,0.000049102797,0.00022104666,0.00020368266,0.00005628544,0.00011883772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010749494,0.00015833403,0.00022554454,0.00005242539,0.00010540012,0.000006732224,0.000132691,0.00015185136,0.00014080307],"category_scores_gemma":[0.0000934949,0.00012193337,0.000037980328,0.000117555726,0.00018948743,0.00005770878,0.00023076257,0.00031976218,0.0000016704499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001351983,0.0017282413,0.95861906,0.0000387751,0.0000963966,0.0000066802936,0.0029240842,0.0000010354888,0.024078786,0.0006546342,0.000014451587,0.011702685],"study_design_scores_gemma":[0.0023664394,0.000072239134,0.92439705,0.000011659766,0.00021100309,0.000008551794,0.00002854311,0.00016157766,0.07152963,0.000526631,0.00055274257,0.00013393855],"about_ca_topic_score_codex":0.00005980744,"about_ca_topic_score_gemma":0.000023473578,"teacher_disagreement_score":0.04745084,"about_ca_system_score_codex":0.000011753084,"about_ca_system_score_gemma":0.00004166891,"threshold_uncertainty_score":0.49722987},"labels":[],"label_agreement":null},{"id":"W2016290546","doi":"10.1111/j.1365-2710.2007.00870.x","title":"Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Pharmacy and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agence Universitaire de la Francophonie","keywords":"CYP2C9; CYP2C19; Acenocoumarol; Pharmacogenetics; CYP3A5; CYP1A2; CYP3A4; Pharmacology; VKORC1; Genetics; Medicine; Gene; Biology; Cytochrome P450; Warfarin; Genotype; Biochemistry; Internal medicine; Microsome; Enzyme; In vitro","score_opus":0.31704571967649586,"score_gpt":0.5557127096929809,"score_spread":0.23866699001648506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016290546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487864,0.04550578,0.00053043885,0.0011406,0.0027492782,0.00044325585,0.00008538077,0.00002428982,0.0007346132],"genre_scores_gemma":[0.8717656,0.11905427,0.0018385297,0.005807627,0.0013330352,0.0000032205292,0.000004698158,0.00006399508,0.00012898674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99410427,0.00082445494,0.003154832,0.0005091545,0.00061287195,0.0007944001],"domain_scores_gemma":[0.99437493,0.0017621093,0.0018868884,0.0002646431,0.0005262262,0.001185227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0075979563,0.00056772446,0.0013309398,0.00034775332,0.0002879053,0.0000519153,0.0004896579,0.00043226426,0.00021876703],"category_scores_gemma":[0.00015743173,0.0004864388,0.0003424272,0.00030620585,0.0011892017,0.000295997,0.00031035073,0.0018055813,0.000005468718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059456346,0.0013652002,0.1904874,0.00012520036,0.0022075737,0.00023514808,0.0009016097,0.000045896224,0.29740462,0.00033608056,0.00032677088,0.5006189],"study_design_scores_gemma":[0.030520244,0.001144973,0.08632989,0.00008747919,0.004044688,0.0008856942,0.00017283794,0.0028202017,0.2641066,0.0032525384,0.605677,0.00095785497],"about_ca_topic_score_codex":0.000010744195,"about_ca_topic_score_gemma":0.0000029860398,"teacher_disagreement_score":0.60535026,"about_ca_system_score_codex":0.000025336032,"about_ca_system_score_gemma":0.00022181317,"threshold_uncertainty_score":0.9997587},"labels":[],"label_agreement":null},{"id":"W2016361130","doi":"10.1124/dmd.30.10.1063","title":"Metabolic Activation of 4-Hydroxyanisole by Isolated Rat Hepatocytes","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cytotoxicity; Glutathione; Chemistry; Metabolite; Biochemistry; Pharmacology; Butylated hydroxyanisole; Buthionine sulfoximine; Toxicity; Antioxidant; Biology; Enzyme; In vitro","score_opus":0.037251659351443506,"score_gpt":0.33387947819396474,"score_spread":0.2966278188425212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016361130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580802,0.036263544,0.0006560635,0.0006246795,0.000847564,0.00044059707,0.00022896909,0.00009325142,0.0027651875],"genre_scores_gemma":[0.9865407,0.010677669,0.00014977624,0.0012678589,0.00025164158,0.000057727568,0.00014520701,0.000036843037,0.0008726214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793684,0.00044848514,0.0005274468,0.00041255075,0.0002448316,0.0004298172],"domain_scores_gemma":[0.9989342,0.00014811671,0.00027113597,0.00022145912,0.00012821317,0.00029685296],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042140324,0.00033061905,0.0005179079,0.00018395905,0.00027991107,0.000036342048,0.0002001493,0.00023482232,0.0012929462],"category_scores_gemma":[0.000034906705,0.0003152079,0.00013477057,0.00034757773,0.00019866029,0.0003774811,0.000078939884,0.00038358202,0.000073616255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000240763,0.00065670855,0.0011326667,0.00005631932,0.00019442709,0.0000034398358,0.0015436294,0.00010415011,0.92743385,0.0052866335,0.011984731,0.05136266],"study_design_scores_gemma":[0.0024386765,0.00002806592,0.0014869968,0.000012879883,0.000497766,0.000011079172,0.0000814559,0.019882409,0.7181758,0.00069851906,0.25631887,0.00036747303],"about_ca_topic_score_codex":0.000059822567,"about_ca_topic_score_gemma":0.0000015236576,"teacher_disagreement_score":0.24433413,"about_ca_system_score_codex":0.000011342879,"about_ca_system_score_gemma":0.000014589904,"threshold_uncertainty_score":0.99993},"labels":[],"label_agreement":null},{"id":"W2016448468","doi":"10.1007/s00204-014-1218-6","title":"Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic","year":2014,"lang":"en","type":"article","venue":"Archives of Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval","keywords":"Monooxygenase; Ex vivo; Esterase; Cytochrome P450; Human skin; Chemistry; Glutathione; Isozyme; Enzyme; In vivo; Xenobiotic; Biochemistry; Pharmacology; In vitro; Biology; Genetics","score_opus":0.10955456522387487,"score_gpt":0.4296709575214729,"score_spread":0.32011639229759803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016448468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634404,0.0025009685,0.00043155858,0.00014371998,0.00048591793,0.00038038986,0.00014009891,0.00003404195,0.009539278],"genre_scores_gemma":[0.99694383,0.0003923358,0.0019788882,0.00031029954,0.00019076206,0.000023985167,0.00003364675,0.00004004368,0.00008623249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995912,0.0017156007,0.00106975,0.0005491898,0.00016129574,0.00059216074],"domain_scores_gemma":[0.9972148,0.0016021292,0.0005907383,0.0003374725,0.000038033864,0.00021685303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006426301,0.00037696265,0.0012586275,0.0005630473,0.00018524477,0.000012562678,0.00051374163,0.00041424282,0.00040018593],"category_scores_gemma":[0.00007722976,0.00039917385,0.00016323489,0.00018234868,0.0013116891,0.00012613731,0.0003262127,0.0010000662,0.0000027947265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023043131,0.00063392526,0.017183766,0.0000953015,0.00026935505,0.000004027299,0.006623716,0.0025562951,0.9307616,0.021702869,0.00007768363,0.019861061],"study_design_scores_gemma":[0.0040124254,0.0003015933,0.034899298,0.000048589303,0.0002623754,0.000008659257,0.0005579123,0.028398028,0.87502986,0.05276886,0.0032893901,0.00042301722],"about_ca_topic_score_codex":0.0002520926,"about_ca_topic_score_gemma":0.00048151703,"teacher_disagreement_score":0.055731717,"about_ca_system_score_codex":0.000015980902,"about_ca_system_score_gemma":0.00006119154,"threshold_uncertainty_score":0.99984604},"labels":[],"label_agreement":null},{"id":"W2016545633","doi":"10.1097/fpc.0b013e3282f3606e","title":"A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"CYP2A6; Pharmacogenetics; Allele; In vivo; Genetics; Allele frequency; Biology; Population; Descent (aeronautics); Enzyme; In vitro; Gene; Medicine; Genotype; Geography; Environmental health; Biochemistry","score_opus":0.0661402791490691,"score_gpt":0.34489303013547035,"score_spread":0.27875275098640123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016545633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884003,0.010174611,0.00014279954,0.000120490964,0.00027405724,0.0006288876,0.00012020646,0.000015632018,0.0001230407],"genre_scores_gemma":[0.970326,0.028326051,0.0005641708,0.0005445759,0.000103245904,0.000037194484,0.000034447356,0.00004180927,0.00002249775],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99770176,0.00024173853,0.0007847413,0.00054146815,0.00016923483,0.00056102726],"domain_scores_gemma":[0.9990418,0.00020127931,0.00023082826,0.00013603675,0.0000578908,0.00033215474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071624864,0.00036457283,0.00054188626,0.0005365601,0.000118119184,0.000019936128,0.00014006002,0.00023783186,0.000039923318],"category_scores_gemma":[0.000038950628,0.00040847872,0.000057685134,0.00038748726,0.00028457277,0.00009584525,0.00018832536,0.00050456583,8.7745184e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016428892,0.0005997171,0.22098768,0.00010827072,0.000084067666,0.000045843703,0.002058941,0.004397042,0.75710386,0.00005907637,0.00003787249,0.012874715],"study_design_scores_gemma":[0.016520271,0.00018824067,0.49417216,0.00004994132,0.0003828981,0.00019509709,0.00041506338,0.13699792,0.33773413,0.0008319186,0.011498358,0.0010139901],"about_ca_topic_score_codex":0.00042810434,"about_ca_topic_score_gemma":0.00025144147,"teacher_disagreement_score":0.41936976,"about_ca_system_score_codex":0.00009867787,"about_ca_system_score_gemma":0.00009051122,"threshold_uncertainty_score":0.9998367},"labels":[],"label_agreement":null},{"id":"W2016959089","doi":"10.1124/dmd.112.048835","title":"The Role of Cytochrome P450–Dependent Metabolism in the Regulation of Mouse Hepatic Growth Hormone Signaling Components and Target Genes by 3-Methylcholanthrene","year":2012,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Biology; Internal medicine; Endocrinology; Aryl hydrocarbon receptor; Cytochrome P450; Wild type; CYP1A2; CYP1B1; Protein kinase B; Signal transduction; Growth hormone receptor; Gene; Hormone; Metabolism; Cell biology; Transcription factor; Biochemistry","score_opus":0.022962910056862552,"score_gpt":0.31610187990290517,"score_spread":0.2931389698460426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016959089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83770263,0.16091482,0.00009846107,0.00017973874,0.00021378798,0.0004578271,0.00026701647,0.000011828314,0.00015390174],"genre_scores_gemma":[0.9831611,0.015975304,0.00019502336,0.00020594921,0.00020284686,0.000070860064,0.00013041605,0.000022153405,0.000036382167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971948,0.0011394086,0.00062437536,0.0002482527,0.00036121815,0.0004318894],"domain_scores_gemma":[0.9987156,0.00044183945,0.00036052588,0.00020517876,0.00010981609,0.00016704768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022335912,0.00026905563,0.00045972853,0.00014427207,0.00033587895,0.00003617622,0.00025911527,0.0001510071,0.00002463472],"category_scores_gemma":[0.000040476716,0.0001830867,0.00008573508,0.00024226452,0.00030418395,0.00031332797,0.00010414074,0.00034417378,0.000002500546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030318918,0.00037284876,0.003896655,0.000038981023,0.00010837501,4.769242e-7,0.0025937099,0.000063176616,0.98077554,0.005425712,0.00008135573,0.006339997],"study_design_scores_gemma":[0.0019636077,0.000017223258,0.1798913,0.000009788072,0.000513307,0.000010731126,0.0006185685,0.0015817686,0.8033422,0.00296273,0.008856761,0.00023199565],"about_ca_topic_score_codex":0.00018391156,"about_ca_topic_score_gemma":0.000004768868,"teacher_disagreement_score":0.17743331,"about_ca_system_score_codex":0.0000104424025,"about_ca_system_score_gemma":0.000017815155,"threshold_uncertainty_score":0.7466059},"labels":[],"label_agreement":null},{"id":"W2017109689","doi":"10.1517/17425255.2011.585968","title":"Have physiologically-based pharmacokinetic models delivered?","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Heartland Health Research Alliance; U.S. Environmental Protection Agency","keywords":"Physiologically based pharmacokinetic modelling; In silico; Pharmacokinetics; Drug development; Drug; Human health; Computational biology; Computer science; Biochemical engineering; Pharmacology; Risk analysis (engineering); Medicine; Biology; Engineering","score_opus":0.2037785665111753,"score_gpt":0.41993476547632874,"score_spread":0.21615619896515345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017109689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.686778,0.07783673,0.004873191,0.0064801183,0.04538698,0.005267649,0.0007694539,0.0020717243,0.17053618],"genre_scores_gemma":[0.93852234,0.01366565,0.0034192046,0.040236615,0.0023667787,0.00076463324,0.000119472046,0.00016196017,0.00074333115],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929118,0.0021616875,0.0011648823,0.0014958994,0.000551304,0.0017144347],"domain_scores_gemma":[0.9966805,0.00058456435,0.0004925072,0.00085074594,0.00033213527,0.0010595678],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011345097,0.0010590119,0.0012486721,0.0005536564,0.0005832841,0.000037214868,0.0014765281,0.0008601531,0.01118997],"category_scores_gemma":[0.00011831245,0.000949361,0.0005851656,0.00046226286,0.00073588314,0.00027530149,0.00035223603,0.0017360382,0.00091101934],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008748741,0.011140175,0.00033720216,0.000085499894,0.0013477615,0.0003063389,0.011203603,0.02842791,0.56325966,0.054289345,0.109050274,0.2118035],"study_design_scores_gemma":[0.006634927,0.000284784,0.001199115,0.000018205303,0.0001012307,0.000022328923,0.00019459748,0.03259135,0.25526178,0.0050813425,0.69749975,0.0011106132],"about_ca_topic_score_codex":0.00007626866,"about_ca_topic_score_gemma":0.000005869605,"teacher_disagreement_score":0.5884495,"about_ca_system_score_codex":0.00010448029,"about_ca_system_score_gemma":0.00024893897,"threshold_uncertainty_score":0.9998669},"labels":[],"label_agreement":null},{"id":"W2017394346","doi":"10.1016/s0009-2797(00)00246-5","title":"Cytochrome P450 2E1 metabolically activates propargyl alcohol: propiolaldehyde-induced hepatocyte cytotoxicity","year":2001,"lang":"en","type":"article","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chemistry; Alcohol dehydrogenase; Glutathione; Cytotoxicity; Biochemistry; Catalase; Pharmacology; Hepatocyte; Alcohol; Enzyme; Biology; In vitro","score_opus":0.2703021651535082,"score_gpt":0.47003989163839943,"score_spread":0.19973772648489124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017394346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770638,0.00050272676,0.000184852,0.0016473064,0.0012276864,0.0011028931,0.00013967266,0.000502796,0.017628271],"genre_scores_gemma":[0.99079823,0.0011213372,0.00042556348,0.003936821,0.0012892034,0.0006551402,0.00014455129,0.00005777793,0.0015713889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961132,0.0005256279,0.000904333,0.0010263573,0.0002622141,0.0011683026],"domain_scores_gemma":[0.9974324,0.00060718,0.00037419942,0.0005172398,0.000311749,0.0007572503],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000584315,0.0006800469,0.0008245734,0.0001966278,0.0006121443,0.00008718454,0.0008274217,0.00070985255,0.0059309048],"category_scores_gemma":[0.00045875463,0.0005360445,0.00045744932,0.00060716056,0.00039074066,0.00031984938,0.00039828275,0.0023462498,0.0008799973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006868513,0.0012118258,0.0035852513,0.000015698664,0.00036992584,0.000081833874,0.00019757233,0.000042938947,0.9840386,0.0005161169,0.0018084525,0.007444967],"study_design_scores_gemma":[0.0012264749,0.00011098882,0.008080632,0.0000140890725,0.00016141108,0.000242574,0.000048150614,0.00086481636,0.6366514,0.0006493934,0.3514262,0.00052388525],"about_ca_topic_score_codex":0.00004155298,"about_ca_topic_score_gemma":0.000010270767,"teacher_disagreement_score":0.34961775,"about_ca_system_score_codex":0.00019056468,"about_ca_system_score_gemma":0.0001290778,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W2017568512","doi":"10.1021/ac202787n","title":"Functional Screening of Cytochrome P450 Activity and Uncoupling by Capillary Electrophoresis","year":2011,"lang":"en","type":"letter","venue":"Analytical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Chemistry; Cytochrome P450; Xenobiotic; Substrate (aquarium); Biochemistry; Monooxygenase; Cytochrome; Capillary electrophoresis; Metabolism; Enzyme; Chromatography; Biology","score_opus":0.09038373432684911,"score_gpt":0.3632725842239597,"score_spread":0.2728888498971106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017568512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8976039,0.017626498,0.0009549493,0.06094966,0.0005563547,0.000532414,0.001237438,0.00016495062,0.020373806],"genre_scores_gemma":[0.7514255,0.0074153966,0.00038678234,0.21369933,0.008069586,0.00008928034,0.0013694366,0.0002699109,0.017274767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976809,0.00012283491,0.00046511923,0.0006756838,0.00037522806,0.0006802273],"domain_scores_gemma":[0.9985273,0.00042403614,0.00029593852,0.00030304972,0.00015403701,0.0002956493],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00036012847,0.00050343346,0.0007521107,0.00007446078,0.00015760066,0.000019733356,0.0003230204,0.0017420974,0.003759998],"category_scores_gemma":[0.000079645506,0.00051061145,0.00026164338,0.0001922366,0.00049670285,0.000051555104,0.0002004178,0.00369289,0.000020548365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015196753,0.00008532042,0.00017123944,0.00030432252,0.0006324134,0.00009513232,0.000013594343,0.000010855228,0.49738055,0.0000060028274,0.5000406,0.0011079888],"study_design_scores_gemma":[0.0007803849,0.000029041414,0.0003632939,0.000026495765,0.0011526179,0.0000515233,0.000004813189,0.0022051395,0.48687106,0.00020290562,0.50779617,0.00051659025],"about_ca_topic_score_codex":0.0000444242,"about_ca_topic_score_gemma":4.4319327e-7,"teacher_disagreement_score":0.15274967,"about_ca_system_score_codex":0.000050674575,"about_ca_system_score_gemma":0.00014855278,"threshold_uncertainty_score":0.9997345},"labels":[],"label_agreement":null},{"id":"W2018457102","doi":"10.1007/s11606-010-1515-6","title":"Personalized Medicine: Understanding Probabilities and Managing Expectations","year":2010,"lang":"en","type":"review","venue":"Journal of General Internal Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Stylized fact; Personalized medicine; Medicine; Creativity; Precision medicine; Health care; Set (abstract data type); Engineering ethics; Data science; Management science; Computer science; Bioinformatics; Psychology; Pathology","score_opus":0.3094777700488312,"score_gpt":0.5173109236552946,"score_spread":0.20783315360646343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018457102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002213631,0.97944653,0.000657263,0.0021928512,0.007486499,0.00035267003,0.000020000914,0.00001705901,0.009605754],"genre_scores_gemma":[0.00026041974,0.9862642,0.0003936052,0.000753155,0.0074805245,0.000017198627,0.000012235476,0.000060216036,0.0047584106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641263,0.00069179764,0.0016949128,0.00031121002,0.0004813586,0.00040810433],"domain_scores_gemma":[0.99651116,0.0009493041,0.001553645,0.0001679876,0.00025448663,0.000563445],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017622681,0.00054485415,0.0022551906,0.0007898049,0.00019616606,0.000024776713,0.0005438294,0.00045317278,0.0015382728],"category_scores_gemma":[0.00042810905,0.00034643538,0.00035871024,0.0002460075,0.0011570068,0.00011952469,0.000113547976,0.00287806,0.000008445448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021692323,0.000109739216,0.00003701829,0.004929823,0.0017499527,0.00045113472,0.005316134,0.000005729908,0.0008161272,0.014105462,0.032208335,0.94005364],"study_design_scores_gemma":[0.002045009,0.00033136824,0.000001956894,0.005685439,0.003654628,0.0021404848,0.0011700495,0.00012249219,0.000018028884,0.0045815106,0.9799596,0.00028941984],"about_ca_topic_score_codex":0.000026516636,"about_ca_topic_score_gemma":0.000006465607,"teacher_disagreement_score":0.9477513,"about_ca_system_score_codex":0.00019728307,"about_ca_system_score_gemma":0.00021349019,"threshold_uncertainty_score":0.9998988},"labels":[],"label_agreement":null},{"id":"W2018954315","doi":"10.1182/blood-2011-03-345173","title":"Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Ottawa; Western University","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; Warfarin; Pharmacogenetics; CYP2C9; Vitamin K epoxide reductase; Medicine; Regimen; Maintenance dose; Internal medicine; Pharmacology; Dosing; Therapeutic index; Atrial fibrillation; Genotype; Biology; Genetics; Drug; Cytochrome P450","score_opus":0.28632132103989605,"score_gpt":0.4536510918270174,"score_spread":0.16732977078712136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018954315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884345,0.004466161,0.0001588006,0.00003570514,0.00031195287,0.0015269592,0.000088967754,0.000018785895,0.004958173],"genre_scores_gemma":[0.9959616,0.0019965724,0.0014516853,0.00016483644,0.0001036943,0.00024340721,0.000009688518,0.000023118619,0.000045413104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854887,0.00029588223,0.00043550815,0.00026622383,0.00020778998,0.0002457094],"domain_scores_gemma":[0.99862784,0.00013339988,0.0003633098,0.00014078863,0.0006375095,0.000097123666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016777527,0.00016714948,0.00027816338,0.000116697316,0.000077224744,0.000004038234,0.00015119398,0.00013474852,0.00023845084],"category_scores_gemma":[0.00010948039,0.00015867414,0.00007912022,0.00015110671,0.00015255691,0.00007237505,0.000044244916,0.00014740427,0.0000018113493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009074374,0.0017813331,0.033944078,0.00010397066,0.0006792993,0.0000018961983,0.005556831,0.00007782552,0.9268538,0.0019387355,0.00023365408,0.027921172],"study_design_scores_gemma":[0.015696835,0.0002096574,0.0280561,0.000016002681,0.0008311567,0.000008957871,0.000085245025,0.0033011572,0.9449303,0.005512351,0.0011863378,0.00016585675],"about_ca_topic_score_codex":0.000014373063,"about_ca_topic_score_gemma":0.000001599093,"teacher_disagreement_score":0.027755314,"about_ca_system_score_codex":0.00001659415,"about_ca_system_score_gemma":0.00011708342,"threshold_uncertainty_score":0.6470544},"labels":[],"label_agreement":null},{"id":"W2019013686","doi":"10.1016/j.clinbiochem.2012.01.002","title":"Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic","year":2012,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Sunnybrook Hospital; University of Toronto","funders":"Sunnybrook Research Institute","keywords":"VKORC1; Warfarin; Genotyping; CYP2C9; Pharmacogenetics; Single-nucleotide polymorphism; Vitamin K epoxide reductase; Medicine; Population; Allele frequency; Anticoagulant; Internal medicine; Genotype; Biology; Genetics; Gene; Atrial fibrillation","score_opus":0.18982417356238343,"score_gpt":0.4939509925637549,"score_spread":0.3041268190013715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019013686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977573,0.018260447,0.0000033677347,0.00031506122,0.0014912195,0.00058731943,0.000068718655,0.000018633298,0.001682277],"genre_scores_gemma":[0.9969834,0.0010643763,0.000048903792,0.0010062981,0.00053527707,0.000054055203,0.0000093103645,0.000025617524,0.0002727284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957166,0.001770097,0.000942489,0.00049169606,0.00054230285,0.00053682126],"domain_scores_gemma":[0.99746877,0.0012646645,0.0003174383,0.00043214686,0.00015023885,0.00036673204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073778937,0.0002919742,0.00051235274,0.000042344298,0.000101725425,0.0000103551765,0.0004015952,0.0005717774,0.0003929196],"category_scores_gemma":[0.001382051,0.00022044194,0.00023734743,0.0001952365,0.0003726057,0.000030355266,0.0002233181,0.0009215318,0.00005149649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011684593,0.002708754,0.10620789,0.00027272606,0.00053456234,0.00002184168,0.00019022769,0.0001607226,0.76331276,0.00008596246,0.00066957425,0.12466654],"study_design_scores_gemma":[0.004617148,0.00014640925,0.04954333,0.000059455077,0.0008163907,0.000015677795,0.0000070216497,0.0036273543,0.9375874,0.00017813407,0.0030916927,0.00030998586],"about_ca_topic_score_codex":0.0000019746842,"about_ca_topic_score_gemma":0.0000016534264,"teacher_disagreement_score":0.17427467,"about_ca_system_score_codex":0.000049014223,"about_ca_system_score_gemma":0.00015590695,"threshold_uncertainty_score":0.89893615},"labels":[],"label_agreement":null},{"id":"W2019329705","doi":"10.1155/2013/943014","title":"Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs","year":2013,"lang":"en","type":"review","venue":"Pain Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pharmacogenomics; Medicine; Adverse effect; Pharmacoeconomics; Opioid; Intensive care medicine; Chronic pain; Precision medicine; Health care; Pharmacogenetics; Psychiatry; Pharmacology; Internal medicine","score_opus":0.4528503072247933,"score_gpt":0.5662816994102443,"score_spread":0.11343139218545101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019329705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001481603,0.9887942,0.000056473946,0.0001848944,0.0004956045,0.007763571,0.0008407241,0.00004435612,0.0003385904],"genre_scores_gemma":[0.00026648463,0.99012166,0.00029967536,0.00046894338,0.00090261735,0.0055449763,0.00038085223,0.00011989494,0.001894874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992667,0.0042238757,0.00061900396,0.00094953814,0.00030259564,0.0012379471],"domain_scores_gemma":[0.99243265,0.0058176187,0.00021239548,0.00034713268,0.00023491362,0.0009552577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005968619,0.0007783004,0.001424949,0.00035694457,0.0006989467,0.000049810857,0.00036970968,0.00055757345,0.00046697393],"category_scores_gemma":[0.00016380934,0.00057104585,0.00037655563,0.00026303742,0.00038806006,0.00006392886,0.00018544141,0.0008725501,0.00009340826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029293288,0.00090067764,0.00008204787,0.0014228038,0.0016638621,0.000026072625,0.00019058863,0.0000015634103,0.000053302832,0.00008642772,0.0046438486,0.9906359],"study_design_scores_gemma":[0.0053967233,0.0010049316,0.000008394544,0.00041590616,0.0005859289,0.00001247123,0.00003768265,0.00040843862,0.00016091493,0.00016153514,0.9913174,0.0004897072],"about_ca_topic_score_codex":0.000094070325,"about_ca_topic_score_gemma":0.000011845627,"teacher_disagreement_score":0.99014616,"about_ca_system_score_codex":0.00045585426,"about_ca_system_score_gemma":0.0005515572,"threshold_uncertainty_score":0.9996741},"labels":[],"label_agreement":null},{"id":"W2019742973","doi":"10.1111/j.1365-2125.2004.02162.x","title":"A convenient five‐drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study","year":2004,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Chlorzoxazone; Pharmacology; Metoprolol; Tolbutamide; CYP1A2; CYP2D6; Paraxanthine; Theophylline; Debrisoquine; Caffeine; Dapsone; Chemistry; Dextromethorphan; Xanthine oxidase; CYP2C9; Drug interaction; Medicine; Drug; CYP2E1; Cytochrome P450; Internal medicine; Endocrinology; Metabolism; Biochemistry; Enzyme; Diabetes mellitus","score_opus":0.2111626489578926,"score_gpt":0.5403817289466539,"score_spread":0.3292190799887613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019742973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529874,0.021604758,0.0015845597,0.0036536728,0.017155614,0.0023965968,0.00024711757,0.000032873846,0.0003374181],"genre_scores_gemma":[0.97938824,0.008951447,0.0016044128,0.006128054,0.003335699,0.00016825536,0.0000059938247,0.00006361707,0.00035429976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914515,0.0028349324,0.0037641665,0.0005253578,0.0006149916,0.000809029],"domain_scores_gemma":[0.9895663,0.0058168066,0.0024951939,0.00024897055,0.0012060838,0.000666599],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012398386,0.0004147527,0.0017934068,0.0002102151,0.00051577424,0.000055481403,0.0014229226,0.000186656,0.00092291046],"category_scores_gemma":[0.00078483764,0.0003595571,0.00084141665,0.00036551149,0.0007904019,0.00020755123,0.00030830005,0.002714696,0.000012537608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023635708,0.10504302,0.044232447,0.0007919208,0.03287756,0.0047884397,0.005746778,0.06717263,0.12358752,0.0047138366,0.3599495,0.22746065],"study_design_scores_gemma":[0.1642022,0.009595993,0.09949857,0.00022659163,0.018015195,0.0021286786,0.0035708488,0.005130565,0.04399092,0.0043771365,0.6477525,0.0015107857],"about_ca_topic_score_codex":0.00014472372,"about_ca_topic_score_gemma":0.0000848416,"teacher_disagreement_score":0.28780305,"about_ca_system_score_codex":0.00008349438,"about_ca_system_score_gemma":0.0011771146,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W2019791623","doi":"10.1016/s0196-9781(01)00364-3","title":"Recognition and oxidative metabolism of cyclodipeptides by hepatic cytochrome P450","year":2001,"lang":"en","type":"article","venue":"Peptides","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Cytochrome P450; Metabolism; Biochemistry; Chemistry; Amino acid; Drug metabolism; Peptide; Biology","score_opus":0.10694778888943761,"score_gpt":0.39257723358628976,"score_spread":0.28562944469685214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019791623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844768,0.0074828235,0.00012908499,0.0002562,0.00030033532,0.00036729747,0.00037713637,0.00006715151,0.0065431837],"genre_scores_gemma":[0.98673236,0.010405435,0.00075469067,0.0010092682,0.00023697068,0.00006969019,0.000098359196,0.00003346005,0.00065978937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981494,0.00037782596,0.00047934215,0.00036779244,0.00019466407,0.00043100302],"domain_scores_gemma":[0.99876875,0.00038456827,0.00024468015,0.00017220795,0.00015617379,0.00027364754],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060599745,0.00028707707,0.00046175407,0.00015326546,0.00017258292,0.000022362176,0.00020146336,0.00020425394,0.0011366274],"category_scores_gemma":[0.0001311404,0.00027376434,0.00010429442,0.00026977208,0.0003760789,0.00019762164,0.00010025898,0.0003891262,0.00014403612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020098784,0.00028375196,0.0029806348,0.00005325431,0.00022464465,0.000014020584,0.0009061366,0.000020351716,0.92625016,0.00014750847,0.003015996,0.06590254],"study_design_scores_gemma":[0.002821262,0.00012820662,0.019454673,0.00004170618,0.00065890583,0.000058819536,0.00031404587,0.0007498894,0.7048822,0.008491145,0.26180434,0.0005947859],"about_ca_topic_score_codex":0.0000923923,"about_ca_topic_score_gemma":0.00001200638,"teacher_disagreement_score":0.25878835,"about_ca_system_score_codex":0.000018652481,"about_ca_system_score_gemma":0.000037533697,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W2020003713","doi":"10.1111/bcpt.12071","title":"Enantiomer Selective Glucuronidation of the Non‐Steroidal Pure Anti‐Androgen Bicalutamide by Human Liver and Kidney: Role of the Human <scp>UDP</scp>‐Glucuronosyltransferase (<scp>UGT</scp>)1A9 Enzyme","year":2013,"lang":"en","type":"article","venue":"Basic & Clinical Pharmacology & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Bicalutamide; Glucuronidation; Chemistry; Microsome; Glucuronosyltransferase; UGT2B7; Enantiomer; Pharmacology; Enzyme; Biochemistry; Internal medicine; Androgen receptor; Prostate cancer; Medicine; Stereochemistry; Cancer","score_opus":0.042002983008611466,"score_gpt":0.3787265330817431,"score_spread":0.3367235500731316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020003713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98589516,0.0031413229,0.000041596704,0.0014822932,0.0037396736,0.003179203,0.0005361511,0.00008481431,0.0018997889],"genre_scores_gemma":[0.9845585,0.0014677044,0.000050436727,0.011189077,0.00093695155,0.00039952123,0.00007269952,0.00011463614,0.0012104368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98941666,0.0047596707,0.0024257463,0.0013581743,0.00050992717,0.0015298045],"domain_scores_gemma":[0.9926993,0.0036365532,0.0014361731,0.0007339092,0.00055983005,0.00093421404],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022828397,0.0008888861,0.0016669852,0.00027199174,0.00097323745,0.00004033205,0.0018409436,0.0016700343,0.0012648108],"category_scores_gemma":[0.00079004833,0.0006603517,0.0007848672,0.0008409714,0.003854681,0.00029412156,0.0009161057,0.003146805,0.00010156369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046725178,0.0021939117,0.08960471,0.000098156714,0.0010877475,0.000009976902,0.0007523187,0.000080452315,0.8196646,0.0003254011,0.08381118,0.002324801],"study_design_scores_gemma":[0.0066521447,0.0006307522,0.13849524,0.000024440613,0.0017951678,0.000043956967,0.00012889827,0.0010057914,0.71436596,0.00084866985,0.13579775,0.0002112311],"about_ca_topic_score_codex":0.00012211672,"about_ca_topic_score_gemma":0.000038606926,"teacher_disagreement_score":0.10529866,"about_ca_system_score_codex":0.0001009167,"about_ca_system_score_gemma":0.0005512693,"threshold_uncertainty_score":0.99964815},"labels":[],"label_agreement":null},{"id":"W2021086919","doi":"10.1002/cbic.200600006","title":"Replacement of Natural Cofactors by Selected Hydrogen Peroxide Donors or Organic Peroxides Results in Improved Activity for CYP3A4 and CYP2D6","year":2006,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Arizona; Vanderbilt University","keywords":"Cofactor; Hydrogen peroxide; Chemistry; Natural product; Dioxygenase; Organic synthesis; Cumene hydroperoxide; Cumene; Enzyme; Stereochemistry; Biochemistry; Organic chemistry; Combinatorial chemistry; Catalysis","score_opus":0.035926567750434624,"score_gpt":0.36059240399073716,"score_spread":0.32466583624030254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021086919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556047,0.0022663118,0.000019024055,0.00034431115,0.00028748362,0.0008235119,0.000402834,0.000052045056,0.00024403982],"genre_scores_gemma":[0.9974275,0.00036619607,0.00019925126,0.00022188047,0.0001265365,0.00008614817,0.00017240852,0.000041182102,0.001358873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980628,0.0001361138,0.0005549308,0.00055976136,0.0001325641,0.0005538297],"domain_scores_gemma":[0.9987778,0.00037984623,0.00029457337,0.00022093007,0.00016392239,0.00016293222],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057873444,0.00033541254,0.0004705166,0.000108937485,0.00011627159,0.000016467608,0.00022518162,0.00032516848,0.00009426263],"category_scores_gemma":[0.0002411689,0.000301009,0.00008714877,0.00037046307,0.00017947587,0.00008300809,0.000106447296,0.0004538524,0.0000024854976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032376437,0.00043383637,0.0022307313,0.000096873286,0.00011938134,0.0000027788965,0.00029227114,0.000009629769,0.9881874,0.000010927363,0.0037665844,0.0016119567],"study_design_scores_gemma":[0.0070418054,0.00015099841,0.0030370452,0.000011135105,0.00013603404,0.0000081859935,0.000073072166,0.0016858702,0.9762095,0.000046526315,0.01126169,0.00033814326],"about_ca_topic_score_codex":0.00014700153,"about_ca_topic_score_gemma":0.00014335247,"teacher_disagreement_score":0.011977892,"about_ca_system_score_codex":0.000106281004,"about_ca_system_score_gemma":0.00014854189,"threshold_uncertainty_score":0.9999442},"labels":[],"label_agreement":null},{"id":"W2021635654","doi":"10.1038/clpt.2013.2","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":453,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute; American Lebanese Syrian Associated Charities; Canadian Institutes of Health Research; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Doxepin; Nortriptyline; Desipramine; Tricyclic; CYP2D6; Pharmacology; Pharmacogenetics; Clomipramine; CYP2C19; Dosing; Active metabolite; Medicine; Imipramine; Pharmacokinetics; Amitriptyline; Genotype; Chemistry; Internal medicine; Antidepressant; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.2465648872691833,"score_gpt":0.5759832517471809,"score_spread":0.3294183644779976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021635654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727828,0.013036054,0.0014691887,0.0048297043,0.004752525,0.0025581217,0.0003004723,0.00008973664,0.00018139747],"genre_scores_gemma":[0.8877426,0.044327933,0.006489545,0.059278946,0.0016718467,0.00020791867,0.00007479814,0.00009792797,0.00010851747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930208,0.0016952534,0.0032006472,0.00094798254,0.00023672952,0.0008985967],"domain_scores_gemma":[0.9935886,0.0036449288,0.0011034756,0.0003013644,0.0006652998,0.00069628964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003530958,0.00055346015,0.001226909,0.00020800634,0.00035061678,0.0000450257,0.0004719698,0.0007523093,0.001023508],"category_scores_gemma":[0.00009382887,0.0005246054,0.0003515073,0.00025169924,0.0016523439,0.00018352526,0.0003439417,0.0011076833,0.00003100665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012414071,0.0012870257,0.21787672,0.00015014163,0.0030170907,0.000010881828,0.0003529487,0.00007852372,0.27029055,0.000095135336,0.03935469,0.46624488],"study_design_scores_gemma":[0.03031716,0.0013277971,0.1023674,0.000020748636,0.008698308,0.000051539762,0.00036238483,0.028985048,0.13288769,0.0022365118,0.6915322,0.0012132324],"about_ca_topic_score_codex":0.00002350261,"about_ca_topic_score_gemma":0.0000045115557,"teacher_disagreement_score":0.6521775,"about_ca_system_score_codex":0.000023874605,"about_ca_system_score_gemma":0.000207218,"threshold_uncertainty_score":0.9998897},"labels":[],"label_agreement":null},{"id":"W2021644601","doi":"10.1016/s0887-2333(00)00016-3","title":"Evidence for the catalysis of Dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver","year":2000,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Canada","funders":"","keywords":"Dextromethorphan; CYP2B6; CYP2E1; Molecular biology; Cytochrome P450; Complementary DNA; Enzyme; Quinidine; Polyclonal antibodies; Biochemistry; Biology; Demethylation; Chemistry; CYP1A2; Pharmacology; Antibody; Gene expression; Gene","score_opus":0.1784145241042837,"score_gpt":0.4493209677791409,"score_spread":0.27090644367485717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021644601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96827507,0.027243778,0.0006320907,0.0014143098,0.0006358957,0.0011630506,0.00014456153,0.000027201635,0.00046401442],"genre_scores_gemma":[0.9888914,0.006246081,0.0008625646,0.0024514834,0.00015574398,0.0004901328,0.00003703097,0.000027967988,0.0008375688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969259,0.0010938166,0.00073103886,0.00046045793,0.00015102256,0.0006378008],"domain_scores_gemma":[0.995367,0.0039054174,0.00020761811,0.00031081264,0.00007990509,0.00012926859],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026565099,0.0002670753,0.00053364254,0.00027687647,0.0001370201,0.000010304181,0.0005791226,0.0004616961,0.002352944],"category_scores_gemma":[0.00029825335,0.00023088588,0.00017214686,0.00066664343,0.0003571077,0.00014148102,0.000074505675,0.00070349616,0.000053726744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002113341,0.00056481914,0.0024123408,0.00003930591,0.00014708028,0.0000144135265,0.0011356864,0.0027200761,0.8190465,0.000087852546,0.0025676985,0.1691509],"study_design_scores_gemma":[0.0043325513,0.00022749702,0.009446576,0.000022992348,0.00051267684,0.000015734371,0.00010402954,0.037173197,0.83885914,0.0010504934,0.10783879,0.0004162959],"about_ca_topic_score_codex":0.00018473266,"about_ca_topic_score_gemma":0.00017241815,"teacher_disagreement_score":0.16873461,"about_ca_system_score_codex":0.00010065636,"about_ca_system_score_gemma":0.000110245164,"threshold_uncertainty_score":0.99855906},"labels":[],"label_agreement":null},{"id":"W2021889472","doi":"10.1038/nbt0806-942","title":"Shifting emphasis from pharmacogenomics to theragnostics","year":2006,"lang":"en","type":"review","venue":"Nature Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"NIH Clinical Center; Université de Montréal; Office of Research and Development; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Pharmacogenomics; Downstream (manufacturing); Biomarker; Upstream (networking); Emphasis (telecommunications); Computational biology; Data science; Engineering ethics; Biology; Bioinformatics; Computer science; Business; Genetics; Engineering; Marketing","score_opus":0.12268277317795143,"score_gpt":0.49455684904083375,"score_spread":0.37187407586288235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021889472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005772744,0.9819206,0.00017638096,0.0011079885,0.008107439,0.0018147898,0.0033545068,0.000691645,0.0022493938],"genre_scores_gemma":[0.00029319333,0.98768276,0.002498249,0.004402094,0.0031618397,0.0002687481,0.0008637767,0.00029690488,0.000532406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943356,0.00073303573,0.0014396835,0.0017006699,0.0003467469,0.001444249],"domain_scores_gemma":[0.99623704,0.0012832736,0.000758516,0.0010462635,0.00015082365,0.00052410754],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0007554299,0.0014284926,0.0029275008,0.001094365,0.0003923667,0.0000695821,0.0024027724,0.011361067,0.0009197424],"category_scores_gemma":[0.00039171957,0.0013111775,0.00087212,0.001441759,0.00030864257,0.000056377492,0.00095174386,0.009585316,0.0015147284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004087381,0.00024582987,0.000007950721,0.000682064,0.00090730307,0.00019678485,0.000046018704,0.000024499142,0.0011354315,0.0009165473,0.022166215,0.9736305],"study_design_scores_gemma":[0.00082243315,0.000055873814,0.0000024812523,0.00045363593,0.0035508985,0.00006328759,0.000008871062,0.0000486765,0.005709369,0.00041359413,0.9876149,0.0012559349],"about_ca_topic_score_codex":0.00005342699,"about_ca_topic_score_gemma":0.000025642346,"teacher_disagreement_score":0.97237456,"about_ca_system_score_codex":0.00032769208,"about_ca_system_score_gemma":0.00046534938,"threshold_uncertainty_score":0.99999356},"labels":[],"label_agreement":null},{"id":"W2022348635","doi":"10.1016/j.cbi.2007.05.004","title":"Differential inhibition of hepatic microsomal alkoxyresorufin O-dealkylation activities by tetrachlorobiphenyls","year":2007,"lang":"en","type":"article","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Microsome; Cytochrome P450; In vitro; Phenobarbital; Chemistry; Microsoma; Enzyme; Internal medicine; Endocrinology; Biochemistry; Biology; Medicine","score_opus":0.08753881808618443,"score_gpt":0.4184558594168284,"score_spread":0.330917041330644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022348635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968804,0.00048330176,0.0021522606,0.00016267317,0.0013028618,0.00028821244,0.00029367817,0.000097173186,0.0055318275],"genre_scores_gemma":[0.9975781,0.0003123297,0.00021430061,0.00050601305,0.00039197592,0.000037457183,0.0003706148,0.00002043348,0.00056877325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820185,0.00015856327,0.0006586144,0.0003608262,0.00013501878,0.0004851379],"domain_scores_gemma":[0.99843156,0.00078572246,0.00031580537,0.00016096413,0.00009354504,0.00021239907],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032623427,0.00027668205,0.00036193698,0.000131315,0.00020942092,0.000019597028,0.00018330415,0.00037889153,0.00332323],"category_scores_gemma":[0.0001087663,0.0002457751,0.00020691913,0.00019679002,0.0003442765,0.00015545328,0.000101752164,0.00083631586,0.000045097295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037333588,0.00076211756,0.004835138,0.00002121846,0.000104458646,0.0000051507036,0.00023721092,0.00001591166,0.9802061,0.00031262022,0.0034480575,0.009678687],"study_design_scores_gemma":[0.00091833295,0.00007380885,0.0027622909,0.0000146951315,0.00009473986,0.000021152726,0.00016261575,0.00031223014,0.95017517,0.00043221615,0.04478565,0.000247132],"about_ca_topic_score_codex":0.000022219598,"about_ca_topic_score_gemma":0.000009535929,"teacher_disagreement_score":0.04133759,"about_ca_system_score_codex":0.000086473745,"about_ca_system_score_gemma":0.000023878249,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W2022811284","doi":"10.1177/0091270004268910","title":"Lack of Weight‐Based Dose Dependency and Intraindividual Variability of Omeprazole for CYP2C19 Phenotyping","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Omeprazole; CYP2C19; Proton-pump inhibitor; Medicine; Interquartile range; Coefficient of variation; Pharmacology; Internal medicine; Chemistry; Metabolism; Chromatography","score_opus":0.34318280028713016,"score_gpt":0.5652223211458592,"score_spread":0.22203952085872908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022811284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343974,0.0018917787,0.005333475,0.0036928032,0.004418072,0.00064907596,0.0001339039,0.000011176543,0.00042994597],"genre_scores_gemma":[0.99046195,0.0021022682,0.002279024,0.0037369158,0.00136406,0.000010352039,0.000003503619,0.000026164946,0.000015784855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942903,0.0021534557,0.0025634046,0.00024697877,0.00029232173,0.0004535359],"domain_scores_gemma":[0.9893062,0.007418753,0.0020540995,0.00020874744,0.0006363536,0.00037582565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013923359,0.00026450097,0.0011540535,0.00016169666,0.00014917184,0.000005390026,0.00074887957,0.000412302,0.00056678656],"category_scores_gemma":[0.0010636925,0.00019013684,0.00041580122,0.00022227774,0.0011351844,0.00011308017,0.00016197591,0.0014094658,0.0000045149477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037194833,0.009973965,0.039219532,0.0010868886,0.0051538944,0.000063681866,0.0032132831,0.033178035,0.6887027,0.007536034,0.0069359094,0.16774127],"study_design_scores_gemma":[0.08770753,0.0040086606,0.052149322,0.00011918783,0.010261725,0.00022477817,0.00028244327,0.0085097095,0.66288185,0.08247456,0.090461485,0.00091877324],"about_ca_topic_score_codex":0.0000069088524,"about_ca_topic_score_gemma":0.0000025612183,"teacher_disagreement_score":0.1668225,"about_ca_system_score_codex":0.00003026439,"about_ca_system_score_gemma":0.0007204206,"threshold_uncertainty_score":0.7753555},"labels":[],"label_agreement":null},{"id":"W2023792717","doi":"10.1517/17425250902865586","title":"Characterization and expression of extrahepatic CYP2S1","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Context (archaeology); Gene expression; Isozyme; Enzyme; Gene; Biochemistry; Genetics; Biology","score_opus":0.1341981640508461,"score_gpt":0.46143677831385393,"score_spread":0.3272386142630078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023792717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012187294,0.9872043,0.00010396858,0.00028136128,0.007864378,0.0018196099,0.00036286694,0.00013433471,0.0010104394],"genre_scores_gemma":[0.00042433882,0.99333036,0.0003543532,0.0020007547,0.0020688558,0.00044075737,0.00062425126,0.0001486852,0.0006076603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925032,0.0029584211,0.0019188157,0.0012451337,0.00044427745,0.0009301517],"domain_scores_gemma":[0.99613273,0.0008585844,0.0015071954,0.0007371107,0.00016284404,0.0006015183],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011559536,0.0012137693,0.0037604754,0.00090733997,0.00030644453,0.000039924023,0.0008472862,0.0016150496,0.0010214661],"category_scores_gemma":[0.00018349352,0.0010379428,0.00066329323,0.00055950554,0.0004141139,0.0001818143,0.0003059181,0.0017024725,0.00012966714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001416077,0.00075485953,0.0000022798938,0.0011370894,0.00020156633,0.000014399413,0.0006989318,0.0000047694216,0.02195306,0.0017977145,0.0023753806,0.97091836],"study_design_scores_gemma":[0.0014622982,0.00012728709,0.000056916415,0.0012393749,0.00036470735,0.00005539918,0.000022903068,0.00006327827,0.012573016,0.0001301727,0.98304373,0.00086090766],"about_ca_topic_score_codex":0.0000063398156,"about_ca_topic_score_gemma":0.0000010027879,"teacher_disagreement_score":0.98066837,"about_ca_system_score_codex":0.000076193384,"about_ca_system_score_gemma":0.0003364855,"threshold_uncertainty_score":0.99989176},"labels":[],"label_agreement":null},{"id":"W2024278415","doi":"10.1097/fpc.0000000000000061","title":"Cancer patients’ acceptance, understanding, and willingness-to-pay for pharmacogenomic testing","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Willingness to pay; Cancer; Genetic testing; Oncology; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.16242019437257235,"score_gpt":0.4190787767134464,"score_spread":0.256658582340874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024278415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98065734,0.0037984466,0.0084072435,0.00084948604,0.0027195858,0.0016284147,0.0006682866,0.000100540914,0.00117068],"genre_scores_gemma":[0.980022,0.0065231607,0.0044387607,0.0069546932,0.0013454302,0.00029163348,0.000039939066,0.00013736942,0.00024699222],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705243,0.00019784283,0.0006601461,0.00089910935,0.00020182312,0.0009886326],"domain_scores_gemma":[0.9976166,0.0006436601,0.0002713709,0.00020807104,0.0002715313,0.0009887632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000936164,0.0005767556,0.0005568041,0.00019861458,0.0007768423,0.00012699015,0.00039718652,0.0002362186,0.00016227398],"category_scores_gemma":[0.00012489098,0.00054626435,0.00010895906,0.0003016251,0.00021183383,0.000096870586,0.000316492,0.0005016248,0.000018465216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080434466,0.00044566937,0.15228719,0.00034978497,0.00062026933,0.000003671236,0.0015247623,0.0048530544,0.47921374,0.0022530006,0.00621914,0.35142538],"study_design_scores_gemma":[0.0081531145,0.00030360132,0.01046076,0.000025525263,0.0010255863,0.000010776161,0.00007578544,0.079809435,0.07626842,0.0040076575,0.8186104,0.0012488982],"about_ca_topic_score_codex":0.000016687858,"about_ca_topic_score_gemma":0.0000097201055,"teacher_disagreement_score":0.8123913,"about_ca_system_score_codex":0.00014170494,"about_ca_system_score_gemma":0.00011371537,"threshold_uncertainty_score":0.9996989},"labels":[],"label_agreement":null},{"id":"W2024912502","doi":"10.1038/mp.2011.38","title":"Genetic variation in CYP3A43 explains racial difference in olanzapine clearance","year":2011,"lang":"en","type":"article","venue":"Molecular Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"NHLBI Division of Intramural Research; National Institutes of Health; National Institute of Mental Health; Eli Lilly and Company","keywords":"Olanzapine; Antipsychotic; Medicine; Atypical antipsychotic; Pharmacology; Internal medicine; Genotype; Drug; Adverse effect; Pharmacogenetics; Discontinuation; Psychiatry; Schizophrenia (object-oriented programming); Biology; Genetics","score_opus":0.06587998474827186,"score_gpt":0.37139545662018325,"score_spread":0.3055154718719114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024912502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98611706,0.004528525,0.0016550279,0.00030522267,0.0025606314,0.00039146296,0.000017459868,0.000042003994,0.004382605],"genre_scores_gemma":[0.9930913,0.00048298654,0.003162327,0.002875447,0.00020377658,0.00008169814,0.000006037087,0.000034468703,0.00006195797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978945,0.0004884014,0.00048727632,0.00044499885,0.0001640496,0.00052075525],"domain_scores_gemma":[0.9993891,0.000027292519,0.00012116189,0.00026193273,0.00003373887,0.00016674439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039807695,0.00025343103,0.00028138736,0.00027004,0.00006806405,0.0000115676585,0.00036281967,0.00025027266,0.0005995698],"category_scores_gemma":[0.000028374398,0.00027731582,0.00008657087,0.00043871347,0.000073663105,0.000053844476,0.000074219235,0.0007173969,0.000115075054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019924107,0.0036182753,0.51329863,0.00015671225,0.00017372136,0.0006282043,0.012065515,0.0024030146,0.40876538,0.0140453465,0.00032230304,0.042530492],"study_design_scores_gemma":[0.0040675453,0.000074246214,0.9689592,0.00002707726,0.000061011287,0.000016551072,0.00005348082,0.0040775905,0.010003282,0.008366989,0.0038630925,0.00042990144],"about_ca_topic_score_codex":0.000118792996,"about_ca_topic_score_gemma":0.00025549272,"teacher_disagreement_score":0.4556606,"about_ca_system_score_codex":0.000037459886,"about_ca_system_score_gemma":0.00011289607,"threshold_uncertainty_score":0.9999679},"labels":[],"label_agreement":null},{"id":"W2025416272","doi":"10.1097/01.jcp.0000227355.54074.14","title":"Phenotype-genotype Relationship and Clinical Effects of Citalopram in Chinese Patients","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Hong Kong Government; H. Lundbeck A/S","keywords":"CYP2C19; Citalopram; Pharmacokinetics; Genotype; Chinese population; Population; Pharmacology; Medicine; Internal medicine; Adverse effect; Gastroenterology; Biology; Genetics; Metabolism; Gene; Antidepressant","score_opus":0.08347896920586216,"score_gpt":0.521271239930772,"score_spread":0.4377922707249098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025416272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802359,0.003955456,0.000059316415,0.0004927909,0.012668861,0.00044711077,0.000017700002,0.000012964485,0.002109915],"genre_scores_gemma":[0.99251384,0.0028053015,0.0006447706,0.0018363693,0.0020265987,0.000006678403,0.0000067649116,0.000033383676,0.00012632283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924009,0.0025271864,0.0039497884,0.0003749433,0.00030497645,0.0004422463],"domain_scores_gemma":[0.98907495,0.007897812,0.0019582424,0.00018116638,0.0004519368,0.00043589115],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0047753034,0.00030514476,0.0013232529,0.00037349047,0.00007646633,0.000009932422,0.00043645324,0.0007625161,0.0002452891],"category_scores_gemma":[0.0021823721,0.00025475913,0.00046895797,0.0004621826,0.00058899546,0.0001633621,0.00010860222,0.0024558753,0.000030389572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004193047,0.0039128717,0.95485026,0.00008432397,0.00027218406,0.00008818634,0.000057527315,0.00015708292,0.0021410193,0.00027001678,0.005139041,0.028834436],"study_design_scores_gemma":[0.026392618,0.0008830442,0.94358,0.000025005103,0.0004817688,0.00001403653,0.000005314109,0.0003165065,0.00029766274,0.005868669,0.021914735,0.00022069053],"about_ca_topic_score_codex":0.000011959568,"about_ca_topic_score_gemma":0.000017543924,"teacher_disagreement_score":0.028613746,"about_ca_system_score_codex":0.000027036289,"about_ca_system_score_gemma":0.00019138899,"threshold_uncertainty_score":0.99999046},"labels":[],"label_agreement":null},{"id":"W2026046906","doi":"10.1038/sj.bjp.0704951","title":"Down‐regulation of hepatic cytochrome P450 in chronic renal failure: role of uremic mediators","year":2002,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; Kidney Foundation of Canada; American Society of Nephrology","keywords":"Internal medicine; Endocrinology; Cytochrome P450; Messenger RNA; CYP3A; Incubation; Biology; Gene isoform; Chemistry; Metabolism; Medicine; Biochemistry; Gene","score_opus":0.03132249171432585,"score_gpt":0.34717265378749074,"score_spread":0.3158501620731649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026046906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96508884,0.03261153,0.00004513781,0.0003244374,0.0008325963,0.0003871261,0.00009181891,0.000013822226,0.00060467917],"genre_scores_gemma":[0.98792416,0.01036764,0.00029447116,0.0003382104,0.0009420639,0.000017997056,0.000008499632,0.000037670376,0.000069277135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99591595,0.0010155704,0.0017726953,0.0002742766,0.00042510036,0.0005964036],"domain_scores_gemma":[0.99736243,0.00042614454,0.0013955233,0.000104142164,0.00041757603,0.00029417922],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001440211,0.00027875352,0.00094484864,0.000592132,0.000085007916,0.000010975169,0.00061021134,0.00041376325,0.008086631],"category_scores_gemma":[0.000116437135,0.00032814321,0.00030328994,0.000599999,0.0004369001,0.0002438532,0.00010608815,0.0013053613,0.000025476847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000266705,0.00065546826,0.00097385736,0.00011119434,0.00035319017,0.00022702853,0.00049864565,0.0049933055,0.94500554,0.00006625804,0.006910977,0.039937854],"study_design_scores_gemma":[0.011924662,0.0005181884,0.024394296,0.00016407296,0.00082287536,0.0017077613,0.00007944856,0.013028371,0.90745753,0.00095717143,0.03854204,0.0004035607],"about_ca_topic_score_codex":0.000050322597,"about_ca_topic_score_gemma":0.00006296573,"teacher_disagreement_score":0.039534293,"about_ca_system_score_codex":0.00022082009,"about_ca_system_score_gemma":0.00027869304,"threshold_uncertainty_score":0.9999171},"labels":[],"label_agreement":null},{"id":"W2026270252","doi":"10.1111/j.1538-7836.2009.03483.x","title":"Predicting warfarin maintenance dose in patients with venous thromboembolism based on the response to a standardized warfarin initiation nomogram","year":2009,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Warfarin; Nomogram; VKORC1; Medicine; Dosing; Maintenance dose; CYP2C9; Internal medicine; Atrial fibrillation","score_opus":0.0854572687441948,"score_gpt":0.39443852602649526,"score_spread":0.30898125728230047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026270252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890584,0.00016683029,0.00013646028,0.009199307,0.00036342698,0.0005874423,0.00009867357,0.000015192827,0.00037427977],"genre_scores_gemma":[0.99076813,0.00027725575,0.00069319207,0.008105642,0.00011054796,0.000012048698,0.000003902861,0.000022327895,0.0000069233606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997403,0.0008049971,0.0006321226,0.00025107054,0.00046837245,0.000440414],"domain_scores_gemma":[0.99814934,0.00060082803,0.0004397207,0.00020694153,0.0003257038,0.00027747068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026480001,0.0002705177,0.00059856055,0.0003117392,0.00028684278,0.00007114457,0.00029125978,0.00015296634,0.00011889082],"category_scores_gemma":[0.00032904104,0.00017531919,0.00011556261,0.00044055228,0.00009918387,0.00014385683,0.000046761692,0.0007937173,0.0000043699138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11815944,0.012131947,0.38965207,0.00010543421,0.0014613182,0.00021285505,0.015803283,0.031456362,0.027631618,0.00086444843,0.009831393,0.39268985],"study_design_scores_gemma":[0.011623487,0.002845593,0.9637174,0.00017804446,0.00033461984,0.000007509816,0.00021063822,0.0017303484,0.0066223913,0.00031211248,0.012111473,0.00030635388],"about_ca_topic_score_codex":0.000010715693,"about_ca_topic_score_gemma":0.000008573232,"teacher_disagreement_score":0.5740654,"about_ca_system_score_codex":0.00012660904,"about_ca_system_score_gemma":0.00016389106,"threshold_uncertainty_score":0.7149309},"labels":[],"label_agreement":null},{"id":"W2026704167","doi":"10.4212/cjhp.v63i5.950","title":"Interaction between Methadone and Ciprofloxacin","year":2010,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"CYP3A4; CYP1A2; CYP2D6; Pharmacology; Methadone; Drug interaction; Cytochrome P450; Medicine; Metabolite; Isozyme; Chemistry; Pharmacokinetics; Internal medicine; Enzyme; Metabolism; Biochemistry","score_opus":0.08319447041285404,"score_gpt":0.417700975120298,"score_spread":0.334506504707444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026704167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783135,0.0018874829,0.000019147172,0.009667168,0.0071805804,0.00021649439,0.00005292937,0.0000101507885,0.00265252],"genre_scores_gemma":[0.9958602,0.0002760225,0.00014017627,0.0014442289,0.0020745539,0.000004807191,0.0000035562073,0.000026722439,0.00016969164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849135,0.00026642744,0.00046981729,0.00015305955,0.00017145793,0.00044789872],"domain_scores_gemma":[0.99786127,0.0002776246,0.00033323417,0.00014717008,0.00025260565,0.0011280787],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015793488,0.00020759755,0.00028418069,0.00023839192,0.0005092182,0.000091216934,0.00050006376,0.000120177916,0.0010874928],"category_scores_gemma":[0.00016620851,0.00015380306,0.00012732673,0.00019401559,0.0004140523,0.00027221467,0.000043859025,0.002345066,0.000053069845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003227483,0.00023489015,0.2546478,0.000053221822,0.0015709054,0.0005228259,0.008524449,0.0001492639,0.26502225,0.0035194596,0.03506984,0.43036237],"study_design_scores_gemma":[0.002195313,0.00014005965,0.016266951,0.000009128313,0.0005342014,0.00015460674,0.00016818839,0.00022752388,0.094325975,0.0022584256,0.88342863,0.00029099156],"about_ca_topic_score_codex":0.001728709,"about_ca_topic_score_gemma":0.002692048,"teacher_disagreement_score":0.8483588,"about_ca_system_score_codex":0.00004415994,"about_ca_system_score_gemma":0.00054938626,"threshold_uncertainty_score":0.99995655},"labels":[],"label_agreement":null},{"id":"W2027139914","doi":"10.1039/b607001a","title":"Progress towards the easier use of P450 enzymes","year":2006,"lang":"en","type":"review","venue":"Molecular BioSystems","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Merck Canada; Centre National de la Recherche Scientifique","keywords":"Cytochrome P450; Cofactor; Enzyme; Substrate (aquarium); Chemistry; Protein engineering; Biochemistry; Heme; Mutagenesis; Hydroxylation; Hemeprotein; Combinatorial chemistry; Biology; Gene; Mutation","score_opus":0.28224781355110473,"score_gpt":0.4799072877840047,"score_spread":0.19765947423289998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027139914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022182985,0.9929718,0.000115907555,0.000085619664,0.0022816774,0.00216284,0.0007672404,0.0000695401,0.0013235873],"genre_scores_gemma":[0.0040717456,0.9932434,0.00008655282,0.0002861519,0.00052132696,0.00040969398,0.00021037598,0.00013824622,0.0010324921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99458134,0.002367977,0.0012904507,0.0006080717,0.00047303046,0.0006791187],"domain_scores_gemma":[0.99755234,0.00026270733,0.00094573345,0.0008072743,0.00020533141,0.00022661993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010602331,0.0007628241,0.0019450415,0.00024942073,0.000173212,0.00007650179,0.0010231279,0.0009882667,0.00015006041],"category_scores_gemma":[0.000049567927,0.0004962416,0.0010974702,0.00060624356,0.000533704,0.00005047577,0.00029705695,0.0010661198,0.0001039274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017781336,0.00023869102,0.00001236216,0.00880614,0.001220726,0.00015008078,0.0000630255,0.000033260763,0.0005780161,0.0013801965,0.008645441,0.9788543],"study_design_scores_gemma":[0.00036518578,0.000033161567,0.0000040048485,0.0010409342,0.0029627602,0.00009029163,0.000007677896,0.00009977546,0.0056393216,0.000019262576,0.9892338,0.00050385075],"about_ca_topic_score_codex":0.00008429016,"about_ca_topic_score_gemma":0.0000047062053,"teacher_disagreement_score":0.9805883,"about_ca_system_score_codex":0.000069254056,"about_ca_system_score_gemma":0.00039730925,"threshold_uncertainty_score":0.99974895},"labels":[],"label_agreement":null},{"id":"W2027851095","doi":"10.1038/clpt.2011.280","title":"Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children; University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Codeine; Medicine; CYP2D6; Odds ratio; Pharmacogenetics; Catechol-O-methyl transferase; Depression (economics); Opioid; Genotype; Clinical pharmacology; Pharmacology; Breastfeeding; Internal medicine; Bioinformatics; Pediatrics; Biology; Genetics; Receptor; Morphine; Gene; Cytochrome P450","score_opus":0.25220514093363794,"score_gpt":0.47173391498590633,"score_spread":0.2195287740522684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027851095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117255,0.003327422,0.00092357944,0.0002760941,0.0033145808,0.00056969747,0.00023104154,0.000025586784,0.00015947061],"genre_scores_gemma":[0.9901591,0.0037088364,0.0010029502,0.004684424,0.00036270067,0.000017288152,0.000008364015,0.000037746937,0.000018595281],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996775,0.00094408967,0.0012753052,0.00030796012,0.00015559379,0.00054208946],"domain_scores_gemma":[0.99799985,0.0008233392,0.00058838964,0.00017112211,0.00015137525,0.00026593334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002004828,0.0002973911,0.0006677041,0.00022624298,0.000077053905,0.000004946401,0.00028192173,0.0005082643,0.00031611396],"category_scores_gemma":[0.000027811102,0.00027384685,0.00014997447,0.00028489355,0.0008372651,0.00013038467,0.00014823514,0.0007678252,0.0000029438936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010960511,0.0017198799,0.42996424,0.000057157213,0.00050214195,0.0000013158818,0.0006202781,0.00061362406,0.5537344,0.000030885683,0.0000790614,0.011580937],"study_design_scores_gemma":[0.010506165,0.000391465,0.63784677,0.000032254266,0.0010931018,0.000033592278,0.00014446148,0.08115508,0.26023585,0.00025258044,0.008006582,0.000302106],"about_ca_topic_score_codex":0.000017560014,"about_ca_topic_score_gemma":0.0000024555068,"teacher_disagreement_score":0.29349858,"about_ca_system_score_codex":0.00004776359,"about_ca_system_score_gemma":0.0000970241,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W2027884629","doi":"10.1159/000242572","title":"Indomethacin Metabolism in Liver Microsomes during Postnatal Development in the Rat","year":2009,"lang":"en","type":"article","venue":"Biology of the Neonate","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Phenobarbital; Metabolism; Endocrinology; Internal medicine; Microsome; Monooxygenase; Enzyme; Chemistry; Drug metabolism; Cytochrome P450; Biology; Biochemistry; Medicine","score_opus":0.0605789463448444,"score_gpt":0.37981095174788804,"score_spread":0.31923200540304364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027884629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827914,0.01375001,0.0000020128562,0.0015064237,0.0008680247,0.00041305987,0.000023181108,0.00001185109,0.0006340009],"genre_scores_gemma":[0.99528146,0.0014057768,0.00017872211,0.0027526263,0.00008973833,0.000025111261,0.000007523503,0.000008514708,0.00025055007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769807,0.0009985381,0.00047223555,0.00026636972,0.00010595636,0.00045882093],"domain_scores_gemma":[0.9992962,0.00022273869,0.00016594243,0.00022345601,0.000037776143,0.000053912438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012314477,0.00021399689,0.00033495805,0.00020049601,0.00013552391,0.000006720838,0.00083810306,0.00025783415,0.000106681015],"category_scores_gemma":[0.0000696109,0.00013097085,0.00010524883,0.00037352822,0.00024159654,0.00004638314,0.00015693059,0.00065781653,0.000018715726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039584175,0.00031087623,0.011379428,0.00001979968,0.00006164407,0.00004082674,0.0038338443,0.0001555611,0.9462517,0.0011530683,0.00014810651,0.036249314],"study_design_scores_gemma":[0.002410258,0.000017552664,0.24239168,0.000009127499,0.00003149699,0.000035066092,0.00006463195,0.0000408067,0.6773178,0.0004978162,0.077023275,0.00016049508],"about_ca_topic_score_codex":0.000025242243,"about_ca_topic_score_gemma":0.000041403644,"teacher_disagreement_score":0.2689339,"about_ca_system_score_codex":0.000031032854,"about_ca_system_score_gemma":0.000079917554,"threshold_uncertainty_score":0.5340836},"labels":[],"label_agreement":null},{"id":"W2028021793","doi":"10.1002/jbt.10023","title":"Acute sodium arsenite treatment induces <i>Cyp2a5</i> but not <i>Cyp1a1</i> in the C57Bl/6 mouse in a tissue (kidney) selective manner","year":2002,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Chemistry; Monooxygenase; Kidney; Cytochrome P450; Sodium arsenite; Heme oxygenase; Glutathione; Heme; Enzyme; Messenger RNA; Bilirubin; Internal medicine; Endocrinology; Biochemistry; Biology; Gene; Medicine","score_opus":0.0485822596568027,"score_gpt":0.3632461314711738,"score_spread":0.3146638718143711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028021793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868477,0.0042978213,0.000014882236,0.006597753,0.00038144542,0.00039884436,0.000049452057,0.000007731744,0.0014043935],"genre_scores_gemma":[0.97823995,0.004037212,0.00019067875,0.016682608,0.00021228922,0.00005123456,0.0000070421133,0.000022168326,0.0005568047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975053,0.0006823323,0.0006835775,0.00033252191,0.00021694419,0.0005793154],"domain_scores_gemma":[0.99886215,0.00023627526,0.0002963369,0.00015747016,0.000086001644,0.00036178928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005319442,0.00032974643,0.0005719192,0.00027406483,0.00009889096,0.000023001223,0.00036398426,0.00049271004,0.00022919147],"category_scores_gemma":[0.00009035102,0.00023531675,0.00015536617,0.00032829176,0.00027571112,0.000065796405,0.000093359755,0.0010049306,0.00003055186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006707298,0.0011251576,0.00026029255,0.000013095857,0.00021045547,0.0013204868,0.0010204393,0.000026502183,0.9854725,0.00008673101,0.0052813673,0.004512265],"study_design_scores_gemma":[0.004710848,0.00055663515,0.00015998594,0.000009087512,0.00025958626,0.0008764813,0.00006282993,0.00018993829,0.892561,0.00019529436,0.100190625,0.00022765534],"about_ca_topic_score_codex":0.000011763866,"about_ca_topic_score_gemma":0.000010199428,"teacher_disagreement_score":0.09490926,"about_ca_system_score_codex":0.00013846242,"about_ca_system_score_gemma":0.000072723386,"threshold_uncertainty_score":0.9595939},"labels":[],"label_agreement":null},{"id":"W2028166816","doi":"10.1097/00004714-200112000-00011","title":"Treatment-Resistance to Clozapine in Association With Ultrarapid CYP1A2 Activity and the C → A Polymorphism in Intron 1 of the CYP1A2 Gene: Effect of Grapefruit Juice and Low-Dose Fluvoxamine","year":2001,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clozapine; Fluvoxamine; CYP1A2; Pharmacology; Atypical antipsychotic; Antipsychotic; Metabolite; Cytochrome P450; CYP2D6; Medicine; Pharmacokinetics; Chemistry; Internal medicine; Schizophrenia (object-oriented programming); Fluoxetine; Metabolism; Psychiatry; Receptor","score_opus":0.0458833678902309,"score_gpt":0.4533985987353348,"score_spread":0.4075152308451039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028166816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562384,0.004396958,0.000011461709,0.0071398816,0.001695833,0.0009054388,0.000025017509,0.0000040108134,0.00019756106],"genre_scores_gemma":[0.9824648,0.01542553,0.00007037289,0.00145311,0.00035653764,0.000036855112,7.207455e-7,0.000019073294,0.00017298426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99355763,0.0039344095,0.0015290469,0.00030301354,0.00029162897,0.00038424332],"domain_scores_gemma":[0.9923398,0.005464964,0.0016094699,0.00018636615,0.0001622068,0.00023720949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049737412,0.00028961504,0.0013023304,0.00024374678,0.00007410289,0.000008553828,0.00036185156,0.00033763135,0.0000678978],"category_scores_gemma":[0.0006138872,0.0001618721,0.00022896989,0.0006041362,0.00054579094,0.00010148365,0.000069017246,0.0012083653,0.0000014350795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09503003,0.0016681901,0.6145554,0.00007955484,0.00086961465,0.00008433446,0.00082202605,0.00040840553,0.23682703,0.00004619324,0.0005027637,0.049106415],"study_design_scores_gemma":[0.11286297,0.0024792585,0.7797001,0.000083061255,0.0012169648,0.000114845156,0.00003166909,0.00067155727,0.08750976,0.0002546892,0.014803756,0.00027137066],"about_ca_topic_score_codex":0.000051685463,"about_ca_topic_score_gemma":0.00015863052,"teacher_disagreement_score":0.16514465,"about_ca_system_score_codex":0.000084033316,"about_ca_system_score_gemma":0.00014826436,"threshold_uncertainty_score":0.6600953},"labels":[],"label_agreement":null},{"id":"W2028825845","doi":"10.1002/rcm.3092","title":"Investigating the <i>in vitro</i> metabolism of fipexide: characterization of reactive metabolites using liquid chromatography/mass spectrometry","year":2007,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Metabolite; Chromatography; Mass spectrometry; Tandem mass spectrometry; Metabolism; Drug metabolism; In vitro; Designer drug; Biochemistry; Drug; Pharmacology","score_opus":0.07958362151495889,"score_gpt":0.39506622960449916,"score_spread":0.31548260808954026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028825845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788155,0.013563356,0.0027619624,0.0004827332,0.00043635743,0.00070065877,0.00016925303,0.000045519384,0.003024638],"genre_scores_gemma":[0.95399046,0.0058226977,0.039505024,0.00033571347,0.00014644959,0.000044616052,0.000091150825,0.0000518576,0.00001201774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99532765,0.0014945075,0.001609305,0.00041861943,0.00041633923,0.0007335784],"domain_scores_gemma":[0.9954824,0.0015615978,0.0010982234,0.001452916,0.00023633875,0.0001685677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047129528,0.00039258169,0.0008854432,0.0018988837,0.00024709103,0.000022672246,0.0017521865,0.00033312745,0.00014337101],"category_scores_gemma":[0.00035650493,0.00037004394,0.00027312443,0.0051447297,0.000912851,0.000282358,0.00034726865,0.0015917262,0.0000042025245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020558959,0.0004807246,0.008984681,0.000052858806,0.00023840861,0.0000024798023,0.00093195966,0.0000958349,0.98074865,0.006833962,0.0000031101017,0.0014217362],"study_design_scores_gemma":[0.0013415706,0.00004595886,0.045417387,0.000043498003,0.0002536963,0.00001022276,0.0005290253,0.0035837214,0.94423276,0.0022129393,0.0020175558,0.000311669],"about_ca_topic_score_codex":0.00010886719,"about_ca_topic_score_gemma":0.000015521306,"teacher_disagreement_score":0.036743063,"about_ca_system_score_codex":0.00013566524,"about_ca_system_score_gemma":0.00017023986,"threshold_uncertainty_score":0.9998751},"labels":[],"label_agreement":null},{"id":"W2028902084","doi":"10.1136/jech-2014-204489","title":"Risk of overdose and death following codeine prescription among immigrants","year":2014,"lang":"en","type":"article","venue":"Journal of Epidemiology & Community Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Codeine; Medical prescription; Immigration; Emergency medicine; Medical emergency; Psychiatry; Anesthesia; Pharmacology","score_opus":0.1801273029800061,"score_gpt":0.48633813327460407,"score_spread":0.30621083029459795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028902084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836105,0.010410322,0.0028502438,0.0011836612,0.0012874472,0.00020047261,0.000041143787,0.0000138661435,0.0004023148],"genre_scores_gemma":[0.9777262,0.015441082,0.0023384446,0.004193439,0.000241548,0.0000030637104,0.0000089487285,0.000018991359,0.000028272121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97958714,0.017987972,0.001617086,0.00016197204,0.0001317091,0.0005141401],"domain_scores_gemma":[0.9898055,0.0067873076,0.0022699318,0.000388887,0.00018501187,0.00056331995],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.029464196,0.00022906336,0.0012500436,0.00023140166,0.00055876625,0.000004556685,0.00044456613,0.00031555523,0.00004353195],"category_scores_gemma":[0.005142013,0.00019447107,0.0002877676,0.00013521743,0.00022558587,0.00014828757,0.0001669364,0.002944302,0.0000025139082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038305423,0.00040998365,0.9598478,0.000118883385,0.0004715649,0.000003115932,0.0011436138,0.0011270054,0.0031882273,0.0010712568,0.0017565447,0.030478926],"study_design_scores_gemma":[0.00347009,0.0009218269,0.94442725,0.00011169791,0.0004723266,0.00005603224,0.00020595008,0.0060153003,0.00091556256,0.009494148,0.033729546,0.0001802955],"about_ca_topic_score_codex":0.0030394553,"about_ca_topic_score_gemma":0.0005403073,"teacher_disagreement_score":0.031973004,"about_ca_system_score_codex":0.00007176498,"about_ca_system_score_gemma":0.00015887975,"threshold_uncertainty_score":0.9993709},"labels":[],"label_agreement":null},{"id":"W2029744552","doi":"10.1016/s0040-4039(02)01206-6","title":"An efficient approach to the synthesis of LTB4 and ω-substituted LTB4 metabolites","year":2002,"lang":"en","type":"article","venue":"Tetrahedron Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); McGill University","funders":"National Institutes of Health","keywords":"Chemistry; Synthon; Metabolite; Aldehyde dehydrogenase; Aldehyde; Total synthesis; Cytosol; Catalysis; Organic chemistry; Biochemistry; Enzyme","score_opus":0.08084426649477261,"score_gpt":0.35883641360099305,"score_spread":0.27799214710622044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029744552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98702866,0.0034472742,0.00069536734,0.0036359802,0.00069365825,0.00053511356,0.000103859245,0.0000748434,0.0037852658],"genre_scores_gemma":[0.9907392,0.00033765522,0.0013492958,0.0070956284,0.0002891998,0.00009420312,0.0000062230147,0.000031356845,0.000057189063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791586,0.0004891305,0.0003866819,0.00043624415,0.00025968326,0.00051239115],"domain_scores_gemma":[0.9987276,0.00034355134,0.00012018942,0.00040587012,0.000052349566,0.0003504375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008051434,0.00028282937,0.00037585304,0.0001859502,0.00024953822,0.000032625372,0.00052682956,0.0001360811,0.0004023146],"category_scores_gemma":[0.00008847873,0.00021235379,0.00010383029,0.00039196046,0.0003292589,0.00006676058,0.00008043893,0.0004220599,0.000079828584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013752568,0.0012691586,0.002343404,0.000089339155,0.00038081504,0.000013892552,0.004258146,0.03979092,0.8767581,0.002530738,0.009035141,0.063392796],"study_design_scores_gemma":[0.0020936192,0.000079257276,0.016066533,0.000019056757,0.0011627519,0.000060665607,0.00040196144,0.13873163,0.5175661,0.000041799864,0.32285735,0.0009192728],"about_ca_topic_score_codex":0.000024338018,"about_ca_topic_score_gemma":0.0000017022206,"teacher_disagreement_score":0.359192,"about_ca_system_score_codex":0.000022103783,"about_ca_system_score_gemma":0.000011460965,"threshold_uncertainty_score":0.8659536},"labels":[],"label_agreement":null},{"id":"W2030018298","doi":"10.1097/fpc.0b013e3283349e84","title":"Cytochrome P450 2C9-CYP2C9","year":2010,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Institute of General Medical Sciences; National Institutes of Health; Mashhad University of Medical Sciences","keywords":"CYP2C9; Cytochrome P450; Biology; Biochemistry; Metabolism","score_opus":0.21651714893957597,"score_gpt":0.504793880293876,"score_spread":0.2882767313543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030018298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013348508,0.98702294,0.000049330116,0.00011422364,0.003835562,0.0019676967,0.001607141,0.00016612353,0.0039021592],"genre_scores_gemma":[0.00012238344,0.99186784,0.0009767218,0.0014175205,0.0031896106,0.00033258102,0.00035489263,0.00037046982,0.0013679652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942553,0.00071407907,0.0016576517,0.001479661,0.000381039,0.0015122792],"domain_scores_gemma":[0.996081,0.00057670794,0.000849269,0.00079196494,0.00019009318,0.001510979],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0012776288,0.0016164635,0.002812355,0.00055559876,0.0006466088,0.00018629408,0.0013390798,0.0020116381,0.001552591],"category_scores_gemma":[0.000062465595,0.0015369364,0.0008971405,0.00049956207,0.0006203877,0.000086282336,0.00089190144,0.004330126,0.0007825859],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036440582,0.00023642264,0.0000061206706,0.0030812777,0.00075785664,0.000096628784,0.0001646992,0.00002027927,0.0069497973,0.00030536164,0.0020118474,0.98633325],"study_design_scores_gemma":[0.0014091356,0.00006137304,0.000007224497,0.0002524326,0.005819357,0.00039395673,0.0000094039915,0.000552443,0.00096219144,0.00042805736,0.988477,0.0016274233],"about_ca_topic_score_codex":0.0000086896025,"about_ca_topic_score_gemma":0.000006125917,"teacher_disagreement_score":0.98646516,"about_ca_system_score_codex":0.00012968734,"about_ca_system_score_gemma":0.00075955567,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W2030065493","doi":"10.1177/1091581810388307","title":"Effects in Rats of Maternal Exposure to Raspberry Leaf and Its Constituents on the Activity of Cytochrome P450 Enzymes in the Offspring","year":2010,"lang":"en","type":"article","venue":"International Journal of Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; McMaster University","keywords":"Offspring; Biotransformation; Kaempferol; Cytochrome P450; Biology; Ellagic acid; Quercetin; Weaning; CYP1B1; Enzyme; Physiology; Internal medicine; Endocrinology; Pregnancy; Biochemistry; Antioxidant; Medicine; Polyphenol","score_opus":0.05433120400376857,"score_gpt":0.4061784750775488,"score_spread":0.3518472710737802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030065493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392813,0.00041957336,0.000014247293,0.0031621105,0.0017130794,0.0002966874,0.000023589251,0.000001898217,0.00044066866],"genre_scores_gemma":[0.9979574,0.00016492895,0.000054580283,0.0015502603,0.0002310729,0.000014769897,3.440579e-7,0.0000075277553,0.000019087534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982916,0.0005861949,0.0005060642,0.00012810671,0.00029418318,0.00019383145],"domain_scores_gemma":[0.9978399,0.0013996405,0.00041472545,0.000083853505,0.00018303715,0.00007881816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015932632,0.00013617978,0.00031741874,0.00033002603,0.000033455013,0.000011719835,0.0006930629,0.00016451525,0.00016477072],"category_scores_gemma":[0.00041838156,0.000089295594,0.0000783707,0.00011918908,0.00016752667,0.00007933778,0.00012279469,0.0009820829,0.0000046118853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010439927,0.00048715502,0.017353347,0.00001938481,0.00014615002,0.00015051842,0.00070207496,0.00076812913,0.9661789,0.007935736,0.00010696517,0.00510766],"study_design_scores_gemma":[0.0016663658,0.0002103563,0.32270265,0.000037564318,0.000033394193,0.0001441974,0.000032619868,0.00020868682,0.6728926,0.00046702055,0.0015412782,0.00006326474],"about_ca_topic_score_codex":0.0000125187535,"about_ca_topic_score_gemma":0.00006954691,"teacher_disagreement_score":0.30534932,"about_ca_system_score_codex":0.000027955033,"about_ca_system_score_gemma":0.00010260631,"threshold_uncertainty_score":0.42667162},"labels":[],"label_agreement":null},{"id":"W2030646690","doi":"10.1592/phco.22.8.673.33210","title":"The Association of St. John's Wort with Elevated Thyroid‐Stimulating Hormone","year":2002,"lang":"en","type":"letter","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Citation; Library science; Computer science","score_opus":0.05185567973223974,"score_gpt":0.3753069574817535,"score_spread":0.32345127774951377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030646690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6203228,0.14248908,0.00003748179,0.22860506,0.0049247863,0.002136805,0.00026599766,0.00009941118,0.0011185274],"genre_scores_gemma":[0.41057423,0.28561065,0.00006420914,0.2870498,0.010288184,0.000095477095,0.000044977576,0.00031323472,0.005959254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98924756,0.0055441167,0.0021408265,0.00052077626,0.0011921369,0.0013545759],"domain_scores_gemma":[0.9881722,0.0051895664,0.0047350726,0.00044302744,0.0011411518,0.00031898767],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0072244196,0.0010985665,0.0015674598,0.00047475877,0.0018141712,0.000105972016,0.0019536058,0.0009977596,0.0014962876],"category_scores_gemma":[0.00004522705,0.0006335392,0.00052855123,0.0006156238,0.0011490328,0.00028435467,0.00014007595,0.0085077705,0.000013854848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031749615,0.00034131887,0.00089779764,0.000047610087,0.004657033,0.00015008252,0.0018014384,0.00039757177,0.33452037,0.000017050148,0.645583,0.008411811],"study_design_scores_gemma":[0.015211355,0.001494747,0.00021624564,0.00004427347,0.0024274155,0.00022991348,0.00012201419,0.00055503176,0.06735229,0.00044798525,0.9111681,0.0007306429],"about_ca_topic_score_codex":0.000020413207,"about_ca_topic_score_gemma":0.0000058181895,"teacher_disagreement_score":0.2671681,"about_ca_system_score_codex":0.00021434033,"about_ca_system_score_gemma":0.00026942734,"threshold_uncertainty_score":0.9996116},"labels":[],"label_agreement":null},{"id":"W2031575997","doi":"10.1007/s00228-013-1592-7","title":"Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates","year":2013,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Beef Cattle Research Council; GlaxoSmithKline","keywords":"Omeprazole; Pharmacology; CYP2C19; Pharmacokinetics; CYP3A4; Rosuvastatin; Chemistry; Pioglitazone; Oral administration; In vivo; Medicine; Cytochrome P450; Endocrinology; Enzyme; Type 2 diabetes; Biology; Biochemistry; Diabetes mellitus","score_opus":0.1660924149876682,"score_gpt":0.4554010342335258,"score_spread":0.2893086192458576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031575997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133134,0.004647267,0.00007481047,0.0011750705,0.0018015081,0.00052425737,0.000015802638,0.000008443431,0.00042150286],"genre_scores_gemma":[0.99037313,0.007159319,0.00020977379,0.0015867117,0.00061204884,0.0000036111712,4.9641164e-7,0.000033280237,0.000021609889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994267,0.0036101262,0.0012829287,0.0002881558,0.00019441966,0.0003574005],"domain_scores_gemma":[0.99429435,0.0038169338,0.0011440126,0.00010950135,0.00020903345,0.00042619556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038661913,0.00028470036,0.00086772843,0.00014180018,0.00012520014,0.000016508662,0.00029960895,0.00015203857,0.00020883341],"category_scores_gemma":[0.00023502692,0.00019873319,0.00018541154,0.00012512544,0.0011852932,0.0001589704,0.00010384429,0.0012761997,0.000004514984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017699355,0.00082547986,0.015261446,0.00029108452,0.0007792502,0.0001635315,0.0006419022,0.000118591386,0.9220406,0.00015682833,0.0012261859,0.056725167],"study_design_scores_gemma":[0.0097114025,0.0017701596,0.32922357,0.0001133074,0.00164599,0.00015505108,0.00008566112,0.0019662832,0.64766216,0.00034756813,0.006996568,0.0003222646],"about_ca_topic_score_codex":0.0000068883396,"about_ca_topic_score_gemma":4.635884e-7,"teacher_disagreement_score":0.31396213,"about_ca_system_score_codex":0.000008700942,"about_ca_system_score_gemma":0.00008798641,"threshold_uncertainty_score":0.81041044},"labels":[],"label_agreement":null},{"id":"W2031623172","doi":"10.1139/bcb-2014-0088","title":"Cytochrome P450 expression in mouse brain: specific isoenzymes involved in Phase I metabolizing system of porphyrinogenic agents in both microsomes and mitochondria","year":2014,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Secretaría de Ciencia y Técnica, Universidad de Buenos Aires; Universidad de Buenos Aires; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Microsome; CYP2E1; Mitochondrion; Cytochrome P450; Chemistry; Pharmacology; Biochemistry; Biology; Enzyme","score_opus":0.053806717972345756,"score_gpt":0.360197004842612,"score_spread":0.30639028687026626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031623172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769785,0.021755977,0.000013556839,0.000060724116,0.0002053647,0.00029280392,0.00009496095,0.000016606082,0.0005815186],"genre_scores_gemma":[0.99591374,0.0032885396,0.00018566388,0.00022227815,0.00012943633,0.000042725977,0.000055476507,0.0000185254,0.00014360448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780506,0.0004785674,0.00063807855,0.0005520684,0.00006278045,0.0004634555],"domain_scores_gemma":[0.99915975,0.00022079478,0.00021459846,0.00020545551,0.000024131936,0.00017523704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006298839,0.00029176055,0.0005969202,0.0002083587,0.00005764152,0.000010942375,0.00022214038,0.0004877024,0.000064562126],"category_scores_gemma":[0.00003390078,0.0002827556,0.000060056984,0.00020138505,0.00027339146,0.00004542487,0.00016606058,0.00044460245,0.0000030123883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037961302,0.00038812333,0.016406352,0.00030856018,0.000018379103,0.000018217701,0.00034470294,0.000017699824,0.9803449,0.00007745023,0.00016914158,0.0015268438],"study_design_scores_gemma":[0.007068174,0.0000587128,0.0035169148,0.000050661805,0.000020065492,0.000009231145,0.00026979353,0.0004943324,0.9717877,0.000056176323,0.01640176,0.00026649705],"about_ca_topic_score_codex":0.000025601015,"about_ca_topic_score_gemma":0.000010267495,"teacher_disagreement_score":0.018935261,"about_ca_system_score_codex":0.0000344527,"about_ca_system_score_gemma":0.000040731557,"threshold_uncertainty_score":0.99996245},"labels":[],"label_agreement":null},{"id":"W2031652509","doi":"10.1002/jps.23288","title":"Comparative Assessment of In Vitro–In Vivo Extrapolation Methods used for Predicting Hepatic Metabolic Clearance of Drugs","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Genentech","keywords":"In vivo; Pharmacology; Chemistry; Drug; Pharmacokinetics; Medicine; Biology","score_opus":0.2504778167021015,"score_gpt":0.5828243398569454,"score_spread":0.33234652315484386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031652509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98561186,0.007727966,0.0037239506,0.00023232058,0.001333508,0.00046650073,0.000037335914,0.000004927598,0.00086166017],"genre_scores_gemma":[0.9687772,0.0007594048,0.030013062,0.00018113786,0.00023440101,0.000016769836,5.9606725e-7,0.000008893186,0.000008528893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958599,0.0015218516,0.0013700309,0.00018837945,0.00048535247,0.00057444634],"domain_scores_gemma":[0.996307,0.0021794948,0.00094319176,0.00007684735,0.00020484657,0.0002885757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011566748,0.00019468092,0.0008511911,0.00047154937,0.000094948526,0.000012084765,0.00043467735,0.00013184824,0.00019804524],"category_scores_gemma":[0.00020076001,0.00015895392,0.00020958921,0.00085320836,0.00051725446,0.000457343,0.0000605728,0.00064879115,5.303757e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046732707,0.00084116583,0.12894413,0.000090839196,0.000098016826,0.0000011775996,0.003036497,0.004007582,0.848548,0.0012171842,0.000018086801,0.012729988],"study_design_scores_gemma":[0.0029598563,0.0001270047,0.039493408,0.000042906184,0.00023569024,0.000008605026,0.0005559756,0.14954077,0.80011976,0.00046535002,0.006307022,0.0001436479],"about_ca_topic_score_codex":0.000014222982,"about_ca_topic_score_gemma":0.000002622213,"teacher_disagreement_score":0.14553319,"about_ca_system_score_codex":0.0000465953,"about_ca_system_score_gemma":0.00021349252,"threshold_uncertainty_score":0.64819527},"labels":[],"label_agreement":null},{"id":"W2032334516","doi":"10.1007/s10552-012-0088-6","title":"CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment","year":2012,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"CYP2C9; Colorectal adenoma; Medicine; Internal medicine; Aspirin; Relative risk; Gastroenterology; Adenoma; Genotype; Allele; Endocrinology; Confidence interval; Colorectal cancer; Genetics; Biology; Cytochrome P450; Cancer; Metabolism","score_opus":0.08161629301114395,"score_gpt":0.39518510890856806,"score_spread":0.31356881589742414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032334516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336893,0.0112344185,0.00012199204,0.00016999737,0.0008466665,0.00060757104,0.00303481,0.00003685076,0.00057875266],"genre_scores_gemma":[0.9943922,0.0039302153,0.00008760754,0.00070670753,0.00043407906,0.00030772926,0.000020800771,0.000027323575,0.0000933313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981282,0.0005156004,0.0003390413,0.0002853897,0.00017804546,0.00055374665],"domain_scores_gemma":[0.9983087,0.00058230344,0.00039226023,0.00015592744,0.00015381744,0.0004069909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050813745,0.00028128503,0.00048736157,0.00009190967,0.0002545103,0.000018862984,0.00013996023,0.00019731118,0.00028170345],"category_scores_gemma":[0.00009737294,0.00023366335,0.00008261621,0.0001535107,0.00018958318,0.00015207866,0.00004113541,0.00036813578,0.000008091448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014369712,0.0006144291,0.90563625,0.000030132409,0.001984171,0.000015895805,0.0014800347,0.0008512023,0.054807395,0.00044199193,0.00016318723,0.032538354],"study_design_scores_gemma":[0.015793683,0.00044000853,0.8436379,0.000039578863,0.005107797,0.000025111889,0.00011603759,0.0047377604,0.106817015,0.00008248052,0.022607101,0.00059555937],"about_ca_topic_score_codex":0.0008607079,"about_ca_topic_score_gemma":0.00014751933,"teacher_disagreement_score":0.061998364,"about_ca_system_score_codex":0.0001694417,"about_ca_system_score_gemma":0.00023791243,"threshold_uncertainty_score":0.9528515},"labels":[],"label_agreement":null},{"id":"W2032586769","doi":"10.1002/jps.1074","title":"Enantiomeric drug development: Issues, considerations, and regulatory requirements","year":2001,"lang":"en","type":"review","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Enantiomer; Pharmacology; Medicine; Drug development; Pharmacodynamics; Pharmacokinetics; Chemistry; Drug; Stereochemistry","score_opus":0.37898506675273774,"score_gpt":0.5552674945783355,"score_spread":0.17628242782559772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032586769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010039168,0.9933697,0.000016867967,0.0004980288,0.0029578484,0.0004626726,0.000022338543,0.00002580187,0.0016428204],"genre_scores_gemma":[0.00051975885,0.99454695,0.0021725516,0.00097083574,0.0010210415,0.00001745017,0.0000047973513,0.00003627074,0.00071034714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944648,0.0013746787,0.0019971742,0.00052269374,0.00085947505,0.0007811931],"domain_scores_gemma":[0.9964531,0.00091833516,0.0013576216,0.0001555599,0.0002438609,0.0008715135],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005575507,0.0005902944,0.0017342593,0.00068107125,0.0007860012,0.00016276185,0.000705825,0.00037404432,0.0019958687],"category_scores_gemma":[0.00027089077,0.00042887562,0.00037092995,0.0008841456,0.001218058,0.00038307768,0.00027034266,0.0016116892,0.00008976644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021127009,0.00024362546,0.00007160937,0.0013833367,0.0004645564,0.00020867206,0.00021000698,0.000009353506,0.00014631891,0.0008882341,0.008603713,0.98774946],"study_design_scores_gemma":[0.0008423993,0.000051096064,0.000014939091,0.0010247707,0.0016014867,0.0011268777,0.00003727594,0.000062820545,0.0006183065,0.0005183918,0.99362385,0.0004777669],"about_ca_topic_score_codex":0.0000025397937,"about_ca_topic_score_gemma":0.0000012423691,"teacher_disagreement_score":0.98727167,"about_ca_system_score_codex":0.00012721767,"about_ca_system_score_gemma":0.0013190162,"threshold_uncertainty_score":0.9998163},"labels":[],"label_agreement":null},{"id":"W2032878259","doi":"10.1016/j.amjopharm.2006.03.001","title":"Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review","year":2006,"lang":"en","type":"review","venue":"˜The œAmerican journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"China Aerospace Science and Technology Corporation; Heart and Stroke Foundation of Canada","keywords":"Warfarin; Azathioprine; Discontinuation; Medicine; Drug interaction; Anticoagulant; Gastroenterology; Internal medicine; Pharmacology; Pharmacokinetics; Atrial fibrillation","score_opus":0.06018615349957545,"score_gpt":0.43892958919414293,"score_spread":0.3787434356945675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032878259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13447827,0.8630171,0.000029650459,0.00019929466,0.0008413614,0.001183906,0.00022693315,0.000008049868,0.000015475669],"genre_scores_gemma":[0.016924646,0.9814737,0.000107226195,0.00054351246,0.0007994765,0.00003533052,0.000009764236,0.000063901796,0.00004243474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926701,0.0038176859,0.0022556894,0.0004262008,0.00047089282,0.00035939654],"domain_scores_gemma":[0.990658,0.0019398164,0.006372451,0.000462303,0.00032677114,0.00024066253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038022178,0.00067510235,0.0033215901,0.00029520673,0.00018173405,0.000034503504,0.00055620295,0.0002140398,0.00006241601],"category_scores_gemma":[0.00010246903,0.00035773544,0.00089406024,0.0013044194,0.00072143937,0.00012168395,0.00018805372,0.0017326412,8.552561e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053945975,0.00017717747,0.00029176346,0.0145243285,0.0014541863,0.008419688,0.0003291641,0.000008166829,0.008709626,0.0000026875,0.0015181504,0.9640256],"study_design_scores_gemma":[0.0035418707,0.00090500095,0.00012578834,0.033848945,0.020835772,0.13971975,0.000018804416,0.00009466438,0.006194034,0.0000681895,0.7938648,0.00078239717],"about_ca_topic_score_codex":0.00009237422,"about_ca_topic_score_gemma":0.0000024876126,"teacher_disagreement_score":0.9632432,"about_ca_system_score_codex":0.000049350183,"about_ca_system_score_gemma":0.00033855962,"threshold_uncertainty_score":0.99988747},"labels":[],"label_agreement":null},{"id":"W2033334346","doi":"10.1016/j.vascn.2006.07.002","title":"Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine","year":2006,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CYP3A; Fluorescence; Substrate (aquarium); Chemistry; Biology; Biochemistry; Cytochrome P450; Enzyme; Ecology; Physics","score_opus":0.3033270995124598,"score_gpt":0.5003424430822251,"score_spread":0.1970153435697653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033334346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721086,0.012257232,0.008716638,0.004728262,0.000710484,0.0013400968,0.00002578781,0.0000071889917,0.00010570589],"genre_scores_gemma":[0.9822458,0.0063433773,0.009554483,0.0014627291,0.0002770866,0.000079816295,0.0000013675251,0.000007968039,0.000027386386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9939361,0.0042338804,0.0010719999,0.00022119626,0.00021812954,0.00031868444],"domain_scores_gemma":[0.9804839,0.018095044,0.0008555244,0.00010286239,0.0003653019,0.00009740516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008818607,0.00023124118,0.0006398792,0.000095077834,0.00022020761,0.00003497254,0.00045968354,0.00023364378,0.00008376001],"category_scores_gemma":[0.0013054329,0.00009277138,0.00023510898,0.00038203155,0.001441012,0.00009585517,0.000113959904,0.0010281986,3.2188746e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009150696,0.0018476975,0.0042235004,0.00007225067,0.00041905238,0.0000368078,0.0007259796,0.0026828982,0.8539609,0.023576986,0.0019473998,0.10135584],"study_design_scores_gemma":[0.014635408,0.0019463233,0.15029131,0.000037675414,0.0032249896,0.00041803188,0.000486286,0.05373105,0.70071596,0.029917741,0.044193767,0.00040144954],"about_ca_topic_score_codex":0.000017639315,"about_ca_topic_score_gemma":0.0000051934626,"teacher_disagreement_score":0.15324491,"about_ca_system_score_codex":0.000020971764,"about_ca_system_score_gemma":0.00005721193,"threshold_uncertainty_score":0.5309469},"labels":[],"label_agreement":null},{"id":"W2033719606","doi":"10.1002/jat.1172","title":"4‐Aminobiphenyl <i>N</i>‐glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP‐glucuronosyltransferase isoforms","year":2006,"lang":"en","type":"article","venue":"Journal of Applied Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"U.S. Public Health Service","keywords":"Glucuronidation; Microsome; Gene isoform; Chemistry; Biochemistry; Isozyme; Enzyme; Gene","score_opus":0.019494362091555875,"score_gpt":0.3024328709927072,"score_spread":0.28293850890115135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033719606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497855,0.00029842218,0.0016517465,0.00072779035,0.0009749881,0.0004976353,0.00018408953,0.000006707182,0.00068009767],"genre_scores_gemma":[0.9978633,0.0009566779,0.00015465183,0.0006743388,0.00018429375,0.000014374444,0.00004436563,0.00001759516,0.00009040591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844617,0.00022995794,0.00079000794,0.00014681305,0.0001848733,0.00020218999],"domain_scores_gemma":[0.99832654,0.00014296053,0.0011045131,0.00014898725,0.00021343784,0.00006356683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004572626,0.0001683532,0.0003190841,0.00010657519,0.00020515645,0.000010328624,0.00026752998,0.00025927663,0.0001382273],"category_scores_gemma":[0.000020059862,0.00011284851,0.00012662461,0.00026787687,0.00037876898,0.00013686309,0.000055639426,0.00045128362,0.0000012966835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002437547,0.0004064474,0.0010355418,0.000041255244,0.00008174376,6.372593e-7,0.0002610242,0.004333576,0.9897734,0.001533503,0.00057926326,0.0017098549],"study_design_scores_gemma":[0.0019547958,0.00009912931,0.024819812,0.000014352922,0.00037592882,0.000047410133,0.000051403174,0.0013027044,0.95371336,0.00048242672,0.017021174,0.00011752077],"about_ca_topic_score_codex":0.0000067653195,"about_ca_topic_score_gemma":0.0000048038287,"teacher_disagreement_score":0.036060054,"about_ca_system_score_codex":0.00005030139,"about_ca_system_score_gemma":0.00013250418,"threshold_uncertainty_score":0.46018288},"labels":[],"label_agreement":null},{"id":"W2033806536","doi":"10.3109/10408363.2014.950407","title":"Is personalized medicine a dream or a reality?","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Clinical Laboratory Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"U.S. Public Health Service","keywords":"Pharmacogenomics; VKORC1; Personalized medicine; Medicine; Warfarin; Precision medicine; Pharmacogenetics; Drug; CYP2C9; Intensive care medicine; Bioinformatics; Pharmacology; Internal medicine; Biology; Genetics; Gene; Cytochrome P450; Atrial fibrillation; Pathology","score_opus":0.7021953646493445,"score_gpt":0.6928524729234234,"score_spread":0.009342891725921065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033806536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008538277,0.98409283,0.00003875653,0.0029554663,0.0051059495,0.0015171196,0.00031599056,0.00006233391,0.0059030014],"genre_scores_gemma":[0.000013962982,0.97319037,0.00052946823,0.022638217,0.002530471,0.0003730922,0.000021159187,0.00005267361,0.0006505802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97728866,0.013639073,0.0052742306,0.0018498487,0.00072433864,0.0012238577],"domain_scores_gemma":[0.9756568,0.02092972,0.0009670392,0.0008100577,0.00031729203,0.0013190538],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity","insufficient_payload"],"category_scores_codex":[0.039193843,0.00096345466,0.0068779434,0.0003822505,0.00042182778,0.00007418439,0.0021550385,0.0015514098,0.008457319],"category_scores_gemma":[0.039098892,0.00057279185,0.0010794991,0.00266262,0.008651409,0.00017038954,0.00036897513,0.0035873677,0.0013780275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004216371,0.00039375812,0.00006155763,0.011159468,0.00006961334,0.000077369405,0.000091685266,1.448773e-7,9.884047e-7,0.011421359,0.04991436,0.9267675],"study_design_scores_gemma":[0.00082409295,0.0003182551,0.0000059448653,0.009979858,0.0016025817,0.000018461804,0.000021682314,0.00007861656,0.0000011204636,0.0013710936,0.9850902,0.0006880824],"about_ca_topic_score_codex":0.000009065593,"about_ca_topic_score_gemma":0.000013952995,"teacher_disagreement_score":0.93517584,"about_ca_system_score_codex":0.000086958324,"about_ca_system_score_gemma":0.0018182541,"threshold_uncertainty_score":0.9997448},"labels":[],"label_agreement":null},{"id":"W2034105674","doi":"10.7326/0003-4819-155-10-201111150-00003","title":"Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios","year":2011,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Warfarin; Internal medicine; Anesthesia; Surgery; Atrial fibrillation","score_opus":0.18559471097793345,"score_gpt":0.4508698301658539,"score_spread":0.26527511918792046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034105674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9351999,0.00045967122,0.00015354416,0.0007852589,0.004069109,0.00040658543,0.00007331359,0.00002691541,0.05882568],"genre_scores_gemma":[0.9946815,0.0006304335,0.00035655586,0.0031359913,0.00034534268,0.00004029121,0.000058351703,0.000025669386,0.00072588923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975411,0.00029238805,0.0008015522,0.00034693806,0.00054419163,0.0004738078],"domain_scores_gemma":[0.99838674,0.00024554803,0.00041385065,0.00023671631,0.00043952648,0.00027763905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010027266,0.0003075612,0.0005168467,0.00035548024,0.00005835825,0.000008352585,0.0005759476,0.00017057545,0.005249913],"category_scores_gemma":[0.00012699416,0.00024020419,0.00008967891,0.00018311941,0.00026513482,0.00026666382,0.00017241793,0.00071750704,0.000028617464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036631018,0.003416429,0.8911955,0.00010049261,0.0019345027,0.00017139692,0.0033789503,0.00026343507,0.011341169,0.0016655796,0.017396098,0.032505482],"study_design_scores_gemma":[0.03850799,0.002702358,0.8117628,0.00031088034,0.00032226802,0.000008181992,0.00034297412,0.0014264677,0.054785356,0.00055065774,0.08867955,0.0006004768],"about_ca_topic_score_codex":0.0005602169,"about_ca_topic_score_gemma":0.00008171153,"teacher_disagreement_score":0.079432614,"about_ca_system_score_codex":0.0000510043,"about_ca_system_score_gemma":0.000118871205,"threshold_uncertainty_score":0.9956594},"labels":[],"label_agreement":null},{"id":"W2034687446","doi":"10.1097/ftd.0b013e31824a1e21","title":"Suspected Opioid Overdose Case Resolved by CYP2D6 Genotyping","year":2012,"lang":"en","type":"article","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"CYP2D6; Genotyping; Opiate; Medicine; Pharmacogenetics; Opioid; Anesthesia; Drug overdose; Opioid overdose; Pharmacology; (+)-Naloxone; Genotype; Poison control; Internal medicine; Emergency medicine; Cytochrome P450; Biology; Genetics; Receptor","score_opus":0.10790998077482065,"score_gpt":0.4240395855465061,"score_spread":0.31612960477168545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034687446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940481,0.04622174,0.00020522578,0.00021415653,0.008022781,0.00047164998,0.0000637386,0.00030698077,0.0040127267],"genre_scores_gemma":[0.9914293,0.0019462727,0.0003341015,0.0008197163,0.003287952,0.00007798923,0.000018095452,0.000102927566,0.0019836065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967624,0.00061805954,0.0005239962,0.00042519497,0.00029841342,0.0013719397],"domain_scores_gemma":[0.9981693,0.00041131515,0.00019552112,0.00041430452,0.000111034875,0.00069852365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012432284,0.00046979127,0.0004207449,0.00015259991,0.00065022655,0.000059614136,0.00040049877,0.00028890322,0.0007016382],"category_scores_gemma":[0.000032721702,0.00047386455,0.00016190104,0.00037219486,0.00015125301,0.00029950374,0.00018046047,0.0010762432,0.0002755809],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030632853,0.00068111176,0.050489,0.000060660474,0.00064617355,0.00027616436,0.008304106,0.00012024008,0.6721883,0.00044509285,0.0019061168,0.26457673],"study_design_scores_gemma":[0.002213845,0.000025456038,0.003939062,0.000020163125,0.00048850506,0.0004104545,0.0008883175,0.00065476785,0.5309988,0.00026520918,0.45935893,0.00073648524],"about_ca_topic_score_codex":0.00010856023,"about_ca_topic_score_gemma":0.0000022577499,"teacher_disagreement_score":0.4574528,"about_ca_system_score_codex":0.0001596735,"about_ca_system_score_gemma":0.00006526341,"threshold_uncertainty_score":0.9997713},"labels":[],"label_agreement":null},{"id":"W2034832094","doi":"10.1002/iub.241","title":"Cytochrome P450 enzymes and the heart","year":2009,"lang":"en","type":"review","venue":"IUBMB Life","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytochrome P450; Biology; Enzyme; Monooxygenase; Disease; Isozyme; Pharmacology; Bioinformatics; Biochemistry; Internal medicine; Medicine","score_opus":0.21103047640168152,"score_gpt":0.5038105398568771,"score_spread":0.2927800634551956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034832094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035279827,0.98910433,0.000005260859,0.0012370499,0.0010991084,0.0013845757,0.00016842481,0.00009594689,0.0068700206],"genre_scores_gemma":[0.00018041798,0.98500013,0.00006213554,0.010622422,0.0020824,0.00023097379,0.00004447932,0.000068834386,0.0017082264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958584,0.0018080927,0.00083245954,0.0005801938,0.00025164674,0.0006692432],"domain_scores_gemma":[0.99728465,0.00127696,0.00035418375,0.00045862753,0.00006414606,0.000561446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017091183,0.0006733349,0.0021836734,0.00016726322,0.00039287363,0.00008166999,0.0006491832,0.0007818262,0.0008256353],"category_scores_gemma":[0.00022061601,0.0004227625,0.00061992946,0.00031358586,0.0006141367,0.00005883341,0.00023852511,0.0018372885,0.00056032353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000792547,0.00010470142,0.0000018729419,0.0015758417,0.0005680156,0.000026524322,0.00014348551,0.0000036164165,0.000017013224,0.0056115626,0.046565626,0.9453025],"study_design_scores_gemma":[0.0018500946,0.000026429743,0.000020216257,0.00033062094,0.002720935,0.00014106862,0.0000073916694,0.000041140476,0.000022306333,0.00052757474,0.99384415,0.00046805164],"about_ca_topic_score_codex":0.0000090131425,"about_ca_topic_score_gemma":0.0000014523429,"teacher_disagreement_score":0.94727856,"about_ca_system_score_codex":0.000035172114,"about_ca_system_score_gemma":0.00040779653,"threshold_uncertainty_score":0.99982244},"labels":[],"label_agreement":null},{"id":"W2034897616","doi":"10.1007/s10549-013-2511-4","title":"CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Tamoxifen; CYP2D6; Breast cancer; Pharmacogenetics; Medicine; Oncology; Internal medicine; Pharmacogenomics; Pharmacology; CYP3A5; Selective estrogen receptor modulator; Genotype; Prospective cohort study; Cancer; Bioinformatics; Biology; Genetics; Cytochrome P450","score_opus":0.16394551591650738,"score_gpt":0.4609639978878481,"score_spread":0.29701848197134073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034897616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843765,0.0024597587,0.0000130284825,0.005373416,0.00012314986,0.0022265501,0.0012287496,0.000015111769,0.00012258878],"genre_scores_gemma":[0.9888468,0.006920136,0.000064418615,0.0006548752,0.0001948237,0.002981123,0.00003283149,0.00002185006,0.00028315416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976583,0.0005020961,0.00025790642,0.0004565635,0.00026929632,0.0008558337],"domain_scores_gemma":[0.99881256,0.00024135549,0.000038846683,0.00012792794,0.00016150306,0.000617781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054106745,0.00022360092,0.0002765485,0.00036920854,0.00018094118,0.00007224624,0.0000991917,0.00011967626,0.00078762847],"category_scores_gemma":[0.000017932423,0.00018877789,0.000027445078,0.0004071285,0.000076512675,0.00013703658,0.00008658259,0.0003102395,0.000052177333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003839233,0.0011592876,0.14482532,0.000028917011,0.00029172833,0.00008186488,0.004479188,0.00035033945,0.23540348,0.00027184898,0.0003444337,0.6089243],"study_design_scores_gemma":[0.007947214,0.00029859034,0.96698785,0.00003155367,0.000016327405,0.000021321524,0.00010281576,0.00052645203,0.01642065,0.000548832,0.00689976,0.00019865736],"about_ca_topic_score_codex":0.0045575546,"about_ca_topic_score_gemma":0.001431144,"teacher_disagreement_score":0.8221625,"about_ca_system_score_codex":0.000479439,"about_ca_system_score_gemma":0.00019365849,"threshold_uncertainty_score":0.8623979},"labels":[],"label_agreement":null},{"id":"W2035212715","doi":"10.1111/j.1365-2125.2007.02984.x","title":"Exposure–response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets","year":2007,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Carbamazepine; Pharmacology; Toxicity; Medicine; Pharmacokinetics; Internal medicine; Epilepsy","score_opus":0.2179767613148042,"score_gpt":0.518435792513046,"score_spread":0.30045903119824174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035212715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97844183,0.007470181,0.0013054626,0.0018342922,0.009083024,0.00058341824,0.0006457023,0.00006959326,0.0005665041],"genre_scores_gemma":[0.9686078,0.012518173,0.001112305,0.011537377,0.005489258,0.000013914276,0.00004116632,0.00007174868,0.00060825027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.981773,0.006375258,0.008273516,0.0009463821,0.0009731353,0.001658671],"domain_scores_gemma":[0.98162025,0.009460003,0.0048761233,0.00041045086,0.0010524441,0.0025807284],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.042310912,0.0006503785,0.0032642183,0.0007070351,0.0004377085,0.000091329384,0.0016840424,0.0012520715,0.0024863256],"category_scores_gemma":[0.003435894,0.00068060757,0.0020152556,0.0012055202,0.0011768523,0.0001769568,0.0004351587,0.004768693,0.000030726602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010825249,0.0026128301,0.7757896,0.00005650303,0.008264556,0.0067498987,0.00020324424,0.00025599028,0.06886918,0.000029507246,0.010837454,0.11550599],"study_design_scores_gemma":[0.011522668,0.0015884825,0.8796726,0.000056130983,0.008977697,0.00079220964,0.000081769685,0.00018843343,0.020314842,0.0005961345,0.075364254,0.0008447917],"about_ca_topic_score_codex":0.000068565445,"about_ca_topic_score_gemma":0.000098769284,"teacher_disagreement_score":0.1146612,"about_ca_system_score_codex":0.00015685904,"about_ca_system_score_gemma":0.0007587952,"threshold_uncertainty_score":0.9995645},"labels":[],"label_agreement":null},{"id":"W2035714354","doi":"10.1016/j.bcp.2008.08.015","title":"The CYP2B2 5′ flank contains a complex glucocorticoid response unit","year":2008,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Glucocorticoid receptor; Glucocorticoid; Hormone response element; Basal (medicine); Dexamethasone; Biology; Flank; Immediate early gene; Gene; Endocrinology; Gene expression; Genetics; Anatomy; Estrogen receptor","score_opus":0.20684548059427788,"score_gpt":0.4588772604516215,"score_spread":0.25203177985734365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035714354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978682,0.0068897633,0.000057465146,0.005753987,0.0037608845,0.0009769966,0.00012254066,0.00021968366,0.0035367163],"genre_scores_gemma":[0.9776471,0.0030493059,0.000117204625,0.014715504,0.0010084405,0.00020970326,0.000056025696,0.00006690256,0.0031297875],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99506104,0.0017673501,0.00080448185,0.00068125944,0.00035179793,0.0013340957],"domain_scores_gemma":[0.9957942,0.0025351406,0.0002707958,0.00043669558,0.00025890575,0.00070426223],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013681406,0.00050859794,0.00056400953,0.0001420509,0.0011333168,0.000025274358,0.0010847577,0.00053103844,0.0029072585],"category_scores_gemma":[0.00027832258,0.00040771867,0.0002899505,0.00049035094,0.0014928577,0.00007455697,0.0004113842,0.0014603203,0.0014365206],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048512327,0.00030974357,0.0012084421,0.000012032031,0.00027293744,0.00017345752,0.00020253663,0.00007548957,0.7061723,0.00028872944,0.28565845,0.000774649],"study_design_scores_gemma":[0.003827939,0.00012255661,0.006797712,0.0000020767736,0.0001831444,0.00022567197,0.000047037945,0.0022778683,0.34495336,0.00011528592,0.6410844,0.00036299237],"about_ca_topic_score_codex":0.000015879266,"about_ca_topic_score_gemma":9.38788e-7,"teacher_disagreement_score":0.36121896,"about_ca_system_score_codex":0.00011750461,"about_ca_system_score_gemma":0.00041890965,"threshold_uncertainty_score":0.99983746},"labels":[],"label_agreement":null},{"id":"W2035815658","doi":"10.1016/j.ympev.2011.10.016","title":"Phylogenetic and functional analyses of the cytochrome P450 family 4","year":2011,"lang":"en","type":"article","venue":"Molecular Phylogenetics and Evolution","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Subfamily; Phylogenetic tree; Evolutionary biology; Gene; Functional divergence; Phylogenetics; Genetics; In silico; Pseudogene; Gene family; Genome","score_opus":0.1551532149022495,"score_gpt":0.38175850900779207,"score_spread":0.22660529410554256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035815658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780887,0.017150149,0.0021807104,0.000055227312,0.0003234144,0.00026100306,0.000046226935,0.000013902908,0.0018806919],"genre_scores_gemma":[0.9977428,0.001033767,0.0005644804,0.00047801406,0.000075942684,0.000021668324,0.0000051981365,0.000021031108,0.000057121906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985917,0.00027809848,0.0003193256,0.00032082928,0.0001937759,0.00029623622],"domain_scores_gemma":[0.99928236,0.000037849968,0.00015240855,0.00023934778,0.00012333861,0.00016466768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027320057,0.00021758332,0.000232158,0.000106298045,0.00020623697,0.000009607238,0.0001624759,0.00019638614,0.00007733061],"category_scores_gemma":[0.000027092317,0.00017493797,0.000107312,0.00024553188,0.00047935898,0.000021928769,0.00020132067,0.00024710884,0.0000051501524],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006554266,0.00011249956,0.015434111,0.00002798715,0.00015754049,0.000003895398,0.00016132333,0.00043027656,0.9775386,0.0021994142,0.00006438729,0.0038044439],"study_design_scores_gemma":[0.00070106925,0.000073176336,0.6267274,0.000006314777,0.00034539265,0.000020857791,0.00003717378,0.001898897,0.36464915,0.0039772848,0.001393053,0.00017027264],"about_ca_topic_score_codex":0.000051055984,"about_ca_topic_score_gemma":0.000004597776,"teacher_disagreement_score":0.61288947,"about_ca_system_score_codex":0.000017308574,"about_ca_system_score_gemma":0.000061589766,"threshold_uncertainty_score":0.71337634},"labels":[],"label_agreement":null},{"id":"W2036131177","doi":"10.1016/s0378-4274(01)00264-8","title":"Interaction of plasma proteins with cytochromes P450 mediated metabolic reactions: inhibition by human serum albumin and α-globulins of the debrisoquine 4-hydroxylation (CYP2D) in liver microsomes of human, hamster and rat","year":2001,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Debrisoquine; Globulin; Hydroxylation; Hamster; Microsome; Albumin; Chemistry; Human serum albumin; Biochemistry; Blood proteins; Serum albumin; Cytochrome P450; Biology; Metabolism; Endocrinology; In vitro; Enzyme; CYP2D6","score_opus":0.03984320214840741,"score_gpt":0.3447167022005488,"score_spread":0.30487350005214137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036131177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996272,0.00095829583,0.000023728184,0.001569256,0.0001631513,0.00080743927,0.00007426736,0.000015535921,0.00011627262],"genre_scores_gemma":[0.9978713,0.00080119906,0.000082215396,0.0009933804,0.000049368275,0.00006408851,0.00003684742,0.000021566177,0.000080056234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810785,0.00053971855,0.00064455735,0.0002967135,0.00014019477,0.00027096862],"domain_scores_gemma":[0.9988992,0.00020766897,0.0005711036,0.00016534059,0.0000801495,0.00007650562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004292859,0.00023085972,0.00047449782,0.0002725206,0.00013773491,0.0000072983944,0.00012257393,0.00024630222,0.00013744933],"category_scores_gemma":[0.000035899364,0.00018720208,0.00005755524,0.0003145571,0.0007328207,0.00018122952,0.00009364889,0.0004607925,0.0000014213564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003374114,0.00035167934,0.046320528,0.00008820808,0.00014400622,0.000008644414,0.0008250544,0.00016951142,0.9504946,0.00009228831,0.00030085386,0.0008672013],"study_design_scores_gemma":[0.003697389,0.00022447442,0.09572761,0.000058791473,0.00022917327,0.00006742213,0.00010817625,0.00045097858,0.8949987,0.000052628468,0.00421137,0.00017323229],"about_ca_topic_score_codex":0.00013492406,"about_ca_topic_score_gemma":0.00035956275,"teacher_disagreement_score":0.05549586,"about_ca_system_score_codex":0.00003274495,"about_ca_system_score_gemma":0.000028587454,"threshold_uncertainty_score":0.7633879},"labels":[],"label_agreement":null},{"id":"W2036181656","doi":"10.1016/j.ejps.2008.11.002","title":"Nonionic surfactants are strong inhibitors of cytochrome P450 3A biotransformation activity in vitro and in vivo","year":2008,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Chemistry; In vivo; Polysorbate; Pharmacology; Microsome; Hydroxylation; Pharmacokinetics; Midazolam; Cytochrome P450; Metabolite; Chromatography; First pass effect; In vitro; Biochemistry; Metabolism; Pulmonary surfactant; Enzyme; Medicine; Biology","score_opus":0.148289908046269,"score_gpt":0.4161611932189839,"score_spread":0.26787128517271497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036181656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467045,0.0018473832,0.00007177497,0.0005832372,0.0004772595,0.00018537587,0.000032797558,0.00000818654,0.0021235417],"genre_scores_gemma":[0.9957245,0.0037111267,0.00018295269,0.00021141923,0.00014428524,9.947327e-7,3.5716775e-7,0.00001243082,0.000011961607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965227,0.0014775128,0.0008466793,0.0002344837,0.00043751017,0.0004810692],"domain_scores_gemma":[0.99873537,0.00029355686,0.00047108962,0.000068733476,0.00009337115,0.000337875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004244958,0.00020883522,0.00043129726,0.00044710896,0.00017707767,0.000020297093,0.0003955237,0.00007185218,0.00018885313],"category_scores_gemma":[0.00009941211,0.00017369408,0.00010064702,0.0006864221,0.00089624204,0.00048958324,0.00008979103,0.000910134,0.0000069391795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069084833,0.00039234725,0.020309022,0.000042908534,0.000028255354,0.00029261666,0.00071401556,0.001767992,0.96204156,0.000020802248,0.000060513634,0.013639116],"study_design_scores_gemma":[0.0037288375,0.00017196331,0.13756771,0.00007013959,0.000051266015,0.00021898329,0.00016983577,0.0063961493,0.8454335,0.000029681196,0.00593244,0.00022948274],"about_ca_topic_score_codex":0.0000070480237,"about_ca_topic_score_gemma":0.0000049403766,"teacher_disagreement_score":0.1172587,"about_ca_system_score_codex":0.000057388137,"about_ca_system_score_gemma":0.0001506695,"threshold_uncertainty_score":0.7083039},"labels":[],"label_agreement":null},{"id":"W2036206840","doi":"10.1016/j.cbi.2003.09.003","title":"Spectral interactions of tetrachlorobiphenyls with hepatic microsomal cytochrome P450 enzymes","year":2003,"lang":"en","type":"article","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Microsome; Cytochrome P450; Cytochrome; Enzyme; Chemistry; Biochemistry","score_opus":0.11657548732323841,"score_gpt":0.4197559361963263,"score_spread":0.30318044887308787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036206840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648858,0.0008003051,0.0003884094,0.0002569132,0.00096532685,0.0003849191,0.00016174075,0.00011483262,0.03204176],"genre_scores_gemma":[0.9954496,0.0003044551,0.0015843312,0.0007171966,0.00025982657,0.00011888467,0.00006701183,0.00003110722,0.0014675602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780613,0.00030820665,0.00065819203,0.0005016465,0.00013161075,0.0005942239],"domain_scores_gemma":[0.99810106,0.0007769655,0.0003132342,0.0002984413,0.0001956372,0.00031464788],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028062353,0.0003841966,0.00051735755,0.0001553294,0.00026214824,0.00002849347,0.00033506844,0.00023820314,0.008417601],"category_scores_gemma":[0.00023338823,0.00029754156,0.00026282575,0.00035663607,0.0005033371,0.00018454347,0.00007126781,0.001257583,0.00017806304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002626023,0.0010193293,0.0047652163,0.000024130297,0.0003179134,0.000023501532,0.00027852834,0.00016279447,0.98745775,0.0033180497,0.0015406591,0.00082953094],"study_design_scores_gemma":[0.0010721008,0.00015307427,0.0031655822,0.000025244111,0.00019298833,0.00032312924,0.00024296694,0.00018889879,0.82896274,0.0006243621,0.16470765,0.00034124014],"about_ca_topic_score_codex":0.000016704063,"about_ca_topic_score_gemma":0.000019667323,"teacher_disagreement_score":0.163167,"about_ca_system_score_codex":0.00010174787,"about_ca_system_score_gemma":0.000090088535,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W2037050175","doi":"10.1080/07357900802574660","title":"Pharmacology and Pharmacogenetics of Chemotherapeutic Agents","year":2009,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Chemotherapeutic drugs; Medicine; Drug; Pharmacology; Precision medicine; Clinical pharmacology; Drug response; Intensive care medicine; Chemotherapy; Bioinformatics; Internal medicine; Biology; Pathology; Genotype","score_opus":0.3330410630973113,"score_gpt":0.5339622308067224,"score_spread":0.20092116770941115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037050175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027831607,0.992187,0.000010684924,0.00017275504,0.002529924,0.001269116,0.00031838572,0.00006686608,0.0006620677],"genre_scores_gemma":[0.0005300961,0.994239,0.00017232826,0.0031462407,0.0010202248,0.00027182902,0.0001282394,0.00009216334,0.0003998807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966436,0.0008244162,0.001082698,0.0006551059,0.00024896848,0.00054520887],"domain_scores_gemma":[0.997894,0.00025509705,0.00096592243,0.00023631855,0.00015972902,0.00048894185],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005842361,0.00068430294,0.0016743571,0.0003567567,0.00014923199,0.000019983654,0.00047512678,0.0008169269,0.0011238538],"category_scores_gemma":[0.000021475298,0.00065481965,0.00031099023,0.00053597236,0.00056589674,0.000083374725,0.00011757189,0.0010433709,0.000038234743],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024321094,0.00008497806,0.000056968533,0.0054681725,0.0006782943,0.000005971726,0.000239837,0.000056702567,0.0021114757,0.000097470926,0.005051129,0.9861247],"study_design_scores_gemma":[0.0011417983,0.000052849817,0.000035109715,0.000854373,0.006123442,0.000023687042,0.0000055065057,0.0005850096,0.009021444,0.00038598676,0.98122317,0.0005476105],"about_ca_topic_score_codex":0.000011663201,"about_ca_topic_score_gemma":0.000001325444,"teacher_disagreement_score":0.98557705,"about_ca_system_score_codex":0.00012135144,"about_ca_system_score_gemma":0.0006010092,"threshold_uncertainty_score":0.99978924},"labels":[],"label_agreement":null},{"id":"W2037171637","doi":"10.1182/blood-2008-01-134247","title":"A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":486,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; University of Washington; National Institute of Neurological Disorders and Stroke; University of Florida","keywords":"VKORC1; Warfarin; CYP2C9; Single-nucleotide polymorphism; Vitamin K epoxide reductase; Biology; Population; Genetics; Medicine; Internal medicine; Genotype; Gene","score_opus":0.06018353544277637,"score_gpt":0.3613729850026524,"score_spread":0.30118944955987603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037171637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939031,0.0011113471,0.00032758442,0.0002889729,0.00029179297,0.00098997,0.0002855226,0.00009218473,0.002709541],"genre_scores_gemma":[0.99067295,0.0009052264,0.0013525323,0.0057255896,0.00024752927,0.00028940712,0.000026178863,0.000059439175,0.0007211665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781007,0.00020627161,0.00037467634,0.00051706017,0.00021255473,0.0008793442],"domain_scores_gemma":[0.99863225,0.00029713867,0.00017334147,0.000378995,0.00014468424,0.00037357167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039150778,0.00034495813,0.0003984584,0.00012129346,0.0005036813,0.000018255536,0.00045907122,0.0002099599,0.00017806092],"category_scores_gemma":[0.00007130526,0.00029582743,0.00010850521,0.00025160183,0.00019963675,0.00006844907,0.00009739017,0.0005249373,0.00011454324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069087306,0.014914285,0.6742913,0.00037199658,0.0024353557,0.002734775,0.0050649205,0.014418964,0.26218668,0.0029229894,0.0040644454,0.009685539],"study_design_scores_gemma":[0.02278947,0.0007633373,0.69334394,0.000035082852,0.0006409984,0.00033622133,0.000033986445,0.0012830999,0.04715633,0.0005936088,0.23224933,0.00077459565],"about_ca_topic_score_codex":0.000018711647,"about_ca_topic_score_gemma":0.000030013782,"teacher_disagreement_score":0.2281849,"about_ca_system_score_codex":0.000030210613,"about_ca_system_score_gemma":0.00017487131,"threshold_uncertainty_score":0.9999494},"labels":[],"label_agreement":null},{"id":"W2037431844","doi":"10.1080/00498250310001657559","title":"Role of individual human cytochrome P450 enzymes in the<i>in vitro</i>metabolism of hydromorphone","year":2004,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ketoconazole; Microsome; CYP3A; CYP3A4; Hydromorphone; CYP1A2; Chemistry; Cytochrome P450; Demethylation; Pharmacology; Drug metabolism; Metabolism; Biochemistry; Biology; Enzyme; Microbiology","score_opus":0.05461144811330217,"score_gpt":0.3783237289665465,"score_spread":0.3237122808532443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037431844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878197,0.006062858,0.0000043464806,0.00040112116,0.00019336322,0.0005084021,0.0002386434,0.000017515511,0.0047540744],"genre_scores_gemma":[0.99833137,0.00028645288,0.00024901782,0.00086180546,0.00015347199,0.00002606543,0.0000412447,0.000025234453,0.000025310484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975303,0.000494073,0.00076890684,0.00031218986,0.00036032917,0.0005342418],"domain_scores_gemma":[0.9990225,0.0002294736,0.00024359598,0.00032309594,0.000060823957,0.000120524135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014345718,0.0002618026,0.00058719225,0.0003393342,0.00008432463,0.000011902645,0.0008115176,0.00030166266,0.00031530714],"category_scores_gemma":[0.000051200313,0.00022424315,0.00014039893,0.00061721465,0.00044011176,0.00007510795,0.00014973489,0.000819423,0.000031226245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021639706,0.0012457846,0.00036083968,0.000043561173,0.00008356798,0.000033543914,0.004247559,0.00078569126,0.97645086,0.0149826845,0.00005811571,0.0014914067],"study_design_scores_gemma":[0.0042463285,0.00008776351,0.043621223,0.000021799908,0.00016735615,0.000021871736,0.00035215289,0.000053747437,0.93691474,0.006588959,0.007698761,0.00022531493],"about_ca_topic_score_codex":0.00014231224,"about_ca_topic_score_gemma":0.000038164406,"teacher_disagreement_score":0.043260384,"about_ca_system_score_codex":0.000028406175,"about_ca_system_score_gemma":0.00013111782,"threshold_uncertainty_score":0.91443706},"labels":[],"label_agreement":null},{"id":"W2037469925","doi":"10.3109/00498254.2013.791410","title":"Potential role of CYP2D6 in the central nervous system","year":2013,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"CYP2D6; Biology; Endocrinology; Serotonin; Human brain; Internal medicine; Pharmacology; In vivo; Central nervous system; Cytochrome P450; Metabolism; Biochemistry; Genetics; Neuroscience; Medicine; Receptor","score_opus":0.03128201951289982,"score_gpt":0.34641311599089253,"score_spread":0.3151310964779927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037469925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97081625,0.0019399404,0.000027881206,0.0008773675,0.0010313023,0.0006349859,0.000042675518,0.000037884154,0.024591714],"genre_scores_gemma":[0.99838364,0.00014784267,0.000093951305,0.00089131936,0.00032380404,0.000031850017,0.000009202343,0.00001638219,0.00010198576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981428,0.0005275238,0.0003898197,0.00021065235,0.000186832,0.00054238475],"domain_scores_gemma":[0.9992877,0.0001430016,0.000109985165,0.00023470231,0.00007352843,0.00015104072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047755463,0.00017092926,0.00025122226,0.00008356631,0.00010309573,0.000024232266,0.00049221877,0.00020834866,0.00088050583],"category_scores_gemma":[0.000023027871,0.00012421588,0.00010733715,0.00021398916,0.00015853255,0.000061829174,0.000078172365,0.000506262,0.00028745842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017849906,0.0010056912,0.010777701,0.00019046535,0.00022437813,0.00008923443,0.004863544,0.0025620325,0.8754985,0.02561113,0.004588068,0.07441076],"study_design_scores_gemma":[0.0060932445,0.00028310236,0.32372546,0.00007126358,0.0008486619,0.00028139667,0.008388036,0.059874702,0.34991577,0.004098252,0.24535257,0.0010675492],"about_ca_topic_score_codex":0.00019748934,"about_ca_topic_score_gemma":0.0000055683117,"teacher_disagreement_score":0.52558273,"about_ca_system_score_codex":0.000028122973,"about_ca_system_score_gemma":0.0000563849,"threshold_uncertainty_score":0.96409214},"labels":[],"label_agreement":null},{"id":"W2037845030","doi":"10.1177/0091270005280851","title":"Effect of a Triphasic Oral Contraceptive on Drug‐Metabolizing Enzyme Activity as Measured by the Validated Cooperstown 5+1 Cocktail","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Pharmacology; CYP2C19; Dextromethorphan; Medicine; CYP3A; CYP1A2; Drug; CYP2C9; Bioequivalence; Pharmacokinetics; Crossover study; Drug metabolism; Dextrorphan; Mephenytoin; Paraxanthine; Active metabolite; Oral administration; Internal medicine; Cytochrome P450; Metabolism; Placebo","score_opus":0.14238138566770764,"score_gpt":0.5159168353209036,"score_spread":0.37353544965319596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037845030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738362,0.007285194,0.0001327028,0.00951816,0.006535164,0.0010462173,0.0000944454,0.00003265966,0.0015192679],"genre_scores_gemma":[0.98041177,0.00472597,0.000029270097,0.011418335,0.0026180982,0.000024760067,0.000003564891,0.000052912328,0.00071530393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9763479,0.019639885,0.0021650796,0.00035599462,0.0006992768,0.0007918312],"domain_scores_gemma":[0.9799019,0.016156683,0.0023917898,0.00034747444,0.00062750565,0.00057463226],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.025175871,0.000546935,0.0018361844,0.00017034705,0.0004496689,0.00002216637,0.0015533095,0.00048577238,0.0022198798],"category_scores_gemma":[0.0015926261,0.00030058387,0.0008108456,0.0004869397,0.0014431736,0.00020121004,0.00018903083,0.0043136664,0.0001654668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041177414,0.0019790167,0.00033490983,0.000028835808,0.0024135343,0.000039184295,0.0008155364,0.0035116766,0.60115,0.00006587391,0.16009964,0.1883844],"study_design_scores_gemma":[0.016424863,0.0018697518,0.00028756796,0.00001502309,0.0031618024,0.00011284568,0.000057901576,0.0017083507,0.61835843,0.0000490542,0.3577215,0.00023288206],"about_ca_topic_score_codex":0.00002617079,"about_ca_topic_score_gemma":0.0000061406995,"teacher_disagreement_score":0.19762185,"about_ca_system_score_codex":0.0000809085,"about_ca_system_score_gemma":0.0004267223,"threshold_uncertainty_score":0.9999446},"labels":[],"label_agreement":null},{"id":"W2038539486","doi":"10.1038/sj.bjp.0704933","title":"Hypoxia‐induced down‐regulation of CYP1A1/1A2 and up‐regulation of CYP3A6 involves serum mediators","year":2002,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); Université de Montréal","funders":"","keywords":"Hypoxia (environmental); Messenger RNA; Cytochrome P450; Internal medicine; Endocrinology; Erythropoietin; Chemistry; Isozyme; Enzyme; Biology; Molecular biology; Metabolism; Biochemistry; Medicine; Oxygen; Gene","score_opus":0.07424612824752516,"score_gpt":0.3677138819621633,"score_spread":0.2934677537146382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038539486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97735065,0.016190967,0.00006142798,0.0007614476,0.004383848,0.00035856114,0.00013971362,0.00002088734,0.00073251117],"genre_scores_gemma":[0.9866379,0.0111025525,0.00033135604,0.00077021844,0.00087706535,0.0000097286875,0.000009519127,0.000040743213,0.00022093038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960246,0.0010515419,0.0016799176,0.00030453072,0.0004394825,0.0004998975],"domain_scores_gemma":[0.99651444,0.00060131826,0.0017131715,0.00010372844,0.0006829419,0.0003843989],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016723496,0.00031172697,0.001038444,0.00048459254,0.00017353184,0.000021319449,0.0004084065,0.00045164343,0.0047112755],"category_scores_gemma":[0.00018110477,0.00034965726,0.0002965815,0.0004075798,0.00047859328,0.00035636453,0.00012900383,0.0009106145,0.000012407271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028603358,0.0005147927,0.002851608,0.00012227333,0.00060767797,0.000063765685,0.00080702914,0.0006957645,0.8785409,0.00016320511,0.012423107,0.10292385],"study_design_scores_gemma":[0.0091746,0.00042648538,0.070171155,0.00008973673,0.0014132067,0.0013102272,0.00015978722,0.0073831794,0.8847514,0.0012317403,0.02346347,0.00042502035],"about_ca_topic_score_codex":0.000026582533,"about_ca_topic_score_gemma":0.0000097517,"teacher_disagreement_score":0.10249882,"about_ca_system_score_codex":0.000051354466,"about_ca_system_score_gemma":0.00011252045,"threshold_uncertainty_score":0.9998955},"labels":[],"label_agreement":null},{"id":"W2038865244","doi":"10.1074/jbc.m109.073908","title":"The Human UGT1A3 Enzyme Conjugates Norursodeoxycholic Acid into a C23-ester Glucuronide in the Liver","year":2009,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronide; Conjugate; Chemistry; Glucuronates; Enzyme; Biochemistry; Human liver; Metabolism; Glucuronic acid","score_opus":0.1014905172757326,"score_gpt":0.4177579687733212,"score_spread":0.3162674514975886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038865244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762711,0.015386926,0.000011627582,0.0049392497,0.00027613773,0.0001280971,0.0000067799792,0.000011534011,0.00296858],"genre_scores_gemma":[0.987761,0.004244398,0.00006152301,0.006870829,0.0009189222,0.0000074254153,0.000004087966,0.0000071010886,0.00012467716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800366,0.00048014295,0.00066143065,0.00019315712,0.00021244759,0.00044914792],"domain_scores_gemma":[0.99861485,0.0005031943,0.0003765452,0.0001984773,0.00011754275,0.00018939626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001856077,0.00023555728,0.00032472267,0.000030109224,0.00034313597,0.00006341587,0.0009975396,0.00035141996,0.00033833826],"category_scores_gemma":[0.00020298643,0.000116194366,0.00022564715,0.00016571977,0.0003513367,0.000063693784,0.00007207758,0.0016279635,0.000022445667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002516274,0.0003973806,0.0020506633,0.000009912389,0.00006599833,0.00019249984,0.00061762054,0.00004392406,0.9763667,0.00020436758,0.002922395,0.016876934],"study_design_scores_gemma":[0.0019087401,0.00024040234,0.012695618,0.000018531986,0.0000985915,0.00036758813,0.00026698757,0.000109070934,0.68326974,0.005444699,0.2953271,0.00025291054],"about_ca_topic_score_codex":0.0000029975822,"about_ca_topic_score_gemma":0.0000020434834,"teacher_disagreement_score":0.29309693,"about_ca_system_score_codex":0.00004359375,"about_ca_system_score_gemma":0.000053250453,"threshold_uncertainty_score":0.7072782},"labels":[],"label_agreement":null},{"id":"W2039139292","doi":"10.1016/j.beem.2008.01.001","title":"Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate","year":2008,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Endocrinology & Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Dihydrotestosterone; LNCaP; Androsterone; Androgen receptor; Androgen; Glucuronidation; Chemistry; Endocrinology; Prostate; Small interfering RNA; Internal medicine; Testosterone (patch); Biology; Prostate cancer; Enzyme; Biochemistry; RNA; Gene; Microsome; Hormone; Medicine; Steroid; Cancer","score_opus":0.5109476191605136,"score_gpt":0.6453303354420363,"score_spread":0.13438271628152276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039139292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064088968,0.98093843,0.0000065289246,0.0013830162,0.0014338319,0.0035895505,0.00063262106,0.00004927959,0.005557842],"genre_scores_gemma":[0.0033095619,0.9923916,0.000111998495,0.0010188419,0.0011465998,0.001105743,0.00033750004,0.00013184015,0.00044633375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9577679,0.03361946,0.0037257231,0.0014935344,0.001289328,0.0021040272],"domain_scores_gemma":[0.97237986,0.023633076,0.0013507704,0.0012503506,0.00089260755,0.00049334613],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.011020119,0.0009390809,0.0036783833,0.0010091792,0.0007721072,0.00007063605,0.0025341052,0.0015405247,0.00037248593],"category_scores_gemma":[0.007853831,0.00070146896,0.0010725078,0.0017973777,0.003046384,0.00049026706,0.0005684237,0.012655583,0.0003344326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038636668,0.007814635,0.00011341683,0.0012518184,0.0012541662,0.0007466318,0.00059093355,0.0000031156035,0.0006035482,0.0048766998,0.013502359,0.96885633],"study_design_scores_gemma":[0.00274846,0.00048193734,0.000047457055,0.0003282156,0.001998391,0.00059218355,0.00028267998,0.0000065064173,0.00044058336,0.00032121057,0.9922036,0.00054880005],"about_ca_topic_score_codex":0.00048672,"about_ca_topic_score_gemma":0.00003433841,"teacher_disagreement_score":0.97870123,"about_ca_system_score_codex":0.00010756722,"about_ca_system_score_gemma":0.0014467787,"threshold_uncertainty_score":0.9997557},"labels":[],"label_agreement":null},{"id":"W2039185379","doi":"10.1038/clpt.2014.126","title":"Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Glucuronosyltransferase; Uridine; Pharmacogenomics; Clinical pharmacology; Uridine diphosphate; Pharmacology; Drug metabolism; Xenobiotic; Pharmacogenetics; Drug; Chemistry; Computational biology; Enzyme; Biochemistry; Biology; RNA; Gene; Microsome","score_opus":0.2620271041099431,"score_gpt":0.5475852774856149,"score_spread":0.2855581733756718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039185379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780274,0.0040029795,0.00085360784,0.008466263,0.0054590576,0.0009280212,0.00023372323,0.0001818151,0.0018471527],"genre_scores_gemma":[0.9189858,0.022228539,0.00054978527,0.055677127,0.002129759,0.00006595726,0.000059594793,0.00010266239,0.00020081672],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924076,0.002798474,0.002615548,0.0010417032,0.00022205408,0.00091461936],"domain_scores_gemma":[0.99362767,0.003787432,0.0007219385,0.0005569837,0.00037374534,0.00093223253],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004062519,0.0006198411,0.0013532228,0.00019065898,0.00051352655,0.000026676576,0.00097088347,0.00088683644,0.00093492045],"category_scores_gemma":[0.000081031285,0.0006082275,0.00061501795,0.00035949305,0.0025221012,0.0001258622,0.00032787138,0.0021624945,0.00009368435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014072051,0.0055229967,0.25384182,0.00013624299,0.0037313702,0.000015978292,0.00030668094,0.00016063474,0.52924395,0.0035290061,0.016471624,0.1856325],"study_design_scores_gemma":[0.01583516,0.001683239,0.07815997,0.00001771047,0.008449194,0.00004160945,0.000041990937,0.0045086876,0.13860576,0.0038121466,0.7476942,0.001150331],"about_ca_topic_score_codex":0.0000098318515,"about_ca_topic_score_gemma":0.000005899565,"teacher_disagreement_score":0.73122257,"about_ca_system_score_codex":0.00003747086,"about_ca_system_score_gemma":0.00019336402,"threshold_uncertainty_score":0.99997836},"labels":[],"label_agreement":null},{"id":"W2039970150","doi":"10.1016/j.ijpharm.2008.05.019","title":"The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat","year":2008,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Amiodarone; Hyperlipidemia; Endocrinology; Poloxamer 407; Internal medicine; Chemistry; Microsome; Cytochrome P450; Kidney; Intraperitoneal injection; Metabolism; Distribution (mathematics); Spleen; Drug metabolism; Thyroid; Saline; Pharmacology; Biology; Medicine; Biochemistry; Enzyme; Poloxamer","score_opus":0.1187817189469937,"score_gpt":0.47096799285012336,"score_spread":0.3521862739031297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039970150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873608,0.008897257,0.000036535304,0.0011357963,0.0019481349,0.00016338678,0.000121600344,0.0000032899115,0.00033321636],"genre_scores_gemma":[0.98852754,0.0106552215,0.000035834975,0.0003253278,0.00039303946,0.0000049510754,0.000005563549,0.000012219391,0.000040296072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786687,0.00049729436,0.0008336328,0.00011218955,0.00046110686,0.00022889616],"domain_scores_gemma":[0.9976446,0.0009763269,0.00070727215,0.00011009176,0.0004287896,0.00013294313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001463489,0.00018034069,0.00032208566,0.00012560807,0.00012721757,0.000012269207,0.00059438637,0.00009941386,0.00013704317],"category_scores_gemma":[0.00023198362,0.000104564366,0.00023358445,0.0001602563,0.00051872816,0.00010525842,0.000108242275,0.00075308356,0.0000028558618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030524624,0.0011784512,0.024703566,0.000008574247,0.0012537654,0.00009096584,0.0019432103,0.006135324,0.9354485,0.005051935,0.0035250683,0.017608134],"study_design_scores_gemma":[0.0037640557,0.0001309886,0.017653333,0.000024345964,0.00011382101,0.000263607,0.0002167813,0.005321486,0.9233496,0.00046506897,0.04856734,0.00012958373],"about_ca_topic_score_codex":0.000019743371,"about_ca_topic_score_gemma":9.98105e-7,"teacher_disagreement_score":0.04504227,"about_ca_system_score_codex":0.000101697435,"about_ca_system_score_gemma":0.00016893912,"threshold_uncertainty_score":0.4264011},"labels":[],"label_agreement":null},{"id":"W2040208101","doi":"10.1016/j.drudis.2008.07.007","title":"Challenges for drug studies in children: CYP3A phenotyping as example","year":2008,"lang":"en","type":"review","venue":"Drug Discovery Today","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Western University; SickKids Foundation","funders":"","keywords":"ADME; Disposition; Drug; CYP3A; Pharmacology; In vivo; Drug metabolism; Computational biology; Medicine; Biology; Psychology; Biotechnology; Metabolism; Cytochrome P450; Internal medicine","score_opus":0.3458736567710027,"score_gpt":0.5051877439248266,"score_spread":0.1593140871538239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040208101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001296548,0.9868674,0.000007838862,0.00025282815,0.004061513,0.0031196706,0.0006460615,0.000112808215,0.003635274],"genre_scores_gemma":[0.00070741994,0.990172,0.000074892356,0.0010062865,0.002017486,0.0014444375,0.00042319996,0.00021062748,0.0039436417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942106,0.0013387449,0.0014152159,0.0014297566,0.00033462566,0.0012710501],"domain_scores_gemma":[0.9957043,0.0025122857,0.00069351326,0.0006628102,0.000118699914,0.00030836946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013727434,0.0012407706,0.0032443798,0.00056004134,0.00044492178,0.00005778061,0.0010504721,0.00062883605,0.00011592447],"category_scores_gemma":[0.00027793294,0.001082759,0.0010948922,0.00043055715,0.00043379742,0.0003539615,0.00049121573,0.0016810661,0.0002611675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008972752,0.0005797569,0.000048739726,0.0062058717,0.00210877,0.000058488877,0.0034787566,0.00010312544,0.000005260501,0.0025069043,0.018944925,0.96586967],"study_design_scores_gemma":[0.0017356898,0.000025595207,0.000018693368,0.0018897498,0.0013730736,0.00013893,0.0002839864,0.000021748208,0.00011576086,0.0010656663,0.9921743,0.0011567936],"about_ca_topic_score_codex":0.00006392143,"about_ca_topic_score_gemma":0.00005702523,"teacher_disagreement_score":0.9732294,"about_ca_system_score_codex":0.00024449575,"about_ca_system_score_gemma":0.0005559231,"threshold_uncertainty_score":0.99916226},"labels":[],"label_agreement":null},{"id":"W2040475315","doi":"10.1097/01213011-200506000-00001","title":"Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes","year":2005,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Aryl hydrocarbon receptor; Biology; Nuclear receptor; Receptor; Drug metabolism; Gene; Xenobiotic; Single-nucleotide polymorphism; Transcription factor; Phenotype; Genetics; Function (biology); Enzyme; Cell biology; Biochemistry; Genotype","score_opus":0.13710172867479412,"score_gpt":0.43579132939100107,"score_spread":0.298689600716207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040475315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01351669,0.9811495,0.000019208437,0.000036537836,0.0018460872,0.0013104726,0.0012177599,0.000049688617,0.0008540902],"genre_scores_gemma":[0.02756584,0.96979594,0.00061158556,0.00031662948,0.0010180116,0.00006170784,0.00010713852,0.0002394083,0.00028376473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949549,0.0009882067,0.0019324291,0.0008709659,0.0004056467,0.0008478732],"domain_scores_gemma":[0.9962346,0.0004567397,0.0019466166,0.0005496204,0.00018326382,0.0006291733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011713366,0.0010717582,0.0031812657,0.0005852118,0.00033319692,0.00003550242,0.0010194127,0.0007884804,0.0011259321],"category_scores_gemma":[0.00002631831,0.0010082751,0.0009004826,0.0003263657,0.00062384777,0.000083999206,0.0004930613,0.0012602132,0.00003132806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012193457,0.00044349945,0.00009031313,0.0037926794,0.0009875341,0.000010305151,0.0008872792,0.00010487861,0.06866043,0.00042132768,0.0017231335,0.9227567],"study_design_scores_gemma":[0.0023982665,0.00005918674,0.000007784894,0.000600856,0.005219046,0.000028641647,0.00006096988,0.00017124205,0.067190535,0.00006694882,0.92337376,0.00082273624],"about_ca_topic_score_codex":0.000017373764,"about_ca_topic_score_gemma":0.0000019323138,"teacher_disagreement_score":0.92193395,"about_ca_system_score_codex":0.00007237816,"about_ca_system_score_gemma":0.00025579173,"threshold_uncertainty_score":0.99978715},"labels":[],"label_agreement":null},{"id":"W2040477888","doi":"10.1016/j.jep.2013.10.029","title":"In vitro inhibition of metabolism but not transport of gliclazide and repaglinide by Cree medicinal plant extracts","year":2013,"lang":"en","type":"article","venue":"Journal of Ethnopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Repaglinide; Gliclazide; Pharmacognosy; Traditional medicine; In vitro; Pharmacology; Medicine; Metabolism; Chemistry; Medicinal plants; Biological activity; Diabetes mellitus; Metformin; Biochemistry; Endocrinology","score_opus":0.06335815634570247,"score_gpt":0.39389301044759367,"score_spread":0.3305348541018912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040477888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98529303,0.008772835,0.000057141995,0.0024827207,0.0021575189,0.00041756514,0.00026906485,0.000009194066,0.0005409019],"genre_scores_gemma":[0.9903138,0.0051417053,0.00058359496,0.0033430853,0.0004442714,0.000022793307,0.000013724135,0.00003067985,0.000106305466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960195,0.0007219528,0.0020261726,0.00029032907,0.000411391,0.00053064444],"domain_scores_gemma":[0.9967491,0.0007098035,0.0014844298,0.00014018167,0.00046299532,0.00045349225],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022951646,0.00032980493,0.0011839947,0.0005726515,0.00007331231,0.0000065726435,0.0003297563,0.00047963505,0.0012780959],"category_scores_gemma":[0.00012962875,0.0002934233,0.00021797721,0.0003037446,0.00070020545,0.00035335778,0.00006798272,0.0015108036,0.000007490513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002828394,0.0006994345,0.0006246163,0.00011971021,0.00033100406,0.00025041902,0.0009769828,0.00011677776,0.98327845,0.00012005686,0.005162774,0.005491359],"study_design_scores_gemma":[0.007879212,0.00024906147,0.0067120795,0.000031253832,0.00067090255,0.00013798964,0.00024610793,0.00053878664,0.96091646,0.0006541183,0.021737276,0.00022674173],"about_ca_topic_score_codex":0.000296494,"about_ca_topic_score_gemma":0.000010426127,"teacher_disagreement_score":0.022362,"about_ca_system_score_codex":0.00005641042,"about_ca_system_score_gemma":0.00027022278,"threshold_uncertainty_score":0.9999518},"labels":[],"label_agreement":null},{"id":"W2040550914","doi":"10.1038/sj.clpt.6100087","title":"The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences; National Institute on Drug Abuse; Wellcome Trust","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Addiction; Clinical pharmacology; Pharmacology; Medicine; Drug; Disease; Informatics; Bioinformatics; Computational biology; Biology; Psychiatry; Genetics; Genotype; Internal medicine; Gene","score_opus":0.7589401969495758,"score_gpt":0.7016421437167268,"score_spread":0.05729805323284898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040550914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004151307,0.91502744,0.00018982314,0.0057819695,0.067111485,0.005624852,0.0010732271,0.0003163076,0.0007235679],"genre_scores_gemma":[0.0001538513,0.88280344,0.000542137,0.07687185,0.031945296,0.0007421684,0.00020681844,0.00056322874,0.0061711967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.925787,0.05543238,0.008170812,0.0033917269,0.0016279838,0.0055901],"domain_scores_gemma":[0.89047843,0.101269916,0.0019543606,0.0022303439,0.0011482293,0.0029187268],"candidate_categories":["metaresearch","metaepi_narrow","sts","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"category_scores_codex":[0.07682076,0.002365253,0.005889229,0.00071253226,0.0033891345,0.0004635007,0.0071699116,0.0045809634,0.0011555052],"category_scores_gemma":[0.000915401,0.0017750153,0.0038031673,0.0029250912,0.0054785996,0.00021237455,0.003940679,0.021317743,0.004808514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060608643,0.0014226404,0.00029783536,0.00025509027,0.007021886,0.00034328792,0.0001496401,0.00008190406,0.00007137591,0.000041974672,0.30087572,0.6833778],"study_design_scores_gemma":[0.004070446,0.0005690082,0.00018919354,0.0005024668,0.014907149,0.0000368388,0.00006979454,0.0002442358,0.00016185467,0.0004833578,0.9769725,0.0017931369],"about_ca_topic_score_codex":0.000021361975,"about_ca_topic_score_gemma":0.00003595947,"teacher_disagreement_score":0.68158466,"about_ca_system_score_codex":0.0005300657,"about_ca_system_score_gemma":0.0036539203,"threshold_uncertainty_score":0.9997576},"labels":[],"label_agreement":null},{"id":"W2040999980","doi":"10.1016/s0960-0760(01)00062-0","title":"Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens","year":2001,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medical Council of Canada; Wilfrid Laurier University; Université Laval","funders":"Medical Research Council","keywords":"Complementary DNA; Glucuronidation; Biology; Glucuronosyltransferase; Enzyme; Molecular biology; Biochemistry; Isozyme; Western blot; Hydroxysteroid; Microsome; cDNA library; Polyclonal antibodies; clone (Java method); Gene; Antibody; Dehydrogenase; Genetics","score_opus":0.026587815379358122,"score_gpt":0.34540920112175333,"score_spread":0.3188213857423952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040999980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957712,0.0021081425,0.00030295583,0.0013756364,0.00017602075,0.00014125988,0.000059144222,0.000002932182,0.000062660394],"genre_scores_gemma":[0.9922099,0.0068919533,0.000029092322,0.0007338203,0.00009433053,0.0000020697953,0.000008170488,0.000008318319,0.000022320648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902564,0.0003318046,0.00029304659,0.00013069868,0.00006590445,0.0001528999],"domain_scores_gemma":[0.99935025,0.00009999559,0.00026205252,0.000106330386,0.000080832804,0.000100546145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000364724,0.00014752359,0.00020518914,0.000038461825,0.0001308678,0.0000070946444,0.00013573321,0.00017093644,0.000016380045],"category_scores_gemma":[0.000031774507,0.000091260474,0.000051641455,0.00008034199,0.00036002384,0.000029677592,0.00006128328,0.00035515355,2.5925345e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008574896,0.0000745693,0.0028023226,0.000018040264,0.00012280064,0.0000052893993,0.0002973359,0.000016777114,0.9839019,0.000054871693,0.00000498646,0.011843588],"study_design_scores_gemma":[0.0011897879,0.0002013945,0.005972976,0.00001514731,0.00023563992,0.00026626943,0.00007527855,0.00023979864,0.990331,0.00022828212,0.0011533896,0.00009105881],"about_ca_topic_score_codex":0.0000028869074,"about_ca_topic_score_gemma":3.4468187e-7,"teacher_disagreement_score":0.011752529,"about_ca_system_score_codex":0.000008498724,"about_ca_system_score_gemma":0.00003081036,"threshold_uncertainty_score":0.3721494},"labels":[],"label_agreement":null},{"id":"W2041631632","doi":"10.1097/fpc.0b013e3283498ecf","title":"Genetic epidemiology of induced CYP3A4 activity","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"CYP3A4; Pharmacogenetics; Genetic variation; Population; Biology; Drug metabolism; Heritability; Genetic variability; Twin study; Pharmacology; Genetics; Cytochrome P450; Drug; Medicine; Metabolism; Environmental health; Biochemistry; Gene; Genotype","score_opus":0.3375756093859221,"score_gpt":0.4534916952181803,"score_spread":0.11591608583225815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041631632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449254,0.00812234,0.00075186294,0.000111798676,0.0013964527,0.0005019627,0.00014330981,0.00005112792,0.004428586],"genre_scores_gemma":[0.9814985,0.010728319,0.005834534,0.0013883988,0.00034074488,0.000044188015,0.000005790077,0.00006296412,0.00009658021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969838,0.0006853162,0.000803936,0.00060764665,0.00013639944,0.00078288745],"domain_scores_gemma":[0.99801725,0.00037649734,0.00045710363,0.0003620447,0.00016474476,0.00062237214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011454263,0.00043786626,0.0007156155,0.00021481207,0.00020176405,0.000005188789,0.00048304122,0.00039187146,0.00082776044],"category_scores_gemma":[0.00009141869,0.00044640497,0.00018715054,0.0002325069,0.0004237611,0.000059863527,0.0003309923,0.00067439344,0.000050272283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059825875,0.0005791971,0.1023959,0.0001017864,0.00049964717,0.000028107237,0.0017028106,0.00021553715,0.673609,0.0012291247,0.00023420261,0.21880643],"study_design_scores_gemma":[0.0033083083,0.00031766255,0.1866578,0.000009083869,0.00082347915,0.000092111884,0.000072968345,0.010696832,0.7428302,0.005987827,0.048378788,0.0008249283],"about_ca_topic_score_codex":0.00009641054,"about_ca_topic_score_gemma":0.000008106513,"teacher_disagreement_score":0.2179815,"about_ca_system_score_codex":0.000034624813,"about_ca_system_score_gemma":0.0001376452,"threshold_uncertainty_score":0.9997988},"labels":[],"label_agreement":null},{"id":"W2041804792","doi":"10.1038/sj.tpj.6500171","title":"Pharmacogenomics of human UDP-glucuronosyltransferase enzymes","year":2003,"lang":"en","type":"review","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":423,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Glucuronidation; Pharmacogenomics; Glucuronosyltransferase; Enzyme; Glycosyltransferase; Biotransformation; Drug; Xenobiotic; Biochemistry; Chemistry; Pharmacology; Biology; Microsome","score_opus":0.3297373214886679,"score_gpt":0.531695184887113,"score_spread":0.20195786339844507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041804792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011624971,0.9830683,0.00017874596,0.00013223941,0.007670319,0.0019280503,0.0012985813,0.00007693412,0.0044843364],"genre_scores_gemma":[0.0011152322,0.99227905,0.0001353678,0.0013344233,0.0032880688,0.0001361995,0.00012863956,0.00042307106,0.0011599731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9882034,0.004551447,0.0037695218,0.00094986137,0.0006961442,0.0018296234],"domain_scores_gemma":[0.9935118,0.001092109,0.0027512773,0.00091268093,0.00043094778,0.0013011908],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0055434727,0.0018298451,0.003851284,0.0008326074,0.0016146413,0.00017346631,0.0037003907,0.0010069504,0.0050452403],"category_scores_gemma":[0.00006266897,0.0013720437,0.002895226,0.0008774802,0.00096391985,0.00022032713,0.00041320478,0.0070994445,0.0004204647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018990992,0.00088903215,0.000008006994,0.0033961276,0.0056037214,0.00027694163,0.00062884827,0.00038419792,0.011590992,0.0019385364,0.012196571,0.9628971],"study_design_scores_gemma":[0.0030358934,0.00011429154,3.425033e-7,0.00048076708,0.014298012,0.0025200401,0.000048946116,0.000112335976,0.009756236,0.0005874396,0.9677503,0.001295356],"about_ca_topic_score_codex":0.0000093030585,"about_ca_topic_score_gemma":0.0000020564228,"teacher_disagreement_score":0.96160173,"about_ca_system_score_codex":0.0004836514,"about_ca_system_score_gemma":0.0015406014,"threshold_uncertainty_score":0.9996851},"labels":[],"label_agreement":null},{"id":"W2042345206","doi":"10.1111/j.1365-2125.2006.02806.x","title":"Warfarin: almost 60 years old and still causing problems","year":2006,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":332,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Warfarin; Medicine; Pharmacology; Intensive care medicine; Internal medicine; Atrial fibrillation","score_opus":0.14617076145120667,"score_gpt":0.4785994965935348,"score_spread":0.3324287351423281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042345206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710976,0.015520194,0.00011986505,0.001001132,0.009849448,0.00035642844,0.00007299454,0.000042091713,0.0019402641],"genre_scores_gemma":[0.9715493,0.013924866,0.00070912595,0.006994455,0.005922432,0.0000107112355,0.000009755971,0.000057244004,0.00082215643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99460477,0.0014661802,0.0023849716,0.00045505897,0.0003432164,0.000745803],"domain_scores_gemma":[0.9963776,0.0012034071,0.0011810736,0.00011848654,0.00042511837,0.0006943245],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042677866,0.00030435872,0.0010676902,0.000186349,0.00020565854,0.00007560249,0.00040893166,0.0005894244,0.0014914036],"category_scores_gemma":[0.0002788887,0.00034999655,0.00037568246,0.00025583955,0.0007473495,0.00024592952,0.00022894156,0.0026530758,0.00004025866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016613208,0.0041896994,0.044945937,0.00019277871,0.0016223075,0.025241766,0.00035116103,0.008019662,0.081909284,0.00038125162,0.23929729,0.5921876],"study_design_scores_gemma":[0.0123187555,0.00040516123,0.11640983,0.00006604281,0.0010377268,0.006461709,0.000029937994,0.0020507104,0.003875103,0.0021614046,0.8546633,0.0005203244],"about_ca_topic_score_codex":0.00013482456,"about_ca_topic_score_gemma":0.000033202145,"teacher_disagreement_score":0.61536604,"about_ca_system_score_codex":0.000038864808,"about_ca_system_score_gemma":0.00023858149,"threshold_uncertainty_score":0.9998952},"labels":[],"label_agreement":null},{"id":"W2042719175","doi":"10.1139/y08-017","title":"Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Universidade Estadual Paulista; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Verapamil; Chemistry; Metabolite; Pharmacology; Pharmacokinetics; Inhalation; Enantiomer; Chromatography; Stereochemistry; Biochemistry; Anesthesia; Medicine; Calcium; Organic chemistry","score_opus":0.056903496862475,"score_gpt":0.3522992351570084,"score_spread":0.2953957382945334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042719175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289966,0.004875886,0.000008856954,0.0007630159,0.0010377403,0.00028363822,0.000032386397,0.0000015693986,0.00009723886],"genre_scores_gemma":[0.99641496,0.0023350602,0.000057393623,0.00094506214,0.0002130972,0.000012963245,0.00000326522,0.000009002514,0.000009200647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976524,0.0011510111,0.0005806081,0.00018808726,0.000077605226,0.00035028713],"domain_scores_gemma":[0.9989359,0.00028066477,0.0002871345,0.00007873011,0.00014302167,0.00027458253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092077453,0.00016457457,0.00052502955,0.00057776255,0.000113258895,0.0000023560463,0.00021566641,0.00020259492,0.0001894324],"category_scores_gemma":[0.00004369492,0.00013702149,0.000064518674,0.00043083885,0.00053733075,0.00009283958,0.00002249936,0.0006340154,8.916481e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054636097,0.00015633719,0.0053628087,0.000050021852,0.000079750804,0.00006805111,0.004285516,0.0008728956,0.9849662,0.00025390324,0.00044693286,0.0029112075],"study_design_scores_gemma":[0.0029925667,0.00032272012,0.2522737,0.000016836739,0.00016724718,0.0004214615,0.00016244342,0.00023363066,0.73722434,0.0011043915,0.0049266582,0.00015401552],"about_ca_topic_score_codex":0.0005659514,"about_ca_topic_score_gemma":0.0005995919,"teacher_disagreement_score":0.2477419,"about_ca_system_score_codex":0.000029217883,"about_ca_system_score_gemma":0.0003561502,"threshold_uncertainty_score":0.5587574},"labels":[],"label_agreement":null},{"id":"W2042929001","doi":"10.1002/jbt.20156","title":"Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat","year":2007,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Ontogeny; CYP2E1; CYP1A2; Weaning; Biology; Internal medicine; Messenger RNA; Endocrinology; Immunohistochemistry; Cytochrome P450; Andrology; Metabolism; Immunology; Biochemistry; Gene; Medicine","score_opus":0.036159059703389326,"score_gpt":0.38982959232492276,"score_spread":0.3536705326215334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042929001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844705,0.013618721,0.00053025485,0.0003707951,0.0005465389,0.0001236956,0.000004597855,0.0000034925113,0.00033142423],"genre_scores_gemma":[0.99547386,0.0018608543,0.0013119223,0.00119268,0.00012557364,0.0000020001155,0.0000014885346,0.0000112169255,0.000020405907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984889,0.00020664373,0.00068762,0.00017036243,0.00013631274,0.0003101751],"domain_scores_gemma":[0.99891704,0.00024570548,0.00032063347,0.00008007176,0.00013432348,0.0003021992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001139936,0.0001571544,0.00042679388,0.00021499435,0.00003288438,0.000004956277,0.0001483206,0.0003536906,0.00006980496],"category_scores_gemma":[0.00022372411,0.00013250267,0.00008508022,0.00013611493,0.0002651685,0.00003952832,0.000088932786,0.0005568589,9.039721e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058815395,0.00029635173,0.0044748653,0.000047415215,0.00005066702,0.0002109785,0.00021306696,0.000010854371,0.98339754,0.00014910565,0.00035480104,0.010206196],"study_design_scores_gemma":[0.0023963447,0.00024076019,0.0028107085,0.000027846281,0.00009968896,0.00021093099,0.00005747805,0.00008165254,0.9825804,0.0009533698,0.010413769,0.00012700574],"about_ca_topic_score_codex":0.0000027959463,"about_ca_topic_score_gemma":0.0000029543519,"teacher_disagreement_score":0.0117578665,"about_ca_system_score_codex":0.000020877726,"about_ca_system_score_gemma":0.00005405214,"threshold_uncertainty_score":0.54033023},"labels":[],"label_agreement":null},{"id":"W2043208032","doi":"10.1002/chir.20334","title":"The stereoselective metabolism of halofantrine to desbutylhalofantrine in the rat: Evidence of tissue‐specific enantioselectivity in microsomal metabolism","year":2006,"lang":"en","type":"article","venue":"Chirality","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Microsome; Chemistry; Cytochrome P450; In vivo; Metabolite; Enantiomer; Halofantrine; Metabolism; Pharmacokinetics; Pharmacology; Stereoselectivity; Biochemistry; Drug metabolism; Enzyme; Stereochemistry; Biology; Genetics","score_opus":0.09011752858820486,"score_gpt":0.42653340339910306,"score_spread":0.3364158748108982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043208032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97013444,0.02518286,0.00011404057,0.0013349258,0.0008537544,0.0013489295,0.00009752567,0.000018772354,0.00091475114],"genre_scores_gemma":[0.9968202,0.0019775531,0.0002080825,0.00038999983,0.00030941193,0.00012212055,0.0000069732437,0.000023370216,0.00014226543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99483687,0.0022367542,0.001177143,0.00053114694,0.00042447392,0.00079360534],"domain_scores_gemma":[0.9971638,0.0014648661,0.000418416,0.0005691003,0.0002696438,0.000114182454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004772256,0.00037336204,0.0008050955,0.00026978657,0.0002296528,0.000035159897,0.0010379073,0.00020985882,0.00007129284],"category_scores_gemma":[0.00029285045,0.00024795518,0.00018239813,0.0017158998,0.00046092644,0.00017568025,0.00021419403,0.00093068345,0.0000137787465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017843671,0.0012451279,0.039210957,0.00009303967,0.000090336944,0.00003159598,0.0017998101,0.0006280883,0.91890377,0.014241627,0.00080725417,0.021164],"study_design_scores_gemma":[0.0015056222,0.00004896241,0.39623588,0.000023204699,0.000084401654,0.000010244624,0.00005668791,0.0000648089,0.5436621,0.0022573553,0.055852983,0.00019776855],"about_ca_topic_score_codex":0.0010198199,"about_ca_topic_score_gemma":0.0010479864,"teacher_disagreement_score":0.37524173,"about_ca_system_score_codex":0.000054881126,"about_ca_system_score_gemma":0.00015305588,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W2043547585","doi":"10.3109/1547691x.2012.707699","title":"Changes in gene expression induced by aromatic amine drugs: Testing the danger hypothesis","year":2012,"lang":"en","type":"article","venue":"Journal of Immunotoxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Aromatic amine; Pharmacology; Chemistry; Gene expression; Drug; Enzyme; Glutathione; Biochemistry; Gene; Biology","score_opus":0.14222412686599273,"score_gpt":0.3913642409011099,"score_spread":0.24914011403511716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043547585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848285,0.009756776,0.000017627539,0.0017319601,0.0025572726,0.0003293556,0.000012922171,0.0000156533,0.0007499432],"genre_scores_gemma":[0.9935517,0.0009687724,0.0009891785,0.0033628594,0.00091642374,0.000051309617,0.0000023702705,0.000037625803,0.000119799064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663955,0.0013439568,0.00083986676,0.0001616679,0.0002580294,0.00075693574],"domain_scores_gemma":[0.99648035,0.0020780533,0.0008479727,0.00023380487,0.00011507225,0.00024477707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031287104,0.00028296292,0.00055319775,0.0002850582,0.00021151407,0.00002105555,0.0006399953,0.0003780798,0.0003814652],"category_scores_gemma":[0.00073633774,0.0001946838,0.0001214514,0.00040186473,0.00016423485,0.00018342039,0.00015987514,0.001328385,0.000042029955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019643005,0.0006180503,0.0043102186,0.0000147919345,0.00012087103,0.00001621016,0.0019873513,0.000041493175,0.9528439,0.0000060325324,0.0022093898,0.037635233],"study_design_scores_gemma":[0.0024771562,0.00023874687,0.014766299,0.000036158544,0.00019766614,0.00024509334,0.00047192693,0.00016316325,0.94042003,0.00020221311,0.040529653,0.00025187834],"about_ca_topic_score_codex":0.00000744256,"about_ca_topic_score_gemma":0.000003021495,"teacher_disagreement_score":0.038320262,"about_ca_system_score_codex":0.00010883527,"about_ca_system_score_gemma":0.00009426012,"threshold_uncertainty_score":0.79389745},"labels":[],"label_agreement":null},{"id":"W2043875467","doi":"10.2174/1389200043335577","title":"Effect of Hypoxia on Cytochrome P450 Activity and Expression","year":2004,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CYP1A2; CYP2B6; Hypoxia (environmental); Pharmacology; Cytochrome P450; In vivo; Ex vivo; Biology; Chemistry; Endocrinology; Internal medicine; In vitro; Biochemistry; Medicine; Oxygen; Metabolism","score_opus":0.11755886781772057,"score_gpt":0.4857253257161715,"score_spread":0.3681664578984509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043875467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017736135,0.9732093,0.00001101405,0.000017677166,0.005328071,0.002221928,0.00073898217,0.000102196645,0.00063468923],"genre_scores_gemma":[0.004758049,0.99320364,0.000030384905,0.000034486588,0.0011610367,0.00039944935,0.0001056057,0.00014263915,0.00016470763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99297154,0.0034482572,0.0010479963,0.0011309995,0.0005413499,0.0008598397],"domain_scores_gemma":[0.9959964,0.0014733842,0.0010728494,0.0007096926,0.000088486384,0.0006591545],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020436225,0.0013461424,0.003994445,0.00062287296,0.00027192617,0.000039449813,0.00079234265,0.0008105661,0.00032614908],"category_scores_gemma":[0.0001855141,0.0010078568,0.0010211491,0.00046786352,0.0004228332,0.00013999936,0.00047409348,0.0028812296,0.00019232415],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020069919,0.0004579037,0.0000011504707,0.023060897,0.00030897013,0.000015032052,0.00013463479,0.00001495614,0.0048439633,0.00031307817,0.00063765404,0.97001106],"study_design_scores_gemma":[0.0025485677,0.00009583987,0.000035382116,0.005165801,0.0049491334,0.000024483556,0.000001599104,0.000014986655,0.027618602,0.0001288678,0.9586111,0.0008056506],"about_ca_topic_score_codex":0.000007330276,"about_ca_topic_score_gemma":4.010074e-7,"teacher_disagreement_score":0.96920544,"about_ca_system_score_codex":0.00009591107,"about_ca_system_score_gemma":0.0003572383,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W2044335128","doi":"10.3109/03602532.2011.596204","title":"The ability of polycyclic aromatic hydrocarbons to alter physiological factors underlying drug disposition","year":2011,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Cytochrome P450; Pharmacokinetics; Drug; Pharmacology; Xenobiotic; Polycyclic aromatic hydrocarbon; Disposition; Enzyme; Physiologically based pharmacokinetic modelling; Drug metabolism; Toxicokinetics; Biochemistry; Environmental chemistry; Metabolism; Biology","score_opus":0.28624432840596054,"score_gpt":0.47608183658350767,"score_spread":0.18983750817754713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044335128","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004518486,0.98522085,0.000040615996,0.0000968271,0.004067504,0.0046590217,0.00015774989,0.00009094395,0.0011479984],"genre_scores_gemma":[0.0032237524,0.9935027,0.00019503842,0.00063056307,0.0006064808,0.001099809,0.00015166777,0.00012778692,0.00046224712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98688173,0.0071365694,0.0032124491,0.0011649528,0.00039787663,0.0012064071],"domain_scores_gemma":[0.9941908,0.0015347545,0.0019759361,0.0014739761,0.00003126042,0.00079326954],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0044334917,0.0014264241,0.005285706,0.00031927216,0.00066868804,0.00006370615,0.0020305745,0.0005997101,0.00019297133],"category_scores_gemma":[0.00052152626,0.00082039164,0.0024833651,0.0010194052,0.00053164474,0.0001401704,0.000505038,0.0021003173,0.0005937498],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027172158,0.0003846195,0.0000060872517,0.0027622203,0.000562171,0.0000033764547,0.0010726738,0.0000011168282,0.0009858292,0.0006006994,0.004221179,0.98937285],"study_design_scores_gemma":[0.00032729792,0.000019059937,0.00021729003,0.0012603116,0.0051503326,0.000008409028,0.000039252587,0.000016052045,0.00031398173,0.0013984705,0.9904277,0.0008218574],"about_ca_topic_score_codex":0.000057770158,"about_ca_topic_score_gemma":0.000012437571,"teacher_disagreement_score":0.988551,"about_ca_system_score_codex":0.00009577352,"about_ca_system_score_gemma":0.00021969316,"threshold_uncertainty_score":0.9998486},"labels":[],"label_agreement":null},{"id":"W2044432552","doi":"10.1542/peds.2013-1416","title":"Public Perceptions of Pharmacogenetics","year":2014,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Medicine; Perception; Family medicine; Genetic testing; Exploratory analysis; Psychology; Data science; Genotype; Internal medicine; Genetics; Computer science","score_opus":0.14413060833045402,"score_gpt":0.42333091163757447,"score_spread":0.2792003033071204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044432552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9478119,0.0023696106,0.004571382,0.0008763739,0.002770332,0.00028622977,0.00015083888,0.00012522668,0.041038096],"genre_scores_gemma":[0.9910282,0.004211316,0.0012479614,0.0013675232,0.0015490938,0.000026118614,0.000030380701,0.000037591573,0.0005018114],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979351,0.00043338092,0.0005098164,0.00030220882,0.00029069552,0.00052875315],"domain_scores_gemma":[0.9983678,0.00039255217,0.00021887838,0.000278718,0.00029691416,0.00044517903],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010212054,0.0002319434,0.0003103196,0.00027687586,0.00019499462,0.000018394367,0.00046593856,0.0002512563,0.0025781814],"category_scores_gemma":[0.00026249397,0.0002355612,0.00017212269,0.0005631107,0.00019011101,0.00007909125,0.00014736007,0.00053447316,0.00031146655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014410814,0.0025827386,0.40766802,0.00036249074,0.00027195708,0.00001190374,0.0013993372,0.0028891573,0.20935495,0.020897588,0.045254964,0.3091628],"study_design_scores_gemma":[0.002578774,0.00011336607,0.015770204,0.000002128065,0.0005751066,0.000016110596,0.00007073887,0.011466146,0.0270175,0.0023320864,0.93952364,0.00053422834],"about_ca_topic_score_codex":0.000004183168,"about_ca_topic_score_gemma":0.0000016781295,"teacher_disagreement_score":0.89426863,"about_ca_system_score_codex":0.000023104702,"about_ca_system_score_gemma":0.000108636596,"threshold_uncertainty_score":0.9983336},"labels":[],"label_agreement":null},{"id":"W2044708845","doi":"10.1016/j.jbiotec.2007.05.009","title":"Sugar-mediated lyoprotection of purified human CYP3A4 and CYP2D6","year":2007,"lang":"en","type":"article","venue":"Journal of Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Merck Canada; Vanderbilt University","keywords":"Trehalose; Sorbitol; Mannitol; Enzyme; Chemistry; Sugar; Biochemistry; Sucrose; Anhydrous; CYP3A4; Enzyme assay; Chromatography; Cytochrome P450; Organic chemistry","score_opus":0.07037182869266764,"score_gpt":0.42333223103471435,"score_spread":0.35296040234204673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044708845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266696,0.003111001,0.0009966523,0.0012769408,0.0010405976,0.00017647754,0.000014076901,0.000036003636,0.0006813174],"genre_scores_gemma":[0.99702424,0.0017425618,0.0005353211,0.0003387523,0.00026732913,0.0000017648234,0.0000021905714,0.00001729798,0.000070564005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835336,0.00013986563,0.00081771985,0.00016428345,0.00016753406,0.0003572103],"domain_scores_gemma":[0.99855596,0.00018330969,0.0007633972,0.00014218513,0.00017424364,0.00018092222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001916827,0.00017207988,0.00043736695,0.00065314875,0.0001234754,0.0000061040287,0.0002816213,0.0008494551,0.00017244353],"category_scores_gemma":[0.00017317767,0.00015256653,0.000110809066,0.0003560757,0.00045390305,0.00006688543,0.00008885748,0.0012664989,0.000007705143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034610208,0.000200675,0.0019564864,0.000027288648,0.00018107143,0.00008174672,0.00017282327,0.000014754077,0.95800734,0.0015898435,0.0003592682,0.0370626],"study_design_scores_gemma":[0.0023194463,0.00043607363,0.0071017253,0.000012351582,0.00015329073,0.00036348248,0.00015706976,0.000047430116,0.91854066,0.001745933,0.06898356,0.00013895976],"about_ca_topic_score_codex":0.000011564803,"about_ca_topic_score_gemma":0.000015084503,"teacher_disagreement_score":0.06862429,"about_ca_system_score_codex":0.00003417377,"about_ca_system_score_gemma":0.00005313537,"threshold_uncertainty_score":0.65517753},"labels":[],"label_agreement":null},{"id":"W2045041505","doi":"10.1007/s00239-010-9402-7","title":"Phylogenetic and Functional Analysis of the Vertebrate Cytochrome P450 2 Family","year":2010,"lang":"en","type":"article","venue":"Journal of Molecular Evolution","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Vertebrate; Phylogenetic tree; Phylogenetics; Genetics; Evolutionary biology; Gene","score_opus":0.03655027407068639,"score_gpt":0.3525491873309859,"score_spread":0.3159989132602995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045041505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312544,0.003065537,0.0020218948,0.00026636472,0.0010618585,0.00009805121,0.000024704235,0.0000037528735,0.00033241688],"genre_scores_gemma":[0.99884665,0.0001952553,0.00023553496,0.0005109903,0.0001592229,0.0000023506307,0.0000024128012,0.00000943866,0.000038173926],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99870837,0.00027812747,0.00043023634,0.00012388924,0.00028668772,0.00017271124],"domain_scores_gemma":[0.99891615,0.00006766123,0.00043292472,0.00015073527,0.0002934834,0.00013904425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007191224,0.00012350029,0.00028216848,0.00028759128,0.00010963722,0.000009694805,0.00019191613,0.00016812036,0.00017515202],"category_scores_gemma":[0.00008076328,0.0000914741,0.0002879666,0.0005597416,0.0002033621,0.0000510938,0.0000666531,0.00065563375,0.0000032351286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009702324,0.00010602066,0.011473278,0.000007520673,0.0010292445,0.0000081240805,0.000055066525,0.00607318,0.97798496,0.0008843071,0.00022295509,0.0020582932],"study_design_scores_gemma":[0.0012305443,0.00006475636,0.7914833,0.00000507438,0.0036562704,0.00007059757,0.000024122266,0.01175881,0.18398428,0.001204119,0.00639704,0.00012107849],"about_ca_topic_score_codex":0.0000055189344,"about_ca_topic_score_gemma":0.000007461189,"teacher_disagreement_score":0.7940007,"about_ca_system_score_codex":0.000023447858,"about_ca_system_score_gemma":0.00013642079,"threshold_uncertainty_score":0.37302056},"labels":[],"label_agreement":null},{"id":"W2045367654","doi":"10.1002/bdd.236","title":"Dose staggering as a strategy to reduce drug–drug interactions due to reversible enzyme inhibition between orally administered drugs with high first pass effect: a computer simulation study","year":2000,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Drug; Pharmacology; Drug interaction; Absorption (acoustics); Pharmacokinetics; First pass effect; Medicine; Chemistry; Materials science","score_opus":0.0503995315314563,"score_gpt":0.40593889976541686,"score_spread":0.35553936823396054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045367654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901769,0.0001567397,0.0005822466,0.002116482,0.0012347598,0.0042787977,0.00051829463,0.00032938828,0.0006063472],"genre_scores_gemma":[0.9928747,0.000078266574,0.0006482788,0.0026365956,0.0013860931,0.0004694464,0.00043101225,0.00013634785,0.0013392862],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99470663,0.0012405412,0.0010353137,0.0012350623,0.0007207281,0.0010617266],"domain_scores_gemma":[0.9968592,0.0006625862,0.0003258008,0.00053784705,0.00035144872,0.0012631533],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012222339,0.00086612254,0.0008286499,0.0006011716,0.0009993794,0.00028630774,0.0004870308,0.0001733073,0.0015382556],"category_scores_gemma":[0.000019794114,0.0008712864,0.00020649325,0.0012542112,0.000115497336,0.00059593975,0.00023668006,0.0011147193,0.0010716324],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02109137,0.0063291583,0.0056659253,0.00053705624,0.0018686092,0.0010003604,0.032132372,0.58399993,0.13044786,0.0001264916,0.008106135,0.20869471],"study_design_scores_gemma":[0.033176772,0.0042947344,0.04824367,0.00087163947,0.0058957296,0.0001749031,0.0023453995,0.0540454,0.668986,0.00022425906,0.17698735,0.004754115],"about_ca_topic_score_codex":0.00028814288,"about_ca_topic_score_gemma":0.00014392486,"teacher_disagreement_score":0.53853816,"about_ca_system_score_codex":0.00039233334,"about_ca_system_score_gemma":0.00016913304,"threshold_uncertainty_score":0.99970615},"labels":[],"label_agreement":null},{"id":"W2045397804","doi":"10.1016/s1056-8719(00)00112-x","title":"Fluorometric screening for metabolism-based drug–drug interactions","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WSP (Canada)","funders":"","keywords":"Drug; Drug metabolism; Drug discovery; Chemistry; High-throughput screening; Computational biology; Pharmacology; Chromatography; Biochemistry; Biology","score_opus":0.23344236357453158,"score_gpt":0.5384354334319789,"score_spread":0.3049930698574473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045397804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94220614,0.013328097,0.030302528,0.005641975,0.0036420717,0.0011353834,0.00013317478,0.0001252041,0.0034854377],"genre_scores_gemma":[0.72506803,0.0033013346,0.25639275,0.011122387,0.00205934,0.00016422967,0.00000945821,0.000047831498,0.0018346222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935132,0.00317401,0.0014734117,0.00056283525,0.00037205583,0.00090444717],"domain_scores_gemma":[0.9912256,0.006390935,0.00067838974,0.00014785022,0.00044327928,0.0011139263],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0062552127,0.0005416455,0.0012274672,0.000525933,0.000583751,0.00008508751,0.0007112754,0.00030285754,0.015148518],"category_scores_gemma":[0.0008828984,0.00038102557,0.00074497436,0.0008863404,0.00048840174,0.00028908407,0.0001269686,0.0019982937,0.000025916974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032034363,0.0016488659,0.00039690154,0.000036889465,0.0006847606,0.000098761026,0.00012599054,0.0028497956,0.19716659,0.0004428645,0.008169987,0.78517514],"study_design_scores_gemma":[0.007256298,0.00046140407,0.0042095035,0.000018270322,0.00198935,0.00019857474,0.000071686,0.016627844,0.16623557,0.0034644394,0.7989165,0.00055053004],"about_ca_topic_score_codex":0.000002987662,"about_ca_topic_score_gemma":8.520011e-7,"teacher_disagreement_score":0.79074657,"about_ca_system_score_codex":0.00006655578,"about_ca_system_score_gemma":0.0001200643,"threshold_uncertainty_score":0.99986416},"labels":[],"label_agreement":null},{"id":"W2045537064","doi":"10.1517/17425250903234709","title":"Glucocorticoids and phenobarbital induce murine<i>CYP2B</i>genes by independent mechanisms","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Phenobarbital; Biology; Gene; Glucocorticoid; Inducer; Glucocorticoid receptor; Nuclear receptor; Cell biology; Transcription factor; Genetics; Pharmacology; Immunology","score_opus":0.10458827221336382,"score_gpt":0.4432972763190783,"score_spread":0.3387090041057145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045537064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042562716,0.9764924,0.000105413026,0.00087890914,0.01564456,0.0027596469,0.00068713794,0.0003463155,0.0026599872],"genre_scores_gemma":[0.0003364229,0.9836242,0.0005240059,0.008822178,0.0033441584,0.0011394128,0.0005914522,0.0003173987,0.0013007239],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886722,0.00349019,0.0023732493,0.0025001212,0.0008600188,0.002104245],"domain_scores_gemma":[0.99490935,0.000942304,0.0013084533,0.0011148382,0.00019561494,0.0015294325],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0017545487,0.002344476,0.004897479,0.0009628907,0.0007294467,0.00015941198,0.0016978979,0.0028654148,0.0015759292],"category_scores_gemma":[0.00017725101,0.002100466,0.0010304248,0.0007704525,0.00055650185,0.0002573531,0.00079814234,0.003936705,0.0005480004],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016492527,0.0013820948,0.0000010381603,0.000549838,0.00083574146,0.0000809054,0.00044668282,0.000008680081,0.0036811503,0.008549918,0.02981842,0.9544806],"study_design_scores_gemma":[0.0031146337,0.00025242427,0.000009194094,0.00042200767,0.0007199909,0.000263041,0.00007900677,0.000048339418,0.00522718,0.0011790675,0.98673373,0.0019514078],"about_ca_topic_score_codex":0.000037150556,"about_ca_topic_score_gemma":0.000005908807,"teacher_disagreement_score":0.95691526,"about_ca_system_score_codex":0.0002292252,"about_ca_system_score_gemma":0.0006410831,"threshold_uncertainty_score":0.9993368},"labels":[],"label_agreement":null},{"id":"W2045715230","doi":"10.1002/rcm.2813","title":"Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometry","year":2006,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Chemistry; Chromatography; Active metabolite; Metabolite; Bioanalysis; Analyte; Mass spectrometry; Tandem mass spectrometry; Liquid chromatography–mass spectrometry; Triple quadrupole mass spectrometer; Electrospray ionization; Selected reaction monitoring; Biochemistry","score_opus":0.04002299090569218,"score_gpt":0.3751251071828876,"score_spread":0.33510211627719544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045715230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786101,0.009494051,0.0003016949,0.00044444492,0.00014444829,0.00058916386,0.00017412615,0.00002308101,0.01021888],"genre_scores_gemma":[0.98723215,0.004985448,0.0074825566,0.000060157232,0.000038823466,0.00008425661,0.000039797753,0.000027942087,0.000048877795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970447,0.0011553001,0.0008196731,0.00032389472,0.0002606583,0.00039580447],"domain_scores_gemma":[0.997525,0.00082550396,0.000603366,0.0008572583,0.000118593955,0.00007032438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090052007,0.0002762039,0.0005635334,0.0010368271,0.00020149827,0.000014512022,0.0011005192,0.00028049017,0.00014057077],"category_scores_gemma":[0.00010176366,0.00026032544,0.00014637716,0.0022438928,0.0007805123,0.00016735222,0.0003011111,0.0010567413,0.0000013456548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104823535,0.00078100397,0.051667236,0.000038044316,0.00009647705,0.0000010756169,0.0003407767,0.000027380065,0.93582934,0.009664018,0.000051612238,0.0013981939],"study_design_scores_gemma":[0.0021061276,0.00013556941,0.10473661,0.000035617966,0.00015196012,0.000006170171,0.00041274622,0.0016441965,0.8800074,0.008780987,0.0017283099,0.00025431957],"about_ca_topic_score_codex":0.00013784294,"about_ca_topic_score_gemma":0.00009719567,"teacher_disagreement_score":0.055821978,"about_ca_system_score_codex":0.00014175108,"about_ca_system_score_gemma":0.000070587914,"threshold_uncertainty_score":0.9999849},"labels":[],"label_agreement":null},{"id":"W2046215289","doi":"10.1021/bi002607y","title":"Isolation and Characterization of the UGT2B28 cDNA Encoding a Novel Human Steroid Conjugating UDP-Glucuronosyltransferase","year":2001,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Complementary DNA; Glucuronidation; Subcellular localization; Biology; Gene isoform; Biochemistry; Gene; Molecular biology; Hydroxysteroid; Enzyme; Microsome; Dehydrogenase","score_opus":0.0710527033254991,"score_gpt":0.374405378057015,"score_spread":0.30335267473151595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046215289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704635,0.00024123673,0.0003965093,0.00026634574,0.00032378893,0.00018693702,0.00008887148,0.000024338955,0.0014256154],"genre_scores_gemma":[0.99869394,0.00019085115,0.000065856584,0.00045988357,0.00025623434,0.000013515312,0.00004755733,0.000015077861,0.00025709264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909467,0.0000704478,0.00030367792,0.0002217952,0.000105388805,0.00020399575],"domain_scores_gemma":[0.999469,0.000052150946,0.00016191181,0.0001533852,0.00006457818,0.000099008335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025947532,0.00015126594,0.00015421577,0.000027561817,0.00023716275,0.000016735556,0.00016629344,0.00016957188,0.00016940005],"category_scores_gemma":[0.000028375036,0.0001335564,0.000057599307,0.00013142797,0.00013843486,0.000057246936,0.00006424568,0.0002726284,0.0000021126261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003884665,0.00009294924,0.024941677,0.000056643108,0.000034053548,0.0000011396376,0.00030738936,0.000010734657,0.97211266,0.000084583146,0.000014400853,0.0023049517],"study_design_scores_gemma":[0.0011004874,0.000012941473,0.015166556,0.000024125473,0.00008715769,0.000019287274,0.00004362333,0.0015534422,0.97830397,0.000028856859,0.003515439,0.00014411582],"about_ca_topic_score_codex":0.00000647712,"about_ca_topic_score_gemma":0.0000010911752,"teacher_disagreement_score":0.009775121,"about_ca_system_score_codex":0.000018133587,"about_ca_system_score_gemma":0.000037076305,"threshold_uncertainty_score":0.54462725},"labels":[],"label_agreement":null},{"id":"W2046405322","doi":"10.1016/j.fct.2006.10.023","title":"Effect of testicular steroids on catalytic activities of cytochrome P450 enzymes in porcine liver microsomes","year":2006,"lang":"en","type":"article","venue":"Food and Chemical Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Microsome; CYP2E1; Internal medicine; Testosterone (patch); Endocrinology; Microsoma; Cytochrome P450; Skatole; Chemistry; Enzyme; Metabolism; Biochemistry; Biology; Medicine","score_opus":0.026498577257160955,"score_gpt":0.35022376348022416,"score_spread":0.32372518622306323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046405322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261075,0.00549781,0.0000027543203,0.000084142695,0.00014377588,0.00031881398,0.00011810599,0.000018713994,0.0012051152],"genre_scores_gemma":[0.99920946,0.00018415316,0.000043057527,0.00021578393,0.00015403576,0.000038728787,0.000026483372,0.000019970295,0.00010830878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998457,0.0002870998,0.0004452129,0.0003119235,0.00011817184,0.00038059664],"domain_scores_gemma":[0.9985356,0.0010071574,0.00016816375,0.00015022515,0.000032019874,0.000106873966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035637617,0.00026099922,0.000666184,0.00017050521,0.000034553814,0.000005085648,0.00017875958,0.0003721507,0.00015495597],"category_scores_gemma":[0.000074488526,0.00022564862,0.00010380027,0.00017176961,0.0004900234,0.000038929156,0.00010935077,0.0004136044,0.0000059096997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007491996,0.0005718843,0.004970015,0.0002673509,0.00009159793,0.000028830827,0.00011158504,0.000055448607,0.987975,0.0013785217,0.00030004815,0.0035004872],"study_design_scores_gemma":[0.0033898416,0.001536479,0.0054255123,0.00002664579,0.00016328937,0.000032630174,0.000011076992,0.00021307684,0.987169,0.00022549988,0.0016169031,0.00019000928],"about_ca_topic_score_codex":0.000014225308,"about_ca_topic_score_gemma":0.0000047474236,"teacher_disagreement_score":0.0065987105,"about_ca_system_score_codex":0.000028694152,"about_ca_system_score_gemma":0.00003573674,"threshold_uncertainty_score":0.92016834},"labels":[],"label_agreement":null},{"id":"W2046420852","doi":"10.1016/s0165-1781(00)00213-4","title":"Effect of venlafaxine on imipramine metabolism","year":2000,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute of Mental Health","keywords":"Venlafaxine; Imipramine; CYP2D6; Desipramine; Pharmacology; Cytochrome P450; Venlafaxine Hydrochloride; Metabolism; Drug interaction; Volume of distribution; Internal medicine; Endocrinology; Pharmacokinetics; Reuptake inhibitor; Drug metabolism; Medicine; Chemistry; Drug; Antidepressant","score_opus":0.13876486953812592,"score_gpt":0.542203822319702,"score_spread":0.40343895278157604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046420852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92169213,0.0063992706,0.0000017626872,0.0019858615,0.0020088712,0.00060077227,0.00008794184,0.000051784755,0.06717162],"genre_scores_gemma":[0.9908902,0.0022274242,0.00011684957,0.00067730836,0.0012874654,0.0001055761,0.000021724787,0.000049403934,0.004624065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949514,0.0025862218,0.0004490175,0.00046709646,0.0006834877,0.0008627415],"domain_scores_gemma":[0.99791414,0.000966704,0.00007241188,0.00048811475,0.0001564976,0.00040215664],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0050570895,0.0002737104,0.00047031065,0.00035949517,0.00030366567,0.000018849478,0.00064262905,0.00029347974,0.014177121],"category_scores_gemma":[0.00013014134,0.00022392656,0.00019898737,0.0008015444,0.00038070735,0.00006022542,0.00008140624,0.0016641238,0.0017321983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010205124,0.002197403,0.022232896,0.0004160848,0.00050662836,0.000037987782,0.00041153777,0.0010454243,0.08378499,0.006741713,0.05736404,0.81505615],"study_design_scores_gemma":[0.0054526306,0.0014566998,0.009909566,0.00003166478,0.00020527,0.000016553846,0.00001809271,0.0010843299,0.13051076,0.0014852092,0.8495067,0.00032255574],"about_ca_topic_score_codex":0.000029252185,"about_ca_topic_score_gemma":0.00000372575,"teacher_disagreement_score":0.8147336,"about_ca_system_score_codex":0.00002337342,"about_ca_system_score_gemma":0.00012767101,"threshold_uncertainty_score":0.9990451},"labels":[],"label_agreement":null},{"id":"W2046515541","doi":"10.1016/j.thromres.2003.12.014","title":"The hepoxilin stable analogue, PBT-3, inhibits primary, platelet-related hemostasis in whole blood measured in vitro with the PFA-100","year":2003,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"In vivo; Chemistry; Medicine; Biochemistry; Biology","score_opus":0.19169147956414898,"score_gpt":0.45380072141703626,"score_spread":0.2621092418528873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046515541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692389,0.008856529,0.0000041804597,0.0060953014,0.0002778937,0.0014203739,0.00007691106,0.000043835025,0.013986112],"genre_scores_gemma":[0.9940677,0.0034222223,0.00008016174,0.0008250838,0.00006771041,0.00029111106,0.000037657566,0.00006702246,0.0011412752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9905242,0.0051780636,0.00071216165,0.00068368984,0.0010967193,0.0018052101],"domain_scores_gemma":[0.9965601,0.0019482524,0.00014452878,0.0006526224,0.00037022933,0.00032428664],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.012029656,0.00038952843,0.00057153794,0.00043740412,0.0010635523,0.00013642288,0.0009627159,0.0004087164,0.00039035067],"category_scores_gemma":[0.00036569854,0.00024464686,0.00010708097,0.0029485049,0.0010018584,0.00016077403,0.00026563942,0.0033639318,0.00017988677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011392683,0.0016107191,0.0062986542,0.000057735982,0.00054249034,0.00013043909,0.002594324,0.0014778363,0.96495414,0.0011213663,0.0067327935,0.013340246],"study_design_scores_gemma":[0.006283101,0.00014607619,0.008668899,0.00003148062,0.000101912636,0.00002647151,0.00081894174,0.0007065795,0.7643038,0.000942423,0.21756753,0.00040275857],"about_ca_topic_score_codex":0.00035671282,"about_ca_topic_score_gemma":0.00087681576,"teacher_disagreement_score":0.21083474,"about_ca_system_score_codex":0.00021332144,"about_ca_system_score_gemma":0.00064959907,"threshold_uncertainty_score":0.99893534},"labels":[],"label_agreement":null},{"id":"W2047398257","doi":"10.1016/j.clpt.2005.06.005","title":"Cytochrome P450 2C9 genotype: Impact on celecoxib safety and pharmacokinetics in a pediatric patient","year":2005,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical pharmacology; Associate editor; Internal medicine; Family medicine; Oncology; Pharmacology; Library science","score_opus":0.13295563203773855,"score_gpt":0.48423952665964093,"score_spread":0.35128389462190235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047398257","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43269378,0.03408995,0.00003861972,0.5042167,0.016873462,0.00524703,0.0017930539,0.00049982424,0.004547636],"genre_scores_gemma":[0.05198761,0.12665136,0.00017218075,0.7984936,0.02092735,0.00019799244,0.00034984018,0.0003543578,0.00086569815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857636,0.004865771,0.0034995454,0.0023040473,0.0008088513,0.0027581593],"domain_scores_gemma":[0.991642,0.0047446666,0.0014175449,0.0008349381,0.00035893655,0.0010019313],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0024315952,0.002070368,0.0027538752,0.0010309519,0.00043861906,0.00008670983,0.0015416822,0.005308592,0.0045651533],"category_scores_gemma":[0.000058786274,0.001882333,0.0010451475,0.0009156079,0.001176845,0.00015069146,0.00066342094,0.018390844,0.0007214088],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005064522,0.0030411114,0.0038403664,0.0002628229,0.0031463404,0.002254491,0.00054268393,0.0026915884,0.0060506267,0.000007805453,0.8746192,0.09847846],"study_design_scores_gemma":[0.011110116,0.0014034102,0.011224915,0.000027480193,0.005470277,0.00010837513,0.00001004223,0.004585078,0.0012490073,0.00013679756,0.9628702,0.0018043072],"about_ca_topic_score_codex":0.000010141308,"about_ca_topic_score_gemma":0.0000050888516,"teacher_disagreement_score":0.38070616,"about_ca_system_score_codex":0.00053412747,"about_ca_system_score_gemma":0.000831676,"threshold_uncertainty_score":0.9992038},"labels":[],"label_agreement":null},{"id":"W2047667596","doi":"10.1016/j.clpt.2003.11.301","title":"Evaluation of herbal products as potential inhibitors of MDR1","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"Pharmacology; Black cohosh; Verapamil; Traditional medicine; Digoxin; Valerian; Phytochemical; Chemistry; Kava; Phytotherapy; Ginseng; Medicine","score_opus":0.2840747636108134,"score_gpt":0.5431562213857632,"score_spread":0.25908145777494984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047667596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97178483,0.0081830695,0.00009324184,0.00512282,0.011547176,0.001245055,0.00007279103,0.00007057382,0.0018804249],"genre_scores_gemma":[0.98023534,0.003645426,0.00047922978,0.013656485,0.0017457223,0.0000619263,0.000024266305,0.000059391437,0.00009223084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9931007,0.0027082309,0.001918862,0.0006708541,0.0009453297,0.0006560031],"domain_scores_gemma":[0.9958914,0.00047573046,0.0009850673,0.00040199037,0.001899616,0.00034619434],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007692278,0.00042221654,0.0008820073,0.0002121755,0.00016222724,0.000008218739,0.00068758713,0.00077639055,0.0013407455],"category_scores_gemma":[0.00018885764,0.00040740066,0.00042747182,0.0005640198,0.0014428931,0.0001229944,0.0002157277,0.0013454586,0.00013767353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016999445,0.0052659386,0.0023364094,0.00010355509,0.0034648885,0.000031234777,0.0007724117,0.01733191,0.8758618,0.00035017033,0.0036467223,0.08913502],"study_design_scores_gemma":[0.017314058,0.00086682267,0.0033375495,0.000022950037,0.010968439,0.000036493733,0.0001232388,0.0030624447,0.8857724,0.0061808066,0.07182046,0.0004943164],"about_ca_topic_score_codex":0.000017226057,"about_ca_topic_score_gemma":0.000002408875,"teacher_disagreement_score":0.088640705,"about_ca_system_score_codex":0.00011140701,"about_ca_system_score_gemma":0.0014739453,"threshold_uncertainty_score":0.99983776},"labels":[],"label_agreement":null},{"id":"W2048088066","doi":"10.1371/journal.pone.0107728","title":"The Cytochrome P450 Superfamily Complement (CYPome) in the Annelid Capitella teleta","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Cytochrome P450; Annelid; Phylogenetics; Pseudogene; Xenobiotic; Phylogenetic tree; Demethylase; Genetics; Hox gene; Gene; Biochemistry; Genome; Enzyme; Zoology; Epigenetics; Gene expression","score_opus":0.21364250109640043,"score_gpt":0.39352596601146383,"score_spread":0.1798834649150634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048088066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97757393,0.0035927333,0.00002056156,0.005635462,0.00029195083,0.0008443166,0.000055035172,0.000047907975,0.011938101],"genre_scores_gemma":[0.98637825,0.0029144585,0.00013808656,0.009004072,0.00069861684,0.00017341644,0.000022787344,0.000031438485,0.0006388761],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668133,0.0012977809,0.0004838693,0.00033528192,0.00046337149,0.00073838874],"domain_scores_gemma":[0.9979123,0.0012171487,0.00010845684,0.0004840056,0.00010232896,0.00017578571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026399293,0.00026676978,0.0003434095,0.00008397945,0.0005844943,0.0000678084,0.0009667206,0.0001484312,0.0006477176],"category_scores_gemma":[0.00012833349,0.00016916943,0.00009463861,0.00028404544,0.00027252187,0.000051645373,0.00016341818,0.00089850003,0.0004737449],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029543473,0.0041250093,0.0076823807,0.00010395161,0.0007225584,0.00003472901,0.0035475413,0.00034295165,0.94499075,0.008436103,0.012347666,0.017370902],"study_design_scores_gemma":[0.0045010303,0.00029696725,0.0438116,0.00004029472,0.0006763417,0.00001535539,0.00063473324,0.014678357,0.14643843,0.003315646,0.78492993,0.0006613397],"about_ca_topic_score_codex":0.000041404655,"about_ca_topic_score_gemma":0.00005993624,"teacher_disagreement_score":0.79855233,"about_ca_system_score_codex":0.000038009308,"about_ca_system_score_gemma":0.00004767042,"threshold_uncertainty_score":0.7092053},"labels":[],"label_agreement":null},{"id":"W2048391139","doi":"10.1006/bbrc.2001.6209","title":"An in Vivo Pilot Study Characterizing the New CYP2A6*7, *8, and *10 Alleles","year":2002,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canada Research Chairs; Centre for Addiction and Mental Health","keywords":"Allele; CYP2A6; Genotyping; Genetics; Biology; In vivo; Homology (biology); Genotype; Gene; In vitro","score_opus":0.3966348491509826,"score_gpt":0.5169513918226329,"score_spread":0.12031654267165032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048391139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982892,0.0036760273,0.0000014902279,0.011424069,0.000033013235,0.00050029694,0.000028652072,0.0000260267,0.0014184449],"genre_scores_gemma":[0.99218756,0.006415216,0.00011415403,0.0004999407,0.00020549072,0.00009463299,0.000008906316,0.000012975985,0.0004611218],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997689,0.0010951763,0.00024384861,0.00031388266,0.00023881304,0.00041925802],"domain_scores_gemma":[0.99783283,0.00095004775,0.00003672875,0.0006742347,0.00009397519,0.00041218524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009678655,0.000149046,0.0001894344,0.00009210249,0.00054638897,0.00008237436,0.0009029257,0.000083791645,0.0003820233],"category_scores_gemma":[0.00016479084,0.00010754628,0.00002548181,0.00039340623,0.00088570814,0.00008714665,0.00060190447,0.0011317699,0.000042402622],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010422389,0.0026927404,0.00072608056,0.0000071392387,0.000031576605,0.0000026353266,0.0008736315,2.7674844e-7,0.9770932,0.0011668834,0.0040141256,0.013287469],"study_design_scores_gemma":[0.0052769766,0.0026218754,0.030028984,0.000039097013,0.00016236189,0.000016500364,0.0016784067,0.028995832,0.3644503,0.003962871,0.5619618,0.00080497115],"about_ca_topic_score_codex":0.00013196396,"about_ca_topic_score_gemma":0.000037806418,"teacher_disagreement_score":0.6126429,"about_ca_system_score_codex":0.000018897126,"about_ca_system_score_gemma":0.00003021848,"threshold_uncertainty_score":0.491704},"labels":[],"label_agreement":null},{"id":"W2048902326","doi":"10.1210/endo.141.7.7583","title":"Distribution of Uridine Diphosphate-Glucuronosyltransferase (UGT) Expression and Activity in Cynomolgus Monkey Tissues: Evidence for Differential Expression of Steroid-Conjugating UGT Enzymes in Steroid Target Tissues*","year":2000,"lang":"en","type":"article","venue":"Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Medical Council of Canada","funders":"","keywords":"Glucuronidation; Glucuronosyltransferase; Steroid; Chemistry; Hydroxysteroid; Androsterone; Biochemistry; Enzyme; Sulfotransferase; Uridine diphosphate; Microsome; Biology; Internal medicine; Endocrinology; Hormone; Dehydrogenase; Medicine","score_opus":0.0831781560007816,"score_gpt":0.4067591959740246,"score_spread":0.323581039973243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048902326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841185,0.013073055,0.00085167534,0.00017162689,0.00045811883,0.0008682619,0.000375543,0.00002764772,0.000055573964],"genre_scores_gemma":[0.9939418,0.005228385,0.00030482034,0.0000478714,0.00011210834,0.00016539253,0.000080072125,0.000026654934,0.00009290672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971393,0.0007110522,0.000760029,0.00056626956,0.00015683484,0.0006665645],"domain_scores_gemma":[0.9985342,0.00076588284,0.00023695292,0.000244694,0.0000651236,0.00015316857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003320689,0.00033539347,0.0007332175,0.0001699128,0.00009699158,0.000009683872,0.00029070978,0.00026711094,0.000819145],"category_scores_gemma":[0.00011998624,0.00032790733,0.00009232768,0.00017015827,0.000261422,0.00023964334,0.0001225525,0.00052298186,0.00000407891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032411,0.0006589421,0.043417417,0.0002679641,0.000033344204,0.00003594853,0.0011251433,0.0010004591,0.9082507,0.00012666895,0.000081696795,0.041760635],"study_design_scores_gemma":[0.0052559325,0.00031018426,0.026207576,0.00018309247,0.00006828119,0.000011371998,0.000058193607,0.0026313188,0.9606557,0.00025485948,0.0041024783,0.00026104855],"about_ca_topic_score_codex":0.00015003643,"about_ca_topic_score_gemma":0.00003492743,"teacher_disagreement_score":0.05240498,"about_ca_system_score_codex":0.000047756508,"about_ca_system_score_gemma":0.000050561892,"threshold_uncertainty_score":0.99991727},"labels":[],"label_agreement":null},{"id":"W2048985510","doi":"10.1016/j.pharmthera.2013.04.004","title":"Functional genomics of pain in analgesic drug development and therapy","year":2013,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Drug repositioning; Analgesic; Drug development; Pharmacogenomics; Drug discovery; Computational biology; Functional genomics; Repurposing; Bioinformatics; Chronic pain; Medicine; Genomics; Neuroscience; Biology; Drug; Pharmacology; Gene; Genetics; Genome","score_opus":0.2564023176093579,"score_gpt":0.44987072339124473,"score_spread":0.19346840578188684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048985510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013649806,0.9812792,0.00003695574,0.00020548835,0.0023048583,0.0020651335,0.00008821942,0.00006281069,0.00030751768],"genre_scores_gemma":[0.0005271025,0.9926817,0.0005532613,0.004205962,0.00051668804,0.000710151,0.00013453617,0.00015270179,0.000517893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99321866,0.0029023068,0.0017718495,0.0008545601,0.00028307797,0.0009695442],"domain_scores_gemma":[0.99680537,0.00145229,0.00091091206,0.0003042941,0.00017233872,0.00035478233],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002868098,0.0010290887,0.002383872,0.0007835792,0.00021509995,0.00002724425,0.0007185615,0.0009683578,0.0017972587],"category_scores_gemma":[0.000008937086,0.0009173232,0.0003815154,0.00061416905,0.0005375969,0.00009873634,0.0002744095,0.0021074424,0.00014332653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012486079,0.00065605785,0.00010042948,0.0017705025,0.0023852093,0.000025670952,0.0006818614,0.000039142713,0.0019267082,0.0000555357,0.0024704935,0.9897635],"study_design_scores_gemma":[0.002416667,0.00007138825,0.00004711346,0.00020587795,0.0020512696,0.00003204279,0.000045445933,0.00031653678,0.004493592,0.00012132361,0.98941654,0.00078223145],"about_ca_topic_score_codex":0.000013130102,"about_ca_topic_score_gemma":0.0000063264024,"teacher_disagreement_score":0.9889813,"about_ca_system_score_codex":0.00021377282,"about_ca_system_score_gemma":0.0010012998,"threshold_uncertainty_score":0.9993277},"labels":[],"label_agreement":null},{"id":"W2049217578","doi":"10.2174/1570160053175027","title":"Multigenic Control of Drug Response and Regulatory Decision-Making in Pharmacogenomics: The Need for an Upper-Bound Estimate of Genetic Contributions","year":2005,"lang":"en","type":"article","venue":"Current Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto","funders":"","keywords":"Pharmacogenomics; Regulatory science; Drug development; Personalized medicine; Precision medicine; Drug; Medicine; Biomarker; Bioinformatics; Computational biology; Biology; Genetics; Pharmacology","score_opus":0.058876441371449754,"score_gpt":0.4508847345390754,"score_spread":0.39200829316762564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049217578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95025307,0.03931075,0.0038616043,0.00038820098,0.0016999377,0.0022184073,0.0022046736,0.00004033674,0.000023029797],"genre_scores_gemma":[0.9920306,0.004316554,0.0021248367,0.000637267,0.00054311455,0.00022153299,0.000032782755,0.00007895093,0.000014363604],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.995515,0.001085781,0.0016195427,0.0006526036,0.00027460165,0.00085250475],"domain_scores_gemma":[0.99502206,0.0029445773,0.0007656722,0.00047153106,0.00039049433,0.00040568848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037098513,0.0005219262,0.0008234881,0.00044243428,0.0003934096,0.000037499172,0.0008382856,0.00021148937,0.00015446717],"category_scores_gemma":[0.00029694798,0.00048003288,0.0003225197,0.00032628773,0.00068257574,0.00022545825,0.00020148058,0.0007702835,0.000010644651],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010534144,0.0010296378,0.009469322,0.00013564657,0.00036747238,0.000004041288,0.0022503727,0.04276168,0.68149984,0.00041685937,0.0005580954,0.25097287],"study_design_scores_gemma":[0.03140225,0.00021487857,0.023475772,0.00013412867,0.0020898161,0.000060434348,0.0003187647,0.50234234,0.26952565,0.002146303,0.16717157,0.0011181224],"about_ca_topic_score_codex":0.0000096627555,"about_ca_topic_score_gemma":0.00002200323,"teacher_disagreement_score":0.45958066,"about_ca_system_score_codex":0.00019187824,"about_ca_system_score_gemma":0.00043312128,"threshold_uncertainty_score":0.99976516},"labels":[],"label_agreement":null},{"id":"W2049258047","doi":"10.1016/j.mrfmmm.2003.08.002","title":"Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5","year":2003,"lang":"en","type":"article","venue":"Mutation research. Fundamental and molecular mechanisms of mutagenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health and Welfare; Korea University; University of Calgary","keywords":"Naringenin; CYP1A2; Chemistry; Quinoline; Biochemistry; Mutagenesis; Mutagen; Cytochrome b5; Quercetin; Cytochrome P450; Enzyme; Mutant; Carcinogen; Antioxidant; Flavonoid; Gene; Organic chemistry","score_opus":0.06792987090676106,"score_gpt":0.405054574289843,"score_spread":0.3371247033830819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049258047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990335,0.0068967906,0.00041326575,0.00030111923,0.00008941645,0.001531337,0.000180183,0.000019083027,0.00023383553],"genre_scores_gemma":[0.9978469,0.0010789679,0.00039071226,0.0003186377,0.000036780828,0.000118350916,0.000046806806,0.00005819333,0.00010462099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99525994,0.0021842278,0.00065042044,0.00058415206,0.00074837514,0.000572867],"domain_scores_gemma":[0.9980011,0.00068938837,0.00044825108,0.00037000817,0.0002410023,0.00025025904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021238043,0.00039245724,0.0005806136,0.00038179173,0.00066895306,0.00005257901,0.00034381132,0.0002868695,0.00012599224],"category_scores_gemma":[0.00027024257,0.00030462942,0.00013963396,0.00052944926,0.0010107365,0.00010934282,0.00026268352,0.000567445,0.0000024031822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021284728,0.00036294365,0.0000540675,0.0003046735,0.00032980167,0.0000138317855,0.0010627075,0.000102666,0.9883773,0.0059286957,0.000065636574,0.0031848352],"study_design_scores_gemma":[0.002179529,0.00045118242,0.005485423,0.00009836393,0.00027497078,0.000026480098,0.0007493381,0.00027821853,0.9861145,0.0033846924,0.0006891753,0.00026809576],"about_ca_topic_score_codex":0.000104483166,"about_ca_topic_score_gemma":0.000002451075,"teacher_disagreement_score":0.00751196,"about_ca_system_score_codex":0.000052858733,"about_ca_system_score_gemma":0.000117181255,"threshold_uncertainty_score":0.9999406},"labels":[],"label_agreement":null},{"id":"W2049540056","doi":"10.1038/nbt0703-747","title":"Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare","year":2003,"lang":"en","type":"article","venue":"Nature Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"","keywords":"Pharmacogenomics; Drug; Business; Drug approval; Health care; Pharmacology; Biotechnology; Risk analysis (engineering); Medicine; Economics; Biology; Economic growth","score_opus":0.04512963305399814,"score_gpt":0.40116465542716306,"score_spread":0.3560350223731649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049540056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94400674,0.041251864,0.000026177024,0.012148593,0.0013726541,0.00067148486,0.000116182244,0.00008306039,0.00032322365],"genre_scores_gemma":[0.987383,0.00475813,0.0024382186,0.0051531564,0.000120890945,0.000044672204,0.000009152824,0.000028982431,0.000063763095],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984979,0.00020811189,0.00033143468,0.00048695528,0.000039938135,0.0004356505],"domain_scores_gemma":[0.9991428,0.000372175,0.00011076478,0.00017078072,0.000042502346,0.00016095169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069129124,0.00022314997,0.00033422746,0.000298809,0.0002526846,0.000018855744,0.00008968146,0.0012033744,0.000057125802],"category_scores_gemma":[0.0001384621,0.000244442,0.000041237483,0.00009542891,0.00032569343,0.000059383703,0.000065209315,0.0013659099,0.000005176441],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002113405,0.00016877848,0.012294787,0.0001650068,0.00020992395,0.000044479006,0.0009148668,0.00019096986,0.32898808,0.6050298,0.006411582,0.045370378],"study_design_scores_gemma":[0.003971841,0.000047142323,0.0015774147,0.000010501452,0.000109562374,0.0002230553,0.00018180585,0.001551479,0.3817831,0.024205089,0.5859262,0.00041285827],"about_ca_topic_score_codex":0.000013106442,"about_ca_topic_score_gemma":0.0001744559,"teacher_disagreement_score":0.58082473,"about_ca_system_score_codex":0.00007800708,"about_ca_system_score_gemma":0.00015045227,"threshold_uncertainty_score":0.9968055},"labels":[],"label_agreement":null},{"id":"W2050349526","doi":"10.1016/s0378-4347(00)00325-x","title":"Liquid chromatographic method for the simultaneous determination of caffeine and fourteen caffeine metabolites in urine","year":2000,"lang":"en","type":"article","venue":"Journal of Chromatography B Biomedical Sciences and Applications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Chromatography; Caffeine; Chemistry; Urine; CYP1A2; Extraction (chemistry); High-performance liquid chromatography; Xanthine oxidase; Acetic acid; Enzyme; Cytochrome P450; Biochemistry","score_opus":0.038831079446932565,"score_gpt":0.4165151362868271,"score_spread":0.3776840568398946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050349526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95499045,0.022241794,0.018570645,0.003092904,0.00014075931,0.000703444,0.00008689173,0.000011286919,0.00016185646],"genre_scores_gemma":[0.97495747,0.014062705,0.01031,0.0003416192,0.00023487331,0.00007101738,0.0000032189034,0.0000074131526,0.000011682794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99854386,0.00014758101,0.00060663675,0.00019369925,0.00025685923,0.00025136385],"domain_scores_gemma":[0.9977772,0.0014916197,0.00030836958,0.00008912111,0.00010967658,0.00022398373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018696643,0.00014038473,0.00033548567,0.00037075698,0.00027665877,0.000024099332,0.00032444688,0.00011543723,0.0001247406],"category_scores_gemma":[0.00005699746,0.00008861841,0.00012849332,0.001060391,0.0010900749,0.00008927713,0.00003480069,0.00021598036,3.7177767e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025793596,0.00067204103,0.0025793877,0.0001321323,0.000171902,0.000007632457,0.00046873637,0.00023142135,0.14793865,0.0032429136,0.00016226755,0.844135],"study_design_scores_gemma":[0.006050177,0.0016897299,0.013576256,0.0000904172,0.0011328489,0.0005022638,0.00042218677,0.10834639,0.03486677,0.010116727,0.82271653,0.00048970245],"about_ca_topic_score_codex":0.000027195914,"about_ca_topic_score_gemma":0.000009359838,"teacher_disagreement_score":0.8436453,"about_ca_system_score_codex":0.0000045720412,"about_ca_system_score_gemma":0.000060808838,"threshold_uncertainty_score":0.40164262},"labels":[],"label_agreement":null},{"id":"W2050415328","doi":"10.2174/1389200053586082","title":"Accelerated Cytotoxicity Mechanism Screening Using Drug Metabolising Enzyme Modulators","year":2005,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytotoxicity; Enzyme; Pharmacology; Biochemistry; Cytochrome P450; Glutathione; Chemistry; In vivo; Drug; Metabolic pathway; Mechanism of action; In vitro; Biology","score_opus":0.342628587452192,"score_gpt":0.5038157467382227,"score_spread":0.16118715928603072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050415328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021003752,0.9699832,0.00179142,0.000048136175,0.019892737,0.003372708,0.0015904924,0.000664409,0.0005565],"genre_scores_gemma":[0.0015477436,0.98329,0.0023620238,0.0004928492,0.009955969,0.00039788522,0.00063500804,0.0006455763,0.0006729357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9842928,0.0048594573,0.0036526178,0.0027366155,0.0013847736,0.0030737252],"domain_scores_gemma":[0.9927435,0.00071321864,0.0025754126,0.001544471,0.0005325,0.0018908831],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.004167044,0.0032865556,0.0071359626,0.0019323518,0.0015026535,0.00040750398,0.0028380977,0.0015594804,0.0020479406],"category_scores_gemma":[0.00021870135,0.0030668653,0.0029709616,0.0022895343,0.00046608545,0.0008406727,0.0013855041,0.007052061,0.00051026134],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049576793,0.0006306639,0.0000031718516,0.002880131,0.0016076358,0.000046560548,0.0005080821,0.0011119599,0.00044990442,0.002401577,0.00237777,0.987933],"study_design_scores_gemma":[0.0021869987,0.000005261031,0.00000453751,0.0018686994,0.01437982,0.00010925677,0.000041833362,0.008279004,0.003406827,0.00042559288,0.96641153,0.0028806315],"about_ca_topic_score_codex":0.000060387796,"about_ca_topic_score_gemma":0.0000072131224,"teacher_disagreement_score":0.98505235,"about_ca_system_score_codex":0.0003534565,"about_ca_system_score_gemma":0.0011959772,"threshold_uncertainty_score":0.9997972},"labels":[],"label_agreement":null},{"id":"W2050440877","doi":"10.1053/j.ajkd.2014.09.015","title":"Effect of CKD and Dialysis Modality on Exposure to Drugs Cleared by Nonrenal Mechanisms","year":2014,"lang":"en","type":"article","venue":"American Journal of Kidney Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research; Lawson Health Research Institute; American Society of Nephrology","keywords":"Medicine; Clearance; Dialysis; Modality (human–computer interaction); Kidney disease; Metabolic clearance rate; Renal function; Intensive care medicine; Internal medicine; Pharmacology; Urology; Pharmacokinetics","score_opus":0.01281538090334569,"score_gpt":0.3623033779102713,"score_spread":0.3494879970069256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050440877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955946,0.00049305434,0.0006166135,0.0019414293,0.00046364774,0.00016689707,0.00042278756,0.000012860323,0.0002881002],"genre_scores_gemma":[0.9916356,0.00030055223,0.00019446753,0.007537305,0.00024464555,0.000009492414,0.000010835837,0.000023939208,0.00004312704],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970153,0.0016104662,0.00049831934,0.00022757186,0.00034232478,0.00030602503],"domain_scores_gemma":[0.99642044,0.00080637634,0.00052995095,0.00017663403,0.00014184805,0.0019247186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001136083,0.00024546054,0.0007286116,0.00018012694,0.000103284154,0.000017163156,0.00029762663,0.00006252902,0.00020546987],"category_scores_gemma":[0.0010047314,0.00019441872,0.0002463379,0.0002614618,0.00027144884,0.000064945525,0.00007142265,0.0003273716,0.000010183248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010204132,0.0011339722,0.01980038,0.00015616309,0.0012831064,0.000027269227,0.0011132321,0.00096114003,0.33312443,0.0003663955,0.026073573,0.6057562],"study_design_scores_gemma":[0.0138456635,0.021546755,0.015656756,0.00018618596,0.0058248155,0.00004893924,0.00045663211,0.0015758132,0.8299214,0.0018574775,0.107919425,0.0011600937],"about_ca_topic_score_codex":0.00001834298,"about_ca_topic_score_gemma":1.6976465e-7,"teacher_disagreement_score":0.60459614,"about_ca_system_score_codex":0.00002290459,"about_ca_system_score_gemma":0.00011857615,"threshold_uncertainty_score":0.7928165},"labels":[],"label_agreement":null},{"id":"W2050603486","doi":"10.1002/phar.1398","title":"Pharmacogenomic Testing for Neuropsychiatric Drugs: Current Status of Drug Labeling, Guidelines for Using Genetic Information, and Test Options","year":2014,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Canadian Institutes of Health Research","keywords":"Medicine; Pharmacogenomics; Drug; Dosing; Carbamazepine; Intensive care medicine; Genetic testing; Personalized medicine; Pharmacogenetics; Pharmacology; Psychiatry; Epilepsy; Bioinformatics; Internal medicine","score_opus":0.24175570729423315,"score_gpt":0.5158485495858426,"score_spread":0.27409284229160946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050603486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034613874,0.954604,0.0005624038,0.00031775233,0.004844177,0.004019716,0.0009780901,0.00004628737,0.000013657082],"genre_scores_gemma":[0.0012239217,0.98796433,0.0036816443,0.0028651035,0.0036941194,0.0002757627,0.000048049136,0.00019599582,0.000051059564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917399,0.0021643927,0.003976668,0.0005293628,0.0003818387,0.0012078024],"domain_scores_gemma":[0.9843288,0.0073353895,0.0051943217,0.0003051602,0.002149781,0.0006865334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0055727237,0.0011960854,0.002733199,0.0010649018,0.0012482636,0.00008918725,0.0012006717,0.0003398829,0.00016853893],"category_scores_gemma":[0.00031352259,0.00088218827,0.00085294934,0.0006063506,0.0007205619,0.00037382613,0.00016797349,0.0017338748,0.0000032404316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001025041,0.00064729893,0.00016954912,0.0058162385,0.0021165928,0.0000022360011,0.0018104586,0.00062003697,0.023251485,0.00008571273,0.027688261,0.9367671],"study_design_scores_gemma":[0.0126554165,0.00049550884,0.000009614091,0.0005145208,0.008258783,0.00019401383,0.00010899536,0.00319849,0.0027483942,0.00047573433,0.9705192,0.00082133367],"about_ca_topic_score_codex":0.000018928293,"about_ca_topic_score_gemma":0.0000010441667,"teacher_disagreement_score":0.9428309,"about_ca_system_score_codex":0.000116570765,"about_ca_system_score_gemma":0.0009468254,"threshold_uncertainty_score":0.9993629},"labels":[],"label_agreement":null},{"id":"W2050701148","doi":"10.1038/clpt.2011.334","title":"PhRMA Survey of Pharmacogenomic and Pharmacodynamic Evaluations: What Next?","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada","funders":"","keywords":"Pharmacogenomics; Pharmacodynamics; Clinical pharmacology; Pharmaceutical industry; Drug development; Pharmacology; Drug; Medicine; Pharmacokinetics","score_opus":0.47578842760430606,"score_gpt":0.5873528190965384,"score_spread":0.1115643914922323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050701148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8948001,0.08433366,0.0001770577,0.0018126576,0.017004875,0.0011832569,0.00019674511,0.00013745388,0.00035419397],"genre_scores_gemma":[0.8241326,0.12559424,0.0003514497,0.04777981,0.0016463517,0.00010807354,0.00010678196,0.000110330824,0.00017032992],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98941916,0.0056712297,0.0021388873,0.00081233046,0.00044604338,0.001512374],"domain_scores_gemma":[0.9924601,0.004367972,0.0009184491,0.00045377217,0.00060986745,0.0011898449],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008883355,0.0007506047,0.0012631966,0.00033346188,0.0004167031,0.000087247536,0.00089827017,0.0008201819,0.002901899],"category_scores_gemma":[0.000108219734,0.0007412103,0.0003820067,0.00068910467,0.0017192351,0.0014453523,0.00047400978,0.0020300222,0.0003104248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021646116,0.0038497073,0.13045277,0.000119961,0.004141862,0.000014126908,0.0015623238,0.00022736308,0.45269823,0.000073741154,0.007933545,0.39676178],"study_design_scores_gemma":[0.020955564,0.00058942015,0.28449932,0.000048329242,0.0112848915,0.00012858317,0.0006033807,0.026814595,0.15912396,0.00031811956,0.49363077,0.0020030525],"about_ca_topic_score_codex":0.00003522362,"about_ca_topic_score_gemma":0.0000064931664,"teacher_disagreement_score":0.48569724,"about_ca_system_score_codex":0.00009233178,"about_ca_system_score_gemma":0.00034310683,"threshold_uncertainty_score":0.9995039},"labels":[],"label_agreement":null},{"id":"W2051347512","doi":"10.1016/s0006-291x(02)02469-5","title":"Identification of the novel splicing variants for the hPXR in human livers","year":2002,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Alternative splicing; Biology; RNA splicing; Pregnane X receptor; CYP3A4; Gene; Gene expression; Molecular biology; Messenger RNA; Genetics; RNA; Transcription factor; Nuclear receptor; Biochemistry; Metabolism; Cytochrome P450","score_opus":0.38998610452843224,"score_gpt":0.5215106350060051,"score_spread":0.1315245304775729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051347512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858744,0.0021218532,0.00007865498,0.010320241,0.00008950077,0.0007300229,0.00010283741,0.000009179399,0.00067327556],"genre_scores_gemma":[0.99752194,0.001692582,0.00008094436,0.00017629068,0.00008706563,0.00013826934,0.000005911114,0.000007168573,0.00028981947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883705,0.00028536498,0.0002691506,0.0001677596,0.00018820839,0.00025248347],"domain_scores_gemma":[0.9975047,0.0015637932,0.00007106192,0.0006122054,0.00016795329,0.00008025056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001044034,0.000079369674,0.00011434689,0.000053539057,0.00062022754,0.000020814668,0.0010588975,0.0001039139,0.00003209555],"category_scores_gemma":[0.00033468517,0.000050102208,0.00007075849,0.00043643478,0.0010850349,0.000032242227,0.00044781447,0.00066114136,0.000006229949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016995275,0.00054314383,0.00013022855,0.00001817884,0.000026615215,4.2538197e-8,0.00033933503,0.000009172064,0.98074436,0.013368461,0.0009044388,0.0038990474],"study_design_scores_gemma":[0.0012171079,0.000039053695,0.010402725,0.000024905541,0.00008470646,0.0000014121706,0.00017732539,0.07206943,0.88470376,0.0027151636,0.028431814,0.00013260955],"about_ca_topic_score_codex":0.000051301326,"about_ca_topic_score_gemma":0.0000071816735,"teacher_disagreement_score":0.09604059,"about_ca_system_score_codex":0.000023443577,"about_ca_system_score_gemma":0.000018693554,"threshold_uncertainty_score":0.47703516},"labels":[],"label_agreement":null},{"id":"W2051366695","doi":"10.1159/000064194","title":"Ethical, Social and Legal Implications of Pharmacogenomics: A Critical Review","year":2001,"lang":"en","type":"review","venue":"Public Health Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international","keywords":"Pharmacogenomics; Bioethics; Multidisciplinary approach; Engineering ethics; Medicine; Psychology; Political science; Sociology; Social science; Pharmacology; Law; Engineering","score_opus":0.5366961779633526,"score_gpt":0.5952239631420325,"score_spread":0.05852778517867996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051366695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017741446,0.9397222,0.00014797367,0.05351065,0.001054052,0.001973731,0.0015689875,0.0000737228,0.0019309825],"genre_scores_gemma":[0.000029486338,0.9512629,0.0004467703,0.046033513,0.0011861738,0.00042933293,0.0003376494,0.00013170735,0.00014246363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920803,0.00282988,0.0025382983,0.0008941715,0.00025955465,0.0013978056],"domain_scores_gemma":[0.99529237,0.0012612285,0.0011768461,0.0004669604,0.0003542872,0.0014483052],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0055402373,0.0007550365,0.0033837513,0.00038321572,0.0006987451,0.00006770881,0.0009177618,0.0014258845,0.0009393734],"category_scores_gemma":[0.0004896338,0.00074814004,0.00067049445,0.00082126627,0.0007268133,0.000099027835,0.00042865577,0.0040147584,0.00009638483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000073596043,0.00025680385,0.0000026324653,0.045790058,0.00034062596,0.000007488954,0.00013118012,2.225067e-7,0.000011263223,0.011866641,0.024190444,0.9173953],"study_design_scores_gemma":[0.00049130054,0.000041945677,0.0000045495262,0.0010976378,0.0014609687,0.00029193322,0.000014059078,0.000022556265,0.0000019039842,0.00021897699,0.9958117,0.0005424864],"about_ca_topic_score_codex":0.00003074026,"about_ca_topic_score_gemma":0.0000055972355,"teacher_disagreement_score":0.9716212,"about_ca_system_score_codex":0.00040708308,"about_ca_system_score_gemma":0.004694296,"threshold_uncertainty_score":0.9999739},"labels":[],"label_agreement":null},{"id":"W2052268395","doi":"10.3109/03602530903219220","title":"Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential","year":2009,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Glucuronidation; Nuclear receptor; Chemistry; Pregnane X receptor; Glucuronosyltransferase; Endogeny; Biochemistry; Transcription factor; Enzyme; Transporter; Bilirubin; Aryl hydrocarbon receptor; Drug metabolism; Enterohepatic circulation; Receptor; Metabolism; Pharmacology; Gene; Biology; Endocrinology; Microsome","score_opus":0.14883391734934248,"score_gpt":0.41339755002485434,"score_spread":0.26456363267551186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052268395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045656078,0.99007016,0.00031220622,0.000034931614,0.0019313423,0.0025152597,0.00038132397,0.000083478226,0.000105709034],"genre_scores_gemma":[0.011710498,0.9851957,0.00008844156,0.00028002582,0.00062338,0.000106740554,0.0016638486,0.00007442973,0.0002569557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99329937,0.0030692131,0.0019153139,0.00084137777,0.00032141316,0.0005532881],"domain_scores_gemma":[0.99731255,0.00017489155,0.0016617308,0.0004269416,0.00014152046,0.00028234173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013898703,0.0009930425,0.0034526319,0.0002994404,0.00023794766,0.000047788762,0.0003928212,0.0009655175,0.00030913856],"category_scores_gemma":[0.00007178241,0.0007387278,0.0009216717,0.0005917971,0.00022039766,0.00019104844,0.000063159845,0.0012570041,0.000060861817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007381657,0.00034339397,0.0000014082793,0.002819396,0.0003108649,6.1994996e-7,0.00011036637,0.000013649617,0.1433138,0.0002733124,0.0021431474,0.85059625],"study_design_scores_gemma":[0.00093439315,0.000074636024,0.0002033479,0.000648056,0.007510621,0.000008550873,0.000010736928,0.00008777658,0.0085496595,0.00041203626,0.980932,0.00062817737],"about_ca_topic_score_codex":0.0000074513246,"about_ca_topic_score_gemma":6.060598e-7,"teacher_disagreement_score":0.97878885,"about_ca_system_score_codex":0.00005304765,"about_ca_system_score_gemma":0.0001019708,"threshold_uncertainty_score":0.99950635},"labels":[],"label_agreement":null},{"id":"W2052300490","doi":"10.1097/fpc.0b013e3283498147","title":"Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"UGT2B7; Exon; Alternative splicing; Biology; Glucuronidation; RNA splicing; Gene isoform; Exon skipping; Messenger RNA; Locus (genetics); Genetics; Gene; Molecular biology; RNA","score_opus":0.10904525793029503,"score_gpt":0.34436475449878223,"score_spread":0.23531949656848722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052300490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97908294,0.0096835205,0.0031665612,0.00096606073,0.00190877,0.0014539539,0.0026319763,0.0000788354,0.0010273511],"genre_scores_gemma":[0.97053146,0.0133572575,0.0011361259,0.013215082,0.0002712223,0.000083467254,0.00006665042,0.000093012284,0.0012457409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965968,0.00040085218,0.00057112245,0.0009718475,0.00042600755,0.0010333832],"domain_scores_gemma":[0.9977568,0.00026366758,0.00028839838,0.00042408626,0.00026672822,0.0010003595],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000806178,0.000660494,0.00052083685,0.0001515125,0.0016876005,0.000049164173,0.0008469403,0.00032644146,0.0019452095],"category_scores_gemma":[0.00002691698,0.00059321703,0.00022672456,0.00028365766,0.00034451854,0.00011539967,0.0012103765,0.0007679727,0.00019698877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016467244,0.0004351925,0.0057428414,0.00004066234,0.00082082575,0.00005634669,0.017972877,0.00071700796,0.9445902,0.00015279127,0.013817965,0.01400655],"study_design_scores_gemma":[0.004878482,0.00016884145,0.008590653,0.000011762014,0.0014229349,0.00008102992,0.00048881624,0.012379929,0.7809516,0.0015044265,0.18853591,0.0009856166],"about_ca_topic_score_codex":0.0003197599,"about_ca_topic_score_gemma":0.000054841927,"teacher_disagreement_score":0.17471795,"about_ca_system_score_codex":0.00013993272,"about_ca_system_score_gemma":0.00008560771,"threshold_uncertainty_score":0.9996519},"labels":[],"label_agreement":null},{"id":"W2052642028","doi":"10.1271/bbb.90199","title":"Comparison of Two Vectors for Functional Expression of a Bacterial Cytochrome P450 Gene in<i>Escherichia coli</i>Using<i>CYP153</i>Genes","year":2009,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Bioconversion; Escherichia coli; Reductase; Cytochrome P450; Octane; Chemistry; Cytochrome; Cyclohexane; Ferredoxin; Monooxygenase; Biochemistry; Stereochemistry; Gene; Biology; Enzyme; Organic chemistry; Fermentation","score_opus":0.09079325676693505,"score_gpt":0.42080295504922166,"score_spread":0.3300096982822866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052642028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516755,0.0031126924,0.000518922,0.0003165992,0.00040482756,0.00026555048,0.0001400152,0.00003123396,0.00004258158],"genre_scores_gemma":[0.99635255,0.00033525325,0.0029594323,0.00017192756,0.00012484886,0.0000134528045,0.000019038918,0.0000071978775,0.000016317019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853355,0.000056503173,0.00051127054,0.00042235554,0.00012669743,0.0003496206],"domain_scores_gemma":[0.99921066,0.000077480254,0.000316279,0.00018768135,0.00010222781,0.0001056654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040099895,0.00020747553,0.00040645833,0.00015535738,0.00013288071,0.000006473014,0.0003169331,0.0006284826,0.000042794018],"category_scores_gemma":[0.00008717949,0.0001935673,0.00007781962,0.00041313434,0.0008577473,0.000048178004,0.00009579506,0.00029063976,4.7314836e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039215572,0.00041876032,0.0029104138,0.000045749286,0.000013410511,0.0000013583259,0.000054920372,0.00006237192,0.9938127,0.0002945189,0.00006392227,0.0019297578],"study_design_scores_gemma":[0.0016657319,0.00017226483,0.0030690017,0.000021987194,0.000053984044,0.000008666443,0.00007621611,0.0011641401,0.9913628,0.00036557016,0.0018434783,0.0001961546],"about_ca_topic_score_codex":0.000007772222,"about_ca_topic_score_gemma":0.0000013320888,"teacher_disagreement_score":0.002777439,"about_ca_system_score_codex":0.000028912857,"about_ca_system_score_gemma":0.0001634931,"threshold_uncertainty_score":0.78934455},"labels":[],"label_agreement":null},{"id":"W2053450751","doi":"10.1067/mjd.2002.126823","title":"Drug interactions: Proteins, pumps, and P-450s","year":2002,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Computational biology; Drug; Pharmacology; Biology","score_opus":0.1446874382603087,"score_gpt":0.4860916144772223,"score_spread":0.34140417621691366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053450751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025660202,0.9902944,0.000007025689,0.004902973,0.0012150506,0.0005414425,0.000074381685,0.000010914279,0.0003878161],"genre_scores_gemma":[0.003223278,0.99368894,0.0003080913,0.001856231,0.00047616896,0.000025419236,0.0000014134528,0.000050364957,0.00037011583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949167,0.002327976,0.0017908688,0.000263117,0.00026561596,0.00043575358],"domain_scores_gemma":[0.99297595,0.000881173,0.00559397,0.00018207224,0.000089056084,0.00027780564],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00055208773,0.00046926417,0.0028671927,0.0004697151,0.00015863894,0.000013385675,0.001187431,0.0002807862,0.00018837047],"category_scores_gemma":[0.00017398655,0.00030690417,0.0008376888,0.00051323685,0.0012198621,0.00011125296,0.00035069024,0.003910085,0.000030217625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007115149,0.0002085078,0.0001593118,0.002092084,0.0012952406,0.000053974305,0.00016689787,0.0000062781924,0.00020659977,0.00020333985,0.019224016,0.9763126],"study_design_scores_gemma":[0.0005183621,0.000023309374,0.000036148645,0.0008700455,0.0027062267,0.010966265,0.000033880202,0.00004147359,0.00060111244,0.00026181721,0.9836858,0.00025556644],"about_ca_topic_score_codex":0.0000065694844,"about_ca_topic_score_gemma":6.7096323e-7,"teacher_disagreement_score":0.97605705,"about_ca_system_score_codex":0.000057812707,"about_ca_system_score_gemma":0.00017356171,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W2053667925","doi":"10.1016/j.taap.2005.12.001","title":"Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: A case study with toluene","year":2006,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; CYP2E1; Toluene; Chemistry; Physiology; Internal medicine; Metabolism; Biochemistry; Medicine; Cytochrome P450; Organic chemistry","score_opus":0.16526360397405881,"score_gpt":0.3903623144458353,"score_spread":0.2250987104717765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053667925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941013,0.0010811405,0.00007441591,0.0009277754,0.00060698105,0.001880377,0.00020032746,0.000053639564,0.0010740495],"genre_scores_gemma":[0.9951491,0.0008792019,0.0000984892,0.0030539823,0.00036408365,0.00034431968,0.000024964344,0.000053073934,0.00003283365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99539393,0.0014912854,0.0008785566,0.0011895073,0.00021356957,0.0008331649],"domain_scores_gemma":[0.99680245,0.0020948583,0.00028636403,0.00053967105,0.00007160002,0.00020507675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001444249,0.0006340458,0.0010108148,0.0004044904,0.00042262912,0.000023169483,0.0007546594,0.00038978556,0.000520259],"category_scores_gemma":[0.000021123311,0.0004572851,0.000050261733,0.00043454647,0.001004419,0.00006079741,0.0005520913,0.0016562006,0.00001203325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018862117,0.016532777,0.032188438,0.00033681176,0.0021900877,0.0034233613,0.005740811,0.037969656,0.81434107,0.016137548,0.0019347544,0.05034255],"study_design_scores_gemma":[0.067588285,0.010132264,0.057099737,0.00012936813,0.004474358,0.0038999554,0.009815775,0.38802543,0.43943343,0.0065072747,0.008686619,0.0042075017],"about_ca_topic_score_codex":0.00014329329,"about_ca_topic_score_gemma":0.0002890672,"teacher_disagreement_score":0.37490767,"about_ca_system_score_codex":0.00004125537,"about_ca_system_score_gemma":0.00008951264,"threshold_uncertainty_score":0.99978787},"labels":[],"label_agreement":null},{"id":"W2053768822","doi":"10.1080/03602530600569828","title":"Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR)","year":2006,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Pregnane X receptor; Constitutive androstane receptor; Pregnane; Nuclear receptor; Pharmacology; Receptor; Chemistry; Biology; Transcription factor; Biochemistry; Gene; Stereochemistry","score_opus":0.07311730853590803,"score_gpt":0.4081307594694231,"score_spread":0.3350134509335151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053768822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028103713,0.98291093,0.0000021739988,0.0001346614,0.005437604,0.0055717146,0.0013011254,0.00008855102,0.0017428596],"genre_scores_gemma":[0.00046520415,0.9927135,0.00078992563,0.00033655667,0.0010613693,0.00055452756,0.0004455037,0.0001693911,0.0034640403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903572,0.0035062358,0.0027600399,0.0018114502,0.0005038645,0.001061216],"domain_scores_gemma":[0.9951941,0.0007063162,0.0021921112,0.0009449979,0.00036116145,0.0006013155],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0031661661,0.001705385,0.0066673984,0.0005667129,0.0003567412,0.00008029271,0.0007686057,0.0008695741,0.00036342363],"category_scores_gemma":[0.0007031079,0.0013238103,0.00080671615,0.001019121,0.0015487144,0.00025860363,0.0005260923,0.0021848285,0.00025037117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068085945,0.0002705873,0.000008924923,0.021958778,0.00065807323,0.000014252651,0.0006083628,0.000001347753,0.0015038766,0.0025386952,0.008517898,0.9638511],"study_design_scores_gemma":[0.0011806944,0.000028638064,0.0000061712494,0.0048195897,0.0065663313,0.00013236662,0.00003534411,0.000013124167,0.0028835034,0.00011763313,0.9829817,0.0012349401],"about_ca_topic_score_codex":0.00006646836,"about_ca_topic_score_gemma":0.0000038295934,"teacher_disagreement_score":0.97446376,"about_ca_system_score_codex":0.000076000746,"about_ca_system_score_gemma":0.0005270116,"threshold_uncertainty_score":0.99956924},"labels":[],"label_agreement":null},{"id":"W2054186041","doi":"10.1002/jps.22554","title":"PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Pharmacokinetics; Predictability; Computer science; Predictive modelling; Data mining; Medicine; Medical physics; Pharmacology; Statistics; Machine learning; Mathematics","score_opus":0.33954721024789325,"score_gpt":0.45141002523332635,"score_spread":0.1118628149854331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054186041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98066777,0.010949902,0.00006433291,0.00055624195,0.001066171,0.0005940985,0.003471595,0.0000115899875,0.0026183177],"genre_scores_gemma":[0.9961823,0.0019007141,0.0002499011,0.0013384167,0.00026366697,0.00000883235,0.000025745856,0.000016031792,0.000014359695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99640185,0.00093761564,0.0010312888,0.00034845702,0.0008128953,0.00046787164],"domain_scores_gemma":[0.9976715,0.0002520977,0.0010859743,0.0002188347,0.00036781415,0.00040378925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001937358,0.00034074142,0.0006420392,0.00021593849,0.00035635306,0.000036248664,0.0010617798,0.00015216877,0.0002459024],"category_scores_gemma":[0.00008577299,0.00018983257,0.00012188667,0.00057624286,0.0026821669,0.0005598495,0.00029367904,0.0012291732,0.0000017328132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0154635655,0.0103893485,0.047022205,0.0012302856,0.003408198,0.00020161063,0.031830657,0.01476244,0.794985,0.010134137,0.049909346,0.020663215],"study_design_scores_gemma":[0.004079084,0.0015512037,0.0019096602,0.0004524223,0.0011033752,0.00010088696,0.0006904817,0.013517919,0.94558936,0.0010209022,0.029640373,0.00034434444],"about_ca_topic_score_codex":0.000009213295,"about_ca_topic_score_gemma":0.0000029281107,"teacher_disagreement_score":0.15060435,"about_ca_system_score_codex":0.000023787112,"about_ca_system_score_gemma":0.00019508436,"threshold_uncertainty_score":0.98825556},"labels":[],"label_agreement":null},{"id":"W2055248098","doi":"10.1038/jhh.2011.111","title":"Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers","year":2012,"lang":"en","type":"article","venue":"Journal of Human Hypertension","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service; National Institutes of Health","keywords":"CYP2A6; Medicine; Odds ratio; Confounding; Confidence interval; Internal medicine; Genotype; Genotyping; Logistic regression; Demography; Genetics; Biology; CYP1A2","score_opus":0.12018983475754252,"score_gpt":0.40614691093053135,"score_spread":0.2859570761729888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055248098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756831,0.021988077,0.000020962763,0.00048331998,0.0014890834,0.00018997559,0.000033023203,0.00001573929,0.0000967343],"genre_scores_gemma":[0.9927047,0.005508417,0.000046613182,0.0008480486,0.000713568,0.0000033617446,0.000039430244,0.000027427172,0.00010845788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977611,0.0005226618,0.00071190845,0.00019120787,0.00035093975,0.0004622387],"domain_scores_gemma":[0.9984369,0.00024616762,0.0005766611,0.00010295611,0.00028959388,0.00034770975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016538245,0.000253948,0.0005507192,0.00027571258,0.00023755072,0.000029340019,0.00013689777,0.00031510324,0.00025915654],"category_scores_gemma":[0.00013380336,0.00020783838,0.00010773703,0.00014928408,0.00006376746,0.00035017802,0.00007128795,0.0010577277,0.000018110737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014908148,0.00034947065,0.6107536,0.000029883045,0.00018372323,0.000020878875,0.00035488754,0.000041388954,0.36403063,0.0000096236845,0.012303525,0.011773288],"study_design_scores_gemma":[0.007204221,0.00019999684,0.9065225,0.000103369784,0.0012389342,0.00031552234,0.00006395089,0.0018413179,0.022562202,0.0002975206,0.059093893,0.00055657],"about_ca_topic_score_codex":0.0000098378905,"about_ca_topic_score_gemma":0.0000028751656,"teacher_disagreement_score":0.34146842,"about_ca_system_score_codex":0.00012897547,"about_ca_system_score_gemma":0.000033212465,"threshold_uncertainty_score":0.8475403},"labels":[],"label_agreement":null},{"id":"W2055589832","doi":"10.1097/01.fpc.0000114754.08559.27","title":"Identification of common polymorphisms in the promoter of the UGT1A9 gene","year":2004,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; National Institute on Drug Abuse; National Institute of Mental Health; National Institute on Aging","keywords":"Single-nucleotide polymorphism; Biology; Genetics; Haplotype; Gene; Genetic variation; Phenotype; Glucuronidation; Allele; Molecular biology; Genotype; Microsome","score_opus":0.08665500048623402,"score_gpt":0.41731882350763433,"score_spread":0.3306638230214003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055589832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918111,0.0033731908,0.000119144635,0.0017235982,0.0013034197,0.00087907765,0.00016462029,0.00001499536,0.0006108758],"genre_scores_gemma":[0.9966512,0.0011326801,0.00012482719,0.001730022,0.00018970307,0.00006191124,0.000010413569,0.000029597628,0.0000696685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99722314,0.00068840914,0.0009724189,0.0002786373,0.00043523838,0.0004021821],"domain_scores_gemma":[0.99857193,0.00016345756,0.00051723886,0.00051411666,0.00013692092,0.00009632299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014127872,0.00025096722,0.0003280596,0.00013401378,0.00014529191,0.000012645091,0.0012066216,0.00017220633,0.00013720569],"category_scores_gemma":[0.000044136068,0.00017021825,0.00020412021,0.0006787154,0.0004427252,0.00005406638,0.00017806147,0.00060121267,0.000020496333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008904523,0.00089499005,0.012618197,0.000043744436,0.000092376926,0.000007306996,0.0023121634,0.008262496,0.9678469,0.00082999334,0.00015340147,0.0068494393],"study_design_scores_gemma":[0.0022503934,0.00003491621,0.031407624,0.000013261082,0.0002987854,0.000026594082,0.000059279006,0.0007537926,0.95588386,0.0025930188,0.0065034893,0.0001749617],"about_ca_topic_score_codex":0.000044758443,"about_ca_topic_score_gemma":0.000015744812,"teacher_disagreement_score":0.018789427,"about_ca_system_score_codex":0.000039224793,"about_ca_system_score_gemma":0.00014151899,"threshold_uncertainty_score":0.6941299},"labels":[],"label_agreement":null},{"id":"W2055769396","doi":"10.1007/s10552-013-0185-1","title":"Risk of prostate cancer death in long-term users of warfarin: a population-based case–control study","year":2013,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Jewish General Hospital; Saskatchewan Cancer Agency; Health Research Board","keywords":"Medicine; Prostate cancer; Warfarin; Cancer; Internal medicine; Population; Rate ratio; Cancer registry; Prostate; Confidence interval; Gynecology; Atrial fibrillation","score_opus":0.05894535400512411,"score_gpt":0.4138610440469393,"score_spread":0.35491569004181517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055769396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850286,0.008842763,0.000074581185,0.00021599805,0.000939055,0.003271498,0.0015501748,0.000033835702,0.000043484004],"genre_scores_gemma":[0.99608195,0.000971637,0.00001671424,0.0009859373,0.00018293138,0.0016296853,0.0000088861225,0.000047466165,0.0000747891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969239,0.0008916623,0.0009045291,0.0004477655,0.0002523662,0.00057975855],"domain_scores_gemma":[0.9978358,0.00055493816,0.00065153453,0.00033449617,0.00037171767,0.00025148108],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006446664,0.00036267607,0.0008430634,0.00026312418,0.00011752278,0.000018209996,0.00028301918,0.00019853341,0.0019544247],"category_scores_gemma":[0.000080139245,0.00032965993,0.00017793707,0.0003130519,0.00011945397,0.0001418799,0.000036536145,0.00055328495,0.000009316388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085472316,0.00070638186,0.93142605,0.00010743624,0.0009584781,0.00013687418,0.0007436799,0.040397264,0.0074511045,0.000014840929,0.000055330565,0.017147815],"study_design_scores_gemma":[0.01901948,0.00016592187,0.95935524,0.000040018636,0.0017502803,0.00000670885,0.00008288221,0.013289668,0.0057342653,0.000048304188,0.00018110858,0.00032613304],"about_ca_topic_score_codex":0.015087729,"about_ca_topic_score_gemma":0.005006704,"teacher_disagreement_score":0.027929155,"about_ca_system_score_codex":0.00014559488,"about_ca_system_score_gemma":0.00032739175,"threshold_uncertainty_score":0.99991554},"labels":[],"label_agreement":null},{"id":"W2055924792","doi":"10.1371/journal.pone.0112640","title":"Exploring the Distribution of Genetic Markers of Pharmacogenomics Relevance in Brazilian and Mexican Populations","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Financiadora de Estudos e Projetos; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Instituto Nacional de Medicina Genómica; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Governo Brasil","keywords":"Pharmacogenomics; Ancestry-informative marker; Biology; Genetic variation; Genetics; Population; Pharmacogenetics; Population genetics; Genetic marker; Evolutionary biology; Allele frequency; Genotype; Gene; Medicine; Environmental health","score_opus":0.2503122258489838,"score_gpt":0.37414523644722825,"score_spread":0.12383301059824442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055924792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973223,0.001089259,0.00012207674,0.00040349524,0.00019049572,0.0003099602,0.00011321401,0.000012343762,0.00043685993],"genre_scores_gemma":[0.9949244,0.0040324638,0.0006566914,0.00016769787,0.00010151477,0.000049443453,0.000020366766,0.00001487366,0.000032508528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986586,0.00033592212,0.0004358318,0.00018501538,0.00015123819,0.00023337414],"domain_scores_gemma":[0.99911517,0.00035745412,0.00017852354,0.00017062826,0.00007608315,0.000102170496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006190763,0.00012710191,0.00027101065,0.00006876952,0.00008991473,0.000004702078,0.0001890089,0.00005985064,0.000053997013],"category_scores_gemma":[0.00018694412,0.00011479511,0.000044228524,0.00022776649,0.00021171206,0.00006844866,0.00007405943,0.00029527664,0.0000034006355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005463718,0.0014810514,0.18821624,0.00030574104,0.00030293223,0.0000024056376,0.00096123834,0.0030196838,0.7145853,0.0030744097,0.00009681491,0.087407805],"study_design_scores_gemma":[0.0021984738,0.00011606271,0.4725869,0.000074981275,0.00068420067,0.0000025930144,0.00009098546,0.039457776,0.47554892,0.0016936982,0.007276776,0.00026864713],"about_ca_topic_score_codex":0.000044830613,"about_ca_topic_score_gemma":0.000022627592,"teacher_disagreement_score":0.28437066,"about_ca_system_score_codex":0.000021652691,"about_ca_system_score_gemma":0.000024653273,"threshold_uncertainty_score":0.46812087},"labels":[],"label_agreement":null},{"id":"W2055932556","doi":"10.1016/j.abb.2014.02.009","title":"Proximal FAD histidine residue influences interflavin electron transfer in cytochrome P450 reductase and methionine synthase reductase","year":2014,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Histidine; Electron transfer; Stereochemistry; Reductase; Hydroquinone; Residue (chemistry); Hydride; Cofactor; Proton-coupled electron transfer; Cytochrome P450 reductase; Enzyme; Biochemistry; Photochemistry; Coenzyme Q – cytochrome c reductase; Cytochrome c; Organic chemistry; Hydrogen; Mitochondrion","score_opus":0.028644775766320622,"score_gpt":0.3573881565029165,"score_spread":0.32874338073659587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055932556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951994,0.0028511523,0.000046399164,0.00044797367,0.00006032557,0.00021197456,0.00017202753,0.000021392594,0.0009893831],"genre_scores_gemma":[0.997398,0.0014713764,0.00053072907,0.00017575077,0.00021664587,0.00002713933,0.000063922,0.00001709951,0.000099302946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842525,0.00023099552,0.00040407293,0.00045617612,0.00011158198,0.00037190528],"domain_scores_gemma":[0.9991669,0.0002859831,0.00009585185,0.0001907631,0.000031298117,0.00022922688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032756643,0.00028301164,0.00038727038,0.00009717459,0.00010994846,0.000015609554,0.00021135133,0.00015925421,0.000025128906],"category_scores_gemma":[0.000087755434,0.00026359985,0.00007068338,0.00016989045,0.0008316127,0.00007110691,0.000104370374,0.0005532197,0.0000013186113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007372709,0.00032040584,0.00043475325,0.00025446733,0.0000731326,0.0000101253545,0.0007024125,0.00001917077,0.97729117,0.0008670118,0.000026508018,0.01926357],"study_design_scores_gemma":[0.0014708426,0.00019094805,0.001705854,0.00006684894,0.0001342377,0.000027091926,0.00009624601,0.0010868163,0.9903381,0.003361237,0.0012329431,0.00028882272],"about_ca_topic_score_codex":0.000034321958,"about_ca_topic_score_gemma":0.0000027863523,"teacher_disagreement_score":0.018974748,"about_ca_system_score_codex":0.0000094224215,"about_ca_system_score_gemma":0.00006869432,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W2056001419","doi":"10.1038/sj.bjp.0705146","title":"Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics","year":2003,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; Karolinska Institutet; Centre for Addiction and Mental Health","keywords":"Nicotine; CYP2E1; Endocrinology; Internal medicine; Ethanol; Cerebellum; Hippocampal formation; Dentate gyrus; Immunostaining; Chemistry; Pharmacology; Medicine; Anesthesia; Biochemistry; Immunohistochemistry; Cytochrome P450","score_opus":0.06577666156730935,"score_gpt":0.40384728455645724,"score_spread":0.3380706229891479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056001419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9505592,0.040384896,0.000003688303,0.006359646,0.0015594494,0.00032353096,0.00006250243,0.0000077788145,0.000739298],"genre_scores_gemma":[0.94110084,0.031492688,0.000121137535,0.02658907,0.00019637276,0.000015479776,0.000002575422,0.000037315604,0.00044454527],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673414,0.0011656862,0.0008677982,0.0004133104,0.00017772969,0.0006413527],"domain_scores_gemma":[0.9985601,0.00047121316,0.00035414015,0.00005909781,0.00011278392,0.00044268646],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018193166,0.0003081518,0.0006839139,0.0003578339,0.00012241803,0.000052177496,0.00020299976,0.00047544038,0.00164496],"category_scores_gemma":[0.00008946554,0.00036799794,0.00006705167,0.00033616667,0.00033064137,0.00022560763,0.00011413509,0.0017471713,0.0000054221823],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040668607,0.0005505712,0.02237294,0.000076716475,0.0002549588,0.00063596293,0.0014202959,0.00001280762,0.84411865,0.00008957112,0.082761936,0.047298875],"study_design_scores_gemma":[0.023568243,0.00029505978,0.010226489,0.000068094545,0.00032553106,0.0028971506,0.00015839499,0.0003081527,0.4706577,0.0007892839,0.49009305,0.00061283197],"about_ca_topic_score_codex":0.000079569676,"about_ca_topic_score_gemma":0.000024094386,"teacher_disagreement_score":0.4073311,"about_ca_system_score_codex":0.00005477646,"about_ca_system_score_gemma":0.0001245682,"threshold_uncertainty_score":0.9998772},"labels":[],"label_agreement":null},{"id":"W2056290988","doi":"10.1016/j.jep.2010.01.039","title":"In vitro inhibitory effect of West African medicinal and food plants on human cytochrome P450 3A subfamily","year":2010,"lang":"en","type":"article","venue":"Journal of Ethnopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa","funders":"","keywords":"Medicinal plants; Biology; CYP3A4; CYP3A; Traditional medicine; Zingiberaceae; Subfamily; Cytochrome P450; Botany; Enzyme; Biochemistry; Medicine; Rhizome; Gene","score_opus":0.06937977054827237,"score_gpt":0.44300267839867324,"score_spread":0.37362290785040086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056290988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99021775,0.0018959072,0.0000024774251,0.00085327553,0.004920145,0.0004101013,0.000079394544,0.000014289453,0.0016066544],"genre_scores_gemma":[0.9958517,0.00051687256,0.00006540476,0.0019323531,0.0015132766,0.000021049362,0.0000042926777,0.000040564686,0.000054479024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962837,0.0011987296,0.0011632651,0.0003330328,0.00039141186,0.0006298743],"domain_scores_gemma":[0.9966433,0.0015882326,0.0008886378,0.0001700939,0.00016631054,0.00054340373],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0032333152,0.0004076911,0.0010838516,0.0008435442,0.00015364874,0.000010402105,0.0005284699,0.00056975655,0.0008071991],"category_scores_gemma":[0.00017979674,0.00033985343,0.00019260307,0.00027723305,0.00072364946,0.00014919451,0.00013564188,0.003540565,0.000016699902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035072525,0.00054837443,0.0016985342,0.00009601793,0.00030494062,0.00043222893,0.0008361961,0.000060453272,0.98258686,0.000103884144,0.0021920416,0.007633196],"study_design_scores_gemma":[0.012540176,0.0029589692,0.0155448085,0.000028532162,0.0004069313,0.00019597949,0.000085298976,0.00012503302,0.946164,0.0003080742,0.021356137,0.00028604956],"about_ca_topic_score_codex":0.000018475288,"about_ca_topic_score_gemma":0.000022771032,"teacher_disagreement_score":0.03642287,"about_ca_system_score_codex":0.000057672896,"about_ca_system_score_gemma":0.00017564849,"threshold_uncertainty_score":0.99990535},"labels":[],"label_agreement":null},{"id":"W2056297313","doi":"10.1586/erp.12.15","title":"Personalized medicine policy challenges: measuring clinical utility at point of care","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Personalized medicine; Pharmacogenomics; Precision medicine; Relevance (law); Point of care; Tipping point (physics); Medicine; Scale (ratio); MEDLINE; Data science; Computer science; Bioinformatics; Nursing; Pharmacology","score_opus":0.5349782942177395,"score_gpt":0.68611998141965,"score_spread":0.15114168720191057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056297313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060626964,0.9741505,0.0000021423095,0.0021037424,0.003500061,0.003909801,0.00061910733,0.000051231043,0.015602823],"genre_scores_gemma":[0.00024369232,0.9921699,0.00014573807,0.0023402076,0.0033276645,0.0006222203,0.00023122612,0.0002208942,0.0006984208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9788394,0.010858297,0.005830639,0.0014574563,0.001166845,0.0018473876],"domain_scores_gemma":[0.9874051,0.005791685,0.0024462254,0.0016265553,0.0012151431,0.001515285],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.022749647,0.0013443864,0.009654071,0.0011639906,0.00034562658,0.000012184062,0.002788323,0.0011675828,0.01075031],"category_scores_gemma":[0.0017307478,0.0010484775,0.0033832365,0.0007412602,0.0022998955,0.0001861387,0.0019488103,0.004010692,0.0004600182],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000138434,0.00046671665,0.000110492496,0.16799657,0.001933013,0.000011793722,0.0015459236,2.5698233e-7,0.0000346504,0.00060233346,0.007650633,0.8195092],"study_design_scores_gemma":[0.0024095785,0.00012796749,0.000024933895,0.017833175,0.002341222,0.00003635748,0.00022130743,0.00001437168,0.00020150101,0.000035499503,0.9760245,0.0007295576],"about_ca_topic_score_codex":0.0001285343,"about_ca_topic_score_gemma":0.000011569602,"teacher_disagreement_score":0.9683739,"about_ca_system_score_codex":0.0009735479,"about_ca_system_score_gemma":0.001890148,"threshold_uncertainty_score":0.99993074},"labels":[],"label_agreement":null},{"id":"W2056362627","doi":"10.1097/00008571-200206000-00009","title":"Novel detection assay by PCR???RFLP and frequency of the CYP3A5 SNPs, CYP3A5 *3 and *6, in a Japanese population","year":2002,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP3A5; Single-nucleotide polymorphism; Biology; Restriction fragment length polymorphism; Allele frequency; Genetics; Pharmacogenetics; Polymerase chain reaction; Allele; Molecular biology; Polymorphism (computer science); Gene; Genotype","score_opus":0.07970406418178103,"score_gpt":0.36744934008213714,"score_spread":0.28774527590035615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056362627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815891,0.015236042,0.00008653413,0.00045343235,0.0010378554,0.0006249707,0.00020729452,0.000035178946,0.0007295951],"genre_scores_gemma":[0.99280274,0.0054599014,0.0002014972,0.001014541,0.00017948145,0.000052840292,0.000012941659,0.00004561459,0.00023043087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758834,0.00050957967,0.00064166676,0.00046836535,0.00028711942,0.0005049265],"domain_scores_gemma":[0.99887764,0.00024715182,0.0002775452,0.00024028543,0.000094164956,0.0002631982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074041454,0.00035379053,0.00037123662,0.0001715503,0.00022884147,0.000027411634,0.00029658925,0.00029252443,0.0003272415],"category_scores_gemma":[0.00009637594,0.00030771323,0.000088356974,0.00045327036,0.00028362987,0.00011564262,0.00018864614,0.00069395156,0.000009644853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005880326,0.00037298465,0.043748625,0.00008366237,0.000084068946,0.0000037120094,0.000869541,0.0003603251,0.920029,0.000028138546,0.0003525212,0.034008652],"study_design_scores_gemma":[0.006579749,0.00007471439,0.07001616,0.000039693594,0.0005640927,0.00012342888,0.000120790355,0.06582737,0.83882433,0.00044129326,0.016637554,0.0007508029],"about_ca_topic_score_codex":0.00021175269,"about_ca_topic_score_gemma":0.0001012322,"teacher_disagreement_score":0.081204616,"about_ca_system_score_codex":0.000047992806,"about_ca_system_score_gemma":0.000017341643,"threshold_uncertainty_score":0.9999375},"labels":[],"label_agreement":null},{"id":"W2056370575","doi":"10.1271/bbb.70.307","title":"Hydroxylation of Testosterone by Bacterial Cytochromes P450 Using the<i>Escherichia coli</i>Expression System","year":2006,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Hydroxylation; Escherichia coli; Cytochrome P450; Testosterone (patch); Bacteria; Cytochrome; Chemistry; Biochemistry; Biology; Enzyme; Gene; Endocrinology; Genetics","score_opus":0.030320790401659102,"score_gpt":0.3293990592002817,"score_spread":0.2990782687986226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056370575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556774,0.0024484894,0.00035707903,0.0004981267,0.00043814993,0.00020847241,0.00013909875,0.00008604832,0.00025678673],"genre_scores_gemma":[0.9988022,0.00017035127,0.00059246743,0.000117983654,0.00016222766,0.000011682372,0.000021135438,0.000010119364,0.00011186766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986644,0.00009575112,0.00037348835,0.00038343572,0.00014179919,0.00034114343],"domain_scores_gemma":[0.9992839,0.00006870472,0.0002857278,0.00023556028,0.00004897776,0.00007714473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043310635,0.00020555011,0.00023093667,0.000061331775,0.00036702675,0.000019605815,0.00038424938,0.00067644205,0.000031287203],"category_scores_gemma":[0.00003443472,0.00015581308,0.000046533904,0.00032651005,0.0012599158,0.00005943502,0.00017943783,0.0003423129,0.0000025749714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056919318,0.00009089158,0.00078926823,0.000056466673,0.000011529438,0.0000022653307,0.000017419283,0.00001403659,0.99764574,0.00018293173,0.00043279465,0.00069972844],"study_design_scores_gemma":[0.00057879556,0.000036440095,0.00041585197,0.000024927629,0.00006176553,0.000030608742,0.000085201274,0.0018715353,0.98583966,0.000044545028,0.010833736,0.00017689973],"about_ca_topic_score_codex":0.00003317337,"about_ca_topic_score_gemma":7.264193e-7,"teacher_disagreement_score":0.011806055,"about_ca_system_score_codex":0.000036971232,"about_ca_system_score_gemma":0.00007285959,"threshold_uncertainty_score":0.6353873},"labels":[],"label_agreement":null},{"id":"W2056697662","doi":"10.1016/j.vascn.2007.06.001","title":"H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"In vitro; Cell culture; Heart cells; Cytochrome P450; Messenger RNA; Gene expression; CYP1B1; Biology; Cell; Enzyme; Cell biology; Molecular biology; Gene; Biochemistry; Myocyte; Genetics","score_opus":0.28450714162708074,"score_gpt":0.5519377379896758,"score_spread":0.2674305963625951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056697662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741256,0.010238975,0.002906426,0.008991563,0.0009557642,0.001489258,0.000014578597,0.00002052292,0.0012573065],"genre_scores_gemma":[0.9206132,0.00096921116,0.040996984,0.036731064,0.00047035198,0.00008579858,5.340586e-7,0.000019934867,0.00011286933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98984635,0.006322351,0.0016557793,0.000530998,0.00057856174,0.0010659613],"domain_scores_gemma":[0.9930372,0.005556887,0.00043671925,0.00020892156,0.00018843882,0.0005717821],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.032050822,0.0004768365,0.0010521892,0.0003806393,0.00037539107,0.000077598204,0.0011887648,0.00035009475,0.00053189084],"category_scores_gemma":[0.00063846953,0.00023931709,0.0003100806,0.0011663933,0.00028209848,0.00015139516,0.00043600125,0.0032416396,0.000010826027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004674737,0.0080261035,0.0036164268,0.000017084034,0.00026168363,0.0006405196,0.007816973,0.0061790626,0.8982732,0.00051186106,0.0023123496,0.06766997],"study_design_scores_gemma":[0.011281766,0.0017598763,0.026023647,0.000011324394,0.001308496,0.00026041642,0.0042861006,0.019627528,0.8595505,0.0112833865,0.06388077,0.0007261835],"about_ca_topic_score_codex":0.000010879496,"about_ca_topic_score_gemma":0.000006698297,"teacher_disagreement_score":0.06694379,"about_ca_system_score_codex":0.000081799124,"about_ca_system_score_gemma":0.00010513722,"threshold_uncertainty_score":0.99905795},"labels":[],"label_agreement":null},{"id":"W2056759774","doi":"10.1023/b:agen.0000011799.47529.fd","title":"Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker","year":2003,"lang":"en","type":"article","venue":"Angiogenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; University of Toronto; Hospital for Sick Children","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada","keywords":"Angiogenesis; In vivo; Cancer research; Pathology; Cell culture; Matrigel; Endothelial stem cell; Carcinoma; Biology; In vitro; Medicine","score_opus":0.03898224097341798,"score_gpt":0.3417008093245264,"score_spread":0.30271856835110844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056759774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402237,0.0038054732,0.00010587325,0.0001125315,0.00020842251,0.0006489877,0.00010028121,0.000019534593,0.00097655604],"genre_scores_gemma":[0.9967048,0.0016841429,0.0005804916,0.0007661171,0.00003308198,0.00008560937,0.000006425255,0.000043865817,0.00009547535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964945,0.00150341,0.00060122646,0.00051657803,0.00021099306,0.0006732938],"domain_scores_gemma":[0.99905133,0.0003167061,0.00013191739,0.00022077923,0.000057331188,0.00022193574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024902136,0.00034229393,0.0006412238,0.00057682506,0.000053706914,0.000012336438,0.0001533335,0.00031768784,0.00016837068],"category_scores_gemma":[0.000094526455,0.00037665328,0.0002084025,0.00075588207,0.00013596339,0.00010390081,0.00010063223,0.0003795884,0.000017018596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056375423,0.0005404539,0.020777555,0.000060233964,0.000079420795,0.00035752464,0.0006318767,0.012952873,0.96240306,0.00008281372,0.00007382375,0.0014766334],"study_design_scores_gemma":[0.0032232688,0.000022349368,0.011495055,0.000023312634,0.00011916783,0.00003404829,0.000102360085,0.037172634,0.94355816,0.0005175649,0.0033600996,0.00037198386],"about_ca_topic_score_codex":0.00049199956,"about_ca_topic_score_gemma":0.00037591966,"teacher_disagreement_score":0.02421976,"about_ca_system_score_codex":0.00006230737,"about_ca_system_score_gemma":0.00015174245,"threshold_uncertainty_score":0.9998685},"labels":[],"label_agreement":null},{"id":"W2056894910","doi":"10.1016/s0944-7113(00)80044-6","title":"An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures","year":2000,"lang":"en","type":"article","venue":"Phytomedicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":350,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Canada","funders":"","keywords":"Matricaria chamomilla; Hypericum perforatum; Hypericin; Traditional medicine; IC50; Chemistry; Glycyrrhiza; CYP3A4; Pharmacology; Metabolite; Cytochrome P450; In vitro; Biology; Biochemistry; Medicine; Enzyme","score_opus":0.08005555040464424,"score_gpt":0.4554864010696971,"score_spread":0.3754308506650529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056894910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436086,0.0027826163,0.000006348904,0.00036391633,0.00013752792,0.000490505,0.000088158995,0.000033322598,0.0017367423],"genre_scores_gemma":[0.9976366,0.00031235398,0.00003425269,0.0011283575,0.0004456374,0.000047143887,0.00033457694,0.000019986246,0.000041084593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794936,0.0006514297,0.0004399213,0.00028088831,0.0003646255,0.00031378446],"domain_scores_gemma":[0.9992755,0.00008833422,0.00012566653,0.00013233435,0.00017197187,0.00020621288],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014269018,0.00019780135,0.00035020927,0.00015683807,0.000112729635,0.0000074939094,0.000103664985,0.00019469636,0.0024309119],"category_scores_gemma":[0.000039129638,0.0001865061,0.000027350581,0.00035933816,0.00021248775,0.000111457826,0.000016238311,0.00046660323,0.000009088504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043456294,0.0005012983,0.0009808003,0.000027038273,0.000032461357,0.0000065280647,0.0007443789,0.000103411396,0.89317966,0.000004155398,0.0014283285,0.10255739],"study_design_scores_gemma":[0.008104196,0.00022395999,0.1407188,0.000023202952,0.00030112723,0.00001635056,0.000038267568,0.005400653,0.8376941,0.0005016369,0.006761022,0.00021670462],"about_ca_topic_score_codex":0.00006711706,"about_ca_topic_score_gemma":0.000030615043,"teacher_disagreement_score":0.139738,"about_ca_system_score_codex":0.000046853445,"about_ca_system_score_gemma":0.00006438272,"threshold_uncertainty_score":0.998481},"labels":[],"label_agreement":null},{"id":"W2057186028","doi":"10.1182/blood-2010-05-283861","title":"In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; CYP2C9; Dosing; Vitamin K epoxide reductase; Medicine; Warfarin; Phenprocoumon; Internal medicine; Genotype; Gastroenterology; Biology; Genetics; Cytochrome P450; Atrial fibrillation","score_opus":0.055102093488590756,"score_gpt":0.40129211118856173,"score_spread":0.346190017699971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057186028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961515,0.0003369056,0.0000018088718,0.00018725739,0.0015404298,0.0003831127,0.00023029314,0.000031673568,0.0011370232],"genre_scores_gemma":[0.9979072,0.00042983677,0.0001861329,0.0005862082,0.0006385192,0.000021172702,0.000039904637,0.000039684175,0.00015131195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826115,0.00019995097,0.00044943974,0.00034316187,0.00022404273,0.0005222411],"domain_scores_gemma":[0.99893725,0.0002511358,0.00021073624,0.0002661969,0.00007797106,0.00025668944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044121762,0.00030148827,0.00038909077,0.00028665102,0.00013902492,0.000026882546,0.00035294463,0.0003283439,0.0006417521],"category_scores_gemma":[0.000097571174,0.0002347282,0.00014471826,0.00037933124,0.00016635071,0.00008860085,0.00009594042,0.00092014426,0.000055143144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011855098,0.0063427705,0.61593705,0.00013284649,0.00021729777,0.00029423524,0.0017547932,0.00028804713,0.36668983,0.00019482343,0.0018564197,0.005106383],"study_design_scores_gemma":[0.010462072,0.0003960904,0.56334215,0.000010705677,0.00059280684,0.000014993454,0.000023561244,0.00020701445,0.40833637,0.00014507578,0.01598136,0.00048777353],"about_ca_topic_score_codex":0.00005415546,"about_ca_topic_score_gemma":0.000059374837,"teacher_disagreement_score":0.05259487,"about_ca_system_score_codex":0.000017257766,"about_ca_system_score_gemma":0.0001666754,"threshold_uncertainty_score":0.9571938},"labels":[],"label_agreement":null},{"id":"W2057828133","doi":"10.1124/dmd.30.10.1070","title":"Quaternary Ammonium-Linked Glucuronidation of 1-Substituted Imidazoles by Liver Microsomes: Interspecies Differences and Structure-Metabolism Relationships","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Glucuronidation; Microsome; Chemistry; Metabolite; Stereochemistry; Enzyme kinetics; Metabolism; Substrate (aquarium); Enzyme; Chromatography; Biochemistry; Active site; Biology","score_opus":0.06322874557579293,"score_gpt":0.3213998346208855,"score_spread":0.25817108904509256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057828133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928368,0.068674326,0.00021394856,0.00046216312,0.00088014937,0.00036643236,0.00074272533,0.0000595842,0.00023271242],"genre_scores_gemma":[0.9747898,0.023987236,0.0003131037,0.00022823684,0.000276514,0.000026040672,0.00019377623,0.000027122189,0.00015815675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977358,0.0005977264,0.00057616364,0.00047838312,0.00023741333,0.00037449904],"domain_scores_gemma":[0.9988512,0.00023522665,0.00032534613,0.00019626932,0.00012052604,0.00027145783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003382709,0.00037924031,0.000516758,0.00024185494,0.00043487432,0.00008123136,0.00021078503,0.0002710743,0.00042486613],"category_scores_gemma":[0.000046958234,0.00034240042,0.00009252549,0.00024080159,0.00051705155,0.0004689855,0.00011786924,0.00056370895,0.000014887337],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005186306,0.0005329759,0.017214268,0.00019802486,0.00034554696,0.000011720456,0.0106041785,0.000059063903,0.9217974,0.012268111,0.0019524504,0.03449761],"study_design_scores_gemma":[0.0073351385,0.000035839283,0.46082482,0.00009512016,0.0021307617,0.00008559873,0.0016074574,0.019199425,0.45943168,0.00430828,0.043550007,0.0013958953],"about_ca_topic_score_codex":0.00008948518,"about_ca_topic_score_gemma":0.000019798295,"teacher_disagreement_score":0.46236575,"about_ca_system_score_codex":0.000015488224,"about_ca_system_score_gemma":0.000014368863,"threshold_uncertainty_score":0.9999028},"labels":[],"label_agreement":null},{"id":"W2058186699","doi":"10.1042/bj20011594","title":"Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones","year":2002,"lang":"en","type":"article","venue":"Biochemical Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronosyltransferase; Biology; Glucuronidation; Androsterone; Dihydrotestosterone; Complementary DNA; Androgen; Molecular biology; Biochemistry; Enzyme; Gene; Microsome; Hormone; Steroid","score_opus":0.056607082899957605,"score_gpt":0.31737335058461297,"score_spread":0.2607662676846554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058186699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350375,0.0044590775,0.000096138974,0.0009384147,0.00041226865,0.00037696,0.00012616678,0.000014315193,0.00007293045],"genre_scores_gemma":[0.99050325,0.0083288085,0.00009906951,0.00067651586,0.00027677527,0.000015349331,0.000017860319,0.000023640765,0.000058730126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855304,0.00021246003,0.00041109585,0.00027633374,0.00022690234,0.0003201997],"domain_scores_gemma":[0.9991024,0.00011358271,0.00026829657,0.00014202297,0.000089933856,0.0002837467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019067929,0.00025478294,0.00029815757,0.00008130252,0.00020799774,0.00003901462,0.00017955517,0.000212453,0.00015717026],"category_scores_gemma":[0.00004448565,0.00018787429,0.00010914802,0.00014665512,0.00021497541,0.00013373684,0.00007006338,0.00051394,0.0000061662645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039650107,0.00023322865,0.015341973,0.000020687545,0.00014545307,0.000009547573,0.00038252427,0.00003336608,0.97257423,0.00005189629,0.00012213105,0.010688485],"study_design_scores_gemma":[0.0020102663,0.00012171033,0.018043175,0.000020581836,0.00026397163,0.00018522456,0.000025472318,0.005146061,0.971604,0.000083240884,0.002292901,0.00020343432],"about_ca_topic_score_codex":0.0000031438499,"about_ca_topic_score_gemma":4.403985e-7,"teacher_disagreement_score":0.01048505,"about_ca_system_score_codex":0.000028373566,"about_ca_system_score_gemma":0.000028940069,"threshold_uncertainty_score":0.7661291},"labels":[],"label_agreement":null},{"id":"W2058631507","doi":"10.1016/j.bbrc.2009.05.033","title":"Purification, characterization, and directed evolution study of a vitamin D3 hydroxylase from Pseudonocardia autotrophica","year":2009,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"New Energy and Industrial Technology Development Organization","keywords":"Hydroxylation; Enzyme; Directed evolution; Biochemistry; Biology; Bioconversion; Cytochrome P450; Mutant; Chemistry; Gene","score_opus":0.1358445377548713,"score_gpt":0.4552206927658562,"score_spread":0.31937615501098493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058631507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443424,0.0011919495,0.000054929456,0.0032310772,0.000045287943,0.0005690707,0.00019273406,0.00006025316,0.00022047147],"genre_scores_gemma":[0.99654543,0.0024623729,0.00035211738,0.00012810333,0.0001381977,0.00008428886,0.00021306824,0.000010579837,0.00006582649],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99765736,0.0009790411,0.0003808305,0.00037771647,0.0002997687,0.00030526705],"domain_scores_gemma":[0.99787873,0.0006005779,0.00010168531,0.0006962121,0.00039788178,0.00032492296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005748438,0.00016240048,0.00028221833,0.00014406638,0.00043500122,0.000035024983,0.000536495,0.00018419512,0.000029250097],"category_scores_gemma":[0.00029303672,0.00014862862,0.000047427657,0.0005997315,0.0007070439,0.00008340503,0.0002979385,0.0007330275,0.000012839709],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013826099,0.0023129631,0.00089724024,0.000008546894,0.00006965429,9.192167e-7,0.0005175232,6.150851e-7,0.978628,0.0021084975,0.00025290032,0.0150649],"study_design_scores_gemma":[0.0038293635,0.00079254084,0.50674605,0.000042310567,0.00036124067,0.000004704282,0.00042817686,0.023542225,0.43711868,0.0063417805,0.020248588,0.0005443244],"about_ca_topic_score_codex":0.00009548622,"about_ca_topic_score_gemma":0.0000025630204,"teacher_disagreement_score":0.54150933,"about_ca_system_score_codex":0.000034298097,"about_ca_system_score_gemma":0.000066464236,"threshold_uncertainty_score":0.60608995},"labels":[],"label_agreement":null},{"id":"W2058632265","doi":"10.2217/pgs.13.130","title":"Sunny Outlook for Personalized Medicine: Tamoxifen and Beyond","year":2013,"lang":"en","type":"editorial","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Tamoxifen; Medicine; MEDLINE; Breast cancer; Oncology; Internal medicine; Family medicine; Pharmacology; Library science; Cancer; Political science; Computer science","score_opus":0.08553001355217504,"score_gpt":0.44312988380152535,"score_spread":0.3575998702493503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058632265","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031390314,0.04556763,0.00030155122,0.0017155088,0.9287052,0.0034367663,0.005399483,0.00024697106,0.011487826],"genre_scores_gemma":[0.0009703641,0.05573407,0.0014128378,0.006649727,0.9025114,0.0014431983,0.002630201,0.0005097558,0.028138429],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942792,0.000590413,0.0013277687,0.0015449947,0.00071262696,0.0015449997],"domain_scores_gemma":[0.99283177,0.0036726932,0.00084262656,0.00051457965,0.00085485354,0.0012835084],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.002233405,0.0013673194,0.0017786257,0.0004403552,0.00067520945,0.000119998105,0.0012159722,0.002227292,0.0037783606],"category_scores_gemma":[0.00074551505,0.0013195532,0.00045090288,0.00023488673,0.0011566387,0.00020483398,0.00046014754,0.002969472,0.0003218462],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007560394,0.0001773771,0.000022592187,0.0004977374,0.0011975425,0.000022672406,0.001216213,0.000020485546,0.058852177,0.0004885845,0.9184926,0.018255977],"study_design_scores_gemma":[0.0107919015,0.0001559862,0.0000030732194,0.00003233529,0.003233899,0.000016004962,0.00006308074,0.0029748476,0.0056912587,0.0022615064,0.97344244,0.001333652],"about_ca_topic_score_codex":0.00006979176,"about_ca_topic_score_gemma":0.0000043907426,"teacher_disagreement_score":0.054949854,"about_ca_system_score_codex":0.00022595891,"about_ca_system_score_gemma":0.0006864058,"threshold_uncertainty_score":0.99990773},"labels":[],"label_agreement":null},{"id":"W2059006559","doi":"10.1016/s0304-4165(02)00488-9","title":"Molecular dynamics of substrate complexes with hamster cytochrome P450c17 (CYP17): mechanistic approach to understanding substrate binding and activities","year":2003,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - General Subjects","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Medical Research Council; University of California, San Francisco; U.S. Public Health Service; National Institutes of Health","keywords":"Substrate (aquarium); Hamster; Chemistry; Stereochemistry; Cytochrome P450; Molecular dynamics; Cytochrome; Hydrogen bond; Heme; CYP17A1; Active site; Pregnenolone; Enzyme; Biochemistry; Computational chemistry; Biology; Steroid; Molecule; Organic chemistry","score_opus":0.08158662111929803,"score_gpt":0.3425933926486129,"score_spread":0.26100677152931484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059006559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129856,0.00018312197,0.0025257356,0.00028053328,0.00030196004,0.000807732,0.0003518664,0.0000809247,0.0041695805],"genre_scores_gemma":[0.99603623,0.00018742855,0.0025888863,0.0006407881,0.00009889575,0.0000681624,0.00012697573,0.00009795505,0.00015466491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969049,0.00058878784,0.0004926877,0.0007885908,0.00036451925,0.0008604941],"domain_scores_gemma":[0.99860245,0.00016259692,0.00032740802,0.00035494208,0.00007156076,0.0004810354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004785627,0.00063356245,0.0007214013,0.00031670468,0.00034528083,0.00012236045,0.00036406488,0.00028067591,0.00003645951],"category_scores_gemma":[0.000019400308,0.00057935464,0.00015154337,0.00059453835,0.00041036727,0.00017806009,0.00012798514,0.00057347515,0.000007487801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039609676,0.0003669624,0.000045998946,0.00014031008,0.000418853,0.000023883877,0.00085785077,0.0006334185,0.93903834,0.057989135,0.000039175073,0.000049997252],"study_design_scores_gemma":[0.0017840195,0.00029679673,0.0007085728,0.000036188863,0.00041372774,0.00005310913,0.00047607403,0.004079054,0.988524,0.0027860394,0.000103321705,0.00073910085],"about_ca_topic_score_codex":0.000030021705,"about_ca_topic_score_gemma":0.000026651043,"teacher_disagreement_score":0.0552031,"about_ca_system_score_codex":0.00017762781,"about_ca_system_score_gemma":0.00024242827,"threshold_uncertainty_score":0.9996658},"labels":[],"label_agreement":null},{"id":"W2059096370","doi":"10.1002/jps.23602","title":"Hepatocyte Composition-Based Model as a Mechanistic Tool for Predicting the Cell Suspension: Aqueous Phase Partition Coefficient of Drugs in In Vitro Metabolic Studies","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hepatocyte; Composition (language); Chemistry; Microsome; In vitro; Partition coefficient; Chromatography; Biochemistry","score_opus":0.1445566727357377,"score_gpt":0.4741265744938992,"score_spread":0.32956990175816153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059096370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98720104,0.0069528418,0.0018114339,0.0020047291,0.0008174125,0.0010061213,0.00004507636,0.000010035405,0.00015134455],"genre_scores_gemma":[0.9954336,0.0011363039,0.0012155522,0.0019324097,0.0001559259,0.000097530865,0.0000024782269,0.000012036845,0.00001412938],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99680716,0.00066022074,0.0011388628,0.00026978157,0.0005559442,0.00056800724],"domain_scores_gemma":[0.9965006,0.002177368,0.000564193,0.00009998104,0.0004298061,0.00022803855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041650897,0.00023237917,0.0005721981,0.000279179,0.00036413877,0.00005457385,0.0004974621,0.00011111205,0.00020820493],"category_scores_gemma":[0.00033291508,0.0001568142,0.00020016408,0.0006143184,0.00062465604,0.00021414954,0.00008319534,0.00064958195,0.0000072185135],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013252727,0.0016948502,0.00045560548,0.000107949876,0.00007380437,0.000020022684,0.0013921432,0.16572084,0.8177541,0.0007059636,0.0002489376,0.010500529],"study_design_scores_gemma":[0.003721925,0.0001667729,0.000036521677,0.000031052914,0.00017493239,0.00001265467,0.0003801202,0.5418135,0.4509321,0.0019055728,0.0007174677,0.000107396954],"about_ca_topic_score_codex":0.00002325492,"about_ca_topic_score_gemma":0.0000037158163,"teacher_disagreement_score":0.37609264,"about_ca_system_score_codex":0.00007712142,"about_ca_system_score_gemma":0.00036019977,"threshold_uncertainty_score":0.63946974},"labels":[],"label_agreement":null},{"id":"W2059224128","doi":"10.1073/pnas.1413481111","title":"Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes","year":2014,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Drug metabolism; Drug; Cytochrome P450; Induced pluripotent stem cell; Biology; Human liver; Drug response; Hepatocyte; Drug development; Pharmacology; Computational biology; Metabolism; Gene; Biochemistry; Enzyme; In vitro; Embryonic stem cell","score_opus":0.17007588872682827,"score_gpt":0.39676754904985845,"score_spread":0.22669166032303018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059224128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984873,0.00018581972,0.000003980964,0.0003365249,0.000062236046,0.00015354941,0.00010102209,0.000006640593,0.000662958],"genre_scores_gemma":[0.9995989,0.000060783055,0.0001264397,0.00012180359,0.00005398679,0.0000062113986,4.6285265e-7,0.0000031839768,0.000028208111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988542,0.00007853997,0.00035284794,0.00019001223,0.00038535704,0.00013903077],"domain_scores_gemma":[0.9991864,0.00025993606,0.00037169323,0.0000065233,0.00013043535,0.000045025896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021519589,0.00009755031,0.00020694597,0.00015756482,0.00020822397,0.000009808022,0.00022411635,0.0000886125,0.000018760498],"category_scores_gemma":[0.00020908272,0.00007378389,0.00004205316,0.00029949957,0.0010203081,0.00019325795,0.00013550365,0.000245825,2.1537961e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013907304,0.00007288114,0.23711516,0.000043501943,0.000018912588,2.8868694e-9,0.00037077424,0.000059880822,0.76054764,0.0010852064,0.00008491303,0.00058719073],"study_design_scores_gemma":[0.00046756177,0.000039697345,0.2804354,0.000051897492,0.000059093545,0.0000046243845,0.0002304011,0.030876033,0.6825037,0.0051251245,0.00012980768,0.000076662596],"about_ca_topic_score_codex":0.000026932112,"about_ca_topic_score_gemma":5.590227e-7,"teacher_disagreement_score":0.07804397,"about_ca_system_score_codex":0.000015518115,"about_ca_system_score_gemma":0.00001740958,"threshold_uncertainty_score":0.37593678},"labels":[],"label_agreement":null},{"id":"W2059431105","doi":"10.1034/j.1601-183x.2002.103083.x","title":"Werner Kalow, Urs A. Meyer and Rachel F. Tyndale (eds): Pharmacogenomics","year":2002,"lang":"en","type":"article","venue":"Genes Brain & Behavior","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Pharmacokinetics; Drug; Pharmacology; Clinical pharmacology; Pharmacodynamics; Medicine; Genetics; Biology; Genotype; Gene","score_opus":0.1360126646776427,"score_gpt":0.41513188181996974,"score_spread":0.279119217142327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059431105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955306,0.036577027,0.000034808527,0.0018823693,0.0025481812,0.0007692596,0.000302449,0.0001747807,0.0024051082],"genre_scores_gemma":[0.9561244,0.014679389,0.0010168303,0.011392055,0.0013675063,0.00037397657,0.00006649996,0.00015412376,0.014825218],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699646,0.00042714947,0.000581307,0.0007527611,0.00028879143,0.0009535523],"domain_scores_gemma":[0.9982474,0.00033330865,0.00018247435,0.00039040108,0.00011826278,0.00072814355],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00072127435,0.0005373385,0.00049549714,0.00021080386,0.00047683212,0.0000743039,0.0005014786,0.0004441812,0.008737848],"category_scores_gemma":[0.000053774063,0.0005458688,0.00020985707,0.00027826635,0.0003831081,0.00017546049,0.0002720726,0.0008180231,0.00088574976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008259955,0.0006565693,0.0076195,0.000022543438,0.00014890978,0.000156008,0.0009970218,0.00007919145,0.5374872,0.00012820287,0.033876292,0.41874593],"study_design_scores_gemma":[0.0031653552,0.00005882819,0.003966181,0.0000045212996,0.0007620665,0.00013698991,0.00006686771,0.0021504988,0.10654599,0.000041806245,0.8824386,0.00066228874],"about_ca_topic_score_codex":0.000022273467,"about_ca_topic_score_gemma":0.000005919527,"teacher_disagreement_score":0.8485623,"about_ca_system_score_codex":0.00005156988,"about_ca_system_score_gemma":0.000044595068,"threshold_uncertainty_score":0.9998922},"labels":[],"label_agreement":null},{"id":"W2059623829","doi":"10.1007/bf03261913","title":"Effect of Ketoconazole on the Pharmacokinetic Profile of Buprenorphine following Administration of a Once-Weekly Buprenorphine Transdermal System","year":2012,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Ketoconazole; Medicine; Buprenorphine; Cmax; Pharmacokinetics; Placebo; Crossover study; Pharmacology; Confidence interval; Transdermal; Area under the curve; Anesthesia; Internal medicine; Opioid","score_opus":0.10642077970965888,"score_gpt":0.43825656655936307,"score_spread":0.33183578684970416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059623829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931711,0.0006927102,0.00005487024,0.00069946324,0.0019337712,0.0015327645,0.00016107116,0.000046128414,0.0017081293],"genre_scores_gemma":[0.99851435,0.000090219466,0.00013986608,0.00032962984,0.0005474792,0.00015645668,0.00007561308,0.000033408778,0.00011296939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99446785,0.002684447,0.0016978213,0.00030844746,0.00043737763,0.0004040307],"domain_scores_gemma":[0.99468136,0.0034886925,0.0009809522,0.00034231757,0.00015988917,0.0003467915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060417904,0.00032005258,0.0007887338,0.00012074849,0.00012227506,0.0000066578373,0.00042172283,0.00028438104,0.00024549416],"category_scores_gemma":[0.00055933674,0.00023331793,0.0004580106,0.0003883893,0.0006057911,0.00015373729,0.00006436494,0.00073839154,0.000030162628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040308335,0.0018061061,0.08532561,0.0022429868,0.0010829545,0.000010820478,0.002644867,0.0014501556,0.8517414,0.0059861876,0.0024160529,0.04126202],"study_design_scores_gemma":[0.003880614,0.0007929891,0.013706112,0.00018179338,0.0010656478,0.0000054833135,0.00008814583,0.010997089,0.9673689,0.00008702775,0.0016093914,0.00021683217],"about_ca_topic_score_codex":0.000017992095,"about_ca_topic_score_gemma":0.00000140866,"teacher_disagreement_score":0.115627475,"about_ca_system_score_codex":0.000028878769,"about_ca_system_score_gemma":0.00014676606,"threshold_uncertainty_score":0.9514429},"labels":[],"label_agreement":null},{"id":"W2060079516","doi":"10.1097/fpc.0b013e328336ef1c","title":"Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Exon; Biology; Glucuronidation; Alternative splicing; Gene; RNA splicing; Gene isoform; Molecular biology; Genetics; Biochemistry; Enzyme; RNA; Microsome","score_opus":0.0675290214685342,"score_gpt":0.38030536502945145,"score_spread":0.3127763435609172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060079516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98867565,0.005328851,0.00064841565,0.00083594304,0.0024269358,0.0006175796,0.00015449703,0.00004454233,0.0012675804],"genre_scores_gemma":[0.9896934,0.006570668,0.0011586206,0.0016561084,0.00071330724,0.00004105904,0.000024778905,0.00006001569,0.000082057275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777466,0.00023160726,0.0006936864,0.0004849293,0.0002190332,0.00059608347],"domain_scores_gemma":[0.9984139,0.00034484893,0.00035653813,0.000317693,0.00025556135,0.00031144606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010969901,0.00038286464,0.00039880228,0.00013925214,0.0005447346,0.000059471568,0.0004729476,0.00024599826,0.00029944172],"category_scores_gemma":[0.00006803448,0.00032470975,0.00015961676,0.00023785332,0.00041682634,0.000095993026,0.00018116961,0.0010236753,0.000016989694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009055012,0.000096682015,0.0014705323,0.00005343781,0.00016927857,0.0000058875794,0.0023402886,0.0039992305,0.9464999,0.0007156651,0.00016171938,0.04439687],"study_design_scores_gemma":[0.0014183229,0.000045427223,0.00090341485,0.000007869673,0.0004082088,0.00004189128,0.00020719835,0.05119691,0.85273933,0.000800203,0.09189822,0.00033300943],"about_ca_topic_score_codex":0.0000321985,"about_ca_topic_score_gemma":0.000019874476,"teacher_disagreement_score":0.093760535,"about_ca_system_score_codex":0.00002195606,"about_ca_system_score_gemma":0.000107200925,"threshold_uncertainty_score":0.9999205},"labels":[],"label_agreement":null},{"id":"W2060134307","doi":"10.1016/s0169-409x(02)00065-0","title":"CYP2A6 genetic variation and potential consequences","year":2002,"lang":"en","type":"review","venue":"Advanced Drug Delivery Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Variation (astronomy); Genetic variation; CYP2A6; Biology; Genetics; Gene","score_opus":0.14631540495016146,"score_gpt":0.43780734581757985,"score_spread":0.29149194086741836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060134307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013440923,0.9930515,0.00010568723,0.00006259974,0.0027631035,0.0025521133,0.00023308341,0.00009212178,0.0010053329],"genre_scores_gemma":[0.000050688213,0.99415475,0.0019662208,0.0009374221,0.00073448295,0.0005299134,0.00010912226,0.00009600556,0.0014213705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939322,0.0022403703,0.0017096146,0.0010501734,0.00025463954,0.0008130115],"domain_scores_gemma":[0.9972616,0.00039248855,0.0011769662,0.0005259462,0.00012298928,0.0005200549],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010673403,0.0009815408,0.0028717446,0.0002688696,0.00036999138,0.00006371544,0.00061197334,0.00059596077,0.0014601162],"category_scores_gemma":[0.00011047188,0.0008226119,0.0007084646,0.00044818904,0.00038801617,0.00020143106,0.00024456214,0.0013404839,0.001218468],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012011834,0.00009073038,0.0000018031234,0.0052180886,0.00021871629,0.000082407474,0.00012777824,0.000047575224,0.00014899594,0.000046381538,0.0025585191,0.991447],"study_design_scores_gemma":[0.00063933874,0.000027700908,0.000004565569,0.0016681624,0.0038531271,0.00022493722,0.0000053487547,0.00024072801,0.000023357867,0.00023391147,0.99224776,0.0008310853],"about_ca_topic_score_codex":0.0000112755815,"about_ca_topic_score_gemma":0.0000035953904,"teacher_disagreement_score":0.9906159,"about_ca_system_score_codex":0.000098193166,"about_ca_system_score_gemma":0.00017516057,"threshold_uncertainty_score":0.9995592},"labels":[],"label_agreement":null},{"id":"W2060234882","doi":"10.1177/0269881114523861","title":"Association of tardive dyskinesia with variation in <i>CYP2D6</i> : Is there a role for active metabolites?","year":2014,"lang":"en","type":"article","venue":"Journal of Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Mental Health; Wellcome Trust","keywords":"Tardive dyskinesia; CYP2D6; Dyskinesia; Odds ratio; Antipsychotic; Parkinsonism; Schizophrenia (object-oriented programming); Internal medicine; Medicine; Genotype; Chlorpromazine; Psychology; Psychosis; Psychiatry; Biology; Genetics; Disease; Gene; Parkinson's disease; Cytochrome P450","score_opus":0.028681409567631027,"score_gpt":0.3901963718726726,"score_spread":0.36151496230504154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060234882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876677,0.002352108,0.0016711579,0.0029686622,0.0025848444,0.0006384974,0.00013742341,0.000011820446,0.001967779],"genre_scores_gemma":[0.9925146,0.0013217553,0.0015073388,0.003349863,0.0009869573,0.00005758481,0.00000512664,0.000036369278,0.00022040062],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99710554,0.00090217957,0.0009431421,0.0002667928,0.0003143349,0.00046801218],"domain_scores_gemma":[0.99594975,0.0010272874,0.0018187731,0.00012612222,0.00087260734,0.00020543677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023690516,0.0002693634,0.000778232,0.00040629206,0.0000818606,0.000011765695,0.0003755628,0.00037694597,0.0006726986],"category_scores_gemma":[0.00016548514,0.00022593435,0.0002452932,0.00041471206,0.000078223726,0.00020913652,0.00003268232,0.00080131355,0.000010025012],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013725873,0.0016260479,0.029849842,0.00012229677,0.0026835657,0.00001818109,0.005792492,0.0030620007,0.9012066,0.0009966855,0.014989529,0.025926853],"study_design_scores_gemma":[0.03418498,0.0012341352,0.08415071,0.000038944207,0.002235869,0.000057236037,0.00028870645,0.004779113,0.29286647,0.0072248722,0.5724518,0.00048721087],"about_ca_topic_score_codex":0.000013291475,"about_ca_topic_score_gemma":0.000011842981,"teacher_disagreement_score":0.60834014,"about_ca_system_score_codex":0.00012757309,"about_ca_system_score_gemma":0.00018207543,"threshold_uncertainty_score":0.9213335},"labels":[],"label_agreement":null},{"id":"W2060473854","doi":"10.1006/abbi.2000.2059","title":"Failure of Ah Receptor to Mediate Induction of Cytochromes P450 in the CYP1 Family in the Human Hepatoma Line SK-Hep-1","year":2000,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"Texas A and M University","keywords":"Receptor; Cytochrome P450; Aryl hydrocarbon receptor; Ligand (biochemistry); Cytosol; Cell culture; Molecular biology; Hep G2; Enzyme inducer; Chemistry; Isozyme; Messenger RNA; Carcinogen; Biochemistry; Biology; In vitro; Enzyme; Gene; Transcription factor","score_opus":0.044752677732869325,"score_gpt":0.36777943593409745,"score_spread":0.3230267582012281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060473854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686354,0.0006750843,0.000002814375,0.000666749,0.000045342655,0.0002470876,0.00018329537,0.0000043954483,0.0013117136],"genre_scores_gemma":[0.9979239,0.0012524296,0.00014319966,0.00038494085,0.00018085018,0.000021937238,0.00004561249,0.0000075570156,0.00003957403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988236,0.00023964465,0.00039082536,0.00020097263,0.00014697216,0.00019802996],"domain_scores_gemma":[0.99932086,0.00024649786,0.00014296902,0.00021090511,0.000023488597,0.000055300134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034654315,0.00015970468,0.0002668222,0.00006139218,0.000060343544,0.000005223313,0.0004037241,0.00011334297,0.00004437849],"category_scores_gemma":[0.000016880698,0.00010958308,0.000079933874,0.00031198474,0.00039770702,0.000030614556,0.000054547563,0.00037580065,0.0000017927894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016873407,0.00043087383,0.0011910166,0.00012107942,0.00003870154,0.000002559783,0.0039016304,0.000066882545,0.96900934,0.00015414592,0.00014179143,0.024773236],"study_design_scores_gemma":[0.0008748941,0.00010977171,0.016281396,0.000040114308,0.000054197753,0.000003274408,0.0008247097,0.00011348441,0.97754467,0.001273548,0.0027580233,0.00012191373],"about_ca_topic_score_codex":0.000043555072,"about_ca_topic_score_gemma":0.0000056988506,"teacher_disagreement_score":0.024651323,"about_ca_system_score_codex":0.0000035460146,"about_ca_system_score_gemma":0.0000359321,"threshold_uncertainty_score":0.44686684},"labels":[],"label_agreement":null},{"id":"W2060516957","doi":"10.1515/dmdi.2011.012","title":"Comparing pharmacokinetics and metabolism of diltiazem in normotensive Sprague Dawley and Wistar Kyoto rats vs. spontaneously hypertensive rats in vivo","year":2011,"lang":"en","type":"article","venue":"Drug metabolism and drug interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Nova Scotia Health Research Foundation","keywords":"Pharmacokinetics; Diltiazem; Chemistry; In vivo; Pharmacology; Metabolism; Desmethyl; Endocrinology; Internal medicine; Calcium; Metabolite; Medicine; Biochemistry; Biology","score_opus":0.07032727981593452,"score_gpt":0.34779390708357394,"score_spread":0.27746662726763943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060516957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97620565,0.016697438,0.000018162938,0.00050011347,0.0022050901,0.00081661163,0.00023187633,0.00004974916,0.0032753095],"genre_scores_gemma":[0.9835528,0.013282353,0.0007627589,0.0015880411,0.00026688413,0.000082514496,0.000020167141,0.00006406228,0.0003803807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99624914,0.0007865264,0.0011139947,0.0008345128,0.00025033636,0.0007655134],"domain_scores_gemma":[0.9977777,0.0006224853,0.0004048063,0.0003277954,0.0003315842,0.0005356503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086062995,0.000639355,0.0013492096,0.00083690864,0.0002256115,0.000052736606,0.000310349,0.000178109,0.0003120855],"category_scores_gemma":[0.00014960385,0.00063377246,0.00012986675,0.0005240881,0.00057445455,0.00049585884,0.0003942906,0.0013254603,0.000011590505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052338927,0.0027863705,0.07270228,0.00051312055,0.0012386463,0.0018195317,0.08177381,0.0006164674,0.7934256,0.008083684,0.0054856464,0.02632094],"study_design_scores_gemma":[0.012653259,0.000058361507,0.16568252,0.000215787,0.002192195,0.0011239828,0.00742314,0.01643545,0.5176124,0.0022242067,0.27240947,0.00196923],"about_ca_topic_score_codex":0.002182365,"about_ca_topic_score_gemma":0.0018811455,"teacher_disagreement_score":0.2758132,"about_ca_system_score_codex":0.000032592394,"about_ca_system_score_gemma":0.00009012551,"threshold_uncertainty_score":0.9996114},"labels":[],"label_agreement":null},{"id":"W2060570337","doi":"10.1089/thy.2010.1642","title":"The Canadian Pharmacogenomics Network for Drug Safety: A Model for Safety Pharmacology","year":2010,"lang":"en","type":"review","venue":"Thyroid","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hospital for Sick Children; SickKids Foundation; BC Children's Hospital; Child and Family Research Institute","funders":"","keywords":"Pharmacogenomics; Drug; Safety pharmacology; Medicine; Pharmacology; Intensive care medicine","score_opus":0.142553412410372,"score_gpt":0.45637777616507913,"score_spread":0.3138243637547071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060570337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000053168815,0.9568779,0.0015103676,0.0015609423,0.015860433,0.009700636,0.010798042,0.00014919821,0.0035371517],"genre_scores_gemma":[0.000024620953,0.96879256,0.0023614229,0.0054028737,0.008622752,0.004198389,0.0015303723,0.00041887775,0.008648147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923518,0.0009916341,0.0020159758,0.0012548696,0.0002760727,0.0031096775],"domain_scores_gemma":[0.9916757,0.004401186,0.0010656316,0.0007553764,0.00046308967,0.001639042],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.005623018,0.0014495668,0.0026693477,0.00031279708,0.004848562,0.0001532849,0.0025457577,0.0018892664,0.0003019698],"category_scores_gemma":[0.00015795493,0.0011575948,0.0018214219,0.00045954832,0.000598573,0.000098714074,0.00030924607,0.0038248224,0.00019544066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007112075,0.00009202675,5.183278e-7,0.0013880545,0.0013216652,0.000008703726,0.00017112169,0.003017462,0.00012255118,0.0039701266,0.20423985,0.7849567],"study_design_scores_gemma":[0.003221983,0.000046128043,1.2758119e-7,0.000113686365,0.007304853,0.000042970918,0.000007310752,0.07028991,0.00009698572,0.0019150468,0.91578877,0.00117223],"about_ca_topic_score_codex":0.0004564281,"about_ca_topic_score_gemma":0.023485878,"teacher_disagreement_score":0.7837845,"about_ca_system_score_codex":0.00068866496,"about_ca_system_score_gemma":0.005348093,"threshold_uncertainty_score":0.9998254},"labels":[],"label_agreement":null},{"id":"W2060688925","doi":"10.2174/1389200043489045","title":"Expression of Cytochrome P450 in Lung Tumor","year":2004,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytochrome P450; Lung cancer; Drug; Drug metabolism; Enzyme; Lung; Pharmacology; Cancer research; Metabolism; Biology; Medicine; Pathology; Internal medicine; Biochemistry","score_opus":0.1495398489201582,"score_gpt":0.4884367072325,"score_spread":0.3388968583123418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060688925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010735292,0.9887458,0.000025198862,0.000018680983,0.006212697,0.0021396724,0.0008040729,0.00009221353,0.0008881156],"genre_scores_gemma":[0.0008937123,0.9964591,0.00015710418,0.00007866529,0.0012493234,0.0005378775,0.00026176762,0.0001674175,0.00019500987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929719,0.0017936428,0.0023540498,0.0011197123,0.00058827805,0.0011723908],"domain_scores_gemma":[0.99660903,0.00045774362,0.00140896,0.00078558194,0.00015562262,0.0005830299],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016681727,0.0012429416,0.0042179967,0.0011752081,0.00015289009,0.000032346263,0.001463869,0.00064958393,0.0011165935],"category_scores_gemma":[0.00014310928,0.0010705033,0.0012354049,0.0010859498,0.00033516175,0.00018507827,0.00057602633,0.0033197014,0.00025105677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059967395,0.0012935436,0.000013964905,0.0380127,0.00024321594,0.000085528845,0.0006472997,0.00012510046,0.0015020118,0.001412613,0.0024874972,0.9541166],"study_design_scores_gemma":[0.0022545292,0.000007209758,0.00006517487,0.008877505,0.0025779328,0.000030741863,0.00001449163,0.000039283797,0.002348418,0.0004403545,0.98239255,0.00095178],"about_ca_topic_score_codex":0.000015138614,"about_ca_topic_score_gemma":0.0000025533243,"teacher_disagreement_score":0.97990507,"about_ca_system_score_codex":0.00020636996,"about_ca_system_score_gemma":0.001141141,"threshold_uncertainty_score":0.9997965},"labels":[],"label_agreement":null},{"id":"W2060938572","doi":"10.1111/j.1749-6632.2000.tb06685.x","title":"Mimicking Gene Defects to Treat Drug Dependence","year":2000,"lang":"en","type":"review","venue":"Annals of the New York Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Dextromethorphan; CYP2A6; Codeine; Nicotine; Pharmacology; Population; CYP2D6; Debrisoquine; Drug; Pharmacogenetics; Cytochrome P450; Genetics; Biology; Genotype; Medicine; Gene; CYP1A2; Enzyme; Internal medicine; Morphine; Biochemistry","score_opus":0.3805598074305748,"score_gpt":0.5164229025892486,"score_spread":0.13586309515867379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060938572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045511257,0.9884352,0.0000021564902,0.0022900007,0.00065229135,0.00081274385,0.0001313477,0.000023383636,0.0031017403],"genre_scores_gemma":[0.003127601,0.9899069,0.00030491996,0.0041050976,0.0005240149,0.000024411538,0.0000017143772,0.000029572662,0.0019757904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996022,0.0008656905,0.0010287121,0.0006818784,0.00064883195,0.00075290725],"domain_scores_gemma":[0.997641,0.00074826437,0.0009006172,0.00021219681,0.00004246779,0.00045543793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002276874,0.0005167219,0.0014988868,0.00036933483,0.00039248678,0.00002766472,0.003375955,0.0005368415,0.00036952968],"category_scores_gemma":[0.000115097646,0.000338911,0.00082400005,0.0015223131,0.0008230663,0.00010506773,0.00042323192,0.0010792835,0.00009697165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027640848,0.00007963266,0.000024198614,0.0010501314,0.00012091884,0.000001052729,0.00034092748,0.000586511,0.0011073826,0.00028036474,0.041232247,0.955149],"study_design_scores_gemma":[0.00016735989,0.00003212304,0.000014712776,0.0013661921,0.00073302,0.000019872869,0.000011565748,0.000015830235,0.074477494,0.0014332571,0.92140555,0.00032304382],"about_ca_topic_score_codex":0.000050462397,"about_ca_topic_score_gemma":0.0000019767303,"teacher_disagreement_score":0.95482594,"about_ca_system_score_codex":0.000015435891,"about_ca_system_score_gemma":0.00048330924,"threshold_uncertainty_score":0.9999063},"labels":[],"label_agreement":null},{"id":"W2061164760","doi":"10.2217/14622416.10.2.255","title":"Call for Nominations – Pacific Rim Association for Clinical Pharmacogenetics – Werner Kalow Best Paper Award in Clinical Pharmacogenetics","year":2009,"lang":"en","type":"letter","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenetics; Bioethics; Medicine; Political science; Biology; Law; Genetics; Genotype","score_opus":0.2528882958559432,"score_gpt":0.5262328410658247,"score_spread":0.2733445452098815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061164760","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07961172,0.050085712,0.003843745,0.6414282,0.120157436,0.036453128,0.05332982,0.0012024471,0.013887792],"genre_scores_gemma":[0.013204113,0.12905772,0.0072980938,0.7405227,0.06919013,0.0037679537,0.008097338,0.0012946498,0.027567333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9809878,0.0035357124,0.006870391,0.0034301544,0.0011596595,0.004016314],"domain_scores_gemma":[0.9830913,0.009063897,0.0034341633,0.0011898488,0.0018053028,0.0014155209],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0112685915,0.0024856608,0.0036695455,0.0010927498,0.00089372584,0.00030013974,0.002829923,0.0064451,0.0007808093],"category_scores_gemma":[0.0012673647,0.0028670602,0.0034456197,0.00083826337,0.0006217053,0.00036460362,0.00046895473,0.0103630265,0.0005848771],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015332979,0.0026190858,0.007262263,0.00048404763,0.002745919,0.00019688478,0.0002260632,0.001037735,0.0076397704,0.00003990811,0.8848539,0.091361105],"study_design_scores_gemma":[0.022309478,0.00055755704,0.00043935239,0.000066225555,0.007732691,0.00003537543,0.000037057205,0.015496752,0.0066998308,0.00077276357,0.9429437,0.0029092308],"about_ca_topic_score_codex":0.000023802115,"about_ca_topic_score_gemma":0.00003043879,"teacher_disagreement_score":0.099094465,"about_ca_system_score_codex":0.0013686068,"about_ca_system_score_gemma":0.0017362218,"threshold_uncertainty_score":0.998788},"labels":[],"label_agreement":null},{"id":"W2061209675","doi":"10.2217/14622416.8.10.1385","title":"Genetic Variability in<i>CYP2A6</i>and the Pharmacokinetics of Nicotine","year":2007,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; Centre for Addiction and Mental Health","keywords":"CYP2A6; Nicotine; Pharmacokinetics; Pharmacology; Biology; Genetics; Neuroscience","score_opus":0.18209797631604696,"score_gpt":0.4837606931305429,"score_spread":0.3016627168144959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061209675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020127783,0.9876874,0.00017851336,0.00009217394,0.0029133924,0.0031307419,0.0005541754,0.00006159216,0.0033692077],"genre_scores_gemma":[0.0028897284,0.9936598,0.00054832967,0.0010819987,0.001121391,0.00026104538,0.000057909092,0.00019207501,0.000187735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99026346,0.0038613833,0.0030724313,0.0011113919,0.0004393497,0.001251994],"domain_scores_gemma":[0.9918726,0.005224601,0.0013884174,0.0007674177,0.000201988,0.00054499373],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009093162,0.0012174677,0.0035577598,0.00062979426,0.000214633,0.000041305302,0.0015732187,0.00093642937,0.00067941693],"category_scores_gemma":[0.00031537007,0.0009169777,0.0009559643,0.0010801392,0.0016256968,0.00007726563,0.0008355796,0.0032680086,0.00008633661],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005213937,0.0004520942,0.00012660178,0.0065605775,0.0009134604,0.00004466834,0.0004150036,0.000161016,0.00035471737,0.0009883754,0.00041941815,0.9890427],"study_design_scores_gemma":[0.006905241,0.000024356748,0.000016767672,0.0003734083,0.0057000937,0.00014153594,0.000013953752,0.0019461465,0.0009131712,0.0005873593,0.98255426,0.0008237209],"about_ca_topic_score_codex":0.000048721242,"about_ca_topic_score_gemma":0.0000078432,"teacher_disagreement_score":0.98821896,"about_ca_system_score_codex":0.00018848915,"about_ca_system_score_gemma":0.0005379946,"threshold_uncertainty_score":0.9993281},"labels":[],"label_agreement":null},{"id":"W2061459550","doi":"10.1007/s40262-013-0065-6","title":"The Integration of Allometry and Virtual Populations to Predict Clearance and Clearance Variability in Pediatric Populations over the Age of 6 Years","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Blackberry (Canada); University of Waterloo","funders":"","keywords":"Allometry; Biology; Pharmacotherapy; Medicine; Demography; Ecology; Internal medicine","score_opus":0.16065767397032374,"score_gpt":0.47878067063202867,"score_spread":0.31812299666170496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061459550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515676,0.0011261299,0.00048875797,0.0008377645,0.001261474,0.00083370006,0.00006365577,0.000014985645,0.00021679155],"genre_scores_gemma":[0.9936342,0.0042766696,0.0006523813,0.0009944952,0.00030049495,0.00004638841,0.000008508269,0.000017831988,0.00006903569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997098,0.0010506761,0.0010634735,0.0003060926,0.00020695683,0.00027475145],"domain_scores_gemma":[0.9972446,0.0018848355,0.00026874634,0.00027142998,0.0001462802,0.00018411159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025453495,0.00016971982,0.0003295951,0.000105212115,0.00014264378,0.000025033012,0.0003170482,0.00018445453,0.00010403634],"category_scores_gemma":[0.0010799186,0.00012265347,0.000086862834,0.00052605575,0.00055133057,0.00008835603,0.00019937544,0.00075930037,0.000007931733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004583059,0.0006169865,0.78639346,0.000055167286,0.000078582234,0.000002832283,0.0008835482,0.0029617923,0.01691192,0.0046654926,0.0032714547,0.18370047],"study_design_scores_gemma":[0.0012176632,0.00009863665,0.9740002,0.000008542171,0.0001723332,0.0000012064189,0.000041164407,0.014686953,0.00043669075,0.0024369974,0.0067766835,0.00012290194],"about_ca_topic_score_codex":0.00005178148,"about_ca_topic_score_gemma":0.00003922757,"teacher_disagreement_score":0.18760678,"about_ca_system_score_codex":0.000012600948,"about_ca_system_score_gemma":0.000037748086,"threshold_uncertainty_score":0.50016636},"labels":[],"label_agreement":null},{"id":"W2062052463","doi":"10.1096/fj.14-258780","title":"Decreased nuclear receptor activity and epigenetic modulation associates with down‐regulation of hepatic drug‐metabolizing enzymes in chronic kidney disease","year":2014,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Pregnane X receptor; Nuclear receptor; Chromatin immunoprecipitation; Acetylation; Epigenetics; Histone; Kidney disease; Internal medicine; Biology; Endocrinology; Receptor; Promoter; Molecular biology; Gene expression; Medicine; Transcription factor; Gene; Biochemistry","score_opus":0.028374229501594614,"score_gpt":0.32485170535872704,"score_spread":0.2964774758571324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062052463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576193,0.0024786836,0.0002679314,0.000737246,0.00029569006,0.00026755268,0.00003411006,0.000016423008,0.00014043586],"genre_scores_gemma":[0.99772537,0.0013089668,0.00017912789,0.0003488398,0.0003414448,0.00000907353,0.00000962821,0.000026533899,0.00005100593],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99767095,0.001240551,0.0003300188,0.00018898996,0.00024079907,0.00032871385],"domain_scores_gemma":[0.99863225,0.00032862418,0.0003804691,0.0001497136,0.00009402005,0.00041490336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014983185,0.00019446104,0.00029314766,0.00014357375,0.0003174241,0.000039208953,0.0001873344,0.000086844695,0.00038388293],"category_scores_gemma":[0.0001807051,0.00014026806,0.00007239082,0.0001998203,0.00018781345,0.00014829802,0.00004974972,0.00051030604,0.000009149733],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008093291,0.00018702884,0.044511106,0.00006660849,0.00014932064,0.0000029777693,0.0007949206,0.011091737,0.9152416,0.00065791764,0.00018032752,0.026307147],"study_design_scores_gemma":[0.0046202634,0.000100291,0.44433832,0.000096845724,0.0005065037,0.000014686705,0.000048234528,0.19553009,0.3476864,0.001627794,0.005122984,0.00030758063],"about_ca_topic_score_codex":0.000034918732,"about_ca_topic_score_gemma":0.000018302659,"teacher_disagreement_score":0.5675552,"about_ca_system_score_codex":0.00009726591,"about_ca_system_score_gemma":0.00021153103,"threshold_uncertainty_score":0.57199657},"labels":[],"label_agreement":null},{"id":"W2062795545","doi":"10.1139/y07-121","title":"Adventures in drug disposition: pas seulement pâté de foie","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Disposition; Drug; Medicine; Pharmacology; Intervention (counseling); Pharmacotherapy; Psychology; Internal medicine; Psychiatry","score_opus":0.04436017988986066,"score_gpt":0.3900812560260888,"score_spread":0.34572107613622816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062795545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98451877,0.0075026657,0.000066325665,0.002169998,0.0036954563,0.0002279194,0.000048900423,0.000008665094,0.0017613212],"genre_scores_gemma":[0.98669875,0.0011927304,0.00017067496,0.010518066,0.0012393675,0.000009975463,0.00001093583,0.000021355214,0.0001381665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997303,0.00067844905,0.0006953562,0.0002569415,0.00008889372,0.0009773558],"domain_scores_gemma":[0.99781126,0.00042741658,0.0003057653,0.00009227153,0.00014559968,0.0012176855],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022408154,0.00026250942,0.00046744375,0.0005621594,0.00026052442,0.000010427293,0.0003573326,0.00033082682,0.0037070406],"category_scores_gemma":[0.000033418113,0.00025489856,0.0001289889,0.00024650234,0.0004651374,0.00011256155,0.00004294703,0.0013132333,0.000016642189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008352812,0.0002199547,0.021623671,0.00009219849,0.00034459098,0.0013228202,0.0027048043,0.0008987675,0.94129854,0.0024975308,0.014908489,0.01325335],"study_design_scores_gemma":[0.005143372,0.00024632108,0.081070565,0.00002351111,0.0003657177,0.0005659281,0.0003360514,0.00024506482,0.47171053,0.0069385455,0.4329258,0.00042859558],"about_ca_topic_score_codex":0.0005303676,"about_ca_topic_score_gemma":0.0037576675,"teacher_disagreement_score":0.469588,"about_ca_system_score_codex":0.00016599573,"about_ca_system_score_gemma":0.0007277948,"threshold_uncertainty_score":0.99999034},"labels":[],"label_agreement":null},{"id":"W2063035659","doi":"10.2165/00003088-200140110-00001","title":"Pharmacogenetics","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Therapeutic drug monitoring; Drug; Pharmacology; CYP2D6; CYP2C19; Pharmacogenomics; Intensive care medicine; Bioinformatics; Internal medicine; Biology; Cytochrome P450; Genotype; Genetics","score_opus":0.5455348796245921,"score_gpt":0.6286190238947967,"score_spread":0.08308414427020461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063035659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004168735,0.94766384,0.00013868259,0.00011859276,0.020741249,0.0025151195,0.00089176703,0.00056152185,0.027327543],"genre_scores_gemma":[0.000019006413,0.9747266,0.00054638047,0.003991864,0.011360194,0.0003792041,0.00052712613,0.0005759499,0.007873671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98484665,0.004403388,0.005364603,0.0022663448,0.00084539416,0.0022736078],"domain_scores_gemma":[0.99011075,0.0034568787,0.0020200512,0.0014072389,0.0004194782,0.0025856085],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.003870181,0.002298019,0.0058225202,0.0006897087,0.00047975924,0.00013756921,0.0031027785,0.0032515214,0.0122276],"category_scores_gemma":[0.0005274066,0.002084641,0.0036439528,0.001908106,0.0011611908,0.00013319528,0.0011636526,0.008218967,0.0073414524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007554422,0.0011784079,0.000061657156,0.0037011025,0.0018515626,0.00050485577,0.00002551484,0.000039546438,0.000009368084,0.00011448428,0.08346148,0.9089765],"study_design_scores_gemma":[0.0030811916,0.000150437,0.0000049606865,0.0009763546,0.015333974,0.00028648574,0.0000065751233,0.0005085869,0.000043488475,0.00019370347,0.9772929,0.0021213316],"about_ca_topic_score_codex":0.0000040152613,"about_ca_topic_score_gemma":0.00000111185,"teacher_disagreement_score":0.90685517,"about_ca_system_score_codex":0.00018952876,"about_ca_system_score_gemma":0.0009514117,"threshold_uncertainty_score":0.9989759},"labels":[],"label_agreement":null},{"id":"W2063194647","doi":"10.1038/clpt.2009.17","title":"Pharmacogenetics of Pharmacoecology: Which Route to Personalized Medicine?","year":2009,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Miller; Clinical pharmacology; Pharmacy; Library science; Medicine; Citation; Family medicine; Pharmacology; Computer science; Biology","score_opus":0.20988326001252208,"score_gpt":0.5630251880812913,"score_spread":0.3531419280687692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063194647","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020662162,0.018750058,0.00025019093,0.017104756,0.9318189,0.0035131716,0.00258481,0.00048074604,0.004835222],"genre_scores_gemma":[0.0059889653,0.07951103,0.0013339518,0.15293029,0.752849,0.00040651514,0.0010320103,0.00056322775,0.0053850217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9797882,0.006571092,0.0056262673,0.0029615527,0.0020020723,0.0030508575],"domain_scores_gemma":[0.97836125,0.011182194,0.0028508785,0.0013328488,0.0036460906,0.0026267401],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.008241235,0.002522314,0.0052476376,0.0011637246,0.0006827784,0.00005011123,0.00453139,0.006750743,0.008660635],"category_scores_gemma":[0.0008852796,0.002432105,0.0014433514,0.0020512138,0.002957459,0.00016847775,0.0010106541,0.011119564,0.0009862458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044955546,0.0025973178,0.00059324945,0.00026187068,0.006572991,0.000156167,0.0008451157,0.0004605191,0.051990315,0.00003088865,0.89430845,0.037687536],"study_design_scores_gemma":[0.016800068,0.0021362382,0.00031063985,0.0001112186,0.017810458,0.000018698227,0.00007480512,0.0010451747,0.014975609,0.00029665456,0.9444133,0.00200715],"about_ca_topic_score_codex":0.00003176556,"about_ca_topic_score_gemma":0.000023247365,"teacher_disagreement_score":0.17896989,"about_ca_system_score_codex":0.00040255504,"about_ca_system_score_gemma":0.0027250818,"threshold_uncertainty_score":0.9997916},"labels":[],"label_agreement":null},{"id":"W2063459644","doi":"10.1021/bi801595t","title":"Reaction of<i>Mycobacterium tuberculosis</i>Cytochrome P450 Enzymes with Nitric Oxide","year":2009,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Ferrous; Heme; Chemistry; Ferric; Biochemistry; Enzyme; Cytochrome; Hemeprotein; Nitric oxide; Sodium dithionite; Cytochrome P450; Inorganic chemistry; Organic chemistry","score_opus":0.03568531832195848,"score_gpt":0.3573246010325339,"score_spread":0.3216392827105754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063459644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98667765,0.002966794,0.000025162535,0.00034153333,0.00013856639,0.00017890206,0.000078924175,0.0000854385,0.009507023],"genre_scores_gemma":[0.9966422,0.00073132373,0.00039759817,0.0010185532,0.00038526268,0.00001885562,0.00006117594,0.000021130176,0.0007239502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986129,0.000084482774,0.0003462917,0.00035634602,0.00020721093,0.00039277424],"domain_scores_gemma":[0.9990334,0.000073970565,0.00020280844,0.000296012,0.00013925497,0.0002545638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025711645,0.00027272207,0.00031470804,0.00008116197,0.000105179526,0.000013582395,0.0002467925,0.00032080637,0.00025361203],"category_scores_gemma":[0.000034426725,0.00024483688,0.00011433605,0.00031024092,0.00013326725,0.00007291861,0.00003705269,0.0004617775,0.000036247347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003233094,0.00031673955,0.0008723434,0.0000659915,0.00011646385,0.000022016951,0.000038912156,0.000021320733,0.9910389,0.000082873084,0.0021349431,0.0049661864],"study_design_scores_gemma":[0.0011708147,0.0000568092,0.025029285,0.000019038154,0.0002560397,0.00008481754,0.000030532927,0.000057981382,0.94429,0.00009588854,0.028625863,0.00028292672],"about_ca_topic_score_codex":0.000011602649,"about_ca_topic_score_gemma":3.1688145e-7,"teacher_disagreement_score":0.046748895,"about_ca_system_score_codex":0.000047540507,"about_ca_system_score_gemma":0.000113752976,"threshold_uncertainty_score":0.99841577},"labels":[],"label_agreement":null},{"id":"W2063523494","doi":"10.1016/s0960-0760(01)00172-8","title":"Comparison of the hamster and human adrenal P450c17 (17α-hydroxylase/17,20-lyase) using site-directed mutagenesis and molecular modeling","year":2002,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of California, San Francisco","keywords":"Pregnenolone; Hamster; CYP17A1; Mutant; Mutagenesis; Hydroxylation; Chinese hamster ovary cell; Cytochrome P450; Biology; Biochemistry; Site-directed mutagenesis; Lyase; Enzyme; Molecular biology; Mutation; Chemistry; Steroid; Gene; Receptor; Hormone","score_opus":0.08079557702632102,"score_gpt":0.4054192553344981,"score_spread":0.32462367830817707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063523494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97348183,0.024855416,0.00079253427,0.00039663355,0.00017438088,0.00013351673,0.000041794214,0.000007318841,0.0001165857],"genre_scores_gemma":[0.9981496,0.0006349719,0.0002584081,0.0007749823,0.000116715266,0.0000015471044,0.000004675607,0.000017529655,0.00004161256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998281,0.00054076384,0.00055932516,0.00020864463,0.00012282206,0.00028744407],"domain_scores_gemma":[0.9989748,0.00009058345,0.0004397523,0.00019362086,0.00012463647,0.00017661757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005778706,0.00025050977,0.00043420572,0.000062958155,0.00028347396,0.000017728336,0.00027189782,0.00027554904,0.000051912266],"category_scores_gemma":[0.000033059612,0.00016606004,0.00010742514,0.000108339395,0.0005608023,0.0000306512,0.00024126786,0.0005543146,3.400452e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013506114,0.00010866175,0.002641119,0.000049948336,0.00025635955,0.000017581606,0.0004213438,0.0012196065,0.99417067,0.000014949209,0.000085250496,0.0008794661],"study_design_scores_gemma":[0.001466533,0.0001185012,0.00011040421,0.00003854942,0.0006912319,0.00045128737,0.000109468885,0.037476525,0.95829105,0.00019219445,0.0008635695,0.00019068555],"about_ca_topic_score_codex":0.000008957206,"about_ca_topic_score_gemma":0.0000014787169,"teacher_disagreement_score":0.036256917,"about_ca_system_score_codex":0.000012937591,"about_ca_system_score_gemma":0.000023051178,"threshold_uncertainty_score":0.6771732},"labels":[],"label_agreement":null},{"id":"W2063753138","doi":"10.1016/s0024-3205(03)00093-6","title":"Interaction of serum proteins with CYP isoforms in human liver microsomes: inhibitory effects of human and bovine albumin, alpha-globulins, alpha-1-acid glycoproteins and gamma-globulins on CYP2C19 and CYP2D6","year":2003,"lang":"en","type":"article","venue":"Life Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Alpha (finance); Albumin; Glycoprotein; Alpha globulin; Globulin; Gamma globulin; Biochemistry; Microsome; Serum albumin; Chemistry; Gene isoform; Pharmacology; Biology; In vitro; Endocrinology; Immunology; Medicine; Antibody; Gene","score_opus":0.04460263588564069,"score_gpt":0.36977810509180953,"score_spread":0.32517546920616885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063753138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122685,0.006253508,0.000014282529,0.00014164939,0.00030303813,0.0010124246,0.000044503435,0.000022108856,0.0009816306],"genre_scores_gemma":[0.99720407,0.0016253553,0.00040344492,0.0005203653,0.000086737775,0.00005322937,0.0000035703117,0.000018927994,0.00008430379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781436,0.00033902764,0.0005287182,0.00056967774,0.0002915817,0.0004566445],"domain_scores_gemma":[0.99891204,0.00018438727,0.0003736815,0.00016519804,0.00008026637,0.00028441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009311067,0.00033416817,0.00051537104,0.00033667684,0.0003855005,0.000034179906,0.00020143972,0.00019773611,0.00006281477],"category_scores_gemma":[0.00010887611,0.0002630585,0.000045924276,0.00039031898,0.0014383201,0.00029423914,0.00011595477,0.00045049874,0.000002387827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033550017,0.00073036517,0.0642283,0.00067803037,0.00010314021,0.000044469703,0.0026202232,0.000048808368,0.9249895,0.0017785099,0.000110756475,0.0043323534],"study_design_scores_gemma":[0.003659704,0.00261928,0.039881933,0.00023973105,0.00011252695,0.00004679814,0.00051638565,0.000249577,0.9492565,0.00038490462,0.0026674876,0.00036517537],"about_ca_topic_score_codex":0.000119776756,"about_ca_topic_score_gemma":0.00015558058,"teacher_disagreement_score":0.024346363,"about_ca_system_score_codex":0.000024720377,"about_ca_system_score_gemma":0.000115613366,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W2063970227","doi":"10.1067/mcp.2001.116714","title":"Pharmacogenetics, pharmacogenomics, and pharmacobiology","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Clinical pharmacology; Medicine; Pharmacology; Biopharmaceutics; Biology; Pharmacognosy; Genotype; Genetics; Gene","score_opus":0.5125665708794018,"score_gpt":0.6075484237968155,"score_spread":0.09498185291741368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063970227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087411253,0.96135575,0.00008111942,0.0012008897,0.02856256,0.0038980462,0.0011551868,0.00062923145,0.0022430832],"genre_scores_gemma":[0.00006309274,0.9223326,0.00038148815,0.06312959,0.010169994,0.0006512888,0.00045164782,0.0006483006,0.0021720189],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9796223,0.008157512,0.005199517,0.003350391,0.00052906474,0.0031412083],"domain_scores_gemma":[0.9887223,0.004823016,0.0024431264,0.0010553198,0.00045980935,0.0024963813],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0043685567,0.0031303274,0.0071054134,0.0010078762,0.0009646615,0.00014122366,0.0029320288,0.0045013865,0.0061692367],"category_scores_gemma":[0.00006109714,0.0029082897,0.002541366,0.0013576152,0.0035824745,0.00023038029,0.0016973602,0.009455074,0.0022362159],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042658628,0.0015811293,0.00023001737,0.0024487586,0.0108438,0.00054409285,0.00012495057,0.000016313683,0.0005223901,0.000034039964,0.05179771,0.9314302],"study_design_scores_gemma":[0.0064854617,0.00034205292,0.000012332125,0.00034015774,0.04467318,0.0008380075,0.000026140568,0.0006026813,0.0003015138,0.0001331864,0.94364697,0.0025983276],"about_ca_topic_score_codex":0.000009761228,"about_ca_topic_score_gemma":0.0000027322342,"teacher_disagreement_score":0.9288319,"about_ca_system_score_codex":0.0003154007,"about_ca_system_score_gemma":0.0012606508,"threshold_uncertainty_score":0.9991292},"labels":[],"label_agreement":null},{"id":"W2063972278","doi":"10.1016/s0009-9236(03)00051-1","title":"Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3a4 activity: comparison with grapefruit juice,","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Grapefruit juice; Chemistry; Felodipine; Lime; Wine; Citrus paradisi; Food science; Metabolite; Pharmacokinetics; Pharmacology; Biochemistry; Botany; Medicine; Endocrinology","score_opus":0.1754512454019363,"score_gpt":0.5006417785127449,"score_spread":0.32519053311080864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063972278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815125,0.004604567,0.00009952433,0.004456743,0.0033724648,0.0012710099,0.00006644249,0.00016907293,0.004447676],"genre_scores_gemma":[0.9662181,0.005080685,0.0006863538,0.025945757,0.0009617226,0.00009708426,0.000020568526,0.00013123192,0.0008585088],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99344987,0.002124667,0.0016855674,0.0011088997,0.0004633875,0.0011675835],"domain_scores_gemma":[0.9952524,0.001873669,0.0010353595,0.0005167676,0.00043263,0.000889175],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023937651,0.00081760937,0.0017253472,0.00031563398,0.0004246217,0.00003489577,0.0006382455,0.0010909406,0.0012567654],"category_scores_gemma":[0.0000636847,0.0007314843,0.00036214676,0.0007724391,0.0021966547,0.00020121438,0.00024265626,0.0027058152,0.000115013136],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008905404,0.009543387,0.09487623,0.00027937058,0.008437385,0.00031986603,0.0013524488,0.0005639619,0.801445,0.00065531465,0.029505339,0.044116255],"study_design_scores_gemma":[0.013899138,0.001997118,0.035468485,0.000031663956,0.005346777,0.00016012958,0.00013620815,0.0012073527,0.24931592,0.00065159757,0.6908015,0.0009841215],"about_ca_topic_score_codex":0.000009871661,"about_ca_topic_score_gemma":0.000008104342,"teacher_disagreement_score":0.6612962,"about_ca_system_score_codex":0.000057481437,"about_ca_system_score_gemma":0.0004283956,"threshold_uncertainty_score":0.9996562},"labels":[],"label_agreement":null},{"id":"W2064377262","doi":"10.3109/00498254.2012.751141","title":"A simplified approach to predict CYP3A-mediated drug–drug interactions at early drug discovery: validation with clinical data","year":2012,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Drug; Drug discovery; Drug-drug interaction; Pharmacology; Drug metabolism; Computational biology; Medicine; Bioinformatics; Biology","score_opus":0.1967283429259725,"score_gpt":0.46054134951206044,"score_spread":0.263813006586088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064377262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97600496,0.00043981423,0.0009549837,0.002148065,0.0032532264,0.0011795004,0.0015529202,0.00019638559,0.0142701175],"genre_scores_gemma":[0.98730993,0.00024295438,0.0013486696,0.0028757756,0.0017187141,0.0000693664,0.001447662,0.00007762055,0.0049092774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957994,0.0011292069,0.00080798287,0.00085794926,0.00040337365,0.0010020717],"domain_scores_gemma":[0.99632984,0.0010879408,0.00028242817,0.0010423623,0.00014208752,0.0011153258],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024139627,0.00044091916,0.00055209,0.00018623275,0.00044891835,0.00010510099,0.0010433678,0.00017208974,0.0005237053],"category_scores_gemma":[0.00026908197,0.00036741307,0.00012869512,0.0005052578,0.0002920565,0.0008087227,0.00093369215,0.0012571212,0.001092666],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055967085,0.01104993,0.4089336,0.00023866183,0.0029997008,0.000037555823,0.013419299,0.0018684096,0.04821458,0.0028884977,0.49567005,0.009082992],"study_design_scores_gemma":[0.004235133,0.00007895403,0.06925556,0.000035413916,0.0015452766,0.000057494468,0.00041709602,0.005670088,0.024914725,0.000060116738,0.8927424,0.0009877665],"about_ca_topic_score_codex":0.000058776757,"about_ca_topic_score_gemma":0.000032388907,"teacher_disagreement_score":0.39707235,"about_ca_system_score_codex":0.00009672012,"about_ca_system_score_gemma":0.00015718289,"threshold_uncertainty_score":0.9998778},"labels":[],"label_agreement":null},{"id":"W2064835492","doi":"10.1016/j.bcp.2004.03.035","title":"Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction","year":2004,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Liver Foundation","keywords":"CYP1A2; Pharmacology; Metabolite; Microsome; Metabolism; Chemistry; Drug interaction; CYP2E1; Drug metabolism; Biochemistry; Pharmacokinetics; Cytochrome P450; Biology; Enzyme","score_opus":0.055181212763018496,"score_gpt":0.4263006129790119,"score_spread":0.3711194002159934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064835492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984195,0.009279084,0.0000133401745,0.00295273,0.00089138874,0.0005425297,0.00004014807,0.000031765736,0.0020540222],"genre_scores_gemma":[0.993438,0.0017479546,0.00015710435,0.0040067765,0.00045993837,0.000097812,0.000024816327,0.00002099253,0.000046605004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979422,0.00044993937,0.00055270095,0.00039565706,0.00017790539,0.00048160303],"domain_scores_gemma":[0.99904835,0.00034641614,0.00018479677,0.00015853674,0.00007468212,0.00018721113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000874821,0.00026302267,0.00035758995,0.00017915465,0.00009609257,0.000010984214,0.00043632876,0.00025860957,0.0005099109],"category_scores_gemma":[0.000052358624,0.00021220419,0.00009923562,0.0003455135,0.00039948782,0.00008825799,0.00016059939,0.0009964954,0.000042491745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045618575,0.00073322176,0.0006021007,0.000038544866,0.000076894554,0.000019479216,0.0015285034,0.00025840432,0.98376065,0.0009959134,0.009193955,0.0023361319],"study_design_scores_gemma":[0.003980029,0.00006239184,0.0015391655,0.000009976435,0.00018689946,0.000042319072,0.00045485602,0.0005404296,0.9109663,0.003068917,0.07892511,0.00022363516],"about_ca_topic_score_codex":0.000073195995,"about_ca_topic_score_gemma":0.0000051066067,"teacher_disagreement_score":0.0727944,"about_ca_system_score_codex":0.000058975318,"about_ca_system_score_gemma":0.00007738851,"threshold_uncertainty_score":0.8653436},"labels":[],"label_agreement":null},{"id":"W2066629394","doi":"10.1191/0748233704th203oa","title":"Occupational exposure limits in the context of solvent mixtures, consumption of ethanol, and target tissue dose","year":2004,"lang":"en","type":"review","venue":"Toxicology and Industrial Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health","funders":"","keywords":"Context (archaeology); Physiologically based pharmacokinetic modelling; CYP2E1; Chemistry; Solvent; Biochemical engineering; Toxicology; Pharmacokinetics; Environmental chemistry; Pharmacology; Organic chemistry; Cytochrome P450; Biology; Enzyme","score_opus":0.33566057100426483,"score_gpt":0.506782810509422,"score_spread":0.17112223950515715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066629394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009869194,0.98530954,0.000004996579,0.0006070429,0.0013502366,0.0019963551,0.00075161183,0.000009458381,0.00010157623],"genre_scores_gemma":[0.035271868,0.96283555,0.00005457394,0.0010856107,0.00038258824,0.0001127066,0.00019671886,0.000020870068,0.00003950717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99484664,0.0027535576,0.00134803,0.00040909997,0.00018937963,0.00045331658],"domain_scores_gemma":[0.9972702,0.0012192926,0.001039462,0.00019621872,0.00006397731,0.00021083368],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002646963,0.00039296265,0.0017396142,0.00029267796,0.0001626252,0.000007826193,0.00029686023,0.0016057601,0.00029423824],"category_scores_gemma":[0.00014401323,0.00029624562,0.00012898959,0.0002459657,0.0006253033,0.000047962076,0.000085412226,0.0019018586,0.0000056026024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004997344,0.00069025124,0.00063331245,0.0060207527,0.00020034361,0.000017015074,0.0012732254,0.000009584105,0.00016287288,0.0030144067,0.0018344746,0.98564404],"study_design_scores_gemma":[0.0045632743,0.0008982589,0.00037719202,0.0012716994,0.00048521764,0.00009417067,0.00007229112,0.0000060832435,0.00071433606,0.00025763593,0.99098533,0.00027448547],"about_ca_topic_score_codex":0.00008534982,"about_ca_topic_score_gemma":0.00004367417,"teacher_disagreement_score":0.9891509,"about_ca_system_score_codex":0.00007857838,"about_ca_system_score_gemma":0.0017007884,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W2066735702","doi":"10.1002/cbic.200700128","title":"CYP3A4 Activity in the Presence of Organic Cosolvents, Ionic Liquids, or Water‐Immiscible Organic Solvents","year":2007,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Chemistry; Ionic liquid; Solvent; Hydroxylation; Aqueous solution; Organic chemistry; Toluene; Enzyme; Catalysis","score_opus":0.08851109300882451,"score_gpt":0.4086276546446671,"score_spread":0.32011656163584257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066735702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409544,0.001230921,0.0001236768,0.0005275244,0.00089544646,0.0005441074,0.000020163163,0.000041308696,0.0025214225],"genre_scores_gemma":[0.9968327,0.00073831965,0.000048257363,0.000795221,0.00027062962,0.00002764083,0.000021943773,0.00003718062,0.0012280768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997567,0.00027242614,0.0005272391,0.00043919293,0.0003450406,0.0008491295],"domain_scores_gemma":[0.9986253,0.00040003113,0.00017646386,0.00047518607,0.000114503164,0.00020850787],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025077742,0.00030790752,0.00038727018,0.00012992258,0.00017970744,0.000020025767,0.00094478443,0.00035538935,0.0022481142],"category_scores_gemma":[0.00014842772,0.00020217127,0.00012779328,0.00058615254,0.0002457903,0.00010411529,0.00028026692,0.0008481187,0.00014997051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006628064,0.00096001104,0.0022009786,0.0000961046,0.000094003044,0.000049993134,0.0016772395,0.000013983417,0.99061537,0.00005431882,0.001027812,0.0025473856],"study_design_scores_gemma":[0.002014125,0.00009320597,0.0030419794,0.000020633835,0.0001169154,0.000029574117,0.00025108023,0.00014011646,0.97433996,0.00018494797,0.019508475,0.00025897674],"about_ca_topic_score_codex":0.000018801473,"about_ca_topic_score_gemma":0.0000711019,"teacher_disagreement_score":0.018480664,"about_ca_system_score_codex":0.000073184536,"about_ca_system_score_gemma":0.00015897973,"threshold_uncertainty_score":0.99866396},"labels":[],"label_agreement":null},{"id":"W2067166101","doi":"10.1021/ac070221o","title":"High-Throughput Cytochrome P450 Inhibition Assays Using Laser Diode Thermal Desorption-Atmospheric Pressure Chemical Ionization-Tandem Mass Spectrometry","year":2007,"lang":"en","type":"article","venue":"Analytical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phytronix (Canada)","funders":"","keywords":"Chemistry; Mass spectrometry; Atmospheric-pressure chemical ionization; Tandem mass spectrometry; Ambient ionization; Desorption electrospray ionization; Chemical ionization; Analytical Chemistry (journal); Tandem; Thermal desorption; Atmospheric pressure; Chromatography; Laser; Ionization; Desorption; Environmental chemistry; Organic chemistry; Adsorption","score_opus":0.04601591275015205,"score_gpt":0.36826010205148413,"score_spread":0.3222441893013321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067166101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715434,0.0008341112,0.019454207,0.0001780335,0.0002908805,0.00022478987,0.000073965835,0.0002001926,0.007200419],"genre_scores_gemma":[0.9889482,0.00011474154,0.006640552,0.00086534634,0.0018296672,0.000011409695,0.00015692283,0.00006428315,0.0013688448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971492,0.00012410578,0.00068852655,0.00065984344,0.00047527693,0.0009029954],"domain_scores_gemma":[0.99835795,0.00030327265,0.00020688474,0.00033263332,0.00021847595,0.0005807968],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086221966,0.00043965635,0.00049015967,0.000030103225,0.00031786476,0.000064580476,0.00027999177,0.0007973297,0.00650595],"category_scores_gemma":[0.00014447448,0.0004465811,0.00027610885,0.000712159,0.00033835843,0.00016670756,0.00013528195,0.0011705145,0.0000999785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016244107,0.0003934484,0.0030403044,0.000088873654,0.0004501086,0.00011932219,0.00004008017,0.0059976056,0.9880353,0.00028168416,0.001099509,0.00029128327],"study_design_scores_gemma":[0.001953151,0.000020880732,0.0016569252,0.00002133394,0.0010353586,0.00006439374,0.00003925964,0.056619205,0.9312645,0.0009879534,0.005744822,0.00059222855],"about_ca_topic_score_codex":0.000017462511,"about_ca_topic_score_gemma":6.993394e-7,"teacher_disagreement_score":0.05677085,"about_ca_system_score_codex":0.0001857866,"about_ca_system_score_gemma":0.00012988185,"threshold_uncertainty_score":0.9997986},"labels":[],"label_agreement":null},{"id":"W2067493036","doi":"10.1097/01.jcp.0000085407.08426.e1","title":"Pharmacokinetic and Pharmacodynamic Evaluation of the Inhibition of Alprazolam by Citalopram and Fluoxetine","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"H. Lundbeck A/S","keywords":"Citalopram; Alprazolam; Serotonin reuptake inhibitor; Pharmacology; Fluoxetine; Reuptake inhibitor; Serotonin Uptake Inhibitors; Antidepressant; Pharmacokinetics; Drug interaction; CYP3A; Pharmacodynamics; CYP3A4; Chemistry; Cytochrome P450; Medicine; Serotonin; Internal medicine; Metabolism; Psychiatry; Receptor","score_opus":0.14907782224679142,"score_gpt":0.5354392699966413,"score_spread":0.3863614477498498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067493036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753512,0.014340534,0.000063646876,0.0013001336,0.0059149666,0.0006563663,0.0000743998,0.000008036258,0.0022907194],"genre_scores_gemma":[0.9856033,0.01159312,0.00022862323,0.0020553903,0.00037791356,0.000015067646,0.0000031545635,0.00003166849,0.00009180877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99170184,0.004190125,0.0026866684,0.0003636847,0.0006729852,0.00038469417],"domain_scores_gemma":[0.99436074,0.0014928674,0.0025106012,0.00019040458,0.0010124657,0.00043292556],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010906561,0.00032159436,0.0009929687,0.00021740505,0.00012339368,0.000009334597,0.00033252672,0.00040099275,0.0011044797],"category_scores_gemma":[0.0010397851,0.00024559474,0.00034468158,0.00040156115,0.0010314757,0.00016322141,0.000104962426,0.0015151103,0.0000033628598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020353417,0.001520707,0.017540999,0.00012918355,0.00084701733,0.000009802452,0.00023149948,0.0004891997,0.85323083,0.00027970396,0.012892354,0.11079333],"study_design_scores_gemma":[0.082252026,0.0013740959,0.033155028,0.0001250377,0.009151393,0.00056347554,0.00020245033,0.0128121665,0.59699136,0.0065651196,0.2560378,0.0007700526],"about_ca_topic_score_codex":0.0000028077718,"about_ca_topic_score_gemma":0.0000010880658,"teacher_disagreement_score":0.2562395,"about_ca_system_score_codex":0.000029855577,"about_ca_system_score_gemma":0.00032896575,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W2067571642","doi":"10.1177/0091270008326716","title":"The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Desipramine; Paroxetine; Pharmacokinetics; CYP2D6; Pharmacology; Medicine; Cytochrome P450; Internal medicine; Antidepressant","score_opus":0.1405376604974933,"score_gpt":0.4776603833222849,"score_spread":0.3371227228247916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067571642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719861,0.009622892,0.000012182974,0.012838518,0.004213319,0.0010615422,0.000024400588,0.0000078012035,0.00023325064],"genre_scores_gemma":[0.93532556,0.055780962,0.000029271905,0.007643787,0.0010847375,0.000021914204,7.420123e-7,0.0000321824,0.000080869955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9891096,0.0067888484,0.0026772758,0.00025746317,0.00051707943,0.0006497716],"domain_scores_gemma":[0.97336495,0.0231592,0.0023486651,0.00038284695,0.00042704362,0.00031731982],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008712397,0.00037417782,0.0010235296,0.00011978066,0.00050143595,0.0000071853037,0.0015427084,0.00030395496,0.00015658281],"category_scores_gemma":[0.0016045792,0.00016731405,0.00038737434,0.0005443612,0.0027742253,0.00006289076,0.00030231226,0.0031554862,0.0000072674175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10573781,0.0072743935,0.05362223,0.000743751,0.0032932577,0.00043613891,0.0044317776,0.005668362,0.7348544,0.0011943512,0.03779846,0.044945087],"study_design_scores_gemma":[0.040455773,0.00707307,0.40596357,0.00023986462,0.0026213012,0.00078927324,0.00026733679,0.004993979,0.46255717,0.0015854738,0.07288358,0.0005695877],"about_ca_topic_score_codex":0.0000186425,"about_ca_topic_score_gemma":0.000013130548,"teacher_disagreement_score":0.35234135,"about_ca_system_score_codex":0.000031976215,"about_ca_system_score_gemma":0.00040188854,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W2067981076","doi":"10.1016/s0009-9236(03)90530-3","title":"Domperidone As A Substrate Marker Drug for CYP3A4 and CYP3A5","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Domperidone; CYP3A4; Drug; Pharmacology; Medicine; Clinical pharmacology; Internal medicine; Cytochrome P450","score_opus":0.21800424138292177,"score_gpt":0.527010602900353,"score_spread":0.3090063615174312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067981076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95954716,0.0133440485,0.00037662985,0.007696841,0.011085503,0.0018517913,0.000117185016,0.00020464351,0.0057761976],"genre_scores_gemma":[0.82964814,0.01855846,0.0014330348,0.14518158,0.0014520911,0.00037414627,0.000032042128,0.00013708843,0.0031834112],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938797,0.002235521,0.0013360737,0.0010527992,0.00022937891,0.0012665342],"domain_scores_gemma":[0.9948508,0.0031524627,0.00040790587,0.0003725843,0.00031629394,0.000899934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036838085,0.0006625687,0.00096993503,0.00016190867,0.00060427224,0.00005474168,0.0005593228,0.00080115104,0.0024212198],"category_scores_gemma":[0.00010868769,0.00062858977,0.0004560632,0.00030146574,0.0013148987,0.00013991291,0.0001429191,0.0017467905,0.00028557985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014959225,0.00956572,0.076085865,0.0004746726,0.013944902,0.00044746022,0.0029619513,0.00085220876,0.53593534,0.012692133,0.2285682,0.10351231],"study_design_scores_gemma":[0.01189886,0.00033740152,0.0023310282,0.0000071043823,0.0026013812,0.00009091479,0.00011995508,0.0023066534,0.060470134,0.004650727,0.91445076,0.00073507],"about_ca_topic_score_codex":0.000003852262,"about_ca_topic_score_gemma":0.0000044529293,"teacher_disagreement_score":0.68588257,"about_ca_system_score_codex":0.000047512953,"about_ca_system_score_gemma":0.00034979352,"threshold_uncertainty_score":0.99961656},"labels":[],"label_agreement":null},{"id":"W2067982635","doi":"10.1111/j.1365-2885.2007.00821.x","title":"Reply to Robert Meyer","year":2007,"lang":"en","type":"article","venue":"Journal of Veterinary Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Hyacinthe","funders":"","keywords":"Pascal (unit); Citation; SAINT; Computer science; Library science; Information retrieval; World Wide Web; Programming language; Computer security","score_opus":0.13197839668232822,"score_gpt":0.4709440028894807,"score_spread":0.33896560620715244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067982635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773583,0.007984643,0.001386873,0.004351247,0.0061907237,0.00029574241,0.000015066263,0.000032925484,0.0023844796],"genre_scores_gemma":[0.9308068,0.0036181007,0.0018171107,0.061845895,0.0014313692,0.000005686981,0.0000014539928,0.00004091248,0.00043262794],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746335,0.00043563746,0.000916422,0.00027471007,0.00024197865,0.0006679174],"domain_scores_gemma":[0.9978479,0.0005688777,0.00042681507,0.00014885886,0.00031315908,0.00069440104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031033834,0.0003227478,0.0005099625,0.0004087083,0.00025087537,0.000022120144,0.0004379058,0.00028257078,0.0006747665],"category_scores_gemma":[0.000025042875,0.00028530808,0.00017358219,0.00030697355,0.0002297747,0.00016606029,0.00017461678,0.0011379628,0.000047657617],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004643404,0.0005454423,0.0024550501,0.000033231972,0.0008841954,0.00097180466,0.00142967,0.0001761552,0.8550672,0.00029490286,0.0062233065,0.12727566],"study_design_scores_gemma":[0.002768509,0.0013852392,0.004023743,0.000010407906,0.0005767854,0.0017885028,0.000113329326,0.00013641486,0.12324126,0.00042341364,0.8652479,0.00028450304],"about_ca_topic_score_codex":0.0000031814543,"about_ca_topic_score_gemma":6.6828653e-7,"teacher_disagreement_score":0.8590246,"about_ca_system_score_codex":0.000057230354,"about_ca_system_score_gemma":0.00009768264,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2068075375","doi":"10.1016/j.clpt.2003.10.006","title":"A novel functional polymorphism in the uridine diphosphate–glucuronosyltransferase 2B7 promoter with significant impact on promoter activity","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Single-nucleotide polymorphism; UGT2B7; Morphine; Glucuronosyltransferase; Glucuronide; Chemistry; Uridine; Internal medicine; Glucuronidation; Biology; Pharmacology; Genotype; Biochemistry; Medicine; In vitro; Gene; Metabolism; RNA","score_opus":0.20729445862948895,"score_gpt":0.47151952957898674,"score_spread":0.26422507094949776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068075375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648707,0.0006338496,0.0014643418,0.027026827,0.0030227324,0.0021532294,0.00022112133,0.0001258036,0.00048139115],"genre_scores_gemma":[0.9117391,0.00090410333,0.00019013247,0.08521204,0.001398832,0.000313329,0.000041354717,0.000097910815,0.000103161474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99438626,0.001597005,0.001045593,0.0010976833,0.00054246135,0.0013310035],"domain_scores_gemma":[0.99687165,0.0015174925,0.00034403394,0.00054558145,0.00017892948,0.00054232037],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026462092,0.00086411805,0.0009050973,0.00023752156,0.00042628226,0.00006051456,0.0009559775,0.000732635,0.0012846454],"category_scores_gemma":[0.000021690337,0.00053965196,0.00051242457,0.0006679143,0.0011826577,0.00019497542,0.0001029815,0.0038344038,0.0002285641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034377217,0.036951944,0.020643234,0.00008244545,0.0051274276,0.0010624323,0.0027406947,0.023785597,0.8342714,0.00055222085,0.0043679094,0.036037497],"study_design_scores_gemma":[0.082282856,0.010439282,0.30390623,0.000098598844,0.0064942404,0.00056363735,0.00016030323,0.0063396273,0.43472692,0.0018352964,0.15008073,0.0030722944],"about_ca_topic_score_codex":0.000041308776,"about_ca_topic_score_gemma":0.000016269292,"teacher_disagreement_score":0.39954448,"about_ca_system_score_codex":0.0002113576,"about_ca_system_score_gemma":0.0007114146,"threshold_uncertainty_score":0.9997055},"labels":[],"label_agreement":null},{"id":"W2068149117","doi":"10.1111/bcp.12475","title":"Genotype‐guided drug prescribing: a systematic review and meta‐analysis of randomized control trials","year":2014,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Medicine; Warfarin; Dosing; Adverse effect; Pharmacogenetics; Odds ratio; Internal medicine; Randomized controlled trial; Meta-analysis; Drug; Inclusion and exclusion criteria; Genotype; Pharmacology; Biology; Pathology","score_opus":0.4100241303029413,"score_gpt":0.5830695597088381,"score_spread":0.1730454294058968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068149117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025220685,0.98634875,0.000216987,0.0005100085,0.0038309253,0.007901935,0.00090607436,0.000026809226,0.00023330362],"genre_scores_gemma":[0.00027528268,0.98728955,0.00018437694,0.009759143,0.0013048379,0.00056728214,0.000042548872,0.000102934915,0.00047404657],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.8961953,0.080697775,0.020970114,0.00077272224,0.0006524379,0.00071165524],"domain_scores_gemma":[0.9174226,0.05609843,0.023505412,0.00042444098,0.0014780511,0.0010710707],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.11367861,0.0010594071,0.08073673,0.001000372,0.00017140023,0.000064818785,0.0015953042,0.0012922912,0.004097406],"category_scores_gemma":[0.021563094,0.0007951206,0.024208544,0.0009928008,0.001193606,0.00013736876,0.0002694862,0.0041036783,0.000025945548],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023465718,0.0005570751,6.991546e-7,0.33450347,0.628456,0.0002599024,0.000023140336,0.00005221646,0.0000031411018,0.000050298877,0.01768288,0.016064588],"study_design_scores_gemma":[0.045951705,0.00006536304,3.690481e-7,0.008694271,0.6714332,0.0006631207,0.0000020562702,0.00015814533,0.000004497074,0.00006727409,0.27254722,0.0004127683],"about_ca_topic_score_codex":0.000020391482,"about_ca_topic_score_gemma":0.0000047448575,"teacher_disagreement_score":0.3258092,"about_ca_system_score_codex":0.000043047745,"about_ca_system_score_gemma":0.0008321758,"threshold_uncertainty_score":0.99944997},"labels":[],"label_agreement":null},{"id":"W2068288884","doi":"10.1081/dmr-46136","title":"Regulation of Cytochrome P450 by Posttranslational Modification","year":2005,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cytochrome P450; Biology; Biochemistry; Post-translational regulation; Enzyme; Aryl hydrocarbon receptor; Phosphorylation; Gene; Transcription factor","score_opus":0.2543033041153936,"score_gpt":0.5029916058813573,"score_spread":0.24868830176596368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068288884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021781798,0.9901857,0.00026093825,0.00014386699,0.0012287995,0.0034268587,0.0016035693,0.00007802925,0.003050468],"genre_scores_gemma":[0.00005903804,0.9909327,0.0010569665,0.00040332586,0.0015868685,0.00068652764,0.002370859,0.00014149945,0.0027622313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99159527,0.0030095263,0.0032195346,0.00094988337,0.0005446299,0.00068113644],"domain_scores_gemma":[0.99560934,0.0004262586,0.002450018,0.00084529177,0.00024959873,0.0004194907],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003185401,0.0010690765,0.0043738685,0.0004985105,0.00021803075,0.000034611796,0.0010307973,0.00091994734,0.0028875996],"category_scores_gemma":[0.0001387162,0.00090754335,0.0015728978,0.00094767316,0.00026013263,0.00025297963,0.00011745795,0.0014206594,0.0010055816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018424944,0.00028764014,5.1217023e-7,0.0048961677,0.00029628127,8.884895e-7,0.00016205075,0.000031033767,0.0027288252,0.0014496641,0.026332911,0.9637956],"study_design_scores_gemma":[0.0007041215,0.0000073679366,0.000028918754,0.0010225229,0.00515591,0.000020721087,0.0000026583618,0.00015840986,0.00040435963,0.00017252004,0.9915587,0.00076384394],"about_ca_topic_score_codex":0.000009235494,"about_ca_topic_score_gemma":0.0000018551531,"teacher_disagreement_score":0.96522576,"about_ca_system_score_codex":0.000087739565,"about_ca_system_score_gemma":0.0003457092,"threshold_uncertainty_score":0.99977225},"labels":[],"label_agreement":null},{"id":"W2068626136","doi":"10.1016/j.jchromb.2007.02.044","title":"An improved HPLC assay with fluorescence detection for the determination of domperidone and three major metabolites for application to in vitro drug metabolism studies","year":2007,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec","keywords":"Domperidone; Chemistry; Chromatography; High-performance liquid chromatography; Metabolite; Drug metabolism; Detection limit; Quantitative analysis (chemistry); Coefficient of variation; Metabolism; Biochemistry","score_opus":0.034578492918093555,"score_gpt":0.39452528455408464,"score_spread":0.3599467916359911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068626136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8401421,0.010045682,0.1477781,0.0002150392,0.00045020456,0.0013100728,0.000043016502,0.000009661848,0.0000061791916],"genre_scores_gemma":[0.972676,0.00077347405,0.025811357,0.00021519471,0.0003317938,0.00016637931,0.0000023679247,0.000020992717,0.0000024622166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985663,0.00012980589,0.0006474508,0.00019467874,0.00017655645,0.00028517848],"domain_scores_gemma":[0.9975651,0.00094674807,0.00058770314,0.00014065448,0.0006076784,0.0001521551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003499879,0.00018936687,0.00045458306,0.00046565555,0.00017112232,0.000020010171,0.00024148324,0.00009429397,0.0000015655759],"category_scores_gemma":[0.0001028198,0.00012620537,0.00015149395,0.0004507693,0.00017421096,0.00019764315,0.000023373419,0.0002314074,1.029497e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026601788,0.00015411388,0.00087312295,0.000075466916,0.00023305445,7.647888e-7,0.0007711949,0.000035255307,0.812311,0.0001301901,0.0000136933095,0.18274195],"study_design_scores_gemma":[0.0034974688,0.00022617535,0.016441787,0.00001555397,0.00076907524,0.000027128293,0.00043116405,0.007523338,0.964177,0.0012172839,0.005518678,0.00015535262],"about_ca_topic_score_codex":0.0000139027825,"about_ca_topic_score_gemma":0.00011503539,"teacher_disagreement_score":0.18258661,"about_ca_system_score_codex":0.000017055398,"about_ca_system_score_gemma":0.00003483659,"threshold_uncertainty_score":0.5146506},"labels":[],"label_agreement":null},{"id":"W2068732634","doi":"10.1002/prp2.82","title":"Modulation of<scp>CYP</scp>3a expression and activity in mice models of type 1 and type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Type 2 diabetes; Modulation (music); Type (biology); Pharmacology; Expression (computer science); Diabetes mellitus; Computational biology; Chemistry; Medicine; Computer science; Biology; Endocrinology; Physics","score_opus":0.15960501819051987,"score_gpt":0.4788953691973568,"score_spread":0.31929035100683695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068732634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98615104,0.00982624,0.00004441209,0.000296612,0.00042395404,0.00055432477,0.000027462842,0.000024279527,0.002651679],"genre_scores_gemma":[0.9912126,0.008032892,0.00023686994,0.000089188914,0.00019522075,0.000041950687,0.0000049031123,0.000028997116,0.00015735177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958171,0.002332476,0.0003489713,0.00055801775,0.0003025312,0.0006408585],"domain_scores_gemma":[0.9962939,0.0023536691,0.00017395377,0.00015615085,0.00075482833,0.00026751234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028771982,0.00023808604,0.0005200904,0.0005658161,0.00018912448,0.000013392152,0.0002700797,0.00030814248,0.000109624794],"category_scores_gemma":[0.0006411363,0.00023194472,0.000045161414,0.00074185577,0.0010843857,0.00026872795,0.00035212608,0.0010805664,0.000005929737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040368832,0.0005409414,0.015078336,0.00014222189,0.00012854711,0.0000031233958,0.0051626484,0.0016068231,0.9701122,0.00093046617,0.0008623318,0.005028679],"study_design_scores_gemma":[0.0028311745,0.0004064643,0.029691305,0.000028921004,0.00010254183,0.0000035331866,0.0009747489,0.12562905,0.8316816,0.0051068272,0.0034040853,0.0001397148],"about_ca_topic_score_codex":0.0000437173,"about_ca_topic_score_gemma":0.000007100685,"teacher_disagreement_score":0.13843057,"about_ca_system_score_codex":0.000052652187,"about_ca_system_score_gemma":0.00013064749,"threshold_uncertainty_score":0.9458431},"labels":[],"label_agreement":null},{"id":"W2068747617","doi":"10.1097/01.fpc.0000054090.48725.a2","title":"CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Nicotine; Allele; Genotype; Ethnic group; Allele frequency; Genotype frequency; Demography; CYP2E1; Medicine; Genetics; Biology; Internal medicine; Gene; Sociology","score_opus":0.07037701125279835,"score_gpt":0.3376240692111136,"score_spread":0.26724705795831527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068747617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97080386,0.004176268,0.000031775115,0.0009322278,0.0010901565,0.0007347171,0.000026037364,0.000088789915,0.02211616],"genre_scores_gemma":[0.9910511,0.00064930227,0.00014503667,0.0024360728,0.0002304293,0.0005250893,0.00000765749,0.00003200973,0.004923306],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979416,0.000432441,0.00027298008,0.00037034162,0.00028985017,0.00069275894],"domain_scores_gemma":[0.99888617,0.00020515488,0.00020520497,0.00018276903,0.00009704966,0.00042363565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015450331,0.00023089116,0.00026795862,0.000108334476,0.00024072213,0.000036365716,0.00015206756,0.0002816222,0.0003264051],"category_scores_gemma":[0.00016019428,0.00020672008,0.00005330246,0.00022112609,0.00011254728,0.00012726971,0.000044130884,0.0005167279,0.00003738145],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005305147,0.00063839136,0.73708206,0.00006004553,0.0010847166,0.00006880974,0.0005483057,0.00024925903,0.025152804,0.009393968,0.0144059975,0.21078512],"study_design_scores_gemma":[0.0050208988,0.000031632575,0.3890716,0.0000037428229,0.0005044564,0.000078869474,0.000045292734,0.00013046122,0.19770592,0.0009006944,0.40600538,0.00050104264],"about_ca_topic_score_codex":0.000009415169,"about_ca_topic_score_gemma":0.000009813087,"teacher_disagreement_score":0.3915994,"about_ca_system_score_codex":0.000096923766,"about_ca_system_score_gemma":0.00006471953,"threshold_uncertainty_score":0.84298},"labels":[],"label_agreement":null},{"id":"W2068880530","doi":"10.1111/jth.12072","title":"The VKORC1 and CYP2C9 genotypes are associated with over‐anticoagulation during initiation of warfarin therapy in children","year":2012,"lang":"en","type":"letter","venue":"Journal of Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children; Newcastle upon Tyne Hospitals NHS Foundation Trust","keywords":"VKORC1; Warfarin; CYP2C9; Medicine; Internal medicine; Genotype; Therapeutic index; Vitamin K epoxide reductase; Scopus; Gastroenterology; Pharmacology; MEDLINE; Biology; Genetics; Atrial fibrillation; Cytochrome P450","score_opus":0.13027643020196125,"score_gpt":0.39682358600366285,"score_spread":0.26654715580170163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068880530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639164,0.013261518,0.0000029123332,0.022028971,0.00034315954,0.00029222053,0.00010692882,0.000005388039,0.00004245804],"genre_scores_gemma":[0.9378895,0.047618467,0.000041348078,0.013592537,0.0007706623,0.0000060308835,0.000026233078,0.000036846937,0.00001833752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793875,0.0005410134,0.00067862414,0.00017450731,0.00032149366,0.00034560196],"domain_scores_gemma":[0.99767953,0.00041452254,0.0014785087,0.000121422054,0.000212341,0.00009364973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009971209,0.00028274773,0.0006620082,0.0002305558,0.0002526955,0.000050694187,0.00019105605,0.00054415496,0.00007187598],"category_scores_gemma":[0.000059959257,0.00018784465,0.00010801941,0.00017945033,0.00020725124,0.00016977383,0.000062412015,0.0014904469,5.5245374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005769818,0.0003119752,0.95050824,0.00010396163,0.0032310684,0.000023339924,0.001306051,0.0001221227,0.006898016,0.000022157208,0.01675162,0.020144474],"study_design_scores_gemma":[0.0034351787,0.00012266474,0.9698043,0.00012904931,0.0007892926,0.000043080458,0.000042837404,0.000060268518,0.008485317,0.00013812368,0.016707772,0.00024211808],"about_ca_topic_score_codex":0.000026536358,"about_ca_topic_score_gemma":0.000016598544,"teacher_disagreement_score":0.03435695,"about_ca_system_score_codex":0.000051208677,"about_ca_system_score_gemma":0.000062487525,"threshold_uncertainty_score":0.76600826},"labels":[],"label_agreement":null},{"id":"W2069734969","doi":"10.1016/j.bcp.2004.04.002","title":"Signal transduction pathways implicated in the decrease in CYP1A1, 1A2 and 3A6 activity produced by serum from rabbits and humans with an inflammatory reaction","year":2004,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Merck Canada","keywords":"Protein kinase A; Kinase; Turpentine; Protein kinase C; Signal transduction; Phosphorylation; Biochemistry; Molecular biology; Biology; Inflammation; Chemistry; Immunology","score_opus":0.04896893482873117,"score_gpt":0.352325636948419,"score_spread":0.30335670211968785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069734969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948705,0.0018517368,0.000024622954,0.001832918,0.00023863533,0.0009183549,0.00014994564,0.00006127616,0.000051996827],"genre_scores_gemma":[0.99649066,0.00083296077,0.00005501742,0.001985428,0.0003007504,0.00022064264,0.00007966767,0.000031562817,0.0000033037488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744695,0.00073902024,0.0003678739,0.0007439463,0.00016180368,0.0005404198],"domain_scores_gemma":[0.99902856,0.000199295,0.0001702698,0.00016904842,0.000051568797,0.00038127005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071322755,0.00035173443,0.00035734227,0.00014612463,0.00016404781,0.000023161743,0.00024020363,0.00042000986,0.00013128525],"category_scores_gemma":[0.000026830287,0.0002898426,0.000037077327,0.00029346664,0.0004356628,0.0002239658,0.00005533362,0.0011526938,0.0000048131387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002084167,0.0010046375,0.0032982698,0.000025266849,0.00006898425,0.000055248493,0.0011347313,0.00008207409,0.98882425,0.000044822653,0.00078914664,0.0025883992],"study_design_scores_gemma":[0.008127567,0.00021336328,0.027796598,0.000010489842,0.00020828447,0.000045664896,0.0001235484,0.000568141,0.95867056,0.00070218253,0.003166755,0.00036685052],"about_ca_topic_score_codex":0.00024271343,"about_ca_topic_score_gemma":0.00003877309,"teacher_disagreement_score":0.030153697,"about_ca_system_score_codex":0.00012199172,"about_ca_system_score_gemma":0.00014322206,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W2070001149","doi":"10.1097/fpc.0b013e3282f1f118","title":"Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Exon; Alternative splicing; Gene isoform; Biology; Gene; Genetics; Exon skipping; Glucuronidation; Locus (genetics); RNA splicing; Microsome; RNA","score_opus":0.08133985469911617,"score_gpt":0.37645900795841075,"score_spread":0.2951191532592946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070001149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98201406,0.0011596099,0.009772157,0.00062497176,0.00070050097,0.0012975226,0.003610679,0.000030711715,0.0007897889],"genre_scores_gemma":[0.992601,0.0015255053,0.0010881423,0.0030639584,0.000400525,0.000052078394,0.00010492512,0.00005851926,0.0011053892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973798,0.00017333469,0.00050379086,0.00070019957,0.0004898537,0.0007530227],"domain_scores_gemma":[0.9980201,0.0004148102,0.00047601457,0.0003122274,0.00020640872,0.0005704222],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010437671,0.00047454954,0.00044282194,0.00020139194,0.0009862637,0.000042094718,0.0005496537,0.00024236423,0.002752748],"category_scores_gemma":[0.000042668602,0.00044569274,0.00016507022,0.00031000102,0.00028477784,0.00008941151,0.0011045609,0.0005433963,0.000081780534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007939954,0.00028740134,0.00142347,0.000038967966,0.00043137372,0.0000094319375,0.0017345014,0.0014614923,0.9606891,0.0002599647,0.00497322,0.027897025],"study_design_scores_gemma":[0.0020140822,0.00012827206,0.0028465511,0.000012656337,0.00039741865,0.000036405432,0.00007776979,0.0034116323,0.8820868,0.00060044014,0.10792774,0.00046020988],"about_ca_topic_score_codex":0.00018231613,"about_ca_topic_score_gemma":0.000056362438,"teacher_disagreement_score":0.102954514,"about_ca_system_score_codex":0.00022581895,"about_ca_system_score_gemma":0.00010934549,"threshold_uncertainty_score":0.9997995},"labels":[],"label_agreement":null},{"id":"W2070312848","doi":"10.1016/s0378-4274(02)00285-0","title":"The interaction of human and bovine serum proteins with CYP3A in human liver microsomes: inhibition of testosterone 6β-hydroxylation by albumin, α-globulins, α1-acid glycoprotein and γ-globulins","year":2002,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Globulin; CYP3A; Hydroxylation; Albumin; Chemistry; Bovine serum albumin; Microsome; Biochemistry; Serum albumin; Glycoprotein; Biology; Endocrinology; Enzyme","score_opus":0.04280737593280513,"score_gpt":0.3327666058703122,"score_spread":0.28995922993750706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070312848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926894,0.0026222176,0.00005376617,0.0031506475,0.00015301486,0.0010257564,0.00008627129,0.000026867558,0.00019211005],"genre_scores_gemma":[0.99707466,0.0007553692,0.00014937,0.0016569858,0.00008811306,0.00010111126,0.000033915094,0.000029573477,0.00011090729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997909,0.0004837793,0.0006394408,0.00039869107,0.0001540615,0.0004150463],"domain_scores_gemma":[0.9989774,0.000157881,0.00046980917,0.00020296474,0.00006772966,0.00012418214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005135107,0.0002943186,0.00042277394,0.00019141563,0.00031463394,0.00002042931,0.00015355383,0.00027317367,0.00017092621],"category_scores_gemma":[0.000029429795,0.00024792165,0.000044952238,0.00021876588,0.0008779727,0.00017162893,0.00011489648,0.0006242809,0.000005095628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002799831,0.00046423756,0.0148954205,0.00009971433,0.000088534514,0.0000269798,0.0009469408,0.00006219231,0.9782531,0.00009912784,0.0009971276,0.0037866314],"study_design_scores_gemma":[0.004811263,0.0011406378,0.017877521,0.00007146632,0.00016896399,0.00008263602,0.00013381819,0.0009905751,0.9686356,0.000083846004,0.0056763906,0.00032728908],"about_ca_topic_score_codex":0.000070843096,"about_ca_topic_score_gemma":0.00013682635,"teacher_disagreement_score":0.009617518,"about_ca_system_score_codex":0.000059513266,"about_ca_system_score_gemma":0.000014422913,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W2070771447","doi":"10.1007/s00702-014-1298-8","title":"Genetic variation in CYP3A43 is associated with response to antipsychotic medication","year":2014,"lang":"en","type":"review","venue":"Journal of Neural Transmission","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Les Laboratories Pierre Fabre; Eli Lilly and Company","keywords":"Single-nucleotide polymorphism; Antipsychotic; Minor allele frequency; Brief Psychiatric Rating Scale; SNP; Internal medicine; Olanzapine; Missense mutation; Medicine; Psychology; Schizophrenia (object-oriented programming); Genotype; Psychiatry; Genetics; Psychosis; Biology; Mutation; Gene","score_opus":0.1399189130807576,"score_gpt":0.4713257361115055,"score_spread":0.3314068230307479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070771447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020533022,0.9741989,0.0019455847,0.0010995186,0.0013305531,0.00076962425,0.00003884927,0.000017606126,0.00006639051],"genre_scores_gemma":[0.012332775,0.9853396,0.00059254497,0.0011436221,0.0003701085,0.00001708021,0.00000864763,0.00006379321,0.00013186682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994097,0.003176117,0.0014924913,0.00033258792,0.0005079325,0.0003938733],"domain_scores_gemma":[0.9966893,0.0011823633,0.0012019016,0.00018718597,0.00019768771,0.0005415427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027069896,0.0004295696,0.0015237272,0.00077599817,0.0000956514,0.000026512722,0.0005106404,0.0006116854,0.00030852616],"category_scores_gemma":[0.00021186392,0.00029938042,0.00036131268,0.0007104986,0.00004856802,0.00008710242,0.000019902647,0.0015414163,0.000022192204],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018625889,0.0003552794,0.0000352816,0.0011858988,0.0002666168,0.00020331364,0.00051600806,0.0005495395,0.003318831,0.0000016017423,0.0013057621,0.9903993],"study_design_scores_gemma":[0.0024426538,0.00048072587,0.0025505244,0.004722504,0.0016831717,0.0002739795,0.000004065833,0.0010826271,0.00010330665,0.00003268877,0.9862768,0.0003469249],"about_ca_topic_score_codex":0.0000019567542,"about_ca_topic_score_gemma":0.0000012652122,"teacher_disagreement_score":0.99005234,"about_ca_system_score_codex":0.00013422451,"about_ca_system_score_gemma":0.0004514775,"threshold_uncertainty_score":0.9999458},"labels":[],"label_agreement":null},{"id":"W2070840005","doi":"10.1016/j.ejpb.2008.03.019","title":"Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration","year":2008,"lang":"en","type":"article","venue":"European Journal of Pharmaceutics and Biopharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pharmacology; Systemic administration; Chemistry; Dosage form; Cytochrome P450; Medicine; Biochemistry; Biology; In vivo; Metabolism","score_opus":0.09937835513620248,"score_gpt":0.3832758603621553,"score_spread":0.2838975052259528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070840005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96438265,0.030173747,0.00021033683,0.00047077803,0.0020347745,0.0007726741,0.00020209813,0.00005572764,0.0016972428],"genre_scores_gemma":[0.9555947,0.041586723,0.00030458733,0.0011495707,0.0009830609,0.000018365,0.000006619612,0.000117795615,0.00023855726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9932311,0.0024500706,0.0017826856,0.000692413,0.0007699614,0.0010737684],"domain_scores_gemma":[0.99639285,0.0003886332,0.0009773009,0.00037851973,0.00040470553,0.0014579929],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0038174398,0.0007925604,0.0009930303,0.00071227655,0.00038498588,0.00013399446,0.0007336403,0.0002943741,0.00013685512],"category_scores_gemma":[0.00010877597,0.00074637035,0.00022835095,0.00058504334,0.0007812985,0.000507718,0.00045947722,0.002648511,0.00004408794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045582987,0.0017543316,0.029796923,0.00097183476,0.00042059712,0.009361503,0.002600404,0.0006549605,0.928143,0.00009299192,0.00078558957,0.020859519],"study_design_scores_gemma":[0.05099182,0.0016305452,0.07253064,0.00059772737,0.002608587,0.021212999,0.00091020553,0.040305737,0.4708009,0.000080890226,0.33518255,0.0031473888],"about_ca_topic_score_codex":0.0000045106576,"about_ca_topic_score_gemma":0.0000015485604,"teacher_disagreement_score":0.45734215,"about_ca_system_score_codex":0.000150079,"about_ca_system_score_gemma":0.00027336628,"threshold_uncertainty_score":0.99965245},"labels":[],"label_agreement":null},{"id":"W2070880390","doi":"10.3390/ijms14048381","title":"Pilot Study of CYP2B6 Genetic Variation to Explore the Contribution of Nitrosamine Activation to Lung Carcinogenesis","year":2013,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse; National Cancer Institute; Centre for Addiction and Mental Health; National Institutes of Health; Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation; Centre for Addiction and Mental Health Foundation; Campbell Family Mental Health Research Institute","keywords":"CYP2A6; Nitrosamine; Carcinogen; Lung cancer; Carcinogenesis; Odds ratio; Genotype; Oncology; Nicotine; Internal medicine; Medicine; Cancer; Gastroenterology; Physiology; Chemistry; Genetics; Biology; Gene; Cytochrome P450; Metabolism; CYP3A4","score_opus":0.11285145300166753,"score_gpt":0.42800498701203527,"score_spread":0.3151535340103677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070880390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876816,0.00025778898,0.008638299,0.0017390036,0.001127696,0.00046959874,0.0000061229093,0.0000029869266,0.00007687801],"genre_scores_gemma":[0.99831903,0.000041811138,0.00065273605,0.0007849465,0.00016364556,0.00002456901,0.000001150407,0.000005585838,0.0000065024956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981187,0.0003332782,0.0005616841,0.00013566371,0.0007033997,0.00014729728],"domain_scores_gemma":[0.9977469,0.00018845515,0.00048128885,0.00008589219,0.0013827085,0.000114741975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009473099,0.000100577345,0.00018017185,0.0003176567,0.000084569394,0.00003147448,0.0007294237,0.000026736108,0.00011516887],"category_scores_gemma":[0.00028269118,0.00007254933,0.000059458496,0.0003740986,0.000080211496,0.00013479838,0.000105445346,0.00013680657,0.000005423144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001877034,0.0006335985,0.015506677,0.0000023445498,0.00018731224,0.000004966015,0.0018215646,0.02768615,0.94946885,0.00023054573,0.00014163386,0.004128663],"study_design_scores_gemma":[0.0014740984,0.0019616068,0.2634272,0.000023242937,0.00014485938,0.000015492276,0.00073452457,0.0027937551,0.72824633,0.0006662869,0.00040016786,0.00011242531],"about_ca_topic_score_codex":0.00015888833,"about_ca_topic_score_gemma":0.000007438708,"teacher_disagreement_score":0.24792051,"about_ca_system_score_codex":0.000042968884,"about_ca_system_score_gemma":0.000109157045,"threshold_uncertainty_score":0.29584756},"labels":[],"label_agreement":null},{"id":"W2070885472","doi":"10.1016/s0167-4781(00)00278-5","title":"Genomic organization of a human 5β-reductase and its pseudogene and substrate selectivity of the expressed enzyme","year":2001,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"Medical Research Council","keywords":"Pseudogene; Biology; Intron; Gene; Reductase; Molecular biology; Complementary DNA; Genetics; Enzyme; Biochemistry","score_opus":0.03625721302176637,"score_gpt":0.3384614510543071,"score_spread":0.3022042380325407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070885472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973264,0.0013890753,0.0000052725627,0.00028443852,0.00021539765,0.0003720199,0.0003452135,0.000020761205,0.00004143506],"genre_scores_gemma":[0.9966895,0.0026941705,0.00010473125,0.00020755317,0.00018340733,0.000006168065,0.000051660554,0.000032665193,0.000030126848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842966,0.0003523963,0.00035477357,0.00043666613,0.00015539814,0.0002710888],"domain_scores_gemma":[0.9990371,0.00007120022,0.00035400208,0.0002358165,0.00012868473,0.00017319366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001690871,0.00030106612,0.00037853545,0.00008775648,0.00031491538,0.000023192195,0.0002211755,0.00025353025,0.000065811175],"category_scores_gemma":[0.00002692733,0.00022466751,0.000054670872,0.0002871099,0.00025710405,0.00010616451,0.0002695099,0.000328852,3.893438e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016022408,0.000108243876,0.00074432965,0.000079273814,0.00008682019,0.0000015703504,0.0010951005,0.000023269495,0.9970589,0.000079781865,0.00013634315,0.00042609093],"study_design_scores_gemma":[0.0011924236,0.00006396919,0.037978828,0.000024905377,0.00021527312,0.000027580443,0.000036174064,0.00020608607,0.95937264,0.0004849889,0.0001713055,0.00022584813],"about_ca_topic_score_codex":0.000013050888,"about_ca_topic_score_gemma":0.0000021750443,"teacher_disagreement_score":0.037686333,"about_ca_system_score_codex":0.00000961157,"about_ca_system_score_gemma":0.000061127364,"threshold_uncertainty_score":0.91616756},"labels":[],"label_agreement":null},{"id":"W2071101196","doi":"10.1097/fpc.0b013e3282f01aa3","title":"CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"","keywords":"Perphenazine; Pharmacogenetics; Pharmacodynamics; CYP2D6; Pharmacology; Gene; Medicine; Biology; Pharmacokinetics; Genetics; Genotype","score_opus":0.035398069190745,"score_gpt":0.4098867385297899,"score_spread":0.3744886693390449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071101196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851209,0.011146826,0.0006503217,0.0004951961,0.0005105929,0.0009710715,0.00093060476,0.000048487687,0.00012599396],"genre_scores_gemma":[0.9888775,0.008452673,0.0010348413,0.00097387115,0.0003497843,0.000016765101,0.000034079872,0.00008561741,0.00017486348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968042,0.0006251439,0.0007298717,0.0007243371,0.00023390395,0.0008825863],"domain_scores_gemma":[0.99721265,0.0008172163,0.0002870875,0.00024833897,0.0002386247,0.0011960937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003197603,0.00061281177,0.0007216762,0.00030670915,0.00031741007,0.000058693426,0.00019900003,0.00027030223,0.00021826042],"category_scores_gemma":[0.000058066733,0.00058388594,0.0001347423,0.0002615719,0.00043260827,0.000083604515,0.00045309166,0.0005612274,0.00001807542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00802787,0.00029563758,0.010791596,0.0000701951,0.00045292967,0.000055758028,0.0011687598,0.0005070818,0.85659796,0.000021280586,0.00014663603,0.12186428],"study_design_scores_gemma":[0.006138357,0.0004903123,0.1338685,0.000021007187,0.0012512266,0.0003379353,0.00015217967,0.050000742,0.7618116,0.00016274428,0.044703048,0.0010623105],"about_ca_topic_score_codex":0.000022282326,"about_ca_topic_score_gemma":0.000019017423,"teacher_disagreement_score":0.12307691,"about_ca_system_score_codex":0.00006347528,"about_ca_system_score_gemma":0.00017078934,"threshold_uncertainty_score":0.99966127},"labels":[],"label_agreement":null},{"id":"W2071268710","doi":"10.1039/c4cc09218j","title":"Expanding the toolbox of organic chemists: directed evolution of P450 monooxygenases as catalysts in regio- and stereoselective oxidative hydroxylation","year":2014,"lang":"en","type":"article","venue":"Chemical Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Hydroxylation; Stereoselectivity; Monooxygenase; Catalysis; Chemistry; Oxidative phosphorylation; Organic chemistry; Combinatorial chemistry; Cytochrome P450; Enzyme; Biochemistry","score_opus":0.0647364823448931,"score_gpt":0.39646363939381846,"score_spread":0.33172715704892536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071268710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186254,0.0030045495,0.00012376002,0.00053887576,0.000035560788,0.00025656848,0.000020984704,0.000025230083,0.004131955],"genre_scores_gemma":[0.99876904,0.00070808636,0.00025950375,0.00007977532,0.000029501361,0.0000487289,0.00005522262,0.000011802853,0.000038317005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875516,0.0004377033,0.00038439885,0.00016775656,0.00009455511,0.00016043888],"domain_scores_gemma":[0.997917,0.0010848299,0.00025654456,0.0005124282,0.00015955702,0.00006965463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005136405,0.00012461065,0.00023950926,0.00008146283,0.000121442754,0.0000057618468,0.00049255055,0.00013771141,0.000020594181],"category_scores_gemma":[0.0005431064,0.000108366825,0.000045803197,0.00043349515,0.00045222728,0.00006958914,0.00021511446,0.00041128384,0.0000033144036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006569299,0.00018911416,0.003111415,0.000023288549,0.00006100545,8.463341e-8,0.0017282177,0.000010934341,0.99073195,0.0018031192,0.000063070656,0.00221208],"study_design_scores_gemma":[0.0007842021,0.00001922167,0.005950678,0.0000263145,0.00010599433,0.000003758169,0.00031339657,0.0031240527,0.98495144,0.0031924914,0.0014165153,0.00011196634],"about_ca_topic_score_codex":0.000076946395,"about_ca_topic_score_gemma":0.00003242911,"teacher_disagreement_score":0.006906546,"about_ca_system_score_codex":0.00008000711,"about_ca_system_score_gemma":0.00006079828,"threshold_uncertainty_score":0.44190708},"labels":[],"label_agreement":null},{"id":"W2071337957","doi":"10.1002/1098-2280(2000)35:4<328::aid-em7>3.0.co;2-c","title":"Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2","year":2000,"lang":"en","type":"article","venue":"Environmental and Molecular Mutagenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Mutagen; Mutagenesis; Escherichia coli; Carcinogen; Enzyme; Recombinant DNA; Quinoline; Biochemistry; Mutant; Mutation; Biology; Cytochrome P450; Enterobacteriaceae; Molecular biology; Chemistry; Genetics; Gene; Organic chemistry","score_opus":0.045951388634159616,"score_gpt":0.35495890128133684,"score_spread":0.30900751264717724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071337957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956716,0.0027436619,0.00009168838,0.000087907254,0.00011129973,0.00033434565,0.00019841871,0.00001667239,0.0007444396],"genre_scores_gemma":[0.9950586,0.0033434366,0.00024621686,0.00046685766,0.000031949574,0.00002918313,0.0001312099,0.00003278262,0.00065975887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831325,0.0002931899,0.00046735845,0.00038386753,0.00022284473,0.00031947796],"domain_scores_gemma":[0.99932593,0.000050554987,0.00019735702,0.00022785473,0.000010447243,0.00018783474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029309146,0.00026320157,0.00036915738,0.00008406739,0.00013872334,0.0000063690895,0.00021760492,0.00021610621,0.002686739],"category_scores_gemma":[0.000006403532,0.00026772165,0.000116538904,0.00010021406,0.00034189146,0.00008464176,0.00008989762,0.0002041504,0.000030965468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010470029,0.0005053089,0.00056854956,0.00003970859,0.0001965558,0.00001822971,0.00023928254,0.00016787252,0.95424014,0.000060075567,0.00013472135,0.043724854],"study_design_scores_gemma":[0.0014338864,0.00015073777,0.018917304,0.000012408673,0.00026178497,0.000015162666,0.000039804374,0.0002577256,0.96418583,0.00021398412,0.0142449755,0.00026638855],"about_ca_topic_score_codex":0.0000425185,"about_ca_topic_score_gemma":3.9448904e-7,"teacher_disagreement_score":0.043458465,"about_ca_system_score_codex":0.00003464231,"about_ca_system_score_gemma":0.000017769873,"threshold_uncertainty_score":0.99997747},"labels":[],"label_agreement":null},{"id":"W2071417087","doi":"10.1016/j.bcp.2004.06.005","title":"GABAA/central benzodiazepine receptor and peripheral benzodiazepine receptor ligands as inducers of phenobarbital-inducible CYP2B and CYP3A","year":2004,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"GABAA receptor; Flunitrazepam; Bicuculline; Pregnane X receptor; Chemistry; Receptor; Benzodiazepine; Agonist; Phenobarbital; Pharmacology; Molecular biology; Biology; Biochemistry; Nuclear receptor; Transcription factor; Gene","score_opus":0.04669701488331166,"score_gpt":0.38053462030408547,"score_spread":0.3338376054207738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071417087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97635007,0.014503556,0.00003401979,0.0035463255,0.0030217115,0.00081116153,0.00038640128,0.00012534267,0.0012214028],"genre_scores_gemma":[0.9833731,0.008049603,0.0015070328,0.0050020143,0.0014596375,0.00010786723,0.00016217573,0.00008713112,0.000251407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961121,0.00027018363,0.00093409885,0.0010552662,0.00031894844,0.00130941],"domain_scores_gemma":[0.99762917,0.00024571453,0.00035942593,0.00027487037,0.00020969677,0.0012811556],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006386721,0.00069089554,0.00095114246,0.00024928316,0.00028270995,0.000033411477,0.00047984903,0.0009037993,0.003914956],"category_scores_gemma":[0.00016327077,0.000703296,0.00019968691,0.00043205684,0.001189478,0.00020015001,0.0004403139,0.0013610901,0.00008570714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013331651,0.00079142407,0.0007878014,0.0001453049,0.0004717299,0.000028271288,0.0009709799,0.0001024801,0.9630282,0.00052543567,0.028443195,0.0033720443],"study_design_scores_gemma":[0.008592858,0.00053268304,0.00064754207,0.000029917403,0.00046126806,0.000079911515,0.00014283747,0.000092548464,0.89846146,0.0008441746,0.08944143,0.0006733913],"about_ca_topic_score_codex":0.000057969733,"about_ca_topic_score_gemma":0.0000013800253,"teacher_disagreement_score":0.06456673,"about_ca_system_score_codex":0.00017942135,"about_ca_system_score_gemma":0.00035588897,"threshold_uncertainty_score":0.9995418},"labels":[],"label_agreement":null},{"id":"W2071498240","doi":"10.1210/endo.142.2.7958","title":"Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members**This work was supported by the Medical Research Council of Canada, the Fonds de la Recherche en Sante du Quebec, and Endorecherche.","year":2001,"lang":"en","type":"article","venue":"Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":330,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medical Council of Canada; Université Laval","funders":"","keywords":"Glucuronidation; Steroid; UGT2B7; Chemistry; Hydroxysteroid; Farnesoid X receptor; Enzyme; Biochemistry; Biology; Hormone; Nuclear receptor; Transcription factor; Microsome; Gene","score_opus":0.36567457736892456,"score_gpt":0.48189703564911074,"score_spread":0.11622245828018618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071498240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97965187,0.00684526,0.0001021755,0.0069884723,0.00014601318,0.000801585,0.00012233194,0.000019185845,0.005323133],"genre_scores_gemma":[0.9953591,0.0029634468,0.000053091393,0.00024156485,0.0000956876,0.0001350509,0.00001568973,0.000022993785,0.0011133498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9798205,0.017626481,0.0005443758,0.0003919456,0.00081945903,0.0007972272],"domain_scores_gemma":[0.98658705,0.012154973,0.00023146418,0.00031766735,0.00046639825,0.00024247615],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01719151,0.0002531671,0.0005009124,0.0000591562,0.00042280287,0.000019326013,0.0005244572,0.00059814233,0.00070930325],"category_scores_gemma":[0.005990925,0.00017918722,0.000051759765,0.00044157953,0.0020943151,0.000079559606,0.00044260445,0.003195833,0.0000013297981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009771497,0.00064656866,0.02215845,0.00020276628,0.00071529,0.00017768174,0.015715823,0.000008529262,0.8768616,0.01176338,0.0152415885,0.055531178],"study_design_scores_gemma":[0.0032983152,0.00021000707,0.026769137,0.00005201349,0.00032967053,0.00028897755,0.0018432504,0.00058569916,0.7092216,0.0068717604,0.2501988,0.00033073957],"about_ca_topic_score_codex":0.11154363,"about_ca_topic_score_gemma":0.08396043,"teacher_disagreement_score":0.23495722,"about_ca_system_score_codex":0.0008221471,"about_ca_system_score_gemma":0.0028871289,"threshold_uncertainty_score":0.99910384},"labels":[],"label_agreement":null},{"id":"W2071524497","doi":"10.2174/1389200043335559","title":"Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection","year":2004,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Inflammation; Cytochrome P450; Drug; Drug metabolism; Cytochrome; Biology; Biotransformation; Pharmacology; Immunology; Enzyme; Biochemistry","score_opus":0.0914768666611086,"score_gpt":0.42805996022643555,"score_spread":0.33658309356532695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071524497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03751802,0.9567743,0.00009164591,0.00008821299,0.0030181145,0.00190446,0.00018967409,0.00018556495,0.00022999606],"genre_scores_gemma":[0.005728522,0.99155223,0.00006913964,0.00001991081,0.0016134226,0.0002817605,0.00048692885,0.00009128669,0.00015680332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606675,0.0009528844,0.0012629224,0.0007633401,0.0003480126,0.0006061189],"domain_scores_gemma":[0.998182,0.00016521015,0.0007797976,0.0003041577,0.00013897798,0.00042985476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011674403,0.0008632212,0.001539728,0.0008185593,0.00058301917,0.00014073784,0.00021304288,0.00055536244,0.00014821495],"category_scores_gemma":[0.00005680677,0.0008065502,0.0003317822,0.0005089093,0.00026837355,0.00063356984,0.00017602317,0.0015470947,0.00010226739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025817664,0.000080563055,0.000010214267,0.017160669,0.00021094174,0.0000027892652,0.0010215469,0.00006687677,0.0009734914,0.0014171796,0.0000947203,0.9789352],"study_design_scores_gemma":[0.0017934643,0.0000056020604,0.0011191546,0.0021747714,0.0032274988,0.000080395934,0.000009430714,0.00017273605,0.001441772,0.00095312134,0.98822534,0.00079668313],"about_ca_topic_score_codex":0.000024114765,"about_ca_topic_score_gemma":0.000008074509,"teacher_disagreement_score":0.9881306,"about_ca_system_score_codex":0.00015088911,"about_ca_system_score_gemma":0.00022319105,"threshold_uncertainty_score":0.9994385},"labels":[],"label_agreement":null},{"id":"W2071537307","doi":"10.1016/j.abb.2003.11.019","title":"Functional characterization of four allelic variants of human cytochrome P450 1A2","year":2003,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Allele; Genetics; Biology; Gene","score_opus":0.06298303521208766,"score_gpt":0.34596978596900635,"score_spread":0.2829867507569187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071537307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957442,0.00020081189,0.00024096407,0.000032430606,0.00009385917,0.00009946471,0.00023282098,0.0000069754897,0.003348462],"genre_scores_gemma":[0.9987905,0.00046563268,0.00020513154,0.00006404316,0.00010182244,0.000005521454,0.00010402942,0.000009609971,0.0002537191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912417,0.000093566174,0.0003345652,0.00018859222,0.00010367374,0.0001554302],"domain_scores_gemma":[0.99934125,0.00009067289,0.00028258923,0.00013891076,0.000054975484,0.00009161157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012466779,0.00014152809,0.0002589043,0.000044259712,0.00007068857,0.0000027254155,0.00011631497,0.00010424286,0.0001237672],"category_scores_gemma":[0.000019814586,0.00013987762,0.00009247878,0.000106893,0.00036711566,0.000033490556,0.000050773302,0.00015979941,0.0000011459986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106705316,0.00033634034,0.0008374912,0.00023340374,0.00014533213,0.0000014265519,0.00017370039,0.000012535835,0.9920709,0.0024444207,0.00001343551,0.0036242998],"study_design_scores_gemma":[0.00093638216,0.00006316015,0.029817501,0.000021175749,0.00010491739,0.0000061463725,0.000023841487,0.00015149622,0.96590143,0.0023332827,0.0005187286,0.000121903206],"about_ca_topic_score_codex":0.0000023888429,"about_ca_topic_score_gemma":8.003655e-8,"teacher_disagreement_score":0.028980011,"about_ca_system_score_codex":0.0000024758444,"about_ca_system_score_gemma":0.000054459168,"threshold_uncertainty_score":0.5704044},"labels":[],"label_agreement":null},{"id":"W2071759664","doi":"10.1124/dmd.31.9.1134","title":"BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"U.S. Public Health Service","keywords":"Biotransformation; Microsome; Human lung; Microsoma; Chemistry; Carcinogen; In vitro; Peripheral; Lung; Pharmacology; Toxicology; Biochemistry; Biology; Medicine; Enzyme; Internal medicine","score_opus":0.03190195871812364,"score_gpt":0.37676368776488006,"score_spread":0.34486172904675644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071759664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797551,0.01325483,0.00038050066,0.00016127317,0.00066672947,0.00047999466,0.00021544668,0.000037090704,0.0050490387],"genre_scores_gemma":[0.9963252,0.0022290156,0.00043149551,0.0005004221,0.00011219144,0.000051414652,0.00014373205,0.00002721416,0.00017932105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976403,0.00066796737,0.0006677159,0.00035625062,0.00020401608,0.0004637089],"domain_scores_gemma":[0.9992265,0.00009377658,0.0001962258,0.000178242,0.000092828166,0.00021244612],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009924677,0.00030761372,0.0004981211,0.00032795663,0.0002441952,0.000035588047,0.00015433501,0.00022806987,0.00041080225],"category_scores_gemma":[0.000028348344,0.000305217,0.00012827398,0.00039064328,0.00022451521,0.00034744904,0.000033796256,0.0004383598,0.000008642418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019017866,0.00047744458,0.010041518,0.00015894767,0.00008264131,0.000010169388,0.002858927,0.0002222905,0.9488207,0.029824384,0.00020572242,0.0071070436],"study_design_scores_gemma":[0.0060019535,0.000034186476,0.06384747,0.00003521508,0.00042534102,0.000031139254,0.00050248415,0.0012708305,0.88077307,0.003619763,0.04288916,0.0005694114],"about_ca_topic_score_codex":0.00006751822,"about_ca_topic_score_gemma":0.000024372064,"teacher_disagreement_score":0.06804769,"about_ca_system_score_codex":0.00003303298,"about_ca_system_score_gemma":0.000050890816,"threshold_uncertainty_score":0.99994},"labels":[],"label_agreement":null},{"id":"W2072017244","doi":"10.1002/cbic.200900318","title":"Mechanistic Insights into the Cytochrome P450‐Mediated Oxidation and Rearrangement of Littorine in Tropane Alkaloid Biosynthesis","year":2009,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Plant Biotechnology Institute","funders":"","keywords":"Chemistry; Tropane; Hydroxylation; Carbocation; Stereochemistry; Iminium; Hyoscyamine; Reaction intermediate; Medicinal chemistry; Organic chemistry; Enzyme; Catalysis; Biochemistry","score_opus":0.048090260856575924,"score_gpt":0.37113188624620275,"score_spread":0.32304162538962683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072017244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919365,0.004641944,0.000034773373,0.001544466,0.00016824644,0.00036144207,0.000008364823,0.000029373867,0.0012748571],"genre_scores_gemma":[0.9946367,0.003840744,0.00014977554,0.0010263504,0.0001569241,0.000029492954,0.00003128083,0.000013482185,0.00011525613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987254,0.00017065296,0.00038303775,0.0002894222,0.00016222554,0.00026922647],"domain_scores_gemma":[0.99921036,0.00021567068,0.00014605091,0.00021650165,0.00007611028,0.00013531644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004844205,0.00020272192,0.00028865293,0.00013178862,0.00009670621,0.000011821144,0.00023157775,0.00018146026,0.00015143541],"category_scores_gemma":[0.00014201626,0.00015906373,0.000052021944,0.00033931358,0.00013382187,0.000048719507,0.00006492179,0.00029662525,0.000024616063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013898316,0.00023823457,0.00008624204,0.0000359498,0.000047727397,0.000008778214,0.0016300997,0.000008695458,0.97972924,0.0007396733,0.00017219644,0.017164184],"study_design_scores_gemma":[0.0012828468,0.00008322988,0.007349948,0.000016620508,0.00010805976,0.0000036243941,0.000119288656,0.0007633955,0.9680704,0.0019065217,0.02012763,0.00016844565],"about_ca_topic_score_codex":0.000027524622,"about_ca_topic_score_gemma":0.000010315498,"teacher_disagreement_score":0.019955432,"about_ca_system_score_codex":0.000044663564,"about_ca_system_score_gemma":0.000039640097,"threshold_uncertainty_score":0.6486431},"labels":[],"label_agreement":null},{"id":"W2072346051","doi":"10.1016/s1359-6446(05)03394-5","title":"Peroxidases: a role in the metabolism and side effects of drugs","year":2005,"lang":"en","type":"review","venue":"Drug Discovery Today","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Peroxidase; Metabolite; Cytochrome P450; Drug metabolism; Chemistry; Biochemistry; Drug; Metabolism; Enzyme; Oxidative stress; Cytotoxicity; Pharmacology; Biology; In vitro","score_opus":0.04769646468540292,"score_gpt":0.4093106950513331,"score_spread":0.3616142303659302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072346051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047404915,0.98492974,0.000002691688,0.00014592303,0.0011241367,0.0016684852,0.0003352925,0.000025568479,0.0070276894],"genre_scores_gemma":[0.0083161695,0.987871,0.000032347692,0.0012312474,0.0007781157,0.00043005927,0.00008421402,0.000081245795,0.0011756344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946063,0.0025855121,0.0010536069,0.00067830796,0.00037387214,0.0007024136],"domain_scores_gemma":[0.99610436,0.0025490534,0.000556504,0.0005533095,0.000041433446,0.00019534024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016114484,0.0007852419,0.0021876476,0.00038092784,0.00015186919,0.00008131127,0.00097088586,0.00052443164,0.000064189175],"category_scores_gemma":[0.00012954803,0.0005265007,0.0006318812,0.00054766,0.0003486296,0.0002695852,0.00031772224,0.0016733063,0.000060061277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003792311,0.00050336006,0.000007984359,0.005265555,0.00036789067,0.00005047569,0.0033995262,0.000019946208,0.00012340017,0.0015992515,0.0010488115,0.9875759],"study_design_scores_gemma":[0.0012477214,0.000017450906,0.00005089569,0.0010746556,0.0028392186,0.000032558884,0.000225991,0.000032599633,0.00049506885,0.00032382383,0.99313277,0.00052723166],"about_ca_topic_score_codex":0.00006006783,"about_ca_topic_score_gemma":0.000020411033,"teacher_disagreement_score":0.99208397,"about_ca_system_score_codex":0.00004817084,"about_ca_system_score_gemma":0.0002941607,"threshold_uncertainty_score":0.99971867},"labels":[],"label_agreement":null},{"id":"W2072370222","doi":"10.1016/s0006-2952(00)00247-1","title":"Growth hormone regulation and developmental expression of rat hepatic CYP3A18, CYP3A9, and CYP3A2","year":2000,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Endocrinology; Hypophysectomy; Messenger RNA; Testosterone (patch); Hormone; Biology; Medicine; Gene","score_opus":0.040511619622718605,"score_gpt":0.3602781545237984,"score_spread":0.3197665349010798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072370222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98613226,0.010238919,0.00002472736,0.0005925203,0.0004972285,0.00045945993,0.000034614397,0.00006395754,0.0019563092],"genre_scores_gemma":[0.9893024,0.0066491743,0.0011598322,0.0019062029,0.00030379678,0.000060941897,0.00004534792,0.000033624106,0.0005387114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978338,0.00036039719,0.00058336335,0.00053526636,0.00018954155,0.00049764826],"domain_scores_gemma":[0.99887276,0.00033507953,0.00015341378,0.00010329055,0.00009844498,0.00043703726],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004345302,0.00034103493,0.00046628702,0.00013690269,0.00019358737,0.000015109552,0.00021764115,0.00042408405,0.003237713],"category_scores_gemma":[0.000045715682,0.00032843256,0.00006983644,0.00021849951,0.000622702,0.000120279125,0.0001676441,0.0004907941,0.000053814616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085203047,0.00026109273,0.0009173156,0.00006654796,0.00008179085,0.000011915367,0.00034230115,0.000009838608,0.9296383,0.00009571248,0.060476653,0.0072464803],"study_design_scores_gemma":[0.003811276,0.00009711082,0.0030523802,0.000011592163,0.00025422339,0.000076929064,0.000032939748,0.0010529754,0.9256929,0.0006895801,0.06488212,0.0003459578],"about_ca_topic_score_codex":0.000012021995,"about_ca_topic_score_gemma":1.8806867e-7,"teacher_disagreement_score":0.0069005224,"about_ca_system_score_codex":0.00004228242,"about_ca_system_score_gemma":0.000067515684,"threshold_uncertainty_score":0.9999168},"labels":[],"label_agreement":null},{"id":"W2073056252","doi":"10.1067/mcp.2001.116892","title":"Red wine–cisapride interaction: Comparison with grapefruit juice","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cisapride; Grapefruit juice; Pharmacokinetics; Crossover study; Citrus paradisi; Pharmacology; Area under the curve; Chemistry; Wine; Drug interaction; Oral administration; Medicine; Food science; Placebo; Rutaceae; Botany; Biology","score_opus":0.36433467423857135,"score_gpt":0.5632199207657329,"score_spread":0.19888524652716155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073056252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9358424,0.0032499358,0.0011993514,0.02820753,0.014658841,0.0012369767,0.000052169362,0.00053532264,0.01501749],"genre_scores_gemma":[0.8530948,0.005915531,0.00087850343,0.13356027,0.004420291,0.00014114149,0.000055833323,0.00013228835,0.0018013233],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933886,0.0020666842,0.0017363825,0.0010912794,0.00042101703,0.0012960556],"domain_scores_gemma":[0.9953461,0.002041481,0.00071843853,0.0005707203,0.00043861548,0.0008846109],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018191017,0.0007587583,0.0012337533,0.00025341802,0.0005841295,0.000060242783,0.0010822583,0.00089104223,0.0047059613],"category_scores_gemma":[0.00003217694,0.00066188816,0.00043764283,0.0007902883,0.001192715,0.00025254028,0.0002626321,0.003552481,0.0008484696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025153419,0.012514984,0.24927062,0.000110414956,0.011846578,0.0018210956,0.0016735763,0.0075209667,0.12400142,0.0002764575,0.3362661,0.22954439],"study_design_scores_gemma":[0.008901616,0.00074932055,0.011868361,0.000014890998,0.0032384968,0.0003003914,0.00017360544,0.008265743,0.01613916,0.00025250023,0.94929576,0.0008001488],"about_ca_topic_score_codex":0.0000081044245,"about_ca_topic_score_gemma":0.000012829649,"teacher_disagreement_score":0.61302966,"about_ca_system_score_codex":0.00010346758,"about_ca_system_score_gemma":0.00025294174,"threshold_uncertainty_score":0.9999295},"labels":[],"label_agreement":null},{"id":"W2073220539","doi":"10.14797/mdcj-10-1-13","title":"Cardiovascular Drugs and the Genetic Response","year":2014,"lang":"en","type":"review","venue":"Methodist DeBakey Cardiovascular Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Webcast; MEDLINE; Medical education; Subject (documents); Subject matter; Library science; World Wide Web","score_opus":0.1187944786931287,"score_gpt":0.4428088466873386,"score_spread":0.3240143679942099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073220539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006094127,0.97772694,0.013323824,0.00014943865,0.0051544816,0.001738242,0.000088518645,0.000080700665,0.0016769238],"genre_scores_gemma":[0.000078847756,0.9907607,0.0034475145,0.0006851947,0.0039826715,0.00032100442,0.00001931803,0.0002616729,0.00044307066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.93598956,0.058192875,0.0019653463,0.0011666082,0.0013923934,0.0012932443],"domain_scores_gemma":[0.9907997,0.0048380755,0.00081841066,0.0020846224,0.00036687034,0.001092272],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.058965903,0.0014516894,0.007608762,0.0005586739,0.0015980074,0.00040353238,0.0017248999,0.0013465801,0.00024267856],"category_scores_gemma":[0.0018472583,0.0009275838,0.015386793,0.00070958294,0.0013301746,0.00010322036,0.0006094515,0.0057057184,0.00021230777],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004962045,0.000041098345,0.0000015525235,0.0020642097,0.032086506,0.0004423463,0.0003664553,0.0006055885,0.000002071925,0.000112872556,0.0013161425,0.9624649],"study_design_scores_gemma":[0.0056670406,0.000033884837,0.000010533653,0.00056122884,0.057972606,0.008903684,0.000041692907,0.00018808899,0.000013055602,0.00039663364,0.92521346,0.0009980985],"about_ca_topic_score_codex":0.000021157379,"about_ca_topic_score_gemma":4.853803e-7,"teacher_disagreement_score":0.96146685,"about_ca_system_score_codex":0.00022184027,"about_ca_system_score_gemma":0.0007383717,"threshold_uncertainty_score":0.9999499},"labels":[],"label_agreement":null},{"id":"W2073499207","doi":"10.1271/bbb.50656","title":"Production of α,ω-Alkanediols Using<i>Escherichia coli</i>Expressing a Cytochrome P450 from<i>Acinetobacter</i>sp. OC4","year":2006,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Ministry of Economy, Trade and Industry; University of Melbourne","keywords":"Biotransformation; Incubation; Bioproduction; Inducer; Escherichia coli; Cytochrome P450; Octane; Chemistry; Cytochrome; Incubation period; Biochemistry; Chromatography; Enzyme; Organic chemistry; Gene","score_opus":0.044698512060910155,"score_gpt":0.3464899682505736,"score_spread":0.30179145618966347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073499207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937179,0.0036876393,0.00014093333,0.0009213108,0.00071545655,0.00024554328,0.00015979705,0.00013071625,0.00028070004],"genre_scores_gemma":[0.9956068,0.0005718702,0.002803084,0.00033039314,0.00042745643,0.000014858469,0.000032762273,0.000016686847,0.00019610541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979711,0.00008779925,0.00050904794,0.0007294535,0.00018557112,0.00051700545],"domain_scores_gemma":[0.99899286,0.00006035701,0.00035118576,0.0003569446,0.000097391814,0.00014126893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043467755,0.0003103366,0.0003782635,0.0001339249,0.000315738,0.000023751834,0.00044842277,0.00093769206,0.00007199583],"category_scores_gemma":[0.000110478875,0.00029100303,0.00007887475,0.0005643101,0.0017738587,0.00010528453,0.00021874782,0.00057435315,0.00000621037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088423236,0.0002184152,0.0031672902,0.000050600585,0.000032047705,0.000010042799,0.000032548225,0.000028460256,0.9935691,0.000098638026,0.00032664998,0.002377781],"study_design_scores_gemma":[0.0006234782,0.00004279598,0.004720341,0.000031859814,0.000119841716,0.00004039312,0.00006542639,0.0006305345,0.9814827,0.0004374709,0.011487835,0.00031735073],"about_ca_topic_score_codex":0.00010925602,"about_ca_topic_score_gemma":0.0000027912654,"teacher_disagreement_score":0.012086431,"about_ca_system_score_codex":0.000042027055,"about_ca_system_score_gemma":0.00014826976,"threshold_uncertainty_score":0.9999542},"labels":[],"label_agreement":null},{"id":"W2073582856","doi":"10.1038/sj.clpt.6100246","title":"Identification of Novel CYP2A6*1B Variants: The CYP2A6*1B Allele is Associated With Faster In Vivo Nicotine Metabolism","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; NIH Clinical Center; National Institutes of Health; National Center for Research Resources; National Institute on Drug Abuse; Canada Research Chairs","keywords":"CYP2A6; Nicotine; Cotinine; In vivo; Genotype; Pharmacology; Metabolism; Chemistry; Biology; Medicine; Endocrinology; Internal medicine; Genetics; Cytochrome P450; Biochemistry; CYP1A2; Gene","score_opus":0.17446933955008317,"score_gpt":0.4823130279593351,"score_spread":0.3078436884092519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073582856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97911453,0.002989065,0.0021522162,0.007255483,0.00528568,0.0014737613,0.00036960677,0.00011328868,0.0012463891],"genre_scores_gemma":[0.9155599,0.0028822285,0.00022951969,0.079077214,0.00096630445,0.00007851549,0.000035389803,0.000107549924,0.0010633732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9926415,0.001705873,0.0028201449,0.0009554085,0.0005615783,0.0013155106],"domain_scores_gemma":[0.99339867,0.0034457713,0.0014556848,0.0006427702,0.00062773784,0.00042935178],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008779608,0.0006723023,0.001225002,0.0003288573,0.0003444805,0.000036587408,0.0013827268,0.0009455581,0.0014815555],"category_scores_gemma":[0.00013351112,0.0005111289,0.00041477158,0.001130459,0.0015414866,0.00020072065,0.00029272187,0.002674763,0.000073896634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044206395,0.014398365,0.023089595,0.000054465658,0.0057974537,0.000082353756,0.0030894254,0.0010731859,0.92389685,0.00048155975,0.01233258,0.011283498],"study_design_scores_gemma":[0.037406825,0.00054415216,0.07168546,0.000038364644,0.0067387875,0.00005356417,0.00050619274,0.020076474,0.48076007,0.00049789745,0.38042563,0.0012665526],"about_ca_topic_score_codex":0.000018026887,"about_ca_topic_score_gemma":0.00006323908,"teacher_disagreement_score":0.4431368,"about_ca_system_score_codex":0.00009890784,"about_ca_system_score_gemma":0.00030399975,"threshold_uncertainty_score":0.99973404},"labels":[],"label_agreement":null},{"id":"W2074172198","doi":"10.1007/s40142-012-0001-3","title":"Pharmacogenetic Advances in Cardiovascular Medicine: Relevance to Personalized Medicine","year":2013,"lang":"en","type":"article","venue":"Current Genetic Medicine Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Medicine; Precision medicine; Relevance (law); Internal medicine; Bioinformatics; Biology; Pathology","score_opus":0.09413028705879177,"score_gpt":0.44987497641419427,"score_spread":0.3557446893554025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074172198","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2933475,0.6698053,0.0017529059,0.00887194,0.015271069,0.002737451,0.000008460736,0.00015148375,0.008053896],"genre_scores_gemma":[0.805314,0.17554258,0.00087742705,0.0074629006,0.0077774217,0.0014861047,0.00008186645,0.000172344,0.00128536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992556,0.0009160295,0.0022069225,0.0015161799,0.0014059107,0.0013989604],"domain_scores_gemma":[0.99568677,0.0005674684,0.0005462694,0.0010438531,0.00059063605,0.0015649941],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028460056,0.00085566996,0.0017954138,0.0007655305,0.0002472862,0.000012906572,0.0006344734,0.00026841855,0.0106375255],"category_scores_gemma":[0.0012153505,0.00066104013,0.00025837222,0.0013541819,0.001316754,0.00018866961,0.00020535944,0.0011653744,0.0002917121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012123068,0.0002625058,0.02160647,0.00043707417,0.00034308108,0.00074236584,0.0031383983,0.0025458792,0.07569706,0.00013428858,0.08110194,0.8138697],"study_design_scores_gemma":[0.004706553,0.000290495,0.011629933,0.00050924084,0.00081576733,0.00049592904,0.0002885279,0.00073366653,0.0030465391,0.0021173102,0.9746824,0.00068365445],"about_ca_topic_score_codex":0.00018989303,"about_ca_topic_score_gemma":0.000011680088,"teacher_disagreement_score":0.89358044,"about_ca_system_score_codex":0.00015722578,"about_ca_system_score_gemma":0.00018363619,"threshold_uncertainty_score":0.9995841},"labels":[],"label_agreement":null},{"id":"W2074185276","doi":"10.1016/j.jaut.2007.02.008","title":"Pharmacogenomics and its implications for autoimmune disease","year":2007,"lang":"en","type":"article","venue":"Journal of Autoimmunity","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Dosing; Disease; Drug; Drug reaction; Pharmacogenetics; Intensive care medicine; Bioinformatics; Pharmacology; Internal medicine; Genetics; Biology; Genotype","score_opus":0.1606746833126483,"score_gpt":0.47461913176092524,"score_spread":0.31394444844827696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074185276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972111,0.020937037,0.0017183884,0.0023554133,0.0016340322,0.0004078863,0.00017338089,0.00002877507,0.0006341086],"genre_scores_gemma":[0.99311227,0.0037847073,0.00081087806,0.0015212217,0.00044529105,0.000010238082,0.000011336142,0.00002985464,0.00027418282],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832046,0.00019406644,0.00079619506,0.00014295746,0.00011665774,0.00042966488],"domain_scores_gemma":[0.99754363,0.0006756705,0.00056233595,0.00017133584,0.00050818926,0.0005388511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032804213,0.0002062254,0.0003539062,0.00022806226,0.0004516322,0.000026571412,0.00042612886,0.00014500797,0.00014010952],"category_scores_gemma":[0.00027114194,0.00019385057,0.00020917245,0.00018644832,0.00012863372,0.00018043192,0.00011339065,0.0007979486,0.000008130681],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002058715,0.00088410435,0.0064827716,0.00010919416,0.00053912407,0.000030859446,0.00078308117,0.00058594637,0.84599566,0.0073247096,0.0019723636,0.1332335],"study_design_scores_gemma":[0.005094744,0.00015500294,0.30851173,0.00001900972,0.00094162876,0.00016774787,0.00009124014,0.002565237,0.05376531,0.005310181,0.6230101,0.00036804943],"about_ca_topic_score_codex":0.000002059784,"about_ca_topic_score_gemma":8.115301e-7,"teacher_disagreement_score":0.7922303,"about_ca_system_score_codex":0.00006425039,"about_ca_system_score_gemma":0.00023462865,"threshold_uncertainty_score":0.7904997},"labels":[],"label_agreement":null},{"id":"W2074828925","doi":"10.1080/00498250050077986","title":"Metabolic activity of fresh and cryopreserved cynomolgus monkey (<i>Macaca fascicularis</i>) hepatocytes","year":2000,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Lethbridge","keywords":"Hepatocyte; Chemistry; Cryopreservation; Incubation; Glutathione; Microsome; Biochemistry; Enzyme; In vitro; Biology","score_opus":0.06825649116434354,"score_gpt":0.3810317269194958,"score_spread":0.3127752357551522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074828925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728386,0.0080429735,0.000028693757,0.00056479865,0.00041733144,0.00048228554,0.00021965583,0.00008775973,0.017317934],"genre_scores_gemma":[0.9908838,0.006045675,0.0004184816,0.0009362855,0.0002804881,0.000026439748,0.000013456125,0.00004262389,0.0013526935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975239,0.0005791079,0.00045283805,0.00053277623,0.0002675779,0.0006437671],"domain_scores_gemma":[0.99857104,0.0003060707,0.00014623896,0.0004156928,0.00010565206,0.00045532858],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006359102,0.0003683421,0.0006389368,0.00012684033,0.00025230777,0.00003240649,0.00043299727,0.00041903649,0.008533742],"category_scores_gemma":[0.00006361848,0.00034849366,0.00018354744,0.0002910831,0.00046933367,0.0001563389,0.00017115875,0.0007816663,0.00015042844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073233235,0.0011211033,0.014707804,0.00012218743,0.000688108,0.000059043115,0.00072873314,0.0004817836,0.8532621,0.0019473193,0.0020952404,0.124054246],"study_design_scores_gemma":[0.0021412452,0.000073123076,0.022466797,0.000010690956,0.0004869549,0.00002669826,0.000020668625,0.0045408863,0.71456856,0.0007708607,0.2545116,0.00038191548],"about_ca_topic_score_codex":0.00017820208,"about_ca_topic_score_gemma":0.00001751931,"teacher_disagreement_score":0.25241634,"about_ca_system_score_codex":0.000016171642,"about_ca_system_score_gemma":0.00008443937,"threshold_uncertainty_score":0.9998967},"labels":[],"label_agreement":null},{"id":"W2075029351","doi":"10.1371/journal.pone.0086435","title":"CYB5D2 Requires Heme-Binding to Regulate HeLa Cell Growth and Confer Survival from Chemotherapeutic Agents","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"University of Illinois at Urbana-Champaign; McMaster University","keywords":"Heme; Biology; HeLa; Biochemistry; Cytochrome P450 reductase; Cytochrome b5; Gene knockdown; Cytochrome; Cell biology; Cytochrome P450; Cytochrome c; Cell; Coenzyme Q – cytochrome c reductase; Apoptosis; Metabolism; Enzyme","score_opus":0.18251045212163602,"score_gpt":0.37310082931436056,"score_spread":0.19059037719272454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075029351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824507,0.00066295767,0.000101977836,0.0017491261,0.0006039656,0.00044194146,0.00011442789,0.000097242584,0.0079833185],"genre_scores_gemma":[0.98969096,0.0009191993,0.00087095465,0.005640136,0.00065920426,0.000039550272,0.000039172242,0.0000630751,0.0020777576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977886,0.00043497165,0.00036496785,0.00052549504,0.00031136666,0.0005745826],"domain_scores_gemma":[0.9986689,0.0003380014,0.0001258154,0.00026365087,0.00009055819,0.0005130709],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005648213,0.0003142101,0.0004856716,0.00012341689,0.00023391662,0.00005291862,0.00032087535,0.00025495412,0.0011588527],"category_scores_gemma":[0.00006798199,0.00029195452,0.00006822383,0.00016462027,0.00012287681,0.00008684901,0.00019347764,0.00045299222,0.00034129532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023703513,0.0009034744,0.008966308,0.00009050607,0.0004993048,0.000006637488,0.0008137381,0.000016357124,0.98466265,0.00030138492,0.0004770062,0.0030256198],"study_design_scores_gemma":[0.0027453532,0.00008921605,0.0053074546,0.00003919658,0.00065948383,0.0000010620191,0.00003512571,0.002581586,0.9633609,0.0012311576,0.023511495,0.00043798066],"about_ca_topic_score_codex":0.00004456457,"about_ca_topic_score_gemma":0.0000067316546,"teacher_disagreement_score":0.023034489,"about_ca_system_score_codex":0.00002377256,"about_ca_system_score_gemma":0.0000304768,"threshold_uncertainty_score":0.99995327},"labels":[],"label_agreement":null},{"id":"W2075089790","doi":"10.1097/fpc.0b013e3283330767","title":"Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institute of Environmental Health Sciences; National Institute on Deafness and Other Communication Disorders; National Institutes of Health","keywords":"Glucuronidation; Complementary DNA; Molecular biology; Recombinant DNA; Biology; genomic DNA; Exon; Glucuronosyltransferase; UGT2B7; Chemistry; Biochemistry; Gene; Enzyme; Microsome","score_opus":0.05646111701490544,"score_gpt":0.36415622683245163,"score_spread":0.3076951098175462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075089790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919281,0.004383583,0.0014832807,0.00071810454,0.00037091822,0.0005471769,0.00018873278,0.000045643035,0.00033444853],"genre_scores_gemma":[0.9889349,0.007407118,0.0012699771,0.0018034403,0.00032035456,0.000029846358,0.00013910337,0.000036961876,0.000058331745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979239,0.00022168565,0.0005754511,0.00062401086,0.00016983044,0.00048512983],"domain_scores_gemma":[0.9990348,0.00007198167,0.00017215553,0.00014999168,0.00010437854,0.00046665955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040410247,0.00041326127,0.00044473758,0.00023075515,0.00044575403,0.000088513545,0.00011595331,0.0002218465,0.00015815347],"category_scores_gemma":[0.000007413456,0.0004044701,0.000036753794,0.00019215368,0.00036269202,0.00014064828,0.000071302726,0.00057907664,0.0000038860658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041019087,0.0002520539,0.054116245,0.000042269286,0.0000733104,0.000013995336,0.000832009,0.0006354246,0.89482796,0.0008535615,0.00009432255,0.047848687],"study_design_scores_gemma":[0.013812652,0.0005242707,0.40151542,0.000053809184,0.00066853693,0.00030513256,0.00032708177,0.014657419,0.4433791,0.0019913712,0.12134519,0.0014200029],"about_ca_topic_score_codex":0.000005766203,"about_ca_topic_score_gemma":0.000008884029,"teacher_disagreement_score":0.45144883,"about_ca_system_score_codex":0.00003227685,"about_ca_system_score_gemma":0.000068332105,"threshold_uncertainty_score":0.99984074},"labels":[],"label_agreement":null},{"id":"W207511860","doi":"10.1097/00008571-200007000-00006","title":"Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates.","year":2000,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada); Université Laval","funders":"American College of Clinical Pharmacy; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Dextrorphan; Dextromethorphan; Metoprolol; CYP2D6; Luteal phase; Medicine; Menstrual cycle; Endocrinology; Internal medicine; Pharmacology; Hormone; Metabolism","score_opus":0.06461701107515362,"score_gpt":0.39633324937229364,"score_spread":0.33171623829714003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W207511860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778773,0.014452426,0.000021556276,0.000061025952,0.00033070974,0.0009864361,0.00061849813,0.000066802226,0.005585224],"genre_scores_gemma":[0.9765978,0.021673858,0.000095059346,0.0005049595,0.00022326919,0.00010719291,0.00009397637,0.0000646702,0.00063920295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99538016,0.00200872,0.0007272761,0.0007142499,0.0004612951,0.0007082903],"domain_scores_gemma":[0.9977544,0.0009088754,0.0003741542,0.0003636614,0.00012169453,0.00047720387],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013006121,0.0006674934,0.0010873413,0.00014502925,0.00019396289,0.000022813047,0.00047587813,0.0004102707,0.0048425584],"category_scores_gemma":[0.00005038472,0.0005828608,0.00023887533,0.00035331832,0.0004640828,0.00010250902,0.0001426167,0.0007439195,0.00010407799],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032693674,0.0017609915,0.001247374,0.00019545078,0.00074403844,0.00002414868,0.0001527917,0.0014339346,0.910443,0.000042653563,0.0029171486,0.077769116],"study_design_scores_gemma":[0.004734532,0.0011365163,0.002803997,0.000012126623,0.0011815999,0.000031292722,0.0000069434545,0.008436915,0.94329894,0.0001470178,0.03770465,0.0005054855],"about_ca_topic_score_codex":0.000017253535,"about_ca_topic_score_gemma":1.6636287e-7,"teacher_disagreement_score":0.07726363,"about_ca_system_score_codex":0.000024878434,"about_ca_system_score_gemma":0.00011422913,"threshold_uncertainty_score":0.9996623},"labels":[],"label_agreement":null},{"id":"W2075397172","doi":"10.1139/y01-063","title":"Differential effects of phenobarbital on the constitutive and inducible expression of P450 2B and 3A subfamilies in sheep tissues","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Benzphetamine; Duodenum; Ileum; Endocrinology; Biology; Jejunum; Internal medicine; Cytochrome P450; Metabolism; Medicine","score_opus":0.04261097855497109,"score_gpt":0.351215316449093,"score_spread":0.3086043378941219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075397172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904929,0.007170937,0.0000056040303,0.00045240152,0.001120348,0.00026434156,0.000040265146,0.0000024295246,0.00045080174],"genre_scores_gemma":[0.9938833,0.005076203,0.000023192233,0.000754731,0.00021638797,0.000009299683,0.0000024746323,0.000010217714,0.000024163002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818766,0.0007257892,0.00044792297,0.0002114832,0.00006932675,0.00035784146],"domain_scores_gemma":[0.9981947,0.0009495635,0.00031083066,0.00007982392,0.00010507067,0.0003600254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034326522,0.0002127355,0.00055638753,0.00031153127,0.000164598,0.000005343617,0.00019300073,0.00026130665,0.0006674337],"category_scores_gemma":[0.00007877648,0.00015765245,0.000055411252,0.00013905886,0.0015507793,0.000075769036,0.000058329726,0.0007389742,0.0000010941292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064110797,0.00012212356,0.01435501,0.00013213442,0.00016886208,0.00010793821,0.001734226,0.00006623197,0.9778634,0.0015708652,0.0005371753,0.0027009528],"study_design_scores_gemma":[0.0033697016,0.0005093599,0.035684492,0.00006481508,0.00025078826,0.00011066609,0.00023971467,0.00013995613,0.9514081,0.00310582,0.004949036,0.00016753418],"about_ca_topic_score_codex":0.00017385319,"about_ca_topic_score_gemma":0.00019549283,"teacher_disagreement_score":0.026455257,"about_ca_system_score_codex":0.000018207418,"about_ca_system_score_gemma":0.00025364434,"threshold_uncertainty_score":0.7307931},"labels":[],"label_agreement":null},{"id":"W2075713006","doi":"10.1038/tpj.2009.11","title":"A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo","year":2009,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Allele; Nonsynonymous substitution; In vivo; Biology; Genetics; Biochemistry; Enzyme; Cytochrome P450; Gene; CYP3A4","score_opus":0.11426631655196424,"score_gpt":0.40404589571936705,"score_spread":0.2897795791674028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075713006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920839,0.0014904896,0.000492138,0.0021107406,0.001252205,0.00076032436,0.00023766594,0.00007355831,0.0014989785],"genre_scores_gemma":[0.9906635,0.002286884,0.00025498113,0.005570695,0.0008906304,0.000030661056,0.000022208616,0.00007431287,0.00020612754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949947,0.0012047982,0.0010721514,0.00070004916,0.0005388017,0.0014895124],"domain_scores_gemma":[0.99762404,0.00027303287,0.00079415913,0.00039766627,0.00025176388,0.00065934495],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0042160326,0.0006861863,0.00075796375,0.00050944317,0.0007874689,0.00018235053,0.0011244512,0.00042243625,0.00081881764],"category_scores_gemma":[0.00011485303,0.0005642136,0.00023076242,0.0009001123,0.00031621734,0.00067921204,0.00013521088,0.0036208038,0.000034878194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036581575,0.0024049096,0.004223201,0.000008714589,0.00027578417,0.00046986763,0.0025965937,0.014089882,0.95695007,0.000113914735,0.0006833158,0.014525567],"study_design_scores_gemma":[0.034436133,0.00085183035,0.031931035,0.00014278818,0.0010084045,0.0014036731,0.0003988195,0.13797627,0.7489461,0.00113236,0.03960173,0.0021708629],"about_ca_topic_score_codex":0.00005717223,"about_ca_topic_score_gemma":0.00023128539,"teacher_disagreement_score":0.208004,"about_ca_system_score_codex":0.00067200075,"about_ca_system_score_gemma":0.00043403383,"threshold_uncertainty_score":0.99968094},"labels":[],"label_agreement":null},{"id":"W2075816225","doi":"10.1016/j.neuropharm.2008.07.017","title":"Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment","year":2008,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Nicotine; Dentate gyrus; Internal medicine; Endocrinology; MPTP; Caudate nucleus; Substantia nigra; Immunocytochemistry; Pharmacology; Neurotoxin; Chemistry; Hippocampus; Medicine; Dopamine","score_opus":0.088787257796526,"score_gpt":0.39387687350573664,"score_spread":0.3050896157092106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075816225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98041004,0.0092149945,0.000007276172,0.0034196125,0.004600056,0.0008580075,0.0001122616,0.000067555775,0.0013102106],"genre_scores_gemma":[0.9847085,0.0073373127,0.000024110594,0.0042959363,0.0006151596,0.00014227492,0.000015358071,0.00006097165,0.002800406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956346,0.0018950816,0.00080690224,0.0006090003,0.00025488858,0.00079951657],"domain_scores_gemma":[0.9983352,0.0005848547,0.00038278228,0.00035535768,0.00009564492,0.00024619006],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047012768,0.0004447035,0.00065648573,0.00024759266,0.00032247877,0.0000062992494,0.00063099596,0.00027597786,0.0010048206],"category_scores_gemma":[0.00008717389,0.00035626587,0.00025315818,0.00073829276,0.00061211514,0.00011883484,0.00022011914,0.0010799343,0.00007313729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027054612,0.0008521148,0.007478973,0.000023535318,0.0001500158,0.00005661847,0.00071207003,0.0027064462,0.9502639,0.00008951075,0.028064728,0.009331553],"study_design_scores_gemma":[0.0047646128,0.00012296834,0.005941778,0.0000037890982,0.00017114604,0.00007440693,0.000015784855,0.001333515,0.6430679,0.000035214707,0.344259,0.00020989962],"about_ca_topic_score_codex":0.00014651242,"about_ca_topic_score_gemma":0.000036493766,"teacher_disagreement_score":0.31619427,"about_ca_system_score_codex":0.00022855321,"about_ca_system_score_gemma":0.00034926087,"threshold_uncertainty_score":0.9999084},"labels":[],"label_agreement":null},{"id":"W2076946354","doi":"10.1139/y03-003","title":"The 2001 Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons","year":2003,"lang":"en","type":"review","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytochrome P450; Aryl hydrocarbon receptor; Xenobiotic; Carcinogen; Aromatic hydrocarbon; Biology; Gene expression; Gene; Chemistry; Biochemistry; Enzyme; Transcription factor","score_opus":0.05570823443388346,"score_gpt":0.35529586240192834,"score_spread":0.2995876279680449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076946354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08983286,0.9056408,0.000008489707,0.00081125955,0.0018229021,0.0007277055,0.00093362265,0.0000016097912,0.00022074822],"genre_scores_gemma":[0.33699635,0.6620604,0.000041153635,0.00056362606,0.00012335031,0.000019057356,0.000021343745,0.000027554672,0.00014716951],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99510574,0.0024168638,0.0014541158,0.00027181188,0.00018442722,0.00056704704],"domain_scores_gemma":[0.99493974,0.0019148727,0.0024235111,0.00016452569,0.00012939265,0.00042797794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010157893,0.00041301423,0.0018820604,0.00018372432,0.00032926624,0.0000033159122,0.0005432857,0.0006328933,0.00017798225],"category_scores_gemma":[0.00007052714,0.00028774448,0.000548687,0.0003482095,0.0025701446,0.00005386697,0.000044841556,0.0011225663,1.7002323e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054836884,0.0003453293,0.0002811697,0.004474563,0.009940078,0.000012872794,0.0025819435,0.00012527748,0.9021885,0.0008513231,0.04114747,0.03750313],"study_design_scores_gemma":[0.0047369893,0.00086726324,0.0036961592,0.00087189866,0.009627794,0.00047566154,0.00041045152,0.00028653865,0.14450191,0.005361446,0.82846314,0.0007007717],"about_ca_topic_score_codex":0.006854222,"about_ca_topic_score_gemma":0.011787416,"teacher_disagreement_score":0.78731567,"about_ca_system_score_codex":0.00014112444,"about_ca_system_score_gemma":0.0051587257,"threshold_uncertainty_score":0.99995744},"labels":[],"label_agreement":null},{"id":"W2076985436","doi":"10.1073/pnas.130155097","title":"St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor","year":2000,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":938,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hyperforin; Hypericum perforatum; Pregnane X receptor; CYP3A4; Hypericum; Pharmacology; Hypericin; Pregnane; Drug metabolism; Chemistry; Cytochrome P450; Indinavir; Nuclear receptor; Angelica sinensis; Drug; Metabolism; Biochemistry; Medicine; Traditional medicine; Transcription factor; Stereochemistry; Human immunodeficiency virus (HIV)","score_opus":0.10874296573715132,"score_gpt":0.40701082468897404,"score_spread":0.29826785895182273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076985436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98098236,0.0008600898,2.2710992e-7,0.004528105,0.00017280891,0.00037945464,0.000064589156,0.000011184658,0.01300117],"genre_scores_gemma":[0.9963389,0.0008565029,0.0004281365,0.0012888586,0.00019897355,0.000024549463,3.976269e-7,0.000007270658,0.00085638394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979077,0.000059127033,0.00052543497,0.00026133153,0.0010154977,0.00023092308],"domain_scores_gemma":[0.9987102,0.00024497617,0.0006786134,0.000018457586,0.00029797936,0.000049770533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017530756,0.00015510153,0.00025991217,0.00009577488,0.00035202646,0.0000127090525,0.0012818282,0.00015551248,0.0006351846],"category_scores_gemma":[0.00027045934,0.00009255039,0.0001454809,0.0010556658,0.0012556042,0.00045357717,0.00014958331,0.00047442637,0.0000041011644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008189358,0.00022724208,0.0030142935,0.000095265605,0.000097676406,3.6856493e-9,0.0015689598,0.0007167564,0.9664126,0.01797884,0.0042371247,0.0055693374],"study_design_scores_gemma":[0.00039466936,0.000011876278,0.019632183,0.000068498885,0.000085536456,0.0000018688444,0.00010095691,0.0004370825,0.9261126,0.025441436,0.027611973,0.00010129995],"about_ca_topic_score_codex":0.00001412089,"about_ca_topic_score_gemma":6.723151e-8,"teacher_disagreement_score":0.04029999,"about_ca_system_score_codex":0.000022378903,"about_ca_system_score_gemma":0.00008143788,"threshold_uncertainty_score":0.6954826},"labels":[],"label_agreement":null},{"id":"W2077136462","doi":"10.1067/mcp.2001.113185","title":"Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"American Association of Pharmaceutical Scientists; U.S. Public Health Service; Medical Research Council Canada; National Center for Research Resources; National Institute of General Medical Sciences; Medical Research Council; University of Washington","keywords":"Grapefruit juice; Chemistry; Felodipine; Orange juice; Furocoumarins; Orange (colour); Food science; Citrus paradisi; Pharmacokinetics; Metabolite; Pharmacology; Chromatography; Biochemistry; Rutaceae; Botany; Medicine; Endocrinology","score_opus":0.3144994907808211,"score_gpt":0.5280572764054656,"score_spread":0.2135577856246445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077136462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97517496,0.0072057415,0.00043465177,0.0073205456,0.0054345494,0.0011247816,0.00005615264,0.00015157551,0.0030970357],"genre_scores_gemma":[0.9294834,0.020059092,0.00076436397,0.047557224,0.001152549,0.00011529152,0.00004345909,0.00008294847,0.00074164337],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951923,0.0012604059,0.0015643388,0.0008161742,0.0003422033,0.0008246079],"domain_scores_gemma":[0.9965116,0.0013249721,0.000775669,0.00039252767,0.0003977115,0.0005975186],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014351675,0.0005932592,0.0011600166,0.00022381345,0.00034407462,0.000029635565,0.00060888135,0.0005787189,0.002124742],"category_scores_gemma":[0.00001714054,0.0005113449,0.00025292565,0.0005437453,0.0012801545,0.00018509012,0.00033182857,0.0019394169,0.00010940506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016873846,0.012191668,0.55759,0.00039963596,0.011740413,0.00030857345,0.0030172223,0.001818555,0.113574296,0.00044225095,0.058053747,0.22398975],"study_design_scores_gemma":[0.010222769,0.0012027643,0.016328383,0.000025962261,0.0036088156,0.00007623861,0.00032047412,0.0052611334,0.019159215,0.00013444175,0.94304407,0.00061575964],"about_ca_topic_score_codex":0.000021646325,"about_ca_topic_score_gemma":0.000050234023,"teacher_disagreement_score":0.8849903,"about_ca_system_score_codex":0.00006132498,"about_ca_system_score_gemma":0.00017573207,"threshold_uncertainty_score":0.9997338},"labels":[],"label_agreement":null},{"id":"W2077169416","doi":"10.1007/s10695-013-9779-5","title":"Molecular cloning and expression analysis of cytochrome P450 3A gene in the turbot Scophthalmus maximus","year":2013,"lang":"en","type":"article","venue":"Fish Physiology and Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Turbot; Biology; Complementary DNA; Molecular biology; Rapid amplification of cDNA ends; CYP3A; Scophthalmus; Open reading frame; Gene expression; Untranslated region; Messenger RNA; Gene; Peptide sequence; Molecular cloning; Cytochrome P450; Biochemistry","score_opus":0.03682035617025701,"score_gpt":0.36337165772820534,"score_spread":0.3265513015579483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077169416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649763,0.0023542799,0.0000046145587,0.0002371103,0.00006500219,0.00018969589,0.00006637499,0.000010418746,0.0005748793],"genre_scores_gemma":[0.99754936,0.0006078021,0.00009031838,0.0014767967,0.000091620495,0.00005953943,0.00008259424,0.000008643885,0.000033328695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987303,0.00024875562,0.0002825836,0.0003551251,0.00008740461,0.0002958187],"domain_scores_gemma":[0.9993058,0.00018870068,0.0001329203,0.00021685251,0.00005146406,0.00010430686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002788929,0.00019604363,0.00036844471,0.00009824708,0.00010641674,0.000012364769,0.00023437962,0.00032130038,0.00032218423],"category_scores_gemma":[0.000034072506,0.00014661952,0.00008860464,0.00033326796,0.00033320684,0.00004039513,0.00014513444,0.0004288625,0.0000030166218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005848476,0.00011973953,0.0058026644,0.00006046722,0.0002586694,0.000017814647,0.00025224482,0.00016770783,0.99226975,0.0000120642235,0.00018083649,0.0007995513],"study_design_scores_gemma":[0.0006310024,0.00002806468,0.1444846,0.000009318624,0.000370437,0.000022245169,0.00008740704,0.0010857435,0.85248697,0.0003167763,0.0003214097,0.00015603955],"about_ca_topic_score_codex":0.000022477732,"about_ca_topic_score_gemma":7.6501146e-7,"teacher_disagreement_score":0.13978279,"about_ca_system_score_codex":0.000007070766,"about_ca_system_score_gemma":0.000023280756,"threshold_uncertainty_score":0.5978971},"labels":[],"label_agreement":null},{"id":"W2077257393","doi":"10.1210/en.2006-0229","title":"Isoform-Specific Regulation of Uridine Diphosphate-Glucuronosyltransferase 2B Enzymes in the Human Prostate: Differential Consequences for Androgen and Bioactive Lipid Inactivation","year":2006,"lang":"en","type":"article","venue":"Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"LNCaP; Glucuronidation; Internal medicine; Endocrinology; Androgen; Glucuronosyltransferase; Chemistry; Dihydrotestosterone; Prostate cancer; Uridine; Biology; Microsome; Enzyme; Biochemistry; Cancer; Hormone; Medicine; Gene; RNA","score_opus":0.061148256697095955,"score_gpt":0.37251597862982144,"score_spread":0.3113677219327255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077257393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933484,0.00334951,0.00023607239,0.0010305997,0.000429687,0.00094999745,0.00015864387,0.000023732962,0.00047332238],"genre_scores_gemma":[0.9982215,0.0008678125,0.00007940252,0.00015196837,0.00025045764,0.00019527889,0.00014398128,0.000014757431,0.00007481024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984466,0.00033370662,0.00042842067,0.0002960639,0.000095820964,0.0003993896],"domain_scores_gemma":[0.99921626,0.0003736868,0.00016348444,0.00012534732,0.00007853079,0.00004271709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023908951,0.00019810688,0.00029272656,0.00016662656,0.00021075785,0.000015602693,0.00016994936,0.0001352265,0.00014314629],"category_scores_gemma":[0.000017857597,0.0001575064,0.00006235544,0.00015575021,0.0005221542,0.000105734085,0.000030237155,0.00027595102,0.0000020488683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071227626,0.00044742264,0.023220234,0.000059250568,0.00007943928,0.00000964212,0.0009813776,0.00014845384,0.8634649,0.09877747,0.0005297014,0.0115698185],"study_design_scores_gemma":[0.0033517885,0.00019412655,0.06359636,0.000005323456,0.000082572864,0.000026893491,0.00017539984,0.0001895802,0.8728701,0.0068534357,0.052486517,0.0001678918],"about_ca_topic_score_codex":0.00011612903,"about_ca_topic_score_gemma":0.00004578132,"teacher_disagreement_score":0.091924034,"about_ca_system_score_codex":0.000026210955,"about_ca_system_score_gemma":0.00003562448,"threshold_uncertainty_score":0.64229244},"labels":[],"label_agreement":null},{"id":"W2078828442","doi":"10.1016/j.jep.2014.06.045","title":"The effect of Cree traditional medicinal teas on the activity of human cytochrome P450-mediated metabolism","year":2014,"lang":"en","type":"article","venue":"Journal of Ethnopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Decoction; Juniperus communis; Traditional medicine; CYP3A4; Cytochrome P450; Juniper; Botany; Chemistry; Biology; Metabolism; Biochemistry; Medicine","score_opus":0.1100198123032564,"score_gpt":0.43263665087699404,"score_spread":0.32261683857373763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078828442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869793,0.0020079426,0.00004773731,0.004457403,0.003193709,0.00048393133,0.000081212296,0.000013931537,0.0027348],"genre_scores_gemma":[0.9960029,0.00073780597,0.000020322039,0.0014666724,0.0016115676,0.000034792454,0.000004347208,0.00003362569,0.000087956374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9925838,0.0046859076,0.0011934933,0.00024405561,0.00073256803,0.0005601929],"domain_scores_gemma":[0.985583,0.011575533,0.0017891799,0.0002823046,0.00043260993,0.0003373775],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008198425,0.00038470066,0.0010423156,0.00029186986,0.00051344896,0.000012154135,0.0011570975,0.00037046766,0.0012617677],"category_scores_gemma":[0.0010393593,0.00021186429,0.00050317426,0.0003825653,0.0012577067,0.00010064117,0.00011584476,0.0023571118,0.000021027423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029428792,0.00041263708,0.00028981478,0.000052517986,0.0010258858,0.000026229407,0.0002820532,0.00047458182,0.97109926,0.0034253083,0.009351714,0.010617117],"study_design_scores_gemma":[0.008056615,0.0027275474,0.0184256,0.000030826275,0.0015137484,0.000050547584,0.000040545365,0.0013183994,0.8935432,0.0017761055,0.07229234,0.00022455877],"about_ca_topic_score_codex":0.000011097203,"about_ca_topic_score_gemma":0.000004340404,"teacher_disagreement_score":0.077556096,"about_ca_system_score_codex":0.00005381006,"about_ca_system_score_gemma":0.00019421703,"threshold_uncertainty_score":0.9999445},"labels":[],"label_agreement":null},{"id":"W2079178949","doi":"10.1016/j.clinbiochem.2006.03.004","title":"Toxicology: Then and now","year":2006,"lang":"en","type":"review","venue":"Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Clinical toxicology; Forensic toxicology; Toxicology; Environmental toxicology; Pharmacology; Medicine; Biology; Chemistry; Toxicity","score_opus":0.3213879074882492,"score_gpt":0.5782470575847082,"score_spread":0.256859150096459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079178949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008871198,0.98177314,0.0000035919347,0.00014074492,0.0022984627,0.00051726913,0.00045584913,0.000107506945,0.013816314],"genre_scores_gemma":[0.00009884866,0.9883648,0.00014441278,0.0011623966,0.0029082592,0.00011068682,0.0003278886,0.000082594044,0.00680009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957012,0.00079169474,0.001598121,0.0010919357,0.00015624604,0.0006607972],"domain_scores_gemma":[0.9962708,0.001819898,0.0006392408,0.0005685067,0.000074520336,0.00062702893],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015956919,0.00071526406,0.0022905772,0.00007567283,0.0001785707,0.000038532733,0.0007075138,0.0030521806,0.00071417465],"category_scores_gemma":[0.0003219772,0.00060158054,0.0008454025,0.00020286681,0.00088971754,0.00002518665,0.0004868381,0.0029464015,0.0004714675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002081372,0.0003712285,0.0001038629,0.0037926259,0.00042088833,0.0000649038,0.0000046277974,2.5356485e-7,0.00010266905,0.00003626876,0.049044937,0.94603693],"study_design_scores_gemma":[0.0007897018,0.0000380758,0.000011113563,0.00040822063,0.00251272,0.00007943556,0.000002711298,0.000013109368,0.00046078302,0.0001652261,0.994898,0.0006209091],"about_ca_topic_score_codex":0.000001548307,"about_ca_topic_score_gemma":7.0317736e-7,"teacher_disagreement_score":0.94585305,"about_ca_system_score_codex":0.000047794852,"about_ca_system_score_gemma":0.00043491568,"threshold_uncertainty_score":0.99964356},"labels":[],"label_agreement":null},{"id":"W2079329807","doi":"10.1016/j.neuropharm.2013.04.022","title":"Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys","year":2013,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Canada Research Chairs; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health","keywords":"Nicotine; CYP2E1; Pharmacology; Putamen; Ethanol; Internal medicine; Endocrinology; Chemistry; Medicine; Anesthesia; Biochemistry; Metabolism; Cytochrome P450","score_opus":0.09390333858416737,"score_gpt":0.4039466296934429,"score_spread":0.31004329110927553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079329807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891932,0.0010245227,0.000004600924,0.006424108,0.0006442091,0.0010588081,0.00008569052,0.0000654361,0.0014994408],"genre_scores_gemma":[0.99393004,0.0018148978,0.00018353682,0.0032143202,0.00020836377,0.00018661808,0.000007241683,0.000040963845,0.00041400196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705756,0.0010164777,0.0006363793,0.00057702145,0.00014050574,0.0005720671],"domain_scores_gemma":[0.9982496,0.00083426747,0.00025465206,0.00017614634,0.00010419426,0.00038112616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033118363,0.0003806962,0.00056295807,0.00030413797,0.00011363935,0.000019611794,0.00021545787,0.00032622388,0.00086477096],"category_scores_gemma":[0.0000597903,0.00036434588,0.00006292848,0.0003152425,0.0003016994,0.00015441635,0.00016125065,0.00059160945,0.000040123065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023034484,0.0007354549,0.011218292,0.00006326607,0.00014363295,0.00007038712,0.001290269,0.000036188012,0.9233782,0.00021927003,0.00041762996,0.06219702],"study_design_scores_gemma":[0.009995257,0.0014207627,0.124120526,0.00000832727,0.00039364796,0.00014981118,0.00012146228,0.0058480045,0.81106025,0.0006023585,0.04572528,0.00055430527],"about_ca_topic_score_codex":0.0002010989,"about_ca_topic_score_gemma":0.000035133355,"teacher_disagreement_score":0.11290223,"about_ca_system_score_codex":0.00005143583,"about_ca_system_score_gemma":0.00014081023,"threshold_uncertainty_score":0.99988085},"labels":[],"label_agreement":null},{"id":"W2079423637","doi":"10.1038/tpj.2014.22","title":"Pharmacogenomic diversity in Singaporean populations and Europeans","year":2014,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Child and Family Research Institute; University of British Columbia","funders":"Biomedical Research Council; Canadian Institutes of Health Research; National University of Singapore; Agency for Science, Technology and Research","keywords":"Pharmacogenomics; CYP2C19; Genetic diversity; Allele frequency; Population; Allele; Medicine; Clopidogrel; Biology; Genetics; Internal medicine; Gene; Genotype; Environmental health","score_opus":0.2535966274977663,"score_gpt":0.43677491240895044,"score_spread":0.18317828491118415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079423637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840191,0.0026840225,0.0006776194,0.002722007,0.002580223,0.00035467115,0.000051316856,0.000050817056,0.0068602334],"genre_scores_gemma":[0.9887263,0.0042311223,0.00027176234,0.0051420997,0.0012781062,0.000007640932,0.0000090311405,0.00005517491,0.000278724],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647677,0.0014806335,0.00066458434,0.00037374446,0.00024405314,0.0007602449],"domain_scores_gemma":[0.9984587,0.00031747323,0.00032494403,0.0002260734,0.00010178918,0.00057100796],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0039177937,0.0003668441,0.0003664923,0.00029211235,0.0017225107,0.00010362961,0.00084076275,0.00012441847,0.0005768628],"category_scores_gemma":[0.00007893252,0.0003018006,0.00015842407,0.00029724633,0.00033515872,0.00020240601,0.00075694575,0.0018423165,0.0001175987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011863139,0.00083526253,0.14625782,0.000050860166,0.0006199942,0.0002710548,0.008413231,0.018868316,0.43984124,0.0091022905,0.008701434,0.36585218],"study_design_scores_gemma":[0.013632249,0.00013417292,0.03829692,0.000026832844,0.0013423015,0.0021294688,0.0003376043,0.09311991,0.017639482,0.017857183,0.81413895,0.0013449324],"about_ca_topic_score_codex":0.000037705206,"about_ca_topic_score_gemma":0.000020837466,"teacher_disagreement_score":0.8054375,"about_ca_system_score_codex":0.00013786378,"about_ca_system_score_gemma":0.00007113436,"threshold_uncertainty_score":0.99994344},"labels":[],"label_agreement":null},{"id":"W2079700993","doi":"10.1210/jc.2007-0359","title":"The Uridine Diphosphate Glucuronosyltransferase 2B15 D85Y and 2B17 Deletion Polymorphisms Predict the Glucuronidation Pattern of Androgens and Fat Mass in Men","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Glucuronidation; Androsterone; Endocrinology; Glucuronosyltransferase; Internal medicine; Chemistry; Dihydrotestosterone; Androgen; Glucuronide; Uridine diphosphate; Urine; Hormone; Biology; Medicine; Steroid; Biochemistry; Microsome; In vitro; Enzyme","score_opus":0.07418747677206014,"score_gpt":0.42673317387834986,"score_spread":0.3525456971062897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079700993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943285,0.045069106,0.0011983297,0.008055946,0.0017130487,0.00044058808,0.00003096623,0.000010403696,0.00019664233],"genre_scores_gemma":[0.90882975,0.08873335,0.000055277455,0.0014761073,0.000827468,0.0000069693406,0.0000027173476,0.000022145447,0.00004623047],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942466,0.0024379243,0.002061398,0.0002468698,0.00034857055,0.0006586415],"domain_scores_gemma":[0.99370545,0.004536958,0.0009677106,0.00030365656,0.00021938318,0.00026682444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009358855,0.0002916626,0.00078243,0.00013909572,0.00035674614,0.000022207014,0.0006374705,0.0002665648,0.000060426806],"category_scores_gemma":[0.0004578663,0.00015272512,0.00020920053,0.0002078328,0.0013693543,0.00013434316,0.00014595772,0.0018666041,0.0000039709844],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008982143,0.00074456236,0.119353354,0.0000466523,0.001708621,0.00018021553,0.0024779919,0.00068563817,0.111309245,0.0045024273,0.0010557005,0.74895346],"study_design_scores_gemma":[0.019104764,0.00074285496,0.5352752,0.00004431705,0.0031155809,0.00081844727,0.00087267597,0.0032301338,0.19380637,0.005523252,0.23699017,0.000476225],"about_ca_topic_score_codex":0.00006459023,"about_ca_topic_score_gemma":0.000051273873,"teacher_disagreement_score":0.7484772,"about_ca_system_score_codex":0.0000139921585,"about_ca_system_score_gemma":0.00009304759,"threshold_uncertainty_score":0.81095695},"labels":[],"label_agreement":null},{"id":"W2079756400","doi":"10.1038/tpj.2015.20","title":"Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing","year":2015,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Transcriptome; Gene; Glucuronidation; Exon; Biology; Glucuronosyltransferase; Alternative splicing; Exon skipping; Human genome; RNA splicing; Computational biology; RNA; Genome; Genetics; RNA-Seq; Gene expression","score_opus":0.15548531622534506,"score_gpt":0.39196674416575117,"score_spread":0.2364814279404061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079756400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612358,0.023748219,0.0027067838,0.0037060976,0.0067254785,0.0008730051,0.00033270763,0.000046169196,0.0006257141],"genre_scores_gemma":[0.9906179,0.0025356095,0.000405631,0.0040575685,0.0020041703,0.000013753958,0.000008644151,0.00011059473,0.00024614134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941847,0.0023334937,0.001339646,0.00042198904,0.00063290825,0.0010872657],"domain_scores_gemma":[0.99709904,0.00048501,0.00078695966,0.00054363575,0.00041810522,0.00066726236],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0062849,0.000611011,0.0006726777,0.0002029868,0.002446234,0.00012020105,0.0021899992,0.00018459579,0.00048225233],"category_scores_gemma":[0.00010852468,0.00031786461,0.0006685049,0.0006763964,0.000560162,0.0002558312,0.00028278786,0.0029467742,0.00001967753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086005236,0.0002722927,0.00009353645,0.000023902323,0.00095731224,0.00003757337,0.012302581,0.038682975,0.93149555,0.00025424187,0.0014035554,0.013616457],"study_design_scores_gemma":[0.008934095,0.00006617598,0.0000095522355,0.00002708154,0.0022265373,0.00062106707,0.0015705083,0.102597296,0.7759199,0.0013472176,0.10623591,0.00044466252],"about_ca_topic_score_codex":0.00007104529,"about_ca_topic_score_gemma":0.000013946342,"teacher_disagreement_score":0.15557562,"about_ca_system_score_codex":0.00024515775,"about_ca_system_score_gemma":0.0012710651,"threshold_uncertainty_score":0.99992734},"labels":[],"label_agreement":null},{"id":"W2081057141","doi":"10.1177/0091270009340417","title":"Toward Optimal Treatment in Women: The Effect of Sex on Metoprolol‐Diphenhydramine Interaction","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Metoprolol; Diphenhydramine; Medicine; Placebo; Pharmacokinetics; CYP2D6; Internal medicine; Chronotropic; Pharmacology; Anesthesia; Blood pressure; Heart rate","score_opus":0.15756673208901237,"score_gpt":0.5327479104422379,"score_spread":0.3751811783532255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081057141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98115337,0.0013836176,0.000026859034,0.010308532,0.005186268,0.00061917346,0.000010542892,0.0000118110265,0.0012998233],"genre_scores_gemma":[0.98255026,0.004360911,0.000027962029,0.010888699,0.0019677277,0.000022349399,0.0000011943424,0.000017257975,0.00016363125],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9909558,0.0061245034,0.0018882157,0.00021495203,0.00028390795,0.000532601],"domain_scores_gemma":[0.9908016,0.007376573,0.0012096253,0.00021499228,0.000119584955,0.00027762508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009509871,0.00032979646,0.0011324894,0.00019204762,0.00011637613,0.000008836544,0.00076221256,0.0002967867,0.0007495539],"category_scores_gemma":[0.0003313494,0.00016422312,0.00042189797,0.00028185634,0.00040304978,0.00009259165,0.000067134664,0.0020838901,0.000033688182],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07740492,0.0043949224,0.0033373686,0.000041750656,0.0022432467,0.0003006798,0.005868436,0.064858064,0.1279162,0.00008271186,0.012523076,0.70102865],"study_design_scores_gemma":[0.034034953,0.035391677,0.01112281,0.000034815585,0.0023547958,0.00035282737,0.00054635137,0.01022062,0.5221941,0.0006809011,0.38263604,0.00043015464],"about_ca_topic_score_codex":0.0000068204945,"about_ca_topic_score_gemma":9.663408e-7,"teacher_disagreement_score":0.7005985,"about_ca_system_score_codex":0.00013318393,"about_ca_system_score_gemma":0.00014310845,"threshold_uncertainty_score":0.9053582},"labels":[],"label_agreement":null},{"id":"W2081060183","doi":"10.1016/j.steroids.2009.07.004","title":"Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation","year":2009,"lang":"en","type":"article","venue":"Steroids","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Glucuronidation; Epitestosterone; Testosterone (patch); Glucuronosyltransferase; Microsome; Chemistry; UGT2B7; Pharmacology; Endocrinology; Glucuronide; Internal medicine; Androgen; Diclofenac; Metabolism; Medicine; Biochemistry; Hormone; Enzyme","score_opus":0.03658619101543597,"score_gpt":0.37481440463715343,"score_spread":0.33822821362171746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081060183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825044,0.00059220823,0.00033294002,0.0010488245,0.00120262,0.00050077116,0.00003379875,0.0001467287,0.013637688],"genre_scores_gemma":[0.9930073,0.00016936925,0.00029717744,0.0046682907,0.0005952363,0.00002962316,0.000053736985,0.000042249598,0.0011370315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787563,0.00020023882,0.0004702073,0.000497537,0.0002914048,0.0006649905],"domain_scores_gemma":[0.99885225,0.00008698324,0.00021430262,0.00036635002,0.0001272778,0.0003528113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047773775,0.00040422886,0.0003880721,0.00019120504,0.00024027386,0.00007298856,0.00041676973,0.00023602472,0.00061546016],"category_scores_gemma":[0.000011649461,0.00035185262,0.00009743665,0.00023076263,0.00014693505,0.00033076102,0.00008186745,0.000752899,0.00042967426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010239325,0.0007692106,0.023391224,0.00006462641,0.00026707147,0.00014473274,0.0040558325,0.0007487818,0.75078493,0.00030866335,0.0048156353,0.21362533],"study_design_scores_gemma":[0.0114146145,0.0014363859,0.1260949,0.00009859731,0.00052045385,0.00015094364,0.00040169922,0.004722133,0.55727744,0.00045807753,0.29595467,0.0014700829],"about_ca_topic_score_codex":0.000004266597,"about_ca_topic_score_gemma":0.00000404806,"teacher_disagreement_score":0.29113904,"about_ca_system_score_codex":0.00006357051,"about_ca_system_score_gemma":0.000090573594,"threshold_uncertainty_score":0.99989337},"labels":[],"label_agreement":null},{"id":"W2081433798","doi":"10.2165/11531190-000000000-00000","title":"Rate and Extent of Drug Accumulation after Multiple Dosing Revisited","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; Pharmacokinetics; Drug; Pharmacology; Bolus (digestion); Medicine; Plasma concentration; Analyte; Intensive care medicine; Chemistry; Internal medicine","score_opus":0.3070457126826455,"score_gpt":0.5598952058502331,"score_spread":0.2528494931675876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081433798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008556254,0.9831538,0.000057827343,0.00007778263,0.0050914367,0.0017761867,0.0006531453,0.000092036,0.00054149213],"genre_scores_gemma":[0.007533439,0.9874971,0.0006842718,0.0011444452,0.002141212,0.00013981303,0.00018898053,0.00016508964,0.0005056513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917299,0.002850666,0.0032673627,0.0010927984,0.00031815472,0.0007411264],"domain_scores_gemma":[0.9920069,0.004513793,0.0016577122,0.0006588267,0.00033336354,0.000829422],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0040225317,0.0009552637,0.0030592885,0.0003473172,0.0001657863,0.000054706736,0.00069873413,0.0014510499,0.0012285569],"category_scores_gemma":[0.00084831077,0.0008360976,0.0010515314,0.0005002997,0.0008044244,0.00011285495,0.0005948611,0.0043067113,0.00012176886],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026039334,0.0005211839,0.0007791688,0.005453069,0.00050890696,0.00004983997,0.00007542695,0.000017527233,0.00040728692,0.0000378889,0.0022906684,0.98959863],"study_design_scores_gemma":[0.002721434,0.000051254236,0.00037455573,0.0011652227,0.0065556937,0.00002291166,0.0000037746804,0.0020861235,0.00043452866,0.000117027994,0.9856801,0.0007873595],"about_ca_topic_score_codex":0.0000040353534,"about_ca_topic_score_gemma":0.0000020602881,"teacher_disagreement_score":0.98881125,"about_ca_system_score_codex":0.000034639903,"about_ca_system_score_gemma":0.00023318904,"threshold_uncertainty_score":0.99984527},"labels":[],"label_agreement":null},{"id":"W2081881629","doi":"10.1139/cjpp-78-7-578","title":"Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Ferrochelatase; Bioassay; Microsome; Isozyme; Biochemistry; Cytochrome P450; Xenobiotic; Recombinant DNA; Heme; Complementary DNA; Hemeprotein; Biology; In vitro; Porphyria; Chemistry; Enzyme; Molecular biology; Gene","score_opus":0.06409154204016622,"score_gpt":0.36463957640535655,"score_spread":0.30054803436519034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081881629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957088,0.0014421552,0.000017223601,0.00027760165,0.0013467323,0.0007719413,0.00035062106,0.000005414594,0.00007950701],"genre_scores_gemma":[0.996435,0.0010750075,0.00032690636,0.0014320359,0.00026079998,0.000039983574,0.000047881444,0.000033145243,0.00034923546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997703,0.0005385264,0.0007987079,0.00030292317,0.00008303073,0.00057377067],"domain_scores_gemma":[0.99764645,0.00045456635,0.0006724148,0.00013814654,0.00048805814,0.00060036464],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047412177,0.0003306874,0.00077445066,0.00040506473,0.00021665618,0.000010135894,0.0002237577,0.00037698422,0.0037918948],"category_scores_gemma":[0.000027955766,0.0002851524,0.00022589361,0.0001885918,0.00095186534,0.0002236004,0.000028685468,0.0007170845,0.000009276866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058057685,0.0002987932,0.0015935487,0.00023313474,0.00094516424,0.00022612722,0.0011308244,0.00038293086,0.98204315,0.00019072442,0.0024643685,0.0046854727],"study_design_scores_gemma":[0.004474717,0.0015910926,0.0036668729,0.000048904807,0.0010184678,0.00058337307,0.00010181293,0.00020797265,0.9210236,0.0007063938,0.06626484,0.00031197106],"about_ca_topic_score_codex":0.00045901956,"about_ca_topic_score_gemma":0.000548834,"teacher_disagreement_score":0.06380047,"about_ca_system_score_codex":0.00006389272,"about_ca_system_score_gemma":0.000618311,"threshold_uncertainty_score":0.99996006},"labels":[],"label_agreement":null},{"id":"W2081931643","doi":"10.1007/s13238-011-1082-6","title":"Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1)","year":2011,"lang":"en","type":"article","venue":"Protein & Cell","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cooperativity; Bacillus megaterium; Chemistry; Ionic strength; Heme; Phosphate; Phospholipid; Cooperative binding; Electron transfer; Kinetics; Biochemistry; Stereochemistry; Binding site; Enzyme; Organic chemistry; Membrane; Biology; Bacteria","score_opus":0.09737550775960752,"score_gpt":0.35876081178476393,"score_spread":0.2613853040251564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081931643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896967,0.0028335107,0.00043314445,0.00015515844,0.0003163084,0.0012664028,0.00008534472,0.00006448983,0.0051489696],"genre_scores_gemma":[0.996839,0.00075620174,0.0007664681,0.0003964016,0.00011511968,0.00027675487,0.000034052806,0.000036311387,0.0007797303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977401,0.00060306437,0.000409046,0.00050813396,0.00018251657,0.0005571695],"domain_scores_gemma":[0.9992598,0.000059085854,0.000157496,0.00019639617,0.000058568396,0.00026863802],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001186875,0.00030805185,0.000325358,0.00015239623,0.00021311472,0.000032125503,0.00025528585,0.00030964817,0.0011732337],"category_scores_gemma":[0.000038259135,0.00030697492,0.00004977765,0.00021460529,0.0001415275,0.00018834762,0.00016851343,0.00077401276,0.00016945951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016885728,0.00049089186,0.0047629457,0.00006252536,0.00003119814,0.000029768275,0.0013902378,0.000010918844,0.98230547,0.00017045769,0.00016755825,0.010409199],"study_design_scores_gemma":[0.0023615928,0.00009211317,0.0026815769,0.000012693045,0.0000498953,0.0000070941246,0.00008369636,0.0008692515,0.98423785,0.00023357417,0.009014873,0.0003558172],"about_ca_topic_score_codex":0.00011518233,"about_ca_topic_score_gemma":0.00003516919,"teacher_disagreement_score":0.010053381,"about_ca_system_score_codex":0.000059124315,"about_ca_system_score_gemma":0.000059132784,"threshold_uncertainty_score":0.99993825},"labels":[],"label_agreement":null},{"id":"W2082018761","doi":"10.1016/j.neurobiolaging.2011.08.014","title":"The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients","year":2011,"lang":"en","type":"article","venue":"Neurobiology of Aging","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Ontario Ministry of Research and Innovation; Research and Innovation Foundation; Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"Substantia nigra; CYP2D6; Internal medicine; Parkinson's disease; Endocrinology; MPTP; Neuroprotection; Human brain; Biology; Pharmacology; Psychology; Medicine; Neuroscience; Disease; Cytochrome P450; Metabolism","score_opus":0.05481556436743853,"score_gpt":0.33412922846110693,"score_spread":0.2793136640936684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082018761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968705,0.00074001687,0.0000022049967,0.0009706966,0.00023922345,0.0004968951,0.00003844605,0.000010776787,0.00063123746],"genre_scores_gemma":[0.9920571,0.000498154,0.000016348344,0.0072844187,0.000038119022,0.000060285423,0.0000038637613,0.000014911394,0.000026812997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977584,0.001248537,0.0002492879,0.00031197077,0.00007482914,0.00035700874],"domain_scores_gemma":[0.99886376,0.0006797933,0.00013097975,0.00019658543,0.000038806764,0.00009009068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000597446,0.00018398998,0.00020153078,0.00010038176,0.00015537423,0.000009270183,0.00032836755,0.00008139703,0.0000392523],"category_scores_gemma":[0.0000939393,0.00010947304,0.000039070394,0.00021299686,0.00060636806,0.000050952727,0.00011683248,0.00061248953,0.0000033223366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020016567,0.0009017292,0.9797852,0.00003234625,0.000069544236,0.00038674707,0.005127467,0.00004651503,0.0032922262,0.0003918379,0.0007166383,0.0072480715],"study_design_scores_gemma":[0.0019812747,0.00022088483,0.96725285,0.000013483223,0.00005659142,0.000007422549,0.00011206708,0.00011767649,0.00478441,0.00060014473,0.024703313,0.00014987697],"about_ca_topic_score_codex":0.000118653385,"about_ca_topic_score_gemma":0.000076721575,"teacher_disagreement_score":0.023986673,"about_ca_system_score_codex":0.000007820778,"about_ca_system_score_gemma":0.000034957116,"threshold_uncertainty_score":0.4464181},"labels":[],"label_agreement":null},{"id":"W2082819068","doi":"10.1016/j.taap.2005.07.001","title":"Inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice","year":2005,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Inhalation; Pharmacokinetics; Cmax; Inhalation exposure; Chemistry; Toxicokinetics; Ethylbenzene; Kinetics; Pharmacology; Toxicology; Animal science; Internal medicine; Medicine; Biology; Anesthesia; Biochemistry","score_opus":0.061876599892132136,"score_gpt":0.4070910698820604,"score_spread":0.3452144699899283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082819068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726695,0.003839676,0.00008349121,0.0024268143,0.0013871276,0.0008961774,0.000058050016,0.00009069065,0.018548468],"genre_scores_gemma":[0.98708546,0.002921227,0.0011746875,0.007448399,0.00079599454,0.00019667408,0.000029425863,0.00005089963,0.00029725832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965124,0.0006126351,0.0010580501,0.00070257636,0.00019106084,0.0009232782],"domain_scores_gemma":[0.99821204,0.00072907435,0.0003918596,0.0001900752,0.0000957323,0.00038119798],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013412288,0.00047567906,0.00080632564,0.00053866126,0.00017511929,0.000009530681,0.0004488546,0.0007952724,0.0034206863],"category_scores_gemma":[0.000031367523,0.00051135215,0.00010315836,0.0005490849,0.00065887184,0.00012677693,0.00026899617,0.001418519,0.00012530829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010968895,0.0009823794,0.0037771964,0.0000820776,0.00019211804,0.00002122109,0.0010556797,0.0068501537,0.89623946,0.0056388145,0.0031893586,0.080874674],"study_design_scores_gemma":[0.008776736,0.0001418817,0.0058311005,0.0000068506743,0.00037137725,0.000054436005,0.00010497503,0.007589392,0.7832549,0.0009999078,0.19235215,0.00051624776],"about_ca_topic_score_codex":0.00000916953,"about_ca_topic_score_gemma":0.000031112693,"teacher_disagreement_score":0.18916279,"about_ca_system_score_codex":0.00008376132,"about_ca_system_score_gemma":0.00014016214,"threshold_uncertainty_score":0.9997338},"labels":[],"label_agreement":null},{"id":"W2083979572","doi":"10.1038/tpj.2014.29","title":"Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients","year":2014,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Medicine; Heart failure; Confidence interval; Odds ratio; Confidentiality; Internal medicine; Heart transplantation; Population; Pharmacology; Environmental health","score_opus":0.09242426398764272,"score_gpt":0.4205480789134788,"score_spread":0.3281238149258361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083979572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808734,0.009296425,0.00018378401,0.005912692,0.002221884,0.0007111464,0.00059865566,0.00003740261,0.00016461362],"genre_scores_gemma":[0.9837644,0.0076464876,0.0007928156,0.0065755765,0.0010464179,0.000024791045,0.000052418538,0.000073258925,0.000023799037],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954136,0.0015580354,0.0012459198,0.0005063768,0.0004086996,0.0008673532],"domain_scores_gemma":[0.99723625,0.0007169291,0.0006993025,0.00023411181,0.00023369819,0.0008797086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031085454,0.0005156809,0.0009021606,0.00027160786,0.0011495332,0.00011619353,0.0006216819,0.00023686048,0.00019154517],"category_scores_gemma":[0.00007069372,0.0004228304,0.00021333566,0.0002144044,0.0005449494,0.000223753,0.0002773169,0.0017940619,0.000020690148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002400927,0.0012822334,0.61486584,0.0001995042,0.001627492,0.000006552092,0.0087532,0.0016752252,0.2580613,0.0007850239,0.045355424,0.0649873],"study_design_scores_gemma":[0.013354149,0.00044248905,0.017863968,0.00006606624,0.0011669088,0.00036989868,0.000262846,0.008136011,0.061366815,0.000590965,0.89564604,0.0007338577],"about_ca_topic_score_codex":0.000022025099,"about_ca_topic_score_gemma":0.000005047882,"teacher_disagreement_score":0.8502906,"about_ca_system_score_codex":0.00008833663,"about_ca_system_score_gemma":0.00014511104,"threshold_uncertainty_score":0.9998224},"labels":[],"label_agreement":null},{"id":"W2084104182","doi":"10.1016/j.rpor.2013.04.014","title":"Minimizing the side effects of ADT","year":2013,"lang":"en","type":"article","venue":"Reports of Practical Oncology & Radiotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine","score_opus":0.07957921634723514,"score_gpt":0.47906558607430466,"score_spread":0.3994863697270695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084104182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538796,0.011011003,0.00083305314,0.011174307,0.0033760292,0.0014805166,0.0000048636557,0.000054987537,0.018185673],"genre_scores_gemma":[0.9847769,0.0036085888,0.0060195387,0.004564272,0.0004528543,0.00014919874,0.0000030280785,0.00003991142,0.00038567823],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966418,0.0011825641,0.0010483915,0.00035680374,0.00028838273,0.0004820317],"domain_scores_gemma":[0.9929015,0.005016241,0.0010868316,0.00046649942,0.00026739232,0.00026154536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001659439,0.00025909525,0.00074115646,0.000108941844,0.00016771244,0.000015689642,0.00026007928,0.00046817787,0.0013567731],"category_scores_gemma":[0.00088020985,0.00018276405,0.00025847895,0.00023341671,0.00093007815,0.00017659595,0.000075297,0.00089194917,0.000023877272],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028620416,0.0013837662,0.0038197457,0.00011689785,0.0009005206,0.0004991041,0.0010416608,0.00013598935,0.842645,0.0016969062,0.0097078765,0.13776632],"study_design_scores_gemma":[0.0018828982,0.00056469947,0.008654945,0.0000187908,0.00046566332,0.00084436807,0.00008502553,0.00087786844,0.35734588,0.0021176303,0.6269047,0.00023749856],"about_ca_topic_score_codex":0.000088167035,"about_ca_topic_score_gemma":0.000004369646,"teacher_disagreement_score":0.61719686,"about_ca_system_score_codex":0.00007090256,"about_ca_system_score_gemma":0.000512224,"threshold_uncertainty_score":0.9995561},"labels":[],"label_agreement":null},{"id":"W2084509790","doi":"10.1331/154434504773062573","title":"Drug-Drug Interactions: Where Do We Go From Here?","year":2004,"lang":"en","type":"letter","venue":"Journal of the American Pharmacists Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Compendium; Drug; Harm; Pharmacology; Law; Political science; Philosophy","score_opus":0.04644596507344729,"score_gpt":0.402242063359116,"score_spread":0.3557960982856687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084509790","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13501704,0.022957884,0.000034034478,0.8104492,0.027764535,0.0006645366,0.0015460461,0.000074021205,0.0014927508],"genre_scores_gemma":[0.15861243,0.062376242,0.00048946164,0.70629233,0.041338034,0.0000618032,0.000091217174,0.00030726468,0.030431192],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99290204,0.0027854238,0.0016354312,0.0004940492,0.001335297,0.00084775884],"domain_scores_gemma":[0.9882976,0.0015704733,0.008589181,0.00045287114,0.00079359766,0.00029630377],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016795269,0.0007261747,0.0013550961,0.00036266437,0.00043211726,0.00017664375,0.0017573173,0.00035945515,0.0015918823],"category_scores_gemma":[0.0002853663,0.0005726825,0.0012294891,0.00068398897,0.0002638461,0.0003418681,0.0002761077,0.0096644685,0.00033864015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026238192,0.00025371264,0.0043502776,0.000057389916,0.0022530435,0.0002692409,0.0009876313,0.0005909205,0.0063291956,0.0000035067285,0.9590163,0.025626404],"study_design_scores_gemma":[0.0026112169,0.000027161064,0.0004293572,0.00018001099,0.0023860615,0.00014259448,0.00011126194,0.00011633173,0.008054922,0.0020546278,0.9833046,0.0005818245],"about_ca_topic_score_codex":0.00013296246,"about_ca_topic_score_gemma":0.000022624587,"teacher_disagreement_score":0.104156815,"about_ca_system_score_codex":0.0022293793,"about_ca_system_score_gemma":0.0006903062,"threshold_uncertainty_score":0.9996725},"labels":[],"label_agreement":null},{"id":"W2084685770","doi":"10.1016/j.bcp.2007.10.032","title":"Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress","year":2007,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Oxidative stress; Menadione; Chemistry; Oxidative phosphorylation; Catalase; Cytochrome P450; Biochemistry; Pharmacology; Molecular biology; Biology; Enzyme","score_opus":0.07061726555809142,"score_gpt":0.4030959073619679,"score_spread":0.33247864180387643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084685770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905718,0.0057253884,0.0010419063,0.00009290111,0.0004963047,0.0008021421,0.00054550794,0.0000581544,0.00066592114],"genre_scores_gemma":[0.99635273,0.0009110915,0.0015003585,0.00077979494,0.00016428703,0.00007107969,0.00006197799,0.00005483281,0.0001038684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962083,0.00036954408,0.0013432632,0.0006780541,0.00038065977,0.0010201868],"domain_scores_gemma":[0.99782,0.00053621177,0.0005801079,0.00030243312,0.0002624111,0.000498798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014129027,0.00044697645,0.0008459617,0.00044032867,0.00009937893,0.000005953092,0.0007158425,0.000654899,0.0006503912],"category_scores_gemma":[0.00009523237,0.00045429036,0.00024541054,0.0005528843,0.0008467744,0.00009375126,0.0003930424,0.0009539361,0.000025708625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002200104,0.0023569823,0.0005508544,0.00016422628,0.0001317054,0.000033861583,0.0008487075,0.009909105,0.9800515,0.00023106542,0.0028416936,0.0006801612],"study_design_scores_gemma":[0.0049559176,0.00012514171,0.00028328024,0.000029002205,0.00020626023,0.0000057047773,0.00010272701,0.013337456,0.9790256,0.00029033655,0.0012367023,0.0004018659],"about_ca_topic_score_codex":0.000027613085,"about_ca_topic_score_gemma":0.0000030558663,"teacher_disagreement_score":0.0057809353,"about_ca_system_score_codex":0.00012572421,"about_ca_system_score_gemma":0.00022428269,"threshold_uncertainty_score":0.9997909},"labels":[],"label_agreement":null},{"id":"W2085034992","doi":"10.1016/s0731-7085(01)00546-5","title":"Analysis of urinary caffeine metabolites by HPLC-DAD: the use of metabolic ratios to assess CYP1A2 enzyme activity","year":2002,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Chemistry; Chromatography; CYP1A2; Caffeine; High-performance liquid chromatography; Urine; Analyte; Extraction (chemistry); Solid phase extraction; Urinary system; Enzyme; Biochemistry; Cytochrome P450; Internal medicine","score_opus":0.2266810644528653,"score_gpt":0.44258972464027624,"score_spread":0.21590866018741095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085034992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97294104,0.016468676,0.004157138,0.0050800378,0.0003782617,0.00024177851,0.0006556935,0.000011671204,0.000065686545],"genre_scores_gemma":[0.9851142,0.011153263,0.000795933,0.0022204418,0.00030624948,0.000010746113,0.0000220722,0.0000172515,0.00035981543],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948753,0.0014910686,0.0015947251,0.00040478152,0.0010543646,0.0005797742],"domain_scores_gemma":[0.9951363,0.001831204,0.00096202124,0.0003183973,0.0005556071,0.0011964429],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023002464,0.00040782508,0.0020101257,0.0016262748,0.00020688564,0.000049257393,0.0006557812,0.00029956718,0.0042687976],"category_scores_gemma":[0.00046251147,0.0002560257,0.0012740259,0.005925089,0.00084827514,0.0002613451,0.00026305948,0.0010217981,0.000007748521],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010316914,0.0052406816,0.024816815,0.000098276345,0.06269068,0.00009007514,0.0007605841,0.0030304948,0.7860833,0.00039352736,0.008440161,0.10732375],"study_design_scores_gemma":[0.002040174,0.00029099055,0.020638088,0.000011012309,0.09319598,0.000037826918,0.00005890504,0.16472356,0.21432954,0.000029995226,0.5042618,0.00038210765],"about_ca_topic_score_codex":0.00005273214,"about_ca_topic_score_gemma":0.0000054732877,"teacher_disagreement_score":0.57175374,"about_ca_system_score_codex":0.000021195649,"about_ca_system_score_gemma":0.000059281047,"threshold_uncertainty_score":0.9999892},"labels":[],"label_agreement":null},{"id":"W2085439942","doi":"10.1177/0269881113512041","title":"Genetic differences in cytochrome P450 enzymes and antidepressant treatment response","year":2013,"lang":"en","type":"article","venue":"Journal of Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"Lundbeckfonden; National Institute for Health and Care Research","keywords":"Antidepressant; Cytochrome P450; Pharmacology; CYP2D6; Psychology; Medicine; Psychiatry; Internal medicine; Metabolism; Anxiety","score_opus":0.08094645007149964,"score_gpt":0.42272629523067207,"score_spread":0.3417798451591724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085439942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97761524,0.01759529,0.000028926437,0.0019659393,0.0018346171,0.0005362933,0.000018656892,0.000017257156,0.00038777883],"genre_scores_gemma":[0.98179734,0.015011396,0.0005419756,0.0016770479,0.0005984009,0.00007317753,5.574767e-7,0.000029598632,0.000270481],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962961,0.0015332133,0.0010188575,0.00033600934,0.00020732875,0.0006084588],"domain_scores_gemma":[0.9977051,0.0009169075,0.00052087614,0.00015387678,0.00018646535,0.00051677745],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009241429,0.00036170598,0.00076025,0.0005898488,0.000119692515,0.00004019346,0.00038983743,0.0003004158,0.0030726236],"category_scores_gemma":[0.00007429974,0.0002839985,0.00016319162,0.0002691871,0.0003165279,0.00019604279,0.000075134325,0.0007461939,0.00008391235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004205468,0.0011512507,0.07885727,0.000025754161,0.00045882972,0.00054189266,0.0011934103,0.00017191778,0.87199503,0.00004886884,0.005143605,0.036206696],"study_design_scores_gemma":[0.012454798,0.0011761449,0.91744643,0.000019837986,0.00032018355,0.0006739352,0.00017722063,0.00104092,0.020695427,0.0008419472,0.04480379,0.00034932946],"about_ca_topic_score_codex":0.000042477906,"about_ca_topic_score_gemma":0.0000072232287,"teacher_disagreement_score":0.8512996,"about_ca_system_score_codex":0.000093377836,"about_ca_system_score_gemma":0.00017083235,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W2085913165","doi":"10.1016/j.cbi.2008.09.013","title":"Safety testing of metabolites: Expectations and outcomes","year":2008,"lang":"en","type":"review","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Metabolite; Toxicity; Pharmacology; Chemistry; Active metabolite; Kidney; Transporter; Biochemistry; Drug; Metabolism; Biology; Endocrinology","score_opus":0.3709393384965347,"score_gpt":0.5204592740062784,"score_spread":0.14951993550974374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085913165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021422708,0.9843053,0.000018614757,0.00004341798,0.0011013225,0.00055552216,0.0007196163,0.000103256636,0.011010632],"genre_scores_gemma":[0.0020214121,0.9952528,0.0010190274,0.00019655841,0.0003007561,0.00021936884,0.00024931287,0.00003948178,0.0007012724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972408,0.00044445487,0.0012037996,0.00056959945,0.00010818455,0.0004332076],"domain_scores_gemma":[0.9944048,0.0041586254,0.00068557484,0.0002778803,0.00018524095,0.0002878891],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019351895,0.0005719008,0.0019522365,0.00021599219,0.00030695938,0.000015770793,0.0003905537,0.0006176972,0.0009273671],"category_scores_gemma":[0.0010261991,0.0004169579,0.0006089417,0.00039127233,0.00050069136,0.00006607481,0.00026032855,0.0015184877,0.00010278699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024754358,0.00048659154,0.00035591415,0.0008176953,0.001073897,0.000017781715,0.00029480987,0.0000031476595,0.0028909508,0.000534554,0.001648202,0.9918517],"study_design_scores_gemma":[0.0003517709,0.000025156676,0.000058060486,0.00030855232,0.0009656907,0.00023265903,0.0000955595,0.000034253895,0.0011741015,0.000113415736,0.9962425,0.00039826258],"about_ca_topic_score_codex":0.000008842066,"about_ca_topic_score_gemma":0.0000011078954,"teacher_disagreement_score":0.99459434,"about_ca_system_score_codex":0.0000603856,"about_ca_system_score_gemma":0.00012773502,"threshold_uncertainty_score":0.99998593},"labels":[],"label_agreement":null},{"id":"W2086310887","doi":"10.1097/00004714-200206000-00014","title":"Treatment of Codeine Dependence With Inhibitors of Cytochrome P450 2D6","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Codeine; Dextromethorphan; Quinidine; CYP2D6; Placebo; Morphine; Pharmacology; Analgesic; Anesthesia; Fluoxetine; Medicine; Randomized controlled trial; Cocaine dependence; Internal medicine; Cytochrome P450; Serotonin; Psychiatry; Addiction","score_opus":0.22944764219403752,"score_gpt":0.5288180988072396,"score_spread":0.2993704566132021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086310887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305273,0.007292937,0.00013093332,0.0015018476,0.0039702095,0.00042792226,0.00006533221,0.000015136491,0.0035429285],"genre_scores_gemma":[0.97671455,0.019145062,0.0010615968,0.0009623895,0.0016154986,0.0000126876,0.00000186957,0.00003821252,0.00044814424],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942817,0.0011663173,0.0032132138,0.00036186297,0.00047246396,0.00050445297],"domain_scores_gemma":[0.99363095,0.0018293215,0.0029022945,0.00027425654,0.00071404723,0.000649126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015413801,0.00037877253,0.0017342452,0.00033850063,0.0000774307,0.0000059875097,0.0005905536,0.0005117854,0.004146933],"category_scores_gemma":[0.00017923645,0.00027556444,0.0006611103,0.0004362056,0.0008789561,0.00014493657,0.00005292638,0.0010360726,0.000045544122],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02459951,0.019017207,0.061086815,0.00019976775,0.00516956,0.0011796406,0.0012537858,0.0030980788,0.63316435,0.00027052703,0.022282226,0.22867851],"study_design_scores_gemma":[0.09481955,0.02263009,0.036934793,0.00011563161,0.004887672,0.0013997136,0.00016671457,0.0042567207,0.2663722,0.0006943986,0.5667838,0.0009387318],"about_ca_topic_score_codex":0.000005511286,"about_ca_topic_score_gemma":0.0000034095463,"teacher_disagreement_score":0.54450154,"about_ca_system_score_codex":0.00004728062,"about_ca_system_score_gemma":0.00019915344,"threshold_uncertainty_score":0.99996966},"labels":[],"label_agreement":null},{"id":"W2086430566","doi":"10.1007/s11010-011-0994-z","title":"Estradiol-mediated suppression of CYP1B1 expression in mouse MA-10 Leydig cells is independent of protein kinase A and estrogen receptor","year":2011,"lang":"en","type":"article","venue":"Molecular and Cellular Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Estradiol benzoate; Internal medicine; Endocrinology; CYP1B1; Estrogen; Estrogen receptor; Biology; Luteinizing hormone; Receptor; Messenger RNA; Antagonist; Hormone; Chemistry; Cytochrome P450; Metabolism; Medicine; Biochemistry; Cancer; Gene","score_opus":0.0308398030580363,"score_gpt":0.30137420925240116,"score_spread":0.27053440619436486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086430566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919247,0.0067294054,0.000070813905,0.000025022242,0.000074598276,0.00034421164,0.00020560763,0.000012956027,0.00061270467],"genre_scores_gemma":[0.99861723,0.00025886978,0.0006512076,0.000080725156,0.000022897133,0.000033129323,0.00006016498,0.000026176482,0.00024958048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984609,0.00019028454,0.00043507206,0.0003967341,0.00018549305,0.0003315188],"domain_scores_gemma":[0.99916935,0.000027114542,0.00021019185,0.00024592533,0.00005955122,0.00028786488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032572972,0.0002539647,0.0003359871,0.00008544899,0.000042384552,0.0000064986875,0.00020321652,0.00042083443,0.00057794567],"category_scores_gemma":[0.000025017018,0.00024723102,0.000083848514,0.000109061286,0.0002259315,0.000032769534,0.0001681448,0.00037047954,0.000003921371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038634462,0.00042706623,0.0015681128,0.0002725782,0.00005448821,0.000060607865,0.00045233936,0.000003653487,0.99570876,0.000019537027,0.000096562304,0.0009499359],"study_design_scores_gemma":[0.0018644497,0.00006812387,0.00004013263,0.000060773673,0.00006616628,0.0000052164974,0.00011697045,0.00011019547,0.9962811,0.00007688536,0.001078049,0.00023192195],"about_ca_topic_score_codex":0.000025089244,"about_ca_topic_score_gemma":1.8260559e-7,"teacher_disagreement_score":0.006692569,"about_ca_system_score_codex":0.000013383754,"about_ca_system_score_gemma":0.000064167245,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W2086562471","doi":"10.1177/009286150303700102","title":"Response to Senn Paper (Drug Information Journal, 2001;35: 1479–1494)","year":2003,"lang":"en","type":"article","venue":"Drug Information Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacy; Drug; Pharmacology; Medicine; Family medicine","score_opus":0.047021281762970046,"score_gpt":0.38541452258122544,"score_spread":0.3383932408182554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086562471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91640306,0.0011471357,0.0056608957,0.017183753,0.01401505,0.0009763572,0.00020898056,0.00016181597,0.044242933],"genre_scores_gemma":[0.8915369,0.004737003,0.0048870486,0.09352071,0.0014459299,0.00006330436,0.00009411252,0.00006263545,0.0036523463],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466175,0.0016238303,0.0018036861,0.00013643978,0.00078232243,0.0009919753],"domain_scores_gemma":[0.99604046,0.00034313384,0.000972244,0.00026868386,0.0009378777,0.0014376248],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008718071,0.00042551107,0.00040665947,0.0009951649,0.001349237,0.00066425046,0.0005925863,0.00025897444,0.0062143896],"category_scores_gemma":[0.001074264,0.00038652396,0.00026187577,0.00066912174,0.000091722024,0.0061133974,0.00009116693,0.0022141945,0.0034939498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022630852,0.00018942574,0.00085626356,0.00004466192,0.00026545033,0.000046316192,0.022859596,0.021229982,0.008513136,0.0010551431,0.87411934,0.06855761],"study_design_scores_gemma":[0.0037258482,0.000063720305,0.00084925117,0.000027752703,0.000115627314,0.0016648783,0.0022503678,0.0010436737,0.0114736715,0.0005901961,0.97772026,0.00047476756],"about_ca_topic_score_codex":0.000003937046,"about_ca_topic_score_gemma":0.0000024549136,"teacher_disagreement_score":0.10360092,"about_ca_system_score_codex":0.0002549465,"about_ca_system_score_gemma":0.0007275896,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W2086609307","doi":"10.1139/y10-023","title":"Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Nephrotoxicity; Pharmacology; Toxicity; Metabolite; Cell culture; Pharmacokinetics; Drug; In vitro; Kidney; Ifosfamide; Active metabolite; Chemistry; Medicine; Biology; Internal medicine; Biochemistry; Chemotherapy; Cisplatin","score_opus":0.07271497306116342,"score_gpt":0.3900717585397407,"score_spread":0.31735678547857726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086609307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993354,0.0010395478,0.000017014936,0.00226056,0.002088432,0.00077862805,0.00011582701,0.0000067466376,0.00033922607],"genre_scores_gemma":[0.9964982,0.00006676472,0.00012038159,0.0022804094,0.00086455187,0.000029260711,0.000005967053,0.000034352423,0.000100110236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967729,0.0009948808,0.00089302426,0.0003551275,0.00019977783,0.0007842936],"domain_scores_gemma":[0.9973625,0.0005260906,0.0008879634,0.0002488236,0.00036994158,0.00060466747],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016824885,0.00039238483,0.0008561463,0.0002922012,0.00068953505,0.000017727078,0.0009328054,0.00040367738,0.0009652408],"category_scores_gemma":[0.0000368539,0.0002507714,0.00016731843,0.00040194072,0.0011667656,0.0001016098,0.00012367032,0.0038425073,0.0000029782161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070633116,0.00045499785,0.015637582,0.000081738064,0.00018727017,0.000043258777,0.002231878,0.001816649,0.9767629,0.000112760434,0.0015846244,0.00038001864],"study_design_scores_gemma":[0.006123752,0.00064707146,0.011199773,0.000015307562,0.00046256778,0.000064024505,0.00029265322,0.0006585685,0.9496948,0.0001886875,0.03037784,0.00027493012],"about_ca_topic_score_codex":0.00039663518,"about_ca_topic_score_gemma":0.006005178,"teacher_disagreement_score":0.028793216,"about_ca_system_score_codex":0.000059555507,"about_ca_system_score_gemma":0.0011907622,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W2087019997","doi":"10.1124/dmd.31.5.670","title":"Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Glucuronidation; Xenobiotic; Glucuronosyltransferase; Enzyme; Chemistry; Biochemistry; Metabolism; Galangin; Microsome; Kaempferol; Flavonoid; Antioxidant","score_opus":0.050512699763427836,"score_gpt":0.3622494155833755,"score_spread":0.31173671581994766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087019997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986865,0.004781582,0.00067477487,0.00055267406,0.0020138891,0.00038903084,0.00013085037,0.000032040774,0.0045601907],"genre_scores_gemma":[0.99721813,0.0013173011,0.00017687006,0.000734792,0.00017501318,0.000018605728,0.00001587066,0.000019574614,0.00032382502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980932,0.00078855513,0.00029978305,0.0002866629,0.00021683253,0.00031495918],"domain_scores_gemma":[0.99913126,0.00012653104,0.00022401477,0.00024466508,0.000105492494,0.00016803286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007073308,0.0002243,0.00029306248,0.000080959995,0.00028507615,0.000025418143,0.00019348077,0.00017006701,0.00021345916],"category_scores_gemma":[0.000079187135,0.0001732691,0.00013325845,0.00027179206,0.0002296243,0.00017818464,0.00007819786,0.0003899635,0.000015729904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026075405,0.0006951609,0.004023433,0.00013416397,0.00017764531,0.0000033483707,0.0023720448,0.0005239771,0.8736411,0.079930656,0.0013162451,0.03692148],"study_design_scores_gemma":[0.0015109417,0.000012496282,0.035300925,0.000009922855,0.00047655235,0.000012988383,0.00009741879,0.00085762626,0.84078753,0.002598214,0.118098825,0.00023655362],"about_ca_topic_score_codex":0.000025272187,"about_ca_topic_score_gemma":0.0000047043236,"teacher_disagreement_score":0.11678258,"about_ca_system_score_codex":0.000017200256,"about_ca_system_score_gemma":0.00007226013,"threshold_uncertainty_score":0.7065709},"labels":[],"label_agreement":null},{"id":"W2087192577","doi":"10.1371/journal.pgen.1004648","title":"Genome-Wide Discovery of Drug-Dependent Human Liver Regulatory Elements","year":2014,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Human Genome Research Institute; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Canadian Institutes of Health Research; National Institutes of Health; Oak Ridge Institute for Science and Education","keywords":"Pregnane X receptor; Biology; Enhancer; Genetics; Drug metabolism; Gene; Computational biology; Genome-wide association study; CYP3A4; Transcription factor; Single-nucleotide polymorphism; Cytochrome P450; Drug; Nuclear receptor; Pharmacology; Genotype; Biochemistry; Enzyme","score_opus":0.07357397746529869,"score_gpt":0.36719074534052165,"score_spread":0.29361676787522295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087192577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843056,0.0036307434,0.00010839412,0.00007959177,0.00075755914,0.0004421446,0.00009338028,0.000053868447,0.0064037675],"genre_scores_gemma":[0.99450654,0.0012122758,0.0002963858,0.0011812345,0.0005396102,0.0000374024,0.000047957492,0.00006413183,0.0021144408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972355,0.00051942986,0.00074661744,0.00045581188,0.00045146444,0.0005911863],"domain_scores_gemma":[0.99846685,0.00020094634,0.00035473198,0.00052886095,0.00016240164,0.00028622482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007932731,0.00033574374,0.0004468195,0.00016155651,0.00022374783,0.000027870685,0.00061397103,0.00022146558,0.00071950536],"category_scores_gemma":[0.000050226412,0.0003440754,0.00016394013,0.0001494667,0.00025598845,0.000083794745,0.0003130414,0.00048362598,0.00014040769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008326085,0.00090195524,0.064236425,0.00016546268,0.00042539084,0.000012286469,0.0006871627,0.001116622,0.9276212,0.0009400843,0.00082798593,0.0029821696],"study_design_scores_gemma":[0.0021283757,0.00010624559,0.032938197,0.000014958851,0.00057957333,0.000004067878,0.000048848866,0.003100643,0.8958086,0.0011300131,0.063670605,0.00046988807],"about_ca_topic_score_codex":0.0000036618237,"about_ca_topic_score_gemma":0.000010474221,"teacher_disagreement_score":0.062842615,"about_ca_system_score_codex":0.000051340692,"about_ca_system_score_gemma":0.000068697314,"threshold_uncertainty_score":0.9999011},"labels":[],"label_agreement":null},{"id":"W2087313521","doi":"10.1517/14740330903405593","title":"Clinically based evidence of drug–herb interactions: a systematic review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine","funders":"","keywords":"Medicine; Drug; Herb; Drug interaction; Pharmacology; Traditional medicine; Medicinal herbs","score_opus":0.26412354879274036,"score_gpt":0.5583105977799898,"score_spread":0.29418704898724946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087313521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.9822033e-7,0.98559207,0.00006621456,0.0015854737,0.005636941,0.0049114903,0.0001842886,0.00012846374,0.0018947838],"genre_scores_gemma":[0.000020355059,0.98443794,0.00032506848,0.012337929,0.0008764397,0.00089851685,0.0001780486,0.00010668298,0.0008190151],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.985894,0.0070828367,0.0046452214,0.0010452876,0.0006791704,0.0006534661],"domain_scores_gemma":[0.98743665,0.007440384,0.0029064,0.0013612346,0.00034614274,0.00050916715],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005598817,0.0010918406,0.0056019993,0.00039596925,0.00024506688,0.000028051414,0.0015391461,0.0005398318,0.0016424172],"category_scores_gemma":[0.001850269,0.00085275195,0.0020694586,0.0007563804,0.0002063107,0.00015610464,0.0001860712,0.002260773,0.00069026963],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022867792,0.00080323423,4.4953282e-7,0.56937426,0.00054521416,0.000014896428,0.0001935179,0.000021996346,0.0000073987308,0.00019225392,0.03405329,0.3945648],"study_design_scores_gemma":[0.00042245045,0.000058443744,2.3238943e-7,0.40596884,0.00082629424,0.000016895756,0.000011868356,0.00010579294,0.000030387771,0.000010678648,0.5920959,0.00045223004],"about_ca_topic_score_codex":0.000009648374,"about_ca_topic_score_gemma":0.000001429374,"teacher_disagreement_score":0.5580426,"about_ca_system_score_codex":0.0002533138,"about_ca_system_score_gemma":0.00083442224,"threshold_uncertainty_score":0.99939233},"labels":[],"label_agreement":null},{"id":"W2087413883","doi":"10.1016/j.abb.2010.06.018","title":"Functional differences in the cytochrome P450 1 family enzymes from Zebrafish (Danio rerio) using heterologously expressed proteins","year":2010,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Environmental Health Sciences; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Cytochrome P450; Danio; Zebrafish; Metabolite; CYP1B1; Biochemistry; Cytochrome; Biology; Enzyme; Benzo(a)pyrene; Coumarin; Hydroxylation; Substrate (aquarium); Chemistry; Gene; Carcinogen; Botany","score_opus":0.06844823868913401,"score_gpt":0.3333913210165195,"score_spread":0.2649430823273855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087413883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975968,0.00065582054,0.00009817102,0.00023263998,0.0002232575,0.00022123026,0.00033348482,0.000016272732,0.0006223337],"genre_scores_gemma":[0.99788487,0.00023838598,0.000678938,0.00055933505,0.0005086677,0.0000305797,0.00005833859,0.000011386208,0.00002949193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987981,0.00015778685,0.00028418883,0.0003375945,0.00014725832,0.00027510457],"domain_scores_gemma":[0.9990906,0.00040023486,0.00015487208,0.00023047756,0.000023542041,0.00010023992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015608655,0.00022381608,0.00026641585,0.00003994006,0.0001675412,0.00002693649,0.0003626776,0.00017813811,0.00005693191],"category_scores_gemma":[0.000028910934,0.00016965512,0.00009505039,0.000109570974,0.00066722394,0.000055335528,0.000130604,0.0007152225,0.0000019280894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021975128,0.0002987014,0.0025205323,0.00003938696,0.00007046636,0.000008055099,0.00069716386,0.000010977697,0.99192965,0.00018462534,0.000049320908,0.0039713914],"study_design_scores_gemma":[0.000945296,0.000040581243,0.058670476,0.000016778318,0.00007307077,0.0000071167833,0.00020869516,0.0013880009,0.9336879,0.004015218,0.0007515887,0.00019526902],"about_ca_topic_score_codex":0.00006530028,"about_ca_topic_score_gemma":0.000005068936,"teacher_disagreement_score":0.058241718,"about_ca_system_score_codex":0.000002846247,"about_ca_system_score_gemma":0.00006437545,"threshold_uncertainty_score":0.6918335},"labels":[],"label_agreement":null},{"id":"W2087442671","doi":"10.1186/1744-8603-7-30","title":"Pharmacogenomic technologies: a necessary \"luxury\" for better global public health?","year":2011,"lang":"en","type":"article","venue":"Globalization and Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Public health; Emerging technologies; Population; Psychological intervention; Medicine; Drug development; Health care; Business; Health administration; Risk analysis (engineering); Biotechnology; Economic growth; Environmental health; Drug; Pharmacology; Economics; Computer science; Biology; Nursing","score_opus":0.3135427175318022,"score_gpt":0.47915067446729187,"score_spread":0.1656079569354897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087442671","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24576719,0.16405487,0.1482639,0.3628562,0.014337965,0.012765114,0.0065957685,0.0043201363,0.041038834],"genre_scores_gemma":[0.90641737,0.01525119,0.004582433,0.072863005,0.00028518366,0.000205087,0.0002170862,0.00003953453,0.00013908176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974638,0.00029878347,0.0006315081,0.00050991366,0.00014972893,0.000946235],"domain_scores_gemma":[0.99867165,0.00003535842,0.00035424274,0.00020738719,0.00013905087,0.00059229095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013855731,0.0002939533,0.00042905356,0.00012560003,0.0006266973,0.000039888877,0.0003300391,0.0002544525,0.000349282],"category_scores_gemma":[0.000039315255,0.00029308867,0.00009054831,0.00042662924,0.00019174429,0.00015121658,0.00013580381,0.00026109695,0.000040973013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021851873,0.0006818638,0.04764018,0.0005000006,0.0002509012,0.000005863992,0.0019956622,0.000013989954,0.00032820913,0.05765008,0.12192762,0.7687871],"study_design_scores_gemma":[0.0034679598,0.00022959035,0.008192375,0.00001579885,0.00005368852,0.000037579073,0.00046135043,0.0024770168,0.00060174696,0.008329704,0.97576684,0.00036636574],"about_ca_topic_score_codex":0.00012603802,"about_ca_topic_score_gemma":0.000039490817,"teacher_disagreement_score":0.8538392,"about_ca_system_score_codex":0.00023284627,"about_ca_system_score_gemma":0.000560607,"threshold_uncertainty_score":0.99995214},"labels":[],"label_agreement":null},{"id":"W2087518177","doi":"10.1080/004982500406390","title":"Regional and cellular distribution of CYP2D subfamily members in rat brain","year":2000,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; Medical Research Council; Centre for Addiction and Mental Health","keywords":"Subfamily; Blot; Human brain; Biology; Molecular biology; Western blot; Gene isoform; Gene; Genetics; Neuroscience","score_opus":0.057534225407250825,"score_gpt":0.3703727062381976,"score_spread":0.3128384808309468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087518177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878873,0.0023535064,0.000017948123,0.0020694733,0.00029826665,0.00022145965,0.00009112735,0.000022992104,0.0070378864],"genre_scores_gemma":[0.9959116,0.0012830446,0.000061149985,0.0016400296,0.00011169707,0.0000066911725,0.000090375586,0.00001432622,0.0008810677],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859977,0.00030990623,0.00034436662,0.00026920397,0.0001327485,0.00034400044],"domain_scores_gemma":[0.9993265,0.00024303129,0.00006519121,0.00014023346,0.000040817224,0.00018420555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058055384,0.00016767033,0.00025897918,0.000066258595,0.00008246858,0.000008961376,0.00015264748,0.00023453987,0.0019856086],"category_scores_gemma":[0.00003548391,0.00016851841,0.000061387014,0.00022563864,0.00029672452,0.00005546707,0.00003743943,0.0004074554,0.00004924994],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001267951,0.0011671424,0.016230961,0.00018219504,0.00019821893,0.00013464814,0.0017524278,0.0021074482,0.845412,0.013664894,0.028899994,0.08898208],"study_design_scores_gemma":[0.003312678,0.00008586477,0.0147029525,0.000023163584,0.00012628896,0.000022618062,0.00007360608,0.004193767,0.18456513,0.0013091173,0.79123783,0.0003469856],"about_ca_topic_score_codex":0.000040006755,"about_ca_topic_score_gemma":0.000009459482,"teacher_disagreement_score":0.76233786,"about_ca_system_score_codex":0.000026611062,"about_ca_system_score_gemma":0.000053829575,"threshold_uncertainty_score":0.9989267},"labels":[],"label_agreement":null},{"id":"W2087592754","doi":"10.1097/01.ypg.0000185030.35558.6d","title":"Assay for the simultaneous detection of the *1C and *1F alleles of the CYP1A2 gene by real-time polymerase chain reaction and melting curve analysis","year":2006,"lang":"en","type":"article","venue":"Psychiatric Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; Government of Canada; Health Canada","funders":"","keywords":"Genotyping; CYP1A2; Allele; Polymerase chain reaction; Genotype; Melting curve analysis; Biology; Pharmacogenetics; Genetics; Gene; Pharmacology; Cytochrome P450; Enzyme; Biochemistry","score_opus":0.01859545749216046,"score_gpt":0.3286212168641466,"score_spread":0.3100257593719861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087592754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97658116,0.019975593,0.0009880112,0.00064375484,0.0006929589,0.0006562517,0.00027705802,0.000013602824,0.0001715841],"genre_scores_gemma":[0.99353445,0.005352962,0.00035469234,0.00017040802,0.00027654652,0.00002753975,0.000011160879,0.000022457216,0.0002497597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982618,0.0005052918,0.00048867223,0.00027604811,0.000200219,0.00026793344],"domain_scores_gemma":[0.9980019,0.0009888328,0.0005128921,0.0003044045,0.00012631783,0.00006570082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090466393,0.0002049113,0.00028243274,0.00009961698,0.00045313587,0.00001482822,0.00026802198,0.00019047954,0.000013606894],"category_scores_gemma":[0.00007501513,0.00012525044,0.00020189631,0.00064428034,0.0002272803,0.000017231892,0.000097952056,0.00025772225,4.833904e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013104719,0.0001751889,0.022082759,0.00004256092,0.0005965319,2.2871289e-7,0.00023336832,0.009088158,0.9393078,0.000048514325,0.0003816782,0.027912136],"study_design_scores_gemma":[0.002170861,0.00009671775,0.049999777,0.0000044585418,0.0068372185,0.00001720534,0.0001400535,0.2519137,0.66716397,0.0006540064,0.020673003,0.0003289976],"about_ca_topic_score_codex":0.00026589338,"about_ca_topic_score_gemma":0.00011124695,"teacher_disagreement_score":0.27214384,"about_ca_system_score_codex":0.000015091389,"about_ca_system_score_gemma":0.00004048641,"threshold_uncertainty_score":0.5107565},"labels":[],"label_agreement":null},{"id":"W2087660740","doi":"10.3399/bjgp09x453800","title":"What affects anticoagulation control in patients taking warfarin?","year":2009,"lang":"en","type":"article","venue":"British Journal of General Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park","funders":"","keywords":"Warfarin; Medicine; Control (management); Intensive care medicine; Internal medicine; Computer science; Atrial fibrillation; Artificial intelligence","score_opus":0.05655407815392492,"score_gpt":0.4202396308953216,"score_spread":0.3636855527413967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087660740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826071,0.009536275,0.00026397608,0.0020394782,0.0035885205,0.00027949724,0.000008039964,0.000012297402,0.001664819],"genre_scores_gemma":[0.9810841,0.0064259153,0.0007504376,0.0108145,0.0008062955,0.0000018284941,0.0000056059243,0.00001609476,0.000095185016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99735147,0.0011191994,0.00061076996,0.0001848879,0.00035208266,0.00038161728],"domain_scores_gemma":[0.997942,0.0003705344,0.00096354744,0.00008428578,0.00041277654,0.00022689177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019998234,0.00016360632,0.0003592283,0.00016764906,0.00014893062,0.00019957469,0.0002400387,0.00019062031,0.00016359854],"category_scores_gemma":[0.00081824773,0.00019150191,0.00011909462,0.00022363174,0.000041831714,0.0017971843,0.000024812889,0.001067464,0.000013911562],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018950738,0.0021882108,0.016383681,0.000016636424,0.00022006531,0.0013411159,0.00038787848,0.012109875,0.037845038,0.0002312221,0.0054762,0.921905],"study_design_scores_gemma":[0.028449675,0.0010267281,0.7447088,0.00025845988,0.0009489914,0.0025142063,0.00018865343,0.010002906,0.012094033,0.0010944016,0.19797656,0.0007366047],"about_ca_topic_score_codex":0.00002464506,"about_ca_topic_score_gemma":0.0000065455815,"teacher_disagreement_score":0.9211684,"about_ca_system_score_codex":0.0000676925,"about_ca_system_score_gemma":0.00008428334,"threshold_uncertainty_score":0.7809221},"labels":[],"label_agreement":null},{"id":"W2088489265","doi":"10.1016/s1056-8719(02)00190-9","title":"Porphyrinogenic xenobiotic-induced N-alkylprotoporphyrin IX formation: a bioassay utilizing chick embryo hepatic ferrochelatase","year":2002,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Xenobiotic; Embryo; Bioassay; Microsome; Ferrochelatase; Cytochrome P450; Biochemistry; Biology; Enzyme; Drug metabolism; Heme; Chemistry; Molecular biology; Cell biology; Genetics","score_opus":0.2873985512816267,"score_gpt":0.49096069544264553,"score_spread":0.2035621441610188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088489265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97481364,0.010533957,0.002642896,0.0028482387,0.00262965,0.0011618863,0.000053714462,0.00012433564,0.005191653],"genre_scores_gemma":[0.96293,0.005352587,0.024478978,0.0056580496,0.0011616263,0.0000851328,0.0000059105782,0.00004031822,0.00028735158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9916312,0.0040426026,0.0019913292,0.00064470683,0.0005458883,0.0011442477],"domain_scores_gemma":[0.9947473,0.0019761967,0.0012244061,0.0002406478,0.0003761021,0.0014353548],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051277583,0.0007225167,0.0013745349,0.0003981636,0.00061019737,0.00011054685,0.0008682275,0.0009465359,0.010251217],"category_scores_gemma":[0.00096710655,0.00051178783,0.00062502315,0.00073461584,0.00053362944,0.00048654215,0.00045958767,0.0029487633,0.0001230334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064900675,0.0019253151,0.0005438435,0.00007303702,0.00054895016,0.000670835,0.00038844487,0.0000924067,0.80411655,0.0009419054,0.0022663276,0.18778336],"study_design_scores_gemma":[0.011440644,0.0036673653,0.005564063,0.0000614734,0.0026557434,0.0031998742,0.00045117215,0.027238483,0.78513277,0.006155264,0.15299948,0.0014336539],"about_ca_topic_score_codex":0.0000023249204,"about_ca_topic_score_gemma":6.020783e-7,"teacher_disagreement_score":0.1863497,"about_ca_system_score_codex":0.00015055628,"about_ca_system_score_gemma":0.00006983756,"threshold_uncertainty_score":0.9997334},"labels":[],"label_agreement":null},{"id":"W2088641690","doi":"10.1016/j.toxlet.2008.10.019","title":"Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacy","year":2008,"lang":"en","type":"review","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacogenomics; Toxicogenomics; Computational biology; Pharmacogenetics; Genotyping; Drug; Medicine; Drug development; Bioinformatics; Biology; Pharmacology; Genetics; Genotype; Gene","score_opus":0.4700305489504826,"score_gpt":0.5615932813255406,"score_spread":0.09156273237505808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088641690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054847866,0.93810576,0.000013012302,0.00089669466,0.0032818974,0.0022959718,0.00020574131,0.00005319786,0.00029985464],"genre_scores_gemma":[0.0016224929,0.992819,0.00033013505,0.0042290934,0.00056099537,0.0002041131,0.00005438263,0.00010820797,0.00007157333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907895,0.003779941,0.0029482255,0.001257975,0.00022358319,0.0010008101],"domain_scores_gemma":[0.99461865,0.0033463852,0.0009508842,0.00047577912,0.00005968595,0.0005486372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027277532,0.0009373744,0.004313996,0.0010321729,0.0001917043,0.000012179527,0.00089266896,0.0011318636,0.00015051653],"category_scores_gemma":[0.00040296456,0.00086815946,0.0007835826,0.0007720009,0.0015331334,0.00007175226,0.00072624313,0.0020720065,0.00015090057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005380251,0.00065983227,0.00044067204,0.002904596,0.0041656923,0.00031659598,0.00072353706,0.00008433039,0.0013068615,0.000055931032,0.008649096,0.9801548],"study_design_scores_gemma":[0.0033203894,0.000117449614,0.00081203,0.0005444845,0.0021618842,0.00020137637,0.00004625536,0.000028638682,0.00018793387,0.000010218047,0.99180055,0.0007687914],"about_ca_topic_score_codex":0.000006208555,"about_ca_topic_score_gemma":0.0000072836606,"teacher_disagreement_score":0.98315144,"about_ca_system_score_codex":0.00020072509,"about_ca_system_score_gemma":0.0002894744,"threshold_uncertainty_score":0.9993769},"labels":[],"label_agreement":null},{"id":"W2089092612","doi":"10.1134/s0006297910050056","title":"Mechanism of steroidogenic electron transport: Role of conserved Glu429 in destabilization of CYP11A1-Adrenodoxin complex","year":2010,"lang":"en","type":"article","venue":"Biochemistry (Moscow)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adrenodoxin; Cholesterol side-chain cleavage enzyme; Chemistry; Hemeprotein; Cytochrome; Ionic strength; Cytochrome c; Electron transport chain; Biophysics; Mutant; Dissociation (chemistry); Stereochemistry; Cytochrome P450; Biochemistry; Enzyme; Mitochondrion; Heme; Biology","score_opus":0.04941577240373465,"score_gpt":0.3619158691488349,"score_spread":0.31250009674510026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089092612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964245,0.0010903899,0.00005486288,0.00004503251,0.00024200245,0.00031197994,0.00032227364,0.000019841926,0.0014891077],"genre_scores_gemma":[0.9989592,0.00024085387,0.00044569583,0.000055370747,0.000063500935,0.000019015102,0.00012557961,0.00002798931,0.00006280708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981854,0.00013834659,0.0008095151,0.00031421837,0.00020143212,0.0003510679],"domain_scores_gemma":[0.99879766,0.00011195098,0.00043974267,0.0003177877,0.00018419245,0.0001486909],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054793764,0.00024036986,0.0005009304,0.000095968724,0.000041258052,0.0000024308677,0.00039468484,0.00041696778,0.0009642615],"category_scores_gemma":[0.00005506912,0.00026337727,0.00014321956,0.00029240228,0.0002876353,0.000036701007,0.000050693743,0.0004853456,0.0000029783798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003609329,0.00060177257,0.0122829955,0.00025095203,0.00006936996,0.0000026634186,0.00035031998,0.00007134901,0.9842641,0.0008025265,0.000026336362,0.0009167076],"study_design_scores_gemma":[0.0020408216,0.000071723814,0.0037984792,0.000017889759,0.00014728331,0.000007864995,0.00009449854,0.0009904766,0.99038047,0.0007901729,0.0014546289,0.00020568728],"about_ca_topic_score_codex":0.00007227618,"about_ca_topic_score_gemma":0.00008350548,"teacher_disagreement_score":0.008484516,"about_ca_system_score_codex":0.000020251407,"about_ca_system_score_gemma":0.00018056773,"threshold_uncertainty_score":0.9999818},"labels":[],"label_agreement":null},{"id":"W2089203579","doi":"10.3109/10408363.2011.620601","title":"Methadone: a review of drug-drug and pathophysiological interactions","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Clinical Laboratory Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Methadone; Medicine; Drug; Pharmacology; Methadone maintenance; Addiction; Drug interaction; Pharmacokinetics; Psychiatry","score_opus":0.5108621722003761,"score_gpt":0.6330056651490932,"score_spread":0.12214349294871707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089203579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006722866,0.9930595,0.0000048649677,0.0003335168,0.00284877,0.0013954737,0.0002879151,0.000027086628,0.0019756234],"genre_scores_gemma":[0.000035739697,0.99263096,0.0013628539,0.0051321206,0.00039827786,0.0003206968,0.000013310689,0.00002714533,0.00007888307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98232967,0.011174039,0.004329885,0.0012071321,0.00028451448,0.00067473383],"domain_scores_gemma":[0.9858499,0.0116120055,0.0010264018,0.0005299985,0.00029454188,0.0006871291],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01991352,0.00065589056,0.0050026546,0.0002456338,0.00019920229,0.000025085177,0.0012052254,0.00050320063,0.0015154898],"category_scores_gemma":[0.014310699,0.0004408682,0.00094825553,0.0015594477,0.0041604745,0.00019843712,0.0005097618,0.003001512,0.000243141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010105867,0.00056187296,0.00007193023,0.066342674,0.00004520097,0.000023250015,0.000030801948,4.1986777e-8,0.000004723394,0.00635303,0.0064417142,0.92011464],"study_design_scores_gemma":[0.00017369959,0.00006939566,0.000022452581,0.049700957,0.0012535491,0.000008988126,0.000010372483,0.000006678991,0.00000621877,0.0011498834,0.9471686,0.00042922667],"about_ca_topic_score_codex":0.0000053651047,"about_ca_topic_score_gemma":0.000004558456,"teacher_disagreement_score":0.9407269,"about_ca_system_score_codex":0.000032189873,"about_ca_system_score_gemma":0.0007209104,"threshold_uncertainty_score":0.9998043},"labels":[],"label_agreement":null},{"id":"W2089947577","doi":"10.1080/00498250310001638460","title":"Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review","year":2004,"lang":"en","type":"review","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Kidney; Intracellular; Biology; Enzyme; Chemistry; Pharmacology; Endocrinology; Internal medicine; Medicine; Cell biology; Biochemistry","score_opus":0.06439543471889159,"score_gpt":0.40965000339739316,"score_spread":0.34525456867850157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089947577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008641682,0.99648494,0.000010427285,0.00013547197,0.00029407474,0.0017926632,0.00016174519,0.000020052545,0.0002364833],"genre_scores_gemma":[0.0073351283,0.99179864,0.000073512,0.0003704424,0.00017697201,0.0000835653,0.000041655243,0.000045162215,0.000074911964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965225,0.0015383398,0.0008919889,0.0004559984,0.00027513862,0.00031607068],"domain_scores_gemma":[0.9963528,0.0021834285,0.0008141334,0.00033763947,0.000086362365,0.00022566393],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007993263,0.000488316,0.0017500978,0.0001671319,0.00016929851,0.000013582969,0.00029237196,0.0003074048,0.00014319569],"category_scores_gemma":[0.00038481326,0.00030878765,0.00030860235,0.0002927626,0.00042801275,0.00004638326,0.00019748455,0.00070188445,0.0000078168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014610382,0.0006130779,0.00001287919,0.2968366,0.00072307716,0.000022745919,0.0003148122,0.000019562427,0.010331575,0.0048647365,0.0022023523,0.68391246],"study_design_scores_gemma":[0.0010946324,0.00009730187,0.00009674031,0.09081885,0.01045703,0.000025764006,0.0000053301796,0.000049365317,0.03415045,0.00054260716,0.8622134,0.000448547],"about_ca_topic_score_codex":0.000003941137,"about_ca_topic_score_gemma":2.887252e-7,"teacher_disagreement_score":0.86001104,"about_ca_system_score_codex":0.00002688235,"about_ca_system_score_gemma":0.00020925442,"threshold_uncertainty_score":0.9999364},"labels":[],"label_agreement":null},{"id":"W2090113900","doi":"10.1016/j.amjopharm.2011.07.003","title":"Cytochrome P450 2D6 Phenotyping in an Elderly Population With Dementia and Response to Galantamine in Dementia: A Pilot Study","year":2011,"lang":"en","type":"article","venue":"˜The œAmerican journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University; Health Sciences North","funders":"","keywords":"Galantamine; Medicine; CYP2D6; Dextromethorphan; Dementia; Population; Dextrorphan; Internal medicine; Pharmacology; Disease; Donepezil; Cytochrome P450","score_opus":0.07233219960403652,"score_gpt":0.39006184127772103,"score_spread":0.3177296416736845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090113900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961479,0.0019921921,0.00040358194,0.00016642269,0.0002949901,0.0009271519,0.000011108107,0.000018393444,0.000038264046],"genre_scores_gemma":[0.9965025,0.00080906437,0.00078519265,0.0015112231,0.00026997217,0.000054513857,0.0000014712184,0.000055017725,0.000011047899],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99538344,0.0024088668,0.0009387577,0.0003664293,0.00033904062,0.00056344864],"domain_scores_gemma":[0.9982781,0.00023204308,0.000757922,0.00020902121,0.00013504765,0.00038787522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034361535,0.00035334012,0.0006448716,0.0008559205,0.00017010407,0.00004179456,0.00052000885,0.000042789427,0.00025286627],"category_scores_gemma":[0.000010334649,0.0002685941,0.000056124692,0.001220501,0.00013490961,0.00026778784,0.000061317995,0.0007537349,0.000004714049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05248542,0.0033123344,0.34587684,0.00001182648,0.00077126286,0.00029337103,0.010757251,0.0007508084,0.49855617,0.000006388277,0.000037603917,0.08714073],"study_design_scores_gemma":[0.013728375,0.012143178,0.9660291,0.000021649717,0.0006675786,0.00015510274,0.0014102956,0.00074973836,0.003014725,0.000096276206,0.001513866,0.00047007875],"about_ca_topic_score_codex":0.00035465654,"about_ca_topic_score_gemma":0.0002843245,"teacher_disagreement_score":0.6201523,"about_ca_system_score_codex":0.00009259473,"about_ca_system_score_gemma":0.00014293894,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W2090767709","doi":"10.1081/dmr-100000140","title":"MECHANISMS OF 1,1-DICHLOROETHYLENE-INDUCED CYTOTOXICITY IN LUNG AND LIVER<sup>*,†</sup>","year":2001,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Glutathione; Chemistry; Biochemistry; Microsome; Epoxide; Cytotoxicity; Lung; In vivo; Hepatocyte; In vitro; Biology; Internal medicine; Enzyme; Medicine","score_opus":0.15371251696697216,"score_gpt":0.4410058204818649,"score_spread":0.2872933035148927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090767709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008043548,0.9904406,0.00009309774,0.000048051817,0.0012874508,0.0049780607,0.0004885917,0.00007922427,0.0017805385],"genre_scores_gemma":[0.00057808444,0.9953618,0.0006716281,0.0007600923,0.0006643199,0.0009109011,0.0001281011,0.0002042986,0.000720753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9876619,0.005061865,0.0038083468,0.0015490392,0.00054143113,0.0013774368],"domain_scores_gemma":[0.9945637,0.0013112255,0.0020624853,0.0010864448,0.00017152894,0.0008046194],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0066449707,0.0017573612,0.008379086,0.0010835037,0.0002275334,0.000052212326,0.0014426241,0.0014476079,0.0012144183],"category_scores_gemma":[0.0007023662,0.0014787089,0.0015051075,0.0018464266,0.00028553547,0.00024231918,0.00069995486,0.003251102,0.00026165572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000325118,0.0005554151,0.000013398649,0.020274714,0.0003543668,0.00012430293,0.000668296,0.000014177982,0.00053728407,0.001580076,0.0014835199,0.97436196],"study_design_scores_gemma":[0.001533984,0.000025480198,0.00001735203,0.0034888082,0.0053848303,0.00011602637,0.000034219203,0.0007152238,0.0010495501,0.00048770124,0.9859203,0.0012265058],"about_ca_topic_score_codex":0.00009767673,"about_ca_topic_score_gemma":0.000022316206,"teacher_disagreement_score":0.9844368,"about_ca_system_score_codex":0.00012696121,"about_ca_system_score_gemma":0.00041818223,"threshold_uncertainty_score":0.9998487},"labels":[],"label_agreement":null},{"id":"W2090887850","doi":"10.1002/em.1045","title":"Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in <i>Escherichia coli lacZ</i> strains","year":2001,"lang":"en","type":"article","venue":"Environmental and Molecular Mutagenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; University of Guelph; Vanderbilt University","keywords":"Mutagen; Escherichia coli; Cytochrome P450; Quinoxaline; Carcinogen; Recombinant DNA; Enzyme; Chemistry; Biochemistry; Indole test; Heterocyclic amine; Quinoline; Reductase; Heterocyclic compound; Gene; Organic chemistry","score_opus":0.0358639784513549,"score_gpt":0.33260369998112005,"score_spread":0.29673972152976513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090887850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588823,0.0026542912,0.00006714023,0.00032151892,0.00012788195,0.00044388013,0.000067569104,0.000013094286,0.0004164041],"genre_scores_gemma":[0.9947437,0.0038069347,0.000054353917,0.0010064942,0.000034522986,0.000050996703,0.000073431576,0.000028746002,0.00020082983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862504,0.00020466195,0.00035135593,0.0003389619,0.00014545645,0.0003345004],"domain_scores_gemma":[0.99947196,0.00004542068,0.0001420089,0.00018295953,0.000004852217,0.00015279182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025974555,0.00024822706,0.00026793525,0.00008895405,0.00020795871,0.000015014099,0.00015377843,0.00015643066,0.00014867734],"category_scores_gemma":[0.0000063778903,0.00020019164,0.0000734088,0.00011688999,0.0003521509,0.00007632809,0.00015607075,0.0002537625,0.000007789029],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067979265,0.00034056214,0.01643912,0.0000200063,0.00009025148,0.000056481975,0.0005168181,0.00008737716,0.97165257,0.00009700032,0.000019649906,0.0106122065],"study_design_scores_gemma":[0.0024942504,0.00013460257,0.21295112,0.000008965391,0.00020038075,0.000043482054,0.00039073278,0.0004586436,0.76201177,0.00030433518,0.020670284,0.0003314116],"about_ca_topic_score_codex":0.0000616907,"about_ca_topic_score_gemma":0.000027666245,"teacher_disagreement_score":0.20964076,"about_ca_system_score_codex":0.000034483513,"about_ca_system_score_gemma":0.000006687628,"threshold_uncertainty_score":0.81635785},"labels":[],"label_agreement":null},{"id":"W2090903342","doi":"10.1002/jbt.20057","title":"Usefulness of studies on the molecular mechanism of action of herbals/botanicals: The case of St. John's wort","year":2005,"lang":"en","type":"review","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pregnane X receptor; Hypericum perforatum; CYP3A4; Mechanism of action; Mechanism (biology); Xenobiotic; Pharmacology; Drug; Kava; Medicine; Cytochrome P450; Traditional medicine; Chemistry; Nuclear receptor; Biochemistry; Enzyme; Transcription factor; Philosophy","score_opus":0.21022730785746369,"score_gpt":0.47937578387000257,"score_spread":0.2691484760125389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090903342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24625,0.7520649,0.000090869224,0.00037522224,0.0006042059,0.0004546484,0.00009484902,0.0000026261553,0.00006268743],"genre_scores_gemma":[0.3438811,0.6554823,0.000106570675,0.00034937554,0.00012317592,0.00001892813,0.0000024781305,0.000026459278,0.000009606331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99530864,0.0016756268,0.0021148927,0.0002844554,0.00030605268,0.0003103457],"domain_scores_gemma":[0.99427843,0.0014750496,0.0031844287,0.00036169673,0.0005329175,0.00016749706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002123854,0.0004387524,0.0024037547,0.00021676559,0.000069967515,0.0000044396015,0.000626518,0.0007846561,0.000095144394],"category_scores_gemma":[0.0005694177,0.00024890612,0.0009189872,0.00036030303,0.0009638332,0.000025332538,0.00022949299,0.0013502693,7.533922e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004390266,0.0011307982,8.891942e-7,0.0045699277,0.0048491172,0.0006453428,0.0002647811,0.00006891826,0.78796184,0.0118904365,0.0006201104,0.18755881],"study_design_scores_gemma":[0.00094797043,0.00055098836,5.49608e-7,0.0009793642,0.0050742854,0.0015701924,0.00023583861,0.00003127797,0.8653415,0.0013462594,0.12370074,0.00022107399],"about_ca_topic_score_codex":0.0000028715697,"about_ca_topic_score_gemma":0.0000015140863,"teacher_disagreement_score":0.18733774,"about_ca_system_score_codex":0.000043140437,"about_ca_system_score_gemma":0.0002649584,"threshold_uncertainty_score":0.9999963},"labels":[],"label_agreement":null},{"id":"W2091173057","doi":"10.1016/j.bcp.2007.09.009","title":"Microarray analysis of hepatic gene expression in pyrazole-mediated hepatotoxicity: Identification of potential stimuli of Cyp2a5 induction","year":2007,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; University Health Network","keywords":"Pyrazole; Microarray analysis techniques; Biology; Gene expression; Downregulation and upregulation; Gene; Cytochrome P450; Biochemistry; Cell biology; Molecular biology; Metabolism; Chemistry","score_opus":0.05231740914517804,"score_gpt":0.40294011078668424,"score_spread":0.3506227016415062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091173057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941484,0.0021933406,0.001422742,0.00008520979,0.001252822,0.0005176981,0.00027750633,0.000026685744,0.00007561691],"genre_scores_gemma":[0.9981487,0.00063730654,0.0005139916,0.00021770125,0.00016922937,0.000027571445,0.00024306223,0.00002540402,0.000017036518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963371,0.00045160585,0.0018650177,0.00049555773,0.0003302935,0.00052043],"domain_scores_gemma":[0.9976506,0.00043606618,0.0010648009,0.00025792513,0.00034813813,0.00024245844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018968767,0.0002927151,0.0009123993,0.0012296161,0.000050887305,0.000003061859,0.00044343568,0.0006222365,0.00066280743],"category_scores_gemma":[0.0001448673,0.00030343598,0.000315001,0.001817537,0.0005660056,0.00008100559,0.00015617424,0.00059550576,0.00000766905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013931745,0.0015147667,0.0130272545,0.00012359655,0.0009070478,0.000014470719,0.00038645117,0.0032362312,0.9774313,0.000008897617,0.00081469875,0.0011420936],"study_design_scores_gemma":[0.0026297136,0.00006663829,0.026709981,0.000010137864,0.0019404035,0.0000032799012,0.00005500354,0.010553329,0.9574578,0.00004333906,0.0003025289,0.00022784155],"about_ca_topic_score_codex":0.00005069202,"about_ca_topic_score_gemma":0.0000028713212,"teacher_disagreement_score":0.019973513,"about_ca_system_score_codex":0.000080451224,"about_ca_system_score_gemma":0.0001027666,"threshold_uncertainty_score":0.99994177},"labels":[],"label_agreement":null},{"id":"W2091598258","doi":"10.1016/j.taap.2006.03.012","title":"The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat","year":2006,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"CYP2E1; Inflammation; Cytochrome P450; Downregulation and upregulation; Cycloheximide; Biology; Messenger RNA; Signal transduction; Pharmacology; Chemistry; Endocrinology; Internal medicine; Molecular biology; Immunology; Biochemistry; Medicine; Metabolism; Protein biosynthesis; Gene","score_opus":0.042709592791396876,"score_gpt":0.36510183227267395,"score_spread":0.3223922394812771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091598258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98553944,0.0010040565,0.000015886479,0.0028390056,0.0009000654,0.001211206,0.000013472989,0.000048599384,0.008428297],"genre_scores_gemma":[0.9968071,0.0005131582,0.00004340864,0.0010765175,0.0008255325,0.0004241885,0.000023926521,0.000025802521,0.00026037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967749,0.0010389892,0.00084114197,0.00043137136,0.00020279048,0.0007107853],"domain_scores_gemma":[0.99795306,0.0012262529,0.0004048867,0.00024141399,0.00007628926,0.00009812904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018745575,0.00033042053,0.00043838436,0.00020291039,0.00073487125,0.000025588746,0.0005286108,0.000508391,0.00037396236],"category_scores_gemma":[0.00002690703,0.00023669584,0.000086042346,0.00044835592,0.0006608438,0.00008832844,0.00015546709,0.0009945664,0.00003615514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008364922,0.00021331788,0.00083854113,0.000041174186,0.00007576512,0.00001217801,0.0005512459,0.0016054773,0.9702955,0.018146824,0.001309776,0.0060737184],"study_design_scores_gemma":[0.004679725,0.000087417786,0.13280292,0.0000038253456,0.00022223832,0.00006265814,0.0001818401,0.0010240839,0.8183416,0.0053061047,0.03701478,0.0002727796],"about_ca_topic_score_codex":0.000017131299,"about_ca_topic_score_gemma":0.00006785758,"teacher_disagreement_score":0.15195388,"about_ca_system_score_codex":0.00005976218,"about_ca_system_score_gemma":0.00009928793,"threshold_uncertainty_score":0.9652176},"labels":[],"label_agreement":null},{"id":"W2091745408","doi":"10.1080/0049825031000121608","title":"Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N -demethylation in human liver microsomes","year":2003,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"AstraZeneca","keywords":"CYP3A4; Microsome; Cytochrome P450; Demethylation; CYP2C8; Chemistry; Pharmacology; Morphine; Hydroxylation; CYP2B6; Enzyme; Biochemistry; Biology; Gene expression; Gene","score_opus":0.07376148550610745,"score_gpt":0.4232556176795827,"score_spread":0.34949413217347525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091745408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930072,0.0035179516,0.00018437959,0.0010101383,0.00024264173,0.0009090616,0.00008200171,0.000019016758,0.0010276154],"genre_scores_gemma":[0.99743664,0.0005317342,0.00034917312,0.0005833483,0.000077375975,0.00005336544,0.000017075818,0.000022247921,0.0009290451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833727,0.00047765384,0.0004929201,0.00028461413,0.00011453119,0.00029298782],"domain_scores_gemma":[0.9988528,0.0005254458,0.0001961298,0.00021712041,0.000118622316,0.000089883055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018049005,0.00016429374,0.0002400095,0.00016894317,0.00024965097,0.000024206414,0.00018829403,0.00020163928,0.00029166846],"category_scores_gemma":[0.00028193963,0.0001379708,0.0000677963,0.00025785854,0.00025878596,0.000077195284,0.000046157464,0.00029595045,0.00002291047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001660034,0.00017023023,0.0007840623,0.00006039396,0.00006363244,0.0000032225153,0.0006659148,0.00009127682,0.9706443,0.026177285,0.0002852266,0.00088844576],"study_design_scores_gemma":[0.0019924585,0.00008120237,0.020625927,0.000009453278,0.00020329485,0.0000147855435,0.00007586934,0.0009336012,0.9368956,0.010059131,0.028937416,0.00017126316],"about_ca_topic_score_codex":0.000017666276,"about_ca_topic_score_gemma":0.000016532365,"teacher_disagreement_score":0.03374871,"about_ca_system_score_codex":0.00002570777,"about_ca_system_score_gemma":0.00008376424,"threshold_uncertainty_score":0.56262857},"labels":[],"label_agreement":null},{"id":"W2092190477","doi":"10.1021/bi0268753","title":"2.1 Å Crystal Structure of Human PXR in Complex with the St. John's Wort Compound Hyperforin<sup>,</sup>","year":2003,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Hyperforin; Pregnane X receptor; Chemistry; Ligand (biochemistry); Hypericum perforatum; Pharmacology; Ligand efficiency; Transporter; Nuclear receptor; Receptor; Stereochemistry; Biochemistry; Biology; Gene; Transcription factor","score_opus":0.060742301055424955,"score_gpt":0.36832489062320156,"score_spread":0.3075825895677766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092190477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900571,0.00094629964,0.000006737144,0.00015438543,0.00010513779,0.00024650776,0.00019203394,0.000022704698,0.00826906],"genre_scores_gemma":[0.9983524,0.00006833839,0.00014896168,0.00046352018,0.00019331601,0.00001227091,0.00009478745,0.000028853889,0.00063756644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844855,0.00021245972,0.00034143298,0.00033959877,0.00022083138,0.00043710912],"domain_scores_gemma":[0.99913865,0.000108988024,0.00015975194,0.00033475284,0.00008921787,0.00016860974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031700262,0.00028670358,0.00033237645,0.000050363244,0.00021145046,0.00001835233,0.00040945603,0.00026181625,0.0017235962],"category_scores_gemma":[0.000021288071,0.00021347286,0.000080232756,0.0002589475,0.00044134023,0.00003155075,0.000071516726,0.0007578244,0.0000045052598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118950666,0.00021497627,0.01963358,0.00008569378,0.00012795883,0.000026077494,0.00030402662,0.0014500886,0.9742063,0.000441647,0.003149292,0.000241406],"study_design_scores_gemma":[0.0023957698,0.00004564791,0.0032649783,0.000012115905,0.00013146432,0.000063503416,0.00041223367,0.00054108765,0.8789344,0.00016906456,0.11371904,0.00031073653],"about_ca_topic_score_codex":0.000012055752,"about_ca_topic_score_gemma":0.000010357281,"teacher_disagreement_score":0.110569745,"about_ca_system_score_codex":0.000041061106,"about_ca_system_score_gemma":0.00012877444,"threshold_uncertainty_score":0.99918896},"labels":[],"label_agreement":null},{"id":"W2092718944","doi":"10.1016/j.ejphar.2006.09.006","title":"Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism","year":2006,"lang":"en","type":"article","venue":"European Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chlorzoxazone; CYP2E1; Phenobarbital; In vivo; Pharmacology; Drug metabolism; Chemistry; Metabolism; In vitro; Endocrinology; Cerebellum; Internal medicine; Cytochrome P450; Biology; Biochemistry; Medicine; Genetics","score_opus":0.05834972505856281,"score_gpt":0.36518217215811544,"score_spread":0.3068324470995526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092718944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829879,0.0031451941,0.00009043717,0.0035574704,0.0038512377,0.0009210771,0.00013470722,0.000054410066,0.005257598],"genre_scores_gemma":[0.9875293,0.00051256875,0.00087792624,0.0063685915,0.0030279031,0.00004634342,0.0000106540965,0.00013641547,0.0014903166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9894462,0.005490262,0.0025122901,0.00064163987,0.0005397997,0.0013697627],"domain_scores_gemma":[0.9970722,0.00069553935,0.001231847,0.00023851095,0.00027347554,0.0004883927],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005360813,0.000718825,0.001324166,0.0012809148,0.00018756688,0.00005929446,0.0012520215,0.000278763,0.0021189624],"category_scores_gemma":[0.00025734637,0.0006334375,0.0003337727,0.0009778059,0.00042687988,0.0003656227,0.00032155804,0.0029433356,0.00015353585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006004225,0.0016266238,0.00033023438,0.00006660971,0.00024229674,0.006663017,0.0007069287,0.0021727441,0.965991,0.00014217535,0.0053629833,0.010691167],"study_design_scores_gemma":[0.01524335,0.00029314458,0.00397738,0.000041205993,0.00031594178,0.0004134478,0.00013102584,0.0012289245,0.8459317,0.00022022206,0.13157143,0.0006322458],"about_ca_topic_score_codex":0.00011060885,"about_ca_topic_score_gemma":0.00005660245,"teacher_disagreement_score":0.12620844,"about_ca_system_score_codex":0.00019627625,"about_ca_system_score_gemma":0.00043077947,"threshold_uncertainty_score":0.9996117},"labels":[],"label_agreement":null},{"id":"W2092854154","doi":"10.1016/j.cbpc.2014.06.008","title":"Expression patterns of cytochrome P450 3B and 3C genes in model fish species","year":2014,"lang":"en","type":"article","venue":"Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Trent University; McMaster University","keywords":"Biology; Zebrafish; Oryzias; Danio; Cytochrome P450; Gene; Xenobiotic; Gene expression; Drug metabolism; Catfish; Genetics; Cell biology; Metabolism; Endocrinology; Fish <Actinopterygii>; Enzyme; Biochemistry; Fishery","score_opus":0.11352140422180933,"score_gpt":0.407139315328244,"score_spread":0.29361791110643465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092854154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408025,0.002038497,0.00014059524,0.0006164953,0.0006842658,0.00048750098,0.00034272674,0.0000498436,0.0015598125],"genre_scores_gemma":[0.992972,0.0027034394,0.00020202427,0.0027361908,0.0005692106,0.00020733844,0.000115245755,0.000027744318,0.0004667873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99607116,0.0011729443,0.0008310587,0.0009770383,0.00012223274,0.0008255714],"domain_scores_gemma":[0.9978382,0.0009021796,0.0004290161,0.00027971662,0.00015060141,0.00040026987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006617469,0.0005811447,0.00124876,0.00019435538,0.00026613422,0.00001178604,0.00044097283,0.0008211361,0.0008862381],"category_scores_gemma":[0.000049949827,0.00057001045,0.00011914013,0.00018782658,0.0015021779,0.000113253685,0.00048875815,0.0010231342,0.000009195873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008918257,0.0005999757,0.006352849,0.00018310487,0.0001852125,0.000010144981,0.000702376,0.0020148198,0.9840719,0.000480475,0.0035506228,0.0009567003],"study_design_scores_gemma":[0.0039461926,0.00025239895,0.027819138,0.000023859568,0.00018772957,0.000036538753,0.00014123092,0.01783226,0.9095799,0.0007995809,0.038879395,0.0005017936],"about_ca_topic_score_codex":0.000004756026,"about_ca_topic_score_gemma":0.000008676914,"teacher_disagreement_score":0.074492015,"about_ca_system_score_codex":0.000042052172,"about_ca_system_score_gemma":0.00010138686,"threshold_uncertainty_score":0.99967515},"labels":[],"label_agreement":null},{"id":"W2093353667","doi":"10.1002/path.2805","title":"Immunohistochemical expression of conjugating UGT1A‐derived isoforms in normal and tumoral drug‐metabolizing tissues in humans","year":2010,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Gene isoform; Biology; Glucuronidation; Drug metabolism; Glucuronosyltransferase; Isozyme; Carcinogenesis; Xenobiotic; Biochemistry; In vitro; Enzyme; Microsome; Gene","score_opus":0.043729141937628314,"score_gpt":0.39713026886093994,"score_spread":0.3534011269233116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093353667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994012,0.0042526475,0.000023340031,0.00030620303,0.0009003747,0.00013703773,0.000007787997,0.000004681297,0.00035592882],"genre_scores_gemma":[0.9976401,0.0010436017,0.000829983,0.00024118011,0.0002040893,0.000003959779,0.0000014157009,0.00001438251,0.0000213062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980066,0.0006043806,0.0008049746,0.00012040119,0.00012806582,0.00033561906],"domain_scores_gemma":[0.9987743,0.00037802084,0.0005236912,0.0001316155,0.000094569434,0.00009782866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026546633,0.00016214327,0.00047636506,0.00022513719,0.00008802129,0.0000057065463,0.0003603825,0.00019053541,0.00017301356],"category_scores_gemma":[0.0001680664,0.00011525347,0.00006424028,0.00013641846,0.00045948135,0.00011475754,0.00016133208,0.0017185681,0.0000025730153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040480314,0.00013765953,0.031288557,0.000019659961,0.000011754313,0.000116055424,0.0060369717,0.00009726845,0.95863885,0.00013636063,0.000044331144,0.0030677507],"study_design_scores_gemma":[0.003157896,0.00008425965,0.042528495,0.00003790979,0.000080631304,0.00050124124,0.0008587621,0.00025068372,0.9496086,0.0012213037,0.0015205753,0.00014959004],"about_ca_topic_score_codex":0.000021973061,"about_ca_topic_score_gemma":0.000033861033,"teacher_disagreement_score":0.0112399375,"about_ca_system_score_codex":0.000013715898,"about_ca_system_score_gemma":0.0000608384,"threshold_uncertainty_score":0.7466419},"labels":[],"label_agreement":null},{"id":"W2093889398","doi":"10.1046/j.1472-8206.2002.00109.x","title":"Pharmacogenetics and personalised medicine","year":2002,"lang":"en","type":"review","venue":"Fundamental and Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Personalized medicine; Mendelian inheritance; Precision medicine; Drug; Medicine; Pharmacology; Bioinformatics; Computational biology; Genetics; Biology; Gene; Genotype","score_opus":0.4544090659561705,"score_gpt":0.593700282924942,"score_spread":0.13929121696877156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093889398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017130096,0.98042834,0.0000032788935,0.00079469965,0.010860343,0.0016083687,0.00051560334,0.00014033915,0.003936047],"genre_scores_gemma":[0.00046960256,0.9823927,0.000087801905,0.00819645,0.005901064,0.0002083334,0.0001639221,0.00015404863,0.0024260292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918627,0.0027185963,0.0023319647,0.0015845736,0.00034725788,0.0011548811],"domain_scores_gemma":[0.99435514,0.0026631635,0.00089427986,0.0002877367,0.000098210665,0.0017014797],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0017890678,0.0012912075,0.0037203142,0.0003597313,0.0005280883,0.00004716348,0.00067300553,0.0016137142,0.013480933],"category_scores_gemma":[0.000100524405,0.0010483862,0.00067804655,0.00039378865,0.0028244935,0.00010209413,0.00079894543,0.0034404467,0.00041781753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012170694,0.00060243276,0.0002468691,0.0026151782,0.002310348,0.00018861463,0.00015705725,4.165517e-7,0.00006571828,0.00009721425,0.054165717,0.93942875],"study_design_scores_gemma":[0.00533918,0.00048742007,0.00004897938,0.0004487503,0.014868279,0.0004016517,0.00005172724,0.00038797688,0.000012542733,0.00010028146,0.97686017,0.0009930211],"about_ca_topic_score_codex":0.000014589342,"about_ca_topic_score_gemma":0.0000022562135,"teacher_disagreement_score":0.93843573,"about_ca_system_score_codex":0.00008215413,"about_ca_system_score_gemma":0.0001508752,"threshold_uncertainty_score":0.99998397},"labels":[],"label_agreement":null},{"id":"W2093903277","doi":"10.1503/cmaj.1031558","title":"Natural products and adverse drug interactions","year":2004,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"Natural (archaeology); Drug; Medicine; Public health; Alternative medicine; Computer science; Internet privacy; Data science; Pharmacology; Pathology; History","score_opus":0.02880084396721209,"score_gpt":0.36818451239638944,"score_spread":0.33938366842917733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093903277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9037906,0.0018218688,0.000011288737,0.08139025,0.007787309,0.00013978657,0.0000353188,0.000024794896,0.0049987705],"genre_scores_gemma":[0.97355247,0.00080119784,0.0001350223,0.021487594,0.0024598443,0.0000058846394,0.0000073026436,0.000012415434,0.0015382767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984186,0.00023749577,0.0002989583,0.00015815727,0.0004289174,0.0004578396],"domain_scores_gemma":[0.99789053,0.00012570021,0.00014447233,0.000055653545,0.00029653063,0.0014871218],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013593729,0.00012229713,0.00015244326,0.00016348345,0.00046547994,0.00003547882,0.00016848942,0.00016146386,0.0021069031],"category_scores_gemma":[0.00092468184,0.000115457544,0.000055885015,0.00018645318,0.00006767354,0.000152933,0.000023758146,0.0020157036,0.00020947699],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015707735,0.0005271042,0.06743282,0.000060200942,0.0015643215,0.0029388273,0.009066796,0.00064595067,0.014066646,0.007162762,0.5362565,0.36012098],"study_design_scores_gemma":[0.0018423641,0.000007893563,0.010304668,0.000013669127,0.000068445595,0.0005582664,0.00022492914,0.00020646694,0.0015101315,0.0005853975,0.9845253,0.00015242075],"about_ca_topic_score_codex":0.00067758985,"about_ca_topic_score_gemma":0.008022291,"teacher_disagreement_score":0.44826883,"about_ca_system_score_codex":0.00047881075,"about_ca_system_score_gemma":0.001731527,"threshold_uncertainty_score":0.9988053},"labels":[],"label_agreement":null},{"id":"W2093920606","doi":"10.1016/s1532-0456(03)00113-3","title":"The role of CYP 1A1 in the in vitro metabolism of pregnenolone by the liver of rainbow trout embryos","year":2003,"lang":"en","type":"article","venue":"Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Agriculture, Food and Rural Affairs","keywords":"Rainbow trout; Metabolite; Pregnenolone; Metabolism; Biology; Cytochrome P450; Catabolism; Isozyme; Incubation; Embryo; Enzyme; In vitro; Trout; Internal medicine; Endocrinology; Biochemistry; Steroid; Hormone; Fish <Actinopterygii>","score_opus":0.05703638152172458,"score_gpt":0.37755930012064637,"score_spread":0.3205229185989218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093920606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9379001,0.057501808,0.0000028523978,0.0005680165,0.00069289195,0.00086816726,0.00020758936,0.000008975622,0.0022495452],"genre_scores_gemma":[0.99394023,0.00435302,0.00003176069,0.0009977364,0.00014379746,0.0003485218,0.00003401602,0.000016535287,0.00013440767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.992966,0.004407845,0.0011353106,0.00055581675,0.00016985011,0.0007651965],"domain_scores_gemma":[0.994996,0.0035151523,0.00078113796,0.0004135424,0.00017254561,0.00012160948],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001997925,0.00044917673,0.0011217718,0.00010558992,0.00028641772,0.0000061061096,0.0010313676,0.0005666007,0.00028031986],"category_scores_gemma":[0.00013397791,0.00028360885,0.00019580495,0.00050999917,0.0039097187,0.000055385393,0.00020019262,0.001330881,0.0000050091126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019854547,0.0011294266,0.00069883233,0.000058166795,0.00041913823,0.000005705349,0.002610846,0.00015196422,0.9865257,0.0021169719,0.0027979366,0.0014998534],"study_design_scores_gemma":[0.0030853215,0.00015095017,0.002546711,0.0000071165564,0.00028324022,0.000032680684,0.0011768754,0.00060841563,0.89743733,0.0014346841,0.0930193,0.00021735675],"about_ca_topic_score_codex":0.00002352522,"about_ca_topic_score_gemma":0.000011579973,"teacher_disagreement_score":0.09022136,"about_ca_system_score_codex":0.00002972572,"about_ca_system_score_gemma":0.00020455419,"threshold_uncertainty_score":0.9999616},"labels":[],"label_agreement":null},{"id":"W2094218863","doi":"10.1016/j.taap.2013.04.013","title":"Cytochrome P450 2A5 and bilirubin: Mechanisms of gene regulation and cytoprotection","year":2013,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Reporter gene; Transfection; Molecular biology; Chemistry; Microsome; Cytoprotection; Endogeny; Gene expression; Biology; In vitro; Gene; Apoptosis; Biochemistry","score_opus":0.0461619068202838,"score_gpt":0.35186476098432645,"score_spread":0.30570285416404264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094218863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908475,0.0016532075,0.0015291949,0.001297827,0.0006363492,0.0016397006,0.00003946699,0.00009615864,0.002260547],"genre_scores_gemma":[0.99242306,0.0013605161,0.0019865297,0.003123576,0.00026940738,0.00050971104,0.000018942199,0.000039267605,0.00026902105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997542,0.00042553584,0.00060018786,0.0006888545,0.00013037855,0.0006130283],"domain_scores_gemma":[0.99862146,0.00038991458,0.000304817,0.00016343899,0.00011094156,0.00040943688],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000748021,0.00040285598,0.0006581145,0.0002895408,0.00038882374,0.000021693477,0.00017342773,0.0007408973,0.0025038528],"category_scores_gemma":[0.000021637956,0.00039427573,0.00005334979,0.00022776611,0.00093040295,0.0001411745,0.00023025964,0.00073379494,0.000048217862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038005674,0.00020751759,0.0002639219,0.000094681855,0.00021879635,0.000005945812,0.00036139425,0.0001013326,0.9540536,0.011761434,0.0007023103,0.03184903],"study_design_scores_gemma":[0.00487629,0.00034993645,0.028645482,0.0000047068497,0.00046472673,0.00020731741,0.00013505526,0.0027332194,0.9278337,0.025010386,0.009289295,0.00044989126],"about_ca_topic_score_codex":0.000025340009,"about_ca_topic_score_gemma":0.000004669023,"teacher_disagreement_score":0.03139914,"about_ca_system_score_codex":0.000029710238,"about_ca_system_score_gemma":0.00005999223,"threshold_uncertainty_score":0.9998509},"labels":[],"label_agreement":null},{"id":"W2094881146","doi":"10.1097/fpc.0b013e3282fb02ba","title":"Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; COPD; CYP3A5; Vital capacity; Odds ratio; Lung transplantation; Internal medicine; Genotype; Spirometry; Pulmonary function testing; Lung; Diffusing capacity; Lung function; Asthma; Biology; Genetics","score_opus":0.0492857758618142,"score_gpt":0.3451118820476309,"score_spread":0.2958261061858167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094881146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758537,0.01952147,0.0002909995,0.0019946867,0.00076698436,0.0007993661,0.00013152964,0.00004581755,0.0005954625],"genre_scores_gemma":[0.9765193,0.018581077,0.00022269691,0.0025772492,0.00080360303,0.00007984886,0.000038238933,0.000054224965,0.0011237748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972135,0.000657018,0.0006411795,0.0005180609,0.00026433362,0.0007059262],"domain_scores_gemma":[0.99847615,0.0005724936,0.00029774648,0.00019724118,0.00008529078,0.00037106927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017697144,0.00039606864,0.0005231299,0.00019895888,0.0006036339,0.000051338684,0.0002701769,0.0003419492,0.00019069803],"category_scores_gemma":[0.000047156278,0.00034793705,0.00012210196,0.00031950994,0.00044860516,0.00008748043,0.00022647482,0.0009250315,0.00002080398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025023979,0.00034505417,0.7108109,0.00012405652,0.0023231283,0.000090380214,0.011564216,0.0017821874,0.16529913,0.00054023124,0.008610219,0.096008085],"study_design_scores_gemma":[0.035649154,0.00014783611,0.5520787,0.000026137148,0.0032367022,0.00014598682,0.0011299705,0.026156023,0.025797596,0.004168322,0.34983504,0.0016285379],"about_ca_topic_score_codex":0.0001444777,"about_ca_topic_score_gemma":0.000051550058,"teacher_disagreement_score":0.34122482,"about_ca_system_score_codex":0.00014890285,"about_ca_system_score_gemma":0.00015609658,"threshold_uncertainty_score":0.99989724},"labels":[],"label_agreement":null},{"id":"W2095886291","doi":"10.1124/mol.111.071787","title":"In Vivo and In Vitro Characterization of a First-in-Class Novel Azole Analog That Targets Pregnane X Receptor Activation","year":2011,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Pregnane X receptor; Constitutive androstane receptor; Pharmacology; In vivo; Chemistry; Nuclear receptor; Receptor; Biology; Biochemistry; Transcription factor","score_opus":0.06212254743634515,"score_gpt":0.3450595616488686,"score_spread":0.28293701421252343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095886291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955706,0.0005203972,0.00036022218,0.0006401869,0.0009863683,0.0008548886,0.000097565346,0.0000214728,0.00094827934],"genre_scores_gemma":[0.9960152,0.0010567055,0.00032937343,0.0021575391,0.00007010934,0.00020783256,0.00004855529,0.0000385411,0.00007617794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976507,0.0004923748,0.0006107974,0.0005069068,0.00015015103,0.0005891085],"domain_scores_gemma":[0.9992423,0.00011989766,0.00028148002,0.00014698693,0.00006686761,0.0001424693],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006506425,0.0003097859,0.00052122166,0.00066945254,0.000049075876,0.0000061961537,0.000270637,0.00038894932,0.0014999643],"category_scores_gemma":[0.000032689404,0.00034978945,0.000067664354,0.00055100716,0.00018528938,0.00022492358,0.00014619218,0.0006484665,0.000010521283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015697515,0.001135927,0.009945488,0.00009101,0.000074043775,0.0000764958,0.0015370653,0.00018038496,0.98392123,0.00012649459,0.0001034877,0.0012386353],"study_design_scores_gemma":[0.005723735,0.000058442787,0.012829325,0.000023691484,0.000067244924,0.000008112195,0.000035243822,0.004928644,0.9618957,0.00014866193,0.013987257,0.00029394604],"about_ca_topic_score_codex":0.00010015898,"about_ca_topic_score_gemma":0.000036522342,"teacher_disagreement_score":0.02202552,"about_ca_system_score_codex":0.00009519476,"about_ca_system_score_gemma":0.00006993173,"threshold_uncertainty_score":0.9998954},"labels":[],"label_agreement":null},{"id":"W2096718798","doi":"10.3109/03602530903210682","title":"UGT genomic diversity: beyond gene duplication","year":2009,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Gene; Glucuronosyltransferase; Biology; Phenotype; Epigenetics; Genetics; Gene duplication; Enzyme; Biochemistry; Microsome","score_opus":0.1939527410100668,"score_gpt":0.45582667840413016,"score_spread":0.2618739373940634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096718798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005181561,0.98222554,0.0000625766,0.00016162002,0.0049468395,0.004497192,0.00056372874,0.00020155842,0.007289106],"genre_scores_gemma":[0.000005519561,0.985066,0.0009068405,0.0038443091,0.0034384164,0.0005904967,0.0008266616,0.00017764134,0.005144112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99010396,0.0037845282,0.0026187382,0.0016439245,0.0005077496,0.0013411011],"domain_scores_gemma":[0.99490166,0.0003468814,0.0020881412,0.001515789,0.00018332597,0.00096417667],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.004206533,0.001724186,0.0063193203,0.0006995125,0.0009960727,0.00010089352,0.0024520375,0.0011871089,0.0019444952],"category_scores_gemma":[0.00015897358,0.0014597941,0.0025419716,0.0011562201,0.00024392291,0.00022801793,0.0013398188,0.0027541593,0.006419849],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001564044,0.0002525528,0.000002811786,0.003425743,0.00043716482,0.000029850864,0.00025009486,0.000005768618,0.00011374185,0.0008086016,0.033368442,0.9612896],"study_design_scores_gemma":[0.00084569125,0.000010820642,0.000020449848,0.0006244823,0.012119546,0.0000784365,0.0000044438343,0.00001963677,0.00009711892,0.0005564856,0.98425764,0.0013652252],"about_ca_topic_score_codex":0.000024527011,"about_ca_topic_score_gemma":0.0000053139015,"teacher_disagreement_score":0.95992434,"about_ca_system_score_codex":0.00019822718,"about_ca_system_score_gemma":0.0003869041,"threshold_uncertainty_score":0.99955046},"labels":[],"label_agreement":null},{"id":"W2097103427","doi":"10.2174/187231210790980462","title":"Assessment of the Inactivation Potential of Desethylamiodarone on Human CYP1A1","year":2010,"lang":"en","type":"article","venue":"Drug Metabolism Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Dilution; Non-competitive inhibition; Enzyme; Food science; Chromatography; Biochemistry; Pharmacology; Biology","score_opus":0.05181478934585863,"score_gpt":0.4172774924222502,"score_spread":0.36546270307639156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097103427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889271,0.00013381249,0.00013048714,0.0032532113,0.0045523187,0.00043754544,0.00009937331,0.000027650081,0.00243847],"genre_scores_gemma":[0.99506503,0.00005939983,0.00049210584,0.0036299587,0.0005545904,0.000033462642,0.000018225363,0.00003246779,0.00011472751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976358,0.0006165519,0.00059687375,0.00031424494,0.00046660702,0.00036996917],"domain_scores_gemma":[0.99854094,0.00016546629,0.00053164724,0.0004963391,0.00013595173,0.00012968414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001136842,0.0002648775,0.00044310553,0.00019449774,0.0002521574,0.000012337316,0.00064816553,0.0001816383,0.00047546366],"category_scores_gemma":[0.00006117675,0.00020347831,0.00026287828,0.0003305046,0.00046350708,0.00009357414,0.00015524722,0.0013144265,0.000009161648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044990782,0.0003571081,0.00363362,0.00003468842,0.00014055721,0.0000025829784,0.0002773041,0.00093995535,0.97901046,0.009918163,0.0018001654,0.003840386],"study_design_scores_gemma":[0.0014572302,0.000011766454,0.23824811,0.000007645231,0.00025264968,0.000002772891,0.00003371191,0.00030980242,0.7265697,0.00038140084,0.032553066,0.00017215611],"about_ca_topic_score_codex":0.000069296264,"about_ca_topic_score_gemma":0.000013051154,"teacher_disagreement_score":0.25244078,"about_ca_system_score_codex":0.00001932583,"about_ca_system_score_gemma":0.00008063081,"threshold_uncertainty_score":0.82976043},"labels":[],"label_agreement":null},{"id":"W2097195964","doi":"10.1136/bmjopen-2013-002857","title":"Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions","year":2013,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; London Health Sciences Centre; Lawson Health Research Institute; Institute for Clinical Evaluative Sciences; Western University","funders":"Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Schulich School of Medicine and Dentistry; Academic Medical Organization of Southwestern Ontario; London Health Sciences Centre; Lawson Health Research Institute","keywords":"Medicine; Azithromycin; Clarithromycin; Internal medicine; Retrospective cohort study; Population; Antibiotics","score_opus":0.3012585843008348,"score_gpt":0.5627864723495077,"score_spread":0.26152788804867294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097195964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859612,0.00024691815,0.0015909569,0.001370276,0.0013255983,0.0051734364,0.00006856141,0.000015755599,0.0042473217],"genre_scores_gemma":[0.9957488,0.00001496529,0.002902606,0.00066381635,0.0001452177,0.000107697975,0.000030548195,0.000018333994,0.00036801695],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988349,0.0002340702,0.00047329115,0.00014879621,0.000107675296,0.00020124755],"domain_scores_gemma":[0.99809885,0.0009951387,0.00038049696,0.00023897017,0.00021372348,0.0000728333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091960805,0.00012219374,0.00031050885,0.00006807936,0.00020417898,0.00006400898,0.000526573,0.000040413757,0.00053511595],"category_scores_gemma":[0.00011158023,0.00009403915,0.000097627635,0.00014019408,0.00008088736,0.00018115697,0.00018455563,0.00020733474,0.000017544251],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065882906,0.0009446786,0.54954135,0.00045910588,0.000736515,0.0000024653716,0.0010074013,0.116823226,0.2514037,0.0051979357,0.0103073055,0.0629175],"study_design_scores_gemma":[0.004017246,0.000027817294,0.13165142,0.000105240964,0.0005784599,0.0000051662037,0.00029917344,0.4650125,0.36253044,0.0015432679,0.03392027,0.00030900308],"about_ca_topic_score_codex":0.00090744026,"about_ca_topic_score_gemma":0.00012791053,"teacher_disagreement_score":0.41788992,"about_ca_system_score_codex":0.000016261713,"about_ca_system_score_gemma":0.00010891531,"threshold_uncertainty_score":0.58591443},"labels":[],"label_agreement":null},{"id":"W2098130430","doi":"10.1002/jps.22136","title":"Extrapolating In vitro Metabolic Interactions to Isolated Perfused Liver: Predictions of Metabolic Interactions between R-Bufuralol, Bunitrolol, and Debrisoquine","year":2010,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Debrisoquine; In vitro; Chemistry; Pharmacology; Biochemistry; Metabolism; Biology; Cytochrome P450; CYP2D6","score_opus":0.12829367325099594,"score_gpt":0.4695342371850012,"score_spread":0.34124056393400526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098130430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892419,0.0038184351,0.0008180337,0.0025488373,0.0024763432,0.00032763038,0.00010294621,0.000024053501,0.00064181024],"genre_scores_gemma":[0.99256724,0.0017145217,0.004124438,0.00071726827,0.00078598154,0.000014858163,0.0000029081662,0.000018667835,0.000054105963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996677,0.0006125111,0.0012809682,0.00035196374,0.00044491465,0.00063268555],"domain_scores_gemma":[0.9967984,0.0012784915,0.0005596234,0.000141337,0.0003694096,0.00085271324],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023704919,0.0003030168,0.0007323862,0.0010698241,0.00041900697,0.000072726696,0.0006140094,0.0001633238,0.0009926631],"category_scores_gemma":[0.0005477967,0.0002540797,0.00021904802,0.0014144572,0.0006748452,0.00070407987,0.00018684179,0.0024462296,0.00001707484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036959143,0.00042156954,0.027189106,0.00001633467,0.00021415045,0.000016538226,0.0010449982,0.0004986546,0.90136427,0.0004728438,0.0001496516,0.06824231],"study_design_scores_gemma":[0.0032962803,0.0002645867,0.049188353,0.000047212274,0.0012760843,0.0004377929,0.00059648027,0.05866782,0.60659367,0.00040862593,0.27876103,0.00046208047],"about_ca_topic_score_codex":0.00008201436,"about_ca_topic_score_gemma":0.00006110608,"teacher_disagreement_score":0.2947706,"about_ca_system_score_codex":0.000022161403,"about_ca_system_score_gemma":0.00020570043,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W2098153346","doi":"10.1124/dmd.112.045245","title":"Down-Regulation of Hepatic CYP3A and CYP2C Mediated Metabolism in Rats with Moderate Chronic Kidney Disease","year":2012,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Metabolism; CYP3A; Kidney disease; Kidney; Biology; Internal medicine; Endocrinology; Pharmacology; Chemistry; Medicine; Cytochrome P450","score_opus":0.024813872870603847,"score_gpt":0.32894159648297205,"score_spread":0.30412772361236823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098153346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727265,0.024328716,0.00016448664,0.00045094837,0.00084320374,0.0006395416,0.0003972052,0.00004015316,0.0004092294],"genre_scores_gemma":[0.9951283,0.002997217,0.00017671223,0.0008803369,0.00036617447,0.00008532752,0.0002121873,0.000038047245,0.00011573148],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997622,0.0006122864,0.0005034876,0.00039831494,0.00028758272,0.00057630724],"domain_scores_gemma":[0.99842244,0.00010159492,0.00025596222,0.00022705246,0.00010054175,0.0008923909],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063237053,0.00037106915,0.0005611837,0.00028039824,0.0001855132,0.000028462524,0.00013024824,0.00018086263,0.00018262399],"category_scores_gemma":[0.000059460504,0.00031676254,0.00007966819,0.00041458555,0.00026163194,0.00058543053,0.000111779096,0.0003660135,0.000009521957],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040161354,0.0018624285,0.12763914,0.0009616149,0.00042886654,0.000017634367,0.0054497686,0.003216496,0.81435454,0.019528635,0.00067952217,0.021845205],"study_design_scores_gemma":[0.007393694,0.000021446964,0.810035,0.00011377077,0.0013419705,0.000014035464,0.00005757047,0.02043755,0.1430835,0.0015023106,0.015346181,0.00065300125],"about_ca_topic_score_codex":0.000060944105,"about_ca_topic_score_gemma":0.00001873759,"teacher_disagreement_score":0.6823958,"about_ca_system_score_codex":0.000034073364,"about_ca_system_score_gemma":0.00015496445,"threshold_uncertainty_score":0.9999285},"labels":[],"label_agreement":null},{"id":"W2098768607","doi":"10.1002/gps.1522","title":"CYP2D6 genotype and venlafaxine‐XR concentrations in depressed elderly","year":2006,"lang":"en","type":"article","venue":"International Journal of Geriatric Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health","keywords":"CYP2D6; Venlafaxine; Pharmacogenetics; Adverse effect; Ven; Internal medicine; Medicine; Tolerability; Genotype; Polypharmacy; Pharmacology; Depression (economics); Endocrinology; Antidepressant; Biology; Genetics","score_opus":0.029391841915274247,"score_gpt":0.387762583106084,"score_spread":0.3583707411908098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098768607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97188604,0.011828568,0.00041571222,0.0028263628,0.009588036,0.00011821075,0.00004403829,0.000011196553,0.0032818606],"genre_scores_gemma":[0.99374944,0.0013490366,0.0014352272,0.0007479589,0.0025688198,0.0000042700976,0.000009648553,0.000014270089,0.000121330275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854267,0.00015371738,0.0006646907,0.00015304744,0.00026575383,0.00022013171],"domain_scores_gemma":[0.9990221,0.00012168373,0.00040120937,0.00007097383,0.0002599398,0.00012407255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004427411,0.00014535642,0.00021570295,0.00032013847,0.000060500606,0.000042535477,0.00034810524,0.00014570596,0.0003055983],"category_scores_gemma":[0.000030209383,0.0001400344,0.000099044766,0.00018428208,0.00006585698,0.00015211973,0.000043509943,0.00049291656,0.000013526869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019929544,0.0020940634,0.7936512,0.000042335814,0.0007916779,0.00037728995,0.00072932814,0.009639033,0.087048575,0.021480061,0.029562127,0.052591313],"study_design_scores_gemma":[0.018136604,0.00033154344,0.5512253,0.00006393998,0.0004838921,0.000977012,0.00024881872,0.0032876646,0.0093589565,0.039154775,0.37600923,0.0007222568],"about_ca_topic_score_codex":0.00005060928,"about_ca_topic_score_gemma":0.00004758572,"teacher_disagreement_score":0.3464471,"about_ca_system_score_codex":0.00004708163,"about_ca_system_score_gemma":0.00023587511,"threshold_uncertainty_score":0.5710437},"labels":[],"label_agreement":null},{"id":"W2099037673","doi":"10.1139/v00-122","title":"The tamoxifen cation reacts to give indene products","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Carbocation; Chemistry; Indene; Yield (engineering); Isomerization; Medicinal chemistry; Ring (chemistry); Intramolecular force; Epimer; Stereochemistry; Photochemistry; Organic chemistry; Catalysis","score_opus":0.05399028719642234,"score_gpt":0.3655880659245553,"score_spread":0.31159777872813293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099037673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96785915,0.0032497188,0.0000027130259,0.008511923,0.0008539828,0.00011898609,0.000032746502,0.0000053344966,0.019365424],"genre_scores_gemma":[0.989422,0.00046728126,0.00007591252,0.0021734498,0.0012639033,0.0000059411686,0.00000492122,0.000016392027,0.006570149],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889946,0.00008848707,0.00034006868,0.00013212257,0.0001377554,0.0004021295],"domain_scores_gemma":[0.99817175,0.000084534644,0.00014754116,0.00017362904,0.000307373,0.0011152038],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006875653,0.0001311842,0.00015367729,0.000044848017,0.00031482466,0.000047181657,0.0004578086,0.00014384367,0.001865132],"category_scores_gemma":[0.00023330779,0.00010607254,0.00005977389,0.00021328905,0.000117031115,0.00006201,0.00000988496,0.0006079588,0.0000992672],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024596477,0.00005799076,0.0014430993,0.00003622618,0.00022410501,0.0002550037,0.0024841493,0.0013324934,0.5493415,0.0000304753,0.14036174,0.3041872],"study_design_scores_gemma":[0.00032145652,0.000011781436,0.0009386871,0.000007770678,0.000040018316,0.00012875049,0.000049241527,0.000015055486,0.33847693,0.0002096265,0.6597122,0.000088484725],"about_ca_topic_score_codex":0.00024713425,"about_ca_topic_score_gemma":0.00041173145,"teacher_disagreement_score":0.51935047,"about_ca_system_score_codex":0.00011125205,"about_ca_system_score_gemma":0.001419886,"threshold_uncertainty_score":0.9990473},"labels":[],"label_agreement":null},{"id":"W2099103888","doi":"10.1124/dmd.112.049072","title":"Regiospecificity and Stereospecificity of Human UDP-Glucuronosyltransferases in the Glucuronidation of Estriol, 16-Epiestriol, 17-Epiestriol, and 13-Epiestradiol","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Glucuronidation; Stereospecificity; Estriol; Chemistry; Stereochemistry; Chromatography; Biochemistry; Enzyme; Microsome; Hormone","score_opus":0.05412782173617828,"score_gpt":0.3502302022940657,"score_spread":0.2961023805578874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099103888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236245,0.014518493,0.00019354936,0.00059314544,0.00022452408,0.00096174126,0.00021809009,0.000023131817,0.00090487004],"genre_scores_gemma":[0.98922014,0.009848883,0.000121354315,0.00037000777,0.00018047975,0.00007903243,0.00010947215,0.000021064128,0.00004955969],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972264,0.0008363247,0.000819871,0.0004719809,0.0002523442,0.0003930747],"domain_scores_gemma":[0.9985072,0.00056588795,0.00032036772,0.00027763238,0.00013184448,0.00019704502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00109988,0.00036687095,0.000664961,0.00023347102,0.00027259073,0.000068918715,0.00024918382,0.00022052032,0.00015238405],"category_scores_gemma":[0.000055254644,0.00029708192,0.000091459406,0.000319264,0.0007246195,0.00044021278,0.000078504985,0.0005051451,0.0000025677227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008952056,0.0022017418,0.11674621,0.0008534233,0.00039779278,0.00002234497,0.015365595,0.00016296875,0.65477777,0.06882173,0.0024223658,0.13733286],"study_design_scores_gemma":[0.004823945,0.00022853384,0.8325241,0.000101000085,0.0006629996,0.00004995527,0.0025766375,0.00062187423,0.13769943,0.009380728,0.01068198,0.0006487817],"about_ca_topic_score_codex":0.00090726913,"about_ca_topic_score_gemma":0.000097922995,"teacher_disagreement_score":0.71577793,"about_ca_system_score_codex":0.000016970998,"about_ca_system_score_gemma":0.00003839803,"threshold_uncertainty_score":0.99994814},"labels":[],"label_agreement":null},{"id":"W2099474750","doi":"10.1124/dmd.113.052613","title":"The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Enzyme; Glucuronosyltransferase; Biochemistry; Chemistry; Isozyme; Bile acid; Microsome","score_opus":0.027515619710265917,"score_gpt":0.3443380838293738,"score_spread":0.3168224641191079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099474750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757442,0.018987557,0.00008641908,0.0023293283,0.0007815352,0.0008161931,0.00014323808,0.000058236332,0.0010533002],"genre_scores_gemma":[0.9910595,0.006758096,0.00006108612,0.0011097533,0.00035528265,0.00030388957,0.00010796559,0.000031219082,0.00021322425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977056,0.0006502825,0.0004461035,0.0004776855,0.00019267415,0.0005276926],"domain_scores_gemma":[0.998965,0.0002468517,0.00016440735,0.00021125359,0.00010961726,0.00030286508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005866255,0.00033928224,0.00035554785,0.00017565803,0.000805992,0.00016361468,0.00020223841,0.00019578807,0.0002140084],"category_scores_gemma":[0.000035011042,0.00026598581,0.000077038385,0.00024201235,0.0003171389,0.000532775,0.00009258068,0.0005609386,0.000050817354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045032322,0.0006398776,0.00826989,0.00010431161,0.00021354474,0.000019987703,0.0047883913,0.00010973042,0.7229681,0.04336976,0.0027888487,0.21627721],"study_design_scores_gemma":[0.005204403,0.000047900434,0.4024443,0.00003394599,0.00043814757,0.000020803214,0.0013797316,0.0015739619,0.45899555,0.009696575,0.11944194,0.0007227379],"about_ca_topic_score_codex":0.00021424517,"about_ca_topic_score_gemma":0.00011241398,"teacher_disagreement_score":0.39417443,"about_ca_system_score_codex":0.000027099519,"about_ca_system_score_gemma":0.00003168016,"threshold_uncertainty_score":0.99997926},"labels":[],"label_agreement":null},{"id":"W2099744961","doi":"10.1177/00912700122010663","title":"Population Pharmacokinetics of Fentanyl in Healthy Volunteers","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Pharmacokinetics; Fentanyl; Volume of distribution; Population pharmacokinetics; Population; Medicine; Distribution (mathematics); Anesthesia; Nonparametric statistics; Pharmacology; Mathematics; Statistics","score_opus":0.23344573158738122,"score_gpt":0.5612801435504464,"score_spread":0.3278344119630652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099744961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97717094,0.0043595703,0.0001428368,0.0050322674,0.011563117,0.0004267588,0.000019301135,0.000015051959,0.00127015],"genre_scores_gemma":[0.96306074,0.024719298,0.00017586509,0.009452925,0.0024115976,0.0000057418833,0.0000041288727,0.00003303345,0.00013665868],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99157387,0.0038031451,0.0033544428,0.00023087105,0.00042157428,0.0006160776],"domain_scores_gemma":[0.9943628,0.00283814,0.0017453588,0.00020380375,0.00039920904,0.00045072744],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009517344,0.00028922904,0.0011296612,0.00035457872,0.00011529905,0.000006121964,0.000946484,0.00038204514,0.0020119676],"category_scores_gemma":[0.0003986745,0.00021451544,0.00039352447,0.00062649784,0.000498417,0.00015424451,0.00015056386,0.002473903,0.000039003087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053548276,0.006082398,0.54139787,0.00015775878,0.0016226759,0.00048397193,0.0015771803,0.043534808,0.14383385,0.0003983665,0.050654814,0.15670802],"study_design_scores_gemma":[0.04227785,0.003064966,0.27513272,0.00006397023,0.002887404,0.0008618133,0.0004320029,0.023960792,0.024711376,0.0023645198,0.6234844,0.0007582098],"about_ca_topic_score_codex":0.000066702014,"about_ca_topic_score_gemma":0.000026795558,"teacher_disagreement_score":0.57282954,"about_ca_system_score_codex":0.00006916329,"about_ca_system_score_gemma":0.0002476841,"threshold_uncertainty_score":0.99982744},"labels":[],"label_agreement":null},{"id":"W2100987417","doi":"10.1097/mcp.0b013e32833b1c6c","title":"Predicting warfarin dose","year":2010,"lang":"en","type":"review","venue":"Current Opinion in Pulmonary Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"National Cancer Institute; Canadian Institutes of Health Research; LEO Pharma; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Warfarin; Intensive care medicine; Internal medicine; Atrial fibrillation","score_opus":0.38462502801839854,"score_gpt":0.5577681301893264,"score_spread":0.17314310217092782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100987417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039149952,0.9173786,0.0000069198736,0.0002134496,0.07603659,0.0014661959,0.00017291492,0.0001216998,0.0045644515],"genre_scores_gemma":[0.00005021763,0.986564,0.00002275411,0.00009775226,0.011391398,0.00045590333,0.0009903775,0.00011558963,0.00031202097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946126,0.0011128207,0.0018553819,0.0010046345,0.00047448464,0.00094012066],"domain_scores_gemma":[0.9969908,0.0009081294,0.0007525937,0.0006042499,0.00009874358,0.00064546184],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021865973,0.0009512629,0.0023808419,0.0008478899,0.00020323196,0.000014104326,0.0010303874,0.0012384747,0.0019103251],"category_scores_gemma":[0.00031956192,0.00075526786,0.00039442818,0.0008934271,0.00048191758,0.00010311998,0.0003942341,0.0065926793,0.00030270082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003784911,0.0004353792,0.0003809936,0.012922392,0.000073681455,0.000032928787,0.00013407669,0.000004840248,0.000016743,0.00027034848,0.0047701085,0.9809207],"study_design_scores_gemma":[0.0012404346,0.0000525435,0.00007290643,0.010923379,0.00065811275,0.00019702663,0.000018770357,0.00061937567,0.0000021837136,0.00022028867,0.98536503,0.00062995224],"about_ca_topic_score_codex":0.000017981009,"about_ca_topic_score_gemma":0.0000017465425,"teacher_disagreement_score":0.98059493,"about_ca_system_score_codex":0.00011975763,"about_ca_system_score_gemma":0.00040274282,"threshold_uncertainty_score":0.99948984},"labels":[],"label_agreement":null},{"id":"W2101434962","doi":"10.1002/jbt.10022","title":"Acute sodium arsenite administration induces pulmonary CYP1A1 mRNA, protein and activity in the rat","year":2002,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cytochrome P450; Heme oxygenase; Microsome; Chemistry; Sodium arsenite; Monooxygenase; Aryl hydrocarbon receptor; Bilirubin; Internal medicine; Messenger RNA; Endocrinology; Pharmacology; Heme; Biochemistry; Enzyme; Biology; Medicine","score_opus":0.055215908450279794,"score_gpt":0.36624236454639597,"score_spread":0.3110264560961162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101434962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864949,0.0048755137,0.00002221375,0.007505338,0.0002461422,0.00025488794,0.0000106485895,0.000004838745,0.00058554666],"genre_scores_gemma":[0.99560755,0.0014732855,0.00012206581,0.002496799,0.0001690851,0.000017859358,0.0000022307297,0.000009850649,0.00010128241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849963,0.00049545226,0.0003578047,0.0002028745,0.00015558509,0.0002886658],"domain_scores_gemma":[0.9992746,0.00013573478,0.00024469424,0.00009277551,0.000055812074,0.00019636635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055148796,0.00018043215,0.0002896703,0.000112295456,0.00010822111,0.00002237137,0.00019647364,0.00033813974,0.00010610887],"category_scores_gemma":[0.000060782662,0.00013186474,0.00007972987,0.00013818144,0.0002784556,0.000071556984,0.00008058217,0.00083127717,0.000004179836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004924447,0.00044719724,0.00018735461,0.000018315952,0.000082316605,0.0007735,0.00020832615,0.000002122899,0.98713505,0.00009412342,0.0005849069,0.009974354],"study_design_scores_gemma":[0.0013445569,0.0003078108,0.0006745087,0.000008646664,0.0001682274,0.0017079121,0.00003371944,0.00043698825,0.9768939,0.00051896577,0.017755434,0.00014933929],"about_ca_topic_score_codex":9.802801e-7,"about_ca_topic_score_gemma":0.0000014938106,"teacher_disagreement_score":0.017170526,"about_ca_system_score_codex":0.00002424362,"about_ca_system_score_gemma":0.000033165863,"threshold_uncertainty_score":0.5377288},"labels":[],"label_agreement":null},{"id":"W2101980933","doi":"10.1373/clinchem.2006.078139","title":"Estimation of Warfarin Maintenance Dose Based on VKORC1 (−1639 G&amp;gt;A) and CYP2C9 Genotypes","year":2007,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"VKORC1; Warfarin; CYP2C9; Maintenance dose; Genotype; Vitamin K epoxide reductase; Internal medicine; Allele; Biology; Medicine; Endocrinology; Gastroenterology; Pharmacology; Genetics; Atrial fibrillation","score_opus":0.16540674597107144,"score_gpt":0.50496501357986,"score_spread":0.3395582676087886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101980933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847264,0.0006333894,0.0012857725,0.000471263,0.0005746014,0.00016776621,0.000054279815,0.000048230857,0.012038282],"genre_scores_gemma":[0.9941531,0.0003515314,0.0020125206,0.0020875242,0.00037149747,0.000007876129,0.000037428337,0.000022244873,0.0009562804],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981768,0.00012079487,0.0007535115,0.00039330355,0.00017903499,0.0003765122],"domain_scores_gemma":[0.99772984,0.0012492659,0.0002689466,0.00029075844,0.00009639716,0.00036476873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002137992,0.00021257706,0.000368449,0.000034575052,0.00009210462,0.000009091814,0.00023358662,0.0004690213,0.00064330216],"category_scores_gemma":[0.0007193832,0.00019877072,0.00013888058,0.00013268918,0.00043835546,0.000029444222,0.00007983318,0.0007762794,0.000048221445],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038976336,0.0025035106,0.07536317,0.00059433206,0.00025079824,0.00008462681,0.00017473844,0.0083308015,0.36608326,0.00054485095,0.007628814,0.53454345],"study_design_scores_gemma":[0.0068236124,0.00013708507,0.028648373,0.00007652498,0.00034305008,0.000015893156,0.000023298164,0.06308026,0.69371396,0.0011006529,0.20544282,0.0005944758],"about_ca_topic_score_codex":0.0000021428202,"about_ca_topic_score_gemma":0.0000012365657,"teacher_disagreement_score":0.533949,"about_ca_system_score_codex":0.000022005353,"about_ca_system_score_gemma":0.000079885926,"threshold_uncertainty_score":0.81056345},"labels":[],"label_agreement":null},{"id":"W2102425178","doi":"10.1503/cmaj.100702","title":"The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers","year":2011,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Clarithromycin; Erythromycin; Azithromycin; Calcium channel blocker; Macrolide Antibiotics; Odds ratio; Anesthesia; Internal medicine; Confidence interval; Pharmacology; Antibiotics; Calcium; Biology; Microbiology","score_opus":0.059706927749916226,"score_gpt":0.35534915277625095,"score_spread":0.29564222502633475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102425178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931629,0.0018353463,0.000085181644,0.0012847723,0.0020447639,0.00011505418,0.000083391526,0.0000058862734,0.001382718],"genre_scores_gemma":[0.99460053,0.0036429025,0.00011362834,0.001238177,0.00031850257,3.854816e-7,0.0000026761177,0.000011627237,0.00007157556],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781185,0.00063565315,0.00052946847,0.00011161372,0.0005195101,0.0003919226],"domain_scores_gemma":[0.9978687,0.00037139296,0.00048572954,0.00007995176,0.00028032638,0.00091387075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037043223,0.000115102295,0.00023908666,0.000119365446,0.0004575943,0.000014016687,0.00021716769,0.00040221837,0.00031298737],"category_scores_gemma":[0.0011676373,0.00008958554,0.00013749389,0.00012802923,0.00014613189,0.000053835218,0.000025020301,0.0010120183,0.00000855396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031950205,0.00026763882,0.7546875,0.00005097783,0.002752305,0.0004226777,0.006717577,0.00008426023,0.032438852,0.0008565124,0.059572846,0.14182934],"study_design_scores_gemma":[0.008899705,0.00031886264,0.34096488,0.00012756394,0.0021032847,0.0004081057,0.0030755159,0.018810881,0.20261468,0.005549183,0.416383,0.00074434857],"about_ca_topic_score_codex":0.0012511725,"about_ca_topic_score_gemma":0.001323642,"teacher_disagreement_score":0.4137226,"about_ca_system_score_codex":0.00009103933,"about_ca_system_score_gemma":0.0005055186,"threshold_uncertainty_score":0.43967724},"labels":[],"label_agreement":null},{"id":"W2103715266","doi":"10.1007/s002280100330","title":"Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine","year":2001,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council Canada","keywords":"CYP1A2; Fluvoxamine; Caffeine; Chemistry; Analysis of variance; Cytochrome P450; Internal medicine; Endocrinology; Biochemistry; Enzyme; Biology; Medicine","score_opus":0.1731870082302075,"score_gpt":0.48344738447724644,"score_spread":0.31026037624703895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103715266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928763,0.0004367901,0.0041536908,0.00014812587,0.001829933,0.00030131225,0.00004094935,0.000013368602,0.00019956076],"genre_scores_gemma":[0.9966631,0.0016843277,0.0003526444,0.00035265472,0.00084483484,0.0000024480123,0.000026544527,0.00004075223,0.000032672182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99166393,0.0054756827,0.002027093,0.00028026346,0.0002675536,0.00028547534],"domain_scores_gemma":[0.9962217,0.0005035018,0.0025301299,0.000116767726,0.0003109946,0.00031686586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026902636,0.0002629342,0.0008541106,0.0002070658,0.00014594516,0.000010677636,0.00022929991,0.00019489476,0.00078006304],"category_scores_gemma":[0.00013982959,0.00024301071,0.00023127419,0.00016108788,0.0004420489,0.00023485787,0.00016593328,0.00086743815,0.0000029555385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002373138,0.0012877964,0.0120539935,0.00005115494,0.00021688067,0.00006243307,0.00031339147,0.00008843477,0.971966,0.0000036215806,0.00023155191,0.011351592],"study_design_scores_gemma":[0.008014388,0.00065231073,0.07605557,0.000049922604,0.00046370344,0.000036695743,0.000024109297,0.002487493,0.910667,0.000018695358,0.0013453277,0.00018477236],"about_ca_topic_score_codex":0.0000029612247,"about_ca_topic_score_gemma":5.509518e-7,"teacher_disagreement_score":0.064001575,"about_ca_system_score_codex":0.000025365804,"about_ca_system_score_gemma":0.00006825859,"threshold_uncertainty_score":0.99096894},"labels":[],"label_agreement":null},{"id":"W2103933819","doi":"10.1124/dmd.32.4.460","title":"THE EFFECT OF CIMETIDINE ON DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF HUMAN LIVER MICROSOMES AND RECOMBINANT CYP2D6","year":2004,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cimetidine; Dextromethorphan; Quinidine; Microsome; CYP2D6; Chemistry; Recombinant DNA; Pharmacology; Microsoma; Cytochrome P450; Drug interaction; Pharmacokinetics; Enzyme; Biochemistry; Biology","score_opus":0.02910905688775452,"score_gpt":0.3750711169909364,"score_spread":0.3459620601031819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103933819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98255897,0.015565473,0.00005174891,0.00027899642,0.00063504605,0.00049334194,0.000106093314,0.000019526417,0.0002908186],"genre_scores_gemma":[0.99265534,0.0068412395,0.00010192336,0.000117592666,0.0001197789,0.000039223432,0.000016984857,0.000021339354,0.00008659569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978948,0.0009134404,0.00036531317,0.00032344338,0.0001878765,0.00031508223],"domain_scores_gemma":[0.9985625,0.0006754965,0.0002887254,0.0002090618,0.000072829826,0.00019134874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015831708,0.00027884537,0.00052032166,0.00015650086,0.00046692617,0.000022392185,0.00016165657,0.00015425554,0.000030205783],"category_scores_gemma":[0.00007170622,0.00019418394,0.00013330452,0.0002044318,0.00049573043,0.000115926036,0.00010518225,0.00037740206,0.000004067206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011128474,0.00026844055,0.0009565544,0.00012905679,0.00016423523,0.000007378551,0.0005529266,0.000040902443,0.9098636,0.0060220426,0.00007461456,0.08080743],"study_design_scores_gemma":[0.004109198,0.00033433447,0.033451185,0.0000299174,0.00060749054,0.000011213144,0.000031113344,0.00007771908,0.9557105,0.0018470044,0.0035961862,0.0001941543],"about_ca_topic_score_codex":0.00011822509,"about_ca_topic_score_gemma":0.000010638629,"teacher_disagreement_score":0.08061328,"about_ca_system_score_codex":0.00001439134,"about_ca_system_score_gemma":0.000022532173,"threshold_uncertainty_score":0.79185915},"labels":[],"label_agreement":null},{"id":"W2103995433","doi":"10.1186/bcr798","title":"Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Research (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"Health Canada","keywords":"CYP1A2; Breast cancer; Internal medicine; Endocrinology; Medicine; Caffeine; Triglyceride; Body mass index; Paraxanthine; Hormone; Physiology; Oncology; Cancer; Cholesterol; Cytochrome P450; Metabolism","score_opus":0.222883660157993,"score_gpt":0.5500821810253077,"score_spread":0.3271985208673147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103995433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98298764,0.0013286022,0.000044685352,0.0008491266,0.00090307894,0.0020789697,0.011560279,0.00007972742,0.00016791561],"genre_scores_gemma":[0.99338925,0.0031057494,0.000022818795,0.0001229889,0.0014215863,0.00144162,0.000015358923,0.00007093507,0.00040968275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959065,0.0007610382,0.00039742579,0.00093300035,0.0007642113,0.0012378771],"domain_scores_gemma":[0.99750185,0.00057961023,0.00016227858,0.00030958198,0.000742639,0.00070405955],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023565735,0.0003896878,0.0004485862,0.00033424835,0.0015005338,0.00017841256,0.00051063136,0.0003422496,0.0018164847],"category_scores_gemma":[0.00006525375,0.0003526665,0.00016189464,0.00058510015,0.0006647614,0.00026352686,0.00033877412,0.001745686,0.000031902488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036399742,0.0015925791,0.8841469,0.00009589686,0.0008019068,0.000020353757,0.0010165263,0.002788869,0.07148775,0.000117463955,0.00030360097,0.033988133],"study_design_scores_gemma":[0.007258775,0.00016379518,0.97687155,0.000013741439,0.00016307409,0.00007918811,0.0001513555,0.00039778,0.00935134,0.0005133935,0.0046592327,0.00037679097],"about_ca_topic_score_codex":0.014145259,"about_ca_topic_score_gemma":0.0015485889,"teacher_disagreement_score":0.092724584,"about_ca_system_score_codex":0.0005562318,"about_ca_system_score_gemma":0.000927657,"threshold_uncertainty_score":0.99989253},"labels":[],"label_agreement":null},{"id":"W2104124411","doi":"10.1124/dmd.106.013508","title":"Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in Liver","year":2007,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Vlaamse regering","keywords":"Hypoxia (environmental); In vivo; P-glycoprotein; Glycoprotein; Biology; Cytochrome P450; Messenger RNA; In vitro; Gene expression; Downregulation and upregulation; Gene isoform; Pharmacology; Internal medicine; Endocrinology; Chemistry; Molecular biology; Biochemistry; Gene; Metabolism; Oxygen; Multiple drug resistance; Medicine","score_opus":0.03312668926294158,"score_gpt":0.32171052393750066,"score_spread":0.28858383467455906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104124411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888344,0.009037956,0.0007968229,0.00008514032,0.00009156075,0.0005735189,0.00033604074,0.000015152612,0.0001803495],"genre_scores_gemma":[0.99664927,0.0026318133,0.00041443238,0.000083175175,0.00004866974,0.000017329816,0.00008380031,0.00002172608,0.000049766673],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99820143,0.00030815307,0.00061719806,0.00035580422,0.00023414014,0.0002832508],"domain_scores_gemma":[0.99877447,0.0001752349,0.0005553213,0.00011468863,0.00021568929,0.00016462017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011278047,0.0002707633,0.000681926,0.00031337116,0.00011209267,0.000018062105,0.00006290742,0.00024424685,0.000021198193],"category_scores_gemma":[0.000022098664,0.00024085185,0.00004882339,0.00027838338,0.0003564552,0.00038777132,0.00007523237,0.00022810056,1.9044838e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004732687,0.0004446752,0.011245031,0.00027595749,0.00044320742,0.000009701154,0.005012625,0.001629563,0.94799906,0.008699873,0.00002815898,0.019479455],"study_design_scores_gemma":[0.0049410416,0.000086102526,0.6803129,0.00010424466,0.0009651291,0.000017169745,0.00018986882,0.0696864,0.2397927,0.003583851,0.000052730364,0.00026789817],"about_ca_topic_score_codex":0.00012284429,"about_ca_topic_score_gemma":0.00007356172,"teacher_disagreement_score":0.70820636,"about_ca_system_score_codex":0.0000132819605,"about_ca_system_score_gemma":0.000031136537,"threshold_uncertainty_score":0.9821653},"labels":[],"label_agreement":null},{"id":"W2104528385","doi":"10.1124/dmd.32.2.212","title":"STEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEP","year":2004,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Fetus; Pharmacokinetics; Chemistry; Metabolite; Volume of distribution; Stereoselectivity; Urine; Internal medicine; Free fraction; Endocrinology; Pregnancy; Medicine; Biology; Biochemistry","score_opus":0.028847113738746464,"score_gpt":0.355603129736175,"score_spread":0.32675601599742854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104528385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757544,0.020970926,0.00021200416,0.0006061837,0.00060156686,0.00054424256,0.00018371554,0.00003559166,0.0010913721],"genre_scores_gemma":[0.98625845,0.012155725,0.0005660692,0.0006122945,0.00018826683,0.000050992763,0.00005877614,0.000030593696,0.000078856305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800026,0.00030249287,0.00056335574,0.00046253589,0.0002065437,0.00046481093],"domain_scores_gemma":[0.99912053,0.000113594244,0.00020365498,0.00014722829,0.0001187988,0.00029621428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006490608,0.00031886486,0.0005086031,0.0003662959,0.00013933473,0.000023667699,0.00014684172,0.00016571463,0.00009290172],"category_scores_gemma":[0.000037749156,0.00030310184,0.00007532805,0.00045379685,0.00031131256,0.00020246663,0.00012215356,0.00045062994,0.000007142618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013380768,0.0014068933,0.008154114,0.00034448874,0.00023931697,0.00006890118,0.0063661346,0.0014344372,0.8530361,0.011503706,0.00013550407,0.115972295],"study_design_scores_gemma":[0.019963054,0.00014513452,0.1420131,0.00018513702,0.0010337865,0.000085625245,0.0005946284,0.0021526515,0.8040319,0.006409668,0.022460233,0.00092506025],"about_ca_topic_score_codex":0.0001244326,"about_ca_topic_score_gemma":0.000027584427,"teacher_disagreement_score":0.13385898,"about_ca_system_score_codex":0.000024268187,"about_ca_system_score_gemma":0.000059114238,"threshold_uncertainty_score":0.9999421},"labels":[],"label_agreement":null},{"id":"W2104585553","doi":"10.1503/jpn.120133","title":"Cytochrome P450–mediated drug metabolism in the brain","year":2013,"lang":"en","type":"review","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Drug metabolism; Cytochrome P450; Drug; Pharmacology; Metabolism; CYP2D6; Medicine; Neuroscience; Biology; Internal medicine","score_opus":0.13171246887353988,"score_gpt":0.4560111337267143,"score_spread":0.32429866485317443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104585553","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032344365,0.98637277,0.000008602188,0.0031723708,0.0061977054,0.000601648,0.00005387839,0.000008966133,0.00034960176],"genre_scores_gemma":[0.0006104474,0.9904943,0.00011620438,0.007391347,0.0011236118,0.000030786654,0.0000024599053,0.00002902316,0.00020179694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951715,0.0021567906,0.0012791816,0.00039923395,0.00045277178,0.0005405253],"domain_scores_gemma":[0.9970962,0.0010013187,0.0012096205,0.00026494003,0.000082119,0.00034579667],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003379175,0.00046702893,0.0013183464,0.0004928623,0.0002575476,0.00011447972,0.0014701764,0.00031515604,0.00013283576],"category_scores_gemma":[0.000288107,0.00027626194,0.0004287823,0.00097493076,0.0004175085,0.0002678205,0.0001353101,0.0027628432,0.000033338638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103758124,0.0016337852,0.00017123211,0.0047513195,0.00018465845,0.0004110369,0.001188177,0.000052505944,0.004528782,0.0036841738,0.068339616,0.91495097],"study_design_scores_gemma":[0.00072104926,0.000067351415,0.0005061942,0.00042206323,0.00059087103,0.0010479147,0.000042614447,0.00004814285,0.000013812761,0.00049500744,0.9957677,0.00027723736],"about_ca_topic_score_codex":0.000004031463,"about_ca_topic_score_gemma":0.0000040725135,"teacher_disagreement_score":0.9274281,"about_ca_system_score_codex":0.000017385395,"about_ca_system_score_gemma":0.00061112165,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W2104938725","doi":"10.2174/157488611794479991","title":"Genetic Transmission of Cytochrome P450 2D6 (CYP2D6) Ultrarapid Metabolism: Implications for Breastfeeding Women taking Codeine","year":2011,"lang":"en","type":"article","venue":"Current Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Codeine; CYP2D6; Medicine; Breastfeeding; Pharmacogenetics; Morphine; Opioid; Pharmacology; Acetaminophen; Genotype; Anesthesia; Cytochrome P450; Internal medicine; Genetics; Pediatrics; Gene; Metabolism; Biology; Receptor","score_opus":0.15908942575721055,"score_gpt":0.4206818796954218,"score_spread":0.2615924539382113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104938725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9123531,0.028982285,0.04266348,0.0011746679,0.0033640433,0.0029836718,0.0024317887,0.00026096214,0.005785986],"genre_scores_gemma":[0.9902377,0.005142326,0.0032425248,0.00023714345,0.00047713294,0.0004208912,0.000079413265,0.00006393154,0.000098911645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971153,0.00030381713,0.0009800488,0.00056354137,0.00019341556,0.0008438525],"domain_scores_gemma":[0.9979123,0.00031557944,0.00057634636,0.0003580348,0.00030320272,0.0005345717],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001007455,0.0004155679,0.00065390166,0.00023982345,0.00039342037,0.000013356432,0.0006202684,0.0001948692,0.0014308916],"category_scores_gemma":[0.000063939864,0.00039795964,0.00029864753,0.0004128769,0.00024211103,0.00014584245,0.000088868095,0.0005323842,0.000022772183],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008894678,0.0009838025,0.0034907327,0.00034762133,0.00035260292,0.000001498065,0.008410197,0.00027396544,0.4446966,0.004507158,0.0007877213,0.5352586],"study_design_scores_gemma":[0.006793666,0.00009545889,0.3946233,0.000088283865,0.0010101562,0.00003255039,0.00021518215,0.003342973,0.16810997,0.0065618316,0.41820005,0.00092658115],"about_ca_topic_score_codex":0.000012446685,"about_ca_topic_score_gemma":0.0000017678876,"teacher_disagreement_score":0.53433204,"about_ca_system_score_codex":0.00007779397,"about_ca_system_score_gemma":0.0001707105,"threshold_uncertainty_score":0.99984723},"labels":[],"label_agreement":null},{"id":"W2105658004","doi":"","title":"Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prodrug; Vitamin D and neurology; Calcitriol; Chemistry; Cytochrome P450; Hydroxylation; Context (archaeology); Vitamin D-binding protein; CYP24A1; Catabolism; Pharmacology; Metabolism; Calcipotriol; Calcitriol receptor; Biochemistry; Vitamin; Biology; Endocrinology; Enzyme; Psoriasis; Immunology","score_opus":0.06507707301676101,"score_gpt":0.3661899331374693,"score_spread":0.30111286012070826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105658004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953641,0.00048371567,0.0001345763,0.00063367863,0.00024331029,0.0007206042,0.000025673166,0.000028281775,0.0023660108],"genre_scores_gemma":[0.998012,0.0005683685,0.00021709366,0.0004347756,0.000174875,0.00030736616,0.000023719558,0.000013975787,0.00024782357],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99864775,0.00022529754,0.00048588435,0.00025076146,0.00012141417,0.00026887798],"domain_scores_gemma":[0.9990808,0.00034882542,0.0002621427,0.00009973501,0.000084840816,0.00012367658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000976676,0.00013975498,0.00023929519,0.00011732221,0.0000887326,0.00001355552,0.00007559244,0.00016131597,0.000019529536],"category_scores_gemma":[0.00018056121,0.0001295372,0.000034232362,0.00016469177,0.0001817116,0.00011582105,0.000059662427,0.00025587287,0.0000014097792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054553145,0.0006634278,0.16013648,0.00018967777,0.00016079133,0.000004617123,0.00041591332,0.00011678404,0.14690554,0.0027373321,0.0013048504,0.6868191],"study_design_scores_gemma":[0.0020692179,0.00003856542,0.7884148,0.0000067260344,0.00016344021,0.0000062008057,0.00004042157,0.0015674119,0.18419652,0.0027640841,0.020530425,0.00020222027],"about_ca_topic_score_codex":0.00006247875,"about_ca_topic_score_gemma":0.0000070677756,"teacher_disagreement_score":0.68661684,"about_ca_system_score_codex":0.000020588108,"about_ca_system_score_gemma":0.000020455489,"threshold_uncertainty_score":0.5282374},"labels":[],"label_agreement":null},{"id":"W2105730642","doi":"10.1210/jcem.85.12.7019","title":"Cellular Localization of Uridine Diphosphoglucuronosyltransferase 2B Enzymes in the Human Prostate by<i>in Situ</i>Hybridization and Immunohistochemistry<sup>1</sup>","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Medical Council of Canada","funders":"","keywords":"Biology; Prostate; Androsterone; Glucuronosyltransferase; In situ hybridization; Epithelium; Molecular biology; Glucuronidation; Androgen; Enzyme; Microsome; Gene expression; Biochemistry; Hormone; Gene; Steroid","score_opus":0.05159917807226991,"score_gpt":0.41615855541824653,"score_spread":0.36455937734597665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105730642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548024,0.041942786,0.00012829348,0.0018455128,0.00034167565,0.00039461086,0.000029299817,0.0000088764245,0.00050654344],"genre_scores_gemma":[0.95869416,0.03880625,0.000036132475,0.001915215,0.0003357982,0.000012535174,0.000019793764,0.000023808812,0.00015630327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940453,0.0027439971,0.0021689592,0.00025635457,0.0002899099,0.0004954862],"domain_scores_gemma":[0.99767923,0.0011097229,0.0006144365,0.00029934422,0.00015192435,0.00014534328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003927336,0.00029156895,0.0008972869,0.00013240417,0.00017064175,0.000014872615,0.0007075185,0.00023804395,0.0004113677],"category_scores_gemma":[0.00022645973,0.00019386942,0.00020216695,0.0003240844,0.00080674386,0.00013749496,0.0000539788,0.0016944405,0.0000066482307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061385036,0.0045529515,0.037114944,0.00017060403,0.00085746736,0.00037267178,0.009915379,0.04210408,0.77528995,0.0038623998,0.0062713595,0.11334971],"study_design_scores_gemma":[0.01684319,0.00038960407,0.016660295,0.000058234906,0.0013593448,0.00033001235,0.0005625284,0.002808686,0.60772425,0.0024892497,0.35028324,0.0004913731],"about_ca_topic_score_codex":0.00005263979,"about_ca_topic_score_gemma":0.0000049066784,"teacher_disagreement_score":0.34401187,"about_ca_system_score_codex":0.00001563052,"about_ca_system_score_gemma":0.000113784605,"threshold_uncertainty_score":0.7905765},"labels":[],"label_agreement":null},{"id":"W2105786255","doi":"10.1093/jnci/djq390","title":"Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation","year":2010,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Pharmacogenomics; Medicine; Clinical trial; Translational research; Observational study; Pharmacoepidemiology; Family medicine; Oncology; Internal medicine; Pharmacology; Pathology","score_opus":0.5333017482597454,"score_gpt":0.605515499141323,"score_spread":0.07221375088157755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105786255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9508893,0.003747937,0.000067303845,0.028763762,0.014368326,0.00047481278,0.00031390737,0.000013745457,0.001360916],"genre_scores_gemma":[0.97159886,0.004184589,0.0010431948,0.01724822,0.00556395,0.00007595546,0.0000032896219,0.000027641781,0.00025429597],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971664,0.00066478585,0.0007443578,0.00027458373,0.0006674952,0.00048239031],"domain_scores_gemma":[0.9972311,0.00055498094,0.00044126733,0.00009241747,0.0013010527,0.00037915033],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005843668,0.00021817924,0.00031738819,0.000337395,0.0006771288,0.000050830025,0.0006981341,0.00021337933,0.00058890175],"category_scores_gemma":[0.0005140613,0.00016514031,0.00015979793,0.0005526394,0.00035251427,0.00033467673,0.00016179284,0.0026367772,0.000013650148],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056706107,0.00008766217,0.004731856,0.000029988725,0.0003128855,0.0000090329795,0.0008501102,0.016294004,0.85061973,0.0005227161,0.038449742,0.08752524],"study_design_scores_gemma":[0.0018442455,0.000026226975,0.0034528149,0.000024677247,0.00018349662,0.00008427468,0.000017136901,0.0036277885,0.14471328,0.0011073757,0.84473515,0.00018351055],"about_ca_topic_score_codex":0.00007313041,"about_ca_topic_score_gemma":0.00017115597,"teacher_disagreement_score":0.80628544,"about_ca_system_score_codex":0.00018300794,"about_ca_system_score_gemma":0.001069914,"threshold_uncertainty_score":0.9996642},"labels":[],"label_agreement":null},{"id":"W2105874372","doi":"10.1517/17425250902800153","title":"Ethnic differences in drug metabolism and toxicity from chemotherapy","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacokinetics; Irinotecan; Drug; Pharmacology; Drug metabolism; Toxicity; Pharmacogenetics; Paclitaxel; Medicine; Pharmacodynamics; Biology; Chemotherapy; Cancer; Internal medicine; Genetics; Genotype; Gene","score_opus":0.1774474249782567,"score_gpt":0.4679789391038559,"score_spread":0.2905315141255992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105874372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007226984,0.97225994,0.000012552668,0.0016779908,0.013140286,0.00260676,0.00064861635,0.00027015677,0.0021566907],"genre_scores_gemma":[0.0014025364,0.97901005,0.00043572325,0.012090546,0.004705332,0.00092382135,0.0003477121,0.00025835697,0.0008259183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9854834,0.006249905,0.0026874933,0.0027486542,0.0007402239,0.0020903407],"domain_scores_gemma":[0.99359745,0.0025642458,0.0013363893,0.0012238681,0.00013985102,0.0011381836],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0022227298,0.0024516338,0.0071946066,0.0014730406,0.00044964597,0.00012760638,0.0020292548,0.0025783426,0.002413412],"category_scores_gemma":[0.00024847777,0.0021114778,0.0011406419,0.0012573677,0.00077813404,0.0002840504,0.00053483725,0.0048013683,0.00034741435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003103355,0.0014782104,0.000012352814,0.00033426157,0.0007257255,0.00006160419,0.0026407738,0.0000063853154,0.00069001224,0.0022438217,0.010579499,0.98091704],"study_design_scores_gemma":[0.004349054,0.000072013616,0.0008153968,0.0007816485,0.00047414724,0.000038447695,0.00011074018,0.00009584943,0.0017483593,0.0014790748,0.9880922,0.0019430676],"about_ca_topic_score_codex":0.00027523443,"about_ca_topic_score_gemma":0.00009292942,"teacher_disagreement_score":0.9789739,"about_ca_system_score_codex":0.00021496731,"about_ca_system_score_gemma":0.0005967363,"threshold_uncertainty_score":0.99882203},"labels":[],"label_agreement":null},{"id":"W2105939555","doi":"10.1080/17441692.2014.887137","title":"Global pharmacogenomics: Where is the research taking us?","year":2014,"lang":"en","type":"review","venue":"Global Public Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Drug development; Medicine; Medical prescription; Health care; Political science; Pharmacology; Drug","score_opus":0.5157097529606041,"score_gpt":0.6047911280183111,"score_spread":0.08908137505770708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105939555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000618369,0.9426501,0.0000954225,0.014419572,0.005923807,0.0029120368,0.0037660117,0.00020183195,0.029969392],"genre_scores_gemma":[0.00034417704,0.96839553,0.000115115814,0.025989868,0.0039536557,0.00038835246,0.00022259106,0.00010480957,0.00048588763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9788876,0.012084023,0.0021867366,0.0016330103,0.0012706106,0.0039380216],"domain_scores_gemma":[0.99296147,0.0010037805,0.0016340902,0.0013126233,0.0006090383,0.0024790275],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.018058486,0.001194886,0.0029287327,0.00026622284,0.0021397553,0.00045703762,0.003722201,0.0013877233,0.0030965446],"category_scores_gemma":[0.0004862142,0.000882627,0.0011271546,0.003016901,0.0008784102,0.00017402814,0.0013416284,0.0040476215,0.0028333971],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014544459,0.00019578329,0.00012747697,0.0043572164,0.0006015687,0.000018975812,0.000106708176,0.00000540012,2.1436054e-7,0.0053946786,0.2323671,0.7568103],"study_design_scores_gemma":[0.0009161802,0.00007704553,0.000035814413,0.00059666275,0.0005135443,0.00021770173,0.000048732112,0.0001972051,4.540634e-7,0.00073274417,0.99595785,0.000706075],"about_ca_topic_score_codex":0.0007211783,"about_ca_topic_score_gemma":0.00017123528,"teacher_disagreement_score":0.76359075,"about_ca_system_score_codex":0.0025689465,"about_ca_system_score_gemma":0.007956794,"threshold_uncertainty_score":0.9999087},"labels":[],"label_agreement":null},{"id":"W2105940326","doi":"10.1038/clpt.2010.340","title":"Pharmacogenomics at the Tipping Point: Challenges and Opportunities","year":2011,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Pharmacogenomics; Citation; Clinical pharmacology; Library science; Addiction; Medicine; Psychology; Psychiatry; Pharmacology; Computer science","score_opus":0.46675862260967427,"score_gpt":0.5089552714008087,"score_spread":0.042196648791134383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105940326","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066096047,0.23584783,0.000012417838,0.013766654,0.73306763,0.0013456998,0.00090316,0.0002702218,0.008176784],"genre_scores_gemma":[0.00084267615,0.55442804,0.000042798532,0.058282916,0.3803036,0.00021691744,0.00020842814,0.00024975892,0.0054248464],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98807424,0.0050924337,0.0024075177,0.0018667415,0.0007181223,0.0018409354],"domain_scores_gemma":[0.9852134,0.010525719,0.0015029308,0.00094751414,0.000676507,0.0011339358],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0065960684,0.001590457,0.0020597407,0.00029254353,0.0012371062,0.00007431428,0.0022035814,0.0043200683,0.0037375453],"category_scores_gemma":[0.00013961432,0.001283494,0.00083801034,0.00015922857,0.004122387,0.00018567474,0.0020417569,0.008554121,0.0006349535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015359002,0.0007039622,0.00003147645,0.00019336923,0.00507331,0.00019745804,0.0014979718,0.000013410447,0.002467839,0.000083834966,0.8570408,0.13116066],"study_design_scores_gemma":[0.005363992,0.0003515112,0.000050740244,0.00003537324,0.009734982,0.000054569668,0.0001918087,0.00037641454,0.0028646719,0.00069426507,0.9789563,0.0013253739],"about_ca_topic_score_codex":0.000010370856,"about_ca_topic_score_gemma":0.000023335482,"teacher_disagreement_score":0.35276404,"about_ca_system_score_codex":0.00022883299,"about_ca_system_score_gemma":0.00088337384,"threshold_uncertainty_score":0.99968433},"labels":[],"label_agreement":null},{"id":"W2106972824","doi":"10.1177/1740774513517063","title":"Simulating sequential multiple assignment randomized trials to generate optimal personalized warfarin dosing strategies","year":2014,"lang":"en","type":"article","venue":"Clinical Trials","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Dosing; Warfarin; Pharmacodynamics; Medicine; Pharmacokinetics; Computer science; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.6609817779989111,"score_gpt":0.6237253747213521,"score_spread":0.03725640327755897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106972824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8651765,0.0015718208,0.11151707,0.0018230976,0.01251036,0.0045435983,0.00018420893,0.00023700733,0.002436347],"genre_scores_gemma":[0.97600746,0.0006676341,0.009555801,0.005262007,0.007470133,0.00031923305,0.000054282504,0.00007212972,0.00059130613],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9211854,0.06989657,0.00642697,0.0010224263,0.0005210407,0.0009476153],"domain_scores_gemma":[0.9079105,0.08803499,0.0021401322,0.0004813036,0.00029410748,0.0011389232],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.17645131,0.000598011,0.0056547974,0.00018378689,0.00047196727,0.0002833848,0.0005558379,0.0007591391,0.0027231444],"category_scores_gemma":[0.08837075,0.00045996622,0.0022205734,0.00024953356,0.00051262835,0.00015749483,0.000285502,0.0011606773,0.0003081437],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20285991,0.0012702873,0.0007273549,0.00008594028,0.0041190004,0.00003986302,0.0013018983,0.21887963,0.3264737,0.007566032,0.0057105734,0.23096581],"study_design_scores_gemma":[0.4256658,0.00029966672,0.00008672919,0.000052421332,0.003639535,0.0000053678023,0.00020364461,0.26505592,0.06490953,0.0031302106,0.2359518,0.0009993712],"about_ca_topic_score_codex":0.000028570146,"about_ca_topic_score_gemma":0.0000028506793,"teacher_disagreement_score":0.26156417,"about_ca_system_score_codex":0.000056926754,"about_ca_system_score_gemma":0.00031245922,"threshold_uncertainty_score":0.9997852},"labels":[],"label_agreement":null},{"id":"W2106988558","doi":"10.1345/aph.1g003","title":"Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials","year":2005,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St. Joseph’s Healthcare Hamilton; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Warfarin; Crossover study; Randomized controlled trial; Crossover; Brand names; Internal medicine; Advertising; Alternative medicine; Artificial intelligence; Atrial fibrillation","score_opus":0.41253580092468994,"score_gpt":0.5213821955737448,"score_spread":0.10884639464905482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106988558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9230771,0.06947078,0.00034817064,0.0031574138,0.0010672421,0.0012989204,0.00041427338,0.000060500155,0.0011056126],"genre_scores_gemma":[0.91373897,0.073843524,0.0005372581,0.010103719,0.0008449402,0.00012542824,0.000012161588,0.000061103165,0.0007329097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948448,0.002112877,0.001635796,0.00046532048,0.00032586785,0.0006153179],"domain_scores_gemma":[0.9952939,0.0021151844,0.0015887183,0.00026758257,0.00036307191,0.00037154063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006032696,0.00045289588,0.0021539829,0.0003133677,0.00014571517,0.00002714422,0.00043669075,0.00029561642,0.0033792139],"category_scores_gemma":[0.00050472864,0.0003802518,0.000697194,0.00026767724,0.0006763613,0.00021768826,0.00011265698,0.000512777,0.00003400858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06217361,0.0008384804,0.0025338507,0.00015644789,0.0019447972,0.000009685222,0.0020512925,0.0010357157,0.7417605,0.0003142983,0.012919271,0.17426203],"study_design_scores_gemma":[0.09104845,0.000044421984,0.00022730428,0.000028618306,0.00031505476,0.0000074393015,0.000044356202,0.005818683,0.6689899,0.00041422292,0.23277245,0.00028911198],"about_ca_topic_score_codex":0.000055157583,"about_ca_topic_score_gemma":0.000010279283,"teacher_disagreement_score":0.21985318,"about_ca_system_score_codex":0.000012405922,"about_ca_system_score_gemma":0.00006155672,"threshold_uncertainty_score":0.99986494},"labels":[],"label_agreement":null},{"id":"W2107702110","doi":"10.3389/fphar.2010.00121","title":"Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants","year":2010,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Genetics; Gene; Exon; Locus (genetics); Genotype; Intron; Allele; CYP2D6","score_opus":0.04969411865652998,"score_gpt":0.36825887915832684,"score_spread":0.31856476050179683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107702110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94899493,0.0008524116,0.016583761,0.0007012596,0.030753732,0.0005578894,0.00018156927,0.00004499311,0.0013294476],"genre_scores_gemma":[0.99389035,0.00062015234,0.002034337,0.0015488364,0.0009879705,0.00013980365,0.00005984876,0.00003768182,0.00068104337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758077,0.000218939,0.000817988,0.00058915414,0.00024190983,0.0005512334],"domain_scores_gemma":[0.99878335,0.00022537609,0.0003492107,0.00019849643,0.00015469159,0.0002888647],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013676935,0.0003102664,0.00047336248,0.0005238441,0.00019635595,0.000016687558,0.00028933142,0.00043685516,0.0012506942],"category_scores_gemma":[0.000084235806,0.0003384332,0.00010577913,0.00040445093,0.0006135501,0.00020697406,0.00014873208,0.0013681633,0.000029712714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006555368,0.0008581687,0.026612937,0.00003952817,0.00025205527,0.000015321228,0.00020456672,0.0009322182,0.9155376,0.0006479159,0.042953838,0.01129029],"study_design_scores_gemma":[0.015846891,0.00010252792,0.20210472,0.000008670978,0.00065647584,0.00016387003,0.00015727396,0.12590075,0.48367983,0.0022138092,0.16840325,0.0007619449],"about_ca_topic_score_codex":0.0000133614485,"about_ca_topic_score_gemma":0.0000064369274,"teacher_disagreement_score":0.4318578,"about_ca_system_score_codex":0.00004503978,"about_ca_system_score_gemma":0.00020411317,"threshold_uncertainty_score":0.9999068},"labels":[],"label_agreement":null},{"id":"W2108129761","doi":"10.1345/aph.1r621","title":"Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy","year":2013,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Jewish General Hospital","funders":"","keywords":"Polypharmacy; Medicine; Drug; Drug interaction; Pharmacology","score_opus":0.040482965453290234,"score_gpt":0.4005104843500155,"score_spread":0.3600275188967253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108129761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201804,0.004399514,0.000024411042,0.0007179762,0.0004460486,0.0015507212,0.0005087689,0.000045033248,0.00028948562],"genre_scores_gemma":[0.9707531,0.02695428,0.0001564393,0.0014364581,0.00011784632,0.0001630392,0.00003230649,0.000058824775,0.00032775334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969033,0.00077548524,0.0008521939,0.0004872996,0.00036954647,0.00061219005],"domain_scores_gemma":[0.9978322,0.00033765272,0.0006913699,0.00024697822,0.00051777856,0.00037405512],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006232306,0.0004241887,0.0006070315,0.0004149377,0.00012631307,0.000022568054,0.00041213832,0.000077962286,0.004402988],"category_scores_gemma":[0.00003408839,0.00036770062,0.00015997507,0.00045421865,0.00040634398,0.0004921247,0.00008868462,0.0007060632,0.00003649951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014159703,0.0022829103,0.5303608,0.0002215787,0.00086211064,0.000008368269,0.002195545,0.00034528223,0.44237673,0.00001919126,0.004831999,0.015079463],"study_design_scores_gemma":[0.011573784,0.000093353956,0.63674873,0.000067961664,0.0002784926,0.000003188504,0.000055824967,0.0022320137,0.34371552,0.00014333514,0.0046649734,0.00042282755],"about_ca_topic_score_codex":0.0006076302,"about_ca_topic_score_gemma":0.00001347347,"teacher_disagreement_score":0.10638788,"about_ca_system_score_codex":0.00001580556,"about_ca_system_score_gemma":0.000083570245,"threshold_uncertainty_score":0.9998775},"labels":[],"label_agreement":null},{"id":"W2108182085","doi":"10.2174/1389200215666140130124910","title":"Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process","year":2014,"lang":"en","type":"article","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":436,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; Instituto de Salud Carlos III; Canadian Institutes of Health Research; Vetenskapsrådet; National Institutes of Health; National Heart, Lung, and Blood Institute","keywords":"Guideline; Clinical Practice; Medicine; Grading (engineering); Pharmacogenomics; Precision medicine; Dosing; Medical physics; Pharmacology; Family medicine; Pathology; Engineering","score_opus":0.1829097713412273,"score_gpt":0.5727360438001791,"score_spread":0.38982627245895174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108182085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495669,0.017032783,0.008043947,0.0029292998,0.01903554,0.0021364274,0.00013681756,0.00014452726,0.00097377715],"genre_scores_gemma":[0.97015977,0.010389034,0.008206597,0.0054461025,0.004991166,0.00021744895,0.00041410723,0.00010004206,0.00007573485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877323,0.0045823287,0.004985576,0.0009802633,0.00087780185,0.0008417416],"domain_scores_gemma":[0.9928358,0.0015820742,0.0027057573,0.0006269219,0.001562699,0.0006867177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.017171124,0.00067990064,0.001129018,0.00023012605,0.00061273423,0.00006661598,0.0012040008,0.00032350502,0.0006063363],"category_scores_gemma":[0.0010309182,0.0005510547,0.0004545797,0.00058070687,0.0007319713,0.00034269394,0.00043942433,0.0018645069,0.00016540014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074899977,0.0019231061,0.024224715,0.0001393659,0.0008351112,0.000004344913,0.002592074,0.0010794161,0.006404149,0.0018775278,0.020861547,0.93930966],"study_design_scores_gemma":[0.007147699,0.000049383456,0.0053363955,0.000014422842,0.0018666793,0.000012271606,0.0004738838,0.0072802147,0.06917349,0.0010084383,0.9070504,0.00058674935],"about_ca_topic_score_codex":0.000018368704,"about_ca_topic_score_gemma":0.000015516149,"teacher_disagreement_score":0.9387229,"about_ca_system_score_codex":0.00006058943,"about_ca_system_score_gemma":0.0010323214,"threshold_uncertainty_score":0.9996941},"labels":[],"label_agreement":null},{"id":"W2109558038","doi":"10.1124/dmd.30.3.314","title":"Inhibition of Cytochromes P450 by Antifungal Imidazole Derivatives","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse","keywords":"Miconazole; Chemistry; Clotrimazole; Econazole; Hydroxylation; CYP2A6; Microsome; CYP2B6; Pharmacology; Stereochemistry; CYP1A2; Biochemistry; Biology; In vitro; Enzyme","score_opus":0.04292062512114255,"score_gpt":0.347355702439152,"score_spread":0.30443507731800945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109558038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96867806,0.02395771,0.00028610916,0.0004920191,0.00049867446,0.00031290337,0.0005235997,0.00006211814,0.0051887897],"genre_scores_gemma":[0.9918078,0.006275601,0.00018472264,0.0008605637,0.00025102546,0.000040308925,0.00012640758,0.000025862992,0.00042770634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829006,0.00035223615,0.00043180273,0.0003513787,0.00021374243,0.00036078008],"domain_scores_gemma":[0.99914867,0.0001435779,0.00020893736,0.00015734462,0.000103575134,0.00023788966],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003618034,0.00026770085,0.0003937653,0.00015818287,0.0002512539,0.000030041761,0.00011761229,0.00017301015,0.0013638433],"category_scores_gemma":[0.000034076147,0.00025641356,0.00010810469,0.00025615972,0.00028994377,0.0003117815,0.00007652511,0.0003138836,0.00004566527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010764726,0.0004790391,0.0008379334,0.00006811214,0.0000975321,0.0000067089813,0.0017541128,0.000035422487,0.95781636,0.0031392816,0.011365858,0.02429199],"study_design_scores_gemma":[0.0023843113,0.000031306434,0.014877127,0.000028276943,0.0003911655,0.000018560035,0.000252977,0.0027557232,0.90466684,0.00096652174,0.07321406,0.0004131254],"about_ca_topic_score_codex":0.000019987525,"about_ca_topic_score_gemma":0.0000013872169,"teacher_disagreement_score":0.0618482,"about_ca_system_score_codex":0.000010653129,"about_ca_system_score_gemma":0.00001122604,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W2109720671","doi":"10.1016/s0022-3565(24)29650-6","title":"Pulmonary Bioactivation of 1,1-Dichloroethylene Is Associated with CYP2E1 Levels in A/J, CD-1, and C57BL/6 Mice","year":2001,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glutathione; CYP2E1; Chemistry; Cytosol; Lung; Metabolite; Molecular biology; Ratón; Conjugate; Glutathione S-transferase; Toxicity; Biochemistry; Immunology; Internal medicine; Biology; Metabolism; Cytochrome P450; Medicine; Enzyme","score_opus":0.10434009170810296,"score_gpt":0.42539914795908,"score_spread":0.3210590562509771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109720671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805244,0.01673619,0.000025632002,0.0012466578,0.0006135077,0.00023101237,0.00003800136,0.000009742072,0.00057486264],"genre_scores_gemma":[0.9876876,0.0070213657,0.0001334946,0.0048162374,0.00018668307,0.000009072799,0.0000031984323,0.000026870928,0.00011547633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981455,0.00038517496,0.0006756303,0.0002251659,0.00020734074,0.00036118145],"domain_scores_gemma":[0.99847776,0.0005208669,0.00060308503,0.00006376183,0.00016273321,0.00017177673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008115341,0.00027447892,0.0005253679,0.00028335466,0.0001258996,0.000011721612,0.00018881947,0.0002966295,0.0004064825],"category_scores_gemma":[0.000015314266,0.00023399571,0.00007157588,0.00030279465,0.00045588877,0.00022856312,0.00007181445,0.000729748,0.0000015121398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018540415,0.0014576551,0.024132889,0.000018091494,0.0005750706,0.00019215039,0.002269432,0.00007967902,0.9615164,0.000036554102,0.00014472134,0.007723306],"study_design_scores_gemma":[0.0070138387,0.00074489514,0.014846393,0.000033534758,0.00043421175,0.0006627025,0.0007298885,0.0016098722,0.9626025,0.00024786722,0.0108063705,0.00026795096],"about_ca_topic_score_codex":0.000007482077,"about_ca_topic_score_gemma":0.0000020723598,"teacher_disagreement_score":0.010661649,"about_ca_system_score_codex":0.00007489395,"about_ca_system_score_gemma":0.0001067043,"threshold_uncertainty_score":0.9542068},"labels":[],"label_agreement":null},{"id":"W2110513442","doi":"10.1124/jpet.109.162610","title":"Role of CYP2A5 in the Clearance of Nicotine and Cotinine: Insights from Studies on a Cyp2a5-null Mouse Model","year":2009,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; University of Toronto; University of Minnesota; Bristol-Myers Squibb","keywords":"Nicotine; CYP2A6; In vivo; Pharmacology; CYP2B6; Drug metabolism; Cytochrome P450; Chemistry; Biology; CYP1A2; Metabolism; Drug; Biochemistry; Neuroscience; Genetics","score_opus":0.09661502666764893,"score_gpt":0.44793950829222745,"score_spread":0.3513244816245785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110513442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9277368,0.07049117,0.0000045643988,0.0008129542,0.00043347693,0.00022342766,0.00003295422,0.0000052993782,0.0002593512],"genre_scores_gemma":[0.9784196,0.0137527585,0.00024086316,0.007340304,0.00020129538,0.00000596019,0.0000016901408,0.000014020183,0.000023535455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979319,0.0005602055,0.00084209273,0.00019776572,0.00022126733,0.00024678826],"domain_scores_gemma":[0.9985971,0.00044674092,0.0006256125,0.00010310781,0.00013035318,0.00009707903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000598354,0.00026225866,0.00063393073,0.0001910311,0.000105529994,0.0000076259926,0.000321962,0.00019267853,0.00003800464],"category_scores_gemma":[0.0000129578075,0.00018494022,0.00010711515,0.00015608042,0.00046026648,0.00010817042,0.00006136446,0.0007581286,0.0000011217177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032967394,0.0014304661,0.00036742404,0.0000146624125,0.0004740753,0.000011174701,0.013359023,0.002592451,0.97450197,0.0009151032,0.00021472987,0.0028221798],"study_design_scores_gemma":[0.005409405,0.0010871397,0.0007545727,0.00002235167,0.00035600242,0.000026743895,0.0029408499,0.0076843468,0.97649556,0.0027168186,0.0023377412,0.00016847478],"about_ca_topic_score_codex":0.0000031477682,"about_ca_topic_score_gemma":0.0000013392637,"teacher_disagreement_score":0.056738414,"about_ca_system_score_codex":0.00002720325,"about_ca_system_score_gemma":0.00006434366,"threshold_uncertainty_score":0.7541643},"labels":[],"label_agreement":null},{"id":"W2110565069","doi":"10.1080/00498250902954296","title":"Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling","year":2009,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Recombinant DNA; Chemistry; Biology; Biochemistry","score_opus":0.26169503692010365,"score_gpt":0.4253406080847287,"score_spread":0.16364557116462503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110565069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98771876,0.0016076533,0.007609265,0.0004753008,0.00073279766,0.0005255337,0.00017812199,0.000103108745,0.0010494583],"genre_scores_gemma":[0.99170655,0.00085935224,0.0054068617,0.0016513092,0.00026570415,0.0000049412643,0.00003888421,0.000026651196,0.000039762952],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978436,0.00034336903,0.0006170694,0.0004640141,0.00020536907,0.00052656705],"domain_scores_gemma":[0.99882454,0.00024433873,0.00025564738,0.0002246859,0.00017465105,0.00027612058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053739425,0.0003336982,0.00049127865,0.0001750875,0.00022268438,0.000024149125,0.00023418764,0.00031103333,0.0002932162],"category_scores_gemma":[0.000053750882,0.00030802112,0.00012942858,0.00027625042,0.0002772969,0.00009920074,0.00006144714,0.0005432912,0.000007294481],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005635064,0.0019180034,0.000075109114,0.000053247608,0.000082688966,0.000018540833,0.00014974321,0.033360276,0.9427342,0.00026268506,0.00019468505,0.020587312],"study_design_scores_gemma":[0.005505238,0.0007454133,0.00045089063,0.000035145455,0.00044383362,0.000017758619,0.00001732583,0.61667794,0.36576408,0.00094611896,0.009131597,0.00026464261],"about_ca_topic_score_codex":0.000004169806,"about_ca_topic_score_gemma":1.3939407e-7,"teacher_disagreement_score":0.5833177,"about_ca_system_score_codex":0.000041887677,"about_ca_system_score_gemma":0.000083677995,"threshold_uncertainty_score":0.9999372},"labels":[],"label_agreement":null},{"id":"W2111074312","doi":"10.1517/14656566.6.8.1299","title":"A pharmacogeneticist’s look at drug effects and the drug development process: an overview","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Medicine; Drug; Drug development; Personalized medicine; Pharmacogenetics; Identification (biology); Drug response; Pharmacology; Drug action; Intensive care medicine; Bioinformatics; Genetics","score_opus":0.21577903902343207,"score_gpt":0.5352320778405615,"score_spread":0.3194530388171294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111074312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041811727,0.98563236,0.0000068743943,0.00081232144,0.006266891,0.0052987537,0.00011237849,0.00030771975,0.0011445686],"genre_scores_gemma":[0.000085691245,0.96760494,0.00019143308,0.021206487,0.0041225585,0.0036561927,0.00025254878,0.00040915818,0.00247097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891325,0.0047421088,0.0018609172,0.0018829474,0.0009270304,0.0014545019],"domain_scores_gemma":[0.9950567,0.0016862361,0.0010832301,0.0008303275,0.00016472871,0.0011788053],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0026328836,0.002099719,0.0031077515,0.0004731022,0.0014205369,0.00015656145,0.0017867575,0.00063178525,0.0027378832],"category_scores_gemma":[0.000034208824,0.0014300399,0.0008490195,0.00058677356,0.0007851757,0.00023289569,0.0003701219,0.0022826504,0.0006106823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991955,0.0009211986,0.0000033090582,0.0032140648,0.0013683914,0.000027377577,0.0063155773,0.000027746453,0.00021997855,0.00031974132,0.02087782,0.96571285],"study_design_scores_gemma":[0.011965494,0.00006324886,0.0000014585365,0.0016075725,0.00050531415,0.000107203035,0.000048731898,0.00039128255,0.0075537437,0.00006478649,0.9760438,0.0016473483],"about_ca_topic_score_codex":0.00001143148,"about_ca_topic_score_gemma":0.000005129186,"teacher_disagreement_score":0.9640655,"about_ca_system_score_codex":0.00039985203,"about_ca_system_score_gemma":0.0007063127,"threshold_uncertainty_score":0.9998795},"labels":[],"label_agreement":null},{"id":"W2111331724","doi":"10.1186/1741-7015-11-179","title":"Personalizing health care: feasibility and future implications","year":2013,"lang":"en","type":"review","venue":"BMC Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Sunnybrook Health Science Centre; Centre for Global Health Research","funders":"Conservatoire National des Arts et Métiers; Vetenskapsrådet; Stockholms Läns Landsting; Karolinska Institutet; NHS Health Scotland","keywords":"Medicine; Pharmacogenomics; Personalized medicine; Precision medicine; Stakeholder; Health care; Risk analysis (engineering); Variety (cybernetics); Intensive care medicine; Pharmacology; Bioinformatics; Public relations; Pathology","score_opus":0.4292138280629503,"score_gpt":0.5653152161168731,"score_spread":0.1361013880539228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111331724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004328593,0.99051535,0.00003060629,0.0021534034,0.0022708052,0.002109862,0.00024420788,0.00008083818,0.0025516474],"genre_scores_gemma":[0.000023550752,0.99005127,0.0004486842,0.0030528798,0.0052833213,0.00033129437,0.00037649437,0.000061672654,0.00037083653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964613,0.0011415173,0.0008916073,0.00074337336,0.00019431094,0.00056790607],"domain_scores_gemma":[0.9975305,0.0005179824,0.000529101,0.0005043434,0.00013933422,0.000778721],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001081225,0.00057210587,0.0019118501,0.00019251554,0.0003943941,0.000015952748,0.00039729467,0.0005584071,0.0016121559],"category_scores_gemma":[0.000082902676,0.00041014852,0.00024073533,0.00032626672,0.00035585533,0.00004520007,0.00014678418,0.0012701661,0.00011191964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000066559255,0.00004586754,0.00010527142,0.011465005,0.0001230295,0.0000016676577,0.0009658228,1.2306839e-7,0.0000048443285,0.001055453,0.024035657,0.9621906],"study_design_scores_gemma":[0.0009017544,0.00006463389,0.00013305995,0.0006522575,0.0012696012,0.00007904843,0.00034316385,0.000006503215,9.5326794e-7,0.00008147545,0.9961447,0.0003228086],"about_ca_topic_score_codex":0.000041709238,"about_ca_topic_score_gemma":0.000018169543,"teacher_disagreement_score":0.9721091,"about_ca_system_score_codex":0.00020154727,"about_ca_system_score_gemma":0.0007644064,"threshold_uncertainty_score":0.999835},"labels":[],"label_agreement":null},{"id":"W2111676569","doi":"10.1124/dmd.32.12.","title":"USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES","year":2004,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Microsome; CYP3A; Hepatocyte; Metabolite; Enzyme inducer; Chemistry; Cytochrome P450; Glucuronidation; Enzyme; Phenobarbital; Biochemistry; Enzyme inhibitor; Molecular biology; Biology; Pharmacology; In vitro","score_opus":0.047391999343260084,"score_gpt":0.3580090161846279,"score_spread":0.3106170168413678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111676569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928909,0.003820814,0.0003918004,0.00028263617,0.00043421448,0.0016825196,0.00037564858,0.000046605244,0.00007485544],"genre_scores_gemma":[0.9963154,0.0014218308,0.0009091171,0.00055049366,0.000235163,0.00027105107,0.0002080612,0.000031894106,0.000056968474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981313,0.00030006142,0.00043145608,0.0005141608,0.00018736048,0.00043571196],"domain_scores_gemma":[0.9990581,0.00013614896,0.00023064078,0.00014838128,0.00015466129,0.0002720338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004289405,0.00035440773,0.0005830616,0.00022027515,0.0002935432,0.00006346341,0.00010308668,0.0002589001,0.000011911337],"category_scores_gemma":[0.00005202739,0.00032987085,0.00011380652,0.00027884432,0.00024789383,0.00060022203,0.00009102867,0.00041008464,0.0000020697237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001841163,0.0011412046,0.0021957227,0.00021337107,0.00013026649,0.000013712032,0.0021085825,0.00017239532,0.9788937,0.007624188,0.00011375812,0.005551957],"study_design_scores_gemma":[0.007686368,0.00007323137,0.06307779,0.000058035967,0.000459007,0.00001646768,0.000062369094,0.00021224476,0.9197125,0.002898755,0.0053454777,0.0003977701],"about_ca_topic_score_codex":0.0003209437,"about_ca_topic_score_gemma":0.00009830612,"teacher_disagreement_score":0.060882065,"about_ca_system_score_codex":0.00006901196,"about_ca_system_score_gemma":0.0001166904,"threshold_uncertainty_score":0.99991536},"labels":[],"label_agreement":null},{"id":"W2111753974","doi":"10.2217/14622416.7.2.219","title":"Pharmacogenomic Data Sample Collection and Storage: Ethical Issues and Policy Approaches","year":2006,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biobank; Pharmacogenomics; Mainstream; Sample (material); Data collection; Perspective (graphical); Population; Ethical issues; Data science; Medicine; Engineering ethics; Political science; Computer science; Sociology; Bioinformatics; Pharmacology; Environmental health; Engineering; Biology; Social science","score_opus":0.4607023734111636,"score_gpt":0.5289519496593159,"score_spread":0.06824957624815231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111753974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063229987,0.98552907,0.00016970938,0.00088937726,0.0019926506,0.0023450076,0.007213683,0.00023170742,0.0009964966],"genre_scores_gemma":[0.00032957713,0.98744565,0.0015217735,0.0017600602,0.004700976,0.00026813112,0.0027692136,0.00033969007,0.0008649411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99219537,0.0021292488,0.0016603632,0.002228796,0.00040022394,0.0013859705],"domain_scores_gemma":[0.99523026,0.0017143697,0.00088612083,0.0010163944,0.00010995534,0.0010428953],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0028723446,0.0015969222,0.0028768606,0.00094008277,0.0009351812,0.0002689821,0.0016753429,0.0020365666,0.00033062548],"category_scores_gemma":[0.00026367872,0.0015897444,0.00037736987,0.0008630312,0.00086829957,0.00027157247,0.0023428584,0.004924757,0.000112070236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013670011,0.00030257035,0.00004127211,0.0057417946,0.0014566561,0.000058048023,0.00024630225,0.00005682567,0.00036913564,0.00067318854,0.02122887,0.96968865],"study_design_scores_gemma":[0.0021324207,0.00004217166,0.0000058440996,0.00019263846,0.0066357474,0.00039693608,0.000020342643,0.008464239,0.00018141723,0.0004491915,0.98004085,0.0014381787],"about_ca_topic_score_codex":0.00047734758,"about_ca_topic_score_gemma":0.000023617595,"teacher_disagreement_score":0.96825045,"about_ca_system_score_codex":0.00034841523,"about_ca_system_score_gemma":0.0011555234,"threshold_uncertainty_score":0.99967784},"labels":[],"label_agreement":null},{"id":"W2111842648","doi":"10.1124/dmd.106.013243","title":"Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation","year":2006,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences","keywords":"Peroxisome proliferator-activated receptor; Genetically modified mouse; Peroxisome proliferator; Peroxisome; Transgene; Metabolism; Drug; Locus (genetics); Biology; Chemistry; Pharmacology; Receptor; Endocrinology; Internal medicine; Biochemistry; Gene; Medicine","score_opus":0.030784343679233744,"score_gpt":0.3366847351071157,"score_spread":0.30590039142788195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111842648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98688656,0.0075175646,0.0000900331,0.0023177906,0.00060130825,0.001260374,0.00051299296,0.00007156306,0.0007418121],"genre_scores_gemma":[0.99576753,0.0018510693,0.000121762496,0.0010120907,0.00041108803,0.00028490915,0.0002723332,0.00006218165,0.0002170468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647117,0.001002035,0.00083961483,0.0007490991,0.00036092426,0.000577174],"domain_scores_gemma":[0.9986144,0.00021303355,0.0004464734,0.00037959643,0.00014738746,0.00019915233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006504614,0.0005339999,0.00065417367,0.00022594641,0.0007072411,0.00006919159,0.00035781917,0.0003378431,0.00011496209],"category_scores_gemma":[0.000034722554,0.0004312461,0.00016839696,0.00059431675,0.0003606545,0.0005245405,0.00011540336,0.0008220489,0.000007898924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034365986,0.0007368625,0.0010536673,0.00008053346,0.00005029227,3.854897e-7,0.0019873935,0.000098993645,0.98538595,0.0060915225,0.0023582012,0.0018125575],"study_design_scores_gemma":[0.003280163,0.000019536312,0.032596417,0.00006614313,0.00031029826,0.0000041451985,0.00020623842,0.000053622105,0.9389753,0.0030986096,0.020954298,0.00043523608],"about_ca_topic_score_codex":0.0002693075,"about_ca_topic_score_gemma":0.000027914399,"teacher_disagreement_score":0.046410635,"about_ca_system_score_codex":0.000053027525,"about_ca_system_score_gemma":0.00006275141,"threshold_uncertainty_score":0.9998139},"labels":[],"label_agreement":null},{"id":"W2112200883","doi":"10.1080/03602530701836712","title":"Expression, Activity and Regulation of CYP3A in Human and Rodent Brain","year":2008,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Division of Materials Research; Canadian Institutes of Health Research","keywords":"CYP3A; Cytochrome P450; Biology; Human brain; Drug metabolism; Isozyme; Enzyme; Function (biology); Rodent; Cell biology; Neuroscience; Biochemistry","score_opus":0.16506738117245323,"score_gpt":0.4740940236489169,"score_spread":0.30902664247646366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112200883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006182958,0.98985505,0.00001125762,0.00006827473,0.0007249185,0.0023441247,0.00011743601,0.00002655357,0.0006694171],"genre_scores_gemma":[0.0005733659,0.99729985,0.0002194777,0.00023617326,0.00041141108,0.00033177584,0.00006674184,0.00007535208,0.000785864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99268836,0.003927991,0.0017379365,0.0008666605,0.00026296498,0.0005160836],"domain_scores_gemma":[0.99714464,0.00049690076,0.0013986771,0.00053773803,0.00007070067,0.0003513543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023935244,0.0008200615,0.004229538,0.0005364159,0.00021413714,0.000022930895,0.00040669035,0.0006372488,0.0002197967],"category_scores_gemma":[0.00021200215,0.000660907,0.00048252678,0.0005346065,0.000358995,0.00017782532,0.00036719936,0.001360486,0.000020967154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001749374,0.00019848126,0.000031698488,0.0074375714,0.00008507205,0.0000108440445,0.00043030627,0.000002872816,0.0041453987,0.00037327342,0.0039684824,0.9832985],"study_design_scores_gemma":[0.0009543485,0.000008734113,0.00051613775,0.0022445559,0.00090524525,0.00006293823,0.0000047257777,0.000022801221,0.0013315127,0.00016547502,0.9932317,0.00055180193],"about_ca_topic_score_codex":0.00004374722,"about_ca_topic_score_gemma":0.00001499202,"teacher_disagreement_score":0.98926324,"about_ca_system_score_codex":0.0000325335,"about_ca_system_score_gemma":0.00014159498,"threshold_uncertainty_score":0.9995842},"labels":[],"label_agreement":null},{"id":"W2112521086","doi":"10.1097/moh.0b013e32833c06b3","title":"Will there be a role for genotyping in warfarin therapy?","year":2010,"lang":"en","type":"review","venue":"Current Opinion in Hematology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Warfarin; Dosing; Medicine; Intensive care medicine; Therapeutic index; Thrombosis; VKORC1; CYP2C9; Internal medicine; Pharmacology; Drug; Atrial fibrillation","score_opus":0.38506051172235367,"score_gpt":0.5514394381103891,"score_spread":0.16637892638803542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112521086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022311528,0.97567475,0.00006542772,0.0001860699,0.02033471,0.002943527,0.0002384326,0.000056819823,0.0002771584],"genre_scores_gemma":[0.00012429924,0.99575347,0.00012679708,0.00015238354,0.0010526554,0.0022513086,0.0003900756,0.000110523266,0.000038511018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99545234,0.0010333367,0.0014583903,0.0008960358,0.00014396005,0.0010159537],"domain_scores_gemma":[0.99750346,0.001159377,0.0005819183,0.00044425554,0.00008215148,0.00022883542],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001207836,0.00075673003,0.0024040476,0.00069680274,0.00012614026,0.000022611563,0.00086621515,0.0016863357,0.00044942016],"category_scores_gemma":[0.00013742615,0.00067755935,0.0005386515,0.00047487227,0.0002019016,0.00010459062,0.00022619872,0.003182782,0.00006418695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000825815,0.00057018554,0.00033078002,0.007687694,0.00009431275,0.000004756045,0.0003139827,0.000008381968,0.000018627503,0.011786296,0.000740065,0.9783623],"study_design_scores_gemma":[0.0022550514,0.000037950813,0.000012121309,0.0017312552,0.00012556194,0.000076648015,0.000019035559,0.00030647774,0.000050271643,0.0021621678,0.9925899,0.00063356076],"about_ca_topic_score_codex":0.000008738007,"about_ca_topic_score_gemma":0.00002262969,"teacher_disagreement_score":0.99184984,"about_ca_system_score_codex":0.00009158196,"about_ca_system_score_gemma":0.00047005885,"threshold_uncertainty_score":0.9996097},"labels":[],"label_agreement":null},{"id":"W2112547742","doi":"10.1067/mcp.2000.110774","title":"Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Grapefruit juice; Naringin; Felodipine; Naringenin; Chemistry; Pharmacology; Furanocoumarin; Citrus paradisi; CYP3A4; Drug interaction; Pharmacokinetics; Food science; Flavonoid; Rutaceae; Chromatography; Biochemistry; Botany; Cytochrome P450; Medicine; Metabolism; Biology","score_opus":0.15016354409023558,"score_gpt":0.5123970513687449,"score_spread":0.36223350727850934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112547742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838666,0.0032296134,0.000017248432,0.0020496321,0.0045128292,0.0011077741,0.00008760024,0.00013405886,0.004994695],"genre_scores_gemma":[0.95766526,0.0144748585,0.0001577506,0.025037086,0.0011387349,0.00014199191,0.000035874586,0.000071904855,0.0012765063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99501675,0.0019031081,0.0012510722,0.00078227604,0.00026539876,0.00078140025],"domain_scores_gemma":[0.9964247,0.0020759485,0.0004650307,0.00029287805,0.00023402944,0.0005074193],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001689468,0.00055376126,0.0010738753,0.00017195077,0.0003124782,0.000022071998,0.0005770852,0.0007239363,0.0064672423],"category_scores_gemma":[0.00004262656,0.00048486792,0.0003094284,0.00047187385,0.0011780971,0.00020913003,0.0001697207,0.0018820813,0.00023905399],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014844782,0.0026810095,0.027450891,0.0003297721,0.004713691,0.000077347104,0.0011870133,0.00049086806,0.1317349,0.000047210397,0.012897177,0.80354536],"study_design_scores_gemma":[0.014038017,0.0018052778,0.006068921,0.000034346263,0.003941765,0.000054955966,0.000052032028,0.0031444295,0.2770573,0.0004003247,0.69276595,0.0006366841],"about_ca_topic_score_codex":0.0000057403763,"about_ca_topic_score_gemma":0.0000027624972,"teacher_disagreement_score":0.80290866,"about_ca_system_score_codex":0.000047413003,"about_ca_system_score_gemma":0.00013293535,"threshold_uncertainty_score":0.99976027},"labels":[],"label_agreement":null},{"id":"W2113122443","doi":"10.1002/jms.3375","title":"Structural elucidation of new urinary tamoxifen metabolites by liquid chromatography quadrupole time‐of‐flight mass spectrometry","year":2014,"lang":"en","type":"article","venue":"Journal of Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Chemistry; Chromatography; Mass spectrometry; Urine; Hydroxylation; Metabolomics; Metabolite; Tamoxifen; Fragmentation (computing); Breast cancer; Cancer; Biochemistry; Internal medicine; Enzyme","score_opus":0.02702595252843914,"score_gpt":0.34420125528986795,"score_spread":0.3171753027614288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113122443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733137,0.016823543,0.0033130061,0.0005883624,0.0015941819,0.00023084288,0.00012660246,0.000033421336,0.0039763404],"genre_scores_gemma":[0.98193115,0.0020206044,0.0137613695,0.00031653832,0.0013911119,0.0000024932494,0.00002695788,0.00006197265,0.00048778957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958068,0.0007191122,0.0016389583,0.0003597344,0.0007892614,0.00068611803],"domain_scores_gemma":[0.99615604,0.00048309352,0.0020201097,0.00038125535,0.0003496966,0.00060978153],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018629926,0.0004763541,0.0012939583,0.0014465966,0.00013022833,0.000031194846,0.00090293033,0.00039114026,0.003978308],"category_scores_gemma":[0.00022381087,0.00042341734,0.0006746096,0.0014460073,0.00026522233,0.00034880269,0.00010264597,0.001144038,0.00004197901],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010445134,0.0003433361,0.0050752657,0.00010769767,0.0009776136,0.000019201101,0.00023905722,0.000119801756,0.9815261,0.0008715888,0.008683582,0.0009922743],"study_design_scores_gemma":[0.0032422727,0.0014420073,0.0074131,0.00003551634,0.00084940065,0.00016245605,0.000070231414,0.0005781186,0.9492218,0.004030141,0.032546755,0.00040822086],"about_ca_topic_score_codex":0.000012451197,"about_ca_topic_score_gemma":3.276711e-7,"teacher_disagreement_score":0.03230429,"about_ca_system_score_codex":0.0000746164,"about_ca_system_score_gemma":0.00020726274,"threshold_uncertainty_score":0.9998218},"labels":[],"label_agreement":null},{"id":"W2113187341","doi":"","title":"Quaternary ammonium-linked glucuronidation of 1-substituted imidazoles: studies of human UDP-glucuronosyltransferases involved and substrate specificities.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Glucuronidation; Chemistry; Enzyme kinetics; Metabolite; Stereochemistry; Tertiary amine; Substrate (aquarium); Lipophilicity; UGT2B7; Enzyme; Organic chemistry; Microsome; Active site; Biochemistry","score_opus":0.2576837597796968,"score_gpt":0.4143162402860982,"score_spread":0.15663248050640138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113187341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98470557,0.012250339,0.000046092675,0.00022201633,0.0008187414,0.0008474468,0.00010884896,0.000058276957,0.00094266754],"genre_scores_gemma":[0.981824,0.017334132,0.000041264237,0.0001234086,0.00022408122,0.00028066547,0.000052064228,0.000029257622,0.00009112454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774855,0.00032400247,0.0008301238,0.0003629386,0.00022119672,0.0005131878],"domain_scores_gemma":[0.9987395,0.00025441908,0.00031957938,0.00022080398,0.00023587432,0.00022982771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007728826,0.00030693994,0.00060665293,0.00023271066,0.00017289918,0.000014986855,0.0002685871,0.00019252204,0.00010446572],"category_scores_gemma":[0.000055162305,0.00029793245,0.00011805155,0.00028151477,0.00075410574,0.00017628027,0.00007655134,0.00034097995,0.000004198816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002583575,0.0014730901,0.24163094,0.000816165,0.0021823735,0.00010833969,0.0050206697,0.0013667496,0.64320916,0.006248154,0.00038948774,0.09497129],"study_design_scores_gemma":[0.0037413156,0.000048176076,0.22591618,0.000027685928,0.00054227695,0.000011404321,0.0009930735,0.0003988666,0.7622708,0.0013616742,0.004280078,0.00040843035],"about_ca_topic_score_codex":0.000063370295,"about_ca_topic_score_gemma":0.00006237778,"teacher_disagreement_score":0.119061664,"about_ca_system_score_codex":0.000035721794,"about_ca_system_score_gemma":0.00004025992,"threshold_uncertainty_score":0.9999473},"labels":[],"label_agreement":null},{"id":"W2113976730","doi":"10.1093/carcin/bgu235","title":"CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers—findings from two independent populations","year":2014,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; National Cancer Institute; Vanderbilt-Ingram Cancer Center; Vanderbilt University","keywords":"Lung cancer; CYP2A6; Odds ratio; Medicine; Internal medicine; Population; Oncology; Demography; Biology; Environmental health","score_opus":0.08900709973242153,"score_gpt":0.42089925420857555,"score_spread":0.331892154476154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113976730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944396,0.0011498858,0.00020171894,0.0005210895,0.0022217063,0.0005564748,0.00033587668,0.00005677651,0.0005168729],"genre_scores_gemma":[0.9972848,0.0011696214,0.0002529023,0.00027762775,0.00061831233,0.00020941657,0.000054391545,0.000056578876,0.00007632293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630636,0.0014121111,0.00053006876,0.0007725293,0.00027034123,0.0007086],"domain_scores_gemma":[0.99870956,0.00016826003,0.00030844242,0.00037195891,0.00010180641,0.00033995678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097554474,0.0003740114,0.00059667695,0.00047983622,0.00023645836,0.00003325298,0.00034583634,0.00024180784,0.0004646136],"category_scores_gemma":[0.00010775118,0.00041288097,0.00013828442,0.00084765686,0.00020827576,0.00014862353,0.00013045922,0.0008307613,0.000020231033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003169962,0.00018513123,0.60506755,0.000008494684,0.00010328488,0.000011880305,0.0011095657,0.0074007977,0.36155343,0.000073630705,0.00010687811,0.02406236],"study_design_scores_gemma":[0.0027294084,0.000023118457,0.8165709,0.000011417469,0.00036173785,0.000004340691,0.00014917135,0.027588176,0.15086226,0.00029254454,0.0009970418,0.0004098811],"about_ca_topic_score_codex":0.021315493,"about_ca_topic_score_gemma":0.0018632922,"teacher_disagreement_score":0.21150333,"about_ca_system_score_codex":0.00038971458,"about_ca_system_score_gemma":0.00021016519,"threshold_uncertainty_score":0.99983233},"labels":[],"label_agreement":null},{"id":"W2114229890","doi":"10.1124/dmd.105.006528","title":"MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pyrrolidine dithiocarbamate; CYP1A2; Nitric oxide; Nitric oxide synthase; Chemistry; Biochemistry; Janus kinase; Pharmacology; Kinase; Molecular biology; Endocrinology; Biology; Cytochrome P450; Enzyme; Signal transduction; NF-κB","score_opus":0.020568682949819898,"score_gpt":0.315790857103446,"score_spread":0.2952221741536261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114229890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923566,0.005977146,0.00007996123,0.00037598508,0.00026316274,0.00033803302,0.00029782072,0.000040449315,0.00027083443],"genre_scores_gemma":[0.9971603,0.0017584919,0.00014864335,0.00032239445,0.00027102703,0.000033654364,0.0001693027,0.00002516374,0.00011103031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866104,0.00022319843,0.00033194904,0.00037544974,0.00016422049,0.0002441191],"domain_scores_gemma":[0.9992063,0.0001236768,0.0002810071,0.00013377455,0.00005504354,0.0002001831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031965727,0.00026374625,0.00035433835,0.00014438227,0.00017874503,0.00004009162,0.00006940728,0.00016406347,0.000028706965],"category_scores_gemma":[0.000013457337,0.0002377894,0.00003659621,0.00010465979,0.00016967366,0.0005283498,0.00006918218,0.0003017978,0.0000026262624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006087706,0.00014984659,0.005711853,0.000065653505,0.00015171777,0.0000030900835,0.0026915455,0.00003880894,0.904951,0.0004328802,0.00017901657,0.085015826],"study_design_scores_gemma":[0.004679026,0.00005004506,0.2524922,0.000053476713,0.00081988395,0.000033604658,0.0005825715,0.0075966627,0.7195379,0.0004895591,0.013197915,0.0004671785],"about_ca_topic_score_codex":0.00013442255,"about_ca_topic_score_gemma":0.000060399158,"teacher_disagreement_score":0.24678032,"about_ca_system_score_codex":0.000017105822,"about_ca_system_score_gemma":0.000027140943,"threshold_uncertainty_score":0.96967703},"labels":[],"label_agreement":null},{"id":"W211447915","doi":"10.1097/fpc.0000000000000143","title":"Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Center for Research Resources; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"VKORC1; Warfarin; CYP2C9; Pharmacogenetics; Vitamin K epoxide reductase; Pharmacogenomics; Vitamin K antagonist; Genotyping; Population; Biology; Therapeutic index; Pharmacology; Medicine; Demography; Internal medicine; Drug; Genetics; Gene; Atrial fibrillation; Environmental health; Genotype","score_opus":0.058967227767481305,"score_gpt":0.38799223859410265,"score_spread":0.32902501082662133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W211447915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875382,0.0103419125,0.00015852379,0.00081866066,0.00035060273,0.0005586614,0.00010654771,0.000018385785,0.00010851495],"genre_scores_gemma":[0.9822973,0.015771741,0.00063888845,0.001013266,0.00014449692,0.000059744594,0.000016553107,0.000034011406,0.000024003217],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977489,0.0007157908,0.00046179965,0.0004790203,0.00013667534,0.0004577869],"domain_scores_gemma":[0.99879616,0.00038390805,0.00017840214,0.000104553925,0.00008258293,0.00045437342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016606104,0.00029233692,0.00042211983,0.0003634114,0.00012549135,0.00005902768,0.00012094121,0.00015059506,0.000010750173],"category_scores_gemma":[0.00007544797,0.00031949452,0.000029109051,0.00032197702,0.00022514397,0.00009836583,0.00016723432,0.00045051597,0.0000034267116],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080836555,0.0005269502,0.3118761,0.00008611926,0.00023279253,0.00013847814,0.0432014,0.013520311,0.42196605,0.00033135238,0.000041534036,0.19999526],"study_design_scores_gemma":[0.019398734,0.00051735266,0.744753,0.000026571746,0.00036829643,0.000119690085,0.002374319,0.16851714,0.037911247,0.002483899,0.022435572,0.0010941774],"about_ca_topic_score_codex":0.0002137932,"about_ca_topic_score_gemma":0.00026626606,"teacher_disagreement_score":0.43287688,"about_ca_system_score_codex":0.00010737336,"about_ca_system_score_gemma":0.0001392761,"threshold_uncertainty_score":0.99992573},"labels":[],"label_agreement":null},{"id":"W2114771048","doi":"10.1124/dmd.109.030528","title":"Chlorzoxazone Metabolism by Porcine Cytochrome P450 Enzymes and the Effect of Cytochrome b5","year":2010,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Chlorzoxazone; Cytochrome P450; Microsome; CYP2E1; Complementary DNA; CYP3A; Metabolism; CYP3A4; Chemistry; Enzyme; Drug metabolism; Biology; Molecular biology; Biochemistry; Gene","score_opus":0.010651027567086016,"score_gpt":0.3300994829181508,"score_spread":0.31944845535106475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114771048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516505,0.042905476,0.0000837123,0.0014844503,0.0011532261,0.0010693609,0.00049095694,0.00007387155,0.0010884695],"genre_scores_gemma":[0.99228716,0.0049293367,0.00013761179,0.0010707574,0.0008021561,0.00014114268,0.00014799097,0.000051515006,0.00043232585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968026,0.0009865746,0.0006701916,0.00058889005,0.0003636831,0.000588039],"domain_scores_gemma":[0.99784476,0.00082992413,0.0003583705,0.00040978607,0.000121379664,0.00043577398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024305284,0.00054598664,0.0010677249,0.00020365432,0.0005013484,0.0000751522,0.00036215922,0.0003583322,0.00037806595],"category_scores_gemma":[0.00014158808,0.0003673928,0.0002160212,0.0003357374,0.0012462087,0.00030150832,0.00022001965,0.0012195245,0.000022690616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019107604,0.00015026788,0.00047878132,0.0001253831,0.00030732522,0.000008822296,0.001092778,0.000009565002,0.9579495,0.020689923,0.0021354356,0.015141441],"study_design_scores_gemma":[0.01889348,0.00008899597,0.06133434,0.000019368636,0.0027109466,0.00012290354,0.00009004782,0.0011517571,0.8077605,0.001960233,0.105229184,0.00063825445],"about_ca_topic_score_codex":0.00012438346,"about_ca_topic_score_gemma":0.000011667612,"teacher_disagreement_score":0.15018903,"about_ca_system_score_codex":0.000006958623,"about_ca_system_score_gemma":0.000038736205,"threshold_uncertainty_score":0.9998778},"labels":[],"label_agreement":null},{"id":"W2114902018","doi":"10.3109/00498251003713958","title":"Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism","year":2010,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"CYP2B6; CYP2A6; Nicotine; Phenobarbital; Genotype; Cytochrome P450; Metabolism; Pharmacology; Drug metabolism; Biology; Endocrinology; Chemistry; Internal medicine; Biochemistry; Medicine; CYP3A4; Gene","score_opus":0.027312478202408817,"score_gpt":0.32761411909839233,"score_spread":0.3003016408959835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114902018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184245,0.0042202943,0.000008265165,0.00031380545,0.001201276,0.00044349217,0.0008895607,0.000052582564,0.0010282709],"genre_scores_gemma":[0.9946773,0.0023091582,0.00030893707,0.001697016,0.00036321915,0.000025600322,0.00015412532,0.000048057886,0.0004166019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767894,0.00027897672,0.0004898657,0.0006262748,0.00019042344,0.0007355445],"domain_scores_gemma":[0.99881065,0.00025165742,0.0001467438,0.0003292129,0.000017968083,0.00044378726],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030354658,0.0004314906,0.0005279914,0.00012463037,0.0002047287,0.00003686693,0.00038474702,0.00047837195,0.0029307422],"category_scores_gemma":[0.00004728262,0.00038964264,0.00010986535,0.00013061179,0.0004094382,0.000090163914,0.00024478644,0.0012534849,0.00014072825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083658946,0.000496349,0.032134775,0.000016970193,0.00009354041,0.0000061669275,0.0008194881,0.000022825734,0.96084213,0.000097821314,0.0010726934,0.0043135504],"study_design_scores_gemma":[0.0022425603,0.00007493814,0.105282806,0.0000040780533,0.0002040333,0.000014728753,0.00020497026,0.003849378,0.75717986,0.000651167,0.1297598,0.00053168705],"about_ca_topic_score_codex":0.00008181578,"about_ca_topic_score_gemma":0.000018421104,"teacher_disagreement_score":0.2036623,"about_ca_system_score_codex":0.00002314583,"about_ca_system_score_gemma":0.00003667088,"threshold_uncertainty_score":0.9998555},"labels":[],"label_agreement":null},{"id":"W2115350199","doi":"10.1098/rstb.2005.1688","title":"Pharmacogenetics in drug development","year":2005,"lang":"en","type":"review","venue":"Philosophical Transactions of the Royal Society B Biological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenetics; Drug development; Scope (computer science); Disease; Drug; Identification (biology); Drug discovery; Risk analysis (engineering); Biology; Computational biology; Medicine; Bioinformatics; Pharmacology; Computer science; Genetics; Gene; Genotype","score_opus":0.3328739654459081,"score_gpt":0.4796032639946208,"score_spread":0.1467292985487127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115350199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012248952,0.9936642,0.00013901235,0.0010160009,0.0011633188,0.0009013368,0.00014497314,0.000048898273,0.0016973437],"genre_scores_gemma":[0.025479803,0.9718936,0.001173245,0.00060145603,0.00044789488,0.00015786671,0.00000857388,0.000021792439,0.00021576777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99572366,0.0011056608,0.0012317263,0.0007404251,0.00045657274,0.0007419694],"domain_scores_gemma":[0.9981782,0.0008168651,0.00042254702,0.00024926552,0.00005840977,0.0002747049],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019998923,0.0005746743,0.0013245104,0.00009242364,0.00069777475,0.00002399982,0.0019243172,0.0008540975,0.0011079196],"category_scores_gemma":[0.00004577463,0.00032836082,0.0014405746,0.0011240876,0.0020070667,0.000041822193,0.00017600582,0.0021205938,0.0000542472],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013449315,0.00070405426,0.00009519238,0.0005431647,0.00024257058,0.0000017334152,0.00019968051,0.001876298,0.0000180256,0.0003108401,0.0001289947,0.995866],"study_design_scores_gemma":[0.00040933027,0.000036388996,0.000043036158,0.00035961423,0.00047092073,0.0000063362436,0.000018555373,0.0009525335,0.00023755021,0.0009143826,0.99609417,0.0004571693],"about_ca_topic_score_codex":0.000015186694,"about_ca_topic_score_gemma":0.000004856527,"teacher_disagreement_score":0.9959652,"about_ca_system_score_codex":0.00014272491,"about_ca_system_score_gemma":0.00047494343,"threshold_uncertainty_score":0.99991685},"labels":[],"label_agreement":null},{"id":"W2116184147","doi":"10.1002/rcm.2996","title":"MS <sup>E</sup> with mass defect filtering for <i>in vitro</i> and <i>in vivo</i> metabolite identification","year":2007,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); TransCanada (Canada)","funders":"","keywords":"Chemistry; Metabolite; Mass spectrometry; In vivo; Chromatography; Mass; Identification (biology); In vitro; Mass spectrum; Biochemistry","score_opus":0.059966717949458376,"score_gpt":0.3859389317189198,"score_spread":0.3259722137694614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116184147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94775325,0.02365584,0.015366169,0.0013134712,0.0002952849,0.0017812036,0.0002508047,0.00009960332,0.009484352],"genre_scores_gemma":[0.9530907,0.008605182,0.03706705,0.0005456938,0.000095413365,0.0003237019,0.00007460313,0.000051745414,0.00014588938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710333,0.0005648092,0.0008510045,0.00051451207,0.00018978919,0.00077658135],"domain_scores_gemma":[0.99724025,0.0012604787,0.00022569223,0.0010179251,0.000079515805,0.00017613266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037597502,0.0003248458,0.00050109363,0.0011181296,0.00021947119,0.00005847252,0.0009386061,0.00025409096,0.00011269967],"category_scores_gemma":[0.00010753608,0.00034488522,0.00011354747,0.0015364664,0.0002700916,0.00022158334,0.00017874507,0.0010353505,0.000009264724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082577247,0.00049437064,0.0166712,0.000077011646,0.00011804755,0.000012191261,0.0008353381,0.0022138811,0.96686006,0.002487439,0.00007547422,0.009329228],"study_design_scores_gemma":[0.008344037,0.00010073135,0.01991738,0.00005552451,0.00027304026,0.00003646265,0.00093228964,0.045365643,0.8205906,0.00485176,0.09863623,0.0008962735],"about_ca_topic_score_codex":0.000041593696,"about_ca_topic_score_gemma":0.00010093475,"teacher_disagreement_score":0.14626943,"about_ca_system_score_codex":0.00017666449,"about_ca_system_score_gemma":0.000063513944,"threshold_uncertainty_score":0.99990034},"labels":[],"label_agreement":null},{"id":"W2116375554","doi":"10.3945/ajcn.112.038794","title":"Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Nutrition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Caffeine; Single-nucleotide polymorphism; CYP1A2; Genotype; Medicine; Internal medicine; Haplotype; Case-control study; Genetics; Endocrinology; Biology; Gene; Cytochrome P450","score_opus":0.23914029559819971,"score_gpt":0.512913269000075,"score_spread":0.27377297340187523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116375554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98742044,0.0046562525,0.0001920201,0.0068171336,0.0005278672,0.00018974724,0.00010046783,0.000007007626,0.00008906843],"genre_scores_gemma":[0.9826,0.012165415,0.0008262902,0.002552638,0.001808759,0.000007269035,0.000020182515,0.0000106571115,0.0000087885555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968406,0.0015593504,0.00097242475,0.00013159108,0.00019873964,0.0002972822],"domain_scores_gemma":[0.9962359,0.0024755998,0.000765262,0.00008962587,0.0001013647,0.00033226472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037509222,0.00013389761,0.0005269709,0.00013780763,0.00015400058,0.00002003679,0.00014697167,0.00014802827,0.000029296425],"category_scores_gemma":[0.00037129252,0.00010382984,0.000122056685,0.00019919699,0.00061305484,0.00018125902,0.000037555074,0.0009363013,0.000006367339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029394054,0.0011253438,0.8896373,0.0000093018425,0.00020139867,0.000015366482,0.0009032335,0.000004372447,0.0033164453,0.00070044614,0.0020207,0.10177217],"study_design_scores_gemma":[0.0039196657,0.0004268623,0.9615384,0.000023663768,0.00049197924,0.0001384716,0.00020860112,0.000052155934,0.00075556355,0.0011161409,0.031171389,0.00015713339],"about_ca_topic_score_codex":0.000020883215,"about_ca_topic_score_gemma":0.000005403091,"teacher_disagreement_score":0.101615034,"about_ca_system_score_codex":0.000020763679,"about_ca_system_score_gemma":0.000040338848,"threshold_uncertainty_score":0.42340583},"labels":[],"label_agreement":null},{"id":"W2116758239","doi":"10.1124/dmd.113.052993","title":"Downregulation of Mouse Hepatic CYP3A Protein by 3-Methylcholanthrene Does Not Require Cytochrome P450-Dependent Metabolism","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"CYP3A; Cytochrome P450; Methylcholanthrene; Metabolism; Drug metabolism; Cytochrome; Downregulation and upregulation; Biology; Chemistry; Biochemistry; Enzyme; Carcinogen; Gene","score_opus":0.0236520422539231,"score_gpt":0.3334170269440819,"score_spread":0.3097649846901588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116758239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893748,0.0050567347,0.00033368656,0.0007713693,0.0007928626,0.0017187187,0.0012811903,0.0001101003,0.0005605337],"genre_scores_gemma":[0.9925613,0.0012948663,0.0005698876,0.0008686256,0.0003634832,0.0003823595,0.00022119338,0.000065521206,0.0036727984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99621916,0.00088323286,0.0009420639,0.0007198003,0.00057195156,0.0006638157],"domain_scores_gemma":[0.99808264,0.00010234335,0.0005513294,0.0004683106,0.00029683253,0.0004985572],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076714315,0.0005453442,0.00082554115,0.00027648118,0.00037611244,0.00009246812,0.0003982377,0.00040793835,0.0010880935],"category_scores_gemma":[0.00007459689,0.00044095083,0.0002424095,0.00034863898,0.00033655675,0.0009810039,0.00024134186,0.00058346335,0.00008426282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020477091,0.00047520504,0.00027159942,0.00017068807,0.00016090447,0.000002336596,0.00053179415,0.00007156603,0.9800339,0.002855301,0.000561171,0.014660789],"study_design_scores_gemma":[0.00320173,0.000019282885,0.033903558,0.000035702786,0.000539336,0.000008353174,0.00009010355,0.0010859144,0.9480464,0.002349443,0.010165188,0.0005550208],"about_ca_topic_score_codex":0.00038495092,"about_ca_topic_score_gemma":0.000013977215,"teacher_disagreement_score":0.033631958,"about_ca_system_score_codex":0.00003923743,"about_ca_system_score_gemma":0.000068722744,"threshold_uncertainty_score":0.99982506},"labels":[],"label_agreement":null},{"id":"W2117192628","doi":"10.1124/dmd.112.050641","title":"Decreased CYP3A Expression and Activity in Guinea Pig Models of Diet-Induced Metabolic Syndrome: Is Fatty Liver Infiltration Involved?","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Endocrinology; Internal medicine; CYP3A; Biology; Fatty acid; Triglyceride; Long chain fatty acid; Fatty liver; Metabolic syndrome; Diabetes mellitus; Biochemistry; Cholesterol; Metabolism; Cytochrome P450; Medicine","score_opus":0.056554426562006724,"score_gpt":0.3395355759340074,"score_spread":0.2829811493720007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117192628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97898835,0.018334571,0.00049349514,0.00032136255,0.00039375815,0.0008896343,0.0001486619,0.000042991294,0.00038714797],"genre_scores_gemma":[0.988933,0.008891474,0.00041758665,0.0013092159,0.00011614904,0.00018673907,0.0000656814,0.000031491705,0.000048654576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755657,0.00065094064,0.00053240976,0.00053776364,0.0002759613,0.00044636457],"domain_scores_gemma":[0.9987407,0.00017679825,0.00027645694,0.00026022957,0.00015514874,0.00039070245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005987904,0.0003851319,0.00065592595,0.00032588356,0.00020658628,0.00005810982,0.00017420389,0.00031770347,0.00035156985],"category_scores_gemma":[0.000033502423,0.00035502823,0.00010502519,0.00033192174,0.00017265498,0.0010105903,0.00014798337,0.0004788021,0.000015410107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054218253,0.0006392824,0.0038552266,0.00014571741,0.00009769971,0.000013162462,0.00246364,0.00019254531,0.95893407,0.001390424,0.0006009642,0.031125115],"study_design_scores_gemma":[0.004385222,0.00006100501,0.24540225,0.000057606925,0.0004659797,0.000018171146,0.00021921318,0.040888444,0.70141566,0.0039215907,0.0026103193,0.0005545265],"about_ca_topic_score_codex":0.0006382805,"about_ca_topic_score_gemma":0.000024204739,"teacher_disagreement_score":0.25751838,"about_ca_system_score_codex":0.000015254836,"about_ca_system_score_gemma":0.000053678443,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W2117195973","doi":"10.1124/dmd.104.002360","title":"EFFECT OF EARLY PHASE ADJUVANT ARTHRITIS ON HEPATIC P450 ENZYMES AND PHARMACOKINETICS OF VERAPAMIL: AN ALTERNATIVE APPROACH TO THE USE OF AN ANIMAL MODEL OF INFLAMMATION FOR PHARMACOKINETIC STUDIES","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Pharmacology; Verapamil; Arthritis; Medicine; Internal medicine","score_opus":0.10021319095670733,"score_gpt":0.42011554140362795,"score_spread":0.3199023504469206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117195973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874861,0.008388075,0.0009723437,0.000107847336,0.00019949056,0.0015478457,0.001255909,0.00001493181,0.000027418306],"genre_scores_gemma":[0.9917694,0.0056964047,0.0017440866,0.00021144372,0.00028053048,0.00016653766,0.000090045425,0.000030615574,0.000010974671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757034,0.0007262834,0.0007760546,0.00036562816,0.0002928385,0.00026886218],"domain_scores_gemma":[0.99823356,0.0005033128,0.0005064317,0.00021514451,0.00034073018,0.00020085055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010850924,0.00032533682,0.0007815115,0.00025621816,0.000120735436,0.000014990026,0.00020083845,0.0000969204,0.000006512653],"category_scores_gemma":[0.00006845308,0.0002511154,0.00011742857,0.00019336828,0.00033176414,0.00038355624,0.00007562968,0.00020243386,3.4892716e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066588908,0.0009862444,0.00011231713,0.00043721258,0.000358239,6.087741e-7,0.008252409,0.058832224,0.7060385,0.0020131401,0.00006228259,0.21624793],"study_design_scores_gemma":[0.0061757835,0.000968615,0.0007299309,0.000040258194,0.0009536795,0.0000023681762,0.000082642706,0.32967708,0.66047466,0.00012334847,0.00060918776,0.00016244952],"about_ca_topic_score_codex":0.000029607672,"about_ca_topic_score_gemma":0.000004928801,"teacher_disagreement_score":0.27084485,"about_ca_system_score_codex":0.000010216327,"about_ca_system_score_gemma":0.000027650076,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W2117518921","doi":"10.1016/s0009-9236(03)90707-7","title":"Teaching pharmacokinetic logic through example: Application of modeling to observations from three perplexing overdoses","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacokinetics; Computer science; Intensive care medicine; Medicine; Pharmacology","score_opus":0.47775503349477993,"score_gpt":0.5345246530623515,"score_spread":0.056769619567571594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117518921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8607071,0.0036979306,0.1212186,0.004313804,0.005985974,0.0015358061,0.0002071618,0.00023223544,0.0021013853],"genre_scores_gemma":[0.8794701,0.0018210853,0.015825283,0.10099203,0.0013447405,0.0002310935,0.00007246006,0.000113841044,0.00012933182],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932324,0.0022728452,0.0019658639,0.0011265083,0.00040032223,0.0010020057],"domain_scores_gemma":[0.9953736,0.0024740458,0.0005890018,0.000609913,0.0004023109,0.000551141],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023740677,0.0006467927,0.0010441879,0.00017988902,0.0005766518,0.000029860123,0.0010432326,0.00070956233,0.0012087005],"category_scores_gemma":[0.00013269039,0.0006512426,0.0004426619,0.0005674437,0.0004653405,0.00022722692,0.00027320627,0.0022741314,0.00019685211],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010855625,0.0034371526,0.04612599,0.00008412709,0.0029643083,0.000024604611,0.0024164543,0.07777453,0.8094714,0.009307099,0.0043985955,0.04291012],"study_design_scores_gemma":[0.0069655706,0.00035112203,0.0037159857,0.000024078909,0.004061276,0.000012343041,0.0002193487,0.24019164,0.051109172,0.024330646,0.6678982,0.0011206268],"about_ca_topic_score_codex":0.00023273111,"about_ca_topic_score_gemma":0.000035117577,"teacher_disagreement_score":0.7583623,"about_ca_system_score_codex":0.000094429015,"about_ca_system_score_gemma":0.0002540982,"threshold_uncertainty_score":0.9997043},"labels":[],"label_agreement":null},{"id":"W2117646661","doi":"10.1007/978-3-319-10527-7_4","title":"Pharmacokinetic Drug Interactions Affecting Antimalarials","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacokinetics; Drug; Pharmacology; Medicine","score_opus":0.11544430794998965,"score_gpt":0.43667013711570335,"score_spread":0.3212258291657137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117646661","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032358964,0.0023912615,0.00037166197,0.0008476301,0.012338627,0.0014966232,0.00014758643,0.00040829674,0.9787624],"genre_scores_gemma":[0.09172414,0.0022967474,0.0003487083,0.00569755,0.0043831775,0.00007760647,0.00012736549,0.00023522858,0.8951095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964773,0.00037007706,0.0010209013,0.00094116095,0.00039043947,0.0008001203],"domain_scores_gemma":[0.99694014,0.0010063056,0.0006577456,0.00054198614,0.0002455884,0.00060824427],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013166954,0.00094642525,0.0010555643,0.0004475672,0.00045298907,0.00007106956,0.00068957097,0.00053451717,0.05148703],"category_scores_gemma":[0.00007394504,0.00093214144,0.0005848457,0.00007294639,0.00026185703,0.00008982337,0.00036422667,0.0028804308,0.00484957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069311564,0.0005489393,0.00005016289,0.000433645,0.0031494922,0.00022789366,0.00063804426,0.00079960586,0.0458249,0.15716518,0.3910246,0.3932064],"study_design_scores_gemma":[0.013272326,0.00005814602,0.0000067292613,0.00006063031,0.0014268787,0.000051544834,0.000008751422,0.0011419937,0.015223232,0.0033697027,0.9644228,0.0009572482],"about_ca_topic_score_codex":0.00001604416,"about_ca_topic_score_gemma":0.000017931927,"teacher_disagreement_score":0.57339823,"about_ca_system_score_codex":0.00008978435,"about_ca_system_score_gemma":0.00013245795,"threshold_uncertainty_score":0.99942},"labels":[],"label_agreement":null},{"id":"W2117908683","doi":"10.1016/j.aquatox.2004.04.010","title":"Characterization and profiling of hepatic cytochromes P450 and phase II xenobiotic-metabolizing enzymes in beluga whales (Delphinapterus leucas) from the St. Lawrence River Estuary and the Canadian Arctic","year":2004,"lang":"en","type":"article","venue":"Aquatic Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fisheries and Oceans Canada; Université de Montréal; University of Windsor","funders":"","keywords":"Beluga Whale; Beluga; CYP3A; Biology; Xenobiotic; Population; Leucas; Estuary; Drug metabolism; Isozyme; Cytochrome P450; Zoology; Enzyme; Biochemistry; Ecology; Fishery; Arctic; Medicine","score_opus":0.054725380970346495,"score_gpt":0.3540452174297862,"score_spread":0.29931983645943966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117908683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810216,0.012523028,0.00012374214,0.00479791,0.0003566142,0.00096804934,0.0001482509,0.00001481993,0.000046016376],"genre_scores_gemma":[0.99249876,0.003950877,0.00045522972,0.002805677,0.0001286057,0.00007497705,0.000048935788,0.000021507594,0.000015418935],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977425,0.00073126366,0.00053107785,0.0003947367,0.000137463,0.00046296875],"domain_scores_gemma":[0.99812645,0.0011357041,0.00024776682,0.00021313159,0.000055077813,0.00022188883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010735271,0.0002785029,0.0005297903,0.00015892026,0.0005721386,0.00004132045,0.00025000898,0.00025206487,0.00006755951],"category_scores_gemma":[0.00033027955,0.00019631446,0.000042746415,0.00021480852,0.0014658059,0.00014992131,0.00018561196,0.00055960205,0.0000033527979],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013534552,0.0011494692,0.10916357,0.00027909188,0.0008883026,0.00017652227,0.05201829,0.00043765703,0.6345476,0.079564646,0.000027836313,0.120393574],"study_design_scores_gemma":[0.061816197,0.0014588215,0.5699993,0.0003848538,0.0031844005,0.00038545261,0.0029694072,0.044390924,0.24560836,0.05817359,0.009892501,0.0017362228],"about_ca_topic_score_codex":0.020679543,"about_ca_topic_score_gemma":0.059320267,"teacher_disagreement_score":0.4608357,"about_ca_system_score_codex":0.00006533201,"about_ca_system_score_gemma":0.00030073297,"threshold_uncertainty_score":0.9858418},"labels":[],"label_agreement":null},{"id":"W2118407518","doi":"10.1016/j.bmcl.2008.09.018","title":"Synthesis and evaluation of novel 4-amino-4,6-androstadiene-3,17-dione: An analog of formestane","year":2008,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Aromatase; In vitro; Cell culture; Cancer; Breast cancer; Cancer cell lines; Chemical synthesis; Stereochemistry; Cancer research; Pharmacology; Biochemistry; Cancer cell; Internal medicine; Biology; Medicine; Genetics","score_opus":0.1496066646559138,"score_gpt":0.40126308749235623,"score_spread":0.2516564228364424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118407518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959582,0.001958964,0.00008962989,0.00070259714,0.00027765665,0.00021265291,0.000121559664,0.00002114106,0.0006576159],"genre_scores_gemma":[0.9981305,0.00052185747,0.00020307062,0.0007401984,0.00029140216,0.000018707244,0.000037733218,0.000022567667,0.000033988905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812,0.0001468627,0.00052146986,0.00034269763,0.0005391653,0.00032981718],"domain_scores_gemma":[0.9986742,0.00021503912,0.00031822827,0.00025805694,0.00024294258,0.00029153586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013204096,0.00023888347,0.0004334768,0.000075414806,0.0001232824,0.0000030316698,0.00025392094,0.00021349236,0.00088654],"category_scores_gemma":[0.0002309412,0.00022467738,0.000075893855,0.00023102584,0.0006375219,0.00008140859,0.00005804435,0.00031589917,0.0000018256252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016011197,0.00030217983,0.0030514833,0.0001283964,0.0001524068,0.000020774485,0.0006283209,0.00006681202,0.98953915,0.0000067592155,0.0007834526,0.005160165],"study_design_scores_gemma":[0.002688148,0.00004274577,0.010579107,0.00003191025,0.0008474062,0.00040339425,0.00017961829,0.0023807508,0.9811359,0.000012158157,0.0014826367,0.0002162323],"about_ca_topic_score_codex":0.000023825814,"about_ca_topic_score_gemma":0.0000018293825,"teacher_disagreement_score":0.008403245,"about_ca_system_score_codex":0.0000556662,"about_ca_system_score_gemma":0.00018310714,"threshold_uncertainty_score":0.97069913},"labels":[],"label_agreement":null},{"id":"W2118451906","doi":"10.3109/09540261.2013.838944","title":"Towards the implementation of<i>CYP2D6</i>and<i>CYP2C19</i>genotypes in clinical practice: Update and report from a pharmacogenetic service clinic","year":2013,"lang":"en","type":"review","venue":"International Review of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2C19; CYP2D6; Pharmacogenetics; Medicine; Pharmacogenomics; Pharmacology; Genotype; Drug; Antidepressant; Internal medicine; Psychiatry; Gene; Genetics; Biology; Cytochrome P450","score_opus":0.15492359490016452,"score_gpt":0.5745530816189005,"score_spread":0.419629486718736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118451906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012481819,0.9830775,0.000012917044,0.006571851,0.0057238294,0.0017566477,0.0006618949,0.000011717269,0.0009354427],"genre_scores_gemma":[0.00012877579,0.9853443,0.0024617545,0.010514827,0.0008763981,0.00024203255,0.0003524644,0.000047287835,0.000032167478],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99315614,0.0017521824,0.003696465,0.0006494398,0.0004705237,0.00027525905],"domain_scores_gemma":[0.99452007,0.0011931116,0.0031952173,0.00041603707,0.00049371074,0.00018188231],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0040737563,0.00047550915,0.00178502,0.00016799112,0.000056634104,0.000023257775,0.0007993572,0.00036767652,0.0020207781],"category_scores_gemma":[0.0003839757,0.0003456423,0.00048267268,0.00034374994,0.00021061483,0.00014407722,0.0004007117,0.0011907881,0.000089629015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038321472,0.00023134067,0.0010561253,0.013618143,0.0013070855,0.000015041288,0.000055254994,2.7530618e-7,0.0000058320265,0.00036336918,0.007910271,0.97539896],"study_design_scores_gemma":[0.0009930336,0.00003370382,0.00077340304,0.0074848467,0.004449518,0.00015074431,0.000056834928,0.0000168755,0.00001392861,0.00085535424,0.98488355,0.00028821907],"about_ca_topic_score_codex":0.00023298405,"about_ca_topic_score_gemma":0.00005890764,"teacher_disagreement_score":0.9769733,"about_ca_system_score_codex":0.000032324708,"about_ca_system_score_gemma":0.0009249997,"threshold_uncertainty_score":0.99989957},"labels":[],"label_agreement":null},{"id":"W2119325428","doi":"10.1158/1078-0432.ccr-05-0252","title":"Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pregnane X receptor; Pharmacology; Paclitaxel; Nuclear receptor; Transcription factor; Biology; In vivo; Chemistry; Cell biology; Biochemistry; Cancer; Gene","score_opus":0.4170434883543968,"score_gpt":0.5987963018884374,"score_spread":0.18175281353404055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119325428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878824,0.00453583,0.00000491528,0.0046502138,0.00087457075,0.0008794209,0.00015912323,0.000020488516,0.0009930809],"genre_scores_gemma":[0.9886752,0.0063675977,0.00009553019,0.0012205943,0.00078482856,0.00009475276,0.000020159358,0.000035003643,0.0027063617],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955899,0.0020662926,0.00077450863,0.0005100469,0.00046006657,0.00059916987],"domain_scores_gemma":[0.9977477,0.0010048412,0.00024071548,0.00036376345,0.0003080366,0.00033492234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038244342,0.00019303209,0.00036666487,0.0000867337,0.00045272007,0.00003047844,0.0006000649,0.00036163226,0.0030765512],"category_scores_gemma":[0.00037363204,0.00015033707,0.00012988586,0.00034570773,0.0009690767,0.000109449684,0.00042073725,0.0018032677,0.00006460966],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004176266,0.00062653056,0.031421933,0.000107514024,0.00013547517,4.8085553e-7,0.0005385013,0.000047543097,0.81981915,0.000055738514,0.054824192,0.092005335],"study_design_scores_gemma":[0.0019498082,0.00012524344,0.0061694146,0.00007544794,0.00004573084,7.0374057e-7,0.00006119407,0.00018959286,0.47499242,0.000058342503,0.5161869,0.00014524235],"about_ca_topic_score_codex":0.00011181393,"about_ca_topic_score_gemma":0.000041752348,"teacher_disagreement_score":0.4613627,"about_ca_system_score_codex":0.00013278142,"about_ca_system_score_gemma":0.0001878095,"threshold_uncertainty_score":0.99783474},"labels":[],"label_agreement":null},{"id":"W2119702644","doi":"10.1093/toxsci/71.1.11","title":"Real-Time Polymerase Chain Reaction Analysis of CYP1B1 Gene Expression in Human Liver","year":2003,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia","keywords":"CYP1A2; CYP1B1; Cytochrome P450; Messenger RNA; Molecular biology; Gene expression; Real-time polymerase chain reaction; Polymerase chain reaction; Enzyme; Chemistry; Biology; Gene; Biochemistry","score_opus":0.1331305506460059,"score_gpt":0.4395979303279824,"score_spread":0.30646737968197646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119702644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97903734,0.0006620594,0.000019414558,0.000094103496,0.00023515863,0.00023089212,0.00002464798,0.000041083516,0.019655284],"genre_scores_gemma":[0.9975115,0.0008685212,0.0007638863,0.00037050032,0.00005463118,0.000029843537,0.000010442957,0.0000060754733,0.0003845673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703336,0.0011353075,0.00050761335,0.0005015104,0.0003099854,0.00051219866],"domain_scores_gemma":[0.9989185,0.00039848275,0.00023865655,0.00016041727,0.000046987425,0.00023696685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024628234,0.00019988613,0.000474286,0.0004973976,0.0003222234,0.000017310747,0.00037679722,0.0003009122,0.004572226],"category_scores_gemma":[0.00016215119,0.00015377972,0.0001700629,0.001887797,0.00061195483,0.00011556876,0.000081569895,0.00033145852,0.000032613672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043331544,0.00059388985,0.013020556,0.0000039953816,0.000069863694,0.000025929823,0.0001992974,0.0016143172,0.98064077,0.0015280439,0.00009956143,0.002160451],"study_design_scores_gemma":[0.000759621,0.0001865159,0.06379665,0.0000047997137,0.00033011974,0.00000414861,0.00007178545,0.004331681,0.9266659,0.00059480086,0.0030099307,0.00024404933],"about_ca_topic_score_codex":0.000069616646,"about_ca_topic_score_gemma":0.000022992239,"teacher_disagreement_score":0.053974863,"about_ca_system_score_codex":0.000049369588,"about_ca_system_score_gemma":0.00006544095,"threshold_uncertainty_score":0.9963377},"labels":[],"label_agreement":null},{"id":"W2119942000","doi":"10.1093/toxsci/kfp255","title":"Effects of Cytochrome P450 Inhibitors on the Biotransformation of Fluorogenic Substrates by Adult Male Rat Liver Microsomes and cDNA-Expressed Rat Cytochrome P450 Isoforms","year":2009,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; McMaster University","keywords":"Microsome; Biotransformation; Cytochrome P450; Biochemistry; Chemistry; Coumarin; CYP2E1; Trifluoromethyl; Microsoma; Chlorzoxazone; Complementary DNA; Isozyme; Gene isoform; Cytochrome; Pharmacology; Enzyme; Biology; Gene","score_opus":0.04330124482707328,"score_gpt":0.3466815848649864,"score_spread":0.30338034003791314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119942000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923622,0.0041039702,0.000017412658,0.0012586153,0.00021552436,0.0009633276,0.00006501127,0.000040658615,0.0009732996],"genre_scores_gemma":[0.9937472,0.0040042643,0.00011839183,0.0019085867,0.00008438713,0.000045378463,0.000007750516,0.0000074099466,0.00007667912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754006,0.00045261392,0.0005930088,0.0004365911,0.0003967021,0.0005810443],"domain_scores_gemma":[0.99816513,0.0010546738,0.00030952628,0.00014402531,0.000102689446,0.00022393967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010300633,0.00032751262,0.0004792858,0.00012460079,0.00049319485,0.000050643022,0.0005915259,0.00035340645,0.00048161854],"category_scores_gemma":[0.00012946283,0.00019153113,0.00015703698,0.000546185,0.0016714212,0.00023741582,0.00007356968,0.00042647723,0.000022277603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020216612,0.0005626142,0.00036781063,0.000065303626,0.000035439956,0.000008936623,0.00038839073,0.00008894334,0.9854641,0.0014938109,0.001095367,0.0102271335],"study_design_scores_gemma":[0.0012259699,0.0012954995,0.012703339,0.000032801425,0.000099987,0.000017255046,0.000098409226,0.0006907491,0.9807672,0.0009710087,0.0018473372,0.0002504514],"about_ca_topic_score_codex":0.000010042699,"about_ca_topic_score_gemma":0.0000029871535,"teacher_disagreement_score":0.012335528,"about_ca_system_score_codex":0.000027676688,"about_ca_system_score_gemma":0.00007165572,"threshold_uncertainty_score":0.78104126},"labels":[],"label_agreement":null},{"id":"W2120604922","doi":"10.1002/rcm.3758","title":"Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies","year":2008,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Chemistry; Drug; Human plasma; Biotransformation; Pharmacology; Tandem mass spectrometry; Metabolite; Liquid chromatography–mass spectrometry; Chromatography; Drug development; Mass spectrometry; Computational biology; Biochemical engineering; Biochemistry; Medicine","score_opus":0.4448887988026948,"score_gpt":0.5502199302394477,"score_spread":0.10533113143675293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120604922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774143,0.009545699,0.00080804527,0.0015103964,0.0007040848,0.00051718246,0.000034524284,0.000094791576,0.009370954],"genre_scores_gemma":[0.9516576,0.011722299,0.03474705,0.0011044596,0.00028636205,0.00023618623,0.000027348968,0.00004349164,0.00017523475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99534535,0.0018968229,0.0012431346,0.00052936655,0.00032449153,0.0006608589],"domain_scores_gemma":[0.99605906,0.0020920797,0.0002693365,0.0011399258,0.000173491,0.0002660971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028052116,0.00032985164,0.00072730286,0.0010140003,0.0006183911,0.00003530813,0.001403854,0.00027772898,0.0005126755],"category_scores_gemma":[0.00073488656,0.00037192483,0.00020270627,0.0016351533,0.00041006182,0.00022212436,0.0005334349,0.0021262832,0.00014834634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010885225,0.0011834754,0.6269221,0.000032323525,0.0006123937,0.00009639423,0.002818315,0.0023268017,0.34969348,0.011921059,0.00031509524,0.003969743],"study_design_scores_gemma":[0.0058575463,0.00029116575,0.8391596,0.00011519202,0.00030197375,0.00011848637,0.0017024124,0.008691187,0.034551978,0.019581703,0.088199034,0.0014296938],"about_ca_topic_score_codex":0.00006741119,"about_ca_topic_score_gemma":0.00005037282,"teacher_disagreement_score":0.3151415,"about_ca_system_score_codex":0.00023299972,"about_ca_system_score_gemma":0.00013088762,"threshold_uncertainty_score":0.9998733},"labels":[],"label_agreement":null},{"id":"W2121373591","doi":"10.1074/jbc.m506683200","title":"Tissue-specific, Inducible, and Hormonal Control of the Human UDP-Glucuronosyltransferase-1 (UGT1) Locus","year":2005,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institute of General Medical Sciences; U.S. Public Health Service","keywords":"Hormone; Locus (genetics); Glucuronosyltransferase; Biology; Cell biology; Endocrinology; Gene; Enzyme; Genetics; Biochemistry; Microsome","score_opus":0.0946326092039207,"score_gpt":0.3832520420772717,"score_spread":0.288619432873351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121373591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847649,0.010691434,0.00038365755,0.0014452687,0.00023135156,0.000118461954,0.00007644459,0.000008382158,0.0022800975],"genre_scores_gemma":[0.995831,0.0019903067,0.00018427767,0.00083106017,0.0010156465,0.000003150216,0.0000026088096,0.000009846048,0.00013210492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984552,0.00020894407,0.00067168364,0.00019082225,0.00018741029,0.00028589685],"domain_scores_gemma":[0.998855,0.00021770498,0.00037687892,0.00014004651,0.00015536246,0.0002550147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007702005,0.00020328282,0.0004258027,0.00002924451,0.00014517018,0.000012750797,0.0004447532,0.00037397895,0.0013173898],"category_scores_gemma":[0.00005013009,0.00012435929,0.00018421607,0.00010948115,0.00037841912,0.000047901573,0.000067398236,0.0010385837,0.000004583711],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020215061,0.0002753407,0.0036547333,0.000018006984,0.00012070232,0.000014451864,0.00006567028,0.00023916391,0.9692853,0.000122066245,0.0011100642,0.024892354],"study_design_scores_gemma":[0.002038014,0.00008796037,0.004150595,0.000009801553,0.00009583735,0.00014974311,0.000022424325,0.0000561835,0.77914774,0.0002640341,0.21385363,0.00012404566],"about_ca_topic_score_codex":0.0000010355994,"about_ca_topic_score_gemma":2.4271296e-7,"teacher_disagreement_score":0.21274357,"about_ca_system_score_codex":0.000026606565,"about_ca_system_score_gemma":0.000053817203,"threshold_uncertainty_score":0.9995955},"labels":[],"label_agreement":null},{"id":"W2121420708","doi":"10.2217/pgs.11.120","title":"Validation of Warfarin Pharmacogenetic Algorithms in Clinical Practice","year":2011,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Warfarin; VKORC1; Pharmacogenetics; Dosing; Algorithm; Medicine; CYP2C9; Internal medicine; Mathematics; Atrial fibrillation; Biology; Genotype","score_opus":0.3181945789941228,"score_gpt":0.5113060201547232,"score_spread":0.19311144116060036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121420708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595156,0.004396453,0.0005793101,0.00020588767,0.0043631354,0.0009264563,0.00014763876,0.00009431548,0.029771207],"genre_scores_gemma":[0.97599584,0.00940397,0.010324262,0.003256681,0.0006457424,0.00008623869,0.000039277682,0.00009109122,0.00015690493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945263,0.0015076249,0.002031995,0.0007394874,0.0003614787,0.00083307904],"domain_scores_gemma":[0.9971882,0.00072693836,0.00077563484,0.00040723613,0.00036305486,0.00053890474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043844893,0.00046926917,0.0007244553,0.00040603898,0.00012082119,0.000015231566,0.00084647903,0.00039926474,0.0023233253],"category_scores_gemma":[0.00031795233,0.0005115177,0.00033325455,0.00064917444,0.00036781045,0.00033757323,0.0002955832,0.0013221274,0.0003053507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00385688,0.00664437,0.058416948,0.00016411144,0.0012306897,0.00041331185,0.005870378,0.002191222,0.48159924,0.0012190246,0.0025529775,0.43584085],"study_design_scores_gemma":[0.006765446,0.00015374791,0.0047605676,0.000013113901,0.00086809346,0.000080507016,0.0002254927,0.007242186,0.7780794,0.00079893717,0.20036668,0.00064585183],"about_ca_topic_score_codex":0.00009117758,"about_ca_topic_score_gemma":0.0000028868062,"teacher_disagreement_score":0.435195,"about_ca_system_score_codex":0.00009047007,"about_ca_system_score_gemma":0.0002839698,"threshold_uncertainty_score":0.9997336},"labels":[],"label_agreement":null},{"id":"W2121452631","doi":"10.1016/s0090-9556(24)15195-1","title":"Role of Reactive Oxygen Intermediates in the Decrease of Hepatic Cytochrome P450 Activity by Serum of Humans and Rabbits with an Acute Inflammatory Reaction","year":2000,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemistry; Lipid peroxidation; Cytochrome P450; Internal medicine; CYP1A2; Endocrinology; Sodium nitroprusside; Reactive oxygen species; Metabolism; Biochemistry; Enzyme; Nitric oxide; Medicine","score_opus":0.01302800869540698,"score_gpt":0.31663505271234377,"score_spread":0.3036070440169368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121452631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603915,0.0025122399,0.0000060668262,0.00007277059,0.00003978976,0.0004424463,0.00039772535,0.000010390408,0.00047939012],"genre_scores_gemma":[0.99701756,0.0026003302,0.000042885782,0.00013529402,0.00005206541,0.000045129083,0.000071114766,0.000015040894,0.000020578444],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838454,0.0006314509,0.0003497581,0.00024992088,0.00018062716,0.00020368333],"domain_scores_gemma":[0.9991637,0.00016389848,0.00027340846,0.00017620326,0.00007600824,0.00014678815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006132906,0.00020184157,0.0004073018,0.00013618665,0.000091534035,0.000009401144,0.00014126205,0.00012383478,0.00005638214],"category_scores_gemma":[0.000013367624,0.00015247749,0.000048014448,0.00018185608,0.00033332498,0.00035391297,0.000028050248,0.000277877,8.2444905e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019086004,0.0005987412,0.004117685,0.00007845514,0.00014263194,0.000004254563,0.0063469047,0.00002369607,0.96250194,0.00023160073,0.000020043657,0.024025448],"study_design_scores_gemma":[0.0022876025,0.00012329618,0.50469404,0.000032807973,0.0006820565,0.000015212571,0.00071608514,0.0008808197,0.4890082,0.00082558754,0.0005644646,0.00016982594],"about_ca_topic_score_codex":0.00029103417,"about_ca_topic_score_gemma":0.00007530315,"teacher_disagreement_score":0.5005764,"about_ca_system_score_codex":0.0000092229775,"about_ca_system_score_gemma":0.00005012735,"threshold_uncertainty_score":0.62178516},"labels":[],"label_agreement":null},{"id":"W2121512476","doi":"10.1080/0049825021000012637","title":"Comparison of rat and human cytochrome P450 (CYP) sources of<i>N</i>-alkylprotoporphyrin IX. Formation after interaction with porphyrinogenic xenobiotics: studies with cDNA-expressed single CYP enzymes","year":2002,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Xenobiotic; CYP1A2; Cytochrome P450; Enzyme; Biochemistry; Complementary DNA; Microsome; Chemistry; CYP2B6; Cytochrome; Biology; Gene","score_opus":0.14730390052528133,"score_gpt":0.4175698082173464,"score_spread":0.27026590769206504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121512476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901516,0.0069744405,0.00010065119,0.000217582,0.0002048617,0.0009760831,0.00005955832,0.000061385756,0.0012538662],"genre_scores_gemma":[0.99815196,0.00051395723,0.00065332477,0.00020015174,0.00014585257,0.00006784919,0.000019481198,0.000045890727,0.00020151776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997717,0.0003019869,0.0007835552,0.00042811892,0.00030959543,0.00045974535],"domain_scores_gemma":[0.99830204,0.0002489946,0.0006268311,0.00031934067,0.00031052387,0.00019224972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031478814,0.0004183529,0.00081288477,0.0002520214,0.0002371005,0.000034636254,0.00023156243,0.00022225888,0.00049301545],"category_scores_gemma":[0.000026680682,0.00032809514,0.00010011892,0.0002765013,0.00074603653,0.000293433,0.00013675315,0.0005102049,0.000017407869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001295373,0.0016491009,0.0192867,0.0007521342,0.00086674385,0.000032673317,0.0076514785,0.0006529265,0.9643597,0.00042417375,0.00063489773,0.0023941165],"study_design_scores_gemma":[0.0029219957,0.0012758004,0.004033165,0.00017470442,0.0007948577,0.000064288826,0.001324928,0.001178785,0.97635,0.00006224726,0.011386214,0.00043301552],"about_ca_topic_score_codex":0.000013899128,"about_ca_topic_score_gemma":0.00003373467,"teacher_disagreement_score":0.0152535355,"about_ca_system_score_codex":0.00005099397,"about_ca_system_score_gemma":0.000023913322,"threshold_uncertainty_score":0.9999171},"labels":[],"label_agreement":null},{"id":"W2122150294","doi":"10.18433/j3sk5v","title":"Effects of Some Antihypertensive Drugs on the Metabolism and Pharmacokinetics of Indapamide in Rats","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Indapamide; Pharmacology; Felodipine; Pharmacokinetics; Diuretic; Chemistry; Bioavailability; Valsartan; Medicine; Endocrinology; Blood pressure","score_opus":0.10997384818204722,"score_gpt":0.44305333763054855,"score_spread":0.3330794894485013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122150294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94072926,0.05234064,0.000012902981,0.0026475417,0.0028315382,0.00056737266,0.000027478123,0.000011156909,0.00083208125],"genre_scores_gemma":[0.9732076,0.02024384,0.00021289654,0.0054112384,0.0008563769,0.000014151141,5.7363354e-7,0.000027824319,0.000025499588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946765,0.0015399558,0.0014669123,0.00032298602,0.0010110452,0.0009826104],"domain_scores_gemma":[0.99417096,0.0035872557,0.0010214403,0.00015415029,0.0003560421,0.000710127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005352438,0.00044705477,0.0009682131,0.0006015986,0.00022416566,0.000028334001,0.00097327336,0.00014816651,0.00032670138],"category_scores_gemma":[0.0005317927,0.00029296032,0.00029799592,0.0010341799,0.0018533398,0.00062313286,0.0002615969,0.0015667469,0.000011365246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011106464,0.0016050283,0.011298336,0.00024321133,0.00034347785,0.00004518103,0.0022193445,0.00039947158,0.91827494,0.005394805,0.0012961555,0.057769407],"study_design_scores_gemma":[0.004984768,0.00015098763,0.0053995247,0.00007633564,0.00076297775,0.00007106225,0.00023321013,0.002685286,0.8664536,0.00057705125,0.118321106,0.00028412737],"about_ca_topic_score_codex":0.000017636237,"about_ca_topic_score_gemma":3.3857086e-7,"teacher_disagreement_score":0.11702495,"about_ca_system_score_codex":0.000042262338,"about_ca_system_score_gemma":0.00022492034,"threshold_uncertainty_score":0.99995226},"labels":[],"label_agreement":null},{"id":"W2122202379","doi":"10.1124/dmd.107.017590","title":"Evaluation of the Assumptions of an Ontogeny Model of Rat Hepatic Cytochrome P450 Activity","year":2007,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Ontogeny; Cytochrome P450; Biology; Internal medicine; Endocrinology; Metabolism; Medicine","score_opus":0.10695472508486922,"score_gpt":0.42814206227395,"score_spread":0.32118733718908077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122202379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942689,0.0022492153,0.001126962,0.000071541246,0.00050946855,0.0006050354,0.00023231046,0.00001249716,0.0009241],"genre_scores_gemma":[0.99904805,0.00029428914,0.00033094772,0.00011133971,0.00010515669,0.000024812876,0.000023368544,0.000015159286,0.000046883702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752873,0.000885892,0.000505763,0.00023450643,0.00060389045,0.00024122708],"domain_scores_gemma":[0.9984597,0.00014419007,0.000447426,0.00029634114,0.0005043246,0.0001479935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004285205,0.00018279471,0.00038020505,0.00015305917,0.00015740763,0.0000059521467,0.00021151696,0.00015899188,0.00009372242],"category_scores_gemma":[0.00007880983,0.00014711516,0.00014629406,0.0002650314,0.00028016084,0.00017409064,0.00007708557,0.00024418774,0.0000013163673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024932405,0.0006304194,0.00056421215,0.0000653011,0.00010636399,2.6992305e-7,0.0012672681,0.0098349815,0.9450869,0.0024207265,0.000021835314,0.039752416],"study_design_scores_gemma":[0.0018051903,0.000020619407,0.12997346,0.00001503368,0.0018726448,0.000002968509,0.00008173119,0.14285243,0.7196418,0.003459265,0.00014160092,0.00013327935],"about_ca_topic_score_codex":0.00008588294,"about_ca_topic_score_gemma":0.00008405483,"teacher_disagreement_score":0.2254451,"about_ca_system_score_codex":0.000025850331,"about_ca_system_score_gemma":0.00014848834,"threshold_uncertainty_score":0.59991825},"labels":[],"label_agreement":null},{"id":"W2122267147","doi":"","title":"A sensitive and specific high performance liquid chromatographic assay for milrinone in rat and human plasma using a commercially available internal standard and low sample volume.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Milrinone; Chromatography; High-performance liquid chromatography; Chemistry; Diethyl ether; Pharmacokinetics; Amrinone; Inotrope; Pharmacology","score_opus":0.0744692657228286,"score_gpt":0.33623586417489354,"score_spread":0.26176659845206496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122267147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955908,0.0019576245,0.00019211261,0.00031951425,0.00038786914,0.0010595903,0.00023100319,0.000029422237,0.00023205979],"genre_scores_gemma":[0.9949092,0.0027096113,0.0010202469,0.0005495738,0.00035445648,0.00024589826,0.00001770972,0.000032548804,0.00016074226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824476,0.00023169006,0.00036683903,0.0004163259,0.00012265818,0.0006177407],"domain_scores_gemma":[0.9991151,0.00027481394,0.00012521468,0.00010829799,0.000080815465,0.0002957243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001256969,0.0002602038,0.00041026121,0.00023727174,0.00032982018,0.000067388806,0.00010184413,0.0001828794,0.00006992937],"category_scores_gemma":[0.000034346318,0.0002724756,0.00003919659,0.00015125117,0.00033467726,0.00018467374,0.00014214746,0.00041191475,0.0000023779426],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012433701,0.0010508148,0.22826354,0.0008144192,0.00085558643,0.000182637,0.0037174535,0.0010200901,0.16727024,0.0013573932,0.0062356973,0.57679844],"study_design_scores_gemma":[0.02278954,0.00047804715,0.1899385,0.00009519645,0.0004665463,0.00044569295,0.00016335215,0.054941457,0.33370358,0.00023432072,0.39538017,0.0013636178],"about_ca_topic_score_codex":0.00007114266,"about_ca_topic_score_gemma":0.0001432711,"teacher_disagreement_score":0.5754348,"about_ca_system_score_codex":0.000056849734,"about_ca_system_score_gemma":0.000033831202,"threshold_uncertainty_score":0.99997276},"labels":[],"label_agreement":null},{"id":"W2122267374","doi":"10.1158/1078-0432.ccr-06-1592","title":"Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Damon Runyon Cancer Research Foundation","keywords":"Pregnane X receptor; Ketoconazole; Pharmacology; Paclitaxel; CYP3A4; Pregnenolone; Transcription factor; Chemistry; In vivo; Biology; Drug metabolism; Nuclear receptor; Cytochrome P450; Drug; Gene; Biochemistry; Cancer; Metabolism; Steroid; Genetics; Antifungal; Hormone","score_opus":0.5732678557880453,"score_gpt":0.6682249783394519,"score_spread":0.09495712255140665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122267374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97630143,0.013227882,0.0001279336,0.0047794203,0.0015411087,0.0017943057,0.00047185202,0.000057613033,0.0016984795],"genre_scores_gemma":[0.9822339,0.007818783,0.0004397042,0.0033549445,0.0017771062,0.00048482968,0.00002974917,0.00005112313,0.0038098649],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964436,0.00069988734,0.00069434114,0.00066438876,0.0003720943,0.0011256613],"domain_scores_gemma":[0.994991,0.0031922276,0.00012673721,0.00021865788,0.0006643996,0.0008069698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008986418,0.00021520311,0.00044554455,0.00020767232,0.00044853383,0.000032872635,0.00044092326,0.0005584611,0.0033815457],"category_scores_gemma":[0.00077784795,0.00019696368,0.00015517249,0.000467795,0.00051234826,0.00009081733,0.00026142242,0.0017702556,0.00015000372],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082885,0.0014081616,0.02358515,0.0002661525,0.00084430026,0.000031893505,0.0008964981,0.000031730604,0.5425807,0.002240888,0.122041605,0.2977844],"study_design_scores_gemma":[0.0037408015,0.00030870427,0.003336607,0.000015696776,0.00005604771,0.0000016300617,0.0000517558,0.00092984614,0.29529393,0.0012367144,0.69482327,0.00020500147],"about_ca_topic_score_codex":0.000029169867,"about_ca_topic_score_gemma":0.000017893752,"teacher_disagreement_score":0.5727816,"about_ca_system_score_codex":0.00006974969,"about_ca_system_score_gemma":0.00031707674,"threshold_uncertainty_score":0.9975295},"labels":[],"label_agreement":null},{"id":"W2123959629","doi":"","title":"Interactions of grapefruit juice and cardiovascular medications: A potential risk of toxicity.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Grapefruit juice; Pharmacology; Bioavailability; CYP3A4; Pharmacodynamics; Pharmacokinetics; Drug; Medicine; Drug interaction; Adverse effect; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.0629832689451676,"score_gpt":0.35311565368548065,"score_spread":0.29013238474031305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123959629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708786,0.016045243,0.0011011263,0.00013892574,0.0015445132,0.00069991575,0.00012253782,0.000024354373,0.009444756],"genre_scores_gemma":[0.9930327,0.005889342,0.00026272697,0.00015357768,0.000083750165,0.00035154657,0.000004506818,0.0000122392985,0.00020963355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836195,0.0006132903,0.00036963102,0.00021129801,0.00018446326,0.0002593657],"domain_scores_gemma":[0.9990547,0.00019552723,0.0001936536,0.00022511744,0.00012724882,0.0002037528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013323186,0.00012406237,0.00030979235,0.00014844559,0.00010077162,0.0000050237836,0.00014323884,0.00011083559,0.00021128854],"category_scores_gemma":[0.00026124172,0.00012042405,0.00020758355,0.00023540523,0.00023233567,0.000064667314,0.000045402987,0.00032842546,0.0000038509315],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034402718,0.0017718894,0.044042844,0.00028458185,0.011284175,0.0000221577,0.001766075,0.0033854085,0.03855606,0.00735544,0.002824058,0.8883633],"study_design_scores_gemma":[0.0038003726,0.000029748455,0.12324309,0.000007687679,0.004664067,0.00007346975,0.0002533207,0.0007153905,0.25884387,0.0030218926,0.6050017,0.00034540932],"about_ca_topic_score_codex":0.000029252997,"about_ca_topic_score_gemma":0.0000050080525,"teacher_disagreement_score":0.8880179,"about_ca_system_score_codex":0.000009338767,"about_ca_system_score_gemma":0.00003331146,"threshold_uncertainty_score":0.491075},"labels":[],"label_agreement":null},{"id":"W2124163794","doi":"10.1080/03602530701468391","title":"Comparison of the 17α-Hydroxylase/C17,20-Lyase Activities of Porcine, Guinea Pig and Bovine P450c17 Using Purified Recombinant Fusion Proteins Containing P450c17 Linked to NADPH-P450 Reductase","year":2007,"lang":"en","type":"article","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Purdue Pharma (Canada)","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences","keywords":"Recombinant DNA; Guinea pig; Reductase; Biochemistry; Enzyme; Fusion protein; Chemistry; Biology; Gene; Endocrinology","score_opus":0.15221926203931693,"score_gpt":0.45903517028110863,"score_spread":0.3068159082417917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124163794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90400827,0.087769456,0.00040473446,0.0005727771,0.0026911704,0.0033217736,0.0001894034,0.000044775396,0.0009976286],"genre_scores_gemma":[0.9840847,0.008394779,0.0048031593,0.0011329137,0.0006994463,0.000112191774,0.000038401286,0.000086154025,0.0006482395],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936003,0.0017697146,0.0024193544,0.000744038,0.0005244171,0.00094218575],"domain_scores_gemma":[0.996002,0.00044796913,0.0017696621,0.000874015,0.0002975167,0.00060883275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006056365,0.00071978,0.0022804954,0.0004325696,0.00050085154,0.000034549877,0.0008221358,0.00034512192,0.00024445093],"category_scores_gemma":[0.0006553364,0.00054136245,0.00046685396,0.0009805313,0.00046251842,0.00021062788,0.00056281156,0.0011591148,0.00001340506],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010240035,0.00075355783,0.0020897225,0.0004642799,0.00017485401,0.000011999858,0.004823774,0.00018196773,0.9140314,0.000991199,0.0018926434,0.073560625],"study_design_scores_gemma":[0.002703736,0.000118738455,0.003453931,0.00028879385,0.0010218658,0.000028166618,0.00072187907,0.001256405,0.49294785,0.00028353583,0.49661458,0.0005605092],"about_ca_topic_score_codex":0.00023693407,"about_ca_topic_score_gemma":0.00007793003,"teacher_disagreement_score":0.49472195,"about_ca_system_score_codex":0.000060439055,"about_ca_system_score_gemma":0.0002235907,"threshold_uncertainty_score":0.99970376},"labels":[],"label_agreement":null},{"id":"W2124210169","doi":"10.1354/vp.43-6-1044","title":"Book Review: Human Drug Metabolism. An Introduction","year":2006,"lang":"en","type":"article","venue":"Veterinary Pathology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Drug metabolism; Drug; Computational biology; Biology; Pharmacology","score_opus":0.07479515352443616,"score_gpt":0.42793590552809724,"score_spread":0.3531407520036611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124210169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6101241,0.3731542,0.000058580565,0.0067859944,0.0043160436,0.000639399,0.00009504974,0.00029083964,0.0045358203],"genre_scores_gemma":[0.61659926,0.10526152,0.0017506658,0.2029194,0.0222534,0.00088009663,0.0016499375,0.00031978765,0.048365913],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634045,0.0015065138,0.0006223993,0.0007076795,0.000164161,0.00065879297],"domain_scores_gemma":[0.9988388,0.000053687196,0.00022537154,0.000535441,0.000115965595,0.00023075927],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010932402,0.00037139567,0.0005554637,0.00020617543,0.0003862946,0.000017757695,0.0004335213,0.00025929077,0.0077579888],"category_scores_gemma":[0.000021981505,0.00037138115,0.00016172265,0.00025256522,0.0003055508,0.00027249395,0.00016901546,0.00072351395,0.00032983144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009420618,0.00041534813,0.000088207045,0.000111043766,0.000030802436,0.000390646,0.00006557461,0.000069594986,0.48423707,0.0014204015,0.5090784,0.0039987294],"study_design_scores_gemma":[0.001038789,0.00020739058,0.0020244597,0.000010103133,0.00027923958,0.0008914423,0.000007838436,0.00008630839,0.023228735,0.0004689098,0.97136956,0.0003872262],"about_ca_topic_score_codex":0.000016974107,"about_ca_topic_score_gemma":0.0000028285015,"teacher_disagreement_score":0.4622912,"about_ca_system_score_codex":0.000028074533,"about_ca_system_score_gemma":0.000035059144,"threshold_uncertainty_score":0.9998738},"labels":[],"label_agreement":null},{"id":"W2124448589","doi":"10.1016/s0140-6736(06)69255-6","title":"Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother","year":2006,"lang":"en","type":"article","venue":"The Lancet","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":678,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; SickKids Foundation; Office of the Chief Medical Examiner; Hospital for Sick Children","funders":"","keywords":"Codeine; Medicine; Morphine; Lethargy; Breastfeeding; Anesthesia; Pediatrics; Internal medicine","score_opus":0.09465134951513061,"score_gpt":0.40540054162882444,"score_spread":0.31074919211369384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124448589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842399,0.004942388,0.0001172385,0.0018113706,0.00039315023,0.0003469906,0.0002541988,0.000031029915,0.007863741],"genre_scores_gemma":[0.9967681,0.00074550323,0.00047834447,0.0010066688,0.00056322664,0.00002557896,0.0000150279075,0.00003089243,0.00036666324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998144,0.00040855532,0.0005806231,0.00020845915,0.00020003335,0.00045832855],"domain_scores_gemma":[0.9989876,0.0002322807,0.000287798,0.00032643494,0.00009790353,0.000067961206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093257,0.00021097338,0.00059667014,0.00012094833,0.000054630214,0.0000069538755,0.0006053521,0.00012721778,0.00056657917],"category_scores_gemma":[0.000032782373,0.00016256736,0.000107489985,0.0003697539,0.0002503297,0.000037933027,0.00012172125,0.00045402927,0.000013929627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012644639,0.00046562374,0.06447399,0.000110109904,0.00017364002,0.000022997678,0.00071275915,0.021210717,0.8916522,0.0023700597,0.006370165,0.011173225],"study_design_scores_gemma":[0.013300939,0.000080545025,0.11028786,0.00006005252,0.00037193863,0.000033824963,0.00007135414,0.04215819,0.7130875,0.0057558175,0.11436094,0.00043102365],"about_ca_topic_score_codex":0.00034221043,"about_ca_topic_score_gemma":0.00005179427,"teacher_disagreement_score":0.17856474,"about_ca_system_score_codex":0.000016029637,"about_ca_system_score_gemma":0.000050687617,"threshold_uncertainty_score":0.6629305},"labels":[],"label_agreement":null},{"id":"W2124808968","doi":"10.1016/j.critrevonc.2006.09.006","title":"Pharmacogenetics of paclitaxel metabolism","year":2006,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Paclitaxel; Pharmacogenetics; Medicine; Pharmacology; Chemotherapy; Drug metabolism; Drug; Oncology; Internal medicine; Biology; Genotype; Genetics","score_opus":0.3217679777041367,"score_gpt":0.5847237841736879,"score_spread":0.2629558064695512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124808968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030525513,0.97285783,0.00013334537,0.00032989116,0.006168138,0.00309624,0.00053872314,0.0000862192,0.016759088],"genre_scores_gemma":[0.000117487274,0.99298686,0.0021658686,0.0014241819,0.00096303603,0.0015152737,0.0002158629,0.00020438555,0.00040705866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98078656,0.008850924,0.006185522,0.0016357872,0.00042446007,0.0021167675],"domain_scores_gemma":[0.9886417,0.007374404,0.0017181183,0.0011003632,0.00034723934,0.00081816793],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0050774594,0.0017081171,0.012139378,0.0011511227,0.00018707683,0.000022121474,0.001995857,0.0039426307,0.0022814837],"category_scores_gemma":[0.0032906616,0.001478582,0.0021305596,0.0014923757,0.0021438268,0.00011518102,0.0007536408,0.0047147814,0.0010885607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005743074,0.0017396336,0.000042855943,0.020131115,0.00031691053,0.00050073105,0.000077382785,0.0000032537343,0.00003867196,0.03898011,0.01722283,0.9208891],"study_design_scores_gemma":[0.0016356165,0.00013635693,0.0000052087626,0.003939641,0.0053825644,0.0007173029,0.000013722442,0.000053043645,0.00022445568,0.0025395667,0.98420835,0.0011441765],"about_ca_topic_score_codex":0.00001940254,"about_ca_topic_score_gemma":0.000022008711,"teacher_disagreement_score":0.9669855,"about_ca_system_score_codex":0.00032452878,"about_ca_system_score_gemma":0.0013014995,"threshold_uncertainty_score":0.9996892},"labels":[],"label_agreement":null},{"id":"W2124959655","doi":"10.1124/jpet.104.068171","title":"Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung","year":2004,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"CYP2E1; Pharmacology; Lung; Chemistry; Toxicology; Internal medicine; Medicine; Biology; Biochemistry; Cytochrome P450; Metabolism","score_opus":0.0539391404406168,"score_gpt":0.4344174515844249,"score_spread":0.3804783111438081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124959655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95682514,0.040247325,0.00011484919,0.0014032081,0.00095822656,0.00021283813,0.000029769017,0.000008232852,0.00020043796],"genre_scores_gemma":[0.9848081,0.011591335,0.0003778719,0.0029685937,0.00018612637,0.000008696176,0.000003626252,0.000021665095,0.000033974367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984158,0.00022035645,0.00070042873,0.00019080151,0.0001629161,0.00030965332],"domain_scores_gemma":[0.998992,0.00023537833,0.00045117963,0.000059018643,0.00009260263,0.00016976567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006716892,0.00023615733,0.00046056198,0.0002403857,0.00009798417,0.00000979863,0.00017499286,0.00024695782,0.00020253271],"category_scores_gemma":[0.000011120381,0.00021650548,0.00007403462,0.00018482174,0.0003974412,0.00019193547,0.000082308376,0.0006704545,0.0000013785688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010093522,0.0012881143,0.004750733,0.00003506977,0.00029043926,0.000032922475,0.0017862415,0.00032197966,0.9849565,0.00019130878,0.00032507224,0.0050122645],"study_design_scores_gemma":[0.010233844,0.0005343213,0.0007951181,0.00001684541,0.00024173269,0.00013969115,0.00040054604,0.00061184843,0.9733151,0.0004564811,0.013062692,0.0001917484],"about_ca_topic_score_codex":0.000010538337,"about_ca_topic_score_gemma":8.447597e-7,"teacher_disagreement_score":0.02865599,"about_ca_system_score_codex":0.00008866713,"about_ca_system_score_gemma":0.00009691687,"threshold_uncertainty_score":0.88288367},"labels":[],"label_agreement":null},{"id":"W2125354536","doi":"10.1016/s0378-4274(01)00383-6","title":"Ovariectomy modulates the response of some cytochrome P450 isozymes to lindane in the rat","year":2001,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; Consejo Nacional de Ciencia y Tecnología","keywords":"Ovariectomized rat; Internal medicine; Cytochrome P450; Endocrinology; Microsome; Isozyme; Chemistry; Corn oil; Western blot; Lindane; Metabolism; Biology; Enzyme; Estrogen; Biochemistry; Medicine","score_opus":0.07791151777792191,"score_gpt":0.40749237052369364,"score_spread":0.32958085274577176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125354536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9166475,0.0010256381,0.00006400706,0.0800328,0.0008889424,0.00093195867,0.000027753507,0.0000401748,0.0003412026],"genre_scores_gemma":[0.8965956,0.0002497367,0.00010768063,0.10215197,0.00039749654,0.00019681013,0.000006216479,0.000028737722,0.0002657753],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951392,0.0027811346,0.0006051156,0.00042204178,0.00025549688,0.0007970506],"domain_scores_gemma":[0.99682355,0.0022449915,0.00018009852,0.0005279109,0.000056676232,0.00016675262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003288143,0.0003271663,0.00045993342,0.0003057498,0.00028072303,0.000025506626,0.001140436,0.0003031654,0.00070362625],"category_scores_gemma":[0.00025547945,0.00021545061,0.00015809106,0.0007095101,0.00059549906,0.0000997604,0.00019809001,0.0010389596,0.00017805182],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026712287,0.00035473442,0.0028346044,0.000010898427,0.000119434575,0.0002467952,0.003647473,0.004707331,0.96932733,0.0008727048,0.013138762,0.002068693],"study_design_scores_gemma":[0.004921496,0.00048426611,0.15851669,0.000017256682,0.00030357784,0.00031637083,0.00047313474,0.0013571966,0.2896137,0.001240609,0.54211426,0.0006414551],"about_ca_topic_score_codex":0.000026778001,"about_ca_topic_score_gemma":0.000025412892,"teacher_disagreement_score":0.67971367,"about_ca_system_score_codex":0.000059959373,"about_ca_system_score_gemma":0.000096399635,"threshold_uncertainty_score":0.87858206},"labels":[],"label_agreement":null},{"id":"W2125711506","doi":"10.1124/dmd.112.048991","title":"NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology","year":2012,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Complementary and Integrative Health; Cancer Research UK; National Cancer Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institute of General Medical Sciences","keywords":"Cytochrome P450; Cytochrome P450 reductase; Biology; Gene isoform; Microsome; Heme; CYP1A2; Computational biology; Biochemistry; Cell biology; Pharmacology; In vitro; Gene; Metabolism; Cytochrome c; Enzyme; Mitochondrion; Coenzyme Q – cytochrome c reductase","score_opus":0.033210786715325645,"score_gpt":0.373365587240539,"score_spread":0.34015480052521335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125711506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94434404,0.050614513,0.000021066284,0.0012287137,0.0018001487,0.00061605347,0.00020500425,0.000083383275,0.0010870877],"genre_scores_gemma":[0.98519105,0.008354238,0.00027233319,0.0042149946,0.0014152017,0.00020522664,0.0001392415,0.00004347776,0.00016426686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966079,0.0010146921,0.00054777856,0.0005909538,0.00016148087,0.0010772209],"domain_scores_gemma":[0.9986003,0.0002767369,0.00019405565,0.00019151194,0.00006621416,0.0006711697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012023225,0.00047233896,0.00067023386,0.0003855382,0.00034060652,0.00003359753,0.00022153884,0.0004255934,0.00063168805],"category_scores_gemma":[0.000038013186,0.00045490914,0.000094620365,0.00034438053,0.0006256425,0.0005159215,0.00025381928,0.00082365464,0.00006455511],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004853542,0.0007664157,0.003990882,0.00007402101,0.0001323188,0.000016984737,0.0021766766,0.00005000649,0.9634187,0.006674373,0.0028154377,0.019398812],"study_design_scores_gemma":[0.007277207,0.000060372677,0.56686044,0.000021077787,0.0008926196,0.00020662323,0.0007256055,0.0011628801,0.20661175,0.002628921,0.21254662,0.0010058827],"about_ca_topic_score_codex":0.00005963865,"about_ca_topic_score_gemma":0.000020813399,"teacher_disagreement_score":0.75680697,"about_ca_system_score_codex":0.000037967642,"about_ca_system_score_gemma":0.00005370718,"threshold_uncertainty_score":0.99979025},"labels":[],"label_agreement":null},{"id":"W2126104556","doi":"10.1258/cvd.2012.012001","title":"Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues","year":2012,"lang":"en","type":"review","venue":"JRSM Cardiovascular Disease","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Medicine; Drug response; Drug; Precision medicine; Quality (philosophy); Intensive care medicine; Pharmacology; Psychology; Bioinformatics; Biology; Genotype; Genetics","score_opus":0.7690919594905862,"score_gpt":0.5755296491581999,"score_spread":0.19356231033238624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126104556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013389379,0.99391705,0.00020940344,0.000015810558,0.00044014468,0.0030828302,0.00091561227,0.000038444523,0.000041772513],"genre_scores_gemma":[0.0036303352,0.99322337,0.0021058354,0.000031665342,0.0004497951,0.00039805236,0.000058181777,0.000092505354,0.000010260549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9851333,0.011690679,0.0010990952,0.00094174204,0.00057801034,0.00055720203],"domain_scores_gemma":[0.99621123,0.0011883193,0.00043514138,0.00080437976,0.00018311315,0.001177804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0057705687,0.0007920119,0.0039830147,0.00023889347,0.00011397392,0.000019995752,0.00043750316,0.0004484416,0.0002450812],"category_scores_gemma":[0.00027994654,0.0006356951,0.00094447,0.00019339664,0.0005858289,0.000102653765,0.00043728176,0.00062755623,0.0000061821893],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018905936,0.0017090306,0.00011526625,0.027105095,0.009223887,0.000113317845,0.00042249027,0.000040192295,0.000016584616,0.00037636395,0.000024005445,0.9606647],"study_design_scores_gemma":[0.0018492559,0.00027413265,0.0010349357,0.0004935291,0.06367543,0.000044118373,0.00011214976,0.00008605914,0.00009096312,0.00028722238,0.9313474,0.00070478214],"about_ca_topic_score_codex":0.000014582096,"about_ca_topic_score_gemma":4.856924e-7,"teacher_disagreement_score":0.9599599,"about_ca_system_score_codex":0.000020453432,"about_ca_system_score_gemma":0.0002114237,"threshold_uncertainty_score":0.9996094},"labels":[],"label_agreement":null},{"id":"W2126333303","doi":"10.1038/clpt.2012.184","title":"Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of General Medical Sciences; National Institutes of Health; National Institute for Health and Care Research","keywords":"VKORC1; Confidence interval; Coumarin; Meta-analysis; Internal medicine; Clinical pharmacology; Medicine; CYP2C9; Polymorphism (computer science); Allele; Pharmacology; Oncology; Biology; Genetics","score_opus":0.617369271961051,"score_gpt":0.6106917275112662,"score_spread":0.006677544449784745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126333303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000904746,0.98805,0.000005468108,0.0011909078,0.0024914471,0.006373171,0.0013831169,0.00006899155,0.00034646687],"genre_scores_gemma":[0.00066887133,0.9512541,0.00002312794,0.045426797,0.0005222427,0.0007505636,0.000091244474,0.00015833456,0.0011046681],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9789687,0.013063988,0.0048693824,0.0012355794,0.00060784037,0.0012545445],"domain_scores_gemma":[0.987809,0.005072624,0.0043020495,0.0016468472,0.00034497824,0.0008245004],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.0067408076,0.0016998552,0.014772485,0.00047980208,0.00038524918,0.000025362107,0.0022508516,0.0017665245,0.005206245],"category_scores_gemma":[0.00010082032,0.0009439735,0.012770726,0.0016774026,0.0015283113,0.00009983206,0.0008162281,0.004121521,0.00022751225],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012325989,0.0022560093,0.00007266957,0.16313443,0.8122722,0.00001747224,0.00007897159,0.000020640939,0.00002143068,0.00005276481,0.0054393816,0.016510777],"study_design_scores_gemma":[0.0008018593,0.00017673495,0.000050408446,0.0010516891,0.6948802,0.000027180246,0.0000015526805,0.000024349994,0.000013230996,0.000022523744,0.30237517,0.00057513337],"about_ca_topic_score_codex":0.000013523424,"about_ca_topic_score_gemma":0.0000028696038,"teacher_disagreement_score":0.2969358,"about_ca_system_score_codex":0.00020003162,"about_ca_system_score_gemma":0.0006107764,"threshold_uncertainty_score":0.99985427},"labels":[],"label_agreement":null},{"id":"W2126347322","doi":"10.1093/toxsci/kfr240","title":"Tissue Distribution and Gender-Divergent Expression of 78 Cytochrome P450 mRNAs in Mice","year":2011,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cytochrome P450; Biology; Kidney; Gene expression; Gene isoform; Drug metabolism; Internal medicine; Gene; Endocrinology; Molecular biology; Genetics; Metabolism","score_opus":0.3241416573998902,"score_gpt":0.4554920667789627,"score_spread":0.1313504093790725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126347322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901829,0.0014962899,0.0001657968,0.00012167634,0.00030883306,0.00028604106,0.000059115802,0.00002864733,0.007350717],"genre_scores_gemma":[0.99789214,0.0009594767,0.0006662023,0.0003264549,0.00005988646,0.000027835136,0.000005955012,0.0000039179663,0.00005811769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981865,0.0004052153,0.00036553384,0.00039251422,0.00021701498,0.00043317533],"domain_scores_gemma":[0.9993286,0.00017201928,0.00014559677,0.00007953755,0.000042007217,0.00023222614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012292089,0.00016561501,0.00026800545,0.00007866766,0.00021222932,0.00001123946,0.0003744415,0.00024562396,0.002176664],"category_scores_gemma":[0.0001153586,0.00012218989,0.000042715837,0.00035971048,0.000854879,0.00011709768,0.00024173556,0.00030078465,0.000027183698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012149537,0.0005034761,0.013108204,0.000020020134,0.000008844885,0.000020200989,0.0008365403,0.00006869418,0.9690591,0.0035144344,0.00028768386,0.012451294],"study_design_scores_gemma":[0.00072793465,0.00030637966,0.22673064,0.000007398807,0.000034084518,0.000011670707,0.0001487982,0.00038116638,0.75766456,0.005151762,0.008646032,0.00018954145],"about_ca_topic_score_codex":0.00002895224,"about_ca_topic_score_gemma":0.0000076543565,"teacher_disagreement_score":0.21362245,"about_ca_system_score_codex":0.000027224542,"about_ca_system_score_gemma":0.000047571393,"threshold_uncertainty_score":0.9987355},"labels":[],"label_agreement":null},{"id":"W2126973461","doi":"10.1016/j.thromres.2015.05.006","title":"Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment","year":2015,"lang":"en","type":"letter","venue":"Thrombosis Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dosing; Pharmacogenetics; Warfarin; Randomized controlled trial; Medicine; Meta-analysis; VKORC1; Clinical trial; Intensive care medicine; CYP2C9; Pharmacology; Internal medicine; Genotype; Biology; Atrial fibrillation","score_opus":0.7663918700285941,"score_gpt":0.6275726054424634,"score_spread":0.1388192645861307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126973461","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010282714,0.28996336,0.0013759147,0.63712156,0.007580715,0.029526241,0.015772574,0.00022306721,0.008153851],"genre_scores_gemma":[0.09472857,0.08694527,0.0077334093,0.778289,0.011513189,0.010280282,0.005486622,0.00084192684,0.004181699],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.8841747,0.09827587,0.009877825,0.0015430673,0.004356739,0.0017717893],"domain_scores_gemma":[0.9194854,0.0689614,0.0046839193,0.0015147141,0.0046265856,0.0007279989],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.17665063,0.0012914224,0.038493,0.004054333,0.00029577903,0.00008326562,0.0025146385,0.0029186844,0.012462541],"category_scores_gemma":[0.008248998,0.00089403964,0.021413174,0.0029192287,0.0031347566,0.00007106126,0.000703524,0.008201483,0.00008489891],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026553897,0.0014054169,0.000036812537,0.00022099978,0.5116278,0.000023216322,0.00017087701,0.0034141652,0.0010490211,0.000041785377,0.45081547,0.004640558],"study_design_scores_gemma":[0.16838638,0.00017716046,0.000011514734,0.000018178382,0.5093242,6.535788e-7,0.000017770053,0.02898073,0.008867919,0.00021094397,0.2835184,0.00048613703],"about_ca_topic_score_codex":0.00027153673,"about_ca_topic_score_gemma":0.000007536545,"teacher_disagreement_score":0.2030181,"about_ca_system_score_codex":0.00016871291,"about_ca_system_score_gemma":0.0015778289,"threshold_uncertainty_score":0.9999837},"labels":[],"label_agreement":null},{"id":"W2127055978","doi":"10.1021/bp000047o","title":"Characterization of a Perfusion Reactor Utilizing Mammalian Cells on Microcarrier Beads","year":2000,"lang":"en","type":"article","venue":"Biotechnology Progress","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; National Aeronautics and Space Administration","keywords":"Microcarrier; Bioreactor; Physiologically based pharmacokinetic modelling; Chemistry; Cell culture; Bioprocess; Biophysics; Cell; Biochemistry; Biology; Pharmacokinetics; Pharmacology","score_opus":0.05107714386584852,"score_gpt":0.36572992009018107,"score_spread":0.3146527762243325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127055978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410844,0.0013218148,0.000008815643,0.0013739966,0.000836825,0.0005261197,0.00016524618,0.00020829831,0.001450455],"genre_scores_gemma":[0.9953825,0.002473505,0.00027537404,0.0010732869,0.00017488174,0.00005522978,0.00006506718,0.00004080566,0.00045934264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822843,0.00021838077,0.00043695353,0.0004604949,0.000142595,0.0005131492],"domain_scores_gemma":[0.9991561,0.000044496042,0.00020784402,0.00036860618,0.00007129277,0.00015166064],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035310187,0.0002915734,0.0003591382,0.00026360026,0.00016218955,0.000012746122,0.00045503915,0.0010105077,0.0019692264],"category_scores_gemma":[0.000013233873,0.0002780603,0.00011321069,0.0003750487,0.00054592866,0.00006413825,0.00009078558,0.00069930236,0.00023968438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002853502,0.00028493366,0.0006276969,0.000023122147,0.00003677746,0.000013842877,0.00012910135,0.0000021268527,0.6816948,0.00056217884,0.0001761642,0.31616393],"study_design_scores_gemma":[0.00071106845,0.00013162875,0.00094483624,0.00002076406,0.00006345076,0.000010637982,0.000022164026,0.00018850614,0.64160115,0.000027126482,0.35610667,0.00017199789],"about_ca_topic_score_codex":0.000007823314,"about_ca_topic_score_gemma":0.0000015161571,"teacher_disagreement_score":0.3559305,"about_ca_system_score_codex":0.000044885073,"about_ca_system_score_gemma":0.000048351383,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W2127594213","doi":"10.1038/sj.bjp.0706138","title":"Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450","year":2005,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Chronic renal failure; Cytochrome P450; Internal medicine; Pharmacology; Endocrinology; Metabolism","score_opus":0.015185397953337228,"score_gpt":0.3263623993519701,"score_spread":0.31117700139863286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127594213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885986,0.007840618,0.000092149916,0.00074197084,0.0015644305,0.00066111604,0.0002777313,0.000028218736,0.00019520073],"genre_scores_gemma":[0.9915159,0.0024177004,0.0005886523,0.0028181486,0.0024221619,0.000027594104,0.000020437259,0.00006519617,0.00012424022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962876,0.001038085,0.0010564772,0.00038229802,0.00051684066,0.0007187399],"domain_scores_gemma":[0.9970245,0.0008252537,0.0010485991,0.00011371154,0.00051711046,0.0004708377],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005988063,0.00040415482,0.0009218624,0.00028666458,0.00020673183,0.000029628025,0.00066964416,0.0003589214,0.003475231],"category_scores_gemma":[0.00007408348,0.00039894693,0.00027207416,0.00029924887,0.00035062875,0.00027036294,0.00011311059,0.0016981969,0.00007520946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017488055,0.0022440632,0.0017710755,0.0001391118,0.0013575798,0.0009133497,0.00022448858,0.00402603,0.8508771,0.000023950899,0.022026714,0.11464772],"study_design_scores_gemma":[0.024995213,0.0016035953,0.056510907,0.00022505234,0.001668777,0.00030493145,0.000008798259,0.0005331598,0.79692,0.000093950024,0.116662085,0.00047352992],"about_ca_topic_score_codex":0.000021438811,"about_ca_topic_score_gemma":0.000054041608,"teacher_disagreement_score":0.11417419,"about_ca_system_score_codex":0.00021008245,"about_ca_system_score_gemma":0.0003582604,"threshold_uncertainty_score":0.9998462},"labels":[],"label_agreement":null},{"id":"W2128181693","doi":"10.1080/15476910701680020","title":"Changes In Gene Expression Induced by Tienilic Acid and Sulfamethoxazole: Testing the Danger Hypothesis","year":2007,"lang":"en","type":"article","venue":"Journal of Immunotoxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sulfamethoxazole; Medicine; Gene; Pharmacology; Biology; Internal medicine; Genetics; Antibiotics","score_opus":0.14361434635551243,"score_gpt":0.4046373724086695,"score_spread":0.2610230260531571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128181693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867387,0.009614011,0.00008546049,0.0014044329,0.0013740762,0.00028244813,0.000011450536,0.000012126114,0.00047729397],"genre_scores_gemma":[0.99298996,0.0015116368,0.0018464385,0.0031247688,0.00041783194,0.000015238274,0.0000012191508,0.000029189247,0.000063691754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973536,0.00084485265,0.00077349995,0.00022007881,0.00020801478,0.0005999571],"domain_scores_gemma":[0.9966209,0.0021597764,0.00065047585,0.0001809127,0.00018225131,0.00020570269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048445906,0.00025002955,0.00047756807,0.00033098902,0.000224098,0.000023237262,0.0004729509,0.00042287595,0.00015520763],"category_scores_gemma":[0.0008073457,0.00017838784,0.0000783582,0.00040101737,0.00023832021,0.00010392149,0.00017188996,0.0014350686,0.0000071407926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043811093,0.00021286769,0.0032258653,0.00000975376,0.000068014015,0.00006631419,0.0007936444,0.000015330354,0.87827647,0.0000103527855,0.0005507475,0.11633253],"study_design_scores_gemma":[0.0022297297,0.00029004598,0.0231776,0.000017782246,0.000100397956,0.00034655683,0.00026165548,0.00008363587,0.94491726,0.00021813215,0.028170796,0.00018643332],"about_ca_topic_score_codex":0.000008073504,"about_ca_topic_score_gemma":0.000017554292,"teacher_disagreement_score":0.116146095,"about_ca_system_score_codex":0.00007344827,"about_ca_system_score_gemma":0.00009670422,"threshold_uncertainty_score":0.72744447},"labels":[],"label_agreement":null},{"id":"W2129122576","doi":"10.1016/j.thromres.2009.11.020","title":"A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: Derivation in a sample with predominantly a history of venous thromboembolism","year":2010,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"VKORC1; Warfarin; Medicine; Dosing; CYP2C9; Vitamin K epoxide reductase; Maintenance dose; Internal medicine; Pharmacogenomics; Cohort; Genotyping; Pharmacogenetics; Vitamin K antagonist; Venous thromboembolism; Thrombosis; Pharmacology; Atrial fibrillation; Biology; Genotype","score_opus":0.30597136883628495,"score_gpt":0.5106648445691896,"score_spread":0.20469347573290464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129122576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955525,0.0016393473,0.00017170119,0.00051190984,0.0003722343,0.000925181,0.00016457855,0.000021866623,0.0006406941],"genre_scores_gemma":[0.99232507,0.0025368896,0.0044232835,0.00028187988,0.00013915185,0.00014889383,0.000025256504,0.00004061976,0.000078980265],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964927,0.0009993345,0.0006921,0.00069301104,0.00045942032,0.0006634618],"domain_scores_gemma":[0.99727035,0.0015879119,0.0001428209,0.0003852053,0.00019825558,0.00041548838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037579776,0.00026012253,0.00076211686,0.00054758723,0.00011606252,0.00002144992,0.00036787274,0.00049075077,0.00020083268],"category_scores_gemma":[0.0006363834,0.00022216127,0.00003791337,0.00048235882,0.0008319489,0.00016161092,0.00042968756,0.0018353652,0.000004933355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002446684,0.002273703,0.18029155,0.00008877226,0.00014029836,0.000027466245,0.010123556,0.00076373544,0.77370226,0.001240529,0.0013877288,0.027513735],"study_design_scores_gemma":[0.009953536,0.0008434625,0.8122055,0.00025648274,0.00016569941,0.000010326398,0.0002607723,0.13542984,0.02259105,0.0083805155,0.009321242,0.0005815598],"about_ca_topic_score_codex":0.0031522755,"about_ca_topic_score_gemma":0.0012739534,"teacher_disagreement_score":0.7511112,"about_ca_system_score_codex":0.00012026178,"about_ca_system_score_gemma":0.0006266039,"threshold_uncertainty_score":0.9059474},"labels":[],"label_agreement":null},{"id":"W2129209019","doi":"10.1681/asn.2009010082","title":"ESRD Impairs Nonrenal Clearance of Fexofenadine but not Midazolam","year":2009,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Fexofenadine; Midazolam; Pharmacology; Medicine; Pharmacokinetics; Chemistry","score_opus":0.059332120989362185,"score_gpt":0.3967026514567031,"score_spread":0.3373705304673409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129209019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859844,0.0012633229,0.00013930835,0.011589874,0.0005653708,0.00013302035,0.00004023375,0.00000818229,0.00027629957],"genre_scores_gemma":[0.9643321,0.0025687278,0.0020611647,0.030294353,0.0006087093,0.0000011701978,6.607565e-7,0.000015628726,0.00011748461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766076,0.00053411286,0.00088746636,0.00016770743,0.00031580817,0.00043415857],"domain_scores_gemma":[0.9967471,0.0003226103,0.0021343369,0.00025646016,0.0003384309,0.00020111288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011387542,0.00022159,0.0008571969,0.00007544839,0.00012371011,0.000004655425,0.0008423083,0.00016460194,0.0001471982],"category_scores_gemma":[0.000053707012,0.00016270066,0.00088460423,0.00040496312,0.0013262165,0.00007131365,0.000099378616,0.0010350145,0.0000047302597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017781595,0.00040840913,0.0015902832,0.000018041943,0.0006156342,0.0000077722125,0.0006702932,0.0014071583,0.93900543,0.000096616845,0.02923661,0.025165565],"study_design_scores_gemma":[0.0048745796,0.002065337,0.33433944,0.000029714005,0.0009616023,0.0004973122,0.000616274,0.0028339517,0.43054676,0.0012142139,0.22165833,0.00036248384],"about_ca_topic_score_codex":0.000029828307,"about_ca_topic_score_gemma":0.0000019465633,"teacher_disagreement_score":0.5084587,"about_ca_system_score_codex":0.00004046626,"about_ca_system_score_gemma":0.00020492925,"threshold_uncertainty_score":0.663474},"labels":[],"label_agreement":null},{"id":"W2129319352","doi":"10.18433/j3688m","title":"Pharmacokinetics of mirodenafil, a new erectogenic, and its metabolite, SK3541, in rats: involvement of CYP1A1/2, 2B1/2, 2D subfamily, and 3A1/2 for the metabolism of both mirodenafil and SK3541","year":2010,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Metabolite; Pharmacokinetics; Pharmacology; Subfamily; Active metabolite; Medicine; Chemistry; Internal medicine; Biochemistry; Gene","score_opus":0.15110300434386886,"score_gpt":0.4599331404346859,"score_spread":0.30883013609081705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129319352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8845556,0.10999634,0.00010137619,0.0019009042,0.0019124437,0.0010909345,0.0002276354,0.000011415554,0.00020335965],"genre_scores_gemma":[0.93984956,0.056175597,0.0020626977,0.0011893174,0.00057028525,0.000029848998,0.000002491281,0.00003996136,0.00008027597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99462765,0.0006850427,0.0022197133,0.00062135985,0.00093755854,0.00090865174],"domain_scores_gemma":[0.99428135,0.0024846992,0.0014418488,0.00022933273,0.0006015159,0.00096124643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0063107796,0.0005953915,0.0014075221,0.0006473215,0.0002852809,0.00006370415,0.0011216103,0.00022693363,0.0003868348],"category_scores_gemma":[0.0004971387,0.00042870338,0.00033437854,0.0009873135,0.0021021587,0.0005419164,0.000460002,0.001531709,0.0000010157204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015301942,0.0006742389,0.011987515,0.0004024591,0.0005581918,0.000013034521,0.0015905892,0.00023311899,0.91729575,0.0021003357,0.000776035,0.06283853],"study_design_scores_gemma":[0.011801707,0.0002473269,0.006863531,0.000055353088,0.0021930286,0.00013653823,0.0003398025,0.020608304,0.7757065,0.0009507139,0.18066761,0.0004295364],"about_ca_topic_score_codex":0.00011030078,"about_ca_topic_score_gemma":0.000035011417,"teacher_disagreement_score":0.17989157,"about_ca_system_score_codex":0.000021315273,"about_ca_system_score_gemma":0.00057412963,"threshold_uncertainty_score":0.9998165},"labels":[],"label_agreement":null},{"id":"W2129470929","doi":"10.1186/1940-0640-9-20","title":"Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds","year":2014,"lang":"en","type":"review","venue":"Addiction Science & Clinical Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacogenetics; Addiction; Personalized medicine; Precision medicine; Medicine; Psychology; Risk analysis (engineering); Psychiatry; Bioinformatics; Biology; Genetics","score_opus":0.7441610175572767,"score_gpt":0.671339387385834,"score_spread":0.07282163017144272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129470929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010757162,0.98114526,0.00010401122,0.00048863277,0.0031383007,0.0026056694,0.0001619123,0.000034763423,0.0015643089],"genre_scores_gemma":[0.041413475,0.9558579,0.0005188148,0.0011704369,0.000701101,0.0002297445,0.000058730777,0.000030525825,0.000019280684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98596984,0.008267305,0.0031557158,0.0012564951,0.0007141613,0.0006364858],"domain_scores_gemma":[0.98038346,0.016312623,0.0020535733,0.0006638062,0.00019800867,0.00038852534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.022530042,0.00052046904,0.0016487377,0.00030106847,0.0004918376,0.0001681379,0.00082235545,0.0006143293,0.00019033915],"category_scores_gemma":[0.0025108783,0.00035506618,0.0006000117,0.001091711,0.0024179528,0.0007862244,0.0001773741,0.0015825905,0.000032540003],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013684083,0.002140266,0.0049879514,0.00022112513,0.00024746757,0.000006087516,0.00032849002,0.000008386279,0.0000031809311,0.00011481963,0.0004327815,0.9913726],"study_design_scores_gemma":[0.0022750031,0.00044996256,0.0043448545,0.00014262013,0.0041826307,0.00003915323,0.00022782246,0.0011772587,0.000011041694,0.0000743241,0.9867639,0.00031146224],"about_ca_topic_score_codex":0.000062574625,"about_ca_topic_score_gemma":0.000041856256,"teacher_disagreement_score":0.99106115,"about_ca_system_score_codex":0.00007803332,"about_ca_system_score_gemma":0.0007816958,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W2129509075","doi":"10.1007/s00228-009-0741-5","title":"Ontogeny of midazolam glucuronidation in preterm infants","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Western University","funders":"","keywords":"Midazolam; Urine; Glucuronidation; Bolus (digestion); Medicine; Chemistry; Anesthesia; Endocrinology; Internal medicine; Microsome","score_opus":0.20983649816865482,"score_gpt":0.531550800048629,"score_spread":0.3217143018799742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129509075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746695,0.002230397,0.00012847426,0.0013318919,0.008648529,0.00028067146,0.000017282575,0.000017601544,0.01267565],"genre_scores_gemma":[0.9872889,0.0032640523,0.00056956726,0.0060927435,0.002632231,0.0000012695158,0.000003996439,0.00002878666,0.00011844416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99029785,0.00516792,0.003420693,0.00030989537,0.0002993648,0.0005042492],"domain_scores_gemma":[0.9959268,0.0009295663,0.0019705289,0.000188726,0.0004957912,0.00048858713],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009242642,0.00027784993,0.0009857091,0.00036530007,0.000060432914,0.000010607399,0.000832778,0.00020058312,0.0011642348],"category_scores_gemma":[0.000858364,0.00025267698,0.00042113804,0.00032575498,0.00029058332,0.00020271662,0.000103008046,0.0019112678,0.0000742055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008781544,0.0039519747,0.042935666,0.00005648015,0.00060463673,0.0014534881,0.0010225646,0.0042848256,0.38029227,0.00024575146,0.029008284,0.5273625],"study_design_scores_gemma":[0.025011392,0.0028273957,0.45691842,0.000072955205,0.0007319722,0.00016040866,0.00004842197,0.0021935906,0.100799,0.0007407433,0.4099626,0.0005331014],"about_ca_topic_score_codex":0.0000012755062,"about_ca_topic_score_gemma":0.0000012125067,"teacher_disagreement_score":0.5268294,"about_ca_system_score_codex":0.000032931366,"about_ca_system_score_gemma":0.00023368574,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W2129684544","doi":"10.1093/annonc/mdr476","title":"Heterogeneity among lists of cautioned or prohibited drugs in protocols of early-phase oncology trials","year":2011,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group; Princess Margaret Cancer Centre; University Health Network","funders":"Centre Léon Bérard; Académie française","keywords":"Medicine; Oncology; Clinical trial; Internal medicine","score_opus":0.7244290692160772,"score_gpt":0.6638508701986854,"score_spread":0.06057819901739181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129684544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054349575,0.9032305,0.000009853128,0.00008879994,0.0013589957,0.034200925,0.0017140288,0.00004769142,0.004999665],"genre_scores_gemma":[0.008637621,0.98007905,0.00025908707,0.0002442644,0.00031252037,0.009947502,0.00014989925,0.00010076377,0.0002693124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98014605,0.011530329,0.006139427,0.0008675233,0.00033021407,0.0009864604],"domain_scores_gemma":[0.9869657,0.0034995982,0.0074999174,0.00073514576,0.0008351607,0.00046443913],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011296752,0.00089115824,0.009598785,0.0012686447,0.000076085234,0.0000062240065,0.0012652727,0.0030253148,0.0013148271],"category_scores_gemma":[0.0014777945,0.00070884416,0.0015351886,0.001135063,0.0013439085,0.00012908745,0.00044592473,0.0017477182,0.000029918514],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054628057,0.008122311,0.0003122098,0.011371177,0.0018379655,0.00010908941,0.001288151,0.000007251591,0.0009916521,0.0004377257,0.0013335828,0.9687261],"study_design_scores_gemma":[0.00840606,0.0053321095,0.00013027525,0.0018591111,0.0019729557,0.000036009114,0.000028835184,0.000018798619,0.01880727,0.00021306766,0.9626468,0.000548701],"about_ca_topic_score_codex":0.00023010325,"about_ca_topic_score_gemma":0.00014639454,"teacher_disagreement_score":0.9681774,"about_ca_system_score_codex":0.00013451191,"about_ca_system_score_gemma":0.0035873712,"threshold_uncertainty_score":0.9995981},"labels":[],"label_agreement":null},{"id":"W2129920562","doi":"10.1081/dmr-120034149","title":"The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics","year":2004,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Cytochrome P450; Biology; Xenobiotic; Isozyme; Drug metabolism; CYP2E1; CYP2B6; Enzyme; Biochemistry; Pharmacology; Cell biology; CYP3A4","score_opus":0.10339823955707572,"score_gpt":0.4435344160855489,"score_spread":0.34013617652847317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129920562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000960038,0.99160993,0.00007617313,0.00036320966,0.001496562,0.00408408,0.00088650826,0.000068120986,0.0013193984],"genre_scores_gemma":[0.00003573643,0.993451,0.0005303157,0.0011451812,0.00075132743,0.0006652928,0.00033320725,0.000181874,0.002906083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892302,0.0051368577,0.003054151,0.001054606,0.000529963,0.0009941816],"domain_scores_gemma":[0.9941708,0.001527662,0.0023801033,0.00113132,0.00023346767,0.0005566888],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.005798949,0.0013494099,0.004547902,0.00030781422,0.00059396704,0.000103183665,0.0013917006,0.0009630613,0.00019856048],"category_scores_gemma":[0.00032755805,0.0009179952,0.0011770804,0.0009104194,0.0008394405,0.00012970043,0.00046650064,0.0019126604,0.00017779451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020034968,0.00012550635,5.594694e-7,0.008248037,0.00042041054,0.0000031962193,0.0003706153,0.000008189258,0.0016160003,0.004103556,0.03856526,0.94651866],"study_design_scores_gemma":[0.0009555524,0.00001768032,0.000016661039,0.0020646497,0.0041215587,0.000029556008,0.000025360025,0.000029163302,0.00093866437,0.0010727164,0.9898726,0.0008558437],"about_ca_topic_score_codex":0.000030304403,"about_ca_topic_score_gemma":0.000004709691,"teacher_disagreement_score":0.95130736,"about_ca_system_score_codex":0.00010163532,"about_ca_system_score_gemma":0.0006277029,"threshold_uncertainty_score":0.9999257},"labels":[],"label_agreement":null},{"id":"W2130120706","doi":"10.1503/cmaj.070946","title":"Drug interactions with warfarin: what clinicians need to know","year":2007,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Warfarin; Drug; Medical prescription; Medicine; Need to know; Drug interaction; Computer science; Intensive care medicine; Data science; Pharmacology; Computer security; Internal medicine; Atrial fibrillation","score_opus":0.049769717128284714,"score_gpt":0.40304007536520536,"score_spread":0.35327035823692066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130120706","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004426366,0.0016121079,0.00009358313,0.9652979,0.018496554,0.00039617458,0.0001890154,0.0000469327,0.00944136],"genre_scores_gemma":[0.0020092097,0.0029995611,0.00014466929,0.94611734,0.03257312,0.000029822924,0.00012405266,0.00009424823,0.015907988],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940098,0.0011074698,0.0010743057,0.0004605949,0.0017459679,0.0016018681],"domain_scores_gemma":[0.99298006,0.0012298666,0.0006735299,0.00022424212,0.0009547746,0.0039375112],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.004290943,0.00049045455,0.0007065067,0.00090651604,0.00072451925,0.00035287056,0.0008686457,0.0019753412,0.018730782],"category_scores_gemma":[0.00081235217,0.00044877795,0.0003008317,0.00056783576,0.00010756932,0.00028900284,0.00006107848,0.01667463,0.0017544746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004389888,0.000044773504,0.0015987422,0.000014354484,0.0005702012,0.0030088625,0.00052837003,0.000040709812,0.000013766878,0.000009401526,0.92881256,0.06531438],"study_design_scores_gemma":[0.0013387882,0.000041063817,0.0002544502,0.00014621654,0.00032333878,0.00051694154,0.00040044525,0.00011810949,0.00007079909,0.000045962588,0.9962222,0.0005217018],"about_ca_topic_score_codex":0.0013072843,"about_ca_topic_score_gemma":0.040703773,"teacher_disagreement_score":0.06740964,"about_ca_system_score_codex":0.0015748915,"about_ca_system_score_gemma":0.004708354,"threshold_uncertainty_score":0.9997964},"labels":[],"label_agreement":null},{"id":"W2130496753","doi":"10.18433/j3fc7f","title":"The Implication of the Polymorphisms of COX-1, UGT1A6, and CYP2C9 among Cardiovascular Disease (CVD) Patients Treated with Aspirin","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CYP2C9; Aspirin; Internal medicine; Genotype; Medicine; Gastroenterology; Cyclooxygenase; Proportional hazards model; Gastritis; Endocrinology; Pharmacology; Biology; Helicobacter pylori; Cytochrome P450; Gene; Genetics; Enzyme; Biochemistry; Metabolism","score_opus":0.11749081024479323,"score_gpt":0.41312356958896257,"score_spread":0.2956327593441693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130496753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98069805,0.015808176,0.000034495184,0.0013836704,0.0008243627,0.0005340584,0.000059135644,0.000010834865,0.0006472132],"genre_scores_gemma":[0.9960483,0.0031501905,0.000070582035,0.00043230673,0.00021798961,0.000014465485,0.0000017659488,0.00001909657,0.000045349716],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99596184,0.0009977752,0.0009483775,0.00031642395,0.0012494542,0.0005261093],"domain_scores_gemma":[0.9966707,0.00046153215,0.0008633783,0.00028332503,0.00079681945,0.0009242065],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0034282673,0.0002982438,0.00050983217,0.00014186797,0.00046080927,0.000050229577,0.001079662,0.0000751957,0.000055815617],"category_scores_gemma":[0.00023976652,0.00015539885,0.0003537238,0.0008130765,0.0028347147,0.00034072294,0.00024569395,0.00068131916,0.0000029042053],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023159294,0.00088665524,0.8444594,0.000077226774,0.0012060734,0.000022317772,0.0005367914,0.0036326821,0.03899611,0.0006105372,0.0009867777,0.10626948],"study_design_scores_gemma":[0.013962606,0.00054636557,0.18185508,0.000100087076,0.004225862,0.00008938572,0.00023827895,0.012080935,0.4370384,0.0005892179,0.3487347,0.0005390708],"about_ca_topic_score_codex":0.00005929536,"about_ca_topic_score_gemma":0.0000028362717,"teacher_disagreement_score":0.66260433,"about_ca_system_score_codex":0.00005534253,"about_ca_system_score_gemma":0.00046526306,"threshold_uncertainty_score":0.999879},"labels":[],"label_agreement":null},{"id":"W2130748375","doi":"10.1002/etc.5620220324","title":"Hepatic microsomal cytochrome P450 enzyme activity in relation to in vitro metabolism/inhibition of polychlorinated biphenyls and testosterone in Baltic grey seal (<i>Halichoerus grypus</i>)","year":2003,"lang":"en","type":"article","venue":"Environmental Toxicology and Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Microsome; Metabolism; Cytochrome P450; Chemistry; Biotransformation; Enzyme; Unspecific monooxygenase; Polychlorinated biphenyl; Biochemistry; Stereochemistry; Monooxygenase; Environmental chemistry","score_opus":0.023236711015658853,"score_gpt":0.3070009450125005,"score_spread":0.2837642339968417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130748375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965385,0.0021819621,0.000006510843,0.00015507948,0.0001271762,0.0004647623,0.00010589446,0.000011318529,0.0004087892],"genre_scores_gemma":[0.9984731,0.0007092328,0.00014719866,0.00039159562,0.000036511334,0.00009533366,0.000030749947,0.000022073984,0.0000941801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800426,0.00040567006,0.0004868074,0.00050297414,0.00011749634,0.00048281768],"domain_scores_gemma":[0.99930376,0.0001813701,0.00014652417,0.00014431747,0.000005632366,0.00021839497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053354644,0.00029144203,0.0004904488,0.00016162662,0.00007323189,0.0000081090875,0.00008969125,0.0004765655,0.00022638276],"category_scores_gemma":[0.000056233475,0.00033778994,0.00003999661,0.00023533718,0.00030523053,0.00013126427,0.00010854853,0.0007146344,0.000007162265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006814547,0.0008127257,0.047702108,0.00006914497,0.000024336287,0.00007330115,0.00046979965,0.0001676667,0.9487212,0.000019311898,0.0000044563035,0.0012545494],"study_design_scores_gemma":[0.0032965196,0.00004627149,0.26906717,0.000014221007,0.000038508402,0.000049762253,0.00006934873,0.00020701272,0.72641355,0.00011257997,0.0004720984,0.00021293771],"about_ca_topic_score_codex":0.000028902801,"about_ca_topic_score_gemma":0.000029519975,"teacher_disagreement_score":0.22230756,"about_ca_system_score_codex":0.00015329021,"about_ca_system_score_gemma":0.000035639307,"threshold_uncertainty_score":0.99990743},"labels":[],"label_agreement":null},{"id":"W2130813724","doi":"10.1016/s0378-4274(03)00230-3","title":"Hepatic CYP1A, 2B, 2C, 2E and 3A regulation by methoxychlor in male and female rats","year":2003,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Methoxychlor; Cytochrome P450; Internal medicine; Endocrinology; CYP2E1; Biology; Enzyme inducer; Corn oil; Inducer; Endocrine system; Enzyme; Metabolism; Hormone; Pesticide; Biochemistry; Medicine; Gene","score_opus":0.06106326262390513,"score_gpt":0.38633070021335,"score_spread":0.3252674375894449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130813724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882186,0.0039985334,0.00019310163,0.0041215797,0.0008690095,0.00054316234,0.00003206195,0.00004205711,0.0019819147],"genre_scores_gemma":[0.97871083,0.0009806096,0.0014156821,0.017818775,0.000098708326,0.00009836414,0.000018781657,0.00003462008,0.00082363555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701524,0.0012269963,0.00044725114,0.0005537021,0.00012228085,0.0006345536],"domain_scores_gemma":[0.9988401,0.00050659914,0.00014896075,0.00019307701,0.00002916691,0.00028210066],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012538423,0.00031532435,0.00045000305,0.00022098066,0.00020810189,0.000026489437,0.00015027229,0.00038860386,0.0011069372],"category_scores_gemma":[0.00012113159,0.00032888952,0.000051693823,0.0002376584,0.00043079982,0.00013212908,0.0000761776,0.00065544824,0.00004765022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001331637,0.0001845537,0.040163286,0.0000423912,0.000083470404,0.000062102685,0.0006508282,0.000158753,0.9439643,0.00066453824,0.007898779,0.005993823],"study_design_scores_gemma":[0.008087406,0.00021908997,0.05450458,0.000020968591,0.00042710206,0.00033848322,0.00020567839,0.004377931,0.5686735,0.0014624214,0.36059448,0.0010883613],"about_ca_topic_score_codex":0.000017477387,"about_ca_topic_score_gemma":0.000028225706,"teacher_disagreement_score":0.3752908,"about_ca_system_score_codex":0.000053093816,"about_ca_system_score_gemma":0.000039828872,"threshold_uncertainty_score":0.9999163},"labels":[],"label_agreement":null},{"id":"W2130987050","doi":"10.1007/s00213-013-3083-z","title":"Adolescence: a time of transition for the phenotype of dcc heterozygous mice","year":2013,"lang":"en","type":"article","venue":"Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Douglas Mental Health University Institute; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds Québécois de la Recherche sur la Nature et les Technologies; Concordia University","keywords":"Sensitization; Amphetamine; Ventral tegmental area; Heterozygote advantage; Downregulation and upregulation; Endocrinology; Internal medicine; Psychology; Biology; Medicine; Neuroscience; Dopamine; Genetics; Allele","score_opus":0.054986061142510055,"score_gpt":0.4073215573902773,"score_spread":0.3523354962477673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130987050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828381,0.00419,0.0016598274,0.0033286135,0.0035437248,0.00246463,0.00026552068,0.000057359823,0.0016522564],"genre_scores_gemma":[0.9920942,0.0010702063,0.00050794287,0.00496224,0.00048800884,0.00044485266,0.000018377314,0.00003942878,0.00037475422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978698,0.00040030404,0.0006986412,0.00034551308,0.0001675501,0.00051818934],"domain_scores_gemma":[0.9978949,0.00092322665,0.00037143732,0.00023810608,0.00039003108,0.00018233183],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006716695,0.00027077764,0.00048685557,0.0001410653,0.00016325996,0.000007673624,0.0005949827,0.0002906247,0.004879696],"category_scores_gemma":[0.00003890575,0.00021494692,0.00026627013,0.00028888322,0.0004825904,0.000091866736,0.000050578536,0.00046058273,0.0002151644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012407275,0.0006028698,0.00014794071,0.00014448166,0.00040262262,0.000001468602,0.001150901,0.0009236548,0.9314591,0.00010103091,0.024406416,0.039418783],"study_design_scores_gemma":[0.016367666,0.0007641806,0.00648167,0.000034222747,0.002000162,0.000037029342,0.0002907669,0.056940094,0.7843138,0.0030755787,0.12897925,0.00071558787],"about_ca_topic_score_codex":0.000033081396,"about_ca_topic_score_gemma":0.0000015772282,"teacher_disagreement_score":0.14714532,"about_ca_system_score_codex":0.000019370182,"about_ca_system_score_gemma":0.00007614456,"threshold_uncertainty_score":0.99603},"labels":[],"label_agreement":null},{"id":"W2131356514","doi":"","title":"Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP2A6; Tranylcypromine; Chemistry; Pharmacology; Hydroxylation; Methoxsalen; Microsome; Dextromethorphan; CYP1A2; Biochemistry; Monoamine oxidase; Biology; Enzyme","score_opus":0.15151453331691345,"score_gpt":0.4104899720855356,"score_spread":0.25897543876862217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131356514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752871,0.014802098,0.000012516978,0.00038394635,0.00046432362,0.001263487,0.000026077832,0.000018378816,0.007742074],"genre_scores_gemma":[0.9938295,0.0048130653,0.00012178229,0.00021602468,0.00019965078,0.0006535346,0.000008137181,0.00001904731,0.00013924547],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977341,0.00084531354,0.00037820303,0.00034234003,0.0003120112,0.00038802554],"domain_scores_gemma":[0.9991345,0.000232133,0.00012536143,0.00010115914,0.00019099226,0.00021585918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037476362,0.00018663582,0.00031717354,0.00025645894,0.0000610972,0.00001186669,0.00009135051,0.0001893603,0.000088541805],"category_scores_gemma":[0.0001857934,0.00018450401,0.00004287486,0.0003853651,0.00017409337,0.00010123807,0.000044766683,0.00035788116,0.0000030370782],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062040443,0.00024977842,0.0056488276,0.00001968253,0.00010970227,0.0000103828515,0.000723546,0.00006275673,0.15579526,0.00009218525,0.00020155638,0.8364659],"study_design_scores_gemma":[0.008270512,0.000042663774,0.3729153,0.000005103015,0.00055004354,0.00005571039,0.00014490685,0.003425669,0.56441367,0.0027528778,0.04711299,0.00031058124],"about_ca_topic_score_codex":0.000024299898,"about_ca_topic_score_gemma":0.000012777103,"teacher_disagreement_score":0.83615535,"about_ca_system_score_codex":0.00005479002,"about_ca_system_score_gemma":0.000052784322,"threshold_uncertainty_score":0.7523855},"labels":[],"label_agreement":null},{"id":"W2131441643","doi":"10.1124/mol.107.039354","title":"Dexamethasone-Mediated Up-Regulation of Human CYP2A6 Involves the Glucocorticoid Receptor and Increased Binding of Hepatic Nuclear Factor 4α to the Proximal Promoter","year":2007,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Chromatin immunoprecipitation; Hepatocyte nuclear factor 4; Transactivation; Glucocorticoid receptor; Molecular biology; Biology; Electrophoretic mobility shift assay; Promoter; Transcription factor; Chemistry; Endocrinology; Nuclear receptor; Gene expression; Glucocorticoid; Gene; Biochemistry","score_opus":0.05278774633892928,"score_gpt":0.3865000972303615,"score_spread":0.3337123508914322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131441643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943569,0.0008427967,0.00019390965,0.0010383065,0.0011510053,0.0020303808,0.00011351716,0.000042488977,0.00023072354],"genre_scores_gemma":[0.99636835,0.000115063114,0.00024132761,0.0028601466,0.00018404298,0.000067649155,0.000033904373,0.000058549205,0.00007093866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966567,0.001141459,0.0008167657,0.00043330799,0.00032794365,0.0006238183],"domain_scores_gemma":[0.99800235,0.0006974107,0.00047981332,0.0003122303,0.00022680423,0.00028140066],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018846836,0.00033821538,0.00050827244,0.00026141218,0.00028175683,0.00001724844,0.00056121143,0.00028731208,0.0016705061],"category_scores_gemma":[0.00017436137,0.000241598,0.00014775102,0.0005243024,0.00051979255,0.0000694167,0.00030185096,0.0006717215,0.00006833006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005119507,0.00026795964,0.004692264,0.00009985581,0.00040642347,0.0000093741055,0.002591093,0.00010019342,0.98488027,0.00033394204,0.0006051179,0.0055015828],"study_design_scores_gemma":[0.0026134949,0.000310663,0.014345286,0.00001440199,0.00046398002,0.000010329898,0.00019066558,0.0020741688,0.95602375,0.00007378159,0.02361867,0.0002608133],"about_ca_topic_score_codex":0.00005584959,"about_ca_topic_score_gemma":0.000009890982,"teacher_disagreement_score":0.0288565,"about_ca_system_score_codex":0.00005243796,"about_ca_system_score_gemma":0.00009281824,"threshold_uncertainty_score":0.9992421},"labels":[],"label_agreement":null},{"id":"W2131567043","doi":"10.1080/03602530600959615","title":"Evaluation of Which Reactive Metabolite, If Any, Is Responsible for a Specific Idiosyncratic Reaction","year":2006,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Metabolite; Reactive intermediate; Circumstantial evidence; Drug reaction; Mechanism (biology); Chemistry; Drug; Pharmacology; Biochemistry; Biology; Epistemology","score_opus":0.3331959719031033,"score_gpt":0.5179051538150201,"score_spread":0.18470918191191682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131567043","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011142653,0.9718699,0.0001477727,0.000119682234,0.0058214297,0.012369307,0.002234515,0.000089085006,0.0072369245],"genre_scores_gemma":[0.00005100247,0.9872505,0.0015166637,0.0003215704,0.0026909134,0.004665005,0.0010911688,0.00027038337,0.002142812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9780124,0.012786287,0.004556502,0.0018021954,0.0015728727,0.001269761],"domain_scores_gemma":[0.989195,0.0015207788,0.0044683497,0.0016421841,0.0026786518,0.00049502985],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.03019213,0.0017210195,0.007771823,0.0012504711,0.00040530984,0.0000803256,0.0012345822,0.0013066696,0.000737164],"category_scores_gemma":[0.0016194083,0.0014446737,0.0027217036,0.0025680687,0.00023378992,0.00040270868,0.00022353936,0.0020057058,0.00044201015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011482521,0.0005739513,5.765115e-7,0.008734121,0.0011369007,0.0000028668994,0.00037047066,0.000016563683,0.0021733353,0.0013965282,0.036183815,0.94929606],"study_design_scores_gemma":[0.002181991,0.000026780677,0.0000131099105,0.0017012651,0.04276961,0.000039298215,0.000026107027,0.0003710959,0.0040324037,0.0016422838,0.9460252,0.0011708356],"about_ca_topic_score_codex":0.000041886397,"about_ca_topic_score_gemma":0.00001614512,"teacher_disagreement_score":0.9481252,"about_ca_system_score_codex":0.00032531822,"about_ca_system_score_gemma":0.002141282,"threshold_uncertainty_score":0.99998987},"labels":[],"label_agreement":null},{"id":"W2131973888","doi":"10.1073/pnas.0705110104","title":"Exploring the biochemical properties and remediation applications of the unusual explosive-degrading P450 system XplA/B","year":2007,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"Biotechnology and Biological Sciences Research Council","keywords":"Environmental remediation; Chemistry; Trinitrotoluene; Environmental chemistry; Contamination; Phytoremediation; Biodegradation; Groundwater remediation; Bioremediation; Degradation (telecommunications); Geobacter; Explosive material; Organic chemistry; Biology","score_opus":0.3192680229988518,"score_gpt":0.4093075712968274,"score_spread":0.09003954829797556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131973888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950042,0.0009420844,0.000005973416,0.0019088656,0.00009754332,0.00042487308,0.000014678324,0.00001071564,0.0015910998],"genre_scores_gemma":[0.9990724,0.0002304846,0.0001518946,0.00022926147,0.00021344781,0.0000639678,9.257853e-8,0.000004537182,0.000033962297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998597,0.000028599849,0.00039708335,0.00017710001,0.00062828953,0.00017190851],"domain_scores_gemma":[0.9989415,0.000282395,0.00044981265,0.00001378521,0.00026622685,0.000046320572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002818553,0.000095915035,0.00013408538,0.00010502631,0.00044684467,0.0000116567635,0.00074110855,0.00007857885,0.0000024800513],"category_scores_gemma":[0.00025628845,0.000048729875,0.00006440354,0.0006960704,0.0012650109,0.0002094243,0.00019873338,0.00030963932,5.131676e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026714535,0.00003634858,0.004071027,0.00010616706,0.000026436233,2.549343e-9,0.00090351555,0.000058743404,0.96238506,0.030365525,0.00011881527,0.0019016344],"study_design_scores_gemma":[0.00018508182,0.000009571695,0.020515895,0.000046599922,0.000058087688,0.0000066183047,0.0012172499,0.0012591447,0.9734139,0.0018408067,0.0013881292,0.000058908652],"about_ca_topic_score_codex":0.0000029886774,"about_ca_topic_score_gemma":6.5145436e-8,"teacher_disagreement_score":0.02852472,"about_ca_system_score_codex":0.000028360331,"about_ca_system_score_gemma":0.000032881395,"threshold_uncertainty_score":0.46609855},"labels":[],"label_agreement":null},{"id":"W2132083761","doi":"10.1124/dmd.108.020966","title":"Cytochrome P450 2C11 5′-Flanking Region and Promoter Mediate in Vivo Suppression by 3-Methylcholanthrene","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Methylcholanthrene; Cytochrome P450; In vivo; Flanking maneuver; Biology; Molecular biology; Genetics; Chemistry; Enzyme; Carcinogen; Biochemistry","score_opus":0.043162318871766525,"score_gpt":0.3520303319730257,"score_spread":0.30886801310125916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132083761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97702175,0.019713107,0.0001401657,0.0008101147,0.00060349575,0.0004884913,0.00016635512,0.00006748833,0.0009890061],"genre_scores_gemma":[0.976623,0.021133523,0.0001502847,0.0011213678,0.00035289177,0.00008146289,0.00010956461,0.00003612672,0.00039180677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764055,0.0005679646,0.0004532957,0.0005709743,0.00023837414,0.0005288137],"domain_scores_gemma":[0.99909353,0.00014600951,0.00016222679,0.00018499208,0.0000565498,0.000356692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006030274,0.0003531973,0.00047516302,0.0002539284,0.00041629234,0.000040641607,0.00016074559,0.0002860435,0.00017030501],"category_scores_gemma":[0.000031923326,0.00032070564,0.00006762957,0.00024861266,0.00028403054,0.0003971071,0.00014011846,0.0005885648,0.000012478251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049980154,0.0003866099,0.0072796554,0.00008335667,0.00006231847,0.00016476066,0.0040025925,0.000025360723,0.96219987,0.00040986284,0.008410207,0.016475633],"study_design_scores_gemma":[0.010064134,0.00006592886,0.16037583,0.000102635146,0.0004801559,0.0005123734,0.00020623708,0.003083325,0.58443874,0.0022600787,0.23725127,0.0011592566],"about_ca_topic_score_codex":0.000078443336,"about_ca_topic_score_gemma":0.0000107523,"teacher_disagreement_score":0.37776107,"about_ca_system_score_codex":0.000020394384,"about_ca_system_score_gemma":0.00003201916,"threshold_uncertainty_score":0.9999245},"labels":[],"label_agreement":null},{"id":"W2132124948","doi":"10.1016/j.psychres.2015.07.032","title":"Physicians' opinions following pharmacogenetic testing for psychotropic medication","year":2015,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacogenetics; Medicine; Medical prescription; CYP2C19; Genetic testing; Drug response; Psychiatry; Drug; Family medicine; Pharmacology; Internal medicine; Genetics; Genotype; Biology","score_opus":0.462524712156223,"score_gpt":0.5800618040460228,"score_spread":0.11753709188979983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132124948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9024191,0.016062198,0.0024284183,0.025792923,0.02671731,0.0027498058,0.00023406745,0.00031139285,0.02328481],"genre_scores_gemma":[0.98093873,0.00021760851,0.009493206,0.0027022562,0.004542117,0.0008214109,0.00013220197,0.0000910548,0.001061398],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99608177,0.00089788996,0.00050587574,0.0006331058,0.0007403961,0.0011409794],"domain_scores_gemma":[0.9973876,0.0007883448,0.0001289857,0.00039009718,0.0005691812,0.0007357868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038772312,0.00026611154,0.0003133429,0.00034183674,0.0007122341,0.000059867158,0.00076438446,0.00025368432,0.00013911072],"category_scores_gemma":[0.00049795385,0.00027383066,0.00020159908,0.0009844591,0.00022116142,0.00012792979,0.0001334036,0.00112057,0.00031592592],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007325776,0.0018760398,0.20984906,0.00023549491,0.00080200884,0.000012834376,0.00183725,0.00090969005,0.07949876,0.0040670303,0.53369707,0.16648221],"study_design_scores_gemma":[0.009039262,0.0005220961,0.008676486,0.000069122725,0.0003633737,0.000016894192,0.00089077937,0.016265258,0.0061090915,0.025219053,0.9321745,0.0006540542],"about_ca_topic_score_codex":0.000019142566,"about_ca_topic_score_gemma":0.000010455943,"teacher_disagreement_score":0.3984775,"about_ca_system_score_codex":0.00008393349,"about_ca_system_score_gemma":0.000709902,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W2132624405","doi":"10.1124/dmd.109.031138","title":"Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases","year":2009,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Helsingin Yliopiston Tiedesäätiö; National Institutes of Health; Academy of Finland; National Institute of General Medical Sciences; Helsingin Yliopisto","keywords":"Glucuronidation; Chemistry; Microsome; Kinetics; Substrate (aquarium); Biochemistry; Enzyme; Biology","score_opus":0.031661021772739266,"score_gpt":0.36931649797112165,"score_spread":0.3376554761983824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132624405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97283137,0.022702387,0.00030103175,0.0016051033,0.00027930358,0.0003667739,0.0002090443,0.000036701018,0.001668297],"genre_scores_gemma":[0.9930881,0.004252617,0.000049471393,0.002028165,0.0001987544,0.000019491732,0.00014574823,0.000013683938,0.00020395563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849653,0.00038708237,0.00036334654,0.000300121,0.00016707736,0.00028582284],"domain_scores_gemma":[0.99935234,0.00011928123,0.00013020803,0.00016181027,0.00006060219,0.00017574726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056121656,0.00023082232,0.000301197,0.00008408575,0.00042711393,0.00003870001,0.00015388358,0.0001234255,0.00011350885],"category_scores_gemma":[0.000015070555,0.00018019807,0.00006936364,0.00015433588,0.00024320289,0.00019347959,0.00003175543,0.00029711303,0.0000053016634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015114615,0.00035074606,0.000983009,0.0000437745,0.000071584356,0.000002276202,0.0016046982,0.00006831569,0.88200575,0.018915247,0.003470612,0.092332825],"study_design_scores_gemma":[0.0045151277,0.00011273234,0.06772655,0.000026226468,0.00096253154,0.000029065402,0.00030651473,0.0017805926,0.79413354,0.008399195,0.12148547,0.000522443],"about_ca_topic_score_codex":0.000052252006,"about_ca_topic_score_gemma":0.000004628993,"teacher_disagreement_score":0.11801486,"about_ca_system_score_codex":0.00000709588,"about_ca_system_score_gemma":0.000018057079,"threshold_uncertainty_score":0.7348264},"labels":[],"label_agreement":null},{"id":"W2132649715","doi":"10.2174/138920008784746373","title":"Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions","year":2008,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Ziprasidone; Quetiapine; Aripiprazole; Amisulpride; Pharmacology; Olanzapine; Clozapine; Atypical antipsychotic; Risperidone; Asenapine; Paliperidone; Sertindole; CYP3A4; Chemistry; CYP2D6; Drug metabolism; Antipsychotic; Cytochrome P450; Medicine; Drug; Metabolism; Biochemistry; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.19780855701770922,"score_gpt":0.4896649825532538,"score_spread":0.2918564255355446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132649715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037687635,0.9786705,0.00015658034,0.00011166043,0.010403715,0.0034109692,0.0032460971,0.000086075015,0.00014567838],"genre_scores_gemma":[0.0018493804,0.99273694,0.0011776793,0.00014592185,0.002025107,0.0007906162,0.00042113158,0.0001969042,0.0006563384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99229646,0.0014742758,0.0031055715,0.0013684675,0.00063847424,0.001116772],"domain_scores_gemma":[0.992872,0.0024374574,0.002411098,0.00094824587,0.0006384975,0.00069269305],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013183017,0.0014356785,0.005191169,0.0009762608,0.00037154762,0.000035352838,0.0012472656,0.00040565565,0.00027807502],"category_scores_gemma":[0.000363115,0.0012808071,0.0018038659,0.00076821767,0.0010004845,0.00027485532,0.00050995057,0.0022085498,0.00004385599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005918433,0.0017393393,0.0000162069,0.016226329,0.0019864992,0.000007757331,0.001752542,0.000026226746,0.0008070232,0.009506606,0.035337515,0.9320021],"study_design_scores_gemma":[0.0028941205,0.000015150858,0.00014674124,0.0020039428,0.0066644037,0.000047787547,0.00006939387,0.00013677988,0.0039330446,0.00087793625,0.9821797,0.0010309975],"about_ca_topic_score_codex":0.000014263073,"about_ca_topic_score_gemma":0.000013197349,"teacher_disagreement_score":0.9468422,"about_ca_system_score_codex":0.00006983393,"about_ca_system_score_gemma":0.0006125461,"threshold_uncertainty_score":0.9998393},"labels":[],"label_agreement":null},{"id":"W2133002022","doi":"10.1592/phco.2005.25.11.1656","title":"Increase in International Normalized Ratio After Smoking Cessation in a Patient Receiving Warfarin","year":2005,"lang":"en","type":"article","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Warfarin; Medicine; Smoking cessation; Emergency medicine; Anesthesia; Pediatrics; Internal medicine; Atrial fibrillation","score_opus":0.04571418493673224,"score_gpt":0.4000730892369731,"score_spread":0.35435890430024086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133002022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97468525,0.016920904,0.00002959521,0.0048793913,0.0021005217,0.000609247,0.00001680692,0.00002451667,0.0007337895],"genre_scores_gemma":[0.9419154,0.04522585,0.00009146454,0.011352823,0.0011555413,0.000086837295,0.0000049328396,0.00004789001,0.000119248565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948622,0.0024942243,0.0013559355,0.00031346426,0.00037295345,0.00060124253],"domain_scores_gemma":[0.9980371,0.000658396,0.00074242643,0.0001455846,0.00016634012,0.00025017688],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004156982,0.0004249741,0.0005414224,0.0007573106,0.0002674934,0.000046139274,0.0006781674,0.00019843438,0.004015955],"category_scores_gemma":[0.0000224712,0.00033330123,0.0001625318,0.00038193818,0.000283858,0.000614089,0.000106991,0.0017671342,0.000008651886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008646638,0.0014969793,0.0395945,0.000016510536,0.0004915575,0.00012784556,0.019479608,0.005602475,0.7278258,0.00007499693,0.0022259045,0.19441716],"study_design_scores_gemma":[0.043380458,0.0003777871,0.027471391,0.00007564975,0.00032530108,0.00030328424,0.0007394324,0.009518548,0.5418528,0.0015422297,0.3735032,0.00090992585],"about_ca_topic_score_codex":0.00009004502,"about_ca_topic_score_gemma":0.00015550351,"teacher_disagreement_score":0.3712773,"about_ca_system_score_codex":0.00019304093,"about_ca_system_score_gemma":0.00011689261,"threshold_uncertainty_score":0.9999119},"labels":[],"label_agreement":null},{"id":"W2133013045","doi":"10.1124/dmd.31.6.748","title":"IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"CYP3A4; CYP2C8; Metabolite; Microsome; Cytochrome P450; Ketoconazole; CYP3A; Pharmacology; CYP2D6; Hydroxylation; Chemistry; Metabolism; In vivo; Biology; In vitro; Biochemistry; Enzyme","score_opus":0.023771396761042746,"score_gpt":0.345650322664084,"score_spread":0.3218789259030413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133013045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788749,0.017383348,0.00047641151,0.0006540774,0.00076685473,0.0006661811,0.0002788211,0.000018701508,0.0008806653],"genre_scores_gemma":[0.99274355,0.0059774034,0.00019400106,0.00058387296,0.0001270617,0.0000840047,0.00012139937,0.00002595908,0.00014273929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974073,0.00057870126,0.00097309635,0.00035359818,0.00029018486,0.00039711167],"domain_scores_gemma":[0.9986261,0.00024231714,0.000536354,0.0002796829,0.00014961867,0.00016594373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002270536,0.0003010611,0.0005427399,0.00033115878,0.00023044385,0.000036099296,0.00021030939,0.00019400928,0.00006894411],"category_scores_gemma":[0.00014721308,0.00023767626,0.00011110013,0.0004922968,0.0003466335,0.0006683139,0.00008682647,0.0004015234,0.000009326162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047046237,0.00022972148,0.00015849542,0.00014974679,0.000076850774,0.000004200902,0.0044198744,0.000121223035,0.95114917,0.03197056,0.00011518256,0.011134511],"study_design_scores_gemma":[0.0026194698,0.000016246739,0.009544611,0.000017209808,0.00045935303,0.00005807906,0.001035437,0.001312012,0.96254766,0.010459227,0.011666113,0.00026460335],"about_ca_topic_score_codex":0.00011386251,"about_ca_topic_score_gemma":0.00001496694,"teacher_disagreement_score":0.021511333,"about_ca_system_score_codex":0.000020811234,"about_ca_system_score_gemma":0.0000564246,"threshold_uncertainty_score":0.96921563},"labels":[],"label_agreement":null},{"id":"W2134046939","doi":"10.4021/jocmr2009.08.1255","title":"Pharmacogenomics: The Right Drug to the Right Person","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacogenetics; Drug; Personalized medicine; Pharmacology; Single-nucleotide polymorphism; Efficacy; Drug reaction; Drug response; Bioinformatics; Computational biology; Gene; Genotype; Genetics; Biology","score_opus":0.4250392385150973,"score_gpt":0.6307897006184299,"score_spread":0.2057504621033326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134046939","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45530704,0.014345281,0.00009131889,0.49064925,0.0072872764,0.00084516854,0.000016578546,0.000017346105,0.031440742],"genre_scores_gemma":[0.9336313,0.009654747,0.00012507474,0.034750674,0.01850802,0.000011584285,0.0000016759993,0.000025522191,0.003291401],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98958164,0.0057507544,0.0018668404,0.0003489315,0.0015294908,0.0009223391],"domain_scores_gemma":[0.9874792,0.0090310555,0.0005808801,0.00047104366,0.0012198586,0.0012179733],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.045289557,0.0002669926,0.0008456515,0.00033406657,0.0008156691,0.0000452125,0.0022443333,0.00023668681,0.003857538],"category_scores_gemma":[0.0038738004,0.00011821181,0.00042815224,0.0008457954,0.0010054411,0.00010073036,0.00015250177,0.0063176653,0.000384792],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017862234,0.0005776015,0.0008119687,0.0000129382,0.00036975552,0.00032841964,0.0022662622,0.00021350362,0.010774297,0.0014357949,0.7494884,0.23193483],"study_design_scores_gemma":[0.0036686524,0.00086183206,0.004585549,0.000050292212,0.00031465918,0.00015839885,0.00048725764,0.00082514784,0.008409468,0.0023159294,0.9781777,0.00014511032],"about_ca_topic_score_codex":0.000013355405,"about_ca_topic_score_gemma":0.000008227452,"teacher_disagreement_score":0.47832426,"about_ca_system_score_codex":0.00006838399,"about_ca_system_score_gemma":0.00048336468,"threshold_uncertainty_score":0.9970531},"labels":[],"label_agreement":null},{"id":"W2134794720","doi":"10.1517/17425255.4.9.1143","title":"Whole body physiologically-based pharmacokinetic models: their use in clinical drug development","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Drug development; Pharmacokinetics; Drug; Pharmacology; Physiologically based pharmacokinetic modelling; Medicine; Intensive care medicine","score_opus":0.3293432199936731,"score_gpt":0.49376141390974265,"score_spread":0.16441819391606954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134794720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025675034,0.97428155,0.00007799134,0.00050729775,0.017011141,0.003661038,0.0004483078,0.00039159585,0.001053553],"genre_scores_gemma":[0.0010428037,0.9773039,0.0012237878,0.012135486,0.0035102828,0.0025317308,0.0010399533,0.00037255444,0.0008394923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9777537,0.010875688,0.0049435445,0.0031011957,0.00078409916,0.002541776],"domain_scores_gemma":[0.9904608,0.00460203,0.0018177967,0.0014367718,0.00029686652,0.0013856937],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0028654567,0.0027274864,0.007000007,0.0015539497,0.00065696856,0.00009936842,0.002678263,0.0026625637,0.0011435207],"category_scores_gemma":[0.00036224347,0.0022044368,0.002192747,0.0012845711,0.0010522677,0.00035213624,0.00085734925,0.0062816627,0.0011026534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069134065,0.00568368,0.000013376411,0.00067515933,0.000991524,0.0002132533,0.0011176057,0.0023433485,0.00038445907,0.0005795795,0.05287864,0.93442804],"study_design_scores_gemma":[0.0057065734,0.000109377266,0.00012561821,0.00085109624,0.00021862399,0.00005772827,0.00004411553,0.003269975,0.0008416351,0.00014854844,0.9864378,0.0021889172],"about_ca_topic_score_codex":0.000032553326,"about_ca_topic_score_gemma":0.000017091354,"teacher_disagreement_score":0.9335591,"about_ca_system_score_codex":0.00038779958,"about_ca_system_score_gemma":0.0021748992,"threshold_uncertainty_score":0.99976957},"labels":[],"label_agreement":null},{"id":"W2135163551","doi":"10.1542/peds.2009-1907","title":"Fatal Hydrocodone Overdose in a Child: Pharmacogenetics and Drug Interactions","year":2010,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; Hospital for Sick Children; University of British Columbia; Child and Family Research Institute; Western University; Office of the Chief Medical Examiner","funders":"","keywords":"Hydrocodone; Medicine; CYP2D6; Pharmacogenetics; Hydromorphone; Drug; Pharmacology; Drug interaction; Metabolite; Anesthesia; Opioid; Cytochrome P450; Internal medicine; Oxycodone; Genotype","score_opus":0.0383720846401747,"score_gpt":0.4019869959442818,"score_spread":0.36361491130410706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135163551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98301417,0.0028537132,0.000042132917,0.0010825002,0.0047652493,0.0003922797,0.0001631581,0.00008141329,0.007605367],"genre_scores_gemma":[0.99034387,0.005272867,0.00058622786,0.0014231957,0.001741464,0.00005415564,0.00003254068,0.000044482338,0.00050121197],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812716,0.00018910105,0.00046033025,0.00045069717,0.00020124792,0.0005714658],"domain_scores_gemma":[0.99874645,0.00035263872,0.00014547737,0.00022255351,0.000073067225,0.00045979614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065813184,0.00030363866,0.00028680128,0.00039403848,0.00024270326,0.00004260704,0.00030802347,0.00017152437,0.00087710546],"category_scores_gemma":[0.00012729813,0.0003221064,0.00008889367,0.0005287937,0.00016085131,0.00016110286,0.00024081064,0.0020676176,0.000141053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000689315,0.0031622862,0.3798969,0.0002832899,0.00023740766,0.0006760072,0.0061137173,0.0013816463,0.4043713,0.0033257985,0.019620141,0.18024218],"study_design_scores_gemma":[0.0054979967,0.00003055363,0.019601358,0.000006006149,0.0004734985,0.00036436462,0.00012767181,0.010092695,0.048879508,0.0011032328,0.9129785,0.0008446338],"about_ca_topic_score_codex":0.00004933017,"about_ca_topic_score_gemma":0.00015939857,"teacher_disagreement_score":0.89335835,"about_ca_system_score_codex":0.00002354992,"about_ca_system_score_gemma":0.000078863515,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W2135247011","doi":"10.1124/dmd.108.022772","title":"Dexamethasone Induction of Murine CYP2B Genes Requires the Glucocorticoid Receptor","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Phenobarbital; Glucocorticoid receptor; Glucocorticoid; Inducer; Constitutive androstane receptor; Enzyme inducer; Biology; Nuclear receptor; Dexamethasone; Reporter gene; Gene expression; Endocrinology; Chemistry; Gene; Biochemistry; Enzyme; Transcription factor","score_opus":0.07280065866725785,"score_gpt":0.36826709757329845,"score_spread":0.29546643890604063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135247011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972233,0.022724003,0.00017107905,0.00088326936,0.0021438932,0.00048367417,0.00011715641,0.00004996172,0.0011939659],"genre_scores_gemma":[0.98075217,0.016528497,0.00039082262,0.00083794445,0.000725021,0.00006387273,0.0000746045,0.000027518465,0.00059951964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979824,0.0005547003,0.00049757597,0.0003516804,0.00026193628,0.00035171182],"domain_scores_gemma":[0.99890023,0.00022570098,0.0002702984,0.00027379277,0.00015088923,0.00017909524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068706216,0.00025937625,0.00039694985,0.00013985431,0.00041680573,0.000015809348,0.00021784415,0.00017269568,0.0003922377],"category_scores_gemma":[0.00005326347,0.00019448297,0.00013251675,0.0002538373,0.0004523614,0.00022918866,0.000109902154,0.00040416242,0.000053470445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056449487,0.0003981557,0.0048301653,0.00007989749,0.00020679654,0.000008968017,0.0024128722,0.00034281638,0.9025065,0.0075448817,0.0019826659,0.0791218],"study_design_scores_gemma":[0.0027356576,0.00004631409,0.07316194,0.000016337544,0.0005636194,0.00010272233,0.00038782725,0.0009758976,0.7039171,0.00074588385,0.21696141,0.0003853188],"about_ca_topic_score_codex":0.00008867172,"about_ca_topic_score_gemma":0.000004481989,"teacher_disagreement_score":0.21497875,"about_ca_system_score_codex":0.0000137139605,"about_ca_system_score_gemma":0.000059373622,"threshold_uncertainty_score":0.79307854},"labels":[],"label_agreement":null},{"id":"W2135338861","doi":"10.1124/dmd.108.025635","title":"Developmental Expression and Endocrine Regulation of CYP1B1 in Rat Testis","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Endocrinology; CYP1B1; Hypophysectomy; Biology; Testosterone propionate; Prolactin; Hormone; Endocrine system; Cytochrome P450; Testosterone (patch); Triiodothyronine; Thyroid; Luteinizing hormone; Androgen; Metabolism; Medicine","score_opus":0.04557831548049369,"score_gpt":0.347539064552609,"score_spread":0.30196074907211534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135338861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902223,0.007688911,0.000075643016,0.00014695128,0.00033018444,0.0002677222,0.000046473044,0.000024132833,0.0011977166],"genre_scores_gemma":[0.9930946,0.004948268,0.0012570985,0.00026235875,0.00011946003,0.000031677668,0.000054691955,0.00001414218,0.00021770272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873966,0.00023453712,0.00036562263,0.00027540376,0.00014546173,0.00023932254],"domain_scores_gemma":[0.99949014,0.00011358516,0.00011748074,0.00006664229,0.000052395906,0.0001597483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029437686,0.00018266393,0.00029172207,0.00019412774,0.00018099898,0.000008450351,0.00007191095,0.00009805645,0.00013795726],"category_scores_gemma":[0.0000316495,0.00017243721,0.00003448826,0.0001900191,0.00019440099,0.00021796905,0.00008555626,0.00021353099,0.000005560314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026075376,0.00019690538,0.020888355,0.00004592442,0.000017289382,0.000020840173,0.00193341,0.0000715488,0.9536978,0.0011457382,0.00049674953,0.02122467],"study_design_scores_gemma":[0.0030560533,0.000013146419,0.34859172,0.000025733083,0.00007875213,0.00012328112,0.00012038189,0.00088486157,0.62654656,0.000860207,0.019475484,0.00022381208],"about_ca_topic_score_codex":0.000040583887,"about_ca_topic_score_gemma":0.000007665665,"teacher_disagreement_score":0.32770336,"about_ca_system_score_codex":0.000012902791,"about_ca_system_score_gemma":0.00003697422,"threshold_uncertainty_score":0.7031785},"labels":[],"label_agreement":null},{"id":"W2135962408","doi":"10.1002/bit.22143","title":"The activity of human CYP2D6 in low water organic solvents","year":2008,"lang":"en","type":"article","venue":"Biotechnology and Bioengineering","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Anhydrous; Chemistry; Hydroxylation; Enzyme; Trehalose; Aqueous solution; Solubility; Biocatalysis; Solvent; Organic chemistry; Limiting; Decane; Combinatorial chemistry; Chromatography; Catalysis; Reaction mechanism","score_opus":0.050849304743231585,"score_gpt":0.3436643498663098,"score_spread":0.2928150451230782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135962408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966342,0.0018917418,0.000100032215,0.00068195135,0.0003876941,0.00014476434,0.0000061232167,0.00006361565,0.000089874906],"genre_scores_gemma":[0.99641526,0.0033391563,0.000033701977,0.00005544981,0.00004696608,0.0000123155205,0.0000019792685,0.000012823302,0.00008236767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991223,0.000054337423,0.00020970128,0.00018450232,0.000059132184,0.00037002715],"domain_scores_gemma":[0.99966913,0.000056597066,0.000043711912,0.00015412242,0.000018817002,0.000057606136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030345746,0.00014614545,0.0001977925,0.00013938264,0.00024370218,0.0000034578725,0.00021531203,0.000411898,0.00004390857],"category_scores_gemma":[0.000015852882,0.000099271696,0.000038966802,0.00015753256,0.00038316322,0.000035175017,0.00015028055,0.0005867233,0.000009687934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035233734,0.000080969054,0.0033097926,0.000022579072,0.000055742614,0.000023326182,0.0001598241,0.000069554284,0.98934984,0.00044103517,0.000018543216,0.00643358],"study_design_scores_gemma":[0.0006954526,0.000046252837,0.005563226,0.0000075518615,0.000022225708,0.000036361096,0.000017996288,0.0014675917,0.98355585,0.00011706391,0.008344993,0.00012545157],"about_ca_topic_score_codex":0.000009162379,"about_ca_topic_score_gemma":0.000010064403,"teacher_disagreement_score":0.008326449,"about_ca_system_score_codex":0.000015685364,"about_ca_system_score_gemma":0.000013517876,"threshold_uncertainty_score":0.40481824},"labels":[],"label_agreement":null},{"id":"W2136168442","doi":"10.1016/s0009-2797(02)00125-4","title":"Metabolic activation of 3-hydroxyanisole by isolated rat hepatocytes","year":2002,"lang":"en","type":"article","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cytotoxicity; Glutathione; Dithiothreitol; Chemistry; Biochemistry; Hepatocyte; Toxicity; Dicoumarol; Pharmacology; Molecular biology; NAD+ kinase; Biology; In vitro; Enzyme","score_opus":0.15510809679379964,"score_gpt":0.4124020892387885,"score_spread":0.25729399244498885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136168442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98034436,0.0030515303,0.00038378214,0.00070191186,0.0010454643,0.0002940744,0.00014509742,0.00013250628,0.013901296],"genre_scores_gemma":[0.99324095,0.002713482,0.00012318067,0.0014997072,0.00021848726,0.000078270576,0.00011623518,0.000020477633,0.0019892368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983855,0.00021819588,0.0005250651,0.00036825932,0.00010571741,0.0003972768],"domain_scores_gemma":[0.99871564,0.00045487488,0.00026351548,0.00020962814,0.0001377025,0.00021863845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018139704,0.00026877172,0.00040665962,0.00008869126,0.00018469132,0.000016903188,0.0003082928,0.00032899273,0.013077358],"category_scores_gemma":[0.00016627533,0.00022756188,0.0001994604,0.00027847785,0.00022809223,0.00016170458,0.00010143419,0.0007772028,0.0003200173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096653814,0.00071548054,0.0012186198,0.000007786032,0.00015801955,0.000001724184,0.00018175262,0.00005382917,0.96089906,0.00035173452,0.0289781,0.0073372233],"study_design_scores_gemma":[0.0005324995,0.00004078446,0.00006454555,0.0000051607085,0.000066163324,0.000011286161,0.000033357377,0.007323603,0.6162691,0.00019150553,0.37530193,0.00016006813],"about_ca_topic_score_codex":0.000015273512,"about_ca_topic_score_gemma":6.386695e-7,"teacher_disagreement_score":0.34632382,"about_ca_system_score_codex":0.000037411406,"about_ca_system_score_gemma":0.000011240943,"threshold_uncertainty_score":0.9878248},"labels":[],"label_agreement":null},{"id":"W2136605181","doi":"10.1124/dmd.114.061812","title":"Characterization of CYP2B6 in a CYP2B6-Humanized Mouse Model: Inducibility in the Liver by Phenobarbital and Dexamethasone and Role in Nicotine Metabolism In Vivo","year":2014,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; University of Toronto; National Institute of Environmental Health Sciences; New York State Department of Health - Wadsworth Center; New York State Department of Health","keywords":"CYP2B6; Nicotine; In vivo; Microsome; Cytochrome P450; Humanized mouse; Phenobarbital; Pharmacology; Transgene; Endocrinology; Chemistry; Internal medicine; Drug metabolism; Genetically modified mouse; Metabolism; Biology; In vitro; Biochemistry; Medicine; CYP3A4","score_opus":0.024986299092443466,"score_gpt":0.31723677047247495,"score_spread":0.29225047138003146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136605181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029857,0.007968462,0.00014941557,0.00023874067,0.00012459271,0.0007517649,0.00024497078,0.000014284136,0.0002091912],"genre_scores_gemma":[0.9933858,0.005407311,0.0001390824,0.00074574235,0.00007681942,0.00010467955,0.00008720124,0.000024238536,0.000029153121],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966995,0.0014055618,0.00070481485,0.00057143247,0.00020245361,0.0004162473],"domain_scores_gemma":[0.9991346,0.0002583991,0.00020179425,0.00022291717,0.000047984675,0.00013429885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027390278,0.00031829704,0.0006554765,0.0003982544,0.00007963369,0.000041225612,0.0001853402,0.0002522045,0.000032539207],"category_scores_gemma":[0.00008967058,0.00027858763,0.000044246503,0.0004360207,0.00022344264,0.00039600837,0.00012492684,0.00063143123,9.30164e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007412879,0.0009935127,0.018258173,0.000103083825,0.00002239445,0.0000039816073,0.011937961,0.00025309104,0.94903785,0.004273429,0.000012811413,0.014362418],"study_design_scores_gemma":[0.016763804,0.000050176055,0.49901915,0.000061976076,0.00032006155,0.0000134863285,0.00081379124,0.1912382,0.28289866,0.0051344265,0.0028907836,0.0007954914],"about_ca_topic_score_codex":0.00055661687,"about_ca_topic_score_gemma":0.00054660055,"teacher_disagreement_score":0.6661392,"about_ca_system_score_codex":0.000020982725,"about_ca_system_score_gemma":0.00003055895,"threshold_uncertainty_score":0.9999666},"labels":[],"label_agreement":null},{"id":"W2136791626","doi":"10.1002/chir.20669","title":"Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate","year":2008,"lang":"en","type":"article","venue":"Chirality","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stereoselectivity; Chemistry; Enantiomer; Pharmacokinetics; Ketoconazole; Oral administration; Volume of distribution; Pharmacology; Stereoisomerism; Blood plasma; Stereochemistry; Biochemistry","score_opus":0.10738721130680544,"score_gpt":0.4315809384688826,"score_spread":0.32419372716207717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136791626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952119,0.000959169,0.00004723365,0.00012943202,0.00058513135,0.0005620967,0.00019953666,0.000019353645,0.002286145],"genre_scores_gemma":[0.9980109,0.0006733565,0.0004588915,0.00040359062,0.00013896251,0.00006244012,0.000025602445,0.000017922193,0.0002083348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980642,0.00041428572,0.00073624996,0.00027367834,0.00019401783,0.00031756822],"domain_scores_gemma":[0.9990424,0.000131182,0.00030235175,0.00020378473,0.00018014389,0.00014016291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059201865,0.00021271697,0.00045425573,0.0001339168,0.00005238008,0.0000030707977,0.00021266608,0.00018883689,0.0006236202],"category_scores_gemma":[0.000051278606,0.00021138281,0.00012606796,0.00032452645,0.0003284848,0.00009402786,0.00007768305,0.00044664324,0.00001638681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063323556,0.0034235327,0.2235729,0.0004573264,0.0002599143,0.00017884118,0.003856677,0.0006615251,0.7516116,0.00031165453,0.00064884516,0.008684836],"study_design_scores_gemma":[0.0029596093,0.00013202292,0.06693859,0.000014518821,0.00009400502,0.000021483002,0.000030955238,0.0018797392,0.91495264,0.00025169743,0.012519861,0.00020486153],"about_ca_topic_score_codex":0.000019062853,"about_ca_topic_score_gemma":0.000016702435,"teacher_disagreement_score":0.16334108,"about_ca_system_score_codex":0.000027736187,"about_ca_system_score_gemma":0.00017329458,"threshold_uncertainty_score":0.861994},"labels":[],"label_agreement":null},{"id":"W2136899763","doi":"10.1017/s1751731111002175","title":"The roles of different porcine cytochrome P450 enzymes and cytochrome b5A in skatole metabolism","year":2012,"lang":"en","type":"article","venue":"animal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Skatole; Boar taint; Metabolite; Cytochrome P450; Biochemistry; Chemistry; CYP2E1; Metabolism; Biology; Indole test; Genetics","score_opus":0.0593100244202329,"score_gpt":0.39616352082760387,"score_spread":0.33685349640737094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136899763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530795,0.044177786,0.000005845886,0.0005806801,0.0003354215,0.00031968206,0.000052964235,0.000026017688,0.001422082],"genre_scores_gemma":[0.99514455,0.0034544969,0.00004482601,0.0005017139,0.00048117334,0.00005588085,0.0000078072335,0.000027622313,0.0002819443],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99802274,0.0003771373,0.0004741329,0.00023863766,0.0001977301,0.0006896547],"domain_scores_gemma":[0.99890924,0.00038300722,0.00016576602,0.0002026037,0.000054900553,0.0002845145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080998155,0.0002745492,0.00045193254,0.00012066414,0.00020111595,0.000019246401,0.00028955174,0.00019323573,0.00026616134],"category_scores_gemma":[0.000053431206,0.00019254824,0.00009795081,0.00017198076,0.00026156573,0.0001364394,0.0002143672,0.0005040868,0.000026893691],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048135576,0.00048507872,0.039139774,0.00003797798,0.00017520266,0.0000107497835,0.0016446535,0.000009643946,0.9246963,0.024069192,0.00062903494,0.008621025],"study_design_scores_gemma":[0.0019618676,0.00007564467,0.58326596,0.000009325521,0.000200433,0.000031180447,0.00025327696,0.00032211342,0.30635482,0.0005578396,0.10672272,0.000244783],"about_ca_topic_score_codex":0.000019860245,"about_ca_topic_score_gemma":0.000045274777,"teacher_disagreement_score":0.6183415,"about_ca_system_score_codex":0.000018867398,"about_ca_system_score_gemma":0.00003646418,"threshold_uncertainty_score":0.7851889},"labels":[],"label_agreement":null},{"id":"W2137173003","doi":"10.1186/2001-1326-2-16","title":"Application of personalized medicine to chronic disease: a feasibility assessment","year":2013,"lang":"en","type":"article","venue":"Clinical and Translational Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bridgepoint Active Healthcare; Western University; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Medicine; Personalized medicine; Precision medicine; Intensive care medicine; Stroke (engine); Health care; Polypharmacy; Drug; Pharmacology; Bioinformatics; Pathology","score_opus":0.22352417141605233,"score_gpt":0.5569070132944096,"score_spread":0.3333828418783573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137173003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8350064,0.014056851,0.017606637,0.12524687,0.0013679937,0.002330598,0.00011004031,0.00005850187,0.00421609],"genre_scores_gemma":[0.9933922,0.0010917193,0.0004672973,0.0035670302,0.0010860647,0.0001221015,0.0000724198,0.000010836696,0.00019032645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797595,0.00032219218,0.0008092642,0.00037144774,0.00031956309,0.00020156418],"domain_scores_gemma":[0.99784005,0.00094883435,0.00013410715,0.00016682304,0.00021698559,0.00069319253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014270318,0.00016403914,0.00045321646,0.00007572877,0.00009199772,0.0000026768037,0.00016205903,0.00012216085,0.003659276],"category_scores_gemma":[0.00018796424,0.00011762609,0.000076088465,0.00019188326,0.0010738117,0.000049954346,0.000028234605,0.00035706742,0.00003308876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005873638,0.00060900964,0.5687566,0.00022779252,0.00022274209,0.000003156759,0.0004413453,0.0001550687,0.028638363,0.022652073,0.0038090318,0.37389746],"study_design_scores_gemma":[0.005599911,0.0002452473,0.84914124,0.00004128296,0.0002980181,0.0000017795328,0.000023461691,0.008631654,0.00011428191,0.014722023,0.12105299,0.00012809645],"about_ca_topic_score_codex":0.000036328987,"about_ca_topic_score_gemma":0.0000039220417,"teacher_disagreement_score":0.37376937,"about_ca_system_score_codex":0.000010596725,"about_ca_system_score_gemma":0.00011551135,"threshold_uncertainty_score":0.9972515},"labels":[],"label_agreement":null},{"id":"W2137455008","doi":"10.1124/dmd.111.042879","title":"Species-Dependent and Receptor-Selective Action of Bilobalide on the Function of Constitutive Androstane Receptor and Pregnane X Receptor","year":2011,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Constitutive androstane receptor; CYP2B6; CYP3A4; Reporter gene; Biology; Pharmacology; Cytochrome P450; Molecular biology; Chemistry; Gene expression; Nuclear receptor; Biochemistry; Enzyme; Gene","score_opus":0.09146622068972644,"score_gpt":0.3410534522227419,"score_spread":0.24958723153301549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137455008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858162,0.0065513253,0.00013476542,0.00025492403,0.0012876912,0.00068839785,0.00069549924,0.000024676783,0.0045465217],"genre_scores_gemma":[0.9865667,0.012307125,0.00015676934,0.00034300375,0.00018352317,0.00004783792,0.00006715104,0.000017710705,0.0003101745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811137,0.000589117,0.0004222741,0.00039840396,0.00021582884,0.0002629973],"domain_scores_gemma":[0.99883395,0.0002752287,0.00034823245,0.00016298419,0.00019848377,0.0001810882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007571294,0.00027552363,0.00041835124,0.00015290926,0.0002724215,0.000018345634,0.000100868325,0.00018835587,0.00053653476],"category_scores_gemma":[0.00007035723,0.00020870716,0.00006842265,0.00022177746,0.00068351015,0.00020710014,0.000077722885,0.00037045652,0.000009954909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004196527,0.0005364988,0.0031059543,0.00012442526,0.00039549032,0.0000016384427,0.0048570037,0.000009359909,0.90049666,0.047824353,0.0018642999,0.036587816],"study_design_scores_gemma":[0.0025127453,0.00026354095,0.03552526,0.00007280984,0.0007210293,0.000012240157,0.0015773958,0.00007149,0.9278856,0.0020794943,0.02895965,0.0003187764],"about_ca_topic_score_codex":0.000084046056,"about_ca_topic_score_gemma":0.000011597904,"teacher_disagreement_score":0.04574486,"about_ca_system_score_codex":0.00002124842,"about_ca_system_score_gemma":0.000044001343,"threshold_uncertainty_score":0.8510831},"labels":[],"label_agreement":null},{"id":"W2138153828","doi":"10.1002/bdd.1931","title":"The guinea‐pig expresses functional CYP2C and P‐glycoprotein: further validation of its usefulness in drug biotransformation/transport studies","year":2014,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Guinea pig; Biology; P-glycoprotein; Transfection; Pharmacology; Molecular biology; Biochemistry; Gene; Multiple drug resistance; Endocrinology","score_opus":0.08987003790453561,"score_gpt":0.3904237972304724,"score_spread":0.30055375932593675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138153828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819414,0.011809603,0.00042957382,0.002284623,0.00177088,0.00096402096,0.00015703046,0.00007009561,0.0005727423],"genre_scores_gemma":[0.9864151,0.011925133,0.00008300003,0.0005820211,0.00036317136,0.00021143902,0.00011156342,0.000039327988,0.00026928238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970301,0.00074765977,0.0008803964,0.0004163676,0.0004201073,0.00050538045],"domain_scores_gemma":[0.9982841,0.00056797644,0.00033643143,0.00023538632,0.00037513877,0.00020099309],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020729613,0.00038618853,0.00041137415,0.00023049656,0.00049787347,0.000039086153,0.00029073536,0.00018428377,0.00012460964],"category_scores_gemma":[0.00006919087,0.0003171139,0.00012402203,0.00042583115,0.00044064078,0.00036526294,0.00007643619,0.00054853765,0.00003184251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027657307,0.0011771698,0.013226345,0.0014472441,0.0008948748,0.000018216952,0.016129518,0.012833414,0.86537045,0.008556822,0.0017552335,0.075824976],"study_design_scores_gemma":[0.0034001735,0.000033539476,0.008924422,0.00009188275,0.00042015573,0.000013500879,0.0008292506,0.0076730214,0.9045364,0.0009821886,0.072654985,0.00044043604],"about_ca_topic_score_codex":0.00001853839,"about_ca_topic_score_gemma":0.000029638619,"teacher_disagreement_score":0.07538454,"about_ca_system_score_codex":0.00006238669,"about_ca_system_score_gemma":0.00006484965,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W2138178267","doi":"10.4212/cjhp.v54i1.611","title":"2001 : L’Odyssée Pharmacogénomique","year":2001,"lang":"fr","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Computer science","score_opus":0.10798500100618877,"score_gpt":0.40219180330035303,"score_spread":0.2942068022941643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138178267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5495186,0.20320523,0.000098631164,0.14835118,0.060169328,0.0009520827,0.0004306667,0.000029406556,0.037244886],"genre_scores_gemma":[0.89827,0.05899033,0.00015838213,0.014704224,0.010320583,0.000020554979,0.0000128766305,0.00014298003,0.017380072],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928751,0.0018375833,0.00169754,0.00048317132,0.00055451714,0.0025520686],"domain_scores_gemma":[0.9918591,0.000530892,0.00119818,0.0004731196,0.0011544996,0.004784211],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0044035297,0.0008625408,0.00093780836,0.0006121311,0.0015564911,0.00032434904,0.0024616697,0.00045082884,0.026221422],"category_scores_gemma":[0.00030952878,0.0007432711,0.0008527657,0.0010498163,0.0018263882,0.00081034563,0.00014053553,0.004593939,0.0011566427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007434933,0.0010177403,0.02835315,0.00011377817,0.0026655176,0.0073681236,0.0047852006,0.0041599264,0.006603618,0.0032809954,0.6987172,0.2421913],"study_design_scores_gemma":[0.0058805863,0.00033484615,0.0011563832,0.00008804993,0.0020976788,0.0027122837,0.00023942521,0.0022911485,0.012480719,0.002563581,0.9693195,0.00083577406],"about_ca_topic_score_codex":0.012698878,"about_ca_topic_score_gemma":0.010534996,"teacher_disagreement_score":0.3487514,"about_ca_system_score_codex":0.00074665016,"about_ca_system_score_gemma":0.006407751,"threshold_uncertainty_score":0.99974334},"labels":[],"label_agreement":null},{"id":"W2138359733","doi":"10.1124/dmd.105.005074","title":"PULMONARY BIOACTIVATION OF TRICHLOROETHYLENE TO CHLORAL HYDRATE: RELATIVE CONTRIBUTIONS OF CYP2E1, CYP2F, AND CYP2B1","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute","keywords":"Microsome; CYP2E1; Recombinant DNA; Chloral hydrate; Cytochrome P450; Chemistry; Hydroxylation; Microsoma; Biochemistry; Cytochrome; Unspecific monooxygenase; Metabolism; Enzyme; Molecular biology; Biology; Pharmacology; CYP1A2; Gene","score_opus":0.02971548909317086,"score_gpt":0.3724688113440229,"score_spread":0.34275332225085203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138359733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829484,0.010270607,0.001197093,0.0019303405,0.0003915329,0.0005601544,0.00079329015,0.00003235355,0.0018762203],"genre_scores_gemma":[0.99537617,0.0026278733,0.00066356244,0.0006206282,0.00031758973,0.000051503393,0.00013006535,0.000019361374,0.00019326707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823153,0.0003363009,0.00057163823,0.0003460396,0.00019888389,0.00031558896],"domain_scores_gemma":[0.99875003,0.00023497237,0.00028708563,0.00015702007,0.00026131887,0.0003095479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007132829,0.0002494849,0.0004869041,0.00030473605,0.00020483485,0.0000141894725,0.00011845998,0.00019759827,0.0000958776],"category_scores_gemma":[0.0000869808,0.00023784307,0.00009062883,0.00043770083,0.00024383089,0.00039683603,0.00010075262,0.00030483786,0.000010354887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009640194,0.00055776554,0.0012545532,0.00007004907,0.00017316038,0.0000041529324,0.0021167072,0.00047018885,0.89480704,0.023757318,0.0002523951,0.07557267],"study_design_scores_gemma":[0.0026657642,0.00006064492,0.04664217,0.000031492928,0.00069198565,0.000023112412,0.00022867644,0.0035965901,0.9079194,0.0026779585,0.035120346,0.00034188118],"about_ca_topic_score_codex":0.000059948725,"about_ca_topic_score_gemma":0.0000051114525,"teacher_disagreement_score":0.07523079,"about_ca_system_score_codex":0.000023026292,"about_ca_system_score_gemma":0.00004731161,"threshold_uncertainty_score":0.9698959},"labels":[],"label_agreement":null},{"id":"W2139251954","doi":"10.1124/dmd.30.7.788","title":"Identification of Human Hepatic Cytochrome P450 Sources of N-alkylprotoporphyrin IX after Interaction with Porphyrinogenic Xenobiotics, Implications for Detection of Xenobiotic-Induced Porphyria in Humans","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Xenobiotic; Microsome; CYP1A2; Cytochrome P450; CYP3A4; Enzyme; Biochemistry; CYP2B6; CYP2C9; Biology; Isozyme; Chemistry","score_opus":0.04493355716597812,"score_gpt":0.3605573143749616,"score_spread":0.31562375720898345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139251954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953962,0.0016127619,0.0007393253,0.0001074521,0.00020610997,0.0015020653,0.0003271331,0.000022576438,0.00008639704],"genre_scores_gemma":[0.9989021,0.00035264326,0.0001251358,0.000050503237,0.00011985575,0.00030016532,0.00007100017,0.00003272932,0.000045857454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787,0.00025636697,0.001034172,0.00039400617,0.00016209231,0.00028332195],"domain_scores_gemma":[0.99834836,0.0001265094,0.0008257119,0.00029322892,0.00029327173,0.000112935435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005694994,0.00026398196,0.00054282084,0.000473174,0.0001434811,0.000016841223,0.00017199095,0.0001845432,0.000086375476],"category_scores_gemma":[0.000027726843,0.00025555593,0.00015001476,0.00038405662,0.0002158869,0.0002598308,0.000043764776,0.00024345194,0.000002771035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004499299,0.00078371656,0.0072552757,0.00032366498,0.00012526955,9.892541e-7,0.0018719337,0.00015384823,0.98225474,0.0014167315,0.0000070434594,0.0053568557],"study_design_scores_gemma":[0.0019914096,0.00012987331,0.28402704,0.000043220207,0.0005095119,0.0000071220484,0.00019099678,0.0009390884,0.71103317,0.00080257864,0.000128781,0.00019720833],"about_ca_topic_score_codex":0.000105797466,"about_ca_topic_score_gemma":0.000078309546,"teacher_disagreement_score":0.27677175,"about_ca_system_score_codex":0.000032992175,"about_ca_system_score_gemma":0.00002287822,"threshold_uncertainty_score":0.9999897},"labels":[],"label_agreement":null},{"id":"W2140459965","doi":"10.1124/dmd.113.053876","title":"Modulation of the UGT2B7 Enzyme Activity by C-Terminally Truncated Proteins Derived from Alternative Splicing","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"UGT2B7; Immunoprecipitation; Glucuronidation; Alternative splicing; HEK 293 cells; Exon; Gene isoform; Biology; Biochemistry; Molecular biology; Enzyme; Microsome; Gene","score_opus":0.03003462281359642,"score_gpt":0.33190162129504924,"score_spread":0.3018669984814528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140459965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388254,0.0016688264,0.0011147525,0.0007480524,0.0007867773,0.0009823999,0.00038670408,0.000036073987,0.00039388248],"genre_scores_gemma":[0.99802643,0.00037717493,0.00017999951,0.0006822135,0.00026482987,0.00014174353,0.000096007716,0.000023584878,0.00020804495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816066,0.00061004737,0.00033948701,0.00035767056,0.00023434799,0.00029776318],"domain_scores_gemma":[0.998985,0.00013702098,0.00033099134,0.00022331181,0.00014955114,0.00017415686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028323464,0.00026071386,0.00034147082,0.00007174239,0.00028635087,0.000043181128,0.00024237369,0.00016158358,0.00031107754],"category_scores_gemma":[0.000030500274,0.00019967469,0.000111926616,0.00018967221,0.0001929694,0.00035602032,0.00012717352,0.00037747336,0.000020899097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013148822,0.00021527873,0.0013970551,0.000019205778,0.000105056686,8.625264e-7,0.0012642613,0.00021784233,0.96313524,0.0002717879,0.0004425266,0.032799423],"study_design_scores_gemma":[0.0014437613,0.000009708059,0.18760677,0.00001643447,0.00026972714,0.0000022387526,0.00006600157,0.020811727,0.7855192,0.0019433171,0.0021054775,0.00020563329],"about_ca_topic_score_codex":0.0015114524,"about_ca_topic_score_gemma":0.000019104888,"teacher_disagreement_score":0.18620971,"about_ca_system_score_codex":0.000020593347,"about_ca_system_score_gemma":0.000035323807,"threshold_uncertainty_score":0.81424975},"labels":[],"label_agreement":null},{"id":"W2140561987","doi":"10.1111/j.1365-2052.2004.01140.x","title":"Molecular cloning, expression and functional characterization of the <i>cytochrome P450 2A6</i> gene in pig liver*","year":2004,"lang":"en","type":"article","venue":"Animal Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Skatole; Biology; CYP2A6; Boar taint; Gene; Cloning (programming); Cytochrome P450; Genetics; Endocrinology; Metabolism; Biochemistry","score_opus":0.0544572035282528,"score_gpt":0.3440955892109555,"score_spread":0.2896383856827027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140561987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556714,0.0027994525,0.00041762323,0.00022889001,0.00030331904,0.00030092135,0.00005536503,0.000015165462,0.00031209274],"genre_scores_gemma":[0.99587494,0.0023796146,0.00033022516,0.0011562764,0.00014617911,0.00001716997,0.000021584006,0.000022654289,0.000051337804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878615,0.00017495798,0.00032544075,0.0002599237,0.00018759476,0.00026595054],"domain_scores_gemma":[0.99946624,0.000032585976,0.0001545929,0.0001608957,0.00007536548,0.00011028985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002288898,0.00017530825,0.00019187816,0.000074995834,0.00011370419,0.00001184801,0.00017390553,0.0001980371,0.00009963116],"category_scores_gemma":[0.000018978828,0.0001506843,0.000064373846,0.00021296699,0.00016373467,0.00004556308,0.00018406622,0.00033215882,0.000009191409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012370231,0.00015680706,0.004528083,0.000023269013,0.000023314442,0.000014721715,0.00031144923,0.0023982548,0.9908885,0.00045186412,0.000017065187,0.001063021],"study_design_scores_gemma":[0.001337275,0.00006793275,0.21216616,0.00001499154,0.00005724932,0.000018984689,0.000009768086,0.0007438841,0.77831036,0.00019652964,0.0069445255,0.00013231064],"about_ca_topic_score_codex":0.000010867557,"about_ca_topic_score_gemma":0.0000041437893,"teacher_disagreement_score":0.21257806,"about_ca_system_score_codex":0.00002697746,"about_ca_system_score_gemma":0.00009659515,"threshold_uncertainty_score":0.61447275},"labels":[],"label_agreement":null},{"id":"W2140675020","doi":"10.18433/j38c88","title":"The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Nakatomi Foundation","keywords":"Pregnane X receptor; Constitutive androstane receptor; Farnesoid X receptor; Pregnane; Nuclear receptor; Internal medicine; Multidrug resistance-associated protein 2; Receptor; Endocrinology; Blot; Chemistry; Biology; Biochemistry; Medicine; Transporter; Transcription factor; Gene; ATP-binding cassette transporter","score_opus":0.1073705201871103,"score_gpt":0.43610816376809325,"score_spread":0.32873764358098295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140675020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91034335,0.07922818,0.000016590555,0.0055740974,0.0024570294,0.0006364964,0.000034644043,0.000015783746,0.0016938598],"genre_scores_gemma":[0.9514412,0.04270251,0.00055002444,0.0042022155,0.00094126625,0.00006283954,0.000002858218,0.000019978606,0.00007706876],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99414736,0.0020634166,0.0012052305,0.00042686617,0.0008703355,0.0012867673],"domain_scores_gemma":[0.99537534,0.0027112307,0.0004912714,0.00017595697,0.0002390617,0.0010071512],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009964316,0.00045845148,0.0005036787,0.0002937654,0.00065805204,0.00016125655,0.0011058755,0.00016729182,0.0021393213],"category_scores_gemma":[0.0010550187,0.0002673499,0.00018741556,0.0010611442,0.0026351453,0.00087213283,0.00030619072,0.0023466493,0.00007703677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006055809,0.0023576154,0.25038892,0.00010285859,0.00015457747,0.00025811026,0.0076408214,0.00011749821,0.43846586,0.0014676984,0.011175871,0.28181434],"study_design_scores_gemma":[0.0047856597,0.00017746129,0.002498446,0.0001288677,0.00022123559,0.000575501,0.0011010504,0.0020312632,0.1740355,0.000118534015,0.8138891,0.00043737338],"about_ca_topic_score_codex":0.00004103779,"about_ca_topic_score_gemma":0.000017977845,"teacher_disagreement_score":0.8027132,"about_ca_system_score_codex":0.0001412708,"about_ca_system_score_gemma":0.00042242892,"threshold_uncertainty_score":0.9999779},"labels":[],"label_agreement":null},{"id":"W2141414647","doi":"10.1016/j.clpt.2004.08.019","title":"Bergamottin contribution to the grapefruit juice?felodipine interaction and disposition in humans","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Medical Research Council; Pfizer","keywords":"Felodipine; Cmax; Grapefruit juice; Chemistry; Metabolite; Pharmacology; Pharmacokinetics; Crossover study; Bioavailability; Oral administration; Medicine; Biochemistry; Internal medicine; Placebo","score_opus":0.17119421496437587,"score_gpt":0.5234489298046765,"score_spread":0.35225471484030063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141414647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414852,0.0022514835,0.0010181312,0.046730217,0.00663145,0.0013160647,0.00006585357,0.00010194544,0.00039963072],"genre_scores_gemma":[0.873876,0.0045982925,0.00015134035,0.11968082,0.0013338554,0.00016706773,0.000043868276,0.00003927413,0.00010952522],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595225,0.0013477948,0.0010753318,0.00066803175,0.00020417172,0.00075242197],"domain_scores_gemma":[0.9979858,0.0008798338,0.000270853,0.00026450996,0.00019105102,0.0004079967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022683279,0.00039402934,0.0005400475,0.00021397123,0.00046110534,0.000043313536,0.00047698073,0.0005243547,0.00039135656],"category_scores_gemma":[0.00005318787,0.00032325415,0.00018742656,0.0005097379,0.0005420515,0.00015442564,0.00022128841,0.0019665651,0.0003151671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012429686,0.0110927615,0.08997863,0.00012875813,0.0041444413,0.0003870869,0.007817413,0.025116092,0.5607535,0.008578777,0.023582907,0.2559899],"study_design_scores_gemma":[0.013073861,0.0006922954,0.08864213,0.000031394724,0.0016008589,0.00004199056,0.0001751701,0.001790253,0.030585578,0.0026318897,0.86008,0.00065455097],"about_ca_topic_score_codex":0.00002008251,"about_ca_topic_score_gemma":0.000096315285,"teacher_disagreement_score":0.8364971,"about_ca_system_score_codex":0.00015178724,"about_ca_system_score_gemma":0.0001144836,"threshold_uncertainty_score":0.999922},"labels":[],"label_agreement":null},{"id":"W2141433964","doi":"10.1104/pp.008011","title":"Cloning, Functional Expression, and Subcellular Localization of Multiple NADPH-Cytochrome P450 Reductases from Hybrid Poplar","year":2002,"lang":"en","type":"article","venue":"PLANT PHYSIOLOGY","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Arabidopsis; Cytochrome P450; Biochemistry; Yeast; Saccharomyces cerevisiae; Subcellular localization; Gene isoform; Green fluorescent protein; Fusion protein; Monooxygenase; Endoplasmic reticulum; Heterologous expression; Cytochrome; Gene; Arabidopsis thaliana; Reductase; Enzyme; Recombinant DNA","score_opus":0.0853372045055348,"score_gpt":0.3239583739178341,"score_spread":0.23862116941229933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141433964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896136,0.0073275706,0.00046189266,0.00008944355,0.0008168074,0.00021540873,0.001215488,0.000049865434,0.00020991736],"genre_scores_gemma":[0.99507177,0.0023744968,0.00018003947,0.00069219753,0.00047883217,0.000030235566,0.0010409772,0.000022717542,0.000108718894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829787,0.00037906863,0.00040012103,0.0004355219,0.00013675702,0.0003506834],"domain_scores_gemma":[0.9988612,0.000457658,0.00022243004,0.0001903877,0.00007811227,0.000190228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015954906,0.00024016664,0.00039522877,0.00010459718,0.00021007517,0.000007395151,0.00016685383,0.0002042176,0.0030840077],"category_scores_gemma":[0.00008713907,0.0002241246,0.00007321445,0.00009589819,0.00027418122,0.000077226745,0.00011341387,0.00034188107,0.00006672045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031725553,0.00029528595,0.0019229472,0.000033124285,0.00012090845,0.000019262221,0.00029403903,0.0024158405,0.98093885,0.000099547935,0.012911344,0.00063161884],"study_design_scores_gemma":[0.0020971661,0.0000759488,0.0054487092,0.000018745413,0.00014127573,0.000042955457,0.000043282176,0.048854157,0.8488978,0.0010369854,0.093071066,0.0002719104],"about_ca_topic_score_codex":0.00006141736,"about_ca_topic_score_gemma":0.0000033943456,"teacher_disagreement_score":0.13204102,"about_ca_system_score_codex":0.000014610784,"about_ca_system_score_gemma":0.000022051958,"threshold_uncertainty_score":0.9978273},"labels":[],"label_agreement":null},{"id":"W2141768943","doi":"10.1681/asn.v122326","title":"Downregulation of Hepatic Cytochrome P450 in Chronic Renal Failure","year":2001,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Endocrinology; Internal medicine; Phenobarbital; Cytochrome P450; CYP1A2; CYP2E1; Dexamethasone; Downregulation and upregulation; Drug metabolism; Medicine; Chemistry; Biology; Metabolism; Gene","score_opus":0.04922851269049775,"score_gpt":0.388355913755556,"score_spread":0.33912740106505823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141768943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936413,0.0012156606,0.00022982524,0.004534135,0.000093634015,0.00015996263,0.00001216836,0.0000043830296,0.0001088859],"genre_scores_gemma":[0.9923801,0.002547862,0.0011081138,0.0034596869,0.00042757226,0.0000034345344,0.0000011876049,0.000014446528,0.00005761683],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99785113,0.00062078517,0.00082607067,0.00013211224,0.0002448322,0.00032508923],"domain_scores_gemma":[0.997484,0.00029201052,0.0017317835,0.00019598096,0.00019634193,0.000099849254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009883519,0.00016271257,0.0006603413,0.00010948256,0.00006661987,0.0000030432495,0.0005220144,0.00014923589,0.00024325513],"category_scores_gemma":[0.000033387205,0.00012246195,0.00048456306,0.0005936012,0.0010054416,0.00007498715,0.000109798115,0.0007492768,0.0000028132797],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042117704,0.00017626832,0.003572308,0.000026327747,0.00031929222,0.000007158539,0.0006742812,0.009121438,0.97094584,0.000048991176,0.0059912927,0.008695632],"study_design_scores_gemma":[0.0041362876,0.0008221335,0.7486221,0.000042995718,0.00045968167,0.00036107685,0.00033051454,0.009182289,0.054525875,0.0013319246,0.17996857,0.00021655031],"about_ca_topic_score_codex":0.000055568773,"about_ca_topic_score_gemma":0.000031083233,"teacher_disagreement_score":0.91642,"about_ca_system_score_codex":0.00013036313,"about_ca_system_score_gemma":0.00029891627,"threshold_uncertainty_score":0.49938536},"labels":[],"label_agreement":null},{"id":"W2141825656","doi":"10.1073/pnas.1019441108","title":"Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system","year":2011,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":342,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Structural Genomics Consortium; University of Toronto","funders":"Knut och Alice Wallenbergs Stiftelse; Karolinska Institutet; Stiftelsen för Strategisk Forskning; Ontario Genomics Institute; Canadian Institutes of Health Research; Ontario Genomics; Genome Canada; Ontario Innovation Trust; Wellcome Trust; GlaxoSmithKline","keywords":"Adrenodoxin; Cholesterol side-chain cleavage enzyme; Pregnenolone; Monooxygenase; Chemistry; Cytochrome P450; Stereochemistry; Heme; Steroid biosynthesis; Cytochrome; Steroid; Biochemistry; Enzyme; Hormone","score_opus":0.18492638363825886,"score_gpt":0.4017444171117118,"score_spread":0.21681803347345296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141825656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919396,0.00095789065,0.0000027270216,0.0017396936,0.0002991693,0.0005961008,0.0003092636,0.000018214694,0.0041373586],"genre_scores_gemma":[0.99776506,0.000057708938,0.0012388681,0.00047616262,0.00023437134,0.00006772686,2.2321245e-7,0.000006773066,0.00015310211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986161,0.000034896395,0.00037032538,0.00024358138,0.0004937168,0.00024140954],"domain_scores_gemma":[0.9988589,0.00034183345,0.0004696573,0.000011892164,0.00025242983,0.00006526669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001288572,0.00013298039,0.00018642038,0.00008642567,0.00048554552,0.0000135047685,0.001192942,0.0001578297,0.00006475977],"category_scores_gemma":[0.00033848014,0.00007439817,0.00013823104,0.00037105105,0.0009687387,0.0001660501,0.00012506281,0.0002297895,0.0000020191148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017409681,0.00005544059,0.00077172776,0.00008909844,0.000097292024,5.7684972e-9,0.0007309613,0.000030760977,0.9691454,0.021855675,0.004626851,0.0024226485],"study_design_scores_gemma":[0.0004153938,0.00003535402,0.0033721435,0.000023980356,0.00012400582,0.0000073524334,0.00029473295,0.0030016531,0.98122317,0.007537872,0.0038639312,0.000100399135],"about_ca_topic_score_codex":0.000008588686,"about_ca_topic_score_gemma":4.993841e-8,"teacher_disagreement_score":0.014317802,"about_ca_system_score_codex":0.000025800495,"about_ca_system_score_gemma":0.000033052416,"threshold_uncertainty_score":0.37344727},"labels":[],"label_agreement":null},{"id":"W2141840620","doi":"10.1001/jama.2013.282426","title":"Calcium-Channel Blocker–Clarithromycin Drug Interactions and Acute Kidney Injury","year":2013,"lang":"en","type":"article","venue":"JAMA","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Western University; St. Michael's Hospital; London Health Sciences Centre; Lawson Health Research Institute; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clarithromycin; Azithromycin; Amlodipine; Calcium channel blocker; Nifedipine; Internal medicine; Population; Acute kidney injury; Pharmacology; Calcium; Blood pressure; Antibiotics","score_opus":0.059671964273727604,"score_gpt":0.4090034394094295,"score_spread":0.3493314751357019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141840620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96505064,0.00070496876,0.0001523622,0.021829797,0.0031304394,0.0005564955,0.00043199744,0.0001380825,0.008005206],"genre_scores_gemma":[0.96848327,0.000895428,0.00039750067,0.022543319,0.0008786759,0.00016383761,0.000054582324,0.000039822644,0.006543551],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983333,0.00027763657,0.00034950115,0.00038477735,0.00014127187,0.0005135556],"domain_scores_gemma":[0.9985882,0.00013689417,0.00011771753,0.00022834378,0.00016623987,0.0007625766],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032466912,0.00027990201,0.00029681664,0.00015486214,0.00033155232,0.00009797731,0.00025460712,0.00019748083,0.00388071],"category_scores_gemma":[0.000062861065,0.00026320937,0.00009921728,0.00019131279,0.00018954155,0.000333923,0.00022541542,0.0010700251,0.00088816375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001544971,0.00036602461,0.001969593,0.000034182533,0.0005628586,0.000028865643,0.0012306591,0.00002245863,0.37015918,0.0009451929,0.55689394,0.06763251],"study_design_scores_gemma":[0.0025890584,0.000036906604,0.0093245525,0.000016644683,0.00041118835,0.000079512494,0.00015362195,0.0070488513,0.1933535,0.0031385992,0.7834011,0.000446462],"about_ca_topic_score_codex":0.00022749299,"about_ca_topic_score_gemma":0.000005690229,"teacher_disagreement_score":0.22650713,"about_ca_system_score_codex":0.000032344833,"about_ca_system_score_gemma":0.00007802652,"threshold_uncertainty_score":0.999982},"labels":[],"label_agreement":null},{"id":"W2141887125","doi":"10.1124/dmd.105.006742","title":"DETERMINATION OF THE ENZYME(S) INVOLVED IN THE METABOLISM OF AMIODARONE IN LIVER AND INTESTINE OF RAT: THE CONTRIBUTION OF CYTOCHROME P450 3A ISOFORMS","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ketoconazole; Cytochrome P450; Microsome; CYP3A4; CYP3A; Metabolite; Metabolism; CYP1A2; In vivo; Isozyme; Pharmacokinetics; Enzyme; Drug metabolism; Pharmacology; Internal medicine; Endocrinology; Chemistry; Biology; Biochemistry; Medicine","score_opus":0.028599046237132556,"score_gpt":0.3363189644912888,"score_spread":0.30771991825415623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141887125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806987,0.017216561,0.00017020326,0.0007307705,0.0002078253,0.000736354,0.000106749896,0.000004632257,0.00012817017],"genre_scores_gemma":[0.99646145,0.0028187674,0.00013859977,0.00038125034,0.000101664664,0.00004701698,0.000024715624,0.000009856741,0.000016649421],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976636,0.0008545623,0.0007920766,0.00019849799,0.00026013958,0.00023113463],"domain_scores_gemma":[0.9984186,0.00055335305,0.00055851636,0.00022732913,0.00019274301,0.00004940512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019683067,0.00019810768,0.00049904163,0.0001893177,0.00009422654,0.00000841934,0.0002999322,0.00014000514,0.000028798135],"category_scores_gemma":[0.00018183401,0.00011329924,0.00010298281,0.00048675187,0.00056906603,0.00020324567,0.00011995784,0.00036384416,5.2294445e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006965739,0.00081714365,0.008825959,0.00017319697,0.00006695016,0.000002037808,0.01044547,0.00033354244,0.9163444,0.020314736,0.00008279189,0.041897196],"study_design_scores_gemma":[0.0033396336,0.000028947426,0.50355875,0.000058198126,0.00043904447,0.000009700856,0.00051057985,0.008882807,0.47855222,0.0017642365,0.0027228652,0.00013302319],"about_ca_topic_score_codex":0.00015701551,"about_ca_topic_score_gemma":0.00021620966,"teacher_disagreement_score":0.49473277,"about_ca_system_score_codex":0.000012391018,"about_ca_system_score_gemma":0.000049741935,"threshold_uncertainty_score":0.4620209},"labels":[],"label_agreement":null},{"id":"W2142335982","doi":"10.1371/journal.pone.0027808","title":"Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation","year":2011,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Robarts Clinical Trials; Western University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Warfarin; Pharmacodynamics; VKORC1; CYP2C9; Dosing; Medicine; Pharmacokinetics; Pharmacogenetics; Pharmacology; Internal medicine; Vitamin K epoxide reductase; Atrial fibrillation; Renal function; Biology; Genotype","score_opus":0.3086663071683788,"score_gpt":0.43226499691060294,"score_spread":0.12359868974222415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142335982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952839,0.002814156,0.000014570522,0.00003161687,0.00027554197,0.0005177408,0.00009951451,0.00004616093,0.00091681245],"genre_scores_gemma":[0.9616013,0.03391871,0.0038140211,0.00022111525,0.00022052029,0.000046551326,0.0000061905994,0.00003745164,0.00013410722],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979807,0.0003384238,0.0007267762,0.0004058463,0.00017259674,0.00037566212],"domain_scores_gemma":[0.9989319,0.00014878753,0.00026798685,0.00017656057,0.00011275786,0.0003620077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030386753,0.00028181408,0.00053743087,0.0001373079,0.0001372445,0.000010190074,0.00015453734,0.0002183405,0.00033991502],"category_scores_gemma":[0.000039779803,0.0002765926,0.00007157626,0.00011640503,0.00038169223,0.00008607632,0.00015104498,0.00033337972,0.000013522419],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005318036,0.0033073446,0.638983,0.00024456388,0.0006649392,0.00007389058,0.0010745015,0.000007470118,0.28525922,0.00002786014,0.000005317831,0.06982006],"study_design_scores_gemma":[0.005846973,0.00033441006,0.34528196,0.00003632773,0.0020028423,0.000030607185,0.000029209627,0.018435847,0.62702614,0.00022314108,0.00042270802,0.00032983418],"about_ca_topic_score_codex":0.000023134588,"about_ca_topic_score_gemma":0.0000085555885,"teacher_disagreement_score":0.34176692,"about_ca_system_score_codex":0.000020095902,"about_ca_system_score_gemma":0.000044358858,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W2142783300","doi":"10.1208/s12248-009-9135-y","title":"Activation of Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) by Herbal Medicines","year":2009,"lang":"en","type":"review","venue":"The AAPS Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Constitutive androstane receptor; Pregnane X receptor; Pregnane; Pharmacology; Receptor; Chemistry; Nuclear receptor; Biology; Biochemistry; Transcription factor; Gene; Stereochemistry","score_opus":0.11987898279930992,"score_gpt":0.45032839951489584,"score_spread":0.3304494167155859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142783300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001006606,0.99376357,0.000035438108,0.000767525,0.0020100863,0.0007605613,0.00047128205,0.000021005608,0.0011639087],"genre_scores_gemma":[0.00046483436,0.99658203,0.000104671395,0.0006976063,0.001296894,0.000021113896,0.00011461114,0.000038978673,0.00067927904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964317,0.0014101787,0.0010435418,0.00031382954,0.00034469756,0.00045601994],"domain_scores_gemma":[0.9972304,0.00069431076,0.0012667684,0.00022283712,0.00023243474,0.00035323156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016693631,0.00051585067,0.0014778967,0.00016398133,0.00041138422,0.00004099442,0.0005383873,0.0005474068,0.000965489],"category_scores_gemma":[0.00019097977,0.0003190027,0.00029504253,0.00030429065,0.0007317985,0.00012085593,0.00010081218,0.0021544842,0.00003190216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016927892,0.00016229559,0.0000073258093,0.0008855247,0.0007288219,0.000010486857,0.0003809829,0.000003773341,0.010117756,0.00016932351,0.05853674,0.9288277],"study_design_scores_gemma":[0.0012330742,0.00016411557,0.0000020807404,0.0021231372,0.0019231787,0.00046700513,0.00007671244,0.000008524378,0.004966066,0.00020856342,0.98851264,0.00031490537],"about_ca_topic_score_codex":0.00000508536,"about_ca_topic_score_gemma":4.446938e-7,"teacher_disagreement_score":0.9299759,"about_ca_system_score_codex":0.000083160194,"about_ca_system_score_gemma":0.0004062436,"threshold_uncertainty_score":0.9999478},"labels":[],"label_agreement":null},{"id":"W2142971789","doi":"10.1124/jpet.111.184671","title":"Generation and Characterization of a Cyp2f2-Null Mouse and Studies on the Role of CYP2F2 in Naphthalene-Induced Toxicity in the Lung and Nasal Olfactory Mucosa","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; University of California, Davis; University of Toronto; University of Michigan","keywords":"Toxicity; Xenobiotic; Olfactory mucosa; Pharmacology; Biology; Chemistry; Respiratory tract; Respiratory system; Biochemistry; Enzyme; Olfactory system; Anatomy","score_opus":0.23798269610214934,"score_gpt":0.4333925461781499,"score_spread":0.19540985007600054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142971789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98183143,0.0170002,0.0000023820219,0.00033183405,0.0004200955,0.0003277637,0.000018683211,0.0000026436512,0.00006494638],"genre_scores_gemma":[0.9876146,0.010277552,0.00003448449,0.0019120668,0.00012591998,0.000016762591,0.000001563764,0.000011844206,0.000005209349],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980896,0.0008532362,0.0005747877,0.00016218881,0.00013013223,0.00019004024],"domain_scores_gemma":[0.99907976,0.0002916399,0.00043083393,0.00006234696,0.00007356719,0.000061818784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011835081,0.00019850761,0.00037279906,0.00017131602,0.00012030718,0.000008739844,0.00014113662,0.00016241537,0.000040269508],"category_scores_gemma":[0.000011651447,0.00013052835,0.000040406252,0.00010910351,0.0003976071,0.0001289151,0.0000771126,0.00051199604,1.6068837e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009345612,0.0005645105,0.010697083,0.00002557989,0.0002801009,0.000012023834,0.022622121,0.0000086828495,0.96230984,0.00065401423,0.000014323217,0.0018771744],"study_design_scores_gemma":[0.0025986827,0.00047659955,0.009230961,0.000014312277,0.00017572468,0.00006699768,0.0033799566,0.0020342362,0.9813625,0.00018726801,0.00035215632,0.00012058786],"about_ca_topic_score_codex":0.000006572562,"about_ca_topic_score_gemma":0.000003935256,"teacher_disagreement_score":0.019242166,"about_ca_system_score_codex":0.000026020334,"about_ca_system_score_gemma":0.000040292896,"threshold_uncertainty_score":0.5322792},"labels":[],"label_agreement":null},{"id":"W2143918910","doi":"10.1111/bcpt.12492","title":"Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome <scp>P</scp>450 3<scp>A</scp> Activity and Single‐Time‐Point Oral Midazolam Microdose Phenotype in Healthy Subjects","year":2015,"lang":"en","type":"article","venue":"Basic & Clinical Pharmacology & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; London Health Sciences Centre","keywords":"MicroDose; CYP3A; Midazolam; Endogeny; Pharmacology; Pharmacokinetics; Endocrinology; Oral administration; Basal (medicine); Chemistry; Internal medicine; In vivo; Cytochrome P450; Medicine; Metabolism; Biology","score_opus":0.2766665519382691,"score_gpt":0.4385634322602433,"score_spread":0.1618968803219742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143918910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978299,0.0032829551,0.00007910976,0.0012096481,0.005312882,0.0025509764,0.0005524013,0.00020364963,0.00850936],"genre_scores_gemma":[0.99198484,0.0011505912,0.00081831083,0.004104911,0.0012177262,0.00021616532,0.00010345584,0.00011973313,0.00028429218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98292667,0.009954711,0.002688309,0.0018067702,0.00045510288,0.0021684563],"domain_scores_gemma":[0.96968395,0.02560692,0.0015144966,0.00055271655,0.000525615,0.0021163116],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008834279,0.0010448915,0.0026621427,0.00087484164,0.00050044106,0.000036503316,0.0009973061,0.002564982,0.00022371637],"category_scores_gemma":[0.006461065,0.0011186516,0.00045169474,0.0011624986,0.004233704,0.00036709028,0.0008358929,0.004594496,0.00038750382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002634138,0.0069397837,0.15441878,0.00019482576,0.0026298538,0.0007190817,0.0030381377,0.00047530502,0.7893375,0.00038046626,0.028174981,0.011057126],"study_design_scores_gemma":[0.07216142,0.008521482,0.24617918,0.00008618064,0.0052716048,0.0006404819,0.0017279005,0.0039933184,0.44843018,0.0036565934,0.20820996,0.0011216861],"about_ca_topic_score_codex":0.000094130824,"about_ca_topic_score_gemma":0.00013169029,"teacher_disagreement_score":0.34090734,"about_ca_system_score_codex":0.00044128508,"about_ca_system_score_gemma":0.0018732683,"threshold_uncertainty_score":0.9991264},"labels":[],"label_agreement":null},{"id":"W2144969114","doi":"10.1124/dmd.105.008128","title":"THE ROLE OF CYP2A AND CYP2E1 IN THE METABOLISM OF 3-METHYLINDOLE IN PRIMARY CULTURED PORCINE HEPATOCYTES","year":2006,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"CYP2E1; Cytochrome P450; Metabolism; Incubation; Microsome; Biology; Isozyme; CYP1A2; Biochemistry; Hepatocyte; Enzyme; Internal medicine; In vitro; Medicine","score_opus":0.014725850361218987,"score_gpt":0.3177207614971744,"score_spread":0.3029949111359554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144969114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87802345,0.11785982,0.000010720377,0.00050930405,0.0002476343,0.0005108578,0.00011965701,0.000010101085,0.002708447],"genre_scores_gemma":[0.99115753,0.007803258,0.00014464933,0.0004452821,0.00021725209,0.00007751025,0.00006477631,0.000016119197,0.0000736389],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975575,0.0008520995,0.000687749,0.0002893175,0.00025339378,0.00035994523],"domain_scores_gemma":[0.99889183,0.00045262836,0.0002771709,0.00021397365,0.00008813384,0.000076266144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017670783,0.00025225343,0.0005084959,0.00017408271,0.00018058454,0.000028765184,0.00026940263,0.00016335731,0.000017315104],"category_scores_gemma":[0.00003681714,0.00016018239,0.00009293918,0.00039007803,0.00036955555,0.00015824255,0.00009640142,0.00042786938,0.0000015993702],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014538575,0.0012515055,0.059666153,0.00016572472,0.00013134192,0.000018598766,0.006886989,0.00043173155,0.7710558,0.07419658,0.0005314145,0.084210314],"study_design_scores_gemma":[0.004693776,0.000020900296,0.67262876,0.00002664691,0.0004151406,0.000019821118,0.001110459,0.0014774798,0.22491463,0.018476961,0.075919285,0.00029615135],"about_ca_topic_score_codex":0.00053211354,"about_ca_topic_score_gemma":0.000118116244,"teacher_disagreement_score":0.6129626,"about_ca_system_score_codex":0.000010414482,"about_ca_system_score_gemma":0.000044127548,"threshold_uncertainty_score":0.65320486},"labels":[],"label_agreement":null},{"id":"W2145560209","doi":"10.1186/bcr2747","title":"Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Breast cancer; Medicine; Surgical oncology; Oncology; Oestrogen receptor; Internal medicine; Cancer; Antidepressant; Pharmacology","score_opus":0.07700388714980293,"score_gpt":0.46746011276293703,"score_spread":0.3904562256131341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145560209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804967,0.0042728866,0.0000040382574,0.0011232888,0.0014353205,0.0017963508,0.010437091,0.00004226781,0.00039205674],"genre_scores_gemma":[0.98946214,0.0072767357,0.000049065915,0.00013872278,0.0016783501,0.0012430481,0.000018911604,0.00006771276,0.00006530725],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9934973,0.003636114,0.00041364948,0.0008256254,0.0006959974,0.0009313304],"domain_scores_gemma":[0.9958088,0.0018615372,0.00025214461,0.0005004983,0.0009958546,0.0005811879],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039807362,0.00038302696,0.0005404697,0.00017099532,0.0008463714,0.00008154747,0.0007590202,0.00041486838,0.0021221098],"category_scores_gemma":[0.00018276904,0.00028417967,0.0001274151,0.00072990946,0.0010884826,0.0001847897,0.00052199676,0.0035412645,0.000032008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041878987,0.00031206122,0.35014847,0.00007169274,0.0005083088,0.000010416297,0.00063573866,0.00009212069,0.54471254,0.00011765343,0.0014695381,0.097733535],"study_design_scores_gemma":[0.0029448797,0.00003566261,0.64220077,0.00008704646,0.00023548765,0.000048983857,0.0000885659,0.00041491128,0.34533152,0.00060572015,0.0077295247,0.00027695295],"about_ca_topic_score_codex":0.024497973,"about_ca_topic_score_gemma":0.00057440955,"teacher_disagreement_score":0.29205227,"about_ca_system_score_codex":0.00012591663,"about_ca_system_score_gemma":0.0007261338,"threshold_uncertainty_score":0.999961},"labels":[],"label_agreement":null},{"id":"W2146261034","doi":"10.1177/1534735408328573","title":"Nutrition and the Prevention and Treatment of Cancer: Association of Cytochrome P450 CYP1B1 With the Role of Fruit and Fruit Extracts","year":2008,"lang":"en","type":"review","venue":"Integrative Cancer Therapies","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer; Cancer prevention; CYP1B1; Health benefits; Enzyme; Cancer treatment; Cancer cell; Medicine; Cytochrome P450; Biotechnology; Biology; Pharmacology; Biochemistry; Traditional medicine; Internal medicine","score_opus":0.0846628672544112,"score_gpt":0.4446114760901638,"score_spread":0.35994860883575264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146261034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037976943,0.9591794,0.000004902799,0.00030465345,0.00009277191,0.0015611085,0.0007398067,0.000005678819,0.00013476233],"genre_scores_gemma":[0.041940037,0.9566263,0.000024318715,0.00004299866,0.00013426621,0.00092729693,0.00001965366,0.000020899332,0.00026424607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981198,0.0008695754,0.00044543354,0.00023652425,0.0001647404,0.00016397651],"domain_scores_gemma":[0.9975797,0.0009073362,0.0011019781,0.00011817741,0.00024536325,0.00004746262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030608888,0.00033772993,0.0012059271,0.00008809363,0.00013447295,0.000011183436,0.000121253965,0.00023947473,0.00007819634],"category_scores_gemma":[0.000016178079,0.00015839323,0.00016821068,0.00016179602,0.00076082995,0.000059236372,0.000027754453,0.00029933357,1.9440355e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004496134,0.00022885717,0.00039338708,0.000895925,0.0031768447,7.992298e-7,0.0090592485,0.0000030843742,0.002417929,0.00058755296,0.00009139152,0.98269534],"study_design_scores_gemma":[0.0036116433,0.0003200162,0.0006583101,0.0016983213,0.002972682,0.000010509896,0.00083176204,0.000031621767,0.0091718165,0.00080552365,0.97969145,0.00019636589],"about_ca_topic_score_codex":0.00035917718,"about_ca_topic_score_gemma":0.00044448578,"teacher_disagreement_score":0.982499,"about_ca_system_score_codex":0.000110357614,"about_ca_system_score_gemma":0.0002128115,"threshold_uncertainty_score":0.64590883},"labels":[],"label_agreement":null},{"id":"W2146859352","doi":"10.18433/j3ss35","title":"Melatonin Interaction Resulting in Severe Sedation","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Health Canada; University of Ottawa","funders":"Canadian Institutes of Health Research; Health Canada; Alberta Innovates; Canadian Patient Safety Institute","keywords":"Melatonin; CYP2C19; Pharmacology; CYP2D6; CYP3A4; Adverse effect; Nortriptyline; Drug interaction; Medicine; Drug; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.354844045881168,"score_gpt":0.5457197620734927,"score_spread":0.19087571619232468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146859352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96797204,0.005494738,0.00014519366,0.0042054257,0.0051943,0.00031000483,0.000014783649,0.000041412957,0.016622098],"genre_scores_gemma":[0.9931318,0.0017533433,0.0011287847,0.0027470412,0.001072548,0.000009175833,0.0000030217655,0.000022383196,0.00013191305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953213,0.001202266,0.0013672019,0.00039564277,0.0009325838,0.00078104483],"domain_scores_gemma":[0.9970864,0.000647678,0.0007008775,0.0001143274,0.0004571135,0.000993598],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007919895,0.00032661844,0.0004944302,0.0006207316,0.00023820261,0.000104296625,0.0008248938,0.00014890377,0.0009757792],"category_scores_gemma":[0.0006789644,0.00027556665,0.00019812488,0.0012115092,0.00044935886,0.0011874604,0.00017862147,0.0018312801,0.00011864301],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042388155,0.0018684551,0.121358454,0.00009542057,0.00027891697,0.0006224462,0.0050686565,0.05504087,0.25050735,0.0019496356,0.0135560855,0.54541487],"study_design_scores_gemma":[0.010019149,0.00020435949,0.0008209045,0.00005436004,0.00022522503,0.00063519884,0.001089891,0.079984345,0.16256125,0.00094328634,0.7430361,0.00042592533],"about_ca_topic_score_codex":0.000036811463,"about_ca_topic_score_gemma":0.000010671061,"teacher_disagreement_score":0.72948,"about_ca_system_score_codex":0.00026263428,"about_ca_system_score_gemma":0.00060448697,"threshold_uncertainty_score":0.99996966},"labels":[],"label_agreement":null},{"id":"W2147147806","doi":"10.1124/dmd.105.004374","title":"CANCER CHEMOTHERAPY AND DRUG METABOLISM","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Prodrug; Pharmacology; Drug metabolism; Drug; Pharmacokinetics; Chemistry; Biology","score_opus":0.031256672280271056,"score_gpt":0.37595169551803365,"score_spread":0.3446950232377626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147147806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89180636,0.09599064,0.000091484384,0.007242091,0.0013825868,0.0004661233,0.0002582666,0.0001279373,0.0026345185],"genre_scores_gemma":[0.9402167,0.043936983,0.00068117055,0.010803668,0.0021670782,0.00015107829,0.000057823563,0.000058647747,0.0019268291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976182,0.0003979745,0.0004652075,0.000628611,0.00026076182,0.0006292547],"domain_scores_gemma":[0.99878454,0.00013113939,0.00018087549,0.00023366949,0.00011305301,0.00055671256],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000764644,0.0004582773,0.00055895315,0.00020916847,0.00048994913,0.00009712849,0.00021549649,0.00021426297,0.0009624621],"category_scores_gemma":[0.000016869903,0.00042014036,0.00012608094,0.00025205122,0.0002910327,0.0004521349,0.00012149997,0.00056923676,0.000060740305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007236622,0.00061914587,0.002545753,0.00010343797,0.00048069184,0.000014889213,0.0074936287,0.00028152458,0.18922998,0.020345662,0.016779054,0.7613826],"study_design_scores_gemma":[0.004257454,0.000006635145,0.032472435,0.000014388727,0.0007254515,0.000026611833,0.00015947627,0.0023723624,0.108131535,0.0013845608,0.84986895,0.00058013806],"about_ca_topic_score_codex":0.0001339178,"about_ca_topic_score_gemma":0.000048151403,"teacher_disagreement_score":0.8330899,"about_ca_system_score_codex":0.000023290799,"about_ca_system_score_gemma":0.000054980606,"threshold_uncertainty_score":0.99995077},"labels":[],"label_agreement":null},{"id":"W2147257532","doi":"10.1155/2009/315687","title":"Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report","year":2009,"lang":"en","type":"article","venue":"Case Reports in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; University Health Network","funders":"","keywords":"Ketoconazole; Warfarin; Medicine; Pharmacology; Adverse effect; Internal medicine; Antifungal; Dermatology; Atrial fibrillation","score_opus":0.10757631726493783,"score_gpt":0.46958141924666263,"score_spread":0.3620051019817248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147257532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879445,0.0018168731,0.000293798,0.0016166377,0.0021194145,0.0006844429,0.000009329813,0.00007801605,0.004587016],"genre_scores_gemma":[0.9960517,0.00045366766,0.00016758234,0.0016058832,0.0011508685,0.000052753083,0.000048299553,0.000022279764,0.00044693542],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99723494,0.000273526,0.0012064796,0.0006206603,0.0002090322,0.00045534232],"domain_scores_gemma":[0.99820215,0.00031335084,0.0005058828,0.00039684933,0.00012600237,0.00045579835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022198567,0.0003172513,0.0006338699,0.00029759627,0.00018488814,0.000013080268,0.00005741938,0.00029639143,0.0005602421],"category_scores_gemma":[0.00048677524,0.00027993205,0.000053601438,0.00031692773,0.00023037693,0.00013197395,0.00006444063,0.0010025941,0.0000061219207],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009634971,0.00011955221,0.0019254196,0.000026901535,0.00006059317,0.82191825,0.0008096785,0.00006241846,0.020593682,0.00006581329,0.00084121403,0.15348014],"study_design_scores_gemma":[0.002763666,0.00017984227,0.004361022,0.00006056734,0.00039249755,0.91441715,0.00039577988,0.00044354296,0.028810067,0.0013717306,0.04646892,0.00033522857],"about_ca_topic_score_codex":0.0003043313,"about_ca_topic_score_gemma":0.00004483092,"teacher_disagreement_score":0.15314491,"about_ca_system_score_codex":0.000079814614,"about_ca_system_score_gemma":0.00008031452,"threshold_uncertainty_score":0.9999653},"labels":[],"label_agreement":null},{"id":"W2147316397","doi":"10.1136/tc.2003.007070","title":"Genetically decreased<i>CYP2A6</i>and the risk of tobacco dependence: a prospective study of novice smokers","year":2004,"lang":"en","type":"article","venue":"Tobacco Control","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; McGill University","funders":"Canadian Institutes of Health Research; National Cancer Institute; Centre for Addiction and Mental Health","keywords":"CYP2A6; Medicine; Psychology; Environmental health; Advertising; Business; Internal medicine","score_opus":0.027399064669853392,"score_gpt":0.3565260057322769,"score_spread":0.3291269410624235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147316397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902646,0.0044061686,0.0003273496,0.00037842838,0.0003680127,0.0022293,0.00013124294,0.00003343968,0.001861485],"genre_scores_gemma":[0.997523,0.00085062376,0.00019257434,0.0010221271,0.00016578811,0.00018680419,0.000001756853,0.000028131608,0.000029213315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970922,0.0009172347,0.000732386,0.0004272477,0.00038595605,0.0004449969],"domain_scores_gemma":[0.99755496,0.0009484914,0.0004860164,0.00040697405,0.0003481013,0.0002554853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017376,0.00031842128,0.0007225531,0.00010895064,0.0002306895,0.000019613588,0.00051293964,0.00020370283,0.00019799505],"category_scores_gemma":[0.0003839488,0.00022554837,0.00018309648,0.00030480933,0.0006621752,0.000073926014,0.00014114556,0.00069603627,0.000019775509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009336969,0.0032051268,0.91411245,0.000033564185,0.002652445,0.00003446838,0.006087043,0.010052659,0.0210791,0.008146499,0.00006815511,0.025191534],"study_design_scores_gemma":[0.22990009,0.0018617604,0.6672812,0.000051926927,0.010314902,0.00006277634,0.004536522,0.0019265325,0.06460928,0.014322424,0.0039167395,0.0012158366],"about_ca_topic_score_codex":0.000811788,"about_ca_topic_score_gemma":0.00028663102,"teacher_disagreement_score":0.24683122,"about_ca_system_score_codex":0.000036931575,"about_ca_system_score_gemma":0.00021075025,"threshold_uncertainty_score":0.9197596},"labels":[],"label_agreement":null},{"id":"W2147950066","doi":"10.1016/j.taap.2010.05.009","title":"Species differences in methanol and formic acid pharmacokinetics in mice, rabbits and primates","year":2010,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Formic acid; Pharmacokinetics; Methanol; Pharmacology; Chemistry; Biology; Biochemistry; Organic chemistry","score_opus":0.056430861379635294,"score_gpt":0.3698630597294164,"score_spread":0.3134321983497811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147950066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847579,0.004659783,0.000011549932,0.0017089372,0.0017472517,0.0010751315,0.000062977735,0.000075974735,0.005900515],"genre_scores_gemma":[0.98432684,0.009856011,0.00055158656,0.004265753,0.00035424138,0.00033680524,0.000015276946,0.000044718898,0.00024876796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99662757,0.00044062734,0.00076352234,0.0009224335,0.00013821483,0.0011076512],"domain_scores_gemma":[0.99821323,0.0009047753,0.0002220917,0.0001419531,0.000045600784,0.00047236885],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001218871,0.00059319724,0.0009526798,0.00062762835,0.00025853663,0.000038654143,0.0003634162,0.0008802373,0.0011945113],"category_scores_gemma":[0.000046847945,0.0005793605,0.00004826957,0.00039495743,0.0014411502,0.00014448716,0.00046512685,0.0024528396,0.000022163847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007031782,0.00044152697,0.044656754,0.00011391504,0.000115182396,0.00006852072,0.0011901759,0.000013717257,0.9264837,0.0046876087,0.00040525425,0.021120489],"study_design_scores_gemma":[0.011867516,0.00018331621,0.11862904,0.000009829264,0.00036657727,0.00021464172,0.00027008823,0.0022345327,0.82683337,0.004053349,0.034468766,0.00086899986],"about_ca_topic_score_codex":0.000017345288,"about_ca_topic_score_gemma":0.00017785058,"teacher_disagreement_score":0.09965034,"about_ca_system_score_codex":0.00002973284,"about_ca_system_score_gemma":0.00009832306,"threshold_uncertainty_score":0.99984854},"labels":[],"label_agreement":null},{"id":"W2148873733","doi":"10.1002/bit.21449","title":"Activity of human P450 2D6 in biphasic solvent systems","year":2007,"lang":"en","type":"article","venue":"Biotechnology and Bioengineering","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cofactor; Substrate (aquarium); Chemistry; Solvent; Hydrogen peroxide; Redox; Combinatorial chemistry; Enzyme; Organic synthesis; Organic chemistry; Catalysis; Biology","score_opus":0.06988047184778479,"score_gpt":0.39278734053143294,"score_spread":0.32290686868364815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148873733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187756,0.0053540412,0.0011796685,0.00020711275,0.0006728033,0.00023098041,0.00001520643,0.000110332396,0.00035231345],"genre_scores_gemma":[0.99887514,0.0008163867,0.00010978783,0.000040051476,0.00008624948,0.000010599695,0.0000025877914,0.000015419215,0.000043776217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886805,0.000044239296,0.00032820515,0.0002499278,0.00007476553,0.00043481597],"domain_scores_gemma":[0.99953973,0.00008179754,0.00009651497,0.00015605483,0.00002325191,0.00010267522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008493178,0.0001853105,0.00031175857,0.00045993915,0.00007511728,0.000005253547,0.00018142155,0.00064859045,0.000020901145],"category_scores_gemma":[0.000019098872,0.00018303415,0.000046027308,0.00033921693,0.00021451242,0.00004288111,0.00010737509,0.0006448378,0.0000042386355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053133313,0.00010211809,0.006644246,0.000087106215,0.000066458095,0.0000367044,0.00007589544,0.00028939798,0.971153,0.0058842725,0.000015721453,0.015591904],"study_design_scores_gemma":[0.001120655,0.00009489245,0.019155389,0.000026515048,0.000053869753,0.0000325395,0.000061375555,0.0035853544,0.96392244,0.00008069938,0.011640542,0.0002257164],"about_ca_topic_score_codex":0.000042931748,"about_ca_topic_score_gemma":0.000019528357,"teacher_disagreement_score":0.015366186,"about_ca_system_score_codex":0.000030295361,"about_ca_system_score_gemma":0.000014746276,"threshold_uncertainty_score":0.7463916},"labels":[],"label_agreement":null},{"id":"W2149041141","doi":"10.1038/sj.clpt.6100125","title":"Identification and Characterization of CYP2D6*56B, an Allele Associated with the Poor Metabolizer Phenotype","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"CYP2D6; Genotype; Allele; Phenotype; Dextromethorphan; Pharmacogenetics; Genetics; Genotype-phenotype distinction; Biology; Allele frequency; Pharmacology; Gene","score_opus":0.15461644015628376,"score_gpt":0.4811678891458,"score_spread":0.32655144898951627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149041141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893791,0.0012427191,0.0013804318,0.0047162035,0.0020307808,0.00079790247,0.000103302234,0.000090435955,0.00025912098],"genre_scores_gemma":[0.954794,0.002519101,0.00009008934,0.041214403,0.0007717084,0.00003524962,0.00013031997,0.000059563103,0.0003855961],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958737,0.0015955622,0.0010937987,0.00054219435,0.0002824743,0.00061229884],"domain_scores_gemma":[0.9967333,0.0013226826,0.000819225,0.0003008605,0.00048006335,0.0003438868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0048454492,0.00035527596,0.0005925943,0.00012645502,0.00036741322,0.000028064607,0.00054357754,0.0005445583,0.00043145538],"category_scores_gemma":[0.00003867602,0.00025799664,0.00013723086,0.00043131041,0.0012523569,0.0001865277,0.000116042684,0.0011476993,0.000025470134],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017569682,0.0015233251,0.009414766,0.000015915979,0.001792686,0.000013353611,0.00089982245,0.000044961358,0.94791245,0.0002594082,0.00092053803,0.035445783],"study_design_scores_gemma":[0.0086138155,0.00075442967,0.30129823,0.000008955118,0.0065011433,0.000017193268,0.00025756643,0.0063112625,0.3296074,0.00034198366,0.34558326,0.0007047719],"about_ca_topic_score_codex":0.0000034359507,"about_ca_topic_score_gemma":0.000017287713,"teacher_disagreement_score":0.6183051,"about_ca_system_score_codex":0.000029094397,"about_ca_system_score_gemma":0.00012504618,"threshold_uncertainty_score":0.99998724},"labels":[],"label_agreement":null},{"id":"W2149415764","doi":"10.18433/j3vk5g","title":"Development of a highly reproducible system to evaluate inhibition of cytochrome P450 3A4 activity by natural medicines","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology","keywords":"CYP3A4; Pharmacology; Ketoconazole; Microsome; Chemistry; Cytochrome P450; Biology; In vitro; Biochemistry; Enzyme; Microbiology","score_opus":0.2253720399815805,"score_gpt":0.5030008218189227,"score_spread":0.2776287818373422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149415764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856391,0.0068803187,0.00036161722,0.0025231733,0.002557149,0.0005865922,0.00005262287,0.00003729577,0.001362144],"genre_scores_gemma":[0.9945635,0.000390963,0.0033204756,0.00097066956,0.0006251021,0.000020634829,0.00000340946,0.000025283389,0.00007996846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.993969,0.0009781031,0.0018389499,0.000580399,0.0018617332,0.000771798],"domain_scores_gemma":[0.9954783,0.00040436038,0.0012962471,0.00022302299,0.0012686024,0.0013295157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010954881,0.00042230324,0.00098312,0.0005669918,0.0002685269,0.00003421815,0.00090440543,0.00012820016,0.00021277272],"category_scores_gemma":[0.00052342995,0.00032529698,0.00024654498,0.0014097482,0.0007826831,0.0005398568,0.00030297486,0.0009592849,0.00003282237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017054483,0.00071327336,0.001025251,0.0002278222,0.00023608343,0.000038048845,0.0016800718,0.0009119272,0.927153,0.00012213203,0.007206268,0.05898065],"study_design_scores_gemma":[0.004716623,0.00023474482,0.0004355319,0.000114177325,0.00043086865,0.0001288875,0.0003810652,0.0065476876,0.7999236,0.000040392973,0.18675992,0.0002864977],"about_ca_topic_score_codex":0.000020273974,"about_ca_topic_score_gemma":0.0000022699785,"teacher_disagreement_score":0.17955364,"about_ca_system_score_codex":0.00025052152,"about_ca_system_score_gemma":0.0012853699,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W2149441567","doi":"10.1007/s12519-013-0429-x","title":"Hepatic CYP3A expression and activity in low birth weight developing female rats","year":2013,"lang":"en","type":"article","venue":"World Journal of Pediatrics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Merck Canada","keywords":"Offspring; CYP3A; Internal medicine; Medicine; Endocrinology; Birth weight; Messenger RNA; Group A; Andrology; Biology; Cytochrome P450; Pregnancy; Metabolism; Gene; Biochemistry","score_opus":0.0523800272155953,"score_gpt":0.37081177119264186,"score_spread":0.31843174397704654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149441567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886215,0.0075239013,0.00019504601,0.00069750403,0.002263321,0.00021562255,0.0000073726505,0.000010007523,0.00046576303],"genre_scores_gemma":[0.9888683,0.007147706,0.0013966177,0.0011391494,0.00081115076,0.0000069504135,4.984646e-7,0.000021115111,0.00060851977],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982479,0.0004015076,0.0005374889,0.00018261753,0.0002527267,0.00037774106],"domain_scores_gemma":[0.998654,0.00027224282,0.00048732036,0.00010738067,0.0001659966,0.00031303597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065277604,0.00020354502,0.00037313448,0.0005222477,0.00012356052,0.000032479307,0.00025552235,0.00015193886,0.0005184144],"category_scores_gemma":[0.000108012704,0.0001749558,0.00009519292,0.0006162085,0.00006256327,0.00029638124,0.00015840119,0.0009576637,0.000025187654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021039402,0.00051947363,0.73145705,0.00040106926,0.000039931398,0.00011879208,0.0007511817,0.0008158387,0.2156839,0.00006924146,0.011890584,0.038042556],"study_design_scores_gemma":[0.007182199,0.000095357136,0.3980372,0.00020228652,0.00030497304,0.00009968868,0.00006487762,0.0026325134,0.45112756,0.0019407864,0.13741724,0.0008953198],"about_ca_topic_score_codex":0.000007446694,"about_ca_topic_score_gemma":0.000012600818,"teacher_disagreement_score":0.33341986,"about_ca_system_score_codex":0.000079003505,"about_ca_system_score_gemma":0.00021461445,"threshold_uncertainty_score":0.71344906},"labels":[],"label_agreement":null},{"id":"W2149451456","doi":"10.1124/dmd.107.017343","title":"Analysis of CYP2A Contributions to Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone in Human Peripheral Lung Microsomes","year":2007,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Metabolite; Microsome; Hydroxylation; Metabolism; Chemistry; CYP2A6; Internal medicine; Enzyme; Endocrinology; Cytochrome P450; Biochemistry; CYP3A4; Biology; Medicine","score_opus":0.02346603515718466,"score_gpt":0.41036627489627375,"score_spread":0.3869002397390891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149451456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98041165,0.0125877885,0.0025050833,0.00025870913,0.00064703193,0.0006064535,0.0021974572,0.00003281492,0.000753015],"genre_scores_gemma":[0.99722,0.000776111,0.00053263904,0.0006563506,0.00024012636,0.000043510987,0.00036584403,0.000028095767,0.00013733181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967354,0.0004986529,0.001204622,0.0005329189,0.00033875057,0.00068965036],"domain_scores_gemma":[0.99813044,0.00030616607,0.00039876698,0.00032676713,0.0003885157,0.00044936506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002309011,0.0003826974,0.0012397241,0.0015065015,0.00023100692,0.00002569862,0.00030809364,0.00027618124,0.00031297322],"category_scores_gemma":[0.000099647565,0.00038517537,0.00036146666,0.002159842,0.00030876556,0.00020803326,0.0001541254,0.00046473983,0.000003502661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005982085,0.0007106934,0.02158475,0.00006376259,0.0010797763,0.000015792792,0.0029387963,0.0013111599,0.9512774,0.014427731,0.00015175545,0.005840196],"study_design_scores_gemma":[0.0030804058,0.00002505624,0.44944605,0.00001754225,0.0045250105,0.000004658224,0.00034876404,0.0014317796,0.5314451,0.0006063695,0.008661384,0.0004078807],"about_ca_topic_score_codex":0.00036709566,"about_ca_topic_score_gemma":0.00021746596,"teacher_disagreement_score":0.4278613,"about_ca_system_score_codex":0.000059307164,"about_ca_system_score_gemma":0.00006395497,"threshold_uncertainty_score":0.99986},"labels":[],"label_agreement":null},{"id":"W2149734586","doi":"10.1096/fj.03-0837lte","title":"The discovery of Captopril: reply","year":2004,"lang":"en","type":"letter","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hypertension Canada","funders":"","keywords":"Bradykinin; Saralasin; Captopril; Renin–angiotensin system; Angiotensin-converting enzyme; Angiotensin II; Medicine; Heart failure; Pharmacology; Internal medicine; Chemistry; Blood pressure; Receptor","score_opus":0.08118373522993777,"score_gpt":0.3869264635912159,"score_spread":0.30574272836127814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149734586","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055168215,0.025983999,0.00015915262,0.89571655,0.014828605,0.00058572605,0.00036861887,0.000037339483,0.0071517783],"genre_scores_gemma":[0.09616288,0.016913844,0.000045877343,0.8548892,0.017633054,0.000025905432,0.00003831316,0.00010350394,0.014187431],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962696,0.0012617708,0.0008477254,0.00026283253,0.00057450717,0.0007835702],"domain_scores_gemma":[0.99702615,0.0010832468,0.00096952595,0.00057508337,0.00020681956,0.00013918571],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002448145,0.0004173552,0.00049242587,0.00010900662,0.0011321543,0.00016233962,0.0016761805,0.00061053055,0.00038541807],"category_scores_gemma":[0.00012713399,0.00021785493,0.0005337994,0.000182586,0.0008093993,0.00010856774,0.0002166886,0.008548661,0.0000946442],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017867672,0.00005802406,0.000079099154,0.000043018536,0.00084586005,0.0004702991,0.00041777955,0.000546262,0.03177856,0.0003282916,0.9583697,0.006884485],"study_design_scores_gemma":[0.0009978587,0.000048046237,0.00005302684,0.000038472663,0.00069450005,0.00073910924,0.000055583667,0.00004251593,0.0766528,0.005928056,0.914499,0.00025104114],"about_ca_topic_score_codex":0.000028441547,"about_ca_topic_score_gemma":0.000003453256,"teacher_disagreement_score":0.044874243,"about_ca_system_score_codex":0.000103472834,"about_ca_system_score_gemma":0.00062417414,"threshold_uncertainty_score":0.99373865},"labels":[],"label_agreement":null},{"id":"W2149799880","doi":"10.1038/clpt.2010.242","title":"Demonstrating Utility of Pharmacogenetics in Pediatric Populations: Methodological Considerations","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenetics; Clinical pharmacology; Quality (philosophy); Medicine; Computer science; Psychology; Intensive care medicine; Pharmacology; Biology; Genetics","score_opus":0.8109777463779481,"score_gpt":0.6636165452362309,"score_spread":0.14736120114171714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149799880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005114395,0.97511137,0.0002129707,0.000511225,0.01414845,0.0027523083,0.0005424699,0.0001520289,0.0014547763],"genre_scores_gemma":[0.0033200916,0.9775701,0.007122896,0.008411493,0.0028497707,0.0003463744,0.00014499824,0.00016245453,0.000071801594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97820914,0.012555641,0.00592486,0.0015219373,0.00044732488,0.0013410739],"domain_scores_gemma":[0.9815509,0.013908262,0.0026009977,0.0007519229,0.00045645394,0.00073150336],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.008503218,0.0013191142,0.0049035763,0.0008032032,0.00037656448,0.0000379527,0.0012713277,0.004256419,0.0039460636],"category_scores_gemma":[0.00061686465,0.0012070119,0.0017574403,0.0012345904,0.0016565368,0.00012162067,0.00052724883,0.009797599,0.00014394175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019457353,0.004763008,0.009221009,0.003212164,0.0016094326,0.0001859109,0.00017789142,0.00009833015,0.0004423208,0.0003090414,0.005477353,0.97430897],"study_design_scores_gemma":[0.0030055027,0.00016770288,0.0010295709,0.00017191282,0.016617533,0.00009866682,0.000015201247,0.001716516,0.00032365447,0.0017952945,0.97397566,0.0010828123],"about_ca_topic_score_codex":0.0000054138773,"about_ca_topic_score_gemma":0.000017823153,"teacher_disagreement_score":0.97322613,"about_ca_system_score_codex":0.00007007455,"about_ca_system_score_gemma":0.0016923036,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W2150274550","doi":"10.1034/j.1600-0447.2001.00299.x","title":"CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages","year":2001,"lang":"en","type":"article","venue":"Acta Psychiatrica Scandinavica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":423,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2D6; CYP2C19; Pharmacogenetics; Pharmacology; Dose; Medicine; Tricyclic; Drug; Pharmacokinetics; Therapeutic drug monitoring; Genotype; Cytochrome P450; Internal medicine; Biology; Genetics; Gene; Metabolism","score_opus":0.13592437100606178,"score_gpt":0.4378611409673693,"score_spread":0.30193676996130747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150274550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8535457,0.022994816,0.00922005,0.080480285,0.010108067,0.004701333,0.0021512762,0.00060700433,0.01619143],"genre_scores_gemma":[0.9769405,0.011210877,0.007392013,0.0024358511,0.00089237245,0.00026217388,0.00027979122,0.00006969279,0.00051673444],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745303,0.00025155116,0.00062161015,0.00071023114,0.00022846328,0.00073509006],"domain_scores_gemma":[0.9981693,0.000484435,0.00029046822,0.00042183985,0.00017066923,0.00046330673],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005969409,0.00041871698,0.00045747764,0.00034387692,0.0009589692,0.000101417965,0.00043316497,0.00034187446,0.0014180907],"category_scores_gemma":[0.00006826389,0.0004082861,0.00019777281,0.00064555666,0.0001712336,0.00023729386,0.00010140325,0.0005063075,0.000046869634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048108166,0.0027642737,0.17792095,0.00027525247,0.0007669084,0.000035876237,0.0011838607,0.0004992218,0.00994225,0.003999771,0.5092906,0.28851026],"study_design_scores_gemma":[0.0058015506,0.00015391155,0.03655358,0.000017397884,0.0003658087,0.000028133207,0.000064902495,0.005255865,0.0006236016,0.0011040074,0.9495181,0.0005131333],"about_ca_topic_score_codex":0.00007824497,"about_ca_topic_score_gemma":0.00006503812,"teacher_disagreement_score":0.44022754,"about_ca_system_score_codex":0.000064461674,"about_ca_system_score_gemma":0.00010147437,"threshold_uncertainty_score":0.9998369},"labels":[],"label_agreement":null},{"id":"W2150276412","doi":"10.1177/0091270004265642","title":"The Influence of St. John's Wort on CYP2C19 Activity with Respect to Genotype","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotype; CYP2C19; Medicine; Traditional medicine; Pharmacology; Genetics; Biology; Gene","score_opus":0.14819380871095922,"score_gpt":0.5163174603508064,"score_spread":0.36812365163984717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150276412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779232,0.00072932703,0.0001263653,0.015851725,0.0035378367,0.00053993444,0.000027556778,0.000016509905,0.00124751],"genre_scores_gemma":[0.9806641,0.004033407,0.00016094638,0.013311536,0.0016232051,0.000011216047,4.1976764e-7,0.000033120537,0.00016206998],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99455774,0.0025525382,0.0014817119,0.00025975727,0.0005319157,0.00061633426],"domain_scores_gemma":[0.9914161,0.00563294,0.0013928948,0.00035952398,0.00063213316,0.0005664172],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008633412,0.00031081578,0.00081720034,0.00014694055,0.00041775688,0.000015482825,0.0014210831,0.00027122657,0.00026741993],"category_scores_gemma":[0.00067676,0.00016159315,0.0002884436,0.0004913696,0.0010056115,0.00010777042,0.00020810662,0.0028026095,0.00007941072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09248932,0.0037305856,0.006727504,0.00004727743,0.0032684884,0.00040400936,0.0013618998,0.45725945,0.33735245,0.0015092988,0.031087667,0.06476203],"study_design_scores_gemma":[0.017080443,0.008087569,0.1380798,0.0000700835,0.0022929388,0.00031177874,0.00011356207,0.00016850038,0.24142678,0.0034306946,0.5883823,0.0005555328],"about_ca_topic_score_codex":0.00001703245,"about_ca_topic_score_gemma":0.000026953234,"teacher_disagreement_score":0.55729467,"about_ca_system_score_codex":0.000072192044,"about_ca_system_score_gemma":0.0007349928,"threshold_uncertainty_score":0.99949795},"labels":[],"label_agreement":null},{"id":"W2150595547","doi":"10.1586/17512433.2014.910111","title":"Understanding and preventing drug–drug and drug–gene interactions","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Institut Universitaire de Gériatrie de Montréal","funders":"","keywords":"Drug; Medicine; Pharmacology; Pharmacogenetics; Drug interaction; Drug action; Cytochrome P450; Drug metabolism; Pharmacogenomics; Computational biology; Gene; Biology; Genetics; Internal medicine; Genotype","score_opus":0.4669670775692211,"score_gpt":0.6204686295753388,"score_spread":0.15350155200611765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150595547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012990407,0.9797756,0.00009377792,0.001608237,0.013673254,0.0022385584,0.00013202066,0.000081430175,0.002267198],"genre_scores_gemma":[0.00022985587,0.98257464,0.00058645714,0.009962912,0.0048487103,0.00037900746,0.00010228848,0.0001339429,0.0011821768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9849058,0.0078329705,0.0046946304,0.0013574746,0.0003333765,0.0008757959],"domain_scores_gemma":[0.98722404,0.008291713,0.00286855,0.00047470912,0.00019648908,0.0009445205],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008425067,0.001062508,0.0064556105,0.00034917446,0.00037115696,0.000030285097,0.0008007892,0.0005766555,0.0022674657],"category_scores_gemma":[0.00063881517,0.0008993753,0.0013905343,0.00043597718,0.0010898615,0.00016061461,0.00088044966,0.0033220777,0.00008845997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005638725,0.00042211724,0.00003923445,0.057798743,0.0014849623,0.00003251235,0.00015247469,8.4459396e-7,0.000060365073,0.00024194182,0.19513544,0.74457496],"study_design_scores_gemma":[0.0015851593,0.000043467302,0.0000042070556,0.016150787,0.0054770093,0.00013987951,0.00002727193,0.00011367076,0.00014011965,0.0001580228,0.97540617,0.00075421063],"about_ca_topic_score_codex":0.000014025818,"about_ca_topic_score_gemma":0.0000058292103,"teacher_disagreement_score":0.78027076,"about_ca_system_score_codex":0.000100968995,"about_ca_system_score_gemma":0.0004205608,"threshold_uncertainty_score":0.99934566},"labels":[],"label_agreement":null},{"id":"W2151552217","doi":"10.1016/j.ejps.2009.01.006","title":"Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver","year":2009,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnane X receptor; CYP3A; Isozyme; Calcitriol receptor; Pharmacology; Chemistry; Biology; Internal medicine; Biochemistry; Nuclear receptor; Cytochrome P450; Metabolism; Receptor; Medicine; Enzyme; Gene; Transcription factor","score_opus":0.17974507132693684,"score_gpt":0.47439486891350224,"score_spread":0.2946497975865654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151552217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899768,0.0074663027,0.000014768706,0.0009810479,0.00030895355,0.00014692984,0.0000023925795,0.0000028383943,0.001099915],"genre_scores_gemma":[0.9977494,0.0017340254,0.00014641629,0.00026801493,0.00008691165,3.385389e-7,2.0728605e-7,0.0000055476976,0.000009136736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979308,0.00083059137,0.0006203779,0.00016077251,0.0002622096,0.00019521275],"domain_scores_gemma":[0.9979804,0.0012268114,0.00045953062,0.00006260709,0.00009913615,0.0001715016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028497789,0.00014409662,0.00036424614,0.00017720896,0.0001255126,0.000016246842,0.00024637848,0.000039335762,0.000041340183],"category_scores_gemma":[0.0002848935,0.000095341115,0.000048033384,0.00026714642,0.0010834429,0.00008601862,0.00008189975,0.00044178628,5.9682435e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087159063,0.00043883972,0.024080152,0.000113237256,0.00005242369,0.00002260768,0.0015311231,0.00022569035,0.9186964,0.0049267183,0.00020879698,0.04883243],"study_design_scores_gemma":[0.0039626476,0.0020941137,0.12445582,0.00017639753,0.00021565215,0.000025156363,0.00015188854,0.004230375,0.86172444,0.00045251157,0.0023828733,0.00012815201],"about_ca_topic_score_codex":0.0000017503463,"about_ca_topic_score_gemma":8.52904e-7,"teacher_disagreement_score":0.10037567,"about_ca_system_score_codex":0.0000070861793,"about_ca_system_score_gemma":0.000025273517,"threshold_uncertainty_score":0.39919907},"labels":[],"label_agreement":null},{"id":"W2152161503","doi":"10.1345/aph.1k615","title":"Induction Effects of Ritonavir: Implications for Drug Interactions","year":2008,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Capital District Health Authority","funders":"","keywords":"Ritonavir; Darunavir; CYP3A; Pharmacology; Medicine; Drug interaction; Drug; Cobicistat; Drug metabolism; Cytochrome P450; Internal medicine; Metabolism; Immunology; Human immunodeficiency virus (HIV)","score_opus":0.29311779385289366,"score_gpt":0.5361824232976135,"score_spread":0.2430646294447198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152161503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98625165,0.0052058366,0.0007613228,0.0033043772,0.002105719,0.0009666019,0.00028515054,0.000060611022,0.0010587272],"genre_scores_gemma":[0.9802414,0.014529235,0.0006583859,0.0029085914,0.0005262489,0.00026927463,0.0000315394,0.000041129497,0.0007941777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844027,0.00024337754,0.0005647752,0.0002751915,0.00012306967,0.00035333523],"domain_scores_gemma":[0.99805623,0.0006858559,0.00039048144,0.00021992734,0.00045033946,0.00019717254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039898494,0.00022219279,0.00039020693,0.00023495662,0.00025649823,0.000003618682,0.00031581972,0.00009062611,0.00029887876],"category_scores_gemma":[0.00004832993,0.00022546576,0.000313976,0.00031284662,0.00025965608,0.00016761749,0.000029675688,0.00032513734,0.000011895304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037558627,0.0008737945,0.0024003487,0.00011666066,0.00040669084,0.0000012071698,0.0010986747,0.00016704487,0.91083723,0.0011115512,0.031285,0.051326226],"study_design_scores_gemma":[0.0017998011,0.000063075044,0.00391021,0.000011420891,0.00009907938,0.000011748273,0.000016777363,0.00023835822,0.74115646,0.0013619326,0.25117993,0.00015121802],"about_ca_topic_score_codex":0.000032679854,"about_ca_topic_score_gemma":0.0000024977537,"teacher_disagreement_score":0.21989493,"about_ca_system_score_codex":0.000011179597,"about_ca_system_score_gemma":0.00010082699,"threshold_uncertainty_score":0.9194227},"labels":[],"label_agreement":null},{"id":"W2152193974","doi":"10.1124/dmd.105.003822","title":"CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"CYP3A5; Biology; Genetics; Allele; Polymorphism (computer science); CYP3A; Population; Allele frequency; White (mutation); Single-nucleotide polymorphism; Genotype; Genetic variation; Gene; Medicine","score_opus":0.08882325038046779,"score_gpt":0.40857120840884986,"score_spread":0.3197479580283821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152193974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657722,0.028552055,0.00027340872,0.0021696636,0.0011079955,0.00040238336,0.000105198065,0.000072422044,0.0015446354],"genre_scores_gemma":[0.9920165,0.0031798761,0.0006864283,0.002390032,0.0010124717,0.000098465076,0.00010015892,0.000032537555,0.00048351896],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979093,0.00043102185,0.00050397514,0.0004318508,0.00019961875,0.00052423443],"domain_scores_gemma":[0.9991996,0.000086046544,0.00011846042,0.00021093365,0.00004370351,0.00034119945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035533644,0.0003252982,0.00038553437,0.0003000553,0.0002278865,0.000035319,0.000183492,0.0002048106,0.00060672837],"category_scores_gemma":[0.000019483361,0.00029193846,0.00011121892,0.00029446665,0.0001253234,0.0002118571,0.00009520211,0.0005073579,0.00009709288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051659194,0.0018871957,0.040153205,0.000059661383,0.0001495609,0.000054429893,0.0056500956,0.004919168,0.24668169,0.026855575,0.003157101,0.66991574],"study_design_scores_gemma":[0.0033209515,0.000015326586,0.88456327,0.000015851818,0.00037082858,0.000032914766,0.000080433536,0.010449306,0.028469905,0.0035196359,0.06863707,0.0005244983],"about_ca_topic_score_codex":0.000075163385,"about_ca_topic_score_gemma":0.00015320197,"teacher_disagreement_score":0.84441006,"about_ca_system_score_codex":0.000037384263,"about_ca_system_score_gemma":0.000026152511,"threshold_uncertainty_score":0.99995327},"labels":[],"label_agreement":null},{"id":"W2152535380","doi":"10.2217/14622416.9.9.1267","title":"Pharmacogenetic Insights into Codeine Analgesia: Implications to Pediatric Codeine Use","year":2008,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation; Western University","funders":"","keywords":"Codeine; Pharmacogenetics; Pharmacogenomics; Medicine; Analgesic; Drug; Pharmacology; Genetic variability; Breastfeeding; Bioinformatics; Anesthesia; Biology; Genotype; Morphine; Gene; Pediatrics; Genetics","score_opus":0.2542039254300078,"score_gpt":0.48577000206218507,"score_spread":0.23156607663217726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152535380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004924945,0.98121285,0.00045852142,0.0003286775,0.0050747124,0.0048619336,0.0017907823,0.0004917864,0.00085579214],"genre_scores_gemma":[0.00084992463,0.9821591,0.0014987377,0.005545543,0.0052180863,0.0016993347,0.0012852192,0.00066468737,0.001079378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98960817,0.001775067,0.0031706572,0.0025582113,0.0006795792,0.0022083346],"domain_scores_gemma":[0.9918953,0.0014706159,0.0014108109,0.0014897904,0.00063151703,0.003101926],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0006990421,0.0025608945,0.00408072,0.0021468035,0.0013328278,0.00020018373,0.0029765328,0.0014654921,0.0012437853],"category_scores_gemma":[0.00019444236,0.0025571007,0.0018053376,0.0032716324,0.0003707335,0.00038279837,0.001283129,0.0035150393,0.004079819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000202888,0.0012340444,0.00016792762,0.0036430608,0.0024347708,0.0004004529,0.0007564219,0.001633464,0.0034576461,0.00017109573,0.074922934,0.9109753],"study_design_scores_gemma":[0.0021871817,0.000098845965,0.000028999933,0.00018573276,0.009464746,0.00044786133,0.0000069369617,0.0005177067,0.0010386062,0.00010616449,0.9834012,0.0025160497],"about_ca_topic_score_codex":0.00004085225,"about_ca_topic_score_gemma":0.000013913041,"teacher_disagreement_score":0.90847826,"about_ca_system_score_codex":0.00076911366,"about_ca_system_score_gemma":0.0017569978,"threshold_uncertainty_score":0.9999673},"labels":[],"label_agreement":null},{"id":"W2152578425","doi":"10.1016/j.gene.2013.03.128","title":"Allele frequency distribution of CYP2C9*2 and CYP2C9*3 polymorphisms in six Mexican populations","year":2013,"lang":"en","type":"article","venue":"Gene","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Instituto Mexicano del Seguro Social; Consejo Nacional de Ciencia y Tecnología","keywords":"Biology; CYP2C9; Allele; Allele frequency; Genetics; Polymorphism (computer science); Population; Genetic variation; Genotype; Demography; Gene","score_opus":0.09817265785402347,"score_gpt":0.4000857656625544,"score_spread":0.3019131078085309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152578425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930064,0.0034229462,0.00024143676,0.0009169899,0.0004559623,0.00036952365,0.00021652458,0.000027408234,0.001342818],"genre_scores_gemma":[0.9971472,0.000723704,0.001055103,0.00047508848,0.0001435982,0.00006616258,0.00020681483,0.000015561132,0.00016676875],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867594,0.00020463155,0.00040106758,0.0002460041,0.00012365234,0.00034872832],"domain_scores_gemma":[0.999358,0.000061833794,0.00012328649,0.00016644396,0.00008547502,0.00020494788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003243135,0.0001650727,0.0002513913,0.00009694581,0.000106855405,0.000011490584,0.00015754299,0.00018493085,0.0009772881],"category_scores_gemma":[0.00004271794,0.00016433328,0.000056063724,0.00023376392,0.00015135088,0.00010147001,0.00007503544,0.0002835864,0.00006131029],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038503975,0.00032018946,0.12743583,0.000017346745,0.00006702464,0.000009223929,0.00041021392,0.0004056591,0.8320053,0.007818908,0.0023234934,0.029148303],"study_design_scores_gemma":[0.0025251037,0.00008403554,0.6432438,0.000008815488,0.00015495824,0.000023472036,0.00006443613,0.0046014744,0.31353724,0.01360042,0.021731028,0.00042523613],"about_ca_topic_score_codex":0.0006674594,"about_ca_topic_score_gemma":0.000078719946,"teacher_disagreement_score":0.5184681,"about_ca_system_score_codex":0.000030693784,"about_ca_system_score_gemma":0.00004582328,"threshold_uncertainty_score":0.9999359},"labels":[],"label_agreement":null},{"id":"W2152964734","doi":"10.1124/dmd.31.7.815","title":"THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":784,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmaceutical industry; Drug; Pharmacology; Business; Drug development; In vivo; Medicine; Biology; Biotechnology","score_opus":0.13308467488237608,"score_gpt":0.4867489728515031,"score_spread":0.353664297969127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152964734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.941055,0.055523172,0.000005392152,0.0012321621,0.00050794246,0.00054369547,0.0000827555,0.000008259687,0.0010416242],"genre_scores_gemma":[0.9692654,0.030075878,0.00010312311,0.00030943888,0.00006623929,0.00006637133,0.000005114679,0.00001615681,0.00009226814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672496,0.0016570311,0.00051373086,0.0004184556,0.00025279174,0.00043304174],"domain_scores_gemma":[0.9979901,0.0012832084,0.00017351953,0.00014470308,0.00023153111,0.00017699527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002219287,0.00023608687,0.00052005594,0.00037002287,0.00023911164,0.000026091802,0.000121874764,0.00009594412,0.00003583015],"category_scores_gemma":[0.00018302536,0.00018597611,0.000052398223,0.00042963863,0.0011705814,0.0002084893,0.00011492969,0.00081239233,0.0000011199886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006956975,0.0012495931,0.0040159062,0.0003992362,0.0005015509,0.000037735415,0.048824478,0.0002287558,0.8916908,0.01913878,0.0016077554,0.025348417],"study_design_scores_gemma":[0.004797709,0.000040600546,0.0049969857,0.000052118816,0.00025259884,0.00002655678,0.04039604,0.0014159258,0.8910688,0.008183973,0.04847166,0.00029700878],"about_ca_topic_score_codex":0.00021686728,"about_ca_topic_score_gemma":0.000058809448,"teacher_disagreement_score":0.046863906,"about_ca_system_score_codex":0.00005042349,"about_ca_system_score_gemma":0.000054960532,"threshold_uncertainty_score":0.7583886},"labels":[],"label_agreement":null},{"id":"W2153126387","doi":"10.1067/mcp.2000.108023","title":"Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings*1","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Mexiletine; Propafenone; Pharmacokinetics; Pharmacology; CYP2D6; Medicine; Pharmacodynamics; Drug interaction; Oral administration; Active metabolite; Antiarrhythmic agent; Anesthesia; Cytochrome P450; Internal medicine; Metabolism; Atrial fibrillation","score_opus":0.1979069222556447,"score_gpt":0.5324100385057167,"score_spread":0.33450311625007195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153126387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840058,0.0039706766,0.000022977125,0.0056622596,0.0019333631,0.001182201,0.000078887046,0.00018950376,0.0029542993],"genre_scores_gemma":[0.9392138,0.023214782,0.00018115313,0.034615073,0.0016943117,0.00012169962,0.000051904357,0.000103237755,0.0008040133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99373144,0.0020721112,0.0016749464,0.0011518657,0.00026512478,0.00110449],"domain_scores_gemma":[0.9972735,0.0012443918,0.00034937004,0.00026473834,0.00011595291,0.0007520642],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023056709,0.00070306833,0.0010840439,0.000354172,0.00043611336,0.000051060364,0.0005284184,0.00071145303,0.004583297],"category_scores_gemma":[0.000016550628,0.0007076756,0.00018884255,0.00046778153,0.00134545,0.00025277064,0.0002573862,0.0031010618,0.0001490307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016497129,0.0017130056,0.16583458,0.00012924553,0.0014921504,0.00020129875,0.0008336613,0.00036035647,0.267144,0.00005411199,0.0024789171,0.558109],"study_design_scores_gemma":[0.027841372,0.00095209887,0.11581592,0.00006334427,0.0052390355,0.00017039894,0.00012942191,0.022027165,0.043840747,0.0013292385,0.78080654,0.001784718],"about_ca_topic_score_codex":0.000033999873,"about_ca_topic_score_gemma":0.000009516707,"teacher_disagreement_score":0.77832764,"about_ca_system_score_codex":0.00008085639,"about_ca_system_score_gemma":0.000084633844,"threshold_uncertainty_score":0.9995374},"labels":[],"label_agreement":null},{"id":"W2153709558","doi":"10.1097/01.asn.0000017575.50319.77","title":"Downregulation of Intestinal Cytochrome P450 in Chronic Renal Failure","year":2002,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; American Society of Nephrology","keywords":"Cytochrome P450; CYP3A; Endocrinology; Internal medicine; Downregulation and upregulation; Cytochrome; Drug metabolism; Gene expression; Chemistry; Biology; Medicine; Metabolism; Enzyme; Gene; Biochemistry","score_opus":0.06625344667382091,"score_gpt":0.3787255714115317,"score_spread":0.3124721247377108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153709558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927816,0.0015534345,0.0001818112,0.005086237,0.00008645937,0.00013341088,0.000013001674,0.000004681032,0.0001594118],"genre_scores_gemma":[0.99329174,0.0012335831,0.0019903386,0.0029573257,0.00044066185,0.000002860463,7.051676e-7,0.000013560223,0.00006922025],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99798065,0.0005460358,0.0007951903,0.00013326468,0.00023475286,0.0003100812],"domain_scores_gemma":[0.99749136,0.00031809273,0.0017028721,0.00017862555,0.00020974067,0.00009929408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007960185,0.00016192201,0.0006027636,0.00010652506,0.00006443906,0.0000031716825,0.00053965807,0.00013431974,0.00048825034],"category_scores_gemma":[0.000048459453,0.00012255322,0.0004557747,0.0005217957,0.0012031308,0.00007254954,0.00011910061,0.0008904415,0.0000042605125],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020459888,0.00019805269,0.0011990431,0.000026396821,0.00023719356,0.000005234174,0.00080958375,0.006143159,0.9624384,0.000055303266,0.017064746,0.011618259],"study_design_scores_gemma":[0.0061120777,0.0015936778,0.6197019,0.00008259811,0.00061150827,0.0006958653,0.00048520527,0.031449553,0.11236085,0.0012359181,0.22532062,0.0003501877],"about_ca_topic_score_codex":0.000026577745,"about_ca_topic_score_gemma":0.000011743695,"teacher_disagreement_score":0.85007757,"about_ca_system_score_codex":0.00011725344,"about_ca_system_score_gemma":0.00013775179,"threshold_uncertainty_score":0.5345999},"labels":[],"label_agreement":null},{"id":"W2153985019","doi":"10.1146/annurev.pharmtox.010909.105826","title":"Pharmacogenetics of Drug Dependence: Role of Gene Variations in Susceptibility and Treatment","year":2010,"lang":"en","type":"review","venue":"The Annual Review of Pharmacology and Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; U.S. Food and Drug Administration","keywords":"Pharmacogenetics; Drug; Genetic variation; Addiction; Heritability; Pharmacogenomics; Affect (linguistics); Biology; Gene; Genetics; Genotype; Pharmacology; Medicine; Psychology; Neuroscience","score_opus":0.06599665463926711,"score_gpt":0.45356391951325814,"score_spread":0.387567264873991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153985019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014099497,0.9796539,0.000003436428,0.0003120756,0.0010771737,0.0028122803,0.0014765074,0.000014441152,0.0005506775],"genre_scores_gemma":[0.013259329,0.9850439,0.00020232135,0.0006718538,0.00025079772,0.00036449323,0.00006964959,0.00004930987,0.00008834751],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99249685,0.0035441217,0.0023746619,0.0007180719,0.00022713501,0.0006391742],"domain_scores_gemma":[0.9945001,0.0025975367,0.0018404376,0.0004477551,0.0003602113,0.000253953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032317669,0.0007522883,0.0037497832,0.0003919569,0.00014432048,0.0000041736785,0.00081843534,0.00090888375,0.00087876007],"category_scores_gemma":[0.00019012648,0.00053890323,0.0005056112,0.0006019287,0.0017525831,0.00008121132,0.0003970923,0.0016069226,0.000008111311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017539425,0.0013349771,0.00043216854,0.024115184,0.001070766,0.000018201803,0.001198887,0.0000063958514,0.013778553,0.0009732229,0.00037710113,0.9565191],"study_design_scores_gemma":[0.002007297,0.00037007945,0.0001971807,0.0018434617,0.0088134445,0.00014410802,0.000098863966,0.00006107977,0.0126629565,0.0003959632,0.9729595,0.00044601783],"about_ca_topic_score_codex":0.00006139776,"about_ca_topic_score_gemma":0.00007057404,"teacher_disagreement_score":0.97258246,"about_ca_system_score_codex":0.000059390124,"about_ca_system_score_gemma":0.00074748055,"threshold_uncertainty_score":0.99970627},"labels":[],"label_agreement":null},{"id":"W2154141109","doi":"10.1128/aac.45.4.1184-1191.2001","title":"Amphotericin B Lipid Complex or Amphotericin B Multiple-Dose Administration to Rabbits with Elevated Plasma Cholesterol Levels: Pharmacokinetics in Plasma and Blood, Plasma Lipoprotein Levels, Distribution in Tissues, and Renal Toxicities","year":2001,"lang":"en","type":"article","venue":"Antimicrobial Agents and Chemotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia","keywords":"Pharmacokinetics; Amphotericin B; Triglyceride; Cholesterol; Pharmacology; Creatinine; Lipoprotein; Blood plasma; Distribution (mathematics); Endocrinology; Toxicity; Internal medicine; Chemistry; Medicine","score_opus":0.08963282707222787,"score_gpt":0.3636514857717986,"score_spread":0.27401865869957076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154141109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958923,0.00007118117,0.000093957366,0.0018761719,0.00019731985,0.0011842331,0.0005942081,0.000049797767,0.00004086777],"genre_scores_gemma":[0.9897843,0.0038905272,0.00065397733,0.004872656,0.00019970594,0.000055081786,0.00016767991,0.000059255788,0.00031684045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974847,0.00026411618,0.00066135084,0.00070916145,0.00019069048,0.00069001724],"domain_scores_gemma":[0.9990966,0.00012743624,0.00020253073,0.00016179548,0.00007117134,0.00034048295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037002537,0.0005485031,0.0006048176,0.0002228894,0.00021254785,0.00012755001,0.0001937282,0.00030004102,0.00021474076],"category_scores_gemma":[0.000023434846,0.00048407153,0.000036116315,0.00044576722,0.0002563415,0.00015823114,0.00009958596,0.00048986176,0.000005312614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008432563,0.00094902894,0.035729367,0.00012364968,0.00018374743,0.0002510737,0.002155903,0.000324834,0.8477848,0.000010078884,0.0010001784,0.103054754],"study_design_scores_gemma":[0.028018529,0.000819189,0.23417059,0.0001855694,0.00013978143,0.0004839434,0.00014016236,0.014414821,0.60745615,0.000008994465,0.113297425,0.00086483755],"about_ca_topic_score_codex":0.00024991375,"about_ca_topic_score_gemma":0.0011887216,"teacher_disagreement_score":0.24032867,"about_ca_system_score_codex":0.000051201507,"about_ca_system_score_gemma":0.0000752174,"threshold_uncertainty_score":0.9997611},"labels":[],"label_agreement":null},{"id":"W2155663558","doi":"10.1124/dmd.32.4.367","title":"TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS","year":2004,"lang":"en","type":"review","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Endogeny; Xenobiotic; Cytochrome P450; Biology; Gene; Drug metabolism; Aryl hydrocarbon receptor; Transcriptional regulation; Gene expression; Regulation of gene expression; Transcription factor; Chemical biology; Biochemistry; Computational biology; Metabolism; Enzyme","score_opus":0.09645135171304067,"score_gpt":0.4007837565954398,"score_spread":0.3043324048823991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155663558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006332996,0.987216,0.000060809743,0.00004644647,0.0006566829,0.0011089005,0.0039948127,0.00005451724,0.0005288498],"genre_scores_gemma":[0.008819202,0.98841846,0.00017994706,0.0001747861,0.00044816834,0.00020262931,0.0015243657,0.00008348686,0.00014895119],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671394,0.00062257686,0.0010068369,0.00075638347,0.00033147584,0.0005687989],"domain_scores_gemma":[0.9984047,0.00022723665,0.00050309196,0.00026795987,0.00010567316,0.0004913384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056877796,0.00075048005,0.0019788272,0.00026422573,0.00031682866,0.000044980487,0.0003106019,0.00073845714,0.00029626093],"category_scores_gemma":[0.000013957113,0.00064679113,0.0004163854,0.00025316625,0.00042347188,0.00016715932,0.00013801444,0.0007485427,0.000017175624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010474602,0.0004731651,0.000001681947,0.008374464,0.00042052296,0.000023247958,0.0005474625,0.0000052731616,0.2662282,0.0011435568,0.0003334539,0.7223442],"study_design_scores_gemma":[0.0016170577,0.000027221073,0.000027427637,0.0009309521,0.0046530203,0.00029399391,0.000024826177,0.000012002498,0.025149662,0.0005183003,0.96610856,0.0006369693],"about_ca_topic_score_codex":0.000035903286,"about_ca_topic_score_gemma":8.9226626e-7,"teacher_disagreement_score":0.96577513,"about_ca_system_score_codex":0.000041404008,"about_ca_system_score_gemma":0.000197987,"threshold_uncertainty_score":0.9995983},"labels":[],"label_agreement":null},{"id":"W2156003012","doi":"10.1007/s10549-010-0902-3","title":"Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis","year":2010,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Tamoxifen; CYP2D6; Breast cancer; Medicine; Oncology; Internal medicine; Genotype; Hazard ratio; Meta-analysis; Adjuvant therapy; Cancer; Pharmacology; Confidence interval; Biology; Cytochrome P450; Genetics","score_opus":0.5229333359174899,"score_gpt":0.5894168278163905,"score_spread":0.06648349189890057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156003012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006217097,0.9778647,5.041813e-7,0.00040754225,0.00008997757,0.0015405394,0.013512984,0.000012717991,0.000353936],"genre_scores_gemma":[0.017580613,0.98001444,0.000048282,0.000044507804,0.000118164804,0.0009694454,0.0001414589,0.0000451442,0.0010379283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958511,0.0012027452,0.0010114117,0.0007692223,0.0005191053,0.00064642844],"domain_scores_gemma":[0.99690455,0.0010731064,0.00056293735,0.00056830974,0.00036935453,0.0005217608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001552362,0.0006253958,0.004639549,0.0008034114,0.00018368107,0.000028401197,0.0003603606,0.00043818797,0.0008141427],"category_scores_gemma":[0.000027413911,0.00036792568,0.0012378314,0.00081963517,0.0007766098,0.000048989023,0.0002180363,0.0008670084,0.0000069790026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065533066,0.0011210587,0.00016852618,0.0007690351,0.18164197,0.000032024345,0.00021336722,0.000004218701,0.00029326245,0.00008331079,0.00010558929,0.8149123],"study_design_scores_gemma":[0.0029135372,0.00049341295,0.0020867607,0.000059852864,0.16086493,0.000033659104,0.00001195967,0.000009797177,0.0004850885,0.00010064357,0.83263564,0.00030473134],"about_ca_topic_score_codex":0.0016775051,"about_ca_topic_score_gemma":0.00032113382,"teacher_disagreement_score":0.83253,"about_ca_system_score_codex":0.00008304232,"about_ca_system_score_gemma":0.0005767357,"threshold_uncertainty_score":0.9998773},"labels":[],"label_agreement":null},{"id":"W2156466727","doi":"10.2217/pgs.12.197","title":"An Evaluation of Pharmacists‘ Expectations Towards Pharmacogenomics","year":2013,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Medicine; Clinical Practice; Test (biology); Family medicine; Clinical pharmacy; Pharmacotherapy; Pharmacy; Medical education; Pharmacology; Nursing","score_opus":0.21882436163117444,"score_gpt":0.4939361860743263,"score_spread":0.27511182444315185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156466727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97329587,0.006240789,0.00046634543,0.00026083447,0.0033229936,0.0024082423,0.0005079611,0.00022395283,0.013273003],"genre_scores_gemma":[0.9913452,0.002500497,0.001779444,0.0019065796,0.001099569,0.0007888591,0.00026928817,0.00014907675,0.00016144454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940808,0.0015572179,0.0014044147,0.0009038534,0.0009679292,0.0010858076],"domain_scores_gemma":[0.99566674,0.00023286315,0.0006775972,0.0006496693,0.0016861465,0.0010869601],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0026656752,0.00070405856,0.0007294054,0.0005108132,0.00043698456,0.00009594176,0.0012650845,0.00034172018,0.014461098],"category_scores_gemma":[0.00010296322,0.0007577022,0.00038410435,0.00067014934,0.00040104953,0.0008329996,0.00019627364,0.0009472733,0.001126229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001593774,0.0009068851,0.0006338304,0.000040438965,0.00044290544,0.0000059787303,0.0017008118,0.008998259,0.7113251,0.00022038408,0.0025064077,0.2730596],"study_design_scores_gemma":[0.0068065478,0.00008852696,0.0008775167,0.0000056639146,0.0017699584,0.000038398735,0.00052501075,0.24248938,0.71073496,0.0016249834,0.03423021,0.0008088549],"about_ca_topic_score_codex":0.00007481406,"about_ca_topic_score_gemma":0.0000026577777,"teacher_disagreement_score":0.27225074,"about_ca_system_score_codex":0.00029423722,"about_ca_system_score_gemma":0.0006706193,"threshold_uncertainty_score":0.9996515},"labels":[],"label_agreement":null},{"id":"W2156560694","doi":"10.1080/0049825021000017948","title":"Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine","year":2003,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"Medical Research Council; Heart and Stroke Foundation of Canada","keywords":"CYP1A2; CYP2B6; CYP2E1; Microsome; Chemistry; Cytochrome P450; Enantiomer; Mexiletine; Enzyme; Pharmacology; Biochemistry; CYP3A4; Stereochemistry; Internal medicine; Biology; Medicine","score_opus":0.059021881531100676,"score_gpt":0.3674600806618039,"score_spread":0.30843819913070325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156560694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798614,0.0049401294,0.00001933596,0.0006590958,0.0004073245,0.0005410708,0.00004257792,0.000009331589,0.01351978],"genre_scores_gemma":[0.9981918,0.00088709407,0.00011467456,0.0005608073,0.00010994072,0.000012975187,0.0000054283832,0.000014203949,0.000103094644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785465,0.00095895055,0.0004642074,0.0002020632,0.00022607161,0.0002940721],"domain_scores_gemma":[0.99901295,0.00028471331,0.00021640776,0.00035516577,0.000074885415,0.000055872442],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011616722,0.00016230471,0.00025591874,0.000086487235,0.000101481266,0.000007966306,0.0004248025,0.00015405503,0.0010014455],"category_scores_gemma":[0.00008847726,0.000103908525,0.0001249032,0.0004086508,0.00027620434,0.00003296711,0.000059845395,0.00042679097,0.000036909172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052404866,0.0003166935,0.0020465732,0.000027862723,0.000045035515,0.000004014155,0.0010384212,0.00030118725,0.96233606,0.031627543,0.00065256155,0.0015516486],"study_design_scores_gemma":[0.0007837662,0.00003093771,0.04392257,0.00001209884,0.000076938486,0.000019133784,0.00017859046,0.00012119819,0.80432147,0.0012392686,0.1491921,0.00010193941],"about_ca_topic_score_codex":0.000009703138,"about_ca_topic_score_gemma":0.0000061107007,"teacher_disagreement_score":0.15801458,"about_ca_system_score_codex":0.000018189683,"about_ca_system_score_gemma":0.00007377535,"threshold_uncertainty_score":0.9999118},"labels":[],"label_agreement":null},{"id":"W2156687558","doi":"10.1001/archinte.165.10.1095","title":"Systematic Overview of Warfarin and Its Drug and Food Interactions","year":2005,"lang":"en","type":"review","venue":"Archives of Internal Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Warfarin; Medicine; MEDLINE; Drug; Rofecoxib; Adverse effect; Drug interaction; Anticoagulant; Intensive care medicine; Pharmacology; Internal medicine; Cyclooxygenase; Atrial fibrillation","score_opus":0.22077615148656668,"score_gpt":0.5050865627263667,"score_spread":0.28431041123979994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156687558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009298231,0.99370563,0.000020843503,0.00014176643,0.0008340664,0.0007913398,0.00014260487,0.00001173857,0.0034222028],"genre_scores_gemma":[0.0091978,0.9892295,0.00008133638,0.00021037707,0.00036870586,0.000057091638,0.000012168333,0.00003247515,0.00081054255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972197,0.00072744745,0.0013614205,0.00030141952,0.000163442,0.00022660829],"domain_scores_gemma":[0.99622077,0.002319339,0.00097532076,0.00019003116,0.00004933049,0.00024523138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052943383,0.0003862626,0.002336399,0.0004103847,0.000045514927,0.0000039691604,0.00036697031,0.00010903359,0.00024884913],"category_scores_gemma":[0.00020414099,0.00026794116,0.00023330188,0.00011393551,0.0003787597,0.00004594679,0.00027921138,0.00079535024,0.000006253244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045134413,0.00014092548,0.00001825996,0.2587694,0.0019245453,0.000008987111,0.001678771,0.0000011987343,0.00031806988,0.0021798545,0.00023985504,0.734675],"study_design_scores_gemma":[0.0011908296,0.00022029222,0.000020459105,0.12970823,0.005555464,0.00031500083,0.00010430193,0.0004502418,0.00029116386,0.00034277167,0.8615368,0.00026445408],"about_ca_topic_score_codex":0.000018840856,"about_ca_topic_score_gemma":0.000010225921,"teacher_disagreement_score":0.86129695,"about_ca_system_score_codex":0.000010551397,"about_ca_system_score_gemma":0.00005426628,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W2156704652","doi":"10.1002/jps.10031","title":"Effect of omeprazole on oral and intravenous RS‐methadone pharmacokinetics and pharmacodynamics in the rat","year":2002,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Omeprazole; Pharmacokinetics; Pharmacodynamics; Pharmacology; Methadone; Medicine","score_opus":0.10772097302449643,"score_gpt":0.45785001049302093,"score_spread":0.35012903746852453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156704652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818956,0.011563069,0.000029820469,0.0027707568,0.0012718485,0.00040528938,0.000019633564,0.000009903964,0.0020340707],"genre_scores_gemma":[0.97869927,0.01803188,0.0001896703,0.0027672437,0.00025585573,0.000008094078,5.3539696e-7,0.000015600555,0.00003186829],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952483,0.002261054,0.000856739,0.0003263506,0.00069729984,0.0006102642],"domain_scores_gemma":[0.9960935,0.0028497612,0.0004266654,0.0001145527,0.00010377639,0.00041170782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0090018455,0.00034155467,0.0006256432,0.00038648362,0.00025705746,0.00006459578,0.00070423016,0.00016357492,0.00046513206],"category_scores_gemma":[0.00032543746,0.00021358544,0.00013263283,0.0007544836,0.001430424,0.00022313718,0.00013091267,0.0014808609,0.000008653419],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021738128,0.0014447572,0.014087281,0.0002813856,0.00024314661,0.00035783267,0.002694015,0.002371266,0.2518909,0.001394056,0.0017841043,0.7212775],"study_design_scores_gemma":[0.023087835,0.007073863,0.004725305,0.00015531851,0.0020437075,0.0018120616,0.0005548338,0.21194391,0.53902024,0.0010884046,0.20747378,0.0010207146],"about_ca_topic_score_codex":0.0000059378967,"about_ca_topic_score_gemma":0.0000015672892,"teacher_disagreement_score":0.72025675,"about_ca_system_score_codex":0.00003188031,"about_ca_system_score_gemma":0.000039445615,"threshold_uncertainty_score":0.8709762},"labels":[],"label_agreement":null},{"id":"W2157062572","doi":"10.1111/j.1365-2125.2006.02629.x","title":"Paroxetine: population pharmacokinetic analysis in late‐life depression using sparse concentration sampling","year":2006,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Baycrest Hospital","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Mental Health","keywords":"Paroxetine; NONMEM; CYP2D6; Pharmacokinetics; Population; Depression (economics); Medicine; Internal medicine; Volume of distribution; Serotonin","score_opus":0.19456734297451442,"score_gpt":0.5156837161460757,"score_spread":0.3211163731715613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157062572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827954,0.007759615,0.0016248871,0.00028176696,0.006599727,0.00040687385,0.000055107022,0.000034025485,0.0004425989],"genre_scores_gemma":[0.9876889,0.004041546,0.0013714073,0.0026091777,0.0041143172,0.000009786491,0.00006237534,0.000041515403,0.000060980186],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9917975,0.0027689543,0.0037209978,0.0005190222,0.00044385786,0.00074964034],"domain_scores_gemma":[0.9955972,0.0012395537,0.0019784812,0.00012841697,0.00043923408,0.0006171023],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004864193,0.00033942494,0.0014043039,0.00046376188,0.00023210548,0.00006233482,0.0004783204,0.00057830766,0.002148108],"category_scores_gemma":[0.00038964543,0.00039022643,0.00068797346,0.0010848427,0.00024416466,0.00033723406,0.00011381463,0.0021850802,0.000015668787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001197279,0.0013321922,0.4393355,0.00003139159,0.0008660752,0.0007166464,0.000041380023,0.4720604,0.046305977,0.000016744903,0.0027458665,0.03535056],"study_design_scores_gemma":[0.01842042,0.0001373052,0.7051605,0.000072475,0.0064747725,0.00034318358,0.00002194161,0.23252189,0.0086417375,0.0008432767,0.026666002,0.000696506],"about_ca_topic_score_codex":0.00041380592,"about_ca_topic_score_gemma":0.00008058789,"teacher_disagreement_score":0.265825,"about_ca_system_score_codex":0.00009841331,"about_ca_system_score_gemma":0.00026985534,"threshold_uncertainty_score":0.999855},"labels":[],"label_agreement":null},{"id":"W2157932545","doi":"10.1177/00912700022009558","title":"Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Sainte Foy","funders":"","keywords":"Bioequivalence; Warfarin; Medicine; Pharmacokinetics; Crossover study; Pharmacology; Therapeutic index; Replicate; CYP2C9; Internal medicine; Drug; Statistics; Mathematics; Placebo","score_opus":0.421124098491936,"score_gpt":0.5880239667940168,"score_spread":0.1668998683020808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157932545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95296407,0.02396154,0.00049193745,0.01045074,0.0099080475,0.0015557198,0.0002248271,0.000038328264,0.00040482086],"genre_scores_gemma":[0.95246047,0.013685669,0.00032224943,0.026165683,0.005625824,0.00011888119,0.0000043895498,0.000062916515,0.0015539271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932654,0.0026400182,0.0025165847,0.0003218655,0.00033762518,0.00091852696],"domain_scores_gemma":[0.9845149,0.01265185,0.0012639601,0.00025305228,0.000789224,0.0005270317],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011560675,0.00045472174,0.0013809794,0.00025940622,0.0006662938,0.000027662649,0.001262336,0.00052829727,0.0015189149],"category_scores_gemma":[0.00047408824,0.00030945273,0.0008156457,0.00039012593,0.0012247084,0.0001966038,0.00014637999,0.0019035278,0.000031615753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03144833,0.0024309678,0.0018404482,0.00032206296,0.009836498,0.00044637374,0.010813419,0.008350524,0.013964014,0.00056752126,0.2306054,0.68937445],"study_design_scores_gemma":[0.022960665,0.0022764516,0.00053448067,0.000025507152,0.0076781088,0.0020848496,0.0016333398,0.008402975,0.013497857,0.0070613325,0.9332677,0.0005767379],"about_ca_topic_score_codex":0.0000046447135,"about_ca_topic_score_gemma":0.0000033628237,"teacher_disagreement_score":0.7026623,"about_ca_system_score_codex":0.000047587884,"about_ca_system_score_gemma":0.00038821693,"threshold_uncertainty_score":0.99993575},"labels":[],"label_agreement":null},{"id":"W2158213155","doi":"10.1007/s11095-004-9010-6","title":"Selective Downregulation of Hepatic Cytochrome P450 Expression and Activity in a Rat Model of Inflammatory Pain","year":2005,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Université de Montréal","funders":"","keywords":"CYP2E1; Downregulation and upregulation; Cytochrome P450; Pharmacology; Chemistry; Inflammation; Endocrinology; Messenger RNA; Pharmacokinetics; Internal medicine; Medicine; Metabolism; Biochemistry","score_opus":0.24672603893382727,"score_gpt":0.5226125022133294,"score_spread":0.27588646327950217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158213155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494225,0.0014457823,0.0007639931,0.00055032584,0.000046219746,0.0008665508,0.00003583481,0.000022962251,0.0013260803],"genre_scores_gemma":[0.9976359,0.0011932848,0.00061768095,0.00017147687,0.000120043806,0.000116300704,0.0000044530207,0.000027823873,0.000113019094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945337,0.0030139897,0.0006043293,0.00044141713,0.00067634875,0.00073022355],"domain_scores_gemma":[0.9967736,0.0020764843,0.00014532254,0.00022045223,0.0003726556,0.00041150308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007797592,0.0002295422,0.00046193617,0.0005429292,0.00013933203,0.000011982937,0.0002990586,0.0003105202,0.00026370268],"category_scores_gemma":[0.0006937444,0.00021960633,0.00008391756,0.00060440955,0.00068916695,0.00023298169,0.00030060136,0.0015194006,0.000012432647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001396552,0.0006671901,0.003915679,0.00029556404,0.000040429542,0.0000044495,0.0009964319,0.011627197,0.92380923,0.00053196197,0.0001947994,0.056520496],"study_design_scores_gemma":[0.0017351537,0.00005628362,0.0038060942,0.00003457035,0.000025594576,0.0000013187201,0.00002571677,0.4185486,0.57313424,0.0009399102,0.0015722746,0.000120228455],"about_ca_topic_score_codex":0.000016119264,"about_ca_topic_score_gemma":0.000015955136,"teacher_disagreement_score":0.40692142,"about_ca_system_score_codex":0.0001335329,"about_ca_system_score_gemma":0.0002719733,"threshold_uncertainty_score":0.8955286},"labels":[],"label_agreement":null},{"id":"W2158774304","doi":"10.1124/dmd.114.062877","title":"Quantitative Profiling of Human Renal UDP-glucuronosyltransferases and Glucuronidation Activity: A Comparison of Normal and Tumoral Kidney Tissues","year":2015,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Center for Research Resources; Canadian Institutes of Health Research","keywords":"Glucuronidation; UGT2B7; Kidney; Chemistry; Glucuronosyltransferase; Endocrinology; Internal medicine; Metabolism; Enzyme; Biology; Biochemistry; Microsome; Medicine","score_opus":0.11136422580705083,"score_gpt":0.43878405707872914,"score_spread":0.3274198312716783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158774304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879235,0.009943792,0.0005618753,0.00022047626,0.0002578226,0.00034940557,0.00030727775,0.000022389788,0.00041347073],"genre_scores_gemma":[0.99784976,0.00079950516,0.00094586686,0.00011179632,0.00010429744,0.000020619022,0.0001293833,0.000016234815,0.000022518494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984324,0.00044565063,0.00041002722,0.00029164247,0.00018975581,0.00023052368],"domain_scores_gemma":[0.99903977,0.00011869678,0.00023764676,0.000094523195,0.00015777293,0.00035160856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061390415,0.00022043393,0.00051626563,0.00016593143,0.00016545544,0.000025016043,0.00007651913,0.00011128623,0.000023102262],"category_scores_gemma":[0.00005624852,0.00021232493,0.00004437782,0.00014080977,0.00037757546,0.00033362713,0.000070130314,0.00024966762,0.0000010860058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011015389,0.00043850107,0.018018566,0.00022726117,0.00012372165,0.0000032285695,0.0064758495,0.000096818825,0.94080204,0.014717795,0.00015876716,0.017835895],"study_design_scores_gemma":[0.0031390258,0.00024563455,0.023705078,0.000041704836,0.0006333032,0.000009293639,0.0008921416,0.0063647423,0.9619044,0.0010869678,0.0017174928,0.0002602291],"about_ca_topic_score_codex":0.00012484839,"about_ca_topic_score_gemma":0.000013097513,"teacher_disagreement_score":0.021102328,"about_ca_system_score_codex":0.0000075220873,"about_ca_system_score_gemma":0.00006217149,"threshold_uncertainty_score":0.86583596},"labels":[],"label_agreement":null},{"id":"W2159639329","doi":"10.1124/jpet.103.052183","title":"Rat Hepatic CYP2E1 Is Induced by Very Low Nicotine Doses: An Investigation of Induction, Time Course, Dose Response, and Mechanism","year":2003,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"CYP2E1; Nicotine; Cotinine; Pharmacology; Metabolite; Chemistry; Toxicity; Tobacco smoke; Enzyme inducer; Toxicology; Internal medicine; Endocrinology; Medicine; Biochemistry; Biology; Metabolism; Enzyme; Cytochrome P450","score_opus":0.06326835787656508,"score_gpt":0.40740661538548645,"score_spread":0.34413825750892135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159639329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852201,0.011413072,0.000017701592,0.00085587695,0.0020470975,0.0003322328,0.00003677515,0.000016874052,0.00006028688],"genre_scores_gemma":[0.9890435,0.0026132734,0.0003124315,0.0075981207,0.00021359544,0.000013411768,0.000007068655,0.000039397484,0.00015923526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963943,0.0018340508,0.000841593,0.00029597955,0.00025503262,0.000379094],"domain_scores_gemma":[0.9982127,0.0003268057,0.00071754685,0.00012268187,0.0002329084,0.0003873782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018138543,0.000354285,0.00057507475,0.00021220498,0.00026124626,0.000026701055,0.00022709799,0.0004181,0.0006888262],"category_scores_gemma":[0.000016872564,0.00032992382,0.000098462886,0.00023164884,0.00046127554,0.00030612075,0.0000601297,0.000808867,0.0000069932735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027829728,0.0008254131,0.00086701376,0.000026203408,0.0005761805,0.000011912435,0.00358013,0.000016515582,0.98819333,0.00016730416,0.0014964134,0.00145659],"study_design_scores_gemma":[0.006364233,0.0013078114,0.00039236623,0.000014596438,0.0006645333,0.00021345078,0.0006990466,0.00068488566,0.97948116,0.00096114614,0.008916514,0.00030028154],"about_ca_topic_score_codex":0.0000033813517,"about_ca_topic_score_gemma":2.8035754e-7,"teacher_disagreement_score":0.008799799,"about_ca_system_score_codex":0.00006399742,"about_ca_system_score_gemma":0.00028236213,"threshold_uncertainty_score":0.9999153},"labels":[],"label_agreement":null},{"id":"W2160380703","doi":"10.1124/dmd.114.060285","title":"Gene Variants in CYP2C19 Are Associated with Altered In Vivo Bupropion Pharmacokinetics but Not Bupropion-Assisted Smoking Cessation Outcomes","year":2014,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Center for Research Resources; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Bupropion; CYP2C19; Pharmacology; CYP2B6; Pharmacokinetics; Active metabolite; Medicine; Smoking cessation; Internal medicine; CYP3A4; Cytochrome P450; Metabolism","score_opus":0.04157439323671207,"score_gpt":0.33988079053459275,"score_spread":0.29830639729788067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160380703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946755,0.0009803163,0.00037352694,0.0007580685,0.0014346527,0.0006974763,0.00030822534,0.00009287186,0.00067936105],"genre_scores_gemma":[0.9956366,0.00091888633,0.0002117005,0.002224682,0.0003525686,0.00013863144,0.00021014351,0.000058465055,0.00024831906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961853,0.0012190935,0.0007677705,0.0007024124,0.0004240997,0.0007013],"domain_scores_gemma":[0.9984857,0.0003411376,0.00047071752,0.00024967693,0.00016410266,0.00028866192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013978966,0.0004993063,0.0007609154,0.0005152101,0.00025766814,0.00008712869,0.00025328848,0.00033918893,0.00018204132],"category_scores_gemma":[0.00013129826,0.00044137528,0.000093706556,0.00061290635,0.00014735144,0.00036014864,0.00010569779,0.00076067867,0.000008451929],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015475164,0.0019593944,0.2962997,0.00016446286,0.00037730864,0.00010046745,0.0027453017,0.0034777042,0.651784,0.001371735,0.00038289247,0.03978954],"study_design_scores_gemma":[0.010956345,0.000036576963,0.8115776,0.00009172034,0.00049144315,0.000014557966,0.00015538739,0.01834383,0.15456158,0.0003737795,0.0027811292,0.0006160174],"about_ca_topic_score_codex":0.00027329646,"about_ca_topic_score_gemma":0.0003041288,"teacher_disagreement_score":0.5152779,"about_ca_system_score_codex":0.00008956533,"about_ca_system_score_gemma":0.000055215038,"threshold_uncertainty_score":0.9998038},"labels":[],"label_agreement":null},{"id":"W2160706662","doi":"10.1124/dmd.30.9.991","title":"N-Glucuronidation of Nicotine and Cotinine in Human: Formation of Cotinine Glucuronide in Liver Microsomes and Lack of Catalysis by 10 Examined UDP-Glucuronosyltransferases","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Glucuronidation; Glucuronide; Cotinine; Chemistry; Metabolite; UGT2B7; Microsome; Nicotine; Chromatography; Microsoma; Electrospray ionization; Enzyme; Mass spectrometry; Biochemistry; Internal medicine","score_opus":0.06293668385582499,"score_gpt":0.3557887957136797,"score_spread":0.29285211185785476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160706662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96813756,0.030548325,0.00005846414,0.00015617846,0.00008209071,0.0003746949,0.0003772892,0.000009748522,0.0002556507],"genre_scores_gemma":[0.9822305,0.01706222,0.000105090854,0.000102123995,0.000036195088,0.000020080428,0.00031750413,0.000016453783,0.00010983212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980937,0.00035166665,0.0008525605,0.0002986594,0.0001551059,0.00024830198],"domain_scores_gemma":[0.9990989,0.00021387299,0.00034645668,0.00012901693,0.00010156152,0.000110177076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005702177,0.00024113189,0.00063001347,0.00036250253,0.00006754056,0.0000111979425,0.000098680146,0.00014741402,0.000218087],"category_scores_gemma":[0.000041766423,0.00024406986,0.000052834395,0.0003371861,0.00032176517,0.00033147418,0.00006006718,0.0002018478,0.0000012918689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036302814,0.00079406594,0.012568715,0.0005467739,0.000055142846,0.000002283329,0.0036952356,0.000112482725,0.9653273,0.0008422782,0.0002864678,0.015406176],"study_design_scores_gemma":[0.006352518,0.00010764601,0.068088874,0.000080542035,0.00041620602,0.00000891838,0.0002487543,0.0065741404,0.9154091,0.0001259282,0.002316515,0.00027087078],"about_ca_topic_score_codex":0.0002459355,"about_ca_topic_score_gemma":0.00010173416,"teacher_disagreement_score":0.05552016,"about_ca_system_score_codex":0.000011114411,"about_ca_system_score_gemma":0.000011274834,"threshold_uncertainty_score":0.995288},"labels":[],"label_agreement":null},{"id":"W2160787317","doi":"","title":"Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Bioequivalence; Bioavailability; Warfarin; Pharmacokinetics; Pharmacology; Medicine; Internal medicine","score_opus":0.19565525350017038,"score_gpt":0.4305156957269867,"score_spread":0.23486044222681635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160787317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94616675,0.026656326,0.018688908,0.0011749926,0.0021039995,0.0037193056,0.0010855711,0.00006392208,0.0003402215],"genre_scores_gemma":[0.99503404,0.0032248439,0.00003422986,0.00086553325,0.00019716064,0.00046905826,0.0000083309415,0.000026790825,0.00014002624],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99758595,0.00034932306,0.00062441616,0.00036341153,0.0004952525,0.0005816403],"domain_scores_gemma":[0.9978703,0.0006031646,0.00050415646,0.00042135332,0.00047347197,0.00012755624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018732911,0.00026748408,0.0003539326,0.00008516118,0.00028766508,0.000024080058,0.00085504993,0.00013674145,0.00018935643],"category_scores_gemma":[0.00006264599,0.00016952114,0.00020265717,0.0004868599,0.0006029167,0.00008468302,0.000102162136,0.00043413855,0.000002149787],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063178357,0.0003517225,0.0019119639,0.00011507764,0.00013840682,4.0869097e-7,0.0010418679,0.33653823,0.00046058072,0.00032348602,0.0006047219,0.65788174],"study_design_scores_gemma":[0.0019962282,0.000037959497,0.027516125,0.000018646457,0.00042241137,0.0000013926177,0.000091510694,0.87765723,0.019301273,0.0006103771,0.072096586,0.0002502698],"about_ca_topic_score_codex":0.0000061504998,"about_ca_topic_score_gemma":0.0000032090902,"teacher_disagreement_score":0.6576315,"about_ca_system_score_codex":0.000055369102,"about_ca_system_score_gemma":0.000119366916,"threshold_uncertainty_score":0.69128716},"labels":[],"label_agreement":null},{"id":"W2160975047","doi":"10.1002/9780470921920.edm036","title":"Physiologically Based Pharmacokinetic (<scp>PBPK</scp>) Modeling: Usefulness and Applications","year":2012,"lang":"en","type":"other","venue":"Encyclopedia of Drug Metabolism and Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Transporter; Drug; Chemistry; Computational biology; Drug metabolism; Biology; Biochemistry","score_opus":0.05412130262230114,"score_gpt":0.3674084926980199,"score_spread":0.31328719007571876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160975047","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030872798,0.08914528,0.0037450446,0.0002906412,0.0063254335,0.0023536342,0.0019742805,0.00043209567,0.8648608],"genre_scores_gemma":[0.27346796,0.18798605,0.0044172513,0.0033634987,0.01174396,0.002690784,0.0007850856,0.0012524216,0.514293],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971952,0.0004785028,0.0007201431,0.000708482,0.00025049355,0.00064721634],"domain_scores_gemma":[0.99768233,0.00059094775,0.00055124296,0.0004119716,0.00014554983,0.0006179687],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040669847,0.0006863771,0.00095810584,0.0005586984,0.00024394644,0.000032328826,0.00041505287,0.00046134953,0.0024046067],"category_scores_gemma":[0.00009364638,0.00062900136,0.00021639513,0.00032446737,0.00038118448,0.00016414488,0.00024063198,0.0012454444,0.00010996085],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018245968,0.00435958,0.0015183355,0.001805225,0.0027641766,0.000018713019,0.0030392963,0.002367866,0.033065554,0.010030717,0.7227385,0.21810956],"study_design_scores_gemma":[0.0013734342,0.0000125307915,0.00030607404,0.000044863296,0.0015451175,0.000011883889,0.00014744479,0.0049877865,0.0021125607,0.0003651133,0.98877466,0.00031850985],"about_ca_topic_score_codex":0.00007891842,"about_ca_topic_score_gemma":0.00001509133,"teacher_disagreement_score":0.35056782,"about_ca_system_score_codex":0.000013892857,"about_ca_system_score_gemma":0.00010833673,"threshold_uncertainty_score":0.99961615},"labels":[],"label_agreement":null},{"id":"W2161324288","doi":"10.1128/jb.187.2.415-421.2005","title":"Evolutionarily Divergent Extradiol Dioxygenases Possess Higher Specificities for Polychlorinated Biphenyl Metabolites","year":2005,"lang":"en","type":"article","venue":"Journal of Bacteriology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Biphenyl; Polychlorinated biphenyl; Genetics; Biochemistry; Ecology","score_opus":0.12245253915983284,"score_gpt":0.40296770736415893,"score_spread":0.2805151682043261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161324288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96625376,0.020989655,0.0004937327,0.0023832205,0.008484518,0.00030707492,0.0003026412,0.000034025074,0.0007513514],"genre_scores_gemma":[0.9857612,0.0028959273,0.002622308,0.0017287745,0.0052802507,0.000030547722,0.000028462007,0.000038058322,0.001614442],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765664,0.0004057187,0.00089083164,0.00026413857,0.00017809372,0.0006045893],"domain_scores_gemma":[0.9978666,0.00047883583,0.0006892168,0.00016975148,0.000432343,0.00036330035],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008176755,0.00032246695,0.0007208207,0.0003202088,0.00023515485,0.000027959046,0.00048864284,0.00032300016,0.0027095089],"category_scores_gemma":[0.00009878903,0.0002691913,0.00040498908,0.00017046521,0.0002753472,0.0002474792,0.00008081441,0.00058920094,0.00004236359],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003179607,0.00078646105,0.009191771,0.000059185862,0.0015259231,0.000066122615,0.0007478536,0.0015888653,0.9209077,0.010344331,0.02225222,0.029349955],"study_design_scores_gemma":[0.0027922033,0.00028934717,0.035213646,0.000009353705,0.0004048498,0.00020240813,0.00007549294,0.0003069596,0.069542706,0.0007775696,0.89009595,0.00028952377],"about_ca_topic_score_codex":0.0000043837854,"about_ca_topic_score_gemma":0.000001839918,"teacher_disagreement_score":0.86784375,"about_ca_system_score_codex":0.00010299276,"about_ca_system_score_gemma":0.00015837306,"threshold_uncertainty_score":0.99997604},"labels":[],"label_agreement":null},{"id":"W2161620765","doi":"10.1002/cpt.147","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":975,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute","keywords":"Fluvoxamine; Escitalopram; Citalopram; CYP2C19; Paroxetine; Pharmacogenetics; Sertraline; Dosing; Medicine; Pharmacology; CYP2D6; Fluoxetine; Psychiatry; Anxiety; Serotonin; Internal medicine; Genotype; Antidepressant; Biology","score_opus":0.294731120690238,"score_gpt":0.567269353284168,"score_spread":0.27253823259393006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161620765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96729636,0.014255148,0.0013213259,0.005628859,0.007798996,0.0027716062,0.0004655329,0.00012669107,0.000335463],"genre_scores_gemma":[0.8777315,0.022861347,0.010054307,0.08552342,0.0031857784,0.0002358772,0.00012186957,0.00015124372,0.00013467977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99223787,0.0021667879,0.0032663096,0.0010658535,0.0003264328,0.00093672663],"domain_scores_gemma":[0.9937359,0.0025791677,0.0012366496,0.0002974693,0.0011128357,0.0010379445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006587692,0.00063449563,0.0013127226,0.00019575036,0.00032577923,0.000036996535,0.0004532022,0.00088828785,0.00013300325],"category_scores_gemma":[0.00014545229,0.0006249586,0.0003514998,0.00034919707,0.0017986282,0.00016204698,0.0003736239,0.0014446918,0.000012810674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00837423,0.0026753552,0.26882976,0.00022909885,0.005837528,0.00004021956,0.0022733714,0.0004694693,0.23720703,0.00025787012,0.15961765,0.31418842],"study_design_scores_gemma":[0.022838846,0.001601697,0.0044578686,0.000014688391,0.005531495,0.000044917022,0.0005062493,0.0075472887,0.16707994,0.001218958,0.7883738,0.0007841996],"about_ca_topic_score_codex":0.000015607518,"about_ca_topic_score_gemma":0.000013951189,"teacher_disagreement_score":0.62875617,"about_ca_system_score_codex":0.00006332676,"about_ca_system_score_gemma":0.00062004273,"threshold_uncertainty_score":0.9996202},"labels":[],"label_agreement":null},{"id":"W2161713195","doi":"10.1016/j.jchromb.2013.11.014","title":"Determination of warfarin alcohols by ultra-high performance liquid chromatography–tandem mass spectrometry: Application to in vitro enzyme kinetic studies","year":2013,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Chemistry; Chromatography; Tandem mass spectrometry; Mass spectrometry; Liquid chromatography–mass spectrometry; Tandem; Enzyme; Warfarin; Biochemistry","score_opus":0.034846416972938075,"score_gpt":0.3609922328969089,"score_spread":0.32614581592397085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161713195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891912,0.0066612167,0.0019985025,0.00037621547,0.0006280407,0.000720859,0.00003411488,0.00002517504,0.0003646935],"genre_scores_gemma":[0.98980296,0.0053878212,0.0039029168,0.0005348496,0.00020753035,0.00010565119,0.000009242951,0.000034893645,0.000014112744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712884,0.00031253387,0.001272194,0.0002946901,0.0004701762,0.00052156526],"domain_scores_gemma":[0.9978009,0.00026074043,0.0009054749,0.00023392047,0.00047766685,0.00032128842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010355691,0.00034517454,0.0008030825,0.0013277095,0.00010235425,0.00002652225,0.00052954635,0.00023527419,0.00013547495],"category_scores_gemma":[0.00006038316,0.0003110011,0.0002802304,0.0015920528,0.00021258109,0.00031284645,0.000046340003,0.00061453955,0.000020270365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030820403,0.00039425638,0.009189863,0.00012240314,0.00028466072,0.0000078877165,0.00044337453,0.00019271631,0.9781746,0.000045667897,0.0011809218,0.00965541],"study_design_scores_gemma":[0.002265427,0.0005854777,0.020329466,0.00006812546,0.00022278454,0.000057052795,0.00015934331,0.0006549883,0.97010165,0.00047809246,0.0047682645,0.00030929912],"about_ca_topic_score_codex":0.000025582654,"about_ca_topic_score_gemma":0.0000021201135,"teacher_disagreement_score":0.011139602,"about_ca_system_score_codex":0.000061449005,"about_ca_system_score_gemma":0.00005033195,"threshold_uncertainty_score":0.9999342},"labels":[],"label_agreement":null},{"id":"W2161848421","doi":"10.1081/dmr-120005667","title":"<i>N</i>-OXIDATION OF DRUGS ASSOCIATED WITH IDIOSYNCRATIC DRUG REACTIONS","year":2002,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Drug; Reactive intermediate; Redox; Reactive oxygen species; Nitro; Reactive nitrogen species; Combinatorial chemistry; Pharmacology; Biochemistry; Organic chemistry; Medicine; Alkyl; Catalysis","score_opus":0.16351389565732402,"score_gpt":0.4358942445447321,"score_spread":0.27238034888740803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161848421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018045472,0.982641,0.000030839474,0.00008890487,0.0027942837,0.004112748,0.0005227858,0.00015762803,0.0094713615],"genre_scores_gemma":[0.00010650313,0.9865977,0.00034739968,0.00049749104,0.0008609888,0.0010539744,0.000655221,0.00024203902,0.009638658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9867094,0.0065976814,0.0037114148,0.0011874979,0.0007162488,0.0010777604],"domain_scores_gemma":[0.9920171,0.0012988017,0.0044372263,0.0012251973,0.00038815508,0.0006335546],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0050339513,0.0015927867,0.007057553,0.0007587936,0.00040256366,0.000063906846,0.0012972109,0.00081000075,0.0027240766],"category_scores_gemma":[0.0006282937,0.0011869837,0.0018078508,0.0021830243,0.0004151542,0.00031175007,0.00022167823,0.0026457806,0.000996161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019276999,0.0006651212,0.0000027811977,0.010481447,0.0012650434,0.000016209273,0.00063592155,0.000012929547,0.00012600489,0.00056701957,0.028802803,0.95740545],"study_design_scores_gemma":[0.0011606017,0.000016076701,0.0000035118376,0.00611234,0.015128775,0.000033466622,0.000028130808,0.00005294351,0.0004218562,0.00008389088,0.97583336,0.0011250668],"about_ca_topic_score_codex":0.000028538048,"about_ca_topic_score_gemma":0.000013640162,"teacher_disagreement_score":0.95628035,"about_ca_system_score_codex":0.00014371546,"about_ca_system_score_gemma":0.0004024042,"threshold_uncertainty_score":0.99978167},"labels":[],"label_agreement":null},{"id":"W2162172301","doi":"10.1177/1060028014561474","title":"Calcium Channel Blocker–Clarithromycin Drug Interaction Did Not Increase the Risk of Nonvertebral Fracture","year":2014,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Clarithromycin; Medicine; Azithromycin; Amlodipine; Internal medicine; Nifedipine; Population; Retrospective cohort study; Pharmacology; Blood pressure; Calcium; Antibiotics","score_opus":0.11720621055397129,"score_gpt":0.44803841139423795,"score_spread":0.33083220084026665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162172301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98206335,0.0034267742,0.0008793887,0.00872259,0.0020735397,0.0006257211,0.00036128343,0.000068088004,0.0017792461],"genre_scores_gemma":[0.96268606,0.0073750266,0.00008360674,0.028168986,0.0009981085,0.000052410716,0.00002812475,0.00006334922,0.0005443239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958243,0.0018506168,0.0008460187,0.0004455315,0.000417369,0.00061620725],"domain_scores_gemma":[0.9970551,0.00086923037,0.00088922743,0.00045108996,0.0003898529,0.00034548395],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002578297,0.0004521045,0.0006752706,0.00021267707,0.00031769273,0.000020524076,0.0007731906,0.00026871418,0.002002236],"category_scores_gemma":[0.00008689115,0.00033637992,0.00047101313,0.00034827998,0.0003986862,0.00020147774,0.00010318837,0.0013186447,0.000059146692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025766483,0.0012386452,0.0033543936,0.00009989499,0.001516331,0.000004995284,0.002978505,0.0052705035,0.88022804,0.00058281695,0.054489624,0.04765962],"study_design_scores_gemma":[0.0024507944,0.00009712308,0.0022305984,0.000017244553,0.00032083935,0.000006812214,0.000088391185,0.023845915,0.72189724,0.0010560928,0.24772064,0.0002683133],"about_ca_topic_score_codex":0.0006077997,"about_ca_topic_score_gemma":0.0000169402,"teacher_disagreement_score":0.19323102,"about_ca_system_score_codex":0.000013934448,"about_ca_system_score_gemma":0.00008354969,"threshold_uncertainty_score":0.9999088},"labels":[],"label_agreement":null},{"id":"W2162575317","doi":"10.1016/s0149-2918(01)80100-4","title":"Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction","year":2001,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pantoprazole; Medicine; Pharmacokinetics; Gastroenterology; Adverse effect; Internal medicine; Proton-pump inhibitor; Pharmacology; Omeprazole","score_opus":0.14867049779999697,"score_gpt":0.4505362289100531,"score_spread":0.30186573111005616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162575317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573934,0.0010778066,0.00025112048,0.00025957465,0.00074790453,0.00043768904,0.00003528851,0.00003137642,0.0014199286],"genre_scores_gemma":[0.9892456,0.007037435,0.00034518391,0.0029946966,0.00014855276,0.000013938326,0.000018254294,0.000034145603,0.00016222657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775743,0.0005069955,0.0007879646,0.00035183993,0.0002114452,0.00038433023],"domain_scores_gemma":[0.99865115,0.0004885116,0.00025764026,0.00021413073,0.0001799145,0.00020862672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084400835,0.00024950653,0.00048151865,0.00010439442,0.000079271114,0.000013523295,0.00018480573,0.00028872243,0.0002162623],"category_scores_gemma":[0.00003327462,0.00020715543,0.000075023,0.00028476652,0.00032074013,0.000088689136,0.00007727995,0.00074640306,0.000012118645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035822976,0.0012860523,0.8308301,0.000032331667,0.0002464356,0.000010419221,0.00019598995,0.0012566772,0.00068226946,0.00012087694,0.00005817244,0.16169839],"study_design_scores_gemma":[0.029929483,0.0011722406,0.78078264,0.000053424894,0.0010360525,0.000014527725,0.000073899864,0.05729382,0.00637532,0.0018942229,0.12055651,0.00081788615],"about_ca_topic_score_codex":0.0000059784425,"about_ca_topic_score_gemma":0.000007423084,"teacher_disagreement_score":0.1608805,"about_ca_system_score_codex":0.00001863717,"about_ca_system_score_gemma":0.000057760655,"threshold_uncertainty_score":0.8447553},"labels":[],"label_agreement":null},{"id":"W2162743898","doi":"10.3402/tdp.v2.24663","title":"Genetics of antipsychotic drug outcome and implications for the clinician: into the limelight","year":2014,"lang":"en","type":"article","venue":"Translational Developmental Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Limelight; Antipsychotic drug; Antipsychotic; Drug; Genetics; Medicine; Psychiatry; Biology; Bioinformatics; Pharmacology; Schizophrenia (object-oriented programming); Chemistry","score_opus":0.10615484739405154,"score_gpt":0.44727457062006065,"score_spread":0.34111972322600914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162743898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8813757,0.02090725,0.00858731,0.07899009,0.0046357447,0.0015545483,0.00020151115,0.000045580888,0.0037023178],"genre_scores_gemma":[0.98199,0.0009914034,0.011472578,0.00487858,0.00036072315,0.00008634529,0.000031876385,0.000021252934,0.00016728604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987259,0.00013689863,0.000560452,0.00023367658,0.00012582638,0.00021725833],"domain_scores_gemma":[0.9985728,0.0009562505,0.00014579916,0.00015134831,0.00008094892,0.00009282513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009163496,0.00017026227,0.0001820937,0.00005112549,0.0005516063,0.00001571525,0.0003488019,0.000100208716,0.00008924641],"category_scores_gemma":[0.00001887931,0.00011162098,0.000111129106,0.00015981776,0.0002807958,0.00003719327,0.000030104935,0.0002596389,0.000014773193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030851385,0.00031162016,0.73539186,0.00010582571,0.00045773925,5.8443415e-8,0.0025957334,0.0005498258,0.00640024,0.07397766,0.005479535,0.17442141],"study_design_scores_gemma":[0.0019616673,0.000024204533,0.6891759,0.000007288068,0.00027841007,0.000007860281,0.00011605525,0.0027076388,0.0011415061,0.037224934,0.26714304,0.00021150711],"about_ca_topic_score_codex":0.0000038023823,"about_ca_topic_score_gemma":0.000049696413,"teacher_disagreement_score":0.2616635,"about_ca_system_score_codex":0.000006998804,"about_ca_system_score_gemma":0.000117342024,"threshold_uncertainty_score":0.45517716},"labels":[],"label_agreement":null},{"id":"W2163125822","doi":"10.1309/1e34uapr06pj6hml","title":"Performance of Commercial Platforms for Rapid Genotyping of Polymorphisms Affecting Warfarin Dose","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Genotyping; Warfarin; Medicine; Genotype; Biology; Genetics; Internal medicine; Gene; Atrial fibrillation","score_opus":0.2488417998922073,"score_gpt":0.4957011130206611,"score_spread":0.2468593131284538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163125822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953112,0.0009418502,0.00057592173,0.00024335814,0.002287078,0.00022370735,0.00003810526,0.0000088611805,0.00036992022],"genre_scores_gemma":[0.9896648,0.0035463367,0.004697696,0.0011831799,0.0008488909,0.000004967479,0.0000034351706,0.000027524706,0.00002319446],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9962665,0.0005687076,0.0023052976,0.0002193802,0.0002031217,0.00043703144],"domain_scores_gemma":[0.9935771,0.0025917455,0.0029367139,0.00019665425,0.00041218812,0.00028554993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040825857,0.00021581606,0.0014926904,0.00021390594,0.00015291586,0.0000017532772,0.00048346943,0.00024425532,0.00011698656],"category_scores_gemma":[0.0007808385,0.00018033877,0.00058145187,0.00025453587,0.0017206512,0.000094211275,0.00010415987,0.0010463044,0.0000045746215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00701285,0.0009490388,0.22942004,0.00006340074,0.0004395605,0.00010127079,0.0013981125,0.0010784866,0.061210323,0.0001169866,0.00033834338,0.69787157],"study_design_scores_gemma":[0.02071209,0.01734723,0.7797686,0.00010646186,0.0013374672,0.0019902063,0.00055119797,0.0060024355,0.14820811,0.00052037084,0.022633165,0.00082266465],"about_ca_topic_score_codex":0.0000070376286,"about_ca_topic_score_gemma":0.0000011949134,"teacher_disagreement_score":0.6970489,"about_ca_system_score_codex":0.000014888348,"about_ca_system_score_gemma":0.0002926181,"threshold_uncertainty_score":0.7354002},"labels":[],"label_agreement":null},{"id":"W2163844104","doi":"10.1016/j.aquatox.2005.11.010","title":"Up-regulation of the alligator CYP3A77 gene by toxaphene and dexamethasone and its short term effect on plasma testosterone concentrations","year":2006,"lang":"en","type":"article","venue":"Aquatic Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Institute for Materials Science; Florida Fish and Wildlife Conservation Commission; National Science Foundation","keywords":"Toxaphene; Internal medicine; Endocrinology; CYP3A; Glucocorticoid receptor; Biology; Estrogen receptor; Cytochrome P450; Testosterone (patch); Alligator; Estrogen; Steroid hormone; Glucocorticoid; Chemistry; Hormone; Metabolism; Medicine; Pesticide","score_opus":0.04345394564975763,"score_gpt":0.3556075802752934,"score_spread":0.31215363462553575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163844104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941946,0.002441679,0.000055846023,0.0008556351,0.00083789264,0.00092590216,0.0001127381,0.000030242347,0.0005454345],"genre_scores_gemma":[0.9980755,0.00022893949,0.00010185126,0.00076449616,0.0001431192,0.00009072419,0.000035912202,0.000026076337,0.00053337804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977975,0.00075462234,0.00048086798,0.00038871137,0.00018058727,0.00039769904],"domain_scores_gemma":[0.9981832,0.001202581,0.00019136102,0.0002101067,0.00004535027,0.00016738856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057146314,0.00028104172,0.00042000663,0.00007443633,0.0002489777,0.000016385942,0.00019770552,0.00033405257,0.0001741887],"category_scores_gemma":[0.00013740182,0.00022208803,0.00006336506,0.00017466587,0.00038690315,0.00006417599,0.00010590803,0.00036931783,0.000013479011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001669657,0.0002212332,0.025160588,0.00003675624,0.00010781191,0.0000019834613,0.00016010825,0.00019724721,0.96075577,0.0014484465,0.0010602903,0.010682777],"study_design_scores_gemma":[0.0025729898,0.00048107558,0.06505541,0.000013570672,0.0003778417,0.000035762525,0.000009775284,0.00982791,0.9169603,0.00048694632,0.003951949,0.00022649579],"about_ca_topic_score_codex":0.0000150722535,"about_ca_topic_score_gemma":0.000032688677,"teacher_disagreement_score":0.043795522,"about_ca_system_score_codex":0.00003591172,"about_ca_system_score_gemma":0.000059576516,"threshold_uncertainty_score":0.9056487},"labels":[],"label_agreement":null},{"id":"W2164576175","doi":"10.1158/0008-5472.can-03-3295","title":"The Functional <b> <i>UGT1A1</i> </b> Promoter Polymorphism Decreases Endometrial Cancer Risk","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Endometrial cancer; Odds ratio; Genotype; Allele; Internal medicine; Confidence interval; Case-control study; Carcinogenesis; Medicine; Endocrinology; Metabolite; Biology; Gastroenterology; Oncology; Cancer; Gene; Genetics","score_opus":0.26724815707206856,"score_gpt":0.5216540665629215,"score_spread":0.2544059094908529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164576175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93037176,0.052036688,0.000102612226,0.007277726,0.0056984313,0.00113833,0.00043236167,0.00008589264,0.002856212],"genre_scores_gemma":[0.9400011,0.049109124,0.00004194447,0.0013245803,0.004694511,0.0016524545,0.000015340122,0.00006019171,0.003100781],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567324,0.001197879,0.00040680994,0.0005538171,0.0009073293,0.0012608969],"domain_scores_gemma":[0.99709207,0.0012703394,0.00013655942,0.0003740125,0.00051957247,0.00060747017],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032487013,0.00027298572,0.0002727208,0.00027388762,0.0020417683,0.00012184667,0.00070502044,0.00026394238,0.003931453],"category_scores_gemma":[0.00051851326,0.00019553196,0.00018675593,0.0010122625,0.00089841225,0.00011941819,0.0002845915,0.0021605175,0.00036626455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006473952,0.0010293546,0.01961111,0.000066140026,0.0012693896,0.00012214851,0.001052628,0.007488405,0.5125889,0.0074821617,0.07755587,0.36525992],"study_design_scores_gemma":[0.0054422244,0.00008121351,0.0032814115,0.000018820618,0.0001360759,0.000011393292,0.000053255964,0.000081661965,0.27334568,0.0051130084,0.7121855,0.00024976343],"about_ca_topic_score_codex":0.0020404034,"about_ca_topic_score_gemma":0.00039232793,"teacher_disagreement_score":0.6346296,"about_ca_system_score_codex":0.00037862093,"about_ca_system_score_gemma":0.001396771,"threshold_uncertainty_score":0.99925745},"labels":[],"label_agreement":null},{"id":"W2164770365","doi":"10.1124/dmd.114.060053","title":"Adaptive Hepatic and Intestinal Alterations in Mice after Deletion of NADPH-Cytochrome P450 Oxidoreductase (Cpr) in Hepatocytes","year":2014,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; York University","keywords":"Cytochrome P450; Constitutive androstane receptor; Biology; Drug metabolism; Small intestine; Internal medicine; Endocrinology; Multidrug resistance-associated protein 2; Metabolism; Pharmacology; Transporter; Biochemistry; ATP-binding cassette transporter; Nuclear receptor; Gene; Medicine; Transcription factor","score_opus":0.026578085971890833,"score_gpt":0.33611946523169967,"score_spread":0.30954137925980885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164770365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199516,0.0061704167,0.00048513192,0.00025783983,0.00021284392,0.00044558215,0.00011000951,0.00001800851,0.00030500055],"genre_scores_gemma":[0.99696916,0.0011395104,0.0008743814,0.0005812296,0.00016193329,0.00016132278,0.00006864549,0.00001839727,0.000025432973],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980048,0.00066203246,0.00050981494,0.00036773866,0.00013763807,0.00031796793],"domain_scores_gemma":[0.999215,0.00025131943,0.00015174554,0.000113827016,0.000084509935,0.00018356644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007703815,0.00024387077,0.00040415756,0.00033592258,0.00009132147,0.00002525222,0.000093778064,0.00013507126,0.00008069391],"category_scores_gemma":[0.00007508655,0.00024273213,0.000050346956,0.00026888546,0.00021963593,0.00025699602,0.00007352402,0.00036938058,0.000007427965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025727209,0.0011573607,0.03522994,0.00028235873,0.00008846953,0.00004900485,0.0078087463,0.000883972,0.88975006,0.014024542,0.00011690651,0.048035942],"study_design_scores_gemma":[0.0066143656,0.00013074443,0.7630653,0.00018219864,0.0004826067,0.000072459254,0.0004763775,0.08924606,0.12827338,0.00831765,0.0024362188,0.0007026598],"about_ca_topic_score_codex":0.0003877993,"about_ca_topic_score_gemma":0.00020847777,"teacher_disagreement_score":0.76147664,"about_ca_system_score_codex":0.00002342987,"about_ca_system_score_gemma":0.000039207724,"threshold_uncertainty_score":0.98983294},"labels":[],"label_agreement":null},{"id":"W2164900475","doi":"10.1177/0091270007305504","title":"Ciprofloxacin Prolonged‐Release Tablets Do Not Affect Warfarin Pharmacokinetics and Pharmacodynamics","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Pharmacokinetics; Warfarin; Pharmacodynamics; Ciprofloxacin; Crossover study; Medicine; Pharmacology; Prothrombin time; Drug interaction; Partial thromboplastin time; Anticoagulant; Antibiotics; Internal medicine; Chemistry; Atrial fibrillation; Coagulation; Placebo","score_opus":0.16523373510749947,"score_gpt":0.5281118326839626,"score_spread":0.36287809757646305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164900475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655806,0.008510392,0.0012227845,0.00497965,0.016337888,0.001044393,0.00006883794,0.00007227773,0.0021831868],"genre_scores_gemma":[0.95002264,0.02143918,0.0005140363,0.020866549,0.0065654535,0.000014148195,0.000005553014,0.00009793557,0.00047450248],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896214,0.0040247007,0.0035618152,0.00057676726,0.00075247616,0.0014628123],"domain_scores_gemma":[0.9872296,0.007828686,0.0022514465,0.00036939743,0.0007547343,0.0015661333],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.026733158,0.00071428996,0.0015292417,0.00043408727,0.0005327641,0.000048612976,0.0015047806,0.00074980926,0.0015653118],"category_scores_gemma":[0.00079654885,0.00051846635,0.0005625559,0.0006236869,0.0014882195,0.00029635473,0.0005590667,0.0055498057,0.00010500291],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023611495,0.002491904,0.014822937,0.0001790069,0.0027857139,0.001127872,0.0013194056,0.0029069283,0.6360517,0.00039816755,0.05440171,0.25990316],"study_design_scores_gemma":[0.025388302,0.0015044431,0.019115992,0.00004037321,0.006062386,0.001208619,0.0002763597,0.012308439,0.26668352,0.0008119255,0.6655609,0.0010387263],"about_ca_topic_score_codex":0.000010160911,"about_ca_topic_score_gemma":0.00000595155,"teacher_disagreement_score":0.6111592,"about_ca_system_score_codex":0.00009732119,"about_ca_system_score_gemma":0.00045768864,"threshold_uncertainty_score":0.9997267},"labels":[],"label_agreement":null},{"id":"W2164909389","doi":"10.1021/tx0498861","title":"Detection of Covalent Adducts to Cytochrome P450 3A4 Using Liquid Chromatography Mass Spectrometry","year":2004,"lang":"en","type":"article","venue":"Chemical Research in Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); TransCanada (Canada)","funders":"","keywords":"Adduct; Chemistry; Mass spectrometry; Chromatography; Cytochrome P450; Liquid chromatography–mass spectrometry; Organic chemistry; Enzyme","score_opus":0.23217138900543147,"score_gpt":0.509172604711702,"score_spread":0.27700121570627056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164909389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410903,0.0013431164,0.0006931784,0.0009558137,0.0005509987,0.000888069,0.00004992158,0.00004889437,0.0013609575],"genre_scores_gemma":[0.99573267,0.00046319474,0.0025880248,0.0005911662,0.00041591816,0.00013395512,0.000008427673,0.000046092613,0.000020573465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957748,0.0007578776,0.0007261182,0.00070636737,0.0005895135,0.0014453061],"domain_scores_gemma":[0.9978154,0.0006239675,0.00012715618,0.00038136193,0.0003135052,0.0007386529],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002474049,0.0002986919,0.00060646184,0.0014361253,0.0001558755,0.000016447433,0.0007021778,0.0006937143,0.00061863504],"category_scores_gemma":[0.00054708513,0.00031668888,0.0001706502,0.00235887,0.00077744375,0.00008632106,0.00039280194,0.0019257712,0.00013545787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012969545,0.0007893553,0.00014764062,0.00011609806,0.000097242584,0.00012338614,0.00024161028,0.0012133261,0.99343914,0.0008503018,0.00006557828,0.0016193419],"study_design_scores_gemma":[0.0026338305,0.00067480333,0.0007578068,0.00003850548,0.000039648836,0.000057423127,0.00007671843,0.00031251393,0.9852978,0.003364765,0.006467404,0.00027879604],"about_ca_topic_score_codex":0.00005740944,"about_ca_topic_score_gemma":0.00001454029,"teacher_disagreement_score":0.00814138,"about_ca_system_score_codex":0.0005733919,"about_ca_system_score_gemma":0.0004039642,"threshold_uncertainty_score":0.99992853},"labels":[],"label_agreement":null},{"id":"W2165341378","doi":"10.18433/j3wc7g","title":"Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: Faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Education and Human Resources Development","keywords":"Omeprazole; Pharmacokinetics; Pharmacology; Oral administration; Diabetes mellitus; Alloxan; Streptozotocin; Endocrinology; Chemistry; Internal medicine; Medicine","score_opus":0.1127287426547365,"score_gpt":0.4475086422129697,"score_spread":0.33477989955823323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165341378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279547,0.002969517,0.00007892049,0.0020551286,0.0008547499,0.0008671315,0.000046741123,0.000014313976,0.00031803924],"genre_scores_gemma":[0.9946802,0.0022173156,0.0007047348,0.0020335363,0.0002701211,0.000024066803,0.0000019707509,0.0000359009,0.0000321414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950811,0.0006371245,0.0016808015,0.0005550558,0.000959327,0.0010865666],"domain_scores_gemma":[0.9969081,0.00087825616,0.000894649,0.00016130967,0.0003512394,0.00080644264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005645648,0.00047982865,0.001049567,0.0011093726,0.00013181863,0.00003944277,0.0007932804,0.0001861989,0.0004908233],"category_scores_gemma":[0.00019297046,0.00036833252,0.000110068235,0.0022180527,0.00081820413,0.00050247135,0.00021432264,0.0013747056,0.000004593769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002992282,0.00093356596,0.11297519,0.00018925434,0.00011546671,0.00010111179,0.0013103188,0.0006450902,0.7883995,0.00002757093,0.00015263644,0.09215801],"study_design_scores_gemma":[0.00768333,0.00096422934,0.023853373,0.00018540691,0.0002474962,0.00007411796,0.0005649065,0.00436855,0.94067156,0.00005944626,0.020876996,0.00045061222],"about_ca_topic_score_codex":0.000049387727,"about_ca_topic_score_gemma":0.00014851918,"teacher_disagreement_score":0.15227203,"about_ca_system_score_codex":0.000099555764,"about_ca_system_score_gemma":0.00028256458,"threshold_uncertainty_score":0.99987686},"labels":[],"label_agreement":null},{"id":"W2165692369","doi":"","title":"In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"CYP1A2; CYP3A4; Cytochrome P450; Microsome; Recombinant DNA; Isozyme; Biochemistry; Enzyme; Chemistry; Metabolism; Biology; Gene","score_opus":0.09776231957590173,"score_gpt":0.358001457043794,"score_spread":0.2602391374678923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165692369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956241,0.0022653353,0.000008801278,0.00023002723,0.0007691589,0.0007832608,0.00006426446,0.000008861485,0.00024614306],"genre_scores_gemma":[0.9974537,0.0012052921,0.000038568993,0.00058992853,0.00012786861,0.00013817173,0.0000087463,0.000019696463,0.00041803738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850065,0.00034357468,0.00045531144,0.00021917745,0.00012304363,0.0003582501],"domain_scores_gemma":[0.99933404,0.000054038926,0.0002785698,0.00017380323,0.00007226838,0.00008730992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060134655,0.00016798032,0.00036950872,0.00015157723,0.000107352374,0.0000100335155,0.00023596952,0.00015313743,0.00010876193],"category_scores_gemma":[0.000030350488,0.00013503326,0.00008263681,0.00031931832,0.00024140869,0.00013356989,0.00014809897,0.00027356553,0.0000012507877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015112518,0.00022620766,0.0032441264,0.000043022937,0.000059503967,0.0000072819325,0.00038684817,0.0000138773385,0.9819765,0.00033414838,0.000029647837,0.013527691],"study_design_scores_gemma":[0.0011343191,0.0000036760223,0.35531324,0.000004759571,0.00010258379,0.00001784962,0.000008014537,0.00019632686,0.6186181,0.000111789,0.02438839,0.000100982805],"about_ca_topic_score_codex":0.000076634766,"about_ca_topic_score_gemma":0.000004505705,"teacher_disagreement_score":0.36335847,"about_ca_system_score_codex":0.000024746969,"about_ca_system_score_gemma":0.000031063217,"threshold_uncertainty_score":0.5506497},"labels":[],"label_agreement":null},{"id":"W2165909199","doi":"10.1002/rcm.3329","title":"Determining protein adducts of fipexide: mass spectrometry based assay for confirming the involvement of its reactive metabolite in covalent binding","year":2007,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; F. Hoffmann-La Roche","keywords":"Chemistry; Metabolite; Adduct; Cysteine; Glutathione; Microsome; Mass spectrometry; Biochemistry; Amino acid; Drug metabolism; Chromatography; Metabolism; Enzyme; Organic chemistry","score_opus":0.1514846472384997,"score_gpt":0.4371948207227738,"score_spread":0.28571017348427413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165909199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96432227,0.012765037,0.014171291,0.0010520886,0.00046941786,0.0028488964,0.0002805704,0.00004102735,0.004049429],"genre_scores_gemma":[0.9385584,0.0016333819,0.059051037,0.000212641,0.00007684053,0.00030850014,0.000054151227,0.000042512533,0.00006253083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958441,0.001248537,0.0013885107,0.00040681945,0.0003658642,0.00074612646],"domain_scores_gemma":[0.99415463,0.003409834,0.0008628609,0.0011808507,0.00025660012,0.00013521106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008924164,0.00033598003,0.00070547144,0.0015730802,0.00021915243,0.000018495679,0.0016052887,0.00026312456,0.00022026167],"category_scores_gemma":[0.0006283378,0.00031840068,0.0002188604,0.0020519842,0.0003755433,0.00013396816,0.0002616537,0.0012344804,0.0000056000677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025863454,0.00065458275,0.011283625,0.00017012817,0.00020806605,0.000004776193,0.000650014,0.00028110424,0.972522,0.008811742,0.0000150441165,0.005140258],"study_design_scores_gemma":[0.0032221263,0.00014177874,0.010517354,0.00011694324,0.0001854994,0.000002861815,0.0011402733,0.012800963,0.96345836,0.0011410249,0.006950799,0.00032202672],"about_ca_topic_score_codex":0.000028650911,"about_ca_topic_score_gemma":0.00005334645,"teacher_disagreement_score":0.044879746,"about_ca_system_score_codex":0.00029064855,"about_ca_system_score_gemma":0.00023143362,"threshold_uncertainty_score":0.9999268},"labels":[],"label_agreement":null},{"id":"W2165921276","doi":"10.1002/bdd.1855","title":"Assessment of CYP3A‐mediated drug–drug interaction potential for victim drugs using an <i>in vivo</i> rat model","year":2013,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Ketoconazole; CYP3A; Pharmacology; Buspirone; Pharmacokinetics; Verapamil; In vivo; Drug interaction; Ritonavir; Chemistry; Microsome; Medicine; In vitro; Biology; Biochemistry; Serotonin; Immunology; Receptor","score_opus":0.06432302620584197,"score_gpt":0.42919626346637796,"score_spread":0.364873237260536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165921276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490685,0.00061613583,0.006683488,0.00058764964,0.0034209467,0.0023157785,0.0006618626,0.00012311708,0.0006841616],"genre_scores_gemma":[0.98994064,0.0008647432,0.005907146,0.0016781804,0.00052190374,0.00037155443,0.00039265293,0.000108565306,0.00021458293],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9957856,0.00077422,0.0012194898,0.0007849612,0.0005021217,0.0009335986],"domain_scores_gemma":[0.99763554,0.00029467265,0.0006316237,0.00037272423,0.0004946186,0.00057082664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013406196,0.0006058936,0.00067045767,0.0005405499,0.00037409595,0.00009977451,0.0005136448,0.00030128888,0.0008194886],"category_scores_gemma":[0.000019124107,0.00064993434,0.00032402668,0.0005114724,0.00018720748,0.0009021115,0.00016373546,0.00092837715,0.000032085376],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004459766,0.0013937821,0.0007923678,0.0001833353,0.000144004,0.00000786852,0.001575317,0.12552977,0.8655228,0.00025652783,0.0012717631,0.0028765048],"study_design_scores_gemma":[0.0034940585,0.000030923806,0.00024417168,0.00003702251,0.00047474803,0.0000088785455,0.000600199,0.6313805,0.36058754,0.000341042,0.0023504784,0.0004504499],"about_ca_topic_score_codex":0.00014856647,"about_ca_topic_score_gemma":0.000019446068,"teacher_disagreement_score":0.50585073,"about_ca_system_score_codex":0.0003183948,"about_ca_system_score_gemma":0.00024795387,"threshold_uncertainty_score":0.99959517},"labels":[],"label_agreement":null},{"id":"W2165936366","doi":"10.1016/j.cbpa.2011.02.014","title":"Ontogenesis of UDP-glucuronosyltransferase enzymes in sheep","year":2011,"lang":"en","type":"article","venue":"Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Fetus; Biology; Enzyme; Messenger RNA; Internal medicine; Endocrinology; Blot; Glucuronosyltransferase; Complementary DNA; Microsome; Ontogeny; Molecular biology; Gene; Biochemistry; Pregnancy; Medicine; Genetics","score_opus":0.12450593394723496,"score_gpt":0.399685223999175,"score_spread":0.27517929005194003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165936366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98590565,0.00764007,0.00012791938,0.000047107496,0.0004378252,0.00037373547,0.00016753412,0.00002980684,0.00527038],"genre_scores_gemma":[0.99791896,0.0006701433,0.00032359586,0.00057821994,0.00011280811,0.0001686172,0.00011690478,0.00002258998,0.00008813031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996789,0.0010446046,0.0006722199,0.0008089701,0.00009397798,0.0005912712],"domain_scores_gemma":[0.9986444,0.00029278954,0.00025903177,0.00034645828,0.00021278115,0.000244529],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027674768,0.00055987266,0.0010840138,0.00013382248,0.00011758945,0.000004469271,0.00042893185,0.0004603682,0.0009827631],"category_scores_gemma":[0.000054685574,0.00048735875,0.00022628215,0.00030151295,0.0015044259,0.00007168889,0.00015607107,0.00077775435,0.000025231397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014876842,0.0007559755,0.0009546236,0.0000726967,0.00040283936,0.000016972797,0.0036807219,0.00007678137,0.9853379,0.0060034064,0.00024017457,0.00097022956],"study_design_scores_gemma":[0.0015698494,0.00028170817,0.010625555,0.000029536794,0.00012940259,0.00001020979,0.00074449467,0.00039549926,0.979375,0.0031156116,0.003280705,0.00044242007],"about_ca_topic_score_codex":0.00006387307,"about_ca_topic_score_gemma":0.000017787634,"teacher_disagreement_score":0.012013368,"about_ca_system_score_codex":0.00003097452,"about_ca_system_score_gemma":0.00011768762,"threshold_uncertainty_score":0.9999305},"labels":[],"label_agreement":null},{"id":"W2166210552","doi":"10.1002/cpt.280","title":"Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Human Genome Research Institute; National Institute on Drug Abuse; Wellcome Trust","keywords":"Workgroup; Standardization; Confusion; Pharmacogenetics; Nomenclature; Chemical nomenclature; Transparency (behavior); Computer science; Computational biology; Medicine; Biology; Genetics; Psychology; Gene; Taxonomy (biology); Genotype","score_opus":0.7130136977464977,"score_gpt":0.6624251810135845,"score_spread":0.0505885167329132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166210552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049571532,0.94263655,0.00032420995,0.008199697,0.039715666,0.004230896,0.0023136993,0.00037103007,0.0021587021],"genre_scores_gemma":[0.000023064265,0.92802256,0.0035182037,0.048920814,0.01167749,0.0016144167,0.0024443932,0.0003642593,0.00341477],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98494387,0.002802541,0.007855088,0.0020792778,0.0005627231,0.0017564875],"domain_scores_gemma":[0.9821507,0.0073367604,0.007162268,0.00083754846,0.0011937754,0.0013189776],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.009809626,0.0016086632,0.0042498275,0.0005695795,0.0006781565,0.00012974383,0.0026784332,0.0030035295,0.0023401727],"category_scores_gemma":[0.0007784889,0.0015000642,0.0023845527,0.0008527177,0.0008958586,0.00018613788,0.0008098893,0.0057497257,0.0005914902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000267554,0.0015839398,0.00006952116,0.0007152391,0.004761472,0.00006612197,0.0001173798,0.000020952852,0.00015044675,0.000018983304,0.34735715,0.64487123],"study_design_scores_gemma":[0.005643948,0.00032887913,0.0000048111197,0.00031222173,0.02015956,0.00013456876,0.00003092187,0.0010981644,0.000118684875,0.00040657452,0.97036463,0.0013970556],"about_ca_topic_score_codex":0.0000020502064,"about_ca_topic_score_gemma":0.0000022515728,"teacher_disagreement_score":0.6434742,"about_ca_system_score_codex":0.00045490157,"about_ca_system_score_gemma":0.0018605435,"threshold_uncertainty_score":0.9996661},"labels":[],"label_agreement":null},{"id":"W2166761612","doi":"10.1093/toxsci/kfh010","title":"Human Interindividual Variation in Lymphocyte UDP-Glucuronosyltransferases as a Determinant of In Vitro Benzo[a]pyrene Covalent Binding and Cytotoxicity","year":2003,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glucuronidation; Chemistry; Carcinogen; UGT2B7; Cytotoxicity; Glucuronosyltransferase; Microsome; Benzo(a)pyrene; Xenobiotic; In vitro; Biochemistry; Isozyme; Population; Pyrene; Pharmacology; Enzyme; Biology; Medicine; Organic chemistry","score_opus":0.1425561427474743,"score_gpt":0.4361603760266812,"score_spread":0.29360423327920687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166761612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963731,0.0006837582,0.000029709532,0.00011907523,0.00031117746,0.00043030718,0.000041418134,0.000021251106,0.0019901793],"genre_scores_gemma":[0.9985436,0.00045391184,0.00039694126,0.00048146385,0.00003086958,0.00005532507,0.000002823443,0.000007000613,0.000028073922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716294,0.00086559553,0.0006156533,0.0005161621,0.0002547875,0.0005848444],"domain_scores_gemma":[0.99912864,0.00039534146,0.00015595142,0.00009432879,0.000027714068,0.00019803246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024800904,0.00023544434,0.00044306653,0.00031803854,0.00023835045,0.00003466155,0.0003443281,0.00025405915,0.0006092543],"category_scores_gemma":[0.00023870006,0.00019364229,0.00006692632,0.0006046785,0.0007078596,0.00014819573,0.00010758634,0.00036044334,0.000009263411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013437765,0.0005987231,0.02344154,0.000022031332,0.0000135186565,0.00004587614,0.00066387793,0.0004676206,0.9660476,0.0025429563,0.0000037538136,0.006018121],"study_design_scores_gemma":[0.0025411048,0.00061969995,0.11040944,0.000023970128,0.000040807965,0.000034889723,0.00018991102,0.0012533801,0.88169366,0.0020364085,0.0008546433,0.00030207023],"about_ca_topic_score_codex":0.00008597779,"about_ca_topic_score_gemma":0.000084011794,"teacher_disagreement_score":0.08696789,"about_ca_system_score_codex":0.00009478387,"about_ca_system_score_gemma":0.00013826095,"threshold_uncertainty_score":0.7896504},"labels":[],"label_agreement":null},{"id":"W2167719907","doi":"10.1517/17425255.2013.799137","title":"Drug absorption, distribution, metabolism and excretion considerations in critically ill adults","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"","keywords":"ADME; Pharmacokinetics; Drug; Critically ill; Excretion; Medicine; Distribution (mathematics); Drug metabolism; Pharmacology; Metabolic clearance rate; Intensive care medicine; Internal medicine","score_opus":0.09864579190547527,"score_gpt":0.4382375260399172,"score_spread":0.33959173413444194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167719907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071037246,0.9746495,0.00008078136,0.005358718,0.012640628,0.00374656,0.0014893587,0.00025120185,0.001072884],"genre_scores_gemma":[0.0006729808,0.97886425,0.0005959577,0.011385359,0.0029951523,0.0028682724,0.0017875078,0.00021365489,0.00061684666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877327,0.005006872,0.002852936,0.002120598,0.0005414314,0.0017454631],"domain_scores_gemma":[0.99347645,0.0024291144,0.0009306793,0.0009386957,0.0011013361,0.0011237392],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0018054879,0.0017750998,0.0042063617,0.0010540559,0.0007115044,0.0001897745,0.00079403614,0.0019312233,0.0040747095],"category_scores_gemma":[0.0016929558,0.0016313295,0.0007713442,0.0008502221,0.0009698002,0.00043332746,0.00048641814,0.0033633644,0.0010122554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018020543,0.0015687718,0.0000074415802,0.0011814645,0.00058480474,0.000056626897,0.0016684958,0.00003664218,0.0002710193,0.0570827,0.115584254,0.8217776],"study_design_scores_gemma":[0.0033990277,0.00004680173,0.00015151351,0.0008078348,0.00042842334,0.00016346877,0.00016431771,0.00022682002,0.00034294408,0.0025017168,0.99026906,0.0014980913],"about_ca_topic_score_codex":0.00012906546,"about_ca_topic_score_gemma":0.000047019817,"teacher_disagreement_score":0.8746848,"about_ca_system_score_codex":0.00025590873,"about_ca_system_score_gemma":0.00068728975,"threshold_uncertainty_score":0.9997656},"labels":[],"label_agreement":null},{"id":"W2167742437","doi":"10.1038/clpt.2013.235","title":"Progress in Pharmacogenomics: Bridging the Gap From Research to Practice","year":2014,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacogenetics; Viewpoints; Drug response; Epigenetics; Clinical Practice; Computational biology; Medicine; Pharmacology; Bioinformatics; Drug; Biology; Gene; Genetics; Genotype","score_opus":0.356520977217391,"score_gpt":0.6184123225768028,"score_spread":0.2618913453594118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167742437","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013731139,0.0276696,0.00019177745,0.04641797,0.90550554,0.0037321544,0.0010341138,0.00024246617,0.0014752415],"genre_scores_gemma":[0.0060101836,0.031244775,0.0010259718,0.15343302,0.80515426,0.0011468082,0.00040101167,0.0004325769,0.0011513687],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9661878,0.022611946,0.0034172852,0.0027263467,0.0019339891,0.0031226699],"domain_scores_gemma":[0.9420042,0.05181961,0.0012419965,0.0014432122,0.0020899384,0.0014010418],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.027868332,0.0014763365,0.0023390201,0.0008215249,0.001105474,0.00026275235,0.005159721,0.0045749126,0.0014415844],"category_scores_gemma":[0.0015630982,0.0012621483,0.0007712011,0.0015906817,0.0029600775,0.00022736438,0.0020668986,0.023511693,0.0028643461],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004196947,0.002046087,0.0007627141,0.00006484191,0.0028317005,0.00025824658,0.0011814521,0.00042115457,0.0021490194,0.00001719082,0.8956122,0.090458475],"study_design_scores_gemma":[0.0075505343,0.00047152996,0.00017010527,0.00007436122,0.0041593006,0.000009071333,0.00018017938,0.0028979066,0.0017640234,0.00039111052,0.9810588,0.0012730901],"about_ca_topic_score_codex":0.00011309971,"about_ca_topic_score_gemma":0.000062011226,"teacher_disagreement_score":0.10701505,"about_ca_system_score_codex":0.0005871999,"about_ca_system_score_gemma":0.0019807587,"threshold_uncertainty_score":0.9997986},"labels":[],"label_agreement":null},{"id":"W2167836153","doi":"10.1124/dmd.110.035584","title":"The Aryl Hydrocarbon Receptor Pathway and the Response to 3-Methylcholanthrene Are Altered in the Liver of Adrenalectomized Rats","year":2010,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Aryl hydrocarbon receptor; Internal medicine; Endocrinology; CYP1B1; Cytochrome P450; Chemistry; CYP1A2; Methylcholanthrene; Enzyme inducer; Adrenalectomy; Metabolism; Carcinogen; Biology; Enzyme; Medicine; Biochemistry","score_opus":0.023980320158408053,"score_gpt":0.33725013076072996,"score_spread":0.3132698106023219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167836153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97509444,0.016468773,0.000016661621,0.0058347112,0.0012738622,0.00092784583,0.00013777158,0.000016427735,0.00022949585],"genre_scores_gemma":[0.9909289,0.005789366,0.000068157264,0.0025095392,0.00039430885,0.00018989133,0.000016433754,0.000018118939,0.000085271924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964051,0.0022260293,0.00044257712,0.0003206206,0.00024531604,0.0003603476],"domain_scores_gemma":[0.9969561,0.0022335362,0.00022314957,0.0003356132,0.000085920896,0.00016565666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005470313,0.00025043776,0.00039872655,0.00012512847,0.00052636163,0.00008314175,0.00039625037,0.00014994429,0.00004989645],"category_scores_gemma":[0.0003295483,0.00012912409,0.00010338423,0.0003265148,0.00056106836,0.000102698104,0.00012779028,0.00083563087,0.000010401732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018331902,0.00021516073,0.00047146404,0.000024265519,0.00010166352,0.00001099066,0.008852583,0.000027932438,0.9251454,0.0057484796,0.001079839,0.039990343],"study_design_scores_gemma":[0.022156581,0.00007181761,0.16277398,0.000049587594,0.000786462,0.00008115092,0.0017237547,0.0034186542,0.5373409,0.004302615,0.26662505,0.00066947984],"about_ca_topic_score_codex":0.00008840289,"about_ca_topic_score_gemma":0.00015599375,"teacher_disagreement_score":0.3878045,"about_ca_system_score_codex":0.00000601929,"about_ca_system_score_gemma":0.0000461846,"threshold_uncertainty_score":0.52655274},"labels":[],"label_agreement":null},{"id":"W2168103670","doi":"10.1124/dmd.31.1.7","title":"Constitutive Androstane Receptor and Pregnane X Receptor Gene Expression in Human Liver: Interindividual Variability and Correlation with CYP2B6 mRNA Levels","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pregnane X receptor; Constitutive androstane receptor; CYP2B6; Biology; Cytochrome P450; Messenger RNA; Gene expression; Receptor; CYP3A4; Gene; Nuclear receptor; Endocrinology; Internal medicine; Molecular biology; Transcription factor; Genetics; Metabolism; Medicine","score_opus":0.03922641977277825,"score_gpt":0.3361975998094348,"score_spread":0.29697118003665657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168103670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885206,0.007482363,0.0009832244,0.00009254701,0.0005346732,0.0007220023,0.00043713272,0.000039356426,0.0011880998],"genre_scores_gemma":[0.99388415,0.003417376,0.0019724648,0.00025282885,0.000107790154,0.000071164206,0.00015027415,0.000022116039,0.00012184863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975177,0.0009545098,0.00039683736,0.00059465365,0.00017425409,0.00036203387],"domain_scores_gemma":[0.9990547,0.00021399105,0.00017764787,0.00015199314,0.00009246811,0.00030923958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010981954,0.0003302033,0.0004213839,0.00016334941,0.0003881508,0.000065884706,0.00008035933,0.00023523183,0.00028677538],"category_scores_gemma":[0.00006552586,0.00028942054,0.000032618373,0.00018289806,0.0004910279,0.0003819228,0.00008936982,0.00047475452,0.0000051358465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010714425,0.00065121264,0.048498742,0.00017525262,0.00013233023,0.000031830794,0.006648898,0.00014183135,0.9045042,0.016834531,0.00026927033,0.021040509],"study_design_scores_gemma":[0.014885453,0.00024195366,0.18363746,0.00027836082,0.0008454307,0.0002191812,0.0009209064,0.0012076969,0.7472707,0.0027798107,0.046356414,0.0013566351],"about_ca_topic_score_codex":0.000024951443,"about_ca_topic_score_gemma":0.000011857478,"teacher_disagreement_score":0.15723345,"about_ca_system_score_codex":0.000028845765,"about_ca_system_score_gemma":0.000050594164,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W2168484164","doi":"10.1677/joe-10-0075","title":"Cytochrome P450-mediated 17β-estradiol metabolism in zebrafish (Danio rerio)","year":2010,"lang":"en","type":"article","venue":"Journal of Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Environmental Health Sciences; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; McMaster University","keywords":"CYP3A; Cytochrome P450; Metabolite; Metabolism; Zebrafish; Danio; CYP1B1; Biology; Drug metabolism; Biochemistry; Cytochrome; Chemistry; Gene; Enzyme","score_opus":0.062031198869780306,"score_gpt":0.4023504431201033,"score_spread":0.340319244250323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168484164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829908,0.0029012181,0.000028175498,0.0022478835,0.006433325,0.00026114282,0.000050004666,0.000038966456,0.0050484636],"genre_scores_gemma":[0.99246377,0.0020470247,0.0007701685,0.002609585,0.0018311064,0.000018040848,0.000008391288,0.00004595325,0.00020594383],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964862,0.0006168726,0.0012660288,0.0003316621,0.00028351063,0.0010157641],"domain_scores_gemma":[0.9976222,0.00057767023,0.00069539604,0.00029471054,0.00029088545,0.00051915424],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010376236,0.0003688957,0.0009143782,0.0007313804,0.00012138112,0.000027473248,0.00086094183,0.00049194205,0.002266115],"category_scores_gemma":[0.00053711777,0.0003343787,0.0002825248,0.0004426796,0.0003900826,0.00023892269,0.00014163043,0.0039162966,0.00015773346],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004398732,0.0005355651,0.0049409135,0.000017307137,0.00027230283,0.0016084659,0.00039009668,0.00013662172,0.9757062,0.0033169258,0.003947702,0.008688012],"study_design_scores_gemma":[0.008277629,0.000206543,0.11397377,0.000011545115,0.0002989582,0.004055941,0.00010337875,0.00029398812,0.13474981,0.0021066326,0.735472,0.0004497877],"about_ca_topic_score_codex":0.000026438172,"about_ca_topic_score_gemma":0.00007108903,"teacher_disagreement_score":0.8409564,"about_ca_system_score_codex":0.00004611797,"about_ca_system_score_gemma":0.00032797566,"threshold_uncertainty_score":0.99991083},"labels":[],"label_agreement":null},{"id":"W2168535709","doi":"10.1016/s0731-7085(03)00528-4","title":"Determination of urinary 13C-caffeine metabolites by liquid chromatography–mass spectrometry: the use of metabolic ratios to assess CYP1A2 activity","year":2004,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Chemistry; Caffeine; Chromatography; CYP1A2; Urine; Mass spectrometry; Liquid chromatography–mass spectrometry; High-performance liquid chromatography; Tandem mass spectrometry; Metabolism; Biochemistry; Endocrinology; Cytochrome P450","score_opus":0.11118737188550944,"score_gpt":0.42220772133978146,"score_spread":0.31102034945427204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168535709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566306,0.007879911,0.03052997,0.0039971834,0.00039650247,0.00026323233,0.00026107396,0.000011547012,0.000029971392],"genre_scores_gemma":[0.9864252,0.0066941134,0.005391304,0.0011010632,0.0003163428,0.000010186665,0.00001431398,0.00001719723,0.000030285713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99622947,0.00083704264,0.0012346552,0.00032260144,0.00089205406,0.00048419027],"domain_scores_gemma":[0.9967332,0.00087457796,0.00083412585,0.00021923266,0.00045801693,0.0008808777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019641754,0.00034581491,0.0012418815,0.0011237345,0.00017551758,0.00003861041,0.0005130461,0.0002571533,0.00053825055],"category_scores_gemma":[0.00034724208,0.00022245546,0.00073132245,0.003210199,0.0007933584,0.0002914364,0.0001646489,0.00084645237,0.0000035239111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001213131,0.0019566875,0.0024749127,0.00008062713,0.003820728,0.000043276166,0.00021228314,0.00030164415,0.9681996,0.00041617625,0.00027470282,0.021006223],"study_design_scores_gemma":[0.0030060774,0.0007837116,0.008163291,0.000024924237,0.012034917,0.00008068675,0.000051746007,0.004881588,0.87521166,0.00025323383,0.09520212,0.0003060762],"about_ca_topic_score_codex":0.00002883228,"about_ca_topic_score_gemma":0.000002317745,"teacher_disagreement_score":0.094927415,"about_ca_system_score_codex":0.000026120091,"about_ca_system_score_gemma":0.00013970026,"threshold_uncertainty_score":0.90714705},"labels":[],"label_agreement":null},{"id":"W2168786728","doi":"10.18433/j30593","title":"Inhibition of Human Liver Cytochrome P450 by Star Fruit Juice","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Fruit juice; Cytochrome P450; Star (game theory); Chemistry; Food science; Human liver; Biochemistry; Metabolism; Enzyme; Mathematics","score_opus":0.17450300688268175,"score_gpt":0.49629016659249814,"score_spread":0.3217871597098164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168786728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776874,0.012727889,0.000539428,0.0008261228,0.0014531158,0.00042749758,0.0001087538,0.000045318495,0.006184434],"genre_scores_gemma":[0.99037886,0.0042068195,0.0007460215,0.003329504,0.0010909843,0.0000057301577,0.0000074382533,0.00003710218,0.0001975698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940208,0.0008765682,0.001986626,0.0005036808,0.0014001378,0.0012121499],"domain_scores_gemma":[0.99565846,0.0010462395,0.0012302875,0.0001782994,0.00063716667,0.0012495716],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009971182,0.00048703857,0.0007906496,0.0005934921,0.0007157931,0.00006738293,0.0010960056,0.00022918808,0.00491965],"category_scores_gemma":[0.00020926307,0.0004150667,0.0004517823,0.0011767625,0.0017053519,0.0007710893,0.00024200112,0.0020528007,0.00007999927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006685925,0.001119823,0.002911344,0.00009753612,0.00021019595,0.00022219229,0.00076174125,0.0000991312,0.93780905,0.0007066689,0.0073453235,0.04804841],"study_design_scores_gemma":[0.004030557,0.00031899335,0.0011865874,0.00003256293,0.0004529982,0.00016690839,0.00020825626,0.0011832567,0.67282677,0.00034665217,0.31890154,0.00034492704],"about_ca_topic_score_codex":0.000047574686,"about_ca_topic_score_gemma":0.0000062183703,"teacher_disagreement_score":0.31155622,"about_ca_system_score_codex":0.00015554302,"about_ca_system_score_gemma":0.0003375867,"threshold_uncertainty_score":0.9998301},"labels":[],"label_agreement":null},{"id":"W2169020135","doi":"10.1124/dmd.106.010363","title":"In Vivo and in Vitro Characterization of Chlorzoxazone Metabolism and Hepatic CYP2E1 Levels in African Green Monkeys: Induction by Chronic Nicotine Treatment","year":2006,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Chlorzoxazone; In vivo; Nicotine; CYP2E1; Pharmacology; Biology; Drug metabolism; In vitro; Metabolism; Microsome; Chemistry; Endocrinology; Internal medicine; Biochemistry; Medicine","score_opus":0.024225973695588397,"score_gpt":0.3164565283292743,"score_spread":0.2922305546336859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169020135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844231,0.013188366,0.00003543104,0.0006604121,0.0003410683,0.0006930221,0.0005226341,0.000017918248,0.000118040334],"genre_scores_gemma":[0.9913156,0.0075995508,0.00005805758,0.00019587624,0.00026708192,0.00013635255,0.00020635522,0.000027608403,0.00019350083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777377,0.00045976345,0.00069618406,0.0004915644,0.00015834701,0.00042034846],"domain_scores_gemma":[0.9993675,0.00008437752,0.00024681474,0.00013506373,0.00004132655,0.00012494223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046089262,0.00034983738,0.0006722638,0.0005253164,0.0000870057,0.000027527563,0.00008259198,0.0002199658,0.000054579174],"category_scores_gemma":[0.000009622705,0.00034069413,0.000046368626,0.00048455395,0.00018097396,0.00036953465,0.000062536696,0.0002922423,0.0000015009259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046093913,0.00058144395,0.004045318,0.00008034571,0.000032283042,0.000008189629,0.0012344075,0.000056126824,0.96950984,0.00047032122,0.0000118992775,0.023508886],"study_design_scores_gemma":[0.0061885817,0.000034807417,0.23972145,0.00002573157,0.0002286394,0.000011396038,0.000086121545,0.003601679,0.74261427,0.000920335,0.0062415157,0.00032549637],"about_ca_topic_score_codex":0.002633725,"about_ca_topic_score_gemma":0.0005595078,"teacher_disagreement_score":0.23567614,"about_ca_system_score_codex":0.00007956273,"about_ca_system_score_gemma":0.00004719982,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W2169470980","doi":"10.1016/s0165-6147(00)01493-0","title":"Ethical considerations in clinical pharmacogenomics research","year":2000,"lang":"en","type":"review","venue":"Trends in Pharmacological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Pharmacogenomics; Confidentiality; Ethical issues; Medicine; Pharmacogenetics; Engineering ethics; Psychiatry; Psychology; Pharmacology; Genotype; Political science; Biology; Genetics","score_opus":0.818077506940643,"score_gpt":0.7092402758541994,"score_spread":0.10883723108644361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169470980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002638199,0.94188523,6.418161e-7,0.001344033,0.0032954162,0.0012738823,0.00022789513,0.00011966031,0.04921503],"genre_scores_gemma":[0.006030322,0.987217,0.00028413205,0.0035090784,0.0013806438,0.0006754546,0.00006477884,0.00006365465,0.0007749515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.972453,0.017945664,0.0036861736,0.0022870784,0.0010589341,0.0025691767],"domain_scores_gemma":[0.98708236,0.010919878,0.00050880417,0.00037105716,0.00012577984,0.0009921107],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.028351896,0.001018152,0.003243221,0.0029784967,0.00087011827,0.00017963492,0.0022005,0.0035838473,0.031572342],"category_scores_gemma":[0.00071484415,0.0008047004,0.0009508781,0.0057916245,0.004641898,0.00018863293,0.00073587016,0.018026134,0.0010471481],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083618106,0.001476947,0.00023135997,0.00026294033,0.0001434156,0.0008220249,0.00014061712,0.0003380406,0.000022982575,0.0019023963,0.014296207,0.98027945],"study_design_scores_gemma":[0.0022200767,0.00020979701,0.00011244447,0.00037282918,0.000594084,0.00009729363,0.000024802375,0.0008255417,0.00003069976,0.0026789256,0.991943,0.0008905062],"about_ca_topic_score_codex":0.000051947995,"about_ca_topic_score_gemma":0.00008838233,"teacher_disagreement_score":0.97938895,"about_ca_system_score_codex":0.0004195559,"about_ca_system_score_gemma":0.0013730511,"threshold_uncertainty_score":0.99973065},"labels":[],"label_agreement":null},{"id":"W2169746137","doi":"10.4997/jrcpe.2012.312","title":"Pharmacogenetics: transforming clinical medicine","year":2012,"lang":"en","type":"review","venue":"The Journal of the Royal College of Physicians of Edinburgh","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Drug response; Medicine; Precision medicine; Genetic testing; Drug development; Genetic variation; Drug; Bioinformatics; Computational biology; Pharmacology; Biology; Genetics; Internal medicine; Genotype; Pathology; Gene; Population","score_opus":0.21062982001683236,"score_gpt":0.4891259861523526,"score_spread":0.2784961661355202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169746137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017562503,0.98161626,0.00003845005,0.0005812133,0.0110198315,0.0009585443,0.0005487464,0.0000074271584,0.0034732951],"genre_scores_gemma":[0.018578937,0.97242177,0.000051925163,0.00045914747,0.0070334924,0.00000939942,0.0000036137358,0.00007486006,0.0013668292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99229723,0.0023533413,0.0036267494,0.0002180203,0.000872439,0.0006322322],"domain_scores_gemma":[0.9905439,0.002849884,0.00516381,0.0005975042,0.0005821437,0.00026277473],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0075988197,0.0006722974,0.0035918576,0.00025342352,0.00024851027,0.0000034737027,0.0029947972,0.0005655806,0.0011642302],"category_scores_gemma":[0.00019668291,0.0003478779,0.0022857576,0.0006895683,0.0014203613,0.00008010448,0.00030066835,0.0029073409,0.000004611273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005018401,0.0009936837,0.0000478931,0.0021873263,0.0042713806,0.000013528994,0.0008660279,0.0005239727,0.00075502484,0.00015047664,0.06726192,0.92242694],"study_design_scores_gemma":[0.0017788825,0.00029295625,0.0000108491695,0.0030508973,0.02573661,0.00006887291,0.00013048631,0.000101165606,0.0023562692,0.0002712869,0.9658939,0.0003077803],"about_ca_topic_score_codex":0.000009116458,"about_ca_topic_score_gemma":0.0000017274178,"teacher_disagreement_score":0.92211914,"about_ca_system_score_codex":0.00006272699,"about_ca_system_score_gemma":0.0005687586,"threshold_uncertainty_score":0.9998973},"labels":[],"label_agreement":null},{"id":"W2170078964","doi":"10.1097/00008571-200108000-00003","title":"Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates","year":2001,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse","keywords":"CYP2D6; Dextromethorphan; Debrisoquine; MDMA; Pharmacology; Cytochrome P450; Sparteine; Chemistry; Stereochemistry; Hydroxylation; Quinidine; Metabolism; Biology; Enzyme; Biochemistry","score_opus":0.1495562412011606,"score_gpt":0.44125100301229303,"score_spread":0.2916947618111324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170078964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868131,0.006840967,0.00034834197,0.0007884882,0.0007539112,0.002195448,0.0008065145,0.00016955349,0.0012836439],"genre_scores_gemma":[0.9866426,0.008046826,0.00052759016,0.0014976327,0.0009268326,0.0005722948,0.00014772304,0.00016223708,0.0014762825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952952,0.0005005976,0.0009195894,0.0011833024,0.00041658408,0.0016847096],"domain_scores_gemma":[0.9968553,0.0011397615,0.00032826746,0.0004913137,0.00025329192,0.00093201955],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010921167,0.0009018586,0.0009686041,0.00045727094,0.00046661455,0.000107213615,0.00071768364,0.0005794399,0.0012702779],"category_scores_gemma":[0.0001786079,0.0009436155,0.0002822565,0.0006720813,0.00049837923,0.00025771794,0.00033329098,0.0010984793,0.00017906143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001889311,0.0011187539,0.013114135,0.00020575289,0.00035303817,0.0001605927,0.00055365596,0.0015671061,0.94459444,0.000060968894,0.0018875911,0.034494676],"study_design_scores_gemma":[0.014513801,0.00032014796,0.12111376,0.000034675093,0.0008586026,0.0001789319,0.000072442715,0.050193563,0.5721477,0.00072987325,0.23836559,0.0014708836],"about_ca_topic_score_codex":0.000054419743,"about_ca_topic_score_gemma":0.000116094285,"teacher_disagreement_score":0.3724467,"about_ca_system_score_codex":0.00016332883,"about_ca_system_score_gemma":0.00021576657,"threshold_uncertainty_score":0.99964267},"labels":[],"label_agreement":null},{"id":"W2170360953","doi":"10.1074/jbc.m005776200","title":"Mutational Analysis of the CYP2B2 Phenobarbital Response Unit and Inhibitory Effect of the Constitutive Androstane Receptor on Phenobarbital Responsiveness","year":2000,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Medical Research Council","keywords":"Constitutive androstane receptor; Retinoic acid; Enhancer; Molecular biology; Transfection; Reporter gene; Transcription (linguistics); Androstane; Transcription factor; Phenobarbital; Biology; Context (archaeology); Nuclear receptor; Chemistry; Gene; Cell biology; Biochemistry; Gene expression; Genetics; Endocrinology","score_opus":0.04596279724641665,"score_gpt":0.3726882575481396,"score_spread":0.32672546030172295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170360953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966099,0.0011738833,0.0000018478447,0.00031470982,0.00029869817,0.00014858307,0.00039463595,0.0000040800996,0.0010536065],"genre_scores_gemma":[0.99913317,0.0002077746,0.00002068786,0.0003110903,0.00014130402,0.000003597275,0.000006268092,0.0000059231083,0.00017016042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730015,0.0014549908,0.0005894151,0.00017993129,0.00028054792,0.0001949964],"domain_scores_gemma":[0.99677753,0.002166761,0.0005406659,0.00016419169,0.00021066613,0.00014019827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016843566,0.00019923916,0.0005320812,0.000063271604,0.00015597735,0.0000073199244,0.00037155527,0.0002816053,0.0011129136],"category_scores_gemma":[0.0007730109,0.00010210969,0.00039226416,0.0005078726,0.0012324622,0.000034173314,0.000088071305,0.00073756033,0.0000018617881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016578216,0.00024015778,0.021848578,0.0000289789,0.0010033366,0.000022500592,0.00019734488,0.002004176,0.9556377,0.000037401092,0.00012151251,0.0022801063],"study_design_scores_gemma":[0.0020636441,0.0003450394,0.05682507,0.000042280804,0.0010185483,0.000078844874,0.000078648976,0.00013030646,0.93404675,0.000118909615,0.0051220073,0.00012996607],"about_ca_topic_score_codex":0.0000013814694,"about_ca_topic_score_gemma":2.1251147e-7,"teacher_disagreement_score":0.034976494,"about_ca_system_score_codex":0.00003703589,"about_ca_system_score_gemma":0.0001820089,"threshold_uncertainty_score":0.9998002},"labels":[],"label_agreement":null},{"id":"W2171032970","doi":"10.1345/aph.10088","title":"Drug Interaction between St. John's Wort and Cyclosporine","year":2000,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CYP3A4; Drug interaction; Drug; Pharmacology; Dialysis; Internal medicine; Cytochrome P450; Metabolism","score_opus":0.16847930061588257,"score_gpt":0.4924598215240041,"score_spread":0.3239805209081215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171032970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97849387,0.0064368965,0.000012548075,0.0031108793,0.00069491117,0.00037481962,0.00023104022,0.000090919704,0.010554144],"genre_scores_gemma":[0.9435431,0.04606276,0.00011168233,0.006359721,0.0009541917,0.000030229883,0.00004019747,0.0000519905,0.002846139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978128,0.00037890463,0.0006040209,0.000420942,0.00024517687,0.0005381601],"domain_scores_gemma":[0.9987683,0.0002476046,0.00021677243,0.00021099992,0.0001367188,0.0004195784],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091318163,0.00034291195,0.00049497373,0.00019168896,0.00018337,0.000023069984,0.00031848304,0.00015902749,0.015548897],"category_scores_gemma":[0.000009505124,0.00033455243,0.00017285057,0.00029188354,0.00022024158,0.0002548019,0.00004066608,0.0006406758,0.00011084262],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091543456,0.00040948024,0.016629824,0.000052430092,0.0006262983,0.000019648698,0.0010738699,0.00022381752,0.21562044,0.00015852253,0.029606877,0.73466337],"study_design_scores_gemma":[0.0015620039,0.00005058227,0.0038981054,0.000010820943,0.00009671304,0.0000067556784,0.00002952764,0.00029980158,0.4124261,0.0005107627,0.58088094,0.00022785035],"about_ca_topic_score_codex":0.00006339709,"about_ca_topic_score_gemma":0.0000035191993,"teacher_disagreement_score":0.7344355,"about_ca_system_score_codex":0.000010532969,"about_ca_system_score_gemma":0.00004529743,"threshold_uncertainty_score":0.99991065},"labels":[],"label_agreement":null},{"id":"W2171154262","doi":"10.1093/bioinformatics/btv232","title":"Cypiripi: exact genotyping of <i>CYP2D6</i> using high-throughput sequencing data","year":2015,"lang":"en","type":"article","venue":"Bioinformatics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute","keywords":"Genotyping; Context (archaeology); Pseudogene; Biology; Computational biology; Copy-number variation; Genotype; Computer science; Genetics; Data mining; Algorithm; Gene; Genome","score_opus":0.4461480385382918,"score_gpt":0.47036580555392304,"score_spread":0.02421776701563122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171154262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475899,0.0041076257,0.024247384,0.00027665656,0.0052833995,0.0007904301,0.001150897,0.0001911995,0.016362537],"genre_scores_gemma":[0.9192274,0.0005593443,0.076211825,0.0028628062,0.0007185376,0.0000067406186,0.00024901913,0.00005569594,0.00010859082],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975804,0.00019258502,0.0009801771,0.0002660928,0.00039002704,0.00059069996],"domain_scores_gemma":[0.9977531,0.00015515753,0.00054373196,0.0008490361,0.000257537,0.0004414796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018015897,0.0003112479,0.0004837466,0.00017055492,0.00017140544,0.00003690472,0.0010025529,0.0004149855,0.00014159031],"category_scores_gemma":[0.00022214881,0.00029636204,0.00007856668,0.00034235194,0.00022716247,0.00063697057,0.0007311639,0.0007107115,0.00013022783],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014521583,0.001365018,0.011207175,0.0024674824,0.0030137682,0.00018773299,0.04069001,0.14268935,0.41237843,0.017595107,0.08920998,0.2777438],"study_design_scores_gemma":[0.0031818727,0.00008809564,0.000109266686,0.000051343348,0.00057893613,0.00009039283,0.0014238525,0.6652908,0.09430514,0.001090946,0.23314375,0.0006456019],"about_ca_topic_score_codex":0.00011395382,"about_ca_topic_score_gemma":0.00000529394,"teacher_disagreement_score":0.5226014,"about_ca_system_score_codex":0.00014478287,"about_ca_system_score_gemma":0.0006802765,"threshold_uncertainty_score":0.99994886},"labels":[],"label_agreement":null},{"id":"W2171597228","doi":"10.1530/eje-11-0596","title":"Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways","year":2011,"lang":"en","type":"article","venue":"European Journal of Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Abdominal obesity; Medicine; Nicotine; Odds ratio; Internal medicine; Cotinine; Insulin resistance; Diabetes mellitus; Obesity; Endocrinology; Type 2 Diabetes Mellitus; Logistic regression; Type 2 diabetes; Genotype; Body mass index; Waist; Biology; Genetics","score_opus":0.1969002856443646,"score_gpt":0.38147365692498625,"score_spread":0.18457337128062165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171597228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793668,0.007183673,0.000010092416,0.00022199881,0.0016654547,0.00007591202,0.000011470821,0.000019469031,0.011445135],"genre_scores_gemma":[0.99459994,0.0036893485,0.00014867909,0.00088110124,0.00057966454,6.936425e-7,0.0000018479919,0.00002834351,0.000070354894],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980572,0.0008885503,0.00041892647,0.00018674618,0.00008502575,0.0003635539],"domain_scores_gemma":[0.99904984,0.00020626622,0.00030351442,0.00007814762,0.00013134562,0.0002308868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006247313,0.00018007407,0.0002974224,0.00022451616,0.00014333245,0.000016339463,0.0001917276,0.00005804313,0.00025999703],"category_scores_gemma":[0.00009978373,0.00015541358,0.000051496187,0.00008468583,0.0001103404,0.00011274076,0.00012568067,0.0008201155,0.000048368944],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019930054,0.0005595061,0.15184882,0.000111677065,0.0018015691,0.0018205089,0.006872842,0.00006831595,0.282658,0.0064441175,0.0022294365,0.5435922],"study_design_scores_gemma":[0.0046420386,0.0030220666,0.27009484,0.00006686716,0.0008274225,0.00074485276,0.00028695576,0.00015276112,0.5260174,0.0014161102,0.19218028,0.00054840057],"about_ca_topic_score_codex":8.0411473e-7,"about_ca_topic_score_gemma":3.0175667e-7,"teacher_disagreement_score":0.5430438,"about_ca_system_score_codex":0.000013691602,"about_ca_system_score_gemma":0.000024642022,"threshold_uncertainty_score":0.6337582},"labels":[],"label_agreement":null},{"id":"W2171600156","doi":"10.1038/srep09257","title":"SNP genotyping using TaqMan® technology: the CYP2D6*17 assay conundrum","year":2015,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Mental Health; National Institutes of Health","keywords":"TaqMan; Genotyping; Genotype; SNP genotyping; Biology; Locus (genetics); Genetics; CYP2D6; SNP; Primer (cosmetics); Single-nucleotide polymorphism; Computational biology; Gene; Allele; Polymerase chain reaction; Chemistry","score_opus":0.23317090470254642,"score_gpt":0.4530663668042264,"score_spread":0.21989546210167998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171600156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.923351,0.009074462,0.0012629132,0.0026872344,0.044695623,0.0008999203,0.000017800647,0.00029878863,0.017712245],"genre_scores_gemma":[0.99003106,0.00004886654,0.0010235931,0.0012090016,0.0005683279,0.000046239118,0.00002541215,0.00004214032,0.0070053292],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966008,0.00043577902,0.00071677024,0.0008598451,0.0005439795,0.0008428167],"domain_scores_gemma":[0.99746865,0.00012345429,0.0005017928,0.0009741516,0.0004850211,0.00044692215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077225347,0.00030063937,0.00033710068,0.00035470488,0.0011537374,0.00021852918,0.00056354457,0.0003648752,0.00049368513],"category_scores_gemma":[0.00048031058,0.00022964054,0.00014302568,0.0011460248,0.0012158664,0.00016453215,0.00040087878,0.0008733445,0.00017925922],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010314088,0.00045346186,0.025072638,0.00003613489,0.00041901975,0.0018344418,0.002715683,0.011150849,0.68100333,0.0021619059,0.2340403,0.041009095],"study_design_scores_gemma":[0.00043806774,0.000013550862,0.000092336755,0.000009647538,0.00019540881,0.00070834445,0.00034806455,0.007781131,0.12279419,0.018016413,0.8493074,0.00029544593],"about_ca_topic_score_codex":0.000018809951,"about_ca_topic_score_gemma":0.000011486679,"teacher_disagreement_score":0.6152671,"about_ca_system_score_codex":0.00011282661,"about_ca_system_score_gemma":0.0006053164,"threshold_uncertainty_score":0.93644696},"labels":[],"label_agreement":null},{"id":"W2171770274","doi":"10.2174/138920011795016845","title":"CYP2A5 Induction and Hepatocellular Stress: An Adaptive Response to Perturbations of Heme Homeostasis","year":2011,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Cytochrome P450; Xenobiotic; Carcinogen; Homeostasis; Detoxification (alternative medicine); Biology; Endoplasmic reticulum; Oxidative stress; Heme; Liver injury; Enzyme; Cell biology; Pharmacology; Biochemistry; Medicine; Pathology","score_opus":0.26377789033262855,"score_gpt":0.4583563841434681,"score_spread":0.19457849381083953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171770274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020960117,0.96859026,0.000067807676,0.00004942386,0.005416679,0.0020125073,0.002606041,0.00009067435,0.0002064943],"genre_scores_gemma":[0.0028489167,0.9944227,0.0003974951,0.00009963776,0.001042267,0.0004911196,0.00025648443,0.00013751545,0.0003039123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928133,0.0035911133,0.0013731192,0.0010959463,0.0003674718,0.00075907854],"domain_scores_gemma":[0.99651915,0.00048487805,0.00085380574,0.0007545808,0.00037301006,0.001014565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020209115,0.0009946639,0.0024763434,0.0010913964,0.00032284227,0.000043377662,0.0008183023,0.00063426717,0.0007317228],"category_scores_gemma":[0.00022689828,0.00088882155,0.0005593859,0.0008288562,0.00034696813,0.00026723265,0.00041807565,0.0017287597,0.00015908029],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045340596,0.00070563337,0.000015749123,0.0019134773,0.0005013638,0.0000078047815,0.0024197176,0.000010017215,0.00045185356,0.001232513,0.0009187356,0.9913697],"study_design_scores_gemma":[0.00080273073,0.00007643455,0.00010612681,0.0008481052,0.004668063,0.000016278482,0.00013611795,0.00008742727,0.0013470248,0.0001644673,0.9908872,0.0008600007],"about_ca_topic_score_codex":0.000029042827,"about_ca_topic_score_gemma":0.000004449255,"teacher_disagreement_score":0.99050975,"about_ca_system_score_codex":0.000070125716,"about_ca_system_score_gemma":0.0005026597,"threshold_uncertainty_score":0.99935627},"labels":[],"label_agreement":null},{"id":"W2171899958","doi":"10.1152/ajprenal.2001.280.2.f266","title":"Molecular and biochemical characterization of prostacyclin receptors in rat kidney","year":2001,"lang":"en","type":"article","venue":"American Journal of Physiology-Renal Physiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Prostacyclin; Vasopressin; Receptor; Endocrinology; Internal medicine; Chemistry; Calcium; Molecular biology; Biology; Biochemistry; Medicine","score_opus":0.024154243843675528,"score_gpt":0.35399867730776596,"score_spread":0.3298444334640904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171899958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774265,0.00045072087,0.00003499662,0.0006793526,0.0008078221,0.00017712946,0.000027522954,0.000009718265,0.00007010521],"genre_scores_gemma":[0.99475807,0.002297824,0.00021413369,0.0022857122,0.00034900237,0.0000103789935,0.00004186,0.000025136282,0.00001789199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973346,0.0008781491,0.0008743706,0.00032610225,0.00013055444,0.00045621852],"domain_scores_gemma":[0.9980883,0.0002038095,0.0009927492,0.00016568374,0.00020993517,0.00033952537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047943494,0.00027924567,0.00090716564,0.00030761614,0.000051161085,0.0000043581977,0.00033028875,0.00019996573,0.00022468917],"category_scores_gemma":[0.00014610348,0.00024265233,0.00016621765,0.00048504595,0.001118887,0.00010587014,0.00011907479,0.00079935166,0.000007498798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018482845,0.00038558504,0.002026425,0.00002622349,0.00016052765,0.000016539248,0.00027159014,0.00021864224,0.9825344,0.00012148655,0.00021953914,0.012170744],"study_design_scores_gemma":[0.0025743206,0.00088490435,0.033110823,0.00004273056,0.00013248113,0.00010110564,0.000091445705,0.00035024717,0.94217277,0.0013467094,0.018899743,0.00029271535],"about_ca_topic_score_codex":0.000013511291,"about_ca_topic_score_gemma":5.148388e-7,"teacher_disagreement_score":0.04036164,"about_ca_system_score_codex":0.000030342902,"about_ca_system_score_gemma":0.00015379938,"threshold_uncertainty_score":0.98950744},"labels":[],"label_agreement":null},{"id":"W2178462841","doi":"10.1124/dmd.115.066357","title":"In Vitro and In Vivo Mechanistic Studies toward Understanding the Role of 1-Aminobenzotriazole in Rat Drug-Drug Interactions","year":2015,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada); Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; Vertex Pharmaceuticals","keywords":"Pharmacokinetics; In vivo; Pharmacology; Drug metabolism; Metabolism; Chemistry; Oral administration; Drug; Absorption (acoustics); First pass effect; Drug interaction; Cytochrome P450; Medicine; Biology; Biochemistry","score_opus":0.10881133443803996,"score_gpt":0.4007740290749717,"score_spread":0.29196269463693175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2178462841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96128565,0.034794606,0.0000675159,0.0011769382,0.0013013006,0.00046441334,0.000084747175,0.000014354382,0.00081048976],"genre_scores_gemma":[0.99475944,0.004276998,0.000075138094,0.0005159126,0.00014837449,0.000080229314,0.0000122914025,0.000016817863,0.000114816015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979421,0.000708517,0.00051567215,0.0003168646,0.00017124857,0.00034558488],"domain_scores_gemma":[0.99908555,0.0004189361,0.00015402635,0.00012457781,0.000062453575,0.000154468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014295354,0.00023782931,0.0004769468,0.00039958372,0.00011023883,0.000027932098,0.00014186365,0.000068292145,0.000027939963],"category_scores_gemma":[0.00008030831,0.00019650528,0.00005015429,0.00041049384,0.00019183065,0.00030021608,0.00014513529,0.0004902459,0.000003034906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029595257,0.00089772337,0.004847266,0.00019290205,0.00018277926,0.000067446745,0.0762187,0.0017989995,0.8701607,0.033288028,0.0011907988,0.008195132],"study_design_scores_gemma":[0.009208372,0.000017990591,0.002680014,0.00010074197,0.0005061108,0.000034928995,0.061337482,0.019446028,0.77923024,0.1060435,0.020782372,0.0006122321],"about_ca_topic_score_codex":0.0002585287,"about_ca_topic_score_gemma":0.00047912658,"teacher_disagreement_score":0.09093047,"about_ca_system_score_codex":0.00009315756,"about_ca_system_score_gemma":0.000055326745,"threshold_uncertainty_score":0.80132526},"labels":[],"label_agreement":null},{"id":"W2183183125","doi":"","title":"Effect of several Chinese natural health products of human cytochrome P450 metabolism.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Therapure Biopharma (Canada); Health Canada","funders":"","keywords":"Cytochrome P450; Isozyme; Drug metabolism; Pharmacology; Metabolism; Traditional Chinese medicine; Natural product; Drug; CYP2C9; Chemistry; Traditional medicine; Biology; Biochemistry; Enzyme; Medicine","score_opus":0.07026630394686059,"score_gpt":0.4010890408121269,"score_spread":0.3308227368652663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183183125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97556585,0.018304814,0.0000026282978,0.00071468664,0.0014505826,0.0016639272,0.000107849715,0.0000600627,0.0021296032],"genre_scores_gemma":[0.99643487,0.00063351245,0.00004680391,0.0006825196,0.0005799233,0.00045094138,0.00002362319,0.00003618244,0.0011116142],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967753,0.001082118,0.0006871771,0.00039192988,0.00031001182,0.0007534516],"domain_scores_gemma":[0.9985168,0.0002290605,0.00044995034,0.00033438765,0.0001397067,0.0003301053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019128401,0.00033677058,0.00087114767,0.00022341122,0.0001549484,0.000008771137,0.00042718087,0.00013338822,0.0003416701],"category_scores_gemma":[0.000213636,0.0002681606,0.00020444886,0.0005451536,0.00025696508,0.000117339165,0.00012947246,0.000626474,0.000017949027],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013535323,0.0021838762,0.014092647,0.0023932832,0.0016297376,0.0000396207,0.0030763461,0.0006461204,0.40806663,0.0010021172,0.017625904,0.5478902],"study_design_scores_gemma":[0.00846252,0.00027090302,0.48065272,0.000012990682,0.00048616703,0.000039608138,0.000008100727,0.0014264958,0.46741414,0.0001731647,0.040477354,0.00057581114],"about_ca_topic_score_codex":0.0000349514,"about_ca_topic_score_gemma":0.0000033100587,"teacher_disagreement_score":0.54731435,"about_ca_system_score_codex":0.000036056717,"about_ca_system_score_gemma":0.000028625844,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W2186092389","doi":"10.1124/mol.105.015891","title":"Inactivation of the Pure Antiestrogen Fulvestrant and Other Synthetic Estrogen Molecules by UDP-Glucuronosyltransferase 1A Enzymes Expressed in Breast Tissue","year":2005,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Glucuronidation; Fulvestrant; Enzyme; Chemistry; Glucuronosyltransferase; Antiestrogen; Biochemistry; Estrogen; Estrogen receptor; Microsome; Biology; Cancer; Endocrinology; Breast cancer","score_opus":0.02167709174274309,"score_gpt":0.34478193430852655,"score_spread":0.3231048425657835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186092389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98459345,0.008694531,0.00051516655,0.003688817,0.0004899163,0.00086939044,0.00055594306,0.000043459382,0.00054934487],"genre_scores_gemma":[0.99446297,0.0007021589,0.00018612771,0.0042298534,0.00014267603,0.0001296438,0.00001904926,0.000063611544,0.000063903426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968547,0.0010785199,0.00062132115,0.00055224856,0.0002411966,0.00065198017],"domain_scores_gemma":[0.9990243,0.00016491456,0.00021329531,0.00027643645,0.00007793545,0.00024312163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004735205,0.00042215214,0.0004893417,0.00018169453,0.00014755293,0.000018914723,0.00053722673,0.00035511734,0.00063650584],"category_scores_gemma":[0.000019773954,0.00037221878,0.00013450767,0.00034072128,0.0005138551,0.00011071429,0.0001411743,0.0007323148,0.000015020236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043117563,0.0005884452,0.001815211,0.0000552731,0.00021407015,0.00003354729,0.00046376974,0.0015708315,0.9808921,0.0010756607,0.001066839,0.0117930705],"study_design_scores_gemma":[0.0029604605,0.000063204825,0.0005520721,0.000015156667,0.000307158,0.00007916358,0.000046641828,0.0021185619,0.8832696,0.00018381396,0.1100956,0.00030858186],"about_ca_topic_score_codex":0.000049339633,"about_ca_topic_score_gemma":0.000006978504,"teacher_disagreement_score":0.10902876,"about_ca_system_score_codex":0.000056891928,"about_ca_system_score_gemma":0.00012236243,"threshold_uncertainty_score":0.999873},"labels":[],"label_agreement":null},{"id":"W2188010897","doi":"10.1002/chir.22054","title":"Effect of serum lipoproteins on stereoselective halofantrine metabolism by rat hepatocytes","year":2012,"lang":"en","type":"article","venue":"Chirality","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Montréal","funders":"Canadian Institutes of Health Research; University of Alberta","keywords":"Chemistry; Internal medicine; Endocrinology; Metabolism; Metabolite; Hepatocyte; Enantiomer; Cytochrome P450; Biochemistry; In vitro; Biology","score_opus":0.057126775801462,"score_gpt":0.4278086637722961,"score_spread":0.3706818879708341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188010897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98425627,0.0068093734,0.00003157154,0.00021361228,0.0023146353,0.0009113361,0.0005342844,0.00008509716,0.0048438306],"genre_scores_gemma":[0.99702567,0.000399201,0.00004003199,0.0011076785,0.00068569666,0.0001044364,0.000033602064,0.000038780083,0.0005649091],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99646753,0.0016331112,0.0004708963,0.00035890038,0.0002778998,0.00079163566],"domain_scores_gemma":[0.99836844,0.0004708416,0.00026039663,0.00035537526,0.000088294,0.0004566484],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021629576,0.00041124833,0.00068953197,0.00010198552,0.0001974881,0.000013251305,0.0003430645,0.00029950828,0.0011653311],"category_scores_gemma":[0.0001671655,0.00033271575,0.00023924801,0.0002723629,0.00021533703,0.00016290366,0.00013333661,0.0007851501,0.0001777129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003134722,0.0022055446,0.14065859,0.00039110257,0.000934464,0.000009300422,0.001218471,0.000050364702,0.62146306,0.0030827655,0.008752917,0.2180987],"study_design_scores_gemma":[0.0025916186,0.00027859816,0.02081215,0.00000814965,0.00033459143,0.000004926487,0.0000062286585,0.00010081142,0.8504378,0.00013064158,0.12501378,0.00028067824],"about_ca_topic_score_codex":0.000049298353,"about_ca_topic_score_gemma":0.0000021888575,"teacher_disagreement_score":0.22897476,"about_ca_system_score_codex":0.000045264616,"about_ca_system_score_gemma":0.00003778202,"threshold_uncertainty_score":0.9999125},"labels":[],"label_agreement":null},{"id":"W2188378454","doi":"","title":"The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Metabolite; Microsome; Demethylation; Chemistry; Cytochrome P450; Metabolism; CYP2D6; Microsoma; Chromatography; Enzyme; Biochemistry; Gene expression","score_opus":0.23152675730749486,"score_gpt":0.3954723274777223,"score_spread":0.16394557017022746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188378454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96810025,0.018746288,0.000113544564,0.0011571851,0.0020757955,0.0029052012,0.00007779275,0.000109922665,0.0067140292],"genre_scores_gemma":[0.95572346,0.030139655,0.00092510664,0.00165639,0.0006206263,0.0022354536,0.00002999577,0.00011754223,0.008551757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940099,0.0017811088,0.0012427903,0.0008119613,0.0005031067,0.0016511498],"domain_scores_gemma":[0.9964844,0.0014423296,0.00050792535,0.0007666398,0.00026561075,0.0005330965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037433512,0.00057768007,0.0007572457,0.00043070395,0.0005330676,0.00013240993,0.0010321179,0.0005841302,0.00043173373],"category_scores_gemma":[0.00040132675,0.00048096746,0.0003610596,0.0010718218,0.0008548298,0.00029084357,0.00045027144,0.0017242165,0.00010306411],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012490253,0.0013417706,0.0270305,0.00008765624,0.0004928632,0.0003725867,0.0015446561,0.00057724887,0.1572957,0.0044201026,0.0066396235,0.7989483],"study_design_scores_gemma":[0.0026949614,0.00004725791,0.115880236,0.000009495547,0.00013639712,0.000040559287,0.000080031656,0.0001559984,0.12906277,0.001797988,0.74960953,0.00048478844],"about_ca_topic_score_codex":0.00046638103,"about_ca_topic_score_gemma":0.00025411625,"teacher_disagreement_score":0.79846346,"about_ca_system_score_codex":0.0001684323,"about_ca_system_score_gemma":0.00010943329,"threshold_uncertainty_score":0.9997642},"labels":[],"label_agreement":null},{"id":"W2188695576","doi":"10.1139/gen-2015-0100","title":"The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in Canada","year":2015,"lang":"en","type":"review","venue":"Genome","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research; University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Pharmacogenomics; Confidentiality; Public policy; Policy development; Political science; Public administration; Bioinformatics; Biology","score_opus":0.42488825775136363,"score_gpt":0.4941829590761387,"score_spread":0.06929470132477505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188695576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002483246,0.9879865,0.0012396832,0.0008139056,0.005421844,0.0024360695,0.0007287121,0.000076489014,0.0010484795],"genre_scores_gemma":[0.00031020612,0.98533106,0.007975855,0.002308738,0.0024724754,0.0010661543,0.00009311307,0.00021953118,0.00022286254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99389285,0.0009922206,0.0016794952,0.00086521864,0.00041899874,0.0021512338],"domain_scores_gemma":[0.9906385,0.006686315,0.0010019128,0.0006150018,0.00043180655,0.00062649394],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035093527,0.0009887106,0.0021174643,0.00036549382,0.0009932076,0.00021367872,0.0019565113,0.0009547628,0.000052406238],"category_scores_gemma":[0.002064872,0.0007969352,0.0004005511,0.0013747741,0.00018810462,0.00009847536,0.0006421883,0.0032921873,0.000051134688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003427498,0.000036332087,0.00005427599,0.0023784237,0.00064841093,0.00004567648,0.0003166191,0.00015291851,0.000022523716,0.013210831,0.000818322,0.9822814],"study_design_scores_gemma":[0.00054434,0.000015496933,0.0000074166137,0.0008354001,0.0007984115,0.000057222984,0.0001498821,0.00020838818,0.00001655186,0.007814197,0.98860985,0.0009428138],"about_ca_topic_score_codex":0.014715361,"about_ca_topic_score_gemma":0.024474232,"teacher_disagreement_score":0.98779154,"about_ca_system_score_codex":0.0027605242,"about_ca_system_score_gemma":0.014297912,"threshold_uncertainty_score":0.9994482},"labels":[],"label_agreement":null},{"id":"W2196030797","doi":"10.1124/dmd.115.066829","title":"Metabolism of Oral Turinabol by Human Steroid Hormone–Synthesizing Cytochrome P450 Enzymes","year":2015,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Steroid; Cholesterol side-chain cleavage enzyme; Chemistry; Cytochrome P450; Stereochemistry; Steroid 11-beta-hydroxylase; Enzyme; Hydroxylation; Biochemistry; Hormone","score_opus":0.0719171909990786,"score_gpt":0.3874007805826685,"score_spread":0.3154835895835899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196030797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92244226,0.07232909,0.00022732979,0.0004145379,0.0007815932,0.0005651804,0.0005771476,0.00011779613,0.0025450706],"genre_scores_gemma":[0.9946802,0.0023376057,0.00047664755,0.0009818908,0.00049832824,0.00009814835,0.00022795344,0.00006662946,0.0006325882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99656224,0.0008287401,0.00079155416,0.0006243212,0.00048356302,0.00070956163],"domain_scores_gemma":[0.9980798,0.00012982273,0.00039091214,0.0003620249,0.00026233515,0.0007751271],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014190074,0.0005360947,0.00093635207,0.0002943203,0.00035588632,0.00007568335,0.00041254936,0.000323567,0.00020627349],"category_scores_gemma":[0.00006147308,0.00050310243,0.00019861499,0.0003416622,0.00039846258,0.00049953995,0.00022619731,0.0005797129,0.000057149246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005143554,0.0007621023,0.0002442069,0.00006618331,0.0002810143,0.000019116564,0.0025656847,0.00005665699,0.9525498,0.011264899,0.013679955,0.017996034],"study_design_scores_gemma":[0.0076081185,0.00007478428,0.017777836,0.000019333607,0.0013781344,0.000041399224,0.00063098734,0.0004477245,0.6059287,0.003437958,0.3618517,0.0008033347],"about_ca_topic_score_codex":0.00019016983,"about_ca_topic_score_gemma":0.000007821826,"teacher_disagreement_score":0.3481717,"about_ca_system_score_codex":0.000030564013,"about_ca_system_score_gemma":0.000081878025,"threshold_uncertainty_score":0.99974203},"labels":[],"label_agreement":null},{"id":"W2202197024","doi":"10.1158/1055-9965.epi-15-0694","title":"Digoxin Use After Diagnosis of Colorectal Cancer and Survival: A Population-Based Cohort Study","year":2015,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Yarmouk University; Queen's University Belfast; Public Health Agency; National Institute for Health and Care Research","keywords":"Medicine; Colorectal cancer; Digoxin; Internal medicine; Population; Cancer; Oncology; Cohort; Cohort study; Proportional hazards model; Confounding; Heart failure","score_opus":0.19942897072172613,"score_gpt":0.4868337639960159,"score_spread":0.2874047932742898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202197024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97920734,0.015163553,0.00012140146,0.0008859094,0.002800191,0.0015067126,0.0002158691,0.00005304075,0.00004601354],"genre_scores_gemma":[0.9935356,0.0023704213,0.00038057394,0.000760474,0.00017511674,0.0025226434,0.000091574504,0.000034454522,0.00012917841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99492025,0.0029541836,0.00086206145,0.000614733,0.00016844396,0.000480336],"domain_scores_gemma":[0.99718386,0.0014555905,0.00052514754,0.00021588091,0.00022881113,0.00039073368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040487493,0.0003176763,0.0007851288,0.00019055267,0.00010877521,0.000009563298,0.00018126622,0.00037112704,0.00047456415],"category_scores_gemma":[0.0006420928,0.00030054597,0.00016452857,0.00026650014,0.00028355655,0.00015919465,0.00010387973,0.00032926892,0.000006151763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015565961,0.000521427,0.9816439,0.000039576866,0.00101869,0.000006580341,0.00018485587,0.0009737454,0.0004639428,0.0000372786,0.0017359448,0.011817447],"study_design_scores_gemma":[0.00315448,0.00018399055,0.98436916,0.000040080224,0.0010280291,0.0000012337648,0.00006181236,0.0029088254,0.0013533467,0.0007027194,0.0059015737,0.00029474066],"about_ca_topic_score_codex":0.0032459102,"about_ca_topic_score_gemma":0.0018163536,"teacher_disagreement_score":0.014328254,"about_ca_system_score_codex":0.00017030329,"about_ca_system_score_gemma":0.00021515413,"threshold_uncertainty_score":0.9999447},"labels":[],"label_agreement":null},{"id":"W2209144082","doi":"10.1016/j.jinorgbio.2015.12.019","title":"The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4","year":2015,"lang":"en","type":"article","venue":"Journal of Inorganic Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"National Institute of General Medical Sciences; Fonds de recherche du Québec – Nature et technologies; National Institutes of Health","keywords":"Chemistry; Allosteric regulation; Binding site; Resonance Raman spectroscopy; Dimer; Stereochemistry; Substrate (aquarium); Allosteric enzyme; Molecule; CYP3A4; Plasma protein binding; Cytochrome P450; Monomer; Biophysics; Enzyme; Raman spectroscopy; Biochemistry; Polymer; Organic chemistry","score_opus":0.19808050682975845,"score_gpt":0.4033312502316051,"score_spread":0.20525074340184665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209144082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953909,0.0022579166,0.000054962227,0.0010368135,0.00089123304,0.0002706722,0.000016183387,0.000009613193,0.000071731454],"genre_scores_gemma":[0.99732643,0.00039431403,0.000633974,0.0011162716,0.0002966763,0.000012400907,0.0000026695948,0.000033325236,0.00018391255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979166,0.0002378979,0.000815703,0.0002170658,0.0003357093,0.0004770588],"domain_scores_gemma":[0.9978215,0.00044741028,0.00047853604,0.00024693838,0.00028468212,0.0007209263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009418942,0.00026020454,0.0004577461,0.00019187393,0.00008222551,0.000041370145,0.0005940332,0.00021584315,0.000041858686],"category_scores_gemma":[0.00058793405,0.0002021302,0.00011152911,0.0007487534,0.00011101233,0.00011573163,0.00020144875,0.00074829184,0.000041188043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052681746,0.00018856979,0.0028211721,0.000058412355,0.00013581285,0.0001103687,0.0012067428,0.00060589454,0.9870187,0.000002274483,0.0036867524,0.0036384503],"study_design_scores_gemma":[0.0018940312,0.00031029896,0.0038227253,0.00008299155,0.00012936963,0.00019587681,0.0004564828,0.000056700006,0.97624695,0.000025485013,0.016545005,0.00023408694],"about_ca_topic_score_codex":0.0000069233447,"about_ca_topic_score_gemma":0.0000022549057,"teacher_disagreement_score":0.012858252,"about_ca_system_score_codex":0.0001584665,"about_ca_system_score_gemma":0.00030408995,"threshold_uncertainty_score":0.82426304},"labels":[],"label_agreement":null},{"id":"W2209243252","doi":"10.2165/00128071-200304090-00005","title":"Drug Interactions of Clinical Significance for the Dermatologist","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Drug; Medicine; Drug interaction; Pharmacogenetics; Intensive care medicine; Pharmacotherapy; Clinical Practice; Pharmacology; Psychiatry; Family medicine; Biology","score_opus":0.4406664389583803,"score_gpt":0.636099180920618,"score_spread":0.1954327419622377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209243252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006406892,0.97790205,0.0014317008,0.0019162135,0.016036801,0.0010506345,0.00022440164,0.000017924298,0.0007795857],"genre_scores_gemma":[0.0050313226,0.988194,0.0016918806,0.0032001203,0.0014475749,0.00009887448,0.000014782588,0.00008149187,0.00023994046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9790111,0.009450981,0.00996011,0.00055369065,0.00031212706,0.0007119993],"domain_scores_gemma":[0.9399848,0.045896377,0.012080162,0.0006145926,0.00079861394,0.00062545296],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0071994592,0.00065253273,0.008261282,0.00028919138,0.00023299536,0.000020302645,0.0018611815,0.0005926463,0.00028661004],"category_scores_gemma":[0.004125844,0.00041756584,0.004520859,0.00056171365,0.004126211,0.00009344535,0.00017112891,0.00500559,0.000058318627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040458335,0.0007782489,0.0010193046,0.0010345381,0.0030596443,0.00011227097,0.000047251466,0.000019591214,8.072521e-7,0.00075872656,0.032165434,0.9605996],"study_design_scores_gemma":[0.001765189,0.0002222815,0.000060280792,0.00040876504,0.006907746,0.0024633326,0.00012186595,0.00013541925,0.000022050759,0.0002333717,0.9872893,0.00037040212],"about_ca_topic_score_codex":0.00001012897,"about_ca_topic_score_gemma":0.000009841037,"teacher_disagreement_score":0.9602292,"about_ca_system_score_codex":0.000028104409,"about_ca_system_score_gemma":0.0020302583,"threshold_uncertainty_score":0.9998276},"labels":[],"label_agreement":null},{"id":"W2216596139","doi":"10.1158/1538-7445.sabcs14-p3-06-43","title":"Abstract P3-06-43: A genetic deletion in the uridine diphosphate glucuronosyltransferase 2B17 affects the pharmacokinetics of exemestane","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exemestane; Glucuronidation; Glucuronosyltransferase; Internal medicine; Uridine diphosphate; Pharmacokinetics; Chemistry; Uridine; Endocrinology; Medicine; Aromatase; Pharmacology; Cancer; Enzyme; Breast cancer; Biochemistry; Microsome; Gene","score_opus":0.2807887475047311,"score_gpt":0.5201519390325852,"score_spread":0.23936319152785407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216596139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654328,0.02544579,0.000043577587,0.0046290285,0.0008731366,0.0014419869,0.000115753035,0.000024974643,0.0019929314],"genre_scores_gemma":[0.98246795,0.014885615,0.00004635213,0.0012238862,0.0006152443,0.00050161267,0.000020932286,0.000044217744,0.00019420625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952721,0.0018775179,0.00050187897,0.00043847712,0.0009331561,0.0009768936],"domain_scores_gemma":[0.99752945,0.0010688602,0.000120213845,0.0004816175,0.00043565014,0.00036420286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005672392,0.00028962127,0.00034309048,0.00022877674,0.0002674082,0.000052279207,0.0012021195,0.00020190823,0.0006147209],"category_scores_gemma":[0.00018550582,0.00018955459,0.000120157405,0.0010530703,0.0006908594,0.000089692214,0.00014875278,0.0018574899,0.000086969725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026959076,0.0013647518,0.013469043,0.000372729,0.00031526975,0.0004056777,0.008193283,0.018170305,0.8008501,0.0008935145,0.04607033,0.10719912],"study_design_scores_gemma":[0.0069821193,0.00033914362,0.027139805,0.000069402464,0.00024491447,0.000034792138,0.0006893763,0.0047139516,0.49169558,0.001263355,0.46637776,0.00044980823],"about_ca_topic_score_codex":0.00033220463,"about_ca_topic_score_gemma":0.000107944325,"teacher_disagreement_score":0.42030743,"about_ca_system_score_codex":0.00013056103,"about_ca_system_score_gemma":0.00054761354,"threshold_uncertainty_score":0.80699724},"labels":[],"label_agreement":null},{"id":"W2224333234","doi":"10.1016/j.yrtph.2016.01.004","title":"Assessing Natural Product–Drug Interactions: An End-to-End Safety Framework","year":2016,"lang":"en","type":"article","venue":"Regulatory Toxicology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Polypharmacy; Drug; Medicine; Pharmacology; Natural product; Population; Risk analysis (engineering); Environmental health; Biology","score_opus":0.07085481792971768,"score_gpt":0.44367235334879906,"score_spread":0.37281753541908136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224333234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664825,0.004106313,0.00065235863,0.010806081,0.014748743,0.0010159033,0.00012170635,0.0003171827,0.0017491903],"genre_scores_gemma":[0.9742786,0.0010633966,0.0017918252,0.01703685,0.0029036102,0.00022789792,0.000027451728,0.0000925668,0.002577775],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99330807,0.00260101,0.0009582773,0.0014261397,0.00029321318,0.0014132934],"domain_scores_gemma":[0.9956483,0.0019776146,0.00036992668,0.0005313635,0.0002643428,0.001208449],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022083235,0.00071339705,0.0008635931,0.0005442264,0.0009988933,0.00007010377,0.00072442036,0.00036468994,0.012142],"category_scores_gemma":[0.00019533276,0.0005784692,0.000187134,0.0004854941,0.0011371211,0.00092661905,0.00043892133,0.0017572723,0.00035371765],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011962719,0.0006215737,0.005610662,0.000045116278,0.00046217206,0.00010401733,0.00087095384,0.0001166214,0.7419877,0.0056317635,0.008389122,0.23496404],"study_design_scores_gemma":[0.0031158912,0.00013904469,0.030774042,0.00004138213,0.00053561194,0.0003292448,0.00016733643,0.00047135263,0.33285055,0.0028507486,0.6278363,0.0008884778],"about_ca_topic_score_codex":0.000014767263,"about_ca_topic_score_gemma":0.000057285026,"teacher_disagreement_score":0.6194472,"about_ca_system_score_codex":0.00022514889,"about_ca_system_score_gemma":0.00033014955,"threshold_uncertainty_score":0.9996667},"labels":[],"label_agreement":null},{"id":"W2231133613","doi":"10.1097/00008571-200301000-00006","title":"Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.","year":2003,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Quinidine; Venlafaxine; CYP2D6; Venlafaxine Hydrochloride; Pharmacology; Pharmacokinetics; Chemistry; Oral administration; Dosing; Internal medicine; Medicine; Metabolism; Cytochrome P450","score_opus":0.0721968665002955,"score_gpt":0.42409105370093014,"score_spread":0.35189418720063464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2231133613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805505,0.009605269,0.000043336335,0.00008181175,0.00036740265,0.0006473777,0.00009053441,0.000009533444,0.008604179],"genre_scores_gemma":[0.99648035,0.0025686573,0.00020730958,0.0005182262,0.00007873007,0.0000731058,0.000015021034,0.000027041762,0.00003158793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969126,0.0012789876,0.0007616185,0.0002964061,0.00028819428,0.00046221347],"domain_scores_gemma":[0.99890584,0.00035822822,0.00027345645,0.00023621223,0.00012858748,0.000097682954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014745726,0.00025397493,0.00040917174,0.00030168152,0.000058271562,0.000006747614,0.00045107643,0.0001702595,0.0003810515],"category_scores_gemma":[0.00006816532,0.00022161,0.000121165234,0.00077426876,0.00020803843,0.000059786245,0.000048997434,0.00063609064,0.000011630152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031308128,0.0014531116,0.08018989,0.00007720857,0.00010197561,0.000018821187,0.005421673,0.0035206,0.88835406,0.0032233922,0.000110606015,0.017215557],"study_design_scores_gemma":[0.0037672701,0.00013092897,0.039872073,0.00002275376,0.00020430145,0.00001106793,0.000613551,0.0015603623,0.91413045,0.0034372383,0.035976913,0.00027307542],"about_ca_topic_score_codex":0.000033981327,"about_ca_topic_score_gemma":0.00003418258,"teacher_disagreement_score":0.04031782,"about_ca_system_score_codex":0.000041161133,"about_ca_system_score_gemma":0.00010153374,"threshold_uncertainty_score":0.90369934},"labels":[],"label_agreement":null},{"id":"W2239796040","doi":"10.1007/978-3-319-10527-7","title":"Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials","year":2014,"lang":"en","type":"book","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacodynamics; Drug; Pharmacokinetics; Medicine; Pharmacology; Computer science; Intensive care medicine; Management science; Medical physics; Engineering","score_opus":0.1078097069697019,"score_gpt":0.46900643608694265,"score_spread":0.36119672911724077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239796040","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027790003,0.0035923598,0.00027066216,0.0009402351,0.0075176647,0.001629646,0.0006545011,0.00048770715,0.9571172],"genre_scores_gemma":[0.054550115,0.0057255826,0.00027363875,0.00792091,0.0027962436,0.0001099404,0.00063209084,0.000268578,0.9277229],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99377275,0.0018391272,0.0015844422,0.0013197353,0.00048704317,0.0009969241],"domain_scores_gemma":[0.9942883,0.002752918,0.0010710051,0.00045999914,0.00041449704,0.0010132648],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029500343,0.001129168,0.0017465557,0.00042822602,0.00044349252,0.00007248677,0.00068671576,0.00075670244,0.0076007466],"category_scores_gemma":[0.0001766856,0.0009656707,0.00041751307,0.00020520581,0.000937988,0.0001762231,0.00037635295,0.0042331843,0.0005206257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001386431,0.0016178882,0.0038032702,0.00033393886,0.008354074,0.0003527782,0.00034156602,0.00046187427,0.0069672745,0.0044756597,0.49266866,0.47923657],"study_design_scores_gemma":[0.0066071763,0.00011355794,0.0007090761,0.00014956895,0.004474999,0.0000748588,0.000008402054,0.010661669,0.0010402041,0.0006835912,0.9742712,0.0012057476],"about_ca_topic_score_codex":0.000010750255,"about_ca_topic_score_gemma":0.00007196297,"teacher_disagreement_score":0.4816025,"about_ca_system_score_codex":0.00015458492,"about_ca_system_score_gemma":0.00058307324,"threshold_uncertainty_score":0.9992794},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2269037162","doi":"10.1007/s40262-015-0352-5","title":"Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug–Drug Interaction Prediction","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Itraconazole; Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Drug; Chemistry; Medicine; Antifungal","score_opus":0.327424888735298,"score_gpt":0.5071408996172214,"score_spread":0.1797160108819234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269037162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958591,0.0024656812,0.027809042,0.0010383072,0.005275179,0.0022570628,0.000721852,0.000287621,0.0015542657],"genre_scores_gemma":[0.95860785,0.0014592021,0.032999575,0.0043305503,0.0012618542,0.00034289787,0.00023357522,0.000119889235,0.00064461713],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9938032,0.00081246137,0.0026852668,0.0011122139,0.00061558175,0.0009713008],"domain_scores_gemma":[0.9947601,0.0014473938,0.0009690223,0.0003963005,0.0010039624,0.0014232503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004010993,0.0007681182,0.0011106661,0.00031422335,0.00028873506,0.000045347995,0.00073248235,0.00041350196,0.00028361083],"category_scores_gemma":[0.0004725656,0.0007427295,0.0004200698,0.0004134747,0.0006849805,0.0002217555,0.00034912679,0.0014544538,0.00004090367],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008133089,0.0057870904,0.00410508,0.00080242066,0.0012524734,0.000023867218,0.0032178022,0.22370969,0.4429493,0.00031948453,0.07818585,0.23151387],"study_design_scores_gemma":[0.011329645,0.0001394676,0.0004970744,0.000036419646,0.00089624646,0.0000070312767,0.00011596395,0.6414244,0.11183193,0.0004495985,0.23272748,0.0005447543],"about_ca_topic_score_codex":0.00000296246,"about_ca_topic_score_gemma":0.0000034948846,"teacher_disagreement_score":0.41771472,"about_ca_system_score_codex":0.00010452852,"about_ca_system_score_gemma":0.0006326602,"threshold_uncertainty_score":0.99950236},"labels":[],"label_agreement":null},{"id":"W2269609889","doi":"10.1002/chem.201600246","title":"Direct Observation of an Oxepin from a Bacterial Cytochrome P450‐Catalyzed Oxidation","year":2016,"lang":"en","type":"article","venue":"Chemistry - A European Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Australian Research Council; University of Queensland","keywords":"Hydroxylation; Chemistry; Tautomer; Cytochrome P450; Catalysis; Flavin group; Reactive intermediate; Phenols; Stereochemistry; Combinatorial chemistry; Photochemistry; Organic chemistry; Enzyme","score_opus":0.09599393693691344,"score_gpt":0.3677334245001588,"score_spread":0.27173948756324534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269609889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953881,0.00025270265,0.00040390258,0.0002174943,0.00053336757,0.00009741113,0.00023994943,0.0000462368,0.0028208194],"genre_scores_gemma":[0.99580103,0.00040922788,0.0006604432,0.00016449651,0.0022623304,0.0000038606327,0.00013630245,0.000044701457,0.00051759294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977443,0.0008121165,0.00062682544,0.00029428324,0.00020580503,0.0003166395],"domain_scores_gemma":[0.9985135,0.00013754796,0.0005139778,0.00025469696,0.00018924144,0.00039104457],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012260725,0.00022754511,0.00028730836,0.000044507113,0.0001672764,0.000042306132,0.00047099503,0.00010673918,0.0048735547],"category_scores_gemma":[0.00018692345,0.00017799085,0.00012962328,0.00011625082,0.00014307242,0.00026491066,0.00008736284,0.00036633704,0.000099658755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045024717,0.00018768678,0.00030970108,0.000015140215,0.00012786458,0.00007153467,0.00020810211,0.000017194709,0.96414876,0.0000024833307,0.00076318346,0.033698115],"study_design_scores_gemma":[0.0036707905,0.00003536245,0.015930198,0.00004098727,0.00015252632,0.0000647831,0.000020737436,0.00024115942,0.90457314,0.000082758204,0.07495913,0.00022841098],"about_ca_topic_score_codex":0.0000028403283,"about_ca_topic_score_gemma":3.8162074e-7,"teacher_disagreement_score":0.074195944,"about_ca_system_score_codex":0.000051093866,"about_ca_system_score_gemma":0.00010007086,"threshold_uncertainty_score":0.9960361},"labels":[],"label_agreement":null},{"id":"W2269993080","doi":"10.1093/toxsci/kfv107","title":"NADPH Oxidase-Mediated Superoxide Production by Intermediary Bacterial Metabolites of Dibenzofuran: A Potential Cause for Trans-Mitochondrial Membrane Potential (ΔΨm) Collapse in Human Hepatoma Cells","year":2015,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Dibenzofuran; Chemistry; Superoxide; Reactive oxygen species; Oxidative stress; Toxicity; Mitochondrion; Biochemistry; Photobacterium phosphoreum; NADPH oxidase; Catalase; Oxidase test; Enzyme","score_opus":0.11021668086561852,"score_gpt":0.3970106824841867,"score_spread":0.28679400161856816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269993080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824155,0.0007833584,0.0001502049,0.000982283,0.007147621,0.0016842951,0.0007151237,0.0000915975,0.00020396567],"genre_scores_gemma":[0.9967125,0.00030314838,0.00067233626,0.00046793753,0.001228013,0.0002577917,0.0001432956,0.000024947009,0.00019003623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99524915,0.0010894835,0.0010731072,0.0009292893,0.000627117,0.0010318556],"domain_scores_gemma":[0.9981897,0.0003880975,0.00032822392,0.00020756996,0.0002377569,0.0006486346],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023997724,0.000453886,0.00084831734,0.00029654233,0.00036610937,0.00007659111,0.00086284993,0.00059053075,0.0009290255],"category_scores_gemma":[0.0005078413,0.0003697597,0.00025708336,0.0007765657,0.0016067479,0.00035731323,0.00015671697,0.00055290526,0.000013205009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018334137,0.0013855761,0.0005020746,0.00003612778,0.00009086745,0.0000407687,0.0005519812,0.0010165113,0.98887724,0.00011460322,0.004475674,0.0010751379],"study_design_scores_gemma":[0.0064996644,0.0009340372,0.00058624364,0.000013061539,0.00026682403,0.000022363565,0.00025067286,0.002612893,0.9695485,0.0007045284,0.01808339,0.00047778687],"about_ca_topic_score_codex":0.0000860008,"about_ca_topic_score_gemma":0.00009357387,"teacher_disagreement_score":0.019328728,"about_ca_system_score_codex":0.00008705448,"about_ca_system_score_gemma":0.00031342838,"threshold_uncertainty_score":0.99998426},"labels":[],"label_agreement":null},{"id":"W2277931495","doi":"10.1385/0-89603-519-0:129","title":"Determination of CYP2CSGatalyzed Diclofenac 4'-Hydroxylation by High-Performance Liquid Chromatography","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Hydroxylation; Chromatography; Perchloric acid; Diclofenac; Chemistry; High-performance liquid chromatography; Acetonitrile; Methanol; Microsome; Organic chemistry; Enzyme; Biochemistry","score_opus":0.07930400567876678,"score_gpt":0.3711577096430251,"score_spread":0.2918537039642583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277931495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543182,0.005196095,0.00049852056,0.000010239455,0.0008323454,0.00045701276,0.000077232646,0.00008677102,0.03852355],"genre_scores_gemma":[0.99702543,0.0012719235,0.00029669038,0.0002421522,0.00009725082,0.00008996783,0.000046671026,0.000036013786,0.00089392473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815243,0.00038053302,0.0005160181,0.00032013076,0.00023992966,0.0003909419],"domain_scores_gemma":[0.9990302,0.00009910193,0.00031165208,0.00027847438,0.00011430199,0.00016631646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005587618,0.00025541737,0.00031879495,0.00015608563,0.00022678531,0.000016330881,0.0002773793,0.00023910393,0.00022851546],"category_scores_gemma":[0.00002496562,0.0002611113,0.00010188912,0.00006607387,0.00022967481,0.00011456761,0.000054831387,0.00033676275,0.000013000756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005943145,0.0005344206,0.000371438,0.00034336664,0.00031050015,0.000011743303,0.0015047936,0.0004399922,0.8483942,0.021861348,0.0027855248,0.12284833],"study_design_scores_gemma":[0.0016468517,0.00011034082,0.0001954327,0.0000136244635,0.0001717687,0.0000048044694,0.000007576391,0.0020377235,0.7848633,0.000301951,0.21040511,0.00024154285],"about_ca_topic_score_codex":0.000037005917,"about_ca_topic_score_gemma":0.0000026701134,"teacher_disagreement_score":0.20761959,"about_ca_system_score_codex":0.000019679952,"about_ca_system_score_gemma":0.000033563498,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2279906559","doi":"10.1139/jpn.0261","title":"Drug-metabolizing cytochrome P450s in the brain","year":2002,"lang":"en","type":"review","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Brain function; Cytochrome P450; Neuroscience; Biology; Drug metabolism; Brain chemistry; Function (biology); Drug; Bioinformatics; Pharmacology; Metabolism; Genetics; Endocrinology","score_opus":0.17418983423724288,"score_gpt":0.47088411652016376,"score_spread":0.2966942822829209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279906559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012771855,0.98880166,0.000010469597,0.0020579707,0.006724721,0.00035693275,0.00002951543,0.0000069759285,0.0007345489],"genre_scores_gemma":[0.0008201882,0.9919314,0.00011530648,0.0056655956,0.0012178472,0.00001168735,7.066901e-7,0.000025222118,0.00021206946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958567,0.0017131146,0.0011513713,0.00037349967,0.00040616601,0.0004991758],"domain_scores_gemma":[0.99775946,0.00065721874,0.0010358649,0.00023904163,0.000050398703,0.00025802365],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003139453,0.00040636453,0.0011429007,0.00046919644,0.00029581736,0.000092960814,0.0012851091,0.0002593383,0.000083052786],"category_scores_gemma":[0.00017868055,0.00025414026,0.0004312976,0.00094948424,0.0003407028,0.00020006596,0.000114143135,0.0026377137,0.000013725414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039858725,0.00081109727,0.00022834926,0.0027098334,0.000061627725,0.00033708144,0.0006549269,0.0000500108,0.0005025794,0.0020519309,0.018062709,0.97449],"study_design_scores_gemma":[0.0005766013,0.000078864796,0.00020641596,0.0006447752,0.0005385768,0.0017742361,0.00003999167,0.000058478858,0.000008156782,0.0003492456,0.99547327,0.0002513842],"about_ca_topic_score_codex":0.0000013617337,"about_ca_topic_score_gemma":0.0000033045403,"teacher_disagreement_score":0.97741055,"about_ca_system_score_codex":0.000017960452,"about_ca_system_score_gemma":0.0003192198,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2283946288","doi":"","title":"St. John's wort may ameliorate 2,4,6-trinitrobenzenesulfonic acid colitis off rats through the induction of pregnane X receptors and/or P-glycoproteins.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pregnane X receptor; Colitis; Inflammatory bowel disease; Pathogenesis; Tumor necrosis factor alpha; Ulcerative colitis; Chemistry; Orosomucoid; Myeloperoxidase; Pharmacology; Receptor; Internal medicine; Endocrinology; Immunology; Medicine; Inflammation; Biochemistry; Nuclear receptor; Glycoprotein","score_opus":0.1697292111323969,"score_gpt":0.37936324949474853,"score_spread":0.20963403836235164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283946288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97555,0.0116889095,0.00003055976,0.0020252736,0.0041906983,0.0023659205,0.00015886704,0.00009796089,0.0038918015],"genre_scores_gemma":[0.987133,0.0069536534,0.00014721922,0.0011191976,0.00067513913,0.001785549,0.000031862248,0.000047476435,0.0021068659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99717426,0.0006721099,0.0006050407,0.00044942473,0.00034668192,0.000752469],"domain_scores_gemma":[0.99837375,0.00016888946,0.00038998472,0.00036381258,0.00027153725,0.0004320478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016491808,0.00033450208,0.00046779236,0.00012411724,0.00022523994,0.000038444723,0.0003645914,0.00034191276,0.0002476459],"category_scores_gemma":[0.00024233838,0.00023891061,0.00010306767,0.0006211858,0.00044832338,0.00024352374,0.00022513134,0.0007278966,0.00002763775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004479683,0.0007716388,0.003065612,0.00015578204,0.0007755351,0.000082139195,0.003749126,0.00045808798,0.017305883,0.002321922,0.030258557,0.936576],"study_design_scores_gemma":[0.003555957,0.000114923736,0.010062831,0.000014698461,0.00029291085,0.00006360791,0.000451051,0.00007789913,0.35183185,0.0023239604,0.630829,0.00038133675],"about_ca_topic_score_codex":0.00007775295,"about_ca_topic_score_gemma":0.00003329118,"teacher_disagreement_score":0.9361947,"about_ca_system_score_codex":0.00007708086,"about_ca_system_score_gemma":0.00021321005,"threshold_uncertainty_score":0.9742492},"labels":[],"label_agreement":null},{"id":"W2284709444","doi":"10.1016/j.xphs.2015.12.009","title":"Ketoconazole Stereoisomers Differentially Induce Cytochrome P450 1A1 Between Human Hepatoma HepG2 and Mouse Hepatoma Hepa1c1c7 Cells","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Ketoconazole; Enzyme; Chemistry; Receptor; Cytochrome P450; In vivo; Recombinant DNA; Biochemistry; Biology; Gene","score_opus":0.16761478360388882,"score_gpt":0.4607510310830186,"score_spread":0.2931362474791298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284709444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928142,0.001528463,0.00018840496,0.0025463786,0.001115706,0.00045038402,0.0001357453,0.00005639482,0.0011643678],"genre_scores_gemma":[0.9939713,0.0025327601,0.00033399728,0.0014518321,0.0012199067,0.000014387725,0.0000020013074,0.00003947775,0.00043436844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949571,0.0009635152,0.0013266134,0.00061574625,0.0009773623,0.0011596931],"domain_scores_gemma":[0.99625707,0.0009742657,0.00074293267,0.00021040255,0.0002760172,0.001539315],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030377908,0.00052615965,0.0008811038,0.00046933908,0.0007333112,0.00015464185,0.0012832346,0.0003656943,0.0015009207],"category_scores_gemma":[0.00011104688,0.00034529218,0.0003161726,0.00051242416,0.0017938563,0.0007909636,0.00045603787,0.0011063464,0.00007310893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018863405,0.0003297165,0.0381903,0.000043489985,0.00029150487,0.00010499711,0.00025034213,0.000007896896,0.91166836,0.0006204185,0.00080633827,0.047498018],"study_design_scores_gemma":[0.005601834,0.0006377089,0.024967078,0.0000738769,0.0006056955,0.00016651835,0.000091199,0.00033517415,0.8513602,0.0011876598,0.114307635,0.0006654027],"about_ca_topic_score_codex":0.00001025973,"about_ca_topic_score_gemma":0.000005648315,"teacher_disagreement_score":0.113501295,"about_ca_system_score_codex":0.000114983275,"about_ca_system_score_gemma":0.00026958482,"threshold_uncertainty_score":0.9998999},"labels":[],"label_agreement":null},{"id":"W2289811051","doi":"10.4212/cjhp.v69i1.1522","title":"Interaction between Warfarin and Apple Juice","year":2016,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Alberta Health Services; University of Calgary","funders":"","keywords":"Warfarin; Food science; Chemistry; Medicine; Internal medicine","score_opus":0.09591263570445974,"score_gpt":0.4058268559580316,"score_spread":0.30991422025357185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289811051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97319406,0.0028234937,0.00008367235,0.018236805,0.0033373795,0.00021142357,0.000118133685,0.00001105416,0.0019839874],"genre_scores_gemma":[0.9960411,0.0007625811,0.000045745044,0.0013388735,0.0013935374,0.0000052614346,0.000002144607,0.000024962446,0.00038579432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984843,0.0002974522,0.0004434326,0.00015500448,0.00016222008,0.00045759007],"domain_scores_gemma":[0.9980044,0.00037855143,0.00031135223,0.0001282775,0.00020402309,0.00097340904],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010560428,0.00019601743,0.000256327,0.00018364082,0.00041433822,0.000059107526,0.0004666966,0.00008393921,0.0009687076],"category_scores_gemma":[0.000115382434,0.00011647502,0.00011449209,0.00014455595,0.0003545327,0.0002986598,0.000048144906,0.00068874424,0.000094934316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032546924,0.0001412199,0.20421787,0.000034753044,0.0011277932,0.00033211274,0.004142141,0.00007217389,0.038734242,0.0017555928,0.06698201,0.6821346],"study_design_scores_gemma":[0.0026324089,0.00013737158,0.00906063,0.00002270518,0.00035001084,0.00012240301,0.00011743523,0.000048042075,0.03808794,0.0016662219,0.94751674,0.00023805947],"about_ca_topic_score_codex":0.0013051452,"about_ca_topic_score_gemma":0.0009792054,"teacher_disagreement_score":0.88053477,"about_ca_system_score_codex":0.000114085524,"about_ca_system_score_gemma":0.00046388927,"threshold_uncertainty_score":0.99994457},"labels":[],"label_agreement":null},{"id":"W2289967391","doi":"10.1111/bcpt.12536","title":"Effect of Omeprazole and Dextromethorphan on the Urinary Metabolic Ratio of Flurbiprofen","year":2015,"lang":"en","type":"article","venue":"Basic & Clinical Pharmacology & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dextromethorphan; Omeprazole; Flurbiprofen; CYP2C19; Pharmacology; CYP2C9; CYP2D6; Drug; Drug metabolism; Medicine; CYP3A4; Cytochrome P450; Drug interaction; Dextrorphan; Pharmacogenetics; Internal medicine; Chemistry; Metabolism; Genotype; Biochemistry","score_opus":0.20651575682134435,"score_gpt":0.5175748918779414,"score_spread":0.311059135056597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289967391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97753423,0.005929713,0.000054252607,0.003740159,0.0068836,0.0016212786,0.00010090724,0.0000723014,0.0040635434],"genre_scores_gemma":[0.98632586,0.0021064074,0.00017647973,0.009497744,0.0011245398,0.0002792164,0.000014900489,0.00006142256,0.00041342925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9851952,0.010849115,0.0018464521,0.00084219594,0.00037933834,0.0008877059],"domain_scores_gemma":[0.98525053,0.012120572,0.00096120173,0.0005523291,0.00032631683,0.0007890711],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012474238,0.00059344026,0.0017958952,0.00033695408,0.00022432566,0.000009849375,0.0009897797,0.00097337586,0.0015276448],"category_scores_gemma":[0.0013413749,0.00042811222,0.00043872866,0.00057579164,0.002605361,0.00010851583,0.0005900165,0.0021230956,0.00014319472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01869631,0.006294925,0.068971135,0.00029690276,0.0037742695,0.00023606358,0.00117594,0.0006547837,0.6861729,0.01185394,0.06508943,0.13678339],"study_design_scores_gemma":[0.01782724,0.010307258,0.017349036,0.000020529085,0.003045905,0.00012656418,0.00012368218,0.0029084887,0.6902015,0.0016665631,0.25578064,0.0006425704],"about_ca_topic_score_codex":0.0000141417695,"about_ca_topic_score_gemma":0.0000032928824,"teacher_disagreement_score":0.1906912,"about_ca_system_score_codex":0.000038949012,"about_ca_system_score_gemma":0.0003925796,"threshold_uncertainty_score":0.9998171},"labels":[],"label_agreement":null},{"id":"W2290974032","doi":"10.1096/fasebj.24.1_supplement.757.11","title":"Rat hepatic cytochrome P450 oxidoreductase is up‐regulated by low dose dexamethasone and down‐regulated by adrenalectomy","year":2010,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Internal medicine; Endocrinology; Adrenalectomy; Dexamethasone; Cytochrome P450; Glucocorticoid; Glucocorticoid receptor; Microsome; Chemistry; Biology; Nuclear receptor; Medicine; Enzyme; Metabolism; Gene; Biochemistry","score_opus":0.029962726809646425,"score_gpt":0.34992204734252597,"score_spread":0.31995932053287957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290974032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865868,0.007531326,0.00009032437,0.002313264,0.0022288642,0.0005362007,0.00042205933,0.00007640044,0.00021475476],"genre_scores_gemma":[0.99029315,0.0024310574,0.00021300222,0.0040195417,0.0006848954,0.000027269187,0.00008695528,0.00007317422,0.0021709756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99642664,0.0009510236,0.00073237065,0.00047582813,0.0004353301,0.0009787828],"domain_scores_gemma":[0.9974658,0.00042719778,0.00044968058,0.00042585004,0.00022656909,0.0010049124],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018013207,0.00054952473,0.00057025166,0.00018222883,0.0010187651,0.00019260673,0.00074464636,0.0004755442,0.0058837193],"category_scores_gemma":[0.00011190782,0.00040183828,0.00020450776,0.0004634914,0.0007930796,0.00022564821,0.0001732822,0.0030852754,0.00014515524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047118764,0.00030237238,0.00029592926,0.000020027508,0.0004388672,0.00006510873,0.00082163856,0.000051119845,0.89873976,0.000022004415,0.08503398,0.0137380315],"study_design_scores_gemma":[0.0060212845,0.00011060507,0.0011005291,0.0000207411,0.0006944039,0.0012153537,0.000062665604,0.0052158707,0.9296544,0.00071995315,0.054648906,0.0005352534],"about_ca_topic_score_codex":0.00003257851,"about_ca_topic_score_gemma":0.0000072443695,"teacher_disagreement_score":0.030914709,"about_ca_system_score_codex":0.000046835245,"about_ca_system_score_gemma":0.00020033648,"threshold_uncertainty_score":0.99984336},"labels":[],"label_agreement":null},{"id":"W2292289790","doi":"10.1096/fasebj.27.1_supplement.673.2","title":"Pharmacogenetics of warfarin safety and effectiveness in children","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia","funders":"","keywords":"VKORC1; CYP2C9; Warfarin; Pharmacogenetics; Dosing; Medicine; Vitamin K epoxide reductase; Genotyping; Genotype; Internal medicine; Cohort; Odds ratio; Pharmacology; Biology; Atrial fibrillation; Genetics","score_opus":0.04394257027666998,"score_gpt":0.3745001369722935,"score_spread":0.33055756669562353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292289790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343354,0.0044284733,0.00012644751,0.00028804762,0.0005089062,0.0005003394,0.000028857608,0.000010089162,0.0006752991],"genre_scores_gemma":[0.9938942,0.005200178,0.00008581707,0.0005105192,0.00022471904,0.000014864065,0.000002994311,0.000019294816,0.00004737218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977688,0.0010698093,0.00045234995,0.00016088257,0.00016735026,0.00038081082],"domain_scores_gemma":[0.9989674,0.00037705997,0.00019467037,0.00013191547,0.00010220277,0.00022673825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001749135,0.00018993752,0.00029999073,0.00013014377,0.00021060552,0.000027152606,0.0003587314,0.00012421169,0.00087748835],"category_scores_gemma":[0.000041835625,0.00013305087,0.0000829212,0.0002000716,0.00026567568,0.00009286551,0.00013304556,0.00095510605,0.000038454185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028138593,0.00017014607,0.46812567,0.000018777704,0.00022975753,0.000007702883,0.0003948419,0.001906762,0.48067352,0.00019670482,0.00015221954,0.047842517],"study_design_scores_gemma":[0.003369957,0.00005378417,0.6680507,0.0000159191,0.00015798002,0.0003222252,0.0000488923,0.0019345151,0.32263368,0.0012507573,0.0019940785,0.00016750529],"about_ca_topic_score_codex":0.000047732094,"about_ca_topic_score_gemma":0.0000018539853,"teacher_disagreement_score":0.19992504,"about_ca_system_score_codex":0.000027956967,"about_ca_system_score_gemma":0.0000641851,"threshold_uncertainty_score":0.9607882},"labels":[],"label_agreement":null},{"id":"W2292946704","doi":"10.1002/cpt.364","title":"Disease–drug database for pharmacogenomic‐based prescribing","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Ontario; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Pharmacogenomics; Drug; Disease; Medicine; Database; Pharmacology; Computer science; Internal medicine","score_opus":0.3552165596201565,"score_gpt":0.5361870192128482,"score_spread":0.18097045959269165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292946704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8207426,0.015121182,0.026538419,0.0850265,0.038407106,0.0060446793,0.0057311566,0.0010747616,0.0013135702],"genre_scores_gemma":[0.74277735,0.007723805,0.0023631752,0.23736376,0.005869095,0.00086639595,0.00016917774,0.0002486964,0.0026185326],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927416,0.0020518077,0.0017174796,0.0014441508,0.00036881756,0.0016761783],"domain_scores_gemma":[0.9906462,0.0059542432,0.0006037757,0.0007034173,0.0004692744,0.001623105],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034412271,0.00081516424,0.00096244237,0.0002628354,0.0006501977,0.000043026583,0.0014481329,0.0004933511,0.0037848756],"category_scores_gemma":[0.00014391435,0.000630934,0.0008904813,0.000316953,0.0012960219,0.0002694474,0.00034218866,0.0012101834,0.0005664401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00870327,0.0029933283,0.015292151,0.00014354182,0.0024440533,0.000110526424,0.000108992,0.0003192054,0.6230169,0.0002893455,0.26583293,0.080745734],"study_design_scores_gemma":[0.016786426,0.00016242238,0.0011331494,0.000031802396,0.004065063,0.0000057301063,0.000013200868,0.010417029,0.13265958,0.0006885044,0.8331892,0.00084792153],"about_ca_topic_score_codex":0.0000025544412,"about_ca_topic_score_gemma":0.0000021118017,"teacher_disagreement_score":0.5673562,"about_ca_system_score_codex":0.00014160754,"about_ca_system_score_gemma":0.00070695946,"threshold_uncertainty_score":0.9996142},"labels":[],"label_agreement":null},{"id":"W2294096027","doi":"10.1053/j.ackd.2015.10.002","title":"The Effects of CKD on Cytochrome P450–Mediated Drug Metabolism","year":2016,"lang":"en","type":"review","venue":"Advances in Chronic Kidney Disease","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Cytochrome P450; Drug metabolism; Kidney disease; Drug; Pharmacology; Population; Pharmacokinetics; Adverse effect; Debrisoquine; CYP2D6; Metabolism; Bioinformatics; Internal medicine; Biology","score_opus":0.037677913953655426,"score_gpt":0.4400270862204303,"score_spread":0.40234917226677486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294096027","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006429699,0.9891473,0.0000061225064,0.00022600176,0.004887496,0.002252765,0.0020444086,0.000072082235,0.0012995001],"genre_scores_gemma":[0.00048521775,0.99496484,0.000008586808,0.00083590916,0.001300087,0.0011784434,0.0002343439,0.00012922699,0.000863349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942481,0.0019235535,0.0012991378,0.00089071586,0.0004936852,0.0011448225],"domain_scores_gemma":[0.99111015,0.0055426713,0.00092199293,0.0009265784,0.000096348485,0.0014022818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009339865,0.00095470913,0.0020055969,0.0003431329,0.00029209605,0.000025222093,0.0014907594,0.00041475566,0.00045619908],"category_scores_gemma":[0.0018680906,0.0005821761,0.00082700397,0.0006126221,0.00078059966,0.00019784123,0.00031145915,0.0014524009,0.0004354662],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022985002,0.0003431912,0.000004290074,0.018979087,0.00043922194,0.00014744459,0.000041932166,0.000027253718,0.0001997079,0.0021367222,0.0051502893,0.972301],"study_design_scores_gemma":[0.0029345748,0.000049890776,0.00001932924,0.007227216,0.0017966939,0.0000031471482,0.0000024217168,0.00004092172,0.00032603883,0.0010566411,0.98589766,0.0006454516],"about_ca_topic_score_codex":0.0000035660562,"about_ca_topic_score_gemma":0.0000050782483,"teacher_disagreement_score":0.9807474,"about_ca_system_score_codex":0.0004783053,"about_ca_system_score_gemma":0.0030763391,"threshold_uncertainty_score":0.999663},"labels":[],"label_agreement":null},{"id":"W2300183130","doi":"10.1139/cjpp-2015-0509","title":"Assessment of 25 <i>CYP2D6</i> alleles found in the Chinese population on propafenone metabolism in vitro","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval","keywords":"Propafenone; CYP2D6; Cytochrome P450; Allele; Hydroxylation; Enzyme; Biology; Population; Chemistry; Biochemistry; Pharmacology; Internal medicine; Medicine; Gene","score_opus":0.04230752384152641,"score_gpt":0.3965363881761747,"score_spread":0.3542288643346483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300183130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232316,0.0023878124,0.000011225409,0.0023577968,0.0018279075,0.00034960214,0.00007632547,0.0000030875497,0.00066309224],"genre_scores_gemma":[0.9949401,0.0008798739,0.00007378532,0.0035206317,0.0005056394,0.000026174106,0.000007679319,0.000016087411,0.0000300352],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966798,0.0016617563,0.0007477674,0.00025026946,0.00012741348,0.00053299515],"domain_scores_gemma":[0.99809855,0.0008686307,0.0004436816,0.00012901967,0.00014409712,0.00031602624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016859854,0.00025607148,0.0006374636,0.0005917524,0.00012632998,0.0000064437695,0.00044490962,0.0002750963,0.00071253255],"category_scores_gemma":[0.00007726015,0.00015285697,0.00010586328,0.00040240402,0.00041965625,0.00012642576,0.000030600244,0.0008729751,0.0000043417385],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057085627,0.00024577137,0.02436803,0.00004993182,0.00014771966,0.00013699516,0.00060723413,0.0005994283,0.9641245,0.0016247104,0.00052096875,0.0070038824],"study_design_scores_gemma":[0.008359668,0.00033924484,0.87037957,0.00003411402,0.00023097079,0.00013605788,0.000086308864,0.00034620377,0.08942545,0.0075507504,0.022796564,0.00031508927],"about_ca_topic_score_codex":0.0005064213,"about_ca_topic_score_gemma":0.001108452,"teacher_disagreement_score":0.874699,"about_ca_system_score_codex":0.00008296688,"about_ca_system_score_gemma":0.00049125415,"threshold_uncertainty_score":0.7801731},"labels":[],"label_agreement":null},{"id":"W2305015145","doi":"","title":"Cytochrome P450 down-regulation by serum from humans with a viral infection and from rabbits with an inflammatory reaction.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cytochrome P450; Hepatocyte; Incubation; Internal medicine; Endocrinology; Enzyme; Chemistry; Enzyme inducer; Metabolism; Biology; In vitro; Biochemistry; Medicine","score_opus":0.04384608622284731,"score_gpt":0.31772365792045854,"score_spread":0.27387757169761123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305015145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996127,0.0006735471,0.00021231361,0.0002630261,0.0003113988,0.0008656632,0.00026523657,0.00014642828,0.0011353727],"genre_scores_gemma":[0.9965338,0.00051928085,0.0000971328,0.0007863022,0.00064552965,0.0006699134,0.00032484854,0.00004459323,0.00037858667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820155,0.00031713513,0.00027893105,0.0005023419,0.00022381195,0.00047624524],"domain_scores_gemma":[0.9989341,0.000098431934,0.00024334426,0.00022851425,0.0000880941,0.00040755107],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032970705,0.00029745052,0.00027614622,0.000117135685,0.00030539974,0.00006453854,0.00011927481,0.00026637196,0.00024552376],"category_scores_gemma":[0.000013806825,0.0002525375,0.000034520446,0.00017885171,0.00018235926,0.0005012695,0.000041286,0.0004904698,0.000019954807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004210384,0.00074518815,0.42121857,0.000024907105,0.00092642976,0.000077651275,0.0012868022,0.00072121195,0.32718176,0.00015186194,0.0016490645,0.24180618],"study_design_scores_gemma":[0.0038422323,0.0000843919,0.89023,0.0000057194907,0.00035054408,0.000018602688,0.000027974731,0.0006463083,0.023538062,0.0005586618,0.08034618,0.00035130058],"about_ca_topic_score_codex":0.00048568167,"about_ca_topic_score_gemma":0.00044619807,"teacher_disagreement_score":0.46901146,"about_ca_system_score_codex":0.00006695426,"about_ca_system_score_gemma":0.000038463928,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W2312978113","doi":"10.1021/es200673q","title":"Factors Affecting Phase I Stereoselective Biotransformation of Chiral Polychlorinated Biphenyls by Rat Cytochrome P-450 2B1 Isozyme","year":2011,"lang":"en","type":"article","venue":"Environmental Science & Technology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"","keywords":"Biotransformation; Stereoselectivity; Atropisomer; Chemistry; Enantiomer; Polychlorinated biphenyl; Congener; Cytochrome; Cytochrome P450; Isozyme; Stereochemistry; Microsome; Environmental chemistry; Chromatography; Biochemistry; Enzyme","score_opus":0.07782877457360367,"score_gpt":0.3754555304196769,"score_spread":0.29762675584607323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312978113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954064,0.0006534703,0.0004351163,0.000066861,0.000662632,0.00056695624,0.00015493628,0.0001348335,0.0019188037],"genre_scores_gemma":[0.999266,0.00023095672,0.00016802741,0.00012018338,0.000026560789,0.000026817972,0.000023321214,0.000021361737,0.00011671425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978806,0.00011784858,0.00044685914,0.0005138032,0.00028705818,0.000753833],"domain_scores_gemma":[0.99918765,0.000049264116,0.00027467665,0.00024995607,0.000018943903,0.000219482],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005952123,0.00031669225,0.00034552533,0.000660791,0.00053997943,0.000011537407,0.0007300524,0.0003447806,0.0010782848],"category_scores_gemma":[0.00003174622,0.00028537787,0.00008883395,0.0011638291,0.0026301953,0.00040353142,0.00021084327,0.000623749,0.000054315136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010440777,0.0007891865,0.0075213406,0.00000726491,0.000044297925,0.0000047928584,0.0023413152,0.000009183709,0.9693663,0.00022212416,0.000031601336,0.019558169],"study_design_scores_gemma":[0.0018738036,0.00055934704,0.004860042,0.0000051052657,0.0000753369,0.000017286726,0.0011058595,0.00038356302,0.98691314,0.00044356257,0.003470401,0.00029254743],"about_ca_topic_score_codex":0.000017039985,"about_ca_topic_score_gemma":0.00000132115,"teacher_disagreement_score":0.019265622,"about_ca_system_score_codex":0.00018327535,"about_ca_system_score_gemma":0.00005305736,"threshold_uncertainty_score":0.9999598},"labels":[],"label_agreement":null},{"id":"W2315359168","doi":"10.3821/1913-701x-144.1.21","title":"Drug Interactions Involving Warfarin: Practice Tool and Practical Management Tips","year":2011,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta; Alberta Health Services","funders":"","keywords":"Warfarin; Drug; Medicine; Intensive care medicine; Pharmacology; Computer science; Internal medicine; Atrial fibrillation","score_opus":0.16964788052966367,"score_gpt":0.39867526183975116,"score_spread":0.22902738131008749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315359168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8780008,0.008149527,0.0005278938,0.0018045546,0.019125098,0.0017033176,0.0007121657,0.00017879781,0.08979788],"genre_scores_gemma":[0.94901997,0.028964803,0.0035904038,0.014463332,0.0012725383,0.00006913272,0.000024051531,0.00010462229,0.0024911445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99513596,0.0009567019,0.0010090232,0.00073438266,0.0005074738,0.0016564457],"domain_scores_gemma":[0.99434185,0.00052250427,0.00050499756,0.00034770893,0.0007147794,0.0035681853],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002101909,0.0006537322,0.000522645,0.00060374785,0.0018515935,0.00023507215,0.0006248259,0.00012423178,0.0043264893],"category_scores_gemma":[0.0004170694,0.0007118309,0.00018211671,0.0006519029,0.00043964843,0.0011916576,0.00023825216,0.0025904372,0.00009222319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017446132,0.0009655986,0.0042048106,0.00057646906,0.0034628266,0.31364673,0.01473313,0.00044264426,0.008148439,0.0064180614,0.22030102,0.42535564],"study_design_scores_gemma":[0.0023233313,0.000024435503,0.000063664535,0.000015073002,0.00094592094,0.3377724,0.0001464756,0.0029314975,0.004712589,0.00037113208,0.64995,0.00074342726],"about_ca_topic_score_codex":0.010486962,"about_ca_topic_score_gemma":0.023350615,"teacher_disagreement_score":0.42964903,"about_ca_system_score_codex":0.0013048237,"about_ca_system_score_gemma":0.0020997922,"threshold_uncertainty_score":0.9997106},"labels":[],"label_agreement":null},{"id":"W2316649866","doi":"10.1097/00004714-200008000-00008","title":"Inhibition of Cytochrome P450 2D6 Modifies Codeine Abuse Liability","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"National Institute on Drug Abuse","keywords":"Codeine; Quinidine; Pharmacology; Morphine; Placebo; Medicine; Anesthesia; Chemistry","score_opus":0.17483217560793057,"score_gpt":0.5378821078846676,"score_spread":0.36304993227673704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316649866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819614,0.0019721796,0.0001073937,0.0016227849,0.004989762,0.00044196149,0.00010363435,0.00003472704,0.008766115],"genre_scores_gemma":[0.9747376,0.015270167,0.0006194936,0.0056681163,0.002770391,0.000015113489,0.0000075702987,0.00004156617,0.0008699847],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99207366,0.0023359684,0.00404039,0.00045455643,0.0004782031,0.0006172345],"domain_scores_gemma":[0.9942657,0.0020767227,0.0017857874,0.0003305752,0.00074790954,0.00079333124],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005914683,0.0003918861,0.0015925202,0.0002846783,0.00014006448,0.000014371687,0.0006536225,0.000789916,0.017990552],"category_scores_gemma":[0.00036278233,0.00034181253,0.0009003204,0.00044253186,0.0010009123,0.00026683652,0.0000557761,0.0025022873,0.000219442],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034241788,0.0098447325,0.010840513,0.00024154581,0.0021717648,0.00049755815,0.00137533,0.0075737704,0.6487945,0.00030358427,0.0485777,0.23553726],"study_design_scores_gemma":[0.038000125,0.0023173213,0.043897483,0.00006902326,0.0017723044,0.00032465695,0.00008137492,0.0026015497,0.07579414,0.0052515496,0.8291834,0.00070704415],"about_ca_topic_score_codex":0.0000049537703,"about_ca_topic_score_gemma":0.0000023406249,"teacher_disagreement_score":0.78060573,"about_ca_system_score_codex":0.000045341796,"about_ca_system_score_gemma":0.0002982838,"threshold_uncertainty_score":0.9999034},"labels":[],"label_agreement":null},{"id":"W2317608031","doi":"10.1097/00004714-200304000-00009","title":"The Role of Cytochrome P450 2C19 Activity in Flunitrazepam Metabolism In Vivo","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; Health Sciences Centre; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse; AstraZeneca Canada","keywords":"Flunitrazepam; CYP2C19; Pharmacology; Pharmacokinetics; Benzodiazepine; Triazolam; In vivo; Chemistry; Omeprazole; Hypnotic; Metabolism; Medicine; Internal medicine; Cytochrome P450; Biology","score_opus":0.11118766353520972,"score_gpt":0.5174642610055018,"score_spread":0.4062765974702921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317608031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97119814,0.009809715,0.000020685071,0.0009779899,0.006200227,0.00046287797,0.000026259968,0.000009802133,0.011294281],"genre_scores_gemma":[0.9828055,0.014322276,0.00024278286,0.001619013,0.00075180683,0.00002535259,3.7421503e-7,0.00003617005,0.00019671035],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897768,0.0054004393,0.003209392,0.00038412405,0.0004114585,0.00081777235],"domain_scores_gemma":[0.99225676,0.004809273,0.0017752883,0.00029806793,0.0003506729,0.0005099593],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011640411,0.00036121436,0.0014734601,0.00048397575,0.00012745164,0.000016128748,0.00094982487,0.0006779008,0.0014088217],"category_scores_gemma":[0.0012255089,0.00027538967,0.0006136767,0.0008013956,0.00067092007,0.00019646111,0.00008812865,0.0035883083,0.000025236488],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011438321,0.0047510318,0.04332643,0.00003795751,0.0008074704,0.00027818416,0.0004729943,0.0013898651,0.8364167,0.0032221375,0.0042112335,0.09364765],"study_design_scores_gemma":[0.019833669,0.00037687575,0.07714374,0.000022198665,0.0003895639,0.00011327356,0.00016588588,0.00077738386,0.12818635,0.010431039,0.76221436,0.00034567426],"about_ca_topic_score_codex":0.000015023546,"about_ca_topic_score_gemma":0.000045407218,"teacher_disagreement_score":0.7580031,"about_ca_system_score_codex":0.00005986684,"about_ca_system_score_gemma":0.0005674635,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W2325105969","doi":"10.1021/tx5000409","title":"Reactive Metabolite Trapping Screens and Potential Pitfalls: Bioactivation of a Homomorpholine and Formation of an Unstable Thiazolidine Adduct","year":2014,"lang":"en","type":"article","venue":"Chemical Research in Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Adduct; Chemistry; Glutathione; Thiazolidine; Reactive intermediate; Metabolite; Stereochemistry; Cysteine; Covalent bond; Nuclear magnetic resonance spectroscopy; Carcinogen; Combinatorial chemistry; Biochemistry; Enzyme; Organic chemistry","score_opus":0.2010250116287437,"score_gpt":0.48419157217810277,"score_spread":0.28316656054935907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325105969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618006,0.0010107416,0.00037687313,0.00072549813,0.00010554718,0.00041763237,0.000071125956,0.000012805404,0.001099748],"genre_scores_gemma":[0.9977604,0.0010835879,0.0007311739,0.00015235285,0.00014487978,0.000040774223,0.00005306559,0.000016017277,0.000017760578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723655,0.0010853563,0.0005357691,0.00035402126,0.0002670452,0.0005212696],"domain_scores_gemma":[0.99821997,0.0008344124,0.00018594472,0.00017581815,0.00030838093,0.00027546307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032754063,0.00016355471,0.00047097183,0.00046455214,0.00008760858,0.000011163553,0.00020639374,0.00036966073,0.00006504728],"category_scores_gemma":[0.0005847168,0.00015837797,0.000041032796,0.0004671313,0.00083950826,0.00024533249,0.0001902136,0.00086084934,0.0000014392858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007915758,0.0004376242,0.00023247108,0.00012772805,0.000042806056,0.0000048778643,0.00048654818,0.000076742035,0.96230274,0.0041273916,0.000044496006,0.03132501],"study_design_scores_gemma":[0.0026650955,0.0002451592,0.0016730507,0.000019910238,0.000053559957,0.00003180979,0.00020833913,0.030273994,0.95612556,0.0039966973,0.004569194,0.00013766057],"about_ca_topic_score_codex":0.000059769143,"about_ca_topic_score_gemma":0.00000865461,"teacher_disagreement_score":0.03118735,"about_ca_system_score_codex":0.00003960972,"about_ca_system_score_gemma":0.000081248705,"threshold_uncertainty_score":0.6458466},"labels":[],"label_agreement":null},{"id":"W2328147613","doi":"10.1182/blood-2010-09-307900","title":"The “age” of understanding VKA dose","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vitamin k; Intensive care medicine; Internal medicine","score_opus":0.1791364927972956,"score_gpt":0.413488375052902,"score_spread":0.23435188225560638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328147613","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058411244,0.024032157,0.0001805675,0.7928143,0.029198699,0.002258806,0.0011439795,0.00032015546,0.09164009],"genre_scores_gemma":[0.09740222,0.007766241,0.00026282744,0.8681561,0.016426757,0.00014105762,0.00036329468,0.00024071493,0.00924083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974959,0.00049809966,0.00055322144,0.00038896248,0.00034416307,0.00071963866],"domain_scores_gemma":[0.99781823,0.0010757684,0.00037632586,0.0005236376,0.00008897363,0.00011704784],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00088242884,0.00040484365,0.0004907746,0.0001299665,0.00047480437,0.000049333135,0.0009356851,0.0024875153,0.00056409015],"category_scores_gemma":[0.000088525405,0.00030107528,0.00029219373,0.00018145726,0.0006150084,0.000033359152,0.00020389375,0.008519609,0.00009298449],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006428545,0.00028803735,0.00028177665,0.00014555473,0.0010391533,0.0006090566,0.00027681293,0.000006413244,0.07012699,0.0013129383,0.92360115,0.0022478278],"study_design_scores_gemma":[0.002097346,0.000035167577,0.00006395105,0.000013341345,0.0011877865,0.000040257262,0.00002377004,0.000018636498,0.027239975,0.0036746077,0.9652815,0.00032367045],"about_ca_topic_score_codex":0.000011598516,"about_ca_topic_score_gemma":0.00001397938,"teacher_disagreement_score":0.082399264,"about_ca_system_score_codex":0.000026421605,"about_ca_system_score_gemma":0.00017221872,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W2332608279","doi":"10.1021/ja200551y","title":"Predictable Stereoselective and Chemoselective Hydroxylations and Epoxidations with P450 3A4","year":2011,"lang":"en","type":"article","venue":"Journal of the American Chemical Society","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Chemistry; Hydroxylation; Stereoselectivity; Selectivity; Substrate (aquarium); Enantioselective synthesis; Enzyme; Stereochemistry; Chemical synthesis; Combinatorial chemistry; Organic chemistry; Biochemistry; Catalysis","score_opus":0.05675445811163024,"score_gpt":0.35489680026309794,"score_spread":0.29814234215146773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332608279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731404,0.00048245306,0.00023318795,0.0005706134,0.00008054629,0.00012934368,0.00001636108,0.000009724177,0.0011637505],"genre_scores_gemma":[0.994983,0.0005984707,0.0028079473,0.0013603731,0.00014911854,0.000006347306,6.232518e-7,0.000013574619,0.00008055166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914855,0.00012144732,0.00023131704,0.00013993023,0.00014001664,0.00021872977],"domain_scores_gemma":[0.9989582,0.0001730557,0.00043765063,0.000085641776,0.00015660467,0.00018889856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002943741,0.00013554991,0.0002582327,0.0000210106,0.00020254747,0.000012728675,0.00017961476,0.00006510792,0.000049506554],"category_scores_gemma":[0.000048019952,0.00008728889,0.00010580036,0.00030144802,0.00076194503,0.000101134654,0.00009476702,0.0006805424,7.581207e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003735027,0.00028760984,0.035238612,0.000012609382,0.0008556699,0.0000038023306,0.0063390257,0.000019189885,0.94473344,0.00010449295,0.0024357953,0.00959624],"study_design_scores_gemma":[0.0018442323,0.00021861888,0.06700587,0.000016636941,0.00078493,0.00037725712,0.00089155056,0.0011568434,0.91787076,0.0018195327,0.0077818464,0.00023193272],"about_ca_topic_score_codex":0.000017709079,"about_ca_topic_score_gemma":0.0000010213856,"teacher_disagreement_score":0.031767257,"about_ca_system_score_codex":0.000044150198,"about_ca_system_score_gemma":0.00009573246,"threshold_uncertainty_score":0.35595375},"labels":[],"label_agreement":null},{"id":"W2333953760","doi":"10.5414/cpp38061","title":"Interethnic differences of drug-metabolizing enzymes","year":2000,"lang":"en","type":"review","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Pharmacogenetics; Biology; Ethnic group; Population; Genetics; Allele; Genotype; Phenotype; Drug; Population genetics; Evolutionary biology; Gene; Pharmacology; Medicine; Environmental health","score_opus":0.37425123815277705,"score_gpt":0.5991028266829549,"score_spread":0.22485158853017784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333953760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006775146,0.97048444,0.000024911928,0.00039670957,0.02081905,0.00033023852,0.00018914074,0.000017348639,0.0009629927],"genre_scores_gemma":[0.013303961,0.9790911,0.00016897557,0.0023427869,0.0046717995,0.000012566869,0.000015520292,0.000056839763,0.0003364139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916681,0.0028125402,0.0041727284,0.00042044887,0.0005006432,0.00042552134],"domain_scores_gemma":[0.99100345,0.00422469,0.0035779104,0.00017315494,0.0006240643,0.00039669746],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031736174,0.0006044521,0.0033805144,0.0005834232,0.00008961443,0.00003284919,0.0017055136,0.0009653798,0.0019938066],"category_scores_gemma":[0.00012443287,0.00045845038,0.0014434519,0.00021657492,0.00097277644,0.0001573735,0.00027349388,0.0034158695,0.000034015087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073949585,0.0007890982,0.0005165495,0.00057898124,0.007914018,0.00012944856,0.00028001895,0.0000070137903,0.00004375501,0.0003513865,0.0016428826,0.9870074],"study_design_scores_gemma":[0.0028078936,0.00017952366,0.00011563134,0.0007915362,0.007029883,0.00028405976,0.00003647362,0.00007212297,0.00024256068,0.0008290081,0.98724145,0.00036987648],"about_ca_topic_score_codex":0.0000030073336,"about_ca_topic_score_gemma":0.000001124302,"teacher_disagreement_score":0.9866375,"about_ca_system_score_codex":0.00003494323,"about_ca_system_score_gemma":0.00066406553,"threshold_uncertainty_score":0.99978673},"labels":[],"label_agreement":null},{"id":"W2334285469","doi":"10.1097/fpc.0000000000000051","title":"Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohort","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; CYP2D6; Phenytoin; Pharmacology; Medicine; Metabolite; Pharmacogenetics; Active metabolite; Therapeutic drug monitoring; Drug interaction; CYP2C9; Genotype; Drug; Internal medicine; Cytochrome P450; Epilepsy; Pharmacokinetics; Biology; Metabolism; Genetics; Cancer; Psychiatry; Breast cancer","score_opus":0.05976936688541686,"score_gpt":0.36975667885828867,"score_spread":0.3099873119728718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334285469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179465,0.0017177647,0.00031170557,0.00075023796,0.0007458287,0.0032223936,0.00026177758,0.00002861439,0.0011670147],"genre_scores_gemma":[0.99209636,0.0020142978,0.0014528752,0.0028772836,0.00046406052,0.00087386963,0.00010520678,0.000070922695,0.000045090863],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967417,0.0007907578,0.0006694882,0.00072580617,0.0002801827,0.0007920763],"domain_scores_gemma":[0.9985275,0.00045994707,0.0002937746,0.00032669673,0.00013978772,0.00025227483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014571045,0.0004899757,0.00062170695,0.0002705566,0.00025989718,0.000066319786,0.00040693482,0.00020672978,0.000046487665],"category_scores_gemma":[0.000042667067,0.000388076,0.00010555572,0.00037891863,0.00023071426,0.000074473115,0.00009534976,0.0007504185,0.000014445792],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016070034,0.0033524798,0.030845992,0.0002885432,0.0012242299,0.00008076707,0.031772267,0.050916318,0.5565864,0.0040290733,0.000998363,0.3038355],"study_design_scores_gemma":[0.024440521,0.0012959397,0.05288696,0.000051875886,0.0015344829,0.00019251063,0.0014554985,0.08515807,0.38244268,0.008253775,0.4404215,0.0018661894],"about_ca_topic_score_codex":0.00005305491,"about_ca_topic_score_gemma":0.000042449155,"teacher_disagreement_score":0.43942314,"about_ca_system_score_codex":0.000113714144,"about_ca_system_score_gemma":0.00012473582,"threshold_uncertainty_score":0.9998571},"labels":[],"label_agreement":null},{"id":"W2334920908","doi":"10.1039/c5ra25948g","title":"Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: key intermediate of ticagrelor","year":2016,"lang":"en","type":"article","venue":"RSC Advances","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Ticagrelor; Ketone; Chemistry; Enantioselective synthesis; Combinatorial chemistry; Organic chemistry; Aspirin; Catalysis; Biochemistry; Clopidogrel","score_opus":0.05125154224645446,"score_gpt":0.3829456032737171,"score_spread":0.3316940610272626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334920908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98568755,0.0072379345,0.0014190703,0.00039054835,0.0022312517,0.00034312607,0.00021525449,0.00005608944,0.0024191951],"genre_scores_gemma":[0.9891624,0.008731351,0.0011200024,0.00011054648,0.00038421454,0.00003267042,0.0000059333993,0.000027187509,0.00042568054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817646,0.00028250544,0.00057724986,0.00033649337,0.0002309455,0.00039636772],"domain_scores_gemma":[0.998556,0.0003116471,0.000448745,0.00020493,0.0003146827,0.0001639608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003780257,0.0002279281,0.00045489558,0.0001853625,0.00008262121,0.0000039775678,0.0003054106,0.00016742841,0.0006364929],"category_scores_gemma":[0.00016278912,0.00016077129,0.00014109994,0.00028927875,0.00062496425,0.00024011293,0.00008748777,0.00023143891,0.000058071866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047163485,0.0002989742,0.0024329252,0.00007206128,0.00016982877,0.0000028355325,0.00029621233,0.000025245414,0.79251516,0.0017316644,0.00015881142,0.20182464],"study_design_scores_gemma":[0.0016619036,0.00021905244,0.0033179217,0.000048916598,0.00021682284,0.000005706809,0.00006285987,0.00005641356,0.9129229,0.004494851,0.076783724,0.00020890024],"about_ca_topic_score_codex":0.000008301453,"about_ca_topic_score_gemma":0.000003152573,"teacher_disagreement_score":0.20161574,"about_ca_system_score_codex":0.00003659491,"about_ca_system_score_gemma":0.000088397675,"threshold_uncertainty_score":0.69691515},"labels":[],"label_agreement":null},{"id":"W2339975648","doi":"10.1016/s0090-9556(24)15124-0","title":"Population-Specific Polymorphisms of the Human FMO3 Gene: Significance for Detoxication","year":2000,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences","keywords":"Trimethylamine; Flavin-containing monooxygenase; Monooxygenase; Population; Biology; Biochemistry; Chemistry; Trimethylamine N-oxide; Genetics; Cytochrome P450; Metabolism; Medicine","score_opus":0.045134006950044464,"score_gpt":0.36369729166876735,"score_spread":0.31856328471872286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339975648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888831,0.0074031134,0.00025162194,0.0005521387,0.0007234374,0.0007549986,0.000366251,0.000034661014,0.0010306926],"genre_scores_gemma":[0.9955697,0.0016381192,0.00034591986,0.0007781128,0.00049771124,0.0001365634,0.00017542086,0.00002474271,0.0008337189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985241,0.00027139037,0.0004267127,0.00032388634,0.00017213449,0.00028174047],"domain_scores_gemma":[0.99923044,0.000102480015,0.00018989842,0.00025632165,0.00008495941,0.00013589374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045621736,0.00020279383,0.00028006546,0.000073477844,0.0005359415,0.000025026293,0.00023725061,0.00014490867,0.00050250796],"category_scores_gemma":[0.000009272759,0.00016472278,0.0001507902,0.00021834843,0.0001717747,0.0001389739,0.000030206025,0.00020058457,0.000011690671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025844146,0.0003091331,0.0038601023,0.00004416927,0.00007713681,6.480708e-7,0.00094400445,0.0005383099,0.84201634,0.029078132,0.0015582383,0.12131533],"study_design_scores_gemma":[0.002378602,0.000017371744,0.3028263,0.000014232631,0.00041007504,0.000007761775,0.00004569918,0.00092819665,0.5176714,0.0076687164,0.16768658,0.00034504136],"about_ca_topic_score_codex":0.00005727958,"about_ca_topic_score_gemma":0.0000064002625,"teacher_disagreement_score":0.32434493,"about_ca_system_score_codex":0.000014636894,"about_ca_system_score_gemma":0.000020683574,"threshold_uncertainty_score":0.67171997},"labels":[],"label_agreement":null},{"id":"W2339993263","doi":"10.71781/30903","title":"Rôles des polymorphismes génétiques dans la détermination de la dose individuelle de la warfarine chez les patients traités avec de l’amiodarone","year":2011,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.07916486725684223,"score_gpt":0.4349378641577295,"score_spread":0.35577299690088726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339993263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9181193,0.003266167,0.00015929285,0.00007851175,0.0006603932,0.0009595186,0.00072418345,0.000015315522,0.076017275],"genre_scores_gemma":[0.9697967,0.0065390174,0.00893172,0.00023828173,0.00034730526,0.00023839482,0.0013082817,0.00014665707,0.01245363],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99106085,0.0058715595,0.0008663921,0.00080623536,0.0002944754,0.0011005074],"domain_scores_gemma":[0.99676085,0.0013617274,0.0006903176,0.00030753965,0.00022555942,0.0006540121],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004131825,0.0008436626,0.0008071889,0.00033563154,0.0008725463,0.00036120007,0.0014434699,0.0021637634,0.0065399897],"category_scores_gemma":[0.00029206768,0.000931928,0.00027590932,0.00028148672,0.0014723953,0.00036056817,0.00037166505,0.0018950189,0.00013156133],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009253563,0.0033266675,0.1681818,0.00026053796,0.00072310766,0.00026293396,0.11503946,0.00019043549,0.15293266,0.0007112295,0.00037305153,0.55707276],"study_design_scores_gemma":[0.00425688,0.00017467806,0.4018094,0.00019542917,0.0018887615,0.00012250536,0.0022813627,0.0012520805,0.49450737,0.00282023,0.08974019,0.00095110654],"about_ca_topic_score_codex":0.0013769472,"about_ca_topic_score_gemma":0.0007141462,"teacher_disagreement_score":0.55612165,"about_ca_system_score_codex":0.00029741376,"about_ca_system_score_gemma":0.0011977097,"threshold_uncertainty_score":0.9993131},"labels":[],"label_agreement":null},{"id":"W2342699699","doi":"10.1097/ftd.0000000000000192","title":"Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy","year":2015,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Child and Family Research Institute; University of Toronto; SickKids Foundation; BC Children's Hospital; Centre Hospitalier de l’Université de Montréal; Hospital for Sick Children; University of British Columbia","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Université de Montréal; Child and Family Research Institute; BC Children's Hospital; London Health Sciences Centre","keywords":"Warfarin; VKORC1; Medicine; Dosing; CYP2C9; Pharmacogenetics; Vitamin K epoxide reductase; Genetic testing; Intensive care medicine; Adverse effect; Internal medicine; Genotype; Atrial fibrillation","score_opus":0.5431120409138199,"score_gpt":0.5915064735913468,"score_spread":0.048394432677526855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342699699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043909615,0.986597,0.000011348999,0.00014453374,0.0047643674,0.0011245083,0.0000607451,0.00005996027,0.0028465812],"genre_scores_gemma":[0.0035388917,0.9909897,0.003362463,0.00030871874,0.0013463971,0.00014913354,0.000014641984,0.000116408715,0.00017365269],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931232,0.0033767163,0.0017909694,0.0007349347,0.00035615626,0.0006180685],"domain_scores_gemma":[0.9929072,0.0049510817,0.0010357344,0.00049865077,0.00025687626,0.00035041277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0048956247,0.0006494092,0.001881643,0.00039109468,0.00015720513,0.000041005864,0.0005960514,0.0006288074,0.00005230997],"category_scores_gemma":[0.00041311063,0.00057855574,0.00023811197,0.0006506988,0.00019209446,0.00012212974,0.00020439217,0.002283092,0.000050533836],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009918299,0.0006333833,0.0014571002,0.0005244733,0.0005281514,0.000034654084,0.00048621028,0.000043426393,0.000038815917,0.000057521702,0.000081606915,0.9960155],"study_design_scores_gemma":[0.0018341255,0.00013233235,0.00078287965,0.0014762833,0.0011248679,0.000050362236,0.000107098014,0.00019309248,0.00010063132,0.00023349485,0.9934521,0.0005127593],"about_ca_topic_score_codex":0.000050282808,"about_ca_topic_score_gemma":0.0000011367557,"teacher_disagreement_score":0.9955027,"about_ca_system_score_codex":0.00011750699,"about_ca_system_score_gemma":0.0005189583,"threshold_uncertainty_score":0.9996666},"labels":[],"label_agreement":null},{"id":"W2343284837","doi":"10.1160/th15-12-0955","title":"An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance","year":2016,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; U.S. Air Force","keywords":"Dosing; Warfarin; VKORC1; Pharmacogenomics; Medicine; CYP2C9; Pharmacogenetics; Cohort; Internal medicine; Pharmacology; Genotype; Biology; Atrial fibrillation; Gene","score_opus":0.19519330878989577,"score_gpt":0.44106752954293865,"score_spread":0.24587422075304288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343284837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933888,0.002601815,0.0006403482,0.00079583377,0.00049282133,0.00047863374,0.000240181,0.00009652475,0.0012650705],"genre_scores_gemma":[0.989463,0.0057655354,0.0022489976,0.0020199975,0.00027701547,0.00006605883,0.00001883589,0.00006044819,0.00008012607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970473,0.0005592459,0.0005446665,0.0006728686,0.00022424516,0.00095168623],"domain_scores_gemma":[0.99858713,0.00019605877,0.000194751,0.00037305764,0.00010285743,0.0005461644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001278702,0.00043473495,0.0005876023,0.00017657249,0.00038976042,0.000070899776,0.0003251444,0.00024648433,0.0007642546],"category_scores_gemma":[0.000019822559,0.0003167451,0.000069011425,0.00037949704,0.000364935,0.0005233296,0.00012340861,0.0003750622,0.000017453669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007965493,0.0006491921,0.16776104,0.000046156867,0.0002070185,0.000014014955,0.0015705352,0.00013363328,0.6552511,0.0003663015,0.00083148904,0.172373],"study_design_scores_gemma":[0.012329632,0.00015901649,0.07535846,0.000100639925,0.0004592619,0.00003052974,0.00030799283,0.004070639,0.8337448,0.00039905476,0.07198524,0.0010547268],"about_ca_topic_score_codex":0.00021029156,"about_ca_topic_score_gemma":0.00008046924,"teacher_disagreement_score":0.17849374,"about_ca_system_score_codex":0.00009828049,"about_ca_system_score_gemma":0.00010967026,"threshold_uncertainty_score":0.9999285},"labels":[],"label_agreement":null},{"id":"W2343497810","doi":"10.1097/fpc.0000000000000182","title":"Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"Biomedical Research Council; National Medical Research Council; Medical Research Council; National University of Singapore; Agency for Science, Technology and Research","keywords":"Pharmacogenomics; Genetic diversity; Population; Biology; Genetics; Evolutionary biology; Medicine; Environmental health","score_opus":0.16080492077681025,"score_gpt":0.3984915745155805,"score_spread":0.23768665373877024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343497810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820558,0.015528963,0.000022148954,0.00035296657,0.00076564675,0.0005042306,0.00019173621,0.000017633356,0.00056088506],"genre_scores_gemma":[0.9907283,0.006714821,0.0016408921,0.0006803003,0.00012397519,0.00002027337,0.000012380285,0.000020557196,0.000058500766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997343,0.0008054638,0.000657717,0.0004654402,0.00022252712,0.0005058334],"domain_scores_gemma":[0.9987512,0.00019790758,0.00019519268,0.00020534193,0.00012759308,0.000522734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019135729,0.0003121393,0.00050359714,0.0004497151,0.00014316519,0.00002217146,0.0003006134,0.00021288256,0.000051852738],"category_scores_gemma":[0.00009149722,0.00034659047,0.000057300596,0.00038328144,0.00024484086,0.000084075575,0.0006757313,0.000528356,0.0000066124185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033260481,0.00083767733,0.7499254,0.00010446422,0.000193333,0.00016604185,0.020101357,0.011766454,0.19021188,0.0014438361,0.0005482158,0.021375323],"study_design_scores_gemma":[0.012330699,0.00006671288,0.8692697,0.000018056286,0.00041361162,0.000030971984,0.0008792681,0.024260703,0.021522544,0.0054970244,0.06499063,0.00072007574],"about_ca_topic_score_codex":0.000487295,"about_ca_topic_score_gemma":0.00039956116,"teacher_disagreement_score":0.16868934,"about_ca_system_score_codex":0.000066101435,"about_ca_system_score_gemma":0.00018079656,"threshold_uncertainty_score":0.9998986},"labels":[],"label_agreement":null},{"id":"W2343915366","doi":"10.1007/s00204-016-1720-0","title":"2,3,7,8 Tetrachlorodibenzo-p-dioxin-induced RNA abundance changes identify Ackr3, Col18a1, Cyb5a and Glud1 as candidate mediators of toxicity","year":2016,"lang":"en","type":"article","venue":"Archives of Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Terry Fox Research Institute; Ontario Institute for Cancer Research; Academy of Finland; Canadian Institutes of Health Research; Dow Chemical Company","keywords":"Toxicity; Abundance (ecology); RNA; Chemistry; Biology; Medicine; Internal medicine; Biochemistry; Ecology; Gene","score_opus":0.05451493813368015,"score_gpt":0.3978568858871757,"score_spread":0.3433419477534956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343915366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98690546,0.0022864335,0.000099705634,0.0029563955,0.0017149074,0.0005728533,0.00039790032,0.000055903543,0.0050104195],"genre_scores_gemma":[0.99264044,0.0048585846,0.0003642645,0.0011291157,0.00031489177,0.00006639293,0.0000090433105,0.000046191162,0.0005710962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99674606,0.0007555607,0.0007739717,0.00064726797,0.0002689512,0.0008081569],"domain_scores_gemma":[0.99661416,0.0017144793,0.0006310897,0.00043095057,0.00010184943,0.00050748605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070406205,0.00042262938,0.000889153,0.00040697685,0.00018251735,0.00001032608,0.0007066277,0.00041136195,0.0008736628],"category_scores_gemma":[0.0004365909,0.0003412421,0.00017536833,0.00023050958,0.0012728584,0.00012836514,0.00043339081,0.0004976344,0.000040663377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007891856,0.00037667688,0.006564955,0.00010885989,0.00032871685,0.000031932766,0.0013563475,0.000007808932,0.90930206,0.002782181,0.00041979476,0.0779315],"study_design_scores_gemma":[0.0035302893,0.00057368824,0.026499577,0.000047305093,0.0002412108,0.000043722117,0.00011642365,0.000093576105,0.94590646,0.005562513,0.01700595,0.00037930635],"about_ca_topic_score_codex":0.000060727663,"about_ca_topic_score_gemma":0.0002722896,"teacher_disagreement_score":0.07755219,"about_ca_system_score_codex":0.000028671293,"about_ca_system_score_gemma":0.00019467877,"threshold_uncertainty_score":0.999904},"labels":[],"label_agreement":null},{"id":"W2346762247","doi":"10.1007/s40272-016-0176-2","title":"Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine","year":2016,"lang":"en","type":"review","venue":"Pediatric Drugs","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacogenetics; Personalized medicine; Population; Dosing; Clinical trial; Intensive care medicine; Bioinformatics; Oncology; Pharmacology; Internal medicine; Genetics; Genotype; Biology","score_opus":0.124043814483962,"score_gpt":0.4609432757484127,"score_spread":0.3368994612644507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346762247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013167784,0.97666633,0.000010140982,0.0001944484,0.008569747,0.002040746,0.0009839864,0.00016599709,0.010051811],"genre_scores_gemma":[0.00028404055,0.9829905,0.0000504963,0.00094072026,0.012671205,0.0005011154,0.0003697758,0.00026288794,0.0019292826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99160355,0.0018325475,0.0026205697,0.0014737928,0.00079846015,0.0016711025],"domain_scores_gemma":[0.9952767,0.0014398819,0.0014223724,0.0005942804,0.00028527703,0.0009814954],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0025854423,0.0015223018,0.0035191588,0.0019039671,0.00024000289,0.000033730335,0.0016327436,0.0014031073,0.004679344],"category_scores_gemma":[0.0003916913,0.0011401079,0.00094197906,0.0019370907,0.0002994149,0.00018191474,0.00052517053,0.0024715774,0.0020317256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008213749,0.0005350538,0.0016490825,0.006813201,0.00021460534,0.000059238177,0.0005755213,0.0000018979787,0.0000010013737,0.0001621366,0.018830003,0.97107613],"study_design_scores_gemma":[0.006526577,0.00006211345,0.000100966725,0.0002920618,0.0063957023,0.0000094116,0.000014445188,0.0000119835895,0.0000024629705,0.00017274496,0.98515,0.0012615399],"about_ca_topic_score_codex":0.000028800592,"about_ca_topic_score_gemma":0.000002003213,"teacher_disagreement_score":0.9698146,"about_ca_system_score_codex":0.00050733174,"about_ca_system_score_gemma":0.0013325243,"threshold_uncertainty_score":0.9998933},"labels":[],"label_agreement":null},{"id":"W2368041099","doi":"10.1186/s12885-016-2342-x","title":"Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case report","year":2016,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Tamoxifen; Surgical oncology; Ulcerative colitis; Active metabolite; Breast cancer; Metabolite; Internal medicine; Oncology; Pharmacology; Cancer; Disease","score_opus":0.0957907317281902,"score_gpt":0.43403624439900496,"score_spread":0.33824551267081476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2368041099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266285,0.00041395624,0.00010510475,0.0004343848,0.0004916544,0.002907691,0.002849955,0.000029850326,0.000104554405],"genre_scores_gemma":[0.9944353,0.00038715414,0.00046350164,0.00030864248,0.00026289016,0.0039591133,0.000049185586,0.000033603475,0.000100599864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975241,0.0005975627,0.0006349408,0.00060285954,0.00014606908,0.00049449666],"domain_scores_gemma":[0.9985991,0.0001554864,0.00043880125,0.00019740805,0.0004007576,0.00020842203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005346083,0.00028871553,0.00052044983,0.0003300717,0.000095547024,0.000012117437,0.00011627053,0.00021082215,0.00020869168],"category_scores_gemma":[0.000062498126,0.00020654275,0.00006747076,0.00054285454,0.00014301039,0.00027103574,0.000041848336,0.00020803175,0.0000020021341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03507046,0.0022045684,0.14839107,0.00022769267,0.00060020364,0.0020341997,0.011659007,0.005553407,0.54798615,0.00032332883,0.00022238407,0.24572754],"study_design_scores_gemma":[0.012540367,0.0005162633,0.35215855,0.00021086447,0.00041340454,0.002069452,0.00083246524,0.0008480408,0.6246057,0.00026501084,0.0048494046,0.0006904632],"about_ca_topic_score_codex":0.0022500665,"about_ca_topic_score_gemma":0.004627522,"teacher_disagreement_score":0.24503706,"about_ca_system_score_codex":0.00037923543,"about_ca_system_score_gemma":0.0005822429,"threshold_uncertainty_score":0.8422569},"labels":[],"label_agreement":null},{"id":"W2395881780","doi":"10.1159/000457103","title":"Hydroxylation and Glucuronidation of Various Xenobiotics by Hepatic Microsomes from the Fetal Lamb, Pregnant Ewe and Human Fetus","year":2017,"lang":"en","type":"article","venue":"Developmental Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute on Drug Abuse","keywords":"Microsome; Glucuronidation; Hexobarbital; Fetus; Hydroxylation; Chemistry; Cytochrome; Biotransformation; Microsoma; Drug metabolism; Internal medicine; Xenobiotic; Endocrinology; Cytochrome P450; Pharmacology; Metabolism; Biochemistry; Biology; Pregnancy; Enzyme; Medicine","score_opus":0.05451451887463708,"score_gpt":0.3804349613715216,"score_spread":0.3259204424968845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395881780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98693234,0.009703415,0.000043660682,0.0012865128,0.0007930676,0.0005192504,0.00023109921,0.000026688736,0.00046394017],"genre_scores_gemma":[0.9883542,0.00853135,0.00031424296,0.0022704373,0.00013470973,0.000023321527,0.00008334088,0.000028520308,0.0002598766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834186,0.00032104854,0.00043765348,0.00039585808,0.00013614813,0.00036746264],"domain_scores_gemma":[0.99887747,0.00034941634,0.0003902402,0.00016359502,0.00006236508,0.00015688845],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0004946978,0.000316536,0.00035469138,0.00005276629,0.0014276715,0.00008003046,0.00032144194,0.00028556644,0.0001451576],"category_scores_gemma":[0.000014030013,0.0002604934,0.000037560643,0.000050673625,0.001088667,0.0001350699,0.0003370075,0.000496073,0.0000069888847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023538333,0.00027780415,0.13392638,0.00004986743,0.00084378035,0.000010023093,0.0027211106,0.000006110214,0.81229407,0.00041810915,0.0005398465,0.048677545],"study_design_scores_gemma":[0.0078996895,0.00018651212,0.19775595,0.000044509296,0.0015584164,0.00006750153,0.0003251052,0.003190128,0.6827062,0.0033576738,0.102178775,0.00072955765],"about_ca_topic_score_codex":0.000090386624,"about_ca_topic_score_gemma":0.00003985443,"teacher_disagreement_score":0.12958786,"about_ca_system_score_codex":0.000031162064,"about_ca_system_score_gemma":0.00006654825,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W2397350160","doi":"10.1385/0-89603-519-0:95","title":"Catalytic Assays for Human Cytochrome P450","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Cytochrome P450; Enzyme; Biochemistry; Biology; Chemistry; Endogeny","score_opus":0.3289435275482273,"score_gpt":0.48429325091120573,"score_spread":0.15534972336297842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397350160","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12857473,0.011260775,0.0013854268,0.00006704159,0.0021127,0.002718016,0.00032430596,0.0003819276,0.8531751],"genre_scores_gemma":[0.97625196,0.00015711687,0.000333317,0.0013836293,0.00052496087,0.0005090869,0.000046147867,0.000080827995,0.02071295],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977574,0.00033484783,0.00045815337,0.00050310546,0.00019083796,0.0007556896],"domain_scores_gemma":[0.99873227,0.00021172453,0.00016864852,0.0004060589,0.00013039459,0.00035088745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085626874,0.0003483718,0.0003920232,0.00011848324,0.000638757,0.00005434686,0.0004469664,0.00029746373,0.00034298614],"category_scores_gemma":[0.00006334232,0.00035534034,0.00021307217,0.000030377647,0.00022787727,0.00005719099,0.000085600426,0.00051993324,0.000056269393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001718208,0.00049472693,0.00004570222,0.0002775225,0.00071535044,0.00006369803,0.0017291823,0.00031821392,0.3169275,0.60238826,0.02540701,0.05146102],"study_design_scores_gemma":[0.002429299,0.00006470721,0.000118668715,0.0000066229204,0.00032573668,0.000013750945,0.000018110608,0.0002566315,0.22024652,0.007849287,0.76830333,0.0003673392],"about_ca_topic_score_codex":0.000038667058,"about_ca_topic_score_gemma":0.000019331339,"teacher_disagreement_score":0.84767723,"about_ca_system_score_codex":0.00004576288,"about_ca_system_score_gemma":0.00006947887,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W2398743016","doi":"10.1385/0-89603-519-0:103","title":"Enzymatic Analysis of cDNA-Expressed Human CYPIAI, CYPlA2, and CYPIBI with 7-Ethoxyresorufin as Substrate","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Complementary DNA; Substrate (aquarium); Enzyme; Biochemistry; Chemistry; Molecular biology; Biology; Gene","score_opus":0.17159127623285714,"score_gpt":0.431553775192021,"score_spread":0.25996249895916385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398743016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8829699,0.005728434,0.000094345894,0.000015741667,0.00016448612,0.0005286609,0.00008899318,0.00007038409,0.11033902],"genre_scores_gemma":[0.9945406,0.00052185403,0.00029758314,0.00047180656,0.00006268352,0.000101013786,0.000027057722,0.00004954519,0.003927883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702215,0.0008247137,0.0006598661,0.0005818028,0.00032074234,0.00059074204],"domain_scores_gemma":[0.9983013,0.00028139204,0.0003904734,0.00050718966,0.0001561465,0.0003634631],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008957253,0.00042496514,0.00080374186,0.00040529564,0.00036050577,0.000055399018,0.00037102206,0.00026834712,0.0006786825],"category_scores_gemma":[0.000038728438,0.00037824016,0.00018422447,0.00017143179,0.00051244296,0.000073824274,0.00008857337,0.00056839635,0.000007952712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011920368,0.0013599676,0.007486041,0.00079268846,0.016490096,0.0003260087,0.01250873,0.005948978,0.57321745,0.3605433,0.0018368487,0.018297853],"study_design_scores_gemma":[0.0059289564,0.00028131183,0.0070602046,0.000048811784,0.010903287,0.000024452263,0.00023737257,0.0023563912,0.76807684,0.0036986754,0.20036109,0.0010225944],"about_ca_topic_score_codex":0.00024252094,"about_ca_topic_score_gemma":0.00012512885,"teacher_disagreement_score":0.35684463,"about_ca_system_score_codex":0.00001833608,"about_ca_system_score_gemma":0.0000705047,"threshold_uncertainty_score":0.99986696},"labels":[],"label_agreement":null},{"id":"W2399384755","doi":"10.1385/1-59259-998-2:133","title":"Thin-Layer Chromatography Analysis of Human CYP3A-Catalyzed Testosterone 6β-Hydroxylation","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"Hydroxylation; Chromatography; Thin-layer chromatography; Chemistry; Metabolite; CYP3A; Cytochrome P450; Microsome; Chloroform; Testosterone (patch); Enzyme; Silica gel; Steroid; Acetone; Biochemistry; Biology; Hormone; Endocrinology","score_opus":0.1476660952029309,"score_gpt":0.41649429899779833,"score_spread":0.26882820379486744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399384755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9140965,0.0045164307,0.0001307517,0.000018005972,0.00038850773,0.00044056482,0.00015090348,0.00013665648,0.080121696],"genre_scores_gemma":[0.99714124,0.00012588307,0.00010498519,0.00023336195,0.00029508883,0.00007087716,0.0002339359,0.000041857547,0.0017527451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975602,0.000364895,0.00078373915,0.00047355794,0.00032481927,0.0004927874],"domain_scores_gemma":[0.9986046,0.00013449817,0.00045301244,0.0004889379,0.00015010292,0.00016887987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005599889,0.00034533272,0.0006568574,0.0006860633,0.00034827858,0.000037430036,0.0004635534,0.000292322,0.0004944736],"category_scores_gemma":[0.000008502995,0.00034968357,0.00040543725,0.00024739973,0.0003192313,0.00008485111,0.00015092263,0.00042227044,0.000014191833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015486447,0.0010790323,0.008210511,0.00014088467,0.004081212,0.00003951479,0.0016544114,0.008817798,0.931154,0.032020252,0.0030074997,0.009640012],"study_design_scores_gemma":[0.0045331,0.00011016739,0.05337759,0.000022573453,0.011807706,0.000006844103,0.000034278404,0.015610267,0.76285005,0.0031706628,0.1475092,0.0009675697],"about_ca_topic_score_codex":0.00061311026,"about_ca_topic_score_gemma":0.000100279416,"teacher_disagreement_score":0.16830398,"about_ca_system_score_codex":0.000023228255,"about_ca_system_score_gemma":0.000024763602,"threshold_uncertainty_score":0.9998955},"labels":[],"label_agreement":null},{"id":"W2401995582","doi":"10.1385/0-89603-519-0:135","title":"CYP2Cl g-Mediated (S)-Mephenytoin 4'-Hydroxylation Assayed by High-Performance Liquid Chromatography with Radiometric Detection","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Mephenytoin; Chromatography; Chemistry; Hydroxylation; High-performance liquid chromatography; Methanol; CYP2C19; Enzyme; Biochemistry; Cytochrome P450; Organic chemistry","score_opus":0.0635677270666119,"score_gpt":0.33677805400717536,"score_spread":0.27321032694056346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401995582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96182925,0.0071380744,0.0011763839,0.000013259786,0.001016483,0.00073988497,0.00006130203,0.0002796334,0.027745716],"genre_scores_gemma":[0.99634516,0.0014858093,0.0001251263,0.0005435515,0.00018861459,0.00020948792,0.000067736044,0.00007607036,0.00095841964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723125,0.0006257223,0.0005019275,0.00054436707,0.00039519815,0.0007015279],"domain_scores_gemma":[0.9986688,0.00019413329,0.00030961167,0.00034881753,0.00014223336,0.00033642977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078871386,0.00042882742,0.00040771178,0.0005294362,0.0005161737,0.00005090663,0.00031265477,0.00036375367,0.00030281473],"category_scores_gemma":[0.00004207835,0.0003991773,0.00009596419,0.0003796497,0.00029108278,0.00016147712,0.000046100737,0.00073396397,0.000046885696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002371987,0.0008609133,0.00077025604,0.00027670292,0.0014908998,0.00005441207,0.0013670815,0.0031609447,0.8674694,0.0032325268,0.004657213,0.11428771],"study_design_scores_gemma":[0.003285401,0.00036093692,0.0005260322,0.000011407831,0.0002777978,0.000020900354,0.000014520851,0.0026149196,0.6623908,0.000057798916,0.3299744,0.00046506093],"about_ca_topic_score_codex":0.000075304335,"about_ca_topic_score_gemma":0.000012284267,"teacher_disagreement_score":0.32531717,"about_ca_system_score_codex":0.00006112522,"about_ca_system_score_gemma":0.000055691416,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W2403825736","doi":"","title":"Drug interactions: gasoline and matches.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Drug; Gasoline; Pharmacology; Waste management","score_opus":0.11604160581165397,"score_gpt":0.39556564523079424,"score_spread":0.2795240394191403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403825736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9098389,0.0073630004,0.00007179314,0.0016912924,0.0033719342,0.0007576915,0.000035849964,0.000111855275,0.076757655],"genre_scores_gemma":[0.9863887,0.0014791107,0.00020803457,0.0031482691,0.00024014006,0.00071794953,0.000005314771,0.00002133297,0.0077911424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998698,0.00028730123,0.00023273703,0.0002479746,0.00008671595,0.00044724613],"domain_scores_gemma":[0.99922425,0.00018539971,0.000072349605,0.00013067486,0.000043384553,0.00034393658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007685252,0.00016014345,0.00017857335,0.000091091024,0.00015209385,0.000025592915,0.00011163367,0.00006331757,0.0006475995],"category_scores_gemma":[0.00011408764,0.00015310758,0.000053214448,0.000124137,0.00010750775,0.00009682976,0.000046026955,0.00043179776,0.00007509665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023562272,0.0007479315,0.03253584,0.00007933194,0.000453635,0.00006290299,0.0010866963,0.0001588812,0.008194199,0.014089137,0.05034596,0.89200985],"study_design_scores_gemma":[0.0011119415,0.0000023674909,0.018069409,0.0000012789732,0.000108693515,0.000052360407,0.00006164628,0.00015171469,0.03976224,0.001820969,0.9386761,0.00018126458],"about_ca_topic_score_codex":0.000007862845,"about_ca_topic_score_gemma":0.000010459453,"teacher_disagreement_score":0.8918286,"about_ca_system_score_codex":0.000022654587,"about_ca_system_score_gemma":0.0000204358,"threshold_uncertainty_score":0.70907605},"labels":[],"label_agreement":null},{"id":"W2407107523","doi":"10.1385/1-59259-998-2:73","title":"Catalytic Assays for Human Cytochrome P450: &lt;i&gt;An Introduction&lt;/i&gt;","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institutes of Health","keywords":"CYP2A6; CYP2B6; Cytochrome P450; CYP2E1; CYP1A2; Enzyme; CYP2C9; Biochemistry; CYP3A4; CYP3A; CYP2C19; Monooxygenase; Chemistry; Biology","score_opus":0.12554574018984838,"score_gpt":0.40653773309797087,"score_spread":0.2809919929081225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407107523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6131373,0.019133208,0.0023307751,0.0008926374,0.006856761,0.005734583,0.0012353681,0.0013493352,0.34933004],"genre_scores_gemma":[0.9576304,0.00012231247,0.00039390134,0.00073959935,0.007796513,0.00068694097,0.00046972418,0.00014287846,0.03201773],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649435,0.00040342452,0.00078805716,0.0009338006,0.00034392858,0.0010364602],"domain_scores_gemma":[0.99810904,0.000163402,0.0003174831,0.00073457474,0.0002751813,0.00040033238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010321147,0.0005521192,0.00058737904,0.00024947408,0.0010555726,0.00011926685,0.00077938254,0.00044840158,0.00044041197],"category_scores_gemma":[0.000034092496,0.00058473664,0.00027573993,0.00006159444,0.00044273995,0.00017232487,0.00019553695,0.0006126469,0.00006402853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001706062,0.00048438003,0.000007982174,0.000114292634,0.00025469865,0.000026653028,0.00043018037,0.0009959955,0.6674999,0.25721654,0.056735676,0.016063116],"study_design_scores_gemma":[0.002765539,0.00013726568,0.0006245318,0.0000057420984,0.0005876984,0.000024020059,0.000006899967,0.0015512535,0.15140183,0.008456778,0.83383775,0.00060068973],"about_ca_topic_score_codex":0.00006838855,"about_ca_topic_score_gemma":0.00021584706,"teacher_disagreement_score":0.77710205,"about_ca_system_score_codex":0.00010031261,"about_ca_system_score_gemma":0.00008676949,"threshold_uncertainty_score":0.99966043},"labels":[],"label_agreement":null},{"id":"W2409043673","doi":"","title":"Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre Hospitalier de l’Université de Montréal; Hospital for Sick Children","funders":"","keywords":"Codeine; Guideline; Medicine; CYP2D6; Genotyping; Pharmacology; Intensive care medicine; Internal medicine; Genotype; Genetics; Pathology; Biology","score_opus":0.17693871812523976,"score_gpt":0.4758073709523521,"score_spread":0.29886865282711234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409043673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8480128,0.055278342,0.0056233704,0.035208184,0.009185332,0.012598957,0.00021587922,0.00036150543,0.033515606],"genre_scores_gemma":[0.9007756,0.01641018,0.014816471,0.05754622,0.0029702573,0.0056110597,0.00005289431,0.00009047251,0.001726836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973357,0.0005023944,0.0008291599,0.0004697081,0.00015081209,0.0007122548],"domain_scores_gemma":[0.9967987,0.0017444467,0.00027447217,0.00023205846,0.0004086998,0.0005416118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030510388,0.00025612995,0.00038929583,0.00007725779,0.0002500061,0.000058689802,0.00026633905,0.0003326289,0.00030937235],"category_scores_gemma":[0.0011347851,0.00022572288,0.00014128505,0.00012532517,0.00018845059,0.00018391939,0.000110522706,0.00056199485,0.0000883202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046082903,0.00032259244,0.0009732883,0.000015026922,0.0003212027,0.0000059056674,0.000111688176,0.000066415494,0.0015598774,0.00044567653,0.04872862,0.9469889],"study_design_scores_gemma":[0.004623644,0.000050317223,0.017975885,0.0000013084157,0.00021557743,0.000024271116,0.00003674446,0.0034831709,0.002545773,0.00083239353,0.96992904,0.00028187752],"about_ca_topic_score_codex":0.000020886,"about_ca_topic_score_gemma":0.0000018413454,"teacher_disagreement_score":0.946707,"about_ca_system_score_codex":0.000020615464,"about_ca_system_score_gemma":0.000055149412,"threshold_uncertainty_score":0.9204712},"labels":[],"label_agreement":null},{"id":"W2411172204","doi":"10.1021/acs.biochem.5b00903","title":"Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies","year":2015,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Chemistry; Electron paramagnetic resonance; Pregnenolone; Photochemistry; Ferric; Ternary complex; Hydroxylation; Hyperfine structure; Ternary operation; Electron nuclear double resonance; Stereochemistry; Steroid; Inorganic chemistry; Organic chemistry; Nuclear magnetic resonance; Enzyme; Biochemistry","score_opus":0.2901483038949986,"score_gpt":0.44708533477791695,"score_spread":0.15693703088291833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411172204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9466322,0.039977938,0.0000075375283,0.011452489,0.00076665566,0.0005105096,0.00016256,0.000031685267,0.00045842153],"genre_scores_gemma":[0.98776966,0.006573276,0.000023010642,0.003715786,0.0003789406,0.00013369332,0.000011810881,0.00002110689,0.0013726886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981606,0.0003420768,0.00029756388,0.00049033924,0.000272206,0.00043722833],"domain_scores_gemma":[0.9983868,0.0006055489,0.00019153807,0.0003589011,0.00016885766,0.00028836567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008688567,0.00031414436,0.00030903675,0.00004312291,0.00033880482,0.00007424378,0.00047203555,0.0001867187,0.000053838812],"category_scores_gemma":[0.00035408913,0.0002132585,0.000052627613,0.00026214597,0.0005369762,0.00012522764,0.00033905564,0.0006353845,0.00002033816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000891283,0.00031896107,0.012370798,0.00017703505,0.00061881356,0.000032327487,0.022108609,0.0005176668,0.80909663,0.000020445572,0.14755404,0.0062934053],"study_design_scores_gemma":[0.0013541705,0.000041231266,0.0016425139,0.00009916967,0.00018203739,0.000055819914,0.0071575455,0.00046784617,0.9355891,0.00010924295,0.053004682,0.0002966481],"about_ca_topic_score_codex":0.00004241091,"about_ca_topic_score_gemma":0.000021193338,"teacher_disagreement_score":0.12649247,"about_ca_system_score_codex":0.00010643259,"about_ca_system_score_gemma":0.000125765,"threshold_uncertainty_score":0.869643},"labels":[],"label_agreement":null},{"id":"W2411332481","doi":"10.1385/0-89603-519-0:111","title":"Spectrofluorometric Analysis of CYP2A6-Catalyzed Coumarin 7-Hydroxylation","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"CYP2A6; Microsome; Hydroxylation; Biochemistry; Chemistry; Cytochrome P450; Enzyme; Biology; Molecular biology; CYP1A2","score_opus":0.21041274969693383,"score_gpt":0.4409976971898734,"score_spread":0.2305849474929396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411332481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73939925,0.011066426,0.00062825787,0.000011469212,0.00074081443,0.00046317527,0.000105805775,0.00008668737,0.24749811],"genre_scores_gemma":[0.99553144,0.0008948618,0.00020778339,0.00018594264,0.00008780437,0.000043066135,0.000049077866,0.000027455344,0.0029725556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978142,0.0005189017,0.000570026,0.0003829499,0.00027955708,0.00043440383],"domain_scores_gemma":[0.99870086,0.00024417834,0.00031155767,0.0003979338,0.00013416214,0.00021133145],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088809174,0.0002532848,0.00056268356,0.0008846527,0.00017252917,0.00002128519,0.00032654044,0.00021574248,0.001342092],"category_scores_gemma":[0.000079894686,0.00025781203,0.0002996823,0.00044835094,0.00017179483,0.00005310075,0.00007478737,0.00039211664,0.0000213798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006599645,0.0016487871,0.008362967,0.00025831553,0.020514464,0.000086079985,0.004609391,0.015193405,0.42089653,0.35351062,0.0032882402,0.17097124],"study_design_scores_gemma":[0.002438423,0.000046558678,0.0061875153,0.0000045117863,0.007065523,0.0000042046577,0.00002833149,0.007673459,0.55948967,0.0014242528,0.41516456,0.0004729642],"about_ca_topic_score_codex":0.00010760574,"about_ca_topic_score_gemma":0.000022608932,"teacher_disagreement_score":0.41187632,"about_ca_system_score_codex":0.000039636696,"about_ca_system_score_gemma":0.000048432597,"threshold_uncertainty_score":0.9999874},"labels":[],"label_agreement":null},{"id":"W2411333350","doi":"10.1385/1-59259-998-2:153","title":"Use of 7-Ethoxycoumarin to Monitor Multiple Enzymes in the Human CYP1, CYP2, and CYP3 Families","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institutes of Health; National Institute for Health and Care Research","keywords":"Cytochrome P450; Enzyme; Microsome; Substrate (aquarium); Biochemistry; Complementary DNA; Chemistry; Cytochrome; Incubation; Chromatography; Biology; Gene","score_opus":0.251794121074398,"score_gpt":0.43181238978303627,"score_spread":0.18001826870863824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411333350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775804,0.005173342,0.000022297261,0.00007495208,0.00032346754,0.0007769892,0.00010100027,0.000040712734,0.015906807],"genre_scores_gemma":[0.9952599,0.00031531675,0.0002862404,0.00087387825,0.0002999838,0.00015504574,0.000011632767,0.000028177108,0.0027698525],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979911,0.0005439148,0.00049258274,0.00033638912,0.0002153031,0.00042072884],"domain_scores_gemma":[0.99881244,0.00055543944,0.0001370701,0.00031542906,0.00006963945,0.000110005436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006339266,0.0002590928,0.00033271516,0.00017721378,0.00024653552,0.00005694364,0.0003968195,0.00017797132,0.000048769652],"category_scores_gemma":[0.000044529952,0.00021120782,0.00007734491,0.00005059562,0.00027107983,0.000067370864,0.00020617477,0.00045261558,0.00000458818],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006845772,0.0015087072,0.03126632,0.00042205348,0.00039601832,0.00018480654,0.019255618,0.0052416506,0.5035134,0.16637348,0.02488872,0.24626465],"study_design_scores_gemma":[0.0019027761,0.00007088188,0.046399325,0.00002270644,0.00017276053,0.0000069863845,0.00018969711,0.00080498075,0.30148837,0.001118784,0.64744425,0.00037845515],"about_ca_topic_score_codex":0.0029643083,"about_ca_topic_score_gemma":0.0007327946,"teacher_disagreement_score":0.62255555,"about_ca_system_score_codex":0.000015156436,"about_ca_system_score_gemma":0.000014333682,"threshold_uncertainty_score":0.8612805},"labels":[],"label_agreement":null},{"id":"W2412549223","doi":"10.1385/1-59259-998-2:97","title":"Determination of CYP2B6 Component of 7-Ethoxy-4-Trifluoromethylcoumarin &lt;i&gt;O&lt;/i&gt;-Deethylation Activity in Human Liver Microsomes","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"CYP2B6; Microsome; CYP1A2; CYP2E1; Chemistry; Cytochrome P450; Drug metabolism; Enzyme; CYP2A6; Biochemistry; Pharmacology; Biology","score_opus":0.10535169178834691,"score_gpt":0.3878317476557571,"score_spread":0.2824800558674102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412549223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96251285,0.0067149126,0.00038181554,0.000014838935,0.00041556353,0.00075241254,0.000102480335,0.000048745194,0.029056353],"genre_scores_gemma":[0.99680704,0.00050769927,0.00058834616,0.000051386833,0.00018418535,0.00007604326,0.00003854772,0.000040195682,0.0017065834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703354,0.00088987953,0.0008449221,0.0004371618,0.00034346574,0.0004510155],"domain_scores_gemma":[0.99837136,0.00034752104,0.0006338792,0.00034121264,0.00019672544,0.00010932404],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010785555,0.00033503116,0.0006158511,0.00042306958,0.00017472797,0.000018013987,0.0003997136,0.00038756098,0.0001566596],"category_scores_gemma":[0.000024678488,0.00036799713,0.00018938645,0.00008716235,0.00039400632,0.00011712569,0.00019755786,0.00047350043,0.0000041610997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020033997,0.0006225938,0.00042813428,0.00024391589,0.00006146464,0.000017361277,0.00074749364,0.00044101625,0.9169967,0.011076684,0.00019012202,0.06897417],"study_design_scores_gemma":[0.0027209432,0.000079229896,0.040208254,0.00003993171,0.00021241883,0.0000035394596,0.0000052057344,0.0039290735,0.9131134,0.0018541486,0.037482623,0.000351195],"about_ca_topic_score_codex":0.00032603007,"about_ca_topic_score_gemma":0.0003271717,"teacher_disagreement_score":0.06862298,"about_ca_system_score_codex":0.000077204415,"about_ca_system_score_gemma":0.000053662952,"threshold_uncertainty_score":0.9998772},"labels":[],"label_agreement":null},{"id":"W2412701302","doi":"","title":"Rational antipsychotic polypharmacy.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Polypharmacy; Medicine; Antipsychotic; Clozapine; Haloperidol; Pharmacodynamics; Schizophrenia (object-oriented programming); Antipsychotic drug; Pharmacology; Psychiatry; Clinical Practice; Pharmacokinetics; Internal medicine; Family medicine","score_opus":0.13169010671454992,"score_gpt":0.4050554166852854,"score_spread":0.2733653099707355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412701302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.848589,0.0027743548,0.000027767817,0.0020749099,0.0023809525,0.0008958951,0.00008168689,0.0001794583,0.14299598],"genre_scores_gemma":[0.9713393,0.0014159455,0.000088227345,0.008429259,0.0010147968,0.0008929291,0.000029109206,0.00003164437,0.016758831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980674,0.00027427718,0.00034575717,0.00035785555,0.00022553658,0.00072919927],"domain_scores_gemma":[0.99907094,0.00012387589,0.00006369201,0.00019304019,0.00005220234,0.00049625215],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006526867,0.00022515027,0.00021471555,0.000105162406,0.00024220557,0.00003602032,0.00033905587,0.0001592974,0.01855619],"category_scores_gemma":[0.000024824116,0.00022112302,0.0001262435,0.0002785593,0.00014249288,0.00013969794,0.000029918434,0.00050194806,0.0012669143],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038939054,0.00032999506,0.003837709,0.000009902996,0.00014475385,0.00003155351,0.00010241304,0.00047605962,0.0025385395,0.0007955872,0.021553516,0.9697906],"study_design_scores_gemma":[0.002276302,0.0000069911225,0.095266744,9.1273284e-7,0.00011351254,0.000039326987,0.000004943048,0.0009460081,0.014759797,0.0007654767,0.88554853,0.0002714433],"about_ca_topic_score_codex":0.0000062450026,"about_ca_topic_score_gemma":0.0000013587219,"teacher_disagreement_score":0.96951914,"about_ca_system_score_codex":0.000028398834,"about_ca_system_score_gemma":0.000038481397,"threshold_uncertainty_score":0.9995107},"labels":[],"label_agreement":null},{"id":"W2414073010","doi":"10.1136/annrheumdis-2015-eular.1627","title":"AB0492 Evaluation of Potential Drug-Drug Interactions with Baricitinib","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Pharmacology; Organic anion transporter 1; CYP2C19; CYP3A4; CYP3A; Ketoconazole; CYP2C9; Rheumatoid arthritis; Drug; Cmax; Pharmacokinetics; TNF inhibitor; Methotrexate; Transporter; Internal medicine; Cytochrome P450; Chemistry; Biochemistry; Etanercept; Metabolism","score_opus":0.27020762959871036,"score_gpt":0.4873810910400886,"score_spread":0.21717346144137822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414073010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98829484,0.0037047397,0.000044720688,0.0018999681,0.0011226821,0.0004834992,0.0002175983,0.000021230864,0.004210716],"genre_scores_gemma":[0.99852526,0.0002883086,0.00006146244,0.0005698094,0.00007814502,0.000051050545,0.000018878176,0.000016852375,0.0003902036],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762374,0.00091019954,0.00045045486,0.00016613219,0.00061943673,0.000230034],"domain_scores_gemma":[0.99795413,0.00021912612,0.0004381641,0.00030705924,0.0008387538,0.00024277972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012700113,0.0001651391,0.00029668648,0.000090317575,0.000106133295,0.00001157214,0.00038422365,0.00003187827,0.00067817396],"category_scores_gemma":[0.0003460005,0.000111328576,0.00017206625,0.00024004735,0.00025041695,0.0001271007,0.000111057154,0.00018581466,0.000024308634],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003425909,0.007563472,0.025204036,0.0008447481,0.0044459514,0.0000108594395,0.010995107,0.23709397,0.0073325485,0.0039651697,0.25482824,0.44428998],"study_design_scores_gemma":[0.023651134,0.00033353962,0.14467916,0.0012151771,0.015787965,0.00008002887,0.007395116,0.27410644,0.3994396,0.05962944,0.071907766,0.0017746189],"about_ca_topic_score_codex":0.00007129034,"about_ca_topic_score_gemma":0.000014096655,"teacher_disagreement_score":0.44251537,"about_ca_system_score_codex":0.000014069197,"about_ca_system_score_gemma":0.0003590877,"threshold_uncertainty_score":0.7425529},"labels":[],"label_agreement":null},{"id":"W2414467383","doi":"10.1007/978-1-60761-849-2_17","title":"Protocols of In Vitro Protein Covalent Binding Studies in Liver","year":2010,"lang":"en","type":"article","venue":"Methods in molecular biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Biochemistry; Covalent bond; Enzyme; Cytochrome P450; Chemistry; In vitro; Drug; Xenobiotic; Drug metabolism; Covalent binding; Microsome; Adduct; Reactive intermediate; Pharmacology; Electrophile; Small molecule; Biology","score_opus":0.249336558853156,"score_gpt":0.5976320094254666,"score_spread":0.3482954505723106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414467383","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983334,0.002881479,0.005282772,0.00014422605,0.00074654276,0.007127394,0.000026197167,0.00001684901,0.000440523],"genre_scores_gemma":[0.48896256,0.00048804565,0.49900776,0.00068763585,0.00010384236,0.010598438,0.000011933415,0.000045468307,0.00009431318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99446,0.003732524,0.00073917187,0.00044276105,0.00008004355,0.0005454893],"domain_scores_gemma":[0.99890476,0.0004828137,0.0002026123,0.0002526995,0.00007262586,0.0000844984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053150808,0.0002459456,0.0006625636,0.00059422303,0.00003053362,0.0000035577827,0.00039091034,0.0004887493,0.00012105497],"category_scores_gemma":[0.00082719384,0.0002314955,0.000093824805,0.0005571938,0.00046724497,0.000028040055,0.00024566485,0.001393781,0.000007725129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003201838,0.00035661872,0.008181023,0.0001128346,0.000051756764,0.00013325168,0.0006105258,0.0000869036,0.9306544,0.0016846968,0.000005181915,0.057802588],"study_design_scores_gemma":[0.0022768658,0.00007207814,0.0006839875,0.000033101456,0.0000197517,0.000009598411,0.00006631858,0.0008876073,0.9729664,0.004129973,0.018634807,0.00021955323],"about_ca_topic_score_codex":0.000038665054,"about_ca_topic_score_gemma":0.000048120848,"teacher_disagreement_score":0.49437147,"about_ca_system_score_codex":0.000047104146,"about_ca_system_score_gemma":0.00009056372,"threshold_uncertainty_score":0.9440113},"labels":[],"label_agreement":null},{"id":"W2420657719","doi":"","title":"Validation of a capillary electrophoresis assay for assessing the metabolic stability of verapamil in human liver microsomes.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Microsome; Verapamil; Chromatography; Human liver; Pharmacology; Chemistry; Reproducibility; Incubation; Drug; In vitro; Biochemistry; Medicine; Calcium","score_opus":0.11406103624738195,"score_gpt":0.3919856510727232,"score_spread":0.27792461482534125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420657719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98508835,0.011864801,0.00011222001,0.00009196086,0.0003815222,0.0012832235,0.00005398401,0.000010956877,0.0011129882],"genre_scores_gemma":[0.9971934,0.0015314977,0.00015505934,0.00023921824,0.00006120457,0.00074739754,0.00001374797,0.000019568424,0.00003888175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973819,0.0012171131,0.00054074766,0.00024649038,0.00015956238,0.00045416504],"domain_scores_gemma":[0.9986189,0.00061024464,0.00028271184,0.0002238765,0.00017425498,0.000090014786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037608552,0.00016584623,0.00037681902,0.00013720494,0.0001313159,0.000013949581,0.00024078069,0.00016302496,0.000101226164],"category_scores_gemma":[0.00032625257,0.00013562027,0.00015328733,0.00035342295,0.00020551118,0.00008837609,0.000034496923,0.0003018953,6.7708055e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012252637,0.00063230714,0.05546778,0.00012742472,0.00023190578,0.0000018921735,0.00076839305,0.00017485344,0.90419805,0.002802544,0.00029194896,0.0351804],"study_design_scores_gemma":[0.0013907872,0.000010220655,0.10844701,0.0000020615473,0.00020925455,0.0000017867009,0.000052922147,0.000121898796,0.86478096,0.0009107423,0.0239536,0.00011874447],"about_ca_topic_score_codex":0.000036638427,"about_ca_topic_score_gemma":0.000008613673,"teacher_disagreement_score":0.05297923,"about_ca_system_score_codex":0.000039566472,"about_ca_system_score_gemma":0.00009146801,"threshold_uncertainty_score":0.5530434},"labels":[],"label_agreement":null},{"id":"W2426519130","doi":"10.1016/bs.apha.2015.03.003","title":"Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer","year":2015,"lang":"en","type":"review","venue":"Advances in pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":213,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Health Canada","keywords":"Reactive oxygen species; Chemistry; Biochemistry; Superoxide; Cytochrome P450; Hydroxyl radical; Oxidative stress; Cancer cell; Hydrogen peroxide; Enzyme; Radical; Biology; Cancer","score_opus":0.20505780416294883,"score_gpt":0.5221956942640424,"score_spread":0.3171378901010936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2426519130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002473293,0.9898925,0.000008975313,0.00009312768,0.0018688118,0.0018813751,0.0004562722,0.000026459209,0.003299232],"genre_scores_gemma":[0.0018440699,0.9956564,0.00010438784,0.000454158,0.00049314817,0.0010627892,0.0001332865,0.00005693433,0.00019482579],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565184,0.0012541354,0.001471053,0.0006442083,0.0002529227,0.00072584127],"domain_scores_gemma":[0.99786735,0.000578148,0.00093701726,0.00020376177,0.00015891384,0.00025478486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013663091,0.0006340417,0.0023974,0.00087975553,0.000067213725,0.000009630459,0.00055336655,0.00064483145,0.00054398406],"category_scores_gemma":[0.00004452186,0.0005936123,0.00017696661,0.00076839194,0.00045528793,0.00046525506,0.00034825088,0.0014732532,0.000019649466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024337957,0.0004349723,0.00011958454,0.0075015575,0.0002513701,0.00008811002,0.0010113502,0.0003628673,0.003371018,0.000363074,0.001324464,0.98492825],"study_design_scores_gemma":[0.00295637,0.00008734629,0.00007572349,0.00078593404,0.00090389396,0.000026890464,0.00011051852,0.00019391296,0.0016268573,0.00062537304,0.9920994,0.00050775],"about_ca_topic_score_codex":0.0000371408,"about_ca_topic_score_gemma":0.000156275,"teacher_disagreement_score":0.990775,"about_ca_system_score_codex":0.0005170619,"about_ca_system_score_gemma":0.00045626043,"threshold_uncertainty_score":0.99965155},"labels":[],"label_agreement":null},{"id":"W2430496159","doi":"","title":"Regulatory approval for new pharmacogenomic tests: a comparative overview.","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; London Health Sciences Centre; BC Children's Hospital","funders":"","keywords":"Pharmacogenomics; Business; Drug development; Risk analysis (engineering); Medicine; Drug; Pharmacology","score_opus":0.4739635311193347,"score_gpt":0.44775541696860494,"score_spread":0.026208114150729767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430496159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9073663,0.017875217,0.0006407475,0.0004449387,0.005970488,0.0059105037,0.00034956384,0.00034642208,0.06109585],"genre_scores_gemma":[0.9847516,0.0006173803,0.0016036207,0.0034947044,0.0013995827,0.0031284534,0.000031949865,0.000059477097,0.0049132556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975634,0.00026404293,0.00050655036,0.00054176716,0.00016996355,0.0009542571],"domain_scores_gemma":[0.9983225,0.00022488466,0.00023402393,0.00029015404,0.00011886922,0.00080959185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009971757,0.00037115233,0.0004829371,0.00015557167,0.00023142753,0.000021890857,0.00054044847,0.00024037,0.00086033245],"category_scores_gemma":[0.000047947357,0.00036562362,0.00025473887,0.00023156377,0.00019241076,0.00015200512,0.00012703644,0.00046819588,0.00014420298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030343924,0.0015030862,0.0064374297,0.00016052685,0.0016650349,0.000033345183,0.0060192435,0.000116839554,0.03610438,0.01404309,0.16755012,0.7633325],"study_design_scores_gemma":[0.005099319,0.000038492166,0.055481404,0.000002836912,0.0005346703,0.000019972407,0.00007489606,0.00062447105,0.16257693,0.004312951,0.7707127,0.00052137795],"about_ca_topic_score_codex":0.000027190978,"about_ca_topic_score_gemma":0.000007404796,"teacher_disagreement_score":0.7628111,"about_ca_system_score_codex":0.00009175738,"about_ca_system_score_gemma":0.00016305324,"threshold_uncertainty_score":0.9998796},"labels":[],"label_agreement":null},{"id":"W2438748188","doi":"10.18433/j3h03r","title":"Evaluation of a Potential Metabolism-Mediated Drug-Drug Interaction Between Atomoxetine and Bupropion in Healthy Volunteers","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atomoxetine; Bupropion; Drug; Pharmacology; Drug metabolism; Medicine; Drug-drug interaction; Drug interaction; Methylphenidate; Psychiatry; Attention deficit hyperactivity disorder; Smoking cessation","score_opus":0.16882104081996316,"score_gpt":0.4996675840237531,"score_spread":0.3308465432037899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438748188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97545516,0.010748788,0.0000959674,0.010091241,0.002704158,0.00049868453,0.000073707066,0.000015896532,0.000316366],"genre_scores_gemma":[0.991249,0.0067701903,0.00016837362,0.0009731782,0.00077732146,0.000015061606,0.0000027227045,0.000020700943,0.00002339813],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99287176,0.0025252793,0.0015839085,0.0004516496,0.0018578088,0.0007096073],"domain_scores_gemma":[0.99630195,0.0010723583,0.0008771508,0.00011430333,0.0009364936,0.00069774454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012944051,0.0003448709,0.00070179865,0.0005732514,0.00020180373,0.000033501605,0.0005933193,0.00009717727,0.0011247562],"category_scores_gemma":[0.0006720734,0.00023698735,0.00017586695,0.00080583245,0.0007318966,0.0007066537,0.00017396575,0.0009101767,0.000014176341],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002499844,0.00065733626,0.0634414,0.00008036104,0.00033552587,0.000043098404,0.00061693235,0.0012081551,0.4215478,0.00012434261,0.0014117676,0.5080334],"study_design_scores_gemma":[0.03634172,0.0002874913,0.034507178,0.0002030855,0.0031110002,0.0002008662,0.000650028,0.066423036,0.5482812,0.000792763,0.3083736,0.0008280401],"about_ca_topic_score_codex":0.0013010174,"about_ca_topic_score_gemma":0.00050439563,"teacher_disagreement_score":0.50720537,"about_ca_system_score_codex":0.00025222494,"about_ca_system_score_gemma":0.0013134255,"threshold_uncertainty_score":0.99978834},"labels":[],"label_agreement":null},{"id":"W2461268409","doi":"10.1055/s-0031-1296226","title":"Pharmacokinetics of felodipine extended-release tablets in healthy Taiwanese subjects: a retrospective review","year":2011,"lang":"en","type":"review","venue":"Arzneimittelforschung","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Felodipine; Pharmacokinetics; Medicine; Pharmacology; Chemistry; Internal medicine; Blood pressure","score_opus":0.15680341751202995,"score_gpt":0.4688459681864443,"score_spread":0.31204255067441433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461268409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022799322,0.9828459,0.000014900959,0.00014665042,0.002611732,0.0039895424,0.0007207004,0.00012612426,0.00931646],"genre_scores_gemma":[0.0012128713,0.9928983,0.00028117077,0.003211956,0.00067669153,0.0007441528,0.00030898713,0.0002579132,0.00040794234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99075806,0.0022088392,0.0033108953,0.001481923,0.00055387383,0.0016864233],"domain_scores_gemma":[0.9949286,0.00056295126,0.0021345366,0.0011018798,0.00041439405,0.0008576133],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002878458,0.0015450841,0.0054632863,0.0009712054,0.00019652647,0.000020854413,0.00154621,0.0012116104,0.0029823554],"category_scores_gemma":[0.00047939003,0.0014183162,0.0012393644,0.0022138187,0.00044228256,0.00021075208,0.0005341701,0.003931842,0.00036496343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033632506,0.0014040653,0.00013133542,0.07193728,0.0009162676,0.00031015777,0.00024944913,0.000007800819,0.00006943377,0.0012166571,0.0078173205,0.91560394],"study_design_scores_gemma":[0.0023816782,0.00026933057,0.0000921908,0.013929083,0.004599163,0.00017117707,0.0000128119145,0.000059752267,0.00017301404,0.0002986106,0.97679734,0.0012158396],"about_ca_topic_score_codex":0.00010747426,"about_ca_topic_score_gemma":0.000026620657,"teacher_disagreement_score":0.96898,"about_ca_system_score_codex":0.0003710033,"about_ca_system_score_gemma":0.0011010303,"threshold_uncertainty_score":0.99972975},"labels":[],"label_agreement":null},{"id":"W2465671661","doi":"10.1186/s13643-016-0280-y","title":"Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis","year":2016,"lang":"en","type":"article","venue":"Systematic Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"VKORC1; Medicine; Warfarin; Meta-analysis; Vitamin K epoxide reductase; MEDLINE; CYP2C9; Internal medicine; Cytochrome P450; Atrial fibrillation","score_opus":0.1790577737719707,"score_gpt":0.4744469414993939,"score_spread":0.2953891677274232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465671661","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018075936,0.13407394,0.00031014826,0.00040607457,0.00009605778,0.8465254,0.00027758937,0.000043113803,0.00019178244],"genre_scores_gemma":[0.17937617,0.0070458753,0.00017888487,0.0013333275,0.00004989938,0.8108468,0.00000868479,0.00006393001,0.001096458],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98815894,0.007935499,0.0025646295,0.00061431644,0.00027760435,0.00044900685],"domain_scores_gemma":[0.9950543,0.0021266602,0.0017615581,0.0007571087,0.000080276615,0.00022011761],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014594393,0.0005740409,0.0070124096,0.00030181766,0.000074581476,0.000025429126,0.00042907652,0.00018965625,0.00016694913],"category_scores_gemma":[0.0014108862,0.0002727192,0.0011031565,0.00051397015,0.0001431305,0.00008720972,0.000106849475,0.00023457741,0.00003268624],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013768776,0.00014523981,0.000740558,0.9751346,0.021601208,0.0000061848236,0.000169578,0.0000030740434,0.0009469467,0.00022691402,0.00060135615,0.00028662468],"study_design_scores_gemma":[0.013050448,0.0009949795,0.0016793627,0.114626534,0.8609207,0.00016192565,0.000024600848,0.00026862256,0.0050104707,0.00026942257,0.0015836176,0.0014093135],"about_ca_topic_score_codex":0.000016744478,"about_ca_topic_score_gemma":0.000010172108,"teacher_disagreement_score":0.8605081,"about_ca_system_score_codex":0.000041962634,"about_ca_system_score_gemma":0.000027740629,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W2467694195","doi":"10.1007/978-3-319-27883-4_20","title":"Clinical Significant Interactions with Opioid Analgesics","year":2016,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacology; Pharmacodynamics; Pharmacokinetics; Medicine; Opioid; Alfentanil; Drug; Pharmacogenetics; Tramadol; Analgesic; Chemistry; Fentanyl; Internal medicine","score_opus":0.19255288915707053,"score_gpt":0.475978156003168,"score_spread":0.2834252668460975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467694195","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060337735,0.0011128796,0.0009900308,0.0009653412,0.0043810434,0.0005976946,0.00045548953,0.00018010294,0.990714],"genre_scores_gemma":[0.016505817,0.0083660595,0.00064693904,0.0048480113,0.0029808013,0.000042348212,0.000067582536,0.00015686822,0.96638554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972259,0.0001962478,0.00094135926,0.00078856025,0.00029897245,0.0005490063],"domain_scores_gemma":[0.9971951,0.0008268946,0.00048758803,0.00051845505,0.0002857066,0.00068620406],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00075477007,0.00064485124,0.0008174609,0.00021686788,0.00022187443,0.00003147008,0.0005154155,0.00083564455,0.03140849],"category_scores_gemma":[0.000027014303,0.00043618132,0.00039771004,0.00004481892,0.0005910203,0.00008399212,0.00017966414,0.0021732543,0.0028837614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011542435,0.00044924518,0.001186142,0.0000773271,0.0031508163,0.00042480498,0.000106781015,0.000023293105,0.0028028905,0.41483206,0.11872139,0.45707104],"study_design_scores_gemma":[0.0016203959,0.00015714123,0.00010146616,0.00006128139,0.0010054267,0.00003526443,0.000006368031,0.000083731145,0.0013706405,0.00970044,0.98516756,0.00069027167],"about_ca_topic_score_codex":0.0000029288888,"about_ca_topic_score_gemma":0.000017941486,"teacher_disagreement_score":0.8664462,"about_ca_system_score_codex":0.00006596849,"about_ca_system_score_gemma":0.00035631188,"threshold_uncertainty_score":0.999809},"labels":[],"label_agreement":null},{"id":"W2474397727","doi":"10.1124/dmd.116.070060","title":"Functional Integrity of the Chimeric (Humanized) Mouse Liver: Enzyme Zonation, Physiologic Spaces, and Hepatic Enzymes and Transporters","year":2016,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vivo; Sulfation; Perfusion; Glucuronidation; Albumin; Biology; Enzyme; Internal medicine; Chemistry; Endocrinology; Biochemistry; Microsome; Medicine","score_opus":0.04095210611705749,"score_gpt":0.3114703662772778,"score_spread":0.2705182601602203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474397727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807764,0.016617449,0.00039562993,0.0010027153,0.0005163874,0.0003120025,0.00023962314,0.000030655643,0.000109108725],"genre_scores_gemma":[0.9868847,0.011658043,0.00010431767,0.00077058544,0.00017837917,0.000032166565,0.000026899239,0.000014217875,0.0003306532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859834,0.00037736594,0.00030089507,0.00033115974,0.0001637087,0.00022850957],"domain_scores_gemma":[0.99923193,0.00020570352,0.00018421063,0.00013480539,0.00009072139,0.0001526279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042514867,0.00023042863,0.00031505877,0.00008871546,0.0002921353,0.000021327052,0.00011058049,0.00013399169,0.00014268867],"category_scores_gemma":[0.000032727745,0.00013677085,0.00007867646,0.00012886319,0.0005118813,0.00020732438,0.000072117626,0.00025427726,0.0000041187513],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059756846,0.0003764142,0.014578908,0.00016496964,0.0002540537,0.000003729074,0.0023132176,0.000017658036,0.84998554,0.05039533,0.0010131273,0.08029946],"study_design_scores_gemma":[0.004408342,0.000047764646,0.7217813,0.000042580505,0.00092499575,0.000032865402,0.00021513112,0.0014811759,0.24749392,0.0041718883,0.018967543,0.00043245996],"about_ca_topic_score_codex":0.00006526956,"about_ca_topic_score_gemma":0.000021417312,"teacher_disagreement_score":0.70720243,"about_ca_system_score_codex":0.000009923435,"about_ca_system_score_gemma":0.000032083703,"threshold_uncertainty_score":0.5577353},"labels":[],"label_agreement":null},{"id":"W2481094411","doi":"10.1186/s12920-016-0207-4","title":"DL-ADR: a novel deep learning model for classifying genomic variants into adverse drug reactions","year":2016,"lang":"en","type":"article","venue":"BMC Medical Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China","keywords":"Pharmacogenomics; Single-nucleotide polymorphism; Biology; Computational biology; Genetics; Linkage disequilibrium; Human genetics; Genome-wide association study; Bioinformatics; Genotype; Gene","score_opus":0.1358765444349655,"score_gpt":0.4152546294074259,"score_spread":0.2793780849724604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481094411","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44584557,0.0010410835,0.54628015,0.0012357527,0.0026738653,0.00077608926,0.00012055494,0.00017765413,0.0018492957],"genre_scores_gemma":[0.945646,0.004211035,0.037092667,0.0029710364,0.0018763562,0.00030318263,0.00004623111,0.00013977948,0.0077137295],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99711585,0.00030270766,0.000777157,0.00063740776,0.0003243339,0.00084255094],"domain_scores_gemma":[0.9966685,0.0016087834,0.00029095332,0.0002966743,0.00013660218,0.0009984823],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002132816,0.0003595826,0.00044599327,0.0001675774,0.000586176,0.000019488027,0.00062125304,0.0005389962,0.0012345994],"category_scores_gemma":[0.0010713096,0.00029635217,0.00027634198,0.0001385628,0.00029200327,0.0001242806,0.0002828372,0.000845438,0.00033605547],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011304272,0.0007602154,0.0025588847,0.0002513777,0.00046625873,0.000021260908,0.0029037034,0.040878527,0.8140624,0.006695143,0.0027920345,0.12747978],"study_design_scores_gemma":[0.0053560175,0.000026559164,0.0003280599,0.00002807393,0.0002458336,0.000027395212,0.0001008952,0.69713044,0.0031851346,0.0013041717,0.291867,0.00040042758],"about_ca_topic_score_codex":0.000016783182,"about_ca_topic_score_gemma":0.0000924505,"teacher_disagreement_score":0.81087726,"about_ca_system_score_codex":0.00025984048,"about_ca_system_score_gemma":0.0009326984,"threshold_uncertainty_score":0.99994886},"labels":[],"label_agreement":null},{"id":"W2481657687","doi":"10.5812/hepatmon.35953","title":"Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis","year":2016,"lang":"en","type":"article","venue":"Hepatitis Monthly","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Universität des Saarlandes; Canadian Liver Foundation","keywords":"Pregnane X receptor; Cholestasis; Constitutive androstane receptor; Medicine; Nuclear receptor; Anabolic steroid; Bile acid; Internal medicine; Cholestyramine; Bile Salt Export Pump; Endocrinology; CYP3A4; Multidrug resistance-associated protein 2; Biology; Gene; Cytochrome P450; Anabolism; Genetics; Transcription factor","score_opus":0.04198835655938451,"score_gpt":0.3247240142313402,"score_spread":0.2827356576719557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481657687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593973,0.00021941896,0.000011415006,0.00086030836,0.00076618727,0.00068037247,0.0001750501,0.000039525512,0.0013079685],"genre_scores_gemma":[0.99784446,0.0006094532,0.00010891448,0.0011511806,0.00008898513,0.0000957279,0.0000058424607,0.000046525267,0.00004891501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99782014,0.0005901045,0.00052206265,0.00034703178,0.00028918567,0.00043145794],"domain_scores_gemma":[0.99884194,0.00016517774,0.00034182693,0.0003635834,0.00012784492,0.0001596231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026230823,0.0002627344,0.00035760063,0.0001581262,0.00013360145,0.00001459345,0.00033342472,0.00019818003,0.000360349],"category_scores_gemma":[0.00009321626,0.00016117364,0.00009192699,0.00040241305,0.00016895498,0.00016682982,0.000117135874,0.00036719296,0.000036535777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058881316,0.0006822514,0.13499376,0.000052195985,0.00016596468,0.000042951284,0.003208965,0.00021639555,0.5351806,0.00034864704,0.0008215886,0.32369787],"study_design_scores_gemma":[0.0062691686,0.00075133314,0.2920657,0.00028749186,0.00019126308,0.000021638618,0.00023331073,0.0018163153,0.64002186,0.00034437553,0.05732416,0.00067339314],"about_ca_topic_score_codex":0.000673513,"about_ca_topic_score_gemma":0.0007481507,"teacher_disagreement_score":0.32302448,"about_ca_system_score_codex":0.00014307965,"about_ca_system_score_gemma":0.00008440347,"threshold_uncertainty_score":0.65724707},"labels":[],"label_agreement":null},{"id":"W2482609357","doi":"10.1016/j.abb.2016.07.018","title":"Role of active site loop in coenzyme binding and flavin reduction in cytochrome P450 reductase","year":2016,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Flavin group; Stereochemistry; Active site; Reductase; Cofactor; Cytochrome P450 reductase; Coenzyme Q – cytochrome c reductase; Biochemistry; Enzyme; Cytochrome c","score_opus":0.024063561760104237,"score_gpt":0.33928532273853024,"score_spread":0.315221760978426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482609357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997601,0.0012711916,0.0000037262705,0.00011864368,0.000042474072,0.00013518933,0.0003006093,0.0000063837774,0.00052079075],"genre_scores_gemma":[0.99717814,0.0024474848,0.00015623808,0.000016429096,0.00009135735,0.0000098369765,0.000021271864,0.000009354729,0.000069894464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906933,0.00008207282,0.0002852234,0.00027543635,0.00006792682,0.00022000416],"domain_scores_gemma":[0.99945253,0.00015968428,0.00015831103,0.000114529124,0.000018521398,0.0000964471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012743975,0.00015488597,0.00025707643,0.00010471849,0.000036358597,0.0000035357587,0.00010091496,0.00011505044,0.000014922663],"category_scores_gemma":[0.000024940193,0.00013137903,0.000043172233,0.00015887377,0.00051874813,0.00006607156,0.00010683047,0.0002111926,0.0000011559789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047467952,0.00022098834,0.0013306782,0.000082802035,0.00003609118,0.0000035813293,0.0010046739,0.0000036584047,0.9274308,0.00014357062,0.000007864523,0.06926062],"study_design_scores_gemma":[0.0014831352,0.000045991073,0.007391422,0.00008766377,0.000038752016,0.000011274333,0.00039757573,0.00017860452,0.98710334,0.0029642205,0.00014643371,0.00015158443],"about_ca_topic_score_codex":0.000027650558,"about_ca_topic_score_gemma":0.0000017195599,"teacher_disagreement_score":0.06910903,"about_ca_system_score_codex":0.000010439521,"about_ca_system_score_gemma":0.000044021384,"threshold_uncertainty_score":0.5357481},"labels":[],"label_agreement":null},{"id":"W2484588887","doi":"10.1002/bmc.3786","title":"<i>In vitro</i> metabolism of specific CYP2D and CYP3A opioid substrates using rat liver S9 fractions and mass spectrometry reveal a severe metabolic impairment with increasing age","year":2016,"lang":"en","type":"article","venue":"Biomedical Chromatography","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Chromatography; Oxycodone; Codeine; Oxymorphone; Mass spectrometry; CYP3A; Ammonium acetate; Pharmacology; Metabolism; Opioid; High-performance liquid chromatography; Morphine; Biochemistry; Cytochrome P450; Receptor; Medicine","score_opus":0.03523743424579491,"score_gpt":0.3294679787834704,"score_spread":0.2942305445376755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484588887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97051144,0.02726738,0.00047967004,0.0002957897,0.0005428451,0.000447808,0.00023963502,0.00004696108,0.00016847797],"genre_scores_gemma":[0.9749802,0.0137278,0.010424923,0.0003942437,0.0003675555,0.00002890106,0.000015189302,0.000042567674,0.000018637136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99719906,0.00053466443,0.00061176775,0.0005840032,0.000390279,0.00068022666],"domain_scores_gemma":[0.9983875,0.0004286632,0.0002586483,0.00023444137,0.00006948655,0.0006212418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009057747,0.0004185117,0.0007585656,0.0008372969,0.00019436023,0.00003379154,0.00020233468,0.0003269925,0.0003100266],"category_scores_gemma":[0.00002605664,0.00029393937,0.00014608743,0.0010976307,0.0012368108,0.00025334183,0.000115232346,0.00046931146,0.0000053150466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000705095,0.0004447475,0.011152488,0.0001029733,0.00032806402,0.00022986783,0.0002512421,0.0000010253345,0.9828512,0.00040507305,0.00024625205,0.0032819402],"study_design_scores_gemma":[0.010826501,0.00021720579,0.08198542,0.00017278045,0.0009797773,0.00095671794,0.00024234322,0.00024851132,0.7727014,0.0013564499,0.12935778,0.0009551545],"about_ca_topic_score_codex":0.00008385952,"about_ca_topic_score_gemma":0.0000035840442,"teacher_disagreement_score":0.21014988,"about_ca_system_score_codex":0.000027836059,"about_ca_system_score_gemma":0.00009930514,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W2497999703","doi":"10.1007/978-1-59745-350-9_14","title":"Cytokines and Pharmacokinetic Drug Interactions","year":2007,"lang":"en","type":"book-chapter","venue":"Methods in pharmacology and toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cytokine; Cytochrome P450; Inflammation; Tumor necrosis factor alpha; Transcription factor; Biology; Drug; Proinflammatory cytokine; Interleukin; Immunology; Pharmacology; Enzyme; Gene; Biochemistry","score_opus":0.17954470780517534,"score_gpt":0.5337244310969486,"score_spread":0.3541797232917732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497999703","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059774637,0.055239886,0.0009688796,0.0040414454,0.02623331,0.0046788594,0.00031266166,0.0004108658,0.84833944],"genre_scores_gemma":[0.055332284,0.11688681,0.0461952,0.04678642,0.0069597205,0.0012881863,0.00019730008,0.00080344063,0.72555065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99343765,0.0017733088,0.0015804295,0.0016063589,0.00023191137,0.001370325],"domain_scores_gemma":[0.9939957,0.003952303,0.0006746767,0.00036251853,0.00018592992,0.0008288474],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0042905156,0.0012414991,0.0017401084,0.001557916,0.00044042314,0.000036368754,0.0005895062,0.0014770906,0.009835942],"category_scores_gemma":[0.000119032185,0.0013202552,0.0002497786,0.00021618207,0.0018741952,0.00016655304,0.00083580165,0.005381339,0.0001273303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016783593,0.0010010601,0.00055212586,0.00045877663,0.0017650557,0.0014665382,0.0013487259,0.000083396895,0.09033053,0.039992694,0.019349946,0.8268676],"study_design_scores_gemma":[0.025266215,0.00024547448,0.00022573074,0.00004224657,0.0015017649,0.0004826579,0.000040163253,0.0014056729,0.016017556,0.018869938,0.93473667,0.0011659208],"about_ca_topic_score_codex":0.000019575886,"about_ca_topic_score_gemma":0.000104213716,"teacher_disagreement_score":0.91538674,"about_ca_system_score_codex":0.00017078921,"about_ca_system_score_gemma":0.0001968556,"threshold_uncertainty_score":0.9998192},"labels":[],"label_agreement":null},{"id":"W2499462156","doi":"10.1016/b978-012406061-6/50048-5","title":"Cytochrome P-450","year":2006,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cytochrome; Chemistry; Biochemistry","score_opus":0.0745697060764952,"score_gpt":0.3817367114837826,"score_spread":0.30716700540728736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499462156","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037312243,0.010104932,0.000004741648,0.00016383937,0.0027264878,0.000904753,0.0004820533,0.0002162873,0.9850238],"genre_scores_gemma":[0.0035277347,0.00097449624,0.00014282425,0.0035936884,0.002774955,0.00008839502,0.00016600103,0.00023505038,0.98849684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690866,0.000152333,0.0008675208,0.0008223149,0.00042928275,0.0008198645],"domain_scores_gemma":[0.9980719,0.00017752987,0.00045917404,0.0006282322,0.00017756782,0.0004855653],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000605357,0.0009075843,0.0009780633,0.00029900178,0.00031708798,0.000047488767,0.00069786,0.0014419622,0.0061328327],"category_scores_gemma":[0.000013385308,0.0009148327,0.0005592376,0.000025963715,0.00043970504,0.00003952624,0.00029823862,0.0022948985,0.0028292318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000708293,0.000051772204,0.000008938358,0.000097104145,0.00043529616,0.00026807425,0.00009412157,0.000034725956,0.0046499628,0.0082951365,0.02045017,0.96554387],"study_design_scores_gemma":[0.001202448,0.00004891701,0.000035520025,0.00006174919,0.00085203326,0.00005890912,0.0000015515008,0.00005663247,0.0024880453,0.013784821,0.9804626,0.0009467349],"about_ca_topic_score_codex":0.0000010615616,"about_ca_topic_score_gemma":0.000008286096,"teacher_disagreement_score":0.9645971,"about_ca_system_score_codex":0.000117697076,"about_ca_system_score_gemma":0.00024354669,"threshold_uncertainty_score":0.9998544},"labels":[],"label_agreement":null},{"id":"W2512717750","doi":"10.1056/wh201005130000001","title":"Revisiting Breast Cancer Outcomes in Concomitant Users of Tamoxifen and Selective Serotonin Reuptake Inhibitors","year":2010,"lang":"en","type":"article","venue":"Journal watch","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paroxetine; Tamoxifen; Breast cancer; Concomitant; Medicine; Serotonin reuptake inhibitor; Oncology; Reuptake inhibitor; Internal medicine; CYP2D6; Serotonin; Pharmacology; Cancer; Cytochrome P450; Receptor","score_opus":0.04575149152006397,"score_gpt":0.4130539609462616,"score_spread":0.36730246942619765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512717750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873733,0.0007266508,0.0000023048176,0.009315632,0.0016290598,0.0002570299,0.00008867881,0.000012549606,0.0005947949],"genre_scores_gemma":[0.99483234,0.003246372,0.00023030497,0.00079511834,0.00062103005,0.000017864108,0.0000011679531,0.000024901337,0.00023090522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982476,0.00030089187,0.0006237157,0.00021681625,0.00019388378,0.00041705792],"domain_scores_gemma":[0.99875057,0.00026104492,0.0003761075,0.000102442755,0.00020760571,0.00030220498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014328039,0.00021527596,0.0004770109,0.00013230136,0.00018077741,0.000029755776,0.00020640784,0.00025152747,0.000384642],"category_scores_gemma":[0.000101276506,0.00017707539,0.00010498148,0.00023289927,0.00015183816,0.0001477249,0.00008248579,0.0020191951,0.000004498148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016319708,0.00008961294,0.61084616,0.000025472265,0.00013100497,0.000041359977,0.0012508498,0.000078183904,0.37031093,0.000047073463,0.0012084998,0.015807673],"study_design_scores_gemma":[0.006402742,0.0000667894,0.59804755,0.000102260725,0.0003279367,0.0007027775,0.00033865636,0.0013510004,0.34574908,0.0009773666,0.04538225,0.0005515907],"about_ca_topic_score_codex":0.00008706861,"about_ca_topic_score_gemma":0.000064549116,"teacher_disagreement_score":0.04417375,"about_ca_system_score_codex":0.00006234266,"about_ca_system_score_gemma":0.00015504337,"threshold_uncertainty_score":0.877251},"labels":[],"label_agreement":null},{"id":"W2515277963","doi":"10.1016/j.foodchem.2016.09.026","title":"CYP2D6 and CYP2A6 biotransform dietary tyrosol into hydroxytyrosol","year":2016,"lang":"en","type":"article","venue":"Food Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Instituto de Salud Carlos III; Canadian Institutes of Health Research; Rat für Forschung und Technologieentwicklung; Department of Psychiatry, University of Toronto; Centre for Addiction and Mental Health Foundation; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya; National Institutes of Health; Generalitat de Catalunya; Centre for Addiction and Mental Health","keywords":"Tyrosol; Hydroxytyrosol; CYP2A6; Chemistry; Biochemistry; Pharmacology; Biotransformation; Cytochrome P450; CYP3A4; Enzyme; Antioxidant; Polyphenol; Biology","score_opus":0.06607398754303452,"score_gpt":0.3770852513657949,"score_spread":0.3110112638227604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515277963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97612387,0.0056917225,0.00008652181,0.0021700093,0.00061318016,0.00021274156,0.00023775725,0.00013608637,0.014728086],"genre_scores_gemma":[0.9936065,0.0027565255,0.00018148642,0.0011148814,0.00063211424,0.00005438888,0.000020266729,0.000042073716,0.0015917479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834657,0.00006383791,0.00036419072,0.00048960483,0.00017376515,0.00056202867],"domain_scores_gemma":[0.9988996,0.0001739516,0.00009580465,0.00027660807,0.00006185098,0.00049217616],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026974385,0.0003351763,0.0003077236,0.000034801,0.0002255296,0.000020930644,0.00031881873,0.00042906438,0.0014795938],"category_scores_gemma":[0.00004489652,0.00025563242,0.00012116811,0.00011616045,0.00036013263,0.00010813073,0.00014163177,0.00044236958,0.00012540298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013339485,0.00013063285,0.00079021207,0.000105989064,0.00018599574,0.00001753856,0.00028405112,0.000003324223,0.94352233,0.00006718487,0.0014866955,0.053272624],"study_design_scores_gemma":[0.0018726863,0.00006669365,0.00015486749,0.000019877405,0.00012813674,0.00003679206,0.000031140484,0.00008474215,0.826669,0.0013064975,0.16928864,0.00034095068],"about_ca_topic_score_codex":0.0000056162585,"about_ca_topic_score_gemma":0.000003367449,"teacher_disagreement_score":0.16780195,"about_ca_system_score_codex":0.000041688665,"about_ca_system_score_gemma":0.00007278239,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W2519223696","doi":"10.1038/srep33099","title":"Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: Special focus on mycobacterial P450s","year":2016,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Department of Higher Education and Training; Ministry of Science, ICT and Future Planning; Central University of Technology; Allard Foundation; National Research Foundation; University of Wisconsin-Madison","keywords":"Monooxygenase; Biology; Cytochrome P450; Phylogenetic tree; Function (biology); Genome; Evolutionary biology; Molecular evolution; Computational biology; Genetics; Functional diversity; Gene; Ecology; Biochemistry; Enzyme","score_opus":0.048340512846255616,"score_gpt":0.38356674936859925,"score_spread":0.3352262365223436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519223696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715875,0.00034856066,0.00027171677,0.0005153211,0.022257552,0.00048716922,0.0003836587,0.000071511,0.004077044],"genre_scores_gemma":[0.9967313,0.0000679056,0.00012052476,0.0001359888,0.0015925679,0.00004245825,0.00007488088,0.00003829608,0.0011960851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964563,0.0003011771,0.0009112626,0.00094108784,0.00062239025,0.0007677691],"domain_scores_gemma":[0.9977848,0.00017781762,0.00059779675,0.00076887716,0.00031400737,0.00035670705],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016052233,0.00032991706,0.00043560565,0.00020679005,0.00044282217,0.000064005566,0.0003797678,0.00030460596,0.0016605196],"category_scores_gemma":[0.00026275925,0.00025587165,0.00027941563,0.00042013038,0.001016815,0.00016195237,0.00024686786,0.00029049526,0.00013165777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003450549,0.0004484013,0.0017692901,0.000022074899,0.00013191102,0.0007692858,0.0002432943,0.00027712245,0.9628332,0.002410776,0.008261766,0.022487812],"study_design_scores_gemma":[0.0015132438,0.000112787195,0.007164497,0.000048779344,0.0001250024,0.00021011522,0.00004184551,0.00034365163,0.7617665,0.028638769,0.19956979,0.00046500683],"about_ca_topic_score_codex":0.000012788854,"about_ca_topic_score_gemma":0.000020445163,"teacher_disagreement_score":0.2010667,"about_ca_system_score_codex":0.00016947619,"about_ca_system_score_gemma":0.00027262184,"threshold_uncertainty_score":0.99998933},"labels":[],"label_agreement":null},{"id":"W2519688704","doi":"10.1016/j.bmcl.2016.09.046","title":"Targeting cytochrome P450 (CYP) 1B1 with steroid derivatives","year":2016,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé","keywords":"Chemistry; Steroid; Cytochrome P450; CYP1B1; Stereochemistry; Heme; Pharmacology; IC50; Enzyme; Estrone; Active site; Docking (animal); CYP3A4; Structure–activity relationship; Biochemistry; In vitro","score_opus":0.04944998651031944,"score_gpt":0.35174573372370865,"score_spread":0.3022957472133892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519688704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244333,0.0013967549,0.0015074112,0.012723343,0.00037758303,0.00024884823,0.000060826744,0.00015097433,0.0010909146],"genre_scores_gemma":[0.98970294,0.00039482635,0.00030450622,0.0074144807,0.0015470244,0.00003786973,0.000023915016,0.00006500523,0.0005094171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976145,0.00016242312,0.00044277034,0.0005954358,0.00039385076,0.000791029],"domain_scores_gemma":[0.9985963,0.00027143536,0.0002409135,0.0002986302,0.00009481855,0.00049788924],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005069383,0.0004363232,0.00041224164,0.000053773267,0.00023321179,0.000019489005,0.0005169838,0.00023142807,0.004435804],"category_scores_gemma":[0.00012451783,0.00028531748,0.00008215129,0.0002490924,0.000614345,0.00011792679,0.00012686898,0.00058083615,0.00016208868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025922278,0.00009529221,0.0017358168,0.000076953205,0.00022681862,0.0001647769,0.0003440033,0.0000050157464,0.9866434,0.000007979894,0.0065160836,0.0039246497],"study_design_scores_gemma":[0.003279762,0.00004145161,0.002232318,0.000072771836,0.00020007676,0.00012571346,0.00014267146,0.000027300424,0.8999495,0.00001747816,0.09346649,0.00044447213],"about_ca_topic_score_codex":0.0000049686087,"about_ca_topic_score_gemma":4.4627794e-7,"teacher_disagreement_score":0.08695041,"about_ca_system_score_codex":0.00011836107,"about_ca_system_score_gemma":0.00012474184,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2520490671","doi":"10.5005/jp-journals-10036-1067","title":"In Silico-based Study of Cytochrome P450 and Multidrug Resistance Protein 1 from Docking Perspective to Understand Kidney Failure","year":2015,"lang":"en","type":"article","venue":"MGM Journal of Medical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docking (animal); Multiple drug resistance; In silico; Computational biology; Cytochrome P450; Perspective (graphical); Computer science; Chemistry; Biology; Drug resistance; Medicine; Biochemistry; Genetics; Artificial intelligence; Veterinary medicine; Enzyme; Gene","score_opus":0.19732961380148267,"score_gpt":0.4854054561425204,"score_spread":0.2880758423410377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520490671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97868013,0.0014411588,0.00016086742,0.018709319,0.00032568647,0.00035778122,0.00001714928,0.000004531286,0.00030338072],"genre_scores_gemma":[0.99758404,0.000039802555,0.00076653477,0.0013528676,0.00022484695,0.0000050967956,2.163104e-7,0.0000058547944,0.0000207135],"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","domain_scores_codex":[0.99695444,0.0007076823,0.00054212456,0.0002565453,0.0012494576,0.00028977593],"domain_scores_gemma":[0.99803686,0.00036306912,0.0002971226,0.00008018429,0.00018871675,0.0010340541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045840987,0.0001429712,0.00038336994,0.0002492493,0.000119361895,0.00002982575,0.00059229357,0.00013545355,0.00030540687],"category_scores_gemma":[0.0015152595,0.00010590925,0.00004276925,0.00052039674,0.00042996655,0.00015782384,0.00010693726,0.00065240153,0.0000022943832],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008046591,0.014247572,0.09780361,0.00023346921,0.0010287577,0.0037978108,0.26157212,0.017336633,0.55062884,0.007454435,0.025315823,0.012534325],"study_design_scores_gemma":[0.107479,0.01049473,0.07266173,0.0022493922,0.0010566325,0.00015650186,0.38791856,0.030006338,0.21546479,0.045463104,0.12451954,0.002529685],"about_ca_topic_score_codex":0.00023791369,"about_ca_topic_score_gemma":0.000590046,"teacher_disagreement_score":0.33516407,"about_ca_system_score_codex":0.0000983807,"about_ca_system_score_gemma":0.00087456306,"threshold_uncertainty_score":0.43188536},"labels":[],"label_agreement":null},{"id":"W2522860656","doi":"10.1038/gim.2016.141","title":"Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study","year":2016,"lang":"en","type":"article","venue":"Genetics in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Center for Advancing Translational Sciences; National Human Genome Research Institute; Brigham and Women's Hospital; National Cancer Institute; National Institutes of Health; University of Minnesota; Stichting Jo Kolk Studiefonds; School of Public Health, University of Michigan; McMaster University; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Pharmacogenomics; Medicine; Medical prescription; Confidence interval; Odds ratio; Adverse effect; Genetic testing; Prescription drug; Pharmacy; Family medicine; Health care; Personal genomics; Internal medicine; Pharmacology; Genomics","score_opus":0.1515590852857511,"score_gpt":0.4378002259921142,"score_spread":0.2862411407063631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522860656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804003,0.007006724,0.000105930405,0.0018417507,0.0015196534,0.0009494328,0.00018322079,0.000027056867,0.0003261763],"genre_scores_gemma":[0.99646413,0.0012672535,0.00024203754,0.0007925068,0.0009471309,0.00009041921,0.00002278551,0.000041320305,0.00013239533],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974662,0.0005383846,0.00056632963,0.00050599856,0.00041388342,0.00050921895],"domain_scores_gemma":[0.9979165,0.0011781179,0.0002059164,0.00028327643,0.00012603712,0.00029013623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001997536,0.00032007962,0.0004974768,0.00021687886,0.00017351763,0.0000097041975,0.0005255163,0.00018718571,0.0006599685],"category_scores_gemma":[0.00056486536,0.00019209895,0.00011271098,0.00035799557,0.00026459334,0.000035195833,0.0001738003,0.00039519474,0.000040150415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017291338,0.00019837421,0.35040906,0.0000056743847,0.00029467617,0.000009271357,0.012668766,0.000085538224,0.6014786,0.0000019075062,0.0013492155,0.033326007],"study_design_scores_gemma":[0.006661494,0.0008044758,0.9481675,0.000101240825,0.00075078785,0.0000076001925,0.0015014973,0.0038396176,0.025643183,0.000188225,0.011936601,0.0003977841],"about_ca_topic_score_codex":0.00047567888,"about_ca_topic_score_gemma":0.00013141551,"teacher_disagreement_score":0.5977584,"about_ca_system_score_codex":0.00020569343,"about_ca_system_score_gemma":0.00018831137,"threshold_uncertainty_score":0.7833568},"labels":[],"label_agreement":null},{"id":"W2522936975","doi":"10.9778/cmajo.20150070","title":"Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study","year":2016,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clinical decision support system; Medicine; Genotyping; Decision support system; Pharmacy; Pharmacogenetics; Pharmacist; Personalized medicine; Clinical pharmacy; Family medicine; Genotype; Bioinformatics; Data mining; Genetics","score_opus":0.21223345675622216,"score_gpt":0.5097739643622945,"score_spread":0.2975405076060723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522936975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852426,0.0007845868,0.0011101903,0.0005322821,0.002064267,0.0033361595,0.000056991696,0.0001201263,0.0067528146],"genre_scores_gemma":[0.98496693,0.00021711238,0.010320955,0.0028867044,0.00082026393,0.0002387116,0.000018167133,0.000078066354,0.0004530595],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9949479,0.0014103353,0.0011065134,0.0013438886,0.00043188626,0.0007594673],"domain_scores_gemma":[0.9959899,0.0016157841,0.00035668205,0.00085486134,0.0004847175,0.00069806055],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004306118,0.00046852388,0.0007959531,0.00012970655,0.00052470097,0.0001205946,0.0015726036,0.00023724789,0.0014755842],"category_scores_gemma":[0.0005181438,0.00030787892,0.00012865673,0.0004813001,0.0003600919,0.00033225204,0.0014936125,0.0007514807,0.0004207217],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017312855,0.0011398968,0.42079142,0.00003402525,0.0001919371,0.00010758536,0.00095738965,0.0000657389,0.0330416,0.0000062943786,0.0018433613,0.5400895],"study_design_scores_gemma":[0.061164796,0.0047071096,0.52103823,0.00022595642,0.0024897722,0.00016583157,0.0011123022,0.00046430025,0.06566163,0.0011323817,0.33943507,0.0024026139],"about_ca_topic_score_codex":0.00010288392,"about_ca_topic_score_gemma":0.000104508705,"teacher_disagreement_score":0.5376869,"about_ca_system_score_codex":0.00021540995,"about_ca_system_score_gemma":0.0007628279,"threshold_uncertainty_score":0.99993736},"labels":[],"label_agreement":null},{"id":"W2523790029","doi":"10.1136/bmj.i5309","title":"Revisiting the drug interaction between tamoxifen and SSRI antidepressants","year":2016,"lang":"en","type":"letter","venue":"BMJ","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Tamoxifen; CYP2D6; Breast cancer; Drug; Medicine; Harm; Pharmacology; Antidepressant; Attribution; Psychology; Psychiatry; Cancer; Internal medicine; Cytochrome P450; Anxiety; Social psychology","score_opus":0.13934483813948334,"score_gpt":0.4614536018219248,"score_spread":0.32210876368244146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523790029","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019442294,0.004596626,0.00004609435,0.9468317,0.004881803,0.0009796261,0.0004915838,0.00010508237,0.022625195],"genre_scores_gemma":[0.115513854,0.0042989124,0.00007392893,0.7632965,0.10348332,0.00016450566,0.00018548087,0.00013659977,0.012846909],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99645555,0.0013272695,0.00064784073,0.0005735631,0.0002990325,0.0006967199],"domain_scores_gemma":[0.9971208,0.0016351825,0.0005588181,0.0004327702,0.00010771667,0.00014469613],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017962885,0.00045158737,0.0005551343,0.00013506145,0.00041668816,0.00008371907,0.0005646062,0.00079088425,0.0008406786],"category_scores_gemma":[0.00014664292,0.00029448787,0.00017430421,0.0001089724,0.00025829705,0.00012590195,0.00035323322,0.003397787,0.0003429601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028177768,0.000004537521,0.0032446093,0.000097181626,0.00031735594,0.00011214808,0.00018990795,0.0000026104879,0.0017122421,0.000010775608,0.86096656,0.13331388],"study_design_scores_gemma":[0.0007257677,0.000006657529,0.0010989559,0.000119912336,0.00059979165,0.000056803052,0.0000143111765,0.00007348202,0.0058090244,0.00048240373,0.99059963,0.0004132741],"about_ca_topic_score_codex":0.000021931308,"about_ca_topic_score_gemma":5.696334e-7,"teacher_disagreement_score":0.1835352,"about_ca_system_score_codex":0.000036786874,"about_ca_system_score_gemma":0.000069749956,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W2524956930","doi":"10.1021/acscatal.6b02154","title":"Evolution of P450 Monooxygenases toward Formation of Transient Channels and Exclusion of Nonproductive Gases","year":2016,"lang":"en","type":"article","venue":"ACS Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"Natural Sciences and Engineering Research Council of Canada; Compute Canada","keywords":"Bacillus megaterium; Monooxygenase; Chemistry; Molecular dynamics; Ligand (biochemistry); Protein dynamics; Allosteric regulation; Biophysics; Enzyme; Cytochrome P450; Biology; Biochemistry; Computational chemistry; Genetics; Bacteria","score_opus":0.07094586892274068,"score_gpt":0.3664268244716949,"score_spread":0.2954809555489542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524956930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241215,0.003762841,0.0026261616,0.00029474162,0.00025656103,0.00023447376,0.00026689994,0.000010639184,0.00013555789],"genre_scores_gemma":[0.9971502,0.0025255375,0.00011704709,0.000030041343,0.000076269855,0.000017262331,0.000025520927,0.000009596138,0.00004854317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988061,0.0001595068,0.00047819992,0.0002043118,0.00017502336,0.00017686147],"domain_scores_gemma":[0.99895924,0.00016301406,0.00035108475,0.00017626023,0.00026496782,0.00008544627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044387547,0.0001376084,0.00035593,0.000219076,0.000052770683,0.0000017692746,0.00013727837,0.00011177314,0.00007627294],"category_scores_gemma":[0.000089022185,0.00010226099,0.00010670169,0.00026876264,0.00024308516,0.00018461373,0.00007438285,0.0000740109,0.000003227792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027129325,0.0002507322,0.00086306385,0.00014059054,0.00014333718,8.0154996e-7,0.0022606559,0.00032082127,0.9622563,0.0002068747,0.00016394835,0.033121563],"study_design_scores_gemma":[0.0011067669,0.00009962474,0.0046184827,0.000030969335,0.0005006035,0.0000045449024,0.0002725485,0.00052117143,0.99073404,0.0004864558,0.0015131108,0.00011167674],"about_ca_topic_score_codex":0.000061333485,"about_ca_topic_score_gemma":0.0000049494342,"teacher_disagreement_score":0.033009887,"about_ca_system_score_codex":0.000030949428,"about_ca_system_score_gemma":0.000040294843,"threshold_uncertainty_score":0.4170082},"labels":[],"label_agreement":null},{"id":"W2527567516","doi":"10.1097/mol.0000000000000351","title":"Pharmacogenomic approaches to lipid-regulating trials","year":2016,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Medicine; Clinical trial; Drug development; Drug; Bioinformatics; Pharmacogenetics; Population; Intensive care medicine; Repurposing; Drug response; Pharmacology; Internal medicine; Biology; Gene; Genetics; Genotype","score_opus":0.82353938007887,"score_gpt":0.5939195800335803,"score_spread":0.2296198000452897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527567516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013641291,0.7812279,0.00020156722,0.00035356832,0.21388844,0.0028756007,0.0006337727,0.00011186316,0.0006936748],"genre_scores_gemma":[0.000012958477,0.9228806,0.00019235135,0.00021107533,0.07438033,0.0015982807,0.00030357068,0.00016931929,0.00025150753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9838481,0.009037484,0.003576612,0.0016259344,0.00030748537,0.0016043786],"domain_scores_gemma":[0.9925151,0.004372237,0.0015176339,0.000682451,0.00007509302,0.0008375102],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.007771404,0.0013168724,0.0053690136,0.0014805656,0.00022705605,0.00004825842,0.0014624409,0.0014011423,0.0024832548],"category_scores_gemma":[0.0010600697,0.0010250625,0.0012719567,0.0008657698,0.00028707137,0.00011674227,0.0007901663,0.0023911598,0.0025245366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011658979,0.00032549902,0.000028224802,0.0067515117,0.00035632006,3.1155523e-7,0.00020028675,0.000043916254,0.00005987401,0.0017110063,0.057874057,0.9325324],"study_design_scores_gemma":[0.0023259693,0.00006130822,0.0000041372396,0.0043210057,0.0007193223,0.00004525354,0.000009453793,0.000077398036,0.000024202229,0.00024560848,0.99107724,0.001089072],"about_ca_topic_score_codex":0.0000030372114,"about_ca_topic_score_gemma":8.7457397e-7,"teacher_disagreement_score":0.9332032,"about_ca_system_score_codex":0.00034078222,"about_ca_system_score_gemma":0.0006988276,"threshold_uncertainty_score":0.9999583},"labels":[],"label_agreement":null},{"id":"W2533187150","doi":"10.1007/s12630-016-0748-1","title":"Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Anesthesia/Journal canadien d anesthésie","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Pharmacogenetics; Medicine; Pharmacogenomics; Pharmacology; Bioinformatics; Biology; Genotype","score_opus":0.10765718170267914,"score_gpt":0.40976121450300707,"score_spread":0.30210403280032794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533187150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009221672,0.9893435,0.000019785159,0.004154306,0.0029798916,0.0019943516,0.00043853966,0.000010528254,0.0001369327],"genre_scores_gemma":[0.0005170397,0.99268055,0.00009786966,0.002604679,0.0033122858,0.00009387526,0.000033541735,0.00021447267,0.00044569527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936227,0.0013722667,0.0023642036,0.0005496946,0.00044434832,0.0016467781],"domain_scores_gemma":[0.98677444,0.0015274255,0.002877378,0.0003985684,0.0043127565,0.0041094306],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0032494476,0.0012260394,0.003063632,0.00093921,0.0017204542,0.00022878229,0.0020494172,0.0007717521,0.000582373],"category_scores_gemma":[0.00067319284,0.00078765966,0.0015048438,0.0005868854,0.0009273183,0.00023201424,0.000057288642,0.0032533314,0.000027725464],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001176452,0.000018077402,0.00001735784,0.0071797986,0.0020274736,0.0597555,0.0038663885,0.000019466674,0.0000067338965,0.000100548314,0.030655526,0.89623547],"study_design_scores_gemma":[0.0010822947,0.00021343931,0.0000015610535,0.0063298745,0.0061420216,0.3966822,0.0010185157,0.0000064362894,0.000013261596,0.000052210864,0.5879144,0.0005437868],"about_ca_topic_score_codex":0.00018017911,"about_ca_topic_score_gemma":0.0005276864,"teacher_disagreement_score":0.8956917,"about_ca_system_score_codex":0.00079985464,"about_ca_system_score_gemma":0.012487808,"threshold_uncertainty_score":0.9995792},"labels":[],"label_agreement":null},{"id":"W2535322980","doi":"10.2217/pgs-2016-0092","title":"Addressing Ethical Challenges at the Intersection of Pharmacogenomics and Primary Care Using Deliberative Consultations","year":2016,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; McGill University","funders":"Canadian Institutes of Health Research; Public Health Agency of Canada; Genome Canada; McGill University; Genomic Health","keywords":"Pharmacogenomics; Intersection (aeronautics); Primary care; Medicine; Psychology; Pharmacology; Family medicine; Geography","score_opus":0.3131163019317046,"score_gpt":0.4709055873271369,"score_spread":0.1577892853954323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535322980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604211,0.030274697,0.0006677998,0.0018160286,0.0016277531,0.0007093895,0.0007128669,0.00006300156,0.0037073847],"genre_scores_gemma":[0.9756734,0.02012253,0.00074253336,0.002662017,0.00048993994,0.00005533392,0.000032086875,0.00007092617,0.00015126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99704236,0.00089092884,0.0007022864,0.000563512,0.0002403438,0.0005605814],"domain_scores_gemma":[0.99736387,0.0012264752,0.0004325415,0.0002503199,0.00039535778,0.00033142004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009804063,0.0004104433,0.00046072088,0.00013276494,0.0006885024,0.000026481144,0.0003715286,0.00038770871,0.00045863475],"category_scores_gemma":[0.00008266381,0.00028828334,0.00017625306,0.00017789402,0.000985387,0.0001550702,0.00045554302,0.00087879243,0.000031859003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006320466,0.000080768696,0.0004348561,0.00013614423,0.0003834558,0.000009964601,0.0060108295,0.00048490305,0.82493466,0.00075703824,0.00025919158,0.16587614],"study_design_scores_gemma":[0.006372526,0.00007273407,0.000649467,0.00007927499,0.0012275933,0.0001715761,0.0013403074,0.0038122614,0.8883497,0.0006875274,0.09660892,0.0006280988],"about_ca_topic_score_codex":0.000016169879,"about_ca_topic_score_gemma":0.000024067254,"teacher_disagreement_score":0.16524804,"about_ca_system_score_codex":0.0004502901,"about_ca_system_score_gemma":0.00027839336,"threshold_uncertainty_score":0.9999569},"labels":[],"label_agreement":null},{"id":"W2535554156","doi":"10.1038/tpj.2016.77","title":"The global spectrum of protein-coding pharmacogenomic diversity","year":2016,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenomics; Biology; Genetics; Genetic variation; Minor allele frequency; 1000 Genomes Project; Genetic diversity; Allele frequency; Evolutionary biology; Genome; Population; Allele; Computational biology; Gene; Single-nucleotide polymorphism; Genotype; Medicine","score_opus":0.1007823355141766,"score_gpt":0.3989009761193356,"score_spread":0.298118640605159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535554156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96793157,0.008909624,0.0014358384,0.012104533,0.004791256,0.00081676006,0.00034038306,0.000060526876,0.0036095304],"genre_scores_gemma":[0.9819915,0.01418679,0.00006637139,0.0012034215,0.0017411631,0.000022088638,0.0000013772657,0.000043512453,0.00074372446],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99585605,0.0011538584,0.0009578376,0.00037036886,0.0005078008,0.0011540832],"domain_scores_gemma":[0.99720407,0.00068142166,0.00087126094,0.00041132967,0.00023612953,0.0005958133],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041010096,0.00045097858,0.00042979207,0.00009413253,0.0032969376,0.00008630775,0.0024039508,0.00016213077,0.0010829783],"category_scores_gemma":[0.00010472152,0.00022969673,0.00048394187,0.00035441047,0.00093415694,0.00021308287,0.0012330661,0.0010868548,0.00021959399],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00187451,0.00023718073,0.0071329004,0.000018618613,0.0013388403,0.00008083983,0.0004905512,0.00023863031,0.820387,0.0076384,0.0037057912,0.15685672],"study_design_scores_gemma":[0.0068904147,0.00010274708,0.0010519589,0.000029961511,0.0009439385,0.0008279729,0.00012989792,0.0008582199,0.47526932,0.023546332,0.4897841,0.0005651513],"about_ca_topic_score_codex":0.000017670076,"about_ca_topic_score_gemma":0.000008575567,"teacher_disagreement_score":0.4860783,"about_ca_system_score_codex":0.00045529695,"about_ca_system_score_gemma":0.00031486305,"threshold_uncertainty_score":0.9998302},"labels":[],"label_agreement":null},{"id":"W2537847509","doi":"10.1182/blood.v118.21.4335.4335","title":"Study of Octaplex Dosing Accuracy: An In Vitro Analysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University; London Health Sciences Centre; McMaster University","funders":"","keywords":"Dosing; Warfarin; Medicine; Internal medicine; Gastroenterology; Factor IX; Prothrombin complex concentrate; Prothrombin time; Factor VII; Surgery; Coagulation; Atrial fibrillation","score_opus":0.20142735202482526,"score_gpt":0.4445880529881058,"score_spread":0.24316070096328052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537847509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542594,0.000524759,0.00001341264,0.000009963285,0.00025067784,0.0003428232,0.00003597936,0.000033109318,0.0033633125],"genre_scores_gemma":[0.9991222,0.00008648703,0.00040112203,0.00021225761,0.00008855408,0.0000330607,0.000013349023,0.000017322418,0.00002563676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981255,0.0005853459,0.0004721865,0.00032507963,0.00014724939,0.00034466066],"domain_scores_gemma":[0.999133,0.00012144122,0.00018545816,0.00030553224,0.00006811233,0.00018646833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070749596,0.00018123849,0.00042718937,0.0004414226,0.000077766395,0.000008020866,0.00036502865,0.00014025935,0.00058047933],"category_scores_gemma":[0.000041727013,0.00017734755,0.00011451355,0.0008970786,0.000062061044,0.00010918946,0.000098007506,0.0003725836,0.000013794919],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006386777,0.021031525,0.26083523,0.000018244515,0.0024188433,0.00016840543,0.02390453,0.00030646106,0.6787764,0.000080897786,0.000016316051,0.011804522],"study_design_scores_gemma":[0.00804562,0.00025911437,0.12424472,0.0000021509939,0.0053970786,0.00000600067,0.0018058468,0.0012576686,0.8577346,0.00023634099,0.0007025293,0.0003083228],"about_ca_topic_score_codex":0.0002707947,"about_ca_topic_score_gemma":0.00011441538,"teacher_disagreement_score":0.17895825,"about_ca_system_score_codex":0.000008194368,"about_ca_system_score_gemma":0.000046583275,"threshold_uncertainty_score":0.72320235},"labels":[],"label_agreement":null},{"id":"W2548208806","doi":"10.1124/jpet.116.237594","title":"Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; U.S. National Library of Medicine; National Institute of General Medical Sciences; National Institute on Drug Abuse","keywords":"CYP2A6; Cotinine; Nicotine; Biology; Genotype; Cytochrome P450; Reductase; Messenger RNA; Phenotype; Endocrinology; Internal medicine; Genetics; Enzyme; Metabolism; Gene; Biochemistry; Medicine; CYP1A2","score_opus":0.05215489596841646,"score_gpt":0.38604787466293217,"score_spread":0.33389297869451573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548208806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877111,0.011432224,0.000020415275,0.00012483961,0.00027956755,0.00037863926,0.000023105013,0.0000039443826,0.000026167043],"genre_scores_gemma":[0.9946457,0.0048883082,0.00012909129,0.00021068606,0.000081002036,0.000013447676,3.097528e-7,0.00001645923,0.0000150098485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808544,0.0005637223,0.0007006236,0.00021581516,0.00015741088,0.00027700438],"domain_scores_gemma":[0.99889,0.00025704663,0.0005539726,0.00006867191,0.0000903973,0.0001399473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005972845,0.00023098735,0.00047967982,0.00032327246,0.000061945946,0.0000058308137,0.0001591988,0.0002507506,0.00010345013],"category_scores_gemma":[0.000013170577,0.00017864462,0.000052801082,0.00014239328,0.0005308316,0.00018255413,0.00010458369,0.00039487937,2.7897767e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007721063,0.00056963175,0.115425535,0.0000516531,0.00021025688,0.000022110773,0.0025730648,0.00015521357,0.8775884,0.000044864268,0.000006279568,0.0025808685],"study_design_scores_gemma":[0.004298078,0.0004860568,0.27580833,0.000034838595,0.00015226669,0.00002863382,0.00006344506,0.00025836102,0.7182193,0.0001308054,0.00038917366,0.00013075357],"about_ca_topic_score_codex":0.00002816015,"about_ca_topic_score_gemma":0.0000056731137,"teacher_disagreement_score":0.16038279,"about_ca_system_score_codex":0.00005459944,"about_ca_system_score_gemma":0.000082607985,"threshold_uncertainty_score":0.72849166},"labels":[],"label_agreement":null},{"id":"W2549035745","doi":"10.18433/j31s53","title":"Substrate Specificity of Human Cytochrome P450 (CYP) 2C Subfamily and Effect of Azole Antifungal Agents on CYP2C8","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ryobi Teien Memory Foundation","keywords":"Ketoconazole; CYP2C8; Azole; CYP2C9; Tolbutamide; Miconazole; Chemistry; Cytochrome P450; Pharmacology; Itraconazole; CYP3A4; CYP2C19; Biochemistry; Metabolism; Biology; Endocrinology; Antifungal; Microbiology","score_opus":0.18777868892371355,"score_gpt":0.4969228298296273,"score_spread":0.3091441409059138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549035745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908156,0.0032520902,0.00003373751,0.00073266716,0.0013104227,0.00046150322,0.00013213574,0.000024127878,0.0032377304],"genre_scores_gemma":[0.993542,0.005057623,0.000089530986,0.00057130033,0.00060110417,0.0000071707705,0.000001384052,0.0000314374,0.00009844975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945277,0.001233585,0.0016463121,0.00054388726,0.0011541764,0.00089436467],"domain_scores_gemma":[0.99580485,0.0014998877,0.0012046753,0.00021069334,0.00036207464,0.00091784867],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005494525,0.0005273653,0.0011054492,0.00053288037,0.00037734167,0.00004336452,0.0011081927,0.00018157926,0.0021654095],"category_scores_gemma":[0.0002001263,0.0003350605,0.0004253302,0.0006893191,0.0023405117,0.00047660698,0.00022736774,0.0009643725,0.000032711672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017597234,0.0006347223,0.077844955,0.00015741443,0.00027609878,0.00010080451,0.00017453992,0.000094759045,0.8836297,0.00060108525,0.00083090947,0.03389531],"study_design_scores_gemma":[0.00916339,0.0013858038,0.03639265,0.00012941707,0.0006182817,0.0001169017,0.00004000282,0.0008525127,0.92013985,0.00026227278,0.03052612,0.00037281483],"about_ca_topic_score_codex":0.000015218364,"about_ca_topic_score_gemma":0.0000014160187,"teacher_disagreement_score":0.0414523,"about_ca_system_score_codex":0.000072114184,"about_ca_system_score_gemma":0.00020350156,"threshold_uncertainty_score":0.9999101},"labels":[],"label_agreement":null},{"id":"W2557663861","doi":"10.1002/cbic.201600546","title":"Active Site Crowding of Cytochrome P450 3A4 as a Strategy To Alter Its Selectivity","year":2016,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Steric effects; Chemistry; Active site; Selectivity; Hydroxylation; Cytochrome P450; Stereochemistry; Stereoselectivity; Substrate (aquarium); Protein engineering; Combinatorial chemistry; Rational design; Steroid; Enzyme; Biochemistry; Catalysis; Biology; Hormone","score_opus":0.10403937678240176,"score_gpt":0.4469718959792338,"score_spread":0.34293251919683204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557663861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829295,0.00053392164,0.00011783375,0.0005642946,0.000316147,0.00045191092,0.00019427126,0.00006833713,0.014823768],"genre_scores_gemma":[0.9952803,0.0001884542,0.00007988098,0.0012152394,0.00038352192,0.00007130391,0.0000077608,0.000040185787,0.0027333193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981356,0.00017091725,0.0003521441,0.000512003,0.00021102624,0.00061830477],"domain_scores_gemma":[0.99858975,0.00026722025,0.00017193533,0.00025906958,0.00025064073,0.0004613871],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044505246,0.0003082265,0.00041214385,0.00014041681,0.00012356916,0.000014464072,0.00033932272,0.00029819488,0.0020452165],"category_scores_gemma":[0.00017228788,0.00025064874,0.00015032344,0.0003581096,0.00012480661,0.00013530307,0.00019395254,0.000350918,0.0007204091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004436031,0.00025450217,0.00025623324,0.000043266264,0.0001849614,0.000015370493,0.0005787446,0.000020709947,0.9679926,0.0004222059,0.0017855656,0.028002247],"study_design_scores_gemma":[0.0017676306,0.00015977907,0.0027617437,0.000027510847,0.000118793774,0.000018391393,0.000030577983,0.00006957555,0.96818006,0.0003664929,0.026166752,0.000332705],"about_ca_topic_score_codex":0.000009793531,"about_ca_topic_score_gemma":0.0000035706491,"teacher_disagreement_score":0.027669543,"about_ca_system_score_codex":0.00009124482,"about_ca_system_score_gemma":0.00016720325,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W2560643933","doi":"10.1016/j.jchromb.2016.12.006","title":"Highly sensitive LC–MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human","year":2016,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Chemistry; Chlorzoxazone; Chromatography; Tolbutamide; Ammonium formate; Formic acid; Paraxanthine; Dextromethorphan; CYP1A2; Tandem mass spectrometry; Dextrorphan; Mass spectrometry; Pharmacology; Cytochrome P450; Metabolism; Insulin; Biochemistry; CYP2E1","score_opus":0.11888473025561992,"score_gpt":0.4681582879903784,"score_spread":0.3492735577347585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560643933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97988224,0.007085519,0.011893934,0.00009499788,0.00043147613,0.00045679856,0.000044261495,0.000008407226,0.0001023898],"genre_scores_gemma":[0.9827548,0.0026610582,0.01428375,0.000060650218,0.0001831414,0.000014526881,0.0000011462713,0.000026808793,0.000014084976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745554,0.0009882331,0.00093368423,0.0001540969,0.00017004496,0.0002983917],"domain_scores_gemma":[0.99686354,0.0013196729,0.0012876478,0.00013954651,0.0002911997,0.000098396646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023730653,0.0002218783,0.0006876866,0.0006094094,0.0001692718,0.000012722067,0.00031513805,0.00018130924,0.000030857052],"category_scores_gemma":[0.000056716726,0.0001386005,0.00047914367,0.00033941594,0.0004033174,0.00017679938,0.000061807645,0.00030576976,1.5513245e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022862137,0.00029408254,0.001822056,0.00017500797,0.0003785409,0.000005951607,0.0019708613,0.000036104353,0.9039455,0.00051826966,0.00001934196,0.09060563],"study_design_scores_gemma":[0.0035702349,0.0002988642,0.004809474,0.00027263683,0.0009096732,0.00007347052,0.00041029393,0.00050255103,0.9786363,0.0030950748,0.0072024786,0.00021893179],"about_ca_topic_score_codex":0.00002203784,"about_ca_topic_score_gemma":0.000012546563,"teacher_disagreement_score":0.090386696,"about_ca_system_score_codex":0.000035694193,"about_ca_system_score_gemma":0.000102097605,"threshold_uncertainty_score":0.56519645},"labels":[],"label_agreement":null},{"id":"W2561831579","doi":"10.1002/cpt.597","title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":678,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institute of General Medical Sciences; National Institute of Mental Health; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Dosing; Pharmacogenetics; Guideline; CYP2C19; CYP2D6; Tricyclic; Medicine; Pharmacology; Internal medicine; Genotype; Biology; Genetics","score_opus":0.19379102528921807,"score_gpt":0.5511572408294994,"score_spread":0.35736621554028125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561831579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95039356,0.021630809,0.0057778494,0.011696309,0.006960765,0.0020856427,0.0011621672,0.0001313431,0.00016152966],"genre_scores_gemma":[0.7508969,0.16289638,0.0047330833,0.07867754,0.0022687465,0.00013524131,0.000059106806,0.00013102997,0.00020199447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921231,0.0019953689,0.003418731,0.0011568929,0.00027197477,0.0010339168],"domain_scores_gemma":[0.9922064,0.004767883,0.0013010392,0.000384808,0.0006040597,0.00073583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047805626,0.0006450521,0.0013641411,0.00021482678,0.00036292148,0.000030816707,0.0005761834,0.0008013642,0.0006058803],"category_scores_gemma":[0.0001165436,0.00050495676,0.00042076097,0.00025200113,0.0022033362,0.00020389135,0.0004179172,0.0008344682,0.000029359866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027301472,0.0009459031,0.09348923,0.00009274479,0.0024832992,0.000016141246,0.00012764275,0.000014885334,0.35957816,0.00013791256,0.045653667,0.49473026],"study_design_scores_gemma":[0.025069758,0.00070628943,0.00983905,0.00002887297,0.0053841136,0.00003338652,0.000066931716,0.0014196996,0.15759946,0.0012571317,0.7978602,0.00073510606],"about_ca_topic_score_codex":0.0000069693447,"about_ca_topic_score_gemma":0.0000050902695,"teacher_disagreement_score":0.7522065,"about_ca_system_score_codex":0.00003381041,"about_ca_system_score_gemma":0.00031426142,"threshold_uncertainty_score":0.9997402},"labels":[],"label_agreement":null},{"id":"W2562914031","doi":"10.4088/jcp.15r10583","title":"Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder?","year":2017,"lang":"en","type":"review","venue":"The Journal of Clinical Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Toronto","funders":"","keywords":"Major depressive disorder; Pharmacogenomics; Psychology; Psychiatry; Medicine; Clinical psychology; Pharmacology; Mood","score_opus":0.45904534040828676,"score_gpt":0.622301210369262,"score_spread":0.16325586996097524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562914031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017770195,0.9134443,0.00016139234,0.0015096941,0.080066636,0.0019465997,0.000558583,0.00003331828,0.00050250103],"genre_scores_gemma":[0.00034924733,0.97449034,0.0018755175,0.0025234912,0.01946964,0.00006881824,0.000015306548,0.00017650683,0.0010311069],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9851746,0.0048074983,0.007983019,0.0006735661,0.00044404948,0.0009172477],"domain_scores_gemma":[0.96256745,0.022253247,0.0127511285,0.001053548,0.0004814747,0.00089314603],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.019679297,0.0009947466,0.005898559,0.00020232669,0.0009982107,0.000099337136,0.0039255223,0.0016276271,0.00017929892],"category_scores_gemma":[0.0062016128,0.00045634838,0.0054309466,0.000151943,0.00094087253,0.00017386643,0.0005031709,0.006905265,0.00010341295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007691372,0.001021891,0.01618218,0.0019253107,0.005198991,0.000017283099,0.000023351202,0.000006769093,0.0000028877223,0.000037279347,0.010198047,0.9646169],"study_design_scores_gemma":[0.007551341,0.0004044712,0.00083867,0.0010143672,0.024652664,0.0000861849,0.00002024096,0.0000821392,0.0000030174642,0.0022501845,0.96246386,0.00063288567],"about_ca_topic_score_codex":0.00000779902,"about_ca_topic_score_gemma":0.000010625619,"teacher_disagreement_score":0.963984,"about_ca_system_score_codex":0.0000374001,"about_ca_system_score_gemma":0.0024816035,"threshold_uncertainty_score":0.9997888},"labels":[],"label_agreement":null},{"id":"W2564304028","doi":"10.18433/j3d313","title":"Can the CEIBA Cocktail Designed for Human Cytochrome P450 Enzymes be Used in the Rat for Drug Interaction Studies?","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fundação para a Ciência e a Tecnologia; Ministerio de Economía y Competitividad","keywords":"Pharmacology; Dextrorphan; Paraxanthine; Pharmacokinetics; Dextromethorphan; Drug; Chemistry; Metabolite; CYP1A2; Cmax; Cytochrome P450; CYP3A4; Active metabolite; CYP2C19; CYP2C9; Medicine; Enzyme; Biochemistry","score_opus":0.40705014789223,"score_gpt":0.5650177962349782,"score_spread":0.15796764834274818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564304028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88269097,0.008999539,0.00062137796,0.10158339,0.0034164106,0.0022637863,0.00013072917,0.000033137258,0.0002606526],"genre_scores_gemma":[0.981118,0.0031437043,0.00025311703,0.013173359,0.0017553223,0.00030637404,0.0000027201202,0.000032652064,0.0002147034],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.994469,0.001725872,0.0013491187,0.0004941957,0.00086775684,0.0010940795],"domain_scores_gemma":[0.98964864,0.008377669,0.0008072871,0.00020962443,0.00055346446,0.00040330118],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0121020395,0.00045879057,0.00067124027,0.0003220405,0.0018985374,0.00013536558,0.0020522464,0.000107969325,0.00036261624],"category_scores_gemma":[0.0007607779,0.00021829833,0.00050952705,0.00068445643,0.0014832808,0.0005578985,0.0002603819,0.00090964686,0.0000070115343],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016060865,0.0006794161,0.0015135456,0.00009733512,0.00042878895,0.000036856596,0.0053444216,0.00041909507,0.90518636,0.005424045,0.026360784,0.052903276],"study_design_scores_gemma":[0.008782053,0.00028322567,0.00014168936,0.000048294238,0.00063461415,0.00010498248,0.0016781122,0.0016540514,0.3952216,0.0042936876,0.5868469,0.0003108242],"about_ca_topic_score_codex":0.000014892605,"about_ca_topic_score_gemma":0.00005666787,"teacher_disagreement_score":0.5604861,"about_ca_system_score_codex":0.00020701103,"about_ca_system_score_gemma":0.00038137782,"threshold_uncertainty_score":0.99940085},"labels":[],"label_agreement":null},{"id":"W2567939023","doi":"10.1177/070674370404900115","title":"Book Review: Psychopharmacology: Pharmacogenetics of Psychotropic Drugs","year":2004,"lang":"en","type":"article","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Psychopharmacology; Pharmacogenetics; Psychotropic drug; Medicine; Psychiatry; Psychology; Pharmacology; Drug; Genetics; Biology; Genotype","score_opus":0.03770103427165227,"score_gpt":0.38996199579033164,"score_spread":0.35226096151867936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567939023","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0673284,0.8322006,0.00006713629,0.07969114,0.016262047,0.0006080818,0.00012087423,0.000015087076,0.0037066161],"genre_scores_gemma":[0.41176945,0.24605812,0.0024953873,0.3341196,0.0041628606,0.00003424894,0.000011381331,0.00013429772,0.0012146679],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681497,0.0005280433,0.0013062706,0.00024609116,0.00038190314,0.0007227468],"domain_scores_gemma":[0.9968115,0.000105570085,0.00103351,0.00038370286,0.00048759964,0.0011780824],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015605461,0.0003630134,0.00063883944,0.00036391706,0.00044627572,0.000022169792,0.0013532713,0.00026091764,0.00495673],"category_scores_gemma":[0.000051104445,0.00028037003,0.00046878483,0.00056569406,0.0006603275,0.00012576359,0.000031979733,0.001601417,0.00010268313],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032722444,0.0003061491,0.0040452844,0.00039482675,0.0009137281,0.000062776875,0.0008644218,0.0019229131,0.004307893,0.0033908833,0.97622466,0.0072392486],"study_design_scores_gemma":[0.005091787,0.00019378595,0.001238251,0.00029246527,0.0012893993,0.0003195427,0.000060913262,0.000016572605,0.0063430523,0.0073638563,0.977476,0.0003143565],"about_ca_topic_score_codex":0.00044840848,"about_ca_topic_score_gemma":0.002098624,"teacher_disagreement_score":0.5861425,"about_ca_system_score_codex":0.00013171672,"about_ca_system_score_gemma":0.0041868673,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W2571716623","doi":"10.1177/070674370304800616","title":"Reply: Methylphenidate and the Cytochrome P450 System","year":2003,"lang":"en","type":"article","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Methylphenidate; Psychiatry; Psychology; Medicine; Attention deficit hyperactivity disorder","score_opus":0.05135224694632641,"score_gpt":0.3607866922528942,"score_spread":0.30943444530656783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571716623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7451373,0.10396275,0.00017331686,0.08787946,0.017473448,0.0008836419,0.00009734341,0.000028138806,0.044364627],"genre_scores_gemma":[0.9881453,0.00035663412,0.000583176,0.0097633945,0.0007830299,0.0000069155753,5.4529255e-7,0.000022365057,0.0003386736],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974392,0.0013536663,0.0005049141,0.00013167695,0.00015899616,0.0004115328],"domain_scores_gemma":[0.9983269,0.00025214223,0.00037132486,0.00025216586,0.00014180735,0.0006556847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042593232,0.00017683404,0.00031167475,0.00012974284,0.00084361644,0.00007170417,0.00049450604,0.00012167417,0.0003285114],"category_scores_gemma":[0.00011680777,0.00009791623,0.00016078918,0.00021372116,0.0005858948,0.000060532835,0.000016464537,0.0010022492,0.00003196959],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005009194,0.000051206996,0.008426449,0.000092594804,0.0012345479,0.00012805675,0.0031080858,0.00058020366,0.0019536288,0.92687905,0.05307284,0.003972431],"study_design_scores_gemma":[0.0062047136,0.00007139439,0.004262472,0.00004295382,0.0011099121,0.002461371,0.001370771,0.000273007,0.0015612247,0.039145596,0.9432109,0.0002857036],"about_ca_topic_score_codex":0.0012627315,"about_ca_topic_score_gemma":0.008516029,"teacher_disagreement_score":0.89013803,"about_ca_system_score_codex":0.000061341045,"about_ca_system_score_gemma":0.0016290717,"threshold_uncertainty_score":0.6488501},"labels":[],"label_agreement":null},{"id":"W2572886822","doi":"10.2217/pme-2016-0083","title":"Highly Personalized Reports for Personalized Drug Selection by Expert Systems as Clinical Decision Support","year":2017,"lang":"en","type":"editorial","venue":"Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optina Diagnostics (Canada)","funders":"","keywords":"Pharmacogenomics; Medicine; MEDLINE; Personalized medicine; Pharmacogenetics; Family medicine; Pharmacology; Bioinformatics; Political science; Genotype","score_opus":0.09652853675061328,"score_gpt":0.502140253848471,"score_spread":0.40561171709785776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572886822","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019287826,0.080594786,0.0011351911,0.0030300228,0.9017233,0.003999414,0.0020435029,0.0004301163,0.005114849],"genre_scores_gemma":[0.0012048783,0.052674558,0.00063555187,0.0034116465,0.7368208,0.0018703565,0.007004572,0.00047786476,0.19589974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98624367,0.0020203642,0.0036323504,0.0030187701,0.0030934392,0.0019914396],"domain_scores_gemma":[0.98287886,0.008041136,0.003583456,0.0012333487,0.0022464674,0.0020167273],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.01278222,0.0019193576,0.004431755,0.0005430497,0.0017450238,0.0002148002,0.0015837881,0.0042407014,0.0069798534],"category_scores_gemma":[0.010569473,0.0016598734,0.0015446601,0.00031880834,0.0026566861,0.00029041787,0.00028656193,0.004487167,0.00023202259],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008195671,0.000678634,0.00010381687,0.00051024184,0.0019067301,0.00039483712,0.0021486902,0.000005174787,0.0055384454,0.00027604858,0.96934307,0.010898635],"study_design_scores_gemma":[0.028034294,0.00082501123,0.0000045036404,0.0005591726,0.0034252305,0.00026411552,0.00043510157,0.0008996187,0.0005413619,0.00037962096,0.9630399,0.0015920717],"about_ca_topic_score_codex":0.00072192657,"about_ca_topic_score_gemma":0.00002597827,"teacher_disagreement_score":0.1907849,"about_ca_system_score_codex":0.00053860416,"about_ca_system_score_gemma":0.0027345743,"threshold_uncertainty_score":0.9995546},"labels":[],"label_agreement":null},{"id":"W2573364903","doi":"10.1161/atvb.32.suppl_1.a20","title":"Abstract 20: Evidence of UGT2B7 as a Pharmacogenetic Determinant of Variability in Serum Fenofibric Acid Levels in Human Subjects","year":2012,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"UGT2B7; Fenofibrate; Pharmacogenetics; Pharmacokinetics; Internal medicine; Medicine; Genotype; Pharmacology; SNP; Area under the curve; Lipid profile; Analysis of variance; Endocrinology; Single-nucleotide polymorphism; Cholesterol; Gastroenterology; Biology; In vitro; Biochemistry; Gene","score_opus":0.20849667805414573,"score_gpt":0.4575235565975492,"score_spread":0.24902687854340344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573364903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613094,0.0024248464,0.000030805164,0.000110006935,0.0004883585,0.00054009416,0.0000799684,0.000014807329,0.00018015847],"genre_scores_gemma":[0.9933108,0.0060073384,0.00014380121,0.00034000468,0.00009053793,0.00006997891,0.000008105242,0.000027538235,0.0000019127858],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959665,0.0015462893,0.0010245937,0.00051422516,0.00015060267,0.00079777604],"domain_scores_gemma":[0.99840254,0.00052575994,0.00035625952,0.00036923523,0.00008311435,0.00026308693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004059855,0.00036394098,0.0009299418,0.00029883703,0.000095473166,0.000008986969,0.000356678,0.0004165955,0.0006802224],"category_scores_gemma":[0.00013839827,0.00034379328,0.00021039277,0.00041373158,0.00047727724,0.00019370398,0.00023782131,0.00042571974,0.000012010849],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011068297,0.00045422596,0.4290409,0.00013647524,0.00008701842,1.7344699e-7,0.00066996407,0.000011642109,0.566957,0.000100624464,0.0000048664488,0.0025260283],"study_design_scores_gemma":[0.0014497966,0.00013730284,0.72640264,0.0001042136,0.0001448312,0.000001044109,0.000045058987,0.00012357252,0.27075398,0.00016834115,0.0004248719,0.0002443645],"about_ca_topic_score_codex":0.00018586106,"about_ca_topic_score_gemma":0.0000661806,"teacher_disagreement_score":0.2973617,"about_ca_system_score_codex":0.000046267032,"about_ca_system_score_gemma":0.000083647,"threshold_uncertainty_score":0.9999014},"labels":[],"label_agreement":null},{"id":"W2580337984","doi":"10.3390/ijms18010217","title":"In Vitro Biotransformation of Two Human CYP3A Probe Substrates and Their Inhibition during Early Zebrafish Development","year":2017,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Universiteit Antwerpen","keywords":"Zebrafish; Biotransformation; CYP3A4; Cytochrome P450; Metabolite; Microsome; Drug metabolism; Biochemistry; Biology; In vitro; Chemistry; Pharmacology; Enzyme","score_opus":0.06568454856530508,"score_gpt":0.41413441973436027,"score_spread":0.3484498711690552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580337984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976963,0.00037515772,0.00026205284,0.00062255457,0.00049935246,0.00007578359,0.000007560575,0.000002318512,0.00045893728],"genre_scores_gemma":[0.9990328,0.00011834831,0.0006246743,0.0001344041,0.00007649975,0.0000022212303,0.0000012647308,0.0000035261678,0.000006287629],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902064,0.00008164103,0.00041324136,0.00009874907,0.00025785386,0.00012787245],"domain_scores_gemma":[0.99921703,0.00002492588,0.00045235816,0.00004451612,0.00019635388,0.00006479232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091689953,0.00008725872,0.0001336643,0.00024359436,0.00020260987,0.000088431705,0.00039937792,0.000046835612,0.000024344166],"category_scores_gemma":[0.000025308122,0.00007117471,0.000046344612,0.000050421673,0.00027607425,0.00047374069,0.000060376427,0.00019360926,9.729008e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073338735,0.00007868886,0.0055764215,0.000008419255,0.000050813298,0.000040369316,0.001387398,0.00018496413,0.9872802,0.0005696837,0.0000015057697,0.0047481926],"study_design_scores_gemma":[0.0013893308,0.00003058065,0.04178993,0.000034136174,0.000010098005,0.000055484845,0.000071900904,0.00017263241,0.95374596,0.0024139762,0.00021435064,0.0000716065],"about_ca_topic_score_codex":0.00001659761,"about_ca_topic_score_gemma":0.0000072612092,"teacher_disagreement_score":0.036213506,"about_ca_system_score_codex":0.000022868231,"about_ca_system_score_gemma":0.00008431316,"threshold_uncertainty_score":0.29024205},"labels":[],"label_agreement":null},{"id":"W2580818401","doi":"10.1139/cjpp-2016-0403","title":"A reappraisal of the 6-<i>O</i>-desmethylnaproxen-sulfating activity of the human cytosolic sulfotransferases","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sulfation; Cytosol; Sulfotransferase; Metabolite; In vivo; In vitro; Chemistry; Biochemistry; Kidney; Enzyme; Molecular biology; Biology; Endocrinology","score_opus":0.09516120243580925,"score_gpt":0.41715914374361557,"score_spread":0.32199794130780635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580818401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907535,0.0011106735,0.000004429414,0.0021182548,0.0039721285,0.00022685502,0.00014942854,0.000003210489,0.0016615195],"genre_scores_gemma":[0.9979933,0.00028840813,0.000023664643,0.0010136036,0.00054537575,0.000008246768,9.3757427e-7,0.000019472343,0.00010698364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99719995,0.0013193743,0.0006296973,0.00022337091,0.00012910394,0.00049851416],"domain_scores_gemma":[0.99718565,0.0004586681,0.0012791177,0.00038468253,0.00029984428,0.00039203698],"candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0010956998,0.00025207,0.0006403564,0.00013389585,0.0013615213,0.000013156706,0.0014061084,0.00033593824,0.00076618587],"category_scores_gemma":[0.00020315613,0.00016552593,0.00032081766,0.00013605344,0.002740988,0.00013387248,0.00016051422,0.0013189982,0.0000013082389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016375375,0.00010032732,0.027513951,0.00010189868,0.0003824559,0.000010891451,0.00066041376,0.00018176323,0.9661477,0.0011694594,0.0008335023,0.0027338879],"study_design_scores_gemma":[0.0019843848,0.00012047223,0.14486787,0.0000263789,0.00048373718,0.00007165026,0.00002769752,0.00006645314,0.8352068,0.0011346234,0.015868694,0.00014124245],"about_ca_topic_score_codex":0.0010881429,"about_ca_topic_score_gemma":0.0010732451,"teacher_disagreement_score":0.13094088,"about_ca_system_score_codex":0.000021887265,"about_ca_system_score_gemma":0.0009211922,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W2585183403","doi":"10.1139/cjpp-2017-0014","title":"Downregulation of cytochrome P450 2C8 by 3-methylcholanthrene in human hepatocellular carcinoma cell lines","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Cytochrome P450; Cell culture; Methylcholanthrene; Hepatocyte; Hepatocellular carcinoma; CYP2C8; Biology; Messenger RNA; Chemistry; Cancer research; Cell biology; Carcinogen; Endocrinology; Metabolism; In vitro; Biochemistry; Gene; CYP2C9; Genetics","score_opus":0.060807045269917155,"score_gpt":0.379998645426156,"score_spread":0.3191916001562389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585183403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99018013,0.0068765087,0.00001117509,0.0005970188,0.0012248025,0.00025541813,0.00016834392,0.000004454981,0.00068214943],"genre_scores_gemma":[0.997623,0.000874598,0.00005491455,0.0006646928,0.00056619546,0.000011270314,0.000026697673,0.000025339365,0.00015326236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975308,0.00065058796,0.00080873974,0.00030554543,0.00009714103,0.0006071674],"domain_scores_gemma":[0.99766135,0.0001950911,0.000959529,0.00023140621,0.00024469465,0.0007079478],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009919367,0.00029443105,0.0007442399,0.00044696138,0.00057549035,0.00002013153,0.0007072703,0.00048937334,0.0020506794],"category_scores_gemma":[0.00004557094,0.00029040858,0.00014458754,0.00010819661,0.0010391654,0.00020712717,0.0000767525,0.0010254504,0.000006929777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020318672,0.00014162024,0.04657979,0.000109765744,0.000120261255,0.00014146305,0.0004218756,0.00019204715,0.94767356,0.00014320733,0.003178339,0.001094898],"study_design_scores_gemma":[0.004111389,0.00023240452,0.13813412,0.000012733817,0.0002336395,0.00005531184,0.00003341524,0.00066527043,0.83568,0.0013242695,0.019267876,0.00024954946],"about_ca_topic_score_codex":0.0012322566,"about_ca_topic_score_gemma":0.0004492379,"teacher_disagreement_score":0.11199354,"about_ca_system_score_codex":0.0000589899,"about_ca_system_score_gemma":0.00048502465,"threshold_uncertainty_score":0.9999548},"labels":[],"label_agreement":null},{"id":"W2586508238","doi":"10.1097/fpc.0000000000000271","title":"Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer","year":2017,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; National Center for Advancing Translational Sciences; National Institute of Mental Health","keywords":"CYP2A6; Cotinine; Nicotine; Genotype; Lung cancer; Biology; Medicine; Genetics; Demography; Internal medicine; Oncology; Metabolism; Gene","score_opus":0.04418432566383716,"score_gpt":0.39351837328252376,"score_spread":0.3493340476186866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586508238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902513,0.006827175,0.00010807634,0.00026033854,0.0009851889,0.00090383616,0.00059543323,0.00002101413,0.000047617574],"genre_scores_gemma":[0.93296176,0.06588811,0.000252642,0.00029269283,0.00034332817,0.00016024911,0.00002148679,0.000060106322,0.00001961293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975945,0.00027050427,0.0006431398,0.0006749133,0.00012198185,0.000695001],"domain_scores_gemma":[0.9985189,0.00023464362,0.0005700239,0.00023896893,0.00005917729,0.00037830914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010948764,0.0004164638,0.0006162084,0.0002864958,0.00054628006,0.0001695904,0.00030638513,0.00019573719,0.000034307577],"category_scores_gemma":[0.00006490657,0.0004490632,0.000069247384,0.00012522742,0.0003519925,0.00016067969,0.00034758783,0.0007316316,6.749148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022629212,0.00010048882,0.81573266,0.000047819492,0.00021918082,0.000012894948,0.0024317412,0.0013009189,0.034748055,0.000091465576,0.0000034035284,0.14508508],"study_design_scores_gemma":[0.009308649,0.000040442686,0.9338982,0.000023767338,0.00052671274,0.000009513223,0.000119848235,0.04090984,0.011036578,0.00069153117,0.0029187645,0.0005161249],"about_ca_topic_score_codex":0.002409738,"about_ca_topic_score_gemma":0.0024993333,"teacher_disagreement_score":0.14456896,"about_ca_system_score_codex":0.00006870989,"about_ca_system_score_gemma":0.000056124325,"threshold_uncertainty_score":0.9997961},"labels":[],"label_agreement":null},{"id":"W2594345661","doi":"10.1182/blood.v112.11.988.988","title":"Use of Pharmacogenetic Factors to Predict Warfarin Dose in Children - a Retrospective Cohort Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Warfarin; VKORC1; Medicine; CYP2C9; Vitamin K epoxide reductase; Pharmacogenetics; Retrospective cohort study; Genotyping; Population; Internal medicine; Dosing; Surgery; Pediatrics; Atrial fibrillation; Genotype; Biology","score_opus":0.10408123361477373,"score_gpt":0.3851185748491991,"score_spread":0.28103734123442536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594345661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954233,0.0006068442,0.0000058941,0.000027621694,0.0004996627,0.00265285,0.00030507278,0.000073446376,0.00040530838],"genre_scores_gemma":[0.9982111,0.000674938,0.00012760425,0.00038324602,0.00017167396,0.00016909737,0.000027702168,0.000050410938,0.00018424226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706876,0.0005743282,0.000677718,0.0006441738,0.00042326958,0.0006117691],"domain_scores_gemma":[0.99869764,0.00015430473,0.00018003986,0.00037511674,0.0001659266,0.00042697426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057341787,0.00038408648,0.0006672192,0.00038176728,0.00016393633,0.000012214966,0.000438385,0.00020028652,0.000472411],"category_scores_gemma":[0.00014796232,0.0003726759,0.00012665965,0.00079944346,0.00015812456,0.00011340049,0.00024059732,0.00068339426,0.000044413322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019438457,0.0055369283,0.9464446,0.0000064012606,0.0007798915,0.00007259802,0.0017350393,0.0007473157,0.0436009,0.0000063389125,0.00050494325,0.00037067832],"study_design_scores_gemma":[0.005668825,0.0003087991,0.88283384,0.000005163489,0.00062056835,0.000035379744,0.000040992472,0.00010538278,0.10880983,0.000011842268,0.0012400381,0.00031933084],"about_ca_topic_score_codex":0.00034691763,"about_ca_topic_score_gemma":0.00003206935,"teacher_disagreement_score":0.065208934,"about_ca_system_score_codex":0.00005310195,"about_ca_system_score_gemma":0.00013414459,"threshold_uncertainty_score":0.9998725},"labels":[],"label_agreement":null},{"id":"W2595774540","doi":"10.71781/31824","title":"Rôle du système endocrinien de la vitamine D³ sur l'induction de cytochromes P450 hépatiques impliquées dans la détoxication-cytoprotection","year":2006,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytoprotection; Medicine; Internal medicine; Oxidative stress","score_opus":0.04551776290879555,"score_gpt":0.41717136367317575,"score_spread":0.3716536007643802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595774540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438909,0.0021110005,0.0010488894,0.0005611201,0.0015981306,0.0021633278,0.0005491181,0.00002808311,0.04804942],"genre_scores_gemma":[0.97407734,0.003670194,0.00367227,0.0001516854,0.0016860458,0.0009456361,0.0016810637,0.00014536516,0.013970408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99299353,0.0035093199,0.0010849873,0.001041811,0.0003474017,0.0010229459],"domain_scores_gemma":[0.9967709,0.0009938518,0.0009076403,0.0004437198,0.000421718,0.00046215978],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027411361,0.0008191563,0.000897671,0.00037010552,0.0009120878,0.00046521306,0.0010888892,0.0016398625,0.0026756513],"category_scores_gemma":[0.000289228,0.0009567579,0.00030826553,0.0004830008,0.0004432222,0.0005219676,0.00021845991,0.00176758,0.0002607421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005869565,0.0016866367,0.0060869996,0.00028556245,0.0006246627,0.0001131339,0.007555173,0.0016756381,0.8810098,0.0012723912,0.0007053432,0.098397665],"study_design_scores_gemma":[0.0022713935,0.00016132524,0.06944831,0.00016625371,0.0014500129,0.00037755107,0.0013028106,0.0032559421,0.7220846,0.0012387518,0.1974082,0.00083488086],"about_ca_topic_score_codex":0.002901492,"about_ca_topic_score_gemma":0.0008492932,"teacher_disagreement_score":0.19670285,"about_ca_system_score_codex":0.00079061463,"about_ca_system_score_gemma":0.0015533938,"threshold_uncertainty_score":0.9996562},"labels":[],"label_agreement":null},{"id":"W2597143300","doi":"10.1097/mib.0000000000001062","title":"CYP3A4 Activity is Markedly Lower in Patients with Crohnʼs Disease","year":2017,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Crohn's disease; Medicine; Crohn disease; Gastroenterology; CYP3A4; Internal medicine; Disease","score_opus":0.035759694919710414,"score_gpt":0.35957335240041804,"score_spread":0.3238136574807076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597143300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933008,0.0005234686,0.0000050457297,0.0004827839,0.0012148059,0.00068910845,0.0010381778,0.00008128636,0.002664512],"genre_scores_gemma":[0.9970168,0.00016644373,0.000013288327,0.0016757849,0.00029346108,0.0001272598,0.00003201177,0.00005473402,0.0006202037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775386,0.0002836288,0.00032494118,0.0005787103,0.0003874959,0.000671363],"domain_scores_gemma":[0.9975937,0.00010985572,0.00032312688,0.00087581977,0.00014779442,0.0009496772],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002457952,0.00041545194,0.0003330939,0.00014472406,0.00065790734,0.00014313677,0.0007484998,0.00017394136,0.0019751913],"category_scores_gemma":[0.0001572775,0.00037172975,0.00016241215,0.000067472414,0.0004016939,0.00055781275,0.0002845347,0.0005037701,0.00023528052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057778875,0.0013168716,0.9800141,0.00009307911,0.00013674801,0.00041073738,0.00009522622,0.00012269586,0.0001337736,0.00008523211,0.004124344,0.0076892897],"study_design_scores_gemma":[0.0050858706,0.00004163056,0.9425453,0.000036980367,0.00025456666,3.89755e-7,0.0000051969923,0.00057163736,0.00032490044,0.0002737562,0.050378613,0.00048117506],"about_ca_topic_score_codex":0.000016306898,"about_ca_topic_score_gemma":0.000015457685,"teacher_disagreement_score":0.04625427,"about_ca_system_score_codex":0.00006857901,"about_ca_system_score_gemma":0.00026448557,"threshold_uncertainty_score":0.99987346},"labels":[],"label_agreement":null},{"id":"W2597899656","doi":"","title":"Approval of new pharmacogenomic tests: is the Canadian regulatory process adequate?","year":2010,"lang":"en","type":"article","venue":"eYLS (Yale Law School)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Process (computing); Pharmacogenomics; Business; Risk analysis (engineering); Computer science; Medicine; Pharmacology","score_opus":0.0579327529319097,"score_gpt":0.3738509795033023,"score_spread":0.3159182265713926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597899656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594533,0.0029360356,0.0000061309815,0.003283431,0.004213241,0.00084176654,0.00027828905,0.00007272645,0.028915072],"genre_scores_gemma":[0.97968507,0.00012030888,0.00026140813,0.01234589,0.0016316928,0.00007921878,0.000024547486,0.00006854025,0.0057833153],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732876,0.00023841875,0.00060681836,0.0005389274,0.00036896137,0.00091814506],"domain_scores_gemma":[0.99717575,0.0001794519,0.00027830343,0.00063091336,0.0002297774,0.0015057736],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011603304,0.0004021389,0.00040533385,0.00014584001,0.0007019627,0.00006717317,0.0011793475,0.0004790502,0.009764769],"category_scores_gemma":[0.0000876037,0.00033337044,0.00021376506,0.0003890356,0.00060664146,0.000178989,0.00011257001,0.0021354842,0.0007248032],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048772394,0.00059957535,0.019286795,0.0001859035,0.0011680424,0.00010089863,0.0056077186,0.00054968044,0.73606014,0.07014054,0.12250067,0.043312326],"study_design_scores_gemma":[0.0018672025,0.00003261464,0.00342725,0.000008084933,0.0003170065,0.00004097005,0.00010116816,0.00047688754,0.25384226,0.004367132,0.7351069,0.0004125391],"about_ca_topic_score_codex":0.022379333,"about_ca_topic_score_gemma":0.044616964,"teacher_disagreement_score":0.6126062,"about_ca_system_score_codex":0.00007731707,"about_ca_system_score_gemma":0.0016308745,"threshold_uncertainty_score":0.99991184},"labels":[],"label_agreement":null},{"id":"W2599508584","doi":"10.1111/bph.13787","title":"Constitutive androstane receptor regulates the intestinal mucosal response to injury","year":2017,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Crohn's and Colitis Canada; Natural Sciences and Engineering Research Council of Canada; Crohn's and Colitis Foundation","keywords":"Constitutive androstane receptor; Ulcerative colitis; Inflammatory bowel disease; Colitis; Inflammation; Pregnane X receptor; Receptor; Intestinal mucosa; Xenobiotic; Pharmacology; Immunology; Downregulation and upregulation; Medicine; Biology; Internal medicine; Chemistry; Nuclear receptor; Disease; Transcription factor; Biochemistry","score_opus":0.06599492103804959,"score_gpt":0.4350965312499956,"score_spread":0.369101610211946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599508584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96879095,0.0037961423,0.00009662181,0.014276749,0.010552021,0.0005456262,0.0002672008,0.000031833642,0.0016428732],"genre_scores_gemma":[0.9863403,0.0021548222,0.0008264606,0.0074302363,0.0022016296,0.00003113983,0.0000036091778,0.000039702372,0.0009721365],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583507,0.0018017886,0.00092311914,0.00035154505,0.00034437748,0.00074411224],"domain_scores_gemma":[0.9962072,0.0010602062,0.0010402205,0.00023979358,0.0008198446,0.00063275365],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046384986,0.00031937892,0.00061408186,0.00020719966,0.0016343,0.00021980211,0.0017600773,0.00027061952,0.0026091486],"category_scores_gemma":[0.0017091528,0.00029159922,0.00026352642,0.00017105471,0.001405557,0.0003212136,0.0004710148,0.0018959638,0.00018372816],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009108158,0.00032570245,0.00082676794,0.000013969893,0.00041124478,0.0015405235,0.0003787324,0.00016611235,0.73204345,0.00013762937,0.17740847,0.077639274],"study_design_scores_gemma":[0.004174624,0.0005348319,0.007103261,0.0000638383,0.0004771783,0.0053165564,0.00011624802,0.00013461255,0.38421935,0.00036692602,0.5971527,0.00033990384],"about_ca_topic_score_codex":0.000039542057,"about_ca_topic_score_gemma":0.000011650063,"teacher_disagreement_score":0.41974422,"about_ca_system_score_codex":0.00011196878,"about_ca_system_score_gemma":0.0005514791,"threshold_uncertainty_score":0.9999536},"labels":[],"label_agreement":null},{"id":"W2602060348","doi":"10.1021/acs.bioconjchem.6b00604","title":"Allosteric Activation of Cytochrome P450 3A4 via Progesterone Bioconjugation","year":2017,"lang":"ca","type":"article","venue":"Bioconjugate Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de recherche du Québec – Nature et technologies; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; University of California, San Francisco","keywords":"Allosteric regulation; Chemistry; Cooperativity; CYP3A4; Cytochrome P450; Allosteric enzyme; Cooperative binding; Bioconjugation; Enzyme; Binding site; Biochemistry; Active site","score_opus":0.09445168265934384,"score_gpt":0.41161321144131896,"score_spread":0.3171615287819751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602060348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809095,0.0024287356,0.00017436825,0.0017116114,0.0013443971,0.0013211166,0.00049421674,0.00008021136,0.011535801],"genre_scores_gemma":[0.9925026,0.0019456171,0.00023873952,0.0005644187,0.0014697555,0.0001495081,0.00024970324,0.000101127815,0.002778476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961906,0.000260326,0.001202473,0.00096752186,0.0004521213,0.0009269551],"domain_scores_gemma":[0.9953775,0.00014172427,0.002071583,0.001377118,0.00045405622,0.0005780361],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009035611,0.00077192805,0.0009053283,0.00010342984,0.0009131243,0.00019451686,0.0014051031,0.0012054257,0.0026824835],"category_scores_gemma":[0.00019470316,0.0008454966,0.00034406997,0.0001655722,0.0011705911,0.0004451014,0.00062246434,0.0010231903,0.00024490838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064178923,0.0007502133,0.001517485,0.0013733426,0.00061985385,0.00002925542,0.00038254797,0.000043844622,0.9710096,0.000056431865,0.00076178595,0.022813814],"study_design_scores_gemma":[0.0041597695,0.00011117753,0.0090192305,0.00018157986,0.0006318533,0.00003522947,0.0000615446,0.0016208827,0.9266277,0.00037164186,0.056414656,0.0007647632],"about_ca_topic_score_codex":0.000052434465,"about_ca_topic_score_gemma":0.0000013736111,"teacher_disagreement_score":0.05565287,"about_ca_system_score_codex":0.00015660086,"about_ca_system_score_gemma":0.0003453623,"threshold_uncertainty_score":0.9993996},"labels":[],"label_agreement":null},{"id":"W2605453051","doi":"10.1016/j.ejmech.2017.04.042","title":"Inhibitors of cytochrome P450 (CYP) 1B1","year":2017,"lang":"en","type":"review","venue":"European Journal of Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Fonds de Recherche du Québec - Santé","keywords":"CYP1B1; Cytochrome P450; Chemistry; Hydroxylation; Enzyme; Carcinogenesis; Carcinogen; Biochemistry; Cytochrome; Unspecific monooxygenase; CYP1A2; Gene","score_opus":0.34223543808148477,"score_gpt":0.5229245309550812,"score_spread":0.1806890928735964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605453051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067441206,0.96044177,0.000016020711,0.00007612767,0.0018775132,0.00018473295,0.00010164985,0.0000130903845,0.036614656],"genre_scores_gemma":[0.0025192325,0.98946637,0.00010725821,0.000120644596,0.006333616,0.000002563403,0.000023598039,0.000108483066,0.0013182278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507785,0.0012092424,0.002285513,0.00032970018,0.00062247104,0.00047522073],"domain_scores_gemma":[0.99341,0.00033659922,0.004633927,0.0005177153,0.00036557147,0.00073620793],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004567054,0.0006191148,0.0025648992,0.00018358571,0.00017054321,0.000025032063,0.0018498963,0.00036218477,0.0013878825],"category_scores_gemma":[0.0005790532,0.00047764686,0.0010999274,0.00014750524,0.000603393,0.00007642364,0.00028330425,0.0033410771,0.000088205576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010107818,0.00021434228,0.0000049709915,0.010743194,0.0010129807,0.002396238,0.00014812905,0.000004967274,0.009853729,0.00000343065,0.012011476,0.96350545],"study_design_scores_gemma":[0.001560818,0.00012423094,0.000011232833,0.0068943934,0.0038129755,0.002067757,0.00002702501,0.000002747949,0.005145122,0.000009130376,0.9799792,0.00036535168],"about_ca_topic_score_codex":7.1287235e-7,"about_ca_topic_score_gemma":4.714358e-8,"teacher_disagreement_score":0.96796775,"about_ca_system_score_codex":0.00007942516,"about_ca_system_score_gemma":0.00072550384,"threshold_uncertainty_score":0.99976754},"labels":[],"label_agreement":null},{"id":"W2606052450","doi":"10.4172/2153-0645.1000164","title":"The Pharmacogenomic Era in Asia: Potential Roles and Challenges for Asian Pharmacists","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmacogenomics & Pharmacoproteomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacology","score_opus":0.1111152566667161,"score_gpt":0.4257625396099905,"score_spread":0.3146472829432744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606052450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8995009,0.07090032,0.0004128304,0.0146032665,0.009750552,0.0026741282,0.00037899576,0.000053681728,0.0017253341],"genre_scores_gemma":[0.7861329,0.20738082,0.0015326561,0.0009661208,0.0034364655,0.0001841076,0.000008681955,0.00016268592,0.00019559158],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99381274,0.00078297744,0.0023147664,0.0008415322,0.0006012387,0.0016467408],"domain_scores_gemma":[0.99391276,0.00069042965,0.0029183128,0.00068114523,0.00069902284,0.001098309],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006836033,0.0009571755,0.0012537857,0.0005395616,0.0025582372,0.00055779057,0.0030731885,0.00045305546,0.00014446714],"category_scores_gemma":[0.00034023315,0.0008219254,0.00070424366,0.00015740248,0.0010044747,0.00093153433,0.00067401864,0.0027456554,0.000027503589],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052994727,0.0005016433,0.0008080674,0.00019908644,0.0010910057,0.00036254848,0.0009776872,0.0009764203,0.5862227,0.000635607,0.0019189445,0.40100682],"study_design_scores_gemma":[0.028954567,0.0002846703,0.0016684881,0.00006096653,0.0016737736,0.0014007613,0.00046638504,0.01933338,0.43354928,0.0045368504,0.50685203,0.0012188498],"about_ca_topic_score_codex":0.0000087658555,"about_ca_topic_score_gemma":0.000011987487,"teacher_disagreement_score":0.50493306,"about_ca_system_score_codex":0.00031792992,"about_ca_system_score_gemma":0.0006291287,"threshold_uncertainty_score":0.99955505},"labels":[],"label_agreement":null},{"id":"W2609096722","doi":"10.1038/tpj.2017.8","title":"CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction","year":2017,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Sildenafil; Medicine; Pharmacogenetics; Heart failure with preserved ejection fraction; Pharmacokinetics; Internal medicine; Heart failure; Ejection fraction; CYP3A4; Population; Cardiology; Pharmacology; Randomized controlled trial; Bioavailability; Genotype; Biology","score_opus":0.060396977084376836,"score_gpt":0.3659489137543977,"score_spread":0.30555193667002084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609096722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994119,0.00026248692,0.00025648787,0.0029223487,0.00065870414,0.0008184473,0.00013752522,0.000036332607,0.00078866794],"genre_scores_gemma":[0.99656814,0.00029350218,0.0002437298,0.0020120826,0.00049185136,0.00004065783,0.00003613099,0.000069002184,0.00024487643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974292,0.00057873665,0.00045610766,0.00037482084,0.00045147177,0.0007096695],"domain_scores_gemma":[0.99773157,0.00017404094,0.00081408373,0.00041197377,0.0005015557,0.000366796],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0010926821,0.0003915871,0.00040281028,0.00014094231,0.002191078,0.00031675986,0.00073547993,0.00019154634,0.0008237609],"category_scores_gemma":[0.000056437613,0.00025113017,0.00008957479,0.0002057881,0.00037353576,0.0005902652,0.00009492389,0.0019550936,0.00004813087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004474212,0.0008907147,0.95259845,0.00001103048,0.001104235,0.00004641241,0.0005107303,0.007488544,0.026605248,0.000041881252,0.0049895826,0.0012389749],"study_design_scores_gemma":[0.035047855,0.0008330044,0.753582,0.000103935265,0.0019896962,0.00018404254,0.00024373212,0.007893734,0.061140314,0.00034682965,0.13746686,0.0011679728],"about_ca_topic_score_codex":0.00004623178,"about_ca_topic_score_gemma":0.00018663939,"teacher_disagreement_score":0.19901642,"about_ca_system_score_codex":0.00027461236,"about_ca_system_score_gemma":0.00032200827,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W2610397959","doi":"10.1124/dmd.117.075945","title":"Crypt Organoid Culture as an In Vitro Model in Drug Metabolism and Cytotoxicity Studies","year":2017,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences","keywords":"Crypt; Drug metabolism; Biology; Xenobiotic; Pregnane X receptor; Gene expression; Metabolism; Organoid; Biochemistry; Molecular biology; Pharmacology; Cell biology; Gene; Nuclear receptor; Enzyme; Endocrinology; Transcription factor","score_opus":0.060010883494069335,"score_gpt":0.40999518758940456,"score_spread":0.3499843040953352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610397959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96189964,0.03362312,0.000033979817,0.0009917857,0.0008897515,0.0006622044,0.00025635504,0.00005897513,0.0015841917],"genre_scores_gemma":[0.97493654,0.020915354,0.0006923991,0.0021876397,0.00046071905,0.00013768426,0.000080435326,0.000045904842,0.0005433012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99687886,0.0006419701,0.0006203843,0.0008522066,0.00028802242,0.0007185466],"domain_scores_gemma":[0.99846107,0.00010203573,0.0003114952,0.0004965321,0.00014956103,0.00047931197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014221354,0.0005532945,0.00092311576,0.00033028628,0.0008722307,0.00019753107,0.00046498814,0.00032586517,0.000052207062],"category_scores_gemma":[0.00015405047,0.00050171174,0.00010044843,0.0001906464,0.00052675774,0.0010803686,0.00038055232,0.00094440446,0.000015604386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018267225,0.0010521556,0.0028045457,0.00015775654,0.0002210695,0.00013524205,0.02566262,0.00068732677,0.9298575,0.014802014,0.00078295625,0.02201009],"study_design_scores_gemma":[0.015276449,0.00003899394,0.0832059,0.00007921171,0.0011686038,0.00007132179,0.0031314343,0.03297078,0.7889729,0.050528735,0.022788359,0.0017672717],"about_ca_topic_score_codex":0.00035078631,"about_ca_topic_score_gemma":0.00026409942,"teacher_disagreement_score":0.14088456,"about_ca_system_score_codex":0.00003919066,"about_ca_system_score_gemma":0.000080924976,"threshold_uncertainty_score":0.99974346},"labels":[],"label_agreement":null},{"id":"W2611653650","doi":"10.1016/j.xphs.2017.04.072","title":"Professor Yuichi Sugiyama: A Brilliant, Creative, Amicable, Charming, and Humorous Pharmaceutical Scientist","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tribute; Art; Psychology; Art history","score_opus":0.19880517040586082,"score_gpt":0.5207006905514581,"score_spread":0.32189552014559725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611653650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95285684,0.009586384,0.00024115675,0.009255531,0.0059216786,0.0006033863,0.0000866131,0.00005016898,0.021398252],"genre_scores_gemma":[0.98568743,0.0068206415,0.0015444623,0.0028289524,0.001482329,0.000016240452,0.0000015503849,0.00003629809,0.0015820998],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949083,0.00076651084,0.0011674975,0.00072002126,0.0010964515,0.0013412469],"domain_scores_gemma":[0.99579334,0.00058481935,0.0012243446,0.00035343357,0.00046978713,0.0015742775],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["sts"],"category_scores_codex":[0.006058417,0.00052099256,0.00087282393,0.00037770875,0.0031886497,0.000631924,0.0020815677,0.00029725808,0.0017217626],"category_scores_gemma":[0.0009873089,0.00040595097,0.0002999201,0.0003918278,0.0051690554,0.0010934868,0.00071350124,0.0018686053,0.00007687173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002205381,0.0026983074,0.10985101,0.00044610124,0.0011155881,0.0015529306,0.0022612184,0.00019218698,0.4493994,0.019545112,0.017744627,0.39298812],"study_design_scores_gemma":[0.009255745,0.0006073636,0.03128257,0.00017774946,0.0012446265,0.0015375437,0.00043445453,0.014359918,0.17955326,0.0036346791,0.756846,0.0010660848],"about_ca_topic_score_codex":0.000028793087,"about_ca_topic_score_gemma":0.000008750591,"teacher_disagreement_score":0.7391014,"about_ca_system_score_codex":0.000084541076,"about_ca_system_score_gemma":0.00041293562,"threshold_uncertainty_score":0.99983925},"labels":[],"label_agreement":null},{"id":"W2614817220","doi":"10.1385/0-89603-519-0:123","title":"High-Performance Liquid Chromatographic Analysis of CYP2CSCatalyzed Paclitaxel 6α-Hydroxylation","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"CYP2C8; Paclitaxel; Hydroxylation; Chemistry; Carbamazepine; Phenobarbital; Pharmacology; High-performance liquid chromatography; Biochemistry; Chromatography; Biology; Cytochrome P450; Metabolism; Enzyme; Chemotherapy; CYP2C9","score_opus":0.12185587697294373,"score_gpt":0.39320834019038564,"score_spread":0.2713524632174419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614817220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635775,0.00461958,0.00014614526,0.0000115638995,0.00072092965,0.00037021516,0.000095459196,0.00009011902,0.030368472],"genre_scores_gemma":[0.99710715,0.0013263859,0.00016901857,0.0002660454,0.00010612161,0.000082242885,0.000067130655,0.00003419384,0.0008417217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976225,0.00051134266,0.0006760842,0.0004189269,0.00028134385,0.0004898331],"domain_scores_gemma":[0.99862236,0.00016112807,0.0003699113,0.0004753128,0.00015031689,0.00022097296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008553647,0.0003087649,0.00061971776,0.0005687164,0.0002533001,0.000019659838,0.0003623601,0.0002715029,0.00052132626],"category_scores_gemma":[0.00003480657,0.00030846527,0.0002849311,0.00029871904,0.00028373007,0.000090989925,0.00007451204,0.00041327512,0.000015496049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019361817,0.0016209914,0.005956782,0.0006588273,0.020829044,0.000052835087,0.005854323,0.053327836,0.64180607,0.2167085,0.0016672051,0.049581382],"study_design_scores_gemma":[0.0024545095,0.00015169082,0.0043840124,0.000015101455,0.005475763,0.0000041903522,0.000024954481,0.009039791,0.8533937,0.00043524228,0.12409094,0.0005301225],"about_ca_topic_score_codex":0.00007996901,"about_ca_topic_score_gemma":0.000019224897,"teacher_disagreement_score":0.21627326,"about_ca_system_score_codex":0.000021215086,"about_ca_system_score_gemma":0.000047279384,"threshold_uncertainty_score":0.99993676},"labels":[],"label_agreement":null},{"id":"W2615474257","doi":"10.1111/j.1365-2885.2000.00269.x","title":"Plasma pharmacokinetics of warfarin enantiomers in cats","year":2000,"lang":"en","type":"article","venue":"Journal of Veterinary Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"Winn Feline Foundation","keywords":"Warfarin; Pharmacokinetics; CATS; Chemistry; Oral administration; Enantiomer; Bolus (digestion); Pharmacology; Area under the curve; Plasma concentration; Chromatography; Medicine; Internal medicine; Stereochemistry; Atrial fibrillation","score_opus":0.12424457437001228,"score_gpt":0.44441829686354795,"score_spread":0.32017372249353565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615474257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986674,0.00828383,0.000015875004,0.0006695135,0.0020783432,0.00026029014,0.000040395484,0.000014663704,0.0019630545],"genre_scores_gemma":[0.95761776,0.039220393,0.00040635368,0.0020587891,0.00036690832,0.00000853937,0.0000031165603,0.0000360787,0.0002820867],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969334,0.0008046405,0.001199006,0.00026195488,0.00024546817,0.00055553333],"domain_scores_gemma":[0.9984436,0.0004250473,0.0005352233,0.0001314128,0.00017138832,0.00029332604],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012769155,0.00034962752,0.00072134804,0.00046215404,0.0001105294,0.000011389776,0.00047073077,0.00034810902,0.0026707654],"category_scores_gemma":[0.000008996792,0.000320423,0.00018564341,0.00040411018,0.0005054993,0.00019238272,0.000083764935,0.0012395227,0.000017973221],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046651103,0.0011700464,0.005680715,0.00010752389,0.0007639391,0.0005548696,0.001531875,0.001983245,0.70887315,0.00008689741,0.00044994312,0.27413267],"study_design_scores_gemma":[0.014772992,0.0019448241,0.008926637,0.000049997027,0.0012115076,0.0018176426,0.00016774709,0.0064419745,0.25358543,0.0005801569,0.70995927,0.0005418452],"about_ca_topic_score_codex":0.0000062552663,"about_ca_topic_score_gemma":0.0000010325589,"teacher_disagreement_score":0.7095093,"about_ca_system_score_codex":0.00004411272,"about_ca_system_score_gemma":0.00013941227,"threshold_uncertainty_score":0.9999248},"labels":[],"label_agreement":null},{"id":"W2615622121","doi":"10.1016/j.japh.2017.05.006","title":"The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Pharmacists Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Human Genome Research Institute; U.S. Food and Drug Administration","keywords":"Medicine; Pharmacogenomics; Pharmacy; Medication therapy management; Family medicine; Pharmacist; Personalized medicine; Pharmacotherapy; Pharmaceutical care; Drug; Pharmacology; Internal medicine; Bioinformatics","score_opus":0.181913459089852,"score_gpt":0.48306418906417253,"score_spread":0.3011507299743206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615622121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868047,0.0003998566,0.000011190716,0.0061141104,0.0032293594,0.00073438924,0.000116749914,0.0000128927695,0.0025767465],"genre_scores_gemma":[0.99304867,0.0011561207,0.000037677204,0.004629015,0.0007632286,0.000034218192,0.0000028636937,0.00004071694,0.00028746697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920507,0.0050765555,0.0011706158,0.0002149996,0.00065510394,0.0008320356],"domain_scores_gemma":[0.99127096,0.001512601,0.005278528,0.0005270427,0.0010010585,0.00040978557],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00978699,0.00035708808,0.0006420267,0.0003111057,0.0040969816,0.00027388736,0.0028054027,0.0000756017,0.000085603024],"category_scores_gemma":[0.0019057818,0.00024987655,0.00025658656,0.0007397654,0.0005244679,0.00046951912,0.00042071406,0.0039890558,0.000019337753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008702585,0.0006454157,0.87907255,0.0000066829143,0.001271198,0.00008786688,0.005631834,0.00046777152,0.016161107,0.00002474877,0.008636734,0.08712382],"study_design_scores_gemma":[0.012117535,0.0002343548,0.8135711,0.00003049612,0.000722875,0.000074790274,0.0032645988,0.0022352403,0.02317231,0.00041257305,0.1435938,0.00057035993],"about_ca_topic_score_codex":0.007716434,"about_ca_topic_score_gemma":0.005350144,"teacher_disagreement_score":0.13495706,"about_ca_system_score_codex":0.0012956321,"about_ca_system_score_gemma":0.00091654237,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W2615961084","doi":"","title":"Effect of St Johns wort extract LI 160 on metabolic activity ofCYP2C6 in isolated perfused rat liver.","year":2004,"lang":"en","type":"article","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Traditional medicine; Pharmacology; Medicine","score_opus":0.06045548227223416,"score_gpt":0.4138055772476079,"score_spread":0.35335009497537373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615961084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98534834,0.0019604946,0.00018569436,0.0002939596,0.0013761574,0.0009189306,0.00007148351,0.00010245672,0.0097424975],"genre_scores_gemma":[0.99410385,0.004123999,0.00006862978,0.0009082386,0.00020537112,0.000065932916,0.000016654223,0.000050168535,0.00045715852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966382,0.00123434,0.00054223806,0.0005583869,0.0003038684,0.0007229784],"domain_scores_gemma":[0.99820477,0.0007608782,0.00023022194,0.0003694204,0.00008338365,0.0003513085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017097552,0.0004907296,0.0008474021,0.00045084325,0.0001463306,0.000020241581,0.00042478132,0.0004751952,0.0027265297],"category_scores_gemma":[0.0001205589,0.00041430054,0.00027410325,0.00072192866,0.00019865837,0.00017389144,0.00011531333,0.0013327916,0.0002143209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065277587,0.0033718303,0.01023545,0.00017023948,0.0004948539,0.00027504342,0.00087707356,0.013958516,0.8096696,0.0012467289,0.000648406,0.15252446],"study_design_scores_gemma":[0.009463647,0.00075091823,0.0075944075,0.000028144339,0.00039738856,0.000017797167,0.000013686059,0.0057347612,0.9325861,0.00007243082,0.042888686,0.00045207606],"about_ca_topic_score_codex":0.00024335629,"about_ca_topic_score_gemma":0.00014629333,"teacher_disagreement_score":0.15207238,"about_ca_system_score_codex":0.000064621985,"about_ca_system_score_gemma":0.00016978469,"threshold_uncertainty_score":0.9998309},"labels":[],"label_agreement":null},{"id":"W2617574211","doi":"10.18433/j3mg71","title":"Quantitative Structure – Pharmacokinetic Relationships for Plasma Clearance of Basic Drugs with Consideration of the Major Elimination Pathway","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Clearance; Chemistry; Lipophilicity; Drug; Stepwise regression; Pharmacology; Drug metabolism; Linear regression; Quantitative structure–activity relationship; Drug development; Stereochemistry; Internal medicine; Medicine; Mathematics","score_opus":0.2080293285512433,"score_gpt":0.47323848451914535,"score_spread":0.26520915596790207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617574211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98786235,0.00198436,0.0004761749,0.0049903733,0.0023908375,0.00088763423,0.0002514795,0.000011516038,0.0011453027],"genre_scores_gemma":[0.9953122,0.0005916848,0.0030734236,0.0005359564,0.00036610238,0.00001723115,0.0000025837141,0.000025704438,0.00007510475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961543,0.0008875934,0.0012068741,0.0003541054,0.00089631794,0.0005007901],"domain_scores_gemma":[0.99415076,0.0016398849,0.0025438503,0.00026636437,0.0010872539,0.0003119173],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0033022503,0.00033307183,0.00059305487,0.00023369817,0.0014261316,0.00008883486,0.0013690795,0.00013216112,0.000374286],"category_scores_gemma":[0.0009096415,0.00021778603,0.00030495838,0.0003966368,0.0023101878,0.0007406983,0.0001480693,0.0011168546,0.0000032561786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005803951,0.00062781485,0.02241958,0.000345218,0.0005810141,0.000012482162,0.0022795256,0.007138259,0.86074734,0.013819893,0.0010015356,0.08522339],"study_design_scores_gemma":[0.008759637,0.00039182208,0.00684896,0.00011118014,0.0010136248,0.0000759492,0.0003569917,0.058207758,0.88044816,0.0018336077,0.04166753,0.00028479882],"about_ca_topic_score_codex":0.0000125711895,"about_ca_topic_score_gemma":0.000011874281,"teacher_disagreement_score":0.08493859,"about_ca_system_score_codex":0.000053097086,"about_ca_system_score_gemma":0.0005870547,"threshold_uncertainty_score":0.9998739},"labels":[],"label_agreement":null},{"id":"W2617724428","doi":"10.1021/acs.jmedchem.7b00343","title":"Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells","year":2017,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Hôpital Saint-François d'Assise","funders":"Canadian Institutes of Health Research","keywords":"Prodrug; Chemistry; In vivo; In vitro; Pharmacology; Cancer; Breast cancer; Mechanism of action; Cancer research; Cytochrome P450; Cancer cell; Human breast; Stereochemistry; Enzyme; Biochemistry; Internal medicine; Medicine; Biology","score_opus":0.050798939599226434,"score_gpt":0.4145257381529548,"score_spread":0.36372679855372836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617724428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844217,0.0048736446,0.000064255444,0.006072007,0.0018216805,0.00013265297,0.000105494844,0.000012695625,0.0024958733],"genre_scores_gemma":[0.9899472,0.00462817,0.00025890334,0.00083373504,0.0033219762,0.0000029185428,0.000008758597,0.000036723533,0.0009615863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976619,0.00009767641,0.00092525955,0.00024947143,0.0006211269,0.00044460534],"domain_scores_gemma":[0.99613863,0.00020994485,0.0021077082,0.00026448397,0.00056591956,0.0007132944],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011088273,0.0003144861,0.0006169448,0.00006234535,0.00031215698,0.000039295355,0.00084391376,0.00034693288,0.0015448992],"category_scores_gemma":[0.00044004075,0.0002704312,0.00020233566,0.000093849,0.00027223682,0.00018672078,0.00012477161,0.0011998176,0.0000069890175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006711001,0.00026191046,0.0026730066,0.000220959,0.00030492948,0.000045949007,0.0004130352,0.00054253166,0.928116,0.000006412909,0.04620804,0.020536112],"study_design_scores_gemma":[0.00302795,0.000047343074,0.00061466097,0.00019575543,0.00048026996,0.00017577595,0.0002437781,0.00059221644,0.94762975,0.00019679348,0.04655403,0.00024168377],"about_ca_topic_score_codex":0.00006628142,"about_ca_topic_score_gemma":4.9825377e-7,"teacher_disagreement_score":0.020294428,"about_ca_system_score_codex":0.00008410948,"about_ca_system_score_gemma":0.0008279829,"threshold_uncertainty_score":0.9999748},"labels":[],"label_agreement":null},{"id":"W2621142725","doi":"10.71781/4943","title":"Études métaboliques des isoenzymes du cytochrome P450 exprimées dans les ventricules de cœurs humains","year":2015,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Fondation du CHUM","keywords":"Physics; Molecular biology; Humanities; Philosophy; Biology","score_opus":0.034460394730334465,"score_gpt":0.2992792217276497,"score_spread":0.26481882699731524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621142725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81902546,0.14811818,0.00023538142,0.0003583525,0.0019554903,0.00062086305,0.0005173517,0.00020063251,0.028968276],"genre_scores_gemma":[0.95061266,0.02740974,0.0012300204,0.00038994802,0.001351578,0.00011519535,0.0007795296,0.00010546577,0.01800583],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948488,0.0012153686,0.00083293614,0.0010049985,0.0007807861,0.0013171462],"domain_scores_gemma":[0.9962658,0.0003708781,0.000712061,0.00041654153,0.0009094804,0.0013252371],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00088750845,0.001051888,0.0009424251,0.0005429296,0.011295348,0.000119071075,0.0010985442,0.0014663441,0.0003676546],"category_scores_gemma":[0.00018494247,0.0012213168,0.00064638315,0.00052263384,0.0014840505,0.00047495964,0.00038300123,0.0014639612,0.00011889136],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026464693,0.0020712377,0.06758829,0.0007163765,0.0024545996,0.006682107,0.16150084,0.015052512,0.65680826,0.06293425,0.0041381815,0.017406855],"study_design_scores_gemma":[0.0043656463,0.0002870772,0.1429919,0.00039670744,0.0035647142,0.0021796743,0.06789953,0.004178482,0.2854957,0.0027020695,0.48404568,0.0018928313],"about_ca_topic_score_codex":0.019744432,"about_ca_topic_score_gemma":0.008776889,"teacher_disagreement_score":0.4799075,"about_ca_system_score_codex":0.007374544,"about_ca_system_score_gemma":0.0045906333,"threshold_uncertainty_score":0.99982995},"labels":[],"label_agreement":null},{"id":"W2625470338","doi":"10.1038/tpj.2017.22","title":"On the readiness of physicians for pharmacogenomics testing: an empirical assessment","year":2017,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; The Quebec Population Health Research Network; Université Laval","funders":"","keywords":"Pharmacogenomics; Test (biology); Psychology; Family medicine; Medical education; Medicine","score_opus":0.3966516316277158,"score_gpt":0.5494180679820447,"score_spread":0.15276643635432896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625470338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716924,0.00053791754,0.0018013837,0.014308803,0.0048946305,0.0012880769,0.00051195076,0.00004310553,0.004921738],"genre_scores_gemma":[0.98141015,0.0011082895,0.0010172352,0.012679393,0.0032256956,0.0001227654,0.0000148655035,0.00011196044,0.00030964878],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99620575,0.001013297,0.0009518354,0.00047018958,0.00042605217,0.0009328764],"domain_scores_gemma":[0.99428827,0.0021404193,0.0016101884,0.0009647161,0.0006085883,0.00038784687],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0052688103,0.0005263541,0.0006006231,0.00013000448,0.0042463494,0.00030293415,0.0034197771,0.0001903762,0.0003985965],"category_scores_gemma":[0.00038431998,0.00033755702,0.0004468942,0.00015140872,0.0008644283,0.00026509637,0.00033915477,0.0020307547,0.000032699663],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001886166,0.0015601773,0.0031548785,0.000046592773,0.0014040049,0.000046881876,0.0013837775,0.011645671,0.8220584,0.0057675135,0.027410274,0.12363568],"study_design_scores_gemma":[0.009876267,0.0006706304,0.0042574434,0.000047665628,0.002581361,0.00042147623,0.00032030256,0.17161085,0.31314856,0.021222524,0.4747643,0.0010786622],"about_ca_topic_score_codex":0.000010158039,"about_ca_topic_score_gemma":0.0000034652123,"teacher_disagreement_score":0.5089098,"about_ca_system_score_codex":0.00016251595,"about_ca_system_score_gemma":0.00043970207,"threshold_uncertainty_score":0.9999077},"labels":[],"label_agreement":null},{"id":"W2625842840","doi":"10.1016/j.ijms.2017.06.002","title":"Mapping ligand binding using microfluidics-enabled millisecond timescale hydrogen-deuterium exchange","year":2017,"lang":"en","type":"article","venue":"International Journal of Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Chemistry; Hydrogen–deuterium exchange; Millisecond; Ligand (biochemistry); Allosteric regulation; Protein dynamics; Binding site; Molecular dynamics; Nanotechnology; Biophysics; Hydrogen; Computational chemistry; Biochemistry; Enzyme","score_opus":0.0961214276129013,"score_gpt":0.4143639466330993,"score_spread":0.31824251902019796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625842840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97909915,0.0055686007,0.001423515,0.0012583823,0.008134282,0.00012466556,0.00014411946,0.000013933965,0.004233369],"genre_scores_gemma":[0.9879109,0.003598167,0.0032430033,0.0007292183,0.003484174,0.000002559466,0.000009844076,0.000042507305,0.0009796125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784786,0.00016155664,0.00073689636,0.00025873055,0.0005231225,0.00047185775],"domain_scores_gemma":[0.9976534,0.0001289961,0.0011791909,0.00025797874,0.00045594655,0.0003244345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013365201,0.00027036943,0.0004479036,0.0008029111,0.0004390073,0.0002561265,0.0015186213,0.00022971726,0.002004504],"category_scores_gemma":[0.00016392565,0.0002651052,0.00032048087,0.0001296928,0.00017921292,0.00047395422,0.0002818247,0.00086424296,0.000074452015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020246374,0.00014793462,0.010537554,0.000021438302,0.0009716634,0.00056414463,0.00026434218,0.00007001546,0.98155713,0.000055483517,0.0017785619,0.0038292443],"study_design_scores_gemma":[0.003195205,0.00005915568,0.0026914633,0.000065045475,0.00016814141,0.0006691389,0.00012454684,0.0011637501,0.8665512,0.0008320141,0.12417105,0.00030924263],"about_ca_topic_score_codex":0.000014973579,"about_ca_topic_score_gemma":9.806913e-7,"teacher_disagreement_score":0.12239249,"about_ca_system_score_codex":0.00023032824,"about_ca_system_score_gemma":0.00015254927,"threshold_uncertainty_score":0.9999801},"labels":[],"label_agreement":null},{"id":"W2626356663","doi":"10.1016/j.bbapap.2017.06.007","title":"Use of bioconjugation with cytochrome P450 enzymes","year":2017,"lang":"en","type":"review","venue":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Bioconjugation; Biocatalysis; Chemistry; Cytochrome P450; Biosensor; Biomolecule; Chemical biology; Enzyme; Biochemistry; Nanotechnology; Combinatorial chemistry; Materials science; Reaction mechanism","score_opus":0.3781391428507866,"score_gpt":0.48329231746081364,"score_spread":0.10515317461002704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626356663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08638827,0.89851713,0.000077153185,0.00045855733,0.00043480308,0.010078734,0.0034611821,0.00013870957,0.00044545566],"genre_scores_gemma":[0.009339198,0.98390466,0.0036157903,0.0002314544,0.0005957298,0.0011476487,0.0005612411,0.00018594279,0.00041835578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958366,0.0008619419,0.0011435593,0.001070483,0.0003602994,0.00072712573],"domain_scores_gemma":[0.9958126,0.00030170608,0.0021873948,0.0010376129,0.00023396016,0.00042671236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000740141,0.001139372,0.002499007,0.00038359308,0.0005102002,0.00025243667,0.00089967134,0.0011281106,0.000068616006],"category_scores_gemma":[0.00010481851,0.00087575277,0.0005382604,0.00031230287,0.00093522226,0.00037378955,0.00046119263,0.0015786879,0.000030795978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008323088,0.0010514315,0.0000019895979,0.016857537,0.0029017774,0.000044190572,0.00052765536,0.0000056819445,0.35076177,0.0022511613,0.0006474498,0.6241171],"study_design_scores_gemma":[0.0010167862,0.0003846928,0.000042278065,0.0020272732,0.002279936,0.000049689825,0.000005767691,0.000073070165,0.2551078,0.00015976366,0.7378548,0.0009981974],"about_ca_topic_score_codex":0.000065496126,"about_ca_topic_score_gemma":0.0000066188445,"teacher_disagreement_score":0.7372073,"about_ca_system_score_codex":0.00006120052,"about_ca_system_score_gemma":0.0007789002,"threshold_uncertainty_score":0.9993693},"labels":[],"label_agreement":null},{"id":"W2726338622","doi":"10.1208/s12248-017-0102-8","title":"Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers","year":2017,"lang":"en","type":"article","venue":"The AAPS Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hamilton Health Sciences Foundation","keywords":"Pharmacokinetics; Pharmacogenomics; Bupropion; Pharmacology; Biopharmaceutics; Immediate release; Bioequivalence; Kinetics; Medicine; Chemistry; Pharmacognosy; Biological activity; Biochemistry; Physics","score_opus":0.10271803527537504,"score_gpt":0.41806851211202434,"score_spread":0.3153504768366493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726338622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940719,0.0019646669,0.00023112785,0.002019731,0.00067605195,0.0005673439,0.00004445449,0.000010824043,0.00041387847],"genre_scores_gemma":[0.9941781,0.004766441,0.000091879614,0.0004926654,0.000350141,0.00002313484,0.000006546201,0.00003992117,0.00005116449],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977251,0.00035873227,0.000773847,0.00026942548,0.0002866599,0.00058619113],"domain_scores_gemma":[0.998412,0.00016772424,0.00059654325,0.00036996367,0.000117744996,0.00033602427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007234508,0.00033987538,0.00048791172,0.0002582514,0.00067616836,0.00008206189,0.00071621215,0.00014463847,0.00016383536],"category_scores_gemma":[0.00004438653,0.00022400523,0.00009081316,0.00010447005,0.00046648702,0.00013775083,0.00023673587,0.0015262272,0.0000024737446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041871876,0.0019678539,0.4373379,0.00015860402,0.00035520564,0.0001509998,0.0025206143,0.007621745,0.49638715,0.0017777263,0.00023653598,0.047298484],"study_design_scores_gemma":[0.023275662,0.00090639084,0.85424525,0.00013936256,0.0006791693,0.0002580566,0.00017785761,0.036834963,0.07034159,0.0063751033,0.0060834256,0.0006831631],"about_ca_topic_score_codex":0.00007389436,"about_ca_topic_score_gemma":0.0005714057,"teacher_disagreement_score":0.42604554,"about_ca_system_score_codex":0.00010614218,"about_ca_system_score_gemma":0.00006360512,"threshold_uncertainty_score":0.9134668},"labels":[],"label_agreement":null},{"id":"W2735996965","doi":"10.1385/0-89603-519-0:175","title":"Use of 7-Ethoxycoumarin to Monitor Multiple Enzymes in the Human CYPI, CYP2, and CYP3 Families","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Enzyme; Microsome; Cytochrome P450; Substrate (aquarium); Recombinant DNA; Biochemistry; Isozyme; Chemistry; Complementary DNA; Enzyme kinetics; Enzyme assay; Biology; Active site; Gene","score_opus":0.31507601908011695,"score_gpt":0.4459606841591989,"score_spread":0.13088466507908192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735996965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97166896,0.005850138,0.000026469494,0.000046888355,0.00042151017,0.00085243594,0.00006769233,0.000033599397,0.0210323],"genre_scores_gemma":[0.99561167,0.0006091176,0.000392795,0.0012674162,0.000115253504,0.00016114618,0.0000045213183,0.000028269153,0.001809839],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.997648,0.0009161443,0.0004568362,0.0003430449,0.00020567812,0.00043028744],"domain_scores_gemma":[0.99866563,0.00063281634,0.0001266674,0.00034262685,0.00007079173,0.00016145522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008938985,0.00026137245,0.00033914912,0.00016857468,0.00025111777,0.00005085587,0.00035895698,0.00017995684,0.00006396796],"category_scores_gemma":[0.00013759702,0.0002127171,0.000075763506,0.000053887194,0.000254952,0.00006604163,0.00013654302,0.0005042076,0.00000505661],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005745973,0.001425215,0.025972722,0.00044985506,0.00064318965,0.00017046752,0.046406537,0.0024890741,0.35425335,0.3544624,0.0140551245,0.19909748],"study_design_scores_gemma":[0.0016324916,0.0000681751,0.010267554,0.000018332092,0.00014252012,0.000008151065,0.0003286674,0.00026342706,0.3166254,0.0008960406,0.6694345,0.00031474666],"about_ca_topic_score_codex":0.0005479425,"about_ca_topic_score_gemma":0.00021942335,"teacher_disagreement_score":0.6553794,"about_ca_system_score_codex":0.000014563965,"about_ca_system_score_gemma":0.000020213214,"threshold_uncertainty_score":0.8674352},"labels":[],"label_agreement":null},{"id":"W2736936940","doi":"10.1007/s40268-017-0195-7","title":"Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"CYP2C19; CYP2C9; Pharmacogenomics; Genotyping; Phenytoin; Genotype; Medicine; Pharmacogenetics; Pharmacokinetics; Allele; Middle East; Genetics; Pharmacology; Epilepsy; Biology; Geography; Gene; Psychiatry","score_opus":0.48975655035397786,"score_gpt":0.5137854583330572,"score_spread":0.02402890797907936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736936940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19013874,0.8065779,0.0000010199228,0.00007058557,0.00074445107,0.0011126879,0.00023506115,0.0000116656,0.0011078621],"genre_scores_gemma":[0.10991499,0.88928896,0.00004167818,0.00017532673,0.00028312943,0.00008629262,0.000025582058,0.000055132736,0.0001289241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507624,0.001896063,0.001451397,0.00068020425,0.00027339178,0.00062273385],"domain_scores_gemma":[0.9966277,0.001502598,0.0009138827,0.0006442501,0.00004674901,0.00026484224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014498333,0.0006882049,0.0021746256,0.0003636506,0.00014684818,0.000045886074,0.0009229293,0.00062540296,0.000050307823],"category_scores_gemma":[0.00018767951,0.000454885,0.00058295304,0.00028035187,0.0006550312,0.000051343664,0.00028059306,0.001996142,0.000016389868],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001338539,0.00089802954,0.08179744,0.0009864542,0.0004811782,0.00013998071,0.0024721674,0.000024473447,0.000001375139,0.00004210713,0.00056738016,0.91245556],"study_design_scores_gemma":[0.0041677183,0.00033328612,0.10478692,0.0011022897,0.0022182656,0.00009507204,0.000093486975,0.00036919312,0.0000014156586,0.00015222323,0.885859,0.0008211432],"about_ca_topic_score_codex":0.000058459696,"about_ca_topic_score_gemma":0.00003052322,"teacher_disagreement_score":0.91163445,"about_ca_system_score_codex":0.000058002624,"about_ca_system_score_gemma":0.000232072,"threshold_uncertainty_score":0.9997903},"labels":[],"label_agreement":null},{"id":"W2745469089","doi":"10.1021/acscatal.7b02634","title":"Substrate-Specific Screening for Mutational Hotspots Using Biased Molecular Dynamics Simulations","year":2017,"lang":"en","type":"article","venue":"ACS Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Molecular dynamics; Docking (animal); Chemistry; Active site; Ligand (biochemistry); Binding site; Stereochemistry; Computational chemistry; Catalysis; Biochemistry","score_opus":0.2488243561479278,"score_gpt":0.4772036746509849,"score_spread":0.2283793185030571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745469089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9640636,0.00061348826,0.032483526,0.00046519036,0.0006318637,0.00039452373,0.0008969326,0.00004487578,0.00040599005],"genre_scores_gemma":[0.99299496,0.00005502583,0.005087667,0.0004319271,0.00027718037,0.00003770326,0.0008575672,0.0000449796,0.00021296399],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984447,0.00010597184,0.00038232884,0.00041332937,0.00020792053,0.00044575203],"domain_scores_gemma":[0.9983574,0.00030720455,0.00034104488,0.0005003157,0.00027051455,0.00022352055],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00044590354,0.00024758017,0.00030293813,0.00019154024,0.0014320712,0.00014952353,0.00054045854,0.00022707805,0.00023101433],"category_scores_gemma":[0.00014329141,0.00027474388,0.00022234528,0.00017063567,0.00021168415,0.00023345431,0.00010502624,0.00029849992,0.000023395705],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039283576,0.0003660263,0.013852673,0.00004293309,0.0011582109,0.00009468679,0.00054763997,0.39583725,0.5404887,0.0048337425,0.00026366083,0.042121585],"study_design_scores_gemma":[0.0030187455,0.000025642055,0.012011311,0.000010001111,0.001145198,0.000013871024,0.000100128666,0.7558499,0.21363373,0.0019002146,0.011728869,0.0005623557],"about_ca_topic_score_codex":0.000045929675,"about_ca_topic_score_gemma":0.000041095947,"teacher_disagreement_score":0.36001268,"about_ca_system_score_codex":0.000075898235,"about_ca_system_score_gemma":0.000119114266,"threshold_uncertainty_score":0.9999705},"labels":[],"label_agreement":null},{"id":"W2747156891","doi":"10.1016/j.bcp.2017.08.015","title":"Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response","year":2017,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Nicotine; Codeine; Morphine; Analgesic; Medicine; Pharmacology; Anesthesia; Drug tolerance; Saline; Opioid; Internal medicine; Receptor","score_opus":0.055320532646532354,"score_gpt":0.3962088917355255,"score_spread":0.3408883590889931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747156891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98029655,0.005547829,0.000057417976,0.010763949,0.0016094729,0.000847361,0.0005659205,0.000049369464,0.00026212892],"genre_scores_gemma":[0.9896772,0.0010452737,0.00012552144,0.0077122124,0.0009951937,0.00012515535,0.000042896027,0.00005296489,0.00022356436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948638,0.002596434,0.0009195105,0.00065886043,0.00022471529,0.0007366823],"domain_scores_gemma":[0.9931431,0.004144536,0.0012636841,0.00082029635,0.00033759052,0.0002908159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031612327,0.0004935345,0.0008497077,0.000097004224,0.00081745256,0.000041790434,0.0017871769,0.0003648745,0.00063675054],"category_scores_gemma":[0.0006295786,0.00031182877,0.0002134147,0.00028844053,0.002063056,0.00014998949,0.00054893957,0.0013125426,0.000015122097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013698438,0.00037283904,0.0036456042,0.0000405322,0.00090000365,0.000041218565,0.00048927695,0.0007404043,0.9412638,0.00006064387,0.037902348,0.0008448946],"study_design_scores_gemma":[0.0064335777,0.00020855863,0.014641318,0.000052350155,0.0012734218,0.000023690625,0.00007436553,0.006092408,0.950718,0.00019793774,0.019952498,0.00033187127],"about_ca_topic_score_codex":0.00029926933,"about_ca_topic_score_gemma":0.000008776126,"teacher_disagreement_score":0.01794985,"about_ca_system_score_codex":0.00004384814,"about_ca_system_score_gemma":0.00030473576,"threshold_uncertainty_score":0.99993336},"labels":[],"label_agreement":null},{"id":"W2748073152","doi":"10.1016/b978-0-12-394591-4.00010-6","title":"Development of Drugs from Plants","year":2012,"lang":"en","type":"book-chapter","venue":"Advances in botanical research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Children's Hospital of Western Ontario","funders":"","keywords":"Drug development; Process (computing); Acknowledgement; Drug; Biology; Biotechnology; Risk analysis (engineering); Engineering ethics; Pharmacology; Business; Engineering; Computer science","score_opus":0.30172983026209554,"score_gpt":0.5443563814510792,"score_spread":0.24262655118898369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748073152","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029010938,0.19200024,0.000027465441,0.00011196909,0.0017766466,0.0007338685,0.0004578918,0.000034109267,0.77584684],"genre_scores_gemma":[0.4939446,0.33026433,0.008836508,0.00075788883,0.00287116,0.00023442825,0.000348924,0.0003198989,0.16242225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611866,0.00035069257,0.0009901176,0.0005806546,0.0010124948,0.000947364],"domain_scores_gemma":[0.996517,0.0021938898,0.00022987857,0.0003906047,0.00019092906,0.00047771813],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002894887,0.0003700637,0.00072100473,0.00026595287,0.00016060821,0.000010457676,0.0008700704,0.0008632079,0.0061854604],"category_scores_gemma":[0.00014583966,0.0003549735,0.00012400528,0.000097269025,0.00060216244,0.0001322723,0.0006102683,0.0033030333,0.0007922151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075239054,0.00034404665,0.00033172077,0.000105526844,0.00021581256,0.000059622485,0.0012759082,0.000022533151,0.013791043,0.027265884,0.0008721484,0.9549634],"study_design_scores_gemma":[0.00096588355,0.000025385305,0.0001692258,0.00012914724,0.00003613364,0.0000014991989,0.00004941189,0.000046001383,0.01698948,0.02096748,0.9602897,0.0003306285],"about_ca_topic_score_codex":0.00000948519,"about_ca_topic_score_gemma":0.00008017,"teacher_disagreement_score":0.9594176,"about_ca_system_score_codex":0.0001807306,"about_ca_system_score_gemma":0.00035445017,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W2750108617","doi":"10.1016/b978-0-12-397220-0.00008-8","title":"Risperidone","year":2012,"lang":"en","type":"review","venue":"Profiles of drug substances, excipients, and related methodology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Risperidone; Pharmacology; Mania; Antipsychotic; ADME; Dopamine receptor D2; Atypical antipsychotic; Chemistry; Schizophrenia (object-oriented programming); Pharmacokinetics; Medicine; Dopamine; Bipolar disorder; Psychiatry; Internal medicine; Lithium (medication)","score_opus":0.33892386013262005,"score_gpt":0.4971902296789574,"score_spread":0.15826636954633733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750108617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013507201,0.9829565,0.00006954638,0.000046423826,0.009155206,0.0014011262,0.00039812693,0.00011040506,0.0045119296],"genre_scores_gemma":[0.00033253647,0.9914825,0.0044382676,0.00011363405,0.0006263712,0.00023389707,0.00025762522,0.000145756,0.0023694057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98919797,0.006194858,0.0020691215,0.0009944625,0.00030818928,0.0012353818],"domain_scores_gemma":[0.99408865,0.0027756717,0.0017470078,0.00056189665,0.0001923651,0.00063442724],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005126076,0.001017041,0.003933771,0.0006184072,0.00028926844,0.000015731966,0.0008080699,0.0020160973,0.0016521012],"category_scores_gemma":[0.00024657245,0.00083172065,0.0007443987,0.0007044391,0.0012416807,0.00015124746,0.00036227144,0.0027151126,0.00017381263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012348486,0.00032839898,0.00015272586,0.008100175,0.0016459203,0.000027594671,0.0012933696,0.0000042134975,0.00016178898,0.0030291455,0.0006507057,0.98448247],"study_design_scores_gemma":[0.0014287863,0.000043595956,0.0000215505,0.00092404155,0.006520204,0.00020089978,0.00011676243,0.0000174607,0.0007593203,0.0012787905,0.9878877,0.0008008879],"about_ca_topic_score_codex":0.00001806329,"about_ca_topic_score_gemma":0.000004293555,"teacher_disagreement_score":0.987237,"about_ca_system_score_codex":0.00006784944,"about_ca_system_score_gemma":0.00025296197,"threshold_uncertainty_score":0.9995857},"labels":[],"label_agreement":null},{"id":"W2751228627","doi":"10.1080/00498254.2017.1376260","title":"The effects of UDP-sugars, UDP and Mg<sup>2+</sup>on uridine diphosphate glucuronosyltransferase activity in human liver microsomes","year":2017,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glucuronidation; Uridine diphosphate; Chemistry; Glucuronosyltransferase; Enzyme; Microsome; Uridine; Glycosyltransferase; Biochemistry; Glucuronic acid; Enzyme kinetics; Enzyme assay; Active site; RNA","score_opus":0.04008693635173147,"score_gpt":0.3796839776649831,"score_spread":0.33959704131325164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751228627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908151,0.004822983,0.000006260876,0.0011023631,0.0006791031,0.00067922124,0.000086479304,0.000028510978,0.0017799897],"genre_scores_gemma":[0.9907229,0.00807822,0.00002725015,0.00049369154,0.00019040726,0.000025800267,0.000005774885,0.00003542545,0.0004205587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979606,0.0004643203,0.0003414956,0.00044675107,0.0001739629,0.0006128267],"domain_scores_gemma":[0.9979102,0.0010105704,0.00018584768,0.00057453325,0.00006174802,0.00025710277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007467242,0.00034421775,0.00045835087,0.00008979472,0.0010739055,0.00009524722,0.0006259569,0.00028399494,0.00010498393],"category_scores_gemma":[0.00022786859,0.00027041725,0.00012134315,0.00007835244,0.00082775264,0.00013163903,0.00021306243,0.0008423244,0.000029741806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094935833,0.00094430154,0.01461882,0.00035085928,0.0002981314,0.00015045918,0.0011378775,0.00014337557,0.92475724,0.0040740795,0.00086445577,0.05171104],"study_design_scores_gemma":[0.0042606406,0.00027925282,0.07313992,0.00006219309,0.00024256979,0.0000069469506,0.000018118852,0.0017247465,0.88194287,0.0004325588,0.03755036,0.0003398368],"about_ca_topic_score_codex":0.000085868014,"about_ca_topic_score_gemma":0.000030777228,"teacher_disagreement_score":0.0585211,"about_ca_system_score_codex":0.00003109465,"about_ca_system_score_gemma":0.000056590172,"threshold_uncertainty_score":0.9999748},"labels":[],"label_agreement":null},{"id":"W2752769263","doi":"10.18433/j3434r","title":"In vitro and in silico Approaches to Study Cytochrome P450-Mediated Interactions","year":2017,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Higher Education, Malaysia","keywords":"In silico; Drug; Computational biology; Drug discovery; Drug development; Computer science; Pharmacology; Bioinformatics; Biology","score_opus":0.6829023743141998,"score_gpt":0.5971896781839786,"score_spread":0.08571269613022114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752769263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05496561,0.9378985,0.0000061307956,0.0014108138,0.0023892613,0.0022480583,0.00013634952,0.000021771024,0.00092350674],"genre_scores_gemma":[0.12481603,0.87271905,0.00020375563,0.001037591,0.00090014574,0.00016673077,0.000006011685,0.000057614405,0.00009308574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99163014,0.0026148271,0.002663826,0.0009786102,0.0008508534,0.0012617208],"domain_scores_gemma":[0.9950238,0.0017969713,0.0013715938,0.00032059327,0.00012208636,0.0013649849],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007639829,0.00091424474,0.0029296118,0.002183752,0.0005013706,0.00026215866,0.002251511,0.0002865064,0.00080145366],"category_scores_gemma":[0.00064327754,0.00072322274,0.0005170654,0.001533383,0.00081305363,0.0008579716,0.0007358371,0.0042861574,0.00010629537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006742012,0.0026993512,0.00074834673,0.0009147073,0.00040558787,0.0010786218,0.0009289378,0.000096136224,0.0045204256,0.000022607623,0.0002753806,0.9876357],"study_design_scores_gemma":[0.004437765,0.00016996806,0.00021540132,0.0005394725,0.0014129572,0.0005474874,0.00018187004,0.0014680047,0.0014477925,0.00006205743,0.98880553,0.00071169075],"about_ca_topic_score_codex":0.00004289792,"about_ca_topic_score_gemma":0.000025544237,"teacher_disagreement_score":0.98853016,"about_ca_system_score_codex":0.00031842172,"about_ca_system_score_gemma":0.00095001573,"threshold_uncertainty_score":0.9995219},"labels":[],"label_agreement":null},{"id":"W2752779553","doi":"10.1176/appi.pn.2017.pp6a2","title":"Should You Order Genetic Tests Before Prescribing Psychotropics?","year":2017,"lang":"en","type":"article","venue":"Psychiatric News","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Genetic testing; Test (biology); Dosing; Medicine; Geneticist; Psychiatry; Psychology; Family medicine; Pharmacology; Genetics; Internal medicine; Biology","score_opus":0.14515483745269475,"score_gpt":0.4550282741424415,"score_spread":0.30987343668974676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752779553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8977919,0.00949082,0.0007077759,0.008223797,0.016998256,0.0010439573,0.00011125024,0.0002268709,0.06540534],"genre_scores_gemma":[0.97397536,0.003077232,0.007801308,0.0059820665,0.0046782885,0.00011873999,0.000018822439,0.000108739965,0.0042394404],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971322,0.00023087766,0.0006210564,0.0007482644,0.00033598102,0.0009316487],"domain_scores_gemma":[0.9975149,0.000069350055,0.00046975605,0.0012077568,0.00017117543,0.00056707603],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039239874,0.00046745167,0.0004425536,0.0002073375,0.0013919622,0.00019300074,0.001418639,0.00044072108,0.0015350214],"category_scores_gemma":[0.00015114681,0.00043425825,0.00023004082,0.00025762408,0.00023446698,0.00020184074,0.00025853165,0.0010645026,0.00063113216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002888484,0.00081102975,0.4920595,0.00009035495,0.00034297214,0.00006507787,0.00065794867,0.0003762085,0.0073037436,0.0018185299,0.08207722,0.41410854],"study_design_scores_gemma":[0.003602194,0.00012610841,0.15014566,0.00000846934,0.00045735043,0.000042371783,0.000036311823,0.0018098075,0.0010508272,0.0058972645,0.8362518,0.0005718614],"about_ca_topic_score_codex":0.00017365976,"about_ca_topic_score_gemma":0.00021276626,"teacher_disagreement_score":0.75417453,"about_ca_system_score_codex":0.000035316687,"about_ca_system_score_gemma":0.00014843234,"threshold_uncertainty_score":0.9999081},"labels":[],"label_agreement":null},{"id":"W2754369675","doi":"10.1002/adsc.201700637","title":"Regioselective Epoxidations by Cytochrome P450 3A4 Using a Theobromine Chemical Auxiliary to Predictably Produce N‐Protected β‐ or γ‐Amino Epoxides","year":2017,"lang":"en","type":"article","venue":"Advanced Synthesis & Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Centre in Green Chemistry and Catalysis","keywords":"Chemistry; Theobromine; Regioselectivity; Steric effects; Selectivity; Double bond; Synthon; Stereoselectivity; Epoxide; Olefin fiber; Stereochemistry; Desymmetrization; Amine gas treating; Organic chemistry; Combinatorial chemistry; Catalysis; Enantioselective synthesis; Caffeine","score_opus":0.10693813652453314,"score_gpt":0.44033620012452096,"score_spread":0.3333980635999878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754369675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217045,0.0010320287,0.0017924103,0.0011742959,0.00041477606,0.0014382354,0.0006112288,0.00020682537,0.0011597368],"genre_scores_gemma":[0.9881179,0.0004592823,0.007908078,0.0006439914,0.0003976776,0.00084160717,0.00007260719,0.00010261601,0.0014562578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961857,0.00043769652,0.0007372865,0.0012328514,0.00041742908,0.0009890369],"domain_scores_gemma":[0.9961824,0.0007248604,0.00062162516,0.0014387111,0.00038320513,0.0006492281],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008431428,0.0006163538,0.0009086752,0.00028108442,0.0014565344,0.00012365026,0.0013185119,0.00038197782,0.00063396763],"category_scores_gemma":[0.004025597,0.0005570502,0.00027538373,0.0005996497,0.00047386106,0.0005467198,0.00044694112,0.00071420235,0.00012420147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092756946,0.00048050546,0.00025865564,0.0000430278,0.00071758626,0.000042227723,0.0004991636,0.00039166654,0.9378058,0.000032168304,0.0010553477,0.057746284],"study_design_scores_gemma":[0.0010909233,0.00007126616,0.0022610049,0.000056358145,0.0013835519,0.000051947292,0.00010474781,0.0019470059,0.9663758,0.00024999984,0.025713032,0.0006943097],"about_ca_topic_score_codex":0.00012893826,"about_ca_topic_score_gemma":0.00003679821,"teacher_disagreement_score":0.057051975,"about_ca_system_score_codex":0.00022310657,"about_ca_system_score_gemma":0.00026426,"threshold_uncertainty_score":0.9998434},"labels":[],"label_agreement":null},{"id":"W2754586269","doi":"10.1016/j.bbapap.2017.09.006","title":"Selecting of a cytochrome P450cam SeSaM library with 3-chloroindole and endosulfan – Identification of mutants that dehalogenate 3-chloroindole","year":2017,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; Simon Fraser University","keywords":"Mutant; Pseudomonas putida; Mutagenesis; Enzyme kinetics; Endosulfan; Chemistry; Stereochemistry; Cytochrome; Biochemistry; Active site; Enzyme; Biology; Pesticide; Ecology; Gene","score_opus":0.06450779699176683,"score_gpt":0.36621596962834835,"score_spread":0.3017081726365815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754586269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952447,0.0004977212,0.0000965846,0.00083250366,0.0001402662,0.0021225573,0.00054397644,0.000057155932,0.00046452694],"genre_scores_gemma":[0.99475706,0.0018065823,0.0026809354,0.000180113,0.00016973601,0.00017670856,0.00004224089,0.00007499398,0.00011163386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976792,0.00027899703,0.00064124423,0.00064562005,0.00026532315,0.00048965483],"domain_scores_gemma":[0.99751085,0.00012311994,0.0013645382,0.0006063213,0.00012649207,0.0002686732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063279213,0.00044432227,0.0006639314,0.00018030933,0.0006052007,0.0001575509,0.0005697381,0.00030479985,0.00003063595],"category_scores_gemma":[0.000070996,0.00038784512,0.00011552381,0.00017131177,0.0007920727,0.00053877296,0.0004207638,0.0005656516,0.0000031855968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010911603,0.00032969515,0.0013620862,0.00033955555,0.00029947297,0.000009046319,0.00085641013,0.000009277634,0.991683,0.0004177607,0.00001819101,0.0035843607],"study_design_scores_gemma":[0.0025766506,0.00034019188,0.03956276,0.00010095446,0.00026711888,0.000046853296,0.00007460411,0.0009866301,0.9544458,0.000895751,0.00028676042,0.00041596193],"about_ca_topic_score_codex":0.00005316268,"about_ca_topic_score_gemma":0.0000075122994,"teacher_disagreement_score":0.038200673,"about_ca_system_score_codex":0.000015174639,"about_ca_system_score_gemma":0.00020804652,"threshold_uncertainty_score":0.99985737},"labels":[],"label_agreement":null},{"id":"W2758448813","doi":"10.3390/pharmaceutics9040040","title":"Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues","year":2017,"lang":"en","type":"article","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Tolbutamide; Endocrinology; Internal medicine; Cytochrome P450; CYP3A; Microsome; Kidney; Biology; Diabetes mellitus; Type 2 diabetes; Drug metabolism; Enzyme; Metabolism; Medicine; Biochemistry","score_opus":0.1396658508275451,"score_gpt":0.43840565405088816,"score_spread":0.29873980322334304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758448813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606764,0.037915286,0.000002690878,0.0001537838,0.00032920658,0.0005194863,0.00014724625,0.00001083948,0.000245087],"genre_scores_gemma":[0.9781543,0.021502718,0.00006117533,0.000088366236,0.00009082696,0.000013788105,0.000006425831,0.000027661781,0.000054731285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981124,0.0005042861,0.00045488274,0.00034296955,0.00018277271,0.00040271878],"domain_scores_gemma":[0.9985467,0.00061807124,0.00037768908,0.00024104213,0.00006107939,0.00015540775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010471657,0.00031910223,0.000566621,0.00018534421,0.00024468175,0.000055075816,0.0002709368,0.000164196,0.00007110777],"category_scores_gemma":[0.00008550282,0.000260212,0.000049416074,0.00013237563,0.0004541557,0.00026414546,0.00019436255,0.0005918966,0.0000014707856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000398553,0.00035142354,0.18901548,0.00017281358,0.0001755613,0.0000089157165,0.0038945873,0.00029022308,0.74934435,0.00025762484,0.00012585014,0.055964634],"study_design_scores_gemma":[0.0019709638,0.00011395704,0.26671383,0.00005219319,0.00015848514,0.0000028379955,0.00013842955,0.018055001,0.71016943,0.00039735454,0.0019679866,0.00025951912],"about_ca_topic_score_codex":0.00022230696,"about_ca_topic_score_gemma":0.000034045308,"teacher_disagreement_score":0.07769837,"about_ca_system_score_codex":0.000035463592,"about_ca_system_score_gemma":0.000042713058,"threshold_uncertainty_score":0.99998504},"labels":[],"label_agreement":null},{"id":"W2759360483","doi":"10.1093/nar/gkx911","title":"PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies","year":2017,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Genentech; Ontario Institute for Cancer Research; Stand Up To Cancer; Princess Margaret Cancer Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Compendium; Pharmacogenomics; Biology; Leverage (statistics); Data curation; Drug discovery; Computational biology; Drug response; Cancer cell lines; Prioritization; Drug; Identifier; Computer science; Bioinformatics; Data science; Cancer; Pharmacology; Cancer cell; Machine learning; Genetics","score_opus":0.43499143138287516,"score_gpt":0.6012958507078576,"score_spread":0.16630441932498247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759360483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98575544,0.004967375,0.00022782148,0.0022625264,0.0014101393,0.0012636038,0.0005125904,0.000064336185,0.0035361813],"genre_scores_gemma":[0.98673356,0.0037862093,0.0055562602,0.00084728806,0.0010522224,0.0004587843,0.000062929,0.000074746524,0.0014279856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99547714,0.0012462945,0.0005121127,0.000827824,0.0005802104,0.0013564392],"domain_scores_gemma":[0.9965143,0.0013819231,0.00019456177,0.00075299246,0.0006569498,0.0004992576],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0070241443,0.00035866126,0.0005906638,0.00046555584,0.002082318,0.00018927945,0.0015754044,0.00019892583,0.00037361178],"category_scores_gemma":[0.0014384121,0.0003192727,0.00013011225,0.0002831475,0.0012816363,0.0006999272,0.00083855266,0.0017926695,0.00004824456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035125911,0.00058331917,0.009202435,0.00015121787,0.00044219088,0.0001418944,0.009541755,0.00009662277,0.6797021,0.0005654017,0.01375651,0.28230393],"study_design_scores_gemma":[0.008896934,0.00017958309,0.003294489,0.00014180734,0.00017328889,0.000009766433,0.00875611,0.071892925,0.6849498,0.0011633576,0.21983759,0.0007043258],"about_ca_topic_score_codex":0.00012153218,"about_ca_topic_score_gemma":0.00010722194,"teacher_disagreement_score":0.2815996,"about_ca_system_score_codex":0.00013184272,"about_ca_system_score_gemma":0.00022325377,"threshold_uncertainty_score":0.9999259},"labels":[],"label_agreement":null},{"id":"W2761432469","doi":"10.1021/acsmedchemlett.7b00265","title":"Structure-Based Design and Synthesis of New Estrane–Pyridine Derivatives as Cytochrome P450 (CYP) 1B1 Inhibitors","year":2017,"lang":"en","type":"article","venue":"ACS Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec - Santé; Consejo Nacional de Ciencia y Tecnología","keywords":"Chemistry; Cytochrome P450; CYP1B1; Steroid; Docking (animal); Stereochemistry; Moiety; IC50; Pharmacology; Potency; Enzyme; Biochemistry; In vitro; Biology; Medicine","score_opus":0.07270678584486652,"score_gpt":0.3891158669613458,"score_spread":0.3164090811164793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761432469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900608,0.00092605146,0.00040630327,0.007383515,0.0003235247,0.00027063914,0.00004979295,0.000035536366,0.00054385816],"genre_scores_gemma":[0.9952112,0.00024648625,0.00094424887,0.002651877,0.0008114847,0.000018125605,0.000013913086,0.000035324683,0.00006736596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982066,0.00014721612,0.0004249121,0.00043553408,0.00033021343,0.00045548534],"domain_scores_gemma":[0.99799395,0.0005579092,0.00044037556,0.0004298408,0.00008181776,0.0004961078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000473409,0.00037182105,0.0005091041,0.000047921978,0.00036326566,0.000036712394,0.00059960055,0.00027671293,0.00067037164],"category_scores_gemma":[0.0005318571,0.00034245904,0.000080776175,0.000090864305,0.000950579,0.000107445725,0.0001019026,0.000630321,0.0000064679357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004176294,0.00007295568,0.0009445035,0.0002036147,0.00019717713,0.00011198521,0.0003151525,0.00041833884,0.9855488,0.000008502096,0.003044923,0.00871644],"study_design_scores_gemma":[0.0024667785,0.00003928656,0.0027426402,0.00008898561,0.00044489233,0.00005924531,0.000057285557,0.00044206125,0.98865545,0.00014523717,0.0045393407,0.0003188135],"about_ca_topic_score_codex":0.000067192836,"about_ca_topic_score_gemma":7.9206825e-7,"teacher_disagreement_score":0.008397627,"about_ca_system_score_codex":0.000033652796,"about_ca_system_score_gemma":0.0002350057,"threshold_uncertainty_score":0.9999027},"labels":[],"label_agreement":null},{"id":"W2761667289","doi":"10.1002/cpt.807","title":"Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; U.S. Food and Drug Administration; National Institutes of Health","keywords":"CYP2C8; CYP2C9; CYP2C19; CYP1A2; Pharmacology; CYP3A4; Cytochrome P450; Tolbutamide; Pharmacokinetics; CYP2D6; Chemistry; Kidney disease; Medicine; Biochemistry; Metabolism; Internal medicine","score_opus":0.1731719731352774,"score_gpt":0.537432668628869,"score_spread":0.3642606954935915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761667289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803479,0.0053935302,0.00018930771,0.0033300188,0.0067317677,0.0025053981,0.0004236098,0.00007503805,0.001003457],"genre_scores_gemma":[0.9789782,0.010149654,0.0001042991,0.009380663,0.0009310637,0.00023113313,0.00004023626,0.0000730412,0.000111678324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9919769,0.0041478756,0.0018738242,0.00079498393,0.0004899498,0.0007164519],"domain_scores_gemma":[0.9917428,0.0041032396,0.001971281,0.000890377,0.0003385584,0.00095374853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005595492,0.0006328334,0.0017152388,0.00023193855,0.0005715478,0.00004345537,0.0011448329,0.0005458527,0.0004340949],"category_scores_gemma":[0.00042581648,0.00052566844,0.0005418398,0.00013747688,0.0018258091,0.0001590916,0.00041779465,0.0015072417,0.000035831214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016852818,0.014238019,0.09387684,0.044067647,0.014753782,0.0005397041,0.0009426035,0.001861355,0.6845308,0.0032229978,0.008881265,0.116232194],"study_design_scores_gemma":[0.06855482,0.018156758,0.10541116,0.0045584063,0.044988796,0.000071161485,0.00007837771,0.22465198,0.48212612,0.0013387853,0.04720386,0.002859803],"about_ca_topic_score_codex":0.000004535408,"about_ca_topic_score_gemma":0.000001284699,"teacher_disagreement_score":0.22279061,"about_ca_system_score_codex":0.00010953674,"about_ca_system_score_gemma":0.0006021519,"threshold_uncertainty_score":0.9997195},"labels":[],"label_agreement":null},{"id":"W2762816559","doi":"10.1016/j.pharmthera.2017.10.008","title":"CYP-mediated drug metabolism in the brain impacts drug response","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; Ontario Ministry of Research, Innovation and Science; Canada Research Chairs; Canada Foundation for Innovation; Campbell Family Mental Health Research Institute; Centre for Addiction and Mental Health","keywords":"Biology; Neuroscience; Drug development; Cytochrome P450; Pharmacology; Human brain; In vivo; Drug metabolism; Drug; Metabolism; Endocrinology","score_opus":0.2815211223130383,"score_gpt":0.5297347115403458,"score_spread":0.24821358922730752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762816559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025582116,0.9680988,0.000003391321,0.011858153,0.010034149,0.0042143795,0.001071868,0.00022723607,0.0019338185],"genre_scores_gemma":[0.00198155,0.94272286,0.00004223861,0.048479587,0.002416604,0.001239317,0.00031574303,0.0003358167,0.0024662944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97245073,0.020063624,0.0024192994,0.001613352,0.00080341846,0.002649579],"domain_scores_gemma":[0.98362964,0.011528291,0.0020993925,0.0017251925,0.00025872848,0.00075875333],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.013697852,0.0021663627,0.0042939773,0.0012332367,0.0013030391,0.00026052294,0.0057915864,0.0017582837,0.0017343092],"category_scores_gemma":[0.00025457604,0.0015934407,0.0015500613,0.0011442237,0.0014272385,0.00032590542,0.00074619456,0.0080073355,0.0015221006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025788832,0.0022378813,0.00004156766,0.0030204607,0.0064617037,0.0015500861,0.007329143,0.000033408975,0.0030220957,0.00023933085,0.11870676,0.85477865],"study_design_scores_gemma":[0.004538058,0.0000550211,0.0000845608,0.00039852053,0.01249763,0.00025381558,0.00012716583,0.00017580655,0.00050710276,0.00020933995,0.97964036,0.0015126432],"about_ca_topic_score_codex":0.000057550853,"about_ca_topic_score_gemma":0.000056963632,"teacher_disagreement_score":0.8609336,"about_ca_system_score_codex":0.00034772887,"about_ca_system_score_gemma":0.0020771676,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2764326385","doi":"10.24870/cjb.2017-a136","title":"To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Acenocoumarol; VKORC1; Medicine; Polymorphism (computer science); Internal medicine; Genetics; CYP2C9; Biology; Genotype; Warfarin; Atrial fibrillation","score_opus":0.11148756650387337,"score_gpt":0.4305755999784015,"score_spread":0.31908803347452813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764326385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802226,0.00027763253,0.0000058939263,0.00075322547,0.00040932267,0.0003596775,0.00006134538,0.0000016572145,0.00010898313],"genre_scores_gemma":[0.99947035,0.00012798325,0.00020030575,0.00016307685,0.000025553603,0.000003865494,5.8320154e-7,0.0000070509363,0.000001211385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978823,0.00049220637,0.0010744088,0.00019509942,0.00010510595,0.00025084754],"domain_scores_gemma":[0.9982571,0.00025813607,0.00081682677,0.00026350396,0.00014554591,0.00025887953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018466125,0.00012326564,0.0006212748,0.0006468573,0.00005608039,0.0000042952565,0.0005244295,0.0004969692,0.00006977732],"category_scores_gemma":[0.0014228176,0.00011338042,0.0000600392,0.0001553303,0.000499138,0.000050166473,0.00009060815,0.00078754954,5.5413864e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046186152,0.00066097203,0.8415902,0.000009219462,0.000027949565,0.000040716306,0.0004065487,0.000019726085,0.011418472,0.00019853159,0.0000052956075,0.14516051],"study_design_scores_gemma":[0.0035264841,0.0018054905,0.91786516,0.000017331575,0.00005329492,0.0000061988985,0.00012731558,0.0003755639,0.07435612,0.0010385639,0.00074149255,0.000086996675],"about_ca_topic_score_codex":0.0010929357,"about_ca_topic_score_gemma":0.0051598605,"teacher_disagreement_score":0.14507352,"about_ca_system_score_codex":0.000021696793,"about_ca_system_score_gemma":0.00027547104,"threshold_uncertainty_score":0.46235192},"labels":[],"label_agreement":null},{"id":"W2765994390","doi":"10.1111/cts.12517","title":"Using Physiologically Based Pharmacokinetic Modeling for Mechanistic Insight: Cases of Reverse Translation","year":2017,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Translation (biology); Computational biology; Computer science; Chemistry; Biology; Biochemistry","score_opus":0.6549223130597572,"score_gpt":0.5847734511055931,"score_spread":0.07014886195416414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765994390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93253857,0.0005690455,0.06404929,0.0007205488,0.0008615414,0.00048185544,0.00016479376,0.000017380184,0.00059698295],"genre_scores_gemma":[0.98560363,0.00020489351,0.013432985,0.0005125049,0.00021014328,0.000012541734,0.000007994998,0.000007401407,0.000007911812],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985258,0.00011478312,0.00051004865,0.00038578457,0.0002099859,0.00025357527],"domain_scores_gemma":[0.9984368,0.000759503,0.00020339646,0.00015186812,0.00022822055,0.00022020639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016058965,0.0001364177,0.00026521613,0.00006864298,0.00089780777,0.000033140113,0.00035434475,0.0001271708,0.000099296565],"category_scores_gemma":[0.00034348154,0.0001152206,0.00013081575,0.00009588951,0.0012451158,0.00019953212,0.00003071771,0.00021573895,0.0000015305743],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014388486,0.00063397666,0.007844382,0.00014397677,0.000081802165,0.000010732835,0.00020496774,0.08512717,0.73336315,0.010930468,0.000012369602,0.16020815],"study_design_scores_gemma":[0.0024908942,0.000086703265,0.004793715,0.00001664912,0.00020217516,0.0000036458193,0.000004947272,0.9692575,0.01124445,0.00958067,0.0021604355,0.00015827101],"about_ca_topic_score_codex":0.000011276731,"about_ca_topic_score_gemma":0.000002906831,"teacher_disagreement_score":0.8841303,"about_ca_system_score_codex":0.000004068381,"about_ca_system_score_gemma":0.00021907446,"threshold_uncertainty_score":0.6905302},"labels":[],"label_agreement":null},{"id":"W2766764745","doi":"10.1016/b978-0-12-802101-9.00020-x","title":"Introduction to Clinical Pharmacology","year":2016,"lang":"en","type":"book-chapter","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacology; Drug; Clinical pharmacology; Drug action; Pharmacogenomics; Drug metabolism; Pharmacokinetics; Systems pharmacology; ADME; Computational biology; Medicine; Biology","score_opus":0.2261056930791441,"score_gpt":0.5263748928313229,"score_spread":0.3002691997521788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766764745","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025062213,0.004564421,0.0015143299,0.12560342,0.07154889,0.0021824276,0.0009173769,0.00025517438,0.76835173],"genre_scores_gemma":[0.183081,0.01839237,0.0028966463,0.043750893,0.11731651,0.00008788138,0.00007747787,0.00016652691,0.6342307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99622375,0.00022098412,0.0012969102,0.001279968,0.0004585493,0.00051982614],"domain_scores_gemma":[0.99678797,0.0012074169,0.00025731043,0.00023595181,0.00033928818,0.0011720449],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004809777,0.00036572188,0.0006349974,0.00022937375,0.00043455535,0.000039794475,0.0005594956,0.0007219246,0.0072096707],"category_scores_gemma":[0.00019682715,0.00029030608,0.00027820928,0.00012628181,0.0037630515,0.00015061848,0.00017933952,0.0013571202,0.0013383493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007207048,0.00025575192,0.0042314944,0.000024590794,0.00027779103,0.000028079723,0.0000664,0.000036639525,0.002889634,0.23470692,0.05457486,0.7021871],"study_design_scores_gemma":[0.0014906728,0.00014710236,0.005502648,0.000013777012,0.00026770207,0.00001693218,8.2448696e-7,0.00015920779,0.0002920709,0.028060202,0.9636645,0.00038438715],"about_ca_topic_score_codex":5.841296e-7,"about_ca_topic_score_gemma":0.000001773819,"teacher_disagreement_score":0.9090896,"about_ca_system_score_codex":0.000016868655,"about_ca_system_score_gemma":0.0005265893,"threshold_uncertainty_score":0.9999549},"labels":[],"label_agreement":null},{"id":"W2767557583","doi":"10.1186/s40360-017-0173-2","title":"Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)","year":2017,"lang":"en","type":"article","venue":"BMC Pharmacology and Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Interdisciplinary Research in Rehabilitation; Institut Universitaire en Santé Mentale de Québec","funders":"","keywords":"CYP2C19; Venlafaxine; CYP2D6; Medicine; Pharmacology; Dextromethorphan; Fexofenadine; Pharmacokinetics; CYP2C9; Internal medicine; Antidepressant; Cytochrome P450","score_opus":0.2965094400008791,"score_gpt":0.43603541099223486,"score_spread":0.13952597099135577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767557583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843151,0.0007900234,0.00081738085,0.00043737952,0.0046068984,0.005187914,0.00006747621,0.00026895796,0.0035088724],"genre_scores_gemma":[0.9929995,0.0004657885,0.0010723802,0.0011067372,0.0013309844,0.0025331278,0.000017263303,0.00011803509,0.00035621235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908998,0.003762896,0.0011339943,0.0019875239,0.00044056514,0.0017752098],"domain_scores_gemma":[0.9954719,0.0012570601,0.0008693999,0.0010872835,0.0003096211,0.0010047316],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039880523,0.0010614485,0.0014718615,0.00050653674,0.0027994323,0.00016749211,0.00161768,0.0004600031,0.0010796738],"category_scores_gemma":[0.00037160332,0.00094477076,0.00018420715,0.0004212057,0.001280348,0.00071600487,0.001200268,0.0023046092,0.00007766537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058894977,0.02885787,0.85683453,0.00035068137,0.0034634047,0.00097198505,0.009250435,0.0026597138,0.047435313,0.000352158,0.0007125931,0.043221813],"study_design_scores_gemma":[0.058541868,0.0031121671,0.8622087,0.000020756725,0.006647833,0.0003181,0.0024500526,0.03207454,0.010854658,0.00030665638,0.02125299,0.002211672],"about_ca_topic_score_codex":0.00016554935,"about_ca_topic_score_gemma":0.00015034508,"teacher_disagreement_score":0.05265237,"about_ca_system_score_codex":0.00014848453,"about_ca_system_score_gemma":0.00032414697,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2769856431","doi":"10.1016/j.bbapap.2017.11.001","title":"Preface: Cytochrome P450","year":2017,"lang":"en","type":"editorial","venue":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Computational biology; Biology","score_opus":0.06422005469217126,"score_gpt":0.4198605908413041,"score_spread":0.3556405361491328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769856431","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58436394,0.0030971544,0.00006724054,0.0028069394,0.387905,0.0081241205,0.0077441293,0.00043147782,0.0054600295],"genre_scores_gemma":[0.15906174,0.028162539,0.0040276996,0.0013494837,0.7929731,0.0029208171,0.0023275989,0.00068107364,0.008495947],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937616,0.0008829101,0.0011057423,0.0018821375,0.0009165685,0.001451038],"domain_scores_gemma":[0.99502563,0.00050523336,0.0015725832,0.0015523134,0.00046252555,0.0008817067],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0015852271,0.0015798567,0.0016973648,0.00032530227,0.0013308537,0.00059929554,0.0020226538,0.0035417231,0.0002461854],"category_scores_gemma":[0.00055405125,0.0014898385,0.0005414271,0.00021780873,0.0010564231,0.00036493354,0.0012419464,0.0052018687,0.00019743544],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000754964,0.00043249194,6.5889606e-7,0.0004984364,0.0006567165,0.000034613764,0.00040589235,0.000003936961,0.6864896,0.000121607336,0.30778465,0.0028164673],"study_design_scores_gemma":[0.0021729823,0.0002908422,0.000084935426,0.00013335879,0.00061570015,0.000008336321,0.000009556305,0.00017702093,0.41091534,0.0008125369,0.5836134,0.0011659939],"about_ca_topic_score_codex":0.00011126106,"about_ca_topic_score_gemma":0.00001764116,"teacher_disagreement_score":0.42530218,"about_ca_system_score_codex":0.00013877782,"about_ca_system_score_gemma":0.0013764083,"threshold_uncertainty_score":0.9999693},"labels":[],"label_agreement":null},{"id":"W2770199471","doi":"10.1002/cpt.921","title":"Commentary on “The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio”","year":2017,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical pharmacology; Pharmacokinetics; Clearance; Drug; Metabolic clearance rate; Drug development; Subject (documents); Pharmacology; Medicine; Intensive care medicine; Nothing; Computer science; Epistemology; Philosophy; Urology","score_opus":0.2219440488571743,"score_gpt":0.4991478039572035,"score_spread":0.27720375510002915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770199471","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21358773,0.0019515128,0.000027327487,0.7685141,0.013457549,0.001472944,0.00018241607,0.00012226886,0.0006841741],"genre_scores_gemma":[0.070125714,0.015946168,0.000049275073,0.9009443,0.010857562,0.00011376335,0.00017946005,0.00013804853,0.0016457272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99037725,0.005673032,0.0014000741,0.0011448556,0.00038927532,0.0010155092],"domain_scores_gemma":[0.99048966,0.0071901763,0.0012399676,0.000626474,0.00019424176,0.00025949941],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0039213737,0.00081492565,0.001092805,0.00027062686,0.000983029,0.000107339394,0.0012247514,0.0022339877,0.0011178206],"category_scores_gemma":[0.00011658518,0.00070896844,0.00033183073,0.00018664515,0.001485895,0.00020586382,0.000319112,0.013028154,0.0002073993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015110731,0.00058892387,0.005639463,0.000068875524,0.0014115864,0.00051845884,0.00040322353,0.00011076301,0.0037137205,0.000007419206,0.9692607,0.016765775],"study_design_scores_gemma":[0.0063026315,0.00017224523,0.003821518,0.00006887973,0.0023106032,0.000028443057,0.00005576453,0.006682572,0.0029220947,0.00028453037,0.9766844,0.0006663297],"about_ca_topic_score_codex":0.000029901974,"about_ca_topic_score_gemma":0.000048558297,"teacher_disagreement_score":0.14346202,"about_ca_system_score_codex":0.00018442373,"about_ca_system_score_gemma":0.00023095838,"threshold_uncertainty_score":0.9997953},"labels":[],"label_agreement":null},{"id":"W2771880689","doi":"10.3390/jpm7040020","title":"Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen","year":2017,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenomics; Tamoxifen; Warfarin; Medicine; Pharmacogenetics; Personalization; Personalized medicine; Intensive care medicine; Pharmacology; Bioinformatics; Internal medicine; Breast cancer; Cancer; Computer science; Biology; World Wide Web","score_opus":0.556044632740589,"score_gpt":0.5981635554475209,"score_spread":0.04211892270693185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771880689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035576196,0.9929782,0.00011442707,0.0004180515,0.003194981,0.00054091617,0.00014578784,0.000010914604,0.002240927],"genre_scores_gemma":[0.00018065216,0.99420595,0.00033718866,0.0005394635,0.0028944286,0.0000125216375,0.000044780703,0.000084056075,0.0017009729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955178,0.0008503763,0.0022355118,0.00035915035,0.0005993166,0.00043785138],"domain_scores_gemma":[0.99316704,0.00060223765,0.0046828333,0.00030684314,0.0006184737,0.0006225952],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003606415,0.00064429943,0.003746568,0.00065555534,0.00022223148,0.000020233996,0.00089487096,0.00065033266,0.001633099],"category_scores_gemma":[0.0006310058,0.00046726628,0.00070074457,0.00021430112,0.0010323459,0.00014319469,0.00016101348,0.0015203053,0.000011462795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022389714,0.00017633454,0.00004259053,0.010062738,0.002041507,0.00019486262,0.0014193876,0.0000043426207,0.0012930376,0.00042364266,0.016417021,0.96770066],"study_design_scores_gemma":[0.004738396,0.0001927252,0.0000062832855,0.004303061,0.010065106,0.0013277453,0.000067036046,0.000088195266,0.00013494503,0.00018025257,0.9785377,0.00035855835],"about_ca_topic_score_codex":0.000014629502,"about_ca_topic_score_gemma":8.9107095e-7,"teacher_disagreement_score":0.9673421,"about_ca_system_score_codex":0.000116668154,"about_ca_system_score_gemma":0.0007800112,"threshold_uncertainty_score":0.9997779},"labels":[],"label_agreement":null},{"id":"W2774341657","doi":"10.3390/jpm7040018","title":"Variation in CYP2A6 Activity and Personalized Medicine","year":2017,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2A6; Nicotine; Pharmacology; Medicine; Cotinine; CYP2B6; Smoking cessation; Biology; Metabolism; CYP1A2; Cytochrome P450; Internal medicine","score_opus":0.37982175830355913,"score_gpt":0.563437463912288,"score_spread":0.18361570560872886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774341657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007730847,0.98918086,0.00007205865,0.0027971854,0.0038249341,0.0006531833,0.00004743121,0.000013938837,0.002637309],"genre_scores_gemma":[0.0005841294,0.9919128,0.000112319416,0.00073344255,0.0045551076,0.000027510176,0.000018233293,0.00007047654,0.001986015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466306,0.0017936169,0.0017240786,0.00049080694,0.00076486164,0.0005635794],"domain_scores_gemma":[0.9939221,0.0013579818,0.003351645,0.000332563,0.0003435369,0.00069217256],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0064255293,0.0007486111,0.004597363,0.0010369298,0.00025500607,0.000022387745,0.0007323184,0.0008754048,0.0028165954],"category_scores_gemma":[0.0015902976,0.00050222967,0.00047461083,0.00032874543,0.0013359733,0.0002082226,0.000120141434,0.0029814814,0.000014974016],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061161164,0.0002238892,0.000031727934,0.0047830623,0.0010460907,0.0005808183,0.003217486,0.0000011635973,0.0011549548,0.00055458787,0.0042221337,0.9835725],"study_design_scores_gemma":[0.010454151,0.0003268166,0.0002499685,0.0077563697,0.0057093906,0.0010251739,0.00009337851,0.00007949134,0.0000057296156,0.00034438676,0.973561,0.0003941372],"about_ca_topic_score_codex":0.00008458803,"about_ca_topic_score_gemma":0.00001094524,"teacher_disagreement_score":0.9831783,"about_ca_system_score_codex":0.00023804988,"about_ca_system_score_gemma":0.00070111017,"threshold_uncertainty_score":0.9997429},"labels":[],"label_agreement":null},{"id":"W2776825260","doi":"10.30699/mmlj17.1.3.107","title":"New Platforms For Drug Screening And Toxicology: Necessity Or Need?","year":2018,"lang":"en","type":"article","venue":"Modern Medical Laboratory Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug; Drug metabolism; Biotransformation; Xenobiotic; Pharmacology; Biology; Risk analysis (engineering); Computational biology; Toxicology; Medicine; Biochemistry","score_opus":0.09705772068852357,"score_gpt":0.4386718224724832,"score_spread":0.3416141017839596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776825260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87578374,0.005718302,0.10645121,0.00626479,0.004463846,0.00042486147,0.00012949004,0.000102091784,0.0006616405],"genre_scores_gemma":[0.930048,0.0025412624,0.018228455,0.034771975,0.012081046,0.00003761915,0.00001556363,0.00009937703,0.0021767356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975545,0.00023586697,0.0005778927,0.00036544775,0.00049762166,0.00076870836],"domain_scores_gemma":[0.9966892,0.00050240534,0.00024767505,0.00015477891,0.00035671177,0.0020492433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028122733,0.0003026524,0.00044385635,0.00015385897,0.0009450632,0.00008275812,0.0005188837,0.0005235014,0.004563093],"category_scores_gemma":[0.0006267254,0.0002231417,0.00009834233,0.00024362277,0.0004751777,0.00025832077,0.00018161454,0.0015324272,0.000033210454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034802272,0.0003501847,0.008416679,0.0000721387,0.00059181545,0.0003165265,0.0029873531,0.000053239633,0.024036227,0.0013397249,0.24216749,0.7161884],"study_design_scores_gemma":[0.008953578,0.00036590738,0.0010755473,0.00005152529,0.0003132013,0.00040417677,0.00020514635,0.033265382,0.023673309,0.0091480855,0.9220304,0.00051374757],"about_ca_topic_score_codex":0.0000048908164,"about_ca_topic_score_gemma":0.000044128534,"teacher_disagreement_score":0.71567464,"about_ca_system_score_codex":0.000039435057,"about_ca_system_score_gemma":0.0011584419,"threshold_uncertainty_score":0.9963469},"labels":[],"label_agreement":null},{"id":"W2781698184","doi":"10.1016/j.jpsychires.2017.09.002","title":"Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT study","year":2018,"lang":"en","type":"article","venue":"Journal of Psychiatric Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; Ontario Ministry of Research, Innovation and Science; Ontario Ministry of Research and Innovation; Centre for Addiction and Mental Health Foundation; Institute for Clinical Evaluative Sciences; National Alliance for Research on Schizophrenia and Depression","keywords":"Medicine; Protocol (science); Pharmacogenetics; Psychiatry; Tolerability; Genetic testing; Personalized medicine; Health care; Population; Mental health; Precision medicine; Alternative medicine; Pharmacology; Bioinformatics; Adverse effect","score_opus":0.30017394012414556,"score_gpt":0.5821929723942281,"score_spread":0.2820190322700825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781698184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734933,0.00067087176,0.00018288314,0.0005427159,0.0006423895,0.023528459,0.000002441182,0.0000058448213,0.0009311146],"genre_scores_gemma":[0.9923106,0.000068657435,0.004622749,0.00007980973,0.001207001,0.0016445917,7.647471e-8,0.000024094963,0.000042407104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99366915,0.0031408963,0.0013874861,0.00027296357,0.00092480954,0.00060469756],"domain_scores_gemma":[0.9965824,0.0010737515,0.0009285291,0.00028937912,0.00090596074,0.00021998092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013155271,0.00018831925,0.00036771197,0.0008139718,0.00039064963,0.00004573141,0.000802249,0.00015547803,0.00028631397],"category_scores_gemma":[0.0014874729,0.00012263938,0.00012082804,0.002183808,0.00031544478,0.000102092075,0.00022105435,0.001611551,0.000008778558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014626205,0.0016316943,0.92100805,0.000114994575,0.00017683397,0.000037106605,0.0025021117,0.0010810896,0.013421359,0.000042037816,0.0044720843,0.05405],"study_design_scores_gemma":[0.0124859,0.005980345,0.9454996,0.00008287143,0.00030425447,0.0004836864,0.0011761562,0.014834999,0.00562959,0.009272755,0.003899045,0.00035078803],"about_ca_topic_score_codex":0.00009659866,"about_ca_topic_score_gemma":0.0000068173463,"teacher_disagreement_score":0.05369921,"about_ca_system_score_codex":0.00006897423,"about_ca_system_score_gemma":0.0012617506,"threshold_uncertainty_score":0.7001477},"labels":[],"label_agreement":null},{"id":"W2782322064","doi":"10.1038/s41397-017-0005-1","title":"Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort","year":2018,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Warfarin; CYP2C9; Calcitriol receptor; Single-nucleotide polymorphism; Nuclear receptor; Pharmacology; Biology; VKORC1; Pharmacogenetics; Internal medicine; Pregnane X receptor; Gene; Medicine; Genetics; Genotype; Transcription factor; Atrial fibrillation","score_opus":0.11906800606484878,"score_gpt":0.41069884615588936,"score_spread":0.29163084009104057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782322064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98184985,0.00386469,0.00004896488,0.007106788,0.0033781012,0.0007696429,0.00006665834,0.00003946467,0.0028758268],"genre_scores_gemma":[0.97134197,0.009096243,0.00025067883,0.015383141,0.0030983493,0.00003452201,0.0000110918645,0.000078355144,0.00070562883],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.995663,0.001569291,0.00086292805,0.00046238757,0.00044323696,0.0009991534],"domain_scores_gemma":[0.99827904,0.00029271856,0.00040960038,0.000412161,0.00016238693,0.00044409366],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005277967,0.000459695,0.0004177128,0.00021682538,0.0014050568,0.00022247736,0.0015208735,0.0002240559,0.0024000558],"category_scores_gemma":[0.0000572089,0.0003046372,0.00017521287,0.00038563355,0.0008878267,0.00023656347,0.00040662367,0.0020530978,0.00042703352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015799865,0.0006044173,0.012891372,0.000012416474,0.0007997272,0.00016865887,0.009000039,0.0001733347,0.85928816,0.0014081465,0.021423142,0.09265063],"study_design_scores_gemma":[0.006951407,0.00018263812,0.01594609,0.000017497945,0.00084408664,0.0015255273,0.00047911695,0.0055603376,0.07576827,0.0018042626,0.89016783,0.00075292913],"about_ca_topic_score_codex":0.00034312095,"about_ca_topic_score_gemma":0.00013214434,"teacher_disagreement_score":0.8687447,"about_ca_system_score_codex":0.00021253127,"about_ca_system_score_gemma":0.00019987568,"threshold_uncertainty_score":0.9999406},"labels":[],"label_agreement":null},{"id":"W2783088493","doi":"10.2174/1386207321666180115094814","title":"Fast Screening Technology for Drug Emergency Management: Predicting Suspicious SNPs for ADR with Information Theory-based Models","year":2018,"lang":"en","type":"article","venue":"Combinatorial Chemistry & High Throughput Screening","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Single-nucleotide polymorphism; SNP; Computational biology; Computer science; Data mining; Bioinformatics; Genetics; Genotype; Biology; Gene","score_opus":0.043012628626827955,"score_gpt":0.3563074274735897,"score_spread":0.3132947988467617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783088493","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21779887,0.0005777142,0.7656819,0.00083116704,0.004806337,0.002576916,0.0005028566,0.00068165764,0.0065425755],"genre_scores_gemma":[0.96457297,0.00006857094,0.030943917,0.00039491238,0.0021943254,0.0008176628,0.00043743127,0.00009682278,0.00047337764],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99699444,0.00011781871,0.0008250023,0.0006573516,0.00035784856,0.0010475618],"domain_scores_gemma":[0.9975828,0.0003013649,0.00057925016,0.0004761392,0.00079758704,0.00026285398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013370853,0.0005638201,0.00054284895,0.00017871156,0.0012656094,0.00007055201,0.0007995804,0.00052889006,0.00021208686],"category_scores_gemma":[0.00013373158,0.0005708734,0.00020498638,0.0005815406,0.00037929366,0.0005626864,0.00024636296,0.0006540186,0.000008757574],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034262124,0.0018828165,0.0055694063,0.0047505763,0.006067636,0.00005199593,0.005134703,0.08639304,0.079690315,0.49006966,0.022278544,0.26384917],"study_design_scores_gemma":[0.024542369,0.0004879086,0.000046123747,0.00019532177,0.001538084,0.000015584576,0.0011465787,0.15475573,0.56838024,0.08918633,0.15828775,0.0014179744],"about_ca_topic_score_codex":0.000012288666,"about_ca_topic_score_gemma":0.0000017835494,"teacher_disagreement_score":0.74677414,"about_ca_system_score_codex":0.00007123577,"about_ca_system_score_gemma":0.00009636673,"threshold_uncertainty_score":0.99967426},"labels":[],"label_agreement":null},{"id":"W2788046162","doi":"10.3390/pharmaceutics10010013","title":"Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape—A Summary of This Indispensable Special Issue","year":2018,"lang":"en","type":"editorial","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; University of Alberta","funders":"","keywords":"Pharmacokinetics; Drug metabolism; Drug; Current (fluid); Pharmacology; Medicine; Engineering","score_opus":0.04818841988891613,"score_gpt":0.3908759117886192,"score_spread":0.34268749189970305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788046162","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012526436,0.08074811,0.0000022183808,0.0009437063,0.88620603,0.0015169645,0.004163623,0.000048357917,0.013844543],"genre_scores_gemma":[0.01058576,0.14657217,0.00006147408,0.0013051862,0.8377903,0.00013175928,0.0004836508,0.0002091638,0.0028604951],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923967,0.0015546095,0.0018154031,0.0011111306,0.0015623898,0.0015597541],"domain_scores_gemma":[0.9941119,0.0026946894,0.0010956496,0.0007059697,0.0006689815,0.0007228232],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002791513,0.0011952636,0.00167405,0.00044364567,0.00037747485,0.00007565055,0.0018024746,0.00072573504,0.0056694574],"category_scores_gemma":[0.00042085495,0.0010102123,0.0002563556,0.0008334909,0.00079478,0.00015519105,0.001000597,0.006508526,0.00011146841],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053679274,0.000303381,0.0010690943,0.00053571083,0.00048141964,0.00006195979,0.0010985169,0.00014452096,0.00048177634,0.00003232159,0.93178827,0.06346625],"study_design_scores_gemma":[0.00449378,0.000023604587,0.0001509778,0.00010802808,0.0019232219,0.0000066611065,0.00010770277,0.0025406715,0.013044311,0.0001644228,0.97645533,0.0009812873],"about_ca_topic_score_codex":0.04447024,"about_ca_topic_score_gemma":0.13018385,"teacher_disagreement_score":0.0857136,"about_ca_system_score_codex":0.0003959153,"about_ca_system_score_gemma":0.0047729686,"threshold_uncertainty_score":0.9992348},"labels":[],"label_agreement":null},{"id":"W2789350728","doi":"10.1016/j.euroneuro.2018.05.009","title":"Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies","year":2018,"lang":"en","type":"review","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"National Human Genome Research Institute; National Institute of General Medical Sciences; Medical Research Council; National Institute of Mental Health; National Institute on Alcohol Abuse and Alcoholism; National Cancer Institute","keywords":"CYP2C19; Escitalopram; Citalopram; Internal medicine; Meta-analysis; CYP2D6; Pharmacogenetics; Medicine; Antidepressant; Pharmacology; Side effect (computer science); CYP3A4; Gastroenterology; Cytochrome P450; Genotype; Biology; Genetics; Gene; Metabolism","score_opus":0.29465795754216945,"score_gpt":0.5144122834458251,"score_spread":0.21975432590365568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789350728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.100889236,0.8891034,0.000012227262,0.000113990325,0.0022607157,0.002029698,0.0046612574,0.00013281856,0.0007966344],"genre_scores_gemma":[0.027212398,0.96972907,0.000071425035,0.0014439076,0.00061836326,0.0001274115,0.00029046068,0.00030949904,0.00019745465],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.94080406,0.05326637,0.0021775682,0.0022233038,0.0006351531,0.00089355436],"domain_scores_gemma":[0.93935007,0.054280277,0.0038460053,0.0017913223,0.00032266098,0.00040968577],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.012760801,0.0015113243,0.010098647,0.0016002127,0.00023351789,0.00003810108,0.0022812237,0.0005819172,0.00027463346],"category_scores_gemma":[0.0044935173,0.0011834217,0.0024537144,0.0017317845,0.0006965188,0.00022508271,0.0018553154,0.0021182767,0.00012993056],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007858501,0.0009560193,0.00013933163,0.0079027945,0.73676777,0.0006771239,0.0004004033,0.000156447,0.04957718,0.000004509856,0.0044967295,0.19106321],"study_design_scores_gemma":[0.0018702797,0.0006342414,0.0022668827,0.00009764679,0.48145637,0.0000045383276,0.000002383012,0.00009086284,0.001300341,0.0000036328606,0.5117498,0.00052304025],"about_ca_topic_score_codex":0.000012597948,"about_ca_topic_score_gemma":0.0000028920472,"teacher_disagreement_score":0.50725305,"about_ca_system_score_codex":0.000119929246,"about_ca_system_score_gemma":0.0001401609,"threshold_uncertainty_score":0.99976355},"labels":[],"label_agreement":null},{"id":"W2789711110","doi":"10.3390/jpm8010009","title":"P450 Pharmacogenetics in Indigenous North American Populations","year":2018,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute","keywords":"Indigenous; Pharmacogenetics; Personalized medicine; Drug response; Precision medicine; Medicine; Drug; Genotype; Bioinformatics; Pharmacology; Biology; Genetics; Ecology; Pathology","score_opus":0.3050140670190541,"score_gpt":0.5476900463026773,"score_spread":0.24267597928362317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789711110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065849633,0.98775697,0.000043631924,0.00029227388,0.0039398917,0.0007363152,0.00015437062,0.000019252697,0.0004723449],"genre_scores_gemma":[0.0004402835,0.9912097,0.0005478285,0.0012824506,0.005783577,0.000031608928,0.00009014394,0.00010920564,0.00050523115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99406874,0.0014516464,0.0025461528,0.0004241222,0.00071574113,0.0007935748],"domain_scores_gemma":[0.99492925,0.00052067405,0.0029822101,0.00028030167,0.0004750179,0.0008125457],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021860278,0.0007529598,0.0035895032,0.0013998733,0.00017875776,0.000015688534,0.00095656124,0.00037256654,0.0013236164],"category_scores_gemma":[0.00031857126,0.0005599297,0.0007439409,0.0016169649,0.0010628144,0.00008057374,0.00010804499,0.0026433172,0.00008126864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001994285,0.00041504338,0.0009367294,0.0018939299,0.0008955425,0.00056701683,0.0023012485,0.000022622853,0.000045081364,0.000025600119,0.011694018,0.98100376],"study_design_scores_gemma":[0.0032177926,0.00042150865,0.00038302632,0.0016828075,0.005493594,0.0007150877,0.00008072437,0.000028089913,0.000009192054,0.000044928904,0.987452,0.00047128773],"about_ca_topic_score_codex":0.00004582293,"about_ca_topic_score_gemma":0.00008426612,"teacher_disagreement_score":0.98053247,"about_ca_system_score_codex":0.00030498236,"about_ca_system_score_gemma":0.0010158602,"threshold_uncertainty_score":0.9996852},"labels":[],"label_agreement":null},{"id":"W2791191356","doi":"10.1007/s00115-017-0479-8","title":"Pharmakogenetik in der Psychiatrie: eine Standortbestimmung","year":2018,"lang":"de","type":"review","venue":"Der Nervenarzt","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Gynecology; Medicine; Philosophy","score_opus":0.19910285398830324,"score_gpt":0.5021384891058726,"score_spread":0.3030356351175693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791191356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004590075,0.96524,0.0000779643,0.00077842653,0.020292865,0.0033145705,0.00137136,0.00016997983,0.004164768],"genre_scores_gemma":[0.004037845,0.9766661,0.00057630596,0.004367934,0.007622528,0.00057155563,0.0009871874,0.00049457484,0.0046759914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98508066,0.00463979,0.0039058232,0.0024733876,0.0009132547,0.002987105],"domain_scores_gemma":[0.99395704,0.0009562627,0.0016527134,0.0015528885,0.0004747997,0.0014063013],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.004010871,0.0025158278,0.004228585,0.001242153,0.00075300096,0.00020123734,0.0024999566,0.0026294135,0.01428386],"category_scores_gemma":[0.0002184287,0.0024628167,0.001868302,0.0021828064,0.0009430817,0.00024239342,0.00097604276,0.005156844,0.0085696075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014445386,0.0052421745,0.0034659125,0.015669594,0.010310213,0.0021575326,0.0014506193,0.00079704943,0.00096982485,0.0003951646,0.19208662,0.76601076],"study_design_scores_gemma":[0.007818397,0.0002625813,0.00020232092,0.0019245473,0.011728651,0.00021081195,0.00002516502,0.0015154628,0.0010787117,0.00030792062,0.9725197,0.0024057534],"about_ca_topic_score_codex":0.00010009877,"about_ca_topic_score_gemma":0.00007936127,"teacher_disagreement_score":0.78043306,"about_ca_system_score_codex":0.00038806675,"about_ca_system_score_gemma":0.0015823629,"threshold_uncertainty_score":0.9987578},"labels":[],"label_agreement":null},{"id":"W2792305076","doi":"10.1016/j.psychres.2018.02.055","title":"Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication","year":2018,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Canadian Institutes of Health Research; Charité – Universitätsmedizin Berlin; U.S. Food and Drug Administration; National Institutes of Health; Berlin Institute of Health; Centre for Addiction and Mental Health Foundation","keywords":"CYP2C19; Pharmacogenetics; CYP2D6; Medicine; Genotyping; Medical prescription; Antipsychotic; Antidepressant; Psychiatry; Pharmacogenomics; Clinical significance; Internal medicine; Clinical psychology; Pharmacology; Genotype; Schizophrenia (object-oriented programming); Genetics","score_opus":0.3046365639389016,"score_gpt":0.5505533726244565,"score_spread":0.24591680868555488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792305076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982408,0.006633014,0.0014152763,0.0038587463,0.0026600182,0.0021489726,0.00020386469,0.000056259305,0.0006158585],"genre_scores_gemma":[0.97583187,0.0006757956,0.01971243,0.00091657747,0.0021089562,0.00041902083,0.000015890833,0.00005664091,0.00026282851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973681,0.0003350576,0.0004967833,0.00067799835,0.00024337096,0.0008786738],"domain_scores_gemma":[0.99712896,0.0014228994,0.00013313732,0.00028857216,0.00058119703,0.00044524026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030577332,0.0002339283,0.00031038985,0.00025783593,0.0008824865,0.00007483249,0.0003229306,0.00027598458,0.00005539507],"category_scores_gemma":[0.000700137,0.00021717385,0.000062255844,0.00030543932,0.0007024753,0.0000778656,0.00014481365,0.00055701495,0.0000128519405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012448851,0.0004102379,0.71867263,0.00071926945,0.0002389806,0.0000027953076,0.0004398787,0.0000064994274,0.14328027,0.001615385,0.010855739,0.12251343],"study_design_scores_gemma":[0.012039721,0.0017847915,0.68664795,0.00007122675,0.000489516,0.000091529524,0.0002583265,0.1194477,0.0066579403,0.025591286,0.14609414,0.00082586886],"about_ca_topic_score_codex":0.00002680175,"about_ca_topic_score_gemma":0.000035690235,"teacher_disagreement_score":0.13662234,"about_ca_system_score_codex":0.000017968754,"about_ca_system_score_gemma":0.0001657387,"threshold_uncertainty_score":0.88560927},"labels":[],"label_agreement":null},{"id":"W2792752410","doi":"10.1124/dmd.117.079921","title":"Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing","year":2018,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Common Fund; National Human Genome Research Institute; National Institute of Mental Health; NIH Office of the Director; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Université Laval","keywords":"Alternative splicing; Gene expression; RNA splicing; Transcriptional regulation; Chemistry; Expression (computer science); Biology; Cell biology; Regulation of gene expression; Biochemistry; Computational biology; Gene; Messenger RNA; RNA; Computer science","score_opus":0.02919582106917623,"score_gpt":0.35785123957489723,"score_spread":0.328655418505721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792752410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194807,0.0036309883,0.0019721973,0.00033072353,0.000713475,0.0002925563,0.00039265206,0.000029178162,0.00069013925],"genre_scores_gemma":[0.9971601,0.0011948955,0.00033636353,0.0005465933,0.00041447498,0.000022297017,0.000095536205,0.00001778227,0.0002119687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985898,0.00036188686,0.0002757903,0.00033187863,0.00020149452,0.00023912295],"domain_scores_gemma":[0.999193,0.00012048934,0.00019071312,0.0001167087,0.00018881037,0.00019028055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046152264,0.00020751834,0.0002846891,0.00012116341,0.00029226128,0.000023855242,0.00008983966,0.00013789651,0.00017520454],"category_scores_gemma":[0.000024724714,0.0001923526,0.0000556312,0.00011895035,0.00033548826,0.0003231754,0.00006231871,0.00022654253,0.0000068778595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004952649,0.000171065,0.0010391924,0.000047915186,0.000047381916,7.60448e-7,0.0017738884,0.00001700316,0.97065705,0.002283528,0.00033469973,0.023132242],"study_design_scores_gemma":[0.0018249732,0.000043855543,0.07818776,0.000027825623,0.00027008835,0.000009262373,0.000089291665,0.006897488,0.9011171,0.002052098,0.009255279,0.00022497345],"about_ca_topic_score_codex":0.00011387761,"about_ca_topic_score_gemma":0.000007578244,"teacher_disagreement_score":0.07714857,"about_ca_system_score_codex":0.0000114261,"about_ca_system_score_gemma":0.000022379161,"threshold_uncertainty_score":0.7843911},"labels":[],"label_agreement":null},{"id":"W2793349513","doi":"10.1002/cpt.1048","title":"Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"U.S. National Library of Medicine; National Institute of General Medical Sciences; National Cancer Institute; National Human Genome Research Institute","keywords":"Pharmacogenomics; Harm; Precision medicine; Matching (statistics); Dosing; Medicine; Pharmacogenetics; Intensive care medicine; Computer science; Data science; Pharmacology; Psychology; Biology","score_opus":0.8349589273527223,"score_gpt":0.7219242324363636,"score_spread":0.11303469491635865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793349513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055743095,0.9340473,0.0000029520509,0.00033867513,0.004661556,0.0046858657,0.00025178125,0.00004180996,0.00022697424],"genre_scores_gemma":[0.0034547537,0.9879349,0.00019390197,0.0051226807,0.0023586797,0.00063096546,0.00014700806,0.000117245385,0.000039893934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9686973,0.023817908,0.0046135257,0.0012326397,0.00054127834,0.0010973093],"domain_scores_gemma":[0.989994,0.0062531144,0.0018925371,0.00074222696,0.0006877409,0.0004303918],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.022548836,0.0007646093,0.003147151,0.00065340893,0.00033146632,0.000036954134,0.0018472216,0.001634902,0.000453335],"category_scores_gemma":[0.000056493274,0.0005741475,0.000995554,0.001556161,0.00399352,0.00014375246,0.0005416172,0.0049753524,0.000043189757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035500003,0.003823221,0.0039973413,0.0026300645,0.0024686132,0.00002906028,0.000946135,8.755968e-7,0.000093364535,0.000094564566,0.0022954769,0.9832663],"study_design_scores_gemma":[0.0034661253,0.0016980176,0.0007016873,0.00037969276,0.008734415,0.00004913925,0.0004418757,0.00012719365,0.00016215083,0.00019333327,0.9835719,0.0004744735],"about_ca_topic_score_codex":0.00006710717,"about_ca_topic_score_gemma":0.00010715968,"teacher_disagreement_score":0.9827918,"about_ca_system_score_codex":0.00008499358,"about_ca_system_score_gemma":0.0014675865,"threshold_uncertainty_score":0.999671},"labels":[],"label_agreement":null},{"id":"W2794045235","doi":"10.1016/bs.apha.2018.02.001","title":"Population Diversity in Pharmacogenetics: A Latin American Perspective","year":2018,"lang":"en","type":"review","venue":"Advances in pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Genetic diversity; Latin Americans; Biology; Population; Diversity (politics); Evolutionary biology; Genotyping; Genetics; Demography; Political science; Gene; Genotype; Sociology; Anthropology","score_opus":0.1612162262032388,"score_gpt":0.5316853596355203,"score_spread":0.3704691334322815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794045235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047712913,0.9811264,0.000016327122,0.00007997156,0.006458689,0.0021388642,0.0003212858,0.0001193682,0.004967803],"genre_scores_gemma":[0.00825981,0.98745775,0.00032022918,0.0012530066,0.0016511244,0.00052159344,0.00014693715,0.00013588736,0.00025363607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99157757,0.0030740513,0.0017966488,0.0016215715,0.000379289,0.0015508527],"domain_scores_gemma":[0.9965463,0.0011594278,0.0012670174,0.00037811452,0.00019404099,0.0004550958],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015397887,0.0011534408,0.003127371,0.0015884619,0.0003594091,0.000022596605,0.0014168198,0.0007927414,0.0016346236],"category_scores_gemma":[0.00013598782,0.0011895236,0.0005502272,0.002191383,0.00096914754,0.00032856996,0.0013105698,0.0029702147,0.000386476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039083982,0.00092146924,0.0075185667,0.0020188678,0.00042128153,0.00040323284,0.0010934477,0.0005210066,0.00004329088,0.00046306476,0.001164251,0.98504066],"study_design_scores_gemma":[0.0028513588,0.00014864323,0.00043755473,0.00045318948,0.0015310473,0.000030263851,0.0001446668,0.0004763638,0.000094049814,0.0010339351,0.99166393,0.0011350013],"about_ca_topic_score_codex":0.00045874363,"about_ca_topic_score_gemma":0.00059184205,"teacher_disagreement_score":0.9904997,"about_ca_system_score_codex":0.0011833765,"about_ca_system_score_gemma":0.00031514833,"threshold_uncertainty_score":0.99933},"labels":[],"label_agreement":null},{"id":"W2794455666","doi":"10.18433/jpps29673","title":"Effect of Cytochrome P450 (CYP) 2D6 Genetic Polymorphism on the Inhibitory Action of Antidepressants on CYP2D6-Mediated Dopamine Formation from p-Tyramine","year":2018,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CYP2D6; Dopamine; Desipramine; Fluvoxamine; Imipramine; Pharmacology; Chemistry; Tyramine; Cytochrome P450; Endocrinology; Biology; Biochemistry; Metabolism; Medicine; Serotonin; Antidepressant; Receptor; Fluoxetine","score_opus":0.15230002310537025,"score_gpt":0.473319538542208,"score_spread":0.3210195154368377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794455666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902367,0.0032874383,0.000111416666,0.001454078,0.0026529506,0.00065865065,0.0001655609,0.000028674154,0.001404533],"genre_scores_gemma":[0.9925614,0.0034843574,0.00011201205,0.0018777356,0.001877461,0.000016194675,0.0000074984796,0.00003213469,0.000031192925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937446,0.0020976816,0.0016041269,0.00044047122,0.0013927332,0.00072037854],"domain_scores_gemma":[0.99345917,0.0036901413,0.0015702074,0.00027177026,0.00048170646,0.0005269802],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042197723,0.0004993874,0.00083101273,0.00053307187,0.0004551485,0.000045370456,0.0011852286,0.00019451565,0.0020750456],"category_scores_gemma":[0.0006188755,0.00031922816,0.00038455156,0.0009617895,0.0021012516,0.00045599998,0.00017707783,0.0013149747,0.00010937533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041080527,0.00066382566,0.0026303234,0.00007932048,0.00026536407,0.000039113314,0.0003258702,0.0004592502,0.90785724,0.00010146863,0.001570785,0.081899405],"study_design_scores_gemma":[0.005995665,0.00221735,0.0042030257,0.00011471927,0.0006483847,0.00006903422,0.000056662284,0.018293725,0.9279655,0.00012995698,0.04002177,0.00028417452],"about_ca_topic_score_codex":0.00003473642,"about_ca_topic_score_gemma":0.00000267281,"teacher_disagreement_score":0.08161523,"about_ca_system_score_codex":0.00009645475,"about_ca_system_score_gemma":0.00020492633,"threshold_uncertainty_score":0.999926},"labels":[],"label_agreement":null},{"id":"W2796276845","doi":"10.1177/1715163518766376","title":"Professional opportunity for pharmacists to integrate pharmacogenomics in medication therapy","year":2018,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; University of Toronto","keywords":"Pharmacogenomics; Medicine; Medication therapy management; Pharmacotherapy; Pharmacist; Family medicine; Medical education; Pharmacy; Nursing; Pharmacology","score_opus":0.18696962716240795,"score_gpt":0.43765473278245304,"score_spread":0.2506851056200451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796276845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967804,0.0018434597,0.0004924941,0.0011813749,0.020765752,0.0025035706,0.0022986368,0.00008164056,0.003029032],"genre_scores_gemma":[0.94943446,0.01091429,0.00059837266,0.031430833,0.0053439126,0.0003728497,0.00017440705,0.00016737511,0.0015634797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99315304,0.0010075175,0.0015906603,0.0010373703,0.00066405954,0.0025473633],"domain_scores_gemma":[0.98972076,0.0004581868,0.000571339,0.00040579255,0.0015905898,0.007253313],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004012858,0.00091862143,0.00085626077,0.0012603183,0.0018363316,0.00017638999,0.0018362176,0.00031899966,0.0054630847],"category_scores_gemma":[0.0005482616,0.0009525897,0.00031094078,0.0013808192,0.00059274305,0.00048136534,0.00014762013,0.0020971962,0.00010913575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031982516,0.00057835475,0.002624736,0.00016895191,0.00063032575,0.009829982,0.0055883233,0.0012562779,0.15400092,0.00019219438,0.17642473,0.645507],"study_design_scores_gemma":[0.0104152,0.00018086424,0.000076024204,0.00002687088,0.00019138084,0.039299373,0.000039616898,0.013588391,0.10874774,0.0005993261,0.82550544,0.0013297448],"about_ca_topic_score_codex":0.003239899,"about_ca_topic_score_gemma":0.020613652,"teacher_disagreement_score":0.64908075,"about_ca_system_score_codex":0.0027076297,"about_ca_system_score_gemma":0.010262785,"threshold_uncertainty_score":0.99946314},"labels":[],"label_agreement":null},{"id":"W2803475077","doi":"10.7554/elife.33953","title":"Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins","year":2018,"lang":"en","type":"article","venue":"eLife","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; University of California, San Francisco; Searle Scholars Program; Damon Runyon Cancer Research Foundation; Natural Sciences and Engineering Research Council of Canada; Bill and Melinda Gates Foundation; David and Lucile Packard Foundation; National Institutes of Health; National Science Foundation","keywords":"Biology; Gene; Heterologous expression; Genetics; Enzyme; Population; Gene cluster; Microbiome; Biochemistry; Recombinant DNA","score_opus":0.10585075698181827,"score_gpt":0.40563600481116885,"score_spread":0.29978524782935057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803475077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606866,0.00023199189,0.0010604078,0.00009034785,0.0008182468,0.00059031363,0.0010410836,0.000006153332,0.00009279347],"genre_scores_gemma":[0.9986944,0.0004398366,0.000044816596,0.00020746644,0.00040448012,0.000036489666,0.00008720507,0.000010417823,0.00007486302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905986,0.00012439495,0.00039832914,0.00013904239,0.0001379249,0.00014043205],"domain_scores_gemma":[0.99912065,0.00017491038,0.00036310736,0.0001249138,0.00017590342,0.000040493072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005164484,0.00010361928,0.00021917012,0.00006591039,0.000098137585,0.000006628386,0.00013100622,0.00008879533,0.000053005067],"category_scores_gemma":[0.00004325027,0.000078099256,0.000057214278,0.000086489374,0.00023826545,0.00007209684,0.000064490705,0.000085877306,6.536435e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061812915,0.00027096536,0.00082276325,0.000096619806,0.0000961337,1.1869289e-7,0.0013850112,0.00001357656,0.9938614,0.0013511516,0.0001947629,0.0012893797],"study_design_scores_gemma":[0.0012705748,0.000256184,0.058815554,0.000019318733,0.00016040329,8.6839015e-7,0.00007150261,0.0017238011,0.91659844,0.000026176294,0.020983284,0.000073922405],"about_ca_topic_score_codex":0.000013801406,"about_ca_topic_score_gemma":0.0000039544548,"teacher_disagreement_score":0.077262975,"about_ca_system_score_codex":0.0000105547615,"about_ca_system_score_gemma":0.000053067175,"threshold_uncertainty_score":0.3184795},"labels":[],"label_agreement":null},{"id":"W2803784234","doi":"10.71781/4686","title":"Pharmacokinetic/pharmacodynamic relationship of pulmonary administration methods for milrinone : a translational approach","year":2016,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Université de Montréal","keywords":"Milrinone; Pharmacodynamics; Medicine; Pharmacokinetics; Administration (probate law); Pharmacology; Anesthesia; Hemodynamics; Political science","score_opus":0.23118770040669043,"score_gpt":0.5521011772569195,"score_spread":0.3209134768502291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803784234","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41407332,0.0145264,0.03924596,0.00097349647,0.009874107,0.014180256,0.008189104,0.00003671776,0.49890062],"genre_scores_gemma":[0.8411268,0.0009281756,0.11088606,0.00014152956,0.0009284263,0.0013375009,0.009723937,0.00017979786,0.03474776],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958243,0.0010101799,0.0013414117,0.0009340348,0.00030749702,0.00058260985],"domain_scores_gemma":[0.99657,0.0013511631,0.0009768496,0.00031714365,0.00044440318,0.0003404381],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023798821,0.0006292757,0.0008761591,0.00037442648,0.00036165456,0.000059267466,0.0011269927,0.0009144588,0.005893127],"category_scores_gemma":[0.00012824529,0.0005986559,0.00040743442,0.00034281096,0.00015453048,0.00027332013,0.00007739433,0.0008748172,0.0000911585],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030649696,0.00072308816,0.00019526719,0.00028043907,0.00046905968,0.0000065002837,0.00065970083,0.00013492606,0.34252453,0.00032475195,0.00028931908,0.65132743],"study_design_scores_gemma":[0.0059418227,0.00012638395,0.0019937472,0.0001097794,0.002805409,0.000051074556,0.00021419386,0.02665422,0.60273325,0.0024460128,0.3558389,0.0010851829],"about_ca_topic_score_codex":0.0000050591493,"about_ca_topic_score_gemma":0.000005911898,"teacher_disagreement_score":0.65024227,"about_ca_system_score_codex":0.000053148266,"about_ca_system_score_gemma":0.0008054466,"threshold_uncertainty_score":0.9996465},"labels":[],"label_agreement":null},{"id":"W2804186901","doi":"10.1136/bmjopen-2017-020922","title":"Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case–control pharmacokinetic study","year":2018,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Tolbutamide; CYP2C19; Pharmacology; CYP2D6; CYP2B6; Population; Drug metabolism; Dextromethorphan; Drug; Type 2 Diabetes Mellitus; Diabetes mellitus; CYP1A2; Internal medicine; Cytochrome P450; Endocrinology; Metabolism","score_opus":0.390045336484067,"score_gpt":0.6305879702458883,"score_spread":0.24054263376182133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804186901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64800954,0.00010777582,0.000015911979,0.00012780918,0.00054353796,0.34859556,0.0002294563,0.000027706808,0.0023426928],"genre_scores_gemma":[0.67876256,0.000004616139,0.00012769757,0.00075177086,0.00081887934,0.3192434,0.0000031422708,0.000045006313,0.00024292016],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99555063,0.0021873827,0.00072781916,0.00050227233,0.00033180698,0.00070008746],"domain_scores_gemma":[0.9966255,0.0015749037,0.0005543263,0.00060555496,0.00041431366,0.00022540153],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005993656,0.00041736825,0.0007350676,0.00013528345,0.0005712384,0.00010083541,0.0010696982,0.00014064768,0.0023808214],"category_scores_gemma":[0.00042124416,0.00026666006,0.00026433112,0.00041500613,0.00027120826,0.00015867664,0.00033781657,0.0004495331,0.000062002844],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052867677,0.010721267,0.021994852,0.00044291178,0.011572871,0.00016376868,0.01330336,0.015993014,0.35408026,0.00062434253,0.021706857,0.49652883],"study_design_scores_gemma":[0.10580216,0.03514563,0.017954707,0.00018113233,0.006192712,0.00021429446,0.0017254057,0.32709,0.36114442,0.0021228697,0.14012358,0.0023030739],"about_ca_topic_score_codex":0.0001126823,"about_ca_topic_score_gemma":0.000014742339,"teacher_disagreement_score":0.49422574,"about_ca_system_score_codex":0.00004464949,"about_ca_system_score_gemma":0.00045202553,"threshold_uncertainty_score":0.99997854},"labels":[],"label_agreement":null},{"id":"W2804291252","doi":"10.1111/bcp.13601","title":"Evaluation of sex‐by‐formulation interaction in bioequivalence studies of efavirenz tablets","year":2018,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Efavirenz; Sample size determination; Statistics; Test (biology); Medicine; Mathematics; Pharmacokinetics; Internal medicine; Human immunodeficiency virus (HIV); Biology; Family medicine","score_opus":0.44848270144107544,"score_gpt":0.620625452050883,"score_spread":0.1721427506098076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804291252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753633,0.014316025,0.00007399337,0.00028899798,0.008644083,0.0003622496,0.00005688762,0.0000073260667,0.00088714686],"genre_scores_gemma":[0.981388,0.016102258,0.0002141523,0.00078436907,0.0014295148,0.000011282577,0.0000054993825,0.000017821067,0.00004712383],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99209535,0.003636381,0.0030041405,0.00026943604,0.0006537448,0.000340928],"domain_scores_gemma":[0.9929718,0.0016504931,0.0022822074,0.000100436824,0.0027958902,0.00019917573],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017473547,0.00018478437,0.0010153425,0.00026832006,0.00008305982,0.000007806076,0.00038837906,0.00034484983,0.0013790099],"category_scores_gemma":[0.0019962715,0.0002010948,0.00025942342,0.0003675993,0.00073766545,0.00031654933,0.0001144868,0.0010948458,0.00001069365],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001673593,0.0021055709,0.014590627,0.00010601749,0.0011966925,0.00005435302,0.00066850637,0.002001012,0.33774406,0.000025867568,0.02103279,0.61880094],"study_design_scores_gemma":[0.032784075,0.002659432,0.03986714,0.00042270526,0.0047204923,0.000613208,0.0007693932,0.034629636,0.79954374,0.0040194616,0.079367936,0.0006027875],"about_ca_topic_score_codex":0.0000311781,"about_ca_topic_score_gemma":0.000026276497,"teacher_disagreement_score":0.61819816,"about_ca_system_score_codex":0.000088404966,"about_ca_system_score_gemma":0.0003918211,"threshold_uncertainty_score":0.9995339},"labels":[],"label_agreement":null},{"id":"W2804371944","doi":"10.1038/s41397-018-0027-3","title":"Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools","year":2018,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Health and Medical Research Council; National Medical Research Council; U.S. Food and Drug Administration","keywords":"Pharmacogenetics; CYP2C19; Medicine; Dosing; Pharmacodynamics; CYP2D6; Pharmacogenomics; Psychiatry; Pharmacology; Psychology; Genotype; Internal medicine; Pharmacokinetics; Genetics; Biology; Gene","score_opus":0.12497483590642317,"score_gpt":0.4306686487054996,"score_spread":0.3056938127990764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804371944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630201,0.0015592255,0.016035497,0.005975078,0.0074806935,0.0009588618,0.00020904164,0.00007822626,0.004683319],"genre_scores_gemma":[0.97274625,0.0049337135,0.0017493833,0.015804447,0.00438971,0.000051238956,0.0000922187,0.000078834186,0.0001541954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960547,0.0010005026,0.0010620193,0.00051867275,0.00048108396,0.00088301324],"domain_scores_gemma":[0.9969964,0.0006715539,0.0006865809,0.00032572137,0.00048460742,0.00083510595],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043483586,0.00049638166,0.000427225,0.00028946443,0.0017769615,0.00022267921,0.0009100607,0.0002561497,0.01049587],"category_scores_gemma":[0.00012877698,0.0004012176,0.00019136128,0.00034885737,0.0008520921,0.00031783522,0.00029452218,0.0014740226,0.0004777859],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014799315,0.000336714,0.0041522915,0.000017114087,0.0004332619,0.000024295361,0.0011226322,0.0004641241,0.10234176,0.00009797232,0.028407585,0.8611223],"study_design_scores_gemma":[0.007994389,0.00028771078,0.011677077,0.000018260442,0.0012389321,0.00021948238,0.00010452476,0.03814899,0.11270332,0.0012104589,0.8257255,0.00067134155],"about_ca_topic_score_codex":0.000012803235,"about_ca_topic_score_gemma":0.000024304487,"teacher_disagreement_score":0.860451,"about_ca_system_score_codex":0.00019691828,"about_ca_system_score_gemma":0.00034992353,"threshold_uncertainty_score":0.99984396},"labels":[],"label_agreement":null},{"id":"W2805727844","doi":"10.1101/cshperspect.a033027","title":"The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics","year":2018,"lang":"en","type":"review","venue":"Cold Spring Harbor Perspectives in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Pharmacogenetics; Computational biology; DNA sequencing; Medicine; Biology; Genetics; Pharmacology; Genotype; Gene","score_opus":0.2544066047952023,"score_gpt":0.45646674879798144,"score_spread":0.20206014400277916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805727844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015836589,0.98038197,0.000011011957,0.00008474866,0.0015405016,0.0013369266,0.00003943843,0.000028865825,0.0007399636],"genre_scores_gemma":[0.04114712,0.9563255,0.00015839926,0.00011734806,0.001924557,0.0001842548,0.0000042047523,0.00009493913,0.000043718126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99564725,0.0010898703,0.0014109421,0.0008133288,0.00031433985,0.00072429655],"domain_scores_gemma":[0.9975327,0.0009302323,0.0006645192,0.00041612796,0.00019056414,0.00026583154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028901473,0.00065830944,0.0016443495,0.00062418863,0.00024753183,0.000032351523,0.0007327113,0.00047739345,0.000110477085],"category_scores_gemma":[0.00034493578,0.0005167784,0.00018757317,0.00075563346,0.0011336107,0.00009452943,0.0002842448,0.0016609367,0.000011480101],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024062785,0.00039185004,0.0006760107,0.0043439693,0.0012307479,0.0001460172,0.0082376385,0.00024321066,0.2047734,0.018706316,0.00033961114,0.7606706],"study_design_scores_gemma":[0.001680385,0.00008342668,0.000032995176,0.001447721,0.0010612648,0.0000085151705,0.00079906586,0.006815956,0.0059642773,0.000097766926,0.9815119,0.0004967258],"about_ca_topic_score_codex":0.000108021966,"about_ca_topic_score_gemma":0.000051731527,"teacher_disagreement_score":0.98117226,"about_ca_system_score_codex":0.00067128864,"about_ca_system_score_gemma":0.0005596876,"threshold_uncertainty_score":0.9997284},"labels":[],"label_agreement":null},{"id":"W2805837446","doi":"10.5539/gjhs.v10n7p36","title":"Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia","year":2018,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Genotype; CYP2C19; Allele; Population; Polymorphism (computer science); Allele frequency; Pharmacogenetics; Genetics; Polymerase chain reaction; Gene polymorphism; Gene; Medicine; Biology; Environmental health","score_opus":0.10033511360053278,"score_gpt":0.48767928307520797,"score_spread":0.3873441694746752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805837446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935969,0.002571528,0.000041267514,0.0022104115,0.00081722485,0.0001651917,0.00002683993,0.0000025274967,0.0005680802],"genre_scores_gemma":[0.99614763,0.000511065,0.00025520966,0.002939909,0.00013284922,0.00000159838,0.0000016766826,0.0000027126155,0.0000073591555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971293,0.0006038583,0.0010241959,0.00019187362,0.0005702611,0.0004804657],"domain_scores_gemma":[0.9984994,0.00011243405,0.0007650419,0.00017058759,0.00026156465,0.00019098626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008200875,0.0001123912,0.00045887972,0.0006152149,0.00020675737,0.000020167863,0.0008004288,0.000080873564,0.00007274184],"category_scores_gemma":[0.00014727435,0.000083431245,0.00009764213,0.004151356,0.0005280488,0.00018448636,0.000053945398,0.00035985903,0.000003463644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028697852,0.00027532296,0.9642034,0.000013286655,0.00006885981,0.000038961985,0.0013248377,0.003362647,0.008785721,0.00045914407,0.0009327565,0.020248063],"study_design_scores_gemma":[0.0008921669,0.00015478615,0.9902694,0.00001623615,0.00012241457,0.00007278039,0.00016606666,0.004080281,0.001933122,0.00042431432,0.001793,0.00007543262],"about_ca_topic_score_codex":0.0012315026,"about_ca_topic_score_gemma":0.00072499993,"teacher_disagreement_score":0.026065977,"about_ca_system_score_codex":0.0002261779,"about_ca_system_score_gemma":0.0006691364,"threshold_uncertainty_score":0.34022275},"labels":[],"label_agreement":null},{"id":"W2806025779","doi":"10.1007/s40262-018-0681-2","title":"The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Pharmacokinetics; Pharmacology; Cytochrome P450; Drug; Drug development; Drug metabolism; Medicine; Physiologically based pharmacokinetic modelling; Pharmacotherapy; Glucuronosyltransferase; Bioinformatics; Computational biology; Enzyme; Biology; Metabolism; Internal medicine; Biochemistry; Microsome","score_opus":0.47038958596848207,"score_gpt":0.5852079668511639,"score_spread":0.11481838088268187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806025779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012819422,0.9691257,0.015972724,0.0011767577,0.0072306646,0.0049262955,0.00119722,0.000119818236,0.00012262959],"genre_scores_gemma":[0.00042112928,0.9775055,0.011157834,0.0022821177,0.006299563,0.0015629871,0.00047844986,0.00016886106,0.00012357792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99130696,0.002281568,0.0036726105,0.0013972211,0.00034416752,0.0009974984],"domain_scores_gemma":[0.98675704,0.008757123,0.0017351111,0.00073210895,0.0015589104,0.0004597242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038558617,0.0011369562,0.0028296702,0.00014579708,0.00093757967,0.00005532639,0.0012806078,0.0010528042,0.00007946798],"category_scores_gemma":[0.0006180213,0.0007986346,0.0012892004,0.00054515136,0.0016698814,0.000103273924,0.0003147917,0.0021435176,0.000026556881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005018909,0.00063507183,0.0000062013373,0.0089100525,0.0022469847,0.0000032307191,0.00015352847,0.0010245523,0.00023060532,0.0013181394,0.0184084,0.9665613],"study_design_scores_gemma":[0.0028162745,0.0003203789,7.9854124e-7,0.0006964975,0.007748816,0.000005526586,0.00007469183,0.02900228,0.001743343,0.0016043563,0.9552077,0.0007793035],"about_ca_topic_score_codex":0.0000026485213,"about_ca_topic_score_gemma":0.0000019118638,"teacher_disagreement_score":0.96578205,"about_ca_system_score_codex":0.000076444245,"about_ca_system_score_gemma":0.0004538099,"threshold_uncertainty_score":0.99944645},"labels":[],"label_agreement":null},{"id":"W2806161302","doi":"10.1038/s41598-018-25044-0","title":"Comparative analyses and structural insights of the novel cytochrome P450 fusion protein family CYP5619 in Oomycetes","year":2018,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Medical Research Council; Central University of Technology; Allard Foundation; South African Medical Research Council","keywords":"Computational biology; Biology; Bioinformatics; Computer science; Evolutionary biology; Genetics","score_opus":0.18691329433641113,"score_gpt":0.4637595945264118,"score_spread":0.27684630019000067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806161302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304307,0.0012248768,0.000020681753,0.000063398154,0.0029877687,0.0006780265,0.000015650034,0.000016440725,0.0019500803],"genre_scores_gemma":[0.998874,0.000010668224,0.0003376579,0.000109294364,0.0001263096,0.000023783592,0.000008864019,0.000008670601,0.00050073257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979813,0.00024760255,0.0005914436,0.00054525095,0.00032574986,0.00030864685],"domain_scores_gemma":[0.9987327,0.00006463173,0.00040835366,0.00040954913,0.00025466896,0.00013013411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008604909,0.00019187958,0.00034553985,0.00021159643,0.00049874134,0.00005317574,0.00023229416,0.00012846469,0.00014546051],"category_scores_gemma":[0.000069306734,0.00012760387,0.00008011058,0.00074764213,0.001378787,0.00012133147,0.00024854895,0.00030787475,0.0000061461715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004255797,0.000090305664,0.0032915457,0.000017829103,0.000042485437,0.000015532649,0.0024846552,0.00016144534,0.992787,0.00016036381,0.0003897151,0.00051658426],"study_design_scores_gemma":[0.00053006544,0.000039132785,0.098036796,0.000028075649,0.00006557861,0.00004164355,0.00018383362,0.0025258646,0.88036317,0.004602334,0.013423326,0.00016017548],"about_ca_topic_score_codex":0.000056179993,"about_ca_topic_score_gemma":0.000087907334,"teacher_disagreement_score":0.11242381,"about_ca_system_score_codex":0.000024095045,"about_ca_system_score_gemma":0.00015944094,"threshold_uncertainty_score":0.5203535},"labels":[],"label_agreement":null},{"id":"W2806906739","doi":"10.1002/slct.201800633","title":"Importance of Azo‐Hydrazo Tautomerization in the Oxidative Degradation of Procarbazine by Cytochrome P450: Computational Insights","year":2018,"lang":"en","type":"article","venue":"ChemistrySelect","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Kermanshah University of Medical Sciences; Iran National Science Foundation","keywords":"Azoxy; Tautomer; Chemistry; Decomposition; Medicinal chemistry; Transition state; Homolysis; Photochemistry; Stereochemistry; Radical; Organic chemistry; Catalysis","score_opus":0.0469106583080535,"score_gpt":0.3907012452624814,"score_spread":0.3437905869544279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806906739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995263,0.00068582426,0.00055950606,0.0001329114,0.00006302408,0.0002845973,0.000072827956,0.0000146305165,0.002923715],"genre_scores_gemma":[0.99875593,0.00010799842,0.0002375992,0.00036247505,0.000115712515,0.000037999256,0.00028790577,0.000012036467,0.00008233122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876916,0.0001540114,0.00044257173,0.0002234058,0.00021640859,0.00019444936],"domain_scores_gemma":[0.999046,0.00017048331,0.00034323626,0.0001327492,0.00025564685,0.000051863404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036693044,0.0001526818,0.00023013589,0.000058343096,0.00007408761,0.0000059266363,0.00027739108,0.00012192363,0.00018112954],"category_scores_gemma":[0.00009388861,0.00012640221,0.000046482346,0.0005788184,0.00030371416,0.0000668079,0.000028859044,0.00024614783,0.00000561994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009600126,0.0002518573,0.0038161203,0.00005801499,0.000055912467,0.000001484842,0.0009494356,0.00029547798,0.9918987,0.0001639989,0.0012000906,0.0012128642],"study_design_scores_gemma":[0.001024933,0.00006545713,0.009787301,0.000011544664,0.000057560123,0.0000062399517,0.000054465025,0.0071565756,0.97744715,0.00066980405,0.0035919896,0.00012698215],"about_ca_topic_score_codex":0.000006967617,"about_ca_topic_score_gemma":0.000004442332,"teacher_disagreement_score":0.014451594,"about_ca_system_score_codex":0.00002873535,"about_ca_system_score_gemma":0.00012049185,"threshold_uncertainty_score":0.5154533},"labels":[],"label_agreement":null},{"id":"W2808278652","doi":"10.1186/s13104-018-3476-5","title":"Evaluation of buccal swabs for pharmacogenetics","year":2018,"lang":"en","type":"article","venue":"BMC Research Notes","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AXYS Technologies (Canada); College of Pharmacists of British Columbia; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Genotyping; Buccal swab; Medicine; Veterinary medicine; Genotype; Biology; Genetics; Gene","score_opus":0.7928889552184284,"score_gpt":0.6712531719170097,"score_spread":0.12163578330141867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808278652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981977,0.004143557,0.0024885978,0.00039144527,0.0017769634,0.0018521643,0.00021538227,0.00004140951,0.0071135173],"genre_scores_gemma":[0.9937953,0.00043125456,0.0028118377,0.00022003306,0.0020991229,0.0003406887,0.00002531945,0.00004022037,0.00023626485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99449885,0.0023822342,0.00047742543,0.00043117328,0.0013976707,0.000812643],"domain_scores_gemma":[0.9920663,0.0025215147,0.00012678563,0.000319687,0.0046362528,0.00032946345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01854125,0.00019418709,0.00028021864,0.00033100005,0.0004283322,0.000025391108,0.00053995004,0.00025675478,0.002221184],"category_scores_gemma":[0.0033324833,0.00018403174,0.00015152147,0.0005228034,0.00089582964,0.0000739103,0.00019447152,0.0005081719,0.00019862482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000900557,0.0005688459,0.0073393886,0.00012546567,0.00026472032,0.0000011747911,0.00068926776,0.00085050944,0.74681634,0.0017283434,0.00899687,0.2317185],"study_design_scores_gemma":[0.003575543,0.0002828648,0.002492155,0.00001023531,0.000371293,0.0000027885449,0.000060392405,0.09226522,0.75660914,0.007888262,0.13626105,0.00018108703],"about_ca_topic_score_codex":0.000027654089,"about_ca_topic_score_gemma":0.0000422027,"teacher_disagreement_score":0.2315374,"about_ca_system_score_codex":0.00007925539,"about_ca_system_score_gemma":0.0007972998,"threshold_uncertainty_score":0.9986909},"labels":[],"label_agreement":null},{"id":"W2809392778","doi":"10.1007/s12104-018-9830-7","title":"Backbone assignment of the apo-form of the human C-terminal domain of UDP-glucuronosyltransferase 1A (UGT1A)","year":2018,"lang":"en","type":"article","venue":"Biomolecular NMR Assignments","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society of Canada","keywords":"Glucuronic acid; Chemistry; Biochemistry; Enzyme; Glucuronosyltransferase; Xenobiotic; Covalent bond; Drug metabolism; Stereochemistry; Polysaccharide; Organic chemistry","score_opus":0.061753110953328846,"score_gpt":0.4007837445645545,"score_spread":0.33903063361122565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809392778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129766,0.0004498593,0.001375305,0.0003482336,0.0011901051,0.00081943104,0.0002557661,0.000012007118,0.004251602],"genre_scores_gemma":[0.9985079,0.000053555406,0.00022412947,0.00070036296,0.00015098712,0.000031144646,0.00000909451,0.00003586392,0.0002869166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99680394,0.0008152545,0.00083621556,0.00035660545,0.0007075626,0.00048044746],"domain_scores_gemma":[0.998332,0.000072066316,0.00055412,0.00070317806,0.00016291672,0.00017571312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009485686,0.00032500064,0.00045715374,0.00009554135,0.00029305718,0.00000953775,0.0011496785,0.00024797424,0.00078312826],"category_scores_gemma":[0.00002688712,0.00021795112,0.00040299003,0.00040863175,0.0012300964,0.000050742816,0.0004681906,0.00034958203,0.000015977423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015956405,0.0007935998,0.010332734,0.00007750059,0.0003634429,0.000006730376,0.0007472776,0.000019575604,0.9824978,0.0011528734,0.000579288,0.00326959],"study_design_scores_gemma":[0.0026499066,0.00024127324,0.013668406,0.000054679436,0.00038767184,0.000010238249,0.00007078193,0.00011082569,0.96149564,0.0017764999,0.019316435,0.00021766535],"about_ca_topic_score_codex":0.000030780608,"about_ca_topic_score_gemma":0.0000065426243,"teacher_disagreement_score":0.021002207,"about_ca_system_score_codex":0.0000621669,"about_ca_system_score_gemma":0.00014862735,"threshold_uncertainty_score":0.88877887},"labels":[],"label_agreement":null},{"id":"W2809836824","doi":"10.1101/cshperspect.a032607","title":"Principles of Translational Control","year":2018,"lang":"en","type":"review","venue":"Cold Spring Harbor Perspectives in Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":204,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Library science","score_opus":0.1967580673874403,"score_gpt":0.48497465983877797,"score_spread":0.2882165924513377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809836824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005396183,0.9931554,0.00014260941,0.00005278566,0.0014041627,0.0010132986,0.0004663598,0.000047655685,0.003178095],"genre_scores_gemma":[0.01932135,0.97903913,0.00037808644,0.000075883545,0.0008256826,0.00019388758,0.000007706677,0.00006095656,0.0000972955],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.996333,0.0011567739,0.0010561825,0.0007560943,0.00011306109,0.0005848733],"domain_scores_gemma":[0.9978438,0.0008909205,0.0005714821,0.00035822758,0.00017218405,0.00016338092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011626432,0.00052044936,0.0018497934,0.0005392078,0.00009552216,0.000008559078,0.00069913245,0.0009959354,0.00056473055],"category_scores_gemma":[0.00020187549,0.00047660316,0.00051582017,0.00038747085,0.00084285653,0.00004093319,0.00011649606,0.0011462136,0.000072291754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033246898,0.0014350978,0.0024507283,0.0056742257,0.0030082047,0.000051521092,0.0011221484,0.000100142446,0.0041335933,0.87664056,0.00008926342,0.10496202],"study_design_scores_gemma":[0.0013585093,0.000074351396,0.0003548465,0.00052286556,0.0008498885,0.0000025147447,0.000016982183,0.00017310759,0.00026577926,0.00011450931,0.9958394,0.0004272482],"about_ca_topic_score_codex":0.000015017637,"about_ca_topic_score_gemma":0.000008780373,"teacher_disagreement_score":0.9957501,"about_ca_system_score_codex":0.00012090746,"about_ca_system_score_gemma":0.0004373961,"threshold_uncertainty_score":0.99976856},"labels":[],"label_agreement":null},{"id":"W2809869273","doi":"10.1186/s12916-018-1093-8","title":"Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial","year":2018,"lang":"en","type":"article","venue":"BMC Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Biomedical Research Council; National Research Foundation Singapore; National Medical Research Council; Medical Research Council; Agency for Science, Technology and Research; National Research Foundation","keywords":"Medicine; Dosing; Warfarin; Randomized controlled trial; Internal medicine; Clinical endpoint; Randomization; Incidence (geometry); Therapeutic index; Clinical trial; Surgery; Pharmacology; Atrial fibrillation","score_opus":0.38548979249823195,"score_gpt":0.5168340295936595,"score_spread":0.13134423709542759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809869273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769523,0.00063932064,0.00011304631,0.00023753881,0.008113427,0.0022415475,0.000030016843,0.000013505142,0.011659261],"genre_scores_gemma":[0.99672943,0.00025774888,0.00044571955,0.00036561646,0.001990252,0.00008676853,0.00003703089,0.00001481501,0.00007263733],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99516636,0.0019450787,0.001958292,0.00028241522,0.00036445665,0.0002833816],"domain_scores_gemma":[0.9954901,0.0030857907,0.00076877413,0.00018820645,0.00027410118,0.00019302507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053106975,0.00020530527,0.0020551044,0.00020315753,0.000051774652,0.0000019859212,0.0002464505,0.00026254094,0.0014111573],"category_scores_gemma":[0.0030188444,0.00014996574,0.00029584792,0.00024169685,0.0012819692,0.00003845848,0.000040842362,0.00040071073,0.000010366562],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9843617,0.0010232136,0.0069740927,0.000035751465,0.00037170312,0.0000022575637,0.0004158718,0.000020920324,0.001271543,0.0010639541,0.001118103,0.0033408874],"study_design_scores_gemma":[0.98410255,0.0011389415,0.007798074,0.00004429035,0.00076480024,6.6094907e-7,0.00003459007,0.0020469765,0.0016664857,0.0006025085,0.0016747847,0.00012533831],"about_ca_topic_score_codex":0.000025404992,"about_ca_topic_score_gemma":0.000015457628,"teacher_disagreement_score":0.019777074,"about_ca_system_score_codex":0.00002248713,"about_ca_system_score_gemma":0.00024981354,"threshold_uncertainty_score":0.9995017},"labels":[],"label_agreement":null},{"id":"W2811069189","doi":"10.1016/j.abb.2018.06.014","title":"Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency","year":2018,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; University of California, San Francisco; National Institutes of Health","keywords":"Allosteric regulation; Bioconjugation; Chemistry; CYP3A4; Steroid; Allosteric enzyme; Active site; Binding site; Cytochrome P450; Enzyme; Stereochemistry; Biochemistry","score_opus":0.034689999569702035,"score_gpt":0.3580046178513884,"score_spread":0.32331461828168634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811069189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980417,0.0007582187,0.000026698708,0.00010198531,0.00013847194,0.00023899325,0.00011021115,0.000017617936,0.0005661029],"genre_scores_gemma":[0.99888027,0.00049579394,0.000087398206,0.00022158753,0.00020707068,0.000009755403,0.000018667608,0.000011908189,0.00006754562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990671,0.00006423778,0.00019887886,0.0003461089,0.00008101334,0.0002426048],"domain_scores_gemma":[0.99926436,0.0002937521,0.00010486471,0.00009832093,0.000027535285,0.0002111723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021982647,0.00020139723,0.00021936628,0.00006441049,0.00021882837,0.00002344942,0.00009313781,0.000090516434,0.000007770936],"category_scores_gemma":[0.000030256444,0.00018124927,0.000034652618,0.0001269417,0.00030313517,0.00003668054,0.00012593946,0.00020899261,0.000007928144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042325552,0.000069721355,0.0017103713,0.00018949054,0.00004506306,0.0000023907512,0.00054106314,0.000013544447,0.9833677,0.00006436889,0.0000055927662,0.013567428],"study_design_scores_gemma":[0.0009544296,0.0004910714,0.002344872,0.000054889497,0.000075348784,0.000006493859,0.00003354874,0.004614851,0.99089825,0.0000990182,0.00023285001,0.00019438885],"about_ca_topic_score_codex":0.0000018477875,"about_ca_topic_score_gemma":2.88373e-7,"teacher_disagreement_score":0.01337304,"about_ca_system_score_codex":0.000003481157,"about_ca_system_score_gemma":0.00001537861,"threshold_uncertainty_score":0.7391131},"labels":[],"label_agreement":null},{"id":"W2883678991","doi":"10.1186/s13034-018-0243-2","title":"A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents","year":2018,"lang":"en","type":"review","venue":"Child and Adolescent Psychiatry and Mental Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; BC Children's Hospital","keywords":"Risperidone; Irritability; Child and adolescent psychiatry; Psychology; Psychiatry; Antipsychotic; Extrapyramidal symptoms; Medicine; Clinical psychology; Schizophrenia (object-oriented programming); Cognition","score_opus":0.02716319449067241,"score_gpt":0.399122026123332,"score_spread":0.3719588316326596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883678991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003732782,0.9885123,1.8253677e-7,0.00040135247,0.0012671676,0.005696477,0.00032391047,0.000007936748,0.000057934063],"genre_scores_gemma":[0.0035962854,0.99250597,0.000008710649,0.0035269002,0.0002009518,0.000060905924,0.00004034001,0.000029313676,0.000030652936],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969605,0.0010391617,0.0010399015,0.00046064024,0.00016252382,0.00033726727],"domain_scores_gemma":[0.9985167,0.00006311029,0.0008585713,0.0002817634,0.000017551762,0.00026229882],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050675875,0.00050123245,0.0021350456,0.00014806395,0.00021038046,0.0000071413647,0.00019227514,0.00020804533,0.000005459253],"category_scores_gemma":[0.000021091406,0.00030316736,0.00025348662,0.00021920315,0.00026982406,0.000023534007,0.000118944816,0.0004964613,0.0000017867673],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055256154,0.0011642128,0.0016310377,0.94975585,0.0002823203,3.4610133e-7,0.00013079455,2.8760075e-8,0.0000014220827,0.00010937233,0.00048716113,0.0463822],"study_design_scores_gemma":[0.0024008462,0.0004799956,0.0023349028,0.9494234,0.001689491,0.000072724666,0.000016939506,0.0000021797314,0.00003212353,0.000015926278,0.043247674,0.00028382966],"about_ca_topic_score_codex":0.000008290253,"about_ca_topic_score_gemma":0.000004531639,"teacher_disagreement_score":0.04609837,"about_ca_system_score_codex":0.000058863243,"about_ca_system_score_gemma":0.00017566688,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W2883772391","doi":"10.1101/368225","title":"Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health; Queen's University; Canadian Institutes of Health Research; Government of Ontario","keywords":"Pharmacogenomics; Linkage disequilibrium; Genetics; Biology; 1000 Genomes Project; Genome; Gene; Genetic association; Genome-wide association study; Computational biology; Haplotype; Allele; Single-nucleotide polymorphism; Genotype","score_opus":0.05802416135768246,"score_gpt":0.346020541855976,"score_spread":0.28799638049829357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883772391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971287,0.013770312,0.00020975257,0.00022259966,0.010047762,0.0015505701,0.0023793438,0.00042721297,0.00010541797],"genre_scores_gemma":[0.987728,0.005609709,0.000982921,0.0010793834,0.0038135755,0.0003664347,0.000008140522,0.0003425991,0.00006922881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9924655,0.0012936643,0.0015847572,0.0020901167,0.0005827809,0.0019832125],"domain_scores_gemma":[0.99565125,0.00022920847,0.0009672364,0.001468941,0.000648578,0.0010348016],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0029501643,0.0014946008,0.0015633075,0.001103942,0.00050276524,0.0003508808,0.0019097505,0.0016555972,0.0026700029],"category_scores_gemma":[0.00013991588,0.0016266687,0.00049491116,0.00094585534,0.0005225787,0.0003444515,0.0015304962,0.0031038192,0.0018592654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024116809,0.00037073353,0.006965577,0.0003524746,0.00093325274,0.00045341652,0.00008691724,0.004273652,0.9850309,0.00006549836,0.0012089756,0.000017462638],"study_design_scores_gemma":[0.0038496244,0.00008777307,0.08706421,0.00020185928,0.0010927435,4.081355e-7,0.000010297571,0.0049456186,0.8230798,0.00004412753,0.077173784,0.00244974],"about_ca_topic_score_codex":0.00031060088,"about_ca_topic_score_gemma":0.000012496865,"teacher_disagreement_score":0.16195105,"about_ca_system_score_codex":0.0011948351,"about_ca_system_score_gemma":0.0018444174,"threshold_uncertainty_score":0.9997803},"labels":[],"label_agreement":null},{"id":"W2883787065","doi":"","title":"Genomics and Biomarker Research in Drug Development: Overrated, or a Revolution to Come?","year":2017,"lang":"en","type":"article","venue":"UBC Faculty of Medicine medical journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Personalized medicine; Drug development; Engineering ethics; Field (mathematics); Biomarker; Precision medicine; Genomics; Data science; Medicine; Computer science; Drug; Bioinformatics; Biology; Engineering; Pharmacology; Pathology; Genome","score_opus":0.36119855020183317,"score_gpt":0.5514500067521504,"score_spread":0.19025145655031722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883787065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95693976,0.0021422023,0.00015915901,0.035546757,0.0014781433,0.00031778534,0.000018545683,0.000009917389,0.0033877394],"genre_scores_gemma":[0.99081767,0.0040118876,0.0009168323,0.0022038473,0.00080539804,0.0000139747635,0.000012587838,0.000020371164,0.0011974314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644303,0.00069072645,0.0008440162,0.00029103048,0.0011091828,0.00062199373],"domain_scores_gemma":[0.9975048,0.00040233054,0.00028800752,0.00021486684,0.00032909025,0.001260922],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010953502,0.00020049821,0.0005071619,0.00046576283,0.00075797515,0.000030169122,0.0008179189,0.00028596155,0.0019861679],"category_scores_gemma":[0.0026249578,0.0001379871,0.000040749906,0.00023371154,0.001176941,0.00010416564,0.00039567033,0.0018466485,0.00003490889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029180986,0.00056578824,0.03308487,0.00019998969,0.0003294376,0.0012916076,0.010748445,0.00002709847,0.03905153,0.0003077022,0.18116558,0.73030984],"study_design_scores_gemma":[0.010067962,0.00015771597,0.10870455,0.00047937644,0.000066116445,0.00057455455,0.00078868703,0.001773276,0.003926038,0.00055021665,0.8726812,0.00023027392],"about_ca_topic_score_codex":0.0001492944,"about_ca_topic_score_gemma":0.00018953747,"teacher_disagreement_score":0.7300796,"about_ca_system_score_codex":0.00012474938,"about_ca_system_score_gemma":0.0007201592,"threshold_uncertainty_score":0.99892616},"labels":[],"label_agreement":null},{"id":"W2886557322","doi":"10.1016/j.tiv.2018.08.004","title":"Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance","year":2018,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"European Commission; U.S. Environmental Protection Agency","keywords":"Biochemical engineering; In vitro; Computational biology; Computer science; Metabolite; Chemistry; Biochemistry; Biological system; Biology; Engineering","score_opus":0.10985869810134706,"score_gpt":0.5039570511157231,"score_spread":0.394098353014376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886557322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97683656,0.0031902336,0.010225427,0.0011602308,0.0039757225,0.0037196537,0.00011274732,0.00013203171,0.0006474157],"genre_scores_gemma":[0.9384659,0.00013711695,0.04717011,0.0105620995,0.0010616507,0.0022655162,0.00002604538,0.00009624934,0.00021532978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99287736,0.0030844193,0.0014192678,0.0009210012,0.00019132855,0.001506605],"domain_scores_gemma":[0.9956087,0.002707677,0.00040361405,0.00060898863,0.00019033956,0.00048068826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005697174,0.00055602164,0.0016688334,0.00088773464,0.00035124685,0.000075566924,0.001011994,0.00086390716,0.00034006545],"category_scores_gemma":[0.0021187826,0.0005696607,0.00022710007,0.0011268815,0.00032652883,0.0002275738,0.00028807385,0.0014243907,0.00017959543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020579188,0.0006106968,0.00044369954,0.0010576755,0.00014790331,0.000032273645,0.003388934,0.00006437941,0.971844,0.0014563075,0.00012832353,0.018767897],"study_design_scores_gemma":[0.0036067395,0.00027486915,0.0038392495,0.00032032205,0.00040552736,0.000028679793,0.00019108185,0.009109216,0.9472185,0.0076078395,0.02658814,0.0008098794],"about_ca_topic_score_codex":0.00005476257,"about_ca_topic_score_gemma":0.000057849473,"teacher_disagreement_score":0.038370654,"about_ca_system_score_codex":0.0001700965,"about_ca_system_score_gemma":0.00012791793,"threshold_uncertainty_score":0.9996755},"labels":[],"label_agreement":null},{"id":"W2889101019","doi":"10.1001/jamapsychiatry.2018.2344","title":"Pharmacogenetics in Psychiatry: A Companion, Rather Than Competitor, to Protocol-Based Care","year":2018,"lang":"en","type":"letter","venue":"JAMA Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto; Centre for Addiction and Mental Health; University of Calgary","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Psychiatry; MEDLINE; Law","score_opus":0.06370917184747929,"score_gpt":0.4318295880493795,"score_spread":0.36812041620190017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889101019","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016227761,0.0033408764,0.00014434717,0.82029927,0.059729606,0.08136401,0.002634665,0.0005271674,0.015732285],"genre_scores_gemma":[0.0022175855,0.000058562862,0.0065205498,0.89998424,0.0450468,0.04375341,0.0006701558,0.00046482668,0.0012838597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9915492,0.0018392003,0.0016867558,0.0018770543,0.000977627,0.0020701392],"domain_scores_gemma":[0.996352,0.00022462345,0.00075047463,0.0013022105,0.00057654455,0.0007941397],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0009308437,0.0016170192,0.0014562629,0.0011301023,0.00045256288,0.00021589785,0.0022780723,0.00330635,0.004292558],"category_scores_gemma":[0.00004393619,0.0016493456,0.00065171166,0.0012388973,0.00039389342,0.0001172011,0.00036944012,0.007209275,0.0018211649],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009827306,0.0008075383,0.036875978,0.0013818283,0.00030539505,0.00010656196,0.0005887979,0.00044278803,0.0005039982,0.000105708874,0.954808,0.0030906573],"study_design_scores_gemma":[0.012472544,0.00036815184,0.0030082292,0.00035717915,0.00043880971,0.000023082084,0.00013171174,0.0006923225,0.0013318153,0.00053482095,0.97881174,0.0018295879],"about_ca_topic_score_codex":0.000076838645,"about_ca_topic_score_gemma":0.00026344045,"teacher_disagreement_score":0.07968497,"about_ca_system_score_codex":0.00027345415,"about_ca_system_score_gemma":0.0020050313,"threshold_uncertainty_score":0.99965775},"labels":[],"label_agreement":null},{"id":"W2889126032","doi":"10.1096/fasebj.31.1_supplement.668.16","title":"Regulation of Hepatic CYP3A4 by 3‐Methylcholanthrene in Humanized PXR‐CAR‐CYP3A4/3A7 Mice","year":2017,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"CYP3A4; Aryl hydrocarbon receptor; Pregnane X receptor; Cytochrome P450; Drug metabolism; Chemistry; Constitutive androstane receptor; Methylcholanthrene; Enzyme inducer; Pharmacology; Enzyme; Carcinogen; Biochemistry; Biology; Nuclear receptor; Gene; Transcription factor","score_opus":0.09914735422546347,"score_gpt":0.4270466895754119,"score_spread":0.3278993353499484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889126032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904716,0.0033294007,0.00013662248,0.0011746756,0.0017228621,0.00026879593,0.00007011456,0.0000144726555,0.0028114708],"genre_scores_gemma":[0.99511266,0.0028323242,0.00015533609,0.00058205135,0.00049480045,0.00001029723,0.000011716691,0.000027771137,0.0007730284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99749446,0.0008780147,0.000661106,0.00021170313,0.00029815297,0.00045656308],"domain_scores_gemma":[0.99809766,0.00029405524,0.0008272385,0.00042064846,0.00015049614,0.00020988962],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027652392,0.00023370369,0.00040707155,0.0001429488,0.0009514252,0.00009564868,0.0010080484,0.00020693363,0.0011135427],"category_scores_gemma":[0.0002136641,0.00017752478,0.00016082387,0.00010736201,0.00037042017,0.00022166168,0.00015199641,0.0012324592,0.00005115436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036989173,0.00021011126,0.012169166,0.000018113948,0.00014687577,0.000019979821,0.0007391958,0.00032447162,0.96782535,0.00023798633,0.0025054945,0.015433388],"study_design_scores_gemma":[0.0050574546,0.000066943685,0.04086543,0.00004073912,0.00031978547,0.00010377014,0.000103896,0.0043605985,0.9278291,0.0032328153,0.017751507,0.00026798365],"about_ca_topic_score_codex":0.000082851315,"about_ca_topic_score_gemma":0.000036768986,"teacher_disagreement_score":0.039996248,"about_ca_system_score_codex":0.000054963202,"about_ca_system_score_gemma":0.00010298437,"threshold_uncertainty_score":0.99979955},"labels":[],"label_agreement":null},{"id":"W2889505073","doi":"10.1016/j.rcp.2018.07.002","title":"High Doses of Drugs Extensively Metabolized by CYP3A4 Were Needed to Reach Therapeutic Concentrations in Two Patients Taking Inducers","year":2018,"lang":"en","type":"article","venue":"Revista Colombiana de Psiquiatría","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"CYP3A4; Pharmacology; Inducer; Chemistry; Medicine; Internal medicine; Cytochrome P450; Biochemistry; Metabolism","score_opus":0.06025166596081876,"score_gpt":0.4254230873435385,"score_spread":0.36517142138271974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889505073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911722,0.003328069,0.00015757738,0.0011379815,0.00094120635,0.0012377196,0.0003339292,0.00006406325,0.0016272546],"genre_scores_gemma":[0.98833334,0.00077458855,0.0006245106,0.009505696,0.00027627157,0.000112875314,0.00007618287,0.000059830156,0.00023670318],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961836,0.0010385924,0.00096239604,0.00058412756,0.00034267295,0.00088862627],"domain_scores_gemma":[0.99769425,0.00036091876,0.00057224295,0.00038426355,0.0005199206,0.00046842903],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010966738,0.00041460508,0.00082484895,0.00028780868,0.0002543593,0.0000650263,0.0005765685,0.0002555977,0.0008214679],"category_scores_gemma":[0.0002757311,0.00043375976,0.00017660788,0.0008707948,0.000331375,0.00014338193,0.00015001744,0.000634648,0.00007834612],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018075182,0.0015162862,0.040110968,0.00013409615,0.00062813377,0.000016750731,0.0066673784,0.0002074162,0.8571516,0.011237158,0.026645103,0.053877532],"study_design_scores_gemma":[0.0164331,0.0005458198,0.03215019,0.00013036904,0.0012160706,0.000008025273,0.0013348517,0.0010986659,0.44055632,0.0010280876,0.50419265,0.0013058285],"about_ca_topic_score_codex":0.0007636603,"about_ca_topic_score_gemma":0.000088073655,"teacher_disagreement_score":0.47754756,"about_ca_system_score_codex":0.00020160129,"about_ca_system_score_gemma":0.00032892212,"threshold_uncertainty_score":0.9998114},"labels":[],"label_agreement":null},{"id":"W2889618178","doi":"10.1038/s41525-018-0065-4","title":"User considerations in assessing pharmacogenomic tests and their clinical support tools","year":2018,"lang":"en","type":"review","venue":"npj Genomic Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; WSP (Canada)","funders":"","keywords":"Pharmacogenomics; Computer science; Test (biology); Key (lock); Clinical decision support system; Decision support system; Risk analysis (engineering); Data science; Data mining; Medicine; Pharmacology","score_opus":0.48380413423267077,"score_gpt":0.5796990875447691,"score_spread":0.0958949533120983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889618178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007729332,0.979182,0.000022167713,0.000421454,0.0054220054,0.0016808099,0.0002975616,0.000074111755,0.0051705614],"genre_scores_gemma":[0.0036324812,0.9853441,0.00024299185,0.0045883027,0.0048596975,0.00016344734,0.0002696483,0.0001401294,0.00075921335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992779,0.0022640626,0.0027086642,0.0011635518,0.00018840263,0.0008962782],"domain_scores_gemma":[0.99353313,0.004119882,0.00090418494,0.00054431806,0.00014095292,0.00075751403],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052925665,0.0009624319,0.0033177682,0.0005591944,0.00030946685,0.000079319674,0.00052233133,0.0011041441,0.0057525714],"category_scores_gemma":[0.0006923274,0.00072736235,0.00037320727,0.00032753192,0.0011688479,0.00016098602,0.00036708105,0.0025126631,0.00047097044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025662112,0.00022337968,0.00057527487,0.0018250739,0.00065503817,0.00018828684,0.0005423545,0.0000023623775,0.0010626139,0.00015404778,0.030661747,0.96408415],"study_design_scores_gemma":[0.0029859082,0.00011668359,0.0003234439,0.0010400532,0.0020284439,0.00039260156,0.000057567573,0.00008377935,0.00005123996,0.00031531428,0.9919461,0.00065888744],"about_ca_topic_score_codex":0.000014396419,"about_ca_topic_score_gemma":0.000017035532,"teacher_disagreement_score":0.9634253,"about_ca_system_score_codex":0.00016751277,"about_ca_system_score_gemma":0.0012605728,"threshold_uncertainty_score":0.9997886},"labels":[],"label_agreement":null},{"id":"W2889861811","doi":"10.1016/j.bmcl.2018.09.016","title":"Methyl-containing pharmaceuticals: Methylation in drug design","year":2018,"lang":"en","type":"review","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Chemistry; Drug; Pharmacokinetics; Methylation; Pharmacology; Pharmacodynamics; Drug metabolism; Biological activity; Computational biology; Combinatorial chemistry; In vitro; Biochemistry; Gene; Medicine","score_opus":0.27395406553412716,"score_gpt":0.4918970300860542,"score_spread":0.21794296455192702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889861811","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011585511,0.9928544,0.00046470677,0.0007790192,0.0022011788,0.0011807354,0.00007765207,0.00015645687,0.001127284],"genre_scores_gemma":[0.001691486,0.9902773,0.00050108985,0.003108682,0.0035343352,0.00022925444,0.00019321694,0.00018801536,0.00027662958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930779,0.0019833646,0.001741143,0.0012810015,0.00060604914,0.0013105648],"domain_scores_gemma":[0.9961059,0.001632172,0.00082382147,0.00057585177,0.00011000306,0.0007522419],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046637165,0.0011826425,0.0024469155,0.00032896377,0.00022649039,0.0000472245,0.0012297044,0.0010862281,0.0036585736],"category_scores_gemma":[0.00048923,0.0010737133,0.0005329373,0.0010270226,0.00057805504,0.000111883055,0.00027797304,0.0033451945,0.00047377087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025204636,0.00032549902,0.000015353678,0.009587624,0.0012366378,0.0006221646,0.00084713683,0.000014913294,0.20068318,0.000012645698,0.019172994,0.7672298],"study_design_scores_gemma":[0.0016428255,0.000019744419,0.0000015750376,0.0016555778,0.00310207,0.00014684287,0.00005945344,0.0001617214,0.06248526,0.000031092968,0.929753,0.00094084704],"about_ca_topic_score_codex":0.000022889888,"about_ca_topic_score_gemma":0.0000015286455,"teacher_disagreement_score":0.91058,"about_ca_system_score_codex":0.000539916,"about_ca_system_score_gemma":0.0006673122,"threshold_uncertainty_score":0.9991713},"labels":[],"label_agreement":null},{"id":"W2890068629","doi":"10.1021/acs.jmedchem.8b00907","title":"Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity","year":2018,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Universidad Nacional Autónoma de México; Fondation CHU de Québec; Consejo Nacional de Ciencia y Tecnología","keywords":"Chemistry; Cytochrome P450; Selectivity; Stereochemistry; CYP1B1; Ring (chemistry); IC50; Docking (animal); Enzyme; Combinatorial chemistry; In vitro; Biochemistry; Organic chemistry; Catalysis","score_opus":0.07483375476805847,"score_gpt":0.36246343762890637,"score_spread":0.2876296828608479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890068629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930485,0.0022069064,0.003586981,0.00030312463,0.0002213389,0.0001360015,0.0000128285465,0.00001694542,0.00046738394],"genre_scores_gemma":[0.99540854,0.0008386013,0.0021947303,0.0000821724,0.0014004909,0.0000066963357,8.6705217e-7,0.000025906722,0.000042018804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815726,0.00030091766,0.0005255689,0.00023323705,0.0004119654,0.00037102756],"domain_scores_gemma":[0.9976817,0.00063110614,0.0007546131,0.00011221089,0.0004728812,0.00034748923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016408094,0.00028455578,0.00061116513,0.00009181207,0.00020267005,0.000015024876,0.0002456362,0.00023772992,0.00024858993],"category_scores_gemma":[0.00046544906,0.00022894802,0.00007326587,0.0002295541,0.00085507735,0.00024859014,0.00006595669,0.0009967093,0.0000011453618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021626519,0.00019748404,0.0015568438,0.00030157377,0.00038663627,0.00018385485,0.0006357989,0.00021750969,0.9916104,0.0000035540413,0.00019743646,0.0025462396],"study_design_scores_gemma":[0.0018211359,0.0002964068,0.0034492447,0.0002346314,0.00046096576,0.0012549572,0.00024896357,0.0005617219,0.9902466,0.000059324037,0.0011416527,0.00022442907],"about_ca_topic_score_codex":0.0000072204048,"about_ca_topic_score_gemma":0.0000017154335,"teacher_disagreement_score":0.0023600264,"about_ca_system_score_codex":0.00005945533,"about_ca_system_score_gemma":0.00039550394,"threshold_uncertainty_score":0.9336229},"labels":[],"label_agreement":null},{"id":"W2891276185","doi":"10.1016/j.bmc.2018.09.001","title":"4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells","year":2018,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital Saint-François d'Assise","funders":"Canada Foundation for Innovation","keywords":"Chemistry; Prodrug; HaCaT; Stereochemistry; Cytochrome P450; Moiety; Chemical synthesis; Structure–activity relationship; Alkyl; Sulfonamide; In vitro; Biochemistry; Enzyme","score_opus":0.0410626882617693,"score_gpt":0.3872433365228238,"score_spread":0.3461806482610545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891276185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851826,0.004151072,0.000013321173,0.0047443123,0.0013637102,0.0004871707,0.00029816816,0.00016718263,0.0035924562],"genre_scores_gemma":[0.9867924,0.0024936642,0.00005703756,0.0043834676,0.003485659,0.00004588375,0.00007245776,0.00010805078,0.0025613809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962563,0.00019251725,0.0007958879,0.0009823161,0.0005591925,0.0012138089],"domain_scores_gemma":[0.9975213,0.0001830522,0.00034331856,0.0004761661,0.00023447328,0.0012416918],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006218001,0.0006859362,0.00073427777,0.00011877655,0.0002614605,0.000042068717,0.00086359965,0.00072035653,0.01482246],"category_scores_gemma":[0.00013796301,0.0006530662,0.00013688568,0.0008351027,0.0005761126,0.00014530151,0.00023363612,0.0013038886,0.00042114977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059467374,0.00042157574,0.0012319321,0.0001505545,0.00019812194,0.000088766865,0.0005725833,0.000010889443,0.94914365,0.000008094652,0.04097737,0.0066017746],"study_design_scores_gemma":[0.0037120245,0.000052212858,0.0033160048,0.00011970107,0.00029750794,0.00018876596,0.00019921869,0.00025739902,0.9294837,0.00013432503,0.061583284,0.00065581774],"about_ca_topic_score_codex":0.0005685345,"about_ca_topic_score_gemma":0.000014894901,"teacher_disagreement_score":0.020605914,"about_ca_system_score_codex":0.00030700222,"about_ca_system_score_gemma":0.0013031571,"threshold_uncertainty_score":0.99959207},"labels":[],"label_agreement":null},{"id":"W2891749579","doi":"10.1096/fasebj.27.1_supplement.666.3","title":"Pharmacogenomics of vincristine‐induced neurotoxicity in pediatric cancer patients","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Context (archaeology); Cohort; Oncology; Pediatric cancer; Internal medicine; Cancer; Bioinformatics; Biology","score_opus":0.0837949048185811,"score_gpt":0.39260042748887886,"score_spread":0.30880552267029776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891749579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944541,0.0011156372,0.0000094428015,0.0005050285,0.002297418,0.00057197566,0.00005645491,0.000013546723,0.00097643887],"genre_scores_gemma":[0.9935852,0.0036637904,0.00002882972,0.001660163,0.00088143355,0.000055559485,0.0000030895699,0.000028098131,0.00009380099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767715,0.00067856064,0.0006794774,0.00018972809,0.00025641988,0.00051868934],"domain_scores_gemma":[0.9986154,0.00023863542,0.00044459853,0.00014769449,0.0002573217,0.00029636745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087207335,0.00022956026,0.0003035763,0.00019815049,0.00022837012,0.000030503506,0.00061923824,0.00013376705,0.0023495415],"category_scores_gemma":[0.000079643396,0.00016749949,0.00013699124,0.00034949643,0.00009328218,0.00014036127,0.00013370003,0.0013611683,0.00009696477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015800865,0.0005593488,0.28855717,0.000027720698,0.000077608005,0.000012552354,0.00055063935,0.001368256,0.6896455,0.000025102318,0.002583556,0.016434537],"study_design_scores_gemma":[0.005981824,0.00013237957,0.28607985,0.000010983477,0.0004113657,0.00003473792,0.00006269378,0.0060353605,0.6956678,0.0006155768,0.00456876,0.0003986236],"about_ca_topic_score_codex":0.00011645296,"about_ca_topic_score_gemma":0.000009114036,"teacher_disagreement_score":0.016035913,"about_ca_system_score_codex":0.000063585845,"about_ca_system_score_gemma":0.00016496812,"threshold_uncertainty_score":0.99856246},"labels":[],"label_agreement":null},{"id":"W2896138992","doi":"10.1097/yco.0000000000000465","title":"Towards the integration of pharmacogenetics in psychiatry","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Pharmacogenomics; CYP2C19; Medicine; Genetic testing; Dosing; Psychiatry; Pharmacology; Psychology; Genetics; Gene; Biology; Genotype; Internal medicine","score_opus":0.35598024054537697,"score_gpt":0.553603772082564,"score_spread":0.19762353153718698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896138992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002521813,0.8437171,0.000056320107,0.00032683424,0.15275526,0.001530389,0.00033092886,0.000032701206,0.0009982656],"genre_scores_gemma":[0.00013404097,0.99330485,0.0004077033,0.00018270049,0.005197494,0.00037936706,0.0002623737,0.00009648749,0.000034965444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939186,0.0017744647,0.0023249476,0.00081896764,0.00041380586,0.0007492369],"domain_scores_gemma":[0.99761474,0.00023339238,0.0011149211,0.0006724817,0.00013966925,0.0002247694],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019503622,0.00084726285,0.0016416338,0.00085946213,0.00013506536,0.000030879703,0.0014433125,0.00085288397,0.00059904327],"category_scores_gemma":[0.00006807314,0.00063319923,0.00072466413,0.0015876456,0.00040994637,0.00008455382,0.00028320556,0.002932907,0.00014427937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006893917,0.001420301,0.00093834347,0.011871469,0.00017059915,4.2207333e-7,0.00032037063,0.000024403726,0.000003918052,0.003158295,0.043669317,0.9383536],"study_design_scores_gemma":[0.0015702333,0.00006598602,0.0002879134,0.0073417523,0.0004999275,0.000015701246,0.000064326756,0.00030895183,0.000014708773,0.0020978018,0.98713714,0.0005955758],"about_ca_topic_score_codex":0.000012922174,"about_ca_topic_score_gemma":0.00002519055,"teacher_disagreement_score":0.9434678,"about_ca_system_score_codex":0.00012249831,"about_ca_system_score_gemma":0.0016308557,"threshold_uncertainty_score":0.9996119},"labels":[],"label_agreement":null},{"id":"W2896289324","doi":"10.1002/dta.2523","title":"Zebrafish (<scp><i>Danio rerio</i></scp>) water tank model for the investigation of drug metabolism: Progress, outlook, and challenges","year":2018,"lang":"en","type":"article","venue":"Drug Testing and Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministério do Esporte; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; World Anti-Doping Agency","keywords":"Danio; Zebrafish; Drug; Drug metabolism; Chemistry; Computational biology; Pharmacology; Biology; Biochemistry; Gene","score_opus":0.1276785978959806,"score_gpt":0.36367371752348066,"score_spread":0.23599511962750006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896289324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688792,0.026791332,0.00039506843,0.0027203767,0.00023629154,0.00039423187,0.000114366405,0.0000744073,0.00039467387],"genre_scores_gemma":[0.9913603,0.0036164531,0.0030069496,0.0008416544,0.0004347251,0.00009956296,0.000027737511,0.00003070006,0.0005819092],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99810064,0.0002888354,0.0004709572,0.00048278386,0.00019058766,0.00046619365],"domain_scores_gemma":[0.9976254,0.001238499,0.00025862895,0.00025806954,0.00039048077,0.00022893891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019085633,0.00028692777,0.0005245073,0.00020799518,0.00059608114,0.000058846745,0.00026193174,0.00013172448,0.0000124016315],"category_scores_gemma":[0.00033630242,0.00019115364,0.0001552612,0.00041773947,0.00080880366,0.000114962866,0.00016823702,0.00028537115,0.0000032679338],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030294116,0.0007596528,0.16855271,0.0015463113,0.015895257,0.000014841567,0.12275496,0.011967801,0.4067933,0.0057241097,0.011536527,0.2541516],"study_design_scores_gemma":[0.0011649362,0.00003364329,0.005810409,0.00001763698,0.0069339992,0.0000048776283,0.0006449576,0.84897524,0.111746736,0.0040347762,0.020438688,0.0001941057],"about_ca_topic_score_codex":0.00003706327,"about_ca_topic_score_gemma":0.000045455647,"teacher_disagreement_score":0.83700746,"about_ca_system_score_codex":0.0000072146695,"about_ca_system_score_gemma":0.000043801963,"threshold_uncertainty_score":0.7795019},"labels":[],"label_agreement":null},{"id":"W2898168462","doi":"10.1016/j.taap.2018.10.021","title":"CYP3C gene regulation by the aryl hydrocarbon and estrogen receptors in zebrafish","year":2018,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada; McMaster University","keywords":"Aryl hydrocarbon receptor; CYP3A; Biology; Cytochrome P450; Estrogen receptor; Subfamily; Vitellogenin; Aryl hydrocarbon receptor nuclear translocator; Gene expression; Gene; Xenobiotic; Receptor; Internal medicine; Endocrinology; Estrogen; Enzyme; Metabolism; Genetics; Biochemistry; Transcription factor","score_opus":0.03933859011057748,"score_gpt":0.3606560253366642,"score_spread":0.3213174352260867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898168462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832569,0.0037974087,0.000046604928,0.0036845303,0.0021456915,0.0009941186,0.000043381242,0.00009575846,0.0059356363],"genre_scores_gemma":[0.9834598,0.0015135285,0.0001520832,0.01312418,0.0009932161,0.00030186065,0.00004245605,0.00004735127,0.0003655359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969837,0.0005574584,0.0006011212,0.0007935824,0.00014701234,0.00091714534],"domain_scores_gemma":[0.99855196,0.0005812043,0.00023219567,0.00021502674,0.00005763342,0.00036198922],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011566473,0.00044965162,0.000541543,0.00020722898,0.0005848379,0.00002764108,0.00039497422,0.000724301,0.0017160277],"category_scores_gemma":[0.000027015927,0.00038845954,0.000057038123,0.0003980941,0.0018292147,0.00009113117,0.0003116626,0.0011308005,0.00009249756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010485464,0.00033772126,0.0044862316,0.000020543644,0.00022461984,0.0000135359705,0.0009704149,0.00007813557,0.925097,0.003974345,0.024795307,0.03895361],"study_design_scores_gemma":[0.00498366,0.00023956297,0.0031373382,0.0000031605555,0.00031503104,0.00011292366,0.00014751234,0.0026306908,0.6418409,0.0034170423,0.34270385,0.0004683792],"about_ca_topic_score_codex":0.000023351695,"about_ca_topic_score_gemma":0.00003423788,"teacher_disagreement_score":0.31790853,"about_ca_system_score_codex":0.00005841434,"about_ca_system_score_gemma":0.000087949906,"threshold_uncertainty_score":0.9998567},"labels":[],"label_agreement":null},{"id":"W2899955386","doi":"10.1007/s10549-018-5027-0","title":"CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada); BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; CYP2D6; Medicine; Oncology; Genotyping; Context (archaeology); Metastatic breast cancer; Critical appraisal; Internal medicine; Gynecology; Cancer; Bioinformatics; Biology; Genotype; Alternative medicine; Pathology; Genetics","score_opus":0.39078011189290024,"score_gpt":0.6369050860232861,"score_spread":0.24612497413038587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899955386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003798334,0.9692634,0.00002276379,0.0012774806,0.0007647542,0.016993819,0.011081604,0.00004119819,0.00017514595],"genre_scores_gemma":[0.00009324255,0.9719182,0.001110639,0.0012213582,0.0012496805,0.02321386,0.00039929207,0.0001696684,0.00062405854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910571,0.0025582353,0.0024105245,0.0016256577,0.0009494981,0.0013990075],"domain_scores_gemma":[0.9881032,0.004632352,0.0013039783,0.00072619994,0.004075187,0.0011591007],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0029803133,0.0013009722,0.004551587,0.00039656236,0.000830141,0.00017467908,0.00055995904,0.0004163379,0.0003688925],"category_scores_gemma":[0.00050657435,0.0007497869,0.0008258704,0.0007472731,0.00052052416,0.00024782078,0.00023873473,0.0007791903,0.00016951219],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028288749,0.004164464,0.00006237664,0.10988603,0.009240626,0.00015096924,0.00014354115,0.0000025060488,3.420029e-7,0.000016307318,0.003845455,0.8696585],"study_design_scores_gemma":[0.010554494,0.0024467467,0.00003923966,0.19215964,0.032513395,0.0010382477,0.00007657879,0.00008030343,0.000008334856,0.00003796461,0.76026595,0.00077909476],"about_ca_topic_score_codex":0.0011615364,"about_ca_topic_score_gemma":0.00019276077,"teacher_disagreement_score":0.86887944,"about_ca_system_score_codex":0.001658145,"about_ca_system_score_gemma":0.0030966655,"threshold_uncertainty_score":0.9999742},"labels":[],"label_agreement":null},{"id":"W2900376768","doi":"10.1016/j.jmb.2018.11.007","title":"Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes","year":2018,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institutes of Health","keywords":"Glucuronidation; Enzyme; Glucuronosyltransferase; Drug resistance; Biochemistry; Allosteric regulation; Drug; Substrate specificity; Biology; In vitro; Drug development; Chemistry; Pharmacology; Computational biology; Genetics; Microsome","score_opus":0.04720221271057111,"score_gpt":0.40730510450216156,"score_spread":0.36010289179159044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900376768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805462,0.008753654,0.006667768,0.0007222995,0.0011998515,0.00017601036,0.00001952334,0.0000049630385,0.0019097447],"genre_scores_gemma":[0.99286765,0.0003640127,0.005756858,0.00064941903,0.0002803356,0.000004121105,0.0000020627647,0.000016233682,0.000059299422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976546,0.00076464255,0.00095885457,0.00016446781,0.00016378784,0.00029361993],"domain_scores_gemma":[0.99822855,0.00031956367,0.00069515395,0.00014623905,0.00051849365,0.000092028225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012269472,0.00018611005,0.0004509162,0.00011520644,0.00014214222,0.0000039652678,0.00043352955,0.0001727851,0.00011346431],"category_scores_gemma":[0.00013552248,0.0001317599,0.00019400354,0.00024608994,0.0005745216,0.00005042512,0.00007218518,0.00052285276,0.0000037950847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006908396,0.00019954277,0.0009814308,0.000031863714,0.0005547394,0.000011490217,0.0055581625,0.000057152887,0.98304516,0.0031091033,0.0013476547,0.0044128606],"study_design_scores_gemma":[0.0011669116,0.000114992115,0.0003168346,0.000025958785,0.00016534273,0.000016994427,0.00016138205,0.000012504788,0.8687833,0.0024135876,0.12670913,0.00011303523],"about_ca_topic_score_codex":0.000004623235,"about_ca_topic_score_gemma":0.000019554845,"teacher_disagreement_score":0.12536149,"about_ca_system_score_codex":0.000034025346,"about_ca_system_score_gemma":0.0003546565,"threshold_uncertainty_score":0.5373013},"labels":[],"label_agreement":null},{"id":"W2900478530","doi":"10.1002/jcph.1336","title":"Analyses of Adverse Drug Reactions–Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"University of British Columbia; Western University; Provincial Health Services Authority; Child and Family Research Institute; Genome British Columbia; Pfizer Canada; Société Canadienne de Pédiatrie; Michael Smith Health Research BC; Canadian Institutes of Health Research; Genome Canada","keywords":"Medicine; Pharmacogenomics; Pharmacovigilance; Database; MedDRA; Drug reaction; Drug; Adverse drug reaction; Cardiotoxicity; Pharmacology; Internal medicine; Toxicity","score_opus":0.22913844339583006,"score_gpt":0.5357776064072207,"score_spread":0.30663916301139066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900478530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312909,0.005610425,0.0026287162,0.0101601295,0.0426156,0.0019058582,0.0016639989,0.000048454254,0.004075878],"genre_scores_gemma":[0.9535595,0.012851662,0.0020630604,0.011428173,0.019363763,0.000022653021,0.00006195406,0.00006704887,0.0005821498],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902551,0.004685934,0.003210761,0.00038826923,0.00034470693,0.0011152026],"domain_scores_gemma":[0.9840509,0.009791069,0.0030000452,0.0003588097,0.0017725326,0.0010265972],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016838377,0.00042939233,0.0013089456,0.00025187616,0.0008500683,0.000008781083,0.0013248087,0.00031256385,0.0021355979],"category_scores_gemma":[0.0008687686,0.0003367395,0.0006890222,0.00069661875,0.0012725382,0.0002614695,0.00020129926,0.001982305,0.00005123294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029282087,0.0010516796,0.013242319,0.00010635387,0.006750873,0.00006858237,0.0009099638,0.12060311,0.06999655,0.0005156834,0.73388225,0.02359056],"study_design_scores_gemma":[0.009078386,0.00029258497,0.008580488,0.000027830522,0.003001859,0.00008468883,0.00015344619,0.013519553,0.04768303,0.001123971,0.91602546,0.00042867864],"about_ca_topic_score_codex":0.0012069284,"about_ca_topic_score_gemma":0.004004436,"teacher_disagreement_score":0.18214324,"about_ca_system_score_codex":0.00012942817,"about_ca_system_score_gemma":0.0015828308,"threshold_uncertainty_score":0.99990845},"labels":[],"label_agreement":null},{"id":"W2900842113","doi":"10.1002/9780470921920.edm145","title":"Oxidative Drug Metabolism by Mammalian Cytochrome<scp>P450</scp>Enzymes Using Their Monooxygenase and Peroxygenase Functions","year":2017,"lang":"en","type":"other","venue":"Encyclopedia of Drug Metabolism and Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Monooxygenase; Cytochrome P450; Biotransformation; Drug metabolism; Enzyme; Chemistry; Biochemistry; Cytochrome; Prodrug; Oxidative phosphorylation; Drug; Metabolism; Pharmacology; Biology","score_opus":0.04009689119924323,"score_gpt":0.3576788264468414,"score_spread":0.31758193524759815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900842113","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22076537,0.26112053,0.00034450478,0.00056385825,0.014891575,0.0024024895,0.017261561,0.0003831509,0.48226696],"genre_scores_gemma":[0.05233305,0.14204726,0.0012042876,0.000743016,0.0046917167,0.00034175187,0.00071591267,0.00079638173,0.79712665],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954942,0.0009154551,0.0009643803,0.0012523191,0.00039000157,0.0009836495],"domain_scores_gemma":[0.9957519,0.00066038675,0.0014685275,0.00091248023,0.0002528047,0.00095387496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007002961,0.0012660606,0.0017409032,0.0009461772,0.0009929006,0.00015698864,0.000745785,0.0006326354,0.0020221227],"category_scores_gemma":[0.00031050475,0.001163359,0.00043743392,0.00030940687,0.000967422,0.000588708,0.0005242499,0.0019031476,0.0000926427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006637214,0.00061217113,0.00012130425,0.00021459359,0.0016999142,0.000023625737,0.0038924483,0.000018442312,0.06162935,0.0004963793,0.9157281,0.01549733],"study_design_scores_gemma":[0.0020730635,0.000017396625,0.00062695664,0.00011498527,0.0023963985,0.00005452565,0.0014859295,0.00029747808,0.02310335,0.00019017785,0.96904707,0.0005926883],"about_ca_topic_score_codex":0.0013690891,"about_ca_topic_score_gemma":0.00035308677,"teacher_disagreement_score":0.31485966,"about_ca_system_score_codex":0.00004152469,"about_ca_system_score_gemma":0.00027597405,"threshold_uncertainty_score":0.9990816},"labels":[],"label_agreement":null},{"id":"W2900859659","doi":"10.1016/j.jpsychires.2018.10.016","title":"Adequate evidence to support improved outcomes in depression by primary care physicians compared to psychiatrists when using combinatorial pharmacogenomics","year":2018,"lang":"en","type":"letter","venue":"Journal of Psychiatric Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Depression (economics); Primary care; Psychiatry; Medicine; Psychology; Clinical psychology; Family medicine; Pharmacology","score_opus":0.2328502124075531,"score_gpt":0.5217908815871977,"score_spread":0.28894066917964456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900859659","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7541081,0.027743926,0.0005182518,0.15195118,0.058319617,0.0050570373,0.0011960603,0.00005626298,0.0010495974],"genre_scores_gemma":[0.2668496,0.006426508,0.013767063,0.6314079,0.07809638,0.00033332,0.0003377,0.0007904959,0.0019910058],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98940074,0.0029660435,0.0023563069,0.0010782128,0.002148443,0.0020502545],"domain_scores_gemma":[0.9940284,0.0011303468,0.0012242232,0.00073035475,0.0019521546,0.0009345051],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004795596,0.0008427937,0.0018074424,0.0025689255,0.000509478,0.00019358627,0.002955878,0.0013339244,0.00043598743],"category_scores_gemma":[0.00020194626,0.00079301465,0.0006309418,0.0015917671,0.00022611978,0.00026156066,0.00074909243,0.009099863,0.00018748232],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031003933,0.0005877086,0.015544429,0.00048375153,0.0004641348,0.0003191823,0.0023233914,0.00021940772,0.026747458,0.0000023461278,0.93822706,0.011980718],"study_design_scores_gemma":[0.0075020785,0.0013807695,0.0009697522,0.00030038424,0.00078477024,0.000073249845,0.00026752573,0.00031292404,0.00344693,0.00046404314,0.983412,0.0010855414],"about_ca_topic_score_codex":0.00017542971,"about_ca_topic_score_gemma":0.000013305725,"teacher_disagreement_score":0.48725846,"about_ca_system_score_codex":0.0010917409,"about_ca_system_score_gemma":0.0018479903,"threshold_uncertainty_score":0.99996257},"labels":[],"label_agreement":null},{"id":"W2901042022","doi":"10.1016/j.vhri.2018.09.003","title":"Drug Utilization Studies in Latin America: A Scoping Review and Survey of Ethical Requirements","year":2018,"lang":"en","type":"review","venue":"Value in Health Regional Issues","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Inro Consultants (Canada)","funders":"","keywords":"Latin Americans; Drug; Medicine; Political science; Pharmacology; Law","score_opus":0.8145457937045636,"score_gpt":0.6734986125990323,"score_spread":0.14104718110553127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901042022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017797723,0.99516183,0.0000015167324,0.0015432946,0.0006027172,0.0023641468,0.00008994285,0.000016098034,0.000042489282],"genre_scores_gemma":[0.00006231659,0.9948946,0.00023074566,0.004191298,0.00016038252,0.00020226394,0.0001401082,0.000039684463,0.000078581004],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886086,0.007812609,0.0021540902,0.0006097072,0.0003153455,0.0004996289],"domain_scores_gemma":[0.99599916,0.0021607762,0.0011584302,0.00023714764,0.0002483176,0.00019617527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007424791,0.00042982932,0.0030396704,0.00038317943,0.00010169073,0.000006720863,0.0002981696,0.00047197044,0.00005308884],"category_scores_gemma":[0.0010906418,0.0003806745,0.0001222417,0.0009716267,0.0006054014,0.00005013276,0.00020712678,0.001335248,0.000016112594],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006353263,0.00033262046,0.0010635406,0.5781493,0.00032214972,0.000019230742,0.002121413,0.000029613415,6.7943495e-7,0.00040409656,0.010934889,0.4065589],"study_design_scores_gemma":[0.00047089133,0.00006171635,0.00019899177,0.24123012,0.00028567616,0.000007686902,0.000030850206,0.000102105674,0.000003253872,0.00015309203,0.75715667,0.00029896994],"about_ca_topic_score_codex":0.0012717381,"about_ca_topic_score_gemma":0.0003381058,"teacher_disagreement_score":0.7462218,"about_ca_system_score_codex":0.00014945334,"about_ca_system_score_gemma":0.0008246112,"threshold_uncertainty_score":0.9998645},"labels":[],"label_agreement":null},{"id":"W2902167120","doi":"10.1002/cpt.1323","title":"Effect of <i> <scp>CYP</scp> 4F2 </i> , <i> <scp>VKORC</scp> 1 </i> , and <i> <scp>CYP</scp> 2C9 </i> in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Western University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Queen's University Belfast; Queen's University; British Heart Foundation; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Dosing; Coumarin; Pharmacology; Acenocoumarol; Confidence interval; Meta-analysis; Medicine; Cytochrome P450; Internal medicine; Chemistry; Metabolism","score_opus":0.30353908317061196,"score_gpt":0.5164399306452812,"score_spread":0.2129008474746692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902167120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1773952,0.8080168,0.000023426324,0.00015998345,0.004359571,0.005067488,0.0038787813,0.00020739633,0.000891368],"genre_scores_gemma":[0.010168902,0.95969343,0.00037004775,0.024802802,0.0015696652,0.0009914099,0.0013978183,0.0005044823,0.0005014501],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.96386755,0.01868486,0.008034247,0.0044197636,0.0014080737,0.0035855325],"domain_scores_gemma":[0.9399329,0.04982931,0.0051643383,0.0028247798,0.0005617856,0.001686921],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.016661836,0.0035592064,0.014011979,0.0025745155,0.00055095804,0.00020379276,0.005554685,0.005241983,0.00021661435],"category_scores_gemma":[0.0015850167,0.003119233,0.0038075268,0.0051536825,0.003957377,0.00058860483,0.0044679423,0.009250644,0.00019143484],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005016478,0.017087167,0.03856657,0.020288132,0.5192034,0.0016935488,0.007928375,0.0014631784,0.005771616,0.000049974828,0.09177356,0.2956728],"study_design_scores_gemma":[0.0067448313,0.0012228806,0.00023740217,0.00036442946,0.28339925,0.000072443996,0.00014088728,0.0012656337,0.003546708,0.000060326533,0.7025284,0.00041679005],"about_ca_topic_score_codex":0.00011912844,"about_ca_topic_score_gemma":0.00013862945,"teacher_disagreement_score":0.61075485,"about_ca_system_score_codex":0.00038008636,"about_ca_system_score_gemma":0.00139642,"threshold_uncertainty_score":0.9998257},"labels":[],"label_agreement":null},{"id":"W2902998103","doi":"10.1124/dmd.118.084301","title":"Optimization of Experimental Conditions of Automated Glucuronidation Assays in Human Liver Microsomes Using a Cocktail Approach and Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry","year":2018,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche; American Society for Pharmacology and Experimental Therapeutics","keywords":"Glucuronidation; UGT2B7; Chemistry; Microsome; Chromatography; Enzyme; Uridine; Tris; Glucuronosyltransferase; Uridine diphosphate; Biochemistry","score_opus":0.030635830685994892,"score_gpt":0.35068469895227855,"score_spread":0.32004886826628365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902998103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925844,0.0045347903,0.001530514,0.000012608409,0.00023002307,0.00039916436,0.000171817,0.000052565618,0.00048411032],"genre_scores_gemma":[0.99452436,0.001464548,0.0035177437,0.000072321345,0.00012354796,0.000025638037,0.00024330927,0.000021394668,0.0000071372247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984794,0.0002998839,0.0004829669,0.00031203433,0.00016251062,0.0002631718],"domain_scores_gemma":[0.9992966,0.000050250186,0.000294424,0.00012101732,0.00012589802,0.000111789486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042098985,0.00022302987,0.0003965577,0.0004257595,0.0002584194,0.000022468668,0.00010142086,0.0001697779,0.000118978496],"category_scores_gemma":[0.000008819692,0.00023055797,0.000054555487,0.0004635668,0.00049327133,0.00034116078,0.000039950814,0.00018069096,8.335345e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021198188,0.0004460394,0.0037948007,0.00009873497,0.00007881881,0.0000013311349,0.0013114979,0.0025590442,0.98976195,0.0016035913,0.000020962572,0.00011126939],"study_design_scores_gemma":[0.0023675754,0.00010721375,0.036436785,0.00003447618,0.0002527557,0.000016355765,0.00029203444,0.10333574,0.85684794,0.000054742755,0.000038036887,0.00021634268],"about_ca_topic_score_codex":0.00006763034,"about_ca_topic_score_gemma":0.0000017908993,"teacher_disagreement_score":0.13291398,"about_ca_system_score_codex":0.000021944817,"about_ca_system_score_gemma":0.00003206919,"threshold_uncertainty_score":0.9401881},"labels":[],"label_agreement":null},{"id":"W2905335582","doi":"10.1186/s13058-018-1083-y","title":"CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Tamoxifen; Breast cancer; Medicine; Internal medicine; CYP2D6; Oncology; Surgical oncology; Population; Cancer; Logistic regression; Metabolism","score_opus":0.14033265430675462,"score_gpt":0.5192617170821467,"score_spread":0.3789290627753921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905335582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864263,0.003730011,0.0000013606204,0.0021669618,0.0005983181,0.0010676606,0.0022486248,0.000015671354,0.0015287688],"genre_scores_gemma":[0.99343824,0.004437843,0.0000055696164,0.00041254587,0.0010977275,0.00036297672,0.0000037565032,0.000028944576,0.00021241217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955096,0.0022880821,0.00038535087,0.00045393707,0.00056697003,0.0007960075],"domain_scores_gemma":[0.9983303,0.00036872076,0.00011930743,0.00031681833,0.00064014643,0.0002247152],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032388403,0.0002246958,0.00034848507,0.00022678555,0.00039085303,0.000044976114,0.0006133247,0.00016621717,0.0032490352],"category_scores_gemma":[0.00003065277,0.00015957044,0.000059741007,0.00071668177,0.0008808444,0.00009946822,0.00023729334,0.0013075063,0.000036077978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024142214,0.00086001435,0.85356486,0.00005415253,0.00040734807,0.000036042227,0.010109967,0.000093989,0.016397452,0.00012429488,0.0028300125,0.11310767],"study_design_scores_gemma":[0.004110311,0.00014279156,0.98090154,0.000031975393,0.00019877528,0.00004270324,0.0010379722,0.0009059849,0.0035773367,0.00031575083,0.008523798,0.00021107674],"about_ca_topic_score_codex":0.009253457,"about_ca_topic_score_gemma":0.0024927054,"teacher_disagreement_score":0.12733668,"about_ca_system_score_codex":0.00007984816,"about_ca_system_score_gemma":0.00029910743,"threshold_uncertainty_score":0.9976621},"labels":[],"label_agreement":null},{"id":"W2905593205","doi":"10.1124/dmd.118.084509","title":"Suppression of Hepatic CYP3A4 Expression and Activity by 3-Methylcholanthrene in Humanized PXR-CAR-CYP3A4/3A7 Mice","year":2018,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Aryl hydrocarbon receptor; CYP3A4; Constitutive androstane receptor; Messenger RNA; CYP3A; Biology; Internal medicine; Cytochrome P450; Endocrinology; Nuclear receptor; Chemistry; Metabolism; Biochemistry; Transcription factor; Medicine; Gene","score_opus":0.03158154888758917,"score_gpt":0.37544842381281734,"score_spread":0.34386687492522816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905593205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98629457,0.0108042685,0.00025259922,0.0002146442,0.00093722506,0.0004704206,0.00030819175,0.00004097426,0.00067712663],"genre_scores_gemma":[0.9933481,0.0052941847,0.00030131382,0.00043536554,0.00030766035,0.00005142691,0.00008927012,0.00003202256,0.0001406159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973859,0.0008919251,0.00047914588,0.00054893823,0.000247987,0.00044608812],"domain_scores_gemma":[0.9988383,0.00025694782,0.0002724353,0.00022720144,0.00011782825,0.0002872638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009229077,0.00034533706,0.000588696,0.00023751459,0.00031356476,0.000038598802,0.00019358596,0.00028747914,0.00027305968],"category_scores_gemma":[0.00006007514,0.00031183162,0.00007671841,0.00026074148,0.00042488604,0.00038004734,0.00019796188,0.0004860772,0.000011581343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009838131,0.00044790364,0.0039157066,0.00009607086,0.00003995414,0.0000049171413,0.0017021956,0.0000053193035,0.96717936,0.00021990595,0.0011481366,0.024256727],"study_design_scores_gemma":[0.0046872925,0.000043692515,0.04489257,0.00006673357,0.00028068863,0.0000093591025,0.00012086675,0.0021748168,0.9314977,0.0007469603,0.015123623,0.00035570015],"about_ca_topic_score_codex":0.00020500344,"about_ca_topic_score_gemma":0.00003379561,"teacher_disagreement_score":0.040976863,"about_ca_system_score_codex":0.000017462804,"about_ca_system_score_gemma":0.00003312124,"threshold_uncertainty_score":0.99993336},"labels":[],"label_agreement":null},{"id":"W2905818180","doi":"","title":"Higher-order epistatic networks underlie the evolutionary fitness landscape of a xenobiotic- degrading enzyme","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epistasis; Fitness landscape; Biology; In silico; Enzyme; Function (biology); Computational biology; Adaptive evolution; Molecular evolution; Xenobiotic; Evolutionary biology; Genetics; Phylogenetics; Gene; Biochemistry; Population","score_opus":0.05139555612601422,"score_gpt":0.3218341852056817,"score_spread":0.2704386290796675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905818180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9047423,0.057799913,0.010142279,0.0022605767,0.019922052,0.0030829988,0.0012129423,0.0004937616,0.00034317115],"genre_scores_gemma":[0.99298024,0.0027577635,0.0012632598,0.0013294963,0.0012336151,0.00018043829,0.0000032981102,0.00017282797,0.00007904049],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954352,0.0010092688,0.0010200609,0.0010220234,0.0004706094,0.0010428504],"domain_scores_gemma":[0.99590325,0.0008062841,0.0009082152,0.0012848998,0.0006910836,0.00040627323],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015066293,0.00084218226,0.001028128,0.00029059852,0.00040078483,0.00009431522,0.001367974,0.0012075604,0.0008087557],"category_scores_gemma":[0.00014129114,0.0007339085,0.00033801145,0.0008016112,0.00051027595,0.00010803381,0.0008645588,0.0026509808,0.00012244386],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009657677,0.0023390073,0.04510395,0.0034017959,0.00557388,0.0002578287,0.00021269407,0.3283802,0.56916857,0.018643945,0.025833428,0.00011893507],"study_design_scores_gemma":[0.007824662,0.00023247582,0.19453679,0.00087168487,0.00483713,5.351227e-7,0.00003666727,0.39211816,0.18241958,0.00017013893,0.21261902,0.004333152],"about_ca_topic_score_codex":0.000030936724,"about_ca_topic_score_gemma":0.0000014615395,"teacher_disagreement_score":0.386749,"about_ca_system_score_codex":0.00017787676,"about_ca_system_score_gemma":0.00085306587,"threshold_uncertainty_score":0.99964994},"labels":[],"label_agreement":null},{"id":"W2912734692","doi":"10.1111/bcp.13884","title":"Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults","year":2019,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Canadian Institutes of Health Research","keywords":"Metronidazole; Medicine; Biology; Microbiology; Antibiotics","score_opus":0.23550837786317888,"score_gpt":0.5712022899553704,"score_spread":0.33569391209219146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912734692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666026,0.010371391,0.00016603578,0.0017124512,0.016016867,0.0010649565,0.000043429467,0.000034470268,0.0039877985],"genre_scores_gemma":[0.96908367,0.0068900394,0.0025691453,0.017706916,0.0033488001,0.000036109264,0.000009396932,0.00007100221,0.0002848967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908371,0.0027962457,0.0038749706,0.0006996457,0.000618522,0.0011735305],"domain_scores_gemma":[0.99348766,0.0027054553,0.0019880235,0.00019913542,0.00069218234,0.0009275178],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011684792,0.00040212134,0.0016632434,0.00039614487,0.00019468834,0.000051081097,0.0009783893,0.000713086,0.00698479],"category_scores_gemma":[0.0013919197,0.00045964387,0.0005896187,0.0005818883,0.0003079003,0.00036345786,0.00029025166,0.0048124767,0.00046710772],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036976553,0.0073449127,0.04437607,0.0004015279,0.00133331,0.0016501247,0.00069873565,0.011760349,0.079609714,0.00040912614,0.008110929,0.80732864],"study_design_scores_gemma":[0.18845358,0.011195351,0.08361698,0.0010098869,0.0020050898,0.0071186917,0.0007296836,0.07245206,0.015619152,0.0032554544,0.61209875,0.0024452838],"about_ca_topic_score_codex":0.00011598161,"about_ca_topic_score_gemma":0.000046177243,"teacher_disagreement_score":0.80488336,"about_ca_system_score_codex":0.00014981575,"about_ca_system_score_gemma":0.0012145666,"threshold_uncertainty_score":0.99978554},"labels":[],"label_agreement":null},{"id":"W2913514525","doi":"10.1007/s00228-019-02632-1","title":"Sex-by-formulation interaction in bioequivalence trials with transdermal patches","year":2019,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Transdermal; Medicine; Pharmacokinetics; Rivastigmine; Pharmacology; Transdermal patch; Internal medicine","score_opus":0.60535816344768,"score_gpt":0.6141343016009941,"score_spread":0.008776138153314128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913514525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054990663,0.9745198,0.0002897811,0.00033383718,0.014932042,0.0013704346,0.00019024021,0.000032722695,0.0028320919],"genre_scores_gemma":[0.01093989,0.98212945,0.00017753005,0.0016343251,0.0044384627,0.000017380062,0.0000601565,0.00014889412,0.0004539096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9601115,0.030404165,0.00761822,0.00068903243,0.00043699343,0.0007401132],"domain_scores_gemma":[0.98465455,0.007696959,0.006479675,0.0002662882,0.00027847177,0.0006240531],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.027242754,0.0008288938,0.006234952,0.0006580682,0.00009693927,0.000044593467,0.0011863337,0.000657702,0.001701821],"category_scores_gemma":[0.00064655126,0.00059020496,0.0017025827,0.00048287192,0.00031012224,0.0003332471,0.00014352247,0.006060686,0.00034373195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001932073,0.0009772966,0.00017088206,0.00198146,0.0017416748,0.0007857286,0.00016964135,0.00032056752,0.0004035384,0.000008138,0.015199699,0.9763093],"study_design_scores_gemma":[0.008574903,0.0009961791,0.000056806566,0.0011481588,0.006832458,0.0003624267,0.00002847534,0.00015810182,0.00034043394,0.000010759212,0.9809098,0.0005814861],"about_ca_topic_score_codex":0.000001908394,"about_ca_topic_score_gemma":9.434968e-7,"teacher_disagreement_score":0.9757278,"about_ca_system_score_codex":0.00011281594,"about_ca_system_score_gemma":0.00078255346,"threshold_uncertainty_score":0.99965495},"labels":[],"label_agreement":null},{"id":"W2913866147","doi":"10.1002/jcph.1391","title":"4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation","year":2019,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Waterloo CFD Engineering Consulting","funders":"","keywords":"CYP3A; Biomarker; Pharmacology; Midazolam; Endogeny; Metabolite; Biology; Cholesterol; Cytochrome P450; Medicine; Endocrinology; Metabolism; Biochemistry","score_opus":0.6130139562391858,"score_gpt":0.6623758551971944,"score_spread":0.04936189895800869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913866147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010688656,0.97858405,0.0000565543,0.0022641125,0.012917013,0.0042484473,0.00032308444,0.00002074827,0.00051712146],"genre_scores_gemma":[0.0011063948,0.9775659,0.0000791045,0.016439712,0.0042185844,0.0001835166,0.000049889826,0.00011548875,0.00024142745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9780873,0.016618207,0.0032828166,0.00066828245,0.00054716313,0.00079622597],"domain_scores_gemma":[0.98114735,0.013334933,0.00285962,0.0005138384,0.0012471009,0.00089718634],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.02567608,0.0008359266,0.0046725646,0.00031264176,0.00032014202,0.0000798265,0.0013667255,0.0015494927,0.0010065429],"category_scores_gemma":[0.0023821634,0.00053536403,0.0014448086,0.0004075499,0.0007389967,0.00045290738,0.00027230597,0.0047838395,0.0001059966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011184248,0.0010135552,0.0000039502606,0.019380415,0.0024218524,0.000084360254,0.000101658356,0.0000068993304,0.0004460514,0.00007063485,0.01722005,0.95813215],"study_design_scores_gemma":[0.0040307795,0.00099408,0.000010614352,0.003302092,0.06573028,0.0030110176,0.0000055713763,0.00034945834,0.0000711884,0.00044089562,0.9215742,0.0004798194],"about_ca_topic_score_codex":0.000001109359,"about_ca_topic_score_gemma":5.322194e-7,"teacher_disagreement_score":0.95765233,"about_ca_system_score_codex":0.000086269,"about_ca_system_score_gemma":0.0013896013,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W2913964388","doi":"10.1038/s41436-018-0431-8","title":"CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial","year":2019,"lang":"en","type":"article","venue":"Genetics in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Florida Health; Agency for Healthcare Research and Quality; National Institutes of Health; National Human Genome Research Institute; American College of Clinical Pharmacy; National Center for Advancing Translational Sciences; Florida Department of Health; University of Florida; Mallinckrodt Pharmaceuticals; Pfizer","keywords":"CYP2D6; Tramadol; Codeine; Medicine; Opioid; Randomized controlled trial; Anesthesia; Pain ladder; Analgesic; Internal medicine; Morphine","score_opus":0.1397296108015888,"score_gpt":0.4937684642770148,"score_spread":0.354038853475426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913964388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597776,0.028578611,0.00014418887,0.0021349527,0.0054057613,0.0028872867,0.000031037827,0.00003759555,0.0010029705],"genre_scores_gemma":[0.9466404,0.034579813,0.00040036422,0.016415583,0.0014607804,0.00020874971,0.000025672969,0.000053970798,0.00021467461],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934072,0.0029917965,0.001742985,0.0007213644,0.00035867858,0.00077798055],"domain_scores_gemma":[0.99640244,0.0022703728,0.0003968383,0.0004070124,0.00010912008,0.00041421846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0102362465,0.00045748884,0.0013077975,0.00041374934,0.00005676418,0.000021238775,0.0005062403,0.0005248025,0.0007157195],"category_scores_gemma":[0.0010009432,0.00037120556,0.00013222975,0.00037713518,0.0005485192,0.00006308868,0.00013397685,0.0014086145,0.00005202076],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03710343,0.0022080403,0.14630969,0.00033294648,0.0008880002,0.00020474949,0.006888342,0.0004834431,0.19475172,0.0007564735,0.006909973,0.6031632],"study_design_scores_gemma":[0.51507825,0.003857362,0.054261863,0.00021354732,0.0005545158,0.000029568262,0.0009925928,0.07855035,0.0045874952,0.007138249,0.3335738,0.0011624],"about_ca_topic_score_codex":0.000044801054,"about_ca_topic_score_gemma":0.000032115247,"teacher_disagreement_score":0.6020008,"about_ca_system_score_codex":0.00004409277,"about_ca_system_score_gemma":0.00018518273,"threshold_uncertainty_score":0.999874},"labels":[],"label_agreement":null},{"id":"W2914594769","doi":"10.18433/jpps30237","title":"Prediction of Hepatic Clearance of Stereoselective Metabolism of Carvedilol in Liver Microsomes and Hepatocytes of Sprague-Dawley and Cytochrome P450 2D-Deficient Dark Agouti Rats","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Education, Culture, Sports, Science and Technology","keywords":"Microsome; In vivo; Cytochrome P450; In vitro; Metabolism; Microsoma; Internal medicine; Endocrinology; Pharmacology; Chemistry; Biology; Biochemistry; Medicine; Genetics","score_opus":0.10818823766416327,"score_gpt":0.4098067367442046,"score_spread":0.30161849908004135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914594769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96179444,0.03604498,0.000032392763,0.00014362093,0.00072541717,0.0006734609,0.0002030659,0.000007252342,0.00037535914],"genre_scores_gemma":[0.98108834,0.018104194,0.0004608168,0.0001903652,0.00011413941,0.000007161318,0.0000014170156,0.000019383913,0.000014159222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955041,0.0008921546,0.0018191519,0.00042847134,0.00080861076,0.0005475386],"domain_scores_gemma":[0.9965045,0.0009123508,0.0014846463,0.00014982771,0.0005807675,0.00036791078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003357443,0.0003560795,0.0012399757,0.0006287267,0.000095792544,0.000019011051,0.0005691175,0.00015019035,0.00028831483],"category_scores_gemma":[0.000173993,0.00029524427,0.00023230324,0.00089431787,0.0018694024,0.00050124066,0.00023501787,0.0008161808,0.000002297247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015337483,0.0007273292,0.13962618,0.00058337534,0.00024032082,0.000014020509,0.0020063634,0.0005191717,0.83698344,0.00027408428,0.000036959882,0.017455023],"study_design_scores_gemma":[0.005986245,0.0005170685,0.08651708,0.00018847195,0.0006717465,0.00009366593,0.00034805122,0.01654354,0.8849406,0.0002479176,0.0037113726,0.00023420612],"about_ca_topic_score_codex":0.00011814454,"about_ca_topic_score_gemma":0.000005831409,"teacher_disagreement_score":0.05310909,"about_ca_system_score_codex":0.00004739838,"about_ca_system_score_gemma":0.00037980796,"threshold_uncertainty_score":0.99995},"labels":[],"label_agreement":null},{"id":"W2918993549","doi":"10.1007/s40262-019-00745-5","title":"Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"University of Illinois at Chicago; Ministry of Education, Culture, Sports, Science and Technology; University of Chicago","keywords":"Warfarin; Pharmacodynamics; CYP2C9; Medicine; VKORC1; Internal medicine; Dosing; Population; Pharmacokinetics; Cohort; Creatinine; Demography; Atrial fibrillation","score_opus":0.18952589734530464,"score_gpt":0.48143453915943135,"score_spread":0.2919086418141267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918993549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901251,0.0014180475,0.00008322182,0.00036706106,0.0055403435,0.0009762179,0.00018162212,0.000070922506,0.0012374381],"genre_scores_gemma":[0.995933,0.0020843756,0.0002762673,0.0007314254,0.00046894644,0.00003531535,0.000024943789,0.000051846873,0.00039386694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99528325,0.0013707002,0.0016771643,0.0006726635,0.00035854813,0.00063767115],"domain_scores_gemma":[0.9966861,0.0018025396,0.00049577525,0.0003369798,0.00015971942,0.00051890814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029405279,0.00041694538,0.0008852647,0.00033126536,0.00010102919,0.00002315046,0.0005538188,0.0005046285,0.0011325666],"category_scores_gemma":[0.0003987911,0.0004052089,0.00022777623,0.0005085855,0.00078053627,0.00016023371,0.00035862683,0.0015852399,0.00005718432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024597135,0.0007310451,0.95960104,0.000069492104,0.00017460094,0.000022170156,0.0003706079,0.0008169305,0.022915859,0.00031889367,0.00039026173,0.012129384],"study_design_scores_gemma":[0.0072520142,0.00023921777,0.90827453,0.000031968088,0.00037651355,0.00000476254,0.000046179877,0.06290625,0.0039467774,0.0007285014,0.015749542,0.00044371767],"about_ca_topic_score_codex":0.000029208259,"about_ca_topic_score_gemma":0.00004766062,"teacher_disagreement_score":0.06208932,"about_ca_system_score_codex":0.00003777514,"about_ca_system_score_gemma":0.00013293434,"threshold_uncertainty_score":0.99983996},"labels":[],"label_agreement":null},{"id":"W2919754601","doi":"10.1111/bcp.13908","title":"Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine","year":2019,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Jejunum; Cytochrome P450; CYP3A4; CYP2B6; Ileum; CYP3A; Tolbutamide; Chlorzoxazone; CYP2C9; Biology; Small intestine; Molecular biology; Chemistry; Internal medicine; Biochemistry; CYP2E1; Endocrinology; Metabolism; Medicine; Insulin","score_opus":0.15703593008825215,"score_gpt":0.48096641535666007,"score_spread":0.32393048526840795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919754601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940505,0.0015548248,0.000043774206,0.00033216018,0.0028419816,0.00044805542,0.00008468489,0.000009743233,0.0006342694],"genre_scores_gemma":[0.9970466,0.0014120941,0.00028782865,0.0005897668,0.00048704923,0.000006662762,0.0000011723199,0.000023039556,0.00014580185],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9950357,0.0023241779,0.0017859061,0.00027970783,0.00021850274,0.0003560201],"domain_scores_gemma":[0.9956159,0.0018591349,0.0015878485,0.00013537322,0.00055351143,0.000248203],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028458165,0.00020043172,0.0010410899,0.0001829096,0.00011389125,0.000010206188,0.00053540274,0.00040490078,0.001214761],"category_scores_gemma":[0.00066223275,0.00018125291,0.00028108555,0.00044380088,0.00054076075,0.00011532789,0.00027526164,0.0023860123,0.0000029549544],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055516284,0.0013808968,0.057925653,0.000090862624,0.00025509446,0.000076778444,0.00015282455,0.0006365002,0.910296,0.000019607118,0.0010787382,0.027531886],"study_design_scores_gemma":[0.0077246255,0.00037120268,0.6530951,0.000103479135,0.0002967888,0.00057043595,0.000023807217,0.00051447714,0.33356136,0.00046119993,0.0031231607,0.00015433112],"about_ca_topic_score_codex":0.000071102426,"about_ca_topic_score_gemma":0.00006448166,"teacher_disagreement_score":0.5951695,"about_ca_system_score_codex":0.000029097573,"about_ca_system_score_gemma":0.00034803056,"threshold_uncertainty_score":0.99991554},"labels":[],"label_agreement":null},{"id":"W2924256667","doi":"10.1055/a-0863-4692","title":"Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?","year":2019,"lang":"en","type":"review","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Pharmacogenetics; Dosing; Medicine; Pharmacology; Drug; CYP2D6; Venlafaxine; Carbamazepine; Sertraline; CYP2C19; Psychiatry; Epilepsy; Internal medicine; Anxiety; Biology; Genetics; Gene; Antidepressant; Genotype","score_opus":0.3365395161513568,"score_gpt":0.5642967053018124,"score_spread":0.22775718915045562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924256667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074413023,0.9564257,0.000014871533,0.0010954672,0.025204558,0.005691333,0.002226921,0.00013628224,0.001763555],"genre_scores_gemma":[0.0062515866,0.9843526,0.0005281001,0.004161713,0.002905326,0.00087008026,0.00035953737,0.0003712684,0.00019982115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98622227,0.0039884173,0.0048656156,0.0018102077,0.0010835703,0.002029944],"domain_scores_gemma":[0.9940031,0.0009958545,0.0026332098,0.001250639,0.00046524117,0.000651967],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003928598,0.002109706,0.0037873185,0.0012049344,0.00048340068,0.000118151656,0.0030633395,0.0009612345,0.003172663],"category_scores_gemma":[0.0000598832,0.001673606,0.0018548515,0.0019025928,0.00043190896,0.00025380772,0.0007256838,0.0038568848,0.00073136075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021870335,0.0006955481,0.0024693962,0.009955151,0.0015418128,0.000017831424,0.0008061441,0.0004946123,0.0009771131,0.00011227193,0.034340866,0.9483706],"study_design_scores_gemma":[0.0069583086,0.00011193197,0.00022749066,0.0017249868,0.008872612,0.00010709985,0.00028087324,0.00023763762,0.00045922192,0.00038087353,0.9790045,0.0016344732],"about_ca_topic_score_codex":0.00020194935,"about_ca_topic_score_gemma":0.00016981937,"teacher_disagreement_score":0.9467361,"about_ca_system_score_codex":0.00027755587,"about_ca_system_score_gemma":0.0027084998,"threshold_uncertainty_score":0.9991644},"labels":[],"label_agreement":null},{"id":"W2932285628","doi":"10.1159/000497322","title":"Assessment of CYP2C9, CYP2C19, and CYP2D6 Polymorphisms in Allergic Patients with Chemical Sensitivity","year":2019,"lang":"en","type":"article","venue":"International Archives of Allergy and Immunology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"CYP2C19; Immunology; Allergy; Medicine; Genotype; Internal medicine; Biology; Gene; Genetics","score_opus":0.016236577491619792,"score_gpt":0.3292117562970293,"score_spread":0.31297517880540954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932285628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906461,0.0005830379,0.00006283067,0.0002922468,0.0003487575,0.0001597405,0.000060490845,0.0000062475888,0.007840525],"genre_scores_gemma":[0.9977348,0.0013458888,0.0005653379,0.00016734017,0.000024512614,0.0000074993295,0.000044523804,0.000009990532,0.000100144076],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989569,0.00018877546,0.00030543664,0.00024498202,0.00011461269,0.00018928744],"domain_scores_gemma":[0.99924785,0.00035633455,0.00017360708,0.00009879319,0.000068039946,0.00005538331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014599274,0.00014776003,0.00029789662,0.00018379823,0.000022542214,0.0000035782264,0.0001430415,0.00010683615,0.00020058072],"category_scores_gemma":[0.000019461104,0.00013026896,0.000036661128,0.000060411363,0.00041894472,0.0000600928,0.00020604968,0.0003257104,0.0000020397472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015875326,0.00083888316,0.36412787,0.00002157007,0.0012573182,0.000012491167,0.0007196265,0.00042310968,0.59188646,0.013716565,0.000008952223,0.025399605],"study_design_scores_gemma":[0.004606526,0.00020652657,0.95243657,0.000029072515,0.000019105233,0.00001600733,0.000040578958,0.0050415294,0.031888187,0.0010522882,0.0045058737,0.00015774574],"about_ca_topic_score_codex":0.00006439707,"about_ca_topic_score_gemma":0.000019655774,"teacher_disagreement_score":0.5883087,"about_ca_system_score_codex":0.000009303465,"about_ca_system_score_gemma":0.00004697623,"threshold_uncertainty_score":0.53122145},"labels":[],"label_agreement":null},{"id":"W2933589606","doi":"10.1007/s10928-019-09628-5","title":"Panos Macheras: a pioneering scientist in pharmaceutical science","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmacokinetics and Pharmacodynamics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmaceutical sciences; Computer science; Medicine; Pharmacology","score_opus":0.046528727715095246,"score_gpt":0.4278935268306968,"score_spread":0.38136479911560156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933589606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98168355,0.0058585126,0.00026725183,0.0006385603,0.0068465597,0.0006054361,0.000059596725,0.00003575772,0.0040047783],"genre_scores_gemma":[0.9866867,0.009423393,0.0010076559,0.001905718,0.0006045876,0.000010671798,0.000004755624,0.000067227,0.000289257],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99541223,0.00035647888,0.0014609173,0.0006289086,0.00097551703,0.0011659218],"domain_scores_gemma":[0.9970501,0.00037658453,0.0006539931,0.00025691607,0.00059088715,0.0010714952],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004291845,0.00052926294,0.0007935966,0.0012972169,0.0002399151,0.00015791482,0.0011076238,0.0002287934,0.0012487548],"category_scores_gemma":[0.00011756628,0.00050553225,0.00022298851,0.0015987074,0.0007873278,0.0006423659,0.0004283265,0.0022805636,0.000067533554],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006619877,0.0006296569,0.0276491,0.0001740372,0.00016535577,0.00023424251,0.0007198812,0.0086719105,0.8885901,0.0012378867,0.0002733958,0.070992455],"study_design_scores_gemma":[0.019652445,0.00038496227,0.01085671,0.00015225986,0.000712929,0.0010244254,0.00031241035,0.4713755,0.19261934,0.0006992001,0.300935,0.0012748357],"about_ca_topic_score_codex":0.000008463257,"about_ca_topic_score_gemma":0.0000020042587,"teacher_disagreement_score":0.6959708,"about_ca_system_score_codex":0.00024016772,"about_ca_system_score_gemma":0.00047733242,"threshold_uncertainty_score":0.99973965},"labels":[],"label_agreement":null},{"id":"W2939463022","doi":"10.1002/cpt.1472","title":"Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CYP3A; Type 2 diabetes; Biomarker; Endocrinology; Internal medicine; Diabetes mellitus; Midazolam; Endogeny; Population; Cholesterol; Pharmacology; Medicine; Chemistry; Biology; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.37673199915207994,"score_gpt":0.5106181238650749,"score_spread":0.13388612471299494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939463022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327785,0.00037587128,0.000018052215,0.0005675057,0.0037348918,0.0014218288,0.00016191407,0.000051854364,0.00039023982],"genre_scores_gemma":[0.98602194,0.0031385003,0.0003576631,0.009945026,0.00026372707,0.000041923715,0.000076633936,0.00006605344,0.0000885491],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9923679,0.0039933515,0.0018370551,0.0007609328,0.0003371415,0.00070362433],"domain_scores_gemma":[0.9936982,0.0039267777,0.0010590921,0.0005096668,0.00040500483,0.00040130856],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002845911,0.00043579112,0.0012116351,0.0002592901,0.00009463354,0.000028273214,0.0006104676,0.0009042013,0.0011558625],"category_scores_gemma":[0.000071233364,0.00039541067,0.00025917808,0.0006017041,0.001160411,0.00043313368,0.00015771986,0.0015210563,0.000131456],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018613617,0.004370269,0.6352308,0.000047320947,0.0018332411,0.000014070519,0.00036078916,0.0011375097,0.33225793,0.000045391924,0.0002686412,0.0225727],"study_design_scores_gemma":[0.021052575,0.004221414,0.2294147,0.000058353642,0.004152228,0.000031904336,0.000121862366,0.019384243,0.6351189,0.00025896923,0.08522903,0.0009558396],"about_ca_topic_score_codex":0.000012082702,"about_ca_topic_score_gemma":0.0000069302037,"teacher_disagreement_score":0.40581608,"about_ca_system_score_codex":0.000038880335,"about_ca_system_score_gemma":0.0004890374,"threshold_uncertainty_score":0.9998498},"labels":[],"label_agreement":null},{"id":"W2940295280","doi":"10.1016/s2215-0366(19)30138-5","title":"CYP2D6 testing to guide risperidone and aripiprazole therapy","year":2019,"lang":"en","type":"letter","venue":"The Lancet Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Aripiprazole; Risperidone; CYP2D6; Pharmacogenomics; Pharmacology; Medicine; Pharmacogenetics; Psychology; Psychiatry; Bioinformatics; Internal medicine; Schizophrenia (object-oriented programming); Genetics; Genotype; Biology; Gene","score_opus":0.19621276371426388,"score_gpt":0.44746666315648914,"score_spread":0.25125389944222526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940295280","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048887704,0.019220486,0.000034109624,0.88455516,0.014776745,0.0012307463,0.0004690903,0.00018469777,0.030641247],"genre_scores_gemma":[0.0018079253,0.0047333394,0.0020574536,0.9446364,0.039917715,0.000114060334,0.000067994224,0.00012789937,0.0065372083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966811,0.0006256582,0.000591359,0.00072363624,0.00031792675,0.0010603198],"domain_scores_gemma":[0.9977786,0.00070853264,0.00033450403,0.0008908819,0.00011609153,0.00017139383],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012934781,0.00061789015,0.0008704535,0.00014252643,0.00038095764,0.00009630584,0.0011583118,0.00095122674,0.00059202197],"category_scores_gemma":[0.00009159639,0.00044952444,0.00015330713,0.0003303497,0.0001851587,0.000052317508,0.0002986235,0.004521277,0.00083772384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017931593,0.00005055853,0.0051371204,0.00009860748,0.00032157847,0.000024066636,0.00030447994,0.00009819962,0.0032155863,0.00008788896,0.9719994,0.01848319],"study_design_scores_gemma":[0.0020937908,0.00008979935,0.0017286105,0.000044489505,0.00022192777,0.00006633481,0.000025978434,0.00026985994,0.000595432,0.0010281197,0.9932385,0.00059717236],"about_ca_topic_score_codex":0.000050210354,"about_ca_topic_score_gemma":0.0000068263685,"teacher_disagreement_score":0.06008123,"about_ca_system_score_codex":0.00003596434,"about_ca_system_score_gemma":0.00025213894,"threshold_uncertainty_score":0.9999402},"labels":[],"label_agreement":null},{"id":"W2940403942","doi":"10.2174/1574884714666190408125206","title":"Science-based Ethnic Bridging in Drug Development; Review of Recent Precedence and Suggested Steps Forward","year":2019,"lang":"en","type":"review","venue":"Current Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health","funders":"","keywords":"Bridging (networking); Medicine; Myocardial bridging; Ethnic group; Drug development; Drug; Pharmacology; Cardiology; Computer science; Sociology; Anthropology","score_opus":0.5696730716559849,"score_gpt":0.6346005067426914,"score_spread":0.06492743508670651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940403942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011543029,0.9760234,0.000018648814,0.00025955657,0.017447293,0.004040982,0.00016498432,0.00006575575,0.0008250725],"genre_scores_gemma":[0.00013473217,0.9956581,0.00017587139,0.002546781,0.0007056369,0.00037769534,0.00016514033,0.00009092798,0.00014510006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870972,0.004435928,0.00460386,0.0017858297,0.0006550428,0.0014221502],"domain_scores_gemma":[0.9921479,0.0035321896,0.0022762723,0.0005698492,0.0005551003,0.00091864046],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012985528,0.0010240267,0.004780117,0.001230114,0.00020513515,0.000022552844,0.0018360963,0.00076871866,0.0020438936],"category_scores_gemma":[0.0011611561,0.00092260895,0.0006728969,0.002736499,0.0018274102,0.00017077474,0.0009978284,0.004693889,0.00022413343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091202666,0.0010029471,0.00019794093,0.08452434,0.00022640878,0.00001641686,0.000054493874,0.000010274072,0.000048928796,0.000032536223,0.005174167,0.90862036],"study_design_scores_gemma":[0.0029754366,0.00009258277,0.000108541295,0.023127068,0.0029979453,0.000015688694,0.000004252454,0.0003289945,0.00031910877,0.000010558974,0.96918947,0.00083038496],"about_ca_topic_score_codex":0.0000027258234,"about_ca_topic_score_gemma":0.0000050973013,"teacher_disagreement_score":0.96401525,"about_ca_system_score_codex":0.00032072014,"about_ca_system_score_gemma":0.007143636,"threshold_uncertainty_score":0.9993225},"labels":[],"label_agreement":null},{"id":"W2940964849","doi":"10.1002/prp2.475","title":"The effect of chronic kidney disease on <scp>CYP</scp>2B expression and activity in male Wistar rats","year":2019,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation","keywords":"Kidney disease; Renal function; Pharmacokinetics; Endocrinology; Metabolite; Internal medicine; Bupropion; Kidney; Medicine; Pharmacology; Population; Western blot; Chemistry; Pathology; Biochemistry","score_opus":0.06449477313228555,"score_gpt":0.46828558648771107,"score_spread":0.40379081335542555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940964849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97433877,0.014552905,0.0000023922412,0.0017163359,0.0012359694,0.0021777418,0.00013863386,0.00004011945,0.005797138],"genre_scores_gemma":[0.986134,0.009566712,0.0000069444977,0.00025657794,0.00048817255,0.00042899372,0.0000077181785,0.000050110622,0.0030607914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9907971,0.005998397,0.0003770813,0.00091262656,0.0005899706,0.001324832],"domain_scores_gemma":[0.99109715,0.0071994276,0.0001773226,0.00041286336,0.00023302584,0.00088021066],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047049397,0.00042330913,0.00058768643,0.0004815652,0.00062567566,0.00004517961,0.0007264342,0.00024971215,0.00092479034],"category_scores_gemma":[0.0009105898,0.0003141595,0.0001624944,0.0006040889,0.0015758782,0.00020281975,0.0005339086,0.0026642047,0.00019423482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036539852,0.0007773074,0.030361628,0.0002540945,0.00024373457,0.00011755631,0.0016380856,0.00038453023,0.93989605,0.0004182709,0.017908204,0.0043465705],"study_design_scores_gemma":[0.007385003,0.0013400877,0.014815807,0.00006129844,0.00013543318,0.000011231512,0.00057891855,0.0051596947,0.86898047,0.00030802604,0.101035215,0.0001888026],"about_ca_topic_score_codex":0.000032391425,"about_ca_topic_score_gemma":0.000010297345,"teacher_disagreement_score":0.08312701,"about_ca_system_score_codex":0.000316496,"about_ca_system_score_gemma":0.00048124435,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W2941824774","doi":"10.1111/1440-1681.13097","title":"Pharmacogenomics guidelines: Current status and future development","year":2019,"lang":"en","type":"review","venue":"Clinical and Experimental Pharmacology and Physiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Medicine; Drug development; Natural Product Research; Pharmacology; Drug; Biology; Genotype; Genetics; Pharmacognosy","score_opus":0.37007485518044514,"score_gpt":0.5846043215873302,"score_spread":0.21452946640688508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941824774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038774118,0.9454771,0.0000016380325,0.00016837534,0.013552174,0.001469353,0.00022016637,0.00008074781,0.00025628935],"genre_scores_gemma":[0.001026231,0.9886914,0.0002219356,0.0036225033,0.0055157105,0.00032198447,0.000290249,0.00010814985,0.0002018398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99285907,0.001805814,0.0022377595,0.0017410379,0.00015254681,0.0012037951],"domain_scores_gemma":[0.9966483,0.0010042166,0.00073804014,0.00027460526,0.00011893442,0.0012158928],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0011449383,0.0012463161,0.003348078,0.00024223128,0.0005381647,0.00004064631,0.0004364108,0.001535605,0.0011122404],"category_scores_gemma":[0.000028816929,0.0010293016,0.00042062104,0.00018721787,0.0015654161,0.00012508532,0.001212931,0.0028517987,0.00021856024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043946475,0.0006473688,0.00010713277,0.0033634512,0.001240522,0.0000176646,0.0003057519,0.0000015298649,0.00150297,0.0002478061,0.0057741823,0.98635215],"study_design_scores_gemma":[0.0041024927,0.00022837867,0.0000955202,0.00019036217,0.0023486286,0.0000882254,0.00008952873,0.00012401029,0.0006485867,0.00009618033,0.99091506,0.0010730015],"about_ca_topic_score_codex":0.0000041272415,"about_ca_topic_score_gemma":5.504555e-7,"teacher_disagreement_score":0.98527914,"about_ca_system_score_codex":0.000059402846,"about_ca_system_score_gemma":0.00046337023,"threshold_uncertainty_score":0.99980086},"labels":[],"label_agreement":null},{"id":"W2942319426","doi":"10.4212/cjhp.v72i2.2882","title":"Survey of Therapeutic Drug Monitoring Practices in Pediatric Health Care Programs across Canada","year":2019,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Child and Family Research Institute; Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Therapeutic drug monitoring; Medicine; Drug; Clinical Practice; Health care; Intensive care medicine; Pharmacology; Family medicine","score_opus":0.11485334203121296,"score_gpt":0.44590243322188033,"score_spread":0.3310490911906674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942319426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378357,0.052172985,3.9185502e-7,0.002579771,0.0064516105,0.00057061313,0.00014189903,0.000004672889,0.00024237756],"genre_scores_gemma":[0.996705,0.0018794225,0.000016477183,0.0007621319,0.00051772693,0.000007799076,0.000010364777,0.000035472065,0.00006560661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965773,0.0010781414,0.0008705173,0.00021387347,0.000401642,0.0008585157],"domain_scores_gemma":[0.996363,0.00045401044,0.0015773444,0.00022007237,0.00058505725,0.00080055674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002989881,0.00026318393,0.0005080279,0.0001270191,0.00028424704,0.00005917611,0.000955683,0.00007160194,0.00013274151],"category_scores_gemma":[0.00014700153,0.0002095984,0.00011558413,0.0006168048,0.00013173965,0.00022583737,0.000050901835,0.0013975311,0.000010045465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001206247,0.000093267416,0.95645565,0.00009984584,0.00014042483,0.00006895696,0.00782192,0.0007208598,0.00009671482,0.000008956181,0.00086172106,0.033511035],"study_design_scores_gemma":[0.0040636524,0.00027339102,0.9275431,0.000043731223,0.00017479033,0.000032405496,0.003140637,0.00017363469,0.004042242,0.000033033808,0.060054574,0.00042482902],"about_ca_topic_score_codex":0.8478816,"about_ca_topic_score_gemma":0.9332346,"teacher_disagreement_score":0.08535299,"about_ca_system_score_codex":0.00048743977,"about_ca_system_score_gemma":0.008138744,"threshold_uncertainty_score":0.9974842},"labels":[],"label_agreement":null},{"id":"W2943669995","doi":"10.1111/pcn.12832","title":"The coming‐of‐age of pharmacogenetic testing in clinical psychiatry","year":2019,"lang":"en","type":"editorial","venue":"Psychiatry and Clinical Neurosciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Randomized controlled trial; Pharmacogenetics; Medicine; Depression (economics); Psychiatry; Internal medicine; Rating scale; Odds ratio; Hamd; Genetic testing; Clinical psychology; Psychology; Anxiety; Genetics","score_opus":0.15748357833527224,"score_gpt":0.5183589797233614,"score_spread":0.36087540138808916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943669995","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24477483,0.010427554,0.000004242711,0.00067694706,0.74229026,0.0005081133,0.00019315862,0.000020094538,0.0011048021],"genre_scores_gemma":[0.2133515,0.10629624,0.0017973735,0.0025458992,0.6744374,0.00006661516,0.000049309216,0.00015192841,0.0013037404],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99095166,0.002722218,0.0036718287,0.0011567213,0.00074602,0.00075158116],"domain_scores_gemma":[0.9787819,0.018249908,0.0017854373,0.00055560353,0.00022946011,0.00039774185],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00936201,0.0005149175,0.0013925936,0.00017203213,0.0003434595,0.000056825655,0.001737386,0.0013367123,0.000039426548],"category_scores_gemma":[0.004655525,0.00038228842,0.0005318917,0.00074278447,0.0030388723,0.000083770174,0.00045445375,0.0041278037,0.000013778733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009863928,0.003371618,0.7724671,0.0005606934,0.00020209294,0.000013642654,0.00002741401,0.00008467103,0.0010132537,0.00041934766,0.18798098,0.032872785],"study_design_scores_gemma":[0.005179376,0.0017089207,0.061855108,0.0002537845,0.00081789424,0.0000063154916,0.000093500086,0.001930712,0.000106431835,0.0019629027,0.9254039,0.00068114063],"about_ca_topic_score_codex":0.00002134323,"about_ca_topic_score_gemma":0.00008612365,"teacher_disagreement_score":0.73742294,"about_ca_system_score_codex":0.000008300508,"about_ca_system_score_gemma":0.0015728165,"threshold_uncertainty_score":0.99995977},"labels":[],"label_agreement":null},{"id":"W2944789729","doi":"10.1016/j.jpba.2019.05.006","title":"Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS/MS-based targeted proteomics","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Chromatography; Formic acid; Microsome; Electrospray ionization; Tandem mass spectrometry; Mass spectrometry; High-performance liquid chromatography; Selected reaction monitoring; Electrospray; Enzyme; Biochemistry","score_opus":0.05859933814958836,"score_gpt":0.4053547009288324,"score_spread":0.34675536277924407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944789729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991156,0.0013940574,0.0066361735,0.0010723675,0.0001271122,0.00072037027,0.00012415774,0.0000053636854,0.000008864369],"genre_scores_gemma":[0.9948448,0.00022951861,0.004446053,0.00022533334,0.000088225665,0.000024247365,0.00007214335,0.000012820613,0.000056842695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974623,0.00042202923,0.0011794545,0.00025482723,0.00039129978,0.00029014447],"domain_scores_gemma":[0.9978489,0.0007263247,0.0007116596,0.000119061675,0.00028986932,0.0003041858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00305297,0.00020258458,0.0006329852,0.0003964458,0.000118333504,0.000022310825,0.00028307948,0.00023253502,0.00019899679],"category_scores_gemma":[0.00015885735,0.00013673966,0.00017984232,0.0005994471,0.00036812612,0.00009010849,0.00005243977,0.00047538755,8.043752e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007628995,0.00087842037,0.0030213078,0.00019682315,0.0010214198,0.000005044325,0.00024486711,0.0011244132,0.9669152,0.00006878627,0.000045007546,0.025715813],"study_design_scores_gemma":[0.0032587391,0.00021955736,0.00160215,0.00002561574,0.0014671745,0.00000501854,0.00005724501,0.17478915,0.7950126,0.00011711564,0.023281759,0.0001638778],"about_ca_topic_score_codex":0.000017167784,"about_ca_topic_score_gemma":0.000005907919,"teacher_disagreement_score":0.17366473,"about_ca_system_score_codex":0.000032253487,"about_ca_system_score_gemma":0.0001281263,"threshold_uncertainty_score":0.5576081},"labels":[],"label_agreement":null},{"id":"W2944956458","doi":"10.1002/cpt.1496","title":"Modulation of <scp>CYP</scp>450 Activities in Patients With Type 2 Diabetes","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Tolbutamide; CYP2B6; CYP2C19; CYP1A2; Chlorzoxazone; Type 2 diabetes; Pharmacology; CYP3A; CYP2D6; CYP2C9; Medicine; Diabetes mellitus; CYP2E1; Internal medicine; Dextromethorphan; Cytochrome P450; Endocrinology; Metabolism","score_opus":0.09800917757700978,"score_gpt":0.4363264046354054,"score_spread":0.3383172270583956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944956458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99086624,0.001021962,0.000011450246,0.00026075786,0.005261615,0.0010176423,0.00006400791,0.00006735394,0.0014289492],"genre_scores_gemma":[0.98402566,0.0011625505,0.00018225289,0.013657885,0.00036947656,0.00003276265,0.000057441568,0.000068938774,0.00044306507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996094,0.0012018966,0.001032655,0.0005909737,0.0003073518,0.00077315234],"domain_scores_gemma":[0.99628204,0.002304821,0.00053614867,0.0003265216,0.00029920036,0.00025123922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011811081,0.00041537252,0.0008711079,0.0002505065,0.00009045581,0.000013191572,0.0005183363,0.00064293295,0.00062167906],"category_scores_gemma":[0.000033374225,0.00036671147,0.0001816137,0.0005337138,0.00058254716,0.00018427004,0.00016125997,0.0014354287,0.00016015285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007537919,0.0022485526,0.925004,0.00006538332,0.0010266366,0.0000041220387,0.00038417112,0.0019101568,0.055782553,0.00003933702,0.0017904394,0.010990832],"study_design_scores_gemma":[0.01770201,0.0016106612,0.7850313,0.00002945473,0.0013165218,0.0000012307864,0.00011645925,0.0107415095,0.05876317,0.0003084013,0.12400367,0.00037557207],"about_ca_topic_score_codex":0.0000023743391,"about_ca_topic_score_gemma":0.0000023944808,"teacher_disagreement_score":0.13997269,"about_ca_system_score_codex":0.00005582481,"about_ca_system_score_gemma":0.0001868956,"threshold_uncertainty_score":0.99987847},"labels":[],"label_agreement":null},{"id":"W2945085657","doi":"10.1097/mbc.0000000000000746","title":"Clinical and genetic factors influencing acenocoumarol dosing","year":2018,"lang":"en","type":"article","venue":"Blood Coagulation & Fibrinolysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"Universidad Nacional de Rosario","keywords":"Acenocoumarol; Dosing; VKORC1; Medicine; CYP2C9; Warfarin; Anticoagulant; Cohort; Internal medicine; Atrial fibrillation","score_opus":0.1255061971591769,"score_gpt":0.43645401427481545,"score_spread":0.31094781711563857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945085657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959307,0.0010656682,0.0002557746,0.00012899083,0.00085411855,0.00029530487,0.000025154124,0.00012240306,0.0013219208],"genre_scores_gemma":[0.9962352,0.00052115566,0.0012127239,0.0007450259,0.0010320373,0.000013037429,0.000013631426,0.00003438304,0.00019280959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976853,0.00043078867,0.00067949126,0.000522055,0.00021796604,0.00046436698],"domain_scores_gemma":[0.99865896,0.00028086032,0.00023576882,0.00028425647,0.00017979158,0.00036036115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000425735,0.0002827781,0.00040545134,0.0001820634,0.0004729187,0.000060239818,0.00020362619,0.00033477467,0.0005878961],"category_scores_gemma":[0.00008893868,0.0002762594,0.00015464272,0.00032824298,0.0004549943,0.0001415628,0.00018073016,0.00038506582,0.00008761056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007896877,0.00012645035,0.8319609,0.000017977409,0.0003988208,0.0000100872185,0.0007846576,0.00018985177,0.09293078,0.00013414898,0.00011394937,0.07325341],"study_design_scores_gemma":[0.0025601513,0.00013626688,0.8624022,0.000013260788,0.0012831745,0.000029013603,0.00008039365,0.0062833214,0.107176,0.00043573003,0.019172747,0.00042774514],"about_ca_topic_score_codex":0.00003247284,"about_ca_topic_score_gemma":0.000012444052,"teacher_disagreement_score":0.07282566,"about_ca_system_score_codex":0.000012556736,"about_ca_system_score_gemma":0.000062796214,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W2945410001","doi":"10.1139/cjpp-2019-0177","title":"Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Russian Science Foundation","keywords":"Mirtazapine; Hamd; CYP2D6; Internal medicine; Major depressive disorder; Adverse effect; Medicine; Pharmacology; Significant difference; Antidepressant","score_opus":0.0208684985091542,"score_gpt":0.3171872740228389,"score_spread":0.29631877551368474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945410001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964034,0.0016865635,0.0000021665437,0.0005387249,0.0005643304,0.00067385985,0.000071001836,0.00000176201,0.000058188343],"genre_scores_gemma":[0.997327,0.0017180291,0.000015130429,0.0008526636,0.000045456338,0.000008388192,0.000003549373,0.000015389907,0.000014381785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982325,0.00078661065,0.00034055734,0.00022365896,0.000076551405,0.00034014016],"domain_scores_gemma":[0.9972477,0.0018093692,0.0004030994,0.00011532836,0.00011482528,0.0003097002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003214063,0.00022150466,0.0005539455,0.00023049647,0.00011285463,0.000004623927,0.00021610175,0.00019979464,0.00025978914],"category_scores_gemma":[0.000082062725,0.00015490783,0.0000470447,0.00014453044,0.0007988788,0.00010071674,0.00006195374,0.000738211,0.000001069011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00682216,0.00053626014,0.58905953,0.00028258463,0.00074748805,0.00001898723,0.0010325544,0.0009024475,0.39280123,0.00042903153,0.0003337558,0.007033982],"study_design_scores_gemma":[0.013651043,0.0009397897,0.90807986,0.000040955845,0.0003028525,0.0000075005496,0.000023491964,0.00014923127,0.072350636,0.00020917696,0.0040761353,0.00016929873],"about_ca_topic_score_codex":0.0003784875,"about_ca_topic_score_gemma":0.00046079158,"teacher_disagreement_score":0.32045057,"about_ca_system_score_codex":0.000018203038,"about_ca_system_score_gemma":0.00017093107,"threshold_uncertainty_score":0.6316958},"labels":[],"label_agreement":null},{"id":"W2946297337","doi":"10.1016/j.biopsych.2019.03.630","title":"F93. CYP2D6 Revisited in GENDEP, a Multicenter Clinical Trial of Nortriptyline and Escitalopram","year":2019,"lang":"en","type":"article","venue":"Biological Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta","funders":"","keywords":"Nortriptyline; CYP2D6; Escitalopram; Pseudogene; CYP2C19; Genotyping; Pharmacology; Medicine; Genotype; Internal medicine; Genetics; Biology; Gene; Genome","score_opus":0.2062728499172168,"score_gpt":0.4991303363883159,"score_spread":0.2928574864710991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946297337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879714,0.00409385,0.00001034984,0.00050705316,0.0041740783,0.0010413588,0.00008311851,0.000034407814,0.0020843735],"genre_scores_gemma":[0.99136204,0.004492283,0.0009104337,0.0023567542,0.00069421215,0.000022879738,0.000028674913,0.000014526254,0.000118182616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971349,0.00078230357,0.001027967,0.0005463415,0.0001082077,0.00040025136],"domain_scores_gemma":[0.9988173,0.00039028202,0.00027789947,0.00021165698,0.00006203864,0.00024077574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016225541,0.0002427636,0.0006408603,0.0001183662,0.000040761555,0.000008906767,0.00027208342,0.00062560133,0.000573142],"category_scores_gemma":[0.00018569184,0.00018202521,0.00020764953,0.00023696238,0.00023751397,0.00004375997,0.00016391193,0.0008216974,0.00009734438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03525204,0.0027283086,0.9249769,0.000068554684,0.00016818049,0.0000069891853,0.000078441044,0.000020841446,0.008649434,0.0024133786,0.0007973447,0.024839599],"study_design_scores_gemma":[0.20146506,0.0028312535,0.57022804,0.000059687445,0.00024509212,0.000015205266,0.00014005348,0.0033423256,0.0010242135,0.0039909347,0.21581125,0.00084685255],"about_ca_topic_score_codex":0.0000065703057,"about_ca_topic_score_gemma":0.0000051236275,"teacher_disagreement_score":0.35474882,"about_ca_system_score_codex":0.000011080781,"about_ca_system_score_gemma":0.000060197774,"threshold_uncertainty_score":0.74227726},"labels":[],"label_agreement":null},{"id":"W2948503358","doi":"10.1186/s12920-019-0527-2","title":"Targeted next generation sequencing as a tool for precision medicine","year":2019,"lang":"en","type":"article","venue":"BMC Medical Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Children's Health Foundation","keywords":"Copy-number variation; Biology; Genetics; Genotyping; Concordance; Exome sequencing; Allele frequency; Exome; Computational biology; Human genetics; DNA sequencing; Pseudogene; Personalized medicine; Massive parallel sequencing; Genotype; Gene; Mutation; Genome","score_opus":0.22920482654003135,"score_gpt":0.4394715403986303,"score_spread":0.21026671385859894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948503358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755551,0.003030747,0.011001169,0.00081204576,0.005610761,0.001276054,0.000041583735,0.00007543727,0.0025970642],"genre_scores_gemma":[0.968603,0.0027520768,0.0064836475,0.01386336,0.004886326,0.0001726006,0.00028060644,0.00007511368,0.0028832315],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974901,0.00037043836,0.0006619693,0.000496398,0.00044855202,0.0005325454],"domain_scores_gemma":[0.9977364,0.0011146464,0.00018374139,0.0002874934,0.00015811347,0.00051962107],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024618057,0.00026627365,0.00043002988,0.00011695599,0.00018652226,0.000023027564,0.0004403764,0.0005299466,0.009045922],"category_scores_gemma":[0.0012398369,0.0002285055,0.0001388952,0.00016106559,0.00013838022,0.000096265576,0.00012382663,0.0005393034,0.0006413493],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000488623,0.00010369187,0.0010587169,0.00012447868,0.000111387286,0.000010970909,0.000786493,0.0020665482,0.90126973,0.0027698362,0.012889127,0.078320414],"study_design_scores_gemma":[0.005511239,0.0002362357,0.00016121208,0.00003029031,0.00018972329,0.000040861218,0.00012522444,0.33242872,0.078515396,0.0015605658,0.58082265,0.0003778919],"about_ca_topic_score_codex":0.000019458403,"about_ca_topic_score_gemma":0.000017286644,"teacher_disagreement_score":0.8227543,"about_ca_system_score_codex":0.00014977643,"about_ca_system_score_gemma":0.000944714,"threshold_uncertainty_score":0.99186},"labels":[],"label_agreement":null},{"id":"W2949512585","doi":"10.1101/259838","title":"Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studies","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"National Institutes of Health; King's College London; National Institute for Health and Care Research; National Institute of Mental Health; Medical Research Council; European Federation of Pharmaceutical Industries and Associations; South London and Maudsley NHS Foundation Trust; GlaxoSmithKline; European Commission; University of Texas Southwestern Medical Center; Pfizer","keywords":"CYP2C19; Escitalopram; Citalopram; Meta-analysis; Internal medicine; Antidepressant; CYP2D6; Pharmacogenetics; Medicine; Side effect (computer science); Pharmacology; CYP3A4; Gastroenterology; Cytochrome P450; Genotype; Biology; Genetics; Gene; Metabolism","score_opus":0.14417274753803808,"score_gpt":0.41512032612302563,"score_spread":0.2709475785849875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949512585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95180553,0.037273567,0.0001543865,0.00020866835,0.001009925,0.001281933,0.008155251,0.00010037982,0.00001037205],"genre_scores_gemma":[0.99284285,0.0054099895,0.00066736375,0.0004613346,0.00030405188,0.00019905684,0.0000073762435,0.000102663005,0.000005298569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98862505,0.0071405917,0.0011406044,0.0016915371,0.00073485915,0.0006673362],"domain_scores_gemma":[0.9779313,0.016472913,0.002304984,0.0022186628,0.00074319006,0.00032891412],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010562556,0.0009594936,0.0043982244,0.0009342231,0.00022532672,0.000063649066,0.0012559537,0.0009561211,0.00009085314],"category_scores_gemma":[0.006094107,0.0008497462,0.00089482235,0.0010015606,0.00039581573,0.0002331075,0.002111973,0.0013814126,0.000017301309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022053628,0.00029167038,0.014265656,0.00066099793,0.22551031,0.000034778237,0.00005303382,0.000542964,0.7562799,0.000007577163,0.00013351151,0.000014258256],"study_design_scores_gemma":[0.0010603776,0.00015664306,0.2092449,0.000035713405,0.220332,3.4593048e-9,0.000001308663,0.0011396396,0.5658167,0.000002594767,0.0017544902,0.00045560198],"about_ca_topic_score_codex":0.00008634458,"about_ca_topic_score_gemma":0.0000055936407,"teacher_disagreement_score":0.19497925,"about_ca_system_score_codex":0.0002065891,"about_ca_system_score_gemma":0.00026606754,"threshold_uncertainty_score":0.9993953},"labels":[],"label_agreement":null},{"id":"W2949677511","doi":"10.1016/j.pec.2019.06.008","title":"Knowledge and understanding of pharmacogenomic testing among patients and health care professionals: A scoping review","year":2019,"lang":"en","type":"review","venue":"Patient Education and Counseling","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institute of Nutrition, Metabolism and Diabetes; Institute of Infection and Immunity; Genome Canada; Canadian Institutes of Health Research; Crohn's and Colitis Canada; Institute of Genetics; Government of Canada","keywords":"Pharmacogenomics; Health professionals; Health care; MEDLINE; Medicine; Psychology; Pharmacology","score_opus":0.33811212014863706,"score_gpt":0.5408053463895551,"score_spread":0.20269322624091807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949677511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058043553,0.98865134,0.000009794851,0.000039382136,0.0017295833,0.0032502613,0.000086844404,0.00002208957,0.00040637585],"genre_scores_gemma":[0.009123486,0.9891798,0.00012445863,0.0010078648,0.00012353786,0.00019809669,0.00016026277,0.000050545143,0.0000319448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997205,0.000658786,0.0010700516,0.0005500514,0.00016759429,0.00034849593],"domain_scores_gemma":[0.997657,0.00051520526,0.0011040719,0.0001416121,0.00026757017,0.00031453572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082153326,0.00043071923,0.0013209154,0.00024418256,0.00037091033,0.000028193337,0.0001229891,0.0002131195,0.00004022608],"category_scores_gemma":[0.00008028178,0.00039128962,0.0000985532,0.00027318133,0.0001276147,0.000095331736,0.00013526094,0.00056269276,0.0000052414052],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044335447,0.00017676274,0.0005030269,0.15874776,0.00007935081,1.6711144e-7,0.0037157827,5.208353e-7,0.0000016490173,0.000026069161,0.00047851668,0.836266],"study_design_scores_gemma":[0.0011605538,0.00020656687,0.000052296476,0.46482372,0.0031499993,0.00002414582,0.0026942736,0.0002542557,0.000019784768,0.00004270039,0.5264894,0.0010823096],"about_ca_topic_score_codex":0.000013429375,"about_ca_topic_score_gemma":0.0000036478639,"teacher_disagreement_score":0.8351837,"about_ca_system_score_codex":0.00017012343,"about_ca_system_score_gemma":0.001609337,"threshold_uncertainty_score":0.9998539},"labels":[],"label_agreement":null},{"id":"W2952541172","doi":"10.1038/s41397-018-0048-y","title":"Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes","year":2018,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Pharmacogenomics; Linkage disequilibrium; Genetics; Biology; Genome-wide association study; Genome; Genetic association; 1000 Genomes Project; Gene; Computational biology; Haplotype; Single-nucleotide polymorphism; Allele; Genotype","score_opus":0.09886308670490605,"score_gpt":0.41698346283839427,"score_spread":0.3181203761334882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952541172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97318906,0.011631069,0.0004245838,0.0015438864,0.0084882695,0.00081601046,0.00039441278,0.000103149476,0.0034095927],"genre_scores_gemma":[0.9753331,0.010674257,0.00025694122,0.004085041,0.008117746,0.000049323447,0.000043367847,0.00016882161,0.0012714188],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.993318,0.0017611188,0.0015925233,0.00078790064,0.000549244,0.0019911984],"domain_scores_gemma":[0.9967761,0.00041748476,0.0008070352,0.00057278393,0.0004367671,0.0009898086],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0053272042,0.0008757467,0.00086312136,0.0007316089,0.0016963797,0.00035304794,0.0022530959,0.00035450706,0.008944837],"category_scores_gemma":[0.00006765433,0.00069137895,0.00051757134,0.00087536516,0.0008556967,0.0005496347,0.0005654936,0.0029017897,0.0027516773],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009834871,0.00027349367,0.001539119,0.000021322508,0.00092897826,0.00039537347,0.0022866803,0.009647392,0.9628093,0.00011849965,0.003825396,0.017170943],"study_design_scores_gemma":[0.013149793,0.00030458704,0.0070544346,0.000044206365,0.0016308666,0.003665091,0.0006447953,0.027410252,0.39901835,0.0054850103,0.5396796,0.0019130682],"about_ca_topic_score_codex":0.00014124211,"about_ca_topic_score_gemma":0.000042743482,"teacher_disagreement_score":0.563791,"about_ca_system_score_codex":0.0010223386,"about_ca_system_score_gemma":0.0008225396,"threshold_uncertainty_score":0.9996033},"labels":[],"label_agreement":null},{"id":"W2954818509","doi":"10.1002/cpt.1471","title":"Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Horizon 2020 Framework Programme; Medical Research Council; National Institute for Health and Care Research; European Commission; Bundesinstitut für Arzneimittel und Medizinprodukte","keywords":"Pharmacogenomics; Agency (philosophy); Harmonization; Regulatory science; Specialty; Precision medicine; Medical education; Medicine; Family medicine; Pharmacology; Sociology","score_opus":0.3948679866942507,"score_gpt":0.55277601827374,"score_spread":0.1579080315794893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954818509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526241,0.013987241,0.000056348013,0.015640108,0.014197204,0.0010168673,0.00010107146,0.000045927685,0.0023311276],"genre_scores_gemma":[0.8938619,0.008935531,0.0003617724,0.09352329,0.0026515562,0.00008233582,0.00004233234,0.000043735625,0.0004975503],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956663,0.0015648457,0.0012798652,0.0005744,0.00025834443,0.0006562064],"domain_scores_gemma":[0.9962523,0.0020708477,0.00061476364,0.00035763564,0.00032697385,0.00037750087],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017233418,0.00043552706,0.0006769829,0.00010031689,0.0003488589,0.00004409613,0.0007502428,0.0004937202,0.0028374214],"category_scores_gemma":[0.00004351162,0.00035502162,0.000279195,0.00044982982,0.0011733585,0.00017881821,0.00028596225,0.001017358,0.00015440886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007638009,0.0017983324,0.119647086,0.00008075542,0.002385457,0.0000043375303,0.0024588127,0.0008187392,0.75050795,0.0020638178,0.045551192,0.07391971],"study_design_scores_gemma":[0.008996167,0.00045375226,0.010353313,0.000018429459,0.003095478,0.0001017996,0.0014415334,0.03350058,0.06332933,0.0011946074,0.87659043,0.00092457555],"about_ca_topic_score_codex":0.000010523975,"about_ca_topic_score_gemma":0.0000028198444,"teacher_disagreement_score":0.83103925,"about_ca_system_score_codex":0.000084584695,"about_ca_system_score_gemma":0.00055535306,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W2955876419","doi":"10.71781/11819","title":"Accélération de l'exploration de l'espace chimique du cytochrome P450 BM3 par des méthodes de criblage à haut débit et bio-informatiques","year":2018,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds Québécois de la Recherche sur la Nature et les Technologies; Centre in Green Chemistry and Catalysis; Génome Québec; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Physics; Chemistry","score_opus":0.038162705829889905,"score_gpt":0.3140264456576361,"score_spread":0.2758637398277462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955876419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464753,0.011466336,0.022910234,0.0017142157,0.001566519,0.0009779595,0.00032790843,0.00025945768,0.014302032],"genre_scores_gemma":[0.9538838,0.020437459,0.013325768,0.0021700934,0.0011361288,0.00019169183,0.0012835916,0.00009506039,0.0074763997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99442804,0.0021936395,0.0008677415,0.0007541485,0.00051784527,0.0012386121],"domain_scores_gemma":[0.9964983,0.00045574427,0.0008847098,0.00040131493,0.00077862333,0.0009813006],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0022989041,0.0008944578,0.0006968043,0.0005873109,0.008626391,0.000220879,0.00075024326,0.0016198509,0.00039001132],"category_scores_gemma":[0.00034184547,0.0010876063,0.00046568603,0.00052822556,0.00088433997,0.0015697557,0.00024714088,0.001432645,0.00014226968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0032828879,0.0008388907,0.018145274,0.0007287449,0.0011078698,0.0011752219,0.1947298,0.022720866,0.6946322,0.052638333,0.0032394712,0.006760493],"study_design_scores_gemma":[0.0032330211,0.00033765569,0.08494598,0.00040260662,0.0020006553,0.0012699146,0.01993555,0.065705866,0.664833,0.005471642,0.15037775,0.0014863409],"about_ca_topic_score_codex":0.00762278,"about_ca_topic_score_gemma":0.00676825,"teacher_disagreement_score":0.17479426,"about_ca_system_score_codex":0.0059939255,"about_ca_system_score_gemma":0.006151169,"threshold_uncertainty_score":0.9996762},"labels":[],"label_agreement":null},{"id":"W2962678857","doi":"10.18433/jpps30558","title":"Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CYP3A4; Steroid; Chemistry; Hydroxylation; Docking (animal); CYP3A; Androstane; Cytochrome P450; Hormone; Stereochemistry; Pharmacology; Biochemistry; Enzyme; Biology; Medicine","score_opus":0.18076087266066707,"score_gpt":0.536497333778581,"score_spread":0.3557364611179139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962678857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97391427,0.02097971,0.00009320196,0.0018640782,0.0007141299,0.00048028532,0.000054267362,0.000021071712,0.0018790071],"genre_scores_gemma":[0.9948856,0.0025367772,0.00048298313,0.0016703948,0.00027162975,0.0000071821055,0.0000024349295,0.0000223904,0.00012058976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965401,0.00048016466,0.0011874613,0.0004367962,0.0006999577,0.000655492],"domain_scores_gemma":[0.99746984,0.00060445385,0.0006073919,0.00012677912,0.00022693958,0.0009645957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023715533,0.00034715634,0.0007844068,0.00039878246,0.0004487877,0.00009603736,0.0006328555,0.0001154842,0.00080586446],"category_scores_gemma":[0.000078564364,0.0002911653,0.0001410442,0.00059460895,0.00078084465,0.0004912714,0.00031883907,0.00094827893,0.000024577228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029606014,0.00039271128,0.07247753,0.000063281084,0.00015383866,0.000011458953,0.0010292907,0.00074707076,0.8890233,0.00030574965,0.0027196193,0.0327801],"study_design_scores_gemma":[0.006392273,0.00075877074,0.007953951,0.000048803708,0.0005668307,0.00017348309,0.0004425708,0.0182721,0.54733586,0.00036034168,0.4171863,0.0005087428],"about_ca_topic_score_codex":0.000017113409,"about_ca_topic_score_gemma":0.0000017867168,"teacher_disagreement_score":0.41446668,"about_ca_system_score_codex":0.000043163414,"about_ca_system_score_gemma":0.00011358607,"threshold_uncertainty_score":0.99995404},"labels":[],"label_agreement":null},{"id":"W2963524270","doi":"10.2196/13848","title":"Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study","year":2019,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Randomized controlled trial; Family medicine; Pharmacogenomics; Anxiety; Protocol (science); Population; Depression (economics); Alternative medicine; Psychiatry; Internal medicine; Pharmacology","score_opus":0.6150635496460872,"score_gpt":0.6538426243084504,"score_spread":0.03877907466236319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963524270","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09108673,0.000021150108,0.000026189397,0.000044861736,0.000083389794,0.9006005,0.00003676804,0.00009692248,0.008003513],"genre_scores_gemma":[0.04899863,7.7859255e-7,0.0009851458,0.00030983452,0.00047926043,0.94846624,0.000009080749,0.00011536285,0.00063568674],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9867436,0.008001583,0.0016479944,0.001023983,0.00088815874,0.0016946371],"domain_scores_gemma":[0.9922674,0.005274966,0.00047471936,0.00053410383,0.001014277,0.000434586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01686717,0.0005578681,0.0021580071,0.0008202087,0.00046859126,0.00016450767,0.0009933065,0.0002680149,0.0007069159],"category_scores_gemma":[0.0007226428,0.00045631276,0.00038847997,0.0009436731,0.0003460677,0.00022496404,0.0004934908,0.0020387722,0.00015939971],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65557367,0.0058958647,0.014808955,0.0020350798,0.0003447066,0.00004885754,0.0014040096,0.0010614593,0.3113185,0.00011508994,0.00044255744,0.0069512744],"study_design_scores_gemma":[0.8860744,0.0019250552,0.00033890252,0.00047031182,0.00006472967,0.0000074650525,0.00026208375,0.014461654,0.010983678,0.00035504365,0.08451722,0.0005394436],"about_ca_topic_score_codex":0.000039003502,"about_ca_topic_score_gemma":0.0000046931978,"teacher_disagreement_score":0.3003348,"about_ca_system_score_codex":0.00050736143,"about_ca_system_score_gemma":0.0013018731,"threshold_uncertainty_score":0.9997889},"labels":[],"label_agreement":null},{"id":"W2965033615","doi":"10.3390/jpm9030040","title":"Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges","year":2019,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Mental Health & Substance Use Services; University of British Columbia","funders":"","keywords":"Medicine; Pharmacogenomics; Medical physics; Pharmacology","score_opus":0.7826698967804986,"score_gpt":0.6623877528341526,"score_spread":0.12028214394634595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965033615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060982286,0.9916165,0.000009973914,0.0011006518,0.0052871737,0.0007929489,0.000038540293,0.000015556441,0.0005288568],"genre_scores_gemma":[0.00015832506,0.9926555,0.00030266144,0.0010330129,0.005416845,0.00001832239,0.000011556498,0.00006789456,0.00033585675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940105,0.002051117,0.0025113672,0.00046168058,0.0005034652,0.00046184345],"domain_scores_gemma":[0.99122405,0.004590422,0.0028727672,0.00020178888,0.0004465941,0.00066435005],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007450902,0.00057586236,0.0032441162,0.0004479079,0.00011172395,0.000015668013,0.0005613236,0.0005202985,0.0017374586],"category_scores_gemma":[0.00094203744,0.00040184867,0.0005786619,0.00025938623,0.00048072365,0.00015142042,0.00013638548,0.0022395859,0.0000601689],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014186665,0.00011324615,0.000103842955,0.0074296314,0.0011760887,0.00013238419,0.00055167155,5.695431e-7,0.00020161111,0.00009827873,0.0059322286,0.9841186],"study_design_scores_gemma":[0.0044977684,0.0006129672,0.000053403946,0.0061576497,0.012580315,0.0011480318,0.00022945857,0.000026892318,0.000010716825,0.00006151062,0.9742859,0.00033539467],"about_ca_topic_score_codex":0.000005124381,"about_ca_topic_score_gemma":7.9183815e-7,"teacher_disagreement_score":0.9837832,"about_ca_system_score_codex":0.00011017575,"about_ca_system_score_gemma":0.00090826256,"threshold_uncertainty_score":0.99984336},"labels":[],"label_agreement":null},{"id":"W2966490111","doi":"10.1016/j.euroneuro.2018.08.332","title":"SA110PHARMACOGENETIC DECISION SUPPORT TOOLS AND SYMPTOM REMISSION: A META-ANALYSIS OF PROSPECTIVE RANDOMIZED CONTROLLED TRIALS IN MAJOR DEPRESSIVE DISORDER","year":2019,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pharmacogenetics; Dosing; CYP2C19; Clinical trial; Drug; Intensive care medicine; Pharmacology; Internal medicine; Genotype","score_opus":0.09509493544963457,"score_gpt":0.4286253783602861,"score_spread":0.3335304429106515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966490111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553411,0.019712957,0.0002107458,0.0006227683,0.002693649,0.007617217,0.00034983057,0.00014256283,0.013309181],"genre_scores_gemma":[0.98606837,0.0070936545,0.00032287012,0.0042166393,0.00021178908,0.00061961706,0.000047711008,0.00016574345,0.0012535849],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9655842,0.026872499,0.0045090234,0.0015230313,0.00058368733,0.0009275356],"domain_scores_gemma":[0.9778777,0.018236777,0.002327078,0.00061300764,0.0003728366,0.00057261577],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019764915,0.0009473039,0.01202508,0.0017365597,0.00014430298,0.0000719269,0.0008531786,0.0003064096,0.014059151],"category_scores_gemma":[0.0028411495,0.00067813566,0.0042939717,0.0015960829,0.0005611753,0.00020934557,0.0004394159,0.0013195298,0.00015630196],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2795556,0.0013841516,0.008762454,0.00010054659,0.20885712,0.00046728857,0.0011911646,0.0088243615,0.47802088,0.00038256834,0.0013380656,0.0111158285],"study_design_scores_gemma":[0.55607826,0.00027844898,0.016745506,0.000011034403,0.39293978,0.000043880813,0.00005433596,0.008746344,0.0060270987,0.000283864,0.01794356,0.0008478837],"about_ca_topic_score_codex":0.000010232292,"about_ca_topic_score_gemma":0.00000481915,"teacher_disagreement_score":0.47199377,"about_ca_system_score_codex":0.000039350514,"about_ca_system_score_gemma":0.00013045421,"threshold_uncertainty_score":0.999567},"labels":[],"label_agreement":null},{"id":"W2969772949","doi":"","title":"Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects","year":2018,"lang":"en","type":"article","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Harm; Precision medicine; Matching (statistics); Medicine; Pharmacogenetics; Data science; Intensive care medicine; Risk analysis (engineering); Computer science; Pharmacology; Psychology; Biology","score_opus":0.6732236853124157,"score_gpt":0.6680118248591355,"score_spread":0.005211860453280259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969772949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920304,0.0030446264,0.000006464182,0.00026421208,0.00041664715,0.0009845244,0.00002615427,0.000012845931,0.0032141565],"genre_scores_gemma":[0.98841566,0.010242048,0.0003092179,0.00056422525,0.0003169356,0.000088108034,0.000012149884,0.000011643249,0.000040006624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632806,0.0022208195,0.00063620583,0.00026682098,0.0002167055,0.00033138948],"domain_scores_gemma":[0.9988678,0.00038442694,0.00014912956,0.0001938688,0.00028911987,0.00011564478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062796352,0.00011371173,0.00024517797,0.00018489081,0.00014813717,0.000013506319,0.0002993071,0.00012296186,0.00052065495],"category_scores_gemma":[0.000029027306,0.00008341254,0.00006115575,0.0005595725,0.000720872,0.000093351475,0.00010692856,0.00048298348,0.000008347713],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034737575,0.0015385955,0.23949353,0.00008917228,0.00014824772,0.0000045485613,0.005526988,0.0000021649248,0.043846652,0.004376542,0.0007710666,0.7038551],"study_design_scores_gemma":[0.00730113,0.0025044216,0.23297244,0.000029898987,0.00039754467,0.000033896617,0.009182137,0.0025235175,0.21247587,0.0023046113,0.52990055,0.00037395998],"about_ca_topic_score_codex":0.0005131104,"about_ca_topic_score_gemma":0.0009445338,"teacher_disagreement_score":0.70348114,"about_ca_system_score_codex":0.0000126402,"about_ca_system_score_gemma":0.00015197547,"threshold_uncertainty_score":0.57008064},"labels":[],"label_agreement":null},{"id":"W2970909648","doi":"10.1111/bcp.14100","title":"Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre‐emptive pharmacogenomic testing","year":2019,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research","keywords":"Pharmacogenomics; Medicine; Dosing; Pharmacogenetics; Drug; Pharmacology; Internal medicine; Intensive care medicine; Biology","score_opus":0.12319083436497238,"score_gpt":0.4530064439289536,"score_spread":0.32981560956398126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970909648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98321587,0.002532132,0.00047519561,0.00005377404,0.009831962,0.0020537553,0.0007754702,0.00004170094,0.0010201534],"genre_scores_gemma":[0.98804927,0.0012146062,0.00445241,0.0036676368,0.0023126772,0.000046509136,0.0000689204,0.00009412202,0.00009383262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895759,0.0026798928,0.0049259528,0.00088449655,0.0008714619,0.0010622584],"domain_scores_gemma":[0.98620933,0.0027543234,0.003060137,0.00036226815,0.0058361934,0.0017777473],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005539476,0.0006302806,0.0028680149,0.0011099599,0.00021229761,0.000043653818,0.0017897907,0.00056933286,0.0019386242],"category_scores_gemma":[0.0011354916,0.0007228839,0.0010605773,0.0018807183,0.0003598487,0.0005296814,0.0005492849,0.0021137032,0.00006618215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016614586,0.0045880126,0.39308327,0.00046729512,0.009352512,0.00020615784,0.0076375552,0.16540664,0.153354,0.000006496699,0.0044722455,0.2448112],"study_design_scores_gemma":[0.05387465,0.012694804,0.6161375,0.00033467554,0.024377037,0.00014851017,0.0015265376,0.005540798,0.21317734,0.00006040088,0.06959941,0.0025283226],"about_ca_topic_score_codex":0.00005225122,"about_ca_topic_score_gemma":0.000005444341,"teacher_disagreement_score":0.24228288,"about_ca_system_score_codex":0.00024479767,"about_ca_system_score_gemma":0.0010009613,"threshold_uncertainty_score":0.9995222},"labels":[],"label_agreement":null},{"id":"W2972367557","doi":"10.1002/jcph.1493","title":"Characterization of the Ontogeny of Hepatic UDP‐Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"UGT2B7; Glucuronidation; Microsome; Gene isoform; Glucuronosyltransferase; Isozyme; In vivo; Enzyme; Internal medicine; Endocrinology; Pharmacokinetics; Ontogeny; In vitro; Chemistry; Pharmacology; Biology; Biochemistry; Medicine; Gene; Genetics","score_opus":0.12747881036509193,"score_gpt":0.4600267149257834,"score_spread":0.3325479045606915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972367557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227107,0.00038155835,0.000112069225,0.0013087884,0.0048786392,0.0007439518,0.000058559,0.00000645149,0.00023892682],"genre_scores_gemma":[0.9957872,0.0010943555,0.000019992443,0.0024828215,0.0005019391,0.000006719943,0.0000047161802,0.000024459252,0.00007779988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9920684,0.0052027223,0.0018012777,0.0002068823,0.00039508307,0.00032564],"domain_scores_gemma":[0.9950046,0.002298324,0.0018282463,0.00028274488,0.00043965055,0.00014642265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0057768617,0.0002492488,0.0008908158,0.00019690154,0.000113850525,0.00000545421,0.00082818215,0.000310125,0.0011131546],"category_scores_gemma":[0.00029845547,0.00016034913,0.00042570563,0.00033215107,0.0004940753,0.00013010498,0.00007969934,0.0014584975,0.000012937916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004034677,0.0016981668,0.041721705,0.00008709119,0.00023565085,0.000005299847,0.00033114242,0.0038425885,0.9424114,0.00006132502,0.00022879402,0.0053421524],"study_design_scores_gemma":[0.0065185134,0.0005902722,0.17610912,0.00004405475,0.0005884338,0.000005808798,0.000013138082,0.0055951807,0.8061316,0.00007660505,0.0041926918,0.0001345798],"about_ca_topic_score_codex":0.000020916197,"about_ca_topic_score_gemma":0.000014032933,"teacher_disagreement_score":0.1362798,"about_ca_system_score_codex":0.000050440805,"about_ca_system_score_gemma":0.0003646668,"threshold_uncertainty_score":0.99979997},"labels":[],"label_agreement":null},{"id":"W2972681847","doi":"10.1002/cpt.1611","title":"Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics‐Based Patient Care Program in a Real‐World Setting","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Citation; Associate editor; Precision medicine; Library science; Medicine; Psychology; Computer science","score_opus":0.2889980624840852,"score_gpt":0.5879891898422483,"score_spread":0.29899112735816313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972681847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771775,0.0040232413,0.000039278162,0.0071716886,0.0063095195,0.0029686766,0.00033461986,0.00016577807,0.0018096694],"genre_scores_gemma":[0.96474904,0.007595068,0.0013387646,0.024820436,0.0007613685,0.0002924386,0.0002544945,0.00010193838,0.00008645816],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918732,0.0031151073,0.0023906808,0.0011129787,0.0005152262,0.0009927958],"domain_scores_gemma":[0.99475986,0.0027910552,0.0010597823,0.00050264545,0.0004403964,0.00044628477],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017547566,0.0006138313,0.0011972084,0.0004935195,0.00015791478,0.000017761533,0.0008164836,0.000603324,0.005660534],"category_scores_gemma":[0.000028007591,0.000580175,0.00038460144,0.00085070863,0.00064186135,0.00011514712,0.00028621082,0.0019107207,0.00012984344],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017102553,0.0019403647,0.1638342,0.00010899003,0.0008450101,0.00003832522,0.002860623,0.0022349323,0.19309083,0.00002696814,0.0028831707,0.63042635],"study_design_scores_gemma":[0.03526165,0.0028993208,0.06650985,0.00013196935,0.003457582,0.0000024137146,0.0029373406,0.02412493,0.3255236,0.0008143086,0.5371269,0.0012101041],"about_ca_topic_score_codex":0.00018723801,"about_ca_topic_score_gemma":0.00013224942,"teacher_disagreement_score":0.62921625,"about_ca_system_score_codex":0.00016371031,"about_ca_system_score_gemma":0.0005079678,"threshold_uncertainty_score":0.99966496},"labels":[],"label_agreement":null},{"id":"W2974606789","doi":"10.1016/j.mce.2019.110583","title":"Evaluating the effects on steroidogenesis of estragole and trans-anethole in a feto-placental co-culture model","year":2019,"lang":"en","type":"article","venue":"Molecular and Cellular Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Estragole; Anethole; Cholesterol side-chain cleavage enzyme; Pregnenolone; Chemistry; Internal medicine; Endocrinology; Hormone; Steroid; Biology; Biochemistry; Enzyme; Cytochrome P450; Medicine","score_opus":0.061996270388481066,"score_gpt":0.41537228130700304,"score_spread":0.353376010918522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974606789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865557,0.010694608,0.00019614738,0.00024469817,0.00024353339,0.0006050299,0.000027147977,0.000014577282,0.0014185546],"genre_scores_gemma":[0.99754757,0.0008303513,0.00015680333,0.0011063772,0.000027254531,0.00004231925,0.000015597969,0.00002221716,0.00025148428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981007,0.00067452335,0.0002718566,0.00037660278,0.00014849025,0.00042784368],"domain_scores_gemma":[0.9994009,0.00018830734,0.000085086795,0.00019731562,0.000026764194,0.000101589474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035468786,0.00023478412,0.000347382,0.00009778546,0.00008683478,0.000010520032,0.00017786553,0.00018927027,0.00005518329],"category_scores_gemma":[0.000020872974,0.00018569842,0.00007760835,0.000102459635,0.00017405093,0.000026935091,0.00006733086,0.00052610267,0.000010136958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032874703,0.00011369184,0.0033577378,0.00012158802,0.00009172595,0.000099668134,0.0009742157,0.0034512759,0.96173054,0.0012306154,0.000014664326,0.028485525],"study_design_scores_gemma":[0.0037444502,0.00048869464,0.000725819,0.00001672801,0.0001708445,0.00007121202,0.000121988276,0.024610559,0.96705025,0.0005796256,0.0022137908,0.00020601638],"about_ca_topic_score_codex":0.0000120936675,"about_ca_topic_score_gemma":0.000002742679,"teacher_disagreement_score":0.028279508,"about_ca_system_score_codex":0.000012802096,"about_ca_system_score_gemma":0.000033104105,"threshold_uncertainty_score":0.75725615},"labels":[],"label_agreement":null},{"id":"W2975972081","doi":"10.1055/a-0979-2322","title":"From the Origins of Pharmacogenetics to First Applications in Psychiatry","year":2019,"lang":"en","type":"review","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenetics; Relevance (law); Clinical pharmacology; Pharmacogenomics; Psychology; Psychiatry; Medicine; Pharmacology; Biology; Genetics; Political science; Gene","score_opus":0.17751723211395196,"score_gpt":0.5055671253013257,"score_spread":0.32804989318737376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975972081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011142741,0.9681315,0.00009786933,0.0009336171,0.018074328,0.0055511314,0.004301662,0.00010021489,0.0016953989],"genre_scores_gemma":[0.00050863996,0.98848903,0.0008939276,0.0030324953,0.0046418007,0.0014947464,0.00046771302,0.0002560932,0.00021552938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933978,0.0011106058,0.0023626217,0.0013823668,0.00057460275,0.0011720586],"domain_scores_gemma":[0.9951678,0.0015892485,0.0011109412,0.0013064308,0.00015579007,0.0006697826],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0010963344,0.0013239271,0.0027927991,0.0006011527,0.00031722983,0.000050700073,0.00312916,0.0008848052,0.0023582203],"category_scores_gemma":[0.000037909547,0.0010208661,0.0011916105,0.0023029938,0.00023850484,0.00009695683,0.0006024951,0.0029442634,0.0014854051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021462122,0.0029056373,0.004149957,0.01313478,0.0025354815,0.0000104300325,0.0011178699,0.0010573458,0.00014087993,0.00249306,0.08009214,0.8921478],"study_design_scores_gemma":[0.0018653155,0.00004104877,0.00007765342,0.0013766182,0.004649899,0.000009985768,0.00009459679,0.00010924578,0.00012026585,0.00032327342,0.9903221,0.001009983],"about_ca_topic_score_codex":0.00021377485,"about_ca_topic_score_gemma":0.00008583344,"teacher_disagreement_score":0.91023,"about_ca_system_score_codex":0.00031749264,"about_ca_system_score_gemma":0.0014249672,"threshold_uncertainty_score":0.9999512},"labels":[],"label_agreement":null},{"id":"W2976816195","doi":"10.1002/cpt.2166","title":"PharmVar GeneFocus: <i>CYP2B6</i>","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Medical Research Council; National Institutes of Health; Canada Research Chairs; Robert Bosch Stiftung; Horizon 2020 Framework Programme; European Federation of Pharmaceutical Industries and Associations; National Research Foundation; Canadian Institutes of Health Research; Australian Centre for HIV and Hepatitis Virology Research; European Commission; Vetenskapsrådet; Centre for Addiction and Mental Health; McGill University","keywords":"Medicine; Pharmacology","score_opus":0.5691523363200172,"score_gpt":0.6343200664153339,"score_spread":0.06516773009531673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976816195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008944722,0.953438,0.00008320921,0.0012892369,0.037760153,0.0023526226,0.0008082735,0.00048444653,0.0036946333],"genre_scores_gemma":[0.000009286534,0.8895588,0.0004331197,0.095075704,0.010379275,0.0005547403,0.0005340551,0.00047671646,0.002978308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97974795,0.009950183,0.0046122707,0.0026194155,0.0006498699,0.0024202948],"domain_scores_gemma":[0.98930323,0.00507206,0.0019935782,0.0013314853,0.000592236,0.0017074029],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0041086073,0.0023030813,0.0071886634,0.0005076202,0.00071906194,0.00012440904,0.0029635606,0.0048273546,0.010378644],"category_scores_gemma":[0.000083909006,0.0020876564,0.0042780265,0.0014050595,0.0016890455,0.00017242624,0.0012700073,0.00962592,0.0037559674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011052294,0.002095104,0.000030567917,0.0019463763,0.01016023,0.00066272373,0.00008251596,0.000017887762,0.00013638621,0.00006301099,0.13484852,0.8498461],"study_design_scores_gemma":[0.0035977399,0.00019664114,0.0000027282956,0.0006143333,0.041573543,0.00028095004,0.000019859808,0.00016690961,0.00037350465,0.00007785618,0.95119035,0.0019055838],"about_ca_topic_score_codex":0.0000037334914,"about_ca_topic_score_gemma":0.0000018745741,"teacher_disagreement_score":0.84794056,"about_ca_system_score_codex":0.0002948664,"about_ca_system_score_gemma":0.002414423,"threshold_uncertainty_score":0.9989708},"labels":[],"label_agreement":null},{"id":"W2977247797","doi":"10.1096/fasebj.24.1_supplement.757.5","title":"Differential activation of rat and human pregnane X receptor by terpene trilactones","year":2010,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Pregnane X receptor; Ginkgolides; Chemistry; Terpene; Pharmacology; Stereochemistry; Biology; Biochemistry; Nuclear receptor; Transcription factor; Gene; Ginkgo biloba","score_opus":0.053562878391010024,"score_gpt":0.38579107872285034,"score_spread":0.3322282003318403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977247797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959414,0.00037529855,0.000094520736,0.00073527906,0.002164307,0.00016373595,0.000027394604,0.000011918762,0.00048612268],"genre_scores_gemma":[0.9975025,0.00053830695,0.000044328248,0.0002815106,0.0006611716,0.0000059998083,0.000013941722,0.000015378728,0.0009368859],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988837,0.00030007525,0.0003072422,0.00012190925,0.00015426628,0.00023280528],"domain_scores_gemma":[0.99919856,0.00016005475,0.00026215427,0.00011861684,0.00007755639,0.00018308882],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004934382,0.00014712947,0.00019873546,0.0000638371,0.00041169822,0.00003516465,0.00025493623,0.00015004685,0.0029174327],"category_scores_gemma":[0.000033474527,0.00009851091,0.00007054132,0.00007231051,0.00024153007,0.00009599769,0.000063542815,0.001091071,0.000009082585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001876124,0.00015887746,0.0021662712,0.000009402835,0.000089649875,0.000001283968,0.0003466841,0.000005285267,0.976403,0.0002780683,0.004579708,0.01577415],"study_design_scores_gemma":[0.0016845264,0.000061810584,0.0012160413,0.000008730143,0.00013108214,0.000046844667,0.000036718313,0.00010798849,0.9486196,0.00039309534,0.04758299,0.00011055896],"about_ca_topic_score_codex":0.0000076359065,"about_ca_topic_score_gemma":0.0000023314306,"teacher_disagreement_score":0.043003283,"about_ca_system_score_codex":0.000007772676,"about_ca_system_score_gemma":0.00003406451,"threshold_uncertainty_score":0.99799407},"labels":[],"label_agreement":null},{"id":"W2977898125","doi":"10.1101/792671","title":"Targeting the Pregnane X Receptor Using Microbial Metabolite Mimicry","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Albert Einstein College of Medicine, Yeshiva University; National Institutes of Health; Georgia Clinical and Translational Science Alliance; Crohn's and Colitis Foundation of America; U.S. Department of Defense","keywords":"Pregnane X receptor; Metabolite; Biology; Drug metabolism; G protein-coupled receptor; Secondary metabolite; Drug discovery; Chemical space; Regulator; Receptor; Pharmacology; Chemistry; Biochemistry; Cell biology; Nuclear receptor; Gene; Drug; Transcription factor","score_opus":0.06159226196383241,"score_gpt":0.3362175906060095,"score_spread":0.27462532864217704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977898125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93753314,0.034617424,0.0008421896,0.0006575435,0.021738311,0.0023622485,0.0017881294,0.00041080872,0.00005019149],"genre_scores_gemma":[0.9814325,0.0055981358,0.0049728416,0.0031791974,0.0041933386,0.00020652177,0.0000041670096,0.00034198095,0.00007134396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.993678,0.0015384378,0.0011975077,0.0015605071,0.000498083,0.0015274935],"domain_scores_gemma":[0.995847,0.0003488722,0.0010570809,0.0015012223,0.0006855211,0.00056033465],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002617223,0.0011805064,0.0011853176,0.00032942247,0.0007105696,0.00027849144,0.0018402261,0.0015423539,0.00074077037],"category_scores_gemma":[0.0002658247,0.0010479663,0.0005134833,0.0006059475,0.00043853803,0.00018320665,0.001628519,0.003988201,0.00057673856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014077326,0.00025470633,0.0020087329,0.0003762522,0.0008147448,0.000029984943,0.000061954874,0.006493298,0.98554385,0.00024252215,0.004019511,0.000013653207],"study_design_scores_gemma":[0.0012218244,0.00001775339,0.0011353202,0.00014088358,0.0010640718,8.5525514e-8,0.0000060111274,0.006897811,0.6429764,0.0000032012777,0.34542087,0.0011157988],"about_ca_topic_score_codex":0.0000528501,"about_ca_topic_score_gemma":4.943971e-7,"teacher_disagreement_score":0.34256747,"about_ca_system_score_codex":0.0002755607,"about_ca_system_score_gemma":0.0011150908,"threshold_uncertainty_score":0.99975383},"labels":[],"label_agreement":null},{"id":"W2979998128","doi":"10.1182/blood.v118.21.1243.1243","title":"The VKORC1 and CYP2C9 Genotypes Significantly Affect Vitamin K Antagonist Dosing Only in Patients Aged 20 Years or Older","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; VKORC1; CYP2C9; Genotyping; Vitamin K epoxide reductase; Genotype; Medicine; Vitamin K antagonist; Internal medicine; Pharmacology; Warfarin; Biology; Genetics; Cytochrome P450","score_opus":0.0583335750379268,"score_gpt":0.3491726163983779,"score_spread":0.2908390413604511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979998128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485403,0.0016723551,0.0000041886715,0.00004905768,0.0007281236,0.0005132051,0.000066986635,0.000037042846,0.0020750102],"genre_scores_gemma":[0.9972125,0.0013938172,0.00016655689,0.0006220361,0.00014225488,0.000030175725,0.000013069983,0.000033154938,0.00038640492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824196,0.00046373808,0.00031298495,0.0003289006,0.00014820544,0.00050418987],"domain_scores_gemma":[0.99917525,0.0002863714,0.00011320159,0.00019260419,0.000039713104,0.00019286796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066644256,0.00022286901,0.00023779548,0.000088914734,0.00031448138,0.000042724052,0.000278453,0.00018545438,0.0002742435],"category_scores_gemma":[0.000057019093,0.0001648086,0.00005693917,0.00019442313,0.00022624072,0.00007043157,0.0001177204,0.00049985235,0.00004379438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021099984,0.004151751,0.75164616,0.00007600133,0.0007179418,0.00034939632,0.009084206,0.000009508913,0.10977071,0.0003850036,0.0024300027,0.119269304],"study_design_scores_gemma":[0.009655974,0.00021694585,0.87389034,0.000016216918,0.00035974768,0.00001594104,0.00015241453,0.0000634251,0.09408017,0.00016419249,0.020992814,0.00039178823],"about_ca_topic_score_codex":0.00003918852,"about_ca_topic_score_gemma":0.00012504596,"teacher_disagreement_score":0.122244194,"about_ca_system_score_codex":0.000014249593,"about_ca_system_score_gemma":0.000091015776,"threshold_uncertainty_score":0.67206997},"labels":[],"label_agreement":null},{"id":"W2981379533","doi":"10.1111/bph.14884","title":"Propranolol is a mechanism‐based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6‐transgenic mice: Effects on activity and drug responses","year":2019,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Dextrorphan; Pharmacology; Dextromethorphan; Catalepsy; In vivo; Propranolol; Haloperidol; Chemistry; CYP2D6; Biology; Endocrinology; Cytochrome P450; Biochemistry; Enzyme; Dopamine","score_opus":0.033260877376308194,"score_gpt":0.37794955088181936,"score_spread":0.3446886735055112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981379533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755723,0.007169581,0.000025088199,0.0012383511,0.0025938577,0.0010998619,0.00013080683,0.000020108806,0.00016512292],"genre_scores_gemma":[0.9904329,0.005366947,0.00023404603,0.0032746163,0.00041899623,0.0000345855,0.000002364135,0.000050707466,0.00018480688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99566656,0.0020587833,0.0008603215,0.0004799665,0.00033617456,0.00059820875],"domain_scores_gemma":[0.99707794,0.0014905684,0.0006967124,0.00010306835,0.00030613877,0.00032559867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002105683,0.0003774819,0.0010372419,0.00056547084,0.00014028576,0.0000330695,0.00034451514,0.00039459608,0.00064820517],"category_scores_gemma":[0.00012750467,0.00041609307,0.0001854082,0.0003522305,0.00029900682,0.00020705679,0.0001111302,0.0016908167,0.000013932894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007099603,0.00085724285,0.0016672851,0.00041501928,0.00036102266,0.0004828247,0.0007602265,0.00005088481,0.9482434,0.000074078824,0.0017143218,0.038274124],"study_design_scores_gemma":[0.021559054,0.0009501264,0.005786941,0.00021167028,0.00055108534,0.000597261,0.000061991035,0.00090414647,0.9618265,0.0004171564,0.0067508863,0.00038316447],"about_ca_topic_score_codex":0.00005201653,"about_ca_topic_score_gemma":0.000021874304,"teacher_disagreement_score":0.03789096,"about_ca_system_score_codex":0.00007266755,"about_ca_system_score_gemma":0.00033373394,"threshold_uncertainty_score":0.9998291},"labels":[],"label_agreement":null},{"id":"W2982435673","doi":"10.4088/jcp.19m12910","title":"Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Mental Health; Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis; Agency for Healthcare Research and Quality; National Institutes of Health; Myriad Genetics; Sunovion; H. Lundbeck A/S; Eisai; Spier Family Foundation; Rogers Family Foundation; Eli Lilly and Company; Canadian Network for Mood and Anxiety Treatments; Assurex Health; Cerecor; Sage Therapeutics; LivaNova; GlaxoSmithKline; University of Kansas; Canadian Institutes of Health Research; Foundation for Barnes-Jewish Hospital; Stanley Medical Research Institute; Pfizer; Biogen; Allergan; Cancer Research Institute; AstraZeneca; Bristol-Myers Squibb; Ontario Brain Institute; Sanofi","keywords":"Pharmacogenomics; Randomized controlled trial; Drug; Medicine; Pharmacogenetics; Clinical trial; Psychiatry; Intensive care medicine; Pharmacology; Internal medicine; Gene; Genetics; Biology; Genotype","score_opus":0.15111043310386782,"score_gpt":0.5658280732367811,"score_spread":0.41471764013291323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982435673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97774726,0.00040392808,0.00013958197,0.0016109607,0.015523288,0.003848007,0.00005815649,0.0000069982,0.00066182396],"genre_scores_gemma":[0.9941926,0.0016304706,0.0007103537,0.0017810187,0.0014560656,0.00006267029,0.0000058603964,0.000030779745,0.00013019978],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9902892,0.004161984,0.00467633,0.00021107108,0.0003478744,0.00031352235],"domain_scores_gemma":[0.97113144,0.02261985,0.005232272,0.00028090118,0.0004453769,0.0002901269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017392803,0.0002751019,0.0028723083,0.00023607732,0.00009243753,0.000010534855,0.00061524054,0.00014973544,0.00040620074],"category_scores_gemma":[0.002392872,0.00013883681,0.0024717539,0.0001730415,0.00033078273,0.00009059353,0.0000458729,0.0017801997,0.000016624388],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68519515,0.00391687,0.30286658,0.000008810316,0.003338752,5.8717904e-7,0.00012798708,0.0015144264,0.00003962553,0.00010183329,0.00095759815,0.0019318167],"study_design_scores_gemma":[0.94066405,0.0015619578,0.050714154,0.000044927077,0.0028459576,0.000005152406,0.0000423601,0.0019878459,0.000023019193,0.0007559984,0.0011957291,0.00015886598],"about_ca_topic_score_codex":0.000011465702,"about_ca_topic_score_gemma":0.000015020194,"teacher_disagreement_score":0.2554689,"about_ca_system_score_codex":0.00003394477,"about_ca_system_score_gemma":0.0008350638,"threshold_uncertainty_score":0.7734181},"labels":[],"label_agreement":null},{"id":"W2982481126","doi":"10.1038/s41397-019-0117-x","title":"CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of British Columbia; BC Centre for Disease Control; Hospital for Sick Children","funders":"","keywords":"VKORC1; Warfarin; CYP2C9; Medicine; Meta-analysis; Internal medicine; Maintenance dose; Pharmacology; Cytochrome P450; Atrial fibrillation","score_opus":0.3003701331734773,"score_gpt":0.4744140693464879,"score_spread":0.17404393617301056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982481126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001274267,0.9929176,0.000046336354,0.0013192543,0.0007250483,0.0038065338,0.0008056114,0.000037017588,0.00021520376],"genre_scores_gemma":[0.0003078766,0.98978996,0.00009070251,0.00669213,0.0005856546,0.00030367106,0.000030486452,0.0001488019,0.002050709],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.991227,0.0037108783,0.0025306058,0.0009982157,0.00044667016,0.0010866692],"domain_scores_gemma":[0.9940106,0.0014362148,0.002638326,0.00070517015,0.00022196186,0.0009877095],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0066553233,0.001417096,0.009069566,0.0007481071,0.0008246518,0.00029256791,0.0012549934,0.00052732514,0.0009919637],"category_scores_gemma":[0.00013602708,0.00084707665,0.0024194422,0.0010300268,0.00040834522,0.00018738104,0.00082346995,0.003525273,0.000112548],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007836429,0.00021719487,0.000016742533,0.5845157,0.3776573,0.00029079954,0.0004335293,0.000044586086,0.000050988652,0.0003810767,0.004074229,0.03223948],"study_design_scores_gemma":[0.0006736382,0.000025916725,0.0000015883465,0.000873321,0.6924241,0.0032349718,0.000009567048,0.00018092769,0.0000035951532,0.00010013181,0.30180898,0.0006632165],"about_ca_topic_score_codex":0.00000938647,"about_ca_topic_score_gemma":0.0000020770274,"teacher_disagreement_score":0.5836424,"about_ca_system_score_codex":0.00012928448,"about_ca_system_score_gemma":0.00035074193,"threshold_uncertainty_score":0.99992126},"labels":[],"label_agreement":null},{"id":"W2985197001","doi":"10.1016/j.dib.2019.104787","title":"Data on the endogenous conversion of tyrosol into hydroxytyrosol in humans","year":2019,"lang":"en","type":"article","venue":"Data in Brief","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"H2020 Marie Skłodowska-Curie Actions; Instituto de Salud Carlos III; Canadian Institutes of Health Research; Generalitat de Catalunya; Instituto Nacional de Ciberseguridad; Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya; Canada Research Chairs","keywords":"Hydroxytyrosol; Tyrosol; Endogeny; Crossover study; Randomized controlled trial; Medicine; Internal medicine; Pharmacology; Placebo; Biology; Food science; Biochemistry; Polyphenol; Pathology","score_opus":0.2463902788206263,"score_gpt":0.4306763440791141,"score_spread":0.18428606525848779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985197001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872907,0.0012379532,0.0000065342124,0.00073862396,0.0010488821,0.0007238573,0.003329565,0.000016687049,0.0056072185],"genre_scores_gemma":[0.99365896,0.0011246742,0.000054868666,0.003239814,0.000109233544,0.00001359029,0.0016592043,0.00002234833,0.00011727896],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779403,0.0005003041,0.00048738677,0.00060514454,0.000230856,0.00038225373],"domain_scores_gemma":[0.99689674,0.0006648354,0.00015720651,0.002163774,0.000028823266,0.00008862328],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019694339,0.00019681735,0.00032617777,0.00013162525,0.00007698126,0.000014910043,0.0028165907,0.00018501017,0.0016208623],"category_scores_gemma":[0.00015933345,0.00016037948,0.00002955377,0.0002856695,0.00017843598,0.00020956079,0.0015482743,0.00077617215,0.00033971178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015774729,0.0031800156,0.26423624,0.00045269143,0.00032478836,0.0002525082,0.004214584,0.0014538129,0.6507238,0.0056628636,0.05195308,0.01596813],"study_design_scores_gemma":[0.0049360264,0.00012478184,0.011112204,0.00005820445,0.00010148217,0.000010944117,0.00025653033,0.02319012,0.13295203,0.0004391683,0.8263943,0.00042420972],"about_ca_topic_score_codex":0.0004348954,"about_ca_topic_score_gemma":0.00014907237,"teacher_disagreement_score":0.77444124,"about_ca_system_score_codex":0.000031410473,"about_ca_system_score_gemma":0.000099164594,"threshold_uncertainty_score":0.9992918},"labels":[],"label_agreement":null},{"id":"W2986454255","doi":"10.1016/j.xphs.2019.11.007","title":"Dietary-Induced Obesity, Hepatic Cytochrome P450, and Lidocaine Metabolism: Comparative Effects of High-Fat Diets in Mice and Rats and Reversibility of Effects With Normalization of Diet","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ministry of Education – Kingdom of Saudi Arabi","keywords":"CYP1A2; CYP3A; Internal medicine; Endocrinology; Cytochrome P450; Lidocaine; Messenger RNA; Drug metabolism; Metabolism; Diet-induced obese; Metabolite; Obesity; Chemistry; Biology; Medicine; Biochemistry; Gene; Anesthesia","score_opus":0.06373226754623942,"score_gpt":0.4070453158476014,"score_spread":0.343313048301362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986454255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901346,0.008582104,0.000027927796,0.00017590764,0.00034122044,0.0006289915,0.000013640426,0.0000036448039,0.00009194478],"genre_scores_gemma":[0.9967142,0.0025030843,0.0005497405,0.00016203315,0.00005227694,0.0000036330746,9.2290554e-7,0.0000072149624,0.0000069424714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99735,0.0008678038,0.00073399686,0.00029733055,0.00043551886,0.00031535156],"domain_scores_gemma":[0.99702394,0.001662604,0.0006875368,0.00008663748,0.00024621582,0.00029305063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018360933,0.00024015797,0.0010175662,0.00026864474,0.00008415345,0.000014938598,0.0002419465,0.00012901824,0.000036126403],"category_scores_gemma":[0.00015474537,0.00017315078,0.00006433597,0.00054816174,0.0009954573,0.00035787365,0.00016949499,0.00045741576,6.4809865e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016258017,0.00065876154,0.08262188,0.0016040569,0.00021943009,0.000031594973,0.0016418423,0.00034198983,0.90873295,0.0003063493,0.000013434848,0.0022018885],"study_design_scores_gemma":[0.0045096586,0.0016314173,0.2568261,0.00024254314,0.00058128254,0.000040215455,0.00010976016,0.0048771305,0.7304176,0.00053604407,0.000063684725,0.0001645756],"about_ca_topic_score_codex":0.000060256047,"about_ca_topic_score_gemma":0.0000177816,"teacher_disagreement_score":0.17831537,"about_ca_system_score_codex":0.000019344225,"about_ca_system_score_gemma":0.00009275923,"threshold_uncertainty_score":0.70608836},"labels":[],"label_agreement":null},{"id":"W2987429045","doi":"10.1002/cctc.201901974","title":"Indigo Formation and Rapid NADPH Consumption Provide Robust Prediction of Raspberry Ketone Synthesis by Engineered Cytochrome P450 BM3","year":2019,"lang":"en","type":"article","venue":"ChemCatChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"","keywords":"Ketone; Indigo; Chemistry; Total synthesis; Cytochrome P450; Hydroxylation; Stereochemistry; Combinatorial chemistry; Organic chemistry; Enzyme","score_opus":0.07110657581077548,"score_gpt":0.333139336138316,"score_spread":0.2620327603275405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987429045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933847,0.0033105386,0.00028524408,0.00020602661,0.0003565251,0.0007464834,0.0004248086,0.000093969895,0.0011917081],"genre_scores_gemma":[0.99636525,0.002174476,0.0003969765,0.00023758133,0.00011567279,0.00012335357,0.00017853396,0.00003381268,0.00037433524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847376,0.00013061662,0.00050965813,0.0003276878,0.00020246462,0.00035579706],"domain_scores_gemma":[0.9989135,0.0002692377,0.00027472404,0.00022167127,0.00011279352,0.00020807532],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006121002,0.00025980652,0.0003976903,0.00013552292,0.00009486238,0.000018240626,0.00016594019,0.00037033073,0.00094042486],"category_scores_gemma":[0.00007923576,0.0002669829,0.00008389216,0.00016729817,0.00013453954,0.0002733158,0.000076035576,0.00040894494,0.00009775558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018038343,0.00018763216,0.0030724492,0.00047675526,0.00015608704,0.0000013635713,0.00072290417,0.00027952762,0.9747849,0.00003620884,0.0042833243,0.015818445],"study_design_scores_gemma":[0.0019790905,0.000051706284,0.007674508,0.000039655555,0.0002610913,0.000023709823,0.00010074985,0.008742765,0.95392555,0.00006868588,0.026890941,0.00024153561],"about_ca_topic_score_codex":0.000008831265,"about_ca_topic_score_gemma":7.261192e-7,"teacher_disagreement_score":0.022607617,"about_ca_system_score_codex":0.00006783877,"about_ca_system_score_gemma":0.00005876587,"threshold_uncertainty_score":0.99997824},"labels":[],"label_agreement":null},{"id":"W2989483429","doi":"10.1007/978-3-030-24100-1_4","title":"Design and Implementing Pharmacogenomics Study in Cancer","year":2019,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pharmacogenomics; Personalized medicine; Drug response; Identification (biology); Computational biology; Medicine; Precision medicine; Drug; Bioinformatics; Pharmacology; Biology; Pathology","score_opus":0.4170549558686819,"score_gpt":0.6158268834182113,"score_spread":0.19877192754952944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989483429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011200727,0.9842401,0.000011045612,0.00004263439,0.0017379099,0.002316683,0.000029024111,0.00001507075,0.0004067646],"genre_scores_gemma":[0.011333451,0.98688644,0.00010817327,0.0005601162,0.00038244255,0.00061794004,0.000033637403,0.000039726994,0.000038085553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648196,0.0011308359,0.00091540685,0.00075868587,0.000069524096,0.00064356707],"domain_scores_gemma":[0.99867326,0.0006911072,0.00032136237,0.00014287628,0.0000168891,0.00015451416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011652461,0.0005385465,0.001779826,0.00041741863,0.00008802428,0.0000068782897,0.00026567018,0.00031978328,0.00033201062],"category_scores_gemma":[0.000022087908,0.00040969515,0.00005669849,0.00027495212,0.0003390623,0.0000980434,0.0003348536,0.00084864156,0.0000067093383],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009838376,0.0003501764,0.0024708016,0.0009647157,0.00013533805,0.000038283517,0.0014212099,0.000014049363,0.0020629857,0.000077239616,0.000038157294,0.99232864],"study_design_scores_gemma":[0.0039943885,0.0005117032,0.000010871862,0.0005658689,0.00048249064,0.000029487024,0.00094840996,0.00015774922,0.0004361692,0.00006946062,0.99237084,0.00042255287],"about_ca_topic_score_codex":0.00008885741,"about_ca_topic_score_gemma":0.00003378069,"teacher_disagreement_score":0.9923327,"about_ca_system_score_codex":0.0000990879,"about_ca_system_score_gemma":0.00009052051,"threshold_uncertainty_score":0.9998355},"labels":[],"label_agreement":null},{"id":"W2990226687","doi":"10.18433/jpps30622","title":"Inhibitory and Stimulatory Effects of Selective Serotonin Reuptake Inhibitors on Cytochrome P450 2D6-mediated Dopamine Formation from p-Tyramine","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CYP2D6; Dopamine; Tyramine; Fluoxetine; Reuptake; Paroxetine; Chemistry; Pharmacology; Serotonin; Reuptake inhibitor; Internal medicine; Endocrinology; Biology; Biochemistry; Cytochrome P450; Metabolism; Medicine; Receptor","score_opus":0.060479866600236576,"score_gpt":0.4121243973624847,"score_spread":0.3516445307622481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990226687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858012,0.008572004,0.000047767127,0.00078840874,0.0025360745,0.0010172942,0.00008312324,0.000043993365,0.001110116],"genre_scores_gemma":[0.99282235,0.0039866623,0.00032700886,0.0018521787,0.0008808542,0.00001971883,0.000009666273,0.000037484697,0.00006407572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951087,0.0009816174,0.0014447173,0.0005531683,0.0011223175,0.0007894379],"domain_scores_gemma":[0.9943614,0.003039206,0.0011436943,0.00018110803,0.00043441623,0.0008401639],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023853139,0.000525843,0.0009136529,0.0006103506,0.0002830673,0.000060942726,0.00068444817,0.0002375375,0.00070208346],"category_scores_gemma":[0.00047263625,0.00042942283,0.00027503265,0.00088956585,0.0008965745,0.00085019117,0.0002138559,0.001657546,0.00009317664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014578314,0.00077118893,0.009971481,0.0002594885,0.00028005516,0.000081326274,0.0007229666,0.0013259161,0.95344573,0.0001232198,0.0011572256,0.030403541],"study_design_scores_gemma":[0.010214294,0.00091514573,0.008409808,0.00017453595,0.00050096714,0.000075036354,0.00012363447,0.01986861,0.8730091,0.0002075313,0.0860511,0.0004502365],"about_ca_topic_score_codex":0.000021110047,"about_ca_topic_score_gemma":0.00000218045,"teacher_disagreement_score":0.084893875,"about_ca_system_score_codex":0.0001546391,"about_ca_system_score_gemma":0.00037612848,"threshold_uncertainty_score":0.99981576},"labels":[],"label_agreement":null},{"id":"W2990740129","doi":"10.1200/jco.2019.37.31_suppl.117","title":"Pharmacogenetic (PGx) guided cancer pain management in an oncology palliative medicine (PM) clinic.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer pain; Opioid; Internal medicine; Cancer; CYP2D6; Pharmacogenetics; McNemar's test; Pain assessment; Oncology; Physical therapy; Pain management; Genotype","score_opus":0.4763321080730114,"score_gpt":0.6492114431055761,"score_spread":0.1728793350325647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990740129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9329379,0.006594631,0.000101152225,0.014278692,0.016522562,0.0010043931,0.000022761857,0.000027804677,0.028510101],"genre_scores_gemma":[0.89232385,0.04321627,0.0023707727,0.05516506,0.0047474946,0.0000735594,0.00001198115,0.000073025534,0.0020179895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9824676,0.009618035,0.0057285246,0.00068430457,0.0005931987,0.00090833945],"domain_scores_gemma":[0.9875782,0.0065489267,0.0036224069,0.00037399726,0.0006919813,0.0011844483],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.028135711,0.00048084938,0.002886609,0.000537941,0.00009162165,0.000011408956,0.0012143797,0.0012703983,0.013341583],"category_scores_gemma":[0.0011566142,0.00038051192,0.000546334,0.00053627946,0.0006149386,0.00020968787,0.00024835096,0.0037455878,0.0003335458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062231147,0.00450247,0.19898884,0.00009661788,0.0015369905,0.0014341158,0.0009345039,0.0026369775,0.005780406,0.00026836264,0.04534935,0.73224825],"study_design_scores_gemma":[0.028402915,0.007137584,0.06204839,0.000080995254,0.0011078794,0.000037021495,0.0005115245,0.0043184278,0.00054431125,0.0016984283,0.89369375,0.00041880165],"about_ca_topic_score_codex":0.000038426402,"about_ca_topic_score_gemma":0.000117221614,"teacher_disagreement_score":0.8483444,"about_ca_system_score_codex":0.00042086653,"about_ca_system_score_gemma":0.001483633,"threshold_uncertainty_score":0.9998647},"labels":[],"label_agreement":null},{"id":"W2991631967","doi":"10.1159/000504253","title":"Estimating the Potential Impact of CYP2C19 and CYP2D6 Genetic Testing on Protocol-Based Care for Depression in Canada and the United States","year":2019,"lang":"en","type":"article","venue":"Complex Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hotchkiss Brain Institute; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"CYP2C19; CYP2D6; Depression (economics); Genotyping; Pharmacogenetics; Protocol (science); Medicine; Demography; Algorithm; Biology; Genetics; Computer science; Genotype; Sociology","score_opus":0.06224234865140358,"score_gpt":0.4142778458330694,"score_spread":0.3520354971816658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991631967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440504,0.0004624049,0.00012169047,0.00031334435,0.00046650358,0.013994949,0.0001306333,0.000009282481,0.00009612988],"genre_scores_gemma":[0.9938608,0.0000054972757,0.0024461376,0.0011336843,0.00011024024,0.0023932825,0.000027687669,0.000019650532,0.0000030276324],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987011,0.00034182286,0.0003233114,0.0002301541,0.00012000211,0.00028361112],"domain_scores_gemma":[0.99865174,0.00077371474,0.00020839831,0.00018398793,0.00009534059,0.000086828586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033545497,0.00018631238,0.00024999277,0.00007110688,0.00023050996,0.00001899873,0.00020774451,0.00006324362,0.00004410489],"category_scores_gemma":[0.000042679545,0.00010835825,0.00005474433,0.00018182785,0.0001415051,0.000015985568,0.0000661546,0.00032465937,5.8236054e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014174825,0.00006126186,0.5921788,0.000308584,0.00006597852,0.0000012910234,0.000366691,0.39358136,0.0029696736,0.00004897539,0.0003753882,0.008624486],"study_design_scores_gemma":[0.0071705906,0.000105873085,0.31746018,0.000044691726,0.00006330487,0.000005482,0.00021332203,0.6733473,0.00030374635,0.0005777357,0.00058117457,0.00012659321],"about_ca_topic_score_codex":0.07166752,"about_ca_topic_score_gemma":0.024342086,"teacher_disagreement_score":0.27976593,"about_ca_system_score_codex":0.000046396148,"about_ca_system_score_gemma":0.00046653757,"threshold_uncertainty_score":0.99346113},"labels":[],"label_agreement":null},{"id":"W2992911505","doi":"10.2147/ceor.s224277","title":"&lt;p&gt;Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications&lt;/p&gt;","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Assurex Health","keywords":"Formulary; Medicine; Medical prescription; Pharmacogenomics; Pharmacy; Antipsychotic; Psychiatry; Test (biology); Family medicine; Schizophrenia (object-oriented programming); Pharmacology","score_opus":0.112147836875957,"score_gpt":0.483614907670712,"score_spread":0.37146707079475505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992911505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733931,0.0028284604,0.0000367126,0.0066676955,0.005148543,0.002705236,0.0006228206,0.000054086187,0.008543376],"genre_scores_gemma":[0.98827934,0.0046828757,0.00023955363,0.0030665416,0.00066686404,0.00045756355,0.00027081405,0.00008244084,0.0022540267],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99615365,0.00059374934,0.00093323854,0.0008221555,0.0003270827,0.0011701332],"domain_scores_gemma":[0.9944262,0.0031407191,0.0003886779,0.00046614313,0.00044531134,0.0011329401],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0069381767,0.0003512421,0.0006754305,0.0005970791,0.0007539083,0.00011266336,0.00082232105,0.0005386015,0.0011049737],"category_scores_gemma":[0.0005124444,0.00033115476,0.00017360618,0.00036783578,0.00049204816,0.00016587865,0.00016000369,0.0010644243,0.0003547358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019779142,0.0015937582,0.67263544,0.00030546702,0.0030986618,0.00001846068,0.0014227161,0.00039367413,0.019606408,0.07855279,0.08382738,0.13656735],"study_design_scores_gemma":[0.012803934,0.00028220608,0.071601324,0.000022019867,0.00030663924,0.000005889744,0.000057347548,0.0141758835,0.00081878906,0.0036470625,0.89571196,0.00056696485],"about_ca_topic_score_codex":0.0001464043,"about_ca_topic_score_gemma":0.0012355829,"teacher_disagreement_score":0.8118846,"about_ca_system_score_codex":0.00037041976,"about_ca_system_score_gemma":0.0013406442,"threshold_uncertainty_score":0.99991405},"labels":[],"label_agreement":null},{"id":"W2994882782","doi":"10.1139/cjpp-2019-0586","title":"Mechanisms of NADPH – cytochrome P450 oxidoreductase induction by dexamethasone in the H4IIE rat hepatoma cell line","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Tyrosine aminotransferase; Agonist; Internal medicine; Endocrinology; Cytochrome P450; Glucocorticoid receptor; Glucocorticoid; Pregnenolone; Microsome; Chemistry; Dexamethasone; Biology; Receptor; Nuclear receptor; Enzyme inducer; Steroid; In vitro; Hormone; Biochemistry; Metabolism; Enzyme; Medicine; Transcription factor","score_opus":0.040533069297932024,"score_gpt":0.34742824668852024,"score_spread":0.3068951773905882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994882782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887545,0.005705209,0.0000352451,0.0013874818,0.003156281,0.00046488285,0.00014555195,0.000005383596,0.00034547187],"genre_scores_gemma":[0.9934498,0.0011294733,0.00011837013,0.004758519,0.00035032473,0.000017717293,0.000027964523,0.000025120931,0.00012267956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966513,0.0014748174,0.00075890793,0.00031637595,0.00013757873,0.00066100474],"domain_scores_gemma":[0.9979801,0.0005188583,0.00058835023,0.00017401633,0.00019878999,0.0005398803],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016000278,0.00030922686,0.00068897946,0.0004529097,0.00016771766,0.000010237091,0.00060430024,0.00049040973,0.0039119655],"category_scores_gemma":[0.000036166246,0.0002500026,0.00014549475,0.00040421187,0.00051912264,0.00014774514,0.000044666787,0.0015535806,0.00003211269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003953458,0.00021806872,0.0006204146,0.00009852664,0.00015489332,0.00009291382,0.0009451913,0.00045917777,0.9871305,0.0004994579,0.0081101125,0.0012753706],"study_design_scores_gemma":[0.0044053355,0.0006990542,0.0023852077,0.000011998195,0.00032789144,0.00030554563,0.0003707964,0.00040763366,0.9405478,0.004643056,0.04561377,0.00028186725],"about_ca_topic_score_codex":0.00040492814,"about_ca_topic_score_gemma":0.0001952578,"teacher_disagreement_score":0.04658268,"about_ca_system_score_codex":0.000065888846,"about_ca_system_score_gemma":0.0007045482,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W2995735764","doi":"10.1002/ccr3.2604","title":"Precision medication: An illustrative case series guiding the clinical application of multi‐drug interactions and pharmacogenomics","year":2019,"lang":"en","type":"article","venue":"Clinical Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Medicine; Precision medicine; Drug; Drug administration; Medical physics; Affect (linguistics); Intensive care medicine; Pharmacology; Psychology; Pathology","score_opus":0.2861139187664311,"score_gpt":0.5536936800650948,"score_spread":0.2675797612986637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995735764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99166495,0.0010745701,0.00061112334,0.00072110235,0.004065697,0.0011119543,0.000059225647,0.000048550835,0.0006428087],"genre_scores_gemma":[0.994887,0.0018401714,0.0010893216,0.00086402753,0.00079327816,0.00007086747,0.000034748806,0.000028311362,0.00039229135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995134,0.0015440765,0.0021865028,0.00068516226,0.0001798169,0.00027043393],"domain_scores_gemma":[0.99505115,0.0023265567,0.001183118,0.00062974036,0.00033833476,0.00047112617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069390107,0.0002437839,0.0005274563,0.00006752594,0.00034067617,0.000025922367,0.0001472819,0.00024141882,0.0003545671],"category_scores_gemma":[0.0006233429,0.0001863559,0.00021915365,0.00017139141,0.000668144,0.00026375274,0.0002124937,0.00091171893,0.000027021397],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012890245,0.003444475,0.1998489,0.0001473227,0.0011007962,0.044633232,0.003578141,0.0009951054,0.020459631,0.00090355455,0.0034072578,0.72019255],"study_design_scores_gemma":[0.0041538402,0.00036095237,0.0064592524,0.00003437882,0.0016733002,0.3297101,0.0029478879,0.07210483,0.014449291,0.00095329556,0.5664247,0.00072814396],"about_ca_topic_score_codex":0.0000611737,"about_ca_topic_score_gemma":0.00009026329,"teacher_disagreement_score":0.7194644,"about_ca_system_score_codex":0.000023619863,"about_ca_system_score_gemma":0.00017526514,"threshold_uncertainty_score":0.7599373},"labels":[],"label_agreement":null},{"id":"W2998100580","doi":"10.1002/jcph.1571","title":"Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Gene isoform; Ontogeny; Biology; Glucuronosyltransferase; Internal medicine; Endocrinology; Western blot; Blot; Uridine; Glucuronidation; Microsome; Genetics; Biochemistry; Medicine; Gene; Enzyme; RNA","score_opus":0.1620544192543954,"score_gpt":0.5110713937836602,"score_spread":0.3490169745292648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998100580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867937,0.002479168,0.0034189054,0.0026615795,0.0026585297,0.0017139983,0.000086773005,0.000013995828,0.00017334476],"genre_scores_gemma":[0.9933092,0.0031677892,0.000740446,0.0019491656,0.00060975685,0.000045998993,0.000010874863,0.000032948607,0.00013380747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962957,0.0010527966,0.0018653576,0.00023193574,0.000179216,0.0003749904],"domain_scores_gemma":[0.9954346,0.0022554754,0.0013201042,0.00021401345,0.00045911432,0.00031670625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004431346,0.0002448565,0.0008205269,0.0001226757,0.0002253341,0.000008615517,0.0005257572,0.0002898381,0.00059615105],"category_scores_gemma":[0.00014988775,0.00017235501,0.0002912085,0.00014714168,0.00035756998,0.00012099835,0.000082217106,0.00075524586,0.000008681526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026975535,0.0006588965,0.006666827,0.00012214089,0.00043078436,0.000001675788,0.0002656774,0.0011045103,0.9672751,0.0018809794,0.0013878524,0.017507993],"study_design_scores_gemma":[0.019485792,0.0037852563,0.061808053,0.00006601952,0.0029366403,0.000081579004,0.0000798451,0.0065209437,0.8536559,0.025223447,0.025952557,0.00040400008],"about_ca_topic_score_codex":0.000006984315,"about_ca_topic_score_gemma":0.0000035300966,"teacher_disagreement_score":0.113619246,"about_ca_system_score_codex":0.000023172423,"about_ca_system_score_gemma":0.00019142333,"threshold_uncertainty_score":0.7028433},"labels":[],"label_agreement":null},{"id":"W2998350645","doi":"10.1101/2019.12.24.870295","title":"Cross-validation of technologies for genotyping <i>CYP2D6</i> and <i>CYP2C19</i>","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute; University of Calgary; University of Alberta","funders":"Medical Research Council; Alberta Innovates; European Commission; National Institute for Health and Care Research; King's College London; University of Alberta; Department of Health and Social Care; South London and Maudsley NHS Foundation Trust; GlaxoSmithKline","keywords":"Genotyping; CYP2C19; Pseudogene; TaqMan; Concordance; Haplotype; Genetics; Amplicon; Biology; Pharmacogenomics; Gene; Copy-number variation; Computational biology; CYP2D6; Genotype; Polymerase chain reaction; Genome","score_opus":0.055161334091821605,"score_gpt":0.3590568890323318,"score_spread":0.3038955549405102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998350645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758456,0.013548084,0.0024199155,0.0003183343,0.003750472,0.002030271,0.0015898837,0.0004512814,0.00004618875],"genre_scores_gemma":[0.99064815,0.003939995,0.0040521296,0.00043519,0.00038070217,0.00038699358,0.00000208725,0.00013545791,0.000019305466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99688953,0.00021271569,0.0008610198,0.0010520926,0.00026311644,0.0007214945],"domain_scores_gemma":[0.99695724,0.00036523255,0.0008457643,0.0008729621,0.0007586493,0.00020017374],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014663143,0.0006472162,0.00090439944,0.00035515593,0.00024442933,0.00011918096,0.00075241626,0.0014792586,0.000054676577],"category_scores_gemma":[0.00035392953,0.00070522004,0.00023483191,0.000314115,0.00046376183,0.00014898734,0.00087512494,0.0012889403,0.00002744321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021568798,0.00017636793,0.01637108,0.001368846,0.00041097455,0.000006160463,0.00002783468,0.0014966866,0.9782245,0.0011777536,0.0004301647,0.000093955125],"study_design_scores_gemma":[0.0016951048,0.000057481015,0.0049774586,0.000114751136,0.00047792445,3.5060083e-8,0.000005360424,0.0019949425,0.92113775,0.00004450065,0.06879279,0.0007018884],"about_ca_topic_score_codex":0.000011072389,"about_ca_topic_score_gemma":3.0985038e-7,"teacher_disagreement_score":0.06836263,"about_ca_system_score_codex":0.00009157334,"about_ca_system_score_gemma":0.0004219735,"threshold_uncertainty_score":0.999817},"labels":[],"label_agreement":null},{"id":"W3000387542","doi":"10.2131/fts.7.9","title":"Usefulness and limitations of mRNA measurement in HepaRG cells for evaluation of cytochrome P450 induction","year":2020,"lang":"en","type":"article","venue":"Fundamental Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"Japan Agency for Medical Research and Development","keywords":"CYP2B6; CYP3A4; CYP1A2; Cytochrome P450; Pharmacology; Phenobarbital; Drug metabolism; Enzyme inducer; Messenger RNA; CYP2A6; Chemistry; Pregnane X receptor; Biology; Metabolism; Drug; Biochemistry; Enzyme; Transcription factor; Nuclear receptor","score_opus":0.6784075094608037,"score_gpt":0.4833525181894373,"score_spread":0.19505499127136644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000387542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595237,0.00071476086,0.000079874975,0.0009337764,0.00031228486,0.0009136157,0.000055637545,0.000010810733,0.001026843],"genre_scores_gemma":[0.9984211,0.00024686827,0.00057843426,0.0005400333,0.00007439326,0.00012758053,0.000003877074,0.0000039827273,0.0000037596274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809396,0.0004324982,0.00041397923,0.00030244124,0.000520943,0.00023616859],"domain_scores_gemma":[0.99902856,0.0003999919,0.00020194962,0.000045756864,0.000177493,0.0001462261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002973958,0.000119461016,0.00025252588,0.00008325978,0.00014192179,0.000013006609,0.00019424527,0.00012919298,0.0002193324],"category_scores_gemma":[0.0005083372,0.00009858318,0.000057949364,0.0004050907,0.00054785016,0.00011245571,0.00007670684,0.00015531448,0.0000028313743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001481611,0.00040786894,0.0026864219,0.000033964778,0.000026410611,4.483055e-7,0.0008066832,0.004110494,0.9606952,0.0007042619,0.000105010695,0.03027507],"study_design_scores_gemma":[0.003468351,0.0011715698,0.059096772,0.000015063693,0.00018549485,0.0000018609256,0.0010392342,0.03685018,0.88926977,0.0024781136,0.006223901,0.00019967902],"about_ca_topic_score_codex":0.0000059577924,"about_ca_topic_score_gemma":0.000018620563,"teacher_disagreement_score":0.07142543,"about_ca_system_score_codex":0.000063439635,"about_ca_system_score_gemma":0.00013247362,"threshold_uncertainty_score":0.40201056},"labels":[],"label_agreement":null},{"id":"W3005677121","doi":"10.1021/acs.biochem.0c00027","title":"Biophysical Techniques for Distinguishing Ligand Binding Modes in Cytochrome P450 Monooxygenases","year":2020,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Australian Research Council; Natural Sciences and Engineering Research Council of Canada; University of Queensland; Rhodes Scholarships; Australian Government; Australian Nuclear Science and Technology Organisation","keywords":"Monooxygenase; Cytochrome P450; Ligand (biochemistry); Chemistry; Cytochrome; Biochemistry; Computational biology; Biology; Receptor; Enzyme","score_opus":0.13157680225465865,"score_gpt":0.42940708549799006,"score_spread":0.2978302832433314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005677121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953837,0.0007434268,0.00029653325,0.0009636461,0.00010432547,0.00036912123,0.00030226918,0.00015237405,0.0016846105],"genre_scores_gemma":[0.9956705,0.00015561427,0.0013674755,0.0012479882,0.0011851157,0.00014393611,0.00007581719,0.000035349763,0.0001181936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986423,0.000050157974,0.00032502032,0.00044034206,0.00010923597,0.00043293636],"domain_scores_gemma":[0.9992194,0.00019603579,0.00010675369,0.00012827778,0.000056177494,0.00029332878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002343938,0.00024353937,0.00030640647,0.000044437144,0.00013667141,0.00003703593,0.00032106382,0.00027408503,0.00005260563],"category_scores_gemma":[0.00029024165,0.00025224753,0.00012403738,0.00021475024,0.00010903871,0.000053583888,0.00012373501,0.00043056684,0.000015217467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016519325,0.00013198044,0.0005229534,0.00017153211,0.000039669812,0.000021707865,0.00023095187,0.00004426074,0.99190754,0.000079728874,0.0019694145,0.004715064],"study_design_scores_gemma":[0.00080817257,0.000035559824,0.00012068459,0.000025313808,0.000057787176,0.000003950069,0.0000936994,0.007759377,0.96928835,0.00013521005,0.021378372,0.00029354173],"about_ca_topic_score_codex":0.0000064932237,"about_ca_topic_score_gemma":4.8426466e-7,"teacher_disagreement_score":0.02261921,"about_ca_system_score_codex":0.000043424516,"about_ca_system_score_gemma":0.000078041776,"threshold_uncertainty_score":0.99999297},"labels":[],"label_agreement":null},{"id":"W3006091015","doi":"10.1038/s41416-019-0722-0","title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Context (archaeology); Cancer; Drug; Drug resistance; Pharmacology; Pharmacogenomics; Medicine; Cancer research; Biology; Internal medicine; Genetics","score_opus":0.09272287703452319,"score_gpt":0.4991450429838892,"score_spread":0.406422165949366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006091015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072545843,0.9949437,0.000025498211,0.0006774066,0.001875953,0.0008439034,0.00078072934,0.000012437766,0.00011493638],"genre_scores_gemma":[0.00027903073,0.99667776,0.00025630175,0.0004692147,0.0015989164,0.00034545086,0.000012467652,0.0000784117,0.00028243876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726295,0.00049693557,0.001169039,0.00037169294,0.00024132259,0.00045804615],"domain_scores_gemma":[0.9982661,0.0003375085,0.00078032096,0.00007221204,0.0001995772,0.0003442636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000771389,0.000383407,0.0017134438,0.00019035436,0.00016701715,0.00007186418,0.00038891713,0.00029557524,0.00027154406],"category_scores_gemma":[0.00008029027,0.00038661162,0.00041353793,0.0002747356,0.00012848311,0.00013738776,0.000056634643,0.0014182702,0.0000011461279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020295051,0.00008159099,0.00005766025,0.0059544644,0.00037457916,0.000333131,0.00019688177,0.000028039472,0.000056936125,0.000022913204,0.0065695792,0.9861213],"study_design_scores_gemma":[0.0017868945,0.000022141892,0.000020204707,0.014883778,0.0017208331,0.00015669622,0.00001949022,0.00002538141,0.0002838246,0.00008788341,0.98061204,0.00038080278],"about_ca_topic_score_codex":0.000046748853,"about_ca_topic_score_gemma":0.001004802,"teacher_disagreement_score":0.9857405,"about_ca_system_score_codex":0.00012740756,"about_ca_system_score_gemma":0.00079971825,"threshold_uncertainty_score":0.99985856},"labels":[],"label_agreement":null},{"id":"W3006140634","doi":"10.1177/0706743720904820","title":"Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada","year":2020,"lang":"en","type":"review","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; University of Alberta; University of Calgary","funders":"","keywords":"Pharmacogenetics; Test (biology); Medicine; Psychiatry; Genetic testing; Family medicine; Psychology; Genetics; Genotype; Biology; Internal medicine","score_opus":0.10031361901779591,"score_gpt":0.412269174999788,"score_spread":0.3119555559819921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006140634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053929235,0.9377397,0.000009183713,0.032112654,0.021483438,0.0012715604,0.0012537949,0.000019349962,0.0007174518],"genre_scores_gemma":[0.009620626,0.9605879,0.0053541497,0.015644414,0.008215989,0.000147282,0.000044047323,0.0002636655,0.00012189284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916756,0.0024574238,0.0026499208,0.000661706,0.00066033704,0.0018949842],"domain_scores_gemma":[0.992739,0.00084984687,0.0014494344,0.000496135,0.00037999603,0.004085562],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021265086,0.0010674687,0.0019826433,0.0007844056,0.00096992275,0.00009727962,0.0026165629,0.0004718921,0.0005657023],"category_scores_gemma":[0.0004860691,0.000906036,0.0005641576,0.0019319963,0.00015130997,0.00010460554,0.00013296642,0.004931545,0.00003960071],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00021218963,0.0003992725,0.05815306,0.0053981813,0.0032595037,0.001532235,0.0011797553,0.01349308,0.00007548048,0.0016135148,0.32711595,0.58756775],"study_design_scores_gemma":[0.0011519428,0.00008343383,0.0022782334,0.001981483,0.0032069597,0.0011586109,0.00019104083,0.0002671998,0.000009073777,0.00041433377,0.9883329,0.00092478463],"about_ca_topic_score_codex":0.988116,"about_ca_topic_score_gemma":0.99989927,"teacher_disagreement_score":0.6612169,"about_ca_system_score_codex":0.0064849,"about_ca_system_score_gemma":0.36185703,"threshold_uncertainty_score":0.99933904},"labels":[],"label_agreement":null},{"id":"W3006589437","doi":"10.1177/0840470419901285","title":"Pharmacogenetics in primary care","year":2020,"lang":"en","type":"article","venue":"Healthcare Management Forum","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Anxiety; Drug; Anxiolytic; Antidepressant; Drug response; Pharmacology; Psychiatry","score_opus":0.11664058369279952,"score_gpt":0.4256577123194398,"score_spread":0.30901712862664027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006589437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59821296,0.061997086,0.00067131984,0.110295825,0.006006902,0.0055609597,0.00052931916,0.00077759475,0.21594805],"genre_scores_gemma":[0.908328,0.0067222845,0.00072772725,0.08328438,0.00033533946,0.00014597889,0.00013455086,0.000057077472,0.00026463883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971332,0.00036529204,0.000587526,0.0006138022,0.000319615,0.0009805945],"domain_scores_gemma":[0.9988442,0.000051069852,0.00012721417,0.00023805155,0.00008048562,0.00065897586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028753243,0.00034194678,0.0003879134,0.00018944893,0.00020024394,0.000024792365,0.00051749655,0.00021096806,0.0004575346],"category_scores_gemma":[0.000008361795,0.00037363253,0.00012798123,0.00058298383,0.00007998074,0.000080699596,0.00041933,0.0008070856,0.00036335224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008805652,0.00035938952,0.11557661,0.003409755,0.0002679259,0.0007442377,0.0048016505,0.0022289616,0.0037554149,0.0076106396,0.02373821,0.83662665],"study_design_scores_gemma":[0.0039675813,0.00011897514,0.011712419,0.000030139205,0.00012473985,0.000004353281,0.0016949659,0.0017612401,0.0037756227,0.00027396163,0.9760686,0.00046736107],"about_ca_topic_score_codex":0.000024165407,"about_ca_topic_score_gemma":0.000025834679,"teacher_disagreement_score":0.9523304,"about_ca_system_score_codex":0.00016167398,"about_ca_system_score_gemma":0.00008386573,"threshold_uncertainty_score":0.99987155},"labels":[],"label_agreement":null},{"id":"W3006908109","doi":"10.1080/14636778.2020.1730165","title":"Clinical usefulness of genetic testing for drug toxicity in cancer care: decision-makers’ framing, knowledge and perceptions","year":2020,"lang":"en","type":"article","venue":"New Genetics and Society","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Framing (construction); Pharmacogenomics; Genetic testing; Perception; Ethnic group; Medicine; Pharmacogenetics; Drug; Context (archaeology); Risk perception; Psychology; Pharmacology; Political science; Internal medicine; Biology; Genetics","score_opus":0.17496592695984658,"score_gpt":0.47352497549923805,"score_spread":0.29855904853939147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006908109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709231,0.025676074,0.0016763344,0.00038665545,0.0005424198,0.00049550534,0.00014656286,0.000019012523,0.00013432612],"genre_scores_gemma":[0.966163,0.013557417,0.017729063,0.0017842518,0.0006473779,0.000039408034,0.0000055685923,0.000029233524,0.000044700464],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983631,0.00014781729,0.00058556156,0.00046021832,0.0001082313,0.00033510666],"domain_scores_gemma":[0.99818957,0.00092429883,0.0001403611,0.000120094635,0.0001626594,0.0004630267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041078788,0.00021587669,0.00041871142,0.000028742448,0.0002000094,0.000020879543,0.00018129275,0.0003034574,0.00007528393],"category_scores_gemma":[0.00014944983,0.00021838203,0.00015849549,0.00022926922,0.00025469222,0.000026978863,0.00019021805,0.00047016004,0.0000017535219],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007972465,0.00018328136,0.38058463,0.00025133454,0.00011655051,0.0000017934791,0.026420634,0.001042657,0.016058924,0.000057274818,0.0064777094,0.56872547],"study_design_scores_gemma":[0.010151653,0.00042911532,0.671775,0.00009296888,0.00077328284,0.000005529862,0.0043478566,0.11893383,0.010689016,0.0014291446,0.18052359,0.0008490578],"about_ca_topic_score_codex":0.00003977691,"about_ca_topic_score_gemma":0.00006925428,"teacher_disagreement_score":0.5678764,"about_ca_system_score_codex":0.000021899266,"about_ca_system_score_gemma":0.00027519435,"threshold_uncertainty_score":0.89053607},"labels":[],"label_agreement":null},{"id":"W3007489417","doi":"10.1111/bcp.14247","title":"<i>CYP2D6</i> polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Université de Montréal","keywords":"Metoprolol; CYP2D6; Bradycardia; Medicine; Meta-analysis; Internal medicine; Blood pressure; Pharmacogenetics; Heart rate; Adverse effect; Cardiology; Pharmacology; Anesthesia; Genotype; Biology","score_opus":0.37394947863201966,"score_gpt":0.5991300640097504,"score_spread":0.22518058537773078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007489417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059366185,0.9800524,0.000009663522,0.011690062,0.0021314383,0.0045208586,0.00089938514,0.000031946773,0.00007058759],"genre_scores_gemma":[0.0010279809,0.9267722,0.000059145154,0.07000535,0.0014533731,0.0003070903,0.000009254584,0.0001057635,0.0002598533],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9511543,0.038266,0.008036227,0.0011017227,0.0005971878,0.0008445685],"domain_scores_gemma":[0.9618852,0.029448524,0.005167517,0.0004125356,0.00059596356,0.0024902627],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0357918,0.0011230006,0.019967359,0.00051379274,0.00033882353,0.000120737976,0.001664222,0.0012892386,0.0023529283],"category_scores_gemma":[0.007846426,0.00071824907,0.008540457,0.0014050034,0.000576605,0.00012788041,0.0006725526,0.007449419,0.00016397181],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029964237,0.0013061984,0.000007122388,0.12980232,0.69511795,0.0050856746,0.00007050204,0.000021736878,0.000012574421,0.000047499256,0.07224672,0.093285255],"study_design_scores_gemma":[0.0010613716,0.0006766442,0.000015370417,0.0031847828,0.54273236,0.0021597384,0.000003471762,0.00003103404,0.0000032619323,0.000020642645,0.44971302,0.00039828927],"about_ca_topic_score_codex":0.0000054713378,"about_ca_topic_score_gemma":0.0000022240015,"teacher_disagreement_score":0.3774663,"about_ca_system_score_codex":0.00006274485,"about_ca_system_score_gemma":0.0010294361,"threshold_uncertainty_score":0.99952686},"labels":[],"label_agreement":null},{"id":"W3011648141","doi":"10.3138/jmvfh.2019-0027","title":"Pharmacogenomics: A primer for the military mental health provider","year":2020,"lang":"en","type":"article","venue":"Journal of Military Veteran and Family Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Canadian Armed Forces","funders":"","keywords":"Pharmacogenomics; Relevance (law); Mental health; Medicine; Data science; Pharmacology; Psychiatry; Computer science; Political science","score_opus":0.16024178068494263,"score_gpt":0.44072059920449397,"score_spread":0.28047881851955137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011648141","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3835839,0.5144332,0.00078618067,0.09673293,0.002414135,0.0014494923,0.00052751374,0.000022742175,0.00004991389],"genre_scores_gemma":[0.54892224,0.19410442,0.0034347565,0.25118846,0.002177204,0.000030039517,0.000027568702,0.000057276695,0.00005804613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996956,0.0006786525,0.0011581656,0.0003175524,0.00025496588,0.00063466054],"domain_scores_gemma":[0.9978558,0.00042195956,0.0003573927,0.00014029675,0.00013624772,0.0010883384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023420989,0.00030498722,0.00067052577,0.00009369246,0.00065525284,0.0000073296437,0.00039996643,0.000104875915,0.00007529216],"category_scores_gemma":[0.000052939915,0.00021907972,0.0002975997,0.00014044724,0.00020270518,0.00015375874,0.00008734354,0.00091304246,0.000008106319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073307212,0.0006198354,0.001336571,0.00091399613,0.0012821241,0.000030917097,0.029280912,0.0008548844,0.051399447,0.00010042676,0.38079742,0.5260528],"study_design_scores_gemma":[0.007207178,0.0018823651,0.0036777896,0.000039054245,0.00016643149,0.00013699538,0.0018059304,0.015278751,0.0005082172,0.00012567335,0.96890926,0.000262376],"about_ca_topic_score_codex":0.00013195557,"about_ca_topic_score_gemma":0.000009019376,"teacher_disagreement_score":0.5881118,"about_ca_system_score_codex":0.000094794086,"about_ca_system_score_gemma":0.00074121775,"threshold_uncertainty_score":0.89338124},"labels":[],"label_agreement":null},{"id":"W3012205610","doi":"10.1007/s12035-020-01896-4","title":"Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice","year":2020,"lang":"en","type":"article","venue":"Molecular Neurobiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tyndale University; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs; Campbell Family Mental Health Research Institute; Centre for Addiction and Mental Health","keywords":"In vivo; Pharmacology; Haloperidol; In vitro; Human brain; Propranolol; Genetically modified mouse; Chemistry; Transgene; Biology; Endocrinology; Biochemistry; Neuroscience; Dopamine","score_opus":0.16822596292093672,"score_gpt":0.4152948120940846,"score_spread":0.24706884917314786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012205610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512775,0.0018086236,0.00028641458,0.010391289,0.0009699777,0.0005314817,0.00018149086,0.00006570444,0.0006372589],"genre_scores_gemma":[0.94083947,0.00023684108,0.00008739046,0.058262166,0.0002866781,0.00006789375,0.00004929648,0.000047962127,0.00012229991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99596953,0.0015986313,0.00068316853,0.0009345402,0.00014209723,0.0006720369],"domain_scores_gemma":[0.99882287,0.00045642172,0.00014384276,0.00024102189,0.00005563846,0.00028023153],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004415539,0.00039064744,0.000569864,0.0001989991,0.00010967681,0.000018137887,0.0005565636,0.00046336144,0.00420101],"category_scores_gemma":[0.0001534702,0.00043155908,0.00019890495,0.00048361692,0.00021385637,0.00008595617,0.00016932846,0.0013258278,0.00020630789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043380796,0.00018274818,0.005660644,0.000020262707,0.00008251673,0.00021693656,0.0013139554,0.0014078311,0.9848473,0.00020860485,0.0051514413,0.0004739324],"study_design_scores_gemma":[0.007854501,0.000317428,0.021611849,0.000029658806,0.0001757534,0.000018185334,0.000061560226,0.0034411687,0.85793215,0.0011295156,0.10666417,0.00076403585],"about_ca_topic_score_codex":0.00015314601,"about_ca_topic_score_gemma":0.00012828376,"teacher_disagreement_score":0.12691514,"about_ca_system_score_codex":0.000045679146,"about_ca_system_score_gemma":0.000100259225,"threshold_uncertainty_score":0.9998136},"labels":[],"label_agreement":null},{"id":"W3012279685","doi":"10.15252/emmm.201911621","title":"Targeting the pregnane X receptor using microbial metabolite mimicry","year":2020,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Congressionally Directed Medical Research Programs; National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Army; Albert Einstein College of Medicine, Yeshiva University; National Cancer Institute; National Institutes of Health; Crohn's and Colitis Canada; Crohn's and Colitis Foundation of America","keywords":"Czech; Library science; Biology; Computer science; Philosophy","score_opus":0.10456797980695445,"score_gpt":0.4044294633954899,"score_spread":0.2998614835885355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012279685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8633874,0.07411853,0.006621961,0.044827543,0.0054839957,0.0012274466,0.000109358516,0.000206354,0.0040173805],"genre_scores_gemma":[0.916419,0.0018534438,0.001951197,0.07564969,0.003676278,0.0000302902,0.00010143959,0.0000949023,0.00022371768],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722934,0.00081186934,0.00055629894,0.00047895045,0.00030819944,0.00061535137],"domain_scores_gemma":[0.99874645,0.00015896339,0.00021713937,0.0002503595,0.00013667252,0.0004903909],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088783127,0.00035493626,0.00048706395,0.000069958965,0.00032269966,0.000018074,0.0005759103,0.00020936607,0.002162451],"category_scores_gemma":[0.00035400921,0.00025186004,0.00014791054,0.00045899965,0.00040521164,0.00005914205,0.00020492414,0.0009830057,0.00014532155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013138977,0.000051596835,0.000103518156,0.000043544842,0.00024319733,0.00007558091,0.0019565204,0.0015763589,0.9778773,0.00046698513,0.013026062,0.0044479496],"study_design_scores_gemma":[0.0018851742,0.000053046264,0.00003042901,0.000021092443,0.0005365504,0.000021251504,0.00016877046,0.007464013,0.3965856,0.00008874373,0.5928988,0.00024652242],"about_ca_topic_score_codex":0.000022352751,"about_ca_topic_score_gemma":2.8909378e-7,"teacher_disagreement_score":0.5812917,"about_ca_system_score_codex":0.000026090567,"about_ca_system_score_gemma":0.00009670216,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W3016652892","doi":"10.1016/j.psychres.2020.112984","title":"Impact of CYP2C19 genotype-predicted enzyme activity on hippocampal volume, anxiety, and depression","year":2020,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Health and Medical Research Council; Australian Research Council","keywords":"CYP2C19; Anxiety; Hippocampal formation; Depression (economics); Genotype; Psychology; Clinical psychology; Internal medicine; Psychiatry; Medicine; Endocrinology; Gene; Biology; Genetics","score_opus":0.17228816830969082,"score_gpt":0.49961777235544796,"score_spread":0.32732960404575717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016652892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887141,0.0026743873,0.000049993516,0.0022344727,0.0009038599,0.0005351121,0.00031290695,0.000062660205,0.0045124977],"genre_scores_gemma":[0.99640834,0.0015993709,0.00016144224,0.0005416952,0.001082089,0.000031095216,0.000018336841,0.00004016187,0.00011749461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664485,0.0011896904,0.0003113891,0.00057118724,0.0005604705,0.00072242535],"domain_scores_gemma":[0.998228,0.00026588727,0.00011450023,0.00030060462,0.00026479593,0.0008262256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001212037,0.00025919097,0.00036700672,0.00020343268,0.0003212269,0.00002896761,0.00044714194,0.0003547518,0.0015686286],"category_scores_gemma":[0.00022810712,0.00022246916,0.00016984895,0.0006461591,0.0003214472,0.000092124894,0.0003149455,0.0018396201,0.00012464494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003671947,0.0007406587,0.6809923,0.000117444164,0.0002932829,0.0000078027815,0.00058799033,0.0004116276,0.21643698,0.000096042786,0.043006156,0.053637754],"study_design_scores_gemma":[0.0053983764,0.0013673401,0.8805304,0.000033621043,0.0001754172,0.00001844401,0.00010308371,0.035328407,0.0363949,0.0010409415,0.039101537,0.0005075304],"about_ca_topic_score_codex":0.000078263736,"about_ca_topic_score_gemma":0.0000062874497,"teacher_disagreement_score":0.19953808,"about_ca_system_score_codex":0.000040978062,"about_ca_system_score_gemma":0.0003545383,"threshold_uncertainty_score":0.99934405},"labels":[],"label_agreement":null},{"id":"W3020879553","doi":"10.3389/fphar.2020.00486","title":"Long-Distance Phasing of a Tentative “Enhancer” Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions","year":2020,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institutes of Health","keywords":"Enhancer; Genetics; Single-nucleotide polymorphism; Biology; SNP; Locus (genetics); Haplotype; Allele; Tag SNP; Population; Computational biology; Gene; Genotype; Gene expression; Medicine","score_opus":0.11491076875049118,"score_gpt":0.3730680697910477,"score_spread":0.2581573010405565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020879553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94360536,0.019597849,0.019370683,0.00421047,0.00453396,0.001364382,0.00055556983,0.00016990473,0.006591824],"genre_scores_gemma":[0.9800928,0.0041094134,0.008012899,0.0068230038,0.0005520167,0.00014398055,0.00005211278,0.0000820407,0.00013173877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99643356,0.0007683745,0.00084257056,0.0007321649,0.0002938229,0.00092954026],"domain_scores_gemma":[0.998361,0.0002470816,0.00048823992,0.00018273739,0.00018479799,0.0005361327],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035811623,0.000486343,0.00090055703,0.0003180664,0.00020163108,0.000016865606,0.0005802123,0.0002869387,0.0019246851],"category_scores_gemma":[0.000046545392,0.000494013,0.00016766215,0.00090938876,0.0008594634,0.00022928408,0.00014439925,0.0011469222,0.000053156036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007755399,0.0031000127,0.03363923,0.000349246,0.002047275,0.0011151537,0.012028381,0.0047531757,0.80711895,0.0005985461,0.09415584,0.033338763],"study_design_scores_gemma":[0.023337904,0.0013361893,0.003032022,0.00007548172,0.0016506148,0.00006961874,0.0019316582,0.026932951,0.7512364,0.0010803702,0.18781479,0.0015020317],"about_ca_topic_score_codex":0.000024775909,"about_ca_topic_score_gemma":0.000018135568,"teacher_disagreement_score":0.09365894,"about_ca_system_score_codex":0.00015345658,"about_ca_system_score_gemma":0.00015882245,"threshold_uncertainty_score":0.99975115},"labels":[],"label_agreement":null},{"id":"W3021250665","doi":"","title":"Comparative toxicoproteogenomics of mouse and rat liver identifies TCDD-resistance genes","year":2019,"lang":"en","type":"article","venue":"STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Aryl hydrocarbon receptor; Transcriptome; Gene; Biology; Gene isoform; Tetrachlorodibenzo-p-dioxin; Toxicity; Phenotype; Messenger RNA; Downregulation and upregulation; Genetically modified mouse; Gene expression; Internal medicine; Endocrinology; Transgene; Genetics; Molecular biology; Transcription factor; Medicine","score_opus":0.08456387764815469,"score_gpt":0.3882592447484522,"score_spread":0.3036953671002975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021250665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593699,0.02500082,0.0001317651,0.00026627045,0.0017895276,0.0012752844,0.00050763163,0.00009994314,0.011558851],"genre_scores_gemma":[0.96762824,0.0054605,0.0010591369,0.0010062344,0.00034885027,0.00008560243,0.00011451388,0.000081385995,0.024215506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99603707,0.00066006737,0.0010552624,0.00093576463,0.00048599698,0.00082585675],"domain_scores_gemma":[0.9974522,0.0005485223,0.0005947087,0.00060098077,0.00036417542,0.0004393922],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001149924,0.0006647149,0.0011405768,0.00030732976,0.00032233837,0.00007725499,0.0007180706,0.00046485473,0.001728584],"category_scores_gemma":[0.00004138659,0.00067188125,0.00026001036,0.0003835365,0.00073168305,0.00024576666,0.00034809692,0.0009841804,0.0005640503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013328408,0.0006456805,0.009944615,0.00054210686,0.00065955904,0.00006163674,0.0029740199,0.0007525357,0.9676979,0.0065519223,0.005883602,0.0029535512],"study_design_scores_gemma":[0.0035949915,0.00016350746,0.0032002938,0.00005574228,0.00035919156,0.000033739772,0.00042733882,0.002738006,0.6315713,0.001239353,0.35564613,0.0009704176],"about_ca_topic_score_codex":0.00005165816,"about_ca_topic_score_gemma":0.00016298496,"teacher_disagreement_score":0.34976253,"about_ca_system_score_codex":0.00009082744,"about_ca_system_score_gemma":0.00022692456,"threshold_uncertainty_score":0.99957323},"labels":[],"label_agreement":null},{"id":"W3022842031","doi":"10.1016/j.jsbmb.2020.105686","title":"Using Omics to better understand steroid biosynthesis, metabolism, and functions","year":2020,"lang":"en","type":"editorial","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fondation CHU de Québec","keywords":"Biosynthesis; Steroid biosynthesis; Steroid; Computational biology; Biology; Metabolism; Steroid Metabolism; Biochemistry; Bioinformatics; Hormone; Gene","score_opus":0.062186974622596716,"score_gpt":0.39560630952035375,"score_spread":0.33341933489775705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022842031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74110144,0.04341406,0.0039015876,0.00401146,0.20578323,0.00039605531,0.0012183246,0.000019817564,0.00015399588],"genre_scores_gemma":[0.50587505,0.024328794,0.0026971318,0.012916144,0.45344228,0.000013522867,0.00021621108,0.00022074161,0.00029015998],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765134,0.0006412056,0.0006798234,0.00037811694,0.00021964143,0.00042984524],"domain_scores_gemma":[0.9978553,0.00056951336,0.00059351954,0.0002377524,0.00024997245,0.00049396453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009856204,0.00047756397,0.0007688972,0.00012787766,0.00026940377,0.000051002567,0.0005059171,0.001054669,0.000038584712],"category_scores_gemma":[0.00028358088,0.00035348436,0.00016608181,0.00014857948,0.00049365254,0.000038277063,0.000392022,0.0017778348,0.000003951701],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079133175,0.00004884769,0.000019102423,0.0000955582,0.000803685,0.000035497476,0.00026923252,0.000022969964,0.923673,0.000008281092,0.071519345,0.0027131538],"study_design_scores_gemma":[0.0011409104,0.00014209365,0.000004223741,0.000030494355,0.0016934304,0.00014288149,0.00022023772,0.000042247102,0.3963551,0.00023346489,0.59968007,0.00031487047],"about_ca_topic_score_codex":0.0000056927925,"about_ca_topic_score_gemma":9.4918846e-7,"teacher_disagreement_score":0.5281607,"about_ca_system_score_codex":0.00004619728,"about_ca_system_score_gemma":0.00024129408,"threshold_uncertainty_score":0.9998917},"labels":[],"label_agreement":null},{"id":"W3023714932","doi":"10.1101/2020.05.10.087312","title":"Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Excellence Research Chairs, Government of Canada; Chan Zuckerberg Initiative; National Institutes of Health; National Science Foundation","keywords":"Vitamin K epoxide reductase; Biology; Missense mutation; Transmembrane domain; Genetics; Gene; Mutation","score_opus":0.08666435947309521,"score_gpt":0.36695506831533015,"score_spread":0.28029070884223495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023714932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906415,0.0035761357,0.00039661088,0.000596248,0.0012289643,0.0014225406,0.0019606045,0.00014848399,0.00002893113],"genre_scores_gemma":[0.99585336,0.0015590598,0.001330758,0.00045671247,0.0005221311,0.00016149976,9.921054e-7,0.000112084745,0.0000034077448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995293,0.0013397296,0.0007722863,0.0013593534,0.0004430725,0.0007925479],"domain_scores_gemma":[0.9965627,0.0002709855,0.00096429675,0.000723807,0.0006249989,0.00085319864],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0022138234,0.0008708424,0.0013634271,0.00025831535,0.00042244224,0.00008527091,0.00049826753,0.0010085838,0.0001554573],"category_scores_gemma":[0.00040509793,0.00088299764,0.00022802311,0.00031659644,0.00059531955,0.00014997572,0.0010203377,0.002356319,0.00001198297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055738084,0.0004381781,0.006316886,0.0005828326,0.0011937456,0.0001619216,0.00012793038,0.0000975904,0.9896595,0.00060377666,0.00021041748,0.00004986152],"study_design_scores_gemma":[0.0027419084,0.00018074442,0.29362848,0.00014803102,0.0010084162,4.235264e-7,0.0000050458607,0.0013601957,0.6963138,0.000043322787,0.0036570632,0.0009125786],"about_ca_topic_score_codex":0.00028461777,"about_ca_topic_score_gemma":0.000010795059,"teacher_disagreement_score":0.2933457,"about_ca_system_score_codex":0.00024355666,"about_ca_system_score_gemma":0.00055236067,"threshold_uncertainty_score":0.9999453},"labels":[],"label_agreement":null},{"id":"W3023817465","doi":"10.1042/bsr20192513","title":"The role of cytochrome P450 gene rs1126742 polymorphism and risk of hypertension: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Bioscience Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Odds ratio; Genetic model; Allele; Confidence interval; Genetics; Publication bias; Heterozygote advantage; Medicine; Subgroup analysis; Internal medicine; Locus (genetics); Polymorphism (computer science); Gene polymorphism; Gene; Bioinformatics; Biology","score_opus":0.18813047877802302,"score_gpt":0.4244418584599765,"score_spread":0.23631137968195348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023817465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009979922,0.99712664,0.0000065153754,0.00013570103,0.0001320906,0.0021147323,0.0002630743,0.000015521982,0.000105906445],"genre_scores_gemma":[0.0018664582,0.9973483,0.00010636002,0.00028123602,0.000034940105,0.00021138572,0.000009413399,0.000023597859,0.000118276075],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.994642,0.0015139054,0.0022339162,0.00076993677,0.0004742856,0.00036594196],"domain_scores_gemma":[0.9941774,0.00079948595,0.0036644964,0.00077784917,0.00021371704,0.0003670656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039657103,0.0005180521,0.006758228,0.00022299263,0.00029767834,0.000028569519,0.00045404173,0.00028557377,0.00008705643],"category_scores_gemma":[0.0007413359,0.0002799401,0.0015966764,0.0013628309,0.00076744746,0.000055818666,0.00037458667,0.0004932226,0.0000031371085],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015311953,0.0002945333,0.00006631389,0.6326818,0.28078625,0.00068510545,0.0002279781,0.000004600948,0.0041086716,0.00024788998,0.00023081613,0.08065077],"study_design_scores_gemma":[0.00005051673,0.000026353298,0.000012988929,0.0011862502,0.74352235,0.0008871753,0.0000090353005,0.00005443586,0.00034646844,0.00005983609,0.2536053,0.00023929698],"about_ca_topic_score_codex":0.000031773896,"about_ca_topic_score_gemma":0.000002638984,"teacher_disagreement_score":0.63149554,"about_ca_system_score_codex":0.000017671506,"about_ca_system_score_gemma":0.00030411143,"threshold_uncertainty_score":0.99996525},"labels":[],"label_agreement":null},{"id":"W3023996685","doi":"10.1177/0706743720925735","title":"Re: Pharmacogenetic Testing Options Relevant to Psychiatry in Canada","year":2020,"lang":"en","type":"letter","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Psychiatry; Psychology; Medicine; Biology; Genetics; Genotype","score_opus":0.09554306668559955,"score_gpt":0.3633850709704804,"score_spread":0.26784200428488086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023996685","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0122003425,0.016894916,0.0000069443654,0.9361273,0.031781476,0.0005859804,0.00054944213,0.000012190482,0.0018414289],"genre_scores_gemma":[0.037000816,0.00033448337,0.0035288741,0.94249904,0.016175,0.000027701863,0.000026575963,0.00013965438,0.0002678424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949869,0.0010865387,0.0015389482,0.00046985247,0.00058106525,0.0013366851],"domain_scores_gemma":[0.9961129,0.0004289607,0.000880553,0.00043797842,0.00034348233,0.0017961576],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010062594,0.00063228403,0.00082804594,0.00063052116,0.0006402091,0.00009185545,0.002021201,0.00055742863,0.0011426753],"category_scores_gemma":[0.00024142327,0.00054428837,0.00028394046,0.0011720987,0.00017009728,0.000064852284,0.000077169694,0.008916527,0.00010915228],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005530934,0.000021794927,0.019264765,0.00010217161,0.00029523557,0.0012106397,0.00024223034,0.004219676,0.00008160336,0.00008481222,0.97238326,0.0020385173],"study_design_scores_gemma":[0.001173159,0.00009566308,0.0016841701,0.00018438534,0.0007056344,0.00032269966,0.00022394003,0.00039814363,0.000063427855,0.0036051245,0.9909165,0.00062718295],"about_ca_topic_score_codex":0.61960423,"about_ca_topic_score_gemma":0.99515164,"teacher_disagreement_score":0.3755474,"about_ca_system_score_codex":0.0010343299,"about_ca_system_score_gemma":0.0647943,"threshold_uncertainty_score":0.9997704},"labels":[],"label_agreement":null},{"id":"W3026543144","doi":"10.1177/0706743720925736","title":"Reply to Dawes et al.","year":2020,"lang":"en","type":"letter","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; University of Alberta; University of Calgary","funders":"","keywords":"Materials science","score_opus":0.09014695755120856,"score_gpt":0.3997217685504358,"score_spread":0.30957481099922723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026543144","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072841614,0.008041818,0.00001829555,0.96224296,0.022877933,0.0002985884,0.00036529926,0.000013717528,0.005412984],"genre_scores_gemma":[0.0016910266,0.00039735573,0.0009832032,0.98409134,0.011494999,0.000008490272,0.000025181656,0.00008948876,0.0012188846],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99682975,0.0009677561,0.0007907276,0.00030379804,0.0003654948,0.00074245094],"domain_scores_gemma":[0.99714285,0.00020732496,0.00061592564,0.0003863851,0.00026496267,0.0013825474],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012606446,0.00040995752,0.0005710702,0.00038757172,0.0004886035,0.00011785775,0.0015779621,0.00044773723,0.0016675884],"category_scores_gemma":[0.00014546608,0.00031212633,0.000391932,0.0003566534,0.00021474686,0.00006260894,0.000055966982,0.007673457,0.0003935294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005485378,0.000012143543,0.0005895554,0.000027848733,0.00044240005,0.0007749702,0.00054602727,0.00013030271,0.00006578494,0.00052302866,0.9956023,0.0012308046],"study_design_scores_gemma":[0.00056334434,0.00011373832,0.0001384267,0.000045990368,0.0004901624,0.0003869991,0.000041117604,0.000014326539,0.000116486495,0.005686019,0.99206096,0.0003424334],"about_ca_topic_score_codex":0.0024327948,"about_ca_topic_score_gemma":0.01567436,"teacher_disagreement_score":0.021848422,"about_ca_system_score_codex":0.00011201777,"about_ca_system_score_gemma":0.006520973,"threshold_uncertainty_score":0.99993306},"labels":[],"label_agreement":null},{"id":"W3027175230","doi":"10.1016/j.jagp.2020.05.005","title":"Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression","year":2020,"lang":"en","type":"article","venue":"American Journal of Geriatric Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; Canadian Institutes of Health Research; Spier Family Foundation; Rogers Family Foundation; Eli Lilly and Company; Canadian Network for Mood and Anxiety Treatments; Assurex Health; Cerecor; ACADIA Pharmaceuticals; National Institutes of Health; Janssen Pharmaceuticals; Sage Therapeutics; H. Lundbeck A/S; Sunovion; Stanley Medical Research Institute; Agency for Healthcare Research and Quality; Sanofi; Novartis; Pfizer; Biogen; GlaxoSmithKline; Pharmaceuticals Bayer; Ontario Brain Institute; Forest Laboratories; Bristol-Myers Squibb; Allergan; AstraZeneca; Takeda Pharmaceutical Company; National Institute of Mental Health; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Major depressive disorder; Depression (economics); Randomized controlled trial; Hamilton Rating Scale for Depression; Pharmacogenomics; Rating scale; Psychiatry; Internal medicine; Physical therapy; Mood; Psychology; Pharmacology","score_opus":0.03469591506181165,"score_gpt":0.364599585868742,"score_spread":0.3299036708069304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027175230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98538065,0.002971308,0.0011093892,0.0027308976,0.0067656976,0.0005978232,0.000059828166,0.00004845648,0.00033595838],"genre_scores_gemma":[0.9797539,0.00022175908,0.011299802,0.005086239,0.003527843,0.00002800254,0.0000039941206,0.000068437395,0.000009982372],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99767256,0.0002621347,0.00085736584,0.00037259728,0.00029351615,0.00054184947],"domain_scores_gemma":[0.9967848,0.00052539055,0.0014486447,0.0001426272,0.00038764987,0.0007108824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000545149,0.0003726978,0.0007732365,0.00016834473,0.00023652818,0.000033524648,0.0005637957,0.0001109547,0.00008665736],"category_scores_gemma":[0.00015625937,0.0002833126,0.000293887,0.0006078659,0.00018270194,0.00016196498,0.00007223218,0.0007821715,0.000010645416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015008616,0.0012050334,0.3530203,0.00025540328,0.0015179437,0.00004856667,0.0021484494,0.00060604507,0.052258324,0.0001455922,0.0068012597,0.5669845],"study_design_scores_gemma":[0.2513086,0.024400704,0.41669953,0.0006732417,0.015922096,0.0020405538,0.010560567,0.024832543,0.06739531,0.0036837766,0.17532822,0.0071548685],"about_ca_topic_score_codex":0.000010212021,"about_ca_topic_score_gemma":4.8005035e-7,"teacher_disagreement_score":0.5598296,"about_ca_system_score_codex":0.000033183078,"about_ca_system_score_gemma":0.00047586337,"threshold_uncertainty_score":0.9999619},"labels":[],"label_agreement":null},{"id":"W3027359205","doi":"10.1093/toxsci/kfaa072","title":"Characterizations of Human UDP-Glucuronosyltransferase Enzymes in the Conjugation of p-Cresol","year":2020,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Glucuronidation; Glucuronide; Chemistry; Microsome; Enzyme; Biochemistry; Kidney; Metabolism; Pharmacology; Toxicity; Internal medicine; Endocrinology; Biology; Medicine","score_opus":0.3516262852390853,"score_gpt":0.48971780631628664,"score_spread":0.13809152107720135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027359205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988939,0.0005029267,0.000116133284,0.004565455,0.00012905747,0.00035826227,0.000057362617,0.000016790307,0.0053150193],"genre_scores_gemma":[0.99580324,0.00017967958,0.000084675645,0.0037960848,0.00008898616,0.000025721083,0.000008463099,0.000003199964,0.000009930862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824375,0.0006133002,0.0004432977,0.00022818177,0.0002278035,0.00024368077],"domain_scores_gemma":[0.9991841,0.0004387131,0.00015071692,0.00007584238,0.000046320674,0.00010434221],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001036319,0.00011552344,0.00025018997,0.00006154089,0.00018454158,0.000012600577,0.0005947213,0.00012100835,0.0012420854],"category_scores_gemma":[0.00017154278,0.00007429925,0.00007197186,0.00064354413,0.0008704243,0.00008375971,0.000051359224,0.0002760481,0.00000983603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006293777,0.00044438345,0.016098239,0.000023989911,0.000014325686,0.000005772554,0.0023732448,0.0008281562,0.92636704,0.049959593,0.00018120035,0.0036411376],"study_design_scores_gemma":[0.0014053104,0.0010618747,0.09946487,0.000009733239,0.000082746425,0.0000032858427,0.0006962382,0.0049167066,0.87531286,0.0020374774,0.014784199,0.00022470622],"about_ca_topic_score_codex":0.000010096831,"about_ca_topic_score_gemma":0.0000065454924,"teacher_disagreement_score":0.08336663,"about_ca_system_score_codex":0.0000057980133,"about_ca_system_score_gemma":0.00005653163,"threshold_uncertainty_score":0.9996709},"labels":[],"label_agreement":null},{"id":"W3027368206","doi":"","title":"Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation","year":2010,"lang":"en","type":"article","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Medicine; Clinical trial; Translational research; Pharmacoepidemiology; Observational study; Family medicine; Pharmacology; Internal medicine; Pathology","score_opus":0.467392606563946,"score_gpt":0.5979599769176936,"score_spread":0.13056737035374766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027368206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670957,0.0023826412,0.00024416373,0.014119145,0.0034265972,0.0010977297,0.00017869294,0.00016080689,0.011294522],"genre_scores_gemma":[0.969299,0.003732453,0.003856024,0.020041741,0.0016310932,0.00034333116,0.000021684276,0.00007025982,0.001004418],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595624,0.0011413022,0.0006316044,0.0007902282,0.00027702027,0.0012036284],"domain_scores_gemma":[0.9972102,0.0011998507,0.000112674534,0.00024599128,0.00031234996,0.0009189244],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006103658,0.00036658108,0.00041444463,0.00041854315,0.00076625834,0.000071965245,0.0004940566,0.00040917448,0.0051511955],"category_scores_gemma":[0.00020260306,0.00034886476,0.00010184748,0.00059059093,0.0003266734,0.00018646884,0.00024917448,0.0027532286,0.00028051448],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027894453,0.00009117625,0.0040135155,0.000026024458,0.0001178041,0.000014497254,0.00093223917,0.0003255309,0.73242134,0.00055500516,0.018015597,0.2432083],"study_design_scores_gemma":[0.0015856555,0.000037026944,0.0011076675,0.000004305982,0.00011881426,0.000020990265,0.0000694708,0.01280654,0.29908434,0.0004809531,0.68434113,0.00034311158],"about_ca_topic_score_codex":0.00015224307,"about_ca_topic_score_gemma":0.00014913213,"teacher_disagreement_score":0.66632557,"about_ca_system_score_codex":0.000039890358,"about_ca_system_score_gemma":0.00020073647,"threshold_uncertainty_score":0.99989635},"labels":[],"label_agreement":null},{"id":"W3029249331","doi":"10.1007/s12687-020-00468-2","title":"The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunities","year":2020,"lang":"en","type":"article","venue":"Journal of Community Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"St. George's, University of London; University of Cambridge","keywords":"Pharmacogenomics; Thematic analysis; Qualitative research; Medicine; Health informatics; Mainstream; Workforce; Health care; Public health; Nursing; Pharmacology; Sociology; Political science; Social science","score_opus":0.5173418183743203,"score_gpt":0.5481457331617672,"score_spread":0.03080391478744693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029249331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93895566,0.051940292,0.000043580796,0.007854248,0.0006097188,0.00030787682,0.000030294592,0.0000072906278,0.00025101347],"genre_scores_gemma":[0.807807,0.18997861,0.0004379427,0.0014429903,0.00029215333,0.000012868084,0.00000217067,0.000020031915,0.000006188927],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9927706,0.0056223297,0.0009325272,0.00009156014,0.0003306294,0.00025233996],"domain_scores_gemma":[0.9961474,0.0016108974,0.00096624595,0.00019218384,0.00063806504,0.00044523305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047427677,0.00021515685,0.00040010098,0.00009365287,0.00064339105,0.000037072194,0.00058414123,0.00007460958,0.0000625424],"category_scores_gemma":[0.00025840342,0.00017773779,0.00010243326,0.00009736432,0.0002941705,0.00018370761,0.0003371691,0.001258408,0.0000010234561],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007445696,0.00027130925,0.00031327916,0.00006829053,0.0012217264,0.00002283656,0.6984455,0.0003054145,0.026186079,0.0006981536,0.00055867614,0.27116418],"study_design_scores_gemma":[0.0032585636,0.0012913233,0.00061957457,0.000006639117,0.0008732865,0.000036461162,0.8057801,0.00022964373,0.035921726,0.0010082938,0.1507744,0.00019996245],"about_ca_topic_score_codex":0.000029453668,"about_ca_topic_score_gemma":0.00003218093,"teacher_disagreement_score":0.2709642,"about_ca_system_score_codex":0.000031681604,"about_ca_system_score_gemma":0.000258639,"threshold_uncertainty_score":0.7247937},"labels":[],"label_agreement":null},{"id":"W3034011777","doi":"10.18332/tid/122465","title":"Cytochrome P450 2A6 whole-gene deletion (&lt;i&gt;CYP2A6*4&lt;/i&gt; ) polymorphism reduces risk of lung cancer: A meta-analysis","year":2020,"lang":"en","type":"review","venue":"Tobacco Induced Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Internal medicine; Genetics; Gene; Oncology; Meta-analysis; CYP2A6; Polymorphism (computer science); Biology; Medicine; Demography; Genotype; Cytochrome P450","score_opus":0.17680851767499803,"score_gpt":0.44814765591339367,"score_spread":0.2713391382383956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034011777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012402815,0.9563946,0.000024680596,0.00033795583,0.0011335157,0.0023791906,0.026651198,0.00023668302,0.00043936766],"genre_scores_gemma":[0.029058734,0.96407986,0.000115282826,0.0005962026,0.001718308,0.001790619,0.0019685705,0.00023692197,0.00043549665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892438,0.0036776206,0.0027124756,0.001975152,0.0010571169,0.001333856],"domain_scores_gemma":[0.9924754,0.0010291769,0.0031389014,0.0012380423,0.00047497894,0.0016435051],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010230558,0.0019116771,0.0085535,0.0013535393,0.0005747993,0.00011348429,0.0018624683,0.0013907156,0.0055499645],"category_scores_gemma":[0.00030694375,0.0016389309,0.0072969017,0.0033518886,0.00041009308,0.00026333492,0.0005211592,0.0017674868,0.00023396572],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029579908,0.0012868774,0.00007439198,0.0032872746,0.4081651,0.00022364303,0.0002916802,0.00050898886,0.04003336,0.00022804619,0.0062454063,0.53935945],"study_design_scores_gemma":[0.0006464177,0.000062377854,0.00013723505,0.000101620106,0.47994098,0.00000951546,0.000005577501,0.00013581103,0.0012209702,0.000041308173,0.5167732,0.00092498946],"about_ca_topic_score_codex":0.000095849835,"about_ca_topic_score_gemma":0.000053292704,"teacher_disagreement_score":0.53843445,"about_ca_system_score_codex":0.0003235416,"about_ca_system_score_gemma":0.0018765726,"threshold_uncertainty_score":0.9999057},"labels":[],"label_agreement":null},{"id":"W3034513236","doi":"10.1101/2020.06.09.142851","title":"Combining small-molecule bioconjugation and hydrogen-deuterium exchange mass spectrometry (HDX-MS) to expose allostery: the case of human cytochrome P450 3A4","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada; Centre in Green Chemistry and Catalysis","keywords":"Allosteric regulation; Chemistry; Hydrogen–deuterium exchange; CYP3A4; Bioconjugation; Small molecule; Biophysics; Allosteric enzyme; Cytochrome P450; Mass spectrometry; Combinatorial chemistry; Enzyme; Biochemistry; Chromatography","score_opus":0.06919058215805077,"score_gpt":0.3384470058391087,"score_spread":0.26925642368105795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034513236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904242,0.0039810995,0.00050102506,0.001153048,0.0009624099,0.0019177903,0.0007768323,0.00020953151,0.00007402607],"genre_scores_gemma":[0.99386495,0.00075882586,0.0013982517,0.0025098145,0.0008907529,0.00038851195,0.0000029431087,0.00017781057,0.000008153268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957673,0.000890896,0.00096297846,0.001252104,0.00028885217,0.0008378756],"domain_scores_gemma":[0.99690086,0.00020687393,0.0007215506,0.0009938063,0.000363923,0.00081300375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014535632,0.00083815283,0.0010016023,0.00046989025,0.0004758459,0.00015755657,0.0009042108,0.00076987955,0.00023082705],"category_scores_gemma":[0.0001355776,0.0008272935,0.00024159103,0.00077229453,0.0003443985,0.00009651827,0.0013966665,0.0016928244,0.00005291642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001232317,0.00019521794,0.00056068087,0.00059969095,0.00059966353,0.0009960037,0.00025556277,0.000058147565,0.995744,0.00058908714,0.0002634661,0.000015253472],"study_design_scores_gemma":[0.0016583059,0.0002405791,0.005086809,0.000116998825,0.000795026,0.0000019867211,0.000024861485,0.0010950951,0.98479015,0.000024808603,0.005240845,0.00092453347],"about_ca_topic_score_codex":0.00008415513,"about_ca_topic_score_gemma":0.0000074474883,"teacher_disagreement_score":0.010953844,"about_ca_system_score_codex":0.00013554565,"about_ca_system_score_gemma":0.0002556042,"threshold_uncertainty_score":0.9994178},"labels":[],"label_agreement":null},{"id":"W3035156032","doi":"10.1016/j.jamda.2020.04.009","title":"Individualized Medication Management in Ontario Long-Term Care Clinical Impact on Management of Depression, Pain, and Dementia","year":2020,"lang":"en","type":"article","venue":"Journal of the American Medical Directors Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baycrest Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Pharmacogenetics; Depression (economics); Cohort; Medical prescription; Drug; Pharmacotherapy; Dementia; Polypharmacy; CYP2D6; CYP2C19; Prior authorization; Emergency medicine; Internal medicine; Psychiatry; Pharmacology","score_opus":0.05600816021249493,"score_gpt":0.44209309481351167,"score_spread":0.3860849346010167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035156032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543357,0.0010624425,0.00008110849,0.0019073139,0.00071222964,0.00025822656,0.0000087844055,0.0000068203117,0.0005295016],"genre_scores_gemma":[0.99271506,0.0032183938,0.0001816057,0.0036705008,0.00016558064,0.0000065779145,0.0000069219723,0.000011200247,0.000024143523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603426,0.0017509122,0.0009043218,0.0001782571,0.00090605917,0.00022621121],"domain_scores_gemma":[0.99726695,0.0005105589,0.0016423381,0.00010319321,0.00010785844,0.00036910002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037651255,0.00015053338,0.00048135014,0.00009456544,0.00006433048,0.000010384328,0.00039070947,0.00012688483,0.0002903343],"category_scores_gemma":[0.00042115265,0.00009998586,0.00021488732,0.00027656174,0.0001242414,0.00004390441,0.00015163756,0.0008832197,0.0000022458612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035002627,0.00021063813,0.78199095,0.000037301434,0.001093641,0.000027394908,0.0007121461,0.00005702006,0.00007327447,0.000008099808,0.0015932303,0.2138463],"study_design_scores_gemma":[0.002707617,0.00020452018,0.9908637,0.00010881568,0.0007295062,0.0000017999499,0.00014978732,0.000179042,0.00033521428,0.000029623825,0.0045973533,0.00009301067],"about_ca_topic_score_codex":0.00028742073,"about_ca_topic_score_gemma":0.00020964333,"teacher_disagreement_score":0.2137533,"about_ca_system_score_codex":0.00028359247,"about_ca_system_score_gemma":0.00013659766,"threshold_uncertainty_score":0.4077305},"labels":[],"label_agreement":null},{"id":"W3038374010","doi":"10.1007/978-3-030-21573-6_234-1","title":"Nuclear Receptor Regulation of Hepatic Cytochrome P450 Enzymes","year":2020,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytochrome P450; Chemistry; Enzyme; Biochemistry; Pharmacology; Biology","score_opus":0.10095984559260092,"score_gpt":0.37567926554553777,"score_spread":0.27471941995293686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038374010","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027947414,0.0042467657,0.000051496238,0.00124787,0.001409442,0.00089177664,0.00047744697,0.00021321815,0.98866725],"genre_scores_gemma":[0.28888977,0.007652942,0.00174342,0.0070940335,0.0024074153,0.000031478652,0.0004654574,0.00037984928,0.6913356],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782133,0.00014130183,0.00082140457,0.0005401216,0.00034629827,0.00032953185],"domain_scores_gemma":[0.9983447,0.0002077335,0.00054426317,0.00033773007,0.00018868413,0.00037684588],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033402635,0.0005172865,0.00083833165,0.0001946871,0.00012736273,0.000015663136,0.00044429058,0.0009273394,0.05481914],"category_scores_gemma":[0.000042137344,0.00051231607,0.00035386873,0.00006812318,0.0002855233,0.000068466186,0.0002105657,0.0010367096,0.0021452499],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041360845,0.00011520638,0.000016432363,0.0003234111,0.00087444513,0.000015257334,0.00042909398,0.00009498761,0.42125738,0.47112024,0.08446281,0.020877138],"study_design_scores_gemma":[0.00096765143,0.00011585573,0.0000919666,0.000044024684,0.0006263782,0.0000055714136,0.0000094029465,0.0012661179,0.049278967,0.009855016,0.9372325,0.000506564],"about_ca_topic_score_codex":0.000005762244,"about_ca_topic_score_gemma":0.0000020347486,"teacher_disagreement_score":0.8527697,"about_ca_system_score_codex":0.000055843517,"about_ca_system_score_gemma":0.00012786216,"threshold_uncertainty_score":0.99973285},"labels":[],"label_agreement":null},{"id":"W3044746939","doi":"10.1038/s41370-020-0252-0","title":"A feasibility study of metabolic phenotyping of dried blood spot specimens in rural Chinese women exposed to household air pollution","year":2020,"lang":"en","type":"article","venue":"Journal of Exposure Science & Environmental Epidemiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medical Research Council","keywords":"Dried blood spot; Dried blood; Pollution; Stove; Environmental science; Exposure assessment; Reproducibility; Air pollution; Medicine; Chromatography; Environmental chemistry; Physiology; Chemistry; Environmental health; Biology; Waste management","score_opus":0.1342770712506827,"score_gpt":0.4054807593360517,"score_spread":0.271203688085369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044746939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962052,0.0016084008,0.00004681564,0.000777417,0.0006222127,0.00061702693,0.000059032784,0.000007366465,0.000056529232],"genre_scores_gemma":[0.99640614,0.0003358797,0.00043858055,0.0025499729,0.000235369,0.000010191935,0.0000013251714,0.000016546495,0.0000060099837],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9948931,0.0015816591,0.0019950639,0.00042685054,0.0004104245,0.0006929508],"domain_scores_gemma":[0.997314,0.00041721723,0.0012566652,0.00026780678,0.000045705772,0.0006986215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069850525,0.0002908557,0.00132445,0.00038742129,0.0001275484,0.000003887817,0.0008604122,0.00016292723,0.00023951993],"category_scores_gemma":[0.0011489985,0.0002446735,0.00018890049,0.00078243174,0.00080262247,0.00024578377,0.00032693893,0.00075829815,0.0000055409646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091521436,0.0016431335,0.36718953,0.000009436008,0.00007898383,0.000016446063,0.0078018224,0.027205557,0.59383637,0.00004636822,0.00001095125,0.0012461992],"study_design_scores_gemma":[0.0059163356,0.0018199591,0.9141415,0.000010760432,0.00016618003,0.00004105801,0.0042494945,0.000404081,0.07230777,0.0003216914,0.00039410242,0.00022707655],"about_ca_topic_score_codex":0.000017197011,"about_ca_topic_score_gemma":0.000005665636,"teacher_disagreement_score":0.54695195,"about_ca_system_score_codex":0.00012796157,"about_ca_system_score_gemma":0.00013374939,"threshold_uncertainty_score":0.9977495},"labels":[],"label_agreement":null},{"id":"W3046490424","doi":"10.1038/s41525-020-0135-2","title":"A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping","year":2020,"lang":"en","type":"article","venue":"npj Genomic Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"National Research Foundation; GlaxoSmithKline","keywords":"Genotyping; Focus (optics); Allele; CYP2D6; Star (game theory); Algorithm; Biology; Genetics; Computational biology; Bioinformatics; Computer science; Genotype; Mathematics; Gene; Physics","score_opus":0.18967526254272118,"score_gpt":0.44300636623285133,"score_spread":0.2533311036901301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046490424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9253163,0.0397693,0.012837061,0.007156704,0.002877242,0.0036254635,0.0003016005,0.00029506796,0.007821299],"genre_scores_gemma":[0.9863814,0.0018344341,0.002769518,0.0074238055,0.0013110365,0.0000706356,0.000060089238,0.00007215742,0.00007693007],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9958804,0.0005134483,0.001923718,0.0004546789,0.0005379422,0.00068977743],"domain_scores_gemma":[0.9971563,0.0006307036,0.00088336546,0.00034097815,0.00020556655,0.0007830456],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013806346,0.0005068763,0.0015249049,0.00023656736,0.00022310851,0.0000127954945,0.00068686414,0.00027661122,0.001270145],"category_scores_gemma":[0.00031338926,0.0004246361,0.00019511838,0.0004220729,0.0002732602,0.000069407026,0.00016677073,0.0009712055,0.00031233844],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001095407,0.0005328398,0.0004698597,0.011576393,0.0019106969,0.00007589765,0.03427761,0.011843104,0.9034524,0.00084512716,0.00892762,0.024993021],"study_design_scores_gemma":[0.009919609,0.0010562715,0.00008657264,0.0009518222,0.0023850098,0.00003093334,0.0031462891,0.688243,0.25751814,0.00026337273,0.03556613,0.0008328889],"about_ca_topic_score_codex":0.00003046887,"about_ca_topic_score_gemma":0.000002542784,"teacher_disagreement_score":0.6763999,"about_ca_system_score_codex":0.00009889783,"about_ca_system_score_gemma":0.00015173429,"threshold_uncertainty_score":0.99982053},"labels":[],"label_agreement":null},{"id":"W3047024975","doi":"10.1007/s12035-020-02050-w","title":"Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice","year":2020,"lang":"en","type":"article","venue":"Molecular Neurobiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Tyndale University; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Harmine; Neurotoxicity; Pharmacology; Hypothermia; In vivo; Human brain; Chemistry; Genetically modified mouse; Biology; Toxicity; Transgene; Medicine; Biochemistry; Internal medicine; Neuroscience","score_opus":0.18703280579641907,"score_gpt":0.42570089714479065,"score_spread":0.23866809134837158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047024975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97195226,0.0008424435,0.0002681059,0.023080595,0.0006832564,0.0023368981,0.00016934349,0.000110024375,0.00055705965],"genre_scores_gemma":[0.86012685,0.00014272226,0.000046911864,0.13885899,0.00038217258,0.00031111998,0.000040327428,0.00006630303,0.000024575138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9926281,0.004362136,0.0007376297,0.0011859598,0.00023471942,0.00085147505],"domain_scores_gemma":[0.99809885,0.0007469646,0.00026546634,0.0004837098,0.0001036841,0.00030134275],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00076664303,0.0005785942,0.0006808725,0.00014896085,0.00032506287,0.000050056045,0.0014255801,0.00049914396,0.00044316344],"category_scores_gemma":[0.00038083186,0.00050301367,0.00032290784,0.0006349387,0.0002771588,0.00010785809,0.00024112423,0.0023083289,0.00018777345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003640252,0.00021747166,0.00032093516,0.00002685065,0.00014325154,0.0003525705,0.004773048,0.00024541636,0.9895676,0.00010147539,0.0017440696,0.002143304],"study_design_scores_gemma":[0.0042340015,0.00059768977,0.0030981682,0.000022605205,0.00025529737,0.000022859138,0.00014014763,0.0019904957,0.94597036,0.0005368167,0.042475034,0.00065652205],"about_ca_topic_score_codex":0.00010667293,"about_ca_topic_score_gemma":0.000035451998,"teacher_disagreement_score":0.1157784,"about_ca_system_score_codex":0.000036136702,"about_ca_system_score_gemma":0.000113802256,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W3047868292","doi":"10.1016/j.pharma.2020.07.005","title":"Recommandations relatives à la réalisation de tests de pharmacogénétique dans les monographies de médicaments au Canada, en France et aux États-Unis","year":2020,"lang":"fr","type":"article","venue":"Annales Pharmaceutiques Françaises","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Humanities; Art; Political science; Physics","score_opus":0.10284766326334145,"score_gpt":0.4308828317683743,"score_spread":0.32803516850503284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047868292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7885128,0.070287265,0.004326337,0.110202774,0.0016542665,0.0011107414,0.0023586773,0.00036879428,0.021178301],"genre_scores_gemma":[0.8269428,0.13123778,0.0021607429,0.035902783,0.0015133022,0.00028584682,0.0001898407,0.00016827401,0.0015986166],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.98839605,0.0069409306,0.0011750992,0.0009972837,0.0005371551,0.0019534873],"domain_scores_gemma":[0.9938039,0.0028395795,0.0006114277,0.00033961108,0.00039468848,0.0020107697],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023857388,0.0010743937,0.00088353903,0.00031172094,0.0019976362,0.00016466164,0.0011433302,0.00081852666,0.0026182323],"category_scores_gemma":[0.0006600343,0.0012830321,0.00044050644,0.0009874597,0.0018207853,0.000775366,0.00033612983,0.0034425694,0.00006437036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011823935,0.0017253194,0.32515103,0.0013130242,0.002894038,0.001009391,0.13775216,0.017031195,0.26931107,0.006054746,0.12748939,0.10908626],"study_design_scores_gemma":[0.0028543188,0.00011786645,0.040914625,0.00020714062,0.0012316749,0.00012388855,0.0011401647,0.020793961,0.16135143,0.0005369451,0.76971394,0.0010140619],"about_ca_topic_score_codex":0.13077468,"about_ca_topic_score_gemma":0.047585677,"teacher_disagreement_score":0.64222455,"about_ca_system_score_codex":0.0006417554,"about_ca_system_score_gemma":0.008079762,"threshold_uncertainty_score":0.9993016},"labels":[],"label_agreement":null},{"id":"W3048303536","doi":"10.3390/jpm10030084","title":"Optimising Seniors’ Metabolism of Medications and Avoiding Adverse Drug Events Using Data on How Metabolism by Their P450 Enzymes Varies with Ancestry and Drug–Drug and Drug–Drug–Gene Interactions","year":2020,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenomics; Polypharmacy; Medicine; Pharmacogenetics; Medical prescription; DrugBank; Drug; Drug metabolism; CYP2D6; Pharmacology; Intensive care medicine; Cytochrome P450; Bioinformatics; Biology; Internal medicine; Metabolism; Genetics","score_opus":0.1412766602688,"score_gpt":0.41645006034328985,"score_spread":0.27517340007448987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048303536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89235747,0.07591343,0.00054752844,0.029373905,0.0008598524,0.00032610094,0.00053238514,0.000020501288,0.00006885346],"genre_scores_gemma":[0.9728684,0.019636821,0.0030399067,0.0027166037,0.0013480412,0.0000065709905,0.000064153646,0.000052915137,0.0002666144],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964681,0.0010194157,0.00085746456,0.00054243737,0.00067263073,0.00043993845],"domain_scores_gemma":[0.99599254,0.0011921568,0.0012016202,0.0002709213,0.00042779677,0.0009149567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002527579,0.00049248047,0.0011970927,0.00035066105,0.0005353295,0.000037904112,0.00048746206,0.00009692057,0.00022120976],"category_scores_gemma":[0.00040922922,0.00035511606,0.00009446586,0.00048615402,0.00095372583,0.0006381501,0.00025917735,0.0014900811,5.5977426e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004275467,0.0008035443,0.0053496794,0.0006880097,0.00559427,0.00020159048,0.10226378,0.00068294816,0.81472737,0.0008042766,0.055212874,0.009396187],"study_design_scores_gemma":[0.040440306,0.000246251,0.006643787,0.0017654153,0.018368516,0.002119857,0.0586201,0.023489624,0.21622635,0.00074271864,0.62955505,0.0017820486],"about_ca_topic_score_codex":0.00007260584,"about_ca_topic_score_gemma":0.00001748638,"teacher_disagreement_score":0.598501,"about_ca_system_score_codex":0.000033209948,"about_ca_system_score_gemma":0.00028715498,"threshold_uncertainty_score":0.9998901},"labels":[],"label_agreement":null},{"id":"W30536383","doi":"10.1111/jgs.15690","title":"Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol","year":2001,"lang":"en","type":"article","venue":"Journal of the American Geriatrics Society","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Haloperidol; Tardive dyskinesia; Cytochrome P450; In vivo; Chemistry; Pharmacology; In vitro; Metabolism; Cytochrome; Drug metabolism; Dyskinesia; Parkinsonism; Biochemistry; Enzyme; Medicine; Schizophrenia (object-oriented programming); Internal medicine; Dopamine; Biology; Parkinson's disease; Psychiatry","score_opus":0.05478259441977181,"score_gpt":0.3854067295891205,"score_spread":0.3306241351693487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W30536383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987996,0.007089192,0.00011379798,0.0023594266,0.0016296614,0.00025760577,0.00007045039,0.000017471584,0.00046639168],"genre_scores_gemma":[0.96618605,0.027378531,0.001583031,0.003526132,0.0010156211,0.000006802022,0.0000021080073,0.000041506806,0.00026022436],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972652,0.0006043738,0.0009456927,0.00023954229,0.00046316415,0.000482023],"domain_scores_gemma":[0.9966704,0.00039989263,0.0018371372,0.0002997511,0.00041902665,0.00037376548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015794383,0.0003059433,0.000878596,0.000118729666,0.0002630511,0.00003086129,0.0007489515,0.00016462564,0.00017053551],"category_scores_gemma":[0.00026877125,0.0002163915,0.0006570795,0.0011495093,0.00084289885,0.00014709156,0.00026904256,0.001057138,0.000007250144],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049859507,0.00033667023,0.0037998196,0.000035681685,0.0007917058,0.000023316847,0.0021804315,0.00049341924,0.9632481,0.00006800096,0.012292487,0.016231779],"study_design_scores_gemma":[0.0064826687,0.00037911997,0.15442708,0.000031582007,0.0021611915,0.000978365,0.00161021,0.0023540815,0.0984342,0.000522526,0.73183125,0.0007877409],"about_ca_topic_score_codex":0.000040017796,"about_ca_topic_score_gemma":0.0000010074718,"teacher_disagreement_score":0.86481386,"about_ca_system_score_codex":0.000067016364,"about_ca_system_score_gemma":0.00031999333,"threshold_uncertainty_score":0.882419},"labels":[],"label_agreement":null},{"id":"W3080763434","doi":"10.1097/fpc.0000000000000418","title":"Identification of high-impact gene–drug pairs for pharmacogenetic testing in Alberta, Canada","year":2020,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services; Women and Children’s Health Research Institute; University of Alberta; University of Calgary","funders":"","keywords":"Pharmacogenetics; Identification (biology); Drug; Genetics; Biology; Computational biology; Gene; Pharmacology; Genotype; Ecology","score_opus":0.08342893702688821,"score_gpt":0.3768694939897619,"score_spread":0.2934405569628737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080763434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892617,0.0048719416,0.0005141945,0.0020173201,0.00089302525,0.0011745533,0.0011394236,0.000023813069,0.00010403124],"genre_scores_gemma":[0.992184,0.002474232,0.0012015505,0.0032667166,0.00051988265,0.00011170612,0.0000801699,0.00008593218,0.00007582361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99683636,0.00026723745,0.0012010643,0.0006934596,0.0002536894,0.0007481732],"domain_scores_gemma":[0.9975446,0.0007622458,0.00050123147,0.00020559407,0.00027181985,0.00071449927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071055436,0.000477742,0.00064686174,0.00014692247,0.00019015817,0.00003393761,0.00049926096,0.00014987242,0.00013079205],"category_scores_gemma":[0.0001933486,0.000514578,0.00014499883,0.0004879067,0.00015404972,0.00006692454,0.00017946481,0.00045194445,0.000006966991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005579093,0.00018559169,0.019207267,0.00024417293,0.00032200292,0.00001637823,0.00095955865,0.06972946,0.86971307,0.00007669983,0.00258446,0.03640342],"study_design_scores_gemma":[0.0047302525,0.000097004326,0.0062463954,0.000008661747,0.00052745925,0.000015614527,0.00007311936,0.18636335,0.7532962,0.00041228364,0.047607765,0.0006218718],"about_ca_topic_score_codex":0.027430743,"about_ca_topic_score_gemma":0.012169957,"teacher_disagreement_score":0.11663389,"about_ca_system_score_codex":0.00012988364,"about_ca_system_score_gemma":0.0008381595,"threshold_uncertainty_score":0.9997306},"labels":[],"label_agreement":null},{"id":"W3082189057","doi":"10.1039/d0cp03083j","title":"Regio- and stereoselectivity in the CYP450<sub>BM3</sub>-catalyzed hydroxylation of complex terpenoids: a QM/MM study","year":2020,"lang":"en","type":"article","venue":"Physical Chemistry Chemical Physics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Natural Science Foundation of China; National Key Research and Development Program of China; European Regional Development Fund; Engineering and Physical Sciences Research Council; Invest Northern Ireland","keywords":"Hydroxylation; Stereoselectivity; QM/MM; Terpenoid; Catalysis; Chemistry; Stereochemistry; Computational chemistry; Organic chemistry; Enzyme","score_opus":0.11547063031908167,"score_gpt":0.3894519867686844,"score_spread":0.27398135644960275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082189057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741834,0.00010054813,0.00007039058,0.00064301444,0.000031128537,0.00050874957,0.000068973095,0.00004168921,0.0011171418],"genre_scores_gemma":[0.99826616,0.000031696993,0.000015382187,0.0007170774,0.0008101616,0.0000614718,0.000065277425,0.000029791536,0.0000029965756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980684,0.00025835686,0.0004126893,0.000533294,0.00033161396,0.000395658],"domain_scores_gemma":[0.99871355,0.0004745972,0.00021315977,0.00027525617,0.00007710947,0.00024632472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027161872,0.00034356804,0.0005679416,0.000012679015,0.00009037659,0.000024047726,0.0004699732,0.0001438751,0.000018992168],"category_scores_gemma":[0.000091557406,0.0002949165,0.00014887487,0.00046480214,0.0003239256,0.00010360148,0.00022422931,0.0010355132,0.000011712808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031317398,0.0022277094,0.001146341,0.00014950718,0.00010771062,0.000009320291,0.0033384657,0.00012083887,0.98564976,0.00004604585,0.00024453792,0.006646614],"study_design_scores_gemma":[0.0024111697,0.000052094652,0.0010750807,0.0000076295355,0.00022134707,0.0000033201877,0.00021038717,0.018812241,0.97430754,0.0021195204,0.00047666742,0.000303024],"about_ca_topic_score_codex":0.000008435451,"about_ca_topic_score_gemma":4.804464e-7,"teacher_disagreement_score":0.018691402,"about_ca_system_score_codex":0.00003311409,"about_ca_system_score_gemma":0.000048747013,"threshold_uncertainty_score":0.9999503},"labels":[],"label_agreement":null},{"id":"W3082311577","doi":"10.7554/elife.58026","title":"Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact","year":2020,"lang":"en","type":"article","venue":"eLife","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Canadian Institutes of Health Research; Canada Excellence Research Chairs, Government of Canada; Chan Zuckerberg Initiative; National Institutes of Health; National Science Foundation","keywords":"Vitamin K epoxide reductase; Biology; Transmembrane domain; Missense mutation; Genetics; Gene; Mutation","score_opus":0.1530283749634961,"score_gpt":0.437107931851903,"score_spread":0.2840795568884069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082311577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455345,0.0018744847,0.0002065907,0.0015120659,0.00030287087,0.0005124704,0.00033497668,0.00004318526,0.00065993366],"genre_scores_gemma":[0.99666387,0.0007047132,0.00034583677,0.0018928678,0.00030117572,0.000025083917,0.0000075559606,0.00002493833,0.000033937937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977936,0.00071072415,0.00035847924,0.00045774187,0.00026901977,0.00041043805],"domain_scores_gemma":[0.99863136,0.0002174873,0.00026742864,0.00016909727,0.00018352816,0.0005310941],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011118384,0.00028866567,0.00054007577,0.000066638524,0.00027763375,0.000018247532,0.0001688731,0.0002264354,0.0003293174],"category_scores_gemma":[0.00024718096,0.00025993062,0.00009455557,0.00015164794,0.00031033848,0.00011060608,0.0001989994,0.0006555742,0.000012706262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075280765,0.00023841135,0.007191593,0.00007765226,0.00039621815,0.00005101057,0.0019230712,0.00010200805,0.9806015,0.00041989243,0.0009759481,0.0072698942],"study_design_scores_gemma":[0.006535717,0.00054161967,0.23681068,0.000028214663,0.00058588275,0.000064977605,0.00012494459,0.0043826913,0.7226058,0.00031912667,0.027408166,0.00059212174],"about_ca_topic_score_codex":0.00015112148,"about_ca_topic_score_gemma":0.000023577475,"teacher_disagreement_score":0.25799564,"about_ca_system_score_codex":0.000043478034,"about_ca_system_score_gemma":0.00009410623,"threshold_uncertainty_score":0.9999853},"labels":[],"label_agreement":null},{"id":"W3082792050","doi":"10.1016/j.steroids.2020.108716","title":"Synthesis of human long-term metabolites of dehydrochloromethyltestosterone and oxymesterone","year":2020,"lang":"en","type":"article","venue":"Steroids","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Hydroxymethyl; Metabolite; Stereochemistry; Stereocenter; Chemistry; Dehydroepiandrosterone; Testosterone (patch); Biochemistry; Biology; Enantioselective synthesis; Androgen; Endocrinology","score_opus":0.11301060817911615,"score_gpt":0.40944562030420906,"score_spread":0.29643501212509293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082792050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940355,0.008218502,0.00008042655,0.00040814877,0.00023741972,0.00027508856,0.00015343561,0.000037049853,0.0011863633],"genre_scores_gemma":[0.99780935,0.0008274711,0.00025479763,0.00078143657,0.00016887688,0.000025483976,0.0000113381675,0.000035163997,0.00008606959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812186,0.00034111788,0.00063925923,0.00035361113,0.00020311296,0.00034104288],"domain_scores_gemma":[0.99872357,0.0003011776,0.00030689235,0.00021728592,0.0000958146,0.00035526007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040840128,0.00026930083,0.00069598074,0.00012784889,0.00008623142,0.000011134145,0.00033812254,0.0001894346,0.00050233817],"category_scores_gemma":[0.00009081059,0.00025923463,0.00011504306,0.0002350593,0.00040149223,0.000106843116,0.00023971681,0.0003256231,0.000015140261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016660699,0.00018327904,0.06988522,0.00033429122,0.00028194062,0.000009901165,0.0011892492,0.000012476986,0.90326303,0.000248537,0.00007035632,0.024355099],"study_design_scores_gemma":[0.001433434,0.00023899616,0.06492043,0.00002507618,0.00054868497,0.000007816795,0.000053157273,0.000097262826,0.9309819,0.000115505274,0.0013532257,0.00022454004],"about_ca_topic_score_codex":0.000007377224,"about_ca_topic_score_gemma":0.0000026220664,"teacher_disagreement_score":0.02771882,"about_ca_system_score_codex":0.000007157985,"about_ca_system_score_gemma":0.00002969032,"threshold_uncertainty_score":0.999986},"labels":[],"label_agreement":null},{"id":"W3083556913","doi":"10.3390/pharmaceutics12090846","title":"Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice","year":2020,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Polypharmacy; Mechanism (biology); Drug; Pharmacology; Drug interaction; Mechanism of action; Medicine; Chemistry; Biochemistry","score_opus":0.38174770870448604,"score_gpt":0.548695033973512,"score_spread":0.166947325269026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083556913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017252157,0.9236642,0.047423016,0.0049888697,0.011218951,0.0055711,0.001732449,0.00033420554,0.0048946836],"genre_scores_gemma":[0.01633716,0.9664312,0.0044879094,0.01036733,0.0010717389,0.0004906989,0.00038933769,0.00026951623,0.00015508104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98838127,0.0045422786,0.0037702657,0.0013980496,0.0008036111,0.0011045005],"domain_scores_gemma":[0.9918139,0.004019035,0.0019436642,0.0005849513,0.0003819028,0.001256569],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0048018205,0.0012221665,0.0033383204,0.0011790551,0.0003199809,0.000082725106,0.00058374123,0.0006894074,0.0009646508],"category_scores_gemma":[0.0008683349,0.0012982524,0.0011881171,0.0021676635,0.00024956628,0.00036804023,0.00057107897,0.005105731,0.00055325567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016970569,0.005848575,0.0000070680985,0.01899147,0.0026206293,0.0048735403,0.0019712655,0.0014192906,0.003740826,0.09683242,0.01693651,0.84506136],"study_design_scores_gemma":[0.0029789472,0.000087463704,5.023376e-7,0.0025549864,0.0049447175,0.00024524212,0.00038141722,0.0028606341,0.013645892,0.0057853,0.9653845,0.0011303884],"about_ca_topic_score_codex":0.000021906266,"about_ca_topic_score_gemma":0.00003758185,"teacher_disagreement_score":0.948448,"about_ca_system_score_codex":0.00086507143,"about_ca_system_score_gemma":0.0012580234,"threshold_uncertainty_score":0.9999486},"labels":[],"label_agreement":null},{"id":"W3085550079","doi":"10.3389/fphar.2020.575540","title":"Pharmacogenetics in Psychiatry: An Update on Clinical Usability","year":2020,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Medicine; Psychiatry; Medical prescription; Genetic testing; Personalized medicine; Genotyping; Pharmacology; Bioinformatics; Genotype; Genetics; Internal medicine; Biology","score_opus":0.2331278570605818,"score_gpt":0.552387905742148,"score_spread":0.3192600486815662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085550079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017691653,0.92727536,0.00007083936,0.0008171535,0.06427279,0.0034501224,0.00072464393,0.00018782409,0.0014321266],"genre_scores_gemma":[0.00040753314,0.98030084,0.0023538952,0.011042181,0.004329506,0.00079798815,0.00037156456,0.00029705433,0.00009942611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9794572,0.011004307,0.0041880943,0.0027712644,0.00048594965,0.0020931936],"domain_scores_gemma":[0.99540585,0.0008367486,0.0012026958,0.0008282466,0.000104637955,0.0016218108],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.004506149,0.0018059257,0.0058421507,0.0014962006,0.00020212331,0.000051333012,0.0027180333,0.0027984092,0.0020052423],"category_scores_gemma":[0.00017606629,0.0018194913,0.0011927221,0.0020706123,0.0009163923,0.00020737079,0.00056012877,0.009149973,0.0006919226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090277294,0.0032737316,0.0051627667,0.001967842,0.00086066924,0.0006164029,0.00012695647,0.00027221665,0.000012064344,0.00015133504,0.093857124,0.8927961],"study_design_scores_gemma":[0.0065047964,0.00049989915,0.00014426187,0.00035525428,0.0027235667,0.000042246553,0.00003652656,0.0027770079,0.000041343123,0.00073486206,0.98458356,0.0015566765],"about_ca_topic_score_codex":0.000012115569,"about_ca_topic_score_gemma":0.000024125387,"teacher_disagreement_score":0.89123946,"about_ca_system_score_codex":0.0006030166,"about_ca_system_score_gemma":0.0018965112,"threshold_uncertainty_score":0.99946856},"labels":[],"label_agreement":null},{"id":"W3087273430","doi":"10.1016/j.bja.2020.08.046","title":"Perioperative genetic screening: entering a new era","year":2020,"lang":"en","type":"letter","venue":"British Journal of Anaesthesia","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Butyrylcholinesterase; Pharmacogenetics; Phenotype; Malignant hyperthermia; Genetics; Genotype; Medicine; Gene; Biology; Anesthesia; Biochemistry; Enzyme","score_opus":0.09446561631948286,"score_gpt":0.37074805763773844,"score_spread":0.2762824413182556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087273430","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06846786,0.08945781,0.0027858505,0.83029383,0.004916643,0.0008811501,0.00024679772,0.000116077106,0.002833983],"genre_scores_gemma":[0.015897866,0.02495225,0.008086108,0.9267944,0.02173676,0.000010616161,0.000046482564,0.00020475901,0.002270743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616086,0.0008983171,0.0011826502,0.0004519375,0.00057940185,0.00072682364],"domain_scores_gemma":[0.99775356,0.0001089747,0.00094137207,0.00017595872,0.00032128434,0.0006988435],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004016719,0.0005364509,0.001101852,0.00024340628,0.0002965485,0.00025686782,0.0010492189,0.0008544499,0.0016771987],"category_scores_gemma":[0.00011337252,0.0006276866,0.0006441488,0.00025193088,0.00019999381,0.00017109796,0.0001379407,0.007542399,0.00008906006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010924341,0.00004790119,0.00017721363,0.000052983134,0.00049684645,0.039694015,0.00038200984,0.00019134767,0.0009697039,0.000003235931,0.69886917,0.25900632],"study_design_scores_gemma":[0.0022787892,0.00031903645,0.00080401025,0.0002358644,0.0007510203,0.010310399,0.00003869261,0.00030166682,0.000966028,0.000117476375,0.9832987,0.0005783222],"about_ca_topic_score_codex":0.00007425843,"about_ca_topic_score_gemma":0.0000058544256,"teacher_disagreement_score":0.2844295,"about_ca_system_score_codex":0.00006619511,"about_ca_system_score_gemma":0.0006539681,"threshold_uncertainty_score":0.99961746},"labels":[],"label_agreement":null},{"id":"W308793356","doi":"10.1096/fasebj.25.1_supplement.1014.7","title":"Meclizine is not an inverse agonist or antagonist of human constitutive androstane receptor","year":2011,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Constitutive androstane receptor; Inverse agonist; Agonist; Antagonist; Pharmacology; Receptor; Pregnane X receptor; Reporter gene; Partial agonist; Chemistry; CYP2B6; Endocrinology; Biology; CYP3A4; Gene expression; Nuclear receptor; Gene; Cytochrome P450; Biochemistry; Transcription factor","score_opus":0.23964407813101987,"score_gpt":0.4324865322181458,"score_spread":0.19284245408712594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W308793356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98335725,0.0003984886,0.000035515477,0.00042479121,0.0018650367,0.00026323306,0.0004995273,0.000028416996,0.013127718],"genre_scores_gemma":[0.9926191,0.0010015587,0.00041429268,0.0040282155,0.00056814734,0.000007239277,0.0000153196,0.000026840578,0.0013192717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777156,0.0006564801,0.00060753635,0.0002335815,0.00025741532,0.00047344124],"domain_scores_gemma":[0.9984113,0.00011712385,0.00046712498,0.00028602328,0.00024847043,0.00046996746],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013958776,0.0002699505,0.00039293736,0.000114153445,0.0009735407,0.0000369691,0.0006526254,0.00018740923,0.012971052],"category_scores_gemma":[0.000047716218,0.00017553238,0.00016303013,0.0002056219,0.0011785126,0.00013289833,0.00011269393,0.0010721607,0.00012311661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002227502,0.0005621793,0.0021910397,0.000018131466,0.00037593843,0.00016401218,0.005900214,0.00001373551,0.9745477,0.0023927747,0.006965038,0.004641736],"study_design_scores_gemma":[0.0029753163,0.00045659207,0.0006723636,0.000015027072,0.00044259033,0.00042045466,0.00088295026,0.00020934192,0.9424144,0.0007601606,0.05049465,0.00025616327],"about_ca_topic_score_codex":0.000052439536,"about_ca_topic_score_gemma":0.000032088472,"teacher_disagreement_score":0.043529607,"about_ca_system_score_codex":0.0000406905,"about_ca_system_score_gemma":0.000275667,"threshold_uncertainty_score":0.98793125},"labels":[],"label_agreement":null},{"id":"W3090949181","doi":"10.1146/annurev-pharmtox-030920-025745","title":"Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings","year":2020,"lang":"en","type":"review","venue":"The Annual Review of Pharmacology and Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institutes of Health","keywords":"Pharmacogenetics; Medicine; Genetic testing; Drug; Drug response; Intensive care medicine; Pharmacology; Biology; Genotype; Genetics; Internal medicine; Gene","score_opus":0.4003053614121597,"score_gpt":0.5433675497631206,"score_spread":0.1430621883509609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090949181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000724597,0.98604536,5.8700476e-7,0.006427873,0.0011463321,0.0025806637,0.00022918233,0.00003843093,0.00280697],"genre_scores_gemma":[0.00078677444,0.98254806,0.00007587461,0.015274855,0.0006356757,0.0005145684,0.00003333887,0.00008078778,0.000050088704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98599577,0.008070754,0.0034184079,0.0011213826,0.00021300031,0.0011806849],"domain_scores_gemma":[0.991564,0.005986788,0.0016120377,0.00027086717,0.00017375273,0.00039255756],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009860301,0.0009098531,0.004440787,0.00045399682,0.0001833878,0.000011600416,0.0009260415,0.0008774921,0.00032444013],"category_scores_gemma":[0.0006819635,0.0007092683,0.00038759326,0.00052999996,0.0012250476,0.00013249289,0.0012780683,0.0033696077,0.000020866895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006687815,0.0002663118,0.000049282367,0.050855394,0.00045496752,0.00039425967,0.00061977,7.667426e-7,0.00006179197,0.00048499074,0.0021864967,0.9445591],"study_design_scores_gemma":[0.0018570999,0.00027306733,0.00009680892,0.007863486,0.0033018913,0.0004699014,0.00021645897,0.0000786394,0.00003360415,0.00017832147,0.98505867,0.0005720296],"about_ca_topic_score_codex":0.0000055643586,"about_ca_topic_score_gemma":0.000014407308,"teacher_disagreement_score":0.9828722,"about_ca_system_score_codex":0.000056453737,"about_ca_system_score_gemma":0.0006294355,"threshold_uncertainty_score":0.99953586},"labels":[],"label_agreement":null},{"id":"W3093182225","doi":"10.1101/2020.10.15.340976","title":"Sequential Measurements of Catalytic Activities of Multi-Drug-Resistance Transporters and Cytochrome P450 Enzymes by Cytometry of Reaction Rate Constant","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Cytochrome P450; Enzyme; Transporter; Microsome; Population; Chemistry; Enzyme assay; ATP-binding cassette transporter; Flow cytometry; Biology; Pharmacology; Biochemistry; Molecular biology; Gene; Medicine","score_opus":0.08672230766472082,"score_gpt":0.33976813025774166,"score_spread":0.25304582259302083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093182225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835201,0.01040471,0.0006350116,0.00011638001,0.0008988747,0.00086169166,0.0034728395,0.00006919588,0.000021200074],"genre_scores_gemma":[0.9965083,0.0022279832,0.000886244,0.000119337936,0.00009744778,0.000066813256,0.0000037475897,0.00008012223,0.000009999951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967838,0.00051812886,0.0010966044,0.000740356,0.0004247603,0.00043634878],"domain_scores_gemma":[0.9972375,0.00017176216,0.0013560903,0.0004730743,0.0004306501,0.000330942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011606751,0.0005613581,0.001183662,0.0003301542,0.00009125948,0.000018637602,0.00044395626,0.0005120171,0.00004468182],"category_scores_gemma":[0.00009903695,0.0006328163,0.00022067435,0.00041974022,0.00071662024,0.00012903102,0.00018380978,0.0009042856,0.000002003776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005662108,0.0004223125,0.0031600788,0.0021660952,0.0011048268,0.000018101828,0.00013773445,0.000045126046,0.992065,0.00008026048,0.00022597241,0.000008254259],"study_design_scores_gemma":[0.002310805,0.00003309735,0.013039675,0.0002327347,0.0010672618,2.9483536e-8,0.000018017174,0.00020796448,0.98123705,0.0000024232208,0.0013707796,0.0004801484],"about_ca_topic_score_codex":0.000056655106,"about_ca_topic_score_gemma":0.000005613692,"teacher_disagreement_score":0.012988207,"about_ca_system_score_codex":0.000105901956,"about_ca_system_score_gemma":0.00055754615,"threshold_uncertainty_score":0.99961233},"labels":[],"label_agreement":null},{"id":"W3094652411","doi":"10.1055/a-1288-1061","title":"Review and Consensus on Pharmacogenomic Testing in Psychiatry","year":2020,"lang":"en","type":"review","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hotchkiss Brain Institute; Centre for Addiction and Mental Health; Alberta Children's Hospital; Women and Children’s Health Research Institute; University of Alberta; McGill University; University of Calgary","funders":"National Institute on Drug Abuse; National Institute of General Medical Sciences; National Institute of Mental Health; Alberta Innovates; National Human Genome Research Institute; National Alliance for Research on Schizophrenia and Depression; Bundesministerium für Bildung und Forschung; National Institutes of Health; University of Alberta","keywords":"Oxcarbazepine; Pharmacogenomics; Genetic testing; Medicine; Psychiatry; Psychology; Carbamazepine; Pharmacology; Epilepsy","score_opus":0.262532474387727,"score_gpt":0.5104466244649591,"score_spread":0.24791415007723216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094652411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006847579,0.97587055,0.000001008883,0.0027784926,0.009629058,0.0035958379,0.00087458285,0.0002765841,0.0069053867],"genre_scores_gemma":[0.00003028887,0.9600978,0.0007862183,0.035639822,0.002308327,0.00058291317,0.00010536402,0.00031697523,0.0001323047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918831,0.0021258332,0.0023687098,0.0018866756,0.0003422073,0.0013934536],"domain_scores_gemma":[0.9958182,0.0011355875,0.0011376499,0.0005518417,0.000101617916,0.0012551241],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.001533315,0.0017931461,0.0042830533,0.00067181105,0.00032874063,0.000058364356,0.0011319326,0.00083070353,0.0011758716],"category_scores_gemma":[0.00020853928,0.0017008246,0.0007301543,0.0017612033,0.00030785336,0.00007835877,0.00042480836,0.005427949,0.0012488565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091269176,0.00048136062,0.000113976304,0.058102336,0.0007224876,0.00013154637,0.00004159408,0.0000084409285,0.000041382387,0.0001826295,0.08195409,0.8581289],"study_design_scores_gemma":[0.0027556054,0.00010208721,0.000006934625,0.013249219,0.009144321,0.0004094457,0.000009872033,0.00017410853,0.000011646055,0.00017577613,0.9724379,0.0015230904],"about_ca_topic_score_codex":0.000013388203,"about_ca_topic_score_gemma":0.0000034165716,"teacher_disagreement_score":0.8904838,"about_ca_system_score_codex":0.00019035525,"about_ca_system_score_gemma":0.0013868995,"threshold_uncertainty_score":0.9997372},"labels":[],"label_agreement":null},{"id":"W3095013792","doi":"10.1093/nar/gkaa990","title":"PK-DB: pharmacokinetics database for individualized and stratified computational modeling","year":2020,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Bundesministerium für Bildung und Forschung","keywords":"Pharmacokinetics; Physiologically based pharmacokinetic modelling; Database; Population; Computer science; Dosing; Bioinformatics; Pharmacology; Biology; Medicine","score_opus":0.40409109245586616,"score_gpt":0.5281909593777224,"score_spread":0.12409986692185626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095013792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95975363,0.002794343,0.020295402,0.008992042,0.00053017697,0.0018280739,0.0015931104,0.00015625823,0.004056982],"genre_scores_gemma":[0.98224545,0.00096211757,0.011247223,0.0041064774,0.0008287629,0.00014105799,0.00028501803,0.0000626378,0.000121267265],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99678653,0.0006799968,0.00046790516,0.0006341722,0.0006314879,0.0007999316],"domain_scores_gemma":[0.9976627,0.00081459264,0.00007003513,0.00017597941,0.0004689094,0.00080778],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002117102,0.00025784277,0.00033646903,0.00018624224,0.00063074374,0.00010918882,0.0005124611,0.00023418592,0.00095838995],"category_scores_gemma":[0.0003643152,0.00026226844,0.00008639442,0.00043689788,0.00033427647,0.00015765951,0.00039984024,0.0013007164,0.0000934003],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045594634,0.0009612067,0.0021803235,0.00089440634,0.0009950704,0.00010587728,0.008222526,0.093116336,0.62659335,0.020559339,0.06758776,0.17422433],"study_design_scores_gemma":[0.0049840207,0.00013428043,0.00007629099,0.000008065828,0.00010622027,0.0000066719217,0.00024113106,0.80588967,0.011967161,0.0029307643,0.17339228,0.000263444],"about_ca_topic_score_codex":0.000008797471,"about_ca_topic_score_gemma":0.000001386678,"teacher_disagreement_score":0.7127733,"about_ca_system_score_codex":0.000029313745,"about_ca_system_score_gemma":0.00021727644,"threshold_uncertainty_score":0.99998295},"labels":[],"label_agreement":null},{"id":"W3095729508","doi":"10.22541/au.159741407.76559359","title":"The Role of Sex, Age and Genetic Polymorphisms of CYP Enzymes on the Pharmacokinetics of Anticholinergic Drugs","year":2020,"lang":"en","type":"preprint","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"CYP2D6; Anticholinergic; Pharmacokinetics; CYP2C19; Medicine; Pharmacology; Drug; Adverse effect; Population; Drug metabolism; Pharmacogenetics; Glucuronidation; Clinical pharmacology; Internal medicine; Cytochrome P450; Biology; Genotype; Metabolism; Genetics","score_opus":0.06837416206811561,"score_gpt":0.3773067141047014,"score_spread":0.30893255203658576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095729508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454664,0.036740914,0.00004372066,0.0021697194,0.0012589818,0.0010781226,0.0005483557,0.000036975354,0.012656824],"genre_scores_gemma":[0.9718119,0.025550278,0.0003120327,0.0014045831,0.0003668816,0.00005242128,0.000019892388,0.00005930661,0.00042271035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99633926,0.00094208476,0.0012105639,0.00054331217,0.00049283524,0.00047197088],"domain_scores_gemma":[0.99639744,0.0015408745,0.0009478298,0.00065228925,0.00020846092,0.000253125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086632604,0.00054587383,0.0009315023,0.00013793068,0.00018078616,0.000024420739,0.001223848,0.00045410253,0.0003940471],"category_scores_gemma":[0.00009028032,0.00034206075,0.0003449174,0.00025135835,0.0011816712,0.000017708602,0.001174826,0.0015491067,0.000007650383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008302015,0.0006612241,0.0020400386,0.00042957402,0.0018981141,0.000040327133,0.004040404,0.0038746274,0.89085954,0.018537372,0.0029279443,0.073860645],"study_design_scores_gemma":[0.0012356938,0.000120853125,0.0011250973,0.000042866777,0.0009857228,0.000006761842,0.00036927077,0.01642131,0.90828043,0.0067589213,0.06431534,0.00033773473],"about_ca_topic_score_codex":0.0000722274,"about_ca_topic_score_gemma":0.0000031996824,"teacher_disagreement_score":0.07352291,"about_ca_system_score_codex":0.000013349676,"about_ca_system_score_gemma":0.00018847249,"threshold_uncertainty_score":0.99990314},"labels":[],"label_agreement":null},{"id":"W3096012551","doi":"10.1007/s00394-020-02421-y","title":"The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies","year":2020,"lang":"en","type":"review","venue":"European Journal of Nutrition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP1A2; Medicine; Cochrane Library; Pharmacology; Drug metabolism; Drug; CYP3A4; Obesity; CYP2D6; Cytochrome P450; Pharmacokinetics; Physiology; Internal medicine; Metabolism; Meta-analysis","score_opus":0.26901509399730383,"score_gpt":0.513582368053952,"score_spread":0.24456727405664813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096012551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013577648,0.9950409,0.0000069802445,0.000114943534,0.00091695326,0.0022658152,0.00019892529,0.000011020509,0.000086722685],"genre_scores_gemma":[0.004715632,0.99423766,0.000031142456,0.000115986804,0.0007562286,0.000059959784,0.000020227506,0.000055617435,0.0000075622675],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98478025,0.01107073,0.0027521113,0.00033331246,0.0007008485,0.0003627167],"domain_scores_gemma":[0.9901108,0.00468473,0.0041707396,0.00024932128,0.0005144269,0.00026995275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0068403804,0.0005590152,0.003396197,0.00032386108,0.00033425292,0.000033498203,0.0006183099,0.00006646577,0.00001343918],"category_scores_gemma":[0.0020051005,0.00035520497,0.00083925854,0.00041669517,0.00029222487,0.00010306933,0.0002146756,0.001604817,0.000015558433],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018200514,0.00043922116,0.0000074365307,0.8928302,0.0010508097,0.000117608935,0.0001118647,0.0000015216145,0.0002494379,0.00015767397,0.0012580259,0.10359418],"study_design_scores_gemma":[0.0015245775,0.0009769601,0.000013481811,0.6983365,0.0071536736,0.00014002142,0.00002697606,0.0000021241765,0.00052644475,0.000033493805,0.2910432,0.00022259532],"about_ca_topic_score_codex":2.0290487e-7,"about_ca_topic_score_gemma":7.266613e-8,"teacher_disagreement_score":0.28978515,"about_ca_system_score_codex":0.00011930343,"about_ca_system_score_gemma":0.000096616575,"threshold_uncertainty_score":0.99988997},"labels":[],"label_agreement":null},{"id":"W3096669115","doi":"10.3390/biom10111517","title":"Functional Expression of All Human Sulfotransferases in Fission Yeast, Assay Development, and Structural Models for Isoforms SULT4A1 and SULT6B1","year":2020,"lang":"en","type":"article","venue":"Biomolecules","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Freie Universität Berlin; World Anti-Doping Agency","keywords":"Yeast; Sulfotransferase; Sulfation; Biochemistry; Enzyme; Chemistry; Cytosol; Gene isoform; Docking (animal); Cofactor; Saccharomyces cerevisiae; Gene","score_opus":0.1867030101747613,"score_gpt":0.4094199454727093,"score_spread":0.22271693529794803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096669115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941788,0.0017830416,0.0028315168,0.00045578333,0.00011935033,0.0003205018,0.0001765483,0.00002035283,0.00011412885],"genre_scores_gemma":[0.9974394,0.00020496924,0.0014711568,0.0006190984,0.00007589346,0.000028313363,0.0001133625,0.000015605277,0.000032241427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898034,0.00009880594,0.00031041406,0.00027663173,0.00010416375,0.00022964092],"domain_scores_gemma":[0.9995493,0.00008761854,0.00006889656,0.000049625156,0.00005002851,0.00019452433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022821805,0.00017024559,0.00021544071,0.000077715566,0.00013330544,0.000012952044,0.00008766991,0.00014651488,0.00005611411],"category_scores_gemma":[0.000026157,0.00014181389,0.000036734808,0.000081398204,0.00013611632,0.00009408882,0.00006777109,0.00014673817,8.896273e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045197437,0.000053155683,0.0017823199,0.00010936306,0.000036091948,0.0000045570387,0.0013310967,0.00025504024,0.98461753,0.0009833826,0.00044766584,0.009927805],"study_design_scores_gemma":[0.003049029,0.00006897076,0.0055561643,0.000019430909,0.00004644157,0.00000482184,0.00012349967,0.009388987,0.96871346,0.0010711476,0.011748725,0.0002092984],"about_ca_topic_score_codex":0.000009458648,"about_ca_topic_score_gemma":0.000009021318,"teacher_disagreement_score":0.015904063,"about_ca_system_score_codex":0.0000088204815,"about_ca_system_score_gemma":0.00004032182,"threshold_uncertainty_score":0.57830024},"labels":[],"label_agreement":null},{"id":"W3099354938","doi":"10.1111/bcp.14667","title":"Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine","year":2020,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; European Commission; National Institute for Health and Care Research; University of Manchester; FP7 Health; GlaxoSmithKline; AstraZeneca","keywords":"Carbamazepine; Pharmacokinetics; Pharmacology; Metabolite; Volume of distribution; Phenytoin; Population; Chemistry; Microsomal epoxide hydrolase; Pharmacogenetics; Epoxide hydrolase; Anticonvulsant; Medicine; Microsome; Epilepsy; Genotype; Biochemistry; Enzyme; Gene","score_opus":0.3830655425053972,"score_gpt":0.563296980206314,"score_spread":0.18023143770091682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099354938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983916,0.009598305,0.000059064143,0.001642876,0.0038318504,0.0006013496,0.000081824655,0.0000068706618,0.00026186934],"genre_scores_gemma":[0.9792552,0.0147795975,0.0003171057,0.003553263,0.0020497765,0.000007660922,0.000009231815,0.000024274543,0.000003901964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98483557,0.008925217,0.0046411026,0.00034705267,0.0009043945,0.0003466889],"domain_scores_gemma":[0.993112,0.002852507,0.0023936776,0.00011492194,0.0010831319,0.00044370894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015352233,0.00023521057,0.0014050968,0.00013877076,0.000067401095,0.000013285826,0.0006463634,0.0004410521,0.00074816804],"category_scores_gemma":[0.0034195974,0.00021022205,0.00046288298,0.00040126964,0.0006677061,0.0001230687,0.00012816176,0.0021019492,0.0000023697103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014675282,0.0018142578,0.5578068,0.00013772711,0.0009112655,0.00026114585,0.0006932359,0.0064615174,0.016465155,0.000031717595,0.006752087,0.4071976],"study_design_scores_gemma":[0.017914966,0.00085361133,0.9251635,0.000044569948,0.0035374898,0.00024705727,0.00015360735,0.029202493,0.0056390646,0.00057431095,0.016422156,0.00024713867],"about_ca_topic_score_codex":0.00005091015,"about_ca_topic_score_gemma":0.000015323662,"teacher_disagreement_score":0.40695044,"about_ca_system_score_codex":0.000014698579,"about_ca_system_score_gemma":0.00038060942,"threshold_uncertainty_score":0.913204},"labels":[],"label_agreement":null},{"id":"W3111048839","doi":"10.1016/j.psychres.2020.113649","title":"Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression","year":2020,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Greenwich Biosciences; Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis; Agency for Healthcare Research and Quality; National Institutes of Health; Spier Family Foundation; Rogers Family Foundation; Eli Lilly and Company; Canadian Network for Mood and Anxiety Treatments; Assurex Health; Cerecor; Myriad Genetics; Sunovion; H. Lundbeck A/S; National Institute of Mental Health; Avanir Pharmaceuticals; Eisai; ACADIA Pharmaceuticals; Sage Therapeutics; University of Kansas; Canadian Institutes of Health Research; Foundation for Barnes-Jewish Hospital; Stanley Medical Research Institute; Pfizer; Biogen; Allergan; Cancer Research Institute; AstraZeneca; Bristol-Myers Squibb; LivaNova; Ontario Brain Institute","keywords":"Medicine; Pharmacogenomics; Major depressive disorder; Pharmacogenetics; Depression (economics); Hamilton Rating Scale for Depression; Clinical trial; Internal medicine; Psychiatry; Pharmacology; Mood; Gene","score_opus":0.38175716343895116,"score_gpt":0.5489436165382022,"score_spread":0.16718645309925106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111048839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951657,0.0009696284,0.000019039364,0.0015066022,0.0014066767,0.0007573915,0.000043907497,0.000020805312,0.00011026666],"genre_scores_gemma":[0.99544096,0.0004090969,0.003044644,0.00042001533,0.00061652384,0.000024340028,0.000014718261,0.000026252214,0.0000034731634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954557,0.0016988295,0.0013892112,0.0005979371,0.00045251145,0.00040581322],"domain_scores_gemma":[0.99725544,0.0015440552,0.0003110244,0.00015729581,0.00036475947,0.0003674343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042780377,0.00018918193,0.00048099086,0.0002178535,0.00012408065,0.000024301706,0.00025849644,0.0002841097,0.000033813394],"category_scores_gemma":[0.0018483466,0.00016330289,0.00004700935,0.00047924818,0.00032134846,0.00013210799,0.00019446036,0.001299325,0.0000027174958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091574003,0.0012330975,0.9706127,0.000072936906,0.00011824173,0.0000027596343,0.00013016092,0.00003933095,0.0046420544,0.000014451736,0.000070746486,0.022147752],"study_design_scores_gemma":[0.01566662,0.00060697267,0.9784227,0.000057697634,0.00013519249,0.0000014118797,0.000038167167,0.0028157542,0.0015490927,0.00037103452,0.00017957883,0.0001557982],"about_ca_topic_score_codex":0.00004986837,"about_ca_topic_score_gemma":0.000012966071,"teacher_disagreement_score":0.021991955,"about_ca_system_score_codex":0.000015527634,"about_ca_system_score_gemma":0.00018595987,"threshold_uncertainty_score":0.66592985},"labels":[],"label_agreement":null},{"id":"W3111078860","doi":"10.1055/a-1312-7175","title":"Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population","year":2020,"lang":"en","type":"article","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2C19; Pharmacogenetics; CYP2D6; Single-nucleotide polymorphism; CYP3A5; SNP; Medicine; Genotype; CYP2C9; Population; Pharmacology; Internal medicine; Statistical significance; Genetics; Biology; Gene","score_opus":0.0703218792811785,"score_gpt":0.4074863423247235,"score_spread":0.337164463043545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111078860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826848,0.009415658,0.00014471203,0.0023428523,0.0033062026,0.000829822,0.00026177074,0.00007902727,0.0009351537],"genre_scores_gemma":[0.9856706,0.0030555425,0.005849206,0.0045008287,0.0007238307,0.00005503585,0.000048847847,0.000069461305,0.000026644573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99483997,0.00080602214,0.0025477181,0.00066626765,0.00049709046,0.00064295955],"domain_scores_gemma":[0.99756265,0.0002475575,0.0011506875,0.0003389267,0.00016293475,0.0005372562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009353087,0.0004571258,0.00085978163,0.0003816162,0.00010530642,0.000009695857,0.0007161495,0.00027979744,0.00086353236],"category_scores_gemma":[0.000098495446,0.00046731252,0.00037601028,0.0010689986,0.00022519541,0.00013446735,0.00017635622,0.000988661,0.000051141404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015922084,0.0013643524,0.746119,0.0004337746,0.00026518636,0.000024483541,0.0029453766,0.0049358956,0.22125925,0.00043578673,0.0034194773,0.017205162],"study_design_scores_gemma":[0.032537006,0.0015934275,0.6179121,0.00018068792,0.0027051533,0.00008349419,0.0005746242,0.05732463,0.23393084,0.00843113,0.041575015,0.0031518778],"about_ca_topic_score_codex":0.00017263847,"about_ca_topic_score_gemma":0.000017268061,"teacher_disagreement_score":0.12820695,"about_ca_system_score_codex":0.000045620916,"about_ca_system_score_gemma":0.00025148242,"threshold_uncertainty_score":0.99977785},"labels":[],"label_agreement":null},{"id":"W3113372188","doi":"10.1177/1755738020972128","title":"Pharmacogenomics: Prescribing based on genetic variation","year":2020,"lang":"en","type":"article","venue":"InnovAiT Education and inspiration for general practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Polypharmacy; Medicine; Drug; Pharmacogenetics; Drug response; Disease; Intensive care medicine; Clinical decision support system; Function (biology); Adverse effect; Clinical Practice; Decision support system; Pharmacology; Family medicine; Computer science; Data mining; Internal medicine; Biology","score_opus":0.14598671452020454,"score_gpt":0.4460471017501133,"score_spread":0.3000603872299088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113372188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80275005,0.0031065408,0.05632537,0.093619674,0.008164287,0.0040073674,0.00031174757,0.0003585193,0.031356435],"genre_scores_gemma":[0.8154232,0.00024281169,0.017870417,0.16347636,0.0022344429,0.00026090798,0.00015738844,0.000043313226,0.0002911651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828565,0.00035412528,0.00047498537,0.00045104438,0.00017103486,0.0002631651],"domain_scores_gemma":[0.9984902,0.00030092316,0.0003261524,0.0001340686,0.0004617721,0.00028689284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005774583,0.00022937737,0.00017926902,0.00013967496,0.00036830956,0.00010863789,0.00015727634,0.00017486805,0.0003224462],"category_scores_gemma":[0.0006355198,0.0002466953,0.000059843896,0.00032261663,0.000049783648,0.0003767926,0.00003038472,0.00038238094,0.00007193973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016917894,0.0013684392,0.00053703133,0.00013836687,0.00016808833,0.000002620738,0.00242391,0.025275929,0.4444198,0.019719163,0.03095976,0.4732951],"study_design_scores_gemma":[0.0017400932,0.0002125262,0.0008576045,0.000004081692,0.00019021348,0.000005441809,0.00007121284,0.20881937,0.022442332,0.00021481383,0.76519805,0.00024427028],"about_ca_topic_score_codex":0.000016365964,"about_ca_topic_score_gemma":6.6177785e-7,"teacher_disagreement_score":0.73423827,"about_ca_system_score_codex":0.000052111798,"about_ca_system_score_gemma":0.00039933028,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W3114326816","doi":"10.1002/cpt.2149","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":399,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Institute on Drug Abuse; National Health and Medical Research Council; National Institute of General Medical Sciences; Medical Research Council; National Institutes of Health","keywords":"Pharmacogenetics; CYP2D6; Guideline; Opioid; Medicine; Pharmacology; Genotype; Internal medicine; Biology; Genetics; Gene; Cytochrome P450","score_opus":0.24691550981230617,"score_gpt":0.5716757893882056,"score_spread":0.3247602795758995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114326816","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89894444,0.06881089,0.001992554,0.014977757,0.011440655,0.0024609182,0.00072522025,0.0002393479,0.0004082122],"genre_scores_gemma":[0.27824736,0.30210835,0.010899897,0.4022786,0.0050991825,0.00033861716,0.00037121636,0.00021228146,0.00044451028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991086,0.0027899821,0.0030071686,0.001534876,0.00031311417,0.0012688788],"domain_scores_gemma":[0.9929993,0.0037811634,0.0007992917,0.00043058887,0.000992772,0.0009968415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004569361,0.0008017036,0.0013799701,0.00014128446,0.0006910145,0.00009414027,0.0005364245,0.0010121507,0.0011562366],"category_scores_gemma":[0.00008971478,0.00079360674,0.0005182908,0.00038139801,0.0014561405,0.00015691233,0.00042001443,0.0018479294,0.000039089064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002780423,0.002200779,0.08549385,0.00011016892,0.0048968513,0.00010212188,0.0005170659,0.00008363484,0.26921377,0.00021133413,0.12420361,0.5101864],"study_design_scores_gemma":[0.017949741,0.00067026966,0.005000585,0.0000066271837,0.0030552542,0.00009454004,0.00014945977,0.0037134164,0.10823847,0.0009789019,0.85936666,0.0007760694],"about_ca_topic_score_codex":0.00000646132,"about_ca_topic_score_gemma":0.000014537488,"teacher_disagreement_score":0.73516303,"about_ca_system_score_codex":0.000042454838,"about_ca_system_score_gemma":0.0007246626,"threshold_uncertainty_score":0.9997568},"labels":[],"label_agreement":null},{"id":"W3114373673","doi":"10.1007/s13318-020-00666-w","title":"Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation","year":2020,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Genentech","keywords":"Microsome; Cytosol; Biochemistry; Biology; Enzyme kinetics; Enzyme; Computational biology","score_opus":0.3040208151044591,"score_gpt":0.41808110510860486,"score_spread":0.11406029000414575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114373673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793999,0.009730767,0.008665515,0.0013201495,0.00035749763,0.00034334988,0.0001257499,0.000015976482,0.00004108642],"genre_scores_gemma":[0.9690972,0.013247976,0.01578149,0.001340595,0.00048495826,0.0000028611928,0.000016099964,0.000025112739,0.0000036889157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968155,0.0016858005,0.00084329845,0.0002910977,0.0001338975,0.00023039462],"domain_scores_gemma":[0.9974435,0.0012366914,0.00058427855,0.000059753103,0.00026219632,0.00041359026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018196219,0.00026184446,0.00058129866,0.00012414384,0.00021410116,0.000069562964,0.00010302044,0.00009286359,0.000039896477],"category_scores_gemma":[0.0007520175,0.00021223626,0.000077712204,0.00012651544,0.0003850215,0.00016910775,0.00013227014,0.00039711915,3.3844194e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055639807,0.00009476542,0.006195276,0.0001439336,0.00022070463,0.000013379717,0.0044896794,0.00029197938,0.95484334,0.00092296564,0.00022537317,0.03200223],"study_design_scores_gemma":[0.013474746,0.00051722996,0.08456462,0.000051890926,0.0020503358,0.00026381353,0.00077129144,0.010248414,0.84318334,0.0026369025,0.041551426,0.0006859871],"about_ca_topic_score_codex":0.0000010919683,"about_ca_topic_score_gemma":6.8595575e-8,"teacher_disagreement_score":0.11165997,"about_ca_system_score_codex":0.0000033268434,"about_ca_system_score_gemma":0.000026453687,"threshold_uncertainty_score":0.86547434},"labels":[],"label_agreement":null},{"id":"W3117825589","doi":"10.3390/jpm11010011","title":"Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia","year":2020,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Pfizer Canada; Genome British Columbia","keywords":"Pharmacogenomics; Medicine; Dosing; Pharmacy; Health care; Pharmacotherapy; Family medicine; Cohort; Pharmacogenetics; Pharmacology; Psychiatry; Internal medicine; Genotype","score_opus":0.16289451940346303,"score_gpt":0.44472927551540536,"score_spread":0.2818347561119423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117825589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552728,0.034347005,0.000022985576,0.0071640993,0.0010478435,0.00055434316,0.0001400974,0.000012367569,0.001438476],"genre_scores_gemma":[0.9740019,0.012627659,0.00011040286,0.011856918,0.001041973,0.000013555433,0.000017223441,0.0000361176,0.0002942795],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99598557,0.0017593628,0.001191667,0.00017934732,0.00048720033,0.00039683603],"domain_scores_gemma":[0.99746037,0.0006778321,0.00087791437,0.00015281317,0.00044013173,0.000390946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002680885,0.00020544167,0.0008664775,0.00010167102,0.0002882618,0.000022361588,0.0007387091,0.00011600998,0.0036764878],"category_scores_gemma":[0.0004565231,0.00020231781,0.0002763675,0.00051714666,0.00076415576,0.00010231829,0.00020266545,0.0021191365,0.0000073319757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004989862,0.00092236756,0.042528167,0.00080722204,0.0011226293,0.0008456833,0.08845396,0.00044242834,0.61040235,0.000021809454,0.1794118,0.07005173],"study_design_scores_gemma":[0.03036933,0.00077813165,0.0026947898,0.0001855355,0.0012512234,0.0007876426,0.0121485,0.0011086097,0.019545292,0.000088612695,0.9307238,0.00031852874],"about_ca_topic_score_codex":0.0035562655,"about_ca_topic_score_gemma":0.0025533189,"teacher_disagreement_score":0.751312,"about_ca_system_score_codex":0.00017096072,"about_ca_system_score_gemma":0.00043797246,"threshold_uncertainty_score":0.9972343},"labels":[],"label_agreement":null},{"id":"W3119947423","doi":"10.1002/cpdd.901","title":"A Colon‐Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Warfarin; Bioequivalence; Pharmacokinetics; Clonazepam; Crossover study; Pharmacology; Cmax; Concomitant; Pharmacodynamics; Drug; Internal medicine; Placebo","score_opus":0.16681087861956184,"score_gpt":0.497394297777827,"score_spread":0.33058341915826517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119947423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97114944,0.003923571,0.000017553846,0.009427566,0.012697265,0.0017870978,0.00010395999,0.00008392451,0.0008096063],"genre_scores_gemma":[0.9591717,0.012283089,0.0010737248,0.024805635,0.00071096834,0.0005477852,0.00006338536,0.00007958112,0.0012641012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9876144,0.0055147037,0.0034144449,0.0012964297,0.000576121,0.0015839195],"domain_scores_gemma":[0.99169856,0.0059742536,0.0007728591,0.0004899555,0.00040270726,0.00066169025],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007374962,0.00073354604,0.0015812514,0.00041602214,0.00028652226,0.000024748091,0.0012189172,0.00070848485,0.00359998],"category_scores_gemma":[0.00079322443,0.00051845826,0.00034782817,0.0014566992,0.00087581476,0.00011161445,0.0008958895,0.00333075,0.00013398219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043595567,0.026357757,0.32180706,0.001447844,0.0035832736,0.0069268253,0.016972689,0.007118163,0.34578693,0.0006311053,0.06103444,0.16473837],"study_design_scores_gemma":[0.018985672,0.00020911296,0.09094456,0.00006750616,0.0003794765,0.000051154173,0.00036837562,0.0023430842,0.5592449,0.00018846456,0.32639384,0.0008239147],"about_ca_topic_score_codex":0.00006366416,"about_ca_topic_score_gemma":0.0010502948,"teacher_disagreement_score":0.2653594,"about_ca_system_score_codex":0.00032663185,"about_ca_system_score_gemma":0.0026533867,"threshold_uncertainty_score":0.9997267},"labels":[],"label_agreement":null},{"id":"W3121479225","doi":"10.1111/cts.12970","title":"Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting<i>CYP3A4*1G</i>allele function","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Pharmacogenetics; Allele; Biology; Genetics; Function (biology); CYP3A4; Evolutionary biology; Genotype; Gene; Cytochrome P450","score_opus":0.0956131092451558,"score_gpt":0.4346596610336445,"score_spread":0.3390465517884887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121479225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681526,0.00055392814,0.000608181,0.00093310804,0.00044195054,0.00017604792,0.00009385412,0.000011932762,0.00036571475],"genre_scores_gemma":[0.9953588,0.0026349016,0.00048119097,0.0012541945,0.00013203321,0.0000127777075,0.00009212425,0.00000721886,0.000026743493],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981963,0.0005014554,0.00054381345,0.00029750462,0.00023069314,0.00023020056],"domain_scores_gemma":[0.9988436,0.00046782804,0.00019351617,0.000078590696,0.00022321548,0.00019326722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015883176,0.0001265114,0.00025028008,0.00012958767,0.00024275485,0.000024947945,0.0001329227,0.00007772962,0.00018331133],"category_scores_gemma":[0.000077847406,0.00012699961,0.000042192027,0.0005853112,0.0013693431,0.00020642964,0.000060058912,0.00039273457,0.0000031040113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027754816,0.00055155926,0.4092474,0.000044810116,0.000068546775,0.000008268868,0.004077877,0.00030097543,0.47831073,0.0018454156,0.000014321913,0.105252564],"study_design_scores_gemma":[0.001784398,0.00007070955,0.96254504,0.000010826243,0.00007515483,0.000007161342,0.00019489003,0.0069740927,0.01853712,0.0015541023,0.00808458,0.00016194826],"about_ca_topic_score_codex":0.000027846587,"about_ca_topic_score_gemma":0.00004404765,"teacher_disagreement_score":0.55329764,"about_ca_system_score_codex":0.000007947827,"about_ca_system_score_gemma":0.00027034135,"threshold_uncertainty_score":0.5178894},"labels":[],"label_agreement":null},{"id":"W3121813483","doi":"10.3389/fpsyt.2021.669446","title":"Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series","year":2021,"lang":"en","type":"article","venue":"Frontiers in Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Fluvoxamine; Clozapine; Pharmacology; CYP3A4; CYP1A2; Medicine; CYP2D6; Psychology; Psychiatry; Schizophrenia (object-oriented programming); Fluoxetine; Internal medicine; Cytochrome P450; Metabolism; Receptor","score_opus":0.033938604948964786,"score_gpt":0.37138168508412134,"score_spread":0.33744308013515656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121813483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841691,0.004842045,0.00043261691,0.001367081,0.0077996696,0.0006564002,0.0003403222,0.000039276925,0.00035344387],"genre_scores_gemma":[0.9756102,0.0003913514,0.018739467,0.004396757,0.00047294176,0.00013303828,0.00006108248,0.000059619968,0.00013555367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973963,0.00038352507,0.0006195498,0.0008144621,0.00020215708,0.00058398634],"domain_scores_gemma":[0.9987315,0.000043378368,0.00017963017,0.00051676144,0.00007269983,0.00045602862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024947574,0.00041074184,0.00058187323,0.0005774709,0.00012949006,0.00002927127,0.00046980032,0.00025010662,0.00037109986],"category_scores_gemma":[0.00006295768,0.00040411248,0.00008589777,0.0013990173,0.000104060826,0.00020148922,0.00017358916,0.00069808686,0.000022633045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028466377,0.0013711483,0.95563173,0.000021636106,0.00019666158,0.0003297228,0.0035829425,0.001969674,0.003254227,0.00037395625,0.0048764776,0.02554518],"study_design_scores_gemma":[0.045060884,0.005321151,0.7264706,0.0007382464,0.0011284499,0.006680053,0.063941315,0.0029248456,0.055486515,0.006593088,0.07991252,0.0057423664],"about_ca_topic_score_codex":0.00037375797,"about_ca_topic_score_gemma":0.001882193,"teacher_disagreement_score":0.22916117,"about_ca_system_score_codex":0.000062628904,"about_ca_system_score_gemma":0.0002334697,"threshold_uncertainty_score":0.9998411},"labels":[],"label_agreement":null},{"id":"W3123280459","doi":"10.3390/pharmaceutics13020148","title":"Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition","year":2021,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Fluoxetine; CYP2D6; Pharmacology; Cytochrome P450; CYP2C9; Drug; Pharmacokinetics; Metabolite; Drug interaction; Chemistry; Active metabolite; CYP2C19; CYP3A; CYP3A4; Enzyme; Medicine; Biochemistry; Receptor; Serotonin","score_opus":0.35251652099592856,"score_gpt":0.5544263198431747,"score_spread":0.20190979884724614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123280459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022810088,0.9879153,0.0002445189,0.00023099872,0.0049740975,0.0015132643,0.0006750759,0.00013494631,0.004083733],"genre_scores_gemma":[0.0012709083,0.99402404,0.00024739007,0.0016288937,0.0012678094,0.00024184042,0.00076169986,0.0001956503,0.00036175165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99217844,0.0033134143,0.0019693829,0.0008420462,0.00066877477,0.0010279253],"domain_scores_gemma":[0.9943617,0.0023664157,0.0015546071,0.0007297347,0.00048344932,0.0005040895],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028637487,0.0010571467,0.002619455,0.00037227132,0.0004862484,0.00014263684,0.00093675614,0.001177169,0.001902824],"category_scores_gemma":[0.00039351886,0.0008004095,0.0011944146,0.0013191834,0.00045813184,0.00020911255,0.00064136786,0.0036248288,0.00028914068],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015636215,0.000555867,0.000004833981,0.007478083,0.0015574336,0.00020080389,0.00032779638,0.000039452025,0.002920934,0.0035143057,0.0030900005,0.9802949],"study_design_scores_gemma":[0.0010780992,0.000021323896,5.694937e-7,0.0016362161,0.007472908,0.00016976144,0.00011025438,0.0011370021,0.01178016,0.0002332947,0.9756104,0.0007500537],"about_ca_topic_score_codex":0.00000641211,"about_ca_topic_score_gemma":0.0000011535572,"teacher_disagreement_score":0.9795448,"about_ca_system_score_codex":0.00015308961,"about_ca_system_score_gemma":0.0010372559,"threshold_uncertainty_score":0.99944466},"labels":[],"label_agreement":null},{"id":"W3123453085","doi":"10.3389/fphar.2020.595219","title":"Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines","year":2021,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Genotyping; Medicine; Pharmacogenomics; Guideline; Precision medicine; Clinical Practice; Personalized medicine; Genotype; Pharmacology; Bioinformatics; Family medicine; Biology; Genetics; Gene; Pathology","score_opus":0.40834520196988233,"score_gpt":0.5718590805218602,"score_spread":0.16351387855197785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123453085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009373079,0.97655785,0.00008834628,0.0009602478,0.01852769,0.001957098,0.00051649974,0.000048719747,0.00040622824],"genre_scores_gemma":[0.00012946402,0.99004614,0.003520938,0.0037985782,0.0013634914,0.0002926163,0.00008586931,0.00015099758,0.0006119226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99039656,0.0031857428,0.0035319715,0.0013114753,0.00046332972,0.0011109189],"domain_scores_gemma":[0.9959843,0.0006922575,0.0015835295,0.0005908907,0.0006235355,0.0005254695],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0021381814,0.001252239,0.004709928,0.0006120399,0.00031418167,0.000044053835,0.0013656116,0.0014082083,0.00055275095],"category_scores_gemma":[0.00037049825,0.001000946,0.0007005288,0.001193909,0.001103693,0.00010289142,0.0014600103,0.0026517385,0.0000102123095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047410846,0.00027804874,0.00201336,0.0049037677,0.0011137325,0.0000432614,0.00021189816,0.00010792194,0.00024404473,0.00008205146,0.21983156,0.77112293],"study_design_scores_gemma":[0.002585863,0.00005036963,0.000044154993,0.0015773115,0.0063726907,0.00013115616,0.00013318995,0.0029140406,0.0010187554,0.00015948358,0.98414433,0.0008686823],"about_ca_topic_score_codex":0.000023053608,"about_ca_topic_score_gemma":0.000011562667,"teacher_disagreement_score":0.77025425,"about_ca_system_score_codex":0.00013977788,"about_ca_system_score_gemma":0.00084082125,"threshold_uncertainty_score":0.9998882},"labels":[],"label_agreement":null},{"id":"W3125345026","doi":"10.1002/cpt.2173","title":"StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"GlaxoSmithKline foundation; National Research Foundation","keywords":"Genotyping; Genetics; Computational biology; 1000 Genomes Project; Biology; Haplotype; Pharmacogenomics; Genome; Gene; Allele; Genotype; Single-nucleotide polymorphism","score_opus":0.342208073002502,"score_gpt":0.5455487412779744,"score_spread":0.20334066827547237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125345026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9287555,0.04029784,0.0038188924,0.014610615,0.009039628,0.0019578596,0.0004321866,0.00025083462,0.0008366005],"genre_scores_gemma":[0.6694984,0.07677455,0.008193184,0.23452955,0.0071723037,0.0005783321,0.00034527094,0.0003004155,0.0026079798],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926559,0.00221033,0.0020662816,0.0012508875,0.0003090659,0.0015075695],"domain_scores_gemma":[0.99410695,0.0036702272,0.00043588353,0.0004898608,0.0006252734,0.00067183294],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002981636,0.0006909639,0.0013273782,0.00023363777,0.00037920705,0.00005243083,0.0008554095,0.0012061114,0.0019805597],"category_scores_gemma":[0.00011409721,0.0007127888,0.0006647115,0.0006122803,0.0006977146,0.00013782039,0.00034269888,0.0022445377,0.00016763496],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031896587,0.005078762,0.007376092,0.00020973143,0.0023711447,0.00070956646,0.0007080818,0.005443091,0.80774695,0.00030370592,0.024062224,0.142801],"study_design_scores_gemma":[0.012130268,0.00022351979,0.0019498322,0.000018459059,0.0017913952,0.00004794361,0.00015565348,0.061484337,0.09636354,0.0011608761,0.82389355,0.0007806113],"about_ca_topic_score_codex":0.000006883164,"about_ca_topic_score_gemma":0.000052018342,"teacher_disagreement_score":0.79983133,"about_ca_system_score_codex":0.00011903111,"about_ca_system_score_gemma":0.0007544252,"threshold_uncertainty_score":0.99953234},"labels":[],"label_agreement":null},{"id":"W3125910964","doi":"10.1016/j.bcab.2021.101917","title":"Promising optimization of bacterial cytochrome P450BM3 enzyme production by engineered Escherichia coli BL21","year":2021,"lang":"en","type":"article","venue":"Biocatalysis and Agricultural Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Research Centre","keywords":"Escherichia coli; Chemistry; Enzyme; Production (economics); Cytochrome; Microbiology; Biochemistry; Biology; Gene; Economics","score_opus":0.026289667789309388,"score_gpt":0.30320795333413103,"score_spread":0.2769182855448216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125910964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987716,0.005600531,0.00035251136,0.0028211398,0.00070317916,0.00029432104,0.00014457876,0.000108568245,0.00009800037],"genre_scores_gemma":[0.9928737,0.003773295,0.0018076681,0.00011606234,0.00026119102,0.000033568227,0.0007529379,0.000015066968,0.00036646303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843156,0.00016001983,0.000444206,0.00050540525,0.00012261579,0.0003361957],"domain_scores_gemma":[0.99921006,0.000038112783,0.00022866443,0.00019640355,0.00020338649,0.00012337136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002198449,0.00026303602,0.0004412746,0.000104437815,0.00017514828,0.000027974655,0.00017510176,0.00062895403,0.0002815808],"category_scores_gemma":[0.000119004166,0.00020432321,0.00010519097,0.00071664987,0.00023005062,0.00010874786,0.00015010237,0.00037328457,0.00000788999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005175185,0.00020699821,0.000031438274,0.00004085651,0.00024431164,0.0000050282647,0.00010385459,0.0011463803,0.9899537,0.00016647765,0.001815413,0.006233776],"study_design_scores_gemma":[0.0007665697,0.00005356297,0.0005633005,0.000010871672,0.0003246871,0.00004208434,0.00018843239,0.0010909082,0.9673772,0.000015198188,0.029299526,0.00026766202],"about_ca_topic_score_codex":0.00001073386,"about_ca_topic_score_gemma":0.000004203338,"teacher_disagreement_score":0.027484111,"about_ca_system_score_codex":0.0000304525,"about_ca_system_score_gemma":0.0000451879,"threshold_uncertainty_score":0.8332059},"labels":[],"label_agreement":null},{"id":"W3127733737","doi":"10.22541/au.159285510.07118043","title":"The influence of tobacco smoke/nicotine on CYP2A expression in human and African green monkey lungs","year":2020,"lang":"en","type":"preprint","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto","funders":"","keywords":"Nicotine; CYP2A6; Lung; Medicine; Pharmacology; Smoke; Internal medicine; CYP1A2; Endocrinology; Physiology; Chemistry; Metabolism","score_opus":0.11338667808223128,"score_gpt":0.4320021168020357,"score_spread":0.3186154387198044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127733737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859504,0.002020057,0.000005627203,0.002882286,0.0005024981,0.00079637085,0.00012146577,0.00005393478,0.0076673557],"genre_scores_gemma":[0.9938807,0.0031385943,0.00008966477,0.0020446063,0.000233018,0.00010762664,0.000024702103,0.00003915605,0.00044193532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997114,0.0006377046,0.0007933584,0.00067801075,0.00029957664,0.00047736836],"domain_scores_gemma":[0.99811363,0.0005265725,0.00043925492,0.00048274716,0.000114834394,0.0003229642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008111482,0.0004538364,0.0006216212,0.0001644179,0.00024164746,0.000036453832,0.0008694748,0.0005513555,0.00018027678],"category_scores_gemma":[0.00011153523,0.00033537537,0.00013199844,0.00021091309,0.00037242178,0.00004644312,0.0014992277,0.0022328773,0.000011475625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012624209,0.0006711949,0.062266137,0.0003922467,0.00035982326,0.000051376785,0.0034065105,0.016548775,0.8775981,0.005348311,0.0033073123,0.028787779],"study_design_scores_gemma":[0.004653783,0.00028605788,0.17584161,0.00026856942,0.00041758077,0.000005724655,0.0003262653,0.0033597096,0.6738297,0.014272177,0.12554808,0.0011907794],"about_ca_topic_score_codex":0.00044114343,"about_ca_topic_score_gemma":0.0000877361,"teacher_disagreement_score":0.20376846,"about_ca_system_score_codex":0.00004069043,"about_ca_system_score_gemma":0.00010989661,"threshold_uncertainty_score":0.9999098},"labels":[],"label_agreement":null},{"id":"W3127901377","doi":"10.1002/ddr.21778","title":"Anatomical distribution and expression of <scp>CYP</scp> in humans: Neuropharmacological implications","year":2021,"lang":"en","type":"review","venue":"Drug Development Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Biology; Cytochrome P450; Epigenetics; Pharmacology; Gene isoform; Drug metabolism; Pharmacokinetics; Drug; Metabolism; Endocrinology; Genetics; Gene","score_opus":0.33657604998038493,"score_gpt":0.5473774208312959,"score_spread":0.210801370850911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127901377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037292775,0.95935035,0.000015645923,0.00008508304,0.00039774735,0.0014584125,0.0002723305,0.000036431913,0.001091252],"genre_scores_gemma":[0.0046459744,0.99223536,0.00021739057,0.00007660652,0.00017277378,0.00079538085,0.0009481569,0.000052531697,0.00085583766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99211264,0.0038893237,0.0013517854,0.0010049528,0.0005964493,0.0010448615],"domain_scores_gemma":[0.9955149,0.0029170013,0.00030473658,0.00036070865,0.00039737672,0.0005052207],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0041380557,0.0005104863,0.0015520697,0.0006189688,0.00042069884,0.000056242658,0.0007325164,0.0007295619,0.00026872204],"category_scores_gemma":[0.00065794186,0.0004441849,0.00021942485,0.0013665549,0.0005071862,0.00007991716,0.0011841609,0.0032639962,0.00006934503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017762915,0.0010906901,0.0007520694,0.0042389818,0.00018768529,0.00013308164,0.0006893546,0.0000061891783,0.0025869664,0.0012154524,0.016467132,0.97261465],"study_design_scores_gemma":[0.00075154507,0.000017320235,0.00080267864,0.00092040695,0.00015476196,0.00001621306,0.00007444524,0.00001883055,0.0057426575,0.000085079584,0.991234,0.00018204571],"about_ca_topic_score_codex":0.000007948992,"about_ca_topic_score_gemma":0.000005079813,"teacher_disagreement_score":0.9747669,"about_ca_system_score_codex":0.00026548706,"about_ca_system_score_gemma":0.0013040685,"threshold_uncertainty_score":0.999801},"labels":[],"label_agreement":null},{"id":"W3128424220","doi":"10.3390/pharmaceutics13020197","title":"Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy","year":2021,"lang":"en","type":"article","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Polypharmacy; Medicine; Precision medicine; Intensive care medicine; Personalized medicine; Pharmacology; Bioinformatics; Biology; Pathology","score_opus":0.05558214301569941,"score_gpt":0.4161266348303737,"score_spread":0.3605444918146743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128424220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808168,0.011563879,0.00011184802,0.00042391827,0.0013004722,0.0012002519,0.00031710407,0.000071512,0.004194203],"genre_scores_gemma":[0.98981464,0.0060091526,0.00045709292,0.0030302075,0.0002906883,0.00006956064,0.00011954998,0.00007788832,0.00013124205],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99661326,0.00048654474,0.00089947827,0.00072505936,0.0005224664,0.0007531864],"domain_scores_gemma":[0.99762297,0.00061666186,0.0003721822,0.00033575445,0.0003822421,0.0006702154],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005634481,0.00052961044,0.00081905624,0.00028712585,0.00017481984,0.000022758615,0.0003897993,0.00021323956,0.0013183573],"category_scores_gemma":[0.000092130664,0.00047433455,0.00008550754,0.00073240744,0.0006498265,0.0001585206,0.00031626277,0.00092037785,0.00002058395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059423163,0.0033527107,0.5719789,0.00050243386,0.00089648773,0.00020574774,0.0030620194,0.0024663287,0.20668104,0.0020268327,0.0015785847,0.20130658],"study_design_scores_gemma":[0.0740372,0.00033563038,0.20282744,0.00014295067,0.0031011065,0.000051845243,0.0004469997,0.0066248104,0.39892206,0.0013364572,0.31035504,0.0018184803],"about_ca_topic_score_codex":0.000013391255,"about_ca_topic_score_gemma":0.000004382954,"teacher_disagreement_score":0.36915147,"about_ca_system_score_codex":0.00008171136,"about_ca_system_score_gemma":0.00025654,"threshold_uncertainty_score":0.9997708},"labels":[],"label_agreement":null},{"id":"W3131026056","doi":"10.3390/books978-3-03842-798-8","title":"Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape","year":2018,"lang":"en","type":"book","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Drug metabolism; Current (fluid); Drug; Medicine; Pharmacology; Engineering","score_opus":0.05875969595178177,"score_gpt":0.37317114679606217,"score_spread":0.3144114508442804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131026056","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022897568,0.22011642,0.000012404147,0.0034342906,0.018056141,0.0019613956,0.0010334668,0.0000977395,0.7323906],"genre_scores_gemma":[0.08527572,0.11635711,0.000102931794,0.017501857,0.0088096885,0.00028102042,0.00034277356,0.00031162985,0.77101725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964851,0.00061069784,0.0008142923,0.000722902,0.00048066347,0.00088634086],"domain_scores_gemma":[0.9979072,0.00068850024,0.0003259639,0.00042567318,0.00017206017,0.00048057784],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011783089,0.0007421254,0.00082076,0.00022164598,0.00025122127,0.000045786717,0.00084557396,0.00028534696,0.004217428],"category_scores_gemma":[0.000041982898,0.0005367351,0.00013246729,0.00019702277,0.00036878392,0.00005610303,0.0004869874,0.0029865233,0.00013370365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000938323,0.000068075155,0.0005529648,0.000100922734,0.00024031177,0.000049322225,0.00031999216,0.00006272416,0.00009968283,0.00168252,0.86969745,0.12703219],"study_design_scores_gemma":[0.0018195367,0.00000780159,0.000934485,0.0000308339,0.00069407094,0.000017318314,0.000030216,0.0019330289,0.00091423537,0.0021126296,0.99086726,0.00063860946],"about_ca_topic_score_codex":0.036358427,"about_ca_topic_score_gemma":0.42713907,"teacher_disagreement_score":0.39078066,"about_ca_system_score_codex":0.00027712874,"about_ca_system_score_gemma":0.0043011014,"threshold_uncertainty_score":0.9997084},"labels":[],"label_agreement":null},{"id":"W3131252500","doi":"10.71781/4996","title":"New and alternative approaches to the assessment of pharmacokinetic and pharmacodynamic equivalence","year":2020,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Equivalence (formal languages); Pharmacodynamics; Pharmacokinetics; Pharmacology; Medicine; Mathematics; Computer science; Discrete mathematics","score_opus":0.37149791538723537,"score_gpt":0.5072271883032126,"score_spread":0.1357292729159772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131252500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8663898,0.009477873,0.00052702305,0.0044104597,0.0034222682,0.0045594648,0.00070598675,0.000007869457,0.110499226],"genre_scores_gemma":[0.9777713,0.005141627,0.0066930586,0.000840859,0.0005973556,0.00015494115,0.0002693104,0.000072197654,0.008459374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756074,0.00043594826,0.0005561093,0.0007635922,0.0003010502,0.00038254476],"domain_scores_gemma":[0.9984668,0.0002641227,0.00041800324,0.00021241204,0.00007335115,0.0005653014],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007266377,0.00046539673,0.0006298672,0.00012861015,0.00023243671,0.00011140019,0.001078476,0.00022659161,0.0025990126],"category_scores_gemma":[0.00003463395,0.0003782104,0.00008079939,0.0002693493,0.000109453096,0.0001199536,0.0005518521,0.0010127666,0.000051702522],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004981198,0.00012957392,0.00031427643,0.0001627649,0.00067417364,0.000022880307,0.006812351,0.0006127611,0.06999128,0.00035576287,0.0015707528,0.9188553],"study_design_scores_gemma":[0.003913138,0.00023351965,0.0035127276,0.000116136434,0.002326672,0.00002173866,0.0010871516,0.043957762,0.19137278,0.00031400047,0.7523035,0.00084092363],"about_ca_topic_score_codex":0.0000533244,"about_ca_topic_score_gemma":0.00005643923,"teacher_disagreement_score":0.9180144,"about_ca_system_score_codex":0.000029348897,"about_ca_system_score_gemma":0.00031390108,"threshold_uncertainty_score":0.99986696},"labels":[],"label_agreement":null},{"id":"W3133060081","doi":"10.18433/jpps31305","title":"The CYP2R1 Enzyme: Structure, Function, Enzymatic Properties and Genetic Polymorphism","year":2021,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Centre National de la Recherche Scientifique; Ministry of Higher Education, Malaysia","keywords":"Biology; Single-nucleotide polymorphism; Genetics; Gene; Genotype","score_opus":0.16437097867124498,"score_gpt":0.4248624400500307,"score_spread":0.26049146137878576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133060081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8246851,0.15827289,0.00032747904,0.009527177,0.005505526,0.00032231156,0.000027636803,0.000040511582,0.0012913704],"genre_scores_gemma":[0.9693937,0.021625916,0.00067785924,0.0064701117,0.0013909262,0.000011460661,0.0000012243038,0.000030453099,0.000398408],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951356,0.0012534155,0.0012227545,0.00047433175,0.00095502083,0.0009588928],"domain_scores_gemma":[0.9968435,0.00088307797,0.00055330864,0.00020629347,0.0006169766,0.0008968097],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019901958,0.00042598194,0.00051732414,0.00018450225,0.0016172009,0.0003316839,0.00089747424,0.00013795914,0.0014855108],"category_scores_gemma":[0.00042420582,0.00027124656,0.00024328075,0.00082263834,0.0018386124,0.00045445247,0.00032114625,0.0014716455,0.000033978118],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000657349,0.00029613925,0.006670868,0.0000865158,0.00047588322,0.00031181102,0.00047844168,0.0008536176,0.72247684,0.002101167,0.005118148,0.26047322],"study_design_scores_gemma":[0.0027094851,0.00011065003,0.0013172129,0.000023754663,0.00067709316,0.0015826948,0.0002290373,0.009072848,0.36727047,0.0023997852,0.6142916,0.000315391],"about_ca_topic_score_codex":0.000008386682,"about_ca_topic_score_gemma":0.000006876027,"teacher_disagreement_score":0.6091734,"about_ca_system_score_codex":0.00006058351,"about_ca_system_score_gemma":0.0007471356,"threshold_uncertainty_score":0.99997395},"labels":[],"label_agreement":null},{"id":"W3135274413","doi":"10.1101/2021.03.09.434557","title":"Structural dynamics of cytochrome P450 3A4 in the presence of substrates and cytochrome P450 reductase","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Centre in Green Chemistry and Catalysis","keywords":"CYP3A4; Chemistry; Hydrogen–deuterium exchange; Cytochrome P450; Stereochemistry; Allosteric regulation; Cytochrome P450 reductase; Helix (gastropod); Enzyme; Ligand (biochemistry); Biophysics; Molecular dynamics; Biochemistry; Cytochrome c; Computational chemistry; Receptor; Hydrogen; Biology; Coenzyme Q – cytochrome c reductase","score_opus":0.04885943678002469,"score_gpt":0.3381783180266697,"score_spread":0.289318881246645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135274413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98592097,0.01076151,0.000020107113,0.00026475263,0.0006621347,0.0010273239,0.0012685789,0.000047078378,0.000027565957],"genre_scores_gemma":[0.99589473,0.0026496109,0.00077710865,0.00019614468,0.00026835522,0.00013483141,0.0000046040786,0.00007167122,0.000002959102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959166,0.0009883586,0.0010763727,0.00089534896,0.00045058443,0.0006727491],"domain_scores_gemma":[0.9969782,0.00044628326,0.0007900306,0.0009806359,0.0005297274,0.00027509884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001489667,0.0006414379,0.0010191032,0.00032153912,0.00014726237,0.00008856984,0.0011161589,0.0008209992,0.00017390867],"category_scores_gemma":[0.0002608993,0.00058372505,0.00019871509,0.0007124575,0.00078566023,0.00015101639,0.00069557404,0.0019019096,0.0000030332837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012616979,0.00025209668,0.00669515,0.0007864612,0.0002913727,0.00012963955,0.0002834658,0.0006790575,0.989241,0.0014562992,0.00003680253,0.000022510543],"study_design_scores_gemma":[0.001301328,0.000064332,0.37819284,0.00021959997,0.00046152002,5.93039e-7,0.00011581983,0.007010096,0.6115629,0.00005053099,0.00036074268,0.00065968],"about_ca_topic_score_codex":0.00012705738,"about_ca_topic_score_gemma":0.000022464672,"teacher_disagreement_score":0.37767807,"about_ca_system_score_codex":0.000102536906,"about_ca_system_score_gemma":0.0007082649,"threshold_uncertainty_score":0.99966145},"labels":[],"label_agreement":null},{"id":"W3135894867","doi":"10.1111/cts.12986","title":"Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto; University of Waterloo","funders":"","keywords":"Pharmacogenomics; Anxiety; Randomized controlled trial; Medicine; Pharmacy; Generalized anxiety disorder; Depression (economics); Psychiatry; Clinical trial; Antidepressant; Physical therapy; Clinical psychology; Internal medicine; Family medicine; Pharmacology","score_opus":0.25914694807119115,"score_gpt":0.5370956216223216,"score_spread":0.27794867355113045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135894867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838583,0.0028976612,0.000113387054,0.002363161,0.0031966416,0.002203543,0.00011682782,0.000036422436,0.005214077],"genre_scores_gemma":[0.99182487,0.0057107606,0.0006898281,0.00094400195,0.00043208053,0.00023238048,0.00002747543,0.000013119896,0.00012551491],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99347126,0.0036037676,0.0014643847,0.00053252664,0.00041486253,0.0005131681],"domain_scores_gemma":[0.9915801,0.0072014243,0.00025059647,0.00020353952,0.00027711983,0.0004871908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010865193,0.0002900822,0.0013397505,0.00013936307,0.0006568851,0.00007915944,0.00033845988,0.00013335273,0.0005173472],"category_scores_gemma":[0.0012473705,0.00022623832,0.0004594449,0.00045873222,0.0019825087,0.00018536388,0.00010243658,0.00087259896,0.000011899718],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9557896,0.001575746,0.0042626904,0.000011864662,0.0003759206,0.00007258379,0.0005530659,0.00054661115,0.0054147756,0.0020439986,0.0000408774,0.02931224],"study_design_scores_gemma":[0.94983137,0.00017696901,0.0009067871,0.000008970465,0.00056505296,0.000014139001,0.00004539328,0.020544408,0.0063752555,0.002042378,0.019236038,0.00025322288],"about_ca_topic_score_codex":0.000047749723,"about_ca_topic_score_gemma":0.000049465325,"teacher_disagreement_score":0.029059017,"about_ca_system_score_codex":0.00003745082,"about_ca_system_score_gemma":0.001345614,"threshold_uncertainty_score":0.9225731},"labels":[],"label_agreement":null},{"id":"W3136441191","doi":"10.1111/bcp.14833","title":"Drug–drug interactions with warfarin: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Hamilton Health Sciences; University of Toronto; University of Ottawa; Western University; Queen's University; McMaster University; St. Joseph’s Healthcare Hamilton; Impact","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Warfarin; Internal medicine; Odds ratio; Observational study; Drug; Confidence interval; Randomized controlled trial; Hazard ratio; Pharmacology; Atrial fibrillation","score_opus":0.3222111686277389,"score_gpt":0.5745221384572651,"score_spread":0.25231096982952617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136441191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027501927,0.99289244,0.000045740348,0.0010309124,0.0030458674,0.0020728982,0.00042112783,0.00003345802,0.00043004175],"genre_scores_gemma":[0.000063571526,0.98411965,0.0003610671,0.010973687,0.0012090926,0.000330151,0.00006224735,0.00010852605,0.0027719869],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97727257,0.013711961,0.0068170344,0.00091422163,0.0005282752,0.0007559188],"domain_scores_gemma":[0.9838579,0.00696454,0.0063205725,0.00039877777,0.0011993325,0.001258828],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0093880985,0.0009515328,0.02112367,0.00061004,0.00030822007,0.00011856668,0.001185375,0.0004854498,0.0072903447],"category_scores_gemma":[0.0007868161,0.00075312034,0.0073012756,0.0014721788,0.00062108,0.00024947236,0.0004135958,0.006752443,0.000056115834],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059725287,0.0010933348,0.000004978201,0.32939824,0.5750075,0.004247547,0.000035935285,0.000031393425,5.6769613e-7,0.000017265194,0.045440413,0.044663116],"study_design_scores_gemma":[0.00078022125,0.00003723521,9.970586e-7,0.0101963105,0.51427186,0.0061474117,0.000010742616,0.000010576466,0.0000021053859,0.000007642255,0.46816623,0.00036869312],"about_ca_topic_score_codex":0.000023044026,"about_ca_topic_score_gemma":0.000066839915,"teacher_disagreement_score":0.4227258,"about_ca_system_score_codex":0.000069424415,"about_ca_system_score_gemma":0.0011044741,"threshold_uncertainty_score":0.999492},"labels":[],"label_agreement":null},{"id":"W3137413844","doi":"10.1002/ansa.202000182","title":"Determining site occupancy of acetaminophen covalent binding to target proteins in vitro","year":2021,"lang":"en","type":"article","venue":"Analytical Science Advances","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; IONICS Mass Spectrometry (Canada); York University; Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Microsome; Chromatography; Peptide; Trypsin; Biochemistry; Tandem mass spectrometry; Glutathione; Cysteine; In vitro; Mass spectrometry; Enzyme","score_opus":0.0894065477130122,"score_gpt":0.45793045371951063,"score_spread":0.3685239060064984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137413844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284434,0.001472629,0.00047906302,0.000486729,0.0005113828,0.00024654527,0.000052889365,0.000018701809,0.0038876892],"genre_scores_gemma":[0.9907503,0.00024635138,0.007594587,0.00100953,0.000087258144,0.00002681239,0.0000050458575,0.000008798174,0.00027128737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774843,0.00015174696,0.00044966082,0.0005330728,0.00042416848,0.0006929406],"domain_scores_gemma":[0.998862,0.00021782196,0.00010935304,0.0002125163,0.00018189405,0.00041635858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011358625,0.0001749088,0.0003670556,0.00027123382,0.00018596223,0.000029473118,0.0004431762,0.00007884956,0.0003592804],"category_scores_gemma":[0.00054006366,0.00015874403,0.00008293067,0.0018431917,0.00048508303,0.00032176258,0.00027052173,0.00033300262,0.00007826387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008167493,0.00018745512,0.027101107,0.000028745497,0.000014178132,0.00013218037,0.00038314346,0.0017984778,0.92712337,0.00040161016,0.000014148794,0.042733904],"study_design_scores_gemma":[0.00059137313,0.000047989484,0.0060843425,0.000023715584,0.000044448854,0.000014376172,0.00014164513,0.011144091,0.94668925,0.00043708013,0.03456509,0.000216618],"about_ca_topic_score_codex":0.0000061680303,"about_ca_topic_score_gemma":0.000010166049,"teacher_disagreement_score":0.042517286,"about_ca_system_score_codex":0.0000673303,"about_ca_system_score_gemma":0.0003106453,"threshold_uncertainty_score":0.64733934},"labels":[],"label_agreement":null},{"id":"W3137479900","doi":"10.1101/2021.03.12.435209","title":"Massively parallel characterization of CYP2C9 variant enzyme activity and abundance","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Human Genome Research Institute; National Institutes of Health; National Institute of General Medical Sciences; Canadian Institute for Advanced Research","keywords":"Missense mutation; CYP2C9; Cytochrome P450; Massive parallel sequencing; Biology; Enzyme; Genetics; Computational biology; Mutation; Gene; Biochemistry; DNA sequencing","score_opus":0.046612369599209114,"score_gpt":0.3204385899186883,"score_spread":0.2738262203194792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137479900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804814,0.0029004547,0.0040302686,0.00039229973,0.0028374502,0.0007328445,0.00089865533,0.00013613983,0.000023753162],"genre_scores_gemma":[0.990208,0.0064141504,0.0019094326,0.000610474,0.00056472333,0.00016974079,0.0000026182304,0.00010405472,0.000016793156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99665385,0.00070470414,0.0006593394,0.0010415455,0.00032171083,0.00061882427],"domain_scores_gemma":[0.9972455,0.00013890206,0.00087157235,0.00071494473,0.00056594686,0.00046314957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008959154,0.0006386908,0.00092745305,0.00022505547,0.00021596263,0.00011893417,0.00049695716,0.001012177,0.00026499663],"category_scores_gemma":[0.00013480663,0.0007251177,0.00018185897,0.00036841678,0.00029533234,0.00020019671,0.00073834934,0.0015543912,0.000015621235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015840563,0.00042082922,0.0024708738,0.000532947,0.0004438479,0.00013387752,0.000052478357,0.00016397914,0.9950557,0.0004722668,0.000043618064,0.000051221145],"study_design_scores_gemma":[0.0011440082,0.000030293491,0.15804768,0.00012560627,0.00044135447,1.2439818e-7,0.000002044962,0.003491188,0.8244552,0.0000034665281,0.011594064,0.0006649658],"about_ca_topic_score_codex":0.000032752447,"about_ca_topic_score_gemma":0.0000014836704,"teacher_disagreement_score":0.17060044,"about_ca_system_score_codex":0.000094363735,"about_ca_system_score_gemma":0.00069193204,"threshold_uncertainty_score":0.99952},"labels":[],"label_agreement":null},{"id":"W3137613371","doi":"10.1002/pds.5226","title":"Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine","year":2021,"lang":"en","type":"review","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; BC Children's Hospital; University of British Columbia; McGill University Health Centre","funders":"National Cancer Institute; International Society for Pharmacoepidemiology; GlaxoSmithKline","keywords":"Pharmacoepidemiology; Medicine; Precision medicine; Multidisciplinary approach; Observational study; Data science; Pharmacology; Computer science; Internal medicine","score_opus":0.2707884065667415,"score_gpt":0.5345554753125937,"score_spread":0.2637670687458522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137613371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023728606,0.9675821,0.009712341,0.0047144787,0.0049307556,0.006231608,0.0014150002,0.000346517,0.005043451],"genre_scores_gemma":[0.000015397509,0.9601795,0.010767484,0.009651511,0.005972674,0.0016651411,0.0024050225,0.0003040769,0.009039185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97604614,0.013486895,0.004234388,0.0033929567,0.0003470684,0.00249255],"domain_scores_gemma":[0.9664424,0.027634764,0.0015679072,0.00096018077,0.00034637324,0.0030483764],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.01887427,0.0023499366,0.0094689205,0.00093638635,0.0011170257,0.000028340311,0.001683327,0.002213539,0.0018948403],"category_scores_gemma":[0.0055024605,0.0018950566,0.0016512817,0.0011396253,0.00086838467,0.00019877621,0.0015191071,0.003833541,0.00051858585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000654956,0.00038450427,0.000026897258,0.0034884275,0.0015552324,0.000028710798,0.0005853483,0.00025462863,0.00017902431,0.0011348141,0.3067116,0.68499583],"study_design_scores_gemma":[0.004918496,0.00014417597,0.000010672647,0.0017683436,0.008162447,0.00038694823,0.000048161754,0.0045089363,0.00005722242,0.0009153172,0.9773231,0.0017561892],"about_ca_topic_score_codex":0.000066259716,"about_ca_topic_score_gemma":0.0000031889435,"teacher_disagreement_score":0.68323964,"about_ca_system_score_codex":0.00025760903,"about_ca_system_score_gemma":0.0010320514,"threshold_uncertainty_score":0.9990818},"labels":[],"label_agreement":null},{"id":"W3137643018","doi":"10.3389/fphar.2021.636650","title":"Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations","year":2021,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Women and Children’s Health Research Institute; University of Alberta; University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Alberta Children's Hospital Research Institute; Alberta Innovates; University of Calgary","keywords":"Pharmacogenomics; Relevance (law); Computer science; Selection (genetic algorithm); Medicine; Pharmacology; Machine learning","score_opus":0.28351022781056223,"score_gpt":0.4678188859377251,"score_spread":0.18430865812716285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137643018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5260563,0.1391823,0.24976018,0.030256068,0.04374224,0.00646848,0.0034371638,0.00035911507,0.00073818484],"genre_scores_gemma":[0.864836,0.0066613946,0.11464731,0.011157755,0.0006295206,0.00077629474,0.0010811683,0.000093775365,0.00011678639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947111,0.0018315659,0.0012499533,0.0010824315,0.0003013984,0.0008235279],"domain_scores_gemma":[0.99677044,0.0014320859,0.00042495492,0.0006413251,0.00044933963,0.000281846],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020791949,0.00045462587,0.000782391,0.00058435596,0.00027534564,0.000030252155,0.0012209942,0.00043422083,0.0013565457],"category_scores_gemma":[0.00035131146,0.0005314693,0.00023627287,0.0009957129,0.00038981027,0.00044576087,0.00019454958,0.00082328136,0.000010274756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014781249,0.0008478279,0.007355727,0.0004238389,0.00034613322,0.000051170467,0.00036496995,0.02056356,0.7467035,0.00004115053,0.09434918,0.12747481],"study_design_scores_gemma":[0.0070111738,0.00007003239,0.00010155846,0.00006261974,0.0006797081,0.0000039619426,0.00007046089,0.34124488,0.3670508,0.00041508835,0.28296077,0.0003289532],"about_ca_topic_score_codex":0.000013714566,"about_ca_topic_score_gemma":0.000020052994,"teacher_disagreement_score":0.37965268,"about_ca_system_score_codex":0.00018802841,"about_ca_system_score_gemma":0.001782915,"threshold_uncertainty_score":0.99971366},"labels":[],"label_agreement":null},{"id":"W3142974974","doi":"10.1080/03602532.2021.1909613","title":"Pharmacogenomics in the era of next generation sequencing – from byte to bedside","year":2021,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada); Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Personalized medicine; Identification (biology); Precision medicine; Drug response; Medicine; Computational biology; Drug development; Bioinformatics; Biology; Drug; Genetics; Pharmacology; Gene","score_opus":0.4136524474297684,"score_gpt":0.4852137435891885,"score_spread":0.07156129615942008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142974974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015780855,0.98722416,0.00007358517,0.00026912088,0.005015926,0.004192152,0.00086810335,0.000031539035,0.0007473556],"genre_scores_gemma":[0.00007964975,0.9857627,0.0018218614,0.0062815477,0.0036106277,0.0011869371,0.0009110089,0.00014459173,0.00020103253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848151,0.008974731,0.003483352,0.0012497631,0.00052516494,0.00095185835],"domain_scores_gemma":[0.995511,0.0010218611,0.0015631121,0.00125633,0.00020104057,0.00044668437],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0063273,0.00124324,0.0056463275,0.00041577296,0.00023660134,0.00012696156,0.0020434558,0.0006415226,0.0012792664],"category_scores_gemma":[0.00043892427,0.00090542564,0.001664188,0.001809224,0.00013837185,0.0002097734,0.00044586635,0.0032459158,0.0005432208],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010859563,0.00017598754,0.0000024260723,0.0019626145,0.00036517406,0.000064303036,0.0021797323,0.00011984846,0.004162882,0.00031298742,0.013014595,0.9776286],"study_design_scores_gemma":[0.0006511404,0.0000070934393,0.0000025393413,0.00199389,0.0054583023,0.000031661875,0.00008917578,0.00022161276,0.001789632,0.00005122031,0.9888804,0.0008233359],"about_ca_topic_score_codex":0.00025579953,"about_ca_topic_score_gemma":0.00010183476,"teacher_disagreement_score":0.97680527,"about_ca_system_score_codex":0.00018244109,"about_ca_system_score_gemma":0.0009024267,"threshold_uncertainty_score":0.99963367},"labels":[],"label_agreement":null},{"id":"W3150399700","doi":"10.1111/fcp.12674","title":"The numerical probability of carcinogenicity to humans of some pharmaceutical drugs: Alkylating agents, topoisomerase inhibitors or poisons, and DNA intercalators","year":2021,"lang":"en","type":"article","venue":"Fundamental and Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacology; Predictive testing; Safety pharmacology; Risk assessment; European union; Carcinogen; Oxcarbazepine; Toxicology; Drug; Carbamazepine; Biology; Genetic testing; Internal medicine; Business; Psychiatry; Computer science","score_opus":0.14353205725434814,"score_gpt":0.48414025489091667,"score_spread":0.3406081976365685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3150399700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867082,0.004592712,0.000014995339,0.0038224305,0.0035379352,0.00081480213,0.00024429132,0.000033440632,0.00023114559],"genre_scores_gemma":[0.98810434,0.003945568,0.00023111218,0.006661012,0.00071137556,0.00006176723,0.000015174747,0.000031444346,0.000238179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99464995,0.001822362,0.0017367891,0.0007756651,0.0003072387,0.00070802105],"domain_scores_gemma":[0.9955022,0.002764431,0.0004021524,0.00024987006,0.00019947943,0.0008818666],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002017684,0.0003942615,0.0009152134,0.00008406786,0.00043254683,0.000027464963,0.00036709072,0.00034824188,0.0012274579],"category_scores_gemma":[0.00041487205,0.00029193002,0.00030213912,0.00035065698,0.0014588101,0.00012076036,0.000951195,0.0011349925,0.00001688962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009723992,0.006353677,0.29824594,0.0006263938,0.0032618633,0.00019932346,0.003655246,0.00009969897,0.43008843,0.0022210057,0.020356307,0.22516815],"study_design_scores_gemma":[0.013294415,0.0016503924,0.04963583,0.000069156755,0.0024824126,0.0001008057,0.0022749412,0.0037917718,0.56777,0.0017292191,0.356203,0.0009980638],"about_ca_topic_score_codex":0.0000348682,"about_ca_topic_score_gemma":0.000017136515,"teacher_disagreement_score":0.33584666,"about_ca_system_score_codex":0.000057970094,"about_ca_system_score_gemma":0.00023708626,"threshold_uncertainty_score":0.99995327},"labels":[],"label_agreement":null},{"id":"W3151820029","doi":"10.1016/j.jbc.2021.100645","title":"Amphipol-facilitated elucidation of the functional tetrameric complex of full-length cytochrome P450 CYP2B4 and NADPH-cytochrome P450 oxidoreductase","year":2021,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Oxidoreductase; Cytochrome P450; Chemistry; Cytochrome; Stereochemistry; Biology; Biochemistry; Enzyme","score_opus":0.14069016616531782,"score_gpt":0.3828959785332188,"score_spread":0.24220581236790095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151820029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947837,0.0032649327,0.00010147311,0.0008130541,0.00019098353,0.000111091715,0.0002265273,0.000009335037,0.00049888017],"genre_scores_gemma":[0.9972606,0.0012868801,0.0005144864,0.00044030452,0.00032468542,0.0000044619474,0.000053593732,0.000009959363,0.00010505855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978979,0.00037721463,0.0008970807,0.00024896767,0.00029490766,0.00028392882],"domain_scores_gemma":[0.9978072,0.00040833006,0.00080497726,0.00018939351,0.00054696103,0.00024315648],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000669053,0.00023223832,0.00056151097,0.000045826986,0.000123918,0.000011224714,0.00031136884,0.00033707608,0.0025041853],"category_scores_gemma":[0.0004649922,0.00015782968,0.00027850532,0.00035221185,0.0007441322,0.00005735749,0.00014688297,0.00080697436,0.0000036383965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048084697,0.000462272,0.0011517704,0.000102733604,0.00028928026,0.000045727887,0.00008680792,0.00029580362,0.9941861,0.00003289542,0.0010575398,0.0018082164],"study_design_scores_gemma":[0.0018792013,0.00014751988,0.08529325,0.000028117982,0.0002130216,0.0012467306,0.00022052672,0.0002699991,0.89767724,0.0004605502,0.012382059,0.00018175447],"about_ca_topic_score_codex":0.000002408861,"about_ca_topic_score_gemma":3.033832e-7,"teacher_disagreement_score":0.09650884,"about_ca_system_score_codex":0.000043696873,"about_ca_system_score_gemma":0.00024176609,"threshold_uncertainty_score":0.99840766},"labels":[],"label_agreement":null},{"id":"W3152442784","doi":"10.1007/978-1-60327-362-6_4","title":"Drug-Metabolizing Enzymes","year":2009,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Xenobiotic; Drug; Enzyme; Drug metabolism; Biology; Computational biology; Pharmacology; Disposition; Biochemistry; Psychology","score_opus":0.21896576076369156,"score_gpt":0.42021657745495455,"score_spread":0.201250816691263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152442784","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001046049,0.13574019,0.0000088122815,0.00006721764,0.0024292553,0.0007374993,0.00021377382,0.00029720637,0.86040145],"genre_scores_gemma":[0.0051810015,0.015613216,0.00015096599,0.003936124,0.0031219518,0.00006545555,0.00008904035,0.00021502863,0.97162724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965674,0.00021874237,0.00087930437,0.000941934,0.000478651,0.00091392075],"domain_scores_gemma":[0.99778837,0.00019031852,0.0005398647,0.0007317559,0.00018919107,0.00056049635],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062443747,0.0010002184,0.0010647209,0.00031900004,0.00048012167,0.00009363393,0.0009805324,0.0010306399,0.0024248168],"category_scores_gemma":[0.000016197864,0.0010410026,0.00053247024,0.0000116727615,0.0003847735,0.00006646328,0.00034100245,0.0024340705,0.00038327312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010908147,0.000054910895,6.026674e-7,0.00008855666,0.0005595508,0.00017247838,0.0005478226,0.000046803605,0.00082116545,0.46820772,0.051087093,0.47830424],"study_design_scores_gemma":[0.001322913,0.000030607178,0.0000075955936,0.00006585227,0.0012391243,0.000021823867,0.000005243214,0.00009429809,0.01859343,0.020097543,0.95750624,0.0010153417],"about_ca_topic_score_codex":0.000032164775,"about_ca_topic_score_gemma":0.000020967429,"teacher_disagreement_score":0.90641916,"about_ca_system_score_codex":0.00006163371,"about_ca_system_score_gemma":0.00012972749,"threshold_uncertainty_score":0.9998674},"labels":[],"label_agreement":null},{"id":"W3153779616","doi":"10.1007/s12010-021-03573-1","title":"Optimisation of Cytochrome P450 BM3 Assisted by Consensus-Guided Evolution","year":2021,"lang":"en","type":"article","venue":"Applied Biochemistry and Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cofactor; Bacillus megaterium; Mutant; Chemistry; Thermostability; Enzyme; Protein engineering; Directed evolution; Biochemistry; Reductase; Oxidase test; Oxidoreductase; Stereochemistry; Biology; Gene","score_opus":0.04895245608808637,"score_gpt":0.3611584704064935,"score_spread":0.31220601431840717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153779616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891587,0.0038502968,0.00023437076,0.0021932593,0.00018342659,0.00018998986,0.0001901986,0.00011600643,0.0038837348],"genre_scores_gemma":[0.99656373,0.00093076326,0.0011885316,0.00048297984,0.00007872791,0.000030765652,0.00016399674,0.00001578362,0.00054473453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985742,0.000073355644,0.00042103013,0.00047699086,0.00011468267,0.00033976045],"domain_scores_gemma":[0.999153,0.00010529847,0.00021528803,0.0002770807,0.0001154317,0.00013391176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002736675,0.00023026118,0.00034078184,0.00006730441,0.00014374442,0.000009162071,0.00018107246,0.0011051627,0.00026997286],"category_scores_gemma":[0.00007752058,0.0002415079,0.00006410064,0.00033612884,0.00062407483,0.000012949336,0.00016467764,0.00053238735,0.00001281972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090931615,0.00022424877,0.0000931924,0.00008478958,0.00013541595,0.000013836077,0.00002624092,0.000012347736,0.9790646,0.002951916,0.0048648654,0.012437624],"study_design_scores_gemma":[0.0015099387,0.00002331683,0.00027419353,0.00000713338,0.00014837953,0.00016199173,0.00014434205,0.00020104008,0.9537274,0.000865284,0.042699374,0.00023757406],"about_ca_topic_score_codex":0.000005112806,"about_ca_topic_score_gemma":8.054102e-7,"teacher_disagreement_score":0.03783451,"about_ca_system_score_codex":0.00004311284,"about_ca_system_score_gemma":0.00013065863,"threshold_uncertainty_score":0.9848407},"labels":[],"label_agreement":null},{"id":"W3154287913","doi":"10.1007/s12104-021-10024-9","title":"1H, 13C and 15N chemical shift assignments of the C-terminal domain of human UDP-Glucuronosyltransferase 2B7 (UGT2B7-C)","year":2021,"lang":"en","type":"article","venue":"Biomolecular NMR Assignments","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institutes of Health","keywords":"UGT2B7; Glucuronidation; Chemistry; Glucuronosyltransferase; Enzyme; Biochemistry; Pharmacology; Stereochemistry; Biology","score_opus":0.05190881118395088,"score_gpt":0.3939884056558117,"score_spread":0.34207959447186087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154287913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360096,0.0016324305,0.0010611376,0.00035804365,0.00055234146,0.00041059955,0.00020069409,0.000017627397,0.0021661653],"genre_scores_gemma":[0.9982171,0.00015556836,0.00034173747,0.0009217625,0.00009615156,0.00003093269,0.000044359596,0.000039937182,0.00015241638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996949,0.0008052094,0.00068182056,0.0005146753,0.0005447786,0.00050449645],"domain_scores_gemma":[0.99878424,0.00009698221,0.0002658827,0.0004519052,0.000091582304,0.00030942104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056297716,0.00035022284,0.0004936005,0.00008277202,0.00019938417,0.000023100723,0.000525374,0.00031179472,0.0005816451],"category_scores_gemma":[0.00003972804,0.00030376235,0.00025963897,0.00029816496,0.00053204916,0.0000624079,0.00046243018,0.00043709838,0.000010289869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011086048,0.0008013404,0.008507988,0.00009770218,0.00037000724,0.00014919086,0.00048564043,0.000011667719,0.98485917,0.0008881194,0.00020594352,0.0035123685],"study_design_scores_gemma":[0.0033729195,0.000080853686,0.00995811,0.00004467786,0.0003927683,0.000043905686,0.00006447745,0.00010378271,0.9735613,0.0017070565,0.010374184,0.0002959928],"about_ca_topic_score_codex":0.000014651104,"about_ca_topic_score_gemma":0.000002183066,"teacher_disagreement_score":0.011297898,"about_ca_system_score_codex":0.000048105012,"about_ca_system_score_gemma":0.00013777112,"threshold_uncertainty_score":0.99994147},"labels":[],"label_agreement":null},{"id":"W3156238525","doi":"10.1002/jgc4.1417","title":"Pharmacogenomic education among genetic counseling training programs in North America","year":2021,"lang":"en","type":"article","venue":"Journal of Genetic Counseling","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Genetic counseling; Medicine; Medical education; Scope (computer science); Family medicine; Psychology; Pharmacology; Genetics; Computer science; Biology","score_opus":0.09227301561252313,"score_gpt":0.3854470921131844,"score_spread":0.2931740765006613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156238525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544591,0.039249633,0.0015449517,0.00022697671,0.003820094,0.0003403241,0.000013686551,0.000026731735,0.00031850397],"genre_scores_gemma":[0.9628649,0.025566254,0.0077849026,0.0018672933,0.0016544173,0.000031458392,0.000018811937,0.000069696165,0.00014227782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959505,0.00065460533,0.0016342489,0.00044582985,0.0005295644,0.00078520505],"domain_scores_gemma":[0.9972022,0.00025883375,0.00090823043,0.0002465721,0.0008455361,0.0005386119],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010548593,0.00039805425,0.00069766643,0.00039789212,0.00022327162,0.000102036756,0.0005114002,0.00022519959,0.00053162075],"category_scores_gemma":[0.000121674726,0.00042390922,0.0002962428,0.0008829044,0.00017898981,0.00015361195,0.00005938004,0.0013593362,0.000036261114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022090573,0.0009042162,0.086084336,0.000092575145,0.00033670754,0.00065136235,0.018944578,0.054932795,0.07621929,0.000004216248,0.00048425212,0.7611248],"study_design_scores_gemma":[0.011454861,0.000505698,0.09508284,0.00049365143,0.002502982,0.0029687486,0.020174773,0.063567534,0.015592842,0.0010191838,0.78435826,0.0022786239],"about_ca_topic_score_codex":0.000025539763,"about_ca_topic_score_gemma":0.00010785056,"teacher_disagreement_score":0.78387403,"about_ca_system_score_codex":0.00016176855,"about_ca_system_score_gemma":0.0019419679,"threshold_uncertainty_score":0.99982125},"labels":[],"label_agreement":null},{"id":"W3158165938","doi":"10.1016/j.taap.2021.115553","title":"Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification","year":2021,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta; University of Alberta","keywords":"Mefenamic acid; Chemistry; Enzyme; Non-competitive inhibition; Metabolism; Sulfotransferase; Recombinant DNA; Biochemistry; Substrate (aquarium); Metabolite; Enzyme kinetics; Sulfation; Pharmacology; Chromatography; Biology; Active site","score_opus":0.0478711672261613,"score_gpt":0.3618449695363472,"score_spread":0.3139738023101859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158165938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913842,0.0037495992,0.0020802894,0.0007924081,0.00053012016,0.0011686356,0.00022053915,0.000017659193,0.00005655858],"genre_scores_gemma":[0.9942347,0.004381805,0.00008136004,0.00064155745,0.00013389382,0.00024895207,0.00021422567,0.000022564942,0.000040975676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783564,0.0004589715,0.00090292405,0.00038034032,0.00012455994,0.00029754476],"domain_scores_gemma":[0.99863946,0.00025237212,0.00061494455,0.00015278309,0.00024357223,0.000096858035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089588185,0.00024228416,0.0005301069,0.00016510331,0.0003412753,0.000013525957,0.00015822277,0.00031078293,0.00007450812],"category_scores_gemma":[0.000023125098,0.00021687905,0.00008112354,0.0001807876,0.00065275293,0.00009913345,0.00010423216,0.00028355778,0.0000010714872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006015724,0.00031384674,0.0001068829,0.00029729487,0.00027049534,0.0000017766976,0.0013835204,0.00007992877,0.9729583,0.006454271,0.000019085584,0.017513005],"study_design_scores_gemma":[0.0032941143,0.000118382995,0.008828007,0.000007830016,0.0012446356,0.000045386863,0.00027490084,0.0018112907,0.98129296,0.0014934099,0.0014138604,0.00017524103],"about_ca_topic_score_codex":0.0000054423754,"about_ca_topic_score_gemma":0.0000064028895,"teacher_disagreement_score":0.017337764,"about_ca_system_score_codex":0.000015603055,"about_ca_system_score_gemma":0.000082053804,"threshold_uncertainty_score":0.8844071},"labels":[],"label_agreement":null},{"id":"W3158869533","doi":"10.3390/ijms22094967","title":"Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity","year":2021,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Diabetes mellitus; Pharmacogenomics; Pharmacology; Population; Type 2 Diabetes Mellitus; Polypharmacy; Cytochrome P450; Disease; Drug; Metabolic syndrome; Internal medicine; Bioinformatics; Endocrinology; Biology; Metabolism","score_opus":0.10230852827192156,"score_gpt":0.42585599530431945,"score_spread":0.3235474670323979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158869533","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5262922,0.473157,0.000011024081,0.0000099311055,0.00038475514,0.00010719298,0.000016241444,0.0000014492164,0.00002024286],"genre_scores_gemma":[0.48874325,0.5110347,0.00009718516,0.000019774996,0.00008266998,0.0000032466146,0.000008900824,0.000008075955,0.0000022021518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978793,0.00052343414,0.00055147574,0.00021765556,0.0006016916,0.0002264169],"domain_scores_gemma":[0.99816126,0.0001736324,0.0010079131,0.000075234675,0.00047318882,0.00010876496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076863705,0.00020070089,0.0006331992,0.0004051921,0.00004487423,0.00003895702,0.00045113135,0.00017854551,0.00005725366],"category_scores_gemma":[0.00010166515,0.00014804401,0.00011785866,0.00029204323,0.00023709693,0.00023625376,0.0001512211,0.0005246385,7.409037e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008314978,0.0003017199,0.01014731,0.0006327068,0.0005626813,0.00006634491,0.0001683819,0.0021812285,0.04175908,0.00008706544,0.000008989931,0.9440013],"study_design_scores_gemma":[0.014336035,0.0027341882,0.25922224,0.027108377,0.0026449533,0.00009261657,0.00013071176,0.0019031401,0.085137464,0.0009483346,0.6033741,0.0023678064],"about_ca_topic_score_codex":0.0000025528323,"about_ca_topic_score_gemma":0.0000019225242,"teacher_disagreement_score":0.9416335,"about_ca_system_score_codex":0.000111293295,"about_ca_system_score_gemma":0.00086498144,"threshold_uncertainty_score":0.60370594},"labels":[],"label_agreement":null},{"id":"W3160783224","doi":"10.3389/fphar.2021.693922","title":"Editorial: Pharmacokinetic Evaluation and Modeling of Clinically Significant Drug Metabolites","year":2021,"lang":"en","type":"editorial","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pharmacokinetics; Drug; Pharmacology; Drug metabolism; Medicine","score_opus":0.0653721387909663,"score_gpt":0.44584092350333554,"score_spread":0.3804687847123692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160783224","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012164094,0.052951686,0.00033609764,0.00024252787,0.93052745,0.0017413577,0.0008178988,0.00007822837,0.0011406863],"genre_scores_gemma":[0.022106608,0.06382364,0.0021439174,0.00051561947,0.9095247,0.0005822165,0.00076953054,0.00018813349,0.00034565723],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9871771,0.0049853246,0.0031009756,0.0017473858,0.0016454736,0.001343769],"domain_scores_gemma":[0.9930692,0.00246713,0.0013405369,0.0004973369,0.001968826,0.0006569829],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009833335,0.00108596,0.0026036128,0.0010137518,0.00020001241,0.00005313033,0.0011432173,0.0026996862,0.0011413627],"category_scores_gemma":[0.0017823001,0.0011887271,0.00044031272,0.0008223732,0.000721577,0.0002080158,0.0006162672,0.005398522,0.000014611487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013900455,0.00077086687,0.00066955504,0.00044699767,0.0012403828,0.000050928586,0.00066103385,0.011576707,0.024345918,0.00001166767,0.9417466,0.017089315],"study_design_scores_gemma":[0.00917881,0.00008709673,0.0000064351993,0.00006772974,0.0041351877,0.000002416664,0.00018325959,0.15707313,0.0075866035,0.0008806994,0.8199282,0.0008704139],"about_ca_topic_score_codex":0.00008825867,"about_ca_topic_score_gemma":0.000006269489,"teacher_disagreement_score":0.14549641,"about_ca_system_score_codex":0.00027992998,"about_ca_system_score_gemma":0.002155097,"threshold_uncertainty_score":0.9997717},"labels":[],"label_agreement":null},{"id":"W3161677145","doi":"10.48087/bjmstf.2014.1211","title":"Update on the drug-food interactions","year":2014,"lang":"en","type":"article","venue":"Batna Journal of Medical Sciences (BJMS)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Theophylline; Pharmacology; Chemistry; Grapefruit juice; Caffeine; Pharmacokinetics; Drug interaction; Drug metabolism; Pharmacodynamics; Free fraction; Medicine; Internal medicine","score_opus":0.18164412083202278,"score_gpt":0.4758485892151876,"score_spread":0.29420446838316483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161677145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8505497,0.0012281502,0.00059200823,0.11927724,0.0071884817,0.00012141875,0.000009402122,0.000017465036,0.021016145],"genre_scores_gemma":[0.9784186,0.0011788246,0.00011567276,0.01838742,0.0016798527,0.000004442906,4.6436622e-7,0.000007898762,0.00020681163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99659264,0.0010082846,0.0005393181,0.00018549274,0.0012727604,0.00040149566],"domain_scores_gemma":[0.9971242,0.0016837934,0.00035531502,0.00013267212,0.00010116284,0.0006028826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008910295,0.00015464891,0.00024947777,0.00015017421,0.00052991975,0.00006303444,0.0014940305,0.00011772141,0.007958824],"category_scores_gemma":[0.0010929662,0.00008519528,0.00016931456,0.00037281736,0.00079494936,0.00012911783,0.00013736256,0.0014533467,0.0002636686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032722135,0.00150042,0.0029730948,0.000028733753,0.000481151,0.00011180246,0.0016924134,0.0022440448,0.008248615,0.18017788,0.3254877,0.47672692],"study_design_scores_gemma":[0.0010166276,0.00024537402,0.00048947474,0.00004016545,0.000092478105,0.00016941715,0.00014983267,0.0066150716,0.00881182,0.004744557,0.9774927,0.00013246978],"about_ca_topic_score_codex":0.0000048327884,"about_ca_topic_score_gemma":0.000014441235,"teacher_disagreement_score":0.652005,"about_ca_system_score_codex":0.000027074198,"about_ca_system_score_gemma":0.0002854913,"threshold_uncertainty_score":0.99294806},"labels":[],"label_agreement":null},{"id":"W3163833951","doi":"10.1002/prp2.775","title":"The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs","year":2021,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University; Nova Scotia Health Research Foundation; Consortium canadien en neurodégénérescence associée au vieillissement","keywords":"Anticholinergic; CYP2D6; Medicine; Pharmacokinetics; Pharmacology; Adverse effect; Drug; CYP2C19; Population; Drug metabolism; Internal medicine; Cytochrome P450; Metabolism","score_opus":0.18636445799063292,"score_gpt":0.5187489279675305,"score_spread":0.3323844699768975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163833951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021203812,0.9706887,0.0000016983284,0.0005368154,0.00087036146,0.0020885027,0.00048294637,0.000025253099,0.004101911],"genre_scores_gemma":[0.08916319,0.9087233,0.00005755695,0.000130374,0.00071957806,0.0003640623,0.000020188614,0.00011355556,0.00070817146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.985821,0.009144663,0.0016763571,0.0010240132,0.0010407071,0.0012932733],"domain_scores_gemma":[0.9853838,0.011295669,0.0010802614,0.00077487365,0.0010584032,0.0004069949],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044594253,0.0008311572,0.0026260295,0.00073654164,0.00071490253,0.00004263356,0.0020137925,0.00067055406,0.0010099073],"category_scores_gemma":[0.0004434761,0.00053378445,0.00082286977,0.0014704886,0.0059642233,0.00005778281,0.0011190491,0.0038659195,0.000018448327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006049218,0.0023037312,0.000080479665,0.0032135365,0.0069917184,0.00025701447,0.009197386,0.00007211362,0.06940637,0.016383655,0.0068586776,0.8846304],"study_design_scores_gemma":[0.0012793913,0.0002958143,0.000024040106,0.0005041152,0.002575494,0.00006424673,0.0031651917,0.00028542904,0.10443048,0.00062394526,0.88631785,0.00043402385],"about_ca_topic_score_codex":0.000046322326,"about_ca_topic_score_gemma":0.0000031159655,"teacher_disagreement_score":0.8841964,"about_ca_system_score_codex":0.00011348339,"about_ca_system_score_gemma":0.000999813,"threshold_uncertainty_score":0.9999033},"labels":[],"label_agreement":null},{"id":"W3163983628","doi":"10.1111/cts.13083","title":"Pharmacogenomic‐based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Health care; Pharmacogenomics; Personalized medicine; Medicine; Business; Public relations; Medical education; Family medicine; Knowledge management; Computer science; Political science; Bioinformatics; Pharmacology","score_opus":0.2621606496445811,"score_gpt":0.5196457410110468,"score_spread":0.2574850913664657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163983628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527321,0.002917514,0.0000437143,0.040662393,0.0006143684,0.00036062117,0.00028624342,0.0000124704575,0.0023706153],"genre_scores_gemma":[0.99035144,0.0003518556,0.00023382556,0.00880523,0.00018742589,0.000019107112,0.00002406286,0.000005180535,0.000021894451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979841,0.00054503017,0.00034604868,0.00045814033,0.00034618948,0.00032045183],"domain_scores_gemma":[0.99824834,0.00086959614,0.000056701843,0.000078586105,0.0001591035,0.0005876634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024897726,0.00012901866,0.00017831073,0.00012209328,0.0008696881,0.000038084603,0.00018447451,0.00008566236,0.00043829883],"category_scores_gemma":[0.00013319142,0.00009716416,0.00004799219,0.0003561462,0.0020255742,0.000075209595,0.000013021183,0.00045375366,0.000004186998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004788925,0.00025889333,0.60471594,0.0001082346,0.00012766007,0.00027311326,0.024969107,0.00071162696,0.0062832274,0.3273593,0.000705693,0.03400834],"study_design_scores_gemma":[0.014189321,0.00014891035,0.8013978,0.000056800338,0.00020363626,0.00008038566,0.020697618,0.03110496,0.0007439759,0.0016402942,0.12924878,0.00048751087],"about_ca_topic_score_codex":0.0013057584,"about_ca_topic_score_gemma":0.005777961,"teacher_disagreement_score":0.325719,"about_ca_system_score_codex":0.000047782545,"about_ca_system_score_gemma":0.0013003505,"threshold_uncertainty_score":0.7463312},"labels":[],"label_agreement":null},{"id":"W3165001409","doi":"10.1001/jamanetworkopen.2021.10446","title":"Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting","year":2021,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; SickKids Foundation; University of Toronto; Institute for Clinical Evaluative Sciences; Ted Rogers Centre for Heart Research; Hospital for Sick Children","funders":"","keywords":"Pharmacogenomics; Medicine; Cohort; Pharmacogenetics; Adverse effect; Dosing; Genetic testing; Intensive care medicine; Internal medicine; Pharmacology; Genotype; Genetics","score_opus":0.07478268916283516,"score_gpt":0.46571302854056784,"score_spread":0.3909303393777327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165001409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987978,0.00378051,0.00001554702,0.0004670899,0.0009519142,0.000756067,0.00008909509,0.00000841485,0.0059534074],"genre_scores_gemma":[0.9952682,0.0006162393,0.0021419262,0.0012764867,0.000536856,0.000068192785,0.00003152191,0.000022025653,0.00003850455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733245,0.0011208863,0.0007035018,0.0002840461,0.0001772706,0.0003818414],"domain_scores_gemma":[0.9985178,0.00045941817,0.0004891642,0.00022687035,0.00022398474,0.00008273174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001473127,0.00016312819,0.00029530007,0.000057163743,0.00015052411,0.000031911917,0.0006608147,0.00011749864,0.00049160706],"category_scores_gemma":[0.000050305254,0.00014432216,0.00009458334,0.00069204415,0.0000460453,0.00012305831,0.00087622926,0.00053705426,0.0000023579369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002087872,0.00009043014,0.89883786,0.00011317677,0.00006958579,0.000014175875,0.0008469124,0.010166786,0.045388404,0.00011694251,0.0007798083,0.04355503],"study_design_scores_gemma":[0.003013604,0.000015644206,0.9266958,0.0000375674,0.000282996,0.000007522406,0.00076739903,0.0034535436,0.06179377,0.00015601146,0.0036194976,0.00015661027],"about_ca_topic_score_codex":0.00010651736,"about_ca_topic_score_gemma":0.00008331061,"teacher_disagreement_score":0.043398418,"about_ca_system_score_codex":0.000065006985,"about_ca_system_score_gemma":0.0006504464,"threshold_uncertainty_score":0.5885287},"labels":[],"label_agreement":null},{"id":"W3167235221","doi":"10.1096/fasebj.27.1_supplement.672.2","title":"FUNCTIONAL ACTIVITY IN HUMAN HEART EXPRESSING CYP1A1","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Metabolite; Western blot; Microsome; Cytosol; Chemistry; Metabolism; Monoclonal antibody; Human heart; Biochemistry; Active metabolite; Molecular biology; Pharmacology; Biology; Antibody; Enzyme; Internal medicine; Medicine; Gene; Immunology","score_opus":0.14030844601327447,"score_gpt":0.4162957883799558,"score_spread":0.2759873423666813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167235221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99086374,0.0007157779,0.00016515843,0.0025205761,0.0014782613,0.0001985432,0.000006804419,0.000022567441,0.00402859],"genre_scores_gemma":[0.9952754,0.0001113194,0.000075296535,0.002495085,0.0010649856,0.000025884681,0.0000021498668,0.000017674423,0.0009322134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981438,0.00074425404,0.000282402,0.00015835503,0.0002129102,0.00045829453],"domain_scores_gemma":[0.99920034,0.00019992147,0.00013323335,0.00014183676,0.0000794183,0.0002452522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011802582,0.00016671236,0.0001929969,0.00011945373,0.00070396747,0.000094389565,0.00027609675,0.0001305953,0.00688621],"category_scores_gemma":[0.000029611152,0.00011885912,0.00011541493,0.00014950888,0.000163746,0.00023658147,0.00008766437,0.0015894966,0.0003193616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005687572,0.00016982462,0.007700837,0.0000036292072,0.00004414652,0.000014400388,0.00026569495,0.0012423105,0.96749425,0.00012289351,0.012535026,0.010350107],"study_design_scores_gemma":[0.00238044,0.000041608004,0.11449442,0.000014983254,0.00007481302,0.00031860376,0.0001416986,0.0028180862,0.8369951,0.004409137,0.03805267,0.00025840465],"about_ca_topic_score_codex":0.00004094899,"about_ca_topic_score_gemma":0.000004962414,"teacher_disagreement_score":0.13049912,"about_ca_system_score_codex":0.000053911073,"about_ca_system_score_gemma":0.000077565855,"threshold_uncertainty_score":0.99402165},"labels":[],"label_agreement":null},{"id":"W3167236456","doi":"10.3389/fendo.2021.633785","title":"Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase","year":2021,"lang":"en","type":"article","venue":"Frontiers in Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Freie Universität Berlin; World Anti-Doping Agency","keywords":"Pregnenolone; Hydroxylation; Steroid; Enzyme; Biosynthesis; Cytochrome P450; Biochemistry; Chemistry; Biotransformation; Steroid biosynthesis; Schizosaccharomyces pombe; Yeast; Saccharomyces cerevisiae; Hormone","score_opus":0.035982251324195226,"score_gpt":0.34676760779807475,"score_spread":0.3107853564738795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167236456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92665845,0.044701196,0.00070776924,0.0008174306,0.0053931363,0.00054605555,0.00049973535,0.00010509573,0.02057111],"genre_scores_gemma":[0.9817789,0.012737055,0.001817363,0.0010891636,0.0001912384,0.0000676536,0.0001533971,0.000050542305,0.0021146717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963613,0.0010955344,0.0008476135,0.00064813375,0.00020073325,0.00084665004],"domain_scores_gemma":[0.9985171,0.00028391226,0.0003352708,0.00046827816,0.00018247784,0.00021294592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034866127,0.00034791027,0.00083599746,0.00033749975,0.000103169754,0.000013397462,0.0004010522,0.0003591158,0.00086342276],"category_scores_gemma":[0.00032901322,0.00038374815,0.0001634667,0.000478022,0.0003376654,0.00012238811,0.00021835488,0.00067767646,0.00010034817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006972652,0.0011167316,0.048576355,0.00017531519,0.00058434764,0.00038156527,0.00043542543,0.000386739,0.8084492,0.00018559991,0.057064444,0.081946984],"study_design_scores_gemma":[0.0028574765,0.00011585676,0.002595725,0.000035225363,0.0002599752,0.00006031866,0.00009651423,0.0028961971,0.6628989,0.00042655464,0.32737607,0.000381187],"about_ca_topic_score_codex":0.000017830887,"about_ca_topic_score_gemma":0.000005760242,"teacher_disagreement_score":0.27031162,"about_ca_system_score_codex":0.00009212051,"about_ca_system_score_gemma":0.00009948106,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W3167472691","doi":"10.1096/fasebj.27.1_supplement.672.3","title":"Genetic and clinical determinants of CYP3A4 activity in patients using 4β‐hydroxycholesterol as an in vivo probe","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"CYP3A; In vivo; CYP3A4; Chemistry; Metabolite; CYP3A5; Pharmacokinetics; Genotyping; Endocrinology; Cytochrome P450; Internal medicine; Pharmacology; Genotype; Metabolism; Biochemistry; Biology; Medicine; Gene; Genetics","score_opus":0.11065352537229572,"score_gpt":0.4468736080368727,"score_spread":0.336220082664577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167472691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854547,0.00020590302,0.000014631767,0.00005497263,0.00061714917,0.0004553667,0.000012274018,0.000004431708,0.00008979135],"genre_scores_gemma":[0.9986602,0.00045558542,0.00018704585,0.00048465334,0.00016643791,0.000007838948,2.9446264e-7,0.000017643071,0.00002031076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972698,0.0013295404,0.00064020115,0.0002063158,0.00017128189,0.00038284302],"domain_scores_gemma":[0.998987,0.00016790103,0.0003343833,0.00016227101,0.00007916205,0.00026925266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013668103,0.00017372351,0.0003401537,0.0001467979,0.00012430931,0.00003330841,0.00030424143,0.00019001456,0.0002921928],"category_scores_gemma":[0.00005960219,0.00012976272,0.00006771927,0.00013962277,0.00022622292,0.00021306217,0.0001111516,0.0009917229,0.00001153203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002254406,0.0006803659,0.79705065,0.000010328292,0.000026794054,0.0000195933,0.0004353494,0.00022859419,0.15734223,0.0000017165922,0.000012915839,0.043966],"study_design_scores_gemma":[0.004374968,0.00025086087,0.8808715,0.000029710978,0.00008965683,0.00007219029,0.00004902213,0.023444438,0.08990661,0.00062711345,0.000118548734,0.00016540995],"about_ca_topic_score_codex":0.00012849907,"about_ca_topic_score_gemma":0.000057496836,"teacher_disagreement_score":0.08382079,"about_ca_system_score_codex":0.00003174401,"about_ca_system_score_gemma":0.000090448746,"threshold_uncertainty_score":0.529157},"labels":[],"label_agreement":null},{"id":"W3169297055","doi":"10.3390/molecules26123614","title":"Molecular Dynamics Simulations of a Cytochrome P450 from Tepidiphilus thermophilus (P450-TT) Reveal How Its Substrate-Binding Channel Opens","year":2021,"lang":"en","type":"article","venue":"Molecules","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cytochrome P450; Molecular dynamics; Chemistry; Substrate (aquarium); Enzyme; Stereochemistry; Molecule; Xenobiotic; Side chain; Biophysics; Biochemistry; Computational chemistry; Organic chemistry; Biology; Polymer","score_opus":0.08729028499090143,"score_gpt":0.38269713511132236,"score_spread":0.29540685012042095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169297055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98404086,0.005386647,0.0014610846,0.0025810667,0.0006048666,0.00049404934,0.0024054726,0.00007772279,0.0029482606],"genre_scores_gemma":[0.9962508,0.0004424786,0.00048785776,0.0012492465,0.00021740809,0.00004010581,0.0006612872,0.000083772335,0.00056700985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970797,0.0006762731,0.0005556127,0.0006589687,0.00035506336,0.00067440455],"domain_scores_gemma":[0.9981478,0.0003298612,0.00031539513,0.0004630939,0.00038232162,0.00036153712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003274041,0.0004451127,0.000633308,0.00017661035,0.00028511684,0.00006938195,0.00052334287,0.0004401316,0.0005850208],"category_scores_gemma":[0.00017758405,0.00047909076,0.00027605132,0.0005343943,0.00018586917,0.00012980784,0.0002969051,0.00071776775,0.00006325814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100456644,0.00035755412,0.00021439389,0.000046789824,0.0005069316,0.0005428717,0.00058268924,0.020407178,0.97352785,0.002103646,0.00019584353,0.001413774],"study_design_scores_gemma":[0.0024428095,0.000058633927,0.0036526609,0.000045993973,0.00056687644,0.00003540707,0.0002023427,0.089592956,0.8963178,0.0025714189,0.003912622,0.0006004794],"about_ca_topic_score_codex":0.000028292783,"about_ca_topic_score_gemma":0.00005108535,"teacher_disagreement_score":0.07721007,"about_ca_system_score_codex":0.00011103209,"about_ca_system_score_gemma":0.00033293464,"threshold_uncertainty_score":0.99976605},"labels":[],"label_agreement":null},{"id":"W3172196938","doi":"10.1096/fasebj.27.1_supplement.666.2","title":"An investigation of morphine‐to‐codeine metabolic ratios in postmortem blood, drug interactions, and cytochrome P450 2D6 (CYP2D6) genotype","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Child and Family Research Institute; Children's & Women's Health Centre of British Columbia; University of British Columbia; Advantage Forensics (Canada); Hospital for Sick Children","funders":"","keywords":"Codeine; Morphine; CYP2D6; Medicine; Forensic toxicology; Genotype; Pharmacology; Opioid; Drug; Heroin; Anesthesia; Internal medicine; Biology; Cytochrome P450; Gene; Chemistry; Genetics","score_opus":0.0530357158078275,"score_gpt":0.3740887740735566,"score_spread":0.3210530582657291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172196938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342424,0.002643732,0.00007510896,0.0025682983,0.0005436305,0.0005379315,0.000036393434,0.000018771329,0.00015192194],"genre_scores_gemma":[0.9947126,0.0012147094,0.0006791488,0.0025474504,0.00055567676,0.000040841667,0.000012639731,0.000025779755,0.00021115868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779594,0.00081483315,0.00061893207,0.00021359946,0.0002074355,0.00034925505],"domain_scores_gemma":[0.9986161,0.00019348788,0.00029946765,0.00021721439,0.00022261126,0.0004511292],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012732169,0.00022174777,0.0003334491,0.00029718896,0.0002582761,0.00006713669,0.00036806747,0.00007758704,0.001010253],"category_scores_gemma":[0.000056463792,0.00016636612,0.00006901151,0.000346786,0.00016677912,0.00038232366,0.00008185704,0.00094435946,0.00007055834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010398399,0.00013870964,0.01576651,0.000010481572,0.00015329046,0.000014990253,0.0029484774,0.001681506,0.97299737,0.0002483718,0.00071703433,0.0052192593],"study_design_scores_gemma":[0.0025510506,0.000118750955,0.18830132,0.000026016929,0.00049809436,0.00044910194,0.00046164475,0.007956576,0.79349554,0.0027293586,0.003104936,0.00030763238],"about_ca_topic_score_codex":0.00018414766,"about_ca_topic_score_gemma":0.000075429205,"teacher_disagreement_score":0.17950188,"about_ca_system_score_codex":0.000021017946,"about_ca_system_score_gemma":0.000113772076,"threshold_uncertainty_score":0.99990296},"labels":[],"label_agreement":null},{"id":"W3173368603","doi":"10.1096/fasebj.27.1_supplement.673.1","title":"Application of a genomics‐guided warfarin dosing nomogram for hospitalized patients","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Warfarin; Dosing; VKORC1; CYP2C9; Pharmacogenomics; Medicine; Pharmacogenetics; Nomogram; Intensive care medicine; Pharmacology; Internal medicine; Emergency medicine; Genotype; Atrial fibrillation; Biology","score_opus":0.068735583091008,"score_gpt":0.39107039752594897,"score_spread":0.32233481443494094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173368603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078876,0.00047015888,0.005488313,0.00060653413,0.00095622713,0.0010317063,0.000051065927,0.000016917162,0.0005903038],"genre_scores_gemma":[0.99684715,0.00027398573,0.0012838318,0.0009227404,0.0003878804,0.000117668504,0.000018540602,0.00002406606,0.00012411937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986793,0.00020804904,0.0004903067,0.00014136813,0.00013833189,0.00034264164],"domain_scores_gemma":[0.9987373,0.00016868864,0.00040871504,0.0001659885,0.00033428328,0.00018505403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077535154,0.00015411779,0.0002244969,0.00007631753,0.00034699062,0.000039415158,0.00040669568,0.000116124895,0.0002895266],"category_scores_gemma":[0.000052195457,0.000110505054,0.00017224955,0.00011209023,0.00012627186,0.00009127514,0.00006567707,0.0003918916,0.000050636263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021125631,0.00044059308,0.021844465,0.00002744357,0.00027667466,6.9014624e-7,0.0008789673,0.0010225722,0.8227433,0.00042726935,0.0051940577,0.14693272],"study_design_scores_gemma":[0.009975789,0.00023916036,0.033186223,0.000013100205,0.0006544519,0.00004256765,0.00012584426,0.044019535,0.7792164,0.012806885,0.11927928,0.0004407292],"about_ca_topic_score_codex":0.00002568072,"about_ca_topic_score_gemma":7.405975e-7,"teacher_disagreement_score":0.14649199,"about_ca_system_score_codex":0.00004463522,"about_ca_system_score_gemma":0.000064230066,"threshold_uncertainty_score":0.45062652},"labels":[],"label_agreement":null},{"id":"W3173531951","doi":"10.1002/cjce.24232","title":"Optimization of operation conditions for improved cytochrome <scp>P450BM3</scp> enzymatic reaction yield","year":2021,"lang":"en","type":"article","venue":"The Canadian Journal of Chemical Engineering","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cofactor; Chemistry; Hydroxylation; Yield (engineering); Redox; Enzyme; Bacillus megaterium; Heme; Monooxygenase; Cytochrome; Biocatalysis; NAD+ kinase; Cytochrome P450; Stereochemistry; Combinatorial chemistry; Biochemistry; Catalysis; Organic chemistry; Reaction mechanism; Biology","score_opus":0.05140083857628043,"score_gpt":0.3333483159485162,"score_spread":0.2819474773722358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173531951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788578,0.0016435176,0.016055167,0.001286282,0.0013719558,0.00030692777,0.00014865819,0.000013378843,0.00031631233],"genre_scores_gemma":[0.99753034,0.00004558234,0.0015935212,0.00034193843,0.0003673304,0.0000123746495,0.000031711366,0.000017976537,0.0000592432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992205,0.00003950234,0.0003762271,0.0000774988,0.00007072221,0.00021557583],"domain_scores_gemma":[0.9986998,0.0004433508,0.00016670008,0.00008649415,0.00031568148,0.00028801753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038833544,0.00010232515,0.00019942287,0.00009682084,0.00009717027,0.000022688002,0.00014811978,0.0001408994,0.00008713201],"category_scores_gemma":[0.0007718487,0.00009173701,0.000107467284,0.00014422016,0.000048531,0.00008959943,0.000009616319,0.0003813936,0.0000013585759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000050795575,0.00001506668,0.0000048797533,0.000029575942,0.000089025154,0.000004085118,0.00020084695,0.19377396,0.80471796,0.00036975852,0.00058875675,0.00020099002],"study_design_scores_gemma":[0.00055618037,0.000019924291,0.000030004272,0.00002459944,0.00017969965,0.000090513815,0.000027346361,0.18764596,0.80522126,0.00014803109,0.0060128113,0.00004364367],"about_ca_topic_score_codex":0.000042088108,"about_ca_topic_score_gemma":0.000028947985,"teacher_disagreement_score":0.01867252,"about_ca_system_score_codex":0.000083904175,"about_ca_system_score_gemma":0.00046966752,"threshold_uncertainty_score":0.37409267},"labels":[],"label_agreement":null},{"id":"W3175746056","doi":"10.1096/fasebj.20.4.a261","title":"Cytochrome P450 2A5 expression in a G6PD‐deficient mouse model of oxidative stress","year":2006,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Oxidative stress; Glutathione peroxidase; Glutathione; Chemistry; Cytochrome P450; Downregulation and upregulation; Superoxide dismutase; Oxidative phosphorylation; Biochemistry; Inducer; Molecular biology; Pharmacology; Biology; Enzyme; Gene","score_opus":0.0834578783792524,"score_gpt":0.38514971319026453,"score_spread":0.30169183481101214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175746056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934044,0.0014579622,0.0017727964,0.00024888798,0.0002769173,0.0002469261,0.0002287999,0.000015336786,0.0023479746],"genre_scores_gemma":[0.9974499,0.00051884406,0.0005723248,0.0003405729,0.00026651815,0.000015680836,0.000009904662,0.000021813566,0.00080447085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791455,0.00056933914,0.0005661165,0.00018646824,0.0003070793,0.00045646276],"domain_scores_gemma":[0.9990178,0.00017395671,0.00033934697,0.00019348312,0.000121605015,0.00015385875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011200834,0.00020961635,0.000296702,0.00018908657,0.0002570645,0.000025075793,0.00048777545,0.00015299163,0.0003827273],"category_scores_gemma":[0.000028347458,0.00014436894,0.00013558682,0.00019373688,0.0002049858,0.000102172104,0.00013030077,0.0010595736,0.000021006117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021859119,0.0004356957,0.0006997887,0.000010228558,0.000028274137,0.000016266109,0.0007581155,0.22570916,0.7704157,0.00035088608,0.0006662081,0.00069105887],"study_design_scores_gemma":[0.0020038586,0.000040335297,0.0008276396,0.000025028725,0.000080211496,0.000029270013,0.00021461105,0.04739993,0.94653064,0.0020281477,0.0006584224,0.00016193106],"about_ca_topic_score_codex":0.000021967611,"about_ca_topic_score_gemma":0.000012907089,"teacher_disagreement_score":0.17830923,"about_ca_system_score_codex":0.00005847603,"about_ca_system_score_gemma":0.0001251518,"threshold_uncertainty_score":0.5887195},"labels":[],"label_agreement":null},{"id":"W3176565487","doi":"10.1096/fasebj.29.1_supplement.940.3","title":"<i>CYP2A6</i> Genetic Variation and Variable Nicotine Metabolism Among Two Distinct American Indian Tribal Groups With Different Levels of Smoking and Risk For Tobacco‐Related Cancer","year":2015,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Cotinine; Genotype; Biology; Allele; Smoking cessation; Genetics; Medicine; Metabolism; Physiology; Internal medicine; Endocrinology; Gene; Pathology","score_opus":0.05170546718661642,"score_gpt":0.35319243738174533,"score_spread":0.30148697019512893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176565487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913951,0.00445774,0.0022999942,0.0001581049,0.0007708881,0.0004294545,0.00039785833,0.000015935748,0.00007490807],"genre_scores_gemma":[0.99707645,0.0016036404,0.0005529997,0.00018756572,0.00045318805,0.000037581725,0.000007038195,0.00003239239,0.000049134593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798214,0.0006631166,0.0004711006,0.00023653152,0.00023081341,0.00041628635],"domain_scores_gemma":[0.99815154,0.00035491178,0.0007399331,0.00013468551,0.00020070928,0.00041824882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014249092,0.00026067346,0.00046004652,0.00010690871,0.00039489366,0.000060034283,0.00021588223,0.00009690388,0.00008499416],"category_scores_gemma":[0.000083350176,0.00016711105,0.000061458566,0.00023457067,0.0003930387,0.00010655866,0.000087045046,0.0007451538,4.129987e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013181043,0.00024245275,0.86506534,0.00003266021,0.0017932898,0.000012771365,0.006148791,0.0059498963,0.055491697,0.0004351282,0.00011425882,0.06339563],"study_design_scores_gemma":[0.012740562,0.00029032672,0.9276728,0.000037549038,0.0035409324,0.00020207504,0.0004219684,0.009569931,0.040611904,0.0031621791,0.0013415167,0.0004082481],"about_ca_topic_score_codex":0.00037591762,"about_ca_topic_score_gemma":0.00011250261,"teacher_disagreement_score":0.06298738,"about_ca_system_score_codex":0.000042696614,"about_ca_system_score_gemma":0.00013783437,"threshold_uncertainty_score":0.68145907},"labels":[],"label_agreement":null},{"id":"W3176657909","doi":"10.1096/fasebj.2018.32.1_supplement.833.4","title":"INVESTIGATION INTO THE EFFECTS OF TESTOSTERONE ON DRUG METABOLIZING ENZYMES IN HEPATIC AND INTESTINAL HUMAN CELL LINES","year":2018,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"CYP3A4; Testosterone (patch); Drug metabolism; Bioavailability; Cytochrome P450; Internal medicine; Hormone; Endocrinology; Pharmacology; Chemistry; Cell culture; Metabolism; Biology; Medicine","score_opus":0.06045401336198806,"score_gpt":0.3719187595688022,"score_spread":0.31146474620681414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176657909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901024,0.007404301,0.000015236227,0.0009466348,0.00088734436,0.0002514231,0.0000020991192,0.000010567936,0.00038000604],"genre_scores_gemma":[0.9964457,0.00071833254,0.00016001664,0.0017351846,0.00074341183,0.000012440187,0.0000013446704,0.000016315269,0.0001672164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796724,0.0010519034,0.00039464608,0.00014658639,0.00017677389,0.00026285715],"domain_scores_gemma":[0.9982601,0.0010621016,0.0002859327,0.0001467121,0.00010609223,0.00013906046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017034296,0.00017975939,0.00022918185,0.000142001,0.00051667576,0.00003541983,0.0003388934,0.00006728148,0.000057968155],"category_scores_gemma":[0.00023277044,0.00010418319,0.00005262253,0.00020802765,0.0006124382,0.00007564165,0.00010381976,0.00087336975,0.0000130434455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010064875,0.00008392635,0.015802799,0.000059340317,0.00004768714,0.00001501301,0.010506835,0.000052050214,0.9644528,0.0005682064,0.00043475485,0.007875942],"study_design_scores_gemma":[0.0014465755,0.00020500913,0.01023955,0.000078780264,0.00021102729,0.000052248717,0.00026796272,0.0011435708,0.9814491,0.0036759875,0.0011136815,0.00011648993],"about_ca_topic_score_codex":0.00006452516,"about_ca_topic_score_gemma":0.000055014963,"teacher_disagreement_score":0.016996318,"about_ca_system_score_codex":0.000019502553,"about_ca_system_score_gemma":0.000057447327,"threshold_uncertainty_score":0.42484674},"labels":[],"label_agreement":null},{"id":"W3176791188","doi":"10.1038/s41397-021-00249-1","title":"Economic evaluation in psychiatric pharmacogenomics: a systematic review","year":2021,"lang":"en","type":"review","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"European Commission","keywords":"Pharmacogenomics; Psychological intervention; Medical prescription; Psychiatry; Medicine; Systematic review; Cost effectiveness; Health care; MEDLINE; Risk analysis (engineering); Pharmacology; Political science","score_opus":0.23009512446407723,"score_gpt":0.5259656722907379,"score_spread":0.29587054782666067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176791188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008817037,0.979188,0.000018185545,0.0005829919,0.010090336,0.0079601975,0.00045672015,0.000054918884,0.0015604343],"genre_scores_gemma":[0.00005191703,0.98972714,0.000066938745,0.00450424,0.003382357,0.001407714,0.00021929214,0.00030062714,0.00033979738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.979278,0.012006728,0.0051512276,0.00114401,0.00080911757,0.0016109151],"domain_scores_gemma":[0.99248725,0.0014312079,0.003734304,0.001075237,0.00039526593,0.00087673264],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.019260116,0.0016397892,0.0060764016,0.0009887434,0.00081441755,0.00028042696,0.0032998498,0.00076706894,0.005080017],"category_scores_gemma":[0.0003203283,0.0012189018,0.0026955304,0.0010956107,0.00023636258,0.0002597817,0.0005812103,0.0066191405,0.0015578758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059075268,0.0005000914,0.0000037187326,0.39540297,0.0046774894,0.0003631458,0.0002862727,0.0009866192,0.00006118396,0.00017337075,0.017162189,0.5803239],"study_design_scores_gemma":[0.0023188465,0.00002461458,1.6153044e-7,0.06731484,0.048076008,0.0046921056,0.00003638925,0.0019643344,0.00002678228,0.00017562705,0.87420994,0.00116032],"about_ca_topic_score_codex":0.0000105831,"about_ca_topic_score_gemma":0.0000123182845,"teacher_disagreement_score":0.8570478,"about_ca_system_score_codex":0.0025264574,"about_ca_system_score_gemma":0.0042416994,"threshold_uncertainty_score":0.9996349},"labels":[],"label_agreement":null},{"id":"W3177401802","doi":"10.1096/fasebj.20.4.a260-d","title":"Cytochrome P450 2C11 5′‐flanking region and promoter: regulation by aromatic hydrocarbons in vitro and in vivo","year":2006,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Luciferase; Biology; Aryl hydrocarbon receptor; In vivo; Cytochrome P450; Messenger RNA; Transcription (linguistics); Molecular biology; Context (archaeology); Transfection; Transcription factor; Cell biology; Gene; Biochemistry; Genetics; Enzyme","score_opus":0.038399309507736436,"score_gpt":0.3329841753167964,"score_spread":0.29458486580905996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177401802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936989,0.003518612,0.00009554946,0.0013250702,0.00015989496,0.00026466025,0.0000069675866,0.000013727652,0.0009166407],"genre_scores_gemma":[0.99827117,0.00075383857,0.00008008985,0.00041908064,0.00023289387,0.000012442518,0.0000049257847,0.000016642016,0.00020891242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984316,0.00051261566,0.00039653375,0.00017752775,0.00013637662,0.0003453249],"domain_scores_gemma":[0.9994518,0.00015721112,0.0001791028,0.00009412856,0.00000711373,0.00011061602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010111525,0.00016914954,0.00022408426,0.0001794117,0.00021590105,0.000054738768,0.0001382454,0.00013673965,0.00002588837],"category_scores_gemma":[0.000019182153,0.0001325777,0.000034338947,0.00018001739,0.00014383922,0.000121104466,0.000049548697,0.0007152694,0.0000024840874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020294891,0.00009705855,0.0049012913,0.0000097220445,0.000020529844,0.0000708098,0.0005441888,0.00014380642,0.9887564,0.000025609299,0.0006474697,0.004580153],"study_design_scores_gemma":[0.0059023555,0.00007149366,0.055038728,0.00008254961,0.00018732566,0.0017374206,0.00013190578,0.037806623,0.864704,0.025520826,0.008386327,0.0004304123],"about_ca_topic_score_codex":0.000042779906,"about_ca_topic_score_gemma":0.000025712274,"teacher_disagreement_score":0.124052376,"about_ca_system_score_codex":0.000048884227,"about_ca_system_score_gemma":0.000031894404,"threshold_uncertainty_score":0.5406361},"labels":[],"label_agreement":null},{"id":"W3177417082","doi":"10.1124/dmd.121.000474","title":"Characterization of Hepatic UDP-Glucuronosyltransferase Enzyme Abundance-Activity Correlations and Population Variability Using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes","year":2021,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytochrome P450; Enzyme; Population; Proteomics; Chemistry; Drug metabolism; Biochemistry; Isozyme; Biology; Gene","score_opus":0.04084995597145074,"score_gpt":0.3417061966385179,"score_spread":0.3008562406670672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177417082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553911,0.001676288,0.04155146,0.00010130372,0.00015443291,0.0007142444,0.0003072559,0.000031098854,0.00007283026],"genre_scores_gemma":[0.995206,0.00079209567,0.0032610067,0.000106976106,0.00011755132,0.00005609294,0.0004212161,0.000023382114,0.000015703437],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99799174,0.0007315007,0.00040494493,0.00046248644,0.00016602498,0.00024331966],"domain_scores_gemma":[0.999115,0.00013641582,0.0002376141,0.00016318305,0.00014985343,0.00019793412],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053888204,0.00026367765,0.000519446,0.000109173,0.00035057584,0.000058327245,0.000052505085,0.00016896553,0.000024191175],"category_scores_gemma":[0.000032440134,0.00025322006,0.00004426432,0.0002627387,0.00021991161,0.00041038793,0.00005370882,0.00032052398,3.8552932e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004491711,0.00054151024,0.040183548,0.00028946565,0.00010684714,0.0000029102314,0.0016435279,0.00074080273,0.9475753,0.0033637884,0.0000014430607,0.0051017227],"study_design_scores_gemma":[0.0021893955,0.00003225153,0.6107641,0.00003526795,0.00089572533,0.00005330523,0.00009547999,0.10896614,0.2759991,0.00042201637,0.00021734924,0.00032988805],"about_ca_topic_score_codex":0.00009192169,"about_ca_topic_score_gemma":0.000021019558,"teacher_disagreement_score":0.67157614,"about_ca_system_score_codex":0.000022135393,"about_ca_system_score_gemma":0.00007686726,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W3177472539","doi":"10.1016/j.cbpc.2021.109114","title":"Development of a microplate method for the determination of hepatic UDP-glucuronosyltransferase activity in rainbow trout (Oncorhynchus mykiss) and Nile tilapia (Oreochromis niloticus)","year":2021,"lang":"en","type":"article","venue":"Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Rainbow trout; Nile tilapia; Glucuronidation; Oreochromis; Tilapia; Chemistry; Microsome; Kinetics; Chromatography; Biochemistry; Fish <Actinopterygii>; Biology; Enzyme; Fishery","score_opus":0.09372552727388625,"score_gpt":0.4297294037586751,"score_spread":0.3360038764847888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177472539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918392,0.0039701797,0.0018754867,0.00049905636,0.0005731392,0.0008447828,0.00022922647,0.000017589675,0.00015135632],"genre_scores_gemma":[0.9923031,0.00091260485,0.005324839,0.0006758904,0.00017937883,0.00039817014,0.00006977567,0.000020861582,0.00011538254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964755,0.0012291346,0.00085448014,0.00074453343,0.00009379117,0.00060253363],"domain_scores_gemma":[0.9958815,0.002962852,0.00046259086,0.00022341973,0.00025929182,0.00021035681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010371255,0.0004432121,0.0011396431,0.0001127952,0.00030930334,0.000007650784,0.00029621657,0.0005243769,0.00041452347],"category_scores_gemma":[0.000086927226,0.00039636035,0.00014452338,0.00026093778,0.0011561795,0.00006687141,0.00020778566,0.0006824165,0.0000025418153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020140705,0.00086376554,0.00055321463,0.00035207852,0.00048783756,0.00001328038,0.0026390546,0.00014239406,0.97691584,0.00009260169,0.00032025218,0.015605614],"study_design_scores_gemma":[0.00493285,0.00019226463,0.004870888,0.000019460855,0.00048141048,0.00005230814,0.00029121983,0.012425072,0.9618064,0.00024705465,0.014351977,0.00032905585],"about_ca_topic_score_codex":0.0000062807626,"about_ca_topic_score_gemma":0.000032264066,"teacher_disagreement_score":0.015276558,"about_ca_system_score_codex":0.00005754032,"about_ca_system_score_gemma":0.00043708942,"threshold_uncertainty_score":0.99984884},"labels":[],"label_agreement":null},{"id":"W3180808017","doi":"10.1016/j.bmcl.2021.128255","title":"Biologically active metabolites in drug discovery","year":2021,"lang":"en","type":"review","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Chemistry; Drug discovery; Drug; Biological activity; Active metabolite; Drug development; Lead compound; Computational biology; Pharmacology; Metabolite; Biochemistry; In vitro; Biology","score_opus":0.12473688721997371,"score_gpt":0.44280691025526087,"score_spread":0.31807002303528714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180808017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009107428,0.9858244,0.000009426466,0.0010372594,0.0016956239,0.00055743585,0.00042907672,0.00007973228,0.0012596383],"genre_scores_gemma":[0.0014806004,0.99087435,0.00005323129,0.0037437216,0.0022257022,0.00016104056,0.000756163,0.000102234044,0.0006029696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99506587,0.00097225234,0.0012583503,0.0012310684,0.0004101228,0.0010623627],"domain_scores_gemma":[0.99741626,0.00085682864,0.0006086071,0.00054887694,0.000075849006,0.0004936067],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009935863,0.0010574637,0.0029445398,0.00017089958,0.00013888937,0.00005658512,0.0011073945,0.0009866755,0.0028546196],"category_scores_gemma":[0.0003696856,0.00085193047,0.00074562593,0.00088134204,0.00050220976,0.000116289986,0.00042033216,0.0032426827,0.00012594525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008905788,0.00061533006,0.000059895723,0.008093551,0.0015850052,0.0018190962,0.00033464193,0.000002513642,0.26658136,0.00006254703,0.011447942,0.70930904],"study_design_scores_gemma":[0.0009372912,0.0000057005823,0.000017825463,0.0016342124,0.0021879168,0.00019688465,0.00009491498,0.00000231662,0.034250177,0.00001304707,0.95984304,0.00081669464],"about_ca_topic_score_codex":0.00002995806,"about_ca_topic_score_gemma":0.0000026025536,"teacher_disagreement_score":0.9483951,"about_ca_system_score_codex":0.0003044742,"about_ca_system_score_gemma":0.0007009182,"threshold_uncertainty_score":0.99939317},"labels":[],"label_agreement":null},{"id":"W3183354255","doi":"10.1016/j.ajhg.2021.07.001","title":"Massively parallel characterization of CYP2C9 variant enzyme activity and abundance","year":2021,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of General Medical Sciences; Canadian Institute for Advanced Research; National Human Genome Research Institute; Howard Hughes Medical Institute","keywords":"Missense mutation; CYP2C9; Massive parallel sequencing; Cytochrome P450; Biology; Computational biology; Enzyme; Genetics; Mutation; Biochemistry; Gene; DNA sequencing","score_opus":0.06611490923011071,"score_gpt":0.39532413658268495,"score_spread":0.32920922735257424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183354255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994964,0.0018678805,0.0015438747,0.0009095031,0.00038911952,0.00008904587,0.000040707328,0.0000052080277,0.00019068553],"genre_scores_gemma":[0.99227226,0.005580591,0.0007064876,0.0009208886,0.0003483366,0.000002332881,0.0000032511482,0.00001976264,0.00014611821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982564,0.00069010915,0.0004594467,0.00014682152,0.00021041044,0.00023681164],"domain_scores_gemma":[0.9980747,0.00015573186,0.0010877836,0.00018860797,0.00032364906,0.00016953431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006185788,0.00016248114,0.00044034157,0.00007300367,0.00017998932,0.000021991138,0.0002983939,0.00005393025,0.00014195447],"category_scores_gemma":[0.000032628937,0.00012757807,0.0001062713,0.0002130752,0.0005684817,0.000054525746,0.000112125024,0.000489978,0.0000027804906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022215642,0.00018424068,0.0015881115,0.000015609394,0.00022577144,0.00006700452,0.0008519996,0.0003577192,0.95561785,0.000297331,0.00007223103,0.040499955],"study_design_scores_gemma":[0.0017363222,0.0005912474,0.16211316,0.000025804473,0.00058668444,0.00054705085,0.0002422117,0.0014159362,0.81240815,0.0011728428,0.018888367,0.0002721932],"about_ca_topic_score_codex":0.000004244039,"about_ca_topic_score_gemma":0.0000020676348,"teacher_disagreement_score":0.16052505,"about_ca_system_score_codex":0.000017764825,"about_ca_system_score_gemma":0.00015402751,"threshold_uncertainty_score":0.52024823},"labels":[],"label_agreement":null},{"id":"W3184054661","doi":"10.1097/ypg.0000000000000293","title":"Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder","year":2021,"lang":"en","type":"article","venue":"Psychiatric Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"CYP2C19; CYP2D6; Pharmacogenetics; Antidepressant; Medicine; Population; Pharmacogenomics; Pharmacology; Depression (economics); Drug; Major depressive disorder; Psychiatry; Internal medicine; Cytochrome P450; Genetics; Biology; Gene; Genotype","score_opus":0.038841423876399044,"score_gpt":0.3912309444820134,"score_spread":0.35238952060561435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184054661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96057546,0.00079059065,0.00015125984,0.000017796254,0.00018812835,0.037653398,0.0005935063,0.000007049306,0.000022832235],"genre_scores_gemma":[0.98847246,0.00020420527,0.0015182791,0.000024513685,0.00005477922,0.009584409,0.00009328502,0.000040502404,0.0000075552684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974327,0.00043342967,0.0011336509,0.0004037237,0.0003149113,0.0002815811],"domain_scores_gemma":[0.99778223,0.00013376158,0.0011351127,0.00025322585,0.0006024158,0.00009324206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030444842,0.000274596,0.0007271674,0.00034902254,0.00006377208,0.0000062575114,0.00019932902,0.00013049778,0.000043104465],"category_scores_gemma":[0.0000400244,0.0002523413,0.00008754844,0.0006844871,0.00010479911,0.00006588172,0.00010975312,0.00017003878,1.4598656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011882718,0.0035583486,0.8676058,0.0011449765,0.00027270694,9.898508e-7,0.001454248,0.00097027695,0.116555855,0.000012800059,0.000007020815,0.0072286925],"study_design_scores_gemma":[0.016385373,0.00036512405,0.7998257,0.000049211332,0.0006544747,0.0000010815855,0.00023000156,0.0010777395,0.18084793,0.00006104462,0.00029542076,0.00020686457],"about_ca_topic_score_codex":0.000029575973,"about_ca_topic_score_gemma":0.000031459127,"teacher_disagreement_score":0.06778007,"about_ca_system_score_codex":0.000008987158,"about_ca_system_score_gemma":0.00011942814,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W3189138644","doi":"10.1007/s00520-021-06451-y","title":"Pharmacogenomics in cancer supportive care: key issues and future directions","year":2021,"lang":"en","type":"editorial","venue":"Supportive Care in Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; Public Health Ontario","funders":"","keywords":"Pharmacogenomics; Pain medicine; Medicine; Nursing research; Cancer; Key (lock); Health informatics; Anesthesiology; Nursing; Intensive care medicine; Public health; Internal medicine; Psychiatry; Pharmacology","score_opus":0.04598488192798831,"score_gpt":0.4575850188968795,"score_spread":0.4116001369688912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189138644","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035523195,0.39719674,4.08714e-7,0.0009828659,0.5514797,0.0009522133,0.01183598,0.00005852689,0.0019703961],"genre_scores_gemma":[0.011567766,0.5254902,0.00004165587,0.0009574257,0.4571132,0.0015703088,0.0018625188,0.00017742733,0.0012194911],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941843,0.0009322019,0.0012343879,0.0016576044,0.00064630614,0.001345198],"domain_scores_gemma":[0.9964651,0.000540241,0.0006181937,0.00038693807,0.001443267,0.0005462917],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00055615674,0.0010781582,0.0015369125,0.0006129749,0.0002680193,0.00008677772,0.00055436895,0.0022253492,0.0052987416],"category_scores_gemma":[0.00015469175,0.0011784824,0.0003221872,0.0008632684,0.00040743902,0.0002390078,0.00040497887,0.004641058,0.000022611284],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008604514,0.00033330682,0.014317012,0.0012160193,0.0008053034,0.0009616416,0.036789097,0.00029479337,0.0021591391,0.000025997788,0.8012264,0.1410109],"study_design_scores_gemma":[0.0037557129,0.00008769415,0.0010488426,0.00020407148,0.0008568057,0.0000042751235,0.007208865,0.000031105563,0.011942888,0.000033150474,0.97364396,0.0011826021],"about_ca_topic_score_codex":0.0036167528,"about_ca_topic_score_gemma":0.015164509,"teacher_disagreement_score":0.17241764,"about_ca_system_score_codex":0.001854667,"about_ca_system_score_gemma":0.0038876603,"threshold_uncertainty_score":0.99907},"labels":[],"label_agreement":null},{"id":"W3193927059","doi":"10.3389/fgene.2021.736626","title":"Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation","year":2021,"lang":"en","type":"editorial","venue":"Frontiers in Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; Robert Bosch Stiftung; European Commission; Japan Agency for Medical Research and Development; McGill University; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Eli Lilly and Company","keywords":"Pharmacogenomics; Identification (biology); Population; Computational biology; Biology; Bioinformatics; Data science; Medicine; Computer science; Environmental health; Ecology","score_opus":0.06669080851206693,"score_gpt":0.48550141907352,"score_spread":0.4188106105614531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193927059","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018301722,0.007172108,0.0031172382,0.00019565424,0.9652317,0.0013712713,0.0044381516,0.00008182165,0.00009034039],"genre_scores_gemma":[0.0023780484,0.020423755,0.008001749,0.0006315495,0.95575076,0.00022409028,0.01206357,0.00018646765,0.00034002916],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919442,0.0019007579,0.002547524,0.0015683206,0.0011110271,0.0009281775],"domain_scores_gemma":[0.99620456,0.000737257,0.0009459753,0.00077195076,0.00066831824,0.0006719502],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0029972207,0.0007606187,0.0012364156,0.0005183381,0.0002404341,0.00019397543,0.0010805094,0.0028040898,0.0005220966],"category_scores_gemma":[0.0005707883,0.0009440832,0.0003631614,0.0006362243,0.00010550203,0.00012343164,0.00043264937,0.0029338247,0.00013000256],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034592493,0.000325889,0.008183811,0.000046370547,0.00048895355,0.000038958024,0.0004239692,0.0012382172,0.0023445957,0.000005403515,0.9161413,0.07041663],"study_design_scores_gemma":[0.0036150878,0.000068446534,0.0019732262,0.00003086472,0.001044213,7.186626e-7,0.0001847451,0.0016511283,0.0032369562,0.000711053,0.98657584,0.0009077021],"about_ca_topic_score_codex":0.00035580943,"about_ca_topic_score_gemma":0.00020267807,"teacher_disagreement_score":0.070434585,"about_ca_system_score_codex":0.00055736327,"about_ca_system_score_gemma":0.0008501783,"threshold_uncertainty_score":0.99936646},"labels":[],"label_agreement":null},{"id":"W3194737239","doi":"10.1016/j.sapharm.2021.08.009","title":"Applications for pharmacogenomics in pharmacy practice: A scoping review","year":2021,"lang":"en","type":"review","venue":"Research in Social and Administrative Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Alberta","funders":"","keywords":"Pharmacogenomics; Pharmacy; Medicine; Pharmacist; Polypharmacy; Pharmacy practice; MEDLINE; Family medicine; Pharmacology","score_opus":0.7828016179235525,"score_gpt":0.7310810426929184,"score_spread":0.051720575230634114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194737239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012473187,0.9768057,0.000042352123,0.0024009014,0.0004389084,0.0134834135,0.0013833451,0.0000421027,0.0053908215],"genre_scores_gemma":[0.00011030886,0.9804029,0.0002999711,0.0017760469,0.0018219998,0.014816663,0.0004695177,0.0001116002,0.00019103101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98781824,0.0063361363,0.0020513046,0.0014975957,0.00061505806,0.0016816374],"domain_scores_gemma":[0.99251854,0.0051585217,0.00067515875,0.00028020667,0.000671481,0.0006961013],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008243916,0.000885492,0.002992463,0.00055305863,0.00083508063,0.00015102432,0.0008700298,0.00039776156,0.0004917041],"category_scores_gemma":[0.00058690365,0.0009122223,0.0006182477,0.00267652,0.00070059835,0.00033702116,0.00071570947,0.0039057382,0.000056655634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016370844,0.0010224263,0.000019660252,0.08361154,0.00035258688,0.00024025673,0.00026627738,7.421962e-7,0.000035505924,0.0019079903,0.0020402074,0.9103391],"study_design_scores_gemma":[0.00376179,0.00003800977,4.189931e-7,0.03284369,0.0011175444,0.00009517625,0.00018044694,0.00005480462,0.00009748495,0.00051093,0.9605316,0.00076812564],"about_ca_topic_score_codex":0.0000526221,"about_ca_topic_score_gemma":0.000040720835,"teacher_disagreement_score":0.9584914,"about_ca_system_score_codex":0.0005465051,"about_ca_system_score_gemma":0.005730928,"threshold_uncertainty_score":0.99990565},"labels":[],"label_agreement":null},{"id":"W3194919207","doi":"10.21203/rs.3.rs-123677/v1","title":"Validation of methodology for efficient genotyping of CYP2D6 and CYP2C19","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"Medical Research Council; H. Lundbeck A/S; Alberta Innovates; HLS Therapeutics; European Commission; National Institute for Health and Care Research; King's College London; University of Alberta; Department of Health and Social Care; South London and Maudsley NHS Foundation Trust; GlaxoSmithKline","keywords":"Genotyping; CYP2C19; CYP2D6; Computer science; Computational biology; Genotype; Biology; Genetics; Gene","score_opus":0.5193495215379011,"score_gpt":0.603594814352703,"score_spread":0.08424529281480186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194919207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97178227,0.01873392,0.0051980414,0.00032592416,0.001098438,0.001643539,0.00059437077,0.000017970957,0.0006055145],"genre_scores_gemma":[0.98683506,0.004198202,0.008015041,0.00006187926,0.00028560043,0.00025089347,0.00021374256,0.00004100318,0.000098603334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940855,0.0035666258,0.00069442624,0.00060902437,0.00045447488,0.0005899763],"domain_scores_gemma":[0.9938576,0.0035628343,0.00034637403,0.00040368378,0.0016042354,0.00022523582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008341498,0.00024664935,0.0007714801,0.00049951405,0.00017285546,0.000023487055,0.00040111842,0.00074445806,0.0002925569],"category_scores_gemma":[0.0014120777,0.00025187992,0.00024101876,0.0003122668,0.00047892748,0.000022275928,0.0011526563,0.0015182252,0.0000024519532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095321,0.000701803,0.002223869,0.007565043,0.00080349104,0.000015109298,0.005600008,0.0318045,0.9005463,0.0038340264,0.00044596082,0.045506664],"study_design_scores_gemma":[0.0015310455,0.0001606955,0.0017319388,0.000207696,0.00029476572,0.0000060721827,0.00079113024,0.015186499,0.9688127,0.0029746257,0.008048451,0.00025439748],"about_ca_topic_score_codex":0.00007216105,"about_ca_topic_score_gemma":0.000004647433,"teacher_disagreement_score":0.06826637,"about_ca_system_score_codex":0.00005766798,"about_ca_system_score_gemma":0.00055285764,"threshold_uncertainty_score":0.9999933},"labels":[],"label_agreement":null},{"id":"W3195965191","doi":"10.3390/pharmaceutics13081261","title":"Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine","year":2021,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Northwestern Polytechnical University; Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China; Northwestern University","keywords":"CYP3A4; Drug; Pharmacology; Bioavailability; Drug metabolism; Pharmacokinetics; Cytochrome P450; Drug delivery; Chemistry; Medicine; Metabolism; Biochemistry","score_opus":0.2717321492503962,"score_gpt":0.5166222329162328,"score_spread":0.2448900836658366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195965191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010882854,0.982463,0.00012306693,0.0008984088,0.00592774,0.0028603706,0.00095431344,0.0005699122,0.005114893],"genre_scores_gemma":[0.0010853736,0.9850156,0.00079658657,0.005029183,0.003898022,0.00089659175,0.0006787158,0.00039374526,0.00220624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877488,0.0035837395,0.002696876,0.0020766219,0.0012929033,0.0026010678],"domain_scores_gemma":[0.99298596,0.0012358566,0.001090501,0.0010753071,0.0009883001,0.002624073],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0031307917,0.0023802272,0.0057079173,0.0009678812,0.0007108269,0.00027042042,0.0022045085,0.0010774957,0.0065378244],"category_scores_gemma":[0.00040595184,0.0020750544,0.0014775365,0.0021207845,0.0010130709,0.0003522801,0.0013086862,0.004434155,0.0010956255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025997797,0.0007679929,0.0000029819616,0.009467805,0.004108482,0.0015391853,0.0029026365,0.0003098851,0.011146947,0.0021676647,0.03401167,0.9333148],"study_design_scores_gemma":[0.003063542,0.00006506688,0.0000068080144,0.003312629,0.016542114,0.00056704617,0.0003565543,0.00057029375,0.003288248,0.00012896476,0.97004765,0.0020510803],"about_ca_topic_score_codex":0.00008975414,"about_ca_topic_score_gemma":0.00001649165,"teacher_disagreement_score":0.936036,"about_ca_system_score_codex":0.00040967527,"about_ca_system_score_gemma":0.0026538346,"threshold_uncertainty_score":0.9996821},"labels":[],"label_agreement":null},{"id":"W3199710005","doi":"10.1111/bph.15538","title":"THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors","year":2021,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":488,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; Université de Sherbrooke; Université de Montréal; University of Toronto","funders":"National Cancer Institute; Novo Nordisk Fonden","keywords":"Clinical pharmacology; Computer science; Key (lock); Receptor; G protein-coupled receptor; Computational biology; Pharmacology; Medicine; Biology; Internal medicine","score_opus":0.0420940447113971,"score_gpt":0.41556435496907457,"score_spread":0.37347031025767746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199710005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88764155,0.04768626,0.00064874155,0.016676243,0.03994363,0.0015081126,0.0001444903,0.00007709854,0.0056738965],"genre_scores_gemma":[0.8818339,0.04320059,0.0029428578,0.036637183,0.013727892,0.00039160112,0.000034860397,0.00022627057,0.021004856],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99223536,0.00295848,0.002019921,0.00065163436,0.00062716554,0.0015074358],"domain_scores_gemma":[0.9943797,0.0012877894,0.0009762257,0.00021427893,0.0019249682,0.0012170366],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0040706396,0.00052548206,0.0010258319,0.00026348635,0.0011277025,0.0001666232,0.0014697849,0.00050531223,0.018776055],"category_scores_gemma":[0.000665468,0.00052348356,0.00056359195,0.00093930453,0.00059330376,0.00025436562,0.0005295313,0.002746982,0.00041508718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071545644,0.00044513348,0.00006696206,0.000021175025,0.00079325895,0.003490518,0.00015015248,0.0006317679,0.5372066,0.00010824668,0.37563366,0.080737054],"study_design_scores_gemma":[0.0048823785,0.00018531765,0.00008599555,0.00002880551,0.00061452773,0.0031420756,0.00018175377,0.00041140078,0.379496,0.0001936197,0.6104278,0.00035033],"about_ca_topic_score_codex":0.000030672672,"about_ca_topic_score_gemma":0.00003814199,"teacher_disagreement_score":0.23479412,"about_ca_system_score_codex":0.00024257916,"about_ca_system_score_gemma":0.001371206,"threshold_uncertainty_score":0.99972165},"labels":[],"label_agreement":null},{"id":"W3199772459","doi":"10.3390/medicina57090955","title":"Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report","year":2021,"lang":"en","type":"article","venue":"Medicina","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Medicine; CYP2D6; Drug; Polypharmacy; Pharmacotherapy; Pharmacogenetics; Pharmacist; Adverse effect; Intensive care medicine; Pharmacology; Internal medicine; Pharmacy; Family medicine","score_opus":0.20119150379588277,"score_gpt":0.4588697448306574,"score_spread":0.25767824103477466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199772459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879785,0.0066913436,0.000034938093,0.00153623,0.0017200849,0.00090540014,0.000038904276,0.000020347812,0.0010742041],"genre_scores_gemma":[0.99331075,0.0049337433,0.00011138291,0.001021571,0.00031745972,0.000116605006,0.00010143334,0.000017691355,0.00006938823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721825,0.0011310921,0.0006173978,0.00037241422,0.00036514606,0.00029568558],"domain_scores_gemma":[0.99809057,0.00097635476,0.00028050022,0.00026884355,0.00021178053,0.00017196251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023892622,0.00022725301,0.000373161,0.00012982145,0.00019370661,0.000011783583,0.00012071265,0.00011553889,0.0005180342],"category_scores_gemma":[0.00023939011,0.00018142628,0.00007677315,0.00024337241,0.0001942318,0.00007033016,0.00003978177,0.00029248482,0.000007644768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005275825,0.002471028,0.02009928,0.00024024706,0.00059841573,0.044790562,0.0750815,0.0005076494,0.55410486,0.000083807114,0.0022296407,0.2992654],"study_design_scores_gemma":[0.02489093,0.00018765294,0.0017773708,0.000047945705,0.0020328648,0.022136254,0.012701198,0.09578338,0.6763888,0.00031301213,0.16328877,0.00045179683],"about_ca_topic_score_codex":0.00017800955,"about_ca_topic_score_gemma":0.00011968159,"teacher_disagreement_score":0.2988136,"about_ca_system_score_codex":0.0001273296,"about_ca_system_score_gemma":0.00029074217,"threshold_uncertainty_score":0.7398349},"labels":[],"label_agreement":null},{"id":"W3201047071","doi":"10.3390/curroncol28050306","title":"Cytochrome 4Z1 Expression Is Correlated with Poor Prognosis in Patients with Cervical Cancer","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cervical cancer; Cancer; Internal medicine; Bioinformatics; Oncology; Cancer research; Biology","score_opus":0.16066684002099804,"score_gpt":0.47739297717695517,"score_spread":0.3167261371559571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201047071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990595,0.0040977593,0.000037381546,0.0012183737,0.0019582293,0.0006904766,0.00016957593,0.000056951423,0.0011762434],"genre_scores_gemma":[0.99614835,0.0010033776,0.00021477688,0.0016780595,0.00023113457,0.0003731503,0.00014071607,0.000043684173,0.00016675994],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973902,0.0005886727,0.00042788783,0.00063721737,0.00028286342,0.0006731713],"domain_scores_gemma":[0.9987016,0.0001691713,0.00020759487,0.00017464168,0.0003898465,0.0003571441],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022343479,0.00033798325,0.00053919724,0.00014508006,0.00014978691,0.000017520546,0.00025367065,0.0003938766,0.0037429307],"category_scores_gemma":[0.000026218113,0.00025901836,0.000067132896,0.00056284276,0.00021052876,0.000098937715,0.00017197787,0.0012306733,0.000079785066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022371337,0.004840921,0.89918303,0.00010331305,0.00019268105,0.00017498533,0.0010874226,0.00029270866,0.0082779415,0.0000490081,0.00628744,0.07727342],"study_design_scores_gemma":[0.019849215,0.00073339924,0.4204097,0.00017148213,0.000492584,0.000024858467,0.00009991983,0.0013906097,0.07301596,0.00006300443,0.48308846,0.0006608045],"about_ca_topic_score_codex":0.000011965442,"about_ca_topic_score_gemma":0.000067822235,"teacher_disagreement_score":0.47877333,"about_ca_system_score_codex":0.00019957374,"about_ca_system_score_gemma":0.00054983655,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W3201233127","doi":"10.17179/excli2021-3890","title":"Arsenic: Various species with different effects on cytochrome P450 regulation in humans","year":2021,"lang":"en","type":"review","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Arsenic; Arsenic toxicity; Xenobiotic; Cytochrome P450; Arsenate; Chemistry; Arsenite; Computational biology; Environmental chemistry; Biology; Biochemistry; Enzyme","score_opus":0.16512130728115157,"score_gpt":0.40933693447159725,"score_spread":0.24421562719044568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201233127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037513548,0.98417467,0.000014693312,0.000087782115,0.0014336342,0.0037618324,0.00010363759,0.00008336535,0.006589061],"genre_scores_gemma":[0.007831338,0.9811663,0.00001542908,0.00041777614,0.0010438182,0.005579989,0.00028265125,0.00011469474,0.003548021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99554366,0.0015089462,0.00075918273,0.0008621022,0.00037020154,0.00095588464],"domain_scores_gemma":[0.9977272,0.0009140751,0.00042069185,0.0005062429,0.00006348234,0.00036827894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006695731,0.00080638664,0.002183589,0.00048133702,0.00015580578,0.00006743455,0.00044868182,0.0007379572,0.00034558497],"category_scores_gemma":[0.00008268231,0.000610114,0.00041794725,0.00054345094,0.00013077937,0.000054491975,0.00015710045,0.0017483273,0.00005935702],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006709291,0.00046241298,0.000043763735,0.0035311505,0.00055672426,0.00031898718,0.00010592728,0.00005108853,0.000038443617,0.0008940606,0.0008584689,0.99307185],"study_design_scores_gemma":[0.0016019037,0.000049311544,0.013366725,0.0010323892,0.0017653048,0.000032516207,0.0000041970943,0.000011044726,0.0004604057,0.000092259135,0.98091453,0.0006694321],"about_ca_topic_score_codex":0.0000044772214,"about_ca_topic_score_gemma":0.000031658747,"teacher_disagreement_score":0.99240243,"about_ca_system_score_codex":0.00032195155,"about_ca_system_score_gemma":0.00014656948,"threshold_uncertainty_score":0.99963504},"labels":[],"label_agreement":null},{"id":"W3201667309","doi":"10.1016/j.euroneuro.2021.08.150","title":"W65. EVALUATING TREATMENT OUTCOMES IN PHARMACOGENOMIC-GUIDED CARE FOR MAJOR DEPRESSION: A RAPID REVIEW AND META-ANALYSIS","year":2021,"lang":"en","type":"review","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Medicine; Pharmacology; Drug; Bioinformatics; Intensive care medicine; Biology; Gene; Genetics; Genotype","score_opus":0.41006557159637663,"score_gpt":0.5511010450781461,"score_spread":0.14103547348176942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201667309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003702268,0.9849418,0.000012140135,0.00051771867,0.0021620905,0.007778249,0.0021383632,0.00022964667,0.0018497631],"genre_scores_gemma":[0.00015804984,0.98085827,0.0005040016,0.011463034,0.0005499643,0.0032910332,0.00069796055,0.00054610113,0.0019315841],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97811574,0.014027352,0.0031582853,0.0028300227,0.00036557106,0.0015030542],"domain_scores_gemma":[0.9937546,0.0022808625,0.0016234972,0.0010671437,0.00040196473,0.00087188976],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0028056388,0.0021620125,0.011794458,0.0011849608,0.0004326491,0.000092093054,0.0012687505,0.000534657,0.0048380103],"category_scores_gemma":[0.00023014529,0.0017084158,0.0058945594,0.0016283477,0.00026997653,0.000118599535,0.00063399656,0.0018306322,0.00013966736],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013332091,0.0009981404,0.00004916604,0.017511873,0.22290777,0.0014213962,0.00043075366,0.000116879935,0.0007350839,0.0000111927,0.0059475065,0.7497369],"study_design_scores_gemma":[0.0029329432,0.00013192318,0.0000212956,0.00009545656,0.45684046,0.00013259801,0.000010086357,0.00003345638,0.000020181647,0.0000016970835,0.53903866,0.0007412687],"about_ca_topic_score_codex":0.000012977383,"about_ca_topic_score_gemma":0.000009505028,"teacher_disagreement_score":0.74899566,"about_ca_system_score_codex":0.00025078343,"about_ca_system_score_gemma":0.0004005297,"threshold_uncertainty_score":0.99911207},"labels":[],"label_agreement":null},{"id":"W3201797936","doi":"10.1038/s41398-021-01600-7","title":"Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis","year":2021,"lang":"en","type":"review","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Reimbursement; Pharmacogenomics; Context (archaeology); Stakeholder; Health care; Commercialization; Psychology; Medicine; Business; Political science; Public relations; Marketing","score_opus":0.28794055085047254,"score_gpt":0.5638701600992077,"score_spread":0.2759296092487351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201797936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001698576,0.98414373,0.000551226,0.0009071799,0.009515275,0.00091997924,0.0011795987,0.000048763595,0.0010356758],"genre_scores_gemma":[0.0035543698,0.975333,0.01663985,0.0015985906,0.0020591675,0.0001581712,0.00050506584,0.000105555235,0.000046270765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927842,0.0021241528,0.002905612,0.0010642459,0.00043838515,0.0006833857],"domain_scores_gemma":[0.9961036,0.0016782312,0.00051793986,0.0004082199,0.00025297375,0.0010390666],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024289035,0.00068640884,0.0029108368,0.001272295,0.00017169552,0.000027636033,0.00063855853,0.0010037663,0.0025593205],"category_scores_gemma":[0.00039168744,0.0007196343,0.0018656522,0.0037622477,0.00022799498,0.00008668814,0.00007612342,0.0020355617,0.00013113137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028658434,0.0016639109,0.10718933,0.007958809,0.0076824552,0.00002843291,0.00024347682,0.0049660215,0.000038806844,0.00874352,0.0028063701,0.8583923],"study_design_scores_gemma":[0.0019719033,0.00008805961,0.0029599047,0.0016771111,0.023524351,0.000027490938,0.0000517221,0.0017854498,0.0000031345558,0.00088385976,0.9659898,0.0010371775],"about_ca_topic_score_codex":0.000012891618,"about_ca_topic_score_gemma":0.00005451024,"teacher_disagreement_score":0.96318346,"about_ca_system_score_codex":0.000053301923,"about_ca_system_score_gemma":0.0034912825,"threshold_uncertainty_score":0.9995255},"labels":[],"label_agreement":null},{"id":"W3202085191","doi":"10.1101/2021.09.21.461211","title":"PharmacoDB 2.0 : Improving scalability and transparency of <i>in vitro</i> pharmacogenomics analysis","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Government of Ontario; Genome Canada","keywords":"Pharmacogenomics; Drug response; Computer science; Profiling (computer programming); Computational biology; Bioinformatics; Data mining; Drug; Medicine; Biology; Pharmacology","score_opus":0.04259184064359825,"score_gpt":0.3287520670365142,"score_spread":0.28616022639291594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202085191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97492063,0.019182373,0.0008873085,0.00016565938,0.0020470058,0.0009891657,0.0016396317,0.00014092153,0.00002727565],"genre_scores_gemma":[0.98949283,0.0063546,0.0027018806,0.0007410543,0.00036567528,0.00021012101,0.000004430441,0.00012607452,0.000003326252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99388033,0.0011291909,0.0017260982,0.0017605743,0.00044370108,0.0010600901],"domain_scores_gemma":[0.99640733,0.00031859573,0.0009054121,0.0010288117,0.00058530923,0.00075455423],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025569214,0.0009618469,0.0018926093,0.0008907449,0.00018822629,0.00011286348,0.0008819063,0.0010585401,0.00035706547],"category_scores_gemma":[0.00014450042,0.0011303448,0.000623509,0.0016650441,0.00046098905,0.00019178363,0.0007863068,0.002583902,0.0000068859545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003455645,0.0007716044,0.038886312,0.0009846232,0.0019605027,0.000109744986,0.00010663897,0.0018438693,0.95477766,0.000025252551,0.000020296085,0.00016793203],"study_design_scores_gemma":[0.0024129392,0.000020484873,0.049622606,0.000049994323,0.0051748133,4.1291447e-8,0.000011104789,0.016482934,0.9229093,0.000002120297,0.002326505,0.0009871632],"about_ca_topic_score_codex":0.00018983614,"about_ca_topic_score_gemma":0.000010549175,"teacher_disagreement_score":0.03186837,"about_ca_system_score_codex":0.00022104182,"about_ca_system_score_gemma":0.00084850984,"threshold_uncertainty_score":0.9997172},"labels":[],"label_agreement":null},{"id":"W3202547533","doi":"10.1016/j.jagp.2021.09.013","title":"Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership","year":2021,"lang":"en","type":"article","venue":"American Journal of Geriatric Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; Centre for Addiction and Mental Health; Alberta Children's Hospital","funders":"","keywords":"Obligation; Mental health; Mental healthcare; Liability; Medicine; Psychology; Association (psychology); Psychiatry; Political science","score_opus":0.16550960732457295,"score_gpt":0.44756832752624665,"score_spread":0.28205872020167366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202547533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750264,0.0067041484,0.000010353622,0.011817452,0.00569269,0.00038018203,0.0002509533,0.00000839228,0.000109429995],"genre_scores_gemma":[0.98864996,0.0057499115,0.001929112,0.0028746668,0.0007060688,0.0000073443343,0.000004236662,0.000046504432,0.000032178057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9880427,0.0076003964,0.0025999588,0.00041778758,0.00077931583,0.00055981975],"domain_scores_gemma":[0.98684776,0.0040648957,0.0072143544,0.0004504322,0.0010982112,0.00032436312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005828168,0.0003702526,0.0013917482,0.0003824124,0.0001617059,0.00001971506,0.00079679815,0.00016222835,0.00012949777],"category_scores_gemma":[0.0025101616,0.00027111534,0.0006479904,0.004028239,0.0007132207,0.00009788378,0.00015975941,0.0016900385,0.0000026671119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018213837,0.0018723086,0.97585744,0.000066989414,0.0009067215,0.0000043432256,0.0010641908,0.001338064,0.0044705844,0.0001668131,0.0035729466,0.0088582095],"study_design_scores_gemma":[0.0032543354,0.0010233137,0.9884316,0.0000852377,0.00074508187,0.000030329262,0.0024596765,0.00048620751,0.0018102496,0.0003140463,0.0010458112,0.00031411674],"about_ca_topic_score_codex":0.00051812624,"about_ca_topic_score_gemma":0.00019614206,"teacher_disagreement_score":0.0136235785,"about_ca_system_score_codex":0.00014645596,"about_ca_system_score_gemma":0.0028243854,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W3203997738","doi":"10.1007/s13237-021-00373-0","title":"Genetic variations and epigenetic modulations in CYP genes: Implications in NSAID-treatment of arthritis patients","year":2021,"lang":"en","type":"article","venue":"The Nucleus","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Pharmacogenomics; CYP2C9; Cytochrome P450; Drug metabolism; Pharmacogenetics; Epigenetics; Pharmacology; Polymorphism (computer science); Biology; Drug; Medicine; Gene; Bioinformatics; Genotype; Genetics; Internal medicine; Metabolism","score_opus":0.07691669789942993,"score_gpt":0.388980085976602,"score_spread":0.31206338807717204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203997738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905694,0.006870463,0.00011802701,0.00077504467,0.00025154548,0.00040925757,0.0002313344,0.000011922526,0.0007629918],"genre_scores_gemma":[0.9851031,0.0136354165,0.00068920746,0.00026871535,0.000057432444,0.0001160096,0.00002960888,0.000016446995,0.0000840971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998676,0.00034514564,0.00041148913,0.00023690269,0.00007863681,0.00025181597],"domain_scores_gemma":[0.99923587,0.00022595402,0.000093531125,0.00025664945,0.00009486317,0.0000931073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013855043,0.00013681235,0.00021906146,0.00011121393,0.00013237531,0.000011622512,0.00012407733,0.000104273124,0.0002219284],"category_scores_gemma":[0.000035196415,0.00012290815,0.000051001593,0.00038635908,0.00010876447,0.000032972617,0.000061802326,0.00012919311,0.000017226088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047465248,0.0023562398,0.52980834,0.00001871647,0.00013644206,0.000018972763,0.0039267982,0.013359087,0.063314386,0.004798461,0.00006362778,0.38215145],"study_design_scores_gemma":[0.0026867506,0.000054066444,0.95841664,0.000008295615,0.00009304942,0.000008435507,0.00006499624,0.006732757,0.0091008125,0.0034137964,0.019277865,0.00014252213],"about_ca_topic_score_codex":0.00011246265,"about_ca_topic_score_gemma":0.000407038,"teacher_disagreement_score":0.4286083,"about_ca_system_score_codex":0.00005219898,"about_ca_system_score_gemma":0.00009214329,"threshold_uncertainty_score":0.5012049},"labels":[],"label_agreement":null},{"id":"W3206242311","doi":"10.1787/56e9bbf0-en","title":"Adverse Outcome Pathway on Cyp2E1 activation leading to liver cancer","year":2021,"lang":"en","type":"report","venue":"OECD series on adverse outcome pathways","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; University of Ottawa; Health Canada","funders":"","keywords":"CYP2E1; Oxidative stress; Reactive oxygen species; Chemistry; Cytochrome P450; Reactive intermediate; Liver injury; Cytotoxicity; Biochemistry; Cancer research; Cell biology; Pharmacology; Metabolism; Biology; Catalysis; In vitro","score_opus":0.3059958296056791,"score_gpt":0.47174545846639687,"score_spread":0.16574962886071776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206242311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5122083,0.0021761975,0.000101172525,0.0028283,0.048934523,0.004420414,0.0076888916,0.001021786,0.42062044],"genre_scores_gemma":[0.7529032,0.012195513,0.00067535497,0.034056593,0.0069736494,0.0015981207,0.0016349275,0.0008431712,0.18911946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9915015,0.0008771501,0.0020208661,0.0019996744,0.0018644525,0.0017363582],"domain_scores_gemma":[0.99477035,0.00063508603,0.0012135514,0.001312438,0.00081296597,0.0012555983],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0019228068,0.0017593441,0.0022647677,0.0009126077,0.00082138064,0.00007700216,0.0010267025,0.0018635067,0.012078635],"category_scores_gemma":[0.0007549647,0.001742393,0.0011265494,0.0005868798,0.000239108,0.0003527276,0.00058971863,0.003898166,0.005045504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010553072,0.0072093992,0.09455615,0.0064554703,0.008365003,0.01183213,0.010417555,0.06236972,0.25189838,0.014325402,0.2525918,0.26942593],"study_design_scores_gemma":[0.0020232296,0.00030145692,0.004039629,0.00025995163,0.00061683625,0.000047552843,0.00035762138,0.00008267978,0.073495395,0.000036529666,0.9169784,0.0017606807],"about_ca_topic_score_codex":0.00018469807,"about_ca_topic_score_gemma":0.00017907997,"teacher_disagreement_score":0.66438663,"about_ca_system_score_codex":0.0017824394,"about_ca_system_score_gemma":0.0017797473,"threshold_uncertainty_score":0.99951524},"labels":[],"label_agreement":null},{"id":"W3206887823","doi":"10.1007/s00439-021-02385-x","title":"Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health","year":2021,"lang":"en","type":"review","venue":"Human Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Innovative Medicines Initiative; Vetenskapsrådet; Karolinska Institutet; European Commission; McGill University; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Horizon 2020 Framework Programme; Eli Lilly and Company","keywords":"Pharmacogenomics; Biology; DPYD; Pharmacogenetics; Thiopurine methyltransferase; Population; Genotyping; Precision medicine; Personalized medicine; Genetics; Genotype; Disease; Internal medicine; Medicine; Gene; Environmental health; Inflammatory bowel disease","score_opus":0.67168818541495,"score_gpt":0.5501291538267473,"score_spread":0.12155903158820269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206887823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014211314,0.980324,0.00007029343,0.0002744462,0.0016498922,0.0018718427,0.0013593581,0.00009552725,0.00014338431],"genre_scores_gemma":[0.0026377735,0.9899176,0.00038882231,0.0023526007,0.0010439354,0.00039000352,0.00285589,0.0001578276,0.00025558897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99424326,0.0021869957,0.0012924786,0.0010488181,0.0003152642,0.0009131775],"domain_scores_gemma":[0.9970087,0.00042489896,0.0008838049,0.00053410925,0.00019943996,0.00094903825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019320913,0.0008618269,0.0020977443,0.000658602,0.0009797128,0.00022450392,0.0006532113,0.0007604126,0.0003424606],"category_scores_gemma":[0.000035223162,0.00081087084,0.00047562574,0.00022896589,0.00024249281,0.00009725668,0.00025234895,0.0010376083,0.000010700914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014996939,0.00034309932,0.00006581085,0.0025520204,0.00042161194,0.000010333364,0.0002283252,0.000009852618,0.000022066592,0.0021448245,0.00093163707,0.99325544],"study_design_scores_gemma":[0.0009104078,0.0003173833,0.000092716255,0.00054581155,0.0011510074,0.000022853088,0.000069668604,0.00031712573,0.000020812196,0.0005909761,0.995198,0.00076324353],"about_ca_topic_score_codex":0.000008300129,"about_ca_topic_score_gemma":0.000020551455,"teacher_disagreement_score":0.99426633,"about_ca_system_score_codex":0.000094828974,"about_ca_system_score_gemma":0.00044603547,"threshold_uncertainty_score":0.99943423},"labels":[],"label_agreement":null},{"id":"W3207996079","doi":"10.14740/wjon1405","title":"Genetic Polymorphisms in Pharmaceuticals and Chemotherapy","year":2021,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Personalized medicine; Medicine; Genome-wide association study; Pharmacogenomics; Precision medicine; Pharmacogenetics; Bioinformatics; Drug reaction; Drug; Single-nucleotide polymorphism; Genotype; Gene; Pharmacology; Genetics; Biology; Pathology","score_opus":0.21311105276420592,"score_gpt":0.5317747000781388,"score_spread":0.3186636473139328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207996079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050310703,0.9915279,0.000013680708,0.0008454622,0.0035281202,0.00048370718,0.000033802156,0.0000114587765,0.0030527466],"genre_scores_gemma":[0.00023306358,0.99291855,0.0010573929,0.00334633,0.001524281,0.000032721047,0.000006567334,0.00008735909,0.00079373625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99383754,0.002555492,0.0021618258,0.00045596575,0.0002637026,0.0007254849],"domain_scores_gemma":[0.9960937,0.0014124315,0.0014502452,0.00022951527,0.00018285881,0.00063126424],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021242613,0.0006219566,0.003730213,0.001200934,0.00009124073,0.000032401305,0.0006344797,0.0008264109,0.0024610404],"category_scores_gemma":[0.0001118929,0.0005322069,0.0006617513,0.0008758642,0.0003630592,0.0000736117,0.00020309338,0.0034080893,0.00003996831],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009029166,0.0005414286,0.0001679438,0.00071237475,0.0006879242,0.002051322,0.00014714287,0.000012894763,0.000085842345,0.00017402634,0.004544784,0.99078405],"study_design_scores_gemma":[0.0031738395,0.00016741132,0.00007593802,0.001068045,0.002119316,0.0029774576,0.000011620265,0.000026311054,0.00006252111,0.00016096242,0.98971546,0.0004411421],"about_ca_topic_score_codex":0.0000039858746,"about_ca_topic_score_gemma":0.000018135705,"teacher_disagreement_score":0.99034286,"about_ca_system_score_codex":0.00026897484,"about_ca_system_score_gemma":0.001456283,"threshold_uncertainty_score":0.99971294},"labels":[],"label_agreement":null},{"id":"W3208185303","doi":"10.14309/ctg.0000000000000263","title":"Utilization of Whole Exome Sequencing Data to Identify Clinically Relevant Pharmacogenomic Variants in Pediatric Inflammatory Bowel Disease","year":2020,"lang":"en","type":"article","venue":"Clinical and Translational Gastroenterology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Medicine; Pharmacogenomics; Exome sequencing; Inflammatory bowel disease; Exome; Disease; Cohort; Bioinformatics; Internal medicine; Gene; Genetics; Mutation; Pharmacology","score_opus":0.29675806365712043,"score_gpt":0.4826146700926952,"score_spread":0.18585660643557478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208185303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886295,0.00079569075,0.0019132091,0.006654971,0.0007469658,0.00045277158,0.0007312962,0.000027679811,0.00004786962],"genre_scores_gemma":[0.9877769,0.0020915123,0.0007594517,0.008433729,0.0006704027,0.000017032851,0.00021873837,0.000023073218,0.000009179708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618036,0.0008958748,0.0016187661,0.00072237325,0.00018769823,0.0003949278],"domain_scores_gemma":[0.9980489,0.00055663945,0.00026668713,0.0002403881,0.000091670474,0.00079573825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017556361,0.00022060718,0.00046317768,0.00013654113,0.00006711627,0.00001134658,0.00053083274,0.00019851327,0.00020849267],"category_scores_gemma":[0.00037130466,0.00022694762,0.00011089689,0.00017633189,0.00024713128,0.00015907214,0.0002606392,0.0006853358,0.00005185139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039242576,0.00030203635,0.9796672,0.00011742822,0.00009692927,0.00006685705,0.00028034174,0.002706343,0.0070195333,0.00009990963,0.00036563954,0.005353567],"study_design_scores_gemma":[0.0051685474,0.00021938395,0.9469173,0.0000108924605,0.0003380302,0.0000054883726,0.000016035558,0.041058023,0.000061428145,0.000516166,0.0055345064,0.00015422722],"about_ca_topic_score_codex":0.000002298347,"about_ca_topic_score_gemma":0.000008415347,"teacher_disagreement_score":0.038351677,"about_ca_system_score_codex":0.000006862688,"about_ca_system_score_gemma":0.00020026394,"threshold_uncertainty_score":0.9254656},"labels":[],"label_agreement":null},{"id":"W3208200825","doi":"10.1124/dmd.121.000637","title":"In Defense of Current Concepts and Applications of Clearance in Drug Development and Therapeutics","year":2021,"lang":"en","type":"letter","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council; Natural Sciences and Engineering Research Council of Canada","keywords":"Physiologically based pharmacokinetic modelling; Metabolic clearance rate; Pharmacokinetics; Clearance; Drug; Pharmacology; Drug development; Clearance rate; Intensive care medicine; Medicine; Extrapolation; Chemistry; Mathematics; Internal medicine; Urology; Statistics","score_opus":0.056319293251576745,"score_gpt":0.3964351982274604,"score_spread":0.3401159049758836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208200825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7632897,0.22528549,0.000095800235,0.008999484,0.00065356557,0.0008793178,0.00034983963,0.000011442114,0.0004353558],"genre_scores_gemma":[0.8833173,0.065390825,0.0004429219,0.04913031,0.00076768314,0.00030037243,0.00038677367,0.00005437449,0.00020943076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997852,0.0005185253,0.0006861918,0.00044934746,0.00018889358,0.0003050261],"domain_scores_gemma":[0.99910504,0.0002317904,0.00030862776,0.00016201398,0.000102499005,0.00009001927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054399774,0.0003118052,0.00068650785,0.0003037984,0.00007221159,0.000016532562,0.00012630348,0.00033712154,0.0000310738],"category_scores_gemma":[0.000008268553,0.0003178445,0.000053500244,0.00027454793,0.00032121025,0.000096290976,0.00012109669,0.001095354,0.0000012869199],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012339537,0.0023500142,0.014976025,0.007928553,0.00081931276,0.00022488527,0.045602553,0.00015532062,0.03221821,0.018777817,0.030607441,0.8451059],"study_design_scores_gemma":[0.0022625648,0.000006009024,0.012217946,0.0001437052,0.00035354935,0.000013157792,0.00020207716,0.00014308137,0.023462677,0.0012613072,0.95956004,0.00037390838],"about_ca_topic_score_codex":0.000041984335,"about_ca_topic_score_gemma":0.000035599343,"teacher_disagreement_score":0.9289526,"about_ca_system_score_codex":0.000016215383,"about_ca_system_score_gemma":0.00011030532,"threshold_uncertainty_score":0.99992734},"labels":[],"label_agreement":null},{"id":"W3209449754","doi":"10.1016/b978-0-12-819869-8.00015-x","title":"Biochemical mechanisms of drug toxicity","year":2021,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adverse effect; Drug; Pharmacology; Drug reaction; Toxicity; Medicine; SAFER; Toxicology; Biology; Internal medicine; Computer science","score_opus":0.05989299927713269,"score_gpt":0.3641601756035457,"score_spread":0.304267176326413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209449754","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028696898,0.010690904,0.000024130322,0.00015697433,0.0023975298,0.0005511592,0.0004704732,0.000072590374,0.98276657],"genre_scores_gemma":[0.02243125,0.0014613196,0.00071351556,0.002465257,0.00071535516,0.000039057417,0.00011246593,0.0001372608,0.97192454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972489,0.00019441672,0.0008925426,0.00070470426,0.00042518578,0.0005342832],"domain_scores_gemma":[0.99797136,0.00021803964,0.0005101741,0.00057589397,0.000285911,0.00043859697],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006950749,0.00065955374,0.0010956124,0.00018443953,0.00013391995,0.000017350469,0.0006103327,0.0010493709,0.0054986067],"category_scores_gemma":[0.00003603299,0.00067580014,0.00060902286,0.000032093332,0.0003785812,0.00002298114,0.00044426223,0.0017130115,0.00019236309],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010689964,0.00011394917,0.000004520468,0.00026960325,0.0007663425,0.00013970691,0.00025895092,0.0000053304643,0.22844256,0.07591424,0.0029081656,0.6910697],"study_design_scores_gemma":[0.0005979071,0.00001697646,0.0000019156969,0.00007925066,0.00056051154,0.000020618618,0.0000074969034,0.000022085842,0.3467703,0.023914063,0.6275968,0.00041210346],"about_ca_topic_score_codex":4.514948e-7,"about_ca_topic_score_gemma":0.0000032867504,"teacher_disagreement_score":0.6906576,"about_ca_system_score_codex":0.0000627643,"about_ca_system_score_gemma":0.00030948012,"threshold_uncertainty_score":0.9995693},"labels":[],"label_agreement":null},{"id":"W3209772594","doi":"10.1093/pch/pxab061.102","title":"127 Impact of CYP2D6, CYP3A4, and CYP2C9 pharmacogenomic profile on pain relief and adverse events in Canadian children treated with oxycodone and ibuprofen","year":2021,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of British Columbia; University of Calgary; Université de Montréal; University of Alberta","funders":"","keywords":"Oxycodone; Medicine; Ibuprofen; CYP2D6; Adverse effect; Analgesic; Pharmacogenomics; CYP2C9; Anesthesia; Internal medicine; Pharmacology; Opioid","score_opus":0.026725463396073977,"score_gpt":0.3615150823519874,"score_spread":0.33478961895591347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209772594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741691,0.021621311,0.0000027535773,0.001260075,0.0001395681,0.0011305944,0.001248009,0.00002488043,0.0004037243],"genre_scores_gemma":[0.9589766,0.037737872,0.00016664588,0.002500046,0.00022178396,0.000037736623,0.0002508761,0.000050163515,0.000058265567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965919,0.001104374,0.00055265875,0.000627733,0.00019118791,0.00093210087],"domain_scores_gemma":[0.9977926,0.00030083596,0.00028678981,0.00021590354,0.00009693309,0.0013069073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019078382,0.00039848147,0.0006414592,0.0004653179,0.0003224796,0.000009016531,0.00013979198,0.00024716352,0.0001305522],"category_scores_gemma":[0.00009628328,0.00035745127,0.00007361535,0.0005852142,0.00013352788,0.0000826287,0.000097669414,0.00090985314,0.0000068293407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041051002,0.00034772936,0.9745354,0.0001387932,0.00023852629,0.00004190512,0.00066398486,0.00015685409,0.00084779673,0.000073103445,0.0007359479,0.021809435],"study_design_scores_gemma":[0.006652177,0.0007137585,0.9855779,0.00006253423,0.00023195815,0.00007770177,0.00006159465,0.001256146,0.0014136075,0.00007142778,0.0034198563,0.00046136414],"about_ca_topic_score_codex":0.024062816,"about_ca_topic_score_gemma":0.0060849003,"teacher_disagreement_score":0.02134807,"about_ca_system_score_codex":0.0002373765,"about_ca_system_score_gemma":0.0011726759,"threshold_uncertainty_score":0.99988776},"labels":[],"label_agreement":null},{"id":"W3211588721","doi":"10.1111/add.15742","title":"Does sex alter the relationship between <i>CYP2B6</i> variation, hydroxybupropion concentration and bupropion‐aided smoking cessation in African Americans? A moderated mediation analysis","year":2021,"lang":"en","type":"article","venue":"Addiction","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Cancer Institute; Campbell Family Mental Health Research Institute; National Institutes of Health; Canada Research Chairs","keywords":"Bupropion; CYP2B6; Smoking cessation; Medicine; Internal medicine; Mediation; Pharmacology","score_opus":0.06990458063834164,"score_gpt":0.3750508901201011,"score_spread":0.30514630948175947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211588721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842529,0.0004504411,0.010091559,0.003550127,0.0006422243,0.00038943594,0.00008178704,0.00007002383,0.00047144742],"genre_scores_gemma":[0.9972701,0.00046252285,0.00013530061,0.0007312003,0.00042041202,0.00010154799,0.0007018779,0.00001717748,0.0001598312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725515,0.0012149082,0.0005493626,0.00042657563,0.00027529872,0.0002786868],"domain_scores_gemma":[0.9983989,0.0007772609,0.00032078053,0.00018946899,0.00019855482,0.00011504194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090947875,0.00019129697,0.0002707539,0.00016542096,0.0004510061,0.000083002145,0.00009541272,0.00023046699,0.00018425047],"category_scores_gemma":[0.000290518,0.00013808087,0.00007333901,0.0015102605,0.00010141854,0.00031415568,0.00003943675,0.0005276345,0.000006000652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062137624,0.00009504961,0.9430871,0.000013404549,0.00049502024,0.0000040034424,0.004214779,0.012128172,0.022569044,0.0009172612,0.00012639623,0.01628764],"study_design_scores_gemma":[0.001327948,0.000021368625,0.87640256,0.00000761453,0.0011662047,0.0000023535245,0.0003299314,0.09632826,0.017954936,0.0030279201,0.003209557,0.00022136142],"about_ca_topic_score_codex":0.00016002925,"about_ca_topic_score_gemma":0.00015756945,"teacher_disagreement_score":0.084200084,"about_ca_system_score_codex":0.00012123022,"about_ca_system_score_gemma":0.00010554362,"threshold_uncertainty_score":0.56307745},"labels":[],"label_agreement":null},{"id":"W3212365385","doi":"10.1038/s41380-021-01340-6","title":"Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application","year":2021,"lang":"en","type":"review","venue":"Molecular Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ted Rogers Centre for Heart Research; University of Calgary; University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Antipsychotic; Medicine; Antidepressant; Psychiatry; Adverse effect; Clinical Practice; Drug; Schizophrenia (object-oriented programming); Pharmacology; Family medicine; Anxiety; Gene; Genetics; Genotype; Biology","score_opus":0.5194177180246066,"score_gpt":0.5761055332194733,"score_spread":0.056687815194866764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212365385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049148565,0.98754376,0.0030138635,0.0002149471,0.0022170169,0.0015583656,0.00046851236,0.000026615611,0.000042078726],"genre_scores_gemma":[0.0014804585,0.98927337,0.007737564,0.00067993347,0.0004174754,0.00015618725,0.00008336102,0.000086155436,0.00008551389],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964112,0.00083858386,0.0012305699,0.00094057265,0.00018603385,0.0003930272],"domain_scores_gemma":[0.9975968,0.0006932349,0.0007317732,0.0005001078,0.00017239891,0.0003056877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016339606,0.0004967607,0.0017052068,0.00015535508,0.00013482441,0.00003092219,0.00039607333,0.00058287923,0.000021541984],"category_scores_gemma":[0.00015745571,0.00043440153,0.00057320466,0.00023084067,0.0003016573,0.000055578526,0.00022288565,0.0007965874,0.0000058706437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006849312,0.00038082854,0.0024005591,0.010401732,0.00097551255,0.000011400039,0.000033372726,0.000003386275,0.0003380697,0.0007221725,0.002314297,0.9823502],"study_design_scores_gemma":[0.0012633714,0.000057909565,0.00040817814,0.002493909,0.0050018188,0.00009042342,0.000011879715,0.00027456495,0.00059361476,0.000608139,0.9886191,0.00057707354],"about_ca_topic_score_codex":0.000005294837,"about_ca_topic_score_gemma":0.000004339777,"teacher_disagreement_score":0.9863048,"about_ca_system_score_codex":0.000011141188,"about_ca_system_score_gemma":0.00032892334,"threshold_uncertainty_score":0.99981076},"labels":[],"label_agreement":null},{"id":"W3212684436","doi":"10.1002/phar.2644","title":"Association of <i>CYP2B6</i> genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thompson Rivers University","funders":"","keywords":"Bupropion; CYP2B6; Medicine; Pharmacology; Meta-analysis; Genotype; Internal medicine; Smoking cessation; Genetics; Biology; Cytochrome P450; CYP3A4; Metabolism; Pathology","score_opus":0.08553217724164386,"score_gpt":0.42135551507733976,"score_spread":0.3358233378356959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212684436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045480123,0.9907715,0.000024941604,0.0012140103,0.00039369406,0.0028627599,0.0001303146,0.000024353132,0.000030422721],"genre_scores_gemma":[0.0027929246,0.9902107,0.00007810476,0.005592802,0.0003073133,0.00023451843,0.000016728065,0.00011362416,0.0006532627],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98732394,0.008385586,0.0024993215,0.00058817235,0.0005831716,0.0006198255],"domain_scores_gemma":[0.99173534,0.0020134377,0.004890551,0.00037112966,0.0005577056,0.0004318102],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0054223933,0.0010860289,0.0078690825,0.00066348235,0.0005107307,0.00005831342,0.0007357614,0.00047486962,0.0011088911],"category_scores_gemma":[0.000028647066,0.0006213259,0.0013371666,0.0009549124,0.0005608607,0.0001995512,0.00014707434,0.0019732493,0.000002040363],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069141487,0.0012544673,0.00015867944,0.21983503,0.72923064,0.00017976138,0.0025927078,0.000048320522,0.010245387,0.0000654494,0.0047365357,0.03096161],"study_design_scores_gemma":[0.0037324014,0.00044537405,0.0000080876125,0.0029002721,0.84761125,0.0005796532,0.00004591481,0.000019265724,0.0021928672,0.000057848887,0.1417177,0.0006893561],"about_ca_topic_score_codex":0.000015434905,"about_ca_topic_score_gemma":0.0000058701626,"teacher_disagreement_score":0.21693476,"about_ca_system_score_codex":0.000080423364,"about_ca_system_score_gemma":0.000258857,"threshold_uncertainty_score":0.99980426},"labels":[],"label_agreement":null},{"id":"W3212700654","doi":"10.1016/j.lfs.2021.120133","title":"Hepatic cytochrome P450 function is reduced by life-long Western diet consumption in guinea pig independent of birth weight","year":2021,"lang":"en","type":"article","venue":"Life Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Children’s Health Research Institute; Western University","funders":"National Health and Medical Research Council; Australian Research Council; Canadian Institutes of Health Research","keywords":"CYP1A2; Internal medicine; Gestation; Endocrinology; Biology; Weaning; Physiology; Birth weight; Drug metabolism; Cytochrome P450; Metabolism; Medicine; Pregnancy","score_opus":0.10215592350348929,"score_gpt":0.4069261618240501,"score_spread":0.3047702383205608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212700654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863535,0.009225918,0.000119417746,0.001317486,0.001563633,0.00025018764,0.00010960345,0.00003334785,0.0010268744],"genre_scores_gemma":[0.9923967,0.003288983,0.0000781137,0.003170767,0.00021467223,0.000035566496,0.00002134031,0.000012983747,0.0007808501],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974189,0.00052789884,0.0006024989,0.00053115736,0.00045734196,0.00046220896],"domain_scores_gemma":[0.99888986,0.00021283622,0.000262781,0.00019419608,0.00010952772,0.00033078773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011437195,0.00021980346,0.00037453652,0.00020658686,0.00022447018,0.00003627313,0.00036533887,0.00020991746,0.0020862194],"category_scores_gemma":[0.00015036901,0.0002046006,0.00009167048,0.00067268,0.00044398365,0.00021675907,0.00015367976,0.00041008394,0.00011161597],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029896127,0.00053980656,0.40346825,0.00012405496,0.00011749959,0.000027829296,0.0010014195,0.0004451067,0.58635974,0.00014393547,0.0044325087,0.003040899],"study_design_scores_gemma":[0.0042512473,0.00042028737,0.46722984,0.000078327845,0.00029211724,0.00002481584,0.00034695235,0.007376183,0.4498329,0.0007201163,0.06876058,0.0006666464],"about_ca_topic_score_codex":0.000048762286,"about_ca_topic_score_gemma":0.000059497183,"teacher_disagreement_score":0.13652687,"about_ca_system_score_codex":0.000031264994,"about_ca_system_score_gemma":0.0003431647,"threshold_uncertainty_score":0.998826},"labels":[],"label_agreement":null},{"id":"W3213251609","doi":"10.1177/07067437211058847","title":"Encountering Pharmacogenetic Test Results in the Psychiatric Clinic","year":2021,"lang":"en","type":"article","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hotchkiss Brain Institute; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Psychiatry; Pharmacogenetics; Test (biology); Psychology; Medicine; Clinical psychology; Genotype; Genetics","score_opus":0.0880198768747529,"score_gpt":0.4125628024559389,"score_spread":0.324542925581186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213251609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.763481,0.06109276,0.000017245988,0.12303125,0.024486376,0.0004126687,0.0003350665,0.000012198486,0.027131435],"genre_scores_gemma":[0.9764652,0.0018388345,0.00054069253,0.01820434,0.0024973643,0.000007638747,0.0000063873517,0.000028017002,0.00041149987],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681205,0.0010194858,0.0010327935,0.00022417982,0.00028697395,0.00062450446],"domain_scores_gemma":[0.99780554,0.00063645164,0.0004636129,0.0003618968,0.00022552136,0.00050700124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003675922,0.00023441717,0.00029731754,0.0002743656,0.0005581766,0.00009977978,0.0011476765,0.00018817758,0.0010105927],"category_scores_gemma":[0.00028265725,0.000155869,0.00025582008,0.0008467962,0.00021707187,0.00007972325,0.000032119024,0.0018860466,0.000119454606],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009345176,0.0013954957,0.46017644,0.0001556483,0.0008743101,0.0023656515,0.01088089,0.0040684463,0.008173735,0.003666845,0.4647497,0.042558327],"study_design_scores_gemma":[0.0065484587,0.0002202583,0.07417993,0.00006547156,0.0007593783,0.0023609784,0.0016737292,0.00036603876,0.0018300414,0.0121205505,0.89940125,0.00047389755],"about_ca_topic_score_codex":0.00045634212,"about_ca_topic_score_gemma":0.07028922,"teacher_disagreement_score":0.43465155,"about_ca_system_score_codex":0.00007644067,"about_ca_system_score_gemma":0.004345337,"threshold_uncertainty_score":0.9999026},"labels":[],"label_agreement":null},{"id":"W3213644771","doi":"10.3390/jpm11111180","title":"Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?","year":2021,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Medicine; Pharmacotherapy; Intensive care medicine; Adverse effect; Precision medicine; MEDLINE; Personalized medicine; Internal medicine; Pharmacology; Bioinformatics; Genotype; Pathology","score_opus":0.37998475150089694,"score_gpt":0.6050634267504011,"score_spread":0.2250786752495042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213644771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026381985,0.9900037,0.0003109303,0.0011651384,0.0056827134,0.0014772443,0.00050382165,0.000012600665,0.00058004964],"genre_scores_gemma":[0.00005882861,0.9907462,0.0010159647,0.0019979083,0.0046813074,0.00021176015,0.00022562395,0.00008587587,0.0009765585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947169,0.0013731219,0.0023881677,0.0004442101,0.00043066192,0.00064694905],"domain_scores_gemma":[0.9956202,0.0012803312,0.0014193502,0.00023541352,0.000725637,0.000719089],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003579616,0.0005838023,0.0034070665,0.0009919102,0.00014637178,0.0000090776775,0.00053396204,0.0005191907,0.0020351673],"category_scores_gemma":[0.00049743353,0.00046930893,0.00088065,0.00072941283,0.00019252431,0.000068644935,0.0000886534,0.0016478351,0.00002712652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034716606,0.00022275376,0.00008045738,0.004839224,0.0027451194,0.0007243199,0.0013058743,0.00014848317,0.0014607775,0.00042237548,0.085874975,0.90182847],"study_design_scores_gemma":[0.0064822435,0.0002855557,0.000011242448,0.002394173,0.007010618,0.0008081773,0.0007294372,0.000011697894,0.00007864927,0.000048660433,0.9817584,0.00038115232],"about_ca_topic_score_codex":0.0000148270965,"about_ca_topic_score_gemma":0.000009968838,"teacher_disagreement_score":0.9014473,"about_ca_system_score_codex":0.00033687308,"about_ca_system_score_gemma":0.001222771,"threshold_uncertainty_score":0.9997759},"labels":[],"label_agreement":null},{"id":"W3214830960","doi":"10.1038/s41398-021-01717-9","title":"Methodology for clinical genotyping of CYP2D6 and CYP2C19","year":2021,"lang":"en","type":"article","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; Alberta Health Services; Alberta Hospital Edmonton; University of Calgary; Women and Children’s Health Research Institute; University of Alberta","funders":"Alberta Innovates; University of Alberta","keywords":"Genotyping; TaqMan; CYP2C19; Pharmacogenomics; Biology; Haplotype; Computational biology; Genetics; SNP genotyping; CYP2D6; Genotype; Polymerase chain reaction; Gene","score_opus":0.5035614336214067,"score_gpt":0.5902992162876949,"score_spread":0.08673778266628818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214830960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8843812,0.05063024,0.03947607,0.01141014,0.00785694,0.0005454328,0.00052431563,0.00004774061,0.005127942],"genre_scores_gemma":[0.8020374,0.0033469147,0.18798876,0.0046765557,0.0014243225,0.000036242694,0.00011297795,0.000035956233,0.0003408484],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824315,0.0005745986,0.000562185,0.00030383756,0.00009513007,0.00022111797],"domain_scores_gemma":[0.9981865,0.001261114,0.00012745296,0.00011332739,0.0001679707,0.00014362186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001346998,0.00013241185,0.00032942143,0.000057376612,0.00011302175,0.000005109439,0.000104011786,0.00027214448,0.00046714896],"category_scores_gemma":[0.000085056956,0.0001386727,0.0001878877,0.00011806955,0.00017146839,0.00003979974,0.000020777194,0.00032961473,0.000006790073],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022454131,0.0013398502,0.34236744,0.00055833574,0.0016403501,0.000008020511,0.0011622746,0.0010544646,0.10236478,0.31221488,0.008467676,0.22657654],"study_design_scores_gemma":[0.011365728,0.00017053224,0.21892716,0.00002724265,0.0011997453,0.000079902275,0.00018139486,0.0059729577,0.027042463,0.18413079,0.55031914,0.0005829837],"about_ca_topic_score_codex":0.0000015803805,"about_ca_topic_score_gemma":0.000010835302,"teacher_disagreement_score":0.54185146,"about_ca_system_score_codex":0.000002770066,"about_ca_system_score_gemma":0.00027138155,"threshold_uncertainty_score":0.56549084},"labels":[],"label_agreement":null},{"id":"W3215139907","doi":"10.1093/nar/gkab1084","title":"PharmacoDB 2.0: improving scalability and transparency of <i>in vitro</i> pharmacogenomics analysis","year":2021,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Government of Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation; Genome Canada","keywords":"Pharmacogenomics; Drug response; Biology; Computational biology; Profiling (computer programming); Cancer cell lines; Genomics; Precision medicine; Bioinformatics; Standardization; Drug; Computer science; Cancer; Genome; Pharmacology; Genetics; Cancer cell; Gene","score_opus":0.1494120533310005,"score_gpt":0.4718074934385607,"score_spread":0.3223954401075602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215139907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98559546,0.008086775,0.0001647966,0.00059524353,0.00036426703,0.00042287097,0.00033120083,0.000035279652,0.0044040945],"genre_scores_gemma":[0.993863,0.0041921963,0.00087770633,0.0004979486,0.0001684171,0.000054373617,0.000047202444,0.000039320716,0.00025986787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946827,0.0019576894,0.0008788726,0.00084213394,0.0006113476,0.0010272472],"domain_scores_gemma":[0.99754405,0.0007682607,0.00013511219,0.00044797835,0.0005710583,0.00053352717],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004637448,0.00029359228,0.00074204826,0.00072010723,0.00027675024,0.00004330163,0.0005300451,0.0003224411,0.0018446492],"category_scores_gemma":[0.0002319751,0.0003113543,0.0002661605,0.0027420393,0.0007015583,0.00015547042,0.00037455757,0.0017652325,0.000029871777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005802877,0.0006249058,0.0380086,0.00017022395,0.0005285029,0.00009454486,0.0009006063,0.00031237004,0.86558723,0.00012545979,0.00013291139,0.09293436],"study_design_scores_gemma":[0.003226275,0.000040842715,0.017298207,0.0000069988187,0.0007500209,0.000013146367,0.0002924818,0.026800388,0.9257372,0.0003623807,0.025158534,0.00031354337],"about_ca_topic_score_codex":0.0001232242,"about_ca_topic_score_gemma":0.000034060446,"teacher_disagreement_score":0.09262082,"about_ca_system_score_codex":0.000109477114,"about_ca_system_score_gemma":0.00037382788,"threshold_uncertainty_score":0.99993384},"labels":[],"label_agreement":null},{"id":"W3216168466","doi":"10.3390/ijms222312791","title":"Determination of CYP450 Expression Levels in the Human Small Intestine by Mass Spectrometry-Based Targeted Proteomics","year":2021,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Jejunum; Ileum; Duodenum; Small intestine; CYP3A4; Internal medicine; Proteomics; Biology; Chemistry; Endocrinology; Biochemistry; Metabolism; Cytochrome P450; Medicine","score_opus":0.09546359815302874,"score_gpt":0.42790314418875736,"score_spread":0.3324395460357286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216168466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94943964,0.0011628892,0.04635205,0.0015722994,0.0006315452,0.00010212913,0.000030593397,0.0000031819152,0.0007056913],"genre_scores_gemma":[0.9712329,0.000051680392,0.02766967,0.0009201175,0.00009123478,0.000004485216,0.0000064141195,0.00000547464,0.000018004535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813396,0.0005044078,0.00049755414,0.00014739668,0.0005565611,0.00016014169],"domain_scores_gemma":[0.9987036,0.00020710994,0.00046736404,0.00007401436,0.0004878811,0.000060037568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017438793,0.00010498023,0.00016172038,0.0002638194,0.00007207477,0.000045647983,0.0008696603,0.0000719077,0.0001971308],"category_scores_gemma":[0.000294919,0.000078282515,0.00010303656,0.00035626747,0.00019954388,0.00009298055,0.000053743468,0.0003782217,0.0000012053199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029772888,0.0002333709,0.0021285762,0.000005421246,0.00002151905,0.00018357894,0.00019133415,0.0012196517,0.9933,0.0003157644,0.00006398365,0.002307021],"study_design_scores_gemma":[0.0010803323,0.000093910334,0.002285606,0.000030822634,0.000027177726,0.000071790455,0.00011522872,0.0033095197,0.9888773,0.0030885695,0.0009375559,0.00008218857],"about_ca_topic_score_codex":0.000004263086,"about_ca_topic_score_gemma":0.0000023199086,"teacher_disagreement_score":0.021793298,"about_ca_system_score_codex":0.000035561636,"about_ca_system_score_gemma":0.00021856095,"threshold_uncertainty_score":0.31922683},"labels":[],"label_agreement":null},{"id":"W334693804","doi":"10.71781/4812","title":"Développement et validation de méthodes de dosage du midazolam, un marqueur de l'activité des CYP3A, et de la fexofénadine, un substrat de la glycoprotéine P, dans les milieux biologiques","year":2009,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.10456814665663251,"score_gpt":0.4905177515325066,"score_spread":0.3859496048758741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W334693804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669545,0.005074921,0.0072317515,0.0010808841,0.00040041472,0.0015377301,0.00054182025,0.00003066297,0.017147288],"genre_scores_gemma":[0.8640118,0.031577542,0.099174075,0.001670376,0.0003740734,0.00040702274,0.0013653679,0.00012492675,0.0012947787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9817856,0.014465578,0.00095339806,0.0009984225,0.0002592435,0.0015377332],"domain_scores_gemma":[0.9951553,0.0027789348,0.0006925357,0.00038222125,0.00022265824,0.00076835003],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.013016984,0.0010347691,0.0008926423,0.0002917903,0.00089906744,0.00054198527,0.0013546952,0.0021767954,0.002369143],"category_scores_gemma":[0.0006447201,0.0011168042,0.00031336592,0.00040100023,0.0006147469,0.00034088327,0.00022861084,0.0024274017,0.000055182827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001457224,0.001738988,0.11899097,0.0001786226,0.00068635785,0.00052222214,0.017845968,0.0034868745,0.6661071,0.0011802022,0.0003406455,0.18746479],"study_design_scores_gemma":[0.0028034213,0.0001977419,0.19785531,0.00017192509,0.0012686439,0.00036120982,0.0012588268,0.0023132688,0.75157243,0.005086761,0.036230013,0.00088045106],"about_ca_topic_score_codex":0.0017233489,"about_ca_topic_score_gemma":0.002063139,"teacher_disagreement_score":0.18658434,"about_ca_system_score_codex":0.00095433404,"about_ca_system_score_gemma":0.0028494303,"threshold_uncertainty_score":0.99987406},"labels":[],"label_agreement":null},{"id":"W4200051059","doi":"10.3390/pharmacy9040201","title":"Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices","year":2021,"lang":"en","type":"article","venue":"Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Centre for Addiction and Mental Health; Trillium Health Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Service (business); Psychological intervention; Documentation; Pharmacy; Thematic analysis; Pharmacist; Workflow; Personalized medicine; Intervention (counseling); Medical education; Medicine; Nursing; Computer science; Qualitative research; Business","score_opus":0.24758046588221072,"score_gpt":0.5155950527501899,"score_spread":0.2680145868679792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200051059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8913744,0.052091677,0.00003701831,0.0011277732,0.0048935856,0.0012030669,0.000114496055,0.00035647044,0.048801493],"genre_scores_gemma":[0.9722109,0.009371373,0.0011042487,0.012014247,0.0025274844,0.0009120625,0.00039177103,0.0001835766,0.0012843274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9904758,0.0022427666,0.0019481729,0.0019114299,0.0010813251,0.0023405135],"domain_scores_gemma":[0.99424046,0.0016863785,0.001513671,0.00056655286,0.0008459267,0.0011470001],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024438973,0.0011788036,0.0013499529,0.0005906948,0.0010348418,0.00016721357,0.0012792401,0.00024162645,0.018606137],"category_scores_gemma":[0.00093354716,0.0012107367,0.00036597272,0.0017546635,0.0006769904,0.0009323802,0.000828069,0.0017797906,0.00040910876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001109063,0.0006899274,0.025316047,0.00036168488,0.00042363352,0.0022920312,0.035027094,0.00008122804,0.82567656,0.00004753815,0.002868405,0.10610681],"study_design_scores_gemma":[0.01934245,0.000057488254,0.00026008286,0.00008527475,0.00064417924,0.00072450476,0.009934133,0.0029758182,0.54610366,0.00008261778,0.41871122,0.0010785735],"about_ca_topic_score_codex":0.00022923085,"about_ca_topic_score_gemma":0.000012044988,"teacher_disagreement_score":0.4158428,"about_ca_system_score_codex":0.0005465563,"about_ca_system_score_gemma":0.0013773623,"threshold_uncertainty_score":0.9990342},"labels":[],"label_agreement":null},{"id":"W4200497292","doi":"10.1152/ajpgi.00160.2021","title":"Xenobiotic receptors and the regulation of intestinal homeostasis: harnessing the chemical output of the intestinal microbiota","year":2021,"lang":"en","type":"review","venue":"American Journal of Physiology-Gastrointestinal and Liver Physiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Government of Canada; Crohn's and Colitis Canada; University of Calgary","keywords":"Pregnane X receptor; Aryl hydrocarbon receptor; Xenobiotic; Receptor; Biology; Immune system; Homeostasis; Cell biology; Catabolism; Intestinal mucosa; Gastrointestinal tract; Microbiology; Biochemistry; Nuclear receptor; Metabolism; Immunology; Enzyme; Internal medicine; Gene","score_opus":0.052256442617631224,"score_gpt":0.3512901231364465,"score_spread":0.29903368051881524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200497292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18895298,0.8092016,0.000032091295,0.00045442072,0.00075974653,0.0005015998,0.000055070024,0.0000088805555,0.000033608776],"genre_scores_gemma":[0.31476888,0.68254244,0.0013888285,0.0003971194,0.00076821115,0.000017128255,0.000022429946,0.000053274198,0.00004170577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99339837,0.0038173702,0.0015883225,0.00048257608,0.00020636429,0.00050697353],"domain_scores_gemma":[0.9911346,0.0036914793,0.0040024384,0.00041046168,0.00058875215,0.0001722842],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001319682,0.0006208709,0.0027625323,0.00016193007,0.0002750099,0.0000192232,0.0010342234,0.00018092545,0.000087060354],"category_scores_gemma":[0.0007698869,0.00030498352,0.00081683,0.0005814677,0.008974705,0.00006487909,0.00074572,0.0023181492,0.0000022886893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012466321,0.00038207116,0.0001270232,0.0022282132,0.00105874,0.000009528625,0.0007590793,0.00007869636,0.355672,0.0009578196,0.00069731893,0.6367829],"study_design_scores_gemma":[0.018902842,0.008221213,0.046707783,0.05731109,0.044315625,0.07740202,0.006402686,0.0027835309,0.03725558,0.0072364826,0.6890838,0.0043773465],"about_ca_topic_score_codex":0.00004372628,"about_ca_topic_score_gemma":0.0000012048494,"teacher_disagreement_score":0.6883865,"about_ca_system_score_codex":0.00004492184,"about_ca_system_score_gemma":0.0004978161,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W4205227961","doi":"10.1093/aje/kwab295","title":"The Random Effects Warfarin Days' Supply (REWarDS) Model: Development and Validation of a Novel Method for Estimating Exposure to Warfarin Using Administrative Data.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Social Innovation; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Intraclass correlation; Warfarin; Statistics; Pearson product-moment correlation coefficient; Correlation coefficient; Mathematics; Mean squared error; Medicine; Dosing; Random effects model; Linear regression; Population; Standard error; Econometrics; Internal medicine","score_opus":0.3018966394437953,"score_gpt":0.4668063103903786,"score_spread":0.16490967094658332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205227961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5680609,0.00087123766,0.42451167,0.00051878433,0.0011869713,0.004040935,0.00063800707,0.000036240384,0.00013530513],"genre_scores_gemma":[0.7344201,0.000019109084,0.26070255,0.0005224855,0.00010680712,0.0039848387,0.00009982022,0.000030144416,0.00011411833],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99774295,0.0005364534,0.0005118771,0.00044514847,0.00026268602,0.00050088833],"domain_scores_gemma":[0.99750626,0.0016284519,0.0002583072,0.00028378709,0.00009874649,0.00022446622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004671506,0.0002183652,0.0003420296,0.000092791786,0.0008774185,0.000037510734,0.0005174745,0.00007905947,0.000008463387],"category_scores_gemma":[0.0004721029,0.00018819369,0.00005257199,0.00020308077,0.0000624708,0.00009361442,0.00070437865,0.00034254696,2.930373e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021365227,0.0004352041,0.0004047533,0.0001773381,0.000556321,0.0000041720837,0.0042833844,0.36450636,0.048819676,0.0007044779,0.0005449312,0.57742685],"study_design_scores_gemma":[0.0060412455,0.000054423588,0.0006814254,0.0000051627426,0.0003683224,0.000017989278,0.0001548912,0.7843834,0.18503937,0.00033148675,0.022660095,0.00026214914],"about_ca_topic_score_codex":0.000013424881,"about_ca_topic_score_gemma":0.0000057327206,"teacher_disagreement_score":0.5771647,"about_ca_system_score_codex":0.00006972692,"about_ca_system_score_gemma":0.00021902037,"threshold_uncertainty_score":0.7674316},"labels":[],"label_agreement":null},{"id":"W4205970496","doi":"10.18433/jpps32488","title":"Piecing together human adult comparative pharmacokinetic trials and rodent studies: What happens to drug clearance in obesity?","year":2022,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Obesity; Medicine; Lean body mass; Human obesity; Body weight; Drug; Internal medicine; Physiology; Endocrinology; Body mass index; Pharmacology","score_opus":0.40322623805008484,"score_gpt":0.5733060068859377,"score_spread":0.17007976883585285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205970496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9343551,0.051477756,0.000027971784,0.007712011,0.0043983543,0.0011318735,0.000044823253,0.00003700941,0.0008151258],"genre_scores_gemma":[0.96728814,0.016863523,0.00035451402,0.014273788,0.0008490936,0.00011089624,0.0000018779431,0.000036619134,0.00022153273],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895937,0.0044658114,0.0024293421,0.00083168066,0.0014461584,0.0012333377],"domain_scores_gemma":[0.9950185,0.0021024216,0.001057803,0.00018448132,0.000480539,0.0011562738],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016169995,0.00060877734,0.0018156475,0.0008992232,0.0013955835,0.00023613812,0.0014468393,0.00007308073,0.0023537532],"category_scores_gemma":[0.00041884082,0.00052225083,0.00037824485,0.0016434733,0.0009340018,0.0010610947,0.0009150348,0.0025599615,0.000040218518],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060894834,0.0036984463,0.026985964,0.0002817507,0.00147804,0.00096692616,0.052398987,0.059567213,0.6753526,0.0022293865,0.012003226,0.158948],"study_design_scores_gemma":[0.017663172,0.0007000245,0.0016499531,0.00020841278,0.0012236759,0.0005203368,0.02297383,0.016200818,0.24295327,0.001342686,0.6933203,0.0012435458],"about_ca_topic_score_codex":0.000048592025,"about_ca_topic_score_gemma":0.000022111873,"teacher_disagreement_score":0.68131703,"about_ca_system_score_codex":0.0003298297,"about_ca_system_score_gemma":0.0002801552,"threshold_uncertainty_score":0.99990445},"labels":[],"label_agreement":null},{"id":"W4205993769","doi":"10.1016/b978-0-12-820472-6.00179-1","title":"Drug-Drug Interactions With a Pharmacokinetic Basis","year":2021,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacokinetics; Drug; Pharmacology; Bioavailability; Drug metabolism; Cytochrome P450; Transporter; Absorption (acoustics); Chemistry; Enzyme; Drug interaction; CYP3A4; Metabolism; Medicine; Biochemistry; Gene","score_opus":0.060892431486886035,"score_gpt":0.3751228454177184,"score_spread":0.31423041393083234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205993769","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001865248,0.012147925,0.0000064590654,0.0008209566,0.004050821,0.0010479672,0.00044003435,0.00020819955,0.9794124],"genre_scores_gemma":[0.009784261,0.0031699066,0.0003963659,0.0057788664,0.0019733917,0.00023466368,0.00017592228,0.00029786568,0.97818875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961857,0.00035445095,0.0009027695,0.0011378134,0.00053801964,0.000881204],"domain_scores_gemma":[0.99710697,0.00039739977,0.00055743894,0.0007403256,0.00043185378,0.00076600147],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00055493147,0.001122824,0.0011552502,0.00040582046,0.00045065358,0.00008965968,0.0007075501,0.0003578535,0.016195834],"category_scores_gemma":[0.000017995855,0.0010435437,0.00056468457,0.00007582942,0.00045905984,0.000085114065,0.0003732218,0.0033273143,0.0009860821],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002523074,0.00013721168,0.000034862296,0.000194079,0.0016580743,0.00068505993,0.0007275112,0.00007133106,0.0032270872,0.0023311756,0.010942972,0.97973835],"study_design_scores_gemma":[0.0021092782,0.000027295337,0.000012456965,0.0002630955,0.002683775,0.0002196363,0.00003798975,0.00014056123,0.013213907,0.00096292334,0.9791766,0.0011524969],"about_ca_topic_score_codex":0.0000024275378,"about_ca_topic_score_gemma":0.0001048985,"teacher_disagreement_score":0.97858584,"about_ca_system_score_codex":0.00015384883,"about_ca_system_score_gemma":0.0004873334,"threshold_uncertainty_score":0.99979174},"labels":[],"label_agreement":null},{"id":"W4206096232","doi":"10.1186/s12888-021-03659-4","title":"Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: a case report","year":2022,"lang":"en","type":"article","venue":"BMC Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada; Université de Montréal","funders":"","keywords":"Major depressive disorder; Drug; Antidepressant; Escitalopram; Medicine; Venlafaxine; Pharmacogenomics; Pharmacogenetics; Pharmacotherapy; Psychiatry; Bupropion; Pharmacology; Anxiety; Mood; Gene","score_opus":0.06500475445872775,"score_gpt":0.43368800107663036,"score_spread":0.36868324661790264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206096232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98723376,0.0026622564,0.00011107341,0.00075898546,0.006336818,0.0007548105,0.0002479715,0.000042345273,0.0018519987],"genre_scores_gemma":[0.99639016,0.00018328044,0.001578587,0.000680679,0.00023363822,0.0003127126,0.00006556217,0.00003637477,0.0005190312],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716413,0.0009402278,0.0007131193,0.0005423503,0.00024756035,0.0003926183],"domain_scores_gemma":[0.99873906,0.00019539535,0.0004510521,0.00031220051,0.00006692322,0.00023536159],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001035388,0.0002726142,0.0003780868,0.0003149002,0.0005487843,0.000014602498,0.00025357254,0.00006905369,0.0011864315],"category_scores_gemma":[0.000024089017,0.00029939663,0.00014347876,0.00040134686,0.00009506874,0.000115594165,0.0004021477,0.0010467161,0.0000062962768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007332386,0.0029082063,0.90732765,0.0002448472,0.00033332076,0.0022640638,0.0019271092,0.0025487184,0.06986425,0.0005878827,0.0063022557,0.00495847],"study_design_scores_gemma":[0.092985496,0.00050466805,0.11628639,0.00012363473,0.0043186652,0.08311571,0.023369033,0.111769326,0.12689339,0.0052509746,0.4309932,0.0043895193],"about_ca_topic_score_codex":0.0003230199,"about_ca_topic_score_gemma":0.0005002482,"teacher_disagreement_score":0.79104125,"about_ca_system_score_codex":0.00008566059,"about_ca_system_score_gemma":0.00037118793,"threshold_uncertainty_score":0.9999458},"labels":[],"label_agreement":null},{"id":"W4206959344","doi":"10.1186/s12860-021-00402-5","title":"A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"BMC Molecular and Cell Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Université de Genève; Oak Foundation","keywords":"In silico; Detoxification (alternative medicine); Hematopoietic stem cell transplantation; Glucuronosyltransferase; Stem cell; Hematopoietic stem cell; Haematopoiesis; Transplantation; Computational biology; Pharmacology; Chemistry; Medicine; Biology; Biochemistry; Internal medicine; Cell biology; Enzyme; Pathology","score_opus":0.03160570246372532,"score_gpt":0.32903786387410877,"score_spread":0.2974321614103834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206959344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970473,0.0014023664,0.0005932289,0.000099469224,0.00009641295,0.0006055292,0.000062870786,0.000006267219,0.00008654846],"genre_scores_gemma":[0.99880016,0.0005942227,0.00008534694,0.00019319817,0.00001725524,0.000110510664,0.00018640008,0.0000108506965,0.0000020802986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968938,0.001966023,0.0005405849,0.00028836995,0.000103767365,0.00020746051],"domain_scores_gemma":[0.99941754,0.00017089694,0.00018319539,0.00015016242,0.000025827148,0.000052396594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012116644,0.00013388808,0.00021435089,0.00028977738,0.000055378758,0.0000041280923,0.0002163895,0.00014354198,0.00002326446],"category_scores_gemma":[0.0000042631273,0.00013070407,0.000049340957,0.00043429417,0.00008086764,0.000039893843,0.000024124733,0.00035763404,6.4907215e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001730239,0.00036078438,0.08631887,0.00019011743,0.0000032674,0.000005415903,0.00787338,0.007383547,0.89589965,0.00044083068,0.0000014829435,0.001349622],"study_design_scores_gemma":[0.0035008804,0.00018343444,0.062471546,0.000003313539,0.00013585691,0.000009740941,0.0017097561,0.0073392834,0.92334276,0.0010384095,0.000076224314,0.00018878825],"about_ca_topic_score_codex":0.000071839546,"about_ca_topic_score_gemma":0.000040561863,"teacher_disagreement_score":0.02744311,"about_ca_system_score_codex":0.000019405892,"about_ca_system_score_gemma":0.000102084865,"threshold_uncertainty_score":0.5329957},"labels":[],"label_agreement":null},{"id":"W4210285601","doi":"10.1111/cts.13230","title":"Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study","year":2022,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Metoprolol; Pharmacogenetics; Dosing; CYP2D6; Medicine; Pharmacogenomics; Observational study; Pharmacology; Pharmacokinetics; Therapeutic drug monitoring; Drug; Internal medicine; Biology; Genotype; Genetics","score_opus":0.3843812829857067,"score_gpt":0.5457340278220729,"score_spread":0.16135274483636625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210285601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569863,0.0019079054,0.00023771421,0.0005937759,0.00072314544,0.0005619334,0.00020344827,0.0000059615877,0.00006749435],"genre_scores_gemma":[0.9985304,0.000045463607,0.00047390422,0.0007238244,0.00008355456,0.00006281444,0.0000043430987,0.0000046540886,0.000071046365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979363,0.00033833148,0.00070391526,0.0003435522,0.0004510991,0.00022679924],"domain_scores_gemma":[0.9986678,0.00072459766,0.0001626896,0.0000965396,0.00019634362,0.00015206041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021816127,0.000102931546,0.00027803733,0.000076588534,0.00051874504,0.000008402642,0.0002893203,0.000022822634,0.00021297437],"category_scores_gemma":[0.00018153344,0.00009195112,0.000063838284,0.0004710747,0.0007411561,0.00011316011,0.0001719951,0.00023096726,8.5906066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013999619,0.001208105,0.9567086,0.000017542421,0.000071888986,0.0000050428453,0.008021018,0.009831504,0.0016091436,0.0014501493,0.000087727305,0.020849248],"study_design_scores_gemma":[0.002580336,0.0002488938,0.9670213,0.000009256592,0.00014357879,0.000004366556,0.0015049897,0.01254266,0.0062040193,0.0033153705,0.006240671,0.00018457603],"about_ca_topic_score_codex":0.0000063433854,"about_ca_topic_score_gemma":0.0000128862475,"teacher_disagreement_score":0.020664673,"about_ca_system_score_codex":0.000008239857,"about_ca_system_score_gemma":0.00034061368,"threshold_uncertainty_score":0.398982},"labels":[],"label_agreement":null},{"id":"W4210644225","doi":"10.1016/j.jmoldx.2021.12.011","title":"CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis","year":2022,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Human Genome Research Institute; School of Medicine, Indiana University; National Institutes of Health","keywords":"Genotyping; Haplotype; Genetics; Biology; Genotype; Allele; DNA sequencing; Haplotype estimation; Computational biology; Pharmacogenetics; Gene","score_opus":0.18788556885217178,"score_gpt":0.39889563791961513,"score_spread":0.21101006906744335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210644225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97955966,0.0074565327,0.011604737,0.00030157654,0.00082313,0.00014382022,0.000068771675,0.000009353571,0.000032390475],"genre_scores_gemma":[0.98935485,0.007003168,0.0014611437,0.0017868702,0.00030503774,0.0000055423266,0.00004365297,0.000025052988,0.000014662404],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981923,0.00055942015,0.0005091172,0.00019460112,0.00031258113,0.00023197338],"domain_scores_gemma":[0.9987756,0.00018919552,0.00049594825,0.00010427419,0.00020524948,0.00022972806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096614356,0.00017421428,0.0003504618,0.0004075562,0.00036996786,0.00006572886,0.00014294958,0.00009982066,0.00013975691],"category_scores_gemma":[0.00020955851,0.00018391445,0.00011505189,0.00048129985,0.00007306546,0.00015245142,0.00016129797,0.0005925961,8.9891967e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055569384,0.00009300112,0.011056565,0.000012422814,0.0006567516,0.00025015866,0.00047831473,0.030478226,0.94756,0.00024011113,0.00006653513,0.009052352],"study_design_scores_gemma":[0.0034347724,0.00052122434,0.015050103,0.000020089621,0.011299902,0.0010407183,0.00040856862,0.55761087,0.35888383,0.00051673804,0.050416075,0.000797081],"about_ca_topic_score_codex":0.000008565427,"about_ca_topic_score_gemma":0.0000019124984,"teacher_disagreement_score":0.58867615,"about_ca_system_score_codex":0.000092852155,"about_ca_system_score_gemma":0.00013567627,"threshold_uncertainty_score":0.74998134},"labels":[],"label_agreement":null},{"id":"W4211158980","doi":"10.1016/j.bcp.2022.114949","title":"Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia","year":2022,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Centre for Addiction and Mental Health; National Institutes of Health; National Institute on Drug Abuse; Canada Research Chairs; Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"Oxymorphone; Oxycodone; Estrous cycle; Microdialysis; Ovariectomized rat; Internal medicine; Endocrinology; Pharmacology; Medicine; Estrogen; Opioid; Central nervous system","score_opus":0.0407211240547757,"score_gpt":0.36902679068056,"score_spread":0.3283056666257843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211158980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97214043,0.021431096,0.000023912671,0.0046004797,0.0005228646,0.00059797487,0.00012363863,0.000028522378,0.0005310911],"genre_scores_gemma":[0.99012893,0.0015658594,0.00014259158,0.0075613167,0.0002643329,0.000177591,0.00004649203,0.000025597166,0.00008726065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99674684,0.0014615796,0.00053905265,0.00048425086,0.00026323495,0.00050505623],"domain_scores_gemma":[0.99863595,0.0007281267,0.00022138754,0.00017132498,0.00003983217,0.0002033855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017455845,0.00027440244,0.00046861757,0.00023207808,0.00026441942,0.000011784675,0.00040180792,0.0001902595,0.00044168672],"category_scores_gemma":[0.000050263963,0.00024824534,0.000077991266,0.00045367822,0.0005377055,0.0000632519,0.00039451028,0.0009921505,0.0000028256434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064448174,0.0003915192,0.0006401797,0.00002836782,0.00014004933,0.000031343126,0.0011931562,0.00036374645,0.9470752,0.00092179416,0.04413507,0.004435072],"study_design_scores_gemma":[0.015804945,0.0004428338,0.057800915,0.0000053488584,0.0011603386,0.00049982173,0.0010375045,0.017021356,0.5903823,0.005137807,0.3097447,0.0009621393],"about_ca_topic_score_codex":0.00004294862,"about_ca_topic_score_gemma":7.288855e-7,"teacher_disagreement_score":0.3566929,"about_ca_system_score_codex":0.000040208623,"about_ca_system_score_gemma":0.000058954673,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W4211225849","doi":"10.1016/b978-0-444-64066-6.00014-9","title":"Pharmacogenomics","year":2019,"lang":"en","type":"book-chapter","venue":"Handbook of analytical separations","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Medicine; Population; Drug; Pharmacology; Biology; Gene; Genetics; Genotype","score_opus":0.16265314139834067,"score_gpt":0.4480534519976671,"score_spread":0.28540031059932647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211225849","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052181905,0.010781628,0.0006133858,0.00029545272,0.0014089964,0.00069637183,0.00090016855,0.00006335763,0.9847188],"genre_scores_gemma":[0.008992953,0.011585337,0.0004151906,0.0018121243,0.0009056928,0.000017012128,0.00033235797,0.00012092799,0.9758184],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976614,0.0000842243,0.00092098146,0.0005323029,0.00034764997,0.00045340208],"domain_scores_gemma":[0.9980236,0.00038459667,0.00042345727,0.00044053313,0.0002981916,0.00042956934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037118688,0.0005186581,0.00089581957,0.00028730594,0.00016237171,0.000023231889,0.00046576638,0.00083079346,0.019446844],"category_scores_gemma":[0.000030488998,0.0005244501,0.0005625669,0.00006901858,0.00041657532,0.000069520036,0.00016792101,0.0011923782,0.0032343809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005756234,0.00048594436,0.00012784798,0.00027048186,0.0035075545,0.000072961186,0.0003250063,0.003956303,0.03434415,0.73705345,0.19778214,0.021498526],"study_design_scores_gemma":[0.0011940671,0.00008513387,0.000007452121,0.00006805931,0.001882998,0.000012976291,0.0000034999637,0.009441527,0.011951304,0.006776129,0.9680594,0.0005174428],"about_ca_topic_score_codex":0.0000033920344,"about_ca_topic_score_gemma":0.0000053426975,"teacher_disagreement_score":0.77027726,"about_ca_system_score_codex":0.0000795634,"about_ca_system_score_gemma":0.00048074388,"threshold_uncertainty_score":0.9997207},"labels":[],"label_agreement":null},{"id":"W4212906205","doi":"10.1097/fpc.0000000000000466","title":"Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes","year":2022,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Genotyping; Gene; SNP genotyping; DNA sequencing; Chromosome; Homologous chromosome; SNP; Single-nucleotide polymorphism","score_opus":0.15998655469186432,"score_gpt":0.3937307608366337,"score_spread":0.2337442061447694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212906205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87760603,0.117888756,0.0019823106,0.00027714417,0.00022662478,0.0011712289,0.0006268328,0.000023745853,0.0001973357],"genre_scores_gemma":[0.9471774,0.047644317,0.0034674231,0.0008227501,0.00024941395,0.0004778691,0.000040425464,0.000047741403,0.00007263589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835557,0.00018588605,0.00043128105,0.00052202644,0.00010678009,0.0003984522],"domain_scores_gemma":[0.9987961,0.0004441139,0.00024436752,0.00015359,0.00006819309,0.00029363114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008051615,0.00027849237,0.00037030163,0.00015950744,0.00081919535,0.00003741438,0.00018629222,0.00011032891,0.000043639113],"category_scores_gemma":[0.000019390673,0.00031182184,0.000051662188,0.00013409395,0.00037453062,0.000048768823,0.0005704185,0.000353516,4.1252304e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022286033,0.000109825625,0.003308419,0.00031748533,0.00029736347,0.0000043012687,0.0019967097,0.0027067286,0.3831283,0.0027369498,0.000079922924,0.60509115],"study_design_scores_gemma":[0.0055112494,0.00028554787,0.0016212496,0.0000068697773,0.0014761585,0.00043586426,0.0017612269,0.11529904,0.1753581,0.009411153,0.68783903,0.0009944827],"about_ca_topic_score_codex":0.00001614466,"about_ca_topic_score_gemma":0.0000031517447,"teacher_disagreement_score":0.68775916,"about_ca_system_score_codex":0.00003510821,"about_ca_system_score_gemma":0.000105747495,"threshold_uncertainty_score":0.99993336},"labels":[],"label_agreement":null},{"id":"W4214770147","doi":"10.1002/cpt.2563","title":"PharmVar GeneFocus: <i>CYP3A5</i>","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; CancerCare Manitoba","funders":"National Human Genome Research Institute; Erzincan Üniversitesi; National Institutes of Health; Vetenskapsrådet; Ontario Institute for Cancer Research; National Institute of General Medical Sciences; European Federation of Pharmaceutical Industries and Associations; Kungliga Tekniska Högskolan; Robert Bosch Stiftung; McGill University","keywords":"Pharmacogenomics; CYP3A5; Pharmacogenetics; Allele; Locus (genetics); Tacrolimus; Biology; Genetics; Computational biology; Medicine; Gene; Bioinformatics; Transplantation; Genotype; Internal medicine","score_opus":0.6241503739757894,"score_gpt":0.6259530102670595,"score_spread":0.0018026362912700877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214770147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007623836,0.9451571,0.000035780995,0.0009811616,0.04274268,0.0030815522,0.0011851925,0.0005960415,0.0061442405],"genre_scores_gemma":[0.000007375356,0.886959,0.00021271594,0.099818066,0.0078629805,0.0012849774,0.0005393617,0.0005256988,0.0027898254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9787068,0.01108003,0.004471429,0.002505953,0.0008022074,0.0024335834],"domain_scores_gemma":[0.98795736,0.0067623183,0.0022670627,0.0012768866,0.00020500706,0.0015313451],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.005384026,0.0022312049,0.005849444,0.00067001773,0.0012528636,0.00008491896,0.003982298,0.0031315351,0.04285545],"category_scores_gemma":[0.00007045574,0.002073228,0.0038282112,0.0014509397,0.0016005195,0.00016783357,0.001833847,0.012248052,0.0034052127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002587704,0.0022084306,0.000025272906,0.0017410167,0.007960233,0.00041836375,0.00011111205,0.00003275433,0.0000623595,0.000040299943,0.119067505,0.8680739],"study_design_scores_gemma":[0.0038349999,0.00036896093,0.000002473082,0.00014383213,0.035732623,0.0002320945,0.00002499124,0.00021584207,0.00009538543,0.0001432338,0.95728296,0.0019226109],"about_ca_topic_score_codex":0.000005250166,"about_ca_topic_score_gemma":0.0000014125809,"teacher_disagreement_score":0.8661513,"about_ca_system_score_codex":0.00046938573,"about_ca_system_score_gemma":0.0019191733,"threshold_uncertainty_score":0.99904275},"labels":[],"label_agreement":null},{"id":"W4220729318","doi":"10.3389/fgene.2022.878191","title":"Editorial: Pharmacogenomics: From Bench to Bedside and Back Again","year":2022,"lang":"en","type":"editorial","venue":"Frontiers in Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Economic and Social Research Council","keywords":"Pharmacogenomics; Pharmacogenetics; Bench to bedside; Medicine; Medical physics; Biology; Pharmacology; Genetics; Genotype; Gene","score_opus":0.03515236113004525,"score_gpt":0.37496462005336606,"score_spread":0.3398122589233208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220729318","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008116284,0.032787066,0.00019363752,0.0002606372,0.9491492,0.0013050763,0.006686036,0.000069652975,0.0014324273],"genre_scores_gemma":[0.0001795118,0.042975895,0.007958644,0.0017200274,0.9431472,0.00029705258,0.0016367629,0.00026268305,0.0018222106],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99353594,0.001170477,0.0012206044,0.0016530831,0.0010951163,0.0013247684],"domain_scores_gemma":[0.99663407,0.000987515,0.00043507112,0.0007121371,0.00023443464,0.000996758],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016266215,0.0010288552,0.0013890319,0.0007081577,0.00034794095,0.00012099211,0.0015628054,0.0021475358,0.0029918868],"category_scores_gemma":[0.00036416124,0.0012589535,0.00023561627,0.0005659955,0.00025403712,0.000076565666,0.0013768421,0.0047164937,0.00022017995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006080381,0.0002607806,0.0018842584,0.00007193716,0.0004936971,0.000058249003,0.0009821092,0.002459628,0.0032038789,0.00000210086,0.9665529,0.023422396],"study_design_scores_gemma":[0.0037572253,0.00013648742,0.00006864128,0.0000228436,0.00066198537,0.0000012645274,0.000169317,0.0013573309,0.0024042076,0.0006898951,0.9894703,0.0012605226],"about_ca_topic_score_codex":0.00017861219,"about_ca_topic_score_gemma":0.000039806066,"teacher_disagreement_score":0.022917353,"about_ca_system_score_codex":0.00050867046,"about_ca_system_score_gemma":0.0007552448,"threshold_uncertainty_score":0.9991479},"labels":[],"label_agreement":null},{"id":"W4220891053","doi":"10.3390/biology11030403","title":"Androgen Glucuronidation in Mice: When, Where, and How","year":2022,"lang":"en","type":"article","venue":"Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Glucuronidation; Biology; Dihydrotestosterone; Androgen; Internal medicine; Sulfotransferase; Androsterone; Endocrinology; Testosterone (patch); Hydroxysteroid; Enzyme; Glucuronosyltransferase; Kidney; Microsome; Hormone; Biochemistry; Dehydrogenase; Steroid","score_opus":0.08825635063079168,"score_gpt":0.4076224078820755,"score_spread":0.3193660572512838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220891053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97678196,0.015369518,0.000029598457,0.004472086,0.0012436503,0.00026776368,0.00012627481,0.000033747245,0.0016753867],"genre_scores_gemma":[0.995011,0.0017683856,0.0001229655,0.0021121528,0.00015588857,0.000113473696,0.00006304683,0.000013832684,0.0006392559],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984108,0.00074710714,0.0001532249,0.00030047656,0.000055953937,0.0003324052],"domain_scores_gemma":[0.9995761,0.00012545631,0.00008032571,0.0000916862,0.00002175425,0.00010466401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006416378,0.00013348498,0.0001916554,0.00013676968,0.00020311777,0.000009580401,0.0001869872,0.00013593172,0.0015903775],"category_scores_gemma":[0.000025553842,0.00013861629,0.00003305826,0.0001349537,0.00011313131,0.00004048809,0.00024395924,0.00048697586,0.000018101051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047602618,0.00042321288,0.1555004,0.00003950209,0.00014665061,0.00006389391,0.0016932162,0.00028434806,0.6529242,0.011305201,0.020432018,0.15671138],"study_design_scores_gemma":[0.0017944142,0.00010228738,0.0027036178,8.556102e-7,0.0000370908,0.00003908341,0.00013876993,0.0015065436,0.012069825,0.0027215523,0.9787072,0.00017877032],"about_ca_topic_score_codex":0.000028207918,"about_ca_topic_score_gemma":0.00003403916,"teacher_disagreement_score":0.9582752,"about_ca_system_score_codex":0.000039172395,"about_ca_system_score_gemma":0.000049826518,"threshold_uncertainty_score":0.9993223},"labels":[],"label_agreement":null},{"id":"W4221008442","doi":"10.1038/s41398-022-01845-w","title":"Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19","year":2022,"lang":"en","type":"erratum","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Calgary; Women and Children’s Health Research Institute; University of Alberta","funders":"","keywords":"Genotyping; CYP2C19; CYP2D6; Medicine; MEDLINE; Psychology; Information retrieval; Computer science; Internal medicine; Genotype; Genetics; Political science; Biology","score_opus":0.3700051956545867,"score_gpt":0.5506330170029412,"score_spread":0.18062782134835448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221008442","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035906215,0.15550117,0.0092873415,0.00796116,0.75747114,0.0021321205,0.003889719,0.00013817326,0.060028575],"genre_scores_gemma":[0.029997505,0.15929009,0.19228639,0.03638642,0.109922566,0.002213365,0.01694771,0.0012581797,0.45169777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961605,0.001330434,0.0011758796,0.000664454,0.00027069627,0.00039801106],"domain_scores_gemma":[0.99661064,0.0021935925,0.0005758651,0.00022856852,0.00017431173,0.00021702083],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027577823,0.00038680458,0.0008892191,0.00024783175,0.0003690066,0.000009744669,0.00035185379,0.0011270662,0.0034062145],"category_scores_gemma":[0.00012875145,0.00042715247,0.0005013727,0.00020949243,0.0003246799,0.000048321832,0.00006717671,0.0025708308,0.000008625248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011246749,0.00035396832,0.0049061757,0.0003585747,0.0009306179,0.0000015744268,0.00028588827,0.00035139284,0.00017134853,0.0057357424,0.9492358,0.036544263],"study_design_scores_gemma":[0.0024369957,0.00017881043,0.0079474235,0.000023741783,0.0011371048,0.000030809966,0.000055424884,0.0035204166,0.000051282695,0.011216886,0.9730071,0.00039400047],"about_ca_topic_score_codex":0.000010198616,"about_ca_topic_score_gemma":0.000027180848,"teacher_disagreement_score":0.64754856,"about_ca_system_score_codex":0.000017948767,"about_ca_system_score_gemma":0.00089092803,"threshold_uncertainty_score":0.999818},"labels":[],"label_agreement":null},{"id":"W4221158461","doi":"","title":"Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; University of Calgary","funders":"","keywords":"Family medicine; Medicine; Dosing; Psychology; Medical education; Pharmacology","score_opus":0.0640097245234779,"score_gpt":0.3428768720807934,"score_spread":0.2788671475573155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221158461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674233,0.025432892,9.963518e-7,0.00076993654,0.0018949874,0.00094962685,0.00009376916,0.00003368388,0.0034008166],"genre_scores_gemma":[0.9937248,0.0017000042,0.000042132684,0.0013176111,0.0006698657,0.0015648789,0.000010047148,0.000039836767,0.0009307886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735963,0.00056021,0.00046358,0.0005527977,0.00022450271,0.0008392717],"domain_scores_gemma":[0.99838954,0.0007445758,0.00016799712,0.00013601735,0.000049646897,0.00051221927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009988539,0.00029909896,0.0003310527,0.0003094762,0.0005073614,0.00002768473,0.00028694078,0.00009846195,0.00010237446],"category_scores_gemma":[0.00012663024,0.0003395217,0.000037889506,0.000813067,0.00009493109,0.00007118485,0.00041832958,0.0009056262,0.000002405224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006327671,0.0002483252,0.9403697,0.00009297568,0.000045409273,0.000049018112,0.00033199176,0.00069074763,0.000068975205,0.000029165603,0.00735219,0.050658174],"study_design_scores_gemma":[0.0022350096,0.000016515884,0.9082406,8.520688e-7,0.00028518084,0.000033652253,0.00004397928,0.0017970849,0.00012757556,0.00007738671,0.08674436,0.00039778152],"about_ca_topic_score_codex":0.032048453,"about_ca_topic_score_gemma":0.16265388,"teacher_disagreement_score":0.13060541,"about_ca_system_score_codex":0.0001318134,"about_ca_system_score_gemma":0.00036188783,"threshold_uncertainty_score":0.9999057},"labels":[],"label_agreement":null},{"id":"W4224292486","doi":"10.1016/j.jmoldx.2022.03.008","title":"Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing","year":2022,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Institutes of Health; National Institute of General Medical Sciences; Indiana University","keywords":"Pharmacogenomics; Exome sequencing; Genotyping; Genetics; Exome; 1000 Genomes Project; Biology; Genotype; Single-nucleotide polymorphism; Gene; Mutation","score_opus":0.17096283068056078,"score_gpt":0.5015537103029486,"score_spread":0.3305908796223878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224292486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78298265,0.0045988974,0.20889945,0.0006405514,0.0019265909,0.00033978518,0.000535041,0.000009452329,0.00006757316],"genre_scores_gemma":[0.93049496,0.0006131728,0.065062016,0.0030293772,0.0006140297,0.000027631992,0.00010072232,0.000043953358,0.000014144812],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.995941,0.0015042234,0.0014417862,0.00025651194,0.0005416221,0.0003148568],"domain_scores_gemma":[0.9940184,0.003903441,0.0010549406,0.000142119,0.0005827934,0.00029831458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033623248,0.0002037329,0.00059333525,0.00024433393,0.00020634041,0.000018316838,0.0004584178,0.0001408446,0.00043622695],"category_scores_gemma":[0.0009728338,0.0002180406,0.0004808352,0.00028080074,0.000103427694,0.00005978075,0.00018507589,0.00091860647,0.000004669533],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006964239,0.0007669457,0.0075413873,0.00004237,0.0010978074,0.00023418046,0.0004571416,0.7884931,0.16240111,0.00062128075,0.004103706,0.03354456],"study_design_scores_gemma":[0.011038205,0.0009819107,0.0024711795,0.000041417545,0.0045063617,0.00022683211,0.0003159443,0.40619475,0.4057912,0.022866989,0.14496179,0.00060343917],"about_ca_topic_score_codex":0.0000047518974,"about_ca_topic_score_gemma":2.0660377e-7,"teacher_disagreement_score":0.38229835,"about_ca_system_score_codex":0.00011572869,"about_ca_system_score_gemma":0.00054059323,"threshold_uncertainty_score":0.88914376},"labels":[],"label_agreement":null},{"id":"W4225296657","doi":"10.2196/32902","title":"Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study","year":2022,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Dosing; Medicine; Medical prescription; Pharmacogenetics; Drug; Retrospective cohort study; Intensive care medicine; Pharmacology; Internal medicine; Genotype","score_opus":0.11658583307125034,"score_gpt":0.4695899407021608,"score_spread":0.3530041076309105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225296657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988986,0.0009645577,0.000020696185,0.00021008166,0.0020087406,0.0023136532,0.00003367157,0.00006564961,0.0044931145],"genre_scores_gemma":[0.9961997,0.00013486244,0.00018209907,0.0013268915,0.00022038158,0.00072813913,0.000007127294,0.000040341187,0.0011604169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99317116,0.0045181667,0.0009051195,0.00054119405,0.00035272483,0.0005116551],"domain_scores_gemma":[0.9978966,0.0012717997,0.00033822947,0.00022922856,0.00007154559,0.00019259802],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007385114,0.00024940178,0.0005540971,0.00030308988,0.00024340485,0.000007898734,0.0005534809,0.00009038202,0.00064067723],"category_scores_gemma":[0.00034885042,0.00027268354,0.0001447188,0.0008381971,0.00011212103,0.000045266683,0.0005429321,0.0013005486,0.000024688376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012706604,0.0100764055,0.7529261,0.00024120495,0.0009783518,0.0011704462,0.002847825,0.0013354997,0.075789526,0.0003044154,0.006775042,0.14628449],"study_design_scores_gemma":[0.032613333,0.001733631,0.76864094,0.000025719366,0.0012463947,0.00001706855,0.0019365571,0.012575033,0.020804886,0.001372137,0.15807407,0.00096025673],"about_ca_topic_score_codex":0.000024512541,"about_ca_topic_score_gemma":0.0000040843024,"teacher_disagreement_score":0.15129903,"about_ca_system_score_codex":0.0001358944,"about_ca_system_score_gemma":0.00006465668,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W4225297281","doi":"10.2196/37242","title":"Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”","year":2022,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pain management; Medicine; Physical therapy; Pharmacology","score_opus":0.1688270014566855,"score_gpt":0.5058544427089622,"score_spread":0.3370274412522767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225297281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989868,0.0015307365,0.000041140436,0.0012601481,0.0019595516,0.003942204,0.00005203678,0.000034646284,0.0013115411],"genre_scores_gemma":[0.99183834,0.0002224277,0.00064664637,0.0015982311,0.0001468913,0.00089483405,0.000005338047,0.00004046066,0.0046068337],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.984116,0.012665624,0.0015964734,0.000595072,0.00051816396,0.0005086362],"domain_scores_gemma":[0.996546,0.002028328,0.0005692917,0.000385994,0.00018603817,0.00028435554],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.029840449,0.00027713567,0.00092577323,0.00047346158,0.00016209352,0.0000059686417,0.00065059116,0.00010779508,0.0006748491],"category_scores_gemma":[0.0031700542,0.0002880628,0.0002104935,0.0012669554,0.00010306994,0.000040076764,0.00062581693,0.0011199431,0.000028155991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01211606,0.009108776,0.31518158,0.0007390797,0.0008711057,0.0006435536,0.010423484,0.001453308,0.44756868,0.0002212126,0.043990314,0.15768284],"study_design_scores_gemma":[0.011531682,0.001956261,0.23576868,0.00006335674,0.00069458573,0.0000070227034,0.00092059845,0.0015007184,0.020453926,0.00029508883,0.7262455,0.00056255434],"about_ca_topic_score_codex":0.000019291641,"about_ca_topic_score_gemma":0.0000041015123,"teacher_disagreement_score":0.6822552,"about_ca_system_score_codex":0.00014309217,"about_ca_system_score_gemma":0.00009050405,"threshold_uncertainty_score":0.99995714},"labels":[],"label_agreement":null},{"id":"W4225326793","doi":"10.2196/37145","title":"Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”","year":2022,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pain management; Pharmacogenomics; Medicine; Retrospective cohort study; Psychology; Physical therapy; Internal medicine; Pharmacology","score_opus":0.15680279152603166,"score_gpt":0.4967567393379063,"score_spread":0.33995394781187466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225326793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95886445,0.024293153,0.000017327244,0.0019503873,0.0022816558,0.0038087887,0.00007824939,0.000047926635,0.00865804],"genre_scores_gemma":[0.9892663,0.004068901,0.00021217081,0.0029779961,0.00014313574,0.0005381884,0.000014820903,0.000034773973,0.0027437634],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99276304,0.004393118,0.0012873032,0.0004539862,0.0007017968,0.00040077747],"domain_scores_gemma":[0.9974858,0.001119499,0.00059586053,0.00030098233,0.00034485295,0.00015296608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015040472,0.00023129504,0.0007949083,0.00023120169,0.00012295868,0.0000032652279,0.0005611358,0.00007693454,0.00090539525],"category_scores_gemma":[0.0014819547,0.00024196933,0.00019786849,0.0009050938,0.00012430087,0.00003955485,0.0004806343,0.0010682389,0.000010986601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001122816,0.0136263985,0.5785132,0.01277951,0.0019838193,0.000864998,0.0031168452,0.00046410758,0.05697816,0.0005559442,0.088635914,0.24135827],"study_design_scores_gemma":[0.026189025,0.0021481249,0.28427646,0.0011444086,0.002803954,0.000022531942,0.0012631085,0.004004801,0.020793097,0.0010626224,0.6551347,0.0011571893],"about_ca_topic_score_codex":0.000018165583,"about_ca_topic_score_gemma":0.0000018755088,"teacher_disagreement_score":0.56649876,"about_ca_system_score_codex":0.00009604328,"about_ca_system_score_gemma":0.00008634075,"threshold_uncertainty_score":0.9913443},"labels":[],"label_agreement":null},{"id":"W4225327440","doi":"10.2196/37513","title":"Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”","year":2022,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pain management; Medicine; Pharmacology; Physical therapy","score_opus":0.15680279152603166,"score_gpt":0.4967567393379063,"score_spread":0.33995394781187466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225327440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95886445,0.024293153,0.000017327244,0.0019503873,0.0022816558,0.0038087887,0.00007824939,0.000047926635,0.00865804],"genre_scores_gemma":[0.9892663,0.004068901,0.00021217081,0.0029779961,0.00014313574,0.0005381884,0.000014820903,0.000034773973,0.0027437634],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99276304,0.004393118,0.0012873032,0.0004539862,0.0007017968,0.00040077747],"domain_scores_gemma":[0.9974858,0.001119499,0.00059586053,0.00030098233,0.00034485295,0.00015296608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015040472,0.00023129504,0.0007949083,0.00023120169,0.00012295868,0.0000032652279,0.0005611358,0.00007693454,0.00090539525],"category_scores_gemma":[0.0014819547,0.00024196933,0.00019786849,0.0009050938,0.00012430087,0.00003955485,0.0004806343,0.0010682389,0.000010986601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001122816,0.0136263985,0.5785132,0.01277951,0.0019838193,0.000864998,0.0031168452,0.00046410758,0.05697816,0.0005559442,0.088635914,0.24135827],"study_design_scores_gemma":[0.026189025,0.0021481249,0.28427646,0.0011444086,0.002803954,0.000022531942,0.0012631085,0.004004801,0.020793097,0.0010626224,0.6551347,0.0011571893],"about_ca_topic_score_codex":0.000018165583,"about_ca_topic_score_gemma":0.0000018755088,"teacher_disagreement_score":0.56649876,"about_ca_system_score_codex":0.00009604328,"about_ca_system_score_gemma":0.00008634075,"threshold_uncertainty_score":0.9913443},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4226112864","doi":"10.22215/etd/2022-14949","title":"Optimizing and Validating a Caenorhabditis Elegans Model as a Tool for Assessing Contaminant-Induced Oxidative Stress and Oxylipin Signalling","year":2022,"lang":"en","type":"dissertation","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Oxylipin; Oxidative stress; Caenorhabditis elegans; Reactive oxygen species; Paraquat; Endoplasmic reticulum; CYP2E1; Oxidative phosphorylation; Cytochrome P450; Antioxidant; Biochemistry; Cell biology; Mitochondrion; Xenobiotic; Biology; Enzyme; Chemistry; Gene","score_opus":0.10265944524360186,"score_gpt":0.4465298166367333,"score_spread":0.3438703713931314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226112864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545396,0.0034418425,0.0029410862,0.00009028749,0.0012618506,0.0015963601,0.0006443547,0.000099158475,0.004471119],"genre_scores_gemma":[0.9820213,0.0018852771,0.008060879,0.0008613442,0.0003523132,0.00078980246,0.0016183255,0.00015778527,0.004253028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968388,0.0004206539,0.0007515496,0.00094399316,0.00029882204,0.0007461506],"domain_scores_gemma":[0.99768513,0.0010223154,0.0005848097,0.00016527799,0.0002457284,0.0002967093],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010330762,0.0006607094,0.0008357308,0.0002917188,0.001259508,0.00026286385,0.00028649307,0.0006079984,0.0005842119],"category_scores_gemma":[0.00018030364,0.0007160291,0.00015866452,0.00017062257,0.00007096445,0.00032609407,0.00015131557,0.0014262656,0.0000023137789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007411986,0.00032532847,0.00024319117,0.0011727096,0.00097632885,0.00006659487,0.015977869,0.009567371,0.8908558,0.0031696407,0.00023058506,0.07667342],"study_design_scores_gemma":[0.0048371856,0.00022553747,0.00012977686,0.00023944861,0.0021074244,0.000033651537,0.013628096,0.37231457,0.59830034,0.00133687,0.00523371,0.001613418],"about_ca_topic_score_codex":0.00011573213,"about_ca_topic_score_gemma":0.000093547926,"teacher_disagreement_score":0.3627472,"about_ca_system_score_codex":0.00008682342,"about_ca_system_score_gemma":0.00043162896,"threshold_uncertainty_score":0.99952906},"labels":[],"label_agreement":null},{"id":"W4229450592","doi":"","title":"Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes","year":2022,"lang":"en","type":"article","venue":"Lancaster EPrints (Lancaster University)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of New Brunswick; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Genotyping; Genetics; Biology; Amplicon; Genotype; 1000 Genomes Project; Single-nucleotide polymorphism; SNP; Molecular Inversion Probe; DNA sequencing; Allele; Gene; Computational biology; Polymerase chain reaction","score_opus":0.1525181934845685,"score_gpt":0.34615258156730344,"score_spread":0.19363438808273495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229450592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886013,0.0033214758,0.0039367704,0.0001645462,0.00013679785,0.00069667824,0.00019269911,0.000022468721,0.0029272502],"genre_scores_gemma":[0.99645686,0.00069450866,0.0011892212,0.00031197732,0.00009766245,0.000032504962,0.000016999014,0.000018162631,0.0011820749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989316,0.00018321747,0.00017564149,0.00037675255,0.000072455274,0.000260372],"domain_scores_gemma":[0.99928457,0.00022930825,0.00014587992,0.00015939909,0.000040196897,0.00014062168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003126238,0.0001605338,0.0002525623,0.00020501077,0.00038148393,0.000015570437,0.00018174789,0.00008405524,0.00014211563],"category_scores_gemma":[0.000007567191,0.00018132785,0.00003963064,0.0001699361,0.00018799935,0.00009444807,0.00056067365,0.00026513793,0.0000025952631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010601247,0.00027985085,0.17262517,0.00071915996,0.00063515775,0.00008021272,0.006052823,0.000105360916,0.07355991,0.016086856,0.00011450381,0.72868085],"study_design_scores_gemma":[0.0053662485,0.00017082348,0.05973098,0.0000150307305,0.0006057092,0.0003509894,0.0044693137,0.010862033,0.014882669,0.0015514273,0.901332,0.00066274614],"about_ca_topic_score_codex":0.000011625633,"about_ca_topic_score_gemma":0.000006187065,"teacher_disagreement_score":0.9012175,"about_ca_system_score_codex":0.000033274086,"about_ca_system_score_gemma":0.000040974744,"threshold_uncertainty_score":0.73943347},"labels":[],"label_agreement":null},{"id":"W4229762152","doi":"10.1139/y01-065","title":"Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotyping; Allele; Allele frequency; Genetics; CYP2C9; Ethnic group; Biology; Population; Genotype; Polymorphism (computer science); Demography; Gene","score_opus":0.08544954109072975,"score_gpt":0.3947893581045216,"score_spread":0.3093398170137919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229762152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98732024,0.0062244157,0.0000025109273,0.003064065,0.0016142067,0.00030995096,0.00019100361,0.000007955951,0.0012656669],"genre_scores_gemma":[0.9908799,0.0022604165,0.00008923825,0.005955154,0.0005754627,0.000020430445,0.000021446567,0.000025957881,0.00017198457],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971748,0.00072052743,0.0006181434,0.00032915777,0.00008266101,0.0010746961],"domain_scores_gemma":[0.99698627,0.00023486192,0.00026766563,0.000102137536,0.00020681832,0.0022022403],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000859396,0.00031516512,0.0005778813,0.0011969282,0.0004748947,0.000022379789,0.00034265703,0.00050659524,0.0051020714],"category_scores_gemma":[0.00008752979,0.0003191393,0.000083670784,0.00042412663,0.00079847296,0.00022077144,0.000039916384,0.001371944,0.000020438376],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048260915,0.00019311409,0.17984642,0.00012908125,0.0007698509,0.00406911,0.018709062,0.0017723128,0.7599785,0.0062388247,0.011600673,0.016210483],"study_design_scores_gemma":[0.007438423,0.00061487727,0.3963871,0.000038035305,0.00053123053,0.0029254816,0.0010068977,0.0011118127,0.027533116,0.024686294,0.5366114,0.0011153843],"about_ca_topic_score_codex":0.10313165,"about_ca_topic_score_gemma":0.69639283,"teacher_disagreement_score":0.73244536,"about_ca_system_score_codex":0.00028894504,"about_ca_system_score_gemma":0.0024490538,"threshold_uncertainty_score":0.9999261},"labels":[],"label_agreement":null},{"id":"W4230805293","doi":"10.1007/978-981-32-9779-1_12","title":"Drug Interactions","year":2019,"lang":"en","type":"book-chapter","venue":"Introduction to Basics of Pharmacology and Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lambda Therapeutic Research; Brampton Civic Hospital","funders":"","keywords":"Drug; Pharmacology; Drug interaction; Pharmacokinetics; In vivo; Pharmacodynamics; Polypharmacy; Chemistry; Medicine; Biology","score_opus":0.050870324620553097,"score_gpt":0.3932708450028266,"score_spread":0.34240052038227353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230805293","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05310487,0.011270336,0.0003993126,0.08575834,0.097780816,0.0053998088,0.0017225456,0.0004592065,0.74410474],"genre_scores_gemma":[0.12251178,0.0057906006,0.000713007,0.014965872,0.014372812,0.00015878594,0.00022082978,0.0002562305,0.8410101],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996204,0.0003827832,0.0011653996,0.0012450353,0.0002603843,0.00074239477],"domain_scores_gemma":[0.9971053,0.00070336094,0.0007478163,0.00044836063,0.0005023124,0.0004928771],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009932044,0.00078709744,0.0013309672,0.0009162729,0.00026940263,0.000016856502,0.0005599809,0.0008627566,0.021081889],"category_scores_gemma":[0.00008170592,0.0008693029,0.00031169812,0.00014904815,0.00076275447,0.00015055302,0.00049986545,0.0026065507,0.0014147642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015841846,0.0005064421,0.00019064845,0.00029816013,0.0020159564,0.000058367423,0.00063310977,0.00133455,0.21794689,0.16538133,0.56098294,0.049067408],"study_design_scores_gemma":[0.0016887998,0.0002479617,0.00007689853,0.00001710465,0.0012301983,0.00014346196,0.000023675351,0.00015080588,0.06936667,0.005100478,0.92130286,0.000651089],"about_ca_topic_score_codex":0.000007493141,"about_ca_topic_score_gemma":0.000030413448,"teacher_disagreement_score":0.3603199,"about_ca_system_score_codex":0.0001464982,"about_ca_system_score_gemma":0.00036258606,"threshold_uncertainty_score":0.99969447},"labels":[],"label_agreement":null},{"id":"W4231693518","doi":"10.1139/y00-030","title":"Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ferrochelatase; Bioassay; Microsome; Isozyme; Cytochrome P450; Biochemistry; Xenobiotic; Porphyria; Heme; Recombinant DNA; Complementary DNA; In vitro; Hemeprotein; Biology; Chemistry; Enzyme; Molecular biology; Gene; Endocrinology","score_opus":0.06409154204016622,"score_gpt":0.36463957640535655,"score_spread":0.30054803436519034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231693518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957088,0.0014421552,0.000017223601,0.00027760165,0.0013467323,0.0007719413,0.00035062106,0.000005414594,0.00007950701],"genre_scores_gemma":[0.996435,0.0010750075,0.00032690636,0.0014320359,0.00026079998,0.000039983574,0.000047881444,0.000033145243,0.00034923546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997703,0.0005385264,0.0007987079,0.00030292317,0.00008303073,0.00057377067],"domain_scores_gemma":[0.99764645,0.00045456635,0.0006724148,0.00013814654,0.00048805814,0.00060036464],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047412177,0.0003306874,0.00077445066,0.00040506473,0.00021665618,0.000010135894,0.0002237577,0.00037698422,0.0037918948],"category_scores_gemma":[0.000027955766,0.0002851524,0.00022589361,0.0001885918,0.00095186534,0.0002236004,0.000028685468,0.0007170845,0.000009276866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058057685,0.0002987932,0.0015935487,0.00023313474,0.00094516424,0.00022612722,0.0011308244,0.00038293086,0.98204315,0.00019072442,0.0024643685,0.0046854727],"study_design_scores_gemma":[0.004474717,0.0015910926,0.0036668729,0.000048904807,0.0010184678,0.00058337307,0.00010181293,0.00020797265,0.9210236,0.0007063938,0.06626484,0.00031197106],"about_ca_topic_score_codex":0.00045901956,"about_ca_topic_score_gemma":0.000548834,"teacher_disagreement_score":0.06380047,"about_ca_system_score_codex":0.00006389272,"about_ca_system_score_gemma":0.000618311,"threshold_uncertainty_score":0.99996006},"labels":[],"label_agreement":null},{"id":"W4233749695","doi":"10.1007/bf02916036","title":"Special Lectures","year":2007,"lang":"en","type":"article","venue":"Indian Journal of Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation; Hospital for Sick Children; SickKids Foundation; Sunnybrook Hospital; University of Toronto","funders":"University of Delhi; Maharashtra University of Health Sciences, Nashik; Indian Council of Medical Research; Postgraduate Institute of Medical Education and Research, Chandigarh","keywords":"Computer science; Medicine","score_opus":0.14235590347051974,"score_gpt":0.5277144605135777,"score_spread":0.385358557043058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233749695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96185553,0.0014603556,0.00008769786,0.0006534187,0.009224532,0.000060271002,0.00002037473,0.000011141489,0.026626697],"genre_scores_gemma":[0.95281094,0.0005345873,0.00052821246,0.0029198246,0.042633846,4.2102027e-7,0.0000032815253,0.00001672593,0.00055214827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972982,0.00019695348,0.001599698,0.00019292886,0.00028685603,0.00042539128],"domain_scores_gemma":[0.99695456,0.00097206584,0.00082416355,0.0001570563,0.00025355714,0.0008386068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051339176,0.00018306797,0.00048193554,0.000092341856,0.00009669486,0.000018547602,0.00051245437,0.00058596465,0.002134143],"category_scores_gemma":[0.0011788082,0.00015594438,0.0004522852,0.00016579713,0.0003239935,0.00004867819,0.00005769804,0.0019400677,0.000075845455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025364617,0.0010503496,0.05016864,0.000058007645,0.00068712747,0.0033943735,0.00048958015,0.000046390724,0.1497628,0.000086925036,0.124984205,0.6667351],"study_design_scores_gemma":[0.0019804297,0.00009331992,0.0042670323,0.000012639812,0.00011058616,0.00034926913,0.00005987406,0.0000029208732,0.44336417,0.00044904233,0.5491582,0.00015249559],"about_ca_topic_score_codex":5.448595e-7,"about_ca_topic_score_gemma":0.0000010244495,"teacher_disagreement_score":0.66658264,"about_ca_system_score_codex":0.000024958563,"about_ca_system_score_gemma":0.00034238628,"threshold_uncertainty_score":0.99877805},"labels":[],"label_agreement":null},{"id":"W4234451010","doi":"10.1139/y00-066","title":"Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Kidney Foundation of Canada","keywords":"CYP3A; CYP2E1; Cirrhosis; Breath test; Internal medicine; Cytochrome P450; Chemistry; Isozyme; Carbon tetrachloride; Endocrinology; Pharmacology; Biology; Metabolism; Biochemistry; Enzyme; Medicine","score_opus":0.061016831606421136,"score_gpt":0.3971796990691203,"score_spread":0.3361628674626992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234451010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931505,0.0047210352,0.000020424395,0.00020372716,0.0009265896,0.00020982165,0.000105492334,0.000003414523,0.00065902126],"genre_scores_gemma":[0.99753827,0.0011985777,0.00007587277,0.00072196615,0.00036305725,0.00001193366,0.000011047475,0.000017239754,0.0000620388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977351,0.0006653774,0.0008389292,0.00022042824,0.00008874341,0.00045144427],"domain_scores_gemma":[0.9987296,0.0001925035,0.0003803936,0.00009371738,0.00013994519,0.0004638289],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003465488,0.0002298562,0.0006869411,0.0004449553,0.000105477244,0.000004552457,0.0003041441,0.0002158428,0.016164199],"category_scores_gemma":[0.000008465942,0.00022444475,0.00014424224,0.0001900548,0.0006076296,0.00016955382,0.000025713733,0.00061025575,0.000005255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072006,0.00025698915,0.00093828427,0.000057304613,0.0002356116,0.000042526815,0.0016613294,0.0077487393,0.983652,0.00063984,0.0006810583,0.00336627],"study_design_scores_gemma":[0.0052057854,0.00037495344,0.0058116973,0.000018693201,0.00022362593,0.00008531691,0.00008376777,0.005967445,0.976154,0.0023239895,0.003542722,0.00020796478],"about_ca_topic_score_codex":0.00057954295,"about_ca_topic_score_gemma":0.000277203,"teacher_disagreement_score":0.016158944,"about_ca_system_score_codex":0.000047410373,"about_ca_system_score_gemma":0.0004213438,"threshold_uncertainty_score":0.98473513},"labels":[],"label_agreement":null},{"id":"W4234704195","doi":"10.1016/j.tiv.2012.10.005","title":"Modulation of trichloroethylene in vitro metabolism by different drugs in rats","year":2012,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Chemistry; Glucuronidation; Naproxen; Mefenamic acid; Metabolite; Acetaminophen; Pharmacology; Salicylic acid; Microsome; Ibuprofen; Metabolism; Chromatography; Biochemistry; In vitro","score_opus":0.057114921182076596,"score_gpt":0.38729107331115775,"score_spread":0.33017615212908114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234704195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98667115,0.008621588,0.000027582417,0.0005947474,0.002072736,0.00073065585,0.00014165443,0.00003251654,0.0011073708],"genre_scores_gemma":[0.9966763,0.001040418,0.00019901872,0.0012479388,0.00027614756,0.00023573072,0.000096505006,0.000042831696,0.00018506426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995467,0.0015043165,0.0011237693,0.00045888728,0.0002450477,0.0012009933],"domain_scores_gemma":[0.9984195,0.0006330006,0.00031298216,0.00028300943,0.000050896862,0.00030058462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017766753,0.0004209766,0.0010089625,0.0008195213,0.000056792916,0.0000071485033,0.00041375184,0.0007280734,0.00042401944],"category_scores_gemma":[0.00012472595,0.0004228547,0.00013626664,0.0007511728,0.00023091152,0.0002187112,0.00017229909,0.0012700513,0.000037126956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001917228,0.0023215963,0.016463704,0.000034313034,0.00005610137,0.000010021613,0.001954705,0.00042748533,0.95361656,0.00024951523,0.00029429572,0.022654474],"study_design_scores_gemma":[0.00568967,0.000033349923,0.09828915,0.000006102713,0.00007841329,0.0000050768613,0.000116284646,0.003945212,0.88335717,0.0006004816,0.007531684,0.00034741094],"about_ca_topic_score_codex":0.000090879854,"about_ca_topic_score_gemma":0.000030060313,"teacher_disagreement_score":0.08182544,"about_ca_system_score_codex":0.0001961874,"about_ca_system_score_gemma":0.00007058237,"threshold_uncertainty_score":0.9998223},"labels":[],"label_agreement":null},{"id":"W4236455061","doi":"10.3410/f.10018.467508","title":"Faculty Opinions recommendation of CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.","year":2006,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"CYP2D6; Tamoxifen; Breast cancer; Antidepressant; Genotype; Oncology; Adjuvant; Medicine; Internal medicine; Pharmacology; Cancer; Bioinformatics; Biology; Metabolism; Genetics; Gene; Cytochrome P450","score_opus":0.08069509797434733,"score_gpt":0.4322443429382367,"score_spread":0.3515492449638894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236455061","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013253963,0.012759266,0.0000037305479,0.04986446,0.0019753103,0.0015456993,0.9336459,0.000037857182,0.000035242574],"genre_scores_gemma":[0.00015606734,0.012413186,0.00016606311,0.0031447134,0.0007422264,0.0003601004,0.9819356,0.00004351363,0.0010384977],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99527943,0.0009644479,0.0015997192,0.0008091253,0.00080254243,0.0005447194],"domain_scores_gemma":[0.9934321,0.00020427139,0.001598447,0.00089396397,0.0034064928,0.00046471224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090242375,0.00074220326,0.0013464019,0.0003825721,0.00040528766,0.00011741787,0.0009959587,0.00095006655,0.00085617753],"category_scores_gemma":[0.0007462464,0.00048885617,0.0005514766,0.0011816814,0.0005037119,0.00037366152,0.00050184666,0.0012540482,0.000019659103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008442431,0.0006726875,0.00015197656,0.0030409805,0.0005968025,0.0000013268412,0.00011451961,0.0000026644484,0.00009525939,0.000072425675,0.99082863,0.0043383013],"study_design_scores_gemma":[0.0020706223,0.000037344118,0.040192563,0.0017244464,0.0013303618,0.00008024365,0.0000074857617,0.000028388182,0.0005512551,0.000015090444,0.9535226,0.00043957017],"about_ca_topic_score_codex":0.00053761574,"about_ca_topic_score_gemma":0.000031405492,"teacher_disagreement_score":0.04828974,"about_ca_system_score_codex":0.00011242383,"about_ca_system_score_gemma":0.00046084073,"threshold_uncertainty_score":0.99975634},"labels":[],"label_agreement":null},{"id":"W4236581453","doi":"10.2165/11634200-000000000-00000","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacokinetics; Population pharmacokinetics; Computer science; Medicine; Pharmacology","score_opus":0.37905310127943986,"score_gpt":0.5525052629288641,"score_spread":0.17345216164942429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236581453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694597,0.0076272166,0.002446949,0.00034778684,0.009206787,0.0007660503,0.00016083533,0.00016468042,0.0098199705],"genre_scores_gemma":[0.9843999,0.005298735,0.0025524208,0.004057415,0.0029114503,0.000041573592,0.0001042621,0.00009111922,0.00054310146],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99477416,0.0010766018,0.0020222492,0.0005062679,0.0005003336,0.0011204093],"domain_scores_gemma":[0.99642587,0.0010357774,0.00070299476,0.00041565174,0.00031124352,0.0011084877],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031847393,0.0004879242,0.0008409204,0.00022875103,0.00018815018,0.000018141116,0.0005997952,0.00045858434,0.003686406],"category_scores_gemma":[0.0002038168,0.00048376524,0.00048695673,0.00049967674,0.0004067739,0.000277649,0.00027220734,0.0013145746,0.0003182741],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015433109,0.0076767933,0.4010251,0.0004453419,0.001528008,0.00002426743,0.0010576914,0.08096462,0.15255274,0.0036089648,0.029616129,0.31995705],"study_design_scores_gemma":[0.008125225,0.0002125509,0.022338359,0.00004076256,0.001943446,0.000032713753,0.00008881704,0.11945528,0.11306572,0.0010027242,0.73257333,0.0011210599],"about_ca_topic_score_codex":0.000021994447,"about_ca_topic_score_gemma":3.9658448e-7,"teacher_disagreement_score":0.7029572,"about_ca_system_score_codex":0.000053407228,"about_ca_system_score_gemma":0.00004712787,"threshold_uncertainty_score":0.9997614},"labels":[],"label_agreement":null},{"id":"W4236647833","doi":"10.1016/j.clinbiochem.2008.08.043","title":"Paediatric reference intervals for 14 chemistries and immunoassays on the Roche Cobas 6000 system—A CALIPER (Canadian Laboratory Initiative on Pediatric Reference Range Database) pilot study","year":2008,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Estrone; Chemistry; Androstenedione; Aromatase; Hydroxylation; Steroid; Metabolite; Cytochrome P450; Docking (animal); CYP17A1; Stereochemistry; Enzyme; Androgen; Internal medicine; Biochemistry; Medicine","score_opus":0.34541354637015115,"score_gpt":0.45410016784922774,"score_spread":0.1086866214790766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236647833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98543763,0.0033870847,0.0000058509795,0.0004926918,0.00080236554,0.0010115555,0.0036442748,0.00007779796,0.0051407516],"genre_scores_gemma":[0.9902001,0.0041207103,0.000031797073,0.0034103368,0.0013240752,0.00033999322,0.00019544257,0.000042383217,0.0003351803],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963151,0.0008425037,0.0009738468,0.000915419,0.00030242236,0.000650708],"domain_scores_gemma":[0.99406254,0.0037396695,0.00038780778,0.0006858585,0.00041833415,0.0007057767],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027150065,0.00048568763,0.0006152804,0.00009076825,0.00073355605,0.000042959146,0.0007463414,0.0004491675,0.0002662795],"category_scores_gemma":[0.0015915404,0.00037791725,0.00011540155,0.0003593059,0.000461412,0.000059045567,0.00020114207,0.0017709865,0.00013457818],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014999189,0.01647771,0.49479446,0.002749447,0.0025406396,0.0008172659,0.0023699142,0.000043239626,0.09929394,0.0022210765,0.35774347,0.0059496425],"study_design_scores_gemma":[0.04627329,0.012277463,0.09291907,0.00036569228,0.006666707,0.00012326102,0.004309016,0.00096101704,0.5614773,0.0004485613,0.26762724,0.0065513537],"about_ca_topic_score_codex":0.00011052495,"about_ca_topic_score_gemma":0.000053375174,"teacher_disagreement_score":0.4621834,"about_ca_system_score_codex":0.00012075398,"about_ca_system_score_gemma":0.00078065385,"threshold_uncertainty_score":0.99986726},"labels":[],"label_agreement":null},{"id":"W4239332495","doi":"10.1002/cbic.200790039","title":"Replacement of Natural Cofactors by Selected Hydrogen Peroxide Donors or Organic Peroxides Results in Improved Activity for CYP3A4 and CYP2D6","year":2007,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Debrisoquine; Hydrogen peroxide; Chemistry; Cofactor; Cytochrome P450; Cumene hydroperoxide; Stereochemistry; CYP2D6; Enzyme; Biochemistry; Biocatalysis; Cytochrome; Catalysis; Reaction mechanism","score_opus":0.04757041394275949,"score_gpt":0.38970879637735384,"score_spread":0.3421383824345944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239332495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599195,0.0019471421,0.000053570126,0.0002559312,0.00037102232,0.0008566605,0.00025645978,0.000049938782,0.00021732997],"genre_scores_gemma":[0.99774414,0.00049750914,0.00026550307,0.00035114365,0.00010975323,0.000043153977,0.00009629608,0.00004139867,0.0008511109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792206,0.00010740935,0.0006028274,0.000561448,0.0001447603,0.0006615101],"domain_scores_gemma":[0.99841756,0.0005931103,0.00030453943,0.00023059918,0.00018483007,0.00026938028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012775842,0.00033548402,0.00046968937,0.0001350877,0.00011720633,0.000013127684,0.00024340267,0.00036404145,0.00009477483],"category_scores_gemma":[0.0004672719,0.00030131053,0.000086526525,0.00042763847,0.00018818535,0.000083067695,0.00011881339,0.0005428468,0.000002486546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059255254,0.00037716393,0.0020960416,0.00009864822,0.00017213948,0.00000446889,0.00079669675,0.0000025084792,0.9842276,0.000006892633,0.0014361595,0.0048561837],"study_design_scores_gemma":[0.0069884607,0.00019482491,0.0032183323,0.0000122191395,0.00012985304,0.000010431237,0.00018247779,0.0007691155,0.97753596,0.000020168929,0.010599559,0.00033861064],"about_ca_topic_score_codex":0.000052953073,"about_ca_topic_score_gemma":0.00012535237,"teacher_disagreement_score":0.0091634,"about_ca_system_score_codex":0.00012257133,"about_ca_system_score_gemma":0.00014674304,"threshold_uncertainty_score":0.9999439},"labels":[],"label_agreement":null},{"id":"W4240682630","doi":"10.1016/b978-0-12-386454-3.00007-5","title":"Biotransformation/Metabolism","year":2014,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Biotransformation; Detoxication; Xenobiotic; Chemistry; Drug metabolism; Metabolism; Enzyme; Biochemistry","score_opus":0.06588997468324723,"score_gpt":0.369760082221813,"score_spread":0.3038701075385658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240682630","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018760866,0.0079235155,0.00004648042,0.00032627504,0.0037899918,0.0008688305,0.00032758806,0.00021656051,0.98631316],"genre_scores_gemma":[0.004740335,0.00269778,0.0002006621,0.0065523363,0.0021384747,0.000072935945,0.00013912974,0.00019100444,0.98326737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970319,0.00020313516,0.00095675536,0.0006474503,0.00043582226,0.00072490086],"domain_scores_gemma":[0.997988,0.00018001086,0.00044756467,0.0005912994,0.00020711632,0.0005860473],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000938272,0.00085268845,0.0009908588,0.00035886824,0.00035677062,0.000055060358,0.0007053474,0.0013728031,0.0053039505],"category_scores_gemma":[0.00002005122,0.00082961825,0.0005526981,0.000028171768,0.00037916788,0.00004880072,0.00015940705,0.002083909,0.0034423787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062279556,0.00001871019,0.0000021889832,0.0001105297,0.00037166933,0.000021712873,0.00025636112,0.0000151754475,0.0013435561,0.06009724,0.002275075,0.9354255],"study_design_scores_gemma":[0.0013406047,0.00002927828,0.0000108931135,0.000057925845,0.00093200983,0.000034172182,0.0000030069784,0.00012371401,0.0038347777,0.013646416,0.9791086,0.00087864377],"about_ca_topic_score_codex":3.7213206e-7,"about_ca_topic_score_gemma":0.0000042495262,"teacher_disagreement_score":0.97683346,"about_ca_system_score_codex":0.00005984977,"about_ca_system_score_gemma":0.0001866609,"threshold_uncertainty_score":0.99992365},"labels":[],"label_agreement":null},{"id":"W4241441403","doi":"10.1385/1-59259-998-2:109","title":"Determination of CYP2C9-Catalyzed Diclofenac 4'-Hydroxylation by High-Performance Liquid Chromatography","year":2006,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research","keywords":"Hydroxylation; Perchloric acid; Chromatography; Chemistry; Diclofenac; High-performance liquid chromatography; Methanol; Acetonitrile; Catalysis; Organic chemistry; Enzyme; Biochemistry","score_opus":0.07435217108953951,"score_gpt":0.34895170139994547,"score_spread":0.27459953031040596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241441403","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.111421905,0.02190611,0.0002848841,0.000020436959,0.0019743117,0.0014580854,0.0011605268,0.0002412303,0.8615325],"genre_scores_gemma":[0.78090876,0.0064981426,0.00017809165,0.00031828348,0.00095540786,0.00016705637,0.001350029,0.00023935201,0.20938489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972327,0.00013933964,0.0010352543,0.00062942517,0.00046114193,0.00050217373],"domain_scores_gemma":[0.99793154,0.00012746314,0.0010068214,0.0005144386,0.00021781864,0.00020191677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004438757,0.0006707272,0.00079536083,0.00037558746,0.00027184407,0.000027306674,0.00058087404,0.0009753281,0.00042168828],"category_scores_gemma":[0.000006637853,0.00072010397,0.0002843785,0.000024084706,0.00047905307,0.00010522476,0.00019273759,0.0009168632,0.000036722697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029952966,0.0009201407,0.000043144904,0.003236083,0.0025730494,0.00012107422,0.0015209344,0.0015208513,0.3469091,0.096544676,0.073443435,0.4701722],"study_design_scores_gemma":[0.0017921648,0.00012495543,0.000033372224,0.00010067112,0.0008843714,0.0000066951875,0.0000010279398,0.0019511525,0.29321972,0.0012661794,0.6999305,0.00068916555],"about_ca_topic_score_codex":0.00009944598,"about_ca_topic_score_gemma":0.000009227362,"teacher_disagreement_score":0.6694868,"about_ca_system_score_codex":0.000052831652,"about_ca_system_score_gemma":0.00006272041,"threshold_uncertainty_score":0.999525},"labels":[],"label_agreement":null},{"id":"W4242214145","doi":"10.3821/1913-701x(2008)141[40:mefypa]2.0.co;2","title":"Made especially for you: Pharmacogenomics and pharmacy practice","year":2008,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacy; Pharmacy practice; Medicine; Business; Family medicine; Pharmacology","score_opus":0.15311925210105362,"score_gpt":0.39505269876622273,"score_spread":0.2419334466651691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242214145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483416,0.017818728,0.00069625425,0.001879523,0.01520092,0.0023169706,0.0035224797,0.0001584879,0.010065022],"genre_scores_gemma":[0.87857133,0.08670026,0.001955645,0.023772607,0.005985143,0.00015043892,0.00010444194,0.00022732202,0.002532792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933453,0.00081379095,0.0014542917,0.0010809156,0.0006607848,0.0026449081],"domain_scores_gemma":[0.99021316,0.0009702855,0.0007435184,0.00037491653,0.0015460043,0.00615213],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023254333,0.0010467602,0.00095525885,0.0007249581,0.0039196224,0.00024010839,0.001334707,0.00026113234,0.0018931944],"category_scores_gemma":[0.00076444465,0.0011838467,0.00039404866,0.0007949263,0.00089987245,0.0009816409,0.0001764126,0.0023420546,0.00005480733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046626437,0.00073992857,0.0034198915,0.00055891176,0.0030436388,0.1115976,0.008026624,0.0053428183,0.16491461,0.0009203805,0.23029058,0.4664824],"study_design_scores_gemma":[0.008004865,0.000055638553,0.000013854591,0.0000062803197,0.0007559292,0.30640155,0.00002479212,0.006414261,0.023062646,0.00014061217,0.65415585,0.0009637346],"about_ca_topic_score_codex":0.006101849,"about_ca_topic_score_gemma":0.005344142,"teacher_disagreement_score":0.46551865,"about_ca_system_score_codex":0.0018045232,"about_ca_system_score_gemma":0.0077481517,"threshold_uncertainty_score":0.9999596},"labels":[],"label_agreement":null},{"id":"W4242256274","doi":"10.1111/j.1538-7836.2005.01455.x","title":"Talking about…","year":2005,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"World Federation of Science Journalists","funders":"","keywords":"Medicine","score_opus":0.18623103296962282,"score_gpt":0.47432279820385015,"score_spread":0.2880917652342273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242256274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97577155,0.0130379805,0.00012797964,0.005356676,0.001082783,0.00009573124,0.000027212109,0.000014525769,0.004485581],"genre_scores_gemma":[0.9737711,0.01889031,0.002293065,0.0038196768,0.0010860183,0.0000022274055,0.0000012534227,0.000019921206,0.000116409945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986144,0.00016788504,0.0005594384,0.00014236287,0.00021096136,0.0003049648],"domain_scores_gemma":[0.99885875,0.00014789507,0.00038856248,0.000101184814,0.0001747018,0.00032888268],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094999245,0.00017647301,0.00039899093,0.0001596519,0.00021447615,0.0000445432,0.0002243301,0.00015921814,0.0013201915],"category_scores_gemma":[0.000048260306,0.00014595632,0.00017311945,0.00014257971,0.00012931059,0.0002213495,0.0000786449,0.0005683442,0.00003436932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023290787,0.0004851678,0.011899995,0.000041964893,0.00083951384,0.000025680123,0.0018236247,0.00053571514,0.060558762,0.0012187428,0.038319856,0.88401806],"study_design_scores_gemma":[0.002333778,0.00009518597,0.016729837,0.000027411432,0.0005186409,0.00012518576,0.00015024992,0.0006073326,0.06290476,0.0003731838,0.91592103,0.000213389],"about_ca_topic_score_codex":0.0000039741444,"about_ca_topic_score_gemma":0.0000032029434,"teacher_disagreement_score":0.8838047,"about_ca_system_score_codex":0.000034031706,"about_ca_system_score_gemma":0.00005525549,"threshold_uncertainty_score":0.9995927},"labels":[],"label_agreement":null},{"id":"W4243623252","doi":"10.1051/medsci/2010261s207","title":"Physiopathologie, modèles cellulaires et animaux (P553 – P604)","year":2010,"lang":"fr","type":"article","venue":"médecine/sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Chemistry","score_opus":0.17052652195277138,"score_gpt":0.46969810772418086,"score_spread":0.29917158577140945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243623252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8472353,0.036139134,0.00023799222,0.017194314,0.022278557,0.00058275857,0.00038350906,0.00019512977,0.075753264],"genre_scores_gemma":[0.96379167,0.008356202,0.005235659,0.008667536,0.0024899067,0.000063440435,0.000018806233,0.00006257963,0.011314195],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.994463,0.0011528919,0.000805524,0.0012727726,0.00064430875,0.0016614726],"domain_scores_gemma":[0.9972369,0.0010766451,0.00040437173,0.00047075187,0.00018848224,0.0006228597],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["sts","insufficient_payload"],"category_scores_codex":[0.0040076883,0.0007501607,0.0007398808,0.00034634527,0.0015106222,0.00024323043,0.0017258566,0.00080482406,0.005603009],"category_scores_gemma":[0.00033991988,0.00068411685,0.0003477683,0.0010738168,0.004708747,0.00052064843,0.0006034401,0.0024009217,0.001176956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115469375,0.0016931058,0.012088534,0.00011349346,0.00011414681,0.0001752234,0.0008488348,0.004052344,0.8000684,0.099843904,0.017487247,0.063399345],"study_design_scores_gemma":[0.002658968,0.0005449961,0.01930631,0.000046450674,0.0004326959,0.00018221056,0.0003289278,0.026956972,0.18206134,0.020229058,0.74617815,0.0010739228],"about_ca_topic_score_codex":0.00014129239,"about_ca_topic_score_gemma":0.00011201812,"teacher_disagreement_score":0.7286909,"about_ca_system_score_codex":0.00003570745,"about_ca_system_score_gemma":0.0007154678,"threshold_uncertainty_score":0.9999006},"labels":[],"label_agreement":null},{"id":"W4244888445","doi":"10.1515/iupac.76.0329","title":"Pharmacogenetics","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Toxicokinetics; Toxicology; Computer science; Medicine; Pharmacology; Biology; Linguistics; Philosophy","score_opus":0.08234467829453146,"score_gpt":0.5477336808670672,"score_spread":0.46538900257253574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244888445","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073408766,0.01092172,0.00006792669,0.0011342759,0.009767535,0.00075100723,0.97578603,0.00017533952,0.00066206075],"genre_scores_gemma":[0.00015287875,0.03392102,0.000047854966,0.0056222877,0.005652756,0.0000765253,0.9526768,0.00013404488,0.0017158759],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99426454,0.0007865576,0.0011342833,0.0010897652,0.0013070194,0.0014178572],"domain_scores_gemma":[0.9961043,0.00039687203,0.00061350886,0.0010008313,0.0008352622,0.0010492208],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001636281,0.0011373903,0.0012125287,0.00046878823,0.00038866486,0.00006783455,0.0014813208,0.0015117654,0.043458868],"category_scores_gemma":[0.00036593442,0.0009359075,0.0005054588,0.0003819173,0.0005383258,0.0000937328,0.0005830294,0.0024265,0.00008132899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050455926,0.0007510148,0.000039085015,0.00017237388,0.00071782956,0.00027046454,0.000023131177,0.000028122295,0.0015705564,0.00001583557,0.95261616,0.043290872],"study_design_scores_gemma":[0.004231936,0.00014512599,0.000022733631,0.00008973357,0.0013986017,0.00005828895,0.000008657148,0.00005466636,0.0034728036,0.00027913708,0.98907197,0.0011663393],"about_ca_topic_score_codex":0.00002936062,"about_ca_topic_score_gemma":0.00006733653,"teacher_disagreement_score":0.04337754,"about_ca_system_score_codex":0.00035828553,"about_ca_system_score_gemma":0.001292063,"threshold_uncertainty_score":0.99987495},"labels":[],"label_agreement":null},{"id":"W4245167824","doi":"10.1007/s40262-019-00839-0","title":"Acknowledgement to Referees","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Lausanne; Université Paris Diderot; Università degli Studi di Udine; Radboud Universiteit; Università degli Studi di Pavia; Universiteit Utrecht; Rijksuniversiteit Groningen; University of Otago; Universiteit Leiden; Universität Heidelberg; University of Waterloo; Karolinska Institutet; University of South Carolina; King's College London; University of Alberta; University of Washington; Helsingin Yliopisto; East Tennessee State University; University of Southern California","keywords":"Pharmacotherapy; Acknowledgement; Medicine; Internal medicine; Computer science","score_opus":0.2598516706215862,"score_gpt":0.5568679580104303,"score_spread":0.2970162873888441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245167824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8801448,0.0011136545,0.00020824405,0.0023688858,0.016199945,0.0013255574,0.00009018487,0.00023450007,0.09831427],"genre_scores_gemma":[0.9511181,0.00183237,0.001314175,0.028659057,0.0024665298,0.000076455144,0.000030409135,0.00008951837,0.014413371],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584115,0.0007280347,0.0012428855,0.00087542983,0.00039029517,0.0009222023],"domain_scores_gemma":[0.9967552,0.0007825255,0.00021134752,0.00061936164,0.0003507229,0.0012808819],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0021742214,0.00043526207,0.00067850994,0.00019386147,0.00014089196,0.00004333848,0.00096820906,0.00040602777,0.019491924],"category_scores_gemma":[0.00031207944,0.00042529713,0.000343149,0.00051216036,0.00016894353,0.00008694102,0.0005774808,0.0014391531,0.026344469],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012876889,0.0023419233,0.084988974,0.00013543955,0.00076952827,0.00006283512,0.0004397203,0.0034209448,0.13207254,0.0026958415,0.3985791,0.37320548],"study_design_scores_gemma":[0.0038657065,0.00029005212,0.010063573,0.0000150459455,0.00027408006,0.000005005189,0.00003112438,0.00285043,0.02954258,0.0004676224,0.9520464,0.0005483616],"about_ca_topic_score_codex":0.0000024813428,"about_ca_topic_score_gemma":0.0000022737133,"teacher_disagreement_score":0.55346733,"about_ca_system_score_codex":0.000056102894,"about_ca_system_score_gemma":0.00011493242,"threshold_uncertainty_score":0.9998199},"labels":[],"label_agreement":null},{"id":"W4245513075","doi":"10.1385/0-89603-519-0:153","title":"Thin-Layer Chromatographic Analysis of Human CYP3A-Catalyzed Testosterone 6P-Hydroxylation","year":2003,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"CYP3A; CYP3A4; Microsome; Cytochrome P450; Biology; Hydroxylation; Testosterone (patch); Chemistry; Enzyme; Biochemistry; Molecular biology; Endocrinology","score_opus":0.21165184569436435,"score_gpt":0.414705455220019,"score_spread":0.20305360952565465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245513075","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039238878,0.020662064,0.000049050497,0.00002303878,0.001173022,0.0012186072,0.0006866245,0.00018862424,0.93676007],"genre_scores_gemma":[0.5989874,0.004119272,0.00011743492,0.0013778504,0.00066082424,0.00015977156,0.0011694622,0.0003338146,0.39307418],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961398,0.0003391547,0.0013744588,0.0009252623,0.0005760337,0.00064525154],"domain_scores_gemma":[0.9969034,0.00019853421,0.001248712,0.0009814231,0.00028908643,0.00037883528],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081785466,0.000890912,0.0016500878,0.0013700089,0.00042557143,0.000048945163,0.0007772038,0.0012375506,0.0025144534],"category_scores_gemma":[0.000014896726,0.00094505225,0.0009444682,0.000096218755,0.00062182546,0.000074130316,0.0002528422,0.0014121913,0.00004139889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006235829,0.0010380034,0.00032566473,0.001307726,0.06557282,0.00030387664,0.0051740245,0.003837917,0.2446906,0.6188912,0.017018957,0.04121565],"study_design_scores_gemma":[0.0029075716,0.00012176172,0.00030015502,0.0000937552,0.03036291,0.000010596325,0.0000089490395,0.0014842179,0.05477276,0.00806467,0.9003775,0.0014951284],"about_ca_topic_score_codex":0.00008105151,"about_ca_topic_score_gemma":0.000072938616,"teacher_disagreement_score":0.88335854,"about_ca_system_score_codex":0.00005776966,"about_ca_system_score_gemma":0.000064533815,"threshold_uncertainty_score":0.9993},"labels":[],"label_agreement":null},{"id":"W4246032552","doi":"10.1542/peds.2007-1131","title":"Do We Need to Incorporate Pharmacogenetics in Randomized, Controlled Trials of Frequently Used Medicines?: In Reply","year":2007,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Pharmacogenetics; Randomized controlled trial; Intensive care medicine; Medical physics; Internal medicine; Genetics; Genotype","score_opus":0.12517342990719016,"score_gpt":0.45828751173402904,"score_spread":0.3331140818268389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246032552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94447833,0.038559213,0.0010379832,0.0036422617,0.004353986,0.0052845115,0.00014240447,0.000057473615,0.0024438482],"genre_scores_gemma":[0.9662907,0.02696264,0.0010867557,0.003689535,0.0014475792,0.00025831212,0.000020554406,0.00006177955,0.00018210449],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9876685,0.004343278,0.0055681677,0.0006485751,0.0007347555,0.001036701],"domain_scores_gemma":[0.9845722,0.01227609,0.0017995936,0.00036416212,0.00035109694,0.0006369048],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.054168556,0.00055456546,0.0051654675,0.0022341372,0.00006550232,0.00002281966,0.00060032797,0.00045484552,0.0006033197],"category_scores_gemma":[0.008541944,0.00044927362,0.0007583781,0.0022183473,0.0002183651,0.00008362559,0.00016267643,0.0010465055,0.000049930008],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4950283,0.0031807695,0.17761989,0.0005627999,0.0012247438,0.0009244175,0.010089788,0.01727236,0.22561483,0.0024263023,0.010665486,0.055390332],"study_design_scores_gemma":[0.86476964,0.00017636528,0.0015907382,0.000073434945,0.003000359,0.000014447918,0.00049809023,0.003640155,0.066963345,0.0054651913,0.052816674,0.0009915851],"about_ca_topic_score_codex":0.0001149336,"about_ca_topic_score_gemma":0.00008377232,"teacher_disagreement_score":0.36974132,"about_ca_system_score_codex":0.0001142072,"about_ca_system_score_gemma":0.00038350353,"threshold_uncertainty_score":0.9998095},"labels":[],"label_agreement":null},{"id":"W4247694356","doi":"10.1210/en.142.2.778","title":"Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members","year":2001,"lang":"en","type":"article","venue":"Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Glucuronidation; Steroid; Hydroxysteroid; Chemistry; Biochemistry; UGT2B7; Enzyme; Biology; Hormone; Microsome","score_opus":0.11544545251868055,"score_gpt":0.42514957715578927,"score_spread":0.3097041246371087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247694356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001175,0.0026656121,0.0003583724,0.00056579715,0.0005297774,0.0008131457,0.00012027446,0.00008137809,0.0048539187],"genre_scores_gemma":[0.9982326,0.0007162988,0.00012145516,0.00016098992,0.00014848838,0.00009992933,0.000041689145,0.000028249697,0.0004502709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971009,0.0010037923,0.00052048045,0.00048045313,0.00018278649,0.00071159203],"domain_scores_gemma":[0.998758,0.0002943878,0.00030100363,0.00029257918,0.00012798396,0.0002260115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005132267,0.00031701388,0.0005855922,0.00014310848,0.0002802913,0.000014512801,0.00026855472,0.00025494775,0.0008156523],"category_scores_gemma":[0.00012313917,0.0003207897,0.00008636891,0.00027191825,0.0006181473,0.00019744565,0.00029504517,0.00078710204,0.00003100928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024636474,0.00043144496,0.013811589,0.00010231929,0.00022693064,0.00006861986,0.0008556259,0.000024987903,0.94155866,0.014454589,0.00016316854,0.0280557],"study_design_scores_gemma":[0.0030520973,0.00029667863,0.032927234,0.000017742404,0.00030165308,0.000107320644,0.00020044704,0.0003521953,0.8872852,0.0046659876,0.07040225,0.00039125435],"about_ca_topic_score_codex":0.00012817096,"about_ca_topic_score_gemma":0.000050647195,"teacher_disagreement_score":0.070239075,"about_ca_system_score_codex":0.00005895894,"about_ca_system_score_gemma":0.00005407745,"threshold_uncertainty_score":0.9999244},"labels":[],"label_agreement":null},{"id":"W4247871824","doi":"10.1139/y01-059","title":"Isolation of regioisomers of N-alkylprotoporphyrin IX from chick embryo liver after treatment with porphyrinogenic xenobiotics","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Structural isomer; Chemistry; Isozyme; Stereochemistry; Enzyme; Biochemistry","score_opus":0.042919526416198735,"score_gpt":0.3288963223380476,"score_spread":0.2859767959218489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247871824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98750883,0.009910264,0.00006365937,0.00033195873,0.0012129875,0.00039994833,0.00021938066,0.0000056290064,0.00034735067],"genre_scores_gemma":[0.99262637,0.0053468156,0.000428056,0.0008504002,0.0005464568,0.000019649413,0.000021458172,0.000028304226,0.00013251822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780834,0.00054016407,0.00074195076,0.00029112503,0.00010422634,0.00051417464],"domain_scores_gemma":[0.99777955,0.00027338302,0.0007766785,0.00016435432,0.00032402837,0.00068201113],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030695746,0.00032836173,0.00078012055,0.00040116094,0.0001282896,0.0000049349233,0.00026062736,0.00037425553,0.0048142723],"category_scores_gemma":[0.000011234324,0.00027223007,0.00018942129,0.00025130057,0.0008833015,0.00011992227,0.000029976056,0.00055943406,0.00001007735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031356285,0.00030269162,0.041599385,0.000074191805,0.0013475355,0.00038892354,0.0015182378,0.00067321584,0.9445669,0.00011124318,0.0005058055,0.0057762233],"study_design_scores_gemma":[0.009250623,0.002869918,0.08087013,0.0000451197,0.00218545,0.0004693944,0.00022188488,0.000920668,0.8419059,0.0011288951,0.059612818,0.0005192258],"about_ca_topic_score_codex":0.0011040884,"about_ca_topic_score_gemma":0.00095307676,"teacher_disagreement_score":0.10266105,"about_ca_system_score_codex":0.00007724877,"about_ca_system_score_gemma":0.0007904482,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W4249455208","doi":"10.1007/3-540-29623-9_1420","title":"Idiosyncratic Drug Reactions","year":2006,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Drug; Pharmacology; Medicine","score_opus":0.10021744136304335,"score_gpt":0.4031214408379278,"score_spread":0.30290399947488444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249455208","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002725983,0.005069758,0.00008788853,0.00087004795,0.0035580315,0.00052094663,0.00025456306,0.00027634762,0.98908985],"genre_scores_gemma":[0.01070129,0.0028443024,0.00021916757,0.0028828403,0.0017594009,0.000036419213,0.0002038893,0.00013839861,0.9812143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977056,0.00011577869,0.00075544894,0.0005921055,0.0002966188,0.0005344705],"domain_scores_gemma":[0.99841064,0.0002855645,0.000335921,0.00044024404,0.00015428507,0.00037334065],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00051002967,0.00063033815,0.0006208771,0.00027618912,0.0003238044,0.00003606714,0.0004176434,0.0008572307,0.029588277],"category_scores_gemma":[0.000016897982,0.0006120082,0.00038215015,0.000051303694,0.0002391339,0.00006955377,0.00014202516,0.0018989895,0.004416828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055038865,0.00013649155,0.000022130474,0.0000990444,0.0005061831,0.00012455143,0.00005659413,0.00039850207,0.0050673117,0.19162859,0.7843027,0.017602846],"study_design_scores_gemma":[0.0007173741,0.000015447862,0.000013865701,0.00002402708,0.00071580656,0.000036784106,0.0000041118733,0.0004535794,0.004701858,0.025083257,0.96758467,0.0006492114],"about_ca_topic_score_codex":0.000040254974,"about_ca_topic_score_gemma":0.000034419376,"teacher_disagreement_score":0.18328196,"about_ca_system_score_codex":0.00008569807,"about_ca_system_score_gemma":0.00017269365,"threshold_uncertainty_score":0.99963313},"labels":[],"label_agreement":null},{"id":"W4250194478","doi":"10.1080/01621459.2016.1240080","title":"Comment","year":2016,"lang":"en","type":"article","venue":"Journal of the American Statistical Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Mathematics","score_opus":0.058158899861969975,"score_gpt":0.43457833319639233,"score_spread":0.37641943333442235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250194478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8382328,0.00021643103,0.020445483,0.13470875,0.0039270516,0.00018403168,0.0003338545,0.00001821482,0.0019333848],"genre_scores_gemma":[0.9867638,0.00032291326,0.0011236606,0.01083975,0.0004287409,0.0000021726773,4.7207502e-7,0.000009360084,0.00050914055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982231,0.00075398386,0.0003896058,0.00007378592,0.00033233812,0.0002271386],"domain_scores_gemma":[0.99690104,0.0015720342,0.0010895967,0.00008264332,0.00020578569,0.00014891158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012538276,0.00008614049,0.00023981486,0.00003877699,0.00009972396,0.000010645609,0.00025450697,0.000042940923,0.00035782304],"category_scores_gemma":[0.0010652303,0.00004331532,0.00010866953,0.00014026907,0.00013116328,0.00004825098,0.00005565312,0.00031001744,0.000055573215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046947724,0.00041581,0.15250131,0.0000061059804,0.0005981445,0.000018564808,0.00019651424,0.000040380324,0.09172417,0.010879302,0.3251309,0.41801932],"study_design_scores_gemma":[0.0015871227,0.00015536399,0.14483073,0.000011632385,0.000312558,0.000017166685,0.0000344964,0.00012404937,0.0143831745,0.008045811,0.8303736,0.00012432614],"about_ca_topic_score_codex":0.0000052319024,"about_ca_topic_score_gemma":0.0000011729376,"teacher_disagreement_score":0.50524265,"about_ca_system_score_codex":0.00027035867,"about_ca_system_score_gemma":0.00006940029,"threshold_uncertainty_score":0.39179114},"labels":[],"label_agreement":null},{"id":"W4251737445","doi":"10.1111/j.1532-5415.2000.tb05017.x","title":"<i>Editors note:</i>","year":2000,"lang":"en","type":"article","venue":"Journal of the American Geriatrics Society","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Donepezil; Medicine; Concomitant; Disease; Gerontology; Psychiatry; Intensive care medicine; Dementia; Internal medicine","score_opus":0.03822560987872146,"score_gpt":0.3953953062565051,"score_spread":0.3571696963777836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251737445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98254836,0.0016543786,0.0001168183,0.004309073,0.008221567,0.00013322478,0.000035485227,0.000021881615,0.0029592214],"genre_scores_gemma":[0.95526844,0.01127869,0.0022687467,0.017052284,0.012455288,0.0000039795455,9.971376e-7,0.00004414629,0.0016274201],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806076,0.00040705994,0.000569984,0.00015140016,0.0004091286,0.0004016714],"domain_scores_gemma":[0.9981785,0.00027186234,0.0008676238,0.00023348248,0.00017122953,0.00027733695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011696122,0.00020031398,0.00041008592,0.000040080453,0.00030244453,0.00002878338,0.00082598283,0.00011717117,0.0008996484],"category_scores_gemma":[0.00006219062,0.0001366636,0.0008412371,0.0007665631,0.00042421825,0.00009733389,0.00008780667,0.0011837326,0.000060940514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041453427,0.00045778704,0.0061310814,0.000018101997,0.00043981092,0.000020820331,0.0020241248,0.005266692,0.05825758,0.000036798516,0.6316423,0.29529038],"study_design_scores_gemma":[0.0010450281,0.00008828955,0.0037086809,0.0000034439947,0.0003702077,0.00009136775,0.00011636652,0.00064260006,0.011423097,0.00030148472,0.9820249,0.00018454246],"about_ca_topic_score_codex":0.000014261433,"about_ca_topic_score_gemma":3.6248335e-7,"teacher_disagreement_score":0.3503826,"about_ca_system_score_codex":0.00009208496,"about_ca_system_score_gemma":0.00022877834,"threshold_uncertainty_score":0.98505193},"labels":[],"label_agreement":null},{"id":"W4252027198","doi":"10.1101/504811","title":"Higher-order epistatic networks underlie the evolutionary fitness landscape of a xenobiotic-degrading enzyme","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Knut och Alice Wallenbergs Stiftelse; Michael Smith Health Research BC; Wenner-Gren Stiftelserna","keywords":"Epistasis; Fitness landscape; Biology; Function (biology); In silico; Computational biology; Enzyme; Molecular evolution; Evolutionary biology; Genetics; Phylogenetics; Gene; Biochemistry; Population","score_opus":0.053576150157889725,"score_gpt":0.32761449007134114,"score_spread":0.2740383399134514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252027198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9218707,0.043225665,0.008550021,0.0023542906,0.019371731,0.0024960109,0.0012093239,0.0005772037,0.00034506328],"genre_scores_gemma":[0.9916178,0.0023902298,0.0018968158,0.0013283901,0.0023360145,0.00019979877,0.0000029253306,0.00017381171,0.00005420685],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528074,0.0010663111,0.0010579367,0.0010422448,0.00047516133,0.0010775799],"domain_scores_gemma":[0.99578106,0.0006627061,0.0009283036,0.0012458621,0.000908035,0.00047405795],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017020701,0.00085488654,0.0009690511,0.00029508083,0.00056487,0.000099310084,0.0014157488,0.0012116388,0.0011799773],"category_scores_gemma":[0.00017553399,0.00074127153,0.0003211761,0.00087519,0.000905736,0.00010666515,0.00091124116,0.0023387736,0.00010617857],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015756936,0.003839702,0.037918985,0.0036955725,0.008508728,0.00043675804,0.0003779811,0.07797531,0.77014303,0.021623196,0.07372764,0.00017740134],"study_design_scores_gemma":[0.0076396875,0.00033547924,0.16610257,0.0009528694,0.005472256,6.655752e-7,0.00003425592,0.25839952,0.27540433,0.0003523922,0.28059846,0.004707481],"about_ca_topic_score_codex":0.000029520163,"about_ca_topic_score_gemma":0.00000189172,"teacher_disagreement_score":0.4947387,"about_ca_system_score_codex":0.00017113837,"about_ca_system_score_gemma":0.00076354254,"threshold_uncertainty_score":0.99996287},"labels":[],"label_agreement":null},{"id":"W4253006784","doi":"10.3410/f.734142754.793552618","title":"Faculty Opinions recommendation of Crystal structure of a membrane-bound O-acyltransferase.","year":2018,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Acyltransferase; Membrane; Crystal (programming language); Chemistry; Crystal structure; Crystallography; Computer science; Biochemistry; Enzyme","score_opus":0.07969987770242147,"score_gpt":0.44598079799164914,"score_spread":0.36628092028922765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253006784","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049879996,0.002170873,0.000015932723,0.04572314,0.0032360868,0.001561884,0.9471236,0.000029037916,0.00008958921],"genre_scores_gemma":[0.00031274903,0.0013952228,0.0003165431,0.0058012824,0.0007292968,0.000085865766,0.9909661,0.00003899551,0.00035397868],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941186,0.0012338528,0.0021940619,0.0007130819,0.0012402842,0.00050015235],"domain_scores_gemma":[0.99027896,0.00028006945,0.0018421222,0.0011712451,0.0059614326,0.00046619182],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015481984,0.0006928341,0.0013825442,0.0004327001,0.0002980057,0.00005653923,0.0020469248,0.0013787113,0.003962279],"category_scores_gemma":[0.002566952,0.0004790787,0.0008146315,0.001808089,0.0010328129,0.00023309838,0.00043534618,0.0019098485,0.000021858723],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008490364,0.0005976432,0.0000075471166,0.009166818,0.0005238784,3.856683e-7,0.00022552257,8.2742525e-7,0.0011559991,0.00018057467,0.9868072,0.0012486748],"study_design_scores_gemma":[0.0016067565,0.00014865007,0.00035440546,0.002659488,0.00084983767,0.000040041967,0.000018650484,0.000017908798,0.004525381,0.00006108927,0.98930293,0.00041486573],"about_ca_topic_score_codex":0.000045355217,"about_ca_topic_score_gemma":0.000010106142,"teacher_disagreement_score":0.04384249,"about_ca_system_score_codex":0.000067878085,"about_ca_system_score_gemma":0.00077069155,"threshold_uncertainty_score":0.9999177},"labels":[],"label_agreement":null},{"id":"W4255081909","doi":"10.1515/iupac.84.0676","title":"Idiosyncratic Drug Reaction (IDR)","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Immunotoxicology; Medicine; Immunology; Immune system; Philosophy; Linguistics","score_opus":0.05997542139695544,"score_gpt":0.5168997462364984,"score_spread":0.45692432483954293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255081909","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025373541,0.005367413,0.000029833078,0.0018373239,0.00883268,0.0006834291,0.98006123,0.00015726621,0.00049345713],"genre_scores_gemma":[0.0005130144,0.017015796,0.00002637928,0.0030938245,0.0044823573,0.000072865245,0.9722007,0.00009616826,0.0024988963],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951993,0.00087627047,0.0009893621,0.0009028315,0.0010376876,0.0009945055],"domain_scores_gemma":[0.9967795,0.00041862045,0.00064197654,0.0008886988,0.00060072367,0.00067046983],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019933395,0.0008701813,0.001064745,0.00041477528,0.00039651874,0.000058215373,0.0008821244,0.0010606952,0.012538049],"category_scores_gemma":[0.00046590355,0.00070947706,0.00038365583,0.000317385,0.0003390174,0.0001571774,0.00030103506,0.0022520465,0.00007285679],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005072441,0.0005585417,0.0000111422705,0.00018766185,0.00048163295,0.00015950366,0.000040223542,0.00000733454,0.0041846,0.000021940086,0.97253513,0.021305032],"study_design_scores_gemma":[0.0028568385,0.000088484,0.000026887974,0.00012936244,0.0011066688,0.000052942032,0.000021858286,0.000040973096,0.002979567,0.0005216192,0.99132466,0.00085015735],"about_ca_topic_score_codex":0.000069537266,"about_ca_topic_score_gemma":0.00021895164,"teacher_disagreement_score":0.020454874,"about_ca_system_score_codex":0.00043286663,"about_ca_system_score_gemma":0.0010326236,"threshold_uncertainty_score":0.9995356},"labels":[],"label_agreement":null},{"id":"W4255200503","doi":"10.1002/9780470249031.ch18","title":"Cytochrome P450 Enzymes","year":2007,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Health Canada","keywords":"Enzyme; Cytochrome P450; Identification (biology); Computational biology; Biochemistry; Biology; Chemistry; Ecology","score_opus":0.13105824435205096,"score_gpt":0.47846744074590253,"score_spread":0.3474091963938516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255200503","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000900179,0.021955032,0.00031272208,0.00017498547,0.0027831413,0.0005509305,0.00023472926,0.0006734245,0.973225],"genre_scores_gemma":[0.0015733717,0.0046762135,0.0008507239,0.0067672236,0.0033255618,0.00004217383,0.00009298483,0.0007217572,0.98195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774057,0.00021150579,0.0004032258,0.0005610631,0.00028126314,0.00080237456],"domain_scores_gemma":[0.99866444,0.00014983775,0.00023353606,0.00039664164,0.000046403027,0.0005091275],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00060458557,0.00056205894,0.00059342285,0.00075035536,0.0000990379,0.000022016287,0.000563082,0.0014177801,0.21465556],"category_scores_gemma":[0.00002695813,0.0005103589,0.00022350028,0.00031067003,0.00023470129,0.000024287569,0.00016956557,0.001183838,0.0079931365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003988654,0.00017792039,0.000040676427,0.000063060135,0.00039052186,0.000109503766,0.000045132823,0.0000045200036,0.009324484,0.0077705667,0.9538954,0.028138332],"study_design_scores_gemma":[0.0011532808,0.000024848054,0.00006943984,0.000019205272,0.00029310727,0.000023696744,0.00001254592,0.00006843107,0.016966892,0.00018194664,0.98058754,0.0005990381],"about_ca_topic_score_codex":0.000062483196,"about_ca_topic_score_gemma":0.000038706323,"teacher_disagreement_score":0.20666243,"about_ca_system_score_codex":0.00003604859,"about_ca_system_score_gemma":0.00011040719,"threshold_uncertainty_score":0.9998786},"labels":[],"label_agreement":null},{"id":"W4255251190","doi":"10.1385/1-59259-998-2:85","title":"Enzymatic Analysis of cDNA-Expressed Human CYP1A1, CYP1A2, and CYP1B1 With 7-Ethoxyresorufin as Substrate","year":2006,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institutes of Health","keywords":"CYP1A2; Cytochrome P450; CYP1B1; Enzyme; Fluorescence; CYP2E1; Chemistry; Substrate (aquarium); Biochemistry; Complementary DNA; Biology; Gene","score_opus":0.15906762667822685,"score_gpt":0.4052943736806498,"score_spread":0.24622674700242295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255251190","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06440188,0.01834001,0.000047262558,0.000023297078,0.0002905594,0.0011967763,0.00083469914,0.00014698748,0.9147185],"genre_scores_gemma":[0.44511586,0.0028163616,0.00020691277,0.00069894193,0.00055096176,0.00018451107,0.00055273896,0.00030227823,0.54957145],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959312,0.00034043094,0.0012830242,0.0010783236,0.00061628124,0.0007507413],"domain_scores_gemma":[0.9968513,0.00035192037,0.001174788,0.0008889055,0.0002933977,0.000439683],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007214682,0.0010556369,0.0019059627,0.0008975136,0.00041525505,0.00008689654,0.0007366685,0.0010276561,0.0013911868],"category_scores_gemma":[0.000011625312,0.0009841042,0.00049519725,0.0000659887,0.0010379198,0.00006850515,0.00028888258,0.0014870635,0.000019357503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022878132,0.000999169,0.00040154514,0.0030357284,0.051967315,0.0013533587,0.00519898,0.008542401,0.08845595,0.76934355,0.021779643,0.046634533],"study_design_scores_gemma":[0.0048162104,0.0003449823,0.0008700711,0.00024592565,0.03577466,0.000024687017,0.000027811804,0.0015930278,0.060359627,0.011853141,0.88197327,0.0021165968],"about_ca_topic_score_codex":0.00045050133,"about_ca_topic_score_gemma":0.00031253073,"teacher_disagreement_score":0.8601936,"about_ca_system_score_codex":0.000046747995,"about_ca_system_score_gemma":0.00012181793,"threshold_uncertainty_score":0.9995217},"labels":[],"label_agreement":null},{"id":"W4255347352","doi":"10.1385/1-59259-998-2:115","title":"CYP2C19-Mediated ( S)-Mephenytoin 4'-Hydroxylation Assayed by High-Performance Liquid Chromatography With Radiometric Detection","year":2006,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Mephenytoin; Chromatography; Chemistry; Hydroxylation; High-performance liquid chromatography; CYP2C19; Methanol; Enzyme; Biochemistry; Cytochrome P450; Organic chemistry","score_opus":0.06016471578409149,"score_gpt":0.31768099410934564,"score_spread":0.25751627832525414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255347352","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13614357,0.03261145,0.0008199395,0.000027634265,0.0025934132,0.0024623869,0.0009288803,0.0008183114,0.82359445],"genre_scores_gemma":[0.83569574,0.00540087,0.00006450643,0.0005750761,0.0011809822,0.00025804594,0.001073707,0.00032604378,0.15542503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962472,0.00024077961,0.0009534051,0.0009853215,0.00071989244,0.00085340795],"domain_scores_gemma":[0.9976027,0.00024178564,0.0009172772,0.00058929116,0.00025595134,0.00039299252],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006149333,0.0010339557,0.00094993645,0.0011478678,0.0005703228,0.00007731022,0.000594026,0.0013530597,0.00055019115],"category_scores_gemma":[0.000011692936,0.0010078279,0.0002481483,0.00013320084,0.0005717394,0.00014128175,0.00014436498,0.0018723952,0.00010528624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011062515,0.0013912225,0.00010926622,0.002391602,0.010940807,0.0005332646,0.0013121516,0.0089541925,0.28978834,0.018923523,0.1291805,0.5254126],"study_design_scores_gemma":[0.0034254622,0.0005473349,0.00008616496,0.00007596943,0.0012341159,0.00002793881,0.0000020407922,0.0022117442,0.13045035,0.00025337594,0.8604812,0.001204292],"about_ca_topic_score_codex":0.00017111041,"about_ca_topic_score_gemma":0.000035562367,"teacher_disagreement_score":0.7313007,"about_ca_system_score_codex":0.0001449578,"about_ca_system_score_gemma":0.000094906216,"threshold_uncertainty_score":0.9999434},"labels":[],"label_agreement":null},{"id":"W4256649737","doi":"10.1385/0-89603-519-0:117","title":"Determination of the CYP2B6 Component of 7-Ethoxy-4-Trifluoromethylcoumarin O-Deethylation Activity in Human Liver Microsomes","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"CYP2B6; Microsome; Chemistry; Drug metabolism; Cytochrome P450; CYP2A6; Hepatocyte; Biochemistry; Molecular biology; Biology; Enzyme; Pharmacology; CYP1A2; In vitro","score_opus":0.17886193844391207,"score_gpt":0.42322992416729627,"score_spread":0.2443679857233842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256649737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97332954,0.0024433546,0.00016188524,0.000011028756,0.00045044548,0.00059832423,0.00003111106,0.000015891794,0.022958437],"genre_scores_gemma":[0.9984797,0.00025853762,0.00026657232,0.000075062926,0.000040199076,0.000041041705,0.000002815543,0.000019437965,0.0008166085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975483,0.0012479086,0.00047306487,0.0002488402,0.00021772934,0.00026415137],"domain_scores_gemma":[0.99888587,0.00024107631,0.0004055206,0.00029511267,0.00010724738,0.000065183245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009801796,0.00019118839,0.00034041505,0.00015681951,0.00014760972,0.000008682527,0.00032259693,0.00021881255,0.00009766869],"category_scores_gemma":[0.00004962938,0.00016744404,0.00013814488,0.00006609738,0.00029616,0.0000582852,0.00011796507,0.0004709311,0.0000010069718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006631306,0.00037498845,0.0022690925,0.00017096818,0.000055202003,0.0000041755134,0.0015385506,0.00028969423,0.9291462,0.0137627395,0.00003780317,0.052284278],"study_design_scores_gemma":[0.00152949,0.000031798096,0.03518075,0.000024160787,0.00011853319,0.0000023930254,0.000014475608,0.001379961,0.94622535,0.0012134055,0.014113637,0.0001660478],"about_ca_topic_score_codex":0.00018202169,"about_ca_topic_score_gemma":0.0000760206,"teacher_disagreement_score":0.05211823,"about_ca_system_score_codex":0.000041505344,"about_ca_system_score_gemma":0.000047906986,"threshold_uncertainty_score":0.682817},"labels":[],"label_agreement":null},{"id":"W4280512618","doi":"10.1002/cpt.2652","title":"Rifampin Drug–Drug–Interaction Studies: Reflections on the Nitrosamine Impurities Issue","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Drug; Pharmacology; Pharmacokinetics; Drug interaction; Cytochrome P450; Chemistry; Medicine; Biochemistry; Enzyme","score_opus":0.7281972667024696,"score_gpt":0.6661751620883808,"score_spread":0.06202210461408886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280512618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053886144,0.9310843,0.000004407261,0.010919728,0.04907388,0.002934055,0.00062260067,0.0003377561,0.0044844523],"genre_scores_gemma":[0.000088104134,0.86890906,0.000041713338,0.112913586,0.008654699,0.0019782917,0.00021109876,0.0002681119,0.0069353613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97850657,0.01435985,0.0032961904,0.0016832092,0.00063308503,0.0015210981],"domain_scores_gemma":[0.9724024,0.023816593,0.0018722471,0.0010397595,0.00030786087,0.00056115317],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0058687907,0.0016478769,0.0037769855,0.00057273277,0.0022215326,0.00008393489,0.0023440889,0.0011056846,0.016552078],"category_scores_gemma":[0.0002339328,0.0012100318,0.0023791844,0.001195095,0.0019594207,0.00013268412,0.0009937868,0.011865267,0.00187249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056079926,0.0029556563,0.0000061253013,0.0014734125,0.013829568,0.00013879512,0.0011308353,0.0001431977,0.000065334105,0.00023912854,0.45848307,0.5209741],"study_design_scores_gemma":[0.0018133597,0.00039761548,0.0000012468576,0.00029639062,0.018696714,0.00010068924,0.0009834938,0.00014871596,0.00019268543,0.00035939823,0.97592664,0.0010830649],"about_ca_topic_score_codex":0.000009757078,"about_ca_topic_score_gemma":0.000011797997,"teacher_disagreement_score":0.519891,"about_ca_system_score_codex":0.00059265585,"about_ca_system_score_gemma":0.00083065033,"threshold_uncertainty_score":0.9996268},"labels":[],"label_agreement":null},{"id":"W4281658853","doi":"10.1038/s41398-022-01963-5","title":"Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial","year":2022,"lang":"en","type":"erratum","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Parkwood Institute; University of Ottawa; Thornhill Medical (Canada); University of Calgary; Impact; Ted Rogers Centre for Heart Research; Western University; University of Toronto; Montfort Hospital; University Health Network; Centre for Addiction and Mental Health; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Randomized controlled trial; Depression (economics); Medicine; Physical therapy; Clinical trial; Double blinded; Pharmacogenomics; Medical physics; Psychology; Psychiatry; Alternative medicine; Internal medicine; Placebo; Pharmacology; Pathology","score_opus":0.10094303150490212,"score_gpt":0.42382641784656444,"score_spread":0.3228833863416623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281658853","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18622206,0.03815301,0.000017851764,0.0011116894,0.67347085,0.01065963,0.0012998265,0.00007384713,0.088991195],"genre_scores_gemma":[0.98040867,0.002868738,0.00035198865,0.0017029524,0.009481991,0.0013213133,0.00080695376,0.00012604323,0.002931355],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9904898,0.0044503403,0.0029796436,0.0008684027,0.0005835321,0.0006282913],"domain_scores_gemma":[0.9945677,0.0031795828,0.0011464037,0.00027635298,0.00023196956,0.00059802283],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005224343,0.000626512,0.0027683997,0.00063730637,0.00042463452,0.000030738138,0.0004193247,0.0012062198,0.005596615],"category_scores_gemma":[0.0004940239,0.00060843606,0.000820313,0.00046793272,0.00047560595,0.00009094248,0.00007757068,0.0043755644,0.000009722592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.811288,0.0011566674,0.011504344,0.000103752165,0.0009878547,0.000020651545,0.0002628742,0.00024272762,0.000015680484,0.00022177542,0.1614776,0.012718056],"study_design_scores_gemma":[0.77620673,0.0001475906,0.00110973,0.00005313129,0.001279499,0.000018677456,0.000034543573,0.016788542,0.000009259205,0.0023798544,0.20150284,0.00046957924],"about_ca_topic_score_codex":0.002515392,"about_ca_topic_score_gemma":0.0022722962,"teacher_disagreement_score":0.7941866,"about_ca_system_score_codex":0.00005948317,"about_ca_system_score_gemma":0.0044423556,"threshold_uncertainty_score":0.9996367},"labels":[],"label_agreement":null},{"id":"W4283032637","doi":"10.3390/jpm12060974","title":"Pharmacogenomics and Drug-Induced Phenoconversion Informed Medication Safety Review in the Management of Pain Control and Quality of Life: A Case Report","year":2022,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Pharmacogenomics; Medicine; Quality of life (healthcare); Pain management; Pain control; Drug; Intensive care medicine; Pharmacogenetics; Analgesic; Pharmacology; Anesthesia; Nursing","score_opus":0.11730885117153748,"score_gpt":0.44965675710503505,"score_spread":0.33234790593349756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283032637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8952114,0.08948458,0.00010804938,0.013404335,0.00052350067,0.0007903413,0.00004356375,0.0000030483786,0.00043116213],"genre_scores_gemma":[0.91740954,0.07410717,0.00012775385,0.0081485305,0.00012609977,0.000021439504,0.0000099450335,0.000007959746,0.000041593998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955872,0.002069765,0.0015072613,0.00014021374,0.0005272194,0.0001682886],"domain_scores_gemma":[0.9968936,0.0010132017,0.0016076365,0.00012870766,0.00016381699,0.0001930658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02022732,0.00014637194,0.0007013966,0.00016080124,0.00012621065,0.0000018194511,0.0002075077,0.00004613438,0.0004881318],"category_scores_gemma":[0.00037508746,0.00010203244,0.00009214536,0.00025198894,0.00025214767,0.000054902524,0.000074983254,0.0005891402,1.3455454e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027696835,0.0032986777,0.027896097,0.031993575,0.008041923,0.026214875,0.081450835,0.00027450456,0.27096406,0.004632629,0.04256707,0.4749689],"study_design_scores_gemma":[0.10477692,0.0012227885,0.011005052,0.0018923652,0.008075974,0.022715194,0.04377763,0.0029500923,0.001772749,0.0005201467,0.80061823,0.00067287317],"about_ca_topic_score_codex":0.00005801651,"about_ca_topic_score_gemma":0.000004400221,"teacher_disagreement_score":0.75805116,"about_ca_system_score_codex":0.00005896321,"about_ca_system_score_gemma":0.00017480624,"threshold_uncertainty_score":0.7010426},"labels":[],"label_agreement":null},{"id":"W4283077391","doi":"10.21203/rs.3.rs-1759048/v1","title":"P450cam (CYP101A1) Mutants for Endosulfan Degradation: Complete Dehalogenation of Endosulfan Diol and Related Compounds","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; Simon Fraser University","keywords":"Chemistry; Diol; Stereochemistry; Endosulfan; Bicyclic molecule; Halogenation; Dihydroxylation; Organic chemistry; Ether; Medicinal chemistry; Catalysis; Pesticide; Enantioselective synthesis","score_opus":0.31663271161903334,"score_gpt":0.5330893440146617,"score_spread":0.21645663239562835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283077391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479685,0.017027598,0.00036595276,0.002238883,0.0034857425,0.006617685,0.010540609,0.00017138229,0.011583653],"genre_scores_gemma":[0.9888113,0.0048450716,0.00060677144,0.00012966005,0.00036015868,0.0011906382,0.002609161,0.00009857262,0.0013486807],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930742,0.0028163285,0.0010505475,0.0010125454,0.0010306326,0.001015771],"domain_scores_gemma":[0.99519867,0.0022219722,0.00049325445,0.0006245782,0.0009827712,0.00047876002],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004960917,0.0004876024,0.0008577276,0.00080227526,0.0009994874,0.00007859367,0.0009127178,0.0007059777,0.0018254817],"category_scores_gemma":[0.0005329488,0.0005191993,0.0003180699,0.00061618007,0.0006571922,0.00009188448,0.0017738439,0.0033271324,0.000018633918],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00604204,0.0038726614,0.041109916,0.00960318,0.0050363913,0.000354438,0.011879373,0.015027301,0.70693,0.035686363,0.017054336,0.14740403],"study_design_scores_gemma":[0.014048014,0.0012410928,0.027560143,0.00030711043,0.0010226575,0.00013734605,0.0014595495,0.07011749,0.08875592,0.03975907,0.75384176,0.0017498261],"about_ca_topic_score_codex":0.00009455575,"about_ca_topic_score_gemma":0.000022310187,"teacher_disagreement_score":0.73678744,"about_ca_system_score_codex":0.0003066557,"about_ca_system_score_gemma":0.0007536139,"threshold_uncertainty_score":0.99972594},"labels":[],"label_agreement":null},{"id":"W4283329104","doi":"10.1002/pcn5.26","title":"Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic","year":2022,"lang":"en","type":"review","venue":"Psychiatry and Clinical Neurosciences Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"Reimbursement; Standardization; Test (biology); Health care; Workflow; Personalized medicine; Medicine; Psychology; Psychiatry; Computer science; Political science; Bioinformatics","score_opus":0.5203715903427888,"score_gpt":0.5533871100410023,"score_spread":0.03301551969821348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283329104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026243992,0.96177113,0.000001933444,0.00020122848,0.007828097,0.0011669173,0.0000497325,0.00002429004,0.002712691],"genre_scores_gemma":[0.004738545,0.99300593,0.0003927541,0.0009881415,0.00059303467,0.00014816644,0.000012320999,0.000035864858,0.000085245716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912172,0.0031518487,0.0032092475,0.0012845902,0.00044937988,0.00068774447],"domain_scores_gemma":[0.9933897,0.0037523636,0.002134471,0.00043947852,0.000023686562,0.0002602488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01007167,0.00051747984,0.0015160113,0.00029206034,0.000643828,0.000066911045,0.0007147711,0.00032595926,0.00025079344],"category_scores_gemma":[0.00066502515,0.00036561216,0.00046677166,0.0013496449,0.0008978462,0.000084198924,0.00056324457,0.0022238202,0.0000020223417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018340694,0.00096214405,0.06862764,0.0025420163,0.00008306356,0.000105224695,0.000062771906,0.000004036895,0.000004126677,0.00006863504,0.00034852506,0.9271735],"study_design_scores_gemma":[0.00047044124,0.0003113264,0.002183932,0.00015505667,0.0018141074,0.0008095719,0.00020514619,0.00022648567,7.098597e-7,0.00071061077,0.992699,0.0004135889],"about_ca_topic_score_codex":0.000008510513,"about_ca_topic_score_gemma":0.000007335858,"teacher_disagreement_score":0.9923505,"about_ca_system_score_codex":0.000009331002,"about_ca_system_score_gemma":0.0005094662,"threshold_uncertainty_score":0.9998796},"labels":[],"label_agreement":null},{"id":"W4285126481","doi":"10.1016/bs.apha.2022.04.003","title":"Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain","year":2022,"lang":"en","type":"article","venue":"Advances in pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Xenobiotic; Drug metabolism; Cytochrome P450; Metabolite; Biology; Pharmacology; Endogeny; Unspecific monooxygenase; Metabolism; Biochemistry; Drug; Enzyme; Monooxygenase","score_opus":0.03397170083542602,"score_gpt":0.40017160548739145,"score_spread":0.36619990465196545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285126481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92665416,0.0634047,0.000015467456,0.0046305996,0.002329078,0.0009761208,0.00019365494,0.000041412633,0.0017547924],"genre_scores_gemma":[0.98008776,0.0068374504,0.0001584638,0.011774959,0.00025547555,0.0005053558,0.000009961618,0.000039399965,0.0003311991],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606025,0.001886184,0.000666609,0.0005575974,0.00025624954,0.00057309563],"domain_scores_gemma":[0.99798,0.0011812641,0.00036684686,0.0002051963,0.000051310442,0.00021541353],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018352503,0.00033421323,0.00054648507,0.00027836236,0.0005019092,0.000013048276,0.0005684053,0.00012260127,0.0011073044],"category_scores_gemma":[0.00006740647,0.00028987424,0.00007678762,0.00051752303,0.00093321817,0.00022250251,0.00074172654,0.0013685619,0.000004666247],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015152583,0.0007567384,0.0045670522,0.00018910873,0.00029769857,0.00019754868,0.010640945,0.010331468,0.8739577,0.034075055,0.004394772,0.05907665],"study_design_scores_gemma":[0.005603561,0.00018260523,0.0067441054,0.0000039162837,0.00029814555,0.00019350658,0.00090106623,0.0035331196,0.11667944,0.0053476007,0.86009556,0.00041735134],"about_ca_topic_score_codex":0.00003199671,"about_ca_topic_score_gemma":0.000022021573,"teacher_disagreement_score":0.8557008,"about_ca_system_score_codex":0.00003493389,"about_ca_system_score_gemma":0.00010112978,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W4285392129","doi":"10.1186/s12896-022-00750-w","title":"Oleic acid based experimental evolution of Bacillus megaterium yielding an enhanced P450 BM3 variant","year":2022,"lang":"en","type":"article","venue":"BMC Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bacillus megaterium; Monooxygenase; Biology; Cofactor; Directed evolution; Biochemistry; Cytochrome P450; Enzyme; Stereochemistry; Mutant; Chemistry; Bacteria; Gene; Genetics","score_opus":0.07481905090783386,"score_gpt":0.3818607414346483,"score_spread":0.30704169052681446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285392129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685664,0.0034512028,0.023372957,0.0004900305,0.0023154996,0.00051371823,0.00021164773,0.00028363577,0.00079486356],"genre_scores_gemma":[0.994652,0.00005462016,0.0041431473,0.00061724475,0.00013103275,0.00022885512,0.000045664783,0.000038688526,0.000088783134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973958,0.000682271,0.00051618344,0.000571676,0.00023581035,0.0005982668],"domain_scores_gemma":[0.99893934,0.000087282984,0.00028085854,0.0004698193,0.00005862883,0.00016408502],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007495908,0.00029051738,0.0004156795,0.00043340173,0.0004427931,0.000009195197,0.000716692,0.00054821896,0.0033141437],"category_scores_gemma":[0.000050121256,0.00032040878,0.00013990521,0.0005249963,0.00035313616,0.00008216988,0.00045137596,0.0009484326,0.000031960448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005253611,0.0007443717,0.00019252795,0.00002654059,0.00006103783,0.000024659557,0.00023964209,0.0030280997,0.9857563,0.0055735046,0.0001433342,0.0036846371],"study_design_scores_gemma":[0.002324997,0.0005110623,0.00023139748,0.0000033646772,0.000094521114,0.000050887662,0.0006825142,0.017832384,0.94736403,0.00040185076,0.030180711,0.00032229908],"about_ca_topic_score_codex":0.000042269006,"about_ca_topic_score_gemma":0.000011009024,"teacher_disagreement_score":0.03839227,"about_ca_system_score_codex":0.00021971596,"about_ca_system_score_gemma":0.00023946041,"threshold_uncertainty_score":0.9999248},"labels":[],"label_agreement":null},{"id":"W4285684482","doi":"10.2147/pgpm.s348851","title":"The Efficacy of a Didactic and Case-Based Pharmacogenomics Education Program on Improving the Knowledge and Confidence of Alberta Pharmacists","year":2022,"lang":"en","type":"article","venue":"Pharmacogenomics and Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health; University of Alberta","funders":"","keywords":"Pharmacogenomics; Likert scale; Medicine; Pharmacy; Medical education; Scale (ratio); Family medicine; Pharmacology; Psychology","score_opus":0.08072898205224215,"score_gpt":0.43765684782878245,"score_spread":0.3569278657765403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285684482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9329267,0.059956014,0.000016505674,0.0026723954,0.0013281254,0.0020112626,0.00013711608,0.000022310516,0.00092958077],"genre_scores_gemma":[0.983382,0.012889286,0.00007625932,0.0024281726,0.00037479674,0.00044884818,0.000026675732,0.000047801692,0.00032614433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713695,0.0008730436,0.00073096785,0.0005181761,0.0002778805,0.00046300289],"domain_scores_gemma":[0.99501824,0.0035765306,0.000592043,0.0002550832,0.00017817605,0.0003799526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023704409,0.00039685756,0.0005331884,0.0001752361,0.0012590049,0.000027281108,0.00038414076,0.00007924081,0.00034375506],"category_scores_gemma":[0.00016548189,0.00027526793,0.00010477468,0.00031922234,0.0015780508,0.00005245514,0.00028909626,0.0008870778,0.0000013004321],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00408289,0.0013738145,0.0008585209,0.0004438395,0.00061670697,0.000056294088,0.010099958,0.00018725109,0.34742066,0.0035911095,0.0015395776,0.6297294],"study_design_scores_gemma":[0.022011315,0.0010594166,0.00057687925,0.000059106962,0.0030847485,0.002165228,0.0024831067,0.06785382,0.056540422,0.00047604923,0.84298474,0.00070513913],"about_ca_topic_score_codex":0.00023417897,"about_ca_topic_score_gemma":0.000011533721,"teacher_disagreement_score":0.8414452,"about_ca_system_score_codex":0.00006119118,"about_ca_system_score_gemma":0.00040717065,"threshold_uncertainty_score":0.99996996},"labels":[],"label_agreement":null},{"id":"W4287460293","doi":"","title":"Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.","year":2021,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Selection (genetic algorithm); Depression (economics); Clinical decision support system; Medicine; Decision support system; Psychology; Computer science; Pharmacology; Data mining; Artificial intelligence","score_opus":0.2483906405352999,"score_gpt":0.4837030444758714,"score_spread":0.2353124039405715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287460293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7787369,0.008857616,0.16966608,0.019463861,0.009026164,0.009762126,0.00092111004,0.0009426258,0.002623496],"genre_scores_gemma":[0.8313581,0.0007638491,0.14591262,0.011503765,0.0007297742,0.008431198,0.0001809026,0.00008227777,0.0010375502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644786,0.00036877257,0.00086397375,0.00087169517,0.00033265149,0.0011150548],"domain_scores_gemma":[0.9971312,0.0008752458,0.00041344756,0.0003257322,0.00047355634,0.00078076246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002710558,0.00035632958,0.00053623813,0.00042454226,0.0007471312,0.00007569413,0.00047438144,0.00036196926,0.0003175532],"category_scores_gemma":[0.0011418788,0.00036664354,0.0001400947,0.0009276888,0.00008440611,0.00018108747,0.00039048272,0.00063038775,0.000040379757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011124153,0.0003873132,0.017939258,0.000049748836,0.00019681192,0.00001480435,0.0000973925,0.00037972216,0.20769143,0.00003816962,0.0107111065,0.762383],"study_design_scores_gemma":[0.004426969,0.000048966205,0.06280086,0.000015147339,0.0002388085,0.00014979701,0.000099183155,0.0049005393,0.43438768,0.00029971145,0.49222702,0.00040530178],"about_ca_topic_score_codex":0.000017532348,"about_ca_topic_score_gemma":0.00003669526,"teacher_disagreement_score":0.7619777,"about_ca_system_score_codex":0.0003805039,"about_ca_system_score_gemma":0.0008480694,"threshold_uncertainty_score":0.9998785},"labels":[],"label_agreement":null},{"id":"W4289918702","doi":"10.1007/s40261-022-01182-2","title":"Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective","year":2022,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Regione Autonoma della Sardegna; Università degli Studi di Cagliari","keywords":"Major depressive disorder; Cost-effectiveness analysis; CYP2C19; Medicine; Psychiatry; Quality-adjusted life year; Cost effectiveness; Cost–utility analysis; Clinical psychology; Risk analysis (engineering); Internal medicine","score_opus":0.3473253564150627,"score_gpt":0.532487651890823,"score_spread":0.18516229547576035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289918702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947245,0.00028202432,0.0005003179,0.0006617019,0.00074439927,0.0016120067,0.00129183,0.000033756056,0.0001494576],"genre_scores_gemma":[0.99751985,0.000037831458,0.00021781265,0.0014747977,0.0001025036,0.00035692216,0.00024683052,0.000031458196,0.000011971598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9888098,0.008286045,0.0011809329,0.0007832158,0.0005378176,0.00040217448],"domain_scores_gemma":[0.9886764,0.009341309,0.0009255625,0.0004242176,0.00032992018,0.0003025674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034985489,0.00035010866,0.00089313753,0.000299146,0.0004962265,0.000027557215,0.00063175184,0.00018954194,0.00067779],"category_scores_gemma":[0.0013471183,0.00028029052,0.00041687244,0.0015424713,0.0010017932,0.00014402076,0.00025093614,0.0014035043,0.0000019143713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007440804,0.0018943253,0.7937901,0.000041526953,0.0010872637,0.000013659239,0.002825738,0.15604657,0.024022553,0.000081556034,0.000046254794,0.019406373],"study_design_scores_gemma":[0.003528949,0.0001533101,0.54006666,0.000022426397,0.0020502945,3.7102714e-7,0.0016050689,0.42356598,0.027690433,0.0009803766,0.0001246388,0.00021150024],"about_ca_topic_score_codex":0.00034514815,"about_ca_topic_score_gemma":0.00014755393,"teacher_disagreement_score":0.2675194,"about_ca_system_score_codex":0.00022412608,"about_ca_system_score_gemma":0.0004557056,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W4292220071","doi":"10.1101/2022.08.17.503990","title":"Single molecule long-read real-time amplicon-based sequencing of <i>CYP2D6</i> : a proof-of-concept with hybrid haplotypes","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; University of Calgary; Women and Children’s Health Research Institute; University of Alberta","funders":"Faculty of Medicine and Dentistry, University of Alberta; Medical Research Council; Directorate for Biological Sciences; Alberta Innovates; European Commission; National Institute for Health and Care Research; U.S. Food and Drug Administration; University of Alberta; Department of Health and Social Care; GlaxoSmithKline","keywords":"Haplotype; Pseudogene; Genetics; Biology; Amplicon; Gene; Computational biology; Hypervariable region; Locus (genetics); Genome; Allele; Polymerase chain reaction","score_opus":0.04844588572887674,"score_gpt":0.31127933355861304,"score_spread":0.2628334478297363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292220071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895107,0.0035440007,0.0013869012,0.00013453478,0.0011646448,0.0016961338,0.0020550394,0.00028525994,0.0002227586],"genre_scores_gemma":[0.99492484,0.0001562928,0.0034035644,0.00053496,0.00029682316,0.0004019347,0.000006941325,0.0002470723,0.000027594833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99523044,0.00083789806,0.0011288135,0.0012369185,0.00065370713,0.00091220083],"domain_scores_gemma":[0.9956641,0.00034313955,0.0014672644,0.0012565687,0.00078061316,0.0004883132],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011430422,0.00088805414,0.0013448433,0.00044621102,0.0002520261,0.000051713265,0.0011293157,0.000526463,0.0013574304],"category_scores_gemma":[0.00013406565,0.0009319225,0.0003377022,0.0006840173,0.00062790787,0.000100472156,0.0006648311,0.0017014943,0.000014858129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000487739,0.0008998082,0.002499918,0.00070750574,0.0007122676,0.00021618635,0.00006069242,0.014844171,0.97917044,0.00012528303,0.00024047706,0.000035488705],"study_design_scores_gemma":[0.0019157758,0.00032250673,0.0010030589,0.00021261189,0.0009255092,1.5560352e-7,0.0000056759955,0.0033721211,0.9851424,0.000004724124,0.0061497292,0.0009457268],"about_ca_topic_score_codex":0.0001408181,"about_ca_topic_score_gemma":0.0000026469909,"teacher_disagreement_score":0.011472049,"about_ca_system_score_codex":0.00035819842,"about_ca_system_score_gemma":0.0022179037,"threshold_uncertainty_score":0.99955547},"labels":[],"label_agreement":null},{"id":"W4293758551","doi":"10.3390/jpm12091394","title":"A Systematic Review of Polygenic Models for Predicting Drug Outcomes","year":2022,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Health Canada; Genome British Columbia; Provincial Health Services Authority; BC Children’s Hospital Foundation; BC Children's Hospital; Children's Hospital Foundation; Canadian Institutes of Health Research; Genome Canada","keywords":"Pharmacogenomics; Context (archaeology); Pharmacogenetics; Precision medicine; Personalized medicine; Polygenic risk score; Predictive modelling; Medicine; Computational biology; Bioinformatics; Computer science; Machine learning; Biology; Genetics; Genotype","score_opus":0.25476346085135876,"score_gpt":0.5184883146027138,"score_spread":0.26372485375135507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293758551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000065878953,0.9920467,0.00016165189,0.0006047218,0.0032734459,0.0030170889,0.0003333063,0.000015290561,0.00054120057],"genre_scores_gemma":[0.000006676859,0.9942478,0.00024210534,0.0026544177,0.0009509783,0.00032511214,0.000058528207,0.000092407696,0.0014219792],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918243,0.002089789,0.0043307864,0.00030973853,0.0009786622,0.0004666913],"domain_scores_gemma":[0.9873258,0.0049929554,0.006448776,0.0003328042,0.0004646898,0.00043496577],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009521403,0.0006396694,0.008195264,0.00057445274,0.00016922952,0.0000056210574,0.0010461329,0.0002681194,0.002794173],"category_scores_gemma":[0.0029154867,0.00040504086,0.0024733397,0.00047342916,0.0002307097,0.0000923846,0.00012994255,0.0017023783,0.0000032340981],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083451865,0.00018235316,0.0000020905843,0.9534043,0.00439968,0.00004544711,0.0007658156,0.000008559881,0.000008516053,0.00025350085,0.008478959,0.032367337],"study_design_scores_gemma":[0.0021347096,0.00014175432,6.5440545e-8,0.30915546,0.037702672,0.0003864627,0.00013658944,0.00014492392,0.000001744659,0.00013362496,0.6498504,0.00021154106],"about_ca_topic_score_codex":0.0000065221057,"about_ca_topic_score_gemma":4.662642e-7,"teacher_disagreement_score":0.64424884,"about_ca_system_score_codex":0.00019455329,"about_ca_system_score_gemma":0.00090753695,"threshold_uncertainty_score":0.99984014},"labels":[],"label_agreement":null},{"id":"W4294200769","doi":"10.1192/j.eurpsy.2022.591","title":"Clinical impact of functional CYP2C19 and CYP2D6 gene variants on treatment outcomes in patients with depression: a Danish cohort study","year":2022,"lang":"en","type":"article","venue":"European Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2C19; CYP2D6; Discontinuation; Medicine; Hazard ratio; Citalopram; Fluoxetine; Cohort; Depression (economics); Internal medicine; Rate ratio; Sertraline; Poisson regression; Psychiatry; Confounding; Confidence interval; Population; Antidepressant; Anxiety","score_opus":0.06780791996725499,"score_gpt":0.42380031599942997,"score_spread":0.355992396032175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294200769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939647,0.00035051198,0.0000039207494,0.000057146135,0.0020139806,0.00089642627,0.00026935924,0.000023326806,0.0024206773],"genre_scores_gemma":[0.9987881,0.000040039366,0.00007778443,0.00057941163,0.00017714214,0.00004523268,0.00005022685,0.000040418567,0.00020161521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663967,0.0017746442,0.00053861266,0.0004937236,0.00028713775,0.00026620665],"domain_scores_gemma":[0.999102,0.00013815585,0.00022981418,0.00028641234,0.00004438445,0.00019924878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009928313,0.00026646705,0.00043331654,0.00013273496,0.00023389926,0.00000996239,0.00018988716,0.00004314842,0.000723026],"category_scores_gemma":[0.000016519994,0.0001893317,0.00013361522,0.00016932128,0.00007362715,0.00003765662,0.00017595438,0.0005251687,0.000016569178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023915481,0.0106507735,0.9792883,0.0000032751436,0.0008279149,0.000033699165,0.00042090306,0.0018993486,0.00004835469,0.000017460454,0.00070105045,0.0037173799],"study_design_scores_gemma":[0.013212537,0.0031460626,0.98196536,0.0000045369948,0.00027176194,0.000004881252,0.00010854745,0.00009831758,0.000008793811,0.000019601293,0.00096701324,0.00019260998],"about_ca_topic_score_codex":0.000023131308,"about_ca_topic_score_gemma":0.000009218555,"teacher_disagreement_score":0.010820989,"about_ca_system_score_codex":0.000060877406,"about_ca_system_score_gemma":0.00014342062,"threshold_uncertainty_score":0.79166275},"labels":[],"label_agreement":null},{"id":"W4294771089","doi":"10.1016/j.bcp.2022.115243","title":"Sulfation of 12-hydroxy-nevirapine by human SULTs and the effects of genetic polymorphisms of SULT1A1 and SULT2A1","year":2022,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Japan Society for the Promotion of Science","keywords":"Sulfation; Sulfotransferase; In vivo; Cytosol; Nevirapine; Enzyme; Mechanism of action; Biology; Rash; Microsome; Pharmacology; Molecular biology; Chemistry; In vitro; Biochemistry; Immunology; Medicine; Human immunodeficiency virus (HIV); Internal medicine; Genetics; Viral load","score_opus":0.024902999844730538,"score_gpt":0.3504658220957387,"score_spread":0.32556282225100813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294771089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604141,0.036903724,0.000017188673,0.00062897225,0.00074068585,0.00081202463,0.0002801433,0.000016734863,0.00018644358],"genre_scores_gemma":[0.9952638,0.0032397783,0.00006471313,0.00094779546,0.00012444088,0.00013270958,0.00005597262,0.00002728126,0.00014348234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971153,0.0010482996,0.00081269996,0.00039447524,0.00025688592,0.0003723096],"domain_scores_gemma":[0.99784935,0.0011016786,0.00057350355,0.00018400798,0.00010393864,0.00018754615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008390761,0.000271538,0.00067550276,0.00014461351,0.00021572523,0.0000035540922,0.0003955241,0.00019893768,0.00047191922],"category_scores_gemma":[0.00010934515,0.00023268616,0.00012420358,0.00026573444,0.0016727909,0.00003307341,0.0004793677,0.00058125047,7.6468e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014274063,0.00053879677,0.0011627917,0.000273164,0.00033935157,0.000006154787,0.0006049166,0.00004604094,0.97187364,0.00054235,0.02148496,0.0017004189],"study_design_scores_gemma":[0.013269686,0.00037366242,0.0018041418,0.000007855661,0.0007631128,0.000026699974,0.000043232358,0.0010073052,0.9696585,0.0005591888,0.012275502,0.00021110826],"about_ca_topic_score_codex":0.00008092837,"about_ca_topic_score_gemma":4.4174547e-7,"teacher_disagreement_score":0.034849744,"about_ca_system_score_codex":0.000024404315,"about_ca_system_score_gemma":0.00005449223,"threshold_uncertainty_score":0.9488666},"labels":[],"label_agreement":null},{"id":"W4294808364","doi":"10.1038/s41397-022-00288-2","title":"The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data","year":2022,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; Karolinska Institutet; European Federation of Pharmaceutical Industries and Associations; Robert Bosch Stiftung; McGill University","keywords":"Biology; Genetics; Computational biology; Exome sequencing; Population; Genotyping; Exome; Gene; Genome; 1000 Genomes Project; Phenotype; Genotype; Single-nucleotide polymorphism; Medicine","score_opus":0.11006691880483373,"score_gpt":0.4088712943942562,"score_spread":0.29880437558942247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294808364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975424,0.019807981,0.00034127117,0.00060841424,0.0013720728,0.00044274796,0.0017546118,0.000027204313,0.00022169473],"genre_scores_gemma":[0.9923771,0.0050204117,0.00052877207,0.0007476073,0.0006067696,0.000027294001,0.0004899302,0.000062652485,0.00013947206],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9941562,0.0025447835,0.0014641957,0.0004634397,0.00067279866,0.00069859147],"domain_scores_gemma":[0.9964709,0.0004784249,0.0013783787,0.0010450089,0.0002702646,0.0003570197],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060869846,0.0003575545,0.0007404151,0.0005130024,0.0022796683,0.0000765767,0.003447607,0.000079653524,0.0025128035],"category_scores_gemma":[0.000028523913,0.00025942334,0.00039275485,0.0015095028,0.0002646703,0.00021664522,0.0012120757,0.0014936719,0.000006329696],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059784413,0.00025198053,0.007921628,0.000011991533,0.0060719517,0.00002885163,0.001847065,0.2551789,0.7036199,0.0001881855,0.0014312573,0.022850445],"study_design_scores_gemma":[0.0043497863,0.00009080469,0.020809572,0.000004427501,0.025491567,0.0005509159,0.0024909128,0.7051862,0.06566608,0.0010135269,0.17359443,0.0007517617],"about_ca_topic_score_codex":0.00016064147,"about_ca_topic_score_gemma":0.00006708518,"teacher_disagreement_score":0.6379538,"about_ca_system_score_codex":0.00014407023,"about_ca_system_score_gemma":0.000333375,"threshold_uncertainty_score":0.9999858},"labels":[],"label_agreement":null},{"id":"W4296028961","doi":"10.1002/cpt.2749","title":"Characterization of <scp><i>CYP2D6</i></scp> Pharmacogenetic Variation in <scp>Sub‐Saharan</scp> African Populations","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; University of the Witwatersrand, Johannesburg; South African Medical Research Council; National Research Foundation; Wellcome Trust; National Human Genome Research Institute; GlaxoSmithKline","keywords":"Genotyping; CYP2D6; Genetics; Allele; Biology; Context (archaeology); Pharmacogenetics; Haplotype; Population; Genotype; Gene; Computational biology; Medicine","score_opus":0.18229329636119448,"score_gpt":0.45458766997590283,"score_spread":0.2722943736147083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296028961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768093,0.004421444,0.0005475376,0.0017724532,0.012377358,0.0018792766,0.00083885744,0.00019539698,0.0011583727],"genre_scores_gemma":[0.94750357,0.0095827365,0.0002749979,0.039593257,0.0013639624,0.0006260035,0.0003342124,0.00015754254,0.0005637433],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98876804,0.005208524,0.0027655598,0.0011774803,0.0006980461,0.0013823782],"domain_scores_gemma":[0.9932101,0.0037310857,0.0015423638,0.00052699,0.00038105212,0.000608438],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00379601,0.0007456331,0.0012744983,0.0007504828,0.00072407903,0.000035539484,0.0013278142,0.0005933635,0.00072461047],"category_scores_gemma":[0.00021521517,0.0008608964,0.00056930626,0.0017683844,0.000681933,0.00023381616,0.0006499974,0.003247939,0.00012425437],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021838227,0.0037297718,0.018335968,0.000055980654,0.0011410611,0.00006671146,0.0023622625,0.0049245046,0.9533674,0.00013475923,0.007858819,0.0078043635],"study_design_scores_gemma":[0.00989002,0.0005201269,0.10262276,0.000012226624,0.003041703,0.000045442393,0.00034945537,0.023765966,0.22263202,0.0009592283,0.635863,0.00029802977],"about_ca_topic_score_codex":0.000015428126,"about_ca_topic_score_gemma":0.000009677976,"teacher_disagreement_score":0.7307354,"about_ca_system_score_codex":0.00022949674,"about_ca_system_score_gemma":0.00053164223,"threshold_uncertainty_score":0.99938416},"labels":[],"label_agreement":null},{"id":"W4296034623","doi":"10.1002/cpt.2748","title":"Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and <scp>Meta‐Analysis</scp> of Prospective, Controlled Clinical Trials","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"Meta-analysis; Pharmacogenomics; Clinical trial; Medicine; MEDLINE; Internal medicine; Pharmacology","score_opus":0.6450440072230488,"score_gpt":0.6158629572286234,"score_spread":0.02918104999442539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296034623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003358613,0.97849065,0.00002998971,0.0003033906,0.0032368845,0.016034843,0.0009388724,0.00016164858,0.0004678438],"genre_scores_gemma":[0.00017511817,0.96821254,0.00023824051,0.025525559,0.0010329552,0.0038564121,0.00009564037,0.00022342027,0.0006400964],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.927877,0.055436194,0.012498433,0.0023393629,0.0006162502,0.0012327789],"domain_scores_gemma":[0.8468499,0.13855194,0.011584682,0.001023595,0.0005971419,0.0013927334],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.04436901,0.0020026516,0.035446916,0.00078615686,0.00068779103,0.000071385424,0.0017549397,0.002058778,0.0017726783],"category_scores_gemma":[0.00747543,0.001463541,0.009035685,0.0018815129,0.0019114336,0.00012752933,0.0014065052,0.0067682187,0.000035231405],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035182416,0.002052051,0.00050351175,0.25326735,0.7000101,0.0001569898,0.00011403246,0.000016143438,0.00009779937,0.000015766504,0.0035940295,0.039820354],"study_design_scores_gemma":[0.007059356,0.0002955065,0.000011960276,0.0022084464,0.6317824,0.00010624102,0.000015270813,0.00041885785,0.000021124439,0.000062177154,0.35759026,0.00042840396],"about_ca_topic_score_codex":0.0000038158164,"about_ca_topic_score_gemma":6.393471e-7,"teacher_disagreement_score":0.35399625,"about_ca_system_score_codex":0.00011412126,"about_ca_system_score_gemma":0.0011508499,"threshold_uncertainty_score":0.99927163},"labels":[],"label_agreement":null},{"id":"W4296252090","doi":"10.1124/dmd.122.000915","title":"Sexual Dimorphism in the Expression of Cytochrome P450 Enzymes in Rat Heart, Liver, Kidney, Lung, Brain, and Small Intestine","year":2022,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates","keywords":"Sexual dimorphism; Cytochrome P450; CYP1A2; Biology; CYP3A; CYP2E1; Internal medicine; Kidney; Endocrinology; CYP1B1; Monooxygenase; Isozyme; Drug metabolism; Enzyme; Metabolism; Biochemistry; Medicine","score_opus":0.03951423021162805,"score_gpt":0.3444009127862823,"score_spread":0.3048866825746543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296252090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96587175,0.030246934,0.00003302214,0.0023720777,0.00040439708,0.0006045924,0.00021733517,0.00002045479,0.0002294255],"genre_scores_gemma":[0.99258274,0.0010771039,0.00013925447,0.005560784,0.00016918154,0.00019869755,0.00012144386,0.000019991265,0.00013081638],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970387,0.0015180138,0.00046330705,0.00039489442,0.00022710008,0.00035798474],"domain_scores_gemma":[0.9989688,0.00046702308,0.00015397866,0.0001863814,0.00003760237,0.00018621598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016767666,0.00024765916,0.00039482614,0.0002914562,0.00028236405,0.000020661992,0.0002493541,0.00009704452,0.0002443946],"category_scores_gemma":[0.000093824645,0.00020758243,0.000053659456,0.0003771794,0.00019455393,0.00014313468,0.00030927476,0.00073138665,0.0000018904184],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007801876,0.00094053254,0.011385172,0.00017585845,0.000029784016,0.00009250233,0.010885991,0.0004449658,0.9544386,0.0053964523,0.008766071,0.006663863],"study_design_scores_gemma":[0.015090527,0.00024895792,0.39368492,0.00010125681,0.0006022035,0.0004011201,0.004191657,0.012407963,0.3295766,0.0031616837,0.23937131,0.0011617703],"about_ca_topic_score_codex":0.00017427097,"about_ca_topic_score_gemma":0.00003014433,"teacher_disagreement_score":0.624862,"about_ca_system_score_codex":0.000020571277,"about_ca_system_score_gemma":0.000061584986,"threshold_uncertainty_score":0.8464966},"labels":[],"label_agreement":null},{"id":"W4297181173","doi":"10.1016/j.jmgm.2022.108339","title":"In-depth analysis of the interactions of various aryl hydrocarbon receptor ligands from a computational perspective","year":2022,"lang":"en","type":"article","venue":"Journal of Molecular Graphics and Modelling","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Aryl hydrocarbon receptor; CYP1B1; Transcription factor; CYP1A2; Chemistry; In silico; Computational biology; Ligand (biochemistry); Cytochrome P450; Small molecule; Cell biology; Receptor; Biochemistry; Biology; Gene; Enzyme","score_opus":0.05420558436473942,"score_gpt":0.37657156900853966,"score_spread":0.32236598464380023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297181173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834007,0.0042245276,0.011145078,0.0004977948,0.00045458475,0.00007845849,0.00008579082,0.0000014406941,0.00011165188],"genre_scores_gemma":[0.99812657,0.00092814426,0.0004872118,0.00040407726,0.000031370353,0.00000314591,0.0000050097274,0.000008928056,0.000005525943],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987949,0.00019538766,0.00049843173,0.00012500215,0.0002753047,0.000110938425],"domain_scores_gemma":[0.99890137,0.0001944656,0.0005362678,0.000083897445,0.000215117,0.000068901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005935525,0.00009947052,0.0003345483,0.0005440297,0.00011302556,0.0000058752503,0.00019618814,0.00005180769,0.00006392249],"category_scores_gemma":[0.000016761864,0.000085839194,0.00030960064,0.00079306925,0.0000891795,0.0000418019,0.00009228501,0.00075475307,5.355391e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018713332,0.00027159048,0.00264881,0.000005342299,0.0015859185,0.000012963266,0.0025958568,0.89754796,0.08981763,0.005175899,0.000019463305,0.00013143313],"study_design_scores_gemma":[0.0012431901,0.00008384471,0.0012088884,0.000014151987,0.0022120012,0.0000160013,0.0006192666,0.9363528,0.030024113,0.027028538,0.0010793587,0.00011782884],"about_ca_topic_score_codex":0.000141399,"about_ca_topic_score_gemma":0.000012231912,"teacher_disagreement_score":0.05979351,"about_ca_system_score_codex":0.00003283666,"about_ca_system_score_gemma":0.00009838611,"threshold_uncertainty_score":0.35004207},"labels":[],"label_agreement":null},{"id":"W4297231491","doi":"10.1038/s41390-022-02313-3","title":"Pharmacogenetic profiling via genome sequencing in children with medical complexity","year":2022,"lang":"en","type":"article","venue":"Pediatric Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children; University of Toronto","keywords":"Pharmacogenomics; Pharmacogenetics; Polypharmacy; Medicine; CYP2C19; Population; Personalized medicine; Computational biology; Bioinformatics; Pharmacology; Gene; Genetics; Biology; Genotype","score_opus":0.2916255501695349,"score_gpt":0.5027168091611328,"score_spread":0.21109125899159792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297231491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986685,0.0053266687,0.00011124635,0.00058310165,0.0003979605,0.0012848302,0.000120741846,0.00007336918,0.0022352312],"genre_scores_gemma":[0.9944692,0.0020876173,0.00038381785,0.00090703764,0.0012323866,0.00057596306,0.0001042377,0.000060658775,0.0001790449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919825,0.003192944,0.00057748525,0.00074860005,0.0020443154,0.0014541472],"domain_scores_gemma":[0.9980505,0.0005985336,0.00011635212,0.00031740346,0.00019015644,0.0007270387],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008371041,0.0002816782,0.00037909782,0.00089709816,0.001027159,0.000033893175,0.0012150933,0.00017353248,0.008312679],"category_scores_gemma":[0.00018100158,0.0002711454,0.00008374556,0.0023058935,0.00037638182,0.000081718965,0.001046492,0.004449871,0.00014186178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007392606,0.00087132084,0.9362902,0.00008306494,0.00023525435,0.00057191506,0.0011255682,0.01722325,0.028044263,0.00040505975,0.0009906718,0.013420156],"study_design_scores_gemma":[0.048779238,0.0026244128,0.47723132,0.000025077203,0.0013125859,0.0037637027,0.0020718854,0.26448512,0.06680928,0.010010559,0.11767571,0.0052111037],"about_ca_topic_score_codex":0.00020557792,"about_ca_topic_score_gemma":0.000018934197,"teacher_disagreement_score":0.45905888,"about_ca_system_score_codex":0.0005586492,"about_ca_system_score_gemma":0.0016284334,"threshold_uncertainty_score":0.9999741},"labels":[],"label_agreement":null},{"id":"W4297535571","doi":"10.1016/j.japh.2022.09.019","title":"Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review","year":2022,"lang":"en","type":"review","venue":"Journal of the American Pharmacists Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Pharmacy; Medicine; Pharmacogenomics; Workflow; Community pharmacy; MEDLINE; Inclusion (mineral); Family medicine; Computer science; Psychology; Pharmacology","score_opus":0.26994694302694977,"score_gpt":0.5389538610506743,"score_spread":0.26900691802372456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297535571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01851788,0.97471386,0.00007563274,0.00065680523,0.0029181333,0.0027187848,0.0002643804,0.000012154242,0.00012235007],"genre_scores_gemma":[0.011318726,0.9839783,0.00023546466,0.0033907476,0.0008300627,0.00013448742,0.00001535122,0.00008098892,0.000015907939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9763376,0.018541768,0.003002477,0.00029027267,0.0010697754,0.00075811445],"domain_scores_gemma":[0.9790181,0.007775379,0.01197511,0.0005229708,0.0005465445,0.00016188923],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01708974,0.0006213661,0.0023721023,0.00035114528,0.0012869325,0.00007081988,0.002522113,0.00015813473,0.0013214553],"category_scores_gemma":[0.0023142076,0.0003674622,0.0010289106,0.004004006,0.00068455696,0.00016912424,0.00084368733,0.006695934,0.000004764929],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008359673,0.00037475847,0.0014788456,0.009529772,0.0019952897,0.00002907891,0.002881319,0.00037937576,0.0012365716,0.00009146879,0.001654045,0.98026586],"study_design_scores_gemma":[0.004029648,0.00019888589,0.00021868496,0.047022,0.019669035,0.0014073751,0.003207323,0.0015172483,0.0014841239,0.0008058707,0.9189563,0.001483516],"about_ca_topic_score_codex":0.000058882957,"about_ca_topic_score_gemma":0.000003670717,"teacher_disagreement_score":0.97878236,"about_ca_system_score_codex":0.0014758639,"about_ca_system_score_gemma":0.0018430053,"threshold_uncertainty_score":0.99987775},"labels":[],"label_agreement":null},{"id":"W4297770594","doi":"10.18103/mra.v10i8.2934","title":"Pharmacogenetics Implementation in Primary Care","year":2022,"lang":"en","type":"article","venue":"Medical Research Archives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Drug; Medical prescription; Intensive care medicine; SAFER; Workload; Drug response; Pharmacology; Computer science; Genotype; Biology","score_opus":0.16949753148391464,"score_gpt":0.5583257447641997,"score_spread":0.38882821328028505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297770594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9368789,0.014878632,0.000059467915,0.0023305314,0.0010068573,0.0008794486,0.00023892152,0.000051762327,0.043675482],"genre_scores_gemma":[0.9896155,0.0057195798,0.00017503666,0.0027092525,0.00039326667,0.0006542302,0.00026763492,0.000034897555,0.00043059106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99206936,0.0041347304,0.00047062902,0.00046799012,0.0017765383,0.0010807479],"domain_scores_gemma":[0.9976314,0.0013087653,0.00005711437,0.0002096656,0.000058203103,0.000734859],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00334663,0.00017659678,0.00024877192,0.0006037279,0.00074879866,0.000019329298,0.0009404196,0.00008468304,0.016680181],"category_scores_gemma":[0.00016647814,0.00018223326,0.00009327273,0.0006856713,0.0004932462,0.00004675836,0.0012876532,0.0031507441,0.00007398431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047431982,0.0004652495,0.030767689,0.000102488826,0.000055827553,0.00040894953,0.006783732,0.00039477675,0.03693194,0.00072159845,0.0040827245,0.9188107],"study_design_scores_gemma":[0.004559259,0.00021455814,0.021231059,0.00000992165,0.000022616978,0.000027406082,0.0036947932,0.0026364992,0.014985226,0.0019767273,0.95039463,0.00024728748],"about_ca_topic_score_codex":0.00006331543,"about_ca_topic_score_gemma":0.00004512103,"teacher_disagreement_score":0.94631195,"about_ca_system_score_codex":0.00018582659,"about_ca_system_score_gemma":0.0010191012,"threshold_uncertainty_score":0.999149},"labels":[],"label_agreement":null},{"id":"W4300658419","doi":"10.17615/tchk-ac83","title":"Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Hjärt-Lungfonden; British Heart Foundation; Fondation Leducq; University of North Carolina at Chapel Hill; Broad Institute; University of Texas Health Science Center at Houston; Donovan Family Foundation; Regione Emilia-Romagna; University of Wisconsin-Milwaukee; Canadian Institutes of Health Research; University of Washington; Massachusetts General Hospital; Russell and Diana Hawkins Family Foundation; U.S. Department of Agriculture","keywords":"Internal medicine; Cardiology; Mutation; Loss function; Coronary disease; Medicine; Function (biology); Coronary heart disease; Genetics; Biology; Gene; Phenotype","score_opus":0.17319856913769158,"score_gpt":0.41081280096376027,"score_spread":0.2376142318260687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300658419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74806315,0.014346176,0.0000113895585,0.0026722816,0.0005248646,0.0010781784,0.22986306,0.00013205418,0.0033088548],"genre_scores_gemma":[0.9855974,0.00012698132,0.000025766318,0.0025424655,0.00015102283,0.000101823236,0.011387692,0.00001590057,0.000050995088],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991371,0.00012561458,0.00023644265,0.00022204837,0.00009111904,0.00018768129],"domain_scores_gemma":[0.9992646,0.0001765786,0.00008455874,0.000075886695,0.000054120406,0.00034422884],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000059480233,0.00012760419,0.00016701678,0.00006241384,0.00006272152,0.000008739306,0.00011651371,0.00009723815,0.062305417],"category_scores_gemma":[0.00031783502,0.00013346948,0.000049287304,0.00021638494,0.000029039775,0.000088052846,0.000084728534,0.00029627894,0.00030269226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008608345,0.0018040778,0.14505395,0.0032451407,0.00065243186,0.0014174221,0.005449312,0.014233846,0.049270246,0.0016572773,0.5096089,0.25899902],"study_design_scores_gemma":[0.0037555452,0.00010992754,0.17019647,0.00011814294,0.00017724512,0.0000086266255,0.00006756096,0.015314888,0.006504628,0.0007432467,0.80264485,0.0003588923],"about_ca_topic_score_codex":0.000002138938,"about_ca_topic_score_gemma":0.0000017394917,"teacher_disagreement_score":0.2930359,"about_ca_system_score_codex":0.000010519164,"about_ca_system_score_gemma":0.00008943734,"threshold_uncertainty_score":0.9385518},"labels":[],"label_agreement":null},{"id":"W4303856660","doi":"10.3390/metabo12100931","title":"Estradiol, Estrone and Ethinyl Estradiol Metabolism Studied by High Resolution LC-MS/MS Using Stable Isotope Labeling and Trapping of Reactive Metabolites","year":2022,"lang":"en","type":"article","venue":"Metabolites","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Courtois Foundation; Université du Québec à Montréal","keywords":"Chemistry; Estrone; Glutathione; Metabolite; Reactive intermediate; Xenobiotic; Adduct; Metabolism; Drug metabolism; Metabolomics; Microsome; Biotransformation; Hydroxylation; Carcinogen; Chromatography; Biochemistry; Hormone; In vitro; Enzyme; Organic chemistry","score_opus":0.08667192492435266,"score_gpt":0.3738234680480534,"score_spread":0.2871515431237007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303856660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81077766,0.1849447,0.00026870557,0.00035948053,0.0010807132,0.00079335726,0.0012681909,0.000091756636,0.00041545308],"genre_scores_gemma":[0.9822689,0.010504685,0.005523323,0.0006189792,0.00042332575,0.00018270261,0.00012488452,0.00009744916,0.00025574872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994377,0.0017923211,0.0011294011,0.0010119153,0.00059907907,0.0010902488],"domain_scores_gemma":[0.99742955,0.0007638452,0.0006887221,0.0004080662,0.00022682169,0.00048297137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002999479,0.0006916162,0.0014747871,0.00045432063,0.0011982683,0.000078740675,0.00045773477,0.00028851282,0.00046187622],"category_scores_gemma":[0.0002243398,0.0007138422,0.0001910662,0.0008247723,0.0005962557,0.00045183455,0.00049690355,0.0016182425,0.000002621088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004272974,0.0005035394,0.0037911334,0.00011729369,0.0011954652,0.000016570526,0.0025987653,0.0024517744,0.97334105,0.00728473,0.00048725217,0.007785114],"study_design_scores_gemma":[0.0068015684,0.00017424245,0.009052187,0.000030630996,0.004013689,0.0001415153,0.0016519079,0.014135188,0.66881835,0.0037305001,0.2901632,0.0012870411],"about_ca_topic_score_codex":0.00079793215,"about_ca_topic_score_gemma":0.000007048926,"teacher_disagreement_score":0.30452272,"about_ca_system_score_codex":0.00007571513,"about_ca_system_score_gemma":0.00019454339,"threshold_uncertainty_score":0.99953127},"labels":[],"label_agreement":null},{"id":"W4304688685","doi":"10.1016/j.neuropharm.2022.109291","title":"CYP2D in the brain impacts oral hydrocodone analgesia in vivo","year":2022,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Institute of Neurosciences, Mental Health and Addiction; Canadian Institutes of Health Research; Centre for Addiction and Mental Health; National Institutes of Health; Rat für Forschung und Technologieentwicklung; National Institute on Drug Abuse; Canada Research Chairs","keywords":"Hydrocodone; Hydromorphone; Pharmacology; Opioid; Microdialysis; Medicine; In vivo; Chemistry; Anesthesia; Internal medicine; Biology; Oxycodone; Receptor; Central nervous system","score_opus":0.08922511991186961,"score_gpt":0.42811228740606333,"score_spread":0.33888716749419373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304688685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97510666,0.0015398357,0.0000040928794,0.011591468,0.0028569968,0.0010607659,0.0001261487,0.00007039983,0.007643615],"genre_scores_gemma":[0.927519,0.000515088,0.000019341374,0.07047491,0.00031208043,0.0005200866,0.000016081494,0.00005535796,0.0005680226],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99061835,0.006286952,0.0007543415,0.00069602375,0.00042129838,0.00122303],"domain_scores_gemma":[0.9976685,0.0014704667,0.00021590773,0.00034147198,0.000037701226,0.00026593017],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031639743,0.00041257427,0.0005379165,0.00064419763,0.0004585178,0.000025804999,0.001351309,0.0001881271,0.009543413],"category_scores_gemma":[0.0001506908,0.0003772969,0.00016002842,0.0016094695,0.00024185846,0.000114038325,0.00051333115,0.0031299712,0.00010497873],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017164288,0.0021827703,0.025666004,0.000035846355,0.00010135847,0.004808439,0.0036032365,0.019594388,0.82831025,0.0012620997,0.10524571,0.00747344],"study_design_scores_gemma":[0.008433333,0.00037182219,0.02588327,0.0000021685785,0.00012568517,0.0003831506,0.00031602843,0.008224063,0.017611811,0.00046992392,0.93769765,0.0004811089],"about_ca_topic_score_codex":0.00012202563,"about_ca_topic_score_gemma":0.00008728223,"teacher_disagreement_score":0.83245194,"about_ca_system_score_codex":0.00016468317,"about_ca_system_score_gemma":0.00021701027,"threshold_uncertainty_score":0.9998679},"labels":[],"label_agreement":null},{"id":"W4306392827","doi":"10.1002/jbt.23243","title":"Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro","year":2022,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Aryl hydrocarbon receptor; Chemistry; Cytochrome P450; In vivo; In vitro; CYP1B1; Methylmercury; Biochemistry; Enzyme; Gene; Environmental chemistry; Transcription factor; Biology","score_opus":0.02700171959952816,"score_gpt":0.347044667466597,"score_spread":0.3200429478670688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306392827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97652453,0.021512225,0.00004081457,0.0013442539,0.0002630469,0.00021561753,0.000036389174,0.0000050997473,0.000058014783],"genre_scores_gemma":[0.9928827,0.0045465357,0.000336528,0.0020980674,0.00007422025,0.000021859682,0.0000033507379,0.000018778952,0.000017920449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979006,0.00065758434,0.0005767357,0.0003234663,0.00016082852,0.00038076646],"domain_scores_gemma":[0.9991308,0.00021290669,0.00021342863,0.000081721184,0.000037064692,0.00032410902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008135497,0.00023289591,0.00058682443,0.00033352227,0.00010218914,0.000018068355,0.00014740296,0.00023569215,0.00012058585],"category_scores_gemma":[0.00007562129,0.00022186417,0.00006218626,0.00017500826,0.00030966173,0.000054175744,0.00033380158,0.0010627466,2.454739e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009259849,0.0002963222,0.0010600955,0.00005537162,0.00010928367,0.0004424281,0.00036399087,0.00003985476,0.9903499,0.00008255348,0.000086763335,0.0061874464],"study_design_scores_gemma":[0.005444066,0.00037616852,0.00891151,0.000014905065,0.00026079384,0.0013648644,0.00012421727,0.0028122086,0.97187454,0.0025353674,0.0059422855,0.00033907016],"about_ca_topic_score_codex":0.000010904173,"about_ca_topic_score_gemma":0.000003578893,"teacher_disagreement_score":0.018475361,"about_ca_system_score_codex":0.000040646493,"about_ca_system_score_gemma":0.0000617232,"threshold_uncertainty_score":0.90473586},"labels":[],"label_agreement":null},{"id":"W4307548945","doi":"10.3390/pharmacy10060139","title":"Experience, Knowledge, and Perceptions of Pharmacogenomics among Pharmacists and Nurse Practitioners in Alberta Hospitals","year":2022,"lang":"en","type":"article","venue":"Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Alberta; Alberta Health Services","funders":"","keywords":"Pharmacogenomics; Family medicine; Medicine; Demographics; Medical prescription; MEDLINE; Pharmacy; Health care; Nursing; Pharmacology","score_opus":0.048876501335424795,"score_gpt":0.43598881142095686,"score_spread":0.38711231008553204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307548945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98459005,0.00538455,0.000010725078,0.00048418753,0.001326921,0.00079930027,0.00024496164,0.000043774067,0.007115518],"genre_scores_gemma":[0.9903181,0.0069317254,0.00010445881,0.0009088732,0.00017768245,0.0004989809,0.000052726486,0.000054093143,0.00095332286],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970529,0.00076859264,0.00070945587,0.0006245811,0.00024292941,0.0006015547],"domain_scores_gemma":[0.9984829,0.0004539788,0.00030211738,0.00019791737,0.000090148154,0.00047295753],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087390176,0.00037850265,0.00048030837,0.00045360098,0.0005262709,0.000027533315,0.00037769874,0.00007704973,0.0038442165],"category_scores_gemma":[0.000051724743,0.00043889153,0.00010693764,0.0005808928,0.0006052452,0.00037814735,0.0004093515,0.0010335388,0.000021019585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091282843,0.0020271095,0.5460077,0.0001688506,0.0003263872,0.00010351126,0.038034648,0.0011717242,0.357042,0.0011790015,0.0051690927,0.04785714],"study_design_scores_gemma":[0.027734768,0.00024431836,0.07848564,0.000032826207,0.0011481695,0.0005867179,0.0074960426,0.04566055,0.13638322,0.0013299678,0.69872636,0.002171412],"about_ca_topic_score_codex":0.00024140111,"about_ca_topic_score_gemma":0.000025539654,"teacher_disagreement_score":0.69355726,"about_ca_system_score_codex":0.00009722278,"about_ca_system_score_gemma":0.00013309983,"threshold_uncertainty_score":0.9998063},"labels":[],"label_agreement":null},{"id":"W4307603329","doi":"10.1101/2022.10.25.513646","title":"Design and performance of a long-read sequencing panel for pharmacogenomics","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Pharmacogenomics; 1000 Genomes Project; Indel; Genetics; Computational biology; Benchmarking; DNA sequencing; Genotyping; Biology; Genome; Single-nucleotide polymorphism; Computer science; Gene; Genotype","score_opus":0.13411612955888316,"score_gpt":0.3511928531752271,"score_spread":0.21707672361634392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307603329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97891015,0.008678294,0.005445321,0.000110007924,0.0032202604,0.0024308872,0.0010043966,0.00018265352,0.000018017685],"genre_scores_gemma":[0.9795341,0.007540601,0.010349565,0.0007702944,0.0005664888,0.0010179691,0.0000021119117,0.00019444207,0.000024431194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99612325,0.000645225,0.00093271665,0.0010827816,0.00032896828,0.00088706356],"domain_scores_gemma":[0.9970605,0.00049028144,0.0008375512,0.0006834272,0.00044561108,0.0004826593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027057657,0.0007495398,0.0009534155,0.00037327767,0.00047704167,0.00006327332,0.00087150885,0.00065412145,0.000466696],"category_scores_gemma":[0.000105826904,0.0008713932,0.00022938622,0.00034460888,0.00030055802,0.00012389838,0.00094043143,0.0017132534,0.00001072848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009070286,0.00025101847,0.0059156693,0.0014838794,0.0007685762,0.00005006274,0.000096166106,0.015378564,0.97455627,0.00014683374,0.00028428703,0.000161677],"study_design_scores_gemma":[0.0028093786,0.00022559483,0.0048260163,0.00008939505,0.0013118339,2.3099153e-7,0.000007545991,0.06933859,0.89514923,0.000006771892,0.025099522,0.0011359162],"about_ca_topic_score_codex":0.000014379428,"about_ca_topic_score_gemma":2.326487e-7,"teacher_disagreement_score":0.07940703,"about_ca_system_score_codex":0.00030929397,"about_ca_system_score_gemma":0.0011285953,"threshold_uncertainty_score":0.9993737},"labels":[],"label_agreement":null},{"id":"W4308766063","doi":"10.1111/bcp.15591","title":"Implementation of pharmacogenomics: Where are we now?","year":2022,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Pharmacogenetics; Computer science; DPYD; Genotyping; Precision medicine; Data science; Medicine; Biology; Pharmacology","score_opus":0.3914069149162076,"score_gpt":0.6033629006466744,"score_spread":0.2119559857304668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308766063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001400021,0.9665381,0.000024490744,0.0005637528,0.02790753,0.0013074739,0.0015967959,0.000035985722,0.0006258669],"genre_scores_gemma":[0.00019310531,0.99021024,0.00023369007,0.0016099623,0.006983752,0.00012026744,0.00007488853,0.00019222943,0.00038188507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9806233,0.008429555,0.008367357,0.00081322144,0.0007518879,0.001014677],"domain_scores_gemma":[0.9820947,0.0042117233,0.011777391,0.0002916786,0.0005799359,0.001044577],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008752295,0.0008619443,0.0064036907,0.0006561291,0.00035940335,0.00004714234,0.0022576007,0.0011814684,0.04514815],"category_scores_gemma":[0.00017178597,0.0009577108,0.0035960088,0.00071555306,0.00066060503,0.0002415959,0.0007320702,0.0076287375,0.00010075783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028586067,0.0011190234,0.00015686786,0.0038789145,0.0036201482,0.0017570374,0.000056871177,0.0000664012,0.00006794799,0.000009927846,0.20551416,0.7834668],"study_design_scores_gemma":[0.0074126506,0.00044630788,0.00003326495,0.0009935615,0.012479911,0.0033844123,0.00018316036,0.000026738982,0.00018828343,0.00009667971,0.974022,0.0007330343],"about_ca_topic_score_codex":0.000025469491,"about_ca_topic_score_gemma":0.000033404503,"teacher_disagreement_score":0.7827338,"about_ca_system_score_codex":0.00022038959,"about_ca_system_score_gemma":0.002414094,"threshold_uncertainty_score":0.99928737},"labels":[],"label_agreement":null},{"id":"W4308998148","doi":"10.1016/j.scr.2022.102970","title":"Generation of cytochrome P450 enzyme-polymorphic human induced pluripotent stem cell lines with CYP2D6*10/CYP3A5*3C and CYP2D6*10/CYP2C19*2","year":2022,"lang":"en","type":"article","venue":"Stem Cell Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"Korea Evaluation Institute of Industrial Technology; Ministry of Science and ICT, South Korea; Ministry of Science ICT and Future Planning; National Research Foundation of Korea","keywords":"Biology; CYP2D6; Induced pluripotent stem cell; Cytochrome P450; Single-nucleotide polymorphism; CYP2C19; CYP3A4; Drug metabolism; Gene; Cell culture; CYP3A5; Genotype; Drug; Genetics; Enzyme; Pharmacology; Biochemistry","score_opus":0.3674746136622723,"score_gpt":0.4653036000068799,"score_spread":0.09782898634460763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308998148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787364,0.008332285,0.000019264184,0.00046104926,0.00038715397,0.0015627476,0.0002885989,0.00006966287,0.0101428665],"genre_scores_gemma":[0.97752315,0.0008329296,0.00005849475,0.00031034456,0.0006154142,0.00047836924,0.00011754969,0.000109280445,0.019954493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9922904,0.0030867353,0.00088009925,0.0010195954,0.0014631442,0.0012600723],"domain_scores_gemma":[0.99710804,0.00053532165,0.00037741684,0.0006555278,0.00068850466,0.0006352007],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036552085,0.0005092252,0.00070035213,0.00073063,0.0015694628,0.000094869174,0.00085464335,0.0003512784,0.004255749],"category_scores_gemma":[0.000010456004,0.00047766874,0.0001539579,0.0010161028,0.00048764204,0.00015516282,0.0009415875,0.0022052845,0.000118403965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008605496,0.00083816895,0.00044546637,0.00028525994,0.00016720682,0.00015285543,0.0017594924,0.0017058214,0.98029476,0.00029521112,0.007880527,0.0053146486],"study_design_scores_gemma":[0.0043140114,0.0014388231,0.0005748075,0.000017195474,0.00018860938,0.000038664093,0.0015765872,0.004981509,0.9068811,0.000097452496,0.07933424,0.0005570183],"about_ca_topic_score_codex":0.000093077084,"about_ca_topic_score_gemma":0.000040589803,"teacher_disagreement_score":0.07341371,"about_ca_system_score_codex":0.00021366394,"about_ca_system_score_gemma":0.0005901217,"threshold_uncertainty_score":0.9997675},"labels":[],"label_agreement":null},{"id":"W4309825818","doi":"10.1093/fampra/cmac124","title":"Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore","year":2022,"lang":"en","type":"article","venue":"Family Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Nanyang Technological University","keywords":"Medicine; Pharmacogenetics; Health care; Clinical decision support system; Primary health care; Primary care; Family medicine; Genotype; Environmental health","score_opus":0.3307162113090567,"score_gpt":0.5082645261015374,"score_spread":0.17754831479248068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309825818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925676,0.0016985337,0.0000438684,0.00034035178,0.0011042962,0.0022235278,0.0000684585,0.00004933053,0.001904007],"genre_scores_gemma":[0.9915073,0.0001655911,0.00328437,0.0045843692,0.000119700715,0.00023255569,0.000019722223,0.00005232187,0.000034082805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909416,0.005045826,0.0016627759,0.00093297666,0.000726745,0.0006900903],"domain_scores_gemma":[0.9938114,0.004253358,0.0008825559,0.00047242793,0.00029442206,0.00028578253],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00980988,0.00033236848,0.0007048699,0.0003570126,0.00030342868,0.000022177155,0.0005831096,0.00015842052,0.00012222257],"category_scores_gemma":[0.001542098,0.00033835974,0.00007992067,0.0012976913,0.00012640876,0.00030617055,0.0006953545,0.0028220448,0.000006013778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009849744,0.013963611,0.7651264,0.00014121213,0.00011547154,0.0010225723,0.0038480498,0.011593689,0.029799737,0.000008010068,0.00037382095,0.16415764],"study_design_scores_gemma":[0.040760048,0.007262998,0.8678926,0.000066208886,0.00096872775,0.00029124852,0.019776573,0.019894848,0.0017412109,0.00013735429,0.04005816,0.0011500076],"about_ca_topic_score_codex":0.00059008313,"about_ca_topic_score_gemma":0.00012798916,"teacher_disagreement_score":0.16300763,"about_ca_system_score_codex":0.00029854462,"about_ca_system_score_gemma":0.0010175353,"threshold_uncertainty_score":0.99990684},"labels":[],"label_agreement":null},{"id":"W4310235306","doi":"10.1177/07067437221140383","title":"Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders","year":2022,"lang":"en","type":"article","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; BC Mental Health & Substance Use Services; University of British Columbia","funders":"Genome British Columbia; Michael Smith Health Research BC; Genome Canada","keywords":"Perception; Pharmacogenomics; Genetic testing; Depression (economics); Medicine; Qualitative research; Test (biology); Psychology; Family medicine; Nursing; Medical education","score_opus":0.19469775877716958,"score_gpt":0.44655914504076316,"score_spread":0.25186138626359356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310235306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430424,0.001317532,0.0000128934225,0.0016843965,0.0017463835,0.00069043285,0.00017406809,0.0000019915517,0.000068034766],"genre_scores_gemma":[0.9986337,0.00000742438,0.0005548957,0.0004939479,0.0001379103,0.00007771554,0.0000010374611,0.000015624633,0.00007778051],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9980229,0.00095935835,0.0004413878,0.000126687,0.00022032383,0.00022930493],"domain_scores_gemma":[0.99844164,0.0003506725,0.00061754487,0.00013330743,0.00022125285,0.0002356045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012178839,0.00012481752,0.00023298008,0.00011501967,0.0012142091,0.0000089812875,0.00048560704,0.000035750014,0.00032476688],"category_scores_gemma":[0.000049736114,0.00007596639,0.00007695568,0.00028892705,0.0002732808,0.00004529339,0.000063937274,0.0006093291,1.7208056e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096077524,0.00062355795,0.539035,0.00006450517,0.00049739104,0.000005029943,0.43132707,0.0034463766,0.020072611,0.00028775798,0.002248386,0.0014314905],"study_design_scores_gemma":[0.009772594,0.0012914408,0.20393948,0.00006927811,0.0012610768,0.0002916994,0.77582324,0.00075548125,0.0019693568,0.0019089552,0.0026031807,0.00031419634],"about_ca_topic_score_codex":0.0012694256,"about_ca_topic_score_gemma":0.009450031,"teacher_disagreement_score":0.34449616,"about_ca_system_score_codex":0.000043690437,"about_ca_system_score_gemma":0.0017179427,"threshold_uncertainty_score":0.9338837},"labels":[],"label_agreement":null},{"id":"W4312428580","doi":"10.21037/atm-2022-60","title":"Pharmacogenetic screening in a knowledge-based economy: shouldn’t more be better?","year":2022,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute; Institute for Clinical Evaluative Sciences; University Health Network","funders":"","keywords":"Pharmacogenetics; Medicine; Pharmacology; Biology; Genetics; Genotype; Gene","score_opus":0.33439564217564294,"score_gpt":0.49886575962029506,"score_spread":0.16447011744465212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312428580","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007513563,0.033194743,0.00022638745,0.94802904,0.0016835337,0.0008994125,0.0010926212,0.00005721559,0.0073034833],"genre_scores_gemma":[0.060785737,0.0012619785,0.0003265208,0.9290834,0.0049083065,0.00028240183,0.0026878447,0.00013247221,0.00053130335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99533033,0.0010301743,0.0013921688,0.000774643,0.0006154374,0.0008572235],"domain_scores_gemma":[0.997108,0.0014951843,0.00050824345,0.00035086792,0.0002743366,0.00026337054],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016206494,0.0006871346,0.0011843601,0.0011239642,0.00018734834,0.000008960815,0.0008461758,0.0008312391,0.016311344],"category_scores_gemma":[0.000056967525,0.00070453365,0.00038626196,0.00062092236,0.0006025499,0.00008982103,0.00007784071,0.0041257436,0.00001590293],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006628526,0.0003690721,0.002038326,0.0006665639,0.00077738863,0.000370882,0.001210078,0.009347377,0.0021443458,0.00005552542,0.9417824,0.040575184],"study_design_scores_gemma":[0.004733108,0.00017467122,0.00073019793,0.0001283107,0.0006377057,0.000013592391,0.000029926714,0.010570387,0.0047614854,0.0008564988,0.97678405,0.00058006763],"about_ca_topic_score_codex":0.000045832232,"about_ca_topic_score_gemma":0.000009917739,"teacher_disagreement_score":0.053272177,"about_ca_system_score_codex":0.000023681681,"about_ca_system_score_gemma":0.00048072406,"threshold_uncertainty_score":0.99954057},"labels":[],"label_agreement":null},{"id":"W4313521109","doi":"10.1503/jpn.220154","title":"Utilizing pharmacogenetics when treating first episode psychosis","year":2023,"lang":"en","type":"article","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Lakeshore General Hospital; McGill University; Douglas Mental Health University Institute; Western University","funders":"","keywords":"Psychosis; Psychiatry; Pharmacogenetics; Persecution; Psychology; Schizophrenia (object-oriented programming); Accident and emergency; Medicine; Clinical psychology; Medical emergency; Genotype; Genetics; Biology","score_opus":0.12346546373801817,"score_gpt":0.42993208609384925,"score_spread":0.3064666223558311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313521109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777519,0.0033322652,0.00019111478,0.006379572,0.010720277,0.00014492092,0.000027631599,0.00005350551,0.0013987914],"genre_scores_gemma":[0.98245037,0.010926117,0.0012115885,0.004143339,0.0009300283,0.0000063297953,8.176723e-7,0.000026459971,0.0003049286],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979432,0.00024386786,0.00064148434,0.00031841244,0.00033727346,0.00051575544],"domain_scores_gemma":[0.9986015,0.00023653587,0.0004500767,0.00014512418,0.0001047567,0.0004620029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013142994,0.00023082021,0.00030559313,0.0003299368,0.0005864773,0.000063175066,0.0005017062,0.00012430288,0.00012983136],"category_scores_gemma":[0.00012874317,0.00020272321,0.00015810084,0.0006772509,0.0002562795,0.00022281152,0.00011714506,0.0006991019,0.000023984463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049829343,0.00076391385,0.5579883,0.00021890152,0.00012089343,0.00019197732,0.0015147212,0.0052110124,0.30380085,0.0017440019,0.053010438,0.074936695],"study_design_scores_gemma":[0.005510908,0.0009450523,0.091015235,0.00014494327,0.00067434047,0.0010183894,0.00047909637,0.031764273,0.06217272,0.0073396508,0.79806787,0.0008675358],"about_ca_topic_score_codex":0.000005430505,"about_ca_topic_score_gemma":0.00001143221,"teacher_disagreement_score":0.7450574,"about_ca_system_score_codex":0.000012186168,"about_ca_system_score_gemma":0.00006652922,"threshold_uncertainty_score":0.82668126},"labels":[],"label_agreement":null},{"id":"W4313825860","doi":"10.3390/medicina59010118","title":"Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall","year":2023,"lang":"en","type":"article","venue":"Medicina","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Tabula Rasa HealthCare","keywords":"Hydrocodone; Medicine; Pharmacogenomics; Bupropion; Major depressive disorder; Antidepressant; Anxiety; Sedation; Hydromorphone; Elvitegravir; Adverse effect; Oxycodone; Pharmacogenetics; Pharmacology; Psychiatry; Mood; Opioid; Internal medicine","score_opus":0.12547143834284463,"score_gpt":0.432728575510951,"score_spread":0.3072571371681064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313825860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692807,0.017023645,0.0001611992,0.0067726895,0.0020805679,0.0018143323,0.00017610422,0.00020157859,0.0024891512],"genre_scores_gemma":[0.96654886,0.018297734,0.00029905498,0.013177133,0.00042373082,0.00033437167,0.00033638303,0.000069708825,0.0005130041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957691,0.00077068247,0.0014176492,0.00069898233,0.00047123307,0.0008723957],"domain_scores_gemma":[0.99788195,0.00054368906,0.00040457255,0.00037288285,0.000120600314,0.0006763196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0051183705,0.0003578027,0.0005959159,0.000367187,0.00035864508,0.00001473122,0.0003165088,0.00022869838,0.0002784485],"category_scores_gemma":[0.0013586695,0.00034446595,0.000111864465,0.0011496771,0.00008969896,0.00010851638,0.00025200925,0.0010273022,0.00014012863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004916859,0.00039319793,0.0013346259,0.0010991861,0.00021895705,0.09788842,0.017512497,0.00080064125,0.13156174,0.000018678593,0.14796764,0.6007127],"study_design_scores_gemma":[0.0038418304,0.00011754284,0.00034155234,0.0010433757,0.0004991703,0.018858446,0.0015809196,0.020708414,0.023329433,0.000022900698,0.9289817,0.00067468383],"about_ca_topic_score_codex":0.00027163594,"about_ca_topic_score_gemma":0.00007712289,"teacher_disagreement_score":0.7810141,"about_ca_system_score_codex":0.00025319017,"about_ca_system_score_gemma":0.00017274808,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W4317773465","doi":"10.1016/s2215-0366(22)00432-1","title":"Psychiatry pharmacogenomics: Africans are not at the table","year":2023,"lang":"en","type":"letter","venue":"The Lancet Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacogenomics; MEDLINE; Table (database); Psychiatry; Medicine; Data science; Psychology; Computer science; Biology; Pharmacology; Data mining","score_opus":0.16241717871434935,"score_gpt":0.41520496587662215,"score_spread":0.2527877871622728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317773465","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011531648,0.019370187,0.000008880198,0.8905869,0.059287127,0.0013498166,0.0045494977,0.0005188418,0.012797078],"genre_scores_gemma":[0.0015427187,0.008706176,0.00014225247,0.85844725,0.09141886,0.0004887921,0.000455851,0.00037237103,0.038425744],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927511,0.0017870903,0.0010667207,0.0012589287,0.0007890913,0.0023470465],"domain_scores_gemma":[0.9953974,0.0009646581,0.0011364112,0.0020522675,0.00015437059,0.00029491645],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.002481395,0.0011931723,0.0013941982,0.00021597478,0.0019466862,0.0001586101,0.003940624,0.001660743,0.0039308383],"category_scores_gemma":[0.000056008226,0.0007642912,0.00071877876,0.00091567094,0.00081592874,0.000084068764,0.00096900633,0.009967129,0.0063865064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041292512,0.00013161753,0.0033824663,0.00029312063,0.0013250783,0.000074283045,0.00031317864,0.00041014436,0.00076044333,0.0003691231,0.99151564,0.0010119872],"study_design_scores_gemma":[0.0025700387,0.000035902096,0.0007627735,0.000062878855,0.0018064122,0.00010250295,0.0001547176,0.00034376793,0.0005489851,0.0035966306,0.9890189,0.0009964533],"about_ca_topic_score_codex":0.000060772483,"about_ca_topic_score_gemma":0.00021479986,"teacher_disagreement_score":0.032139685,"about_ca_system_score_codex":0.00018216042,"about_ca_system_score_gemma":0.00068873406,"threshold_uncertainty_score":0.99963534},"labels":[],"label_agreement":null},{"id":"W4318052381","doi":"10.12659/ajcr.938850","title":"Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report","year":2023,"lang":"en","type":"article","venue":"American Journal of Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Polypharmacy; Statin; Atorvastatin; Rosuvastatin; Intensive care medicine; Internal medicine","score_opus":0.08689469882592063,"score_gpt":0.40972132838870234,"score_spread":0.32282662956278174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318052381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623996,0.0015880242,0.00003346334,0.00042920382,0.000801185,0.00037270875,0.000028098772,0.000068778456,0.00043857004],"genre_scores_gemma":[0.99666613,0.0007847487,0.0009138719,0.0009349164,0.0004298284,0.000021916703,0.000005585349,0.00006966387,0.00017333878],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9964876,0.00051562104,0.0014262466,0.00045938167,0.00039167618,0.0007194482],"domain_scores_gemma":[0.9960239,0.00091425166,0.001671538,0.0002844967,0.0003545998,0.00075119897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024671003,0.00038334678,0.00077153783,0.0006672049,0.0002494876,0.000048957943,0.000111187015,0.00008545132,0.00010952285],"category_scores_gemma":[0.00043729672,0.00033580544,0.00012799165,0.0013999281,0.0005617901,0.0001900682,0.00012798939,0.0010253567,0.0000062319136],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034276873,0.00016540589,0.101276256,0.000038385853,0.00026206873,0.85312283,0.0010915066,0.0019217129,0.011578457,0.0000018538432,0.0007532304,0.029445527],"study_design_scores_gemma":[0.0026042615,0.00035246648,0.0019344835,0.000056016856,0.0004565075,0.95962745,0.0020783173,0.0031383901,0.009100028,0.000044768905,0.020217355,0.00038995148],"about_ca_topic_score_codex":0.0003866984,"about_ca_topic_score_gemma":0.000060986862,"teacher_disagreement_score":0.10650463,"about_ca_system_score_codex":0.00007073379,"about_ca_system_score_gemma":0.00039592793,"threshold_uncertainty_score":0.9999094},"labels":[],"label_agreement":null},{"id":"W4318773532","doi":"10.1016/j.jsps.2023.01.011","title":"Prediction of herb-drug interactions involving consumption of furanocoumarin-mixtures and cytochrome P450 1A2-mediated caffeine metabolism inhibition in humans","year":2023,"lang":"en","type":"article","venue":"Saudi Pharmaceutical Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"King Abdullah International Medical Research Center; Simon Fraser University","keywords":"Physiologically based pharmacokinetic modelling; Pharmacology; Drug; Caffeine; In vivo; Drug interaction; Furanocoumarin; Chemistry; Drug metabolism; Cytochrome P450; Pharmacokinetics; Medicine; Biology; Metabolism; Biochemistry; Biotechnology; Internal medicine","score_opus":0.1461295095450139,"score_gpt":0.4292556543516228,"score_spread":0.28312614480660886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318773532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992366,0.006366652,0.00011255645,0.00080372876,0.0014333626,0.00048958807,0.00036224525,0.000082992985,0.0004252147],"genre_scores_gemma":[0.9781371,0.020536112,0.00011090602,0.00045301448,0.000484571,0.000038567574,0.00008756815,0.000039492617,0.000112665446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964428,0.00089772686,0.0012446693,0.0003637681,0.00044053368,0.00061053294],"domain_scores_gemma":[0.9978905,0.00071470067,0.00049732084,0.00015270834,0.00029006985,0.0004547359],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020456137,0.0003333015,0.0006303922,0.00091413106,0.0002601928,0.000031968044,0.00017855191,0.00020916453,0.0011988706],"category_scores_gemma":[0.00022950668,0.00032311046,0.00018380683,0.0007502336,0.00048227826,0.00036823412,0.0001811605,0.0017806021,0.000044889013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058709533,0.00043703718,0.019126965,0.00028080578,0.0002995647,0.00011145124,0.0014076632,0.0009728775,0.96785337,0.00036920997,0.0014521062,0.007101858],"study_design_scores_gemma":[0.014343542,0.00012671677,0.34245342,0.00037624073,0.0011733735,0.0004769868,0.00051217695,0.026503094,0.5658896,0.0032838231,0.044225678,0.0006353703],"about_ca_topic_score_codex":0.000027069162,"about_ca_topic_score_gemma":0.000029567802,"teacher_disagreement_score":0.40196377,"about_ca_system_score_codex":0.00008570763,"about_ca_system_score_gemma":0.0001170218,"threshold_uncertainty_score":0.9999221},"labels":[],"label_agreement":null},{"id":"W4319262795","doi":"10.3389/jpps.2023.11137","title":"Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition","year":2023,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Inflammation; Medicine; Rheumatoid arthritis; Immunology; Tumor necrosis factor alpha; Pharmacology; Arthritis; Receptor; Internal medicine","score_opus":0.5114341975051152,"score_gpt":0.6247455163738764,"score_spread":0.11331131886876122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319262795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03110628,0.957012,0.000016592017,0.0015163475,0.008421971,0.00095335534,0.00017392967,0.000063187654,0.00073634106],"genre_scores_gemma":[0.027858024,0.9687334,0.000080729355,0.0005244783,0.0025739004,0.000036214973,0.000017490325,0.000049620565,0.00012619824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99141085,0.0030800763,0.0031411564,0.0006630865,0.0010716488,0.00063315587],"domain_scores_gemma":[0.9916676,0.0036394866,0.0029249715,0.00018945843,0.0003970294,0.001181411],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0072812806,0.00065855094,0.0019091185,0.0009465125,0.00043188522,0.000115715055,0.0009073027,0.00028822589,0.0005803288],"category_scores_gemma":[0.0005504391,0.00049934234,0.0009935912,0.0011141738,0.0021011636,0.00064144953,0.0002260799,0.0026756895,0.00012371683],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074331154,0.0004009549,0.00020939221,0.0039071804,0.00059737795,0.00011036966,0.00018303559,0.0001556804,0.0007330165,0.00062716525,0.0015625292,0.99077],"study_design_scores_gemma":[0.0018997482,0.00018980366,0.000031307904,0.002371167,0.004262029,0.00014655311,0.00012652855,0.0016856822,0.0035458156,0.00044081107,0.9848297,0.00047081866],"about_ca_topic_score_codex":0.000009057631,"about_ca_topic_score_gemma":0.0000013103364,"teacher_disagreement_score":0.99029917,"about_ca_system_score_codex":0.00013688586,"about_ca_system_score_gemma":0.0011164631,"threshold_uncertainty_score":0.99974585},"labels":[],"label_agreement":null},{"id":"W4319459775","doi":"10.1016/j.psychres.2023.115102","title":"Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Mental Health & Substance Use Services; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Meta-analysis; Medicine; Major depressive disorder; MEDLINE; Randomized controlled trial; PsycINFO; Depression (economics); Pharmacogenomics; Relative risk; Strictly standardized mean difference; Psychiatry; Confidence interval; Internal medicine; Clinical psychology; Mood; Pharmacology","score_opus":0.8086740056597296,"score_gpt":0.6918852842257752,"score_spread":0.11678872143395436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319459775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010713948,0.98443824,0.0000028661862,0.0013355984,0.00087582076,0.009985422,0.002743903,0.00007821468,0.00043280018],"genre_scores_gemma":[0.000018751321,0.9816541,0.000867952,0.0007954209,0.00040437718,0.012691225,0.00053387205,0.00018307583,0.0028512059],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98846585,0.0056677503,0.0020005943,0.0017031329,0.0007039452,0.0014587492],"domain_scores_gemma":[0.9944695,0.0029881394,0.00056950795,0.00089650817,0.00045389446,0.00062240224],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007953392,0.0010563039,0.0076057245,0.0017944026,0.0006751921,0.00008481837,0.0010034979,0.00070425693,0.0024588786],"category_scores_gemma":[0.00030383948,0.00074258295,0.0039607394,0.0026545965,0.00019795849,0.00007023998,0.00047805478,0.0018015144,0.00021400588],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008821707,0.000621202,0.0007000587,0.08551045,0.29286087,0.00003195514,0.00032726803,0.000036145033,0.000009233737,0.00005426013,0.0064162835,0.6133441],"study_design_scores_gemma":[0.0012231793,0.00008710839,0.000012005309,0.00022723884,0.44040298,0.000008051821,0.000036774265,0.00007392635,0.000004132941,0.00007874389,0.55744094,0.00040493184],"about_ca_topic_score_codex":0.00009315013,"about_ca_topic_score_gemma":0.00016051187,"teacher_disagreement_score":0.6129391,"about_ca_system_score_codex":0.00029640715,"about_ca_system_score_gemma":0.0011535236,"threshold_uncertainty_score":0.99950254},"labels":[],"label_agreement":null},{"id":"W4319656047","doi":"10.1007/s12104-023-10122-w","title":"1H, 13C, 15N Backbone and sidechain chemical shift assignments of the C-terminal domain of human UDP-glucuronosyltransferase 2B17 (UGT2B17-C)","year":2023,"lang":"en","type":"article","venue":"Biomolecular NMR Assignments","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Institutes of Health","keywords":"Glucuronidation; Chemistry; Enzyme; Glucuronosyltransferase; Biochemistry; Glycosyltransferase; Stereochemistry; Transferase; Pharmacology; Biology; Microsome","score_opus":0.06540106714075897,"score_gpt":0.40402326957454904,"score_spread":0.33862220243379004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319656047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558425,0.00058549235,0.0007376547,0.0004119272,0.0005830834,0.000716123,0.000262013,0.00004952042,0.001069912],"genre_scores_gemma":[0.9985601,0.00016926538,0.00018241853,0.0006156599,0.00010441374,0.00005964825,0.00006234264,0.000056399418,0.00018978628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965443,0.00078591553,0.00078987837,0.00055698614,0.0006537354,0.00066918915],"domain_scores_gemma":[0.9986322,0.00015821567,0.00031567333,0.0004773665,0.00006103582,0.00035551295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011021219,0.00041298906,0.00055625563,0.00019660084,0.00024264802,0.000022257687,0.0006995474,0.0003587244,0.0003275216],"category_scores_gemma":[0.000048819,0.0003525733,0.00026889893,0.0005443661,0.0006250662,0.00006871999,0.0005455898,0.0004665678,0.000037609192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015735361,0.00047821554,0.0066240546,0.00011268095,0.00033795944,0.00010538243,0.0006184638,0.000030970656,0.9865235,0.00066463434,0.0005869054,0.00375987],"study_design_scores_gemma":[0.0041263714,0.00014058976,0.013178141,0.000056789027,0.00034472902,0.000019931917,0.00008961526,0.00045359993,0.97129226,0.0030494418,0.006863986,0.00038452153],"about_ca_topic_score_codex":0.00002618125,"about_ca_topic_score_gemma":0.0000021951737,"teacher_disagreement_score":0.015231226,"about_ca_system_score_codex":0.000052991392,"about_ca_system_score_gemma":0.00008716915,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W4321764998","doi":"10.1101/2023.02.23.529697","title":"Signatures of co-evolution and co-regulation in the CYP3A and CYP4F genes in humans","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Montreal Heart Institute; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Genetics; Gene; Epistasis; Gene cluster; CYP3A; Linkage disequilibrium; Population; Single-nucleotide polymorphism; Computational biology; Evolutionary biology; Haplotype; Allele; Genotype","score_opus":0.07105387842394927,"score_gpt":0.3655496045629635,"score_spread":0.2944957261390142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321764998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874501,0.010016409,0.000083874496,0.0003035014,0.00071886973,0.0008453798,0.0004981168,0.00006405458,0.000019680465],"genre_scores_gemma":[0.99511915,0.0039902553,0.00014699953,0.0002689882,0.00026722703,0.0001484967,0.0000026624325,0.000051978925,0.0000042301226],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974005,0.00075086486,0.00057894544,0.0006105545,0.00024607053,0.00041305463],"domain_scores_gemma":[0.9987437,0.00030944918,0.00031926055,0.0003789722,0.00012463906,0.00012396171],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020145199,0.00037386335,0.00049126864,0.0004946601,0.00013596448,0.00005092675,0.00035784065,0.00073538715,0.00003369305],"category_scores_gemma":[0.00009260729,0.00034871028,0.00006438316,0.00040577917,0.00032075428,0.00007905685,0.0002050486,0.0012185166,0.000007920601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011205731,0.00020113676,0.14997593,0.0004125857,0.000103700746,0.00003859892,0.00021521753,0.0016380788,0.8448198,0.002059864,0.0003952236,0.00002782868],"study_design_scores_gemma":[0.0012646562,0.000028426639,0.84980565,0.00009584546,0.00014197422,2.7598274e-8,0.000020527308,0.0025124496,0.1388082,0.00008564544,0.0068482743,0.00038831236],"about_ca_topic_score_codex":0.00012325816,"about_ca_topic_score_gemma":0.00003584668,"teacher_disagreement_score":0.7060116,"about_ca_system_score_codex":0.00007510643,"about_ca_system_score_gemma":0.00018292903,"threshold_uncertainty_score":0.99989647},"labels":[],"label_agreement":null},{"id":"W4322623465","doi":"10.1515/dmpt-2022-0194","title":"A review of pharmacogenetic studies in the Bangladeshi population","year":2023,"lang":"en","type":"review","venue":"Drug Metabolism and Personalized Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenetics; Population; Medicine; Biology; Genetics; Environmental health; Genotype","score_opus":0.4195277884471696,"score_gpt":0.5550168823125288,"score_spread":0.13548909386535918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322623465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060957635,0.9940545,6.0409565e-7,0.00036344733,0.0017420524,0.002524624,0.0004626109,0.000054086675,0.0001885009],"genre_scores_gemma":[0.000047644073,0.9911535,0.000029847204,0.0065123467,0.0007597182,0.00084184867,0.00026487958,0.000107895146,0.00028231615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922026,0.0045684953,0.001494383,0.00067387475,0.00045811976,0.00060257537],"domain_scores_gemma":[0.99678475,0.0016561938,0.0008236124,0.00042431935,0.00014491621,0.00016622286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047246628,0.00082370435,0.0033136527,0.00046602837,0.00020304476,0.00002477517,0.00082358974,0.00035602317,0.0003762569],"category_scores_gemma":[0.00014694993,0.00052325556,0.00079997384,0.0013401792,0.00046140433,0.00008365191,0.00012984562,0.0012084697,0.000049459602],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070790134,0.00017598023,0.000008380823,0.0663493,0.001305149,0.000032454285,0.0031600366,0.0000012110143,0.00002119413,0.0010419313,0.0090874005,0.9187462],"study_design_scores_gemma":[0.0017829813,0.000013806034,0.0000199007,0.014994384,0.0022482104,0.000052757998,0.00018576345,0.000015403635,0.00001857707,0.00040426978,0.9797665,0.000497444],"about_ca_topic_score_codex":0.000045776058,"about_ca_topic_score_gemma":0.000006470223,"teacher_disagreement_score":0.9706791,"about_ca_system_score_codex":0.000031332605,"about_ca_system_score_gemma":0.0001676935,"threshold_uncertainty_score":0.9997219},"labels":[],"label_agreement":null},{"id":"W4322771077","doi":"10.3390/ijms24054776","title":"Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"MEDLINE; Medicine; Scopus; Mental illness; Pharmacogenomics; Population; Clinical trial; Standardization; Intensive care medicine; Psychiatry; Mental health; Pharmacology; Pathology; Environmental health; Biology; Computer science","score_opus":0.23180612150393992,"score_gpt":0.5683719450807853,"score_spread":0.33656582357684534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008260136,0.99048764,0.000014328572,0.00030171534,0.0067977617,0.00096943293,0.00012500159,0.000009100396,0.00046898352],"genre_scores_gemma":[0.001132347,0.99728554,0.00011719094,0.0010951988,0.00017133761,0.00004115758,0.000009045286,0.00002847712,0.000119692966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919078,0.0022773782,0.003926246,0.0003326009,0.0012475065,0.00030847924],"domain_scores_gemma":[0.99452245,0.0012876478,0.0034394318,0.00016034204,0.00038146687,0.00020868276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008399303,0.00037675843,0.0031772084,0.00079408207,0.000049297316,0.00003329038,0.0024287628,0.00024898243,0.00024242714],"category_scores_gemma":[0.0012145697,0.00026301792,0.001476331,0.00066986575,0.00039238474,0.00012602149,0.0002893883,0.0010281429,0.00004782554],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014898714,0.0011401426,0.00049430865,0.43211007,0.009466622,0.002416796,0.00022955707,0.00023111318,0.00007741287,0.0004765394,0.002400532,0.5508079],"study_design_scores_gemma":[0.0032424491,0.00031757806,0.000046827172,0.44383234,0.010449785,0.001396308,0.00014967738,0.0002979772,0.000114855,0.00046223466,0.53871626,0.0009737183],"about_ca_topic_score_codex":0.0000063639654,"about_ca_topic_score_gemma":0.0000016907768,"teacher_disagreement_score":0.5498342,"about_ca_system_score_codex":0.0000763137,"about_ca_system_score_gemma":0.0007531781,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W4323035103","doi":"10.1111/cts.13497","title":"Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males","year":2023,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Université de Montréal","keywords":"Metoprolol; Allopurinol; Medicine; Gout; Internal medicine; Dosing; Bisoprolol; Pharmacology; Adverse effect; Physiology; Heart failure","score_opus":0.3109674915822188,"score_gpt":0.5002438537530536,"score_spread":0.18927636217083477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323035103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079365,0.001581735,0.000018007844,0.0046493644,0.0006565933,0.00028290728,0.00009528007,0.000044590415,0.0018778619],"genre_scores_gemma":[0.99630564,0.0023434637,0.00022530905,0.00028633594,0.0002183984,0.00002001742,0.000013535636,0.0000063638636,0.0005809088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835706,0.00018362072,0.00047401787,0.00038677314,0.00028371054,0.00031483916],"domain_scores_gemma":[0.99864215,0.00074254407,0.00009667075,0.00010209977,0.0001140197,0.0003025194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012074012,0.0001294916,0.00022822634,0.00009728019,0.0002828097,0.0000227334,0.00021885066,0.00010519332,0.00020093065],"category_scores_gemma":[0.000048962214,0.000107464686,0.0000694879,0.0004398883,0.002257133,0.00014463461,0.000086817556,0.00026814893,0.00001944244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017523518,0.00029494724,0.90788126,0.0000579735,0.000105468745,0.000012009498,0.00078493584,0.00053627504,0.022976749,0.036475208,0.0002920694,0.03040789],"study_design_scores_gemma":[0.0012606913,0.000031426054,0.948473,0.000007345316,0.00008711093,0.0000038778994,0.00003129813,0.0053906688,0.0062092976,0.003091461,0.03528335,0.00013048993],"about_ca_topic_score_codex":0.000012206524,"about_ca_topic_score_gemma":0.000010480822,"teacher_disagreement_score":0.040591747,"about_ca_system_score_codex":0.0000024362769,"about_ca_system_score_gemma":0.0001308535,"threshold_uncertainty_score":0.83165},"labels":[],"label_agreement":null},{"id":"W4323049184","doi":"10.1101/2023.02.27.530342","title":"Haplotype phasing of <i>CYP2D6</i> : an allelic ratio method using Agena MassARRAY data","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Women and Children’s Health Research Institute; Alberta Hospital Edmonton; University of Alberta","funders":"Alberta Innovates; European Commission; Alberta Precision Laboratories","keywords":"Pharmacogenomics; Haplotype; CYP2D6; Concordance; Biology; Computational biology; Genetics; Data mining; Computer science; Allele; Gene; Genotype","score_opus":0.27911776992344267,"score_gpt":0.44847408559571494,"score_spread":0.16935631567227227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323049184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9185665,0.00767032,0.052338745,0.00048462776,0.012151664,0.0020996814,0.0056046788,0.0010251133,0.000058662896],"genre_scores_gemma":[0.93888783,0.0022367279,0.055121426,0.0010782306,0.0021038323,0.0000946896,0.000017945767,0.00043404082,0.00002524681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99300396,0.0018658999,0.00139082,0.0019957828,0.00062236976,0.0011211644],"domain_scores_gemma":[0.9938683,0.00040382604,0.001164777,0.003081257,0.00071305427,0.0007687915],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0048061083,0.0009781602,0.0013245653,0.0005604122,0.000414868,0.00016075546,0.0026744714,0.0013598136,0.00028326907],"category_scores_gemma":[0.0004094616,0.0011068088,0.00025390743,0.00084878085,0.00030721907,0.0003883843,0.0024228878,0.0023852524,0.00010284231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015202242,0.00046064344,0.001655211,0.00046113704,0.0009162147,0.00012073974,0.00007651487,0.006070616,0.98880124,0.00029064022,0.0009329039,0.00006212789],"study_design_scores_gemma":[0.0018347021,0.00006384518,0.0033481768,0.0001802738,0.0018726554,1.6162956e-7,0.000013641287,0.11400243,0.8189737,0.000029173498,0.058229484,0.0014517343],"about_ca_topic_score_codex":0.00019497632,"about_ca_topic_score_gemma":0.000010355719,"teacher_disagreement_score":0.1698275,"about_ca_system_score_codex":0.00016758595,"about_ca_system_score_gemma":0.0013363514,"threshold_uncertainty_score":0.99993664},"labels":[],"label_agreement":null},{"id":"W4361213412","doi":"10.1016/j.rpth.2023.100137","title":"Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review","year":2023,"lang":"en","type":"review","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Drug; Medicine; Intensive care medicine; Pharmacology","score_opus":0.738607884384061,"score_gpt":0.6859977651049778,"score_spread":0.05261011927908321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361213412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036077388,0.98832077,6.0381564e-7,0.002572567,0.0004292426,0.0037032166,0.00066934625,0.000051506184,0.00064500177],"genre_scores_gemma":[0.001491773,0.99668634,0.00012015251,0.0006768756,0.00017849685,0.00032072412,0.000078451594,0.00009564461,0.0003515388],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9832928,0.011714835,0.0022338894,0.001179287,0.0005724205,0.0010067333],"domain_scores_gemma":[0.95712495,0.04045664,0.0007854759,0.000490542,0.0002744678,0.0008679149],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.020619845,0.0007323336,0.0056029353,0.00071095594,0.0006603814,0.00031638402,0.00039931404,0.0004113288,0.000072567105],"category_scores_gemma":[0.008386181,0.0005595986,0.00027263054,0.00095244945,0.0009363448,0.00045465276,0.00096801406,0.0034177515,0.00007644205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079656726,0.00062496663,0.007792329,0.54038036,0.0052750087,0.00018943538,0.00064494344,4.334249e-8,0.0000016019603,0.00011732975,0.004925037,0.43996927],"study_design_scores_gemma":[0.0019498551,0.00015551939,0.0024263388,0.16694807,0.021034488,0.00027112267,0.00078797154,0.000046533416,0.000004684339,0.00029885262,0.8049804,0.001096151],"about_ca_topic_score_codex":0.00040088073,"about_ca_topic_score_gemma":0.00020537498,"teacher_disagreement_score":0.8000554,"about_ca_system_score_codex":0.000057194808,"about_ca_system_score_gemma":0.0003073544,"threshold_uncertainty_score":0.9999666},"labels":[],"label_agreement":null},{"id":"W4362735831","doi":"10.1002/cpt.2903","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, and <i>HTR2A</i> Genotypes and Serotonin Reuptake Inhibitor Antidepressants","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":403,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health; Patient-Centered Outcomes Research Institute","keywords":"CYP2C19; Pharmacogenetics; Serotonin reuptake inhibitor; Medicine; CYP2B6; CYP2D6; Guideline; Internal medicine; Genotype; Serotonin; CYP3A4; Biology; Genetics; Cytochrome P450","score_opus":0.260799143689104,"score_gpt":0.5708299925254577,"score_spread":0.31003084883635373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362735831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94851613,0.013446378,0.000696018,0.0148301935,0.01511685,0.004602026,0.001651451,0.00073272124,0.00040825614],"genre_scores_gemma":[0.5453092,0.16619845,0.0058427164,0.27104867,0.008424581,0.0010038937,0.00077872805,0.00046673254,0.0009270321],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881504,0.0026784362,0.004376078,0.0021496213,0.00055630255,0.0020891214],"domain_scores_gemma":[0.9909659,0.0046638744,0.0012786676,0.00067061454,0.0009446402,0.0014763116],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008320654,0.0011768707,0.0018794336,0.00039157414,0.0010329301,0.00013361953,0.00095358875,0.0014543647,0.0005420597],"category_scores_gemma":[0.00019508539,0.0011828222,0.00059221225,0.0009481951,0.0022692324,0.00029834142,0.0009199998,0.0023943018,0.00018249635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003543274,0.0014958446,0.1462594,0.00027466574,0.003985549,0.00015355599,0.0006385595,0.00025858113,0.2164234,0.00014642696,0.40586504,0.2209557],"study_design_scores_gemma":[0.019419566,0.00083871116,0.012112369,0.000021503703,0.004607944,0.00006439245,0.00027290793,0.008978627,0.059389513,0.0007241533,0.8923309,0.0012394025],"about_ca_topic_score_codex":0.000014775565,"about_ca_topic_score_gemma":0.000021412721,"teacher_disagreement_score":0.48646587,"about_ca_system_score_codex":0.00005743818,"about_ca_system_score_gemma":0.00051164173,"threshold_uncertainty_score":0.9999072},"labels":[],"label_agreement":null},{"id":"W4375815274","doi":"10.1007/978-3-030-42825-9_130-1","title":"Pharmacogenomics and Precision Psychiatry","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Drug reaction; Medicine; Psychiatry; Data science; Machine learning; Computer science; Artificial intelligence; Psychology; Drug; Pharmacology; Biology","score_opus":0.14946949354012568,"score_gpt":0.429653680193629,"score_spread":0.2801841866535033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375815274","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002111726,0.012242621,0.00004766256,0.0012689937,0.011274486,0.00084920926,0.0005808954,0.000464449,0.97115993],"genre_scores_gemma":[0.0017470403,0.04819427,0.0006303679,0.004820489,0.0020887188,0.000034658107,0.00013298371,0.00028102647,0.9420704],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749476,0.000094390605,0.0006938145,0.0008382164,0.00029714598,0.0005816582],"domain_scores_gemma":[0.99828756,0.0003332936,0.00029053955,0.00036004293,0.00011769771,0.0006108596],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00078824407,0.0007070358,0.00067210285,0.00036002268,0.00029391274,0.000047445403,0.00044681857,0.0011783789,0.0070333574],"category_scores_gemma":[0.000021800011,0.00068864925,0.00026095228,0.00006389907,0.00026843575,0.00006669829,0.0004578953,0.0017564299,0.0031815835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004873966,0.00014186198,0.00025123943,0.00025623507,0.0014604172,0.00012883187,0.00022551644,0.0001243919,0.0075341435,0.41437328,0.23174049,0.34327617],"study_design_scores_gemma":[0.0014933174,0.000048250167,0.000048097536,0.00003611555,0.0007773026,0.000041591604,0.000009047368,0.0008111378,0.0011840054,0.06482136,0.9299986,0.00073118287],"about_ca_topic_score_codex":0.0000040209243,"about_ca_topic_score_gemma":0.000011922576,"teacher_disagreement_score":0.6982581,"about_ca_system_score_codex":0.00004233152,"about_ca_system_score_gemma":0.00020315824,"threshold_uncertainty_score":0.9995565},"labels":[],"label_agreement":null},{"id":"W4376629962","doi":"10.1503/jpn.230048-l","title":"Response to: “Consistent terminology for medication-related problems in pharmacogenomic cases”","year":2023,"lang":"en","type":"letter","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Lakeshore General Hospital; McGill University; Douglas Mental Health University Institute; Western University","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Terminology; Drug response; Psychosis; Psychiatry; Medicine; Psychology; Pharmacology; Drug; Biology; Genetics; Genotype; Philosophy","score_opus":0.13966962000009234,"score_gpt":0.43376094413887295,"score_spread":0.2940913241387806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376629962","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32554656,0.0023273125,0.000042790332,0.648016,0.023062095,0.0007508271,0.00019281819,0.000023554268,0.000038081194],"genre_scores_gemma":[0.12896352,0.0043967958,0.0004545772,0.8608038,0.0031327517,0.00012449386,0.0000141563205,0.000100674595,0.0020092693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633443,0.00093645044,0.001207614,0.0005430595,0.00031282226,0.0006656392],"domain_scores_gemma":[0.99717414,0.0012881542,0.0008503234,0.00020097432,0.0001415544,0.00034484977],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003069276,0.00034831898,0.0006071988,0.0009353462,0.00022338954,0.0000392983,0.00075095234,0.0006421599,0.000051244933],"category_scores_gemma":[0.00055799657,0.00031513907,0.00021461937,0.00052518747,0.00033444323,0.0001048204,0.00012581855,0.0025883573,0.000020275129],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012357652,0.00033925255,0.003924704,0.00030713336,0.00010908249,0.0010701456,0.00051007536,0.0012802155,0.16827504,0.00005848736,0.81798303,0.0049070697],"study_design_scores_gemma":[0.0027950748,0.00068237906,0.0038149883,0.00009757851,0.0002839394,0.0016859826,0.000024866964,0.0006383164,0.0010710772,0.0011603609,0.9873932,0.00035224122],"about_ca_topic_score_codex":0.000003922675,"about_ca_topic_score_gemma":0.0000055711616,"teacher_disagreement_score":0.21278782,"about_ca_system_score_codex":0.00005375559,"about_ca_system_score_gemma":0.00074620417,"threshold_uncertainty_score":0.9999301},"labels":[],"label_agreement":null},{"id":"W4376631075","doi":"10.1503/jpn.230022-l","title":"Consistent terminology for medication-related problems in pharmacogenomic cases","year":2023,"lang":"en","type":"letter","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; CYP2D6; Pharmacogenetics; Adverse effect; Terminology; Medicine; Psychiatry; MEDLINE; Psychology; Pharmacology; Internal medicine; Genetics; Biology; Cytochrome P450; Philosophy; Genotype","score_opus":0.16456838910427543,"score_gpt":0.4321141501341668,"score_spread":0.26754576102989136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376631075","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22859904,0.011547288,0.000050099505,0.7129,0.045355514,0.0010181883,0.00032166424,0.000042236396,0.00016597268],"genre_scores_gemma":[0.18162945,0.023546161,0.00035347225,0.786006,0.0063328566,0.00011447325,0.000036397865,0.00012251643,0.0018587252],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970889,0.00045172515,0.0011499446,0.00045854508,0.00026869096,0.00058221153],"domain_scores_gemma":[0.9976386,0.00080044975,0.0010647278,0.00015482845,0.00012644105,0.00021496782],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014069979,0.00032452695,0.0005975442,0.00061933167,0.00020911952,0.000034346223,0.0006276281,0.0006520529,0.000059385457],"category_scores_gemma":[0.0002315946,0.00028556326,0.00021546814,0.00034638995,0.0005234429,0.000114455404,0.0000909235,0.0027103578,0.00001017254],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018622902,0.0004624816,0.011737843,0.0007593964,0.0001767651,0.0011218395,0.00036243838,0.00085717766,0.050729048,0.00023107934,0.92592025,0.0074554593],"study_design_scores_gemma":[0.0031475646,0.00041650404,0.002390193,0.00010352456,0.00046379198,0.0023108635,0.000026817346,0.001242242,0.00082654663,0.0031834987,0.98552424,0.00036421092],"about_ca_topic_score_codex":0.000004651469,"about_ca_topic_score_gemma":0.0000063005564,"teacher_disagreement_score":0.07310596,"about_ca_system_score_codex":0.00003371347,"about_ca_system_score_gemma":0.00058107235,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W4377019502","doi":"10.1101/2023.05.15.540828","title":"Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5-a]pyrimidines Toward the Development of an In Vivo Chemical Probe for CSNK2A","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Gillings School of Public Health; Genentech; Pharmaron; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; Pfizer; Bristol-Myers Squibb; North Carolina Biotechnology Center; Bayer; McGill University; University of North Carolina at Chapel Hill; U.S. Department of Defense","keywords":"In vivo; Chemistry; Pharmacokinetics; Dosing; Pharmacology; Enzyme; Covalent bond; Combinatorial chemistry; Biochemistry; Medicine; Biology; Organic chemistry","score_opus":0.09888589641764382,"score_gpt":0.35888334109182574,"score_spread":0.2599974446741819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377019502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853338,0.0007793002,0.008227325,0.00040262222,0.002098301,0.0023940012,0.0005964418,0.00015884997,0.000009369553],"genre_scores_gemma":[0.95773387,0.00045941278,0.040169686,0.0001534129,0.0003854068,0.0009477157,0.0000036692998,0.00014018678,0.0000066245225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99642974,0.00031756773,0.0013774425,0.0008356959,0.00034594364,0.0006936343],"domain_scores_gemma":[0.99724454,0.0002929576,0.0008541256,0.00067419483,0.0006837195,0.0002504886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020251237,0.00056897465,0.0008713406,0.00036669013,0.0001269708,0.000032978623,0.0010453527,0.00090160203,0.00008495759],"category_scores_gemma":[0.00032625734,0.0005119388,0.00019689137,0.0005706065,0.0002959258,0.000091258735,0.00059355004,0.0009142926,0.000005609392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003146093,0.0005484912,0.001625508,0.0010563228,0.0002834068,0.0000072959065,0.00034597714,0.015974786,0.97947747,0.000207605,0.000121322315,0.000037211095],"study_design_scores_gemma":[0.0014399649,0.000038434722,0.0036718955,0.00013285238,0.00026634854,2.1467262e-8,0.00002076047,0.02159658,0.9689023,0.00001889448,0.0033880372,0.0005239382],"about_ca_topic_score_codex":0.000014696547,"about_ca_topic_score_gemma":0.000004560246,"teacher_disagreement_score":0.03194236,"about_ca_system_score_codex":0.00014260216,"about_ca_system_score_gemma":0.0011145876,"threshold_uncertainty_score":0.9997332},"labels":[],"label_agreement":null},{"id":"W4377138764","doi":"10.1186/s13063-023-07361-6","title":"The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care","year":2023,"lang":"en","type":"article","venue":"Trials","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical Research Future Fund","keywords":"Medicine; Depression (economics); Patient Health Questionnaire; Randomized controlled trial; Pharmacogenomics; Antidepressant; Clinical trial; Major depressive disorder; Psychiatry; Quality of life (healthcare); Physical therapy; Internal medicine; Anxiety; Depressive symptoms; Mood; Pharmacology","score_opus":0.12379675085023355,"score_gpt":0.43405438778251443,"score_spread":0.31025763693228087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377138764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96367794,0.0029129698,0.0000043876325,0.000055723423,0.0020246927,0.030023908,0.00026460923,0.000050472834,0.0009853168],"genre_scores_gemma":[0.99307126,0.0021719404,0.00003175528,0.00014085631,0.0001782655,0.0040744008,0.00014667535,0.0000909459,0.00009390142],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9895174,0.0037409223,0.004120443,0.0007882003,0.00080346403,0.0010295922],"domain_scores_gemma":[0.9860812,0.010556256,0.0022806788,0.0005945681,0.0002470553,0.00024027898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006639959,0.0006964881,0.0032085364,0.0010598727,0.00022166314,0.000043132524,0.00096284866,0.00046718755,0.00008883485],"category_scores_gemma":[0.00163211,0.00045191604,0.0005422475,0.0008811583,0.0002449442,0.00025472144,0.0003435735,0.00085620215,0.000010232321],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.809063,0.001754813,0.15488622,0.00015692381,0.00062475854,0.000023781382,0.0011853883,0.009751847,0.009655677,0.000007695946,0.00007804475,0.012811834],"study_design_scores_gemma":[0.8999331,0.0003511401,0.03440011,0.00017897566,0.0006637679,3.7017796e-7,0.00012195279,0.00050294574,0.062948756,0.000060955375,0.00040785162,0.00043009786],"about_ca_topic_score_codex":0.0001285828,"about_ca_topic_score_gemma":0.00011970843,"teacher_disagreement_score":0.12048611,"about_ca_system_score_codex":0.00016524295,"about_ca_system_score_gemma":0.0005982974,"threshold_uncertainty_score":0.99979323},"labels":[],"label_agreement":null},{"id":"W4378624996","doi":"","title":"Stated Preferences for Attributes of a CYP2C19 Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario","year":2020,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Pharmacogenetics; Acute coronary syndrome; Test (biology); Medicine; Population; Internal medicine; Genetics; Biology; Genotype; Environmental health","score_opus":0.4066049649316228,"score_gpt":0.5819580487747488,"score_spread":0.17535308384312598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378624996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98611796,0.0085178,0.00037525353,0.0009993007,0.00045894133,0.0020957852,0.0011876307,0.000046123634,0.00020120341],"genre_scores_gemma":[0.9913313,0.0064459913,0.00035385907,0.0011582179,0.00017769545,0.00021159938,0.00012776234,0.00007145312,0.00012212746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962803,0.00077659066,0.0011279713,0.00057203986,0.0006135184,0.0006295879],"domain_scores_gemma":[0.99636394,0.0011884087,0.0010559915,0.00029330395,0.00052485144,0.0005734936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010291112,0.00047668917,0.0009797969,0.00027615798,0.0003930388,0.00026360547,0.002350172,0.00020531774,0.0034199168],"category_scores_gemma":[0.00024156804,0.0003390348,0.00024076179,0.0009427763,0.00052002876,0.0006679129,0.00065607793,0.0007745382,0.0000064939322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020805607,0.00059892243,0.6908963,0.00013544882,0.001393407,0.00007506214,0.00031479268,0.004209153,0.28739843,0.000027361166,0.008099646,0.0047709066],"study_design_scores_gemma":[0.0035107865,0.00016005352,0.8168407,0.000094139934,0.0017079571,0.00008052401,0.000045833178,0.013165235,0.15664741,0.0010533357,0.0061958046,0.0004982096],"about_ca_topic_score_codex":0.0001908453,"about_ca_topic_score_gemma":0.000021246104,"teacher_disagreement_score":0.13075103,"about_ca_system_score_codex":0.00004173,"about_ca_system_score_gemma":0.00022759549,"threshold_uncertainty_score":0.9999062},"labels":[],"label_agreement":null},{"id":"W4379422197","doi":"10.51731/cjht.2023.664","title":"An Overview of Pharmacogenomic Testing for Psychiatric Disorders","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenomics; Generalizability theory; Medicine; Guideline; Genetic testing; Health care; Personalized medicine; Test (biology); Psychiatry; Psychology; Bioinformatics; Pharmacology","score_opus":0.32274797548898837,"score_gpt":0.507439021635251,"score_spread":0.18469104614626264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379422197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76508594,0.21838723,0.00020964406,0.01137706,0.003410933,0.0007566185,0.00036687823,0.00020353851,0.00020215215],"genre_scores_gemma":[0.98596364,0.01162377,0.0014373391,0.00082318863,0.00006811638,0.00002346922,0.000009080788,0.000032689815,0.00001867939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784636,0.00021329748,0.00089414854,0.00019034633,0.00011344889,0.0007424079],"domain_scores_gemma":[0.9982489,0.00032439936,0.00075548113,0.00019606373,0.00023460799,0.00024059151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022204586,0.00018976879,0.000489589,0.0011315467,0.0004013312,0.000014476134,0.00073431386,0.00022097456,0.000050245213],"category_scores_gemma":[0.0004028711,0.00018159655,0.00014943298,0.0011170462,0.00023982266,0.0001065245,0.000026704258,0.00058644416,0.0000103166285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044596047,0.00006085109,0.015273938,0.0003327137,0.00010528356,0.000012351887,0.0003140616,0.0012872946,0.0077577145,0.0011389925,0.0062244246,0.96744776],"study_design_scores_gemma":[0.0030466348,0.0010596814,0.011501464,0.000081931736,0.00022002177,0.00007246419,0.0016387,0.0034612035,0.010375015,0.026415616,0.9417024,0.00042486712],"about_ca_topic_score_codex":0.00047982135,"about_ca_topic_score_gemma":0.00038799623,"teacher_disagreement_score":0.9670229,"about_ca_system_score_codex":0.00009860576,"about_ca_system_score_gemma":0.0020507898,"threshold_uncertainty_score":0.7405293},"labels":[],"label_agreement":null},{"id":"W4380422510","doi":"10.1002/psp4.12980","title":"Model‐based meta‐analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism","year":2023,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ethnic group; Mechanism (biology); Medicine; Drug; Markov chain Monte Carlo; Pharmacology; Statistics; Monte Carlo method","score_opus":0.4743222873254233,"score_gpt":0.5033028148323203,"score_spread":0.028980527506897003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380422510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007009965,0.9783113,0.0008276946,0.000075664786,0.0036595622,0.0034583204,0.0061842883,0.00018520355,0.00028799634],"genre_scores_gemma":[0.1449624,0.8521277,0.00009446688,0.00039571273,0.00014112171,0.0013870228,0.00018684995,0.0002261327,0.00047859928],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9849893,0.0059337737,0.0045873313,0.0019416964,0.00085371814,0.001694193],"domain_scores_gemma":[0.986736,0.0077919383,0.0034046408,0.00077270705,0.00055718113,0.0007375053],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.007131407,0.0019099712,0.012916144,0.007562474,0.00021790981,0.0000511985,0.002192753,0.0018792788,0.00054154295],"category_scores_gemma":[0.00018615743,0.0016048325,0.0029667385,0.014861793,0.0010832367,0.00022398267,0.0006378259,0.003258466,0.000026351969],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016589471,0.004883758,0.00014397097,0.09686728,0.51753646,0.00011215173,0.0034531476,0.03459906,0.018524675,0.0038062134,0.005306211,0.31310815],"study_design_scores_gemma":[0.0055444506,0.0002405612,0.000026094927,0.0005440301,0.43328518,0.000013670156,0.00028538977,0.29919127,0.0049136844,0.00036559746,0.25327992,0.0023101675],"about_ca_topic_score_codex":0.00021734493,"about_ca_topic_score_gemma":0.000013961987,"teacher_disagreement_score":0.31079796,"about_ca_system_score_codex":0.00026031845,"about_ca_system_score_gemma":0.00075227796,"threshold_uncertainty_score":0.9994165},"labels":[],"label_agreement":null},{"id":"W4381599207","doi":"10.1080/17425255.2023.2228680","title":"The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Drug; Drug metabolism; CYP3A4; Cytochrome P450; Coronavirus disease 2019 (COVID-19); Virology; Biology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pharmacology; Medicine; Metabolism; Infectious disease (medical specialty); Disease; Internal medicine; Biochemistry","score_opus":0.07521101245961502,"score_gpt":0.46952742211583703,"score_spread":0.394316409656222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381599207","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042870294,0.03317349,0.000022478907,0.0063838353,0.9091956,0.0025613531,0.0037440092,0.00065673917,0.0013921984],"genre_scores_gemma":[0.051008303,0.33765152,0.000073366806,0.0040513445,0.5942256,0.0026076133,0.002816178,0.00074250164,0.0068236077],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9860093,0.006096373,0.0023513047,0.0020886282,0.0014036985,0.0020506673],"domain_scores_gemma":[0.9731693,0.020861467,0.0020159043,0.001408619,0.00075130595,0.0017933502],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0047546434,0.0019563688,0.0028357315,0.0017290752,0.0018459179,0.00019952758,0.0015978352,0.0017905241,0.0012427871],"category_scores_gemma":[0.007033403,0.0015129906,0.0013332785,0.0014222824,0.0014562329,0.00031912196,0.00082426734,0.006350075,0.00064879615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002531822,0.0011889505,0.000020998194,0.00009668798,0.002016004,0.00003725892,0.0037041856,0.0018138938,0.018715428,0.0012752113,0.9612399,0.0073597133],"study_design_scores_gemma":[0.0060623446,0.00020295395,0.0012018897,0.00007087613,0.00034794788,0.000019186724,0.00024950842,0.00074421935,0.0052916147,0.0008107072,0.98371214,0.0012865847],"about_ca_topic_score_codex":0.0022173643,"about_ca_topic_score_gemma":0.00041269002,"teacher_disagreement_score":0.31497005,"about_ca_system_score_codex":0.00066659466,"about_ca_system_score_gemma":0.0022581995,"threshold_uncertainty_score":0.9996702},"labels":[],"label_agreement":null},{"id":"W4383070034","doi":"10.3389/fonc.2023.1199741","title":"Computational pharmacogenotype extraction from clinical next-generation sequencing","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Genotyping; Pharmacogenomics; DNA sequencing; 1000 Genomes Project; Reference genome; DPYD; Genetics; Exome sequencing; Whole genome sequencing; Biology; Computational biology; Genotype; Genome; Single-nucleotide polymorphism; Pharmacogenetics; Gene; Mutation","score_opus":0.4059619616281072,"score_gpt":0.5253191977642967,"score_spread":0.11935723613618948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383070034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95551354,0.002031325,0.0077821324,0.0015672252,0.028761173,0.00047720698,0.00012463356,0.00022931714,0.0035134247],"genre_scores_gemma":[0.97241884,0.00423854,0.01365183,0.0050531547,0.0032378002,0.00010617654,0.0007259332,0.00004972101,0.0005179966],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99626905,0.0014570871,0.00087606267,0.00059578085,0.00021915008,0.00058288703],"domain_scores_gemma":[0.9984631,0.0007254179,0.00025542063,0.00016313102,0.00011230026,0.0002806281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002102924,0.0002495192,0.00051118276,0.00041493686,0.0002260359,0.000027137423,0.00031604664,0.0006342476,0.0008979613],"category_scores_gemma":[0.000184115,0.00027737542,0.00014656504,0.00065761746,0.00021395933,0.00021416477,0.00010720552,0.0011945235,0.00060260826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005407935,0.0003921232,0.059628382,0.000011765773,0.000324148,0.00037195106,0.0009961791,0.07486487,0.111846186,0.00023159027,0.22768556,0.52310646],"study_design_scores_gemma":[0.0031212221,0.000086207045,0.0077342405,0.000004172606,0.00013823961,0.000011735442,0.0002798325,0.4982565,0.005621154,0.004028319,0.48043624,0.00028210806],"about_ca_topic_score_codex":0.00006837074,"about_ca_topic_score_gemma":0.000036575388,"teacher_disagreement_score":0.52282435,"about_ca_system_score_codex":0.00038778363,"about_ca_system_score_gemma":0.0004830182,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W4383874757","doi":"10.20944/preprints202307.0703.v1","title":"Association of CYP2C9*2 Allele with Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population","year":2023,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"King Saud University","keywords":"Sulfonylurea; Pharmacogenetics; Allele; CYP2C9; Population; Hypoglycemia; Type 2 Diabetes Mellitus; Medicine; Allele frequency; Internal medicine; CYP2C19; Genetics; Pharmacology; Diabetes mellitus; Genotype; Biology; Endocrinology; Gene; Environmental health","score_opus":0.2005716952847194,"score_gpt":0.446049235203789,"score_spread":0.24547753991906957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383874757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933248,0.00059165,0.0000011773255,0.00020674206,0.0020385927,0.0031324248,0.00015032705,0.00013286306,0.0004213893],"genre_scores_gemma":[0.9966817,0.0015010557,0.000036588026,0.00020436435,0.00019590529,0.0005420101,0.0004085442,0.00012898575,0.00030085043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99345875,0.0019013729,0.001618877,0.0013362056,0.00075696403,0.00092782796],"domain_scores_gemma":[0.9968368,0.00048323593,0.0011888861,0.0007362233,0.0005008411,0.0002540122],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002984161,0.0006993387,0.0011900503,0.00073570234,0.00009675557,0.00002172209,0.00079637684,0.000894174,0.0007821285],"category_scores_gemma":[0.00044028542,0.0007348441,0.0001729014,0.0009869783,0.000060464037,0.00011244474,0.0010421786,0.0024479877,0.00024506368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009505771,0.002685598,0.9624815,0.00024480166,0.0007127003,0.00003322793,0.002833015,0.010878099,0.016663535,0.0000069463013,0.000058665155,0.0024513588],"study_design_scores_gemma":[0.0067842887,0.00017005097,0.95888317,0.000101613594,0.00060759194,3.32144e-7,0.00024107135,0.0011556309,0.029386789,0.00043307006,0.0015541202,0.0006822905],"about_ca_topic_score_codex":0.0011285361,"about_ca_topic_score_gemma":0.0010706295,"teacher_disagreement_score":0.012723254,"about_ca_system_score_codex":0.0006611062,"about_ca_system_score_gemma":0.00028296065,"threshold_uncertainty_score":0.99985343},"labels":[],"label_agreement":null},{"id":"W4385237423","doi":"10.3389/fphar.2023.1252030","title":"Editorial: The practical implication of clinical pharmacokinetics in drug development, pharmaceutical analysis, and clinical research","year":2023,"lang":"en","type":"editorial","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacokinetics; Clinical pharmacology; Pharmacology; Medicine; Drug development; Drug","score_opus":0.22519592954582393,"score_gpt":0.6051608834136852,"score_spread":0.37996495386786133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385237423","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024144573,0.0044123717,0.00015867065,0.0016312292,0.96648526,0.002085951,0.0003838833,0.000102904836,0.00059518404],"genre_scores_gemma":[0.009917021,0.08501923,0.0016644064,0.00051056413,0.9007627,0.00065165915,0.00049193203,0.00020835086,0.0007741478],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96981364,0.017492378,0.0059644105,0.002356961,0.00205349,0.0023191045],"domain_scores_gemma":[0.9616492,0.033678845,0.001580356,0.00079033617,0.0012989151,0.0010023824],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.051119808,0.0009713289,0.0033279154,0.0027373359,0.00038860718,0.0000710962,0.0020629193,0.0041762344,0.00030433122],"category_scores_gemma":[0.0071310103,0.0008690685,0.0006914353,0.004806255,0.0033472315,0.00019978234,0.0015698605,0.019259768,0.00010118959],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027088644,0.0018506154,0.040165015,0.00021395847,0.0039040593,0.00013674391,0.00052668917,0.00012940091,0.00043618077,0.000037047987,0.92358005,0.026311371],"study_design_scores_gemma":[0.008858276,0.00012053747,0.0052865515,0.000037682745,0.0040055667,0.0000026407306,0.00019857772,0.0064426083,0.0017311956,0.00033420537,0.97224396,0.00073821924],"about_ca_topic_score_codex":0.00019464505,"about_ca_topic_score_gemma":0.00027944276,"teacher_disagreement_score":0.080606855,"about_ca_system_score_codex":0.00035296168,"about_ca_system_score_gemma":0.0032577375,"threshold_uncertainty_score":0.999376},"labels":[],"label_agreement":null},{"id":"W4385955318","doi":"10.3390/biomedicines11082282","title":"Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population","year":2023,"lang":"en","type":"article","venue":"Biomedicines","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"King Saud University","keywords":"CYP2C9; Pharmacogenetics; Allele; Type 2 Diabetes Mellitus; Internal medicine; Population; Medicine; Allele frequency; Genotype; Biology; Diabetes mellitus; Pharmacology; Genetics; Endocrinology; Gene","score_opus":0.05939322768167714,"score_gpt":0.39923071904395196,"score_spread":0.3398374913622748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385955318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961103,0.0010295393,5.619441e-7,0.0003998015,0.0011760684,0.0010318117,0.000048123336,0.00006849364,0.00013527366],"genre_scores_gemma":[0.9980441,0.0009353331,0.000022257498,0.0003102978,0.00020069961,0.000096814176,0.00022158636,0.000037534526,0.0001314079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731237,0.00055164116,0.0007216471,0.00040245312,0.00044870665,0.00056318834],"domain_scores_gemma":[0.9987781,0.00033995442,0.00033121393,0.00017921739,0.00022197427,0.00014952396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001319538,0.00027631634,0.0005193535,0.0007134678,0.000064625856,0.00000975945,0.0002268468,0.00022283783,0.00021517086],"category_scores_gemma":[0.00015662862,0.0002362966,0.00004544804,0.002208979,0.00005274754,0.00008401791,0.00006899886,0.00036806826,0.000036438007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040167817,0.001035958,0.93254715,0.00006367333,0.00017781663,0.000026701016,0.0018492083,0.0002443524,0.04613884,0.000004330596,0.0010639768,0.016446302],"study_design_scores_gemma":[0.009296789,0.0005602443,0.96937394,0.000036905454,0.0002505847,4.1183432e-7,0.00067372964,0.0011921012,0.008948634,0.00008132206,0.009297012,0.00028830298],"about_ca_topic_score_codex":0.00035184342,"about_ca_topic_score_gemma":0.00044121512,"teacher_disagreement_score":0.037190206,"about_ca_system_score_codex":0.00015535888,"about_ca_system_score_gemma":0.00007459127,"threshold_uncertainty_score":0.96358955},"labels":[],"label_agreement":null},{"id":"W4385997350","doi":"10.1007/s40273-023-01309-z","title":"Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University","funders":"Canadian Institutes of Health Research","keywords":"Warfarin; Apixaban; Rivaroxaban; Medicine; Pharmacogenomics; Atrial fibrillation; Quality-adjusted life year; Cost-effectiveness analysis; Cost effectiveness; Internal medicine; Pharmacology; Risk analysis (engineering)","score_opus":0.17157161540634408,"score_gpt":0.43830788094396717,"score_spread":0.2667362655376231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385997350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914289,0.0012083136,0.00043958635,0.0002523905,0.0027608636,0.0021839899,0.0014963022,0.000030177007,0.00019948989],"genre_scores_gemma":[0.9960589,0.0028634244,0.0002444674,0.00020149775,0.0001389645,0.00013702198,0.00025236516,0.000042920004,0.000060457343],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99753374,0.00029173814,0.0009054809,0.00050900073,0.00019790589,0.000562112],"domain_scores_gemma":[0.9966993,0.0022018177,0.000466401,0.00027928833,0.0001561826,0.00019703452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020206345,0.00035264544,0.000811502,0.00047233427,0.00018737788,0.00002062935,0.00041176178,0.00014196134,0.000321843],"category_scores_gemma":[0.000024779463,0.0003481302,0.00036519804,0.0007632216,0.00017399757,0.00008997719,0.00019365808,0.00039104398,0.0000025052982],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014018234,0.00005530305,0.058192752,0.0002820615,0.008386974,0.0000127307385,0.0004122642,0.8674371,0.0048461594,0.0006739456,0.00043533265,0.045247134],"study_design_scores_gemma":[0.027516833,0.00014361944,0.06332721,0.000021374071,0.011237171,0.0000012267525,0.00020475879,0.61254424,0.07954708,0.00016527875,0.20465222,0.0006389999],"about_ca_topic_score_codex":0.1270072,"about_ca_topic_score_gemma":0.30664796,"teacher_disagreement_score":0.2548929,"about_ca_system_score_codex":0.00067119236,"about_ca_system_score_gemma":0.0007646346,"threshold_uncertainty_score":0.99989706},"labels":[],"label_agreement":null},{"id":"W4386116271","doi":"10.2217/pgs-2023-0097","title":"Effects of <i>CYP3A4</i> and <i>CYP2C9</i> Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S0226","year":2023,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; American Association of Colleges of Pharmacy; Breast Cancer Research Foundation","keywords":"Anastrozole; Fulvestrant; Oncology; CYP2C9; Genotype; Internal medicine; Medicine; CYP3A4; Pharmacology; Dosing; Endocrine system; Tamoxifen; Breast cancer; Cancer; Hormone; Biology; Genetics; Gene","score_opus":0.05199140185514887,"score_gpt":0.3800571171164778,"score_spread":0.32806571526132894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386116271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851395,0.008250091,0.000031604977,0.00031839794,0.0010665915,0.00087809673,0.00022363102,0.00008978879,0.00062783493],"genre_scores_gemma":[0.9736207,0.024668671,0.000090929476,0.0011815456,0.00018441817,0.00008311128,0.000032528722,0.000047864938,0.00009020434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777466,0.0003506761,0.0005817318,0.00048778774,0.00017680477,0.00062832126],"domain_scores_gemma":[0.9986139,0.00060216704,0.00019013922,0.00016275799,0.00006119132,0.0003698307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006849859,0.00034338256,0.00048516825,0.00024500393,0.00017136481,0.000024242709,0.00023388593,0.00019658965,0.00004548723],"category_scores_gemma":[0.000029769128,0.00036021223,0.00007760252,0.00048724917,0.00025642372,0.00009697807,0.00014232773,0.00059047143,0.000058552672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041440432,0.00022914242,0.009274159,0.0005272389,0.00019831103,0.00014183536,0.0012876868,0.0025756177,0.96587443,0.0013142551,0.00055479084,0.017608108],"study_design_scores_gemma":[0.01061953,0.00020487736,0.015594992,0.00014059446,0.0006506799,0.00009842457,0.00023918015,0.017470773,0.91668767,0.00073332863,0.036823742,0.00073620817],"about_ca_topic_score_codex":0.00002177721,"about_ca_topic_score_gemma":0.0000045361644,"teacher_disagreement_score":0.04918678,"about_ca_system_score_codex":0.000046603018,"about_ca_system_score_gemma":0.00010147078,"threshold_uncertainty_score":0.99988496},"labels":[],"label_agreement":null},{"id":"W4386171477","doi":"10.1016/j.xphs.2023.08.018","title":"A New Version of the Tissue Composition-Based Model for Improving the Mechanism-Based Prediction of Volume of Distribution at Steady-State for Neutral Drugs","year":2023,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec","funders":"","keywords":"Volume of distribution; Mechanism (biology); Steady state (chemistry); Computer science; Pharmacology; Biological system; Chemistry; Medicine; Pharmacokinetics; Biology","score_opus":0.09912042181857075,"score_gpt":0.41415640236038753,"score_spread":0.3150359805418168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386171477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89500153,0.00032794525,0.09686286,0.0034411938,0.0016147802,0.0009024586,0.0018084015,0.000013866476,0.000026959924],"genre_scores_gemma":[0.99825776,0.00006556503,0.0010270172,0.00034534265,0.00014725009,0.0000157732,0.000019481186,0.000010256949,0.00011154641],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99793553,0.00027828905,0.00077020266,0.00018012334,0.00047672863,0.00035910166],"domain_scores_gemma":[0.99752367,0.00090823683,0.00084459624,0.00010871449,0.00042150935,0.00019326767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029700068,0.00015382851,0.00032110346,0.000102904014,0.00051217264,0.00001643669,0.00060239783,0.000108446184,0.00008021212],"category_scores_gemma":[0.00011670137,0.00009606635,0.0003226098,0.0005358709,0.000516588,0.00011533794,0.00008492491,0.00028562927,0.0000011797732],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012344695,0.00017128413,0.0004485967,0.00016257359,0.000057166933,4.524774e-7,0.00027829653,0.232482,0.75593317,0.00056961016,0.0025212392,0.0061411383],"study_design_scores_gemma":[0.0018770241,0.00021079168,0.00019756315,0.000020833439,0.0002789844,0.000001546038,0.00003976312,0.50906426,0.48449823,0.00088044483,0.002882622,0.0000479418],"about_ca_topic_score_codex":0.000012600467,"about_ca_topic_score_gemma":0.0000035494184,"teacher_disagreement_score":0.27658227,"about_ca_system_score_codex":0.00005950066,"about_ca_system_score_gemma":0.0005288982,"threshold_uncertainty_score":0.39392698},"labels":[],"label_agreement":null},{"id":"W4386237249","doi":"10.1007/978-3-031-35205-8_14","title":"Bioactive Natural Products from Medicinal Plants","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg","funders":"","keywords":"Natural product; Phytochemical; Drug discovery; Chemistry; Natural Product Research; Traditional medicine; Biology; Biochemistry; Biological activity; Medicine; Pharmacognosy; In vitro","score_opus":0.17425675327775234,"score_gpt":0.42276422176436446,"score_spread":0.24850746848661212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386237249","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033791517,0.01206574,0.0000076909555,0.001954304,0.02100127,0.0009097539,0.0025150802,0.00052689615,0.9576401],"genre_scores_gemma":[0.029790346,0.008513389,0.000149298,0.004032481,0.005044123,0.000033562937,0.001138362,0.00019272327,0.9511057],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972537,0.000120979756,0.0005683422,0.000941625,0.00047922804,0.0006360946],"domain_scores_gemma":[0.9981938,0.00053230976,0.00031663937,0.0004057883,0.00019269799,0.00035875657],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004419881,0.0007164951,0.00077660783,0.00029462337,0.00021100618,0.000024894352,0.0005838354,0.0010075318,0.007549894],"category_scores_gemma":[0.00006478183,0.0006215716,0.0002061254,0.000067294124,0.0003574186,0.000068501926,0.00029133228,0.0026139575,0.0060147103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018178272,0.0002833373,0.000101397316,0.00017332932,0.0066115335,0.0019758777,0.0015596137,0.000032432923,0.07828288,0.082727276,0.54388964,0.28254485],"study_design_scores_gemma":[0.0014604103,0.000043608492,0.00015976945,0.000052664247,0.0007154501,0.000021312557,0.000033390148,0.00027503123,0.0327338,0.017148403,0.9466008,0.00075538637],"about_ca_topic_score_codex":0.000061940125,"about_ca_topic_score_gemma":0.000037072143,"teacher_disagreement_score":0.40271112,"about_ca_system_score_codex":0.00007366572,"about_ca_system_score_gemma":0.00025407327,"threshold_uncertainty_score":0.9996871},"labels":[],"label_agreement":null},{"id":"W4386374956","doi":"10.1016/j.bioorg.2023.106820","title":"4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamide salts: Novel hydrosoluble prodrugs of antimitotics selectively bioactivated by the cytochrome P450 1A1 in breast cancer cells","year":2023,"lang":"en","type":"article","venue":"Bioorganic Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Hôpital Saint-François d'Assise","funders":"","keywords":"Chemistry; Prodrug; HaCaT; Cancer cell; Stereochemistry; Cytochrome P450; Alkyl; Lipophilicity; Mechanism of action; Biochemistry; Cancer; In vitro; Enzyme; Organic chemistry","score_opus":0.053035989475981496,"score_gpt":0.3659227316207345,"score_spread":0.31288674214475304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386374956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921637,0.0017191604,0.000012796004,0.002167163,0.00054625707,0.00057300803,0.0018564932,0.00017990875,0.00078148476],"genre_scores_gemma":[0.99355704,0.0039763,0.000034378176,0.0006007052,0.00041506038,0.00008824978,0.00011900668,0.00010159433,0.0011076417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969944,0.00015227227,0.0007668542,0.0007208571,0.00039037442,0.0009752561],"domain_scores_gemma":[0.9982994,0.0003300206,0.0004108242,0.00045415395,0.00022408401,0.00028152444],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069168187,0.00050980074,0.0005892374,0.000108759916,0.00023779823,0.0000337951,0.00086056185,0.0005453752,0.00094872323],"category_scores_gemma":[0.000065696724,0.00044503974,0.00015905467,0.00188841,0.0003639119,0.00010035829,0.0003201448,0.0010079665,0.00007411661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024308714,0.0006073318,0.0011968781,0.00024207667,0.0002604214,0.000013916097,0.00041802705,0.00060768303,0.98399776,0.000011221621,0.010950634,0.0014509694],"study_design_scores_gemma":[0.002644965,0.000012309434,0.004821799,0.000045209556,0.00017371692,0.000038418715,0.00019690768,0.0048149354,0.95846385,0.00004595303,0.028258104,0.00048382027],"about_ca_topic_score_codex":0.00020803616,"about_ca_topic_score_gemma":0.000011005661,"teacher_disagreement_score":0.025533894,"about_ca_system_score_codex":0.00021706276,"about_ca_system_score_gemma":0.0005160663,"threshold_uncertainty_score":0.99996454},"labels":[],"label_agreement":null},{"id":"W4386378387","doi":"10.1136/military-2023-002447","title":"Evaluating the prospective utility of pharmacogenetics reporting among Canadian Armed Forces personnel receiving pharmacotherapy: a preliminary assessment towards precision psychiatric care","year":2023,"lang":"en","type":"review","venue":"BMJ Military Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Glycemic Index Laboratories; Defence Research and Development Canada; Public Health Ontario; University of Toronto; St Joseph's Health Care","funders":"","keywords":"Pharmacogenetics; Pharmacotherapy; Medicine; Psychiatry; Population; Genotype; Genetics; Environmental health","score_opus":0.3796208073157095,"score_gpt":0.6049190133848275,"score_spread":0.22529820606911793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386378387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023773033,0.9545778,0.000031407322,0.00040633668,0.0046680407,0.013360666,0.0016762291,0.0001851495,0.0013213484],"genre_scores_gemma":[0.025660293,0.9674361,0.0015602653,0.0007367536,0.0015096292,0.0021077045,0.00040072875,0.0002776753,0.00031085854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98279744,0.0065079257,0.005760395,0.0017503112,0.001214387,0.0019695254],"domain_scores_gemma":[0.9898672,0.001627407,0.0053219125,0.0011274806,0.0007112014,0.0013447619],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.016234497,0.0013103591,0.0034416968,0.000900696,0.0018941617,0.000036036836,0.0015085315,0.0008423185,0.00064358406],"category_scores_gemma":[0.0010413907,0.001031242,0.0014023613,0.00189024,0.0004609248,0.00015003572,0.00042622475,0.0035342327,0.000028203605],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021632262,0.0002712715,0.003129572,0.025818033,0.0012432524,0.000054319975,0.008488541,0.000580927,0.0000160024,0.0000071651025,0.0034513627,0.9567232],"study_design_scores_gemma":[0.0049408968,0.0021990638,0.019998372,0.01026457,0.008831993,0.00023787231,0.00783803,0.045040373,0.00013098739,0.00028753935,0.8972974,0.0029329003],"about_ca_topic_score_codex":0.027591683,"about_ca_topic_score_gemma":0.00882541,"teacher_disagreement_score":0.9537903,"about_ca_system_score_codex":0.0011350072,"about_ca_system_score_gemma":0.013822503,"threshold_uncertainty_score":0.9999648},"labels":[],"label_agreement":null},{"id":"W4386462042","doi":"10.1002/cpt.3044","title":"PharmVar Tutorial on <i>CYP2D6</i> Structural Variation Testing and Recommendations on Reporting","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); University of Calgary","funders":"National Human Genome Research Institute; National Institute on Drug Abuse; National Institutes of Health","keywords":"Variation (astronomy); CYP2D6; Medical physics; Medicine; Internal medicine; Physics","score_opus":0.6853737617081412,"score_gpt":0.635492340409372,"score_spread":0.04988142129876927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386462042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003253311,0.90632206,0.000022831437,0.0036623369,0.07841417,0.0042423736,0.0010264626,0.0009887797,0.0020676602],"genre_scores_gemma":[0.00021724786,0.95301455,0.00046789116,0.032515485,0.012229124,0.0003666448,0.00024301076,0.0003044959,0.0006415483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98661524,0.004684247,0.0052147144,0.0017777246,0.0004445865,0.0012634827],"domain_scores_gemma":[0.9762844,0.016950909,0.005120131,0.0005853931,0.00032902585,0.00073015195],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0058986647,0.0013208378,0.0032813605,0.0005170564,0.001089161,0.00010561654,0.0008904052,0.0021659585,0.00059070386],"category_scores_gemma":[0.0012063417,0.0011649968,0.00092819904,0.0009806801,0.0006228632,0.00011426333,0.00045071426,0.0064712595,0.0007565782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003651297,0.00056521205,0.0000774156,0.0012396774,0.0040302505,0.00017177023,0.00016510244,0.00011206751,0.00020785209,0.0001724524,0.017949663,0.9749434],"study_design_scores_gemma":[0.002950225,0.0005472787,0.00008617197,0.0007160977,0.011816492,0.000072788636,0.000011374024,0.0017511871,0.00008391423,0.000699397,0.9802267,0.0010383817],"about_ca_topic_score_codex":0.0000074914883,"about_ca_topic_score_gemma":0.000001440831,"teacher_disagreement_score":0.973905,"about_ca_system_score_codex":0.000226375,"about_ca_system_score_gemma":0.00070991775,"threshold_uncertainty_score":0.9999543},"labels":[],"label_agreement":null},{"id":"W4386529157","doi":"10.1080/03602532.2023.2254525","title":"Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models","year":2023,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Arsenic; Cytochrome P450; Xenobiotic; Enzyme; Biochemistry; Biology; Chemistry","score_opus":0.2563365913839806,"score_gpt":0.5178157993822631,"score_spread":0.26147920799828245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386529157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001900059,0.9899379,0.00007483077,0.000019210469,0.001771039,0.0045003714,0.0009082026,0.00009127873,0.00079708063],"genre_scores_gemma":[0.00317215,0.991228,0.000112595655,0.00016435773,0.00089484826,0.0016755346,0.00093073555,0.0002394661,0.0015823253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98976225,0.0033374713,0.004058892,0.0012522181,0.0005505617,0.0010386094],"domain_scores_gemma":[0.9960978,0.00041726418,0.0019972634,0.0009098557,0.00009293041,0.00048489458],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0022971386,0.0013783848,0.007113034,0.00078874023,0.0001718762,0.00004813711,0.0013292751,0.0010206475,0.0011624446],"category_scores_gemma":[0.000086146,0.001164323,0.001840838,0.0011239877,0.00029228872,0.00024981092,0.00053345744,0.0018830687,0.0004514204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005029529,0.0017495828,0.000002291787,0.018472353,0.00093922665,0.00003538751,0.0010531243,0.00020913634,0.032017037,0.0026307208,0.0245347,0.9183062],"study_design_scores_gemma":[0.0015306161,0.00001724109,0.000015690648,0.0024331894,0.0023762397,0.00000794402,0.000016894423,0.0011730836,0.0027617877,0.00038314483,0.9882931,0.0009910655],"about_ca_topic_score_codex":0.000058498576,"about_ca_topic_score_gemma":0.000008429249,"teacher_disagreement_score":0.9637584,"about_ca_system_score_codex":0.00011466516,"about_ca_system_score_gemma":0.00017041381,"threshold_uncertainty_score":0.9998967},"labels":[],"label_agreement":null},{"id":"W4386592972","doi":"10.1097/fpc.0000000000000507","title":"Annual Scientific Meeting of the Pharmacogenomics Global Research Network (PGRN) June 12-13, 2023 Memphis, TN, USA","year":2023,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Memphis; Pharmacogenomics; Pharmacogenetics; Biology; Genetics; Genotype","score_opus":0.17590150158555848,"score_gpt":0.4591286800394171,"score_spread":0.2832271784538586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386592972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96387786,0.014440102,0.00003013035,0.0013225455,0.011495809,0.001327775,0.0032674822,0.000102304635,0.0041359733],"genre_scores_gemma":[0.96918195,0.021801082,0.00045096508,0.0012904783,0.002351567,0.000112537506,0.000099682424,0.0001263831,0.0045853243],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99284583,0.0014571962,0.0012727801,0.0012036437,0.00086743635,0.0023531108],"domain_scores_gemma":[0.99646074,0.0006955657,0.00049669,0.00075923774,0.0007348808,0.00085288833],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0075666164,0.0006575267,0.0007246963,0.00035985245,0.0023881446,0.00014344776,0.0017550678,0.00044405827,0.00047032646],"category_scores_gemma":[0.00016953386,0.0005990635,0.00036764643,0.0029373833,0.0019159463,0.00013379662,0.0023911104,0.0014653504,0.00032132128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008178262,0.0005575715,0.047723003,0.00032244186,0.0011645132,0.0000820175,0.002676487,0.082318366,0.5898745,0.002073477,0.20592988,0.06645993],"study_design_scores_gemma":[0.0029438443,0.000062177554,0.006059261,0.000033562097,0.00058138504,0.000047456237,0.00034975944,0.025949704,0.11157617,0.0044278135,0.8472539,0.0007149251],"about_ca_topic_score_codex":0.00009876011,"about_ca_topic_score_gemma":0.00022970537,"teacher_disagreement_score":0.6413241,"about_ca_system_score_codex":0.00018751952,"about_ca_system_score_gemma":0.0006426272,"threshold_uncertainty_score":0.99964607},"labels":[],"label_agreement":null},{"id":"W4386898192","doi":"10.1016/j.tem.2023.08.016","title":"Disentangling the nonmetabolic roles of metabolites: lactate as a case study","year":2023,"lang":"en","type":"article","venue":"Trends in Endocrinology and Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Computational biology; Covalent bond; Biochemistry; Chemistry; Pharmacology; Biology","score_opus":0.11360307909307416,"score_gpt":0.4553452717993028,"score_spread":0.34174219270622863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386898192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97372067,0.020331979,0.0000018249153,0.0007531205,0.0016397126,0.0004549917,0.00009655729,0.00013401805,0.0028671331],"genre_scores_gemma":[0.98983526,0.007756088,0.000041282918,0.00063246273,0.00032014138,0.00022038147,0.000017285942,0.00004502515,0.0011320858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959479,0.0013357311,0.0008192435,0.0006245349,0.00024112608,0.0010314935],"domain_scores_gemma":[0.9983037,0.0006484734,0.00025266063,0.00048125532,0.00007477265,0.00023910422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012965307,0.00044521113,0.00088630745,0.0010901833,0.00036625215,0.000022797898,0.0004811722,0.00020415409,0.00043113803],"category_scores_gemma":[0.00012000068,0.0003335435,0.00018941767,0.001543309,0.0005996313,0.00013668844,0.00042834453,0.001042063,0.00007539513],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063549314,0.0018804607,0.1427634,0.00005294253,0.0015122131,0.011236818,0.034579873,0.0010794994,0.015280107,0.021675885,0.0006902803,0.76861304],"study_design_scores_gemma":[0.021719974,0.00027632492,0.1770649,0.000020206764,0.0041032154,0.0068880706,0.043449864,0.005869499,0.05639602,0.006608583,0.6760606,0.0015427081],"about_ca_topic_score_codex":0.000250836,"about_ca_topic_score_gemma":0.0003780801,"teacher_disagreement_score":0.7670703,"about_ca_system_score_codex":0.000010520574,"about_ca_system_score_gemma":0.000052080864,"threshold_uncertainty_score":0.99991167},"labels":[],"label_agreement":null},{"id":"W4386910959","doi":"10.1002/prp2.1137","title":"Impact of amiodarone use on metoprolol concentrations, <scp>α‐OH</scp>‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study","year":2023,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Canadian Institutes of Health Research; Fondation Institut de Cardiologie de Montréal","keywords":"Metoprolol; Amiodarone; Medicine; Antiarrhythmic agent; Bisoprolol; Pharmacokinetics; CYP2D6; Heart rate; Regimen; Pharmacology; Internal medicine; Anesthesia; Atrial fibrillation; Cardiology; Heart failure; Heart disease; Blood pressure; Cytochrome P450","score_opus":0.25031480168469356,"score_gpt":0.5557490032381033,"score_spread":0.3054342015534097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386910959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918843,0.0032369506,0.000018462302,0.00070617406,0.0011514646,0.0040186234,0.00061691366,0.00027598836,0.000786991],"genre_scores_gemma":[0.99300486,0.0032643676,0.000094239724,0.0004989544,0.00085646886,0.0009605481,0.000085989464,0.00008999163,0.0011445757],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9877465,0.006604018,0.001141262,0.0015408639,0.0010012037,0.0019661898],"domain_scores_gemma":[0.9897318,0.0069879377,0.00035771023,0.00047022334,0.0015845062,0.00086781866],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0078020357,0.00068233407,0.0009827769,0.0013075082,0.0017208796,0.00026787966,0.0006708618,0.00054196466,0.0011131018],"category_scores_gemma":[0.001923873,0.0006345608,0.00037916773,0.0021047154,0.0024522063,0.0006595756,0.00047227138,0.0029835736,0.00025340612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014114135,0.0029844118,0.45497057,0.000044385983,0.0021344128,0.00012322611,0.007498624,0.0026894738,0.5166083,0.0012311206,0.00983021,0.0004738867],"study_design_scores_gemma":[0.008912156,0.0023376062,0.8672364,0.000011842195,0.00043034882,0.00005885547,0.0037481661,0.0065580914,0.09989417,0.00065868616,0.009799663,0.0003540236],"about_ca_topic_score_codex":0.00029989498,"about_ca_topic_score_gemma":0.000024889061,"teacher_disagreement_score":0.4167141,"about_ca_system_score_codex":0.00047025,"about_ca_system_score_gemma":0.0008963593,"threshold_uncertainty_score":0.9998},"labels":[],"label_agreement":null},{"id":"W4387020481","doi":"10.20944/preprints202309.1566.v1","title":"CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia","year":2023,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenomics; CYP2C19; Genetic testing; CYP2D6; Selection (genetic algorithm); Dosing; Allele; Pharmacogenetics; Standardization; Medicine; Genetics; Biology; Computer science; Genotype; Pharmacology; Gene; Machine learning","score_opus":0.4911112998570809,"score_gpt":0.48410311898694713,"score_spread":0.007008180870133773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387020481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98483443,0.0010135624,0.000037410853,0.00020222187,0.006120583,0.001555539,0.00096982636,0.00018274228,0.005083693],"genre_scores_gemma":[0.9903588,0.0056647053,0.00020820169,0.0003236408,0.00086045585,0.00023606316,0.00011188987,0.00013546881,0.0021007485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993812,0.0012012132,0.0018228736,0.0016237501,0.00043117732,0.001108983],"domain_scores_gemma":[0.99627924,0.001021286,0.0010127631,0.0009160981,0.00026693146,0.00050370133],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0036413865,0.000848027,0.0014266444,0.00052988867,0.00020920258,0.000037587248,0.0011410994,0.0010619849,0.0040016626],"category_scores_gemma":[0.000562084,0.0009651379,0.00025985664,0.00048529808,0.00037576078,0.00012836033,0.0036358996,0.0034689247,0.0018560799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035811582,0.000491467,0.6637941,0.00060197356,0.00052599935,0.00035682597,0.0011252022,0.0060424316,0.32463872,0.00009407468,0.0005359226,0.0014351511],"study_design_scores_gemma":[0.0046903645,0.000043298027,0.6587299,0.00029409438,0.0009388448,0.00005497964,0.000044292592,0.005156701,0.2835884,0.0023934888,0.042777933,0.0012877103],"about_ca_topic_score_codex":0.001630217,"about_ca_topic_score_gemma":0.00004002682,"teacher_disagreement_score":0.042242013,"about_ca_system_score_codex":0.0001552324,"about_ca_system_score_gemma":0.00039852285,"threshold_uncertainty_score":0.9992799},"labels":[],"label_agreement":null},{"id":"W4387099129","doi":"10.22541/au.169581272.28215116/v1","title":"In vitro drug-drug interactions in rat liver between oxycodone and commonly co-consumed drugs","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Canada Research Chairs; University of Toronto; University of New Brunswick","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Oxymorphone; Pharmacology; Chemistry; Diazepam; Oxycodone; Triazolam; Drug; Drug interaction; Dextromethorphan; Opioid; Benzodiazepine; Medicine; Biochemistry; Receptor","score_opus":0.16136379018777028,"score_gpt":0.4597759441883765,"score_spread":0.29841215400060617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387099129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97626674,0.0046975827,0.000029356677,0.004741929,0.005334735,0.0018513543,0.0009414349,0.00021766777,0.0059192097],"genre_scores_gemma":[0.9779137,0.006739075,0.00037215283,0.0022633772,0.0006694004,0.00055920344,0.00046015842,0.00010900268,0.010913962],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99511045,0.0015018692,0.0011634182,0.0010386228,0.00028108744,0.00090457837],"domain_scores_gemma":[0.99662507,0.0019844312,0.00032785512,0.00048346163,0.000095809875,0.00048335863],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020168542,0.000705491,0.0011843453,0.0010672904,0.00018241293,0.000086008615,0.00070211594,0.00044627985,0.0011792511],"category_scores_gemma":[0.000080465245,0.0007498248,0.00020887096,0.00043511772,0.0003523797,0.00017335653,0.0014125003,0.004890798,0.0005188534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040385653,0.004064696,0.2220605,0.002366317,0.002607057,0.0024295126,0.039905548,0.0049629146,0.17955609,0.0010687814,0.3594287,0.17751132],"study_design_scores_gemma":[0.009562386,0.000014728941,0.035000134,0.0002017857,0.0008850803,0.000027908221,0.0009529163,0.013831315,0.2661153,0.005392943,0.66584086,0.0021746058],"about_ca_topic_score_codex":0.003062307,"about_ca_topic_score_gemma":0.0019551716,"teacher_disagreement_score":0.30641216,"about_ca_system_score_codex":0.00019524562,"about_ca_system_score_gemma":0.00025143358,"threshold_uncertainty_score":0.9997338},"labels":[],"label_agreement":null},{"id":"W4387128352","doi":"10.21203/rs.3.rs-3359484/v1","title":"Pharmacogenomic Insights in Psychiatric Care: Uncovering Novel Actionability, Allele-Specific CYP2D6 Copy Number Variation, and Phenoconversion in 15,000 Patients","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; CYP2D6; CYP2C19; Medicine; Pharmacogenetics; Allele; Haplotype; Psychiatry; Bioinformatics; Genetics; Pharmacology; Biology; Internal medicine; Genotype; Gene","score_opus":0.16290618877574106,"score_gpt":0.47780534826788684,"score_spread":0.31489915949214575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387128352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98566335,0.005005023,0.00004774739,0.0004023331,0.003732536,0.0030668143,0.0007259304,0.00009621571,0.0012600694],"genre_scores_gemma":[0.97855383,0.018888203,0.00020446608,0.00016139002,0.00071344234,0.00054473977,0.00061955984,0.00011600252,0.00019835394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99356985,0.0017226725,0.0010312598,0.0015217689,0.00097584154,0.0011785899],"domain_scores_gemma":[0.9970784,0.0009102922,0.00026088877,0.00053620286,0.0007261385,0.0004880406],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023579984,0.0005892238,0.0007034311,0.0014228302,0.00040962893,0.00012691025,0.0007517625,0.0010235143,0.00104423],"category_scores_gemma":[0.00016468902,0.00065291306,0.00017206266,0.0013973534,0.00025543233,0.0002034571,0.001866713,0.004824192,0.00034405134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025213053,0.0032624293,0.89311695,0.003101382,0.00037871546,0.00011794519,0.023528067,0.030931229,0.018919041,0.00046728086,0.008231143,0.015424517],"study_design_scores_gemma":[0.019781092,0.00017535672,0.70436805,0.00028160305,0.00015596057,0.0000061345786,0.0014979475,0.008082028,0.0063813506,0.008566015,0.24902177,0.0016826688],"about_ca_topic_score_codex":0.0010654203,"about_ca_topic_score_gemma":0.0003121478,"teacher_disagreement_score":0.24079064,"about_ca_system_score_codex":0.0012140351,"about_ca_system_score_gemma":0.0005822235,"threshold_uncertainty_score":0.9998689},"labels":[],"label_agreement":null},{"id":"W4387157765","doi":"10.1017/s0033291723002817","title":"The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review","year":2023,"lang":"en","type":"review","venue":"Psychological Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Tolerability; Pharmacogenomics; Psychiatry; Precision medicine; Personalized medicine; Medicine; Population; Major depressive disorder; Dosing; Psychology; Bioinformatics; Pharmacology; Adverse effect; Biology; Mood","score_opus":0.24564556537310583,"score_gpt":0.5923748923089253,"score_spread":0.3467293269358194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387157765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012526226,0.9820542,0.0000020062553,0.007619817,0.0065836,0.002131404,0.00014469985,0.000041566178,0.0012974809],"genre_scores_gemma":[0.000041614923,0.99392384,0.000043953034,0.0032727572,0.0019366207,0.0005231927,0.00010797231,0.000048608756,0.00010143352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99501383,0.0015742019,0.0018856046,0.0006648637,0.0002881258,0.00057338877],"domain_scores_gemma":[0.9975134,0.00082923344,0.0009044091,0.000312609,0.00014515647,0.0002951935],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029905909,0.0005800654,0.0020627293,0.00023639167,0.00023207115,0.0000064325236,0.00073283206,0.00044483063,0.0013886036],"category_scores_gemma":[0.00015918042,0.0003225701,0.00026226547,0.0014101263,0.00063203357,0.000033628938,0.0001558714,0.0015293121,0.00004384652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004334227,0.000120145,0.000033162323,0.009403207,0.00033741663,0.000016418198,0.000371803,7.222962e-8,0.0000094597835,0.00270593,0.08293609,0.90402293],"study_design_scores_gemma":[0.0013529398,0.00017133965,0.0001136922,0.0034850463,0.0016125147,0.000043285294,0.0004844813,0.0000025594873,0.0000017836842,0.001626403,0.9907995,0.00030647384],"about_ca_topic_score_codex":0.000010316133,"about_ca_topic_score_gemma":0.000017943501,"teacher_disagreement_score":0.9078634,"about_ca_system_score_codex":0.000028142633,"about_ca_system_score_gemma":0.000071275776,"threshold_uncertainty_score":0.99992263},"labels":[],"label_agreement":null},{"id":"W4387429401","doi":"10.21203/rs.3.rs-3399061/v1","title":"A Call for Increased Inclusivity and Global Representation in Pharmacogenetic Testing","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children","keywords":"Representation (politics); Pharmacogenetics; Political science; Computer science; Law; Genetics; Biology; Genotype","score_opus":0.4768760798581836,"score_gpt":0.6027504125227185,"score_spread":0.12587433266453496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387429401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802995,0.0056460155,0.00017656019,0.0018985299,0.001463215,0.0048816223,0.0023569083,0.0002157894,0.0030619053],"genre_scores_gemma":[0.9929502,0.001970758,0.0010572495,0.0006166166,0.00088803004,0.00188453,0.00033643484,0.00008593549,0.00021023935],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99333835,0.0026612084,0.00071899133,0.0012535694,0.0007206083,0.001307295],"domain_scores_gemma":[0.99438405,0.0035471078,0.0001966581,0.00045468073,0.00079019705,0.0006272908],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006269725,0.0004471096,0.00064136175,0.00047610325,0.0005666156,0.00013456511,0.0006502894,0.00081191224,0.00006981764],"category_scores_gemma":[0.0021616607,0.000490268,0.00016200547,0.0010523186,0.00047614507,0.0000774021,0.0028459737,0.0026668676,0.00005178204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051732953,0.002893024,0.50582045,0.010993725,0.0013101354,0.0012891613,0.0038948613,0.03362175,0.16541696,0.0048590098,0.030538892,0.23418874],"study_design_scores_gemma":[0.021173526,0.00061365677,0.2179804,0.0012066639,0.0008524565,0.000068666035,0.0006431009,0.4383118,0.050307617,0.1474691,0.11864844,0.0027245795],"about_ca_topic_score_codex":0.0028437714,"about_ca_topic_score_gemma":0.00092330156,"teacher_disagreement_score":0.40469006,"about_ca_system_score_codex":0.0003868252,"about_ca_system_score_gemma":0.00069234555,"threshold_uncertainty_score":0.9997549},"labels":[],"label_agreement":null},{"id":"W4387476844","doi":"10.1016/j.euroneuro.2023.08.005","title":"ISSUES IN IMPLEMENTATION AND COST-BENEFIT OF PHARMACOGENETIC TESTING FOR DEPRESSION","year":2023,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Reimbursement; Pharmacogenomics; Stakeholder; Commercialization; Genetic testing; Medicine; Health care; Business; Political science; Public relations; Pharmacology; Marketing","score_opus":0.1473397772594919,"score_gpt":0.4862785579953165,"score_spread":0.3389387807358246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387476844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062556,0.0018614563,0.000035036468,0.0007744206,0.0021770718,0.0015929037,0.00015021912,0.00027431548,0.002509012],"genre_scores_gemma":[0.99315876,0.002763104,0.0004608124,0.0023479972,0.00048486076,0.00022534192,0.00005015551,0.00014775363,0.0003612032],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966526,0.0009568662,0.0008154655,0.0006630398,0.00016409723,0.00074794254],"domain_scores_gemma":[0.9982035,0.00086640386,0.0003062617,0.00018929571,0.00016196248,0.00027254882],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015737457,0.00033688883,0.00042213517,0.0005414917,0.00015349922,0.000018271834,0.00038523102,0.00010633595,0.00024360376],"category_scores_gemma":[0.000111615205,0.00035778445,0.00009013146,0.0008668359,0.00018943081,0.00010099163,0.00024379301,0.00046271793,0.00006661408],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042152283,0.00012997298,0.028510192,0.00008612289,0.00005422843,0.000079551,0.00042066645,0.0013087499,0.7382285,0.000056007462,0.0070828227,0.22362168],"study_design_scores_gemma":[0.02114856,0.00051174295,0.37437835,0.000036147758,0.00039319444,0.00006841205,0.00028493183,0.015443008,0.15513141,0.0006692101,0.43114835,0.00078664394],"about_ca_topic_score_codex":0.000012718537,"about_ca_topic_score_gemma":0.000006085196,"teacher_disagreement_score":0.58309704,"about_ca_system_score_codex":0.000020220277,"about_ca_system_score_gemma":0.000039154627,"threshold_uncertainty_score":0.9998874},"labels":[],"label_agreement":null},{"id":"W4387492877","doi":"10.1021/acsomega.3c05377","title":"Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5- <i>a</i> ]pyrimidines toward the Development of an In Vivo Chemical Probe for CSNK2A","year":2023,"lang":"en","type":"article","venue":"ACS Omega","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Common Fund; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases; Takeda Oncology; Genentech; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; Pfizer; Bristol-Myers Squibb; North Carolina Biotechnology Center; Bayer; McGill University; University of North Carolina at Chapel Hill; U.S. Department of Defense","keywords":"In vivo; Chemistry; Pharmacokinetics; Enzyme; Covalent bond; Pharmacology; Combinatorial chemistry; Biochemistry; Stereochemistry; Organic chemistry; Medicine; Biology","score_opus":0.11611231560955293,"score_gpt":0.4087436076058137,"score_spread":0.29263129199626076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387492877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959031,0.00027070224,0.0011533481,0.00066874037,0.0005491994,0.0008910075,0.00008935692,0.00005415755,0.00042041394],"genre_scores_gemma":[0.9913789,0.0002674255,0.007391309,0.0003178084,0.00013872456,0.00027735412,0.00007359785,0.000032196906,0.00012269708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982916,0.00013390809,0.0006685928,0.00028608358,0.00018956227,0.0004302577],"domain_scores_gemma":[0.9989843,0.00030063663,0.00022842824,0.00020411838,0.00017344567,0.00010911439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010655703,0.00020054281,0.000346351,0.00017716589,0.00009061168,0.0000082763845,0.0004586983,0.00022486292,0.00004522872],"category_scores_gemma":[0.00013013884,0.0001591221,0.00007788941,0.0005744808,0.00016654276,0.000088961584,0.00014694557,0.00024181293,0.0000058824703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036899914,0.00035655597,0.0010251008,0.00018579201,0.000093309834,0.000002968878,0.004505108,0.015036486,0.9650479,0.00032670176,0.0007612396,0.012289832],"study_design_scores_gemma":[0.0017279829,0.000045112407,0.0005525662,0.000013702682,0.000076220036,0.0000026420691,0.00027736282,0.017456759,0.95939434,0.0005173371,0.01975104,0.00018492366],"about_ca_topic_score_codex":0.000005248498,"about_ca_topic_score_gemma":0.000007742908,"teacher_disagreement_score":0.018989801,"about_ca_system_score_codex":0.000029011862,"about_ca_system_score_gemma":0.00019460882,"threshold_uncertainty_score":0.6488811},"labels":[],"label_agreement":null},{"id":"W4387501476","doi":"10.1016/j.euroneuro.2023.08.002","title":"EDUCATION DAY: PHARMACOGENETICS TESTING","year":2023,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Context (archaeology); Pharmacogenomics; Medicine; Psychiatry; Clinical trial; Clinical Practice; Genetic testing; Randomized controlled trial; Family medicine; Pharmacology","score_opus":0.1472888560881657,"score_gpt":0.4462916695570566,"score_spread":0.2990028134688909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387501476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.815337,0.0011764051,0.000054044674,0.0014301458,0.018229993,0.0007836456,0.000073792246,0.0026750236,0.16023998],"genre_scores_gemma":[0.96433556,0.0022888416,0.00042869878,0.022657126,0.003971582,0.00013104237,0.00008795293,0.00042622763,0.0056729834],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927578,0.0035319468,0.0008978075,0.0010710045,0.0003667852,0.0013746466],"domain_scores_gemma":[0.99709034,0.0008150149,0.0003459405,0.0005117027,0.00033375368,0.00090325915],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023689414,0.0006214971,0.0004555018,0.0007021571,0.00050925865,0.00006961089,0.0011390644,0.00019840483,0.0015907267],"category_scores_gemma":[0.00036902569,0.0006723579,0.00020991577,0.0023252661,0.00034680738,0.00016058536,0.00048407403,0.001484275,0.009244208],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011756356,0.00037974326,0.0024997455,0.000032678705,0.00011178312,0.00038923745,0.00028346144,0.0013215173,0.6293798,0.00019254943,0.12178259,0.2435093],"study_design_scores_gemma":[0.0028634667,0.00013054909,0.041333005,0.000011476091,0.0002493875,0.00014238482,0.00005928627,0.0060103326,0.010890143,0.00029463024,0.9373171,0.0006982412],"about_ca_topic_score_codex":0.000004005853,"about_ca_topic_score_gemma":4.4975064e-7,"teacher_disagreement_score":0.81553453,"about_ca_system_score_codex":0.00005364283,"about_ca_system_score_gemma":0.0002862708,"threshold_uncertainty_score":0.99957275},"labels":[],"label_agreement":null},{"id":"W4387502285","doi":"10.1016/j.euroneuro.2023.08.003","title":"PHARMACOGENETIC INFORMED PRESCRIBING FOR MAJOR DEPRESSIVE DISORDER","year":2023,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tolerability; Major depressive disorder; Medicine; Pharmacogenetics; Pharmacogenomics; Psychiatry; Intensive care medicine; Pharmacotherapy; Population; Precision medicine; Pharmacology; Cognition; Adverse effect","score_opus":0.09736212529367805,"score_gpt":0.4229185710199656,"score_spread":0.32555644572628756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387502285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569638,0.0019970676,0.00044955645,0.0024183826,0.013081154,0.0026432264,0.00040627024,0.0022344526,0.019806137],"genre_scores_gemma":[0.9679445,0.003973427,0.00035015558,0.018615594,0.002789583,0.00074550236,0.00021956251,0.00055523304,0.0048064524],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99375296,0.0018063106,0.0010638756,0.0011800181,0.00034206995,0.0018547652],"domain_scores_gemma":[0.99661756,0.0013357697,0.00041057172,0.0005113533,0.00027731294,0.0008474133],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014137721,0.00074354245,0.0006175524,0.0006589108,0.0007498936,0.00007933395,0.0013216408,0.0002418361,0.0012533817],"category_scores_gemma":[0.00034657354,0.00076454645,0.00042483365,0.0011468402,0.0003923227,0.00022311448,0.0005229044,0.0011516879,0.0024621282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013812754,0.00036349669,0.002138328,0.00015193017,0.00046589316,0.00040826635,0.0006979319,0.004475136,0.71239954,0.00018418662,0.19114448,0.08618954],"study_design_scores_gemma":[0.014814728,0.00022849024,0.012780575,0.00001208814,0.000621001,0.00007262708,0.00006393423,0.008451254,0.019975852,0.00023217716,0.94191706,0.0008302132],"about_ca_topic_score_codex":0.000003894683,"about_ca_topic_score_gemma":0.0000032689031,"teacher_disagreement_score":0.7507726,"about_ca_system_score_codex":0.000051683088,"about_ca_system_score_gemma":0.00016635108,"threshold_uncertainty_score":0.9996596},"labels":[],"label_agreement":null},{"id":"W4387608768","doi":"10.1124/dmd.123.001517","title":"Canadian Content in the Pages of Drug Metabolism and Disposition: A Comprehensive Historical Analysis","year":2023,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"University of Toronto; American Society for Pharmacology and Experimental Therapeutics","keywords":"Disposition; Excellence; Realm; Political science; Government (linguistics); Law; Psychology","score_opus":0.08036230862281062,"score_gpt":0.35549424069077196,"score_spread":0.2751319320679613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387608768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607968,0.030189075,0.000026131067,0.0063662026,0.0008603115,0.00052890857,0.00045219212,0.000043683136,0.0007367154],"genre_scores_gemma":[0.98581034,0.010429189,0.000057371177,0.0025819093,0.00027178664,0.00011447224,0.000282843,0.000021682077,0.0004304153],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969942,0.001025664,0.0006052089,0.00048744364,0.0003187948,0.0005687157],"domain_scores_gemma":[0.99852085,0.0004231495,0.00019515108,0.0002688435,0.00015801004,0.00043399844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011281396,0.0003371793,0.000762478,0.00091744825,0.00038483384,0.00005794965,0.0002767496,0.00017496562,0.00010176157],"category_scores_gemma":[0.000035447505,0.00026890013,0.00022507318,0.0014820076,0.00021004221,0.00016431141,0.000097997596,0.0005046693,0.00001700019],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003495708,0.003403748,0.17957734,0.0013235982,0.009741998,0.0013866881,0.12958546,0.005444734,0.26755267,0.13928598,0.09011249,0.16908959],"study_design_scores_gemma":[0.002763751,0.000017698183,0.7827585,0.000018299526,0.004068997,0.000024277093,0.0022961614,0.0034131883,0.0045754393,0.0015182908,0.19804947,0.0004959467],"about_ca_topic_score_codex":0.023703013,"about_ca_topic_score_gemma":0.011326062,"teacher_disagreement_score":0.6031811,"about_ca_system_score_codex":0.000072569135,"about_ca_system_score_gemma":0.00007856604,"threshold_uncertainty_score":0.99997634},"labels":[],"label_agreement":null},{"id":"W4387668743","doi":"10.3390/genes14101945","title":"CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia","year":2023,"lang":"en","type":"article","venue":"Genes","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"CYP2C19; Pharmacogenomics; CYP2D6; Antidepressant; Biology; Medicine; Genetics; Biotechnology; Genotype; Psychiatry; Gene","score_opus":0.2312887317903889,"score_gpt":0.4308645587577955,"score_spread":0.1995758269674066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387668743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228346,0.0022948913,0.000021621885,0.00012325021,0.0022212688,0.00042047625,0.0003276779,0.00008104018,0.0022263082],"genre_scores_gemma":[0.99247664,0.0053761606,0.00021049961,0.00032702202,0.0005244375,0.000043261243,0.00003510399,0.00003841368,0.00096847216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765754,0.00039491523,0.0006558453,0.0004454405,0.00018305516,0.00066323346],"domain_scores_gemma":[0.9987197,0.0005356742,0.00021786851,0.00020444761,0.00009185072,0.00023046513],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012421611,0.00029174532,0.00048633234,0.0002808458,0.00016758937,0.00002556098,0.00030122738,0.0002275353,0.0011825473],"category_scores_gemma":[0.000092421,0.00030138064,0.00007413343,0.0006444525,0.00016553844,0.000101730795,0.00026513461,0.00045567396,0.00040699044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018575384,0.00017693528,0.16506247,0.00012499973,0.0001434477,0.00025769538,0.00062064035,0.0025545605,0.79971,0.00012611864,0.0037600189,0.027277384],"study_design_scores_gemma":[0.0060682483,0.000106708634,0.18043546,0.000046552363,0.000388774,0.00008291436,0.00008234505,0.012859711,0.480594,0.0008501287,0.31772086,0.00076431053],"about_ca_topic_score_codex":0.0002768708,"about_ca_topic_score_gemma":0.000017725231,"teacher_disagreement_score":0.31911597,"about_ca_system_score_codex":0.00002710692,"about_ca_system_score_gemma":0.0000953823,"threshold_uncertainty_score":0.99994385},"labels":[],"label_agreement":null},{"id":"W4387910477","doi":"10.1016/j.ejpb.2023.10.016","title":"Pharmacokinetics of cycloheximide in rats and evaluation of its effect as a blocker of intestinal lymph formation","year":2023,"lang":"en","type":"article","venue":"European Journal of Pharmaceutics and Biopharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Bioavailability; Pharmacology; Lymph; Chemistry; Cmax; Oral administration; Medicine; Pathology","score_opus":0.13794898727040145,"score_gpt":0.4454693812962794,"score_spread":0.30752039402587794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387910477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808074,0.01581603,0.000031625987,0.0002816328,0.0010553891,0.0006757702,0.00010322636,0.000021182834,0.0012077478],"genre_scores_gemma":[0.959218,0.03990573,0.00030630463,0.00024024758,0.0002208143,0.0000061193045,0.0000130497865,0.00005873165,0.000030986495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99305123,0.002903615,0.0022098825,0.0003190282,0.0009714148,0.00054482825],"domain_scores_gemma":[0.99551564,0.000788997,0.0018349092,0.00018685656,0.0012201152,0.0004534613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011955742,0.0004535948,0.0009073092,0.0010819499,0.00009393841,0.000021113668,0.000470807,0.0001464734,0.00014678879],"category_scores_gemma":[0.0005021117,0.00041436122,0.00021243638,0.0011109426,0.00047134495,0.00025213722,0.00032611765,0.0009094356,0.000011322412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001375707,0.00037893667,0.010585247,0.0010180783,0.0003350557,0.00012890717,0.0018043236,0.0032628672,0.8437762,0.00008938827,0.00013221947,0.13711306],"study_design_scores_gemma":[0.011964642,0.0004629683,0.006887839,0.00031300588,0.0019543115,0.00029772051,0.0002776556,0.10226034,0.8655574,0.00015559359,0.00953384,0.0003347167],"about_ca_topic_score_codex":0.0000029330402,"about_ca_topic_score_gemma":5.944899e-7,"teacher_disagreement_score":0.13677835,"about_ca_system_score_codex":0.00005874025,"about_ca_system_score_gemma":0.00021459466,"threshold_uncertainty_score":0.99983084},"labels":[],"label_agreement":null},{"id":"W4388669934","doi":"10.1503/cmaj.221785","title":"Cost-effectiveness of pharmacogenomic-guided treatment for major depression","year":2023,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Positive Living North; Fraser Health; University of British Columbia; Simon Fraser University","funders":"","keywords":"Medicine; Pharmacogenomics; Major depressive disorder; Quality-adjusted life year; Quality of life (healthcare); Medical prescription; Population; Health care; Cost effectiveness; Cohort; Economic evaluation; Psychiatry; Intensive care medicine; Internal medicine; Pharmacology; Environmental health; Mood","score_opus":0.15563632723205795,"score_gpt":0.46473867866936075,"score_spread":0.3091023514373028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388669934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98628104,0.0010252855,0.00023850407,0.0033190013,0.0052426355,0.0010962365,0.00065239624,0.000049379338,0.002095553],"genre_scores_gemma":[0.99244636,0.0018719946,0.0000798451,0.0027624194,0.0017491467,0.00020742667,0.00008881773,0.000037279693,0.00075671216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973041,0.0008302304,0.00051079725,0.00020423501,0.0004733639,0.00067730906],"domain_scores_gemma":[0.99635804,0.0012416666,0.00027803186,0.0000829893,0.0004052827,0.0016340036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004469521,0.00017892996,0.00035815043,0.00030636726,0.00038349183,0.000023047502,0.00027699856,0.0004757927,0.0024469376],"category_scores_gemma":[0.0007138307,0.00016053529,0.00022401003,0.00032102774,0.000049297574,0.000063197236,0.000023696792,0.00054271077,0.00016295374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006985376,0.00039568564,0.12682049,0.00014359616,0.0021615967,0.00046253737,0.001026223,0.0015807261,0.082019016,0.00045168528,0.20434122,0.5798987],"study_design_scores_gemma":[0.008158716,0.00007108207,0.011089836,0.000029774506,0.00025748665,0.000078782476,0.0000741517,0.00424011,0.056620955,0.00039250884,0.9187909,0.00019573906],"about_ca_topic_score_codex":0.00034858508,"about_ca_topic_score_gemma":0.00045872125,"teacher_disagreement_score":0.71444964,"about_ca_system_score_codex":0.00075883407,"about_ca_system_score_gemma":0.0018737528,"threshold_uncertainty_score":0.99846494},"labels":[],"label_agreement":null},{"id":"W4388831231","doi":"10.3390/pharmacy11060180","title":"The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics","year":2023,"lang":"en","type":"editorial","venue":"Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacology","score_opus":0.1557937624307845,"score_gpt":0.5578813258797378,"score_spread":0.40208756344895336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388831231","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1242581,0.008947507,0.00001426093,0.00074342,0.8607035,0.0016894428,0.0030259627,0.00006924024,0.0005485237],"genre_scores_gemma":[0.31348544,0.16229324,0.000042932003,0.00066326733,0.52157855,0.0004458531,0.00086791563,0.00023501938,0.00038779128],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99004316,0.0036433479,0.0030889232,0.00076581433,0.0013639053,0.0010948668],"domain_scores_gemma":[0.98822373,0.008374768,0.0019171353,0.0006333829,0.000589593,0.0002614129],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010499811,0.0007116158,0.0011431815,0.00033925317,0.0003930712,0.00006218561,0.0028145832,0.00059963117,0.0005038449],"category_scores_gemma":[0.00052378204,0.000505566,0.00079957576,0.0008195776,0.0008331003,0.00013923516,0.00051340245,0.0037274368,0.00011321815],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001145083,0.00050719816,0.000832713,0.00022009884,0.00092727056,0.000083403036,0.0012558382,0.00028209042,0.015508098,0.00006519973,0.85189945,0.12727356],"study_design_scores_gemma":[0.008571783,0.00007511887,0.00022359306,0.000022991891,0.0015203886,0.0000066599355,0.0005692728,0.0011589567,0.028751008,0.00037827616,0.95826906,0.00045286195],"about_ca_topic_score_codex":0.000145797,"about_ca_topic_score_gemma":0.000103407765,"teacher_disagreement_score":0.339125,"about_ca_system_score_codex":0.00007861184,"about_ca_system_score_gemma":0.0011118525,"threshold_uncertainty_score":0.9997396},"labels":[],"label_agreement":null},{"id":"W4389322814","doi":"10.1002/cpt.3124","title":"Characterization of <i>CYP2B6</i> and <i>CYP2A6</i> Pharmacogenetic Variation in <scp>Sub‐Saharan</scp> African Populations","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"National Institutes of Health; Medical Research Council; South African Medical Research Council; National Research Foundation; Wellcome Trust; National Human Genome Research Institute; GlaxoSmithKline; National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation","keywords":"1000 Genomes Project; Allele; Pharmacogenetics; Haplotype; CYP2A6; Genetics; Biology; Allele frequency; Genotype; Evolutionary biology; Gene; Single-nucleotide polymorphism","score_opus":0.21288528920082814,"score_gpt":0.4750250815627104,"score_spread":0.26213979236188223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389322814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861809,0.0022682426,0.0002490106,0.003000719,0.006080806,0.0011739697,0.00030297638,0.00023921927,0.00050415925],"genre_scores_gemma":[0.93982357,0.032554027,0.00017072198,0.025790213,0.0009504207,0.00018028382,0.00018765948,0.00009956456,0.00024356485],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9939765,0.0019799918,0.0018869648,0.0008430811,0.0003386427,0.0009748555],"domain_scores_gemma":[0.99607104,0.002142454,0.0007358279,0.0003191182,0.00026016397,0.0004714215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025864393,0.00052057364,0.0009256893,0.0006073283,0.00026690742,0.000028922046,0.0005594238,0.00063145364,0.00014272348],"category_scores_gemma":[0.00011657663,0.00055503007,0.00026386022,0.0016018174,0.00068813516,0.00020277803,0.00028358883,0.0014092567,0.00017164192],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002109539,0.0009056939,0.024006154,0.00007250525,0.0005594966,0.00003899477,0.0010627132,0.00062827097,0.95361423,0.00008970978,0.0040819743,0.014729277],"study_design_scores_gemma":[0.009702567,0.00027719006,0.34256765,0.00003203409,0.0024059166,0.000024576962,0.00013021853,0.031232052,0.29992193,0.0012627856,0.31197304,0.0004700646],"about_ca_topic_score_codex":0.000008940934,"about_ca_topic_score_gemma":0.000010085244,"teacher_disagreement_score":0.6536923,"about_ca_system_score_codex":0.000054399312,"about_ca_system_score_gemma":0.00020758063,"threshold_uncertainty_score":0.9996901},"labels":[],"label_agreement":null},{"id":"W4390176255","doi":"10.3390/jpm14010022","title":"User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients","year":2023,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Medicine; Psychiatry; Psychology; Pharmacology","score_opus":0.11460016882536611,"score_gpt":0.44199853347815776,"score_spread":0.32739836465279165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390176255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894956,0.0043917703,0.000014917638,0.000955537,0.0042773127,0.00017180246,0.000023750463,0.000018913945,0.000650435],"genre_scores_gemma":[0.99500555,0.0022177952,0.0005401035,0.00084100926,0.0010946463,0.000010800858,0.000008194951,0.000021721295,0.0002601846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981619,0.00024072683,0.0007662842,0.00016560801,0.00036112074,0.00030433605],"domain_scores_gemma":[0.9980173,0.00052375154,0.0006706819,0.00007903132,0.00033720318,0.00037203918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012674624,0.00018670385,0.00049541274,0.00035378325,0.00014636197,0.000005723597,0.00025257445,0.00011237996,0.0007757895],"category_scores_gemma":[0.0004390774,0.00014161237,0.000102213184,0.000504872,0.0006068517,0.000112845984,0.00006653631,0.0004786182,0.000006714708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010172029,0.0005962484,0.7219203,0.0003030889,0.00085712736,0.00007561905,0.056277126,0.00016669072,0.13088569,0.00036336703,0.05843977,0.029097736],"study_design_scores_gemma":[0.06323543,0.002621239,0.48944333,0.0010077978,0.003230326,0.0003275789,0.05368013,0.0061878017,0.027309053,0.0020956455,0.34964207,0.001219592],"about_ca_topic_score_codex":0.000010049612,"about_ca_topic_score_gemma":6.875141e-7,"teacher_disagreement_score":0.2912023,"about_ca_system_score_codex":0.000018188386,"about_ca_system_score_gemma":0.00013696904,"threshold_uncertainty_score":0.8494351},"labels":[],"label_agreement":null},{"id":"W4390426604","doi":"10.59931/rcp.23.0003","title":"Construction of a 10-year Pharmacogenetic Literature Database with Information on Alternative Allele Frequency: PharmGAF DB","year":2023,"lang":"en","type":"article","venue":"Research in Clinical Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministry of Food and Drug Safety","keywords":"Pharmacogenetics; Allele; Allele frequency; Genetics; Computer science; Medicine; Information retrieval; Biology; Genotype; Gene","score_opus":0.461898859138493,"score_gpt":0.6147177162906688,"score_spread":0.15281885715217586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390426604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97885674,0.00094627263,0.000041483854,0.0020551851,0.0015539555,0.0016292023,0.0011199238,0.00015361981,0.013643607],"genre_scores_gemma":[0.97912824,0.01631134,0.000936544,0.0014248717,0.000969947,0.00026439136,0.0006149909,0.000058888647,0.0002907568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992149,0.003186498,0.00151772,0.0007162579,0.001252652,0.00117789],"domain_scores_gemma":[0.9946248,0.00283369,0.0004014523,0.0005025816,0.0009151156,0.000722378],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008778302,0.0004087856,0.0006376236,0.0013745796,0.00026040705,0.0000758426,0.00090618787,0.0002761985,0.0024113536],"category_scores_gemma":[0.00077312806,0.00035458157,0.00020919088,0.0031310134,0.0010128128,0.0006630355,0.0003516227,0.0034973011,0.0015558525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03181684,0.005891287,0.10802296,0.0017971233,0.0023652974,0.0018416557,0.0055092974,0.009906884,0.12912557,0.013285739,0.13029923,0.5601381],"study_design_scores_gemma":[0.04593067,0.0014185603,0.005103102,0.0005305773,0.0003383863,0.000074416566,0.00084020203,0.043960694,0.27866784,0.011637236,0.61010957,0.0013887549],"about_ca_topic_score_codex":0.00006515607,"about_ca_topic_score_gemma":0.0000060138877,"teacher_disagreement_score":0.5587494,"about_ca_system_score_codex":0.00010937534,"about_ca_system_score_gemma":0.0005667827,"threshold_uncertainty_score":0.9998906},"labels":[],"label_agreement":null},{"id":"W4390477239","doi":"10.1016/j.ejps.2023.106689","title":"Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation","year":2024,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Oxymorphone; Oxycodone; Pharmacology; Pharmacokinetics; CYP2D6; UGT2B7; CYP3A4; Physiologically based pharmacokinetic modelling; Active metabolite; Opioid; Drug interaction; Chemistry; Medicine; Internal medicine; Glucuronidation; Receptor; Cytochrome P450; Metabolism; In vitro","score_opus":0.3695771790641956,"score_gpt":0.48213048425642424,"score_spread":0.11255330519222861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390477239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820408,0.014724202,0.0011365094,0.0007681912,0.00082029554,0.00025996697,0.000049648974,0.000029284076,0.00017105942],"genre_scores_gemma":[0.9851298,0.012971984,0.00068437785,0.00066204125,0.0005087827,0.0000029345517,0.0000019898762,0.000031080715,0.000007011943],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966346,0.0013672309,0.0007624007,0.00043029012,0.00036637273,0.00043907945],"domain_scores_gemma":[0.99724597,0.001783627,0.00027327184,0.000087058186,0.00015878784,0.00045129398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032220185,0.00035324568,0.0004125547,0.00034512032,0.0004186568,0.00015604189,0.00027406,0.00003411718,0.00010720358],"category_scores_gemma":[0.00019059607,0.00022438589,0.00012558336,0.00047347255,0.0010144246,0.00039184702,0.00020124478,0.0010309658,0.0000034386778],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051863596,0.0001415974,0.0005860838,0.000086417196,0.00022639388,0.000098992605,0.00066002266,0.33113077,0.61012584,0.000031757198,0.00006476084,0.0563287],"study_design_scores_gemma":[0.0018054136,0.00029617173,0.0023603463,0.00013114742,0.00046783237,0.00017998365,0.00009667618,0.9592189,0.03186514,0.00009179253,0.0032327557,0.00025384707],"about_ca_topic_score_codex":0.000010946693,"about_ca_topic_score_gemma":2.8817013e-7,"teacher_disagreement_score":0.6280881,"about_ca_system_score_codex":0.000036426965,"about_ca_system_score_gemma":0.00009009069,"threshold_uncertainty_score":0.9150191},"labels":[],"label_agreement":null},{"id":"W4390572203","doi":"10.3389/fgene.2023.1295963","title":"Moving towards the implementation of pharmacogenetic testing in Quebec","year":2024,"lang":"en","type":"review","venue":"Frontiers in Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Université de Sherbrooke","keywords":"Pharmacogenetics; Computer science; Data science; Genotype; Biology","score_opus":0.19186639285994792,"score_gpt":0.49436024732789835,"score_spread":0.3024938544679504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390572203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019144547,0.9888209,0.000090371504,0.00008790271,0.0064173564,0.0016954781,0.0002765687,0.00003450944,0.00066244666],"genre_scores_gemma":[0.0009173762,0.9953345,0.0021245407,0.00022517469,0.0005072236,0.00032107448,0.00006493996,0.00012436985,0.00038080828],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952911,0.0011792174,0.0017341237,0.0006658942,0.00033976554,0.00078991073],"domain_scores_gemma":[0.99853563,0.00027192495,0.0005456652,0.00039992592,0.000087853325,0.00015901301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015210537,0.0006819265,0.0015687349,0.00084053236,0.000086884895,0.0000507593,0.0010156876,0.00057657604,0.0001521193],"category_scores_gemma":[0.00005943604,0.00053504336,0.00038401558,0.0016609821,0.00025701718,0.000047453286,0.00040370997,0.0018051729,0.000029615943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010170824,0.000080142905,0.001098874,0.004855274,0.00030286782,0.00005326981,0.0008668868,0.00039826182,0.00008342523,0.000016287577,0.005936016,0.9862985],"study_design_scores_gemma":[0.0007743236,0.000031400563,0.00014818179,0.0011495808,0.0027547057,0.0000149861235,0.0004229066,0.0024077904,0.00058441894,0.00025484557,0.9909391,0.0005177526],"about_ca_topic_score_codex":0.00077386555,"about_ca_topic_score_gemma":0.00087792106,"teacher_disagreement_score":0.9857808,"about_ca_system_score_codex":0.00032193848,"about_ca_system_score_gemma":0.0012468405,"threshold_uncertainty_score":0.9997101},"labels":[],"label_agreement":null},{"id":"W4390599050","doi":"10.1002/cpdd.1364","title":"Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP3A; CYP3A4; Tacrolimus; Pharmacology; Medicine; Pharmacokinetics; Drug interaction; CYP3A5; Calcineurin; Crossover study; P-glycoprotein; Pharmacokinetic interaction; Cmax; Inducer; Cytochrome P450; Internal medicine; Metabolism; Chemistry; Transplantation; Antibiotics; Biochemistry","score_opus":0.07446660461163242,"score_gpt":0.4725914293935504,"score_spread":0.398124824781918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390599050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97961926,0.0011495036,0.0000473996,0.0038200095,0.011081115,0.0027824382,0.00015321017,0.00021617256,0.0011308846],"genre_scores_gemma":[0.99029404,0.0007139752,0.00026887885,0.0050304933,0.0010720819,0.0008136334,0.00012645782,0.000097020726,0.0015834285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917203,0.0029780432,0.0021939573,0.0014250589,0.00052345026,0.0011591766],"domain_scores_gemma":[0.9922435,0.005710079,0.00038138308,0.00039334636,0.00028100525,0.0009906705],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.006765561,0.0007785872,0.0012551952,0.00075293536,0.00028279415,0.00003967042,0.00072289596,0.0003274515,0.0023024692],"category_scores_gemma":[0.00038715478,0.0006514548,0.00033363744,0.0010602366,0.00032720144,0.00024757732,0.0003756463,0.0029700682,0.00089721906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06409511,0.010847031,0.13394354,0.002711745,0.004580063,0.002281061,0.014467175,0.034096945,0.0519399,0.0003650859,0.25444964,0.4262227],"study_design_scores_gemma":[0.01234826,0.00101259,0.037799653,0.00032121225,0.0011476378,0.000033148026,0.000111958565,0.01123,0.42862538,0.00009721654,0.50597143,0.0013015326],"about_ca_topic_score_codex":0.000030614898,"about_ca_topic_score_gemma":0.00023936798,"teacher_disagreement_score":0.42492118,"about_ca_system_score_codex":0.00042490946,"about_ca_system_score_gemma":0.00080368633,"threshold_uncertainty_score":0.9998807},"labels":[],"label_agreement":null},{"id":"W4390734338","doi":"10.1093/gbe/evad236","title":"Signatures of Co-evolution and Co-regulation in the CYP3A and CYP4F Genes in Humans","year":2024,"lang":"en","type":"article","venue":"Genome Biology and Evolution","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute; Université de Montréal; Mila - Quebec Artificial Intelligence Institute; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Alliance de recherche numérique du Canada; Fondation Institut de Cardiologie de Montréal; Université de Montréal; Institut de Cardiologie de Montréal; Canada Foundation for Innovation","keywords":"Biology; Gene; Evolutionary biology; Genetics; Computational biology","score_opus":0.056756904403381464,"score_gpt":0.41228698556459875,"score_spread":0.3555300811612173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390734338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91347784,0.084871314,0.00025897517,0.00034760556,0.00026785833,0.00026311367,0.00011048134,0.000015203915,0.00038758956],"genre_scores_gemma":[0.99463296,0.0048768767,0.000029509587,0.00015533935,0.00015545591,0.000025529187,0.00008679207,0.0000067857623,0.00003077088],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998719,0.00047544882,0.0002578294,0.00027209503,0.000049511695,0.00022613126],"domain_scores_gemma":[0.9996103,0.00019718852,0.000052834617,0.00007289698,0.000021205271,0.00004558383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010103927,0.0001357856,0.00018475082,0.00021429302,0.00012522165,0.000011830633,0.00007630616,0.00032138446,0.00004340748],"category_scores_gemma":[0.000016898071,0.00010656345,0.000024197367,0.00017889676,0.00038809562,0.00007276603,0.00003315068,0.00034949393,0.0000039067836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023833822,0.000102548554,0.2748011,0.0001571366,0.00006940698,0.000008603173,0.0026935572,0.00040787202,0.6661905,0.042506374,0.0002016849,0.012622892],"study_design_scores_gemma":[0.00083369785,0.0000970009,0.95072,0.000014105435,0.00006894762,0.000018608422,0.00022332973,0.004003119,0.0018807327,0.014641682,0.027347207,0.00015158406],"about_ca_topic_score_codex":0.000082582286,"about_ca_topic_score_gemma":0.000085962434,"teacher_disagreement_score":0.6759189,"about_ca_system_score_codex":0.000034051533,"about_ca_system_score_gemma":0.000036056917,"threshold_uncertainty_score":0.43455312},"labels":[],"label_agreement":null},{"id":"W4391223294","doi":"10.1002/hsr2.1844","title":"Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic review","year":2024,"lang":"en","type":"review","venue":"Health Science Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba","funders":"","keywords":"Pharmacogenomics; Pharmacy; Clinical pharmacy; Medicine; Pharmacy practice; Perception; Medical education; Family medicine; MEDLINE; Health care; Pharmacist; Psychology; Nursing; Pharmacology; Political science","score_opus":0.2646831729790185,"score_gpt":0.5970368052841961,"score_spread":0.3323536323051776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391223294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010412366,0.985838,0.000004817161,0.00019464588,0.0044554407,0.0076790317,0.00013797104,0.00023795606,0.0004108843],"genre_scores_gemma":[0.00221806,0.9923982,0.00008243218,0.0023743322,0.0005135817,0.0014030791,0.000054734064,0.00014117625,0.0008144187],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99058574,0.0010714001,0.0035344365,0.002225066,0.0010220011,0.0015613653],"domain_scores_gemma":[0.9944953,0.00027516115,0.0019154907,0.0007363605,0.00032533155,0.002252389],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.012402452,0.0012873926,0.004539603,0.00097088557,0.0011084031,0.0004306261,0.001081583,0.000302502,0.00025670545],"category_scores_gemma":[0.00023178098,0.0010146537,0.00052216975,0.0017781868,0.0016684505,0.00044976507,0.001400436,0.0022923676,0.00019120095],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004439646,0.00027509374,0.00045246125,0.8434064,0.00046268033,0.00041040423,0.0006192822,3.8067532e-7,0.000017732164,0.00002163102,0.004269122,0.15006039],"study_design_scores_gemma":[0.00046661042,0.000043484535,0.000050756254,0.20033135,0.0130745955,0.007340371,0.00003565859,0.00014378017,0.000010858522,0.000033359825,0.7773824,0.0010867821],"about_ca_topic_score_codex":0.000023079388,"about_ca_topic_score_gemma":0.0000034773905,"teacher_disagreement_score":0.77311325,"about_ca_system_score_codex":0.00058527343,"about_ca_system_score_gemma":0.003193428,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W4391482464","doi":"10.3389/fphar.2024.1232595","title":"Measurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study","year":2024,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Warren Y. Soper Charitable Trust; Jewish General Hospital; Fonds de Recherche du Québec - Santé; Fondation De Famille Alvin Segal; Genome Canada; Faculty of Medicine, McGill University; McGill University","keywords":"CYP1A2; CYP3A4; Pharmacology; Medicine; Cohort; CYP2C19; Cytochrome P450; Bioinformatics; Biology; Internal medicine; Metabolism","score_opus":0.09208448011742877,"score_gpt":0.39002576583360976,"score_spread":0.297941285716181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391482464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96730006,0.025007997,0.0010804974,0.00016391379,0.003043072,0.0021509498,0.00026193136,0.000053943575,0.0009376452],"genre_scores_gemma":[0.9960883,0.0023461124,0.0005835258,0.00026544175,0.00013044063,0.00046948218,0.000008261925,0.000055389704,0.000053004278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948098,0.0020536594,0.0010096687,0.0008503844,0.00052131707,0.00075513776],"domain_scores_gemma":[0.9986637,0.00038227934,0.000281502,0.00029375043,0.0001274762,0.00025126597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049213003,0.00045766853,0.0011299059,0.0008786019,0.00008114634,0.00001942734,0.00064980297,0.00027962693,0.00016859584],"category_scores_gemma":[0.00012090511,0.00047706257,0.000095733536,0.0009014959,0.00045429787,0.00016260466,0.00046560823,0.0012682183,0.0000023669027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010685053,0.0071630715,0.5493451,0.0005552632,0.0016169233,0.00006196989,0.003172612,0.00081286224,0.39023077,0.00004469276,0.02773392,0.018194342],"study_design_scores_gemma":[0.03423769,0.004019992,0.50711095,0.0003152086,0.005163339,0.00007114828,0.0035657568,0.10591659,0.29403305,0.0016596351,0.0413708,0.0025358126],"about_ca_topic_score_codex":0.00021291275,"about_ca_topic_score_gemma":0.00003521095,"teacher_disagreement_score":0.10510372,"about_ca_system_score_codex":0.00021743789,"about_ca_system_score_gemma":0.0002936826,"threshold_uncertainty_score":0.9997681},"labels":[],"label_agreement":null},{"id":"W4391487769","doi":"10.1177/23743735241229384","title":"Patients’ Experiences of a Precision Medicine Clinic","year":2024,"lang":"en","type":"article","venue":"Journal of Patient Experience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Feeling; Family medicine; Health care; Psychology","score_opus":0.11201083667860304,"score_gpt":0.4807917054613771,"score_spread":0.36878086878277405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391487769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771551,0.011321652,0.00015967386,0.0001235774,0.009197351,0.00017059717,0.0000074311065,0.000014620195,0.0018500119],"genre_scores_gemma":[0.99715954,0.0016447275,0.00028015932,0.00037589777,0.0003754979,0.000019698296,0.000001621701,0.000014442665,0.00012840162],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974675,0.00027591217,0.001219305,0.00021099714,0.00056749344,0.0002587963],"domain_scores_gemma":[0.99819875,0.000476704,0.00054806453,0.0001428601,0.00037428728,0.0002593644],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007038107,0.00018339815,0.0004055989,0.00027024225,0.00008069042,0.000014063388,0.00041143753,0.0001305872,0.0034558303],"category_scores_gemma":[0.0003493439,0.00012668666,0.00017659267,0.0003982616,0.00041462554,0.0002577369,0.00008761491,0.00047969643,0.000029391995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010261707,0.0011899464,0.010341558,0.00014546237,0.00023822374,0.00015630205,0.60974026,0.00019703862,0.07242068,0.0004149141,0.01789541,0.28623402],"study_design_scores_gemma":[0.0028692298,0.0036404629,0.0018704784,0.0005108859,0.00026965307,0.00008828334,0.04241836,0.0015245329,0.26296893,0.00085160823,0.6825511,0.00043646904],"about_ca_topic_score_codex":0.0000024366143,"about_ca_topic_score_gemma":1.7681461e-7,"teacher_disagreement_score":0.6646557,"about_ca_system_score_codex":0.00003404148,"about_ca_system_score_gemma":0.000110949535,"threshold_uncertainty_score":0.9974551},"labels":[],"label_agreement":null},{"id":"W4391751786","doi":"10.1038/s41398-024-02809-y","title":"Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data","year":2024,"lang":"en","type":"article","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Women and Children’s Health Research Institute; Alberta Hospital Edmonton; University of Alberta","funders":"Alberta Innovates; Canada Foundation for Innovation; Alberta Precision Laboratories","keywords":"Haplotype; Allele; CYP2D6; Genetics; Biology; Genotype; Gene","score_opus":0.37549385761937176,"score_gpt":0.5610005516089334,"score_spread":0.1855066939895616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391751786","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43285188,0.06419022,0.4625322,0.00736265,0.017581722,0.001078483,0.0030046029,0.00042190732,0.010976364],"genre_scores_gemma":[0.8848097,0.00032268703,0.11122892,0.0011449334,0.0016975853,0.0000071378818,0.0005739217,0.0000680114,0.00014715668],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978055,0.0004901068,0.0005507456,0.0005433291,0.0002935245,0.00031683486],"domain_scores_gemma":[0.9990014,0.00022173142,0.00009731583,0.00040314737,0.00007844924,0.0001979431],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013131925,0.00024215286,0.00027637175,0.00019670813,0.00018424065,0.00004104391,0.00052017387,0.00023258028,0.001546847],"category_scores_gemma":[0.000011545928,0.00024184253,0.000119281125,0.00035493597,0.00010720347,0.00040106065,0.000045088258,0.00055679877,0.000043850203],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007250927,0.0011279234,0.0064412896,0.0005921244,0.0016549745,0.000028732333,0.0029583187,0.046174698,0.7596098,0.057770073,0.004873617,0.11804334],"study_design_scores_gemma":[0.0018377794,0.00006440237,0.0019164275,0.00005713563,0.0010678668,0.00006362253,0.00009610812,0.77869594,0.012740264,0.01921123,0.18372995,0.00051929214],"about_ca_topic_score_codex":0.000026451446,"about_ca_topic_score_gemma":0.000028691276,"teacher_disagreement_score":0.74686956,"about_ca_system_score_codex":0.0000128781385,"about_ca_system_score_gemma":0.00048268426,"threshold_uncertainty_score":0.99936587},"labels":[],"label_agreement":null},{"id":"W4391838815","doi":"10.1097/fpc.0000000000000523","title":"Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Genotyping; Pharmacogenomics; Genetics; Allele; Biology; Computational biology; Genome; Pharmacogenetics; Genome-wide association study; Genotype; Single-nucleotide polymorphism; Gene","score_opus":0.09909228692229773,"score_gpt":0.41518326556243795,"score_spread":0.31609097864014024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391838815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9058757,0.0773289,0.0063189995,0.00029473336,0.0013011098,0.0008234896,0.0010368931,0.00014621827,0.0068739625],"genre_scores_gemma":[0.9467404,0.049389407,0.0011502958,0.0014030983,0.0005619202,0.000067606954,0.00020372272,0.000079067126,0.00040449834],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961782,0.0004321927,0.0011379705,0.0010026327,0.0003311183,0.00091785775],"domain_scores_gemma":[0.99784625,0.00057633687,0.00029578138,0.00037271698,0.00021327338,0.00069562264],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011218007,0.00068582286,0.00107712,0.0008425964,0.00033802286,0.00013591946,0.00059334346,0.00029431898,0.0015127028],"category_scores_gemma":[0.00002034056,0.00071217574,0.0005512584,0.0012240369,0.00043091373,0.00014531711,0.00035252748,0.00091313245,0.00012839059],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050125853,0.00040912634,0.006089509,0.00040424592,0.01229954,0.00012159468,0.006259252,0.085959725,0.844258,0.0016586701,0.0011457442,0.040893327],"study_design_scores_gemma":[0.0018664347,0.00008969066,0.0026120676,0.000012319808,0.006873026,0.00003368041,0.00016095818,0.14535885,0.14648573,0.0007897248,0.6948532,0.00086433615],"about_ca_topic_score_codex":0.000028539524,"about_ca_topic_score_gemma":0.00001300017,"teacher_disagreement_score":0.69777226,"about_ca_system_score_codex":0.0001255447,"about_ca_system_score_gemma":0.0002703163,"threshold_uncertainty_score":0.99953294},"labels":[],"label_agreement":null},{"id":"W4391878438","doi":"10.3389/jpps.2024.12671","title":"Revolutionizing pharmacokinetics: the dawn of AI-powered analysis","year":2024,"lang":"en","type":"editorial","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Computer science; Drug discovery; Data science; Engineering ethics; Artificial intelligence; Pharmacology; Medicine; Engineering; Bioinformatics; Biology","score_opus":0.12183269623071001,"score_gpt":0.508050274395433,"score_spread":0.386217578164723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391878438","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009496556,0.1483333,0.00042364595,0.0070573967,0.8275264,0.0008835912,0.0012015123,0.00010222797,0.004975405],"genre_scores_gemma":[0.386348,0.07167442,0.0005510096,0.0032633303,0.5367781,0.000050953542,0.00006822345,0.00017283122,0.0010931584],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98725814,0.0024029417,0.0037209082,0.0011347074,0.003842154,0.0016411594],"domain_scores_gemma":[0.98867565,0.004938651,0.0025166157,0.00054741715,0.0021360691,0.0011856108],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012273125,0.001174935,0.0023196177,0.001927813,0.000839453,0.00035561615,0.0044646654,0.0008519428,0.0042880136],"category_scores_gemma":[0.001376838,0.0007987199,0.002411941,0.0054053897,0.0033051693,0.00058483024,0.0008778022,0.009681476,0.00016653401],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009578621,0.0007142969,0.0007582828,0.0005647667,0.007996086,0.00026978884,0.0007181085,0.0038868024,0.032652017,0.0005486903,0.91687113,0.034062166],"study_design_scores_gemma":[0.0029647874,0.00020654556,0.000023416584,0.00013907484,0.02549981,0.00006881953,0.00011002022,0.020412363,0.037599724,0.0008282863,0.91139793,0.0007492173],"about_ca_topic_score_codex":0.00007100472,"about_ca_topic_score_gemma":0.000011103988,"teacher_disagreement_score":0.37685144,"about_ca_system_score_codex":0.0002977643,"about_ca_system_score_gemma":0.0027331642,"threshold_uncertainty_score":0.9994464},"labels":[],"label_agreement":null},{"id":"W4392003043","doi":"10.3389/fninf.2023.1244336","title":"Comparing feature selection and machine learning approaches for predicting CYP2D6 methylation from genetic variation","year":2024,"lang":"en","type":"article","venue":"Frontiers in Neuroinformatics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council; Ministry of Health, British Columbia; Agency for Science, Technology and Research; National Research Foundation","keywords":"Single-nucleotide polymorphism; Genome-wide association study; Computational biology; Biology; DNA methylation; Feature selection; CpG site; Genetics; Heritability; Elastic net regularization; Genetic association; Computer science; Gene; Artificial intelligence; Genotype; Gene expression","score_opus":0.09958599240446081,"score_gpt":0.3419818027543144,"score_spread":0.24239581034985358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392003043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74096334,0.009271672,0.2443033,0.00025149423,0.0035282883,0.0007889845,0.00008663618,0.00019414115,0.0006121313],"genre_scores_gemma":[0.9606709,0.0013208963,0.037133496,0.00017322783,0.00035947323,0.00005767521,0.00015465847,0.00003574942,0.00009395245],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987086,0.00019770532,0.00040863035,0.0002469543,0.00013391906,0.00030419324],"domain_scores_gemma":[0.9993619,0.00029639926,0.00013146318,0.00007390074,0.000032776163,0.0001035875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005717337,0.00020863295,0.00026608232,0.00027209893,0.00022110585,0.00011444877,0.000111840316,0.00022176781,0.000010523844],"category_scores_gemma":[0.00012070358,0.00021414232,0.000058919166,0.000283646,0.000037113507,0.00029068577,0.000057994082,0.00088709046,0.0000032527164],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003515568,0.0000968615,0.15775305,0.0005974372,0.00040725683,0.000009121906,0.012128299,0.6045971,0.0056363796,0.0007207775,0.002365967,0.21533622],"study_design_scores_gemma":[0.0008847524,0.00004403101,0.011627236,0.000024868272,0.00021611406,0.000006292583,0.00014806607,0.94601035,0.0019782044,0.0014461598,0.03742824,0.00018569974],"about_ca_topic_score_codex":0.00001686973,"about_ca_topic_score_gemma":0.000009994341,"teacher_disagreement_score":0.34141326,"about_ca_system_score_codex":0.000059286445,"about_ca_system_score_gemma":0.00004232723,"threshold_uncertainty_score":0.873247},"labels":[],"label_agreement":null},{"id":"W4392004785","doi":"10.3390/ijms25052522","title":"Stereoselective Analysis of the Antiseizure Activity of Fenfluramine and Norfenfluramine in Mice: Is l-Norfenfluramine a Better Follow-Up Compound to Racemic-Fenfluramine?","year":2024,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Hebrew University of Jerusalem","keywords":"Fenfluramine; Pharmacology; Chemistry; Medicine; Biochemistry","score_opus":0.05030341087919062,"score_gpt":0.4247452365154824,"score_spread":0.3744418256362918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392004785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893596,0.003209368,0.0006686979,0.004447756,0.0017515715,0.0002081714,0.000157608,0.0000056837575,0.00019150488],"genre_scores_gemma":[0.9976891,0.00033679508,0.00048369096,0.0012682179,0.00009910588,0.000004461004,0.0000026424534,0.000012362529,0.00010357281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974388,0.00034616247,0.0007655769,0.0003395958,0.0008333221,0.00027656092],"domain_scores_gemma":[0.99825203,0.00043460148,0.0004729748,0.00013424171,0.00056131656,0.00014482696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00131702,0.00022888843,0.00054780545,0.0012492517,0.00007366831,0.00007251759,0.0009907212,0.00013141638,0.000117177675],"category_scores_gemma":[0.00017012678,0.00016521708,0.00034355198,0.0020159986,0.0005119475,0.0002435528,0.00026521645,0.0005333506,0.000002030902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035781038,0.00021901044,0.024863852,0.000033197506,0.0021572178,0.00013516781,0.0021251289,0.003118631,0.9444651,0.0002656149,0.00021443248,0.022044837],"study_design_scores_gemma":[0.0020217828,0.0002939642,0.100179315,0.00016641716,0.001442801,0.00017361573,0.00020462643,0.024698438,0.86242557,0.00052870304,0.0075798403,0.0002849103],"about_ca_topic_score_codex":0.00008682759,"about_ca_topic_score_gemma":0.00005751895,"teacher_disagreement_score":0.082039505,"about_ca_system_score_codex":0.00007200325,"about_ca_system_score_gemma":0.00021693432,"threshold_uncertainty_score":0.6737357},"labels":[],"label_agreement":null},{"id":"W4392037327","doi":"10.1038/s41525-024-00403-1","title":"A call for increased inclusivity and global representation in pharmacogenetic testing","year":2024,"lang":"en","type":"article","venue":"npj Genomic Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ted Rogers Centre for Heart Research; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; Sick Kids Foundation","keywords":"Pharmacogenetics; Genetic testing; Dosing; Cohort; Genetic variation; Genetics; Medicine; Adverse effect; Biology; Gene; Genotype; Internal medicine","score_opus":0.18311857179338334,"score_gpt":0.4958389406991425,"score_spread":0.31272036890575916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392037327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642872,0.022158334,0.00057340116,0.002657805,0.0018443216,0.00096359104,0.0001472865,0.00010310678,0.00726495],"genre_scores_gemma":[0.9923119,0.0007722631,0.0007756309,0.004664052,0.0011293269,0.00013555045,0.00004447446,0.000028124,0.00013867434],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813664,0.0002888888,0.0004816198,0.00051615265,0.00014513134,0.000431545],"domain_scores_gemma":[0.99847835,0.0009337434,0.00007400112,0.00013769501,0.00007248934,0.0003037394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014048619,0.00023866387,0.0003546186,0.00013664192,0.00015162272,0.000020693882,0.00017505902,0.00016410736,0.00021998996],"category_scores_gemma":[0.0002743903,0.00021695936,0.000047627145,0.00040176796,0.000258601,0.00006268714,0.0001337179,0.00036999583,0.000021670272],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038798747,0.0001082726,0.01423473,0.0003314607,0.00015943412,0.00014357157,0.0011551323,0.000480513,0.79508096,0.0022460448,0.005751556,0.17992032],"study_design_scores_gemma":[0.0159753,0.0003975498,0.030647231,0.00024786222,0.0013908307,0.0003161718,0.00020361772,0.31106797,0.03733459,0.01985345,0.58168274,0.00088270823],"about_ca_topic_score_codex":0.0004629318,"about_ca_topic_score_gemma":0.00009631986,"teacher_disagreement_score":0.7577464,"about_ca_system_score_codex":0.00013199123,"about_ca_system_score_gemma":0.00014135569,"threshold_uncertainty_score":0.88473463},"labels":[],"label_agreement":null},{"id":"W4392659185","doi":"10.3390/genes15030352","title":"A New Cloud-Native Tool for Pharmacogenetic Analysis","year":2024,"lang":"en","type":"article","venue":"Genes","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Computer science; Pipeline (software); Cloud computing; Workflow; Genomics; Data science; Computational biology; Data mining; Genome; Biology; Database; Gene; Genetics","score_opus":0.11050324154634676,"score_gpt":0.4666755262621332,"score_spread":0.35617228471578644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392659185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72361296,0.15678148,0.09029995,0.003434825,0.016707959,0.0019741305,0.0012279146,0.0007084869,0.005252312],"genre_scores_gemma":[0.9634525,0.006234793,0.0054918,0.0038863386,0.0054458873,0.00036935793,0.00016147007,0.00010148365,0.014856363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798065,0.0002092818,0.00041674037,0.0005985945,0.00019550775,0.0005992236],"domain_scores_gemma":[0.99878883,0.0004622684,0.00006877706,0.00021628564,0.000116286574,0.00034754668],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006435634,0.00032847188,0.00040855742,0.000423512,0.00021577804,0.00009018136,0.00036446226,0.00021734019,0.0038008231],"category_scores_gemma":[0.00003158521,0.00030546685,0.0005474168,0.0010938866,0.000076619224,0.000088101646,0.00009472592,0.00033612805,0.00028927551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028858145,0.00012336302,0.0015825508,0.00013739301,0.006790143,0.000053960805,0.0011190656,0.007799553,0.2342913,0.0031302026,0.08440655,0.66027737],"study_design_scores_gemma":[0.000937901,0.000040337898,0.0003743585,0.000004683077,0.0046654055,0.000007921817,0.000023778972,0.03141097,0.1692168,0.0019101831,0.79106784,0.00033985727],"about_ca_topic_score_codex":0.000014798861,"about_ca_topic_score_gemma":0.000009342516,"teacher_disagreement_score":0.7066613,"about_ca_system_score_codex":0.000043272044,"about_ca_system_score_gemma":0.0002632948,"threshold_uncertainty_score":0.99993974},"labels":[],"label_agreement":null},{"id":"W4392700120","doi":"10.1097/fpc.0000000000000526","title":"Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"VKORC1; Warfarin; CYP2C9; Odds ratio; Internal medicine; Pharmacogenetics; Univariate analysis; Medicine; Vitamin K epoxide reductase; Logistic regression; Genotype; Single-nucleotide polymorphism; Biology; Multivariate analysis; Genetics; Gene; Atrial fibrillation","score_opus":0.03598974033285063,"score_gpt":0.3694414487508352,"score_spread":0.33345170841798455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392700120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534487,0.044315383,0.000040780244,0.00040373352,0.0005590368,0.0005623152,0.0004326795,0.000027506896,0.00020986443],"genre_scores_gemma":[0.92272294,0.076057725,0.00041987514,0.00034219734,0.00025581787,0.000015677353,0.00003427543,0.000047074085,0.00010441671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789846,0.00024036548,0.000650614,0.0005598551,0.00018583101,0.00046487965],"domain_scores_gemma":[0.9987276,0.0005352472,0.00016377264,0.00012000593,0.00007187267,0.00038147706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071235537,0.0003673599,0.00049653475,0.00026545854,0.00015187396,0.0000687102,0.00013356809,0.00028146917,0.000048401012],"category_scores_gemma":[0.00005083146,0.00036115572,0.00004774158,0.00024225868,0.00021310152,0.000074422736,0.00031620933,0.0005226688,0.00000409352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020816676,0.00013843272,0.71584004,0.00019829188,0.00044768682,0.000013502355,0.0015744354,0.00015803808,0.05285813,0.00008362732,0.00009985661,0.22837979],"study_design_scores_gemma":[0.006479887,0.00015370092,0.9090021,0.000036564285,0.00093668816,0.000016584305,0.000025724863,0.013254346,0.013765638,0.0009600273,0.05480976,0.000558928],"about_ca_topic_score_codex":0.000038053822,"about_ca_topic_score_gemma":0.000011086773,"teacher_disagreement_score":0.22782086,"about_ca_system_score_codex":0.000058022964,"about_ca_system_score_gemma":0.000060849547,"threshold_uncertainty_score":0.99988407},"labels":[],"label_agreement":null},{"id":"W4392711372","doi":"10.1515/jbcpp-2023-0250","title":"Maternal separation influences hepatic drug-metabolizing CYP450 gene expression without pathological changes in adult mice","year":2024,"lang":"en","type":"article","venue":"Journal of Basic and Clinical Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Al-Zaytoonah University of Jordan; University of Jordan","keywords":"Pathological; Gene expression; Gene; Drug; Biology; Pharmacology; Medicine; Cell biology; Endocrinology; Internal medicine; Genetics","score_opus":0.07965093412923616,"score_gpt":0.4734750038522279,"score_spread":0.3938240697229918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392711372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809031,0.012754593,0.000043629425,0.0014906,0.0044071022,0.00023888415,0.000027775392,0.000028840703,0.000105510044],"genre_scores_gemma":[0.95233035,0.040224295,0.0003566165,0.005204464,0.0017608582,0.000020895695,0.0000054933103,0.000020135518,0.00007688737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958311,0.001898959,0.0011522962,0.0004882277,0.00015281815,0.0004766221],"domain_scores_gemma":[0.9975786,0.0013895178,0.0004336312,0.00008348897,0.0001568399,0.0003578991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002202195,0.0003234775,0.0008757968,0.00026435926,0.00016583233,0.000031665928,0.00025721616,0.00051014597,0.00045105678],"category_scores_gemma":[0.00011147729,0.00024115237,0.00016337812,0.00019218186,0.0006855274,0.0002177675,0.00016399896,0.0018085897,0.000019606176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016039814,0.00035059915,0.08222761,0.0001792399,0.00028256036,0.00033976816,0.0006564267,0.000118781725,0.8945137,0.00016464679,0.0010335447,0.018529132],"study_design_scores_gemma":[0.010246183,0.001341994,0.3930752,0.00023889053,0.0018473427,0.0011416073,0.0002627208,0.010476893,0.53549325,0.0053591114,0.039649952,0.0008668209],"about_ca_topic_score_codex":0.000012625176,"about_ca_topic_score_gemma":0.000015162423,"teacher_disagreement_score":0.3590204,"about_ca_system_score_codex":0.00002101571,"about_ca_system_score_gemma":0.00011526066,"threshold_uncertainty_score":0.98339087},"labels":[],"label_agreement":null},{"id":"W4392895297","doi":"10.1080/15622975.2024.2321553","title":"Frequencies of <i>CYP2C19</i> and <i>CYP2D6</i> gene variants in a German inpatient sample with mood and anxiety disorders","year":2024,"lang":"en","type":"article","venue":"The World Journal of Biological Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"CYP2C19; German; Anxiety; CYP2D6; Mood; Cohort; Affect (linguistics); Pharmacogenomics; Gene; Medicine; Sample (material); Mood disorders; Psychology; Psychiatry; Clinical psychology; Genotype; Genetics; Internal medicine; Pharmacology; Biology; Chemistry","score_opus":0.043176747399623905,"score_gpt":0.37076151614059666,"score_spread":0.32758476874097275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392895297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608723,0.033100594,0.00010902984,0.003825382,0.001003302,0.00019439384,0.00007481145,0.00001107343,0.00080914167],"genre_scores_gemma":[0.9789808,0.01799748,0.0013819949,0.0013786362,0.0002198296,0.000005755189,0.000002340706,0.000011675487,0.000021517602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985303,0.00035722228,0.0005086136,0.00020087574,0.00013472897,0.00026824878],"domain_scores_gemma":[0.9990675,0.00042566351,0.00021094875,0.000103227845,0.00004325714,0.00014939267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009942349,0.00019305859,0.00034599644,0.00016119113,0.00009370106,0.00002149784,0.00022182016,0.00011345042,0.000094930176],"category_scores_gemma":[0.00002622991,0.000103580096,0.000081416816,0.00036742352,0.00046201338,0.000072064526,0.00008627868,0.0007817132,0.0000011899058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037147538,0.001561208,0.7117665,0.0003327945,0.001239447,0.000055138655,0.0040361388,0.00080296234,0.12089847,0.026703132,0.0036388438,0.12525061],"study_design_scores_gemma":[0.012485097,0.0031902478,0.42600337,0.00055302726,0.0014064017,0.001192411,0.0009911216,0.0027443776,0.01607723,0.17914963,0.35480618,0.0014009227],"about_ca_topic_score_codex":0.000017667675,"about_ca_topic_score_gemma":0.00013227963,"teacher_disagreement_score":0.35116735,"about_ca_system_score_codex":0.000013134316,"about_ca_system_score_gemma":0.00008710276,"threshold_uncertainty_score":0.42238736},"labels":[],"label_agreement":null},{"id":"W4393073512","doi":"10.1038/s41467-024-46559-3","title":"Diindoles produced from commensal microbiota metabolites function as endogenous CAR/Nr1i3 ligands","year":2024,"lang":"en","type":"article","venue":"Nature Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Natural Sciences and Engineering Research Council of Canada; University of Illinois at Urbana-Champaign; Canadian Institutes of Health Research; American Cancer Society; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services; Government of Canada; Agence Nationale de la Recherche","keywords":"Nuclear receptor; Microbiome; Biology; Human microbiome; Computational biology; Function (biology); Bacteria; Receptor; Host (biology); Gene; Cell biology; Genetics; Transcription factor","score_opus":0.11939479922796875,"score_gpt":0.4313304683252504,"score_spread":0.31193566909728165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56118035,0.40160355,0.000032140764,0.012584463,0.006409413,0.0007945467,0.0013262786,0.0005751249,0.015494137],"genre_scores_gemma":[0.97884506,0.012516076,0.00055328355,0.005474188,0.00084458926,0.00013827169,0.001011624,0.00006532339,0.0005516104],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978544,0.00054122193,0.000443187,0.00051330414,0.00019074375,0.0004571065],"domain_scores_gemma":[0.9970493,0.0009744391,0.0001077785,0.0014014018,0.00021957462,0.00024752138],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006168655,0.00035288787,0.00035723762,0.00022579015,0.0006802389,0.00014178862,0.0013410852,0.00073724514,0.0005387899],"category_scores_gemma":[0.00014631441,0.00033154577,0.00022265023,0.00058619835,0.0002798296,0.00016035578,0.00052786455,0.0032541093,0.0005865546],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096414136,0.00039764674,0.0012221799,0.000025135123,0.00074824993,0.000015357515,0.0011431571,0.000018006458,0.9485349,0.014062347,0.015982648,0.017753942],"study_design_scores_gemma":[0.00053824804,0.000025367097,0.0008618329,0.000018714618,0.0007282556,0.000035826117,0.00008807226,0.0006567615,0.32158056,0.0014994978,0.6737004,0.00026643442],"about_ca_topic_score_codex":0.000095594,"about_ca_topic_score_gemma":0.000066207904,"teacher_disagreement_score":0.65771776,"about_ca_system_score_codex":0.000066759225,"about_ca_system_score_gemma":0.00022089522,"threshold_uncertainty_score":0.99991363},"labels":[],"label_agreement":null},{"id":"W4393311212","doi":"10.1021/acscatal.4c00086","title":"Choose Your Own Adventure: A Comprehensive Database of Reactions Catalyzed by Cytochrome P450 BM3 Variants","year":2024,"lang":"en","type":"article","venue":"ACS Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs; Government of Canada","keywords":"Catalysis; Cytochrome P450; Chemistry; Database; Combinatorial chemistry; Computer science; Organic chemistry; Enzyme","score_opus":0.0872332195924262,"score_gpt":0.42037099045078896,"score_spread":0.33313777085836277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393311212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95428926,0.033979237,0.0004395124,0.001046925,0.001803035,0.00061043334,0.0058619827,0.00022841552,0.0017412174],"genre_scores_gemma":[0.9884283,0.0058129258,0.0001982617,0.0007160585,0.00037132215,0.00011329244,0.0027999463,0.00006523102,0.0014946496],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973731,0.00032044374,0.0007119399,0.00068962446,0.00034377162,0.0005610897],"domain_scores_gemma":[0.99810404,0.00040671605,0.00021902473,0.00066165905,0.00020225382,0.00040632873],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005044814,0.00039888275,0.00059046486,0.00037080754,0.00024058613,0.00004802162,0.00055319566,0.0003046515,0.0017229189],"category_scores_gemma":[0.00009209288,0.00037938534,0.0003097679,0.0011010073,0.00025028025,0.00030582346,0.00027452875,0.00087964046,0.0005138243],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001165819,0.0004772712,0.0000864934,0.00024519672,0.0015707203,0.00012717709,0.00068930816,0.00016715357,0.9560064,0.00032865466,0.026142113,0.014042922],"study_design_scores_gemma":[0.0013604837,0.000027708053,0.0012386357,0.000048085807,0.002385715,0.00007204591,0.00017804487,0.0021038083,0.4845393,0.00021227231,0.5073838,0.0004500707],"about_ca_topic_score_codex":0.00031706697,"about_ca_topic_score_gemma":0.000010308057,"teacher_disagreement_score":0.48124173,"about_ca_system_score_codex":0.00006992997,"about_ca_system_score_gemma":0.00018419315,"threshold_uncertainty_score":0.99986583},"labels":[],"label_agreement":null},{"id":"W4394128195","doi":"10.6084/m9.figshare.20164657","title":"Additional file 3 of Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Quantitative structure–activity relationship; Group (periodic table); Molecule; Chemistry; Small molecule; Computational biology; Stereochemistry; Computational chemistry; Biology; Biochemistry; Organic chemistry","score_opus":0.11617462400845852,"score_gpt":0.3352030744840913,"score_spread":0.2190284504756328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394128195","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050103504,0.0011230971,1.9646053e-7,0.0000581601,0.00008974021,0.0004532965,0.9481425,0.000006296245,0.000023149227],"genre_scores_gemma":[0.023819145,0.0000683429,0.00003891848,0.0002686491,0.00005346354,0.00029955446,0.9754286,0.000012142451,0.000011219575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998449,0.00047130592,0.0004479867,0.00025176845,0.00020665339,0.00017328183],"domain_scores_gemma":[0.99738145,0.0017912036,0.0004481718,0.00016823702,0.00013657911,0.00007436707],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002038919,0.00020168496,0.00028325713,0.00012998168,0.0002277643,0.0000140578995,0.00024602725,0.00016136741,0.6536611],"category_scores_gemma":[0.0009983071,0.00016361874,0.0000525691,0.00032035317,0.000091677306,0.00005609374,0.00026838842,0.00054001773,0.0000044933627],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011244153,0.000029904842,0.000035893605,0.00017493586,0.00008778647,0.0000021265314,0.0001526832,0.0014182456,0.014548776,0.000019651114,0.98315775,0.00025978536],"study_design_scores_gemma":[0.00052737485,0.00004333582,0.010362193,0.00031003446,0.00010456406,0.000010497994,0.000121424164,0.0016790555,0.013648127,0.00009561386,0.97289985,0.0001979457],"about_ca_topic_score_codex":0.00009747861,"about_ca_topic_score_gemma":0.00009926443,"teacher_disagreement_score":0.65365654,"about_ca_system_score_codex":0.000024658375,"about_ca_system_score_gemma":0.00020581191,"threshold_uncertainty_score":0.66721785},"labels":[],"label_agreement":null},{"id":"W4394206967","doi":"10.6084/m9.figshare.20164660","title":"Additional file 4 of Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Quantitative structure–activity relationship; Group (periodic table); Molecule; Chemistry; Small molecule; Stereochemistry; Biochemistry; Organic chemistry","score_opus":0.11682425758372002,"score_gpt":0.3355695517308271,"score_spread":0.21874529414710708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394206967","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04993913,0.0011265087,1.974688e-7,0.000058086815,0.00008912621,0.00045367985,0.9483039,0.0000063039915,0.000023105977],"genre_scores_gemma":[0.024273582,0.00006832369,0.000038940478,0.00026880266,0.00005302806,0.00029948808,0.9749748,0.000012136683,0.000010911129],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984489,0.00047125755,0.00044811243,0.00025178824,0.0002066432,0.00017329725],"domain_scores_gemma":[0.9973806,0.0017938834,0.00044822568,0.0001683047,0.00013458384,0.0000743692],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002040203,0.00020169596,0.00028330958,0.0001300291,0.0002278532,0.000014063768,0.00024616922,0.0001613781,0.6506575],"category_scores_gemma":[0.0009873536,0.00016364313,0.00005257229,0.00032032107,0.00009169022,0.000056100173,0.00026846866,0.00054000464,0.0000044212447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113541035,0.000029965022,0.000036014615,0.00017414089,0.00008792958,0.0000021357769,0.00015305103,0.001404992,0.0143989995,0.000020243146,0.9833189,0.00026004654],"study_design_scores_gemma":[0.00053033093,0.00004429796,0.010491654,0.00031332948,0.00010609999,0.00001067588,0.00012277724,0.0016983316,0.01354723,0.00009721666,0.97283834,0.0001997097],"about_ca_topic_score_codex":0.000096799165,"about_ca_topic_score_gemma":0.00009958369,"teacher_disagreement_score":0.65065306,"about_ca_system_score_codex":0.000024583918,"about_ca_system_score_gemma":0.00020520673,"threshold_uncertainty_score":0.6673173},"labels":[],"label_agreement":null},{"id":"W4394301895","doi":"10.6084/m9.figshare.20164663","title":"Additional file 5 of Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Quantitative structure–activity relationship; Group (periodic table); Molecule; Chemistry; Small molecule; Computational biology; Stereochemistry; Computational chemistry; Biology; Biochemistry; Organic chemistry","score_opus":0.11616798793691223,"score_gpt":0.3353219944772633,"score_spread":0.21915400654035105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394301895","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050108008,0.0011252136,1.969488e-7,0.000058319707,0.00008911256,0.0004535131,0.94813627,0.0000063031075,0.000023069968],"genre_scores_gemma":[0.024095811,0.00006833166,0.000038945287,0.00026897906,0.00005304168,0.0002995226,0.97515225,0.000012140027,0.000010976815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844855,0.00047156887,0.00044810117,0.00025181347,0.0002066528,0.00017329385],"domain_scores_gemma":[0.99738157,0.0017921007,0.00044820926,0.0001682808,0.00013544006,0.000074375086],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020410088,0.00020171162,0.00028334773,0.000130025,0.00022786144,0.0000140588945,0.00024609658,0.00016138425,0.65060925],"category_scores_gemma":[0.0009904653,0.00016364551,0.00005257786,0.00032040212,0.00009169057,0.000056100103,0.00026847934,0.0005400544,0.000004397904],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011207888,0.000029946548,0.000035892823,0.00017406157,0.000087870576,0.0000021342535,0.00015288338,0.0014176741,0.014472663,0.000020237932,0.98323435,0.00026018824],"study_design_scores_gemma":[0.0005309464,0.000043905664,0.010643612,0.0003140192,0.000106302934,0.0000106941025,0.00012302591,0.0016916761,0.013650888,0.00009696915,0.9725879,0.00020005628],"about_ca_topic_score_codex":0.00009748828,"about_ca_topic_score_gemma":0.000099864286,"teacher_disagreement_score":0.65060484,"about_ca_system_score_codex":0.000024588138,"about_ca_system_score_gemma":0.00020538764,"threshold_uncertainty_score":0.66732705},"labels":[],"label_agreement":null},{"id":"W4394553871","doi":"10.6084/m9.figshare.20164654","title":"Additional file 2 of Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Group (periodic table); Quantitative structure–activity relationship; Small molecule; Molecule; Chemistry; Stereochemistry; Computational biology; Biology; Biochemistry","score_opus":0.1147917583116876,"score_gpt":0.33508067717374357,"score_spread":0.22028891886205598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394553871","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049603038,0.0011327883,1.9239299e-7,0.000058161553,0.00008950842,0.00045283668,0.94863373,0.0000063035823,0.000023456898],"genre_scores_gemma":[0.023343273,0.000069006135,0.000038631246,0.0002689813,0.00005362559,0.00029964332,0.97590363,0.000012137045,0.000011085292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844897,0.00047153718,0.0004479863,0.0002517079,0.00020658031,0.00017324268],"domain_scores_gemma":[0.99738955,0.0017839137,0.0004486022,0.00016818364,0.00013540937,0.00007436348],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020309997,0.00020165743,0.00028328827,0.0001299496,0.00022779258,0.000014058963,0.00024604218,0.00016137888,0.6547347],"category_scores_gemma":[0.0009891632,0.00016360989,0.000052563835,0.00032025296,0.000091671216,0.00005608978,0.00026851104,0.00054000766,0.000004418352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011126515,0.000029860754,0.000034914465,0.0001735699,0.00008770408,0.0000021478324,0.00015253335,0.001420901,0.014111558,0.000019984996,0.9835936,0.0002619631],"study_design_scores_gemma":[0.0005233667,0.0000432955,0.010259462,0.00030691127,0.00010478354,0.000010570718,0.00012065036,0.0016646751,0.013329792,0.00009577747,0.97334355,0.00019718055],"about_ca_topic_score_codex":0.00009737575,"about_ca_topic_score_gemma":0.00009919269,"teacher_disagreement_score":0.65473026,"about_ca_system_score_codex":0.00002458753,"about_ca_system_score_gemma":0.0002050124,"threshold_uncertainty_score":0.66718173},"labels":[],"label_agreement":null},{"id":"W4394579813","doi":"10.1007/s12687-024-00705-y","title":"Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study","year":2024,"lang":"en","type":"article","venue":"Journal of Community Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Canada Research Chairs; McMaster University; Canadian Institutes of Health Research; Fondation Brocher","keywords":"Pharmacogenomics; Equity (law); Health care; Medicine; Major depressive disorder; Family medicine; Psychiatry; Pharmacology; Political science","score_opus":0.2515052777096751,"score_gpt":0.4823314612768248,"score_spread":0.23082618356714968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394579813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680382,0.027816769,0.00034555784,0.00012239281,0.0016403852,0.0009900278,0.00010616845,0.00003020677,0.0009102695],"genre_scores_gemma":[0.99629545,0.0011581918,0.0016800702,0.00039039558,0.00035444804,0.00004308116,0.0000095417045,0.000051212883,0.000017598317],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99469197,0.0034611435,0.0009500269,0.00018984156,0.00031480758,0.00039221154],"domain_scores_gemma":[0.99636817,0.0022774108,0.0003655131,0.00023871094,0.00056651694,0.00018369207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031488219,0.0002947946,0.0004769768,0.0004950684,0.00036889326,0.00009730526,0.0004620463,0.00013582174,0.00002163675],"category_scores_gemma":[0.00027109854,0.00027504106,0.0001947027,0.00036556314,0.0001248924,0.00015422175,0.0001728977,0.002209471,0.0000049734554],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014575105,0.0033589532,0.00615403,0.00042200007,0.00069073966,0.00010891409,0.5891756,0.014686937,0.24542385,0.00008537611,0.000727593,0.1377085],"study_design_scores_gemma":[0.01728081,0.012619102,0.04001701,0.0008866926,0.0026384387,0.0002350763,0.75819266,0.014663297,0.107276484,0.0028792254,0.041766163,0.0015450647],"about_ca_topic_score_codex":0.000029690978,"about_ca_topic_score_gemma":0.000012253293,"teacher_disagreement_score":0.16901705,"about_ca_system_score_codex":0.00037697674,"about_ca_system_score_gemma":0.00030708459,"threshold_uncertainty_score":0.9999702},"labels":[],"label_agreement":null},{"id":"W4394783108","doi":"10.1007/978-3-030-73317-9_66-1","title":"Metabolism Pharmacology","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Pharmacology; Medicine; Pharmacodynamics; Pharmacokinetics","score_opus":0.12427546743698595,"score_gpt":0.4375534331231647,"score_spread":0.3132779656861787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394783108","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012954076,0.06013425,0.000023171002,0.0017965576,0.022749608,0.0007624835,0.0006243405,0.0006445634,0.91313547],"genre_scores_gemma":[0.003032745,0.016177954,0.0001633056,0.010744474,0.00609213,0.00008912507,0.00015351594,0.00033699273,0.96320975],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963733,0.00011132018,0.0009437427,0.0011799479,0.00042770302,0.0009640006],"domain_scores_gemma":[0.99798167,0.0002952294,0.00027231104,0.00045561197,0.0002085306,0.000786647],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00073675055,0.0011257033,0.0011526484,0.0006174267,0.00023126775,0.00006699309,0.00085035205,0.0019549036,0.11894813],"category_scores_gemma":[0.000010925718,0.0010346228,0.0007430565,0.00010144348,0.00047965135,0.00008775156,0.0005567334,0.003888754,0.028897032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012026288,0.00007390981,0.000001016497,0.00014317204,0.0019328927,0.0005002345,0.000119127086,0.000051945895,0.011949836,0.6014929,0.35261467,0.031000063],"study_design_scores_gemma":[0.0010301644,0.00003174309,0.0000018433693,0.000024206463,0.0035057345,0.00008936307,0.0000056064505,0.00048698194,0.014164019,0.09135676,0.88833374,0.0009698173],"about_ca_topic_score_codex":0.0000067493984,"about_ca_topic_score_gemma":0.000005156051,"teacher_disagreement_score":0.5357191,"about_ca_system_score_codex":0.000104147104,"about_ca_system_score_gemma":0.00027168723,"threshold_uncertainty_score":0.9993408},"labels":[],"label_agreement":null},{"id":"W4394795767","doi":"10.1134/s1061934824040026","title":"Development of an UHPLC-UV Method for Quantification of Three Phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates in CD-1® IGS Female Mouse Plasma","year":2024,"lang":"en","type":"article","venue":"Journal of Analytical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Chemistry; Chromatography; Prodrug; Biochemistry","score_opus":0.15895684766263257,"score_gpt":0.46532161059816324,"score_spread":0.30636476293553067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394795767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101657,0.0015169039,0.0059251683,0.0002599057,0.00035063724,0.00015997914,0.00009911405,0.000013368885,0.0006583577],"genre_scores_gemma":[0.9731542,0.00021000032,0.025935423,0.000066366374,0.0003070769,0.000010828279,0.00002456371,0.000031946915,0.00025962215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747986,0.00010805689,0.0014495606,0.00028609807,0.0003348946,0.00034154177],"domain_scores_gemma":[0.9979985,0.00068348506,0.00047690686,0.00017820104,0.00036961585,0.0002932981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023956527,0.00024031448,0.0006398144,0.0001922417,0.000058247148,0.000024623847,0.0004305147,0.00033019396,0.00032892288],"category_scores_gemma":[0.00024096377,0.00021334016,0.00027807953,0.00033992235,0.00011787568,0.00013099247,0.00006311478,0.00066030095,0.0000036041454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007717006,0.0007190715,0.00062656484,0.00080633274,0.00047785192,0.000031162795,0.00053628406,0.00376161,0.9695453,0.0007953266,0.00023119205,0.02169757],"study_design_scores_gemma":[0.00137883,0.000052330823,0.00044572505,0.00007424057,0.0004040361,0.000041802068,0.00021660657,0.1067818,0.87458116,0.00066964736,0.015162676,0.0001911288],"about_ca_topic_score_codex":0.000003155746,"about_ca_topic_score_gemma":0.0000077258255,"teacher_disagreement_score":0.10302019,"about_ca_system_score_codex":0.00008365077,"about_ca_system_score_gemma":0.0005010401,"threshold_uncertainty_score":0.8699759},"labels":[],"label_agreement":null},{"id":"W4395022322","doi":"10.1093/ajhp/zxae110","title":"Recommendations for pharmacogenetic testing in clinical practice guidelines in the US","year":2024,"lang":"en","type":"review","venue":"American Journal of Health-System Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Pharmacogenetics; Clinical Practice; Medical physics; Medicine; Psychology; Engineering ethics; Family medicine; Engineering; Biology; Genetics; Genotype","score_opus":0.5804898949683032,"score_gpt":0.6605198470699329,"score_spread":0.08002995210162978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395022322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014957368,0.94874597,0.00011750384,0.038729057,0.008745261,0.002722523,0.00033230335,0.00003985476,0.00041796578],"genre_scores_gemma":[0.0005851998,0.9704258,0.0072372183,0.017398579,0.003654903,0.00046394975,0.00003291878,0.00015446128,0.00004700657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9751471,0.01280684,0.009552977,0.0007377984,0.0005939259,0.0011613059],"domain_scores_gemma":[0.98111856,0.009997786,0.006789798,0.00040450582,0.0011565132,0.0005328105],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.034414526,0.0008591537,0.0040882495,0.0011676954,0.0002862899,0.00010876708,0.0016883457,0.00022951695,0.000042635646],"category_scores_gemma":[0.0027388493,0.00059875526,0.0012015032,0.0025093271,0.00028132863,0.00022984784,0.00016901726,0.0045930105,0.00007431876],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001685885,0.0004291403,0.00005854937,0.0065042814,0.0006000697,0.0002867215,0.00040874668,0.00011007649,0.0000033265817,0.00004991054,0.049088623,0.942292],"study_design_scores_gemma":[0.0025976917,0.0003885314,0.0000050462645,0.0064066793,0.00390642,0.0025681702,0.0007391848,0.0013706429,0.000002447584,0.000021569656,0.9815107,0.00048294372],"about_ca_topic_score_codex":0.00023111205,"about_ca_topic_score_gemma":0.000015997057,"teacher_disagreement_score":0.941809,"about_ca_system_score_codex":0.0005537712,"about_ca_system_score_gemma":0.0042385575,"threshold_uncertainty_score":0.99964637},"labels":[],"label_agreement":null},{"id":"W4395034505","doi":"10.1055/s-0044-1779566","title":"Pharmacogenetics in Psychiatry: Precision medicine or ‘mystic, magic, and mysterious’?","year":2024,"lang":"en","type":"article","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Pharmacogenetics; MAGIC (telescope); Mysticism; Precision medicine; Medicine; Psychiatry; Psychology; Computer science; Philosophy; Physics; Theology; Biology; Astronomy; Genetics","score_opus":0.10913207041235133,"score_gpt":0.4850029080486718,"score_spread":0.37587083763632045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395034505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69994146,0.19637656,0.00070067425,0.016120758,0.054388274,0.001959299,0.00031225092,0.00074365013,0.029457096],"genre_scores_gemma":[0.9511477,0.030542828,0.0016622863,0.008861833,0.004170492,0.00014981808,0.00004633323,0.00018348632,0.0032352633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99524224,0.00069347484,0.0012246632,0.0012120922,0.00050789036,0.0011196249],"domain_scores_gemma":[0.9979584,0.00057528995,0.00016490913,0.0003745272,0.00010214076,0.0008246868],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017146624,0.0007843703,0.00077126233,0.0008322902,0.00024421897,0.00012374336,0.00064034836,0.0004188482,0.0075366604],"category_scores_gemma":[0.000073900155,0.00062850845,0.00016124752,0.0012644876,0.00049085706,0.00033247285,0.00027725345,0.0017871395,0.00050557154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039197,0.0012110999,0.019542092,0.001816477,0.0008572538,0.0007820892,0.003729861,0.00063306175,0.17893845,0.006308645,0.2770686,0.5051927],"study_design_scores_gemma":[0.009942714,0.0003601025,0.0063898144,0.0005678148,0.0012029132,0.0005905325,0.00034489314,0.045831423,0.006988174,0.0074570244,0.9189797,0.0013448645],"about_ca_topic_score_codex":0.000040857925,"about_ca_topic_score_gemma":0.00007437697,"teacher_disagreement_score":0.64191115,"about_ca_system_score_codex":0.00008980199,"about_ca_system_score_gemma":0.00038657564,"threshold_uncertainty_score":0.9996166},"labels":[],"label_agreement":null},{"id":"W4396495613","doi":"10.5376/ijccr.2024.14.0007","title":"The Impact of Drug Metabolism Enzyme Gene Polymorphism on Drug Response","year":2024,"lang":"en","type":"article","venue":"International Journal of Clinical Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug metabolism; Drug; Gene; Polymorphism (computer science); Enzyme; Drug response; Genetics; Biology; Pharmacology; Biochemistry; Genotype","score_opus":0.13401931629282618,"score_gpt":0.5416623980489467,"score_spread":0.4076430817561205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396495613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594756,0.015750883,0.000043317385,0.003780915,0.019861352,0.00014667977,0.000103629194,0.000020759422,0.00081689487],"genre_scores_gemma":[0.9911524,0.0034531353,0.00009457808,0.0006425975,0.0034426013,0.0000051578504,0.0000040944337,0.000032503332,0.001172915],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99412566,0.001636011,0.0028636672,0.00029211032,0.0007794375,0.0003031206],"domain_scores_gemma":[0.9909121,0.0059878784,0.0015106901,0.0002825094,0.00086219946,0.0004446397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0132380845,0.00025238848,0.00059368426,0.00030371713,0.00012654447,0.00008854916,0.00040742842,0.00018354785,0.0005577321],"category_scores_gemma":[0.0023147077,0.00015421958,0.0013265995,0.00018460762,0.0003145385,0.00015642126,0.00013419813,0.0015607093,0.000027449425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024125261,0.002036456,0.0040402296,0.000023495904,0.010151153,0.59932816,0.0015310078,0.0067810845,0.047760107,0.0015387934,0.10565672,0.19702756],"study_design_scores_gemma":[0.0030050818,0.000348159,0.010727166,0.00011496242,0.00091820495,0.1590412,0.00009048085,0.0031476235,0.09299492,0.0059382604,0.7232746,0.00039935563],"about_ca_topic_score_codex":0.000057192592,"about_ca_topic_score_gemma":0.0000038357953,"teacher_disagreement_score":0.61761785,"about_ca_system_score_codex":0.00008064502,"about_ca_system_score_gemma":0.0009698748,"threshold_uncertainty_score":0.6780592},"labels":[],"label_agreement":null},{"id":"W4396946152","doi":"10.1016/s0140-6736(24)00709-8","title":"Totality of evidence refutes neoplasm risk with fezolinetant","year":2024,"lang":"en","type":"letter","venue":"The Lancet","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Astellas Pharma","keywords":"Philosophy","score_opus":0.31758362272187646,"score_gpt":0.4642884210715953,"score_spread":0.14670479834971883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396946152","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066207945,0.041991506,0.000033840184,0.87292266,0.0045637167,0.0009021514,0.00232325,0.0002056786,0.010849262],"genre_scores_gemma":[0.08872193,0.031583745,0.00038226193,0.8370872,0.030056428,0.0001554054,0.00013603253,0.00015817505,0.011718778],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966808,0.0011654265,0.00052364223,0.00052158366,0.00042281952,0.0006857189],"domain_scores_gemma":[0.9969806,0.0013838317,0.0004670661,0.00092767965,0.00014530792,0.00009551669],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017308872,0.00046829975,0.0010227357,0.00009182956,0.00016281333,0.000046590143,0.0011914182,0.0007088612,0.0005268966],"category_scores_gemma":[0.00014764571,0.00024113969,0.00020690398,0.00031020393,0.0005125163,0.000055623223,0.00025628041,0.005509385,0.00029718658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034948625,0.00003418116,0.0010189097,0.0005963496,0.000826543,0.00024197143,0.00037053396,0.0002514047,0.0011397954,0.00011924525,0.98959625,0.0054553524],"study_design_scores_gemma":[0.00074249576,0.00006913328,0.00061295857,0.00021308161,0.0018720466,0.000062910854,0.000009604804,0.0006928706,0.005823729,0.001756388,0.9877927,0.00035211467],"about_ca_topic_score_codex":0.00011480273,"about_ca_topic_score_gemma":0.000022279548,"teacher_disagreement_score":0.03583541,"about_ca_system_score_codex":0.000035177905,"about_ca_system_score_gemma":0.00019285691,"threshold_uncertainty_score":0.9967849},"labels":[],"label_agreement":null},{"id":"W4398195102","doi":"10.1007/978-3-030-73317-9_93-1","title":"An Introduction to Safety Pharmacokinetics","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nuclear Laboratories","funders":"","keywords":"Pharmacokinetics; Medicine; Pharmacology","score_opus":0.07881437904304522,"score_gpt":0.4278404040705888,"score_spread":0.3490260250275436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398195102","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029758067,0.004019103,0.0003902277,0.011176831,0.017622672,0.0011266416,0.000848252,0.00063924404,0.96387947],"genre_scores_gemma":[0.004918779,0.004019672,0.00065776205,0.0095846625,0.018582819,0.00004863929,0.000410932,0.0002967564,0.96147996],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668056,0.00010347017,0.000832526,0.0012769784,0.00041361133,0.0006928398],"domain_scores_gemma":[0.9977224,0.00009590765,0.00015584844,0.0006806366,0.00025306805,0.0010921637],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008456312,0.00084461767,0.00069599017,0.00055242394,0.0002210719,0.000087909146,0.00069144985,0.0010055949,0.044108827],"category_scores_gemma":[0.00001654317,0.0008226598,0.0003015198,0.00013393218,0.00016576888,0.000102004735,0.00027404644,0.002320115,0.009358567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005059101,0.00015555558,0.0000037472523,0.00013152316,0.0007731267,0.00013708121,0.00029880856,0.002343066,0.045877986,0.46921232,0.34978336,0.13077751],"study_design_scores_gemma":[0.0006321889,0.00015585627,0.000004280962,0.000015896225,0.0012391902,0.00004893252,0.000010045854,0.0016164507,0.016970577,0.014980338,0.96340925,0.0009169838],"about_ca_topic_score_codex":0.000004401728,"about_ca_topic_score_gemma":0.000009560158,"teacher_disagreement_score":0.6136259,"about_ca_system_score_codex":0.00015933173,"about_ca_system_score_gemma":0.00013943671,"threshold_uncertainty_score":0.9999816},"labels":[],"label_agreement":null},{"id":"W4398251719","doi":"10.1038/s41380-024-02588-4","title":"Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients","year":2024,"lang":"en","type":"article","venue":"Molecular Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; CYP2D6; CYP2C19; Medicine; Pharmacogenetics; Allele; Haplotype; Psychiatry; Genetics; Pharmacology; Biology; Internal medicine; Genotype; Gene","score_opus":0.02195494573506975,"score_gpt":0.3488336787059868,"score_spread":0.3268787329709171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398251719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669767,0.021085002,0.00051786593,0.00053826696,0.0076502506,0.0008368396,0.000101352074,0.00008439312,0.0022093086],"genre_scores_gemma":[0.9946524,0.00231462,0.0010137738,0.0013532129,0.0003687329,0.00008476215,0.00009965559,0.00007066262,0.00004221557],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973101,0.00032913097,0.0006743146,0.0008688149,0.0002846534,0.00053298596],"domain_scores_gemma":[0.99921024,0.00009334011,0.00011104133,0.00025266857,0.000089752175,0.00024298554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038519115,0.0004132536,0.0003508716,0.00047617508,0.00015243069,0.00007521617,0.00028248207,0.0003176593,0.0006645236],"category_scores_gemma":[0.000012005956,0.00045111318,0.00013731261,0.0008736246,0.00008916682,0.00022383388,0.00015500364,0.0010251069,0.00013955009],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014259528,0.0035074132,0.7187967,0.0011830411,0.0005731591,0.00015765787,0.0116602145,0.011289067,0.20933367,0.0075952364,0.0071423203,0.027335597],"study_design_scores_gemma":[0.026443275,0.00021299049,0.24634302,0.00015553784,0.0005962463,0.00006519183,0.00070283824,0.0106901275,0.024871524,0.013588766,0.6739132,0.0024172917],"about_ca_topic_score_codex":0.00009284245,"about_ca_topic_score_gemma":0.00005194339,"teacher_disagreement_score":0.6667709,"about_ca_system_score_codex":0.00025942907,"about_ca_system_score_gemma":0.00021164722,"threshold_uncertainty_score":0.99979407},"labels":[],"label_agreement":null},{"id":"W4399125390","doi":"10.1080/17425255.2024.2362190","title":"Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medications","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Drug; Pharmacogenetics; Medicine; Pharmacology; Epilepsy; Biology; Genetics; Genotype; Psychiatry; Gene","score_opus":0.03801018489628528,"score_gpt":0.40443367718177314,"score_spread":0.3664234922854879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399125390","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012751222,0.39848968,0.0000201791,0.0025276009,0.5828341,0.0011128831,0.0008298061,0.00014793847,0.0012865948],"genre_scores_gemma":[0.06551836,0.34856892,0.0010724509,0.0043332935,0.57493716,0.0011618832,0.0006727995,0.0005266828,0.0032084475],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.990823,0.0021480136,0.0022491207,0.002061076,0.0011662927,0.00155255],"domain_scores_gemma":[0.99427557,0.0025914286,0.0009213066,0.0010125673,0.0003858845,0.00081325823],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0019897711,0.0014613555,0.0027354753,0.001986931,0.0003096824,0.000086835724,0.001397479,0.0027920497,0.0016424059],"category_scores_gemma":[0.0006007271,0.0014046783,0.00051995786,0.0010975412,0.0010358568,0.00018445952,0.0007540528,0.004655554,0.00021327894],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027097092,0.0010851015,0.000101694,0.0002294282,0.00075026025,0.000096784075,0.0051317113,0.00020789314,0.011212814,0.0055916663,0.9563216,0.01900005],"study_design_scores_gemma":[0.0043443986,0.000059828697,0.0016326586,0.00023219394,0.00038774422,0.000025370098,0.00024441784,0.0004879087,0.01633585,0.00085916003,0.9742268,0.0011636843],"about_ca_topic_score_codex":0.00029302016,"about_ca_topic_score_gemma":0.000064478736,"teacher_disagreement_score":0.052767135,"about_ca_system_score_codex":0.00014665817,"about_ca_system_score_gemma":0.0012086345,"threshold_uncertainty_score":0.9998136},"labels":[],"label_agreement":null},{"id":"W4399590993","doi":"10.1002/cpt.3338","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2B6</i> Genotype and Methadone Therapy","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institutes of Health; National Human Genome Research Institute; Universidad Autónoma de Madrid; National Institute of General Medical Sciences; Canada Research Chairs","keywords":"Methadone; CYP2B6; Pharmacogenetics; Pharmacology; Medicine; Opioid; Context (archaeology); Opioid use disorder; Pharmacokinetics; Anesthesia; Genotype; Internal medicine; Chemistry; Metabolism; CYP3A4; Receptor; Biology; Cytochrome P450","score_opus":0.5190700035271528,"score_gpt":0.6601642049216446,"score_spread":0.1410942013944918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399590993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006312364,0.95465475,0.000521033,0.002600448,0.032074444,0.0065898676,0.0023219995,0.00039222522,0.00021401435],"genre_scores_gemma":[0.00004993162,0.8954041,0.0027095182,0.088487394,0.010170603,0.001126669,0.0008840315,0.00050825736,0.00065949635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9816448,0.0058822185,0.007526785,0.0026173857,0.0004659243,0.0018628894],"domain_scores_gemma":[0.9887651,0.0061891414,0.0022054228,0.00078984915,0.00070746755,0.0013429796],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.010082673,0.002046621,0.0053768815,0.00053922867,0.0005714242,0.00014254708,0.001575501,0.0033628314,0.0016501929],"category_scores_gemma":[0.00007498752,0.0017132853,0.002908376,0.0007589771,0.0019296447,0.00013174885,0.00076326507,0.005564731,0.00051048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056957384,0.00096130156,0.00010488986,0.001933344,0.0114170695,0.00006313971,0.000087133754,0.0000047215667,0.0003138385,0.00005393476,0.1855967,0.79889435],"study_design_scores_gemma":[0.008365378,0.00082052127,0.000009229189,0.00019303864,0.054034572,0.00008664306,0.00003507728,0.0007991925,0.00040825433,0.00038741835,0.93331456,0.0015461426],"about_ca_topic_score_codex":0.000005529443,"about_ca_topic_score_gemma":0.00000480289,"teacher_disagreement_score":0.7973482,"about_ca_system_score_codex":0.00014233463,"about_ca_system_score_gemma":0.0016840425,"threshold_uncertainty_score":0.99926245},"labels":[],"label_agreement":null},{"id":"W4399634301","doi":"10.33552/appr.2020.02.000546","title":"Is Dexamethasone a Substrate, an Inducer, or a Substrate-Inducer of CYP3As?","year":2020,"lang":"en","type":"article","venue":"Archives of Pharmacy & Pharmacology Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Inducer; Substrate (aquarium); Dexamethasone; Chemistry; Biology; Biochemistry; Ecology; Endocrinology","score_opus":0.49554042035332735,"score_gpt":0.5653964294270049,"score_spread":0.0698560090736775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399634301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97850114,0.004018512,0.00006249415,0.00474565,0.0011348107,0.0018766595,0.00066745235,0.00014602403,0.008847246],"genre_scores_gemma":[0.98539823,0.0062775705,0.00090949575,0.005091602,0.0012665995,0.00026633768,0.00007227866,0.00015811651,0.00055976165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98809236,0.0051412913,0.0018699259,0.0015299898,0.0011598378,0.00220661],"domain_scores_gemma":[0.9925037,0.0032244006,0.0006846875,0.0006251288,0.0007421179,0.00221995],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003145719,0.00082928664,0.0014924997,0.0010017967,0.0005328651,0.000043974753,0.002722547,0.00044477743,0.015877055],"category_scores_gemma":[0.00031237293,0.0007656513,0.0004885856,0.0022076822,0.0029760078,0.0005302307,0.0008934923,0.0044080657,0.00023982869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012721016,0.002478675,0.011731456,0.00056721515,0.0012326458,0.00030217128,0.010330019,0.00039609513,0.9185961,0.00040354094,0.0073002083,0.033940893],"study_design_scores_gemma":[0.0118663395,0.0010709245,0.0023889393,0.000027265472,0.00060063385,0.000052234653,0.0006981151,0.016469447,0.869111,0.00066253345,0.09640079,0.0006517942],"about_ca_topic_score_codex":0.00023444893,"about_ca_topic_score_gemma":0.000021592392,"teacher_disagreement_score":0.089100584,"about_ca_system_score_codex":0.0000499024,"about_ca_system_score_gemma":0.0016029559,"threshold_uncertainty_score":0.9997373},"labels":[],"label_agreement":null},{"id":"W4399643619","doi":"10.1080/10408444.2024.2353174","title":"Data derived extrapolation factors (DDEFs) for rat to human interspecies extrapolation for the HPPD inhibitor mesotrione","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Syngenta (Canada)","funders":"","keywords":"Toxicodynamics; Extrapolation; Toxicokinetics; In vivo; Biology; Pharmacology; Computational biology; Statistics; Pharmacokinetics; Mathematics; Biotechnology","score_opus":0.6152899435320234,"score_gpt":0.616036910959938,"score_spread":0.0007469674279145799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399643619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049660553,0.9701482,0.0058672875,0.002070149,0.009368232,0.009803608,0.0024674684,0.00007268025,0.00015271042],"genre_scores_gemma":[0.00052005146,0.98753816,0.0011959351,0.0018443275,0.0024720854,0.0044198306,0.0014095708,0.00014890092,0.00045116842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931137,0.0017113382,0.0024189733,0.0014496569,0.00020955049,0.0010967801],"domain_scores_gemma":[0.98920226,0.00874032,0.00037479668,0.0010538051,0.00019750943,0.000431298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043158974,0.00095552043,0.002925266,0.0005547138,0.00051727454,0.00013481764,0.0018249198,0.0012714503,0.00057906425],"category_scores_gemma":[0.0055798655,0.00064976845,0.00093137857,0.0006851802,0.00049331045,0.0001857676,0.0007138855,0.0017368563,0.00016382395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000918905,0.0003537285,0.0000033346232,0.014211893,0.00032267915,0.000008767475,0.00036867312,0.00000474435,0.0019985705,0.015718853,0.074477896,0.89243895],"study_design_scores_gemma":[0.0006213752,0.00019989515,0.0000040714,0.0018625038,0.0053962106,0.000015048066,0.00006013848,0.0005772973,0.00020409138,0.0015826459,0.98883134,0.00064538256],"about_ca_topic_score_codex":0.0000035693824,"about_ca_topic_score_gemma":0.00008056719,"teacher_disagreement_score":0.91435343,"about_ca_system_score_codex":0.0002877816,"about_ca_system_score_gemma":0.0003194275,"threshold_uncertainty_score":0.99959534},"labels":[],"label_agreement":null},{"id":"W4399670224","doi":"10.1124/pharmrev.124.001017","title":"Pharmacology and Precision Medicine—Preparing for the Next Era in Clinical Medicine—Editorial","year":2024,"lang":"en","type":"review","venue":"Pharmacological Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Honor; Privilege (computing); Engineering ethics; Medicine; Political science; Law; Computer science; Engineering","score_opus":0.5457612831235339,"score_gpt":0.6281871811351069,"score_spread":0.08242589801157296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399670224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014537495,0.8507411,0.000069663525,0.001618429,0.1358521,0.009467905,0.00010764516,0.00013895165,0.0019896463],"genre_scores_gemma":[0.000034973662,0.8949624,0.000101340076,0.0044980785,0.09447721,0.005170002,0.000085616746,0.00014596626,0.0005244476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9836035,0.0066498914,0.005498301,0.002172232,0.0005734151,0.0015026802],"domain_scores_gemma":[0.97800195,0.018801307,0.0014881156,0.0005453084,0.00019448248,0.0009688555],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.020904819,0.0017056743,0.006753005,0.0005469798,0.0005008066,0.000080515645,0.0020205968,0.0021799107,0.002648481],"category_scores_gemma":[0.0030901055,0.00086946023,0.0014967714,0.0011845627,0.0018507316,0.00017877793,0.0010676122,0.0076703965,0.00049610005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017838704,0.0001584087,0.0000032397093,0.004931352,0.00054171035,0.00002962534,0.00011017931,0.0000040364744,0.000085108535,0.00024615644,0.40754637,0.5861654],"study_design_scores_gemma":[0.0036276893,0.00040478064,0.0000038345424,0.0034613914,0.02407955,0.00006891156,0.000019440819,0.0011301654,0.0000075011435,0.0009218399,0.9654406,0.00083435094],"about_ca_topic_score_codex":0.000022285401,"about_ca_topic_score_gemma":0.000009269762,"teacher_disagreement_score":0.5853311,"about_ca_system_score_codex":0.00022899192,"about_ca_system_score_gemma":0.00041223972,"threshold_uncertainty_score":0.99956894},"labels":[],"label_agreement":null},{"id":"W4399805744","doi":"10.1038/s41574-024-01011-w","title":"Mind the (human-based new approach methodology) gap!","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Computer science; Psychology; Cognitive science","score_opus":0.5687607096110431,"score_gpt":0.5905776517575271,"score_spread":0.021816942146483997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399805744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012157301,0.96693224,0.00026592973,0.00083576096,0.00816765,0.0038904918,0.00020555753,0.00015269704,0.019548437],"genre_scores_gemma":[0.000002508383,0.97220165,0.003674535,0.0054409173,0.0039880425,0.0010217832,0.00042920184,0.00021307333,0.013028319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98377603,0.010099186,0.0021929082,0.0018698819,0.00033362114,0.0017283601],"domain_scores_gemma":[0.9944974,0.00214699,0.0011049117,0.001574534,0.00010834537,0.00056778855],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.003722545,0.0017398207,0.005507569,0.0007305868,0.00046181493,0.000081404905,0.0028567247,0.003963586,0.0029108105],"category_scores_gemma":[0.0006967617,0.0010066404,0.002743937,0.0013214041,0.0006501333,0.000051240073,0.0006082843,0.015580769,0.0055262432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000115144885,0.00012513135,6.955818e-7,0.009130275,0.00086764066,0.00012561052,0.000056721965,0.0000051214356,0.000017674058,0.0058540483,0.16761145,0.8161941],"study_design_scores_gemma":[0.0006341581,0.000037502956,3.059447e-7,0.0010791965,0.016530884,0.0007325446,0.000005861449,0.000038215476,0.00005477478,0.0006436497,0.9793571,0.00088576763],"about_ca_topic_score_codex":0.0000143339375,"about_ca_topic_score_gemma":0.000006575984,"teacher_disagreement_score":0.81530833,"about_ca_system_score_codex":0.0001852359,"about_ca_system_score_gemma":0.0010724495,"threshold_uncertainty_score":0.9995348},"labels":[],"label_agreement":null},{"id":"W4399903684","doi":"10.3399/bjgp24x737901","title":"Pharmacogenomics in primary care: a quality improvement project at Alconbury and Brampton surgeries 2019–2023","year":2024,"lang":"en","type":"article","venue":"British Journal of General Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Medicine; Pharmacogenomics; Medical prescription; Primary care; Pharmacogenetics; Adverse effect; Genetic testing; CYP2C19; Intensive care medicine; Drug; Pediatrics; Internal medicine; Family medicine; Psychiatry; Pharmacology; Genotype","score_opus":0.07444806620528673,"score_gpt":0.442867335041007,"score_spread":0.3684192688357203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399903684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8206424,0.17073002,0.000021441969,0.0009713958,0.0034423005,0.00037830963,0.00023762955,0.000025479585,0.0035510238],"genre_scores_gemma":[0.7837982,0.20122148,0.0018737904,0.007493777,0.0022614335,0.000039801056,0.00008307988,0.00009007868,0.0031383203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653304,0.0011002023,0.0010959452,0.00039192376,0.00036902144,0.00050984765],"domain_scores_gemma":[0.997978,0.000850444,0.00048376338,0.00011335344,0.0002930478,0.00028139874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036425698,0.00027218793,0.0005178164,0.00025484245,0.00021382187,0.00022702597,0.00025424332,0.00022532132,0.0002488916],"category_scores_gemma":[0.00025681878,0.00030538673,0.00019238917,0.00031086372,0.00017423142,0.00075749884,0.0002505439,0.0014425049,0.000019164463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001916206,0.0004302828,0.0012026689,0.00052622857,0.0007093079,0.004102562,0.0015710563,0.0002811045,0.40680978,0.0001526017,0.041068707,0.5412295],"study_design_scores_gemma":[0.0028325513,0.0001664725,0.0023531357,0.000108058186,0.0005379683,0.005237861,0.00036346816,0.000280418,0.034786988,0.00011835033,0.95279056,0.00042415695],"about_ca_topic_score_codex":0.00063286495,"about_ca_topic_score_gemma":0.0000717894,"teacher_disagreement_score":0.9117219,"about_ca_system_score_codex":0.00035060415,"about_ca_system_score_gemma":0.00061113393,"threshold_uncertainty_score":0.9999398},"labels":[],"label_agreement":null},{"id":"W4399940744","doi":"10.1080/15622975.2024.2366235","title":"Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics","year":2024,"lang":"en","type":"review","venue":"The World Journal of Biological Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Janssen Biotech; Japan Society for the Promotion of Science; Italfarmaco; H. Lundbeck A/S; Angelini Pharma; Boehringer Ingelheim; ZonMw; Takeda Pharmaceutical Company; AbbVie; GlaxoSmithKline; Servier; Sanofi-Aventis Deutschland; Pfizer; Astellas Pharma; Abbott Fund","keywords":"Pharmacogenetics; Pharmacotherapy; Psychiatry; Medicine; Drug; Schizophrenia (object-oriented programming); Drug response; Antipsychotic drug; Psychology; Antipsychotic; Pharmacology; Biology; Genotype","score_opus":0.12974375704468197,"score_gpt":0.48533450961602626,"score_spread":0.3555907525713443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399940744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015068295,0.9643561,0.000026881726,0.006178368,0.012795593,0.00090386986,0.00007566737,0.000033389148,0.00056182157],"genre_scores_gemma":[0.04255717,0.95127773,0.000995489,0.002977912,0.0019617358,0.000033613513,0.000006028268,0.000107418055,0.0000829221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99389595,0.0022247524,0.0021856045,0.00061452563,0.00041232677,0.00066681654],"domain_scores_gemma":[0.9966731,0.0009574565,0.0016228774,0.00037746437,0.000116562514,0.00025251036],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002376664,0.0009104821,0.001937268,0.00073239626,0.00015321716,0.000059298585,0.0011450339,0.00036901602,0.00019569517],"category_scores_gemma":[0.00003503214,0.0005458736,0.0009506593,0.0011411862,0.0005129878,0.000087482615,0.00013502594,0.0035293149,0.000023462342],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011119338,0.0015638312,0.0030222032,0.003021109,0.0022576682,0.00010315592,0.00041410816,0.0002749825,0.004900758,0.0036006956,0.011560535,0.96816903],"study_design_scores_gemma":[0.0039276253,0.00035631334,0.00029802122,0.006280829,0.004946503,0.0003815219,0.0001564646,0.00009363511,0.0017303413,0.030915402,0.9498936,0.0010197683],"about_ca_topic_score_codex":0.0000028719562,"about_ca_topic_score_gemma":0.000003006997,"teacher_disagreement_score":0.96714926,"about_ca_system_score_codex":0.000087126464,"about_ca_system_score_gemma":0.000417274,"threshold_uncertainty_score":0.9996993},"labels":[],"label_agreement":null},{"id":"W4399996207","doi":"10.1097/fpc.0000000000000541","title":"Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Health care; Pharmacogenetics; Test (biology); Clinical Practice; Family medicine; Clinical decision support system; Medicine","score_opus":0.15340570376545057,"score_gpt":0.5266863950790736,"score_spread":0.37328069131362296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399996207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9140645,0.073018335,0.000019818046,0.009732434,0.0009913982,0.001375963,0.00028523093,0.000031686075,0.0004805928],"genre_scores_gemma":[0.8928042,0.102236,0.00047267813,0.0039323666,0.00032900428,0.000132343,0.00001286596,0.000048035985,0.00003248962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667853,0.0009621082,0.00097467535,0.00067954033,0.00022561407,0.00047954568],"domain_scores_gemma":[0.99802196,0.0010672904,0.00022820279,0.00021246029,0.00016142076,0.0003086518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012986757,0.0003858936,0.00041022972,0.00019213035,0.00018489882,0.00006835297,0.00017479958,0.00015934788,0.00019778842],"category_scores_gemma":[0.00005776025,0.00029385363,0.0001283564,0.00026559737,0.00030271756,0.00007675596,0.00014861666,0.00057323644,0.000012686098],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007316361,0.0009962855,0.009795501,0.00019697796,0.0010433202,0.000118871096,0.029307494,0.0006217839,0.07448143,0.0059144534,0.0019514975,0.87484074],"study_design_scores_gemma":[0.0056012613,0.0012590671,0.0055598975,0.000045736317,0.0011230726,0.00013112747,0.014680102,0.015107333,0.17701434,0.0007922126,0.77800906,0.00067681033],"about_ca_topic_score_codex":0.00013405703,"about_ca_topic_score_gemma":0.000027000433,"teacher_disagreement_score":0.8741639,"about_ca_system_score_codex":0.00012160481,"about_ca_system_score_gemma":0.0003036498,"threshold_uncertainty_score":0.99995136},"labels":[],"label_agreement":null},{"id":"W4400167090","doi":"10.1248/yakushi.23-00204","title":"Evaluation of Sources of Drug Interaction Information for Nirmatrelvir/ritonavir","year":2024,"lang":"en","type":"article","venue":"YAKUGAKU ZASSHI","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Consistency (knowledge bases); Package insert; Drug; Ritonavir; Extended release; Family medicine; Pharmacology; Human immunodeficiency virus (HIV); Computer science; Antiretroviral therapy; Viral load","score_opus":0.15626776307171508,"score_gpt":0.4933173106341657,"score_spread":0.3370495475624506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400167090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97914577,0.0067514777,0.00062675966,0.00045721157,0.004182296,0.0008076782,0.0003251746,0.000070992086,0.0076326537],"genre_scores_gemma":[0.99852616,0.00040078934,0.00023214695,0.00018722752,0.00028515622,0.000122019184,0.000091767346,0.000016496148,0.00013826201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982073,0.00036145325,0.00060708425,0.00015771255,0.0004342018,0.00023228266],"domain_scores_gemma":[0.99843717,0.0004581203,0.00024468155,0.0001383083,0.00064178417,0.000079942816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035739543,0.0001558197,0.00023730435,0.0002768403,0.00008029773,0.000026010392,0.00017808648,0.00015456074,0.0005614668],"category_scores_gemma":[0.00021059222,0.00014766982,0.00017160198,0.00024369097,0.000087487555,0.00050371594,0.0000507408,0.00027979948,0.00006293228],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046110997,0.0003123873,0.00145811,0.0009719458,0.0007298355,0.0000012231442,0.0077274432,0.009595691,0.10914702,0.008634782,0.01427513,0.84668535],"study_design_scores_gemma":[0.0016995822,0.000067783956,0.0010041158,0.00007142064,0.0013510536,0.000008548342,0.00059179513,0.17982905,0.31480768,0.004815802,0.49555248,0.0002006939],"about_ca_topic_score_codex":0.000027895989,"about_ca_topic_score_gemma":0.0000069722705,"teacher_disagreement_score":0.84648466,"about_ca_system_score_codex":0.00006125096,"about_ca_system_score_gemma":0.0002004386,"threshold_uncertainty_score":0.6147668},"labels":[],"label_agreement":null},{"id":"W4400255781","doi":"10.2147/tacg.s463965","title":"The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine","year":2024,"lang":"en","type":"article","venue":"The Application of Clinical Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Mahidol University; Rangsit University; Thailand Center of Excellence for Life Sciences","keywords":"CYP2C19; Diversity (politics); Precision medicine; Korean population; Genetics; Medicine; Biology; Genotype; Internal medicine; Gene; Sociology; Anthropology","score_opus":0.3070593084405237,"score_gpt":0.5653913490503782,"score_spread":0.25833204060985454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400255781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89689463,0.01961267,0.016658263,0.059820194,0.0016960787,0.0030212516,0.00024125045,0.000041397794,0.0020142428],"genre_scores_gemma":[0.992614,0.005275815,0.00023744915,0.0010627279,0.0005114075,0.00014710899,0.000030084753,0.000011566281,0.000109881235],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978452,0.000535975,0.0009950466,0.00023382774,0.0002087954,0.00018120457],"domain_scores_gemma":[0.9920727,0.0068466184,0.00032543848,0.0005503136,0.00014328216,0.00006162667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050147,0.00011851392,0.00026053286,0.000044630906,0.00035160818,0.0000096637295,0.0009942255,0.00016477244,0.000026225243],"category_scores_gemma":[0.00027645173,0.00006029386,0.00016357968,0.0003819695,0.0005420254,0.000021038082,0.00021193069,0.00038230958,0.000007796039],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037468594,0.00034226867,0.06621908,0.000054127326,0.00017591943,2.3986664e-7,0.0016273968,0.001371937,0.008391083,0.12854503,0.0072063366,0.7856919],"study_design_scores_gemma":[0.0011084343,0.00015363788,0.44076562,0.000016535909,0.00045151258,0.0000033372803,0.00013153926,0.018276438,0.002317842,0.10495589,0.43169823,0.00012097124],"about_ca_topic_score_codex":0.00003648577,"about_ca_topic_score_gemma":0.000024011824,"teacher_disagreement_score":0.7855709,"about_ca_system_score_codex":0.000009569994,"about_ca_system_score_gemma":0.00005281881,"threshold_uncertainty_score":0.27043214},"labels":[],"label_agreement":null},{"id":"W4400391710","doi":"10.1016/j.vascn.2024.107536","title":"Effects of species of origin and mode of induction of microsomes on carbamazepine-induced cell toxicity","year":2024,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacology; Toxicity; In vitro; Microsome; Cytotoxicity; Carbamazepine; Clofibrate; Chemistry; Biology; Biochemistry","score_opus":0.14554465809443098,"score_gpt":0.5017164650487971,"score_spread":0.3561718069543661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400391710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855922,0.010462379,0.00065420085,0.0002868495,0.001714648,0.00042075294,0.00006799034,0.000015596848,0.000785378],"genre_scores_gemma":[0.9821199,0.0084521845,0.008748374,0.00025309715,0.00031273536,0.000010428809,0.000001063534,0.00001600105,0.00008622408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99527097,0.0021669345,0.0015220708,0.0003455697,0.00034118549,0.00035326387],"domain_scores_gemma":[0.993607,0.0045943563,0.0010358802,0.00009610612,0.00033106844,0.0003356254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024913384,0.00035381978,0.0014980829,0.0003744404,0.00006421104,0.000011949393,0.0003265619,0.00056374114,0.00036546323],"category_scores_gemma":[0.0005783257,0.00023507793,0.00038126388,0.00046530683,0.0007577853,0.00011921312,0.00019369823,0.001218177,7.4041674e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013892128,0.0016455353,0.0007717863,0.0009099427,0.0005235171,0.00006551526,0.00041480846,0.00020437536,0.9474326,0.0016733352,0.00017929543,0.04479012],"study_design_scores_gemma":[0.0024689047,0.0030916124,0.008637868,0.00010366754,0.0011412399,0.000048482812,0.00007235458,0.00092613435,0.9763369,0.0028328034,0.0041348604,0.00020518884],"about_ca_topic_score_codex":0.000004503132,"about_ca_topic_score_gemma":2.3841774e-7,"teacher_disagreement_score":0.04458493,"about_ca_system_score_codex":0.000038491118,"about_ca_system_score_gemma":0.000118105316,"threshold_uncertainty_score":0.95861995},"labels":[],"label_agreement":null},{"id":"W4400440181","doi":"10.1016/j.abb.2024.110088","title":"Modulation of aryl hydrocarbon receptor activity by tyrosine kinase inhibitors (ponatinib and tofacitinib)","year":2024,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Ponatinib; Tofacitinib; Aryl hydrocarbon receptor; Pharmacology; Chemistry; Tyrosine kinase; Transcription factor; Cancer research; Signal transduction; Biology; Biochemistry; Dasatinib; Immunology; Rheumatoid arthritis","score_opus":0.026463369011650067,"score_gpt":0.3387403461492126,"score_spread":0.31227697713756253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400440181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271744,0.0050354116,0.00006894341,0.00023720684,0.00021107525,0.00011330144,0.0007764665,0.000023873095,0.00081627426],"genre_scores_gemma":[0.99708796,0.0022988007,0.00016452542,0.000046067238,0.00016231422,0.000007012417,0.000096153664,0.000013041972,0.00012410906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992055,0.000038092647,0.00022060862,0.00027898667,0.000094783805,0.00016200887],"domain_scores_gemma":[0.99944097,0.00021329543,0.000103045524,0.00010060151,0.000018793116,0.0001232695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113306545,0.00017174939,0.00021748887,0.000044736888,0.000058449004,0.000011057394,0.00008041126,0.00012015493,0.000022740885],"category_scores_gemma":[0.00001819246,0.00016377395,0.000069408,0.00012912998,0.00043543612,0.00005603062,0.00008965413,0.00025449594,8.4380815e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015204267,0.00014918229,0.0004259792,0.00038685053,0.00007985904,0.0000015426602,0.00024852596,0.000009218065,0.86229384,0.0001950462,0.00017123857,0.13588668],"study_design_scores_gemma":[0.00049452635,0.000048335252,0.00049152074,0.000057697485,0.00008526355,0.000002846585,0.00002645039,0.00876071,0.98494625,0.001176178,0.0037513385,0.00015887026],"about_ca_topic_score_codex":0.000009389929,"about_ca_topic_score_gemma":1.0710215e-7,"teacher_disagreement_score":0.13572782,"about_ca_system_score_codex":0.0000039120646,"about_ca_system_score_gemma":0.000034193195,"threshold_uncertainty_score":0.6678508},"labels":[],"label_agreement":null},{"id":"W4400643063","doi":"10.3390/biom14070850","title":"Hepatic Gene Expression and Metabolite Profiles of Androstenone and Skatole Relative to Plasma Estrone Sulfate Levels in Boars","year":2024,"lang":"en","type":"article","venue":"Biomolecules","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Canada First Research Excellence Fund","keywords":"Androstenone; Estrone sulfate; Estrone; Metabolite; Skatole; Internal medicine; Endocrinology; Chemistry; Biology; Estrogen; Biochemistry; Medicine","score_opus":0.06719651469228174,"score_gpt":0.3978443840954117,"score_spread":0.33064786940312996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400643063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96996784,0.02761955,0.00033835357,0.00052354485,0.00031575735,0.00045044866,0.00040070215,0.000036234767,0.0003475426],"genre_scores_gemma":[0.99404234,0.0015602654,0.0037339164,0.00018919441,0.00005787554,0.000056109086,0.000017491126,0.00002744101,0.00031534993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985025,0.00026526922,0.00036924926,0.00040700348,0.00013232119,0.00032366274],"domain_scores_gemma":[0.99934417,0.0001944019,0.00006691079,0.0001196367,0.000043683674,0.00023117216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037229373,0.00022676407,0.0003488626,0.0002837942,0.00006984098,0.000029451232,0.00010822855,0.0001659241,0.000057818484],"category_scores_gemma":[0.000044571258,0.0001992177,0.000044062203,0.0003169493,0.00024634352,0.00011386612,0.00017414009,0.00025713388,0.000012509403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014350357,0.000086758846,0.0028144,0.00012530183,0.00009017282,0.000076672135,0.0013875591,0.00004544551,0.9794807,0.0012988648,0.00017699978,0.014273657],"study_design_scores_gemma":[0.0012012235,0.0000816384,0.010418392,0.00008931005,0.0001473404,0.000029246445,0.00009526747,0.0030576377,0.96967286,0.0007256897,0.014246362,0.00023500857],"about_ca_topic_score_codex":0.000027699463,"about_ca_topic_score_gemma":0.000008827443,"teacher_disagreement_score":0.026059283,"about_ca_system_score_codex":0.000014644831,"about_ca_system_score_gemma":0.000054738044,"threshold_uncertainty_score":0.8123862},"labels":[],"label_agreement":null},{"id":"W4400930961","doi":"10.1002/cpt.3380","title":"Solanidine Metabolites as Diet‐Derived Biomarkers of <scp>CYP2D6</scp>‐Mediated Tamoxifen Metabolism in Breast Cancer Patients","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Tamoxifen; Internal medicine; Endocrinology; Metabolite; CYP2D6; Medicine; Chemistry; Breast cancer; Metabolism; Cancer; Cytochrome P450","score_opus":0.1032164564343435,"score_gpt":0.46476276253494675,"score_spread":0.36154630610060323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400930961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931137,0.045390915,0.000015345477,0.004355674,0.0153722055,0.0011975722,0.001313212,0.00025667372,0.00096137647],"genre_scores_gemma":[0.9052541,0.055700608,0.000116363146,0.036509566,0.0015530022,0.00025785362,0.0001406429,0.00016541584,0.000302437],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919631,0.002490201,0.0023390185,0.0012350348,0.00051437126,0.0014583025],"domain_scores_gemma":[0.9928849,0.004826469,0.0005887237,0.00039348193,0.00053000625,0.0007764727],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002423967,0.00087424315,0.0016273513,0.00064529775,0.00019441573,0.000053935986,0.0010925352,0.0012126688,0.0015259414],"category_scores_gemma":[0.00014482158,0.00079010555,0.00072317943,0.0014226938,0.0013801767,0.00028162284,0.00042389217,0.00263921,0.00031683923],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002702589,0.00595879,0.13244317,0.00032790288,0.012298374,0.0002353059,0.0022754741,0.00026334953,0.7816513,0.00029776167,0.035849,0.025696993],"study_design_scores_gemma":[0.012223335,0.0004302328,0.16098118,0.00007775526,0.007241601,0.000023036815,0.00018271749,0.009954632,0.15853794,0.0008795922,0.64881706,0.00065092475],"about_ca_topic_score_codex":0.000065568966,"about_ca_topic_score_gemma":0.000011333479,"teacher_disagreement_score":0.62311333,"about_ca_system_score_codex":0.00011710791,"about_ca_system_score_gemma":0.00065744214,"threshold_uncertainty_score":0.99966174},"labels":[],"label_agreement":null},{"id":"W4400982324","doi":"10.1002/cpt.3387","title":"PharmVar GeneFocus: <i>CYP2A6</i>","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Human Genome Research Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health","keywords":"CYP2A6; Allele; Genetics; Biology; Genetic variation; Gene; Phenotype; Genotype; Locus (genetics); Computational biology; Genotype-phenotype distinction; Bioinformatics","score_opus":0.5594046779091968,"score_gpt":0.6417700626406821,"score_spread":0.08236538473148536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400982324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005858697,0.9332068,0.000039959956,0.0017292881,0.055867482,0.0027058194,0.0011151875,0.0008838994,0.0043929773],"genre_scores_gemma":[0.000014199554,0.9051451,0.00022162568,0.073876925,0.013973619,0.000686715,0.0002986345,0.0006231879,0.0051599625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9842603,0.005715067,0.004447909,0.0026352936,0.00061215484,0.002329265],"domain_scores_gemma":[0.9925136,0.003124014,0.0013608531,0.0011195263,0.00031631635,0.0015656991],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0040923087,0.0024575857,0.0057833362,0.0007457063,0.00053835934,0.0001545886,0.0030129422,0.0046345475,0.005238939],"category_scores_gemma":[0.00004313331,0.0019936538,0.004155255,0.0014476972,0.0017478986,0.00016160341,0.0012577921,0.011396106,0.016540466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001350268,0.0011246838,0.000008016907,0.004385939,0.010592427,0.00054055994,0.00009671501,0.000008326576,0.00009827349,0.000075468655,0.24731472,0.73561984],"study_design_scores_gemma":[0.002202522,0.00022971568,0.0000010121372,0.00070664915,0.0826648,0.0002267274,0.000012345465,0.00035290723,0.00015867491,0.00032671532,0.91135806,0.0017598472],"about_ca_topic_score_codex":0.0000037290486,"about_ca_topic_score_gemma":0.0000017928703,"teacher_disagreement_score":0.73386,"about_ca_system_score_codex":0.00032015351,"about_ca_system_score_gemma":0.0017549382,"threshold_uncertainty_score":0.9988161},"labels":[],"label_agreement":null},{"id":"W4401009397","doi":"10.1016/j.pnpbp.2024.111108","title":"Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response","year":2024,"lang":"en","type":"article","venue":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; University of Toronto; National Institute on Drug Abuse; Canada Research Chairs","keywords":"Estrous cycle; Genetically modified mouse; Transgene; Biology; Drug response; Drug; Neuroscience; Internal medicine; Endocrinology; Andrology; Cell biology; Pharmacology; Medicine; Genetics; Gene","score_opus":0.06406262244914894,"score_gpt":0.45304790466819855,"score_spread":0.3889852822190496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401009397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94425046,0.04120826,0.000007153072,0.007426919,0.0058248546,0.0008099465,0.00013678077,0.000116445386,0.00021915637],"genre_scores_gemma":[0.9918754,0.003265456,0.0001159032,0.0038761285,0.00051880867,0.00024952652,0.000008894175,0.000037871945,0.00005202456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455464,0.0024153132,0.0010287205,0.00089105876,0.0001621103,0.0009481836],"domain_scores_gemma":[0.99783003,0.0015057747,0.00017975972,0.0002323995,0.000040631923,0.00021141933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003087724,0.0004761583,0.00069710467,0.00026560805,0.00032676346,0.000054465843,0.00071223726,0.00050141296,0.00025368936],"category_scores_gemma":[0.00006543312,0.0003324699,0.00022999092,0.00074425165,0.0016298713,0.000116170195,0.00022697159,0.002163025,0.00001553358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010303727,0.0021451535,0.8628768,0.0003808026,0.0004364426,0.00031464652,0.0050549717,0.00053993816,0.06728747,0.004011292,0.0014963149,0.04515247],"study_design_scores_gemma":[0.00776957,0.0006341604,0.924968,0.00011574908,0.00022797234,0.00016514797,0.0005111156,0.0029124434,0.0025200434,0.007892085,0.051510848,0.0007728379],"about_ca_topic_score_codex":0.000013143156,"about_ca_topic_score_gemma":0.000053066604,"teacher_disagreement_score":0.06476742,"about_ca_system_score_codex":0.000027221518,"about_ca_system_score_gemma":0.00010106661,"threshold_uncertainty_score":0.99991274},"labels":[],"label_agreement":null},{"id":"W4401388296","doi":"10.1211/pj.2024.1.325201","title":"Closing the ethnicity gap in pharmacogenomics","year":2024,"lang":"en","type":"article","venue":"Pharmaceutical journal/˜The œpharmaceutical journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Closing (real estate); Pharmacogenomics; Ethnic group; Medicine; Political science; Sociology; Pharmacology; Anthropology; Law","score_opus":0.24461595433399475,"score_gpt":0.5072910514976905,"score_spread":0.26267509716369575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401388296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4986992,0.2804287,0.008342862,0.13589595,0.05295995,0.0033251771,0.00023950028,0.0007439487,0.019364715],"genre_scores_gemma":[0.8928817,0.064386874,0.0003313048,0.03131731,0.009941254,0.00008139155,0.000007904746,0.00026346455,0.0007887875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98408526,0.006334056,0.0030235786,0.0011000786,0.0019244433,0.0035326064],"domain_scores_gemma":[0.99080735,0.0045275325,0.0005602705,0.00063808076,0.0005378408,0.002928903],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.017913202,0.0013356021,0.0011429377,0.0008703738,0.002995651,0.0019013133,0.003606827,0.0007537645,0.0072481097],"category_scores_gemma":[0.0005188371,0.00081989233,0.001377304,0.0022438997,0.0019034314,0.0009776405,0.0008480641,0.023430564,0.0013289615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029183528,0.0018302173,0.0029013013,0.00033025738,0.0032128238,0.009739912,0.0054297443,0.00947569,0.17072082,0.009214858,0.077525504,0.7067005],"study_design_scores_gemma":[0.0046153706,0.000096094904,0.0003361928,0.00016061889,0.0018272632,0.017150989,0.0004596912,0.10602887,0.02049104,0.007940592,0.8399147,0.0009785786],"about_ca_topic_score_codex":0.000012005156,"about_ca_topic_score_gemma":0.0000097321235,"teacher_disagreement_score":0.7623892,"about_ca_system_score_codex":0.00090707425,"about_ca_system_score_gemma":0.0011567095,"threshold_uncertainty_score":0.9999395},"labels":[],"label_agreement":null},{"id":"W4401449137","doi":"10.1124/pharmrev.123.000750","title":"Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test","year":2024,"lang":"en","type":"review","venue":"Pharmacological Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"Pharmacogenetics; Test (biology); Genome-wide association study; Genetic association; Association (psychology); Medicine; Computational biology; Biology; Genetics; Bioinformatics; Genotype; Single-nucleotide polymorphism; Psychology; Gene; Ecology","score_opus":0.33494227886665684,"score_gpt":0.5308978687206324,"score_spread":0.19595558985397554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401449137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020772358,0.9816368,0.0003770831,0.0000633617,0.007309903,0.0050698807,0.0029424585,0.00009798352,0.000425282],"genre_scores_gemma":[0.0011153155,0.99163747,0.0014962505,0.00084158493,0.003005986,0.0009954697,0.0003088721,0.00016147572,0.0004375721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.984788,0.0058161197,0.0058095246,0.0016768877,0.0008886865,0.0010207972],"domain_scores_gemma":[0.991499,0.0038299689,0.0026625886,0.0007979098,0.00037712418,0.00083341263],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.00602684,0.0013822683,0.008063991,0.00046359858,0.000116189396,0.000059290636,0.0016140449,0.0016684792,0.0012592542],"category_scores_gemma":[0.0020465287,0.0010402319,0.0061010458,0.001369049,0.0002925393,0.00012702472,0.00089960155,0.0028326395,0.0019233294],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008404823,0.0011052731,0.000374131,0.009335629,0.006436464,0.00006745938,0.00006831051,0.00008598338,0.0039575454,0.0000123131185,0.014475049,0.9639978],"study_design_scores_gemma":[0.00111697,0.00023188633,0.00013128054,0.0024604558,0.05734135,0.0000093793315,0.0000050074486,0.000113961236,0.0017043211,0.00007233774,0.9359298,0.0008832705],"about_ca_topic_score_codex":0.00002041702,"about_ca_topic_score_gemma":0.0000020010295,"teacher_disagreement_score":0.9631145,"about_ca_system_score_codex":0.00036488616,"about_ca_system_score_gemma":0.00051364285,"threshold_uncertainty_score":0.9998928},"labels":[],"label_agreement":null},{"id":"W4401534435","doi":"10.3390/biomedicines12081843","title":"Upholding or Breaking the Law of Superposition in Pharmacokinetics","year":2024,"lang":"en","type":"review","venue":"Biomedicines","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Mitacs","keywords":"Superposition principle; ADME; Pharmacokinetics; Dosing; Pharmacology; Law; Drug; Drug development; Saturation (graph theory); Medicine; Computer science; Mathematics; Political science","score_opus":0.33663019281589995,"score_gpt":0.5600501622615701,"score_spread":0.22341996944567016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401534435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019242949,0.990393,0.000008669031,0.0003177993,0.005450889,0.0009739672,0.00028415807,0.00005823958,0.0023208405],"genre_scores_gemma":[0.0031921454,0.9934372,0.00003395079,0.00084406324,0.0017184392,0.00016037063,0.000101413636,0.000083640996,0.00042881575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695474,0.000610594,0.0011808834,0.0004647268,0.00029098694,0.00049808744],"domain_scores_gemma":[0.998425,0.0007116002,0.00033642788,0.00029858266,0.00007448347,0.00015391462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012864614,0.0005576638,0.0014613824,0.0005364726,0.000115973,0.000025803924,0.0006595202,0.0005316456,0.0005569222],"category_scores_gemma":[0.000045385954,0.00029742252,0.00036879242,0.0012958443,0.00054667576,0.000049761093,0.0002312107,0.0012878437,0.00009453748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006840733,0.00017842554,0.0000058250193,0.016229138,0.00059569394,0.00022516449,0.0005637954,0.0000059052436,0.0014409523,0.002600696,0.0069117276,0.97117424],"study_design_scores_gemma":[0.0006490635,0.000049119324,0.0000015766741,0.0047033033,0.0050949263,0.00016223032,0.00006081852,0.00020983572,0.00051416317,0.0001520251,0.9880919,0.0003110464],"about_ca_topic_score_codex":0.000070595896,"about_ca_topic_score_gemma":0.000021065582,"teacher_disagreement_score":0.9811802,"about_ca_system_score_codex":0.00007442964,"about_ca_system_score_gemma":0.0002369593,"threshold_uncertainty_score":0.9999478},"labels":[],"label_agreement":null},{"id":"W4401553233","doi":"10.1002/cpt.3405","title":"<scp>PharmVar GeneFocus</scp>: <i>CYP4F2</i>","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health; National Institute on Drug Abuse; National Institute of General Medical Sciences; Österreichische Forschungsförderungsgesellschaft; National Human Genome Research Institute; Universidad Autónoma de Madrid","keywords":"Chemistry","score_opus":0.44551167257493557,"score_gpt":0.5966109123631308,"score_spread":0.15109923978819523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401553233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002295297,0.93005043,0.000049515616,0.00093286653,0.055597145,0.0031443709,0.0014329907,0.0010009338,0.007562202],"genre_scores_gemma":[0.000019923005,0.90216964,0.0002480034,0.07104529,0.013937727,0.00080856617,0.0003877072,0.00074577145,0.010637397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98150575,0.0067110853,0.0049957135,0.0030659286,0.00076381874,0.0029576914],"domain_scores_gemma":[0.98717004,0.0073553952,0.0017460181,0.0013024963,0.00042176034,0.0020043165],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0049486645,0.0028976293,0.0064656753,0.00089445565,0.0006777129,0.00020332143,0.0035990009,0.005608844,0.0020323533],"category_scores_gemma":[0.00013004204,0.0024176138,0.004598053,0.0017673827,0.002075276,0.00019577908,0.0015846814,0.013274276,0.016294006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004801768,0.0013259146,0.0000164976,0.0044033127,0.011455246,0.00086114637,0.00016266035,0.000015315321,0.0001252669,0.00008961036,0.39375424,0.58774275],"study_design_scores_gemma":[0.00251018,0.00028452565,0.000002890574,0.000651315,0.07857206,0.0003557865,0.000026342079,0.00041140994,0.00029120402,0.00041935808,0.9155287,0.00094624696],"about_ca_topic_score_codex":0.0000041032445,"about_ca_topic_score_gemma":0.0000021625035,"teacher_disagreement_score":0.5867965,"about_ca_system_score_codex":0.0003414073,"about_ca_system_score_gemma":0.0020300383,"threshold_uncertainty_score":0.9988799},"labels":[],"label_agreement":null},{"id":"W4401667571","doi":"10.1111/cts.70007","title":"Dose‐dependent induction of <scp>CYP3A</scp> activity by St. John's wort alone and in combination with rifampin","year":2024,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacology; Midazolam; CYP3A4; Inducer; CYP3A; Enzyme inducer; Pregnane X receptor; Oral administration; Drug interaction; Medicine; Hyperforin; Chemistry; Hypericum perforatum; Cytochrome P450; Pharmacokinetics; Metabolism; Enzyme; Internal medicine; Biochemistry; Nuclear receptor","score_opus":0.10897468422640176,"score_gpt":0.4498997666936486,"score_spread":0.34092508246724684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401667571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523884,0.0017119627,0.00048635685,0.000977631,0.00049913477,0.00021131485,0.00007376238,0.000016993381,0.0007840106],"genre_scores_gemma":[0.99832803,0.0011490779,0.00017503338,0.0001514992,0.0000695597,0.000010732808,0.000009916178,0.0000054300417,0.00010071698],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986881,0.00016035739,0.00030142267,0.00038087,0.0002751032,0.00019416801],"domain_scores_gemma":[0.9989508,0.00069351227,0.00006125613,0.000056752648,0.00006507352,0.00017261435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019312688,0.00010755504,0.00018409098,0.00012337757,0.000125935,0.000032052136,0.00010447989,0.00012947353,0.00003244426],"category_scores_gemma":[0.000064193235,0.000087230495,0.000028343915,0.00045343136,0.0010865994,0.000281123,0.000028414703,0.0004756288,0.0000025529846],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045239725,0.0016981178,0.28650957,0.00015446491,0.00012698767,0.000027653856,0.001057499,0.00062114786,0.18953468,0.008741712,0.0004971908,0.5105786],"study_design_scores_gemma":[0.0036086708,0.00018804529,0.9156175,0.000041793697,0.00011203982,0.0000206702,0.000035500318,0.019684212,0.02611758,0.0069908113,0.027456097,0.00012707787],"about_ca_topic_score_codex":0.000015895725,"about_ca_topic_score_gemma":0.000019060331,"teacher_disagreement_score":0.62910795,"about_ca_system_score_codex":0.0000073333867,"about_ca_system_score_gemma":0.00016089181,"threshold_uncertainty_score":0.40036207},"labels":[],"label_agreement":null},{"id":"W4401673332","doi":"10.1080/03602532.2024.2385928","title":"Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions","year":2024,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Drug; Pharmacogenomics; Genetic variation; Genotyping; Biology; Gene; Genetics; Pharmacology; Computational biology; Medicine; Genotype","score_opus":0.14274760694577707,"score_gpt":0.47772526060447207,"score_spread":0.33497765365869503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401673332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007133824,0.9570133,0.00004631924,0.00081189757,0.031881437,0.005450657,0.000947666,0.00044283748,0.002692472],"genre_scores_gemma":[0.00030082776,0.96188956,0.0014588663,0.002651102,0.007268295,0.002917215,0.0011817958,0.0006157973,0.02171655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9819742,0.007054819,0.0051294137,0.0031935961,0.000821789,0.0018261904],"domain_scores_gemma":[0.9922057,0.0012105228,0.0023236952,0.0018466206,0.000464821,0.0019486697],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0033707605,0.0034166866,0.0077419127,0.0021253366,0.0011652339,0.00048541153,0.0022643008,0.00067892746,0.0020345275],"category_scores_gemma":[0.00029899733,0.0027934494,0.0031419427,0.002369072,0.0007304732,0.00066752115,0.0017671307,0.0068520405,0.0068764524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044572465,0.0005558287,0.0000026764592,0.012870804,0.0021827645,0.00015039725,0.002449121,0.0000118273165,0.0015723628,0.00050470704,0.17422189,0.80543303],"study_design_scores_gemma":[0.001197003,0.000008903018,0.0000023926577,0.0035593335,0.028168568,0.00028884778,0.000106036256,0.0001812229,0.004879325,0.00059675035,0.9585158,0.00249581],"about_ca_topic_score_codex":0.00016201762,"about_ca_topic_score_gemma":0.00020404266,"teacher_disagreement_score":0.80293727,"about_ca_system_score_codex":0.00037090367,"about_ca_system_score_gemma":0.0008265321,"threshold_uncertainty_score":0.99887776},"labels":[],"label_agreement":null},{"id":"W4401928844","doi":"10.3389/fpls.2024.1451298","title":"Parallel evolution of methyltransferases leads to vobasine biosynthesis in Tabernaemontana elegans and Catharanthus roseus","year":2024,"lang":"en","type":"article","venue":"Frontiers in Plant Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"Natural Sciences and Engineering Research Council of Canada; Alliance de recherche numérique du Canada; Ministry of Education, India","keywords":"Catharanthus roseus; Biology; Methyltransferase; Apocynaceae; Ajmaline; Methylation; Genetics; Biochemistry; Botany; Gene","score_opus":0.0398448446355752,"score_gpt":0.36308861965299966,"score_spread":0.32324377501742446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401928844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748967,0.016970059,0.0034853679,0.0006133466,0.002573118,0.00033892813,0.00042255732,0.000030824285,0.00066909945],"genre_scores_gemma":[0.9937626,0.0025663131,0.0032712186,0.00021021905,0.00005764186,0.000024326251,0.0000043789323,0.000011180054,0.00009212436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982078,0.00015018598,0.0003836238,0.0004900777,0.00025736867,0.0005109632],"domain_scores_gemma":[0.9994029,0.00018169686,0.000035418187,0.00013508643,0.00003383641,0.00021107197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015533555,0.00018237144,0.0003256153,0.00090647367,0.000077019584,0.000030942407,0.0003877967,0.000115321905,0.000024952682],"category_scores_gemma":[0.00011827951,0.00017057809,0.000037958776,0.0014178159,0.00049768446,0.00021232107,0.000061438834,0.00035760278,0.0000068108793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004969527,0.00025593757,0.19290116,0.00014461791,0.000043995322,0.00024004813,0.0028787896,0.0031680057,0.74918455,0.0024244185,0.0027180025,0.045543544],"study_design_scores_gemma":[0.002351016,0.00021920669,0.16052796,0.00032057147,0.00023784378,0.00010521055,0.00074195786,0.10212866,0.6779277,0.0024237942,0.052058097,0.0009580059],"about_ca_topic_score_codex":0.00031775888,"about_ca_topic_score_gemma":0.00021430568,"teacher_disagreement_score":0.09896066,"about_ca_system_score_codex":0.00015666748,"about_ca_system_score_gemma":0.00025559825,"threshold_uncertainty_score":0.69559723},"labels":[],"label_agreement":null},{"id":"W4402220180","doi":"10.1007/978-3-030-51366-5_130","title":"Pharmacogenomics and Precision Psychiatry","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Psychiatry; Psychology; Medicine; Pharmacology","score_opus":0.09730162313094975,"score_gpt":0.42209901100645597,"score_spread":0.3247973878755062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402220180","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013124776,0.08099927,0.000027980277,0.0013460567,0.010788101,0.0006259074,0.00048084185,0.00025848276,0.90416086],"genre_scores_gemma":[0.0037911192,0.04463297,0.000628984,0.004851852,0.002557053,0.000027611444,0.000085560554,0.00023090884,0.9431939],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976078,0.00005330401,0.0006665745,0.00090435083,0.00026178572,0.00050613476],"domain_scores_gemma":[0.99863344,0.00018433004,0.000185731,0.00032566124,0.00009237696,0.00057844055],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00059179746,0.0007464819,0.000627599,0.00034476368,0.00020275294,0.00007869492,0.00038841087,0.0011395318,0.012548606],"category_scores_gemma":[0.000008085642,0.0006864311,0.00029374205,0.000049389062,0.00027007403,0.00006615212,0.00045026702,0.0021870804,0.0031524242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026492664,0.0000922121,0.00004894376,0.00035021405,0.0012633199,0.00011822389,0.00017281546,0.00004283979,0.00591719,0.68174475,0.13420463,0.17577997],"study_design_scores_gemma":[0.0008304487,0.000043813623,0.0000057531774,0.00005653894,0.0012930238,0.000088144945,0.0000068137556,0.0009761668,0.001411216,0.13799252,0.8566445,0.00065103965],"about_ca_topic_score_codex":0.0000028596287,"about_ca_topic_score_gemma":0.0000068004356,"teacher_disagreement_score":0.7224399,"about_ca_system_score_codex":0.000055611992,"about_ca_system_score_gemma":0.00019445493,"threshold_uncertainty_score":0.9995587},"labels":[],"label_agreement":null},{"id":"W4402330563","doi":"10.2196/57705","title":"Design and Implementation of a Dashboard for Drug Interactions Mediated by Cytochromes Using a Health Care Data Warehouse in a University Hospital Center: Development Study","year":2024,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dashboard; Preprint; Data warehouse; Health care; Computer science; Medicine; Data science; Medical emergency; World Wide Web; Database; Political science","score_opus":0.10868641297336078,"score_gpt":0.4858274659126044,"score_spread":0.3771410529392436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402330563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870171,0.00078552915,0.008210266,0.0004473395,0.00047327665,0.0020878396,0.00091385876,0.00005181681,0.000012949062],"genre_scores_gemma":[0.9933423,0.0005793051,0.004882399,0.00046775045,0.000037691065,0.00004367123,0.0006210711,0.000015218504,0.000010623832],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848133,0.00021428513,0.00061914563,0.00016152942,0.00025291648,0.000270769],"domain_scores_gemma":[0.99908346,0.00032428952,0.00015402804,0.0001341618,0.000059669237,0.00024437485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089771993,0.00014694514,0.0002609994,0.00020142146,0.00012407565,0.00002128042,0.00029288608,0.00006670731,0.00008472011],"category_scores_gemma":[0.000021969758,0.00014063162,0.000024497804,0.00022637626,0.00007661461,0.00029260246,0.00022265577,0.0003494998,0.000002347691],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044037303,0.002280118,0.011215628,0.0025407495,0.0010702765,0.00005758958,0.6607622,0.00021927441,0.0005761109,0.00005826043,0.043993264,0.27678615],"study_design_scores_gemma":[0.012491021,0.00043118626,0.001298645,0.0002728844,0.00026720017,0.000020893833,0.14589351,0.2788421,0.0024619708,0.000013515054,0.5574543,0.00055277586],"about_ca_topic_score_codex":0.00005176205,"about_ca_topic_score_gemma":0.0001441669,"teacher_disagreement_score":0.5148687,"about_ca_system_score_codex":0.00013910537,"about_ca_system_score_gemma":0.00074812945,"threshold_uncertainty_score":0.57347906},"labels":[],"label_agreement":null},{"id":"W4402481221","doi":"10.1097/ftd.0000000000001243","title":"Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Health Services Authority; University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Test (biology); Medical physics","score_opus":0.3247910157054581,"score_gpt":0.5892996101861243,"score_spread":0.2645085944806662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402481221","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007414842,0.9869155,0.00001869073,0.00017240571,0.0036311077,0.008154329,0.0000825717,0.00010881477,0.00017505533],"genre_scores_gemma":[0.0019857879,0.99195874,0.00031582685,0.00022644812,0.001284557,0.003985103,0.00007081006,0.00014255669,0.000030187544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583113,0.00095599046,0.0012997016,0.000833101,0.00035101917,0.00072905666],"domain_scores_gemma":[0.9979806,0.0009009717,0.0005329355,0.00022314016,0.00018668079,0.00017567635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003745004,0.0007237679,0.001449254,0.00035969607,0.00021744972,0.00015763035,0.00033942616,0.00026205313,0.00007756588],"category_scores_gemma":[0.000054204273,0.00066711224,0.00027951045,0.00062062946,0.00007931804,0.00019247734,0.00015416581,0.00094768446,0.000026074922],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000057567295,0.00005406337,0.00003227519,0.10428614,0.00030497336,0.0000067987035,0.0005220699,0.000020377853,0.00010788849,0.00002088027,0.00015627911,0.8944825],"study_design_scores_gemma":[0.0024682088,0.00012713311,0.000013055447,0.3283802,0.025417317,0.000048354104,0.0009995124,0.0016674781,0.0004936244,0.0011672346,0.637544,0.001673941],"about_ca_topic_score_codex":0.00001184411,"about_ca_topic_score_gemma":0.0000047942885,"teacher_disagreement_score":0.89280856,"about_ca_system_score_codex":0.00021827238,"about_ca_system_score_gemma":0.0010641132,"threshold_uncertainty_score":0.999578},"labels":[],"label_agreement":null},{"id":"W4402567628","doi":"10.1002/cpt.3404","title":"Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?","year":2024,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Medicine; Intensive care medicine; Pharmacology; Biology; Genotype; Genetics","score_opus":0.17465712181962192,"score_gpt":0.5086332172790551,"score_spread":0.3339760954594332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402567628","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02320904,0.024040285,0.0005838712,0.0014596111,0.9394227,0.004825442,0.005209896,0.00037609247,0.00087306],"genre_scores_gemma":[0.04321816,0.044403132,0.0043245982,0.071179606,0.8231004,0.0024964467,0.0016002618,0.0013591365,0.008318242],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886987,0.0016276398,0.004133811,0.0023299388,0.0011696008,0.0020403115],"domain_scores_gemma":[0.9842511,0.010779238,0.0017535929,0.0008314121,0.0017434828,0.00064116553],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0041311225,0.0017250425,0.0025426107,0.00054474507,0.00047623581,0.00009977628,0.002191227,0.0032781707,0.0011695053],"category_scores_gemma":[0.0001333584,0.0017001202,0.0017054686,0.0010084794,0.0011546732,0.00014052447,0.0009377064,0.0055099283,0.00042472628],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002354565,0.0026683502,0.00083461375,0.0025636202,0.014886055,0.000075131175,0.0003368743,0.0001085929,0.012014562,0.000017744904,0.87385625,0.090283655],"study_design_scores_gemma":[0.010616383,0.0008265057,0.00019745812,0.00024585973,0.027081927,0.0000025631396,0.00003696285,0.0023443238,0.021375954,0.0009462321,0.93481064,0.0015151999],"about_ca_topic_score_codex":0.000002831687,"about_ca_topic_score_gemma":0.0000025527265,"teacher_disagreement_score":0.11632229,"about_ca_system_score_codex":0.00026209548,"about_ca_system_score_gemma":0.0009556265,"threshold_uncertainty_score":0.9997436},"labels":[],"label_agreement":null},{"id":"W4403071576","doi":"10.1093/clinchem/hvae106.646","title":"B-289 Assessing the Shift in Positivity Rates of Cocaine and Its Metabolites in a Community Based Population: A Transition from utilization of Cutoff Concentrations to Qualitative Structure Identification","year":2024,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Cutoff; Identification (biology); Transition (genetics); Population; Qualitative analysis; Qualitative research; Medicine; Psychology; Chemistry; Sociology; Biology; Environmental health; Physics; Biochemistry; Social science","score_opus":0.27457477545100567,"score_gpt":0.5788821163032498,"score_spread":0.30430734085224415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403071576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461997,0.0024870283,0.00054685463,0.0011642822,0.00016850405,0.00026152987,0.0007116741,0.00001171941,0.000028461582],"genre_scores_gemma":[0.9989146,0.00012283579,0.00009809343,0.00031870892,0.00006597042,0.000016429527,0.0004514707,0.0000079400315,0.000003924941],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705124,0.0017883204,0.0007503933,0.00019257313,0.00010492305,0.00011252251],"domain_scores_gemma":[0.9966396,0.002916057,0.00015609084,0.00012496507,0.0000955985,0.00006767938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019641388,0.00011195728,0.0002837741,0.000044570417,0.00007398107,0.000025425577,0.00012105955,0.00019769627,0.00007797132],"category_scores_gemma":[0.00048746946,0.000097964454,0.00005745077,0.00036694852,0.00014922734,0.00011197566,0.000027447806,0.00065104343,5.1581105e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018650987,0.0004953686,0.050736375,0.0004200284,0.000089562534,0.0000029193063,0.010865949,0.0017930408,0.93140054,0.0005591818,0.0000188549,0.0034316787],"study_design_scores_gemma":[0.00094731484,0.000015322852,0.25345886,0.00012051478,0.00016067813,5.2326493e-7,0.00088178983,0.044158496,0.6958883,0.00412204,0.00013370578,0.000112450405],"about_ca_topic_score_codex":0.00008544038,"about_ca_topic_score_gemma":0.000053423602,"teacher_disagreement_score":0.23551223,"about_ca_system_score_codex":0.000020204414,"about_ca_system_score_gemma":0.00008586303,"threshold_uncertainty_score":0.39948744},"labels":[],"label_agreement":null},{"id":"W4403233605","doi":"10.1002/pds.70014","title":"The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia","year":2024,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft; McGill University","keywords":"Medicine; Warfarin; Hypoglycemia; Sulfonylurea; Hazard ratio; Concomitant; Pharmacoepidemiology; Drug interaction; Internal medicine; Propensity score matching; Drug; Drug-drug interaction; Medical prescription; Pharmacology; Confidence interval; Insulin; Atrial fibrillation","score_opus":0.14236780409675806,"score_gpt":0.4376447361769628,"score_spread":0.2952769320802048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403233605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472655,0.018121354,0.0014034833,0.025363917,0.0038478163,0.0027629465,0.00016476626,0.00008060971,0.0009896068],"genre_scores_gemma":[0.97696865,0.017447397,0.00018161151,0.0029366764,0.00044702864,0.00020460699,0.000006596798,0.00003718828,0.0017702443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9883266,0.009182853,0.0010990421,0.0006521089,0.000217063,0.00052229885],"domain_scores_gemma":[0.9677473,0.030960165,0.00042772075,0.00045965638,0.00012747875,0.00027772947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012386545,0.0004363206,0.0005884789,0.00014597797,0.0009402327,0.000035280573,0.00059458235,0.00009613079,0.00043159892],"category_scores_gemma":[0.0010747123,0.00022869396,0.00019765552,0.0003688382,0.0004966956,0.00013998157,0.00039655145,0.0018617223,0.000040882187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019684298,0.001774676,0.06506024,0.00027432028,0.007686079,0.00003718656,0.04416118,0.030559061,0.019362902,0.022518579,0.27962816,0.5092533],"study_design_scores_gemma":[0.0033113635,0.00023046046,0.028342575,0.000111313835,0.0027720404,0.00010559476,0.003372283,0.017543692,0.041230373,0.007918734,0.8944952,0.00056640204],"about_ca_topic_score_codex":0.001183568,"about_ca_topic_score_gemma":0.00018291349,"teacher_disagreement_score":0.614867,"about_ca_system_score_codex":0.000050246545,"about_ca_system_score_gemma":0.00013603078,"threshold_uncertainty_score":0.9325869},"labels":[],"label_agreement":null},{"id":"W4403423749","doi":"10.1186/s12916-024-03700-9","title":"Common pitfalls in drug target Mendelian randomization and how to avoid them","year":2024,"lang":"en","type":"review","venue":"BMC Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"NIHR Cambridge Biomedical Research Centre; Medical Research Council; Fonds de Recherche du Québec - Santé; National Institute for Health and Care Research; Wellcome Trust","keywords":"Mendelian randomization; Medicine; Mendelian inheritance; Drug; Drug trial; Drug development; Clinical trial; Risk analysis (engineering); Intensive care medicine; Genetic variants; Pharmacology; Genetics; Pathology; Biology","score_opus":0.20920286024555193,"score_gpt":0.4820214774620004,"score_spread":0.2728186172164485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403423749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017327866,0.988438,0.00014544556,0.0019059981,0.003326126,0.0019925442,0.00014426663,0.00007771909,0.0037966203],"genre_scores_gemma":[0.0009008692,0.99083096,0.0002508887,0.0017137743,0.0015557369,0.00031583765,0.00022677155,0.00009745359,0.0041077035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611473,0.001552843,0.0008076313,0.0007124034,0.0002820565,0.0005303477],"domain_scores_gemma":[0.9978815,0.0009634076,0.00025360665,0.00032032465,0.00005720165,0.0005239626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030377042,0.0006655573,0.0024076328,0.0005752623,0.00010025522,0.000032957032,0.0004237542,0.0004780951,0.00075331575],"category_scores_gemma":[0.00028871954,0.00045927532,0.0002007308,0.0007252683,0.00017035799,0.00004986254,0.00023690317,0.0014082264,0.00026888392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000335066,0.00016700568,0.00014635068,0.024256697,0.0005140129,0.00015131792,0.0019852077,0.00004695592,0.000132387,0.0014097692,0.14363153,0.8272237],"study_design_scores_gemma":[0.0040611164,0.000032632423,0.000004420873,0.0037615297,0.0025330496,0.000049683324,0.00005796543,0.00031488066,0.000050079347,0.0005738109,0.9881225,0.0004383197],"about_ca_topic_score_codex":0.000025941763,"about_ca_topic_score_gemma":0.00005556959,"teacher_disagreement_score":0.844491,"about_ca_system_score_codex":0.00008615214,"about_ca_system_score_gemma":0.00021908435,"threshold_uncertainty_score":0.9997859},"labels":[],"label_agreement":null},{"id":"W4403604981","doi":"10.1007/978-3-031-35529-5_93","title":"An Introduction to Safety Pharmacokinetics","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nuclear Laboratories","funders":"","keywords":"Pharmacokinetics; Medicine; Computer science; Pharmacology","score_opus":0.07881437904304522,"score_gpt":0.4278404040705888,"score_spread":0.3490260250275436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403604981","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029758067,0.004019103,0.0003902277,0.011176831,0.017622672,0.0011266416,0.000848252,0.00063924404,0.96387947],"genre_scores_gemma":[0.004918779,0.004019672,0.00065776205,0.0095846625,0.018582819,0.00004863929,0.000410932,0.0002967564,0.96147996],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668056,0.00010347017,0.000832526,0.0012769784,0.00041361133,0.0006928398],"domain_scores_gemma":[0.9977224,0.00009590765,0.00015584844,0.0006806366,0.00025306805,0.0010921637],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008456312,0.00084461767,0.00069599017,0.00055242394,0.0002210719,0.000087909146,0.00069144985,0.0010055949,0.044108827],"category_scores_gemma":[0.00001654317,0.0008226598,0.0003015198,0.00013393218,0.00016576888,0.000102004735,0.00027404644,0.002320115,0.009358567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005059101,0.00015555558,0.0000037472523,0.00013152316,0.0007731267,0.00013708121,0.00029880856,0.002343066,0.045877986,0.46921232,0.34978336,0.13077751],"study_design_scores_gemma":[0.0006321889,0.00015585627,0.000004280962,0.000015896225,0.0012391902,0.00004893252,0.000010045854,0.0016164507,0.016970577,0.014980338,0.96340925,0.0009169838],"about_ca_topic_score_codex":0.000004401728,"about_ca_topic_score_gemma":0.000009560158,"teacher_disagreement_score":0.6136259,"about_ca_system_score_codex":0.00015933173,"about_ca_system_score_gemma":0.00013943671,"threshold_uncertainty_score":0.9999816},"labels":[],"label_agreement":null},{"id":"W4403616501","doi":"10.1007/s10549-024-07519-z","title":"CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"Genomic Health; Foundation Medicine; Veracyte; Genentech; Max-Planck-Gesellschaft; Eisai; Puma Biotechnology; Natera; National Institutes of Health; ECOG-ACRIN Cancer Research Group; BeiGene; Susan G. Komen; Sanofi Genzyme; Pfizer; Incyte; American College of Radiology Imaging Network; National Cancer Institute; Gilead Sciences; Sanofi; Johns Hopkins University; Susan G. Komen for the Cure; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Metastatic breast cancer; Cancer; Internal medicine; Mammary gland; Antiestrogen","score_opus":0.14977172718728982,"score_gpt":0.44882049944701197,"score_spread":0.29904877225972215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403616501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763126,0.0037608538,0.0000039082875,0.0021881508,0.00023805711,0.0012137276,0.015736612,0.00006894165,0.00047716746],"genre_scores_gemma":[0.9942164,0.0035381757,0.000047927217,0.00011098178,0.000240081,0.0008711555,0.00020769623,0.00006650764,0.0007011084],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99659514,0.0005882905,0.0003199127,0.0009611764,0.0005475856,0.0009879116],"domain_scores_gemma":[0.99843216,0.00034562798,0.0000814338,0.00029100524,0.00024310146,0.00060666166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037792602,0.00047036196,0.00049629423,0.0003305022,0.00026739432,0.00014165508,0.00017997509,0.00012567545,0.0008389897],"category_scores_gemma":[0.0000055406645,0.00030773706,0.00006391678,0.00071535533,0.00037152108,0.00021697523,0.000099088094,0.0006395176,0.000039467595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04750128,0.0077691693,0.24696071,0.00013776663,0.003764497,0.0012487354,0.0020920597,0.0009658319,0.0075541413,0.000047729965,0.0011278965,0.6808302],"study_design_scores_gemma":[0.029624904,0.0017979385,0.91394794,0.00040764292,0.0008722944,0.000061668674,0.00013898098,0.0019871022,0.027182968,0.00012609965,0.023063876,0.0007885666],"about_ca_topic_score_codex":0.015038956,"about_ca_topic_score_gemma":0.005232987,"teacher_disagreement_score":0.6800416,"about_ca_system_score_codex":0.0009016942,"about_ca_system_score_gemma":0.0005187974,"threshold_uncertainty_score":0.9999375},"labels":[],"label_agreement":null},{"id":"W4403859485","doi":"10.1124/dmd.124.001893","title":"Uncovering the impact of COVID-19–mediated bidirectional dysregulation of cytochrome P450 3A4 on systemic and pulmonary drug concentrations using physiologically based pharmacokinetic modeling","year":2024,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Tobacco Research Unit; College of Physicians and Surgeons of Ontario","funders":"Leslie Dan Faculty of Pharmacy, University of Toronto; Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacokinetics; CYP3A4; Drug; Coronavirus disease 2019 (COVID-19); Pharmacology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Chemistry; Computational biology; Biology; Medicine; Cytochrome P450; Enzyme; Disease; Biochemistry; Infectious disease (medical specialty); Internal medicine","score_opus":0.06550685127745885,"score_gpt":0.40176460207453585,"score_spread":0.336257750797077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403859485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98046744,0.014781761,0.0026665402,0.00022028165,0.0004247974,0.0005511193,0.0007142708,0.00006179503,0.000112003494],"genre_scores_gemma":[0.997303,0.0017696366,0.00008628779,0.00030719032,0.00026444744,0.0000398354,0.00019416961,0.000022560625,0.000012865714],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998037,0.00060634996,0.0005044295,0.000364007,0.00022838816,0.0002598644],"domain_scores_gemma":[0.99876344,0.0005762327,0.00018328422,0.00012944188,0.00011521393,0.00023236343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072263967,0.00026746592,0.00037257906,0.0002184235,0.0002937836,0.00003930601,0.00011693093,0.00011954207,0.00012017216],"category_scores_gemma":[0.00005724812,0.00019245295,0.00016244744,0.00038780153,0.00023663642,0.00017382645,0.00005009024,0.0003223007,0.0000022326328],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003029734,0.00010965242,0.00022714247,0.000184241,0.00012551346,0.0000054509355,0.00040957518,0.38694397,0.61000884,0.0004676915,0.000045257755,0.0011696897],"study_design_scores_gemma":[0.0010955989,0.000028860697,0.008038259,0.00009357615,0.0005609485,0.000037537116,0.00010926734,0.96018463,0.028278656,0.0010469505,0.00031345547,0.00021225063],"about_ca_topic_score_codex":0.0001577659,"about_ca_topic_score_gemma":0.0000015778587,"teacher_disagreement_score":0.5817302,"about_ca_system_score_codex":0.00006525256,"about_ca_system_score_gemma":0.00023475623,"threshold_uncertainty_score":0.78480035},"labels":[],"label_agreement":null},{"id":"W4403922127","doi":"10.21203/rs.3.rs-5262235/v1","title":"Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Science and Technology Council; Academia Sinica; Taiwan Biobank","keywords":"Pharmacogenetics; Cohort; Medicine; Internal medicine; Genetics; Genotype; Biology; Gene","score_opus":0.19713075590552875,"score_gpt":0.6173031579643765,"score_spread":0.42017240205884776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403922127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95036995,0.031450305,0.00001803884,0.00017456785,0.003685517,0.0028083364,0.0057639447,0.00009481553,0.005634545],"genre_scores_gemma":[0.9534605,0.043469235,0.000105836436,0.000106388994,0.0015847647,0.00044491765,0.00022731848,0.0001468047,0.0004541942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98453367,0.0087636635,0.0019494139,0.0015904902,0.0012520881,0.0019106593],"domain_scores_gemma":[0.9944688,0.0022462073,0.0004478923,0.0010510402,0.0007768727,0.0010091658],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.02087534,0.0007780413,0.0016306698,0.0015327926,0.00021563139,0.00008754108,0.0015024228,0.0017041304,0.0044461787],"category_scores_gemma":[0.0013710222,0.00064632995,0.0013432663,0.0016159776,0.00058724335,0.00005238751,0.0045165904,0.01490939,0.0006886692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010425851,0.0025104713,0.9547227,0.0013645355,0.0022411207,0.00060923636,0.0008466702,0.0047505423,0.0045868843,0.00008749048,0.007186567,0.020051215],"study_design_scores_gemma":[0.00489981,0.00037428588,0.904829,0.00042866066,0.0007103306,0.000018059098,0.000055579298,0.062244367,0.0011188565,0.013535182,0.011005471,0.0007803459],"about_ca_topic_score_codex":0.0006215948,"about_ca_topic_score_gemma":0.00010781986,"teacher_disagreement_score":0.057493825,"about_ca_system_score_codex":0.00034967496,"about_ca_system_score_gemma":0.0023820705,"threshold_uncertainty_score":0.9995988},"labels":[],"label_agreement":null},{"id":"W4403968392","doi":"10.1097/fpc.0000000000000547","title":"The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of General Medical Sciences; University of North Carolina at Chapel Hill; University of California, Davis; University of Montana; University of Pennsylvania Health System; University of Illinois at Urbana-Champaign; National Institutes of Health; Univerza v Ljubljani; Rijksuniversiteit Groningen; St. Jude Children's Research Hospital; University of Minnesota; University of Pennsylvania; Moffitt Cancer Center; U.S. Department of Veterans Affairs","keywords":"Pharmacogenetics; Pharmacogenomics; Workflow; Dosing; Drug response; Medicine; Drug; Computer science; Pharmacology; Biology; Genotype; Genetics","score_opus":0.12556258059787465,"score_gpt":0.5459056649859957,"score_spread":0.42034308438812107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403968392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86881965,0.10459224,0.0030467033,0.0055537233,0.0108463,0.00363846,0.0014143428,0.00028121605,0.001807358],"genre_scores_gemma":[0.93527174,0.053622436,0.0023193832,0.0040500974,0.003678597,0.0006127441,0.00021538322,0.00011821386,0.00011142041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99305385,0.0012625422,0.0013527558,0.0013393123,0.0006956381,0.0022958915],"domain_scores_gemma":[0.9971838,0.00059609103,0.0002383168,0.00042503295,0.00046010432,0.0010966386],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.004976564,0.00072152435,0.00045443303,0.00018486565,0.0025678633,0.0010034499,0.00091982563,0.0002597669,0.00038310746],"category_scores_gemma":[0.00003317535,0.0006842964,0.00019398112,0.0024650164,0.00039268626,0.00022654743,0.0008187733,0.0009563161,0.00025051786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056348345,0.00010157677,0.0064795054,0.000082679784,0.0006815426,0.000059388305,0.00096235354,0.0093785785,0.10420673,0.010655505,0.028640624,0.83818805],"study_design_scores_gemma":[0.0022724788,0.0001784143,0.0013535678,0.00002185413,0.00060849235,0.00007336,0.0011530787,0.014127956,0.027955007,0.008265181,0.9432309,0.00075967226],"about_ca_topic_score_codex":0.000070324364,"about_ca_topic_score_gemma":0.0006577155,"teacher_disagreement_score":0.9145903,"about_ca_system_score_codex":0.00094778644,"about_ca_system_score_gemma":0.0006336318,"threshold_uncertainty_score":0.99956083},"labels":[],"label_agreement":null},{"id":"W4404104523","doi":"10.1007/s10571-024-01504-2","title":"Synergistic Epistasis and Systems Biology Approaches to Uncover a Pharmacogenomic Map Linked to Pain, Anti-Inflammatory and Immunomodulating Agents (PAIma) in a Healthy Cohort","year":2024,"lang":"en","type":"article","venue":"Cellular and Molecular Neurobiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Isfahan; Guilan University of Medical Sciences","keywords":"Pharmacogenomics; Oxycodone; Medicine; Pharmacogenetics; Addiction; Cohort; Opioid; Pharmacology; Bioinformatics; Psychiatry; Genetics; Biology; Gene; Genotype; Internal medicine","score_opus":0.11228683517720484,"score_gpt":0.3577869469488756,"score_spread":0.24550011177167075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404104523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96417886,0.029046815,0.0023417156,0.001088253,0.0016753307,0.0013477859,0.00011972405,0.000076157856,0.00012537447],"genre_scores_gemma":[0.99309814,0.0015452538,0.00014331425,0.0046750437,0.00015335187,0.00019134156,0.00007547045,0.000068903115,0.00004917696],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957786,0.0016835774,0.0006196197,0.0010697986,0.000073882584,0.0007744992],"domain_scores_gemma":[0.99871725,0.0003905973,0.00008761943,0.00023422916,0.00003557472,0.00053473475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017164409,0.00044975642,0.00064790685,0.00044661705,0.00018232877,0.00007576789,0.00020642178,0.00036100222,0.00003055651],"category_scores_gemma":[0.000089855144,0.0004484073,0.00007761445,0.00025941184,0.00024164408,0.00004424207,0.00036576405,0.00063260546,0.000031321208],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002770541,0.00008090832,0.012149292,0.0005084952,0.00029003998,0.00046049678,0.0005197981,0.0014182809,0.97303516,0.0016997168,0.00024654932,0.009314235],"study_design_scores_gemma":[0.009914908,0.0024665918,0.031450626,0.00038393977,0.0018779445,0.0004515731,0.00043500192,0.20137624,0.13500856,0.0018035822,0.6107795,0.004051496],"about_ca_topic_score_codex":0.000061480525,"about_ca_topic_score_gemma":0.0000046230507,"teacher_disagreement_score":0.8380266,"about_ca_system_score_codex":0.00005166844,"about_ca_system_score_gemma":0.00008909923,"threshold_uncertainty_score":0.99979675},"labels":[],"label_agreement":null},{"id":"W4404373822","doi":"10.1016/j.encep.2024.09.003","title":"CYP2D6 and CYP2C19 ultrarapid metabolisms are associated with suicide attempts in schizophrenia","year":2024,"lang":"en","type":"article","venue":"L Encéphale","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"CYP2C19; Schizophrenia (object-oriented programming); Medicine; Psychiatry; Psychology; Internal medicine; Cytochrome P450","score_opus":0.0831350508802647,"score_gpt":0.3982467273946035,"score_spread":0.3151116765143388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404373822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95933974,0.032664828,0.000039746814,0.00093426567,0.0010676244,0.00040791137,0.0002090197,0.00019448949,0.0051423768],"genre_scores_gemma":[0.99438655,0.0023217995,0.00015946601,0.0016639776,0.00025315146,0.00008684538,0.00004296118,0.0000576326,0.0010276415],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99776816,0.00040782787,0.00039121867,0.0005755201,0.00023937396,0.0006179198],"domain_scores_gemma":[0.99886197,0.00047840553,0.00010524081,0.000188997,0.00006571189,0.00029968776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080810295,0.00035465581,0.0004669513,0.00029016638,0.00014436536,0.00008278583,0.00023714101,0.00029903973,0.00057786965],"category_scores_gemma":[0.0000947789,0.00030160314,0.000081183425,0.0006489896,0.00022799759,0.00021868662,0.00007583293,0.0009784066,0.00010659732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028634572,0.0024891703,0.32116327,0.0008465077,0.0037432227,0.0055693034,0.009408081,0.0032620279,0.36079612,0.025002798,0.01636762,0.24848843],"study_design_scores_gemma":[0.017024217,0.00032043483,0.41465807,0.0007327586,0.0017530448,0.00030601368,0.0005200427,0.023274459,0.18852341,0.0061954153,0.34411865,0.0025734792],"about_ca_topic_score_codex":0.00008209849,"about_ca_topic_score_gemma":0.0002427822,"teacher_disagreement_score":0.32775104,"about_ca_system_score_codex":0.00004692742,"about_ca_system_score_gemma":0.000118089585,"threshold_uncertainty_score":0.9999436},"labels":[],"label_agreement":null},{"id":"W4404871083","doi":"10.1016/b978-0-323-98808-7.00005-9","title":"Pharmacogenetic clinical implementation","year":2024,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AXYS Technologies (Canada)","funders":"","keywords":"Pharmacogenetics; Medicine; Medical physics; Biology; Genotype; Genetics","score_opus":0.15808417665270968,"score_gpt":0.5031369954639489,"score_spread":0.34505281881123917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404871083","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012030598,0.023771796,0.0000019322022,0.00037795855,0.011428653,0.0012602399,0.0006652008,0.00026145464,0.9610297],"genre_scores_gemma":[0.004221743,0.008322211,0.00011337551,0.00587811,0.004550476,0.00012782434,0.00019932653,0.00028870846,0.9762982],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583626,0.0002535973,0.0015829578,0.0011030907,0.0004592283,0.00076484296],"domain_scores_gemma":[0.99788946,0.00025853296,0.00046107397,0.00051324,0.00017856111,0.00069911464],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015227414,0.0008878763,0.0009656304,0.00033021913,0.00022977195,0.000078549434,0.0006459055,0.0011378827,0.013451378],"category_scores_gemma":[0.00001023628,0.0008768071,0.0008578801,0.000037425776,0.0004110586,0.000041058312,0.00041155383,0.0029429507,0.0064477585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008208913,0.000039844424,0.00004424272,0.0001542955,0.0012379276,0.00023484425,0.00018880861,0.0000040960244,0.0013245994,0.0076851523,0.011871357,0.97713274],"study_design_scores_gemma":[0.0015695967,0.000093465365,0.000017275415,0.00007029519,0.0029054696,0.000048634905,0.000013014205,0.00009195728,0.0026894733,0.022648612,0.96899444,0.0008577651],"about_ca_topic_score_codex":4.2138774e-7,"about_ca_topic_score_gemma":0.000010502769,"teacher_disagreement_score":0.97627497,"about_ca_system_score_codex":0.00010422534,"about_ca_system_score_gemma":0.00037492596,"threshold_uncertainty_score":0.99936825},"labels":[],"label_agreement":null},{"id":"W4405476348","doi":"10.1002/cpt.3534","title":"Prevalence Estimates of Cytochrome <scp>P450</scp> Phenoconversion in Youth Receiving Pharmacotherapy for Mental Health Conditions","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"CYP2C19; Pharmacogenetics; Medicine; Pharmacotherapy; CYP2D6; CYP2B6; Pharmacology; CYP3A4; Internal medicine; Cytochrome P450; Genotype; Biology; Genetics; Gene","score_opus":0.21507940728317868,"score_gpt":0.5323083967818297,"score_spread":0.3172289894986511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405476348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91664964,0.056328066,0.0010902289,0.0060940953,0.012499995,0.0034581074,0.0030982783,0.00034861444,0.00043296497],"genre_scores_gemma":[0.86899126,0.082067385,0.0013220533,0.044904448,0.0014411389,0.00030776154,0.00030163844,0.0001641718,0.00050013437],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99427706,0.0013621774,0.0018884997,0.0010002196,0.0002951169,0.0011769439],"domain_scores_gemma":[0.99354917,0.0049220137,0.0005135914,0.00028903215,0.00019745367,0.0005287638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033633295,0.00059401436,0.0010598004,0.00043760618,0.00036651615,0.000041331277,0.0007915332,0.00059968745,0.0007752462],"category_scores_gemma":[0.00006686571,0.00058986514,0.0005548042,0.00063113647,0.0010028653,0.00024178179,0.00017345654,0.0016947115,0.00008808155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013353191,0.0051487256,0.020868754,0.0020774212,0.004907365,0.00006288871,0.015378192,0.001501156,0.7709991,0.00045253415,0.09637766,0.08089093],"study_design_scores_gemma":[0.019832056,0.0017968576,0.009103809,0.00043846786,0.003737372,0.000048112586,0.0010820494,0.08000112,0.1999332,0.002761233,0.68049634,0.00076935923],"about_ca_topic_score_codex":0.000011552523,"about_ca_topic_score_gemma":0.000003627814,"teacher_disagreement_score":0.5841187,"about_ca_system_score_codex":0.00018718293,"about_ca_system_score_gemma":0.00063715753,"threshold_uncertainty_score":0.99965525},"labels":[],"label_agreement":null},{"id":"W4405915226","doi":"10.21037/tlcr-24-662","title":"Fuel for thought: targeting metabolism in lung cancer","year":2024,"lang":"en","type":"review","venue":"Translational Lung Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; OPKO Health; National Cancer Institute; A Breath of Hope Lung Foundation; Gilead Sciences","keywords":"Medicine; Lung cancer; Bioinformatics; Cancer; Intensive care medicine; Cancer research; Oncology; Internal medicine; Biology","score_opus":0.3340065270848984,"score_gpt":0.6206894767633551,"score_spread":0.28668294967845664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405915226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000414761,0.9827386,0.000072861,0.0014544019,0.0042772423,0.0043578856,0.005040577,0.000080216676,0.0019367448],"genre_scores_gemma":[0.0002581264,0.98136413,0.0002768622,0.00022420222,0.0045296284,0.009024336,0.0005333071,0.00022665954,0.0035627556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99344784,0.0015856889,0.0012718177,0.0011906063,0.00095499336,0.0015490296],"domain_scores_gemma":[0.99702805,0.0016439317,0.00019539277,0.00027542716,0.00045158959,0.00040561822],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004759432,0.0007317844,0.0017177509,0.0011807858,0.00038527197,0.00011597407,0.000930416,0.0009782439,0.0028784485],"category_scores_gemma":[0.00007603433,0.00063244434,0.000802457,0.0017539888,0.00026318835,0.00015944267,0.00014936375,0.004298057,0.00006827484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033758886,0.00023924316,0.00009319565,0.080095746,0.0025284607,0.000056110337,0.0012429077,0.0013271124,0.00020370694,0.010986309,0.05835114,0.84453845],"study_design_scores_gemma":[0.001237865,0.000009006112,0.000012290326,0.002818345,0.0034408513,0.0000038415496,0.000010614242,0.009243223,0.00005933165,0.0010120156,0.9815295,0.00062313845],"about_ca_topic_score_codex":0.00022396648,"about_ca_topic_score_gemma":0.00021627618,"teacher_disagreement_score":0.9231783,"about_ca_system_score_codex":0.00045839022,"about_ca_system_score_gemma":0.0032213472,"threshold_uncertainty_score":0.9996127},"labels":[],"label_agreement":null},{"id":"W4405985381","doi":"10.1016/s0026-895x(24)12330-9","title":"Heterogeneous Nuclear Ribonucleoprotein A1 and Regulation of the Xenobiotic-Inducible Gene Cyp2a5","year":2002,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Xenobiotic; Gene; Ribonucleoprotein; Chemistry; Cell biology; Computational biology; Biology; Genetics; Biochemistry; RNA; Enzyme","score_opus":0.056557291679361237,"score_gpt":0.3442259826809943,"score_spread":0.28766869100163306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405985381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98670983,0.0052017327,0.00006415682,0.0020879323,0.0018003953,0.00082804525,0.00005973024,0.00007255203,0.003175629],"genre_scores_gemma":[0.9927441,0.00080436416,0.0003805028,0.005212696,0.00023608987,0.000036435253,0.0000058440046,0.00006684175,0.00051310874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971888,0.00087784993,0.0005361513,0.00053661,0.00025085322,0.00060972874],"domain_scores_gemma":[0.99881035,0.00009528778,0.00029498164,0.00038742635,0.00012951517,0.0002824149],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048307772,0.0003438069,0.00041851387,0.0001499373,0.00033816035,0.000019627905,0.00052208314,0.00038891815,0.0043590646],"category_scores_gemma":[0.00003913217,0.00029794688,0.0002007655,0.00036002343,0.0005357784,0.00007146241,0.00037342613,0.0006843003,0.00011708283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096356285,0.0003175453,0.00027715604,0.00004414871,0.00027837837,0.0000521662,0.00033752783,0.0019985402,0.9810454,0.0007150487,0.0021374198,0.012700316],"study_design_scores_gemma":[0.0021747467,0.00008987392,0.0007786566,0.0000058636438,0.00043059952,0.00015136553,0.00001026845,0.016514478,0.84631115,0.00033140322,0.13292475,0.00027682018],"about_ca_topic_score_codex":0.000016846425,"about_ca_topic_score_gemma":0.000001941621,"teacher_disagreement_score":0.13473421,"about_ca_system_score_codex":0.000042254196,"about_ca_system_score_gemma":0.00003502743,"threshold_uncertainty_score":0.99994725},"labels":[],"label_agreement":null},{"id":"W4405993801","doi":"10.1016/s0026-895x(24)23106-0","title":"Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking","year":2000,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Genotyping; CYP2A6; Identification (biology); Genetics; Gene; In vivo; Biology; Computational biology; Genotype; In vitro","score_opus":0.029895145519548284,"score_gpt":0.38029568406195907,"score_spread":0.35040053854241077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405993801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98820764,0.0061829705,0.00004250953,0.0020342583,0.00043603094,0.00095893076,0.000019093291,0.00003405111,0.0020845348],"genre_scores_gemma":[0.98029417,0.0032961671,0.000050581177,0.015627237,0.00015108223,0.00041529068,0.000010625369,0.000029740022,0.000125118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970927,0.0012787476,0.00040572273,0.00054949615,0.00014942313,0.0005239012],"domain_scores_gemma":[0.9989592,0.00053024874,0.000092036666,0.000225821,0.000033950968,0.00015873369],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010932141,0.0002733244,0.00027811815,0.00027702661,0.00022785904,0.000037702706,0.0003370345,0.00025047275,0.00051529997],"category_scores_gemma":[0.00004178629,0.00025134746,0.000051921474,0.00044845135,0.00020547773,0.00006598362,0.000066771645,0.0007950194,0.00004034273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020522276,0.00033590407,0.0091931205,0.000051249135,0.000084683576,0.00025887266,0.0012055042,0.0017716874,0.9481289,0.00087689044,0.0012122911,0.036675673],"study_design_scores_gemma":[0.004856976,0.000086220796,0.07626667,0.000014507068,0.0003142448,0.000109825785,0.000038911603,0.0036632216,0.78599876,0.0016326018,0.12658122,0.00043683313],"about_ca_topic_score_codex":0.000024450344,"about_ca_topic_score_gemma":0.000018596751,"teacher_disagreement_score":0.16213013,"about_ca_system_score_codex":0.000042825428,"about_ca_system_score_gemma":0.000044261804,"threshold_uncertainty_score":0.99999386},"labels":[],"label_agreement":null},{"id":"W4406465021","doi":"10.1016/s0000-0000(11)55107-1","title":"10.1016/s0000-0000(11)55107-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mathematics","score_opus":0.04497348627129081,"score_gpt":0.33544096773399723,"score_spread":0.2904674814627064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406465021","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013495128,0.00086118735,0.0000013111548,0.0010812806,0.000035514982,0.0004692551,0.00016014028,0.00024663712,0.98364955],"genre_scores_gemma":[0.0021622304,0.000018773308,0.00011740155,0.0013074343,0.0008085001,0.00008070108,0.000042111315,0.00006542055,0.99539745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976766,0.00034852594,0.00042750136,0.00049803016,0.00025388907,0.0007954706],"domain_scores_gemma":[0.9985618,0.0001720316,0.00006999435,0.00038016634,0.00009122781,0.00072475703],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005954233,0.0003648456,0.0003868763,0.00015831285,0.00028295274,0.000044136686,0.00058997096,0.00029824878,0.99910605],"category_scores_gemma":[0.000037982205,0.00036985078,0.00016492396,0.00038820363,0.0001271912,0.00010766428,0.00011088967,0.0005507945,0.9937244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028245733,0.00021621231,0.0000015436477,0.0000083065615,0.00007779616,0.000025802234,0.000052624975,0.00070485345,0.0031362649,0.0000056146782,0.39028716,0.60520136],"study_design_scores_gemma":[0.0013271028,0.000093865885,0.000055803495,0.0000065074983,0.0001822957,0.0000267077,0.0000015375894,0.0012566295,0.00858011,0.000043930486,0.9879686,0.00045688127],"about_ca_topic_score_codex":0.000017724611,"about_ca_topic_score_gemma":4.2280172e-7,"teacher_disagreement_score":0.6047445,"about_ca_system_score_codex":0.00004470847,"about_ca_system_score_gemma":0.00008094701,"threshold_uncertainty_score":0.99987537},"labels":[],"label_agreement":null},{"id":"W4406517188","doi":"10.1016/s0029-7437(11)70029-5","title":"10.1016/s0029-7437(11)70029-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Tamoxifen; Metabolism; Medicine; Internal medicine; Breast cancer; Cancer","score_opus":0.043614038191269924,"score_gpt":0.333657006754359,"score_spread":0.2900429685630891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406517188","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012863709,0.0008448674,0.0000015979592,0.0009345631,0.000008921991,0.000452185,0.0001426184,0.0002701428,0.9844814],"genre_scores_gemma":[0.0016390865,0.00001726487,0.00015257568,0.0011761173,0.0006891903,0.00007850157,0.00003915334,0.00006276537,0.99614537],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775,0.0003323455,0.00041358126,0.00048625,0.00024429063,0.0007735567],"domain_scores_gemma":[0.9985909,0.00017966238,0.00006867538,0.00037287158,0.00009135176,0.00069653196],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005905546,0.00035468896,0.00037380058,0.00014918268,0.0002764893,0.000042042375,0.0005763256,0.00029225042,0.9990347],"category_scores_gemma":[0.0000344473,0.0003591747,0.0001608108,0.00036709907,0.00012497391,0.000100039266,0.00011439185,0.0005412845,0.993712],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022783644,0.00019153403,0.0000011211876,0.0000071072395,0.000069246846,0.000017329357,0.000045666722,0.00060763553,0.0028174552,0.00000528413,0.64097,0.3550398],"study_design_scores_gemma":[0.0012978201,0.00008728542,0.000031293075,0.0000062806394,0.00016379147,0.000035384877,0.0000014971885,0.0015146574,0.009859037,0.00003946657,0.9865202,0.00044329165],"about_ca_topic_score_codex":0.000013881838,"about_ca_topic_score_gemma":3.6684006e-7,"teacher_disagreement_score":0.35459653,"about_ca_system_score_codex":0.000041908243,"about_ca_system_score_gemma":0.00007019434,"threshold_uncertainty_score":0.99988604},"labels":[],"label_agreement":null},{"id":"W4406521198","doi":"10.1016/s0029-7437(05)70521-8","title":"10.1016/s0029-7437(05)70521-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Key (lock); Fentanyl; Gene; Medicine; Computational biology; Neuroscience; Biology; Genetics; Pharmacology; Computer science; Computer security","score_opus":0.04495290016387798,"score_gpt":0.33603763648975504,"score_spread":0.29108473632587706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406521198","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008596995,0.00086893677,0.0000014992387,0.0008700779,0.000010211796,0.000434328,0.00014234317,0.00025551816,0.9888201],"genre_scores_gemma":[0.0016637439,0.000019135608,0.00013765773,0.0014851476,0.00078555953,0.00006900752,0.000040068062,0.00005873884,0.99574095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783283,0.00032360153,0.00039917795,0.00046419664,0.00022983196,0.0007503722],"domain_scores_gemma":[0.99864495,0.00016858232,0.000065918626,0.00034909588,0.000087087246,0.0006843565],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005763679,0.00033975317,0.00036485767,0.00014397275,0.00026355046,0.000038618375,0.00053881016,0.00027897165,0.9990226],"category_scores_gemma":[0.000041107578,0.00034258375,0.00015585826,0.00035966779,0.00011627174,0.00009630656,0.00010579142,0.00060239004,0.9941179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002776522,0.00017798836,5.8658856e-7,0.000006944882,0.000078975885,0.000020134237,0.00004738619,0.0005340705,0.0032057983,0.000003900403,0.6133574,0.38228914],"study_design_scores_gemma":[0.0012897442,0.00011618796,0.00003948752,0.000005944785,0.00016872058,0.000030620566,0.0000015627762,0.0014493031,0.008166541,0.00004355405,0.988266,0.00042236442],"about_ca_topic_score_codex":0.000010736042,"about_ca_topic_score_gemma":1.8648748e-7,"teacher_disagreement_score":0.38186678,"about_ca_system_score_codex":0.00004050015,"about_ca_system_score_gemma":0.000069644586,"threshold_uncertainty_score":0.9999026},"labels":[],"label_agreement":null},{"id":"W4406555704","doi":"10.1016/s1634-6939(21)49710-3","title":"10.1016/s1634-6939(21)49710-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Medicine","score_opus":0.045133677221794836,"score_gpt":0.3381398435766605,"score_spread":0.29300616635486565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555704","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009305165,0.0010777612,0.000001433511,0.0008513832,0.00003891285,0.0004393587,0.00014423474,0.00022470446,0.98791707],"genre_scores_gemma":[0.0019430753,0.000022070832,0.00012464984,0.001444208,0.0007762891,0.00007069901,0.000051073275,0.000059622096,0.9955083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978189,0.00032527733,0.00040407002,0.00046671293,0.00023497277,0.00075008185],"domain_scores_gemma":[0.99864006,0.00016356228,0.00006558853,0.0003575279,0.00008911654,0.00068413385],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00057748245,0.00034064442,0.00036408543,0.0001450336,0.00026098258,0.000039405244,0.0005438437,0.00028079678,0.99845904],"category_scores_gemma":[0.00004088114,0.0003439497,0.0001553703,0.00036566905,0.00012127464,0.000096054224,0.00010806401,0.00060035056,0.9949288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003495095,0.00020228369,7.944651e-7,0.00000890182,0.000093094466,0.000024813251,0.00005426336,0.0006551095,0.0040776446,0.0000044527415,0.40270132,0.5918278],"study_design_scores_gemma":[0.0012876218,0.00010496306,0.000044319677,0.000006464615,0.00017497697,0.00002422163,0.0000014790031,0.0013407615,0.007702351,0.0000442131,0.9888426,0.00042602114],"about_ca_topic_score_codex":0.000009873662,"about_ca_topic_score_gemma":1.8131254e-7,"teacher_disagreement_score":0.5914018,"about_ca_system_score_codex":0.00004090485,"about_ca_system_score_gemma":0.00007478233,"threshold_uncertainty_score":0.99990124},"labels":[],"label_agreement":null},{"id":"W4406560968","doi":"10.1016/s2211-9698(23)47771-0","title":"10.1016/s2211-9698(23)47771-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mathematics","score_opus":0.04634207960470298,"score_gpt":0.3401207311691029,"score_spread":0.2937786515643999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406560968","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009459581,0.0010483274,0.0000013289861,0.00081640284,0.000038475053,0.00043833334,0.00014561105,0.00022067006,0.9878313],"genre_scores_gemma":[0.002063238,0.000022036624,0.00012645683,0.0014080486,0.0007716131,0.00007296683,0.000050415736,0.000059491427,0.99542576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782825,0.00032316498,0.00039842149,0.00046582147,0.00023436532,0.00075000024],"domain_scores_gemma":[0.9986567,0.00015580474,0.00006544431,0.00035166522,0.00008901289,0.0006814101],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005731405,0.00033968725,0.00037730986,0.00014471535,0.00026524716,0.000039205886,0.0005412382,0.00027998057,0.9985575],"category_scores_gemma":[0.000039803068,0.00034321018,0.00015697011,0.00036105016,0.00011638759,0.00009685956,0.00010706588,0.00059618853,0.9951019],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030667387,0.00019758286,8.224884e-7,0.000007796583,0.00009076277,0.000023875187,0.00005026288,0.00062744296,0.004815699,0.0000051300635,0.41729212,0.57658184],"study_design_scores_gemma":[0.0012542792,0.000102963815,0.000046853143,0.000005878067,0.0001753546,0.000023350918,0.0000014417102,0.0014012862,0.009710727,0.00004260848,0.98681116,0.00042406883],"about_ca_topic_score_codex":0.000008869358,"about_ca_topic_score_gemma":1.8583187e-7,"teacher_disagreement_score":0.57615775,"about_ca_system_score_codex":0.000039949853,"about_ca_system_score_gemma":0.000074195836,"threshold_uncertainty_score":0.999902},"labels":[],"label_agreement":null},{"id":"W4406570226","doi":"10.1016/j.cnur.2024.12.006","title":"The Use of Pharmacogenomics in Mental Health","year":2025,"lang":"en","type":"review","venue":"Nursing Clinics of North America","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital","funders":"","keywords":"Medicine; Pharmacogenomics; Mental health; MEDLINE; Psychiatry; Pharmacology","score_opus":0.2981826777562113,"score_gpt":0.5514604454402324,"score_spread":0.2532777676840211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406570226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031548052,0.9916086,0.000028179544,0.00036142027,0.0042918622,0.0013848945,0.0016971863,0.00002161864,0.0002907351],"genre_scores_gemma":[0.000082587954,0.99755687,0.0005934336,0.00092457636,0.00016626374,0.000046904584,0.00028528715,0.000054359927,0.0002897091],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942302,0.0017236215,0.0025587098,0.00051107944,0.0002685754,0.0007078019],"domain_scores_gemma":[0.99350953,0.0032973434,0.0022783086,0.00051899103,0.00013747042,0.00025834027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010162144,0.00053203094,0.0025102566,0.00038871216,0.00025868227,0.000017730983,0.00093158707,0.00032498207,0.000040084287],"category_scores_gemma":[0.000261226,0.00043507243,0.00076372566,0.0010313013,0.00091158046,0.000059466507,0.00016352457,0.0016453153,0.000010641682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001434429,0.00063159893,0.00017695242,0.0028456787,0.0003480144,0.0000030198046,0.0003200384,0.0002483927,0.0000013592102,0.000026687538,0.008091086,0.9871637],"study_design_scores_gemma":[0.0007339192,0.00009914255,0.000031923286,0.0029231755,0.00081503205,0.000004460455,0.000020962994,0.00048764437,0.0000058358883,0.000024661736,0.9945629,0.00029031996],"about_ca_topic_score_codex":0.000034387936,"about_ca_topic_score_gemma":0.000022347347,"teacher_disagreement_score":0.9868734,"about_ca_system_score_codex":0.0001920636,"about_ca_system_score_gemma":0.0018544672,"threshold_uncertainty_score":0.9998101},"labels":[],"label_agreement":null},{"id":"W4406583238","doi":"10.1016/s1155-1976(02)00048-7","title":"10.1016/s1155-1976(02)00048-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Disposition; Psychology; Social psychology","score_opus":0.04572781173066551,"score_gpt":0.3391572638153699,"score_spread":0.2934294520847044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406583238","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010069071,0.0009834209,0.0000015580978,0.000821092,0.000038775986,0.00044591897,0.00014678367,0.00022961266,0.98726374],"genre_scores_gemma":[0.0029168997,0.000018839539,0.00011478786,0.0014496696,0.0007774469,0.00007468506,0.00004033009,0.000059410377,0.9945479],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978286,0.00032252722,0.00039836657,0.0004682689,0.00022921461,0.0007530127],"domain_scores_gemma":[0.99865997,0.0001638532,0.0000638684,0.00035388095,0.00007952018,0.0006788948],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005678306,0.00034068112,0.00036387853,0.00014485407,0.00027840413,0.000040327846,0.0005393856,0.00028246982,0.9987614],"category_scores_gemma":[0.00003632284,0.00034509704,0.00015936338,0.0003196249,0.000117993535,0.000094907504,0.00010491083,0.0006069776,0.9937289],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034717337,0.00021335829,9.343364e-7,0.000008541159,0.00009687687,0.000026004069,0.00005349374,0.0010460281,0.0035095783,0.0000044123067,0.37929487,0.6153987],"study_design_scores_gemma":[0.0012731729,0.00010721825,0.000046844514,0.0000058781548,0.000174215,0.000024753337,0.0000013301024,0.0013569624,0.010442023,0.000040231076,0.98610115,0.00042620717],"about_ca_topic_score_codex":0.000011978061,"about_ca_topic_score_gemma":2.085409e-7,"teacher_disagreement_score":0.61497253,"about_ca_system_score_codex":0.000042238185,"about_ca_system_score_gemma":0.00007733108,"threshold_uncertainty_score":0.9999001},"labels":[],"label_agreement":null},{"id":"W4406666103","doi":"10.1016/b978-0-323-08475-8.00060-8","title":"10.1016/b978-0-323-08475-8.00060-8","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.05311223364517546,"score_gpt":0.31992495093562995,"score_spread":0.26681271729045447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406666103","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011170431,0.004469948,7.655028e-7,0.0004523114,0.00010410155,0.00094467343,0.0010653803,0.00030652992,0.99264514],"genre_scores_gemma":[0.00001106748,0.000074885196,0.000066019835,0.0012915372,0.0020917244,0.00007756711,0.00030875625,0.00026887542,0.99580956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996543,0.00018995938,0.00083067885,0.0009785725,0.00046721625,0.0009905992],"domain_scores_gemma":[0.99752057,0.00026716283,0.00028645052,0.0007044465,0.00018357567,0.0010378057],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005965333,0.0010089768,0.0010318777,0.00046169886,0.00031498593,0.00006228234,0.0010021593,0.0013897383,0.9990337],"category_scores_gemma":[0.000030445948,0.0010788247,0.00047344438,0.000114751456,0.00025856352,0.00008082277,0.00032683794,0.0020111548,0.9957667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041938457,0.000094883224,2.3559402e-8,0.000028095243,0.00039211175,0.00009650849,0.000027053524,0.0001697702,0.00038437752,0.00016981001,0.36782485,0.63039315],"study_design_scores_gemma":[0.0012133023,0.00015667322,0.0000010102367,0.00004707103,0.00087617995,0.000047757883,3.4160607e-7,0.00017021192,0.0009802749,0.0008500085,0.99447834,0.0011788065],"about_ca_topic_score_codex":0.000006705593,"about_ca_topic_score_gemma":3.2306173e-7,"teacher_disagreement_score":0.62921435,"about_ca_system_score_codex":0.00011127846,"about_ca_system_score_gemma":0.0002300659,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W4407147371","doi":"10.2174/011573403x334668241227074314","title":"Pharmacogenomics and its Role in Cardiovascular Diseases: A Narrative Literature Review","year":2025,"lang":"en","type":"review","venue":"Current Cardiology Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Pharmacogenomics; Medicine; Intensive care medicine; Pharmacogenetics; Personalized medicine; Adverse effect; Precision medicine; Bioinformatics; Pharmacology; Pathology","score_opus":0.1272630510619573,"score_gpt":0.4792411730001591,"score_spread":0.3519781219382018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407147371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004722222,0.98478675,0.0000085955835,0.000049044098,0.0050120014,0.0074541373,0.0017326873,0.0000641626,0.0008878934],"genre_scores_gemma":[0.0000028014404,0.99256915,0.000013760937,0.0009916557,0.0013675698,0.0035661808,0.0011978688,0.00008222097,0.00020876546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9853439,0.009438007,0.0022678082,0.0016990151,0.00022337359,0.0010278955],"domain_scores_gemma":[0.99694544,0.000621465,0.000761207,0.00089113374,0.00019703698,0.0005837256],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003314902,0.0015413931,0.010862589,0.0006163738,0.00023177554,0.000039708182,0.0010284587,0.0010548377,0.00015142035],"category_scores_gemma":[0.00065406953,0.0012417912,0.0037030042,0.0014690948,0.00021634821,0.00013518053,0.00066392997,0.0037767747,0.0002043207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013682876,0.00008007044,0.000021096997,0.16724968,0.0013989554,0.00013002814,0.0001573334,0.0000074607947,0.000001305292,0.000057783738,0.011020027,0.8198626],"study_design_scores_gemma":[0.00078944385,0.000018561106,0.0000027464866,0.08432733,0.016528985,0.0002330432,0.000005997387,0.00002011499,0.0000010547457,0.000055294917,0.89712375,0.00089367235],"about_ca_topic_score_codex":8.3539646e-7,"about_ca_topic_score_gemma":6.5551626e-7,"teacher_disagreement_score":0.88610375,"about_ca_system_score_codex":0.00019425334,"about_ca_system_score_gemma":0.0006138549,"threshold_uncertainty_score":0.99973345},"labels":[],"label_agreement":null},{"id":"W4407366891","doi":"10.3390/pharmaceutics17020233","title":"Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models","year":2025,"lang":"en","type":"article","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Hôpital Saint-François d'Assise","funders":"Fonds de Recherche du Québec - Santé; Canada Foundation for Innovation; Réseau Québécois de Recherche sur les Médicaments; Canadian Institutes of Health Research; Université Laval","keywords":"Prodrug; Pharmacology; Medicine; Paclitaxel; Toxicity; Chemotherapy; Internal medicine","score_opus":0.1307785560044418,"score_gpt":0.4282220137369749,"score_spread":0.2974434577325331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407366891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811341,0.0060412157,0.0005877775,0.0014784058,0.0015790352,0.0014166507,0.00031821328,0.00016218034,0.0072823805],"genre_scores_gemma":[0.987589,0.0069453907,0.0006433501,0.00348335,0.00018890573,0.00009931748,0.000029995688,0.0000847991,0.00093591865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955746,0.0005733731,0.0011324438,0.0010094899,0.00049284426,0.0012172498],"domain_scores_gemma":[0.9973475,0.00069346454,0.00046028633,0.0005248414,0.00033031855,0.0006436337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015236322,0.00076975883,0.0011630751,0.0007648157,0.0003251603,0.00007032797,0.0007771794,0.0005280752,0.00024048658],"category_scores_gemma":[0.00030615702,0.00081753207,0.00023184325,0.0011707676,0.00055325223,0.00045775218,0.0006725827,0.0015537577,0.00002713098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013001839,0.002770722,0.015002981,0.0007895791,0.0005596265,0.0000532844,0.0010970687,0.018363332,0.9423175,0.010031094,0.00034828068,0.007366387],"study_design_scores_gemma":[0.0069236066,0.000061640865,0.0022084322,0.00006779347,0.00050373713,0.000022434042,0.00021268474,0.13424751,0.8437702,0.0019016823,0.009380589,0.00069967477],"about_ca_topic_score_codex":0.00014960869,"about_ca_topic_score_gemma":0.00004376871,"teacher_disagreement_score":0.115884185,"about_ca_system_score_codex":0.00012512099,"about_ca_system_score_gemma":0.00063477753,"threshold_uncertainty_score":0.99942756},"labels":[],"label_agreement":null},{"id":"W4407599227","doi":"10.1016/j.drup.2025.101213","title":"Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"H2020 Marie Skłodowska-Curie Actions; FP7 People: Marie-Curie Actions; National Institutes of Health; Universidad de Zaragoza; National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; European Commission; Horizon 2020 Framework Programme","keywords":"Antibiotics; Medicine; Lactam; Tuberculosis; Microbiology; Chemistry; Biology; Pathology","score_opus":0.0657759882485501,"score_gpt":0.4339001372049818,"score_spread":0.36812414895643164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407599227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952772,0.03250471,0.00030810243,0.005750358,0.0021404272,0.0018119608,0.00050061045,0.000105046885,0.004106759],"genre_scores_gemma":[0.9795031,0.009910298,0.0010390545,0.0014103891,0.0001784271,0.0001229189,0.00008643094,0.000028032686,0.0077213454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982834,0.00027300988,0.00047110938,0.00040648066,0.00012934025,0.00043668284],"domain_scores_gemma":[0.9981829,0.0008649175,0.00016552418,0.00048248068,0.00018022922,0.00012393213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005605721,0.00027849042,0.00043573987,0.00014565051,0.0003613621,0.00003125038,0.00043207876,0.00013970582,0.00024269389],"category_scores_gemma":[0.000062370775,0.00019830976,0.00021888486,0.00042045434,0.00025844018,0.0000799617,0.000035729554,0.0001618428,0.000012352425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008455484,0.009004921,0.029319992,0.00079914526,0.0043956814,0.000035498037,0.004399977,0.0018352867,0.30087984,0.03455114,0.13311887,0.47320417],"study_design_scores_gemma":[0.0022362538,0.00006076068,0.003247507,0.000013575562,0.00058096077,4.8651975e-7,0.00014596741,0.0015446455,0.33746833,0.00087185274,0.6536742,0.00015547095],"about_ca_topic_score_codex":0.0000346595,"about_ca_topic_score_gemma":0.00021231172,"teacher_disagreement_score":0.5205553,"about_ca_system_score_codex":0.00006614984,"about_ca_system_score_gemma":0.000107012274,"threshold_uncertainty_score":0.8086837},"labels":[],"label_agreement":null},{"id":"W4407700137","doi":"10.1200/jco.2025.43.5_suppl.538","title":"Efficacy outcomes with belzutifan versus everolimus by baseline disease characteristics and burden subgroups in the phase 3 LITESPARK-005 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Everolimus; Internal medicine; Baseline (sea); Oncology; Disease","score_opus":0.20794132234252433,"score_gpt":0.574952022184666,"score_spread":0.3670106998421417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407700137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97755754,0.0024092768,0.00008937342,0.015911758,0.002844693,0.0006100618,0.00009482654,0.0000110009205,0.00047146887],"genre_scores_gemma":[0.9879955,0.0022624067,0.00011671909,0.00852484,0.0008584471,0.000020541618,0.000015104073,0.00001749164,0.00018894681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929638,0.0037320002,0.002200648,0.00033499213,0.00033773688,0.00043083774],"domain_scores_gemma":[0.9857293,0.012100175,0.0011218181,0.0002681034,0.0002234097,0.0005571941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0090258485,0.00029977586,0.0013691245,0.0001979607,0.00015855886,0.000035068868,0.00062427676,0.0003286543,0.00013837614],"category_scores_gemma":[0.0034860396,0.00018321413,0.00023670272,0.00032480934,0.00042265953,0.000105921,0.00013654045,0.0022910286,0.000007761831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072121,0.020315666,0.4197777,0.000033164913,0.0016243244,0.0017243839,0.0010870678,0.000104607614,0.0002816454,0.00021892418,0.01112566,0.47158587],"study_design_scores_gemma":[0.08003467,0.0049462277,0.3976722,0.000026124968,0.0023339095,0.000021689943,0.00045410133,0.0012075973,0.00003809861,0.00013330813,0.5128834,0.00024862302],"about_ca_topic_score_codex":0.000013187641,"about_ca_topic_score_gemma":0.000028073193,"teacher_disagreement_score":0.5017578,"about_ca_system_score_codex":0.0000547946,"about_ca_system_score_gemma":0.0007772834,"threshold_uncertainty_score":0.9953507},"labels":[],"label_agreement":null},{"id":"W4407945358","doi":"10.1002/bcp.70014","title":"Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions","year":2025,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Calgary Foundation","keywords":"Micronutrient; Pharmacology; Pharmacokinetics; Cmax; CYP3A4; Dextromethorphan; Chemistry; Medicine; CYP3A; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.09333039578855917,"score_gpt":0.4792569214368342,"score_spread":0.385926525648275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407945358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720566,0.011435582,0.00042183796,0.0022456523,0.011025899,0.00073979405,0.00015040547,0.000023600664,0.0019006268],"genre_scores_gemma":[0.9818243,0.012449043,0.00073929434,0.003045199,0.0010192586,0.000025330224,0.000020780137,0.000032052583,0.00084477745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9925976,0.0019398909,0.0041096928,0.00042372354,0.00037964937,0.00054946524],"domain_scores_gemma":[0.9933744,0.001993215,0.002895322,0.00018877914,0.0010618502,0.00048643883],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003577881,0.0003288256,0.0013413761,0.0006475815,0.00019025094,0.000026405785,0.00077146204,0.00028661918,0.0015555598],"category_scores_gemma":[0.00054573844,0.00037048492,0.00075825845,0.00081124983,0.00064877,0.00031160045,0.00022895141,0.0020122286,0.000018218849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069892853,0.0033463521,0.040127587,0.000497857,0.0029337562,0.0002657853,0.00083564065,0.0021477349,0.75734895,0.00079595635,0.08811195,0.09659914],"study_design_scores_gemma":[0.015879096,0.0004758113,0.02569485,0.00036453104,0.0022754013,0.00059992494,0.00011352676,0.0020728381,0.7757095,0.0058739814,0.17059517,0.00034536974],"about_ca_topic_score_codex":0.00009488103,"about_ca_topic_score_gemma":0.00002225822,"teacher_disagreement_score":0.09625377,"about_ca_system_score_codex":0.00009619512,"about_ca_system_score_gemma":0.0009091905,"threshold_uncertainty_score":0.9998747},"labels":[],"label_agreement":null},{"id":"W4408045789","doi":"10.1016/b978-0-443-23848-2.00013-9","title":"Journey from lab to shelf: Amoxicillin, Alprazolam, Penicillin, Acetaminophen, Metformin","year":2025,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Amoxicillin; Penicillin; Medicine; Metformin; Acetaminophen; Pharmacology; Internal medicine; Microbiology; Antibiotics; Biology","score_opus":0.07715100299753948,"score_gpt":0.38302237178648146,"score_spread":0.305871368788942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408045789","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025231708,0.023426265,0.00004168689,0.0007878222,0.0070923525,0.0019834908,0.0028865926,0.00024669748,0.96101195],"genre_scores_gemma":[0.002291602,0.005676284,0.0013091075,0.018301273,0.0026978296,0.00020619646,0.00036798845,0.00025446093,0.96889526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99426866,0.00036078942,0.00170963,0.0015768199,0.0007721876,0.0013119098],"domain_scores_gemma":[0.9954613,0.0007507995,0.00068338186,0.0012586346,0.00054103107,0.0013048924],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0013606127,0.0015521791,0.0019768474,0.0006891954,0.00054162065,0.00012727003,0.0017412014,0.002015772,0.008794412],"category_scores_gemma":[0.00014778093,0.0015401725,0.00088879454,0.00010403385,0.00033425025,0.00009373025,0.0010172514,0.0036752194,0.0027954304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000337597,0.000090161004,0.000018802408,0.000109027795,0.0016408323,0.00025972538,0.00083431986,0.00005346509,0.005671259,0.0050687124,0.027451122,0.958465],"study_design_scores_gemma":[0.0019784644,0.00009672458,0.000020304798,0.0002455654,0.0024289894,0.00001935001,0.00002596196,0.00012696862,0.01774605,0.0109684225,0.9648636,0.0014795952],"about_ca_topic_score_codex":0.000010445013,"about_ca_topic_score_gemma":0.00009652228,"teacher_disagreement_score":0.95698535,"about_ca_system_score_codex":0.00028214685,"about_ca_system_score_gemma":0.00071505876,"threshold_uncertainty_score":0.99972266},"labels":[],"label_agreement":null},{"id":"W4408131915","doi":"10.3390/jpm15030101","title":"Implementation of Pharmacogenomics Testing in Daily Clinical Practice: Perspectives of Prescribers from Two Canadian Armed Forces Medical Clinics","year":2025,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McMaster University; Canadian Armed Forces; Defence Research and Development Canada","funders":"Innovation, Science and Economic Development Canada","keywords":"Workflow; Medicine; Observational study; Stakeholder; Test (biology); Pharmacogenomics; Qualitative research; Population; Health care; Variety (cybernetics); Medical education; Family medicine; Computer science; Public relations","score_opus":0.14388016907494117,"score_gpt":0.5696804310817613,"score_spread":0.4258002620068201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408131915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96045333,0.025532458,0.00021247186,0.007909173,0.0026598978,0.00035088157,0.000106029096,0.000006141405,0.002769588],"genre_scores_gemma":[0.97827137,0.013373425,0.003042808,0.00403378,0.0011717811,0.0000050905837,0.00001361304,0.000019333798,0.000068791516],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.995059,0.0011773789,0.0024823968,0.00026481214,0.00063061435,0.00038579048],"domain_scores_gemma":[0.9922008,0.004421936,0.0016242142,0.00013883384,0.0010084205,0.0006057804],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0073212245,0.00022778437,0.0009988297,0.0006115155,0.00007673056,0.0000057432585,0.0005074465,0.00026159376,0.0019608536],"category_scores_gemma":[0.005045256,0.00019527963,0.00026539768,0.00055923307,0.00069434376,0.00015920133,0.00006586538,0.0013533373,0.0000014815978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008157952,0.0014940277,0.45190182,0.0002797671,0.0052726646,0.00068219914,0.038653653,0.0004931301,0.07397533,0.0021762596,0.011850582,0.40506262],"study_design_scores_gemma":[0.13109943,0.0020771888,0.0825365,0.0014695735,0.010467914,0.00024818775,0.1599853,0.011773226,0.030775247,0.0038415587,0.56482613,0.00089972554],"about_ca_topic_score_codex":0.011790426,"about_ca_topic_score_gemma":0.0040630894,"teacher_disagreement_score":0.55297554,"about_ca_system_score_codex":0.00016648516,"about_ca_system_score_gemma":0.0031212713,"threshold_uncertainty_score":0.9989515},"labels":[],"label_agreement":null},{"id":"W4408154106","doi":"10.1016/j.psc.2025.01.004","title":"Psychiatric Pharmacogenomic Testing","year":2025,"lang":"en","type":"review","venue":"Psychiatric Clinics of North America","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Mental Health Research Canada; Alberta Children's Hospital; Centre for Addiction and Mental Health; Ontario Brain Institute","funders":"","keywords":"Psychology; Psychiatry; Medicine","score_opus":0.17479296492407626,"score_gpt":0.500747854779213,"score_spread":0.32595488985513676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408154106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003138394,0.9739768,0.000121824065,0.00007621259,0.01265601,0.0020612872,0.001992709,0.0002036138,0.008597686],"genre_scores_gemma":[0.00010003566,0.98974675,0.004929504,0.0014314823,0.002276977,0.0002718717,0.00041024626,0.00017391154,0.0006592492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913763,0.0014220984,0.003927389,0.0014899872,0.00049556565,0.0012886921],"domain_scores_gemma":[0.989601,0.0045475666,0.003633596,0.0010988588,0.0003992431,0.000719732],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0011191258,0.001417962,0.004423124,0.0016234063,0.00042790722,0.000034341843,0.0023117468,0.00091514044,0.0006041869],"category_scores_gemma":[0.00064668275,0.0013598684,0.002173297,0.005600956,0.00040770916,0.0000846452,0.0005659494,0.0033865704,0.00040935728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007916805,0.0009333796,0.0026781885,0.013986208,0.0011055225,0.000015681375,0.00002991135,0.00009502595,6.581913e-7,0.00002141444,0.009768816,0.971286],"study_design_scores_gemma":[0.0014228245,0.00018041524,0.000072583025,0.000505793,0.01179261,0.00002488217,0.0000061705055,0.00030760028,6.734172e-7,0.00011999436,0.9844678,0.0010986598],"about_ca_topic_score_codex":0.00003721294,"about_ca_topic_score_gemma":0.0000057419898,"teacher_disagreement_score":0.97469896,"about_ca_system_score_codex":0.00014195588,"about_ca_system_score_gemma":0.002625457,"threshold_uncertainty_score":0.99985707},"labels":[],"label_agreement":null},{"id":"W4408244566","doi":"10.1111/hae.70021","title":"Exploring the Impact of Laboratory Reagents on Pharmacokinetic Profiling","year":2025,"lang":"en","type":"article","venue":"Haemophilia","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Waterloo","funders":"Sick Kids Foundation","keywords":"Reagent; Medicine; Dosing; Population; Pharmacokinetics; Statistics; Mathematics; Pharmacology; Chemistry; Environmental health","score_opus":0.25381826807796604,"score_gpt":0.4784073528578552,"score_spread":0.22458908477988915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408244566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815123,0.0014016022,0.000019145462,0.0004439642,0.0024983594,0.00057598454,0.00017035843,0.00006507187,0.013313208],"genre_scores_gemma":[0.9962287,0.0013013362,0.000050625982,0.0012577595,0.00030716808,0.00013506094,0.000010091807,0.000025809897,0.0006834397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980978,0.00047854855,0.0004442058,0.00032749408,0.00019799975,0.00045398567],"domain_scores_gemma":[0.9987782,0.0003651299,0.00015111268,0.00038227264,0.00016973105,0.00015353903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083882565,0.00028076395,0.00032890472,0.00022449269,0.00024373051,0.000015907384,0.00051304704,0.00010657526,0.00045003556],"category_scores_gemma":[0.00012121402,0.00019705226,0.0002312696,0.0007139173,0.00020234258,0.000092990784,0.00013553492,0.00074097916,0.00009415217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010773808,0.00085053896,0.0154246455,0.00016295644,0.0011086047,0.000048570822,0.0007957766,0.016960083,0.8389761,0.004053539,0.012826271,0.10771558],"study_design_scores_gemma":[0.0021293317,0.00011224968,0.029682266,0.000047658225,0.0002808627,0.0000029874227,0.00006469058,0.004217977,0.898291,0.0008944614,0.06400818,0.00026834555],"about_ca_topic_score_codex":0.000022622213,"about_ca_topic_score_gemma":6.6999985e-7,"teacher_disagreement_score":0.10744723,"about_ca_system_score_codex":0.00006900064,"about_ca_system_score_gemma":0.00019064317,"threshold_uncertainty_score":0.8035558},"labels":[],"label_agreement":null},{"id":"W4408679963","doi":"10.1007/s00228-025-03817-7","title":"Influence of cigarette smoking on drugs’ metabolism and effects: a systematic review","year":2025,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacokinetics; Jadad scale; Pharmacodynamics; Pharmacology; Observational study; Drug; Meta-analysis; Internal medicine","score_opus":0.14036840201208808,"score_gpt":0.5251490608771655,"score_spread":0.3847806588650774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408679963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014397127,0.9861194,0.000011937273,0.0002974067,0.0074635088,0.002381941,0.00009787411,0.00003010859,0.0021581366],"genre_scores_gemma":[0.0008980474,0.9789481,0.00005628052,0.01798867,0.0017085521,0.00004890577,0.000008377822,0.00010472836,0.00023831375],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9603912,0.029553285,0.008124574,0.0006957568,0.0005831707,0.0006520136],"domain_scores_gemma":[0.97510105,0.014738159,0.00822875,0.00050470344,0.0006506452,0.00077667757],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.021074831,0.0009788574,0.010137129,0.0007208139,0.00014956301,0.000022710277,0.0018295834,0.00055558933,0.0001660003],"category_scores_gemma":[0.0048032966,0.000718465,0.0021659762,0.00068545836,0.00066301215,0.00012349505,0.00055672514,0.005638361,0.00005147799],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019692081,0.00049637206,0.0000041202734,0.70622337,0.0056040008,0.00074716046,0.00007285392,0.000054292763,0.000019922627,0.00009313049,0.01240553,0.27408233],"study_design_scores_gemma":[0.0026625993,0.00033817737,0.000022659093,0.25739187,0.049041014,0.00016758018,0.0000034756367,0.00000671682,0.000064020176,0.000025082112,0.6898562,0.0004206544],"about_ca_topic_score_codex":4.8612344e-7,"about_ca_topic_score_gemma":4.249315e-8,"teacher_disagreement_score":0.67745066,"about_ca_system_score_codex":0.000049045528,"about_ca_system_score_gemma":0.0007300733,"threshold_uncertainty_score":0.9995266},"labels":[],"label_agreement":null},{"id":"W4408726292","doi":"10.1016/j.bidere.2025.100011","title":"Bioproduction of 3,4-methylenedioxymethamphetamine and derivatives","year":2025,"lang":"en","type":"article","venue":"BioDesign Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bioproduction; Pharmacology; Computer science; Chemistry; Medicine; Biochemistry","score_opus":0.3702322680400097,"score_gpt":0.5794538830619878,"score_spread":0.20922161502197806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408726292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642115,0.020063639,0.0013490233,0.002192961,0.000738827,0.00056535634,0.0000355663,0.000039324634,0.010803758],"genre_scores_gemma":[0.9907204,0.004420407,0.0014334851,0.00019877232,0.00014340022,0.000050001974,0.000005547653,0.000010377111,0.0030175948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748516,0.0012580347,0.00028218105,0.00034542507,0.00024017156,0.0003890296],"domain_scores_gemma":[0.9985326,0.00070033036,0.00005408116,0.00021397203,0.00037258794,0.00012642262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003982501,0.00012829682,0.00023330326,0.00053083856,0.0002279688,0.000015506344,0.00023697555,0.00019315325,0.00024222859],"category_scores_gemma":[0.0004374452,0.00011632933,0.000044306966,0.00091074244,0.00075421954,0.000061962135,0.0001838615,0.0005444975,0.0000179246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024151723,0.00018231638,0.0042899027,0.000104311606,0.00011874398,0.0000029724742,0.00025122598,0.00001587266,0.8798154,0.0062473053,0.0032249514,0.105505496],"study_design_scores_gemma":[0.00078698236,0.00006982171,0.0058351858,0.000014015752,0.00003646167,0.000002227729,0.00017075615,0.00039156494,0.85306877,0.00394026,0.13559261,0.000091361515],"about_ca_topic_score_codex":0.00003355353,"about_ca_topic_score_gemma":0.0000014993058,"teacher_disagreement_score":0.13236766,"about_ca_system_score_codex":0.000022582819,"about_ca_system_score_gemma":0.0001371091,"threshold_uncertainty_score":0.47437721},"labels":[],"label_agreement":null},{"id":"W4409279342","doi":"10.3390/scipharm93020018","title":"Polygenic Risk Scores for Personalized Cardiovascular Pharmacogenomics―A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Scientia Pharmaceutica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Polygenic risk score; Medicine; Personalized medicine; Bioinformatics; Pharmacology; Biology; Genetics; Genotype; Single-nucleotide polymorphism","score_opus":0.12530812981169875,"score_gpt":0.48443829794383114,"score_spread":0.3591301681321324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409279342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036759727,0.9208172,0.008851453,0.002573972,0.012052034,0.008334393,0.0009518541,0.00042885973,0.009230506],"genre_scores_gemma":[0.27288195,0.6610878,0.0045333453,0.04710886,0.0017665067,0.0028884076,0.00022673815,0.00023558091,0.009270761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942984,0.0011905332,0.0010841677,0.0013432495,0.0005678627,0.0015158108],"domain_scores_gemma":[0.9969999,0.00070630736,0.00034585936,0.00076366274,0.00046712687,0.0007171457],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0056496374,0.00066755514,0.0011495322,0.00049496285,0.0013711425,0.00011675509,0.001259391,0.0002855678,0.002316993],"category_scores_gemma":[0.00046032318,0.000670707,0.0014949911,0.0013280072,0.00076187955,0.00022673991,0.0004154304,0.0010651588,0.00027739548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030472546,0.001982039,0.0054869023,0.032294918,0.017080206,0.000097243785,0.0009344443,0.0047013485,0.30280438,0.012278343,0.15955879,0.45973414],"study_design_scores_gemma":[0.007975176,0.000033784563,0.000092123984,0.0026272673,0.0078334585,0.00001998774,0.000027137758,0.008859152,0.09416157,0.0007644106,0.87682617,0.0007797897],"about_ca_topic_score_codex":0.000016214588,"about_ca_topic_score_gemma":0.000004687041,"teacher_disagreement_score":0.71726733,"about_ca_system_score_codex":0.00014314655,"about_ca_system_score_gemma":0.0008469756,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W4409680632","doi":"10.1186/s13293-025-00708-5","title":"Sexual dimorphism in metabolomic and phenotypic spectra of UGT deficiency: findings from the Canadian Longitudinal Study on Aging","year":2025,"lang":"en","type":"article","venue":"Biology of Sex Differences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Canada Foundation for Innovation","keywords":"Metabolome; Metabolomics; Metabolite; Phenotype; Gene; Biology; Glucuronidation; Genetics; Metabolic pathway; Glucuronosyltransferase; Genome; Medicine; Internal medicine; Bioinformatics; Endocrinology","score_opus":0.1399421760155425,"score_gpt":0.41327330861236417,"score_spread":0.2733311325968216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409680632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143505,0.0059712543,0.000008732366,0.0006767859,0.000639611,0.00034199216,0.00013891987,0.000008601507,0.0007790344],"genre_scores_gemma":[0.99914604,0.0002923301,0.000032273696,0.00038969773,0.000051945135,0.000019248731,0.000008718687,0.0000054991738,0.000054225486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998323,0.0004953914,0.0003885077,0.00036583608,0.00008037796,0.00034686315],"domain_scores_gemma":[0.9988069,0.0007893433,0.00011296191,0.00016822308,0.000034758617,0.00008780254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066992105,0.00019973812,0.0004553025,0.00025468503,0.00019948231,0.000009927665,0.0004196294,0.000187815,0.0001568162],"category_scores_gemma":[0.00006542399,0.00014097115,0.000036510595,0.00025364585,0.0006044712,0.000022882197,0.00009502852,0.00046643117,0.000003356835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008699161,0.00024658185,0.9618663,0.000009469876,0.00015671604,0.0000040530117,0.0025162962,0.000009697577,0.02425975,0.0029330703,0.000050375627,0.007860705],"study_design_scores_gemma":[0.001120026,0.00015205298,0.9796319,0.000010903864,0.00017467345,6.4516894e-7,0.0012439714,0.00012659626,0.013083224,0.0037518092,0.00057865406,0.00012556899],"about_ca_topic_score_codex":0.03387181,"about_ca_topic_score_gemma":0.05271208,"teacher_disagreement_score":0.018840268,"about_ca_system_score_codex":0.000027294784,"about_ca_system_score_gemma":0.00019536805,"threshold_uncertainty_score":0.9725617},"labels":[],"label_agreement":null},{"id":"W4409852902","doi":"10.1002/cpt.3697","title":"Estimating the Frequency of False‐Negative Pharmacogenetic Test Results by Self‐Reported Ancestry","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"Alberta Innovates; Alberta Children's Hospital Foundation; American College Health Foundation; Children's Hospital Foundation","keywords":"Pharmacogenetics; Statistics; Test (biology); Medicine; Genetics; Biology; Mathematics; Genotype; Gene","score_opus":0.2090136641616907,"score_gpt":0.5244458290443401,"score_spread":0.3154321648826494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409852902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92668986,0.01721528,0.0009063446,0.022976886,0.019713761,0.002452266,0.0014892523,0.00045488786,0.008101433],"genre_scores_gemma":[0.88851434,0.006548857,0.0030359838,0.09924637,0.0013308399,0.0002202037,0.00008119043,0.00008405641,0.0009381491],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917123,0.0025957697,0.0030646273,0.00110076,0.00040918394,0.0011173685],"domain_scores_gemma":[0.9872307,0.009481961,0.0014805162,0.0007202779,0.00066834886,0.00041818377],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040582493,0.0007308248,0.0011333736,0.00019978854,0.0006924943,0.00003843274,0.0016841613,0.0008968197,0.00052347453],"category_scores_gemma":[0.00045041938,0.0005877676,0.00051991316,0.0011388757,0.00206679,0.00012864215,0.00040865244,0.0029739458,0.000087428925],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017545293,0.00701401,0.06089989,0.00021416093,0.0116754025,0.00010697581,0.001256402,0.0023855877,0.6275396,0.00011556853,0.22956823,0.057469673],"study_design_scores_gemma":[0.020596636,0.0006245903,0.010790098,0.00007470957,0.013776987,0.000044049,0.00017787497,0.053133596,0.4473849,0.0042124153,0.44798827,0.0011958637],"about_ca_topic_score_codex":0.000016286842,"about_ca_topic_score_gemma":0.00000410144,"teacher_disagreement_score":0.21842004,"about_ca_system_score_codex":0.00009712035,"about_ca_system_score_gemma":0.00076456595,"threshold_uncertainty_score":0.9996574},"labels":[],"label_agreement":null},{"id":"W4409952685","doi":"10.1038/s41467-025-59132-3","title":"Drug-induced cis-regulatory elements in human hepatocytes affect molecular phenotypes associated with adverse reactions","year":2025,"lang":"en","type":"article","venue":"Nature Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Agency for Medical Research and Development; Takeda Science Foundation","keywords":"Affect (linguistics); Phenotype; Drug reaction; Gene; Chemistry; Drug; Genetics; Biology; Medicine; Pharmacology; Psychology","score_opus":0.055298746755027724,"score_gpt":0.43291506440470917,"score_spread":0.37761631764968145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409952685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696696,0.005521876,0.000014935308,0.0018693936,0.00044122647,0.00072738726,0.00006258059,0.0001285795,0.021564467],"genre_scores_gemma":[0.99598587,0.0004071136,0.00035763637,0.002126612,0.000028288165,0.00022216656,0.00020347939,0.000026937414,0.0006419257],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977073,0.0010271707,0.00042205572,0.00029950571,0.00017484542,0.00036910782],"domain_scores_gemma":[0.9979061,0.00053958443,0.00020061452,0.0010303117,0.00020222538,0.000121189405],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008542624,0.00024644297,0.0002898863,0.00034019072,0.0005811286,0.000017878754,0.0009904039,0.00046547633,0.00011555193],"category_scores_gemma":[0.00018336969,0.00024585726,0.00009971883,0.0008215164,0.0001927998,0.00009632516,0.00030081332,0.0023654427,0.00001811987],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022067362,0.0032163605,0.154337,0.000055192526,0.0015743345,0.00003138401,0.0009132628,0.0008886301,0.73664457,0.088342726,0.006985786,0.006790092],"study_design_scores_gemma":[0.010573345,0.00011170079,0.30433124,0.00031004252,0.0014538557,0.00000575902,0.00048500477,0.0063013253,0.258259,0.004335389,0.41259968,0.001233639],"about_ca_topic_score_codex":0.00004931181,"about_ca_topic_score_gemma":0.0012365871,"teacher_disagreement_score":0.47838557,"about_ca_system_score_codex":0.00017915647,"about_ca_system_score_gemma":0.00018064621,"threshold_uncertainty_score":0.99999934},"labels":[],"label_agreement":null},{"id":"W4409956483","doi":"10.1002/cpt.3693","title":"Impaired Drug Metabolism Caused by Compound Heterozygous Loss‐of‐Function Variants in <i>CYP3A4</i>: A Case Report","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children; University of Toronto","keywords":"CYP3A4; Pharmacogenetics; Medicine; Drug; Pharmacology; Population; Drug metabolism; Internal medicine; Metabolism; Biology; Genetics; Genotype; Gene","score_opus":0.11761001336131921,"score_gpt":0.47329417444472477,"score_spread":0.35568416108340556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409956483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96287477,0.011132306,0.0006070674,0.0051077884,0.017107252,0.001391356,0.0002575922,0.00017853282,0.001343331],"genre_scores_gemma":[0.9322463,0.0041364995,0.00015660396,0.061121624,0.000649269,0.00015974556,0.00008416885,0.000077498094,0.0013682919],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99106765,0.003376079,0.002933904,0.0011620964,0.00031330078,0.0011469512],"domain_scores_gemma":[0.9951313,0.0024038472,0.0009184343,0.00065693166,0.00040125655,0.0004882328],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003942029,0.00072042784,0.0015971132,0.00047306583,0.0003535438,0.000032953878,0.00078811264,0.0010449812,0.000735675],"category_scores_gemma":[0.00008333086,0.00072503166,0.00054969714,0.0010590104,0.001289887,0.00018214197,0.000360601,0.0026756593,0.00006143039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011641413,0.01901449,0.090484664,0.0004552291,0.014577011,0.07484237,0.0019795755,0.0018276076,0.4616948,0.0006501557,0.27499774,0.04783494],"study_design_scores_gemma":[0.026925344,0.00031376196,0.012272789,0.00004364972,0.008224629,0.003271042,0.00020421422,0.007816891,0.06687334,0.0023288666,0.8704904,0.0012351238],"about_ca_topic_score_codex":0.000092533264,"about_ca_topic_score_gemma":0.000055066266,"teacher_disagreement_score":0.5954926,"about_ca_system_score_codex":0.00011528549,"about_ca_system_score_gemma":0.00054649013,"threshold_uncertainty_score":0.9996252},"labels":[],"label_agreement":null},{"id":"W4409975278","doi":"10.3389/fgene.2025.1435416","title":"Leveraging long-read sequencing technologies for pharmacogenomic testing: applications, analytical strategies, challenges, and future perspectives","year":2025,"lang":"en","type":"review","venue":"Frontiers in Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Computer science; Genotyping; Data science; Identification (biology); DNA sequencing; Computational biology; Bioinformatics; Biology; Genetics","score_opus":0.19453360944736553,"score_gpt":0.4504044710312519,"score_spread":0.2558708615838864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409975278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003156847,0.98824954,0.0038350278,0.00022258324,0.0018222497,0.0031875302,0.0002799571,0.0002089632,0.0021625888],"genre_scores_gemma":[0.00008399332,0.9808603,0.016078385,0.000085318934,0.0010804955,0.001364224,0.00010298561,0.00009424654,0.00025006634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633443,0.00041718205,0.000956446,0.0012249559,0.00017819283,0.00088880374],"domain_scores_gemma":[0.9980743,0.0006351701,0.00041193358,0.0004933339,0.00018987604,0.00019539788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008488572,0.0008590145,0.0018566782,0.00089471304,0.0002885513,0.000082316416,0.00089061644,0.001232168,0.000019431462],"category_scores_gemma":[0.000096953,0.0008614758,0.00030576315,0.00067590416,0.0004276601,0.00007398521,0.0003379684,0.0016812523,0.0000040185805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026766425,0.00011003783,0.000045900277,0.010168541,0.0005677215,0.000021662463,0.00051486364,0.000080358834,0.000012666105,0.0011779267,0.0014474738,0.9858261],"study_design_scores_gemma":[0.00092945475,0.000040586478,0.000011589834,0.0007181228,0.0025320596,0.000037452905,0.004683545,0.0024464056,0.000027904638,0.002292936,0.9854946,0.00078530726],"about_ca_topic_score_codex":0.0000021641629,"about_ca_topic_score_gemma":0.0000023703024,"teacher_disagreement_score":0.9850408,"about_ca_system_score_codex":0.00046762757,"about_ca_system_score_gemma":0.0013191466,"threshold_uncertainty_score":0.99938357},"labels":[],"label_agreement":null},{"id":"W4409984050","doi":"10.1002/cpt.3702","title":"Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community‐Dwelling Older Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Institute on Aging; National Health and Medical Research Council; Monash University; National Cancer Institute; National Institutes of Health; Australian Government; Commonwealth Scientific and Industrial Research Organisation; Medical Research Council","keywords":"Polypharmacy; Pharmacogenetics; Medicine; Genotype; Pharmacogenomics; Internal medicine; Pharmacology; Genetics; Biology; Gene","score_opus":0.15653193806827218,"score_gpt":0.4792447535376588,"score_spread":0.32271281546938657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409984050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96408886,0.025495842,0.0003251928,0.0032018686,0.0048916196,0.0012565546,0.00014765473,0.00010033054,0.00049208896],"genre_scores_gemma":[0.90365785,0.052900143,0.0004800823,0.04189567,0.00032035974,0.00013510465,0.0000392787,0.00004496223,0.00052651984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99277055,0.0037249303,0.0017381571,0.00069558294,0.00029048577,0.00078030553],"domain_scores_gemma":[0.9944374,0.003828338,0.00054208597,0.0004248605,0.00040765462,0.00035966304],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030322582,0.0004949527,0.00075862405,0.00048859196,0.00046593838,0.000025190295,0.0008480244,0.0007108357,0.00092455914],"category_scores_gemma":[0.00010759583,0.0005194334,0.00020947885,0.0007315559,0.0014609816,0.0002834611,0.00037402732,0.0030365095,0.000029273719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005727615,0.006574042,0.59268224,0.0017887154,0.0027305246,0.00006385003,0.0028468936,0.0017102652,0.2931302,0.00037563895,0.011135239,0.0812348],"study_design_scores_gemma":[0.02530256,0.0004959961,0.5742708,0.00035301424,0.006144799,0.000051016148,0.000535443,0.04092873,0.16576084,0.0016593558,0.18322824,0.0012692416],"about_ca_topic_score_codex":0.00011473144,"about_ca_topic_score_gemma":0.000015099006,"teacher_disagreement_score":0.172093,"about_ca_system_score_codex":0.00012235924,"about_ca_system_score_gemma":0.0005624784,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W4410587725","doi":"10.1097/01.hjh.0001116692.69387.54","title":"ROLE OF CYTOCHROME P450 GENE RS1126742 POLYMORPHISM AND RISK OF HYPERTENSION","year":2025,"lang":"en","type":"article","venue":"Journal of Hypertension","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Genetics; Gene; Polymorphism (computer science); Cytochrome P450; Internal medicine; Allele; Metabolism","score_opus":0.06701860276290747,"score_gpt":0.35216861903650093,"score_spread":0.2851500162735935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410587725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96168905,0.036242727,0.000067388944,0.0005072217,0.00077385246,0.00016695712,0.00004038432,0.000008611559,0.00050379836],"genre_scores_gemma":[0.9768197,0.021052307,0.0009917509,0.0008034202,0.00019909929,0.0000015806228,0.0000026304924,0.000018726476,0.000110775596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978864,0.00040578237,0.000948515,0.00020121389,0.00028565683,0.00027242402],"domain_scores_gemma":[0.9976931,0.0003786903,0.00085066725,0.0002081672,0.0006600522,0.00020928093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010700958,0.00022498566,0.0008075047,0.00043908597,0.00013185809,0.0000071641916,0.00025290882,0.0002859739,0.000107289954],"category_scores_gemma":[0.00022340262,0.00017660669,0.00024135404,0.00028987185,0.00022493243,0.00010383663,0.00015377808,0.00066963007,0.0000040361742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007880575,0.0004133426,0.00611041,0.000047003203,0.0004955842,0.00006939911,0.00013699959,0.00024723957,0.95901847,0.0001243476,0.0015285995,0.031020569],"study_design_scores_gemma":[0.005086192,0.00031875158,0.10064835,0.00011499625,0.0020016741,0.00066319964,0.00015403182,0.004261755,0.8592808,0.0016324349,0.025636952,0.00020080674],"about_ca_topic_score_codex":0.000040829247,"about_ca_topic_score_gemma":0.0000019593683,"teacher_disagreement_score":0.0997376,"about_ca_system_score_codex":0.000020688783,"about_ca_system_score_gemma":0.00015665352,"threshold_uncertainty_score":0.72018117},"labels":[],"label_agreement":null},{"id":"W4410618198","doi":"10.1016/j.xphs.2025.103827","title":"Which unbound fraction should we use in the well-stirred model for more accurately predicting hepatic clearance of drugs for humans?","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec","funders":"","keywords":"Fraction (chemistry); Chemistry; Metabolic clearance rate; Liver circulation; Pharmacology; Chromatography; Biological system; Medicine; Pharmacokinetics; Internal medicine; Biology","score_opus":0.36731491034039404,"score_gpt":0.5433098460654809,"score_spread":0.1759949357250869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410618198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95999736,0.0028869824,0.021212155,0.012299671,0.001841804,0.0011190185,0.00011052908,0.000014201419,0.00051831175],"genre_scores_gemma":[0.9918121,0.0019935868,0.0026890542,0.0030505834,0.00027534994,0.0000572064,0.0000022143254,0.0000119148835,0.000108004184],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972031,0.0004168321,0.0010419885,0.00029712587,0.00049414113,0.0005467776],"domain_scores_gemma":[0.9942727,0.004377564,0.0005731994,0.0001232461,0.0004922972,0.00016100945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005510462,0.00022809315,0.00046952942,0.00030973993,0.00048354737,0.00010025296,0.0008745416,0.00020045474,0.000049686052],"category_scores_gemma":[0.0010979655,0.00015837736,0.00023661343,0.000867635,0.0005449702,0.0005190283,0.000066825334,0.00088247773,0.0000010632837],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011247231,0.0036616873,0.109048896,0.0016385614,0.0009463307,0.000015508733,0.0109112235,0.59696287,0.14717613,0.015100129,0.014872202,0.088419214],"study_design_scores_gemma":[0.0033985313,0.00017272128,0.0026625341,0.00010741701,0.0005126749,0.000007285177,0.0007931082,0.9115788,0.027500736,0.00782489,0.045266848,0.00017446587],"about_ca_topic_score_codex":0.000014151195,"about_ca_topic_score_gemma":0.000024103545,"teacher_disagreement_score":0.3146159,"about_ca_system_score_codex":0.00006418053,"about_ca_system_score_gemma":0.00035672513,"threshold_uncertainty_score":0.64584416},"labels":[],"label_agreement":null},{"id":"W4410822690","doi":"10.1200/jco.2025.43.16_suppl.e15561","title":"Deciphering colorectal cancer progression through integrative epigenomic analysis for precision therapeutics.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Epigenomics; Colorectal cancer; Cancer; Precision medicine; Oncology; Internal medicine; Bioinformatics; Pathology; DNA methylation; Genetics; Biology","score_opus":0.3445006426527239,"score_gpt":0.6433972210706295,"score_spread":0.29889657841790557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9468177,0.013178391,0.022660783,0.003841431,0.009222097,0.0006563605,0.000051785883,0.0000190833,0.0035523854],"genre_scores_gemma":[0.96847564,0.015590067,0.009182379,0.0050376826,0.0011864573,0.00007790191,0.000005804292,0.000020193605,0.00042388984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950422,0.0014689201,0.0025260523,0.00033800752,0.00021096152,0.00041382734],"domain_scores_gemma":[0.99059874,0.00625912,0.0019091695,0.00013978712,0.000847778,0.0002453892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053656506,0.00025846667,0.0017329507,0.00026286845,0.00020564768,0.000020399591,0.0005563516,0.00081338605,0.00036032594],"category_scores_gemma":[0.0010856284,0.00017935605,0.0011733569,0.00062489137,0.0003284811,0.00013831088,0.00013108872,0.0015825899,0.0000064355695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010214578,0.0017235162,0.0621071,0.000024823055,0.009196275,0.000031326676,0.00083243597,0.0037291674,0.018163567,0.0007241389,0.002748686,0.89050436],"study_design_scores_gemma":[0.0080809845,0.0019072945,0.040633556,0.00005333715,0.0077813687,0.000007420153,0.00018456703,0.008601593,0.036660604,0.004800303,0.8910525,0.00023650023],"about_ca_topic_score_codex":0.000012110998,"about_ca_topic_score_gemma":0.000077314726,"teacher_disagreement_score":0.8902679,"about_ca_system_score_codex":0.00019554107,"about_ca_system_score_gemma":0.0015781515,"threshold_uncertainty_score":0.73139274},"labels":[],"label_agreement":null},{"id":"W4410953553","doi":"10.3390/bioengineering12060595","title":"Graph Representation Learning for the Prediction of Medication Usage in the UK Biobank Based on Pharmacogenetic Variants","year":2025,"lang":"en","type":"article","venue":"Bioengineering","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Biobank; Pharmacogenetics; Representation (politics); Graph; Computer science; Computational biology; Medicine; Data science; Bioinformatics; Biology; Genotype; Genetics; Gene; Theoretical computer science; Political science","score_opus":0.083822643326512,"score_gpt":0.40743610165880645,"score_spread":0.32361345833229443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410953553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72744876,0.0061334507,0.2478138,0.005318283,0.007083851,0.0033322212,0.0001761484,0.00015105182,0.0025424405],"genre_scores_gemma":[0.9978333,0.0006606374,0.00015483561,0.00086940837,0.00015203048,0.0002474221,0.0000329682,0.000011086451,0.000038284503],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99887353,0.0002397051,0.00031709854,0.0001966164,0.00015634728,0.00021668893],"domain_scores_gemma":[0.99864936,0.0009946047,0.000094915835,0.00017534061,0.000050418497,0.00003534782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011567759,0.00013102971,0.00013210796,0.00023489505,0.00015901154,0.000013354571,0.00028614473,0.00010533289,0.00005947453],"category_scores_gemma":[0.00017068018,0.000093011404,0.000081741266,0.0005332878,0.00006330642,0.00002803438,0.000021853532,0.00035263418,0.0000020625198],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025978277,0.00018094748,0.01475533,0.00010952496,0.00014208331,0.000002303605,0.00058045454,0.62992173,0.3157978,0.0008619372,0.0017533777,0.035634734],"study_design_scores_gemma":[0.002132882,0.000055216085,0.060594488,0.000034842855,0.00025571176,0.0000014930447,0.000114719274,0.8142713,0.09621818,0.00017981992,0.026045311,0.00009605857],"about_ca_topic_score_codex":0.000012363647,"about_ca_topic_score_gemma":0.0000019534016,"teacher_disagreement_score":0.27038458,"about_ca_system_score_codex":0.000022733218,"about_ca_system_score_gemma":0.000045432884,"threshold_uncertainty_score":0.3792895},"labels":[],"label_agreement":null},{"id":"W4410972074","doi":"10.26434/chemrxiv-2025-vfkd9","title":"Giving an Enzyme Scissors: Serotonin Derivatives as Potent Organocatalytic Switches of DNA Repair Enzyme OGG1","year":2025,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agencia Estatal de Investigación; Novo Nordisk Fonden; Science for Life Laboratory; Vetenskapsrådet; Kungliga Tekniska Högskolan; Karolinska Institutet; European Commission; Ministerio de Ciencia, Innovación y Universidades; Leverhulme Trust; Stockholms Universitet; Centro de Biología Molecular Severo Ochoa; Cancerfonden; Diamond Light Source; Novo Nordisk; European Federation of Pharmaceutical Industries and Associations; McGill University; Åke Wiberg Stiftelse","keywords":"Enzyme; Chemistry; DNA; Biochemistry; Serotonin; DNA repair","score_opus":0.09559389812020229,"score_gpt":0.41285020647945375,"score_spread":0.31725630835925145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410972074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97661406,0.008200014,0.0001984921,0.00072455686,0.0029496844,0.001440964,0.00017367047,0.00045289344,0.009245691],"genre_scores_gemma":[0.9894252,0.00196228,0.0010756549,0.001692185,0.00076868234,0.00028400018,0.0001973205,0.00010018845,0.004494481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952061,0.00062221807,0.0013026379,0.0014446641,0.00046955666,0.00095481356],"domain_scores_gemma":[0.9963155,0.00047235904,0.0008292163,0.0012812049,0.00048110026,0.00062063884],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0017334439,0.0009644822,0.0013589793,0.0004895532,0.00031714365,0.00006409107,0.0015622465,0.0013529528,0.0015805472],"category_scores_gemma":[0.00045832168,0.0010017141,0.0006324148,0.0005534254,0.0005741004,0.00017079803,0.0018394942,0.0024106316,0.000108123866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005868517,0.002008247,0.006199866,0.002876924,0.002654371,0.000107057014,0.007018134,0.0059023756,0.95929193,0.0014851807,0.004013193,0.007855862],"study_design_scores_gemma":[0.0013532871,0.00008316773,0.00161653,0.00026103263,0.00085508515,0.000016514734,0.00032118283,0.0054025105,0.93776757,0.0030562396,0.048386596,0.0008802774],"about_ca_topic_score_codex":0.00011207597,"about_ca_topic_score_gemma":0.00001186187,"teacher_disagreement_score":0.0443734,"about_ca_system_score_codex":0.0001760226,"about_ca_system_score_gemma":0.0011247331,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W4410995022","doi":"10.1016/j.dmpk.2025.101159","title":"Intra-patient variation in CYP2D6 activity over time assessed using the dietary biomarker solanidine in breast cancer patients on tamoxifen","year":2025,"lang":"en","type":"article","venue":"Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Biomarker; Oncology; CYP2D6; Internal medicine; Endocrinology; Cancer; Biology; Metabolism; Genetics","score_opus":0.041734982363930105,"score_gpt":0.38359745841927795,"score_spread":0.34186247605534786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410995022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897916,0.0029160285,0.000027652683,0.0018067638,0.0028569987,0.0010346412,0.0006957453,0.000040511382,0.00083006744],"genre_scores_gemma":[0.9901426,0.0038825085,0.000060328763,0.0053073657,0.00026904614,0.00011447488,0.000036628266,0.000044723558,0.0001423402],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99630994,0.0012365989,0.00069157087,0.00066288875,0.00036127152,0.0007377424],"domain_scores_gemma":[0.9985835,0.00048783002,0.00027692126,0.00028722826,0.00015130201,0.0002132045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009704789,0.00053417555,0.0006149785,0.00053346576,0.0002550839,0.00006817685,0.0003915226,0.00026644242,0.00057843217],"category_scores_gemma":[0.00004650876,0.00043642303,0.00011597495,0.0010670095,0.00019102427,0.00022296085,0.00027053576,0.0011279229,0.00001279092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036583105,0.004219355,0.09857014,0.00018996242,0.0006603153,0.000046150097,0.0036853156,0.013142149,0.73054355,0.00039307456,0.006653927,0.13823777],"study_design_scores_gemma":[0.007348453,0.000020321577,0.7943604,0.00007187945,0.0006246085,0.0000036079311,0.00002620809,0.13108267,0.036394756,0.00041113005,0.02907868,0.0005773007],"about_ca_topic_score_codex":0.00058371905,"about_ca_topic_score_gemma":0.00004436438,"teacher_disagreement_score":0.69579023,"about_ca_system_score_codex":0.00012407325,"about_ca_system_score_gemma":0.0001595445,"threshold_uncertainty_score":0.9998087},"labels":[],"label_agreement":null},{"id":"W4410996209","doi":"10.1016/j.dmpk.2025.101162","title":"Solanidine metabolites as dietary CYP2D6 biomarkers of tamoxifen metabolism","year":2025,"lang":"en","type":"article","venue":"Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"CYP2D6; Tamoxifen; Metabolism; Pharmacology; Chemistry; Medicine; Internal medicine; Biochemistry; Cytochrome P450; Cancer; Breast cancer","score_opus":0.04519431671995172,"score_gpt":0.39185814562178606,"score_spread":0.34666382890183434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410996209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8109063,0.15409212,0.00014129268,0.0020752405,0.0061834245,0.0011259053,0.00066187675,0.00022087309,0.024592984],"genre_scores_gemma":[0.9433496,0.044150457,0.0015533114,0.0064592315,0.0008578106,0.00013954012,0.00013511928,0.00010781705,0.0032471071],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942477,0.0011673617,0.0015820843,0.0011114173,0.00061442214,0.0012770235],"domain_scores_gemma":[0.9965531,0.00081302354,0.00057384546,0.0007159768,0.00053174066,0.0008122911],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019425005,0.001025472,0.0016731488,0.00094993773,0.00047128054,0.00008556712,0.0010726018,0.00048258188,0.0010489285],"category_scores_gemma":[0.00025695172,0.00096540863,0.00051198254,0.0015172923,0.00096937775,0.00032138804,0.00070022827,0.0012826007,0.00006932982],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016020861,0.0011472923,0.0037584566,0.0005707262,0.003971679,0.000064479274,0.0022136131,0.0003687598,0.8113426,0.032996602,0.023455648,0.11850806],"study_design_scores_gemma":[0.004355459,0.000020585929,0.00783155,0.00003105298,0.0030724742,0.000021536001,0.00020886619,0.0016743155,0.4410591,0.004298535,0.5368036,0.0006229076],"about_ca_topic_score_codex":0.00018267194,"about_ca_topic_score_gemma":0.0000072479315,"teacher_disagreement_score":0.5133479,"about_ca_system_score_codex":0.00002581847,"about_ca_system_score_gemma":0.0002905465,"threshold_uncertainty_score":0.9998642},"labels":[],"label_agreement":null},{"id":"W4411111155","doi":"10.63995/zxpk7782","title":"Gene Variation: The Key to Understanding Pharmacogenomics and Drug Response Variability","year":2020,"lang":"en","type":"article","venue":"Fusion of Multidisciplinary Research An International Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Drug response; Variation (astronomy); Key (lock); Drug; Genetic variation; Pharmacogenetics; Computational biology; Biology; Pharmacology; Gene; Genetics; Genotype; Ecology","score_opus":0.33735732841915406,"score_gpt":0.5174235326278225,"score_spread":0.18006620420866842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411111155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9468867,0.0002367898,0.0025237428,0.04792457,0.0013217733,0.00043593606,0.000271425,0.000019018733,0.0003800065],"genre_scores_gemma":[0.9940739,0.0012371358,0.0019127445,0.0011395629,0.0014693594,0.000017255375,0.000011804299,0.000023108267,0.00011513019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940256,0.0036556318,0.0005701648,0.000380564,0.00094455166,0.00042349802],"domain_scores_gemma":[0.99641186,0.001629922,0.00018667393,0.00018052808,0.00067968824,0.00091130775],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011099611,0.00017620689,0.00021150397,0.00026808676,0.00093089056,0.00009975049,0.0010946209,0.00010672066,0.0010511562],"category_scores_gemma":[0.00090658956,0.00013713146,0.000094773066,0.00037556846,0.00031327145,0.00026417855,0.000996349,0.0013904562,0.000035936224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019080156,0.00054734456,0.0067732814,0.000018713654,0.00032642178,0.00016307199,0.032347545,0.0047471956,0.9212862,0.0018997786,0.0032935557,0.009516725],"study_design_scores_gemma":[0.018137801,0.002468913,0.15226778,0.00010913443,0.00035131612,0.00096943165,0.010643315,0.24972308,0.2697184,0.029716741,0.26450637,0.0013877052],"about_ca_topic_score_codex":0.000012217291,"about_ca_topic_score_gemma":0.0000030508268,"teacher_disagreement_score":0.6515678,"about_ca_system_score_codex":0.00020351348,"about_ca_system_score_gemma":0.00034647094,"threshold_uncertainty_score":0.999862},"labels":[],"label_agreement":null},{"id":"W4412011715","doi":"10.1016/j.jaccas.2025.103881","title":"Lost Rate Control and Tachycardia-Induced Cardiomyopathy as a Result of an Interaction Between Enzalutamide and Diltiazem","year":2025,"lang":"en","type":"article","venue":"JACC Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health; Alberta Health Services","funders":"","keywords":"Diltiazem; Cardiology; Internal medicine; Tachycardia; Medicine; Cardiomyopathy; Enzalutamide; Heart failure; Calcium; Androgen receptor","score_opus":0.05821791193063771,"score_gpt":0.4297481678029917,"score_spread":0.371530255872354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412011715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073404,0.0020188699,0.000049334772,0.00027059502,0.0013436122,0.0005877844,0.000121793215,0.00004046,0.004833482],"genre_scores_gemma":[0.99827445,0.00037574457,0.00004717109,0.00071741507,0.0003037099,0.000035844154,0.000022420842,0.000021247319,0.00020199554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975755,0.0007412198,0.0007235909,0.00051830197,0.00012665008,0.00031469768],"domain_scores_gemma":[0.99830914,0.00048306142,0.0003849581,0.00033229165,0.00017849292,0.00031206346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018192481,0.00026186628,0.00060340855,0.0002347864,0.00018978314,0.00004080427,0.000054278353,0.00028482097,0.000041666983],"category_scores_gemma":[0.0002808509,0.00025752242,0.000113983675,0.0002071988,0.00013328267,0.00017475907,0.000115114446,0.0005209222,0.000003958132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015123597,0.00037060503,0.08289801,0.0003102727,0.0020538766,0.07769666,0.0015159695,0.00024670627,0.59292805,0.00036057728,0.0008283119,0.23927857],"study_design_scores_gemma":[0.010263606,0.0004663299,0.07079047,0.000114197974,0.005185763,0.051016286,0.0009721297,0.0034907819,0.65165025,0.0030820088,0.20187993,0.0010882429],"about_ca_topic_score_codex":0.0003494171,"about_ca_topic_score_gemma":0.000023234643,"teacher_disagreement_score":0.23819032,"about_ca_system_score_codex":0.000037915408,"about_ca_system_score_gemma":0.00013437896,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W4412187638","doi":"10.1002/prp2.70121","title":"Pharmacogenomics Education and Knowledge Assessment in Healthcare Curricula: A Scoping Review of the Middle East and North Africa Region","year":2025,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacogenomics; Curriculum; CINAHL; Medical education; Pharmacy; Health care; MEDLINE; Medicine; Psychology; Family medicine; Political science; Nursing; Psychological intervention; Pedagogy; Pharmacology","score_opus":0.4932962013590145,"score_gpt":0.5932413751997943,"score_spread":0.09994517384077978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412187638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012090444,0.9856444,0.0000016400952,0.0019490059,0.0015569623,0.0068478594,0.00015576676,0.000028957085,0.002606344],"genre_scores_gemma":[0.0027716404,0.99350446,0.000054145625,0.00053336704,0.00048583263,0.002076359,0.000031246873,0.000059860304,0.00048306797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9869739,0.00907648,0.0012742224,0.00122241,0.00039222484,0.0010607896],"domain_scores_gemma":[0.9956916,0.0018973162,0.0006293241,0.00042780378,0.0008888857,0.0004650913],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035866657,0.0006918971,0.0021829354,0.00090741506,0.0006202164,0.000035101475,0.000967976,0.0005097234,0.00013560124],"category_scores_gemma":[0.0003556345,0.0005524575,0.00036961676,0.0022689626,0.0014359712,0.00013139278,0.0013717606,0.004424497,0.000008202212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077093726,0.0018518256,0.0004665886,0.3463971,0.00056400767,0.000027064814,0.0059508896,0.0000021896567,0.000079040554,0.0010650986,0.007977003,0.6355421],"study_design_scores_gemma":[0.0018222118,0.00012637571,0.0001528654,0.20653427,0.002675431,0.00014493709,0.0015837789,0.000093920666,0.00004647963,0.00024521785,0.7857969,0.00077762024],"about_ca_topic_score_codex":0.000048839447,"about_ca_topic_score_gemma":0.000067553636,"teacher_disagreement_score":0.7778199,"about_ca_system_score_codex":0.0006127374,"about_ca_system_score_gemma":0.0075113075,"threshold_uncertainty_score":0.9996927},"labels":[],"label_agreement":null},{"id":"W4412617735","doi":"10.3390/biomedicines13081797","title":"Correction: Yousef et al. Upholding or Breaking the Law of Superposition in Pharmacokinetics. Biomedicines 2024, 12, 1843","year":2025,"lang":"en","type":"erratum","venue":"Biomedicines","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Superposition principle; Engineering ethics; Library science; Philosophy; Political science; Computer science; Medicine; Physics; Engineering","score_opus":0.09033562033081427,"score_gpt":0.4428682889242324,"score_spread":0.35253266859341814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412617735","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068540103,0.08232525,0.0003691238,0.054567553,0.6428748,0.003527958,0.0014842817,0.0003764956,0.20762055],"genre_scores_gemma":[0.19188513,0.16719876,0.00024677633,0.18455179,0.019658742,0.0007932856,0.0029235631,0.00041257244,0.4323294],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528784,0.0009046628,0.0014457125,0.0008485939,0.00068616954,0.0008270076],"domain_scores_gemma":[0.99700725,0.0012040619,0.0006416172,0.00054309034,0.00034214137,0.0002618471],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020796016,0.00082206266,0.0012585591,0.0011495291,0.00033735248,0.000043317898,0.00095500797,0.0008996442,0.0019815043],"category_scores_gemma":[0.00023487996,0.00055784767,0.00027194788,0.0017037705,0.0011755626,0.00012395805,0.00034308498,0.0028518513,0.000025607487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005527658,0.00038768165,0.00029855332,0.00047037133,0.0004715429,0.00013571972,0.00086016447,0.0000708888,0.038843,0.00025437307,0.9424946,0.015160348],"study_design_scores_gemma":[0.00333703,0.00018663802,0.00039719156,0.0011470973,0.001146006,0.00010938713,0.0004142139,0.0039251116,0.012013699,0.00011315227,0.9766857,0.0005247566],"about_ca_topic_score_codex":0.00091451063,"about_ca_topic_score_gemma":0.00043336826,"teacher_disagreement_score":0.62321603,"about_ca_system_score_codex":0.00013151093,"about_ca_system_score_gemma":0.0006250457,"threshold_uncertainty_score":0.9996873},"labels":[],"label_agreement":null},{"id":"W4412711389","doi":"10.1007/s13318-025-00960-5","title":"Population Pharmacokinetic Model Evaluation with a Small Real-World Dataset Versus a Large Virtual Dataset: Does Sample Size Affect Decision-Making?","year":2025,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal; McGill University Health Centre; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Affect (linguistics); Sample size determination; Sample (material); Pharmacokinetics; Population; Statistics; Medicine; Computer science; Psychology; Internal medicine; Mathematics; Chemistry; Chromatography; Environmental health","score_opus":0.0685641862903685,"score_gpt":0.42004607954738077,"score_spread":0.3514818932570123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412711389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487423,0.007732293,0.012891417,0.00074380933,0.0073847063,0.0013996542,0.01865626,0.000084244435,0.0023653281],"genre_scores_gemma":[0.97678417,0.0075354786,0.0100948075,0.0030246286,0.001198613,0.000021428892,0.0010761045,0.00011291489,0.00015186501],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927539,0.003188374,0.0015548775,0.000743179,0.00089633773,0.00086332264],"domain_scores_gemma":[0.99380916,0.0033656363,0.0010867051,0.00055389485,0.0005769939,0.0006076041],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0066897767,0.00076279714,0.0009832998,0.00077633746,0.0005168012,0.00017736129,0.00102768,0.000107020234,0.0008560771],"category_scores_gemma":[0.00085852767,0.00057801465,0.00020407357,0.00091050065,0.00023950258,0.00040618074,0.00048610335,0.0014721393,0.000018917077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0300217,0.0025522197,0.005782965,0.00040724358,0.0039642234,0.0005821407,0.0023295523,0.16822758,0.02854597,0.0023190468,0.13820197,0.61706537],"study_design_scores_gemma":[0.045430355,0.000304989,0.018569188,0.00030961103,0.011928317,0.000056778546,0.00021208126,0.17221561,0.007267186,0.0016940329,0.7406403,0.0013715471],"about_ca_topic_score_codex":0.000028604649,"about_ca_topic_score_gemma":0.00008613047,"teacher_disagreement_score":0.61569387,"about_ca_system_score_codex":0.00008181215,"about_ca_system_score_gemma":0.00028728868,"threshold_uncertainty_score":0.9996671},"labels":[],"label_agreement":null},{"id":"W4412765612","doi":"10.3389/fmed.2025.1572921","title":"A roadmap for personalized medicine: the findings of the IC2PerMed project","year":2025,"lang":"en","type":"article","venue":"Frontiers in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"European Commission","keywords":"Business; Interoperability; European union; Action plan; Health care; Sustainability; Delphi method; Harmonization; Member state; Knowledge management; Process management; Political science; Member states; Management; Computer science","score_opus":0.08790889478428382,"score_gpt":0.4574754429727955,"score_spread":0.3695665481885117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412765612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5370296,0.10820154,0.012798076,0.21752663,0.059136394,0.010612395,0.00019408338,0.00012335689,0.054377887],"genre_scores_gemma":[0.9312292,0.0051062554,0.0012535059,0.032709707,0.00143129,0.0006179976,0.00003222808,0.000049108654,0.027570717],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802613,0.00049110886,0.0005512181,0.00028184557,0.00025546443,0.0003942353],"domain_scores_gemma":[0.99874353,0.0006050256,0.00016046624,0.00030416084,0.00012312536,0.00006371044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023583688,0.0002188551,0.00059775996,0.0002578169,0.00021909259,0.0000031316988,0.0007741029,0.00019374846,0.00023097491],"category_scores_gemma":[0.0009388409,0.00011065906,0.00012648651,0.0008203557,0.0015533689,0.000026756832,0.00009687504,0.0006170115,0.0000010629416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000915973,0.00011794052,0.03583282,0.00021861574,0.00038599136,0.0000031469858,0.0069173137,0.000047985348,0.017336342,0.006686903,0.9132112,0.018325735],"study_design_scores_gemma":[0.0085149575,0.000084398285,0.006907671,0.00017870014,0.00062281254,0.0000033112092,0.0022216525,0.0034604564,0.0073891724,0.005012678,0.9654774,0.00012679056],"about_ca_topic_score_codex":0.0000660068,"about_ca_topic_score_gemma":0.000011371491,"teacher_disagreement_score":0.39419955,"about_ca_system_score_codex":0.00005981724,"about_ca_system_score_gemma":0.00021442983,"threshold_uncertainty_score":0.57234526},"labels":[],"label_agreement":null},{"id":"W4412883513","doi":"10.1080/14622416.2025.2541402","title":"Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review","year":2025,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Shores Centre for Mental Health Sciences; University of Toronto; Centre for Addiction and Mental Health; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Antidepressant; Medicine; Pharmacology; Psychology; Psychiatry; Biology; Genetics; Genotype; Anxiety; Gene","score_opus":0.6277444561261495,"score_gpt":0.5615282100637023,"score_spread":0.06621624606244714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412883513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014343936,0.9721614,0.00013192692,0.00014598838,0.0028415548,0.020641156,0.003286783,0.0001821963,0.00059462816],"genre_scores_gemma":[0.0000209227,0.9806051,0.0007889099,0.0036851713,0.0008531961,0.011917582,0.00031047314,0.00026849203,0.0015501421],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891092,0.0028020495,0.0039864024,0.0018861032,0.0003911044,0.0018251505],"domain_scores_gemma":[0.9861971,0.009855185,0.0018544194,0.0010236297,0.00039827384,0.00067136093],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0035239628,0.0020663296,0.0076930993,0.0010597435,0.00041343822,0.00010187122,0.0021263156,0.0007204707,0.00027955807],"category_scores_gemma":[0.0020659498,0.0018125683,0.0019844463,0.0017852786,0.0001957962,0.00020944791,0.00047009322,0.0015181039,0.00022975673],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005944903,0.0004114496,0.000007233594,0.6284579,0.0012170604,0.00009021385,0.000052317584,0.000068492045,0.00022455833,0.0000144164605,0.0012364038,0.3681605],"study_design_scores_gemma":[0.0018754058,0.000075990414,3.021035e-7,0.37826553,0.03320798,0.000109892695,0.0000051219854,0.0011504312,0.00035657373,0.000030889187,0.58374673,0.0011751393],"about_ca_topic_score_codex":0.000024507073,"about_ca_topic_score_gemma":0.000009385304,"teacher_disagreement_score":0.58251035,"about_ca_system_score_codex":0.0009178275,"about_ca_system_score_gemma":0.0024097585,"threshold_uncertainty_score":0.99920785},"labels":[],"label_agreement":null},{"id":"W4413260718","doi":"10.1016/j.psycr.2025.100274","title":"Retraction notice to “Pharmacogenetic testing utility in psychiatry: A case report of serotonin syndrome” [Psychiatry Research Case Reports Volume 2, Issue 1, June 2023, 100128]","year":2025,"lang":"en","type":"article","venue":"Psychiatry Research Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; University of Saskatchewan; Alberta Children's Hospital; Centre for Addiction and Mental Health","funders":"","keywords":"Notice; Psychiatry; Serotonin syndrome; Pharmacogenetics; Medicine; Psychology; Serotonin; Political science; Biology; Genetics; Internal medicine; Serotonergic; Gene","score_opus":0.16847433260936817,"score_gpt":0.5158027804543307,"score_spread":0.34732844784496253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413260718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92610735,0.009894684,0.00006522638,0.010818749,0.036343373,0.0057299156,0.00017302315,0.000203963,0.010663732],"genre_scores_gemma":[0.9824371,0.00032840567,0.0069876094,0.00072080776,0.0017987353,0.0010225204,0.000065936074,0.00018534908,0.006453558],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9787686,0.0063738576,0.0053181625,0.00351308,0.0025559685,0.0034703389],"domain_scores_gemma":[0.9880092,0.0016272939,0.0014646744,0.0032673653,0.0035939994,0.0020374744],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.04311811,0.0010619791,0.0016430872,0.004302871,0.002237693,0.00022500507,0.0005175895,0.0016546452,0.0018759199],"category_scores_gemma":[0.0044566393,0.0011848685,0.0005150638,0.011418907,0.0010003384,0.00045099834,0.001177165,0.008841988,0.00014220721],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007103052,0.0025622142,0.13784373,0.0013296818,0.00045135195,0.75154597,0.00039179553,0.00076590996,0.0030694942,0.00006732197,0.09672972,0.0045324904],"study_design_scores_gemma":[0.0015698547,0.0003675193,0.0044483026,0.0004403779,0.00047826456,0.85127085,0.0021709146,0.0031817774,0.0016726012,0.0023900387,0.13117167,0.0008378341],"about_ca_topic_score_codex":0.008035938,"about_ca_topic_score_gemma":0.008283671,"teacher_disagreement_score":0.13339542,"about_ca_system_score_codex":0.00057401025,"about_ca_system_score_gemma":0.0067724804,"threshold_uncertainty_score":0.9996414},"labels":[],"label_agreement":null},{"id":"W4413676345","doi":"10.20944/preprints202508.1747.v1","title":"Hepatic and Biliary Glucuronidation of Bisphenol A in Mice: A Reaction Catalyzed by the UDP-Glucuronosyltransferase (Ugt2b)1 and Ugt2b34 Enzymes","year":2025,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Glucuronidation; Enzyme; Chemistry; Bisphenol A; Glucuronosyltransferase; Liver enzyme; Biochemistry; Internal medicine; Medicine; Organic chemistry; Microsome","score_opus":0.13037230434538866,"score_gpt":0.4306293772723793,"score_spread":0.30025707292699066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413676345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98392016,0.010323526,0.000050168175,0.0013370484,0.00094449834,0.0015625862,0.00043790057,0.000056957455,0.0013671594],"genre_scores_gemma":[0.9838841,0.014608333,0.000041932395,0.00045777994,0.00008980093,0.0003385757,0.000164124,0.00003011902,0.00038524228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996498,0.0010429095,0.00087448896,0.00094593246,0.00022064178,0.0004180627],"domain_scores_gemma":[0.9981621,0.00060700945,0.00036205593,0.00056335586,0.00012132394,0.00018415741],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017134729,0.00047970813,0.0006688141,0.0002830856,0.000168091,0.00001945736,0.00048686654,0.00061593304,0.00024306729],"category_scores_gemma":[0.00021338699,0.00043574473,0.00012627532,0.00027897273,0.00039532542,0.00010917006,0.00088179787,0.0017545664,0.000022725057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066480855,0.00061472895,0.21624513,0.0010587709,0.00046639022,0.000009659143,0.0040109986,0.0003925053,0.75686383,0.00040803207,0.00017840126,0.019086739],"study_design_scores_gemma":[0.0029344975,0.000026158375,0.104484536,0.00018308667,0.00094329164,0.000014590486,0.00023622603,0.004331244,0.867746,0.0019048179,0.016627634,0.0005679027],"about_ca_topic_score_codex":0.0012509133,"about_ca_topic_score_gemma":0.00017886428,"teacher_disagreement_score":0.111760594,"about_ca_system_score_codex":0.00008781661,"about_ca_system_score_gemma":0.00028980186,"threshold_uncertainty_score":0.99980944},"labels":[],"label_agreement":null},{"id":"W4413778921","doi":"10.1136/bmjopen-2024-091562","title":"Key informant perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care in Ontario, Canada: a qualitative description study","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; McMaster University; Hamilton Health Sciences","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Fondation Brocher","keywords":"Medicine; Pharmacogenomics; Primary care; Family medicine; Key (lock); Qualitative research; Alternative medicine; Data science; Pharmacology","score_opus":0.26493740017807804,"score_gpt":0.4990448851646785,"score_spread":0.23410748498660044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413778921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587346,0.00074149354,0.000020995185,0.00017343502,0.0008734708,0.014456863,0.00013038618,0.000020607673,0.024848174],"genre_scores_gemma":[0.99368036,0.00002507944,0.00050714065,0.0016423428,0.000065394925,0.003277006,0.000054613654,0.000025213627,0.0007228783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969101,0.0008980416,0.0008092212,0.00057706423,0.00021941023,0.00058618083],"domain_scores_gemma":[0.99844724,0.0007340589,0.00023340988,0.00025236313,0.00020966117,0.00012324574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025624812,0.00032561063,0.00057469576,0.00033943102,0.000260017,0.00008983215,0.000696606,0.00012134825,0.000081099395],"category_scores_gemma":[0.00024889957,0.00033211184,0.000060292812,0.0003957382,0.000057790254,0.00029002875,0.00049334124,0.00082360784,0.000004028562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009986022,0.0020846378,0.5150113,0.00047345425,0.00053212175,0.00019741838,0.41402835,0.010988026,0.02185245,0.00074975856,0.0032993513,0.020797089],"study_design_scores_gemma":[0.031765245,0.0007456518,0.6816826,0.0005956836,0.000417059,0.0000076619945,0.23704396,0.0052138735,0.0098369,0.00039105632,0.031081328,0.0012189721],"about_ca_topic_score_codex":0.6536254,"about_ca_topic_score_gemma":0.89801884,"teacher_disagreement_score":0.24439344,"about_ca_system_score_codex":0.0019091859,"about_ca_system_score_gemma":0.003739259,"threshold_uncertainty_score":0.9999131},"labels":[],"label_agreement":null},{"id":"W4413802936","doi":"10.1017/cts.2026.10592","title":"448 A systematic review of real-world evidence on the clinical relevance, characterization, and utility of CYP2D6 biomarker testing","year":2025,"lang":"en","type":"review","venue":"Journal of Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; CYP2D6; Biomarker; Pharmacogenetics; Medicine; Precision medicine; Relevance (law); Personalized medicine; Drug response; Drug; Bioinformatics; Pharmacology; Internal medicine; Biology; Pathology","score_opus":0.5539761840844515,"score_gpt":0.6081250858641786,"score_spread":0.05414890177972709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413802936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011543044,0.9953407,0.000107279746,0.0007562266,0.0008894163,0.0009520921,0.00011040102,0.000003473592,0.0006860957],"genre_scores_gemma":[0.007544993,0.991225,0.00025188073,0.000701789,0.00018085388,0.000011638271,0.0000029209489,0.0000067329356,0.000074180854],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9911654,0.0025822686,0.0050418656,0.0003512136,0.0006431401,0.00021612532],"domain_scores_gemma":[0.9632956,0.031376496,0.0038337572,0.00023503578,0.0009825894,0.00027653654],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.030035438,0.00024484968,0.0026696783,0.00021196612,0.00016716495,0.000017928449,0.0006385,0.00020737255,0.00007509957],"category_scores_gemma":[0.01755976,0.00013589804,0.0005538675,0.0011849791,0.0018044913,0.0001616384,0.00008482006,0.0010665515,0.0000012805067],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117728996,0.0002801799,0.005090904,0.38406643,0.00030889834,0.0000054804545,0.000023505456,5.0176493e-7,0.000030468453,0.0010600016,0.00007591583,0.60894],"study_design_scores_gemma":[0.0008382847,0.00023025526,0.04459423,0.81026536,0.0076047056,0.000056246397,0.000003826538,0.0006360156,0.000023792496,0.00092758733,0.13450782,0.0003118582],"about_ca_topic_score_codex":0.000001989348,"about_ca_topic_score_gemma":0.0000012139644,"teacher_disagreement_score":0.60862815,"about_ca_system_score_codex":0.000006305016,"about_ca_system_score_gemma":0.0018318009,"threshold_uncertainty_score":0.99878263},"labels":[],"label_agreement":null},{"id":"W4414024538","doi":"10.1002/cpt.70059","title":"<scp>GenoStaR</scp> : An R Package for Genotype to Star Allele Conversion for Major Cytochrome <scp>P450</scp> Family of Genes","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Myriad Genetics; Assurex Health","keywords":"Pharmacogenomics; Genotyping; Genotype; CYP2D6; Genetics; Allele; CYP2C19; Pharmacogenetics; Biology; CYP2C9; Haplotype; Computational biology; Gene","score_opus":0.1804791213810116,"score_gpt":0.4970048930810093,"score_spread":0.31652577169999774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414024538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611212,0.011148112,0.008802126,0.0021338619,0.0085465815,0.0052645644,0.0017726321,0.00022815737,0.0009827383],"genre_scores_gemma":[0.6913668,0.015156147,0.013633769,0.26645327,0.003914496,0.0015904948,0.0007686332,0.00037079162,0.0067455918],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99302846,0.0014614969,0.0020764486,0.0013922452,0.00033667547,0.0017046842],"domain_scores_gemma":[0.9872641,0.009191887,0.0007127663,0.00071689865,0.0011328076,0.0009815391],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033189962,0.0008512036,0.0016189687,0.00047267735,0.00066351774,0.00004589395,0.0016513021,0.0014061545,0.00014448361],"category_scores_gemma":[0.00035489292,0.00086242263,0.0008345883,0.0006814692,0.00087971665,0.00017538064,0.00046060156,0.0012917328,0.00011738064],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012701286,0.0025162068,0.0024458033,0.0003361705,0.0034838438,0.000017422286,0.0008662844,0.00047973613,0.8225046,0.00042745276,0.1502427,0.01540969],"study_design_scores_gemma":[0.009355138,0.00143418,0.00427991,0.000012207532,0.0035533325,0.000002965164,0.00038070747,0.003469912,0.29449463,0.0011570484,0.6816782,0.00018182423],"about_ca_topic_score_codex":0.0000124215685,"about_ca_topic_score_gemma":0.000012535076,"teacher_disagreement_score":0.53143543,"about_ca_system_score_codex":0.00012399752,"about_ca_system_score_gemma":0.00079142,"threshold_uncertainty_score":0.9998902},"labels":[],"label_agreement":null},{"id":"W4414135359","doi":"10.63946/aubiomed/16743","title":"Pharmacogenomics Applications in Clinical Practice: Revolutionizing Patient Care","year":2025,"lang":"en","type":"article","venue":"Australian Journal of Biomedical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"","keywords":"Pharmacogenomics; Health care; Pharmacy; Personalized medicine; Precision medicine; Clinical Practice; Healthcare system; Patient care","score_opus":0.29672700016251796,"score_gpt":0.6262425940166643,"score_spread":0.3295155938541463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414135359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452345,0.02162327,0.0007797549,0.016741479,0.004385496,0.0012278787,0.000096799806,0.00002403948,0.009886823],"genre_scores_gemma":[0.9897675,0.0057074707,0.002189626,0.0010378264,0.00076862366,0.000035567526,0.000014753038,0.00001612814,0.00046252325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944144,0.0021966172,0.0016107167,0.00030068756,0.0007685726,0.0007089943],"domain_scores_gemma":[0.9953539,0.0020955487,0.00034423888,0.00021649548,0.0012802285,0.00070961704],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0077059395,0.00016721954,0.00040634934,0.00088948547,0.0002829468,0.00004008005,0.0007210322,0.00041148256,0.0003702625],"category_scores_gemma":[0.0018912159,0.0001481696,0.00021232461,0.0014982135,0.0008094178,0.00015173928,0.00021414465,0.0037297197,0.000059673097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011451927,0.0025257503,0.014516581,0.0001984247,0.0005259053,0.0005890638,0.0019484836,0.00014940294,0.027687378,0.002390837,0.08025247,0.8680705],"study_design_scores_gemma":[0.0022885264,0.00029217397,0.0025534069,0.00006860209,0.00013745656,0.000045124616,0.0035124396,0.00008236039,0.0074577057,0.0008163061,0.98262113,0.00012477416],"about_ca_topic_score_codex":0.000018424455,"about_ca_topic_score_gemma":0.000002768431,"teacher_disagreement_score":0.90236866,"about_ca_system_score_codex":0.0002856492,"about_ca_system_score_gemma":0.0012196788,"threshold_uncertainty_score":0.9985687},"labels":[],"label_agreement":null},{"id":"W4414154142","doi":"10.1016/j.bioorg.2025.108979","title":"Metabolite profiling in human and mouse liver microsomes of the aminosteroid RM-581, a new orally active anticancer agent","year":2025,"lang":"en","type":"article","venue":"Bioorganic Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal; Université Laval","funders":"Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Metabolite; Pyrrolidine; Active metabolite; Microsome; Primary metabolite; Proline; Human liver; Steroid; Amino acid","score_opus":0.054088246087837036,"score_gpt":0.38471022886079875,"score_spread":0.33062198277296173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414154142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819953,0.0091170035,0.000007990849,0.00034884384,0.0002536962,0.00031971742,0.000083373714,0.000020923828,0.0016489272],"genre_scores_gemma":[0.9930887,0.0015307219,0.00010648759,0.00080546626,0.0001230271,0.000013496144,0.000010095451,0.000017501594,0.004304453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878436,0.00010427115,0.0003539678,0.0003348192,0.00011047949,0.00031209263],"domain_scores_gemma":[0.99934494,0.00007308991,0.00015214886,0.00025032563,0.000060572285,0.000118946125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020451038,0.00021784747,0.00031343577,0.000045862253,0.00011319316,0.000016962718,0.00035342597,0.00022737324,0.00038778567],"category_scores_gemma":[0.000053323394,0.00018115682,0.000084731444,0.00030459816,0.00020177235,0.000043185813,0.00032405142,0.0004904428,0.0000032945409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084563224,0.00014990798,0.009832349,0.00017020287,0.00014068079,0.000004812849,0.00043183207,0.000007037111,0.982544,0.00009958147,0.00043907663,0.006095967],"study_design_scores_gemma":[0.0018478467,0.0000056309104,0.012675342,0.000023732822,0.00019303079,0.0000044801445,0.00011149602,0.00008192024,0.9702034,0.00014980826,0.014543548,0.0001597649],"about_ca_topic_score_codex":0.00004400772,"about_ca_topic_score_gemma":0.000009972445,"teacher_disagreement_score":0.014104472,"about_ca_system_score_codex":0.00005750997,"about_ca_system_score_gemma":0.00024194589,"threshold_uncertainty_score":0.7387361},"labels":[],"label_agreement":null},{"id":"W4415093753","doi":"10.1021/acs.jmedchem.5c01467","title":"Use of P450 Enzymes for Late-Stage Functionalization in Drug Discovery","year":2025,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Wellcome Trust","keywords":"Drug discovery; Hydroxylation; Chemical synthesis; Enzyme; Metabolic stability; High-throughput screening; Drug; Biocatalysis","score_opus":0.104177169566298,"score_gpt":0.4332439196006316,"score_spread":0.3290667500343336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415093753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880041,0.0064576985,0.00200814,0.0009660227,0.0011606567,0.00013398829,0.00006820046,0.000004793576,0.0011964231],"genre_scores_gemma":[0.9895451,0.001542544,0.00025420374,0.000942173,0.00037136124,0.000007187205,0.000015942514,0.000009613382,0.0073118634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987803,0.00008362046,0.00065110286,0.00011380966,0.00019648799,0.00017466981],"domain_scores_gemma":[0.99861276,0.0005572593,0.00041061206,0.000080767764,0.00024329493,0.00009532147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089764025,0.00012319488,0.000325052,0.000119445125,0.000043025226,0.000010486472,0.0001725481,0.00014506206,0.00025549647],"category_scores_gemma":[0.00036808744,0.00010621042,0.00013041237,0.00019354344,0.00010569922,0.00015591491,0.00003254861,0.00046174138,4.6281295e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00205019,0.00046524216,0.012150733,0.000664546,0.00030435796,0.00004013531,0.0003164095,0.0147061655,0.9441717,0.00081060414,0.019018952,0.005300924],"study_design_scores_gemma":[0.002875632,0.00002962589,0.0019862903,0.00013281385,0.0002651176,0.0000103433495,0.00015604265,0.002277812,0.706213,0.00053513434,0.28542462,0.000093565446],"about_ca_topic_score_codex":0.000008309681,"about_ca_topic_score_gemma":0.000002531738,"teacher_disagreement_score":0.26640567,"about_ca_system_score_codex":0.000053910655,"about_ca_system_score_gemma":0.00028491463,"threshold_uncertainty_score":0.43311355},"labels":[],"label_agreement":null},{"id":"W4415170017","doi":"10.1080/14622416.2025.2571387","title":"Characterizing models for delivery of pharmacogenomic testing: a scoping review","year":2025,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"Genome British Columbia","keywords":"Pharmacogenomics; Healthcare delivery; Service delivery framework; Work (physics); Health care; Selection (genetic algorithm); Health care delivery","score_opus":0.412099249233429,"score_gpt":0.5263678696704787,"score_spread":0.11426862043704966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415170017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028482944,0.97641575,0.00058021606,0.00006422011,0.004042256,0.011472238,0.0044128187,0.00019599732,0.0027880147],"genre_scores_gemma":[0.00002240172,0.9889834,0.0019525741,0.0036542923,0.0011999502,0.002733536,0.00075175444,0.00029999414,0.00040209433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917707,0.0011250633,0.0036878658,0.0015351238,0.00036040464,0.0015208569],"domain_scores_gemma":[0.99117976,0.0040733353,0.0025872488,0.0007877794,0.0007067797,0.00066508946],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0027506587,0.0016696864,0.00574986,0.00085001986,0.00044347384,0.00005105647,0.0020503069,0.00087982527,0.0004265109],"category_scores_gemma":[0.00033181097,0.0017188296,0.0022609828,0.0011993198,0.00027667588,0.0002681041,0.00076797925,0.0017270398,0.00008000555],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094597555,0.00024777284,6.999575e-7,0.32571253,0.0011885854,0.000014953222,0.000048290647,0.00011398195,0.0026150148,0.000078160534,0.0016462984,0.6682391],"study_design_scores_gemma":[0.0018155106,0.00004902024,2.6578066e-8,0.16595106,0.017022468,0.00005799301,0.0000041961634,0.0020213847,0.0030818188,0.00012345664,0.8086139,0.0012591617],"about_ca_topic_score_codex":0.00000991926,"about_ca_topic_score_gemma":9.0026293e-7,"teacher_disagreement_score":0.8069676,"about_ca_system_score_codex":0.00030061477,"about_ca_system_score_gemma":0.0037436956,"threshold_uncertainty_score":0.999605},"labels":[],"label_agreement":null},{"id":"W4415567623","doi":"10.1007/s40261-025-01489-w","title":"Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia","year":2025,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Melbourne; International Society of Oncology Pharmacy Practitioners","keywords":"Reimbursement; DPYD; Genotyping; Standard of care; Pharmacotherapy; Health care; Pharmacogenetics; Health economics","score_opus":0.21893161215604237,"score_gpt":0.5177472132587021,"score_spread":0.2988156011026597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415567623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531883,0.00033732416,0.00018822626,0.00011308988,0.0012678811,0.0022472607,0.00036731284,0.000023528806,0.00013652252],"genre_scores_gemma":[0.99857694,0.00016153314,0.0004421109,0.0002594065,0.00005624778,0.00029254664,0.00013696341,0.000016782073,0.00005744775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961181,0.0018935867,0.0010688201,0.00043784874,0.00018447186,0.0002971438],"domain_scores_gemma":[0.99733615,0.0013331131,0.00038672826,0.00021279654,0.00050048047,0.00023074272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001327079,0.00024442983,0.00078078755,0.00024629303,0.00008183526,0.000009179675,0.00022181435,0.00024316167,0.00006082364],"category_scores_gemma":[0.00044137053,0.00023873324,0.00016595131,0.0005194915,0.0004019751,0.000077545934,0.00007491834,0.00037530888,0.0000036968438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002145558,0.00043612797,0.9195383,0.0004248743,0.00016356702,0.0000011317684,0.0017461092,0.040452745,0.021191537,0.00008640958,0.00013618357,0.013677457],"study_design_scores_gemma":[0.0039112396,0.00015064335,0.5788607,0.000312348,0.00017190026,1.1916142e-8,0.000069087924,0.0021640982,0.41341102,0.00013917965,0.0006822936,0.00012747168],"about_ca_topic_score_codex":0.00040343264,"about_ca_topic_score_gemma":0.0002498683,"teacher_disagreement_score":0.39221948,"about_ca_system_score_codex":0.00028321068,"about_ca_system_score_gemma":0.0003623159,"threshold_uncertainty_score":0.9735259},"labels":[],"label_agreement":null},{"id":"W4415782400","doi":"10.1097/fpc.0000000000000579","title":"Pharmacogenetic testing coverage by Canadian insurance providers","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Dalhousie University","funders":"","keywords":"Reimbursement; Test (biology); Genetic testing; Quality (philosophy); Pharmacogenetics","score_opus":0.06169952826165205,"score_gpt":0.3837315103934607,"score_spread":0.32203198213180867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415782400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9300575,0.0396687,0.00054415734,0.0023540203,0.002669882,0.0011733361,0.0011635313,0.0001307525,0.022238096],"genre_scores_gemma":[0.96218777,0.015461939,0.00063445006,0.019256538,0.00030029417,0.0001259698,0.0000720041,0.00008091931,0.0018800984],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965457,0.0003327079,0.0007407301,0.00087875075,0.00021718777,0.0012849648],"domain_scores_gemma":[0.9976991,0.00035477406,0.00019245478,0.00032923886,0.00025233487,0.0011721429],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074306,0.0006261441,0.00051537063,0.0004153385,0.0008498707,0.00016094123,0.00063793256,0.00035621435,0.0003486993],"category_scores_gemma":[0.00009903865,0.00070474006,0.00012720986,0.00071116595,0.0003576802,0.00011491982,0.00024792866,0.000924685,0.000083878345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016532493,0.00020443795,0.03483321,0.00013969837,0.00047285587,0.000047184898,0.00030488582,0.0023278832,0.57991314,0.0002893143,0.034202997,0.34709907],"study_design_scores_gemma":[0.0032901256,0.000043375934,0.002827739,0.000016932738,0.00037768378,0.000026673288,0.000035264147,0.012567336,0.17099902,0.0008952947,0.8082501,0.00067044713],"about_ca_topic_score_codex":0.0016700863,"about_ca_topic_score_gemma":0.0005847298,"teacher_disagreement_score":0.77404714,"about_ca_system_score_codex":0.00020326981,"about_ca_system_score_gemma":0.00085362536,"threshold_uncertainty_score":0.9995404},"labels":[],"label_agreement":null},{"id":"W4416038602","doi":"10.1101/2025.11.06.687066","title":"A <i>De Novo</i> Algorithm for Allele Reconstruction from Oxford Nanopore Amplicon Reads, with Application to <i>CYP2D6</i>","year":2025,"lang":"","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Royal Columbian Hospital; University of British Columbia Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Nanopore sequencing; Amplicon; Allele; Sequence (biology); Genotyping; Indel; Gene; Genomics; Reference genome","score_opus":0.02589207618818109,"score_gpt":0.31166156853584176,"score_spread":0.2857694923476607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416038602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47899342,0.009521225,0.45512837,0.0030616417,0.010530875,0.0146269845,0.026851486,0.0009651026,0.00032090352],"genre_scores_gemma":[0.6942819,0.018611383,0.24667618,0.018281268,0.006957993,0.014127217,0.000054180637,0.0007125143,0.00029738963],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918233,0.00071762846,0.0017279148,0.0031929747,0.0005406497,0.0019975193],"domain_scores_gemma":[0.99291867,0.0005996173,0.0013125959,0.0019292277,0.0016925152,0.0015473596],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0017318727,0.0017546585,0.001775262,0.00062225165,0.0010056162,0.00035685243,0.0016113981,0.002312053,0.00040355782],"category_scores_gemma":[0.00013482566,0.0019979537,0.00048721157,0.0013260649,0.0004299754,0.00025452854,0.0007201822,0.002510396,0.00011381058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013384187,0.0012409495,0.0022585476,0.0006405017,0.0023486016,0.000043473352,0.00015076698,0.0017546982,0.97302824,0.00080025883,0.0032931466,0.013102406],"study_design_scores_gemma":[0.0037836707,0.00018909782,0.0008906737,0.00026544265,0.0019342882,3.1828995e-7,0.000014959403,0.025527075,0.46773568,0.000030394254,0.49804625,0.0015821602],"about_ca_topic_score_codex":0.00015521128,"about_ca_topic_score_gemma":0.00001717005,"teacher_disagreement_score":0.50529253,"about_ca_system_score_codex":0.00074500166,"about_ca_system_score_gemma":0.0016998937,"threshold_uncertainty_score":0.99979085},"labels":[],"label_agreement":null},{"id":"W4416274157","doi":"10.1080/17425255.2025.2592133","title":"The clinical implication of inflammation-driven regulation of drug-metabolizing enzymes","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Enzyme; Disease; Glycolysis; Immune system","score_opus":0.08362478333396023,"score_gpt":0.4659520106390106,"score_spread":0.38232722730505037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416274157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83550894,0.09785106,0.0008140683,0.019599902,0.028174799,0.0026594326,0.00014472357,0.00020934269,0.015037705],"genre_scores_gemma":[0.95767283,0.03712444,0.00074929703,0.0017393255,0.0013848401,0.00027332242,0.000058083653,0.000041954856,0.00095592637],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938572,0.0024508846,0.0020911333,0.000629034,0.00037799994,0.00059374154],"domain_scores_gemma":[0.99458843,0.002731197,0.0011398286,0.00078940124,0.000546065,0.00020504737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002952411,0.00041192432,0.00097602274,0.00044583736,0.000497182,0.000025054846,0.0009231593,0.00048157515,0.0002651723],"category_scores_gemma":[0.00069511886,0.00033431323,0.00042916214,0.00073830906,0.00081646885,0.00015993146,0.00027639474,0.00081775547,0.000041399315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010799001,0.00069404853,0.0021273252,0.000051546896,0.00060735823,7.8013517e-7,0.0016787819,0.0016554587,0.373931,0.32855946,0.030467765,0.25914657],"study_design_scores_gemma":[0.0019971407,0.000032062595,0.023322392,0.0000232836,0.00007064921,0.0000016758191,0.00019907797,0.0018219234,0.36591628,0.0031062635,0.60331887,0.00019037844],"about_ca_topic_score_codex":0.000029743707,"about_ca_topic_score_gemma":0.000014672331,"teacher_disagreement_score":0.5728511,"about_ca_system_score_codex":0.000046092387,"about_ca_system_score_gemma":0.00036972237,"threshold_uncertainty_score":0.9999109},"labels":[],"label_agreement":null},{"id":"W4416364121","doi":"10.24926/iip.v16i3.6347","title":"Clinical pharmacogenetics: A feasibility study of pharmacy students using a clinical decision support system during their didactic training","year":2025,"lang":"en","type":"article","venue":"INNOVATIONS in pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; AXYS Technologies (Canada)","funders":"","keywords":"Pharmacy; Clinical decision support system; Health care; Pharmacy practice; Decision support system; Quality (philosophy); Clinical pharmacy; Intervention (counseling); Qualitative research","score_opus":0.4021849442830466,"score_gpt":0.6064238514067891,"score_spread":0.20423890712374254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416364121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860536,0.0007212545,0.0006460986,0.00010562806,0.007843859,0.003076726,0.00015877493,0.00018301039,0.0012110808],"genre_scores_gemma":[0.9964516,0.0006715744,0.00090818654,0.00095161324,0.0006109948,0.00019810202,0.000024421872,0.00007669971,0.00010678431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98838735,0.0030522363,0.005396412,0.0013768169,0.0007489612,0.001038199],"domain_scores_gemma":[0.99488837,0.0018739206,0.0011593978,0.00084464595,0.0008347641,0.00039890182],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009649083,0.0007110232,0.0015606255,0.001358997,0.0005409859,0.00007933841,0.001637387,0.00029187897,0.00047496788],"category_scores_gemma":[0.000632274,0.000718743,0.0004277672,0.003491006,0.00045033605,0.00035233982,0.0009039313,0.0025770983,0.000030785133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026441275,0.010265527,0.8768566,0.0002266416,0.0010221106,0.00013684407,0.0021168017,0.0017479941,0.02495699,0.00010695765,0.00021159786,0.07970779],"study_design_scores_gemma":[0.15094174,0.0005513557,0.6353165,0.00047182114,0.0035452284,0.0001354934,0.009916628,0.10066029,0.05239761,0.00052721996,0.043424845,0.0021112864],"about_ca_topic_score_codex":0.00010447069,"about_ca_topic_score_gemma":0.000032875996,"teacher_disagreement_score":0.24154013,"about_ca_system_score_codex":0.0003500447,"about_ca_system_score_gemma":0.0010053532,"threshold_uncertainty_score":0.999724},"labels":[],"label_agreement":null},{"id":"W4416416572","doi":"10.1016/j.steroids.2025.109720","title":"In vitro metabolic profiling of 6-chloro-testosterone and 6-ene-testosterone by liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-time of flight (GC-TOF) mass spectrometry","year":2025,"lang":"en","type":"article","venue":"Steroids","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Hydroxylation; Mass spectrometry; Metabolism; Chlorine; Double bond; Metabolic pathway; Microsome; Incubation; In vitro","score_opus":0.018150434789968906,"score_gpt":0.32305036269700343,"score_spread":0.3048999279070345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416416572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380394,0.05671717,0.00040746585,0.0005172449,0.0007433212,0.00092164864,0.0004777786,0.00007741811,0.0020985585],"genre_scores_gemma":[0.98539805,0.008188056,0.00498591,0.0007967535,0.00015824994,0.00008282769,0.000068350804,0.000078954035,0.00024286826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99555504,0.0006343132,0.0013805617,0.00095963327,0.0004245424,0.0010459349],"domain_scores_gemma":[0.9978844,0.00045954596,0.0005477042,0.00056241534,0.00014805973,0.00039786502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012094877,0.0007415237,0.0016381324,0.0019007843,0.00017282364,0.000048252565,0.0005742146,0.0005396261,0.00026025798],"category_scores_gemma":[0.00006432929,0.000760133,0.00025748723,0.0021364815,0.00084723823,0.00032065486,0.00034333442,0.00094820326,0.00000867715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011987421,0.00054185744,0.01547215,0.0005228411,0.00076990447,0.000026756377,0.00035057723,0.000007668995,0.9790342,0.00041012128,0.00048021876,0.0011849519],"study_design_scores_gemma":[0.0053208745,0.00048177488,0.005224583,0.000096311705,0.0006765093,0.000033981447,0.00012255405,0.00046292527,0.9817924,0.0009707412,0.0042435774,0.0005737502],"about_ca_topic_score_codex":0.00005584977,"about_ca_topic_score_gemma":0.0000043341674,"teacher_disagreement_score":0.04852911,"about_ca_system_score_codex":0.000039522936,"about_ca_system_score_gemma":0.000112244044,"threshold_uncertainty_score":0.99948496},"labels":[],"label_agreement":null},{"id":"W4416454402","doi":"10.1007/978-3-031-93616-6_3","title":"Pharmacogenomics","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Pharmacogenomics; Adverse effect; Drug; Pharmacogenetics; Drug response; MEDLINE; Precision medicine","score_opus":0.13499341856451516,"score_gpt":0.4394437847789956,"score_spread":0.3044503662144804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416454402","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007094289,0.011338961,0.00012165758,0.0006865279,0.0059196106,0.0006564404,0.0006127405,0.00027558216,0.98031753],"genre_scores_gemma":[0.0010255118,0.014950936,0.00036188736,0.012781659,0.0013287924,0.000033240973,0.00017208915,0.00011052407,0.96923536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975328,0.000088461675,0.00073089974,0.0007533899,0.00025910945,0.00063535897],"domain_scores_gemma":[0.9982615,0.00031020367,0.0002774097,0.00047096668,0.00020286837,0.0004770148],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00051358517,0.00077897526,0.0007695466,0.00039010594,0.00025930023,0.000035672587,0.00076876517,0.0013162515,0.04433943],"category_scores_gemma":[0.000023203798,0.0007919927,0.0004996374,0.00005990761,0.00024787025,0.00005151508,0.0003981745,0.0021635494,0.0031696032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001652635,0.000084878404,0.00001278557,0.00010896095,0.0010940946,0.000112111295,0.0000532752,0.00007165021,0.0048941276,0.3744309,0.39703116,0.2219408],"study_design_scores_gemma":[0.0012806872,0.000021612255,0.0000019870313,0.000026928168,0.001135943,0.00001659277,0.000003017634,0.000567576,0.010147555,0.01774707,0.96830976,0.00074127427],"about_ca_topic_score_codex":0.000004654182,"about_ca_topic_score_gemma":0.0000042663332,"teacher_disagreement_score":0.5712786,"about_ca_system_score_codex":0.00011934441,"about_ca_system_score_gemma":0.00040712292,"threshold_uncertainty_score":0.9999803},"labels":[],"label_agreement":null},{"id":"W4416526318","doi":"10.1016/b978-0-443-29025-1.00016-3","title":"How STOPP/START and American Geriatrics Society criteria medications are metabolized by the P450 enzyme system and medication metabolism varies by genome","year":2025,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oracle (Canada); University of Calgary","funders":"","keywords":"Geriatrics; Odds ratio; Cytochrome P450; Pharmacogenetics; CYP2D6; Polypharmacy; Odds; MEDLINE","score_opus":0.03285428611762365,"score_gpt":0.335121174674793,"score_spread":0.3022668885571694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416526318","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019159429,0.6047068,0.0008194982,0.020129075,0.004415054,0.004310017,0.011227361,0.0004563693,0.35201988],"genre_scores_gemma":[0.018623814,0.08685486,0.0007314159,0.0095798625,0.0015738695,0.00065779075,0.0007237741,0.00019010055,0.88106453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647826,0.00058820826,0.0008090095,0.0009545894,0.0005333709,0.0006365667],"domain_scores_gemma":[0.9968644,0.0005808363,0.0010611423,0.00065045885,0.00028729442,0.00055588793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014688435,0.0008532981,0.0013891438,0.00016909248,0.0009582683,0.0002263094,0.0006850046,0.000733616,0.00015047131],"category_scores_gemma":[0.00006228441,0.00068656605,0.0003010283,0.00009624939,0.001771279,0.00009348536,0.000434027,0.0015540295,0.000010069849],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013842495,0.000083637446,0.000015704596,0.0007556297,0.0040489277,0.000012371545,0.0029965641,8.3851666e-7,0.021600451,0.018248264,0.08205087,0.87004834],"study_design_scores_gemma":[0.001305711,0.000019166877,0.00006767708,0.000045225443,0.0046070404,0.000028484164,0.0003863172,0.00022777703,0.00085048337,0.0008418275,0.9909969,0.00062338915],"about_ca_topic_score_codex":0.0000073846318,"about_ca_topic_score_gemma":0.00000787876,"teacher_disagreement_score":0.90894604,"about_ca_system_score_codex":0.00008898141,"about_ca_system_score_gemma":0.00029221215,"threshold_uncertainty_score":0.99955857},"labels":[],"label_agreement":null},{"id":"W4416605728","doi":"10.5256/f1000research.9367.r14596","title":"Referee report. For: Assessment of pharmacogenomic agreement [version 1; referees: 2 approved]","year":2016,"lang":"en","type":"article","venue":"Faculty of 1000 Research Ltd","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Higher Education Discipline Innovation Project; Government of Ontario; National Natural Science Foundation of China; Pershing Square Sohn Cancer Research Alliance; National Supercomputer Centre in Guangzhou; National Aeronautics and Space Administration; Cancer Research Society; National Heart, Lung, and Blood Institute; WorldQuant Foundation; Vallee Foundation; Canadian Cancer Society Research Institute; National Institutes of Health; Yale University","keywords":"Measure (data warehouse); Set (abstract data type); Selection (genetic algorithm); Context (archaeology)","score_opus":0.24427002342645424,"score_gpt":0.5282931489550033,"score_spread":0.28402312552854914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416605728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93819904,0.0011191345,0.0021534164,0.01281961,0.0012067711,0.0023438258,0.005078847,0.00006590861,0.03701346],"genre_scores_gemma":[0.9662274,0.0017024264,0.0021096114,0.00015143688,0.00032598776,0.00019267503,0.00034507664,0.000045928635,0.028899439],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952682,0.00095734914,0.0010279745,0.00065720046,0.001152121,0.00093710294],"domain_scores_gemma":[0.99528944,0.0009704643,0.00048619698,0.0006223871,0.0021872239,0.00044429032],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0072527146,0.00029795652,0.00059248606,0.00040254495,0.00028246254,0.000013039508,0.0008995565,0.00031573756,0.0026859546],"category_scores_gemma":[0.00046709095,0.00021740067,0.00029731382,0.00033645512,0.00058840256,0.00012694864,0.00046697224,0.0006371841,0.000109614],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065777166,0.0006331436,0.004012602,0.00021780349,0.0003905884,0.000026520163,0.00014603602,0.00003474768,0.8664023,0.0016247232,0.084134296,0.04171944],"study_design_scores_gemma":[0.0032748135,0.00023674186,0.001703952,0.000048166603,0.000096935975,0.000009593826,0.00008541211,0.0002852664,0.3971888,0.00056581246,0.5963313,0.00017318076],"about_ca_topic_score_codex":0.00007303521,"about_ca_topic_score_gemma":0.000017429833,"teacher_disagreement_score":0.512197,"about_ca_system_score_codex":0.00026457224,"about_ca_system_score_gemma":0.0005546056,"threshold_uncertainty_score":0.99822575},"labels":[],"label_agreement":null},{"id":"W4416619207","doi":"10.5256/f1000research.10354.r22599","title":"Referee report. For: Revisiting inconsistency in large pharmacogenomic studies [version 1; referees: 1 approved, 1 approved with reservations, 1 not approved]","year":2017,"lang":"en","type":"article","venue":"Faculty of 1000 Research Ltd","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Higher Education Discipline Innovation Project; National Natural Science Foundation of China; Government of Ontario; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society; National Supercomputer Centre in Guangzhou; National Cancer Institute; Yale University","keywords":"MEDLINE; Precision medicine; Matching (statistics); Pharmacogenomics; Set (abstract data type)","score_opus":0.3215265235399312,"score_gpt":0.5278834465567952,"score_spread":0.20635692301686398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416619207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534693,0.0031012595,0.00015305995,0.02622565,0.00058977935,0.0030125417,0.0026284761,0.00008924785,0.0107307155],"genre_scores_gemma":[0.9762173,0.0028277705,0.0030882512,0.00050291687,0.0006689878,0.0006178758,0.000832026,0.00009527619,0.015149545],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99381083,0.001237813,0.001262699,0.0011237588,0.0011021331,0.0014627337],"domain_scores_gemma":[0.9928374,0.0010682913,0.00096927665,0.0013712688,0.0033416213,0.0004121224],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.013477002,0.00048333776,0.0009936672,0.0005374392,0.0019202571,0.0001218296,0.0016918071,0.00036639263,0.00016673926],"category_scores_gemma":[0.0049145715,0.00041721447,0.00023211044,0.0004057489,0.0009227853,0.00046358097,0.0011393977,0.0018936542,0.000058242644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011711937,0.0023028275,0.09204432,0.0032058132,0.002496502,0.0006862791,0.0052648713,0.00034532516,0.68662095,0.004807774,0.14208375,0.048429657],"study_design_scores_gemma":[0.009434831,0.00025215693,0.008813709,0.00031142368,0.00020364228,0.000039248152,0.0026124201,0.0026043353,0.100452565,0.0008941482,0.87376267,0.0006188727],"about_ca_topic_score_codex":0.00041574592,"about_ca_topic_score_gemma":0.0006008315,"teacher_disagreement_score":0.7316789,"about_ca_system_score_codex":0.00030668784,"about_ca_system_score_gemma":0.00058623403,"threshold_uncertainty_score":0.999828},"labels":[],"label_agreement":null},{"id":"W4416674688","doi":"10.3390/ph18121789","title":"Protein Levels of 16 Cytochrome P450s and 2 Carboxyl Esterases Using Absolute Quantitative Proteomics: CYP2C9 and CYP3A4 Are the Most Abundant Isoforms in Human Liver and Intestine, Respectively","year":2025,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"CYP3A4; Gene isoform; Cytochrome P450; Isozyme; Microsome; In vitro; Human liver; Enzyme","score_opus":0.19957581549359965,"score_gpt":0.47821498722673283,"score_spread":0.2786391717331332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416674688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98223555,0.013221159,0.00040551866,0.00085513614,0.00015118504,0.0022091814,0.0002704372,0.000036761485,0.0006150884],"genre_scores_gemma":[0.9956687,0.0013902787,0.0012685856,0.0012581794,0.00007267906,0.00016400211,0.0000030972021,0.00003446222,0.00013998064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714303,0.00069653144,0.00075007,0.00061105844,0.00020300364,0.00059628853],"domain_scores_gemma":[0.99819195,0.000808037,0.00031901972,0.0002116644,0.00021354521,0.00025580905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015082217,0.00042525557,0.00066135416,0.00034242164,0.00042091616,0.00007460187,0.0002747216,0.00021805143,0.00007336139],"category_scores_gemma":[0.00037208715,0.00033335487,0.000060872106,0.0005050603,0.0012642164,0.00020638708,0.00047338216,0.000991153,0.000002083405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000637885,0.00031154905,0.017053232,0.0004336457,0.00030391722,0.00005824978,0.0017329537,0.000097265285,0.96562666,0.008183882,0.000044158645,0.0055166143],"study_design_scores_gemma":[0.0087832725,0.00027462654,0.14465658,0.0006757486,0.0008887364,0.00012347708,0.0016994831,0.056214273,0.76922566,0.01056413,0.0059486544,0.0009453647],"about_ca_topic_score_codex":0.00017071028,"about_ca_topic_score_gemma":0.00007463657,"teacher_disagreement_score":0.196401,"about_ca_system_score_codex":0.000089519985,"about_ca_system_score_gemma":0.00014407792,"threshold_uncertainty_score":0.99991184},"labels":[],"label_agreement":null},{"id":"W4416694888","doi":"10.1038/s41598-025-26258-9","title":"Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland","year":2025,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Medical Research Council; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Scottish Government","keywords":"Shetland; Pharmacogenomics; Genetic variation; Variation (astronomy); Pharmacogenetics; 1000 Genomes Project; Allele frequency; Allele; Precision medicine","score_opus":0.05349752720516733,"score_gpt":0.40223606292014275,"score_spread":0.34873853571497543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416694888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991365,0.0012479938,0.00003256622,0.00054219295,0.0041829213,0.00046886635,0.000007860789,0.000008813217,0.0021437854],"genre_scores_gemma":[0.99891263,0.00025928003,0.000033557146,0.00036024975,0.000051147803,0.000036125006,0.000024547868,0.000005161183,0.00031731074],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982965,0.0003666384,0.0005767604,0.00037683867,0.00015736505,0.00022590796],"domain_scores_gemma":[0.9992971,0.0001530699,0.00022139648,0.00022542632,0.000059163965,0.00004383205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039176685,0.00011739551,0.00019710914,0.00037776917,0.00012996218,0.000058477024,0.00014315624,0.00010426318,0.00010287762],"category_scores_gemma":[0.00008929973,0.00009345643,0.000035526435,0.0006004356,0.00018869927,0.00010625758,0.000058312417,0.00026683146,0.000003008089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009096505,0.00025325967,0.24724472,0.00006842807,0.000032018965,0.0000822217,0.0040166914,0.00035130102,0.7336119,0.00036398764,0.0012975537,0.01258699],"study_design_scores_gemma":[0.002265096,0.000020357065,0.6912183,0.00006076034,0.00015817102,0.00007565139,0.0002476073,0.0055822367,0.14353669,0.014536554,0.14203691,0.00026165362],"about_ca_topic_score_codex":0.000056040724,"about_ca_topic_score_gemma":0.000059030874,"teacher_disagreement_score":0.5900752,"about_ca_system_score_codex":0.000025521767,"about_ca_system_score_gemma":0.0001251821,"threshold_uncertainty_score":0.38110426},"labels":[],"label_agreement":null},{"id":"W4416705609","doi":"10.1055/s-0043-1777159","title":"Givinostat in DMD: Results of the EPIDYS Study with Particular Attention to NSAA","year":2023,"lang":"en","type":"article","venue":"Neuropediatrics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Public health; MEDLINE; Quality of Life Research; Urban park","score_opus":0.09727768270867634,"score_gpt":0.4076726689381504,"score_spread":0.31039498622947403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416705609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557185,0.000110510126,0.000008094673,0.0010701972,0.0013278851,0.00097263046,0.00008700946,0.000056304263,0.0007954929],"genre_scores_gemma":[0.9978149,0.00036258428,0.00002110176,0.00088428217,0.00022303803,0.000049120543,0.0000054129373,0.000030092877,0.00060948025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997539,0.00084565894,0.0004771447,0.00035794542,0.00033865264,0.0004416212],"domain_scores_gemma":[0.99886996,0.00032892215,0.00015635371,0.00035199258,0.000112614005,0.00018017828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012665448,0.00017743203,0.00023098494,0.00024178505,0.00011500928,0.0000129647715,0.00038372664,0.00007809406,0.000024449868],"category_scores_gemma":[0.0003450775,0.00012468528,0.0000657152,0.0022151999,0.000057048805,0.000047497866,0.00025406186,0.00047995395,0.00016909363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017286644,0.0019497514,0.8641549,0.00007417469,0.00010371091,0.00043611316,0.003154809,0.03965733,0.05726913,0.00012465236,0.018076377,0.013270435],"study_design_scores_gemma":[0.0064629894,0.0006524677,0.8333307,0.000008285264,0.00035131568,0.0000050268764,0.00029643814,0.0019832177,0.012189766,0.000039534123,0.14436162,0.0003186524],"about_ca_topic_score_codex":0.000024250901,"about_ca_topic_score_gemma":0.000037579008,"teacher_disagreement_score":0.12628523,"about_ca_system_score_codex":0.000017639757,"about_ca_system_score_gemma":0.00006830846,"threshold_uncertainty_score":0.5084518},"labels":[],"label_agreement":null},{"id":"W4416850271","doi":"10.1002/cpt.70153","title":"An Update to the Clinical Pharmacogenetics Implementation Consortium ( <scp>CPIC</scp> ) <i>SLCO1B1</i> Allele Functionality Table Leveraging Evidence from Participants of Predominantly Sub‐Saharan African Ancestry","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Allele; Table (database); 1000 Genomes Project; Perspective (graphical); MEDLINE; Precision medicine","score_opus":0.3652053681126602,"score_gpt":0.5602017774771113,"score_spread":0.19499640936445112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416850271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96260417,0.01160096,0.0029728818,0.00762343,0.011988864,0.002010049,0.0008408184,0.00014903072,0.00020979221],"genre_scores_gemma":[0.8757632,0.023120172,0.0007979453,0.097676285,0.0019591008,0.00031526643,0.00013801384,0.00007064313,0.0001593719],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98674977,0.0061934856,0.0034281581,0.0015193125,0.0005626297,0.00154662],"domain_scores_gemma":[0.9886591,0.007445184,0.0011846623,0.00095783244,0.0007861474,0.0009670733],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0076719318,0.00074162026,0.0013902516,0.00019792389,0.00072292227,0.0000829851,0.001997861,0.00074131275,0.00083428586],"category_scores_gemma":[0.00029543927,0.00064739527,0.0005364231,0.0010324545,0.001492633,0.00031004957,0.00057266315,0.002364762,0.00015875297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026695193,0.0038461937,0.35669628,0.00008676147,0.005319019,0.000043631135,0.0011570733,0.00614184,0.38030097,0.000054467273,0.15287964,0.0908046],"study_design_scores_gemma":[0.0066464455,0.0004967929,0.096918724,0.000034839344,0.0058951173,0.0000043301725,0.00051537267,0.0095930975,0.2930265,0.00051084196,0.5860011,0.00035685417],"about_ca_topic_score_codex":0.00008867036,"about_ca_topic_score_gemma":0.00008820383,"teacher_disagreement_score":0.4331214,"about_ca_system_score_codex":0.00010514629,"about_ca_system_score_gemma":0.0011831381,"threshold_uncertainty_score":0.9999368},"labels":[],"label_agreement":null},{"id":"W4417342758","doi":"10.1097/fpc.0000000000000590","title":"NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"CYP2D6; Tamoxifen; Metabolism; Affect (linguistics); Pharmacogenetics; Metabolite; Genetic variation","score_opus":0.07339022960160214,"score_gpt":0.4154692999812545,"score_spread":0.34207907037965235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417342758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98069376,0.010486024,0.00026867032,0.0010277071,0.002423732,0.0019657074,0.0011115333,0.000103198996,0.0019196934],"genre_scores_gemma":[0.97338486,0.019806264,0.0012088601,0.0032145048,0.0005212333,0.00022625507,0.000090399524,0.000075872624,0.0014717737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963577,0.0005209373,0.0011020919,0.00080068223,0.00029613235,0.0009224537],"domain_scores_gemma":[0.99766314,0.0006974599,0.0003732275,0.00040585373,0.00029891476,0.00056142313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011366655,0.00065963593,0.00096431805,0.0003680733,0.00033592078,0.000064604224,0.0006681199,0.000492673,0.00082003674],"category_scores_gemma":[0.0001434889,0.0005082482,0.0002232007,0.0005581618,0.00053994096,0.0000880932,0.00039389834,0.000909202,0.000040379302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030905139,0.0006100823,0.004560707,0.00037284172,0.0010020711,0.000044257475,0.00054206245,0.00040825686,0.95649713,0.0018631599,0.0014262294,0.029582715],"study_design_scores_gemma":[0.0047547775,0.00009970536,0.0041839364,0.000021251508,0.0009985612,0.000018578123,0.000060963048,0.006294838,0.71648407,0.000982183,0.26558575,0.00051541417],"about_ca_topic_score_codex":0.00003356448,"about_ca_topic_score_gemma":0.000028709705,"teacher_disagreement_score":0.2641595,"about_ca_system_score_codex":0.000052580188,"about_ca_system_score_gemma":0.00044879568,"threshold_uncertainty_score":0.9997369},"labels":[],"label_agreement":null},{"id":"W4417500693","doi":"10.1021/acscatal.5c06523","title":"Indigo Formation as a Predictor of Non-Native Aromatic Hydroxylation in Cytochrome P450 BM3","year":2025,"lang":"en","type":"article","venue":"ACS Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Cegep Edouard Montpetit; Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"Fonds de recherche du Québec; Hydro-Québec; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Hydroxylation; Cytochrome P450; Substrate (aquarium); Indole test; Enzyme; Mutagenesis; Reactivity (psychology); Active site","score_opus":0.037600080198854774,"score_gpt":0.4065164021075998,"score_spread":0.368916321908745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417500693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890805,0.00058422907,0.0007584271,0.00029392034,0.0002534161,0.0005445888,0.00006158699,0.00003130626,0.0083920285],"genre_scores_gemma":[0.9981374,0.00030396922,0.00010234681,0.00055841316,0.000057034358,0.00012737139,0.00021458893,0.00001252743,0.00048632972],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983637,0.00023590977,0.00064869336,0.00025127074,0.000205167,0.00029529867],"domain_scores_gemma":[0.99901545,0.0002743344,0.00028721613,0.00024173436,0.0000883544,0.00009289529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006641833,0.000197554,0.00040685202,0.0006616187,0.00010342252,0.000013628335,0.00029844232,0.00023612299,0.00017202127],"category_scores_gemma":[0.000151975,0.00019941262,0.000115160205,0.0010965011,0.00011176909,0.0002657523,0.000111666945,0.00036002247,0.00007657764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003682882,0.00094767957,0.014423392,0.00036940005,0.00096043106,0.000022965796,0.011696674,0.006091889,0.9246449,0.0009247121,0.0012831523,0.038266502],"study_design_scores_gemma":[0.004340652,0.000083597064,0.0867179,0.00008828719,0.001033243,0.0000066997204,0.0004749769,0.059599407,0.8328509,0.007999081,0.006447341,0.00035791568],"about_ca_topic_score_codex":0.00006977871,"about_ca_topic_score_gemma":0.000034519828,"teacher_disagreement_score":0.091794014,"about_ca_system_score_codex":0.00009958589,"about_ca_system_score_gemma":0.00013308239,"threshold_uncertainty_score":0.81318104},"labels":[],"label_agreement":null},{"id":"W56588887","doi":"10.1385/0-89603-519-0:147","title":"Spectrophotometric Analysis of Human CY P2El -Catalyzed pNitrophenol Hydroxylation","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Hydroxylation; Chemistry; CYP2E1; Trichloroacetic acid; Cytochrome P450; Catalysis; Microsome; Enzyme; Organic chemistry; Biochemistry; Chromatography","score_opus":0.20157877951981568,"score_gpt":0.4473165896919867,"score_spread":0.245737810172171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W56588887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.849187,0.0056243152,0.00020048916,0.000004766777,0.000436173,0.0004403,0.000078485806,0.00007768815,0.14395076],"genre_scores_gemma":[0.99670255,0.00042344752,0.00014937828,0.0001666838,0.00012889938,0.000065657456,0.000059781658,0.000039177226,0.0022644494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99741685,0.00058963953,0.0006830368,0.00046117944,0.00032674448,0.000522517],"domain_scores_gemma":[0.99854326,0.00016556864,0.00039517746,0.00048682504,0.00015876122,0.0002504305],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007304028,0.00031391846,0.0006540425,0.0011919398,0.00031088802,0.000028732353,0.000412096,0.000240246,0.0013800029],"category_scores_gemma":[0.00005916458,0.0003225227,0.00036338868,0.0005486453,0.00022133044,0.000059096637,0.00008527528,0.0004909164,0.00002152767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019282388,0.0007258215,0.0013301697,0.00010299788,0.0065449914,0.000047014706,0.0018662349,0.0032715858,0.8805667,0.08721662,0.000593223,0.017541783],"study_design_scores_gemma":[0.0030723726,0.00008710045,0.003995631,0.0000059276335,0.007655555,0.0000044981416,0.000042584,0.0040480876,0.85223424,0.0022810812,0.12598187,0.0005910469],"about_ca_topic_score_codex":0.00014126417,"about_ca_topic_score_gemma":0.000018965806,"teacher_disagreement_score":0.1475155,"about_ca_system_score_codex":0.00004988207,"about_ca_system_score_gemma":0.000042836054,"threshold_uncertainty_score":0.9999227},"labels":[],"label_agreement":null},{"id":"W571182331","doi":"10.71781/31269","title":"Étude pharmacogénomique de la warfarine et de l'activité physique","year":2014,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Philosophy","score_opus":0.017101765336010075,"score_gpt":0.29696530216026557,"score_spread":0.27986353682425547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W571182331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8907572,0.023303775,0.0013193303,0.0011527697,0.003281958,0.0006916651,0.0002214049,0.00018470998,0.07908717],"genre_scores_gemma":[0.94888854,0.014679788,0.0010263239,0.0038710802,0.0011522977,0.00013582711,0.00048390674,0.00012584917,0.029636366],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99292004,0.0035624132,0.0006999877,0.0010192032,0.0005004976,0.0012978354],"domain_scores_gemma":[0.99601215,0.0011908966,0.00074414705,0.00044094704,0.00035319448,0.0012586406],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0019668173,0.001017943,0.00090369146,0.000428143,0.005614596,0.00010561952,0.0009578145,0.0017687714,0.00044316906],"category_scores_gemma":[0.00015213987,0.0012740492,0.0007007391,0.0003936702,0.0007524344,0.0003618912,0.0003599899,0.003123108,0.00017494298],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036475798,0.0018570776,0.03199284,0.0006161044,0.0023828386,0.0038514559,0.039757848,0.046004273,0.79677266,0.044701535,0.003611134,0.024804663],"study_design_scores_gemma":[0.0043875664,0.00010608681,0.07040139,0.00013874058,0.0021239792,0.0014082055,0.002628335,0.014575974,0.40957233,0.0009289172,0.49257126,0.0011572127],"about_ca_topic_score_codex":0.021439664,"about_ca_topic_score_gemma":0.004198282,"teacher_disagreement_score":0.48896012,"about_ca_system_score_codex":0.005834738,"about_ca_system_score_gemma":0.0053330427,"threshold_uncertainty_score":0.99952716},"labels":[],"label_agreement":null},{"id":"W574556610","doi":"10.2174/1872312809666150602151213","title":"Ontogeny of Human Conjugating Enzymes","year":2015,"lang":"en","type":"review","venue":"Drug Metabolism Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Glucuronidation; Ontogeny; Enzyme; Sulfation; Biology; Fetus; Xenobiotic; Biochemistry; Pharmacology; Pregnancy; Genetics; Microsome","score_opus":0.22655051534464452,"score_gpt":0.4933616011427294,"score_spread":0.2668110857980849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W574556610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013151531,0.9856672,0.000011423832,0.00016091358,0.006422799,0.0013074776,0.0007336244,0.00014531141,0.0042360504],"genre_scores_gemma":[0.00030647314,0.9924167,0.00031681452,0.002399117,0.0029233566,0.00023718129,0.00034715992,0.000222168,0.00083106966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925543,0.0025135332,0.0021762324,0.0009552974,0.0006833498,0.0011172986],"domain_scores_gemma":[0.99575436,0.0005263665,0.0017803028,0.00083228206,0.0003850826,0.0007216074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030811133,0.0012143825,0.0045330157,0.0006805897,0.00029523886,0.00004935849,0.0015486119,0.0007620594,0.0008979564],"category_scores_gemma":[0.00019731601,0.0010848941,0.001335667,0.00071563537,0.00055863865,0.00015391309,0.00045670022,0.0022461016,0.00033182502],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023133809,0.00025755516,0.000011964436,0.00550313,0.0015226452,0.00006455002,0.0010249806,0.000027371396,0.00350081,0.0026477834,0.063271455,0.9221446],"study_design_scores_gemma":[0.0013318326,0.000011556037,0.0000052149776,0.00066017295,0.006234528,0.000025272071,0.000046331897,0.000010559144,0.0027627167,0.00012945956,0.98780614,0.00097621104],"about_ca_topic_score_codex":0.00007493872,"about_ca_topic_score_gemma":0.000005905496,"teacher_disagreement_score":0.9245347,"about_ca_system_score_codex":0.000103691076,"about_ca_system_score_gemma":0.00044176943,"threshold_uncertainty_score":0.9991601},"labels":[],"label_agreement":null},{"id":"W611003191","doi":"10.1017/cbo9780511543944.005","title":"Statistical approaches in psychopharmacogenetics","year":2002,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Trait; Single-nucleotide polymorphism; Genetic architecture; Pharmacogenetics; Computational biology; Genetic association; Biology; Genetics; Quantitative trait locus; Computer science; Gene; Genotype","score_opus":0.2035239594911129,"score_gpt":0.3487263016566087,"score_spread":0.14520234216549577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W611003191","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010184065,0.0022310214,0.00021001314,0.00005353332,0.0012854378,0.000800658,0.0017232237,0.000118532465,0.9925592],"genre_scores_gemma":[0.009861132,0.0041480903,0.00030876795,0.00051219214,0.00046755638,0.000005480045,0.00013614756,0.00012103723,0.9844396],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972106,0.00028925805,0.00050772674,0.0009015692,0.00034448365,0.00074635237],"domain_scores_gemma":[0.99828,0.00025911815,0.0002805737,0.00047362215,0.000100049496,0.00060662127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033731575,0.00072255835,0.0007540512,0.00040965757,0.00019816576,0.00003176369,0.00081527745,0.0011052162,0.00036266982],"category_scores_gemma":[0.000013203242,0.0008936197,0.00024845928,0.000026918382,0.0005680854,0.00005258204,0.00039239012,0.002257911,0.00016191299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058460794,0.00020733704,0.000052644617,0.00019012255,0.00053084246,0.0017693227,0.00014587291,0.00019811411,0.0006722463,0.85339063,0.10834041,0.033917844],"study_design_scores_gemma":[0.00301932,0.00004758093,0.000052587613,0.00003915234,0.00070423895,0.000030784522,0.000014007401,0.0024299899,0.0014747771,0.000055120418,0.9912722,0.00086025347],"about_ca_topic_score_codex":0.000025032019,"about_ca_topic_score_gemma":0.0000016587483,"teacher_disagreement_score":0.88293177,"about_ca_system_score_codex":0.00019776974,"about_ca_system_score_gemma":0.00011309184,"threshold_uncertainty_score":0.99935144},"labels":[],"label_agreement":null},{"id":"W611917486","doi":"10.71781/4546","title":"Étude pharmacogénomique sur l’utilisation de la warfarine en pratique clinique réelle","year":2010,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.08924771524499857,"score_gpt":0.4716146445027049,"score_spread":0.3823669292577063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W611917486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91908354,0.0022219687,0.00028546865,0.002415809,0.00736678,0.003312229,0.0006618922,0.000018536071,0.06463378],"genre_scores_gemma":[0.9333824,0.016481325,0.008319412,0.0031561214,0.0028871794,0.00079544133,0.0028644751,0.00028352233,0.03183013],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98925066,0.006004293,0.0016522293,0.0014583236,0.0003543943,0.0012800858],"domain_scores_gemma":[0.99363893,0.0029891084,0.0011755369,0.000625291,0.0005369379,0.0010342178],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.007914906,0.0011878529,0.0012806795,0.00035976546,0.0007443029,0.00064069126,0.002817847,0.004181669,0.04752458],"category_scores_gemma":[0.00074515404,0.0013427477,0.0004375655,0.00045590647,0.00047789764,0.0007426317,0.0008351502,0.0072833644,0.0014107153],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019866007,0.002502508,0.008326094,0.0003158557,0.001083066,0.00030108102,0.015376669,0.002010552,0.62263507,0.000806404,0.0036743875,0.3409817],"study_design_scores_gemma":[0.0033679688,0.00008411246,0.006769166,0.00007069321,0.0011760963,0.00007389688,0.00026694415,0.010028593,0.45821714,0.0006623845,0.5184502,0.0008328306],"about_ca_topic_score_codex":0.0011936156,"about_ca_topic_score_gemma":0.0022310985,"teacher_disagreement_score":0.5147758,"about_ca_system_score_codex":0.0002864719,"about_ca_system_score_gemma":0.0037004722,"threshold_uncertainty_score":0.9993668},"labels":[],"label_agreement":null},{"id":"W648966041","doi":"10.71781/4597","title":"Characterizing the Expression of Cytochrome P450s in Breast Cancer Cells","year":2011,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Université de Montréal","keywords":"Cytochrome; Breast cancer; Cancer research; Cancer; Biology; Internal medicine; Medicine; Biochemistry","score_opus":0.1315405015179271,"score_gpt":0.45612494128732184,"score_spread":0.3245844397693948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W648966041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96394,0.0017062475,3.5415056e-7,0.000112557245,0.0023423252,0.0009449753,0.0007960578,0.0000016156343,0.03015582],"genre_scores_gemma":[0.9860481,0.0036458995,0.000121109835,0.0003380344,0.0003554482,0.00023287415,0.00030376395,0.000057182016,0.008897569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980804,0.00037235479,0.0005792537,0.00042119008,0.00016985027,0.0003770062],"domain_scores_gemma":[0.9988038,0.000106379746,0.00056221586,0.00028985052,0.00010958364,0.00012818335],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069874845,0.00032430238,0.00052565435,0.0001403136,0.00013226156,0.000038137132,0.0011408268,0.00052753906,0.02285908],"category_scores_gemma":[0.000007164505,0.00024626154,0.00011160985,0.00019753832,0.00008050035,0.00012990572,0.0001930396,0.0010069257,0.00018896746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070420204,0.00023554695,0.00040610175,0.00005615852,0.00006955634,0.000015513084,0.0046224133,0.000016011332,0.9069179,0.0000053612416,0.00044226117,0.086508945],"study_design_scores_gemma":[0.00094946247,0.000012578645,0.015361433,0.00017916517,0.00021617324,0.000004362981,0.00038308173,0.000039263065,0.8871658,0.00003270025,0.0953842,0.00027179168],"about_ca_topic_score_codex":0.00021150637,"about_ca_topic_score_gemma":0.00018273052,"teacher_disagreement_score":0.094941944,"about_ca_system_score_codex":0.00003123623,"about_ca_system_score_gemma":0.00028202822,"threshold_uncertainty_score":0.999999},"labels":[],"label_agreement":null},{"id":"W650154501","doi":"10.71781/31425","title":"Études in vitro et in vivo évaluant le rôle du métabolisme des médicaments par les CYP450s comme facteurs de variabilité interindividuelle dans la réponse aux médicaments","year":2008,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Medicine; Pharmacology","score_opus":0.17144212613222945,"score_gpt":0.45604347448578786,"score_spread":0.28460134835355844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W650154501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96931314,0.0012000451,0.00001751113,0.00030145023,0.0008246243,0.0013606843,0.0008112362,0.000010789645,0.026160512],"genre_scores_gemma":[0.99024457,0.004201592,0.0015861666,0.00056675595,0.00009630323,0.0004134615,0.0006856023,0.000112768976,0.0020927817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937005,0.0029989977,0.0010732444,0.0009140636,0.00036304604,0.0009501278],"domain_scores_gemma":[0.99795926,0.00067403866,0.00044708213,0.00038579904,0.00011133677,0.00042248],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029193966,0.00072090543,0.0010302254,0.00045242478,0.00043823782,0.00016105328,0.0016245784,0.00096980756,0.0020412416],"category_scores_gemma":[0.00024381156,0.00077562616,0.00020156149,0.00039925822,0.00044566143,0.00028550875,0.0005253821,0.0018630748,0.00007249549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054538986,0.0070526577,0.11025915,0.00020506264,0.0007630964,0.0009866453,0.044266324,0.0014051014,0.7229354,0.00041484844,0.0018385273,0.10441928],"study_design_scores_gemma":[0.011388464,0.00013769731,0.10938541,0.0003224201,0.00051872764,0.00011919234,0.0102667445,0.0019647947,0.4863543,0.0010074622,0.37693703,0.001597755],"about_ca_topic_score_codex":0.0019409184,"about_ca_topic_score_gemma":0.0019048481,"teacher_disagreement_score":0.37509853,"about_ca_system_score_codex":0.00024574925,"about_ca_system_score_gemma":0.0014665739,"threshold_uncertainty_score":0.99946946},"labels":[],"label_agreement":null},{"id":"W6889128256","doi":"10.25384/sage.17032680.v1","title":"sj-pdf-1-cpa-10.1177_07067437211058847 - Supplemental material for Encountering Pharmacogenetic Test Results in the Psychiatric Clinic","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Test (biology); Psychiatric diagnosis; Schizophrenia (object-oriented programming); Affect (linguistics)","score_opus":0.14667932358405203,"score_gpt":0.45087167488473284,"score_spread":0.3041923513006808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6889128256","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053664,0.0029244784,0.0000020352086,0.0024173374,0.0031619794,0.0018570112,0.9157817,0.00009792825,0.020093566],"genre_scores_gemma":[0.6095787,0.0006689271,0.0005518503,0.012235686,0.004752704,0.0025876665,0.36211732,0.00013782462,0.007369326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669737,0.00045676072,0.00093281246,0.0007118312,0.00030090558,0.0009003322],"domain_scores_gemma":[0.9974932,0.0013877703,0.0002806761,0.0004086944,0.00020428948,0.00022533322],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007641491,0.0004213884,0.00040047118,0.00015817989,0.00036565194,0.00013371526,0.0008330388,0.00030613414,0.5847739],"category_scores_gemma":[0.0006995908,0.00037725831,0.00027756716,0.0005529468,0.000034499404,0.00012858045,0.00026078447,0.00066184223,0.0044766366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000492068,0.0006186187,0.00023914543,0.00018179721,0.000083557345,0.00014072472,0.00040626066,0.00008177515,0.031667583,0.0000043880755,0.9610426,0.005041522],"study_design_scores_gemma":[0.0063177072,0.00013554329,0.0011721858,0.000065807966,0.00016667393,0.000070426075,0.0001808207,0.0009453373,0.0767003,0.0000852995,0.91374046,0.00041945616],"about_ca_topic_score_codex":0.00000383462,"about_ca_topic_score_gemma":0.000030503028,"teacher_disagreement_score":0.58029723,"about_ca_system_score_codex":0.0000677419,"about_ca_system_score_gemma":0.0003450425,"threshold_uncertainty_score":0.9998679},"labels":[],"label_agreement":null},{"id":"W6889143631","doi":"10.25402/pgs.25442359","title":"Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada","year":2024,"lang":"en","type":"other","venue":"Future Science Group","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Perception; Qualitative research; Pharmacy practice","score_opus":0.043550220072360965,"score_gpt":0.3820029152545616,"score_spread":0.3384526951822006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6889143631","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40027678,0.07589974,0.000012831325,0.0002815353,0.030088073,0.0015251593,0.0018567779,0.00017915216,0.48987994],"genre_scores_gemma":[0.8452527,0.021931587,0.0003561323,0.0010583625,0.0059942272,0.00014525987,0.000079102625,0.00059373135,0.12458892],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974272,0.00018349521,0.00048280973,0.0008257528,0.0003665769,0.0007141263],"domain_scores_gemma":[0.99888676,0.00005476182,0.00021997414,0.00027748005,0.00007237319,0.00048865855],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092856894,0.0004736549,0.0005446892,0.00083505496,0.00013555777,0.00003949453,0.0007964609,0.00038000583,0.0025514294],"category_scores_gemma":[0.000016626293,0.00045536394,0.000090023066,0.00105155,0.0011809686,0.00009282778,0.00035875407,0.0012500368,0.00009999309],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005799723,0.00033795866,0.009847711,0.0008164062,0.00021029888,0.00021921954,0.0019331492,0.000019239224,0.0682011,0.0011943098,0.87032676,0.046835825],"study_design_scores_gemma":[0.0009839374,0.000018815117,0.0037411794,0.000082847546,0.0002717435,0.000035258417,0.0004480674,0.0007578446,0.002197103,0.00013370639,0.9908022,0.0005272936],"about_ca_topic_score_codex":0.020850336,"about_ca_topic_score_gemma":0.2356738,"teacher_disagreement_score":0.4449759,"about_ca_system_score_codex":0.00023449388,"about_ca_system_score_gemma":0.0008687668,"threshold_uncertainty_score":0.99978983},"labels":[],"label_agreement":null},{"id":"W6901480414","doi":"10.60692/8c7kc-66w24","title":"Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Genotyping; CYP2D6; Allele; Context (archaeology); Pharmacogenetics; Allele frequency; Genotype; Gene","score_opus":0.11508791568029686,"score_gpt":0.33519760910665297,"score_spread":0.2201096934263561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901480414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917488,0.000031609517,0.0024174901,0.000102812286,0.0019198237,0.00084225717,0.0012501178,0.00009150855,0.0015955693],"genre_scores_gemma":[0.9986613,0.000005186323,0.00006422419,0.0004591169,0.00010674356,0.0003633161,0.00027394568,0.000018333612,0.000047833455],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973987,0.00064363726,0.0010579622,0.00019828044,0.00036855286,0.0003328785],"domain_scores_gemma":[0.9988279,0.000015907328,0.0006564734,0.00022007519,0.00014985021,0.00012980914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001014808,0.00021106446,0.00031453327,0.0006904658,0.00029743672,0.00002940318,0.00028029009,0.000093080016,0.000515022],"category_scores_gemma":[0.000014206423,0.00023041446,0.00009535777,0.0007861712,0.000037607228,0.00035010304,0.00013249063,0.00036598495,0.00012541079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018567339,0.0002217314,0.33153027,0.00088990247,0.00039244466,0.00002750282,0.23232375,0.07509548,0.34231558,0.0017429013,0.00040736215,0.013196307],"study_design_scores_gemma":[0.008463012,0.00012743197,0.73578084,0.000041443207,0.00038995701,0.000081547885,0.0037526414,0.11169206,0.10493633,0.000022290826,0.033852316,0.00086014165],"about_ca_topic_score_codex":0.0000141809,"about_ca_topic_score_gemma":4.893167e-7,"teacher_disagreement_score":0.40425053,"about_ca_system_score_codex":0.00018505646,"about_ca_system_score_gemma":0.00008727821,"threshold_uncertainty_score":0.9396029},"labels":[],"label_agreement":null},{"id":"W6901879103","doi":"10.6084/m9.figshare.18864868.v1","title":"Additional file 1 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; In vivo; In vitro; Detoxification (alternative medicine); Drug; Inhibitory postsynaptic potential; Transplantation; Cell","score_opus":0.05827887287607926,"score_gpt":0.3335455240895678,"score_spread":0.27526665121348853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901879103","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4765036,0.00008486661,8.88974e-7,0.000043971962,0.000020965745,0.0003828923,0.52289236,0.0000048164693,0.00006561667],"genre_scores_gemma":[0.70332384,0.000020470858,0.000031374795,0.00007270343,0.000026191643,0.00096179015,0.2955499,0.000009261245,0.000004487078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783075,0.00087903225,0.000635761,0.00022139403,0.00026118502,0.00017188958],"domain_scores_gemma":[0.998369,0.0010117346,0.0003483682,0.00014900777,0.00007312329,0.000048763704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037462192,0.00012330458,0.00019678341,0.00032715814,0.00005468112,0.000004280764,0.00029768405,0.00010737801,0.3107665],"category_scores_gemma":[0.000058117286,0.00013047249,0.000061936895,0.00071942894,0.000022087694,0.00010897609,0.000023314147,0.00040527794,0.000011614126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010486926,0.005180525,0.0094525805,0.004587276,0.000049837752,0.00004542371,0.07474321,0.08390252,0.45676956,0.00017657534,0.35091853,0.01312525],"study_design_scores_gemma":[0.00809597,0.00041468893,0.42647824,0.0004143583,0.00025891513,0.000035332618,0.0052822935,0.03909163,0.49462223,0.00088217994,0.023606135,0.0008180188],"about_ca_topic_score_codex":0.0000138233845,"about_ca_topic_score_gemma":0.00002375841,"teacher_disagreement_score":0.41702566,"about_ca_system_score_codex":0.000035984747,"about_ca_system_score_gemma":0.00021255278,"threshold_uncertainty_score":0.68986356},"labels":[],"label_agreement":null},{"id":"W6902018336","doi":"10.6084/m9.figshare.18864892.v1","title":"Additional file 8 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Identification (biology); Transplantation; Virtual screening; Cofactor; Stevia rebaudiana; Detoxification (alternative medicine)","score_opus":0.057475225775953966,"score_gpt":0.33328348761627896,"score_spread":0.275808261840325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902018336","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4782998,0.00008561514,8.9817297e-7,0.000044058786,0.000021010115,0.00038370877,0.5210939,0.0000048001366,0.000066188295],"genre_scores_gemma":[0.70570296,0.000020570638,0.000031213855,0.000072974915,0.000026291842,0.0009506797,0.29318154,0.000009277158,0.000004507697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978305,0.0008788846,0.0006361441,0.00022135557,0.00026118668,0.00017190937],"domain_scores_gemma":[0.99837536,0.0010055025,0.00034845062,0.00014887503,0.00007302896,0.000048767295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037487343,0.00012331133,0.0001968617,0.000327127,0.00005469921,0.0000042891224,0.0002976179,0.00010737868,0.30393305],"category_scores_gemma":[0.000057658883,0.00013047282,0.00006194098,0.00071900757,0.000022093047,0.00010904954,0.000023305976,0.00040525885,0.0000115384755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010677385,0.0052720434,0.009568348,0.004702626,0.00005069384,0.0000467856,0.07616366,0.08542478,0.46007228,0.00018305518,0.34377974,0.013668244],"study_design_scores_gemma":[0.008097603,0.0004131574,0.42269424,0.00041198224,0.0002569335,0.00003512475,0.00524003,0.038989294,0.49918076,0.0008849651,0.022983063,0.00081284164],"about_ca_topic_score_codex":0.000013932224,"about_ca_topic_score_gemma":0.000024012399,"teacher_disagreement_score":0.4131259,"about_ca_system_score_codex":0.000035996945,"about_ca_system_score_gemma":0.00021228114,"threshold_uncertainty_score":0.69670326},"labels":[],"label_agreement":null},{"id":"W6902045106","doi":"10.6084/m9.figshare.18864877","title":"Additional file 4 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; AutoDock; Docking (animal); Detoxification (alternative medicine); Transplantation; Ligand (biochemistry); Hematopoietic stem cell transplantation","score_opus":0.05780838960482853,"score_gpt":0.33353113093136527,"score_spread":0.27572274132653674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902045106","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47750482,0.00008558786,8.987127e-7,0.000043821918,0.000021008664,0.00038377038,0.5218894,0.0000048246507,0.00006589175],"genre_scores_gemma":[0.7049986,0.000020735462,0.000031173702,0.00007285602,0.000026267937,0.0009497431,0.2938869,0.000009276161,0.0000044406725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978311,0.0008782955,0.0006361597,0.000221338,0.00026121506,0.00017189556],"domain_scores_gemma":[0.998375,0.0010063101,0.00034845504,0.0001488955,0.000072560055,0.000048762307],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037472355,0.00012329781,0.00019683491,0.00032719155,0.00005469855,0.0000042893225,0.00029770884,0.000107377986,0.30388752],"category_scores_gemma":[0.000057475412,0.00013046598,0.00006193756,0.00071915175,0.00002209198,0.0001090532,0.000023308006,0.00040520425,0.000011526578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010821697,0.0052788947,0.009658623,0.0047070114,0.000050751143,0.000046841607,0.07622295,0.08459623,0.46096325,0.00018408362,0.34369144,0.013517752],"study_design_scores_gemma":[0.008160006,0.0004198349,0.4262318,0.00041458054,0.00025869728,0.000035370824,0.005277049,0.039257105,0.4950326,0.00089140615,0.023203047,0.0008184964],"about_ca_topic_score_codex":0.000013848502,"about_ca_topic_score_gemma":0.000023958843,"teacher_disagreement_score":0.4165732,"about_ca_system_score_codex":0.00003598742,"about_ca_system_score_gemma":0.00021202647,"threshold_uncertainty_score":0.69674885},"labels":[],"label_agreement":null},{"id":"W6902045470","doi":"10.6084/m9.figshare.16900743.v1","title":"Additional file 2 of Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Degree (music); Airflow; Statistical analysis; Post hoc","score_opus":0.26837214078498695,"score_gpt":0.4103348117906738,"score_spread":0.14196267100568688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902045470","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23333973,0.00022609728,0.0000014390583,0.00011025334,0.00009210215,0.00037916217,0.76542777,0.000003861987,0.00041960733],"genre_scores_gemma":[0.80237067,0.000014393409,0.00023626376,0.00024293129,0.00009823827,0.00010384413,0.19675167,0.000011293977,0.0001706945],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794644,0.0005780459,0.00072407816,0.00023911912,0.0003381872,0.00017413731],"domain_scores_gemma":[0.9930857,0.0047341343,0.00085865526,0.0003986723,0.0008456467,0.00007718489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002963573,0.00014547246,0.00055423466,0.00015319187,0.000085929525,0.000003190899,0.00046214965,0.00015194279,0.7076637],"category_scores_gemma":[0.0051756096,0.00010820898,0.0006114554,0.0010532263,0.00006286517,0.00004227771,0.00036622092,0.00022532081,0.000021820915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006509292,0.0005700875,0.00039301158,0.00024502547,0.0017169797,0.0000024914061,0.000746415,0.0030408774,0.028929075,0.000006592636,0.9519267,0.005913426],"study_design_scores_gemma":[0.017399324,0.00057404203,0.10924617,0.0012348152,0.0040451847,0.0000072434073,0.00079825235,0.0072587496,0.48292288,0.000026854526,0.3761037,0.00038280062],"about_ca_topic_score_codex":0.0000066829098,"about_ca_topic_score_gemma":0.000048208727,"teacher_disagreement_score":0.7076419,"about_ca_system_score_codex":0.000020740592,"about_ca_system_score_gemma":0.0002065405,"threshold_uncertainty_score":0.6196062},"labels":[],"label_agreement":null},{"id":"W6902045540","doi":"10.6084/m9.figshare.18864883","title":"Additional file 6 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Docking (animal); Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis","score_opus":0.0574577716503202,"score_gpt":0.3332532209878559,"score_spread":0.27579544933753575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902045540","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4778209,0.000085800406,8.9911543e-7,0.000044078068,0.00002103256,0.00038451125,0.52157146,0.0000048294664,0.000066520864],"genre_scores_gemma":[0.7057452,0.000020734138,0.000031199765,0.00007297222,0.000026300719,0.00095162616,0.29313815,0.000009287752,0.0000044932576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783045,0.00087889866,0.0006361555,0.00022136324,0.00026122818,0.00017190604],"domain_scores_gemma":[0.9983754,0.0010054499,0.00034845,0.00014887686,0.000073028306,0.00004876831],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037487995,0.00012330836,0.0001968594,0.00032717633,0.000054693206,0.000004289468,0.00029764225,0.00010737784,0.30248058],"category_scores_gemma":[0.000057656333,0.0001304724,0.00006194047,0.00071936235,0.000022093094,0.00010906044,0.000023309738,0.000405265,0.000011486004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010710931,0.005288074,0.009595405,0.004698997,0.000050654835,0.000046733265,0.07621678,0.08431405,0.462106,0.00018503392,0.34292728,0.013499922],"study_design_scores_gemma":[0.008136085,0.00041429792,0.4279472,0.00041344482,0.00025802426,0.000035250177,0.0052702376,0.038749073,0.49382296,0.0008887768,0.023248367,0.0008162932],"about_ca_topic_score_codex":0.000014057144,"about_ca_topic_score_gemma":0.000024348261,"teacher_disagreement_score":0.41835177,"about_ca_system_score_codex":0.000035957797,"about_ca_system_score_gemma":0.00021223842,"threshold_uncertainty_score":0.6981571},"labels":[],"label_agreement":null},{"id":"W6902060760","doi":"10.6084/m9.figshare.18864862","title":"Additional file 10 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Workflow; Docking (animal); Hematopoietic stem cell transplantation; Transplantation","score_opus":0.058926112205234624,"score_gpt":0.3351414189359377,"score_spread":0.27621530673070305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902060760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55196357,0.000105280255,9.926089e-7,0.000050752777,0.000022875043,0.00041636138,0.44735086,0.000005356212,0.000083965984],"genre_scores_gemma":[0.76224226,0.000023034694,0.000029257286,0.000071079245,0.000029424185,0.00085623073,0.23672988,0.00001032016,0.0000085203565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977824,0.00089518423,0.00065099046,0.0002278979,0.0002679167,0.0001755992],"domain_scores_gemma":[0.9985243,0.00083947135,0.00035056414,0.00015368847,0.00008154412,0.000050417708],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041828444,0.00012721587,0.00020182996,0.00033230768,0.00005624535,0.0000045455618,0.00030431905,0.00011198161,0.26948538],"category_scores_gemma":[0.00005407829,0.00013469555,0.00006366278,0.00071992946,0.00002283413,0.00011211919,0.000023946657,0.00038932226,0.000014837133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014501535,0.0058437684,0.009356708,0.005161831,0.000057049656,0.0000486299,0.076791845,0.08626004,0.52710074,0.00021731315,0.2734801,0.014231857],"study_design_scores_gemma":[0.0089754565,0.00045954587,0.3513688,0.00036000626,0.00028217406,0.000032754986,0.0046910658,0.040398583,0.56946653,0.0009674177,0.02217228,0.0008253302],"about_ca_topic_score_codex":0.000013653692,"about_ca_topic_score_gemma":0.00002383668,"teacher_disagreement_score":0.3420121,"about_ca_system_score_codex":0.000036803838,"about_ca_system_score_gemma":0.00021207014,"threshold_uncertainty_score":0.7311824},"labels":[],"label_agreement":null},{"id":"W6902069077","doi":"10.6084/m9.figshare.18864895","title":"Additional file 9 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Transplantation; Haematopoiesis; Cytotoxicity; Cell","score_opus":0.05748542301556154,"score_gpt":0.33329291555187474,"score_spread":0.2758074925363132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902069077","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4780996,0.00008564268,8.991975e-7,0.000044078464,0.00002101962,0.00038378715,0.52129424,0.000004826967,0.000065933644],"genre_scores_gemma":[0.7056759,0.000020761432,0.000031183503,0.00007297569,0.000026295911,0.000945528,0.29321358,0.00000928264,0.0000044825892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783057,0.00087885815,0.00063614105,0.00022133607,0.0002612128,0.0001718979],"domain_scores_gemma":[0.9983756,0.0010053829,0.00034841715,0.00014884154,0.000073025614,0.000048762344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037481473,0.0001233001,0.00019683782,0.00032718567,0.000054701526,0.0000042884685,0.00029745421,0.00010736521,0.3032028],"category_scores_gemma":[0.000057656638,0.00013046106,0.00006193984,0.0007193064,0.000022092661,0.00010906036,0.00002330114,0.0004051481,0.000011501761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010648756,0.005258164,0.009599333,0.004689742,0.00005055098,0.000046653317,0.07595853,0.08518619,0.46147987,0.00018063879,0.3431153,0.013370147],"study_design_scores_gemma":[0.008113897,0.00041351997,0.42606264,0.00041292564,0.0002575067,0.000035204408,0.0052531133,0.03908007,0.49560577,0.00088715093,0.023063587,0.00081460975],"about_ca_topic_score_codex":0.000013728823,"about_ca_topic_score_gemma":0.000023984128,"teacher_disagreement_score":0.41646332,"about_ca_system_score_codex":0.000035991285,"about_ca_system_score_gemma":0.00021218882,"threshold_uncertainty_score":0.6974342},"labels":[],"label_agreement":null},{"id":"W6902078429","doi":"10.6084/m9.figshare.18864883.v1","title":"Additional file 6 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Docking (animal); Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis","score_opus":0.0574577716503202,"score_gpt":0.3332532209878559,"score_spread":0.27579544933753575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902078429","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4778209,0.000085800406,8.9911543e-7,0.000044078068,0.00002103256,0.00038451125,0.52157146,0.0000048294664,0.000066520864],"genre_scores_gemma":[0.7057452,0.000020734138,0.000031199765,0.00007297222,0.000026300719,0.00095162616,0.29313815,0.000009287752,0.0000044932576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783045,0.00087889866,0.0006361555,0.00022136324,0.00026122818,0.00017190604],"domain_scores_gemma":[0.9983754,0.0010054499,0.00034845,0.00014887686,0.000073028306,0.00004876831],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037487995,0.00012330836,0.0001968594,0.00032717633,0.000054693206,0.000004289468,0.00029764225,0.00010737784,0.30248058],"category_scores_gemma":[0.000057656333,0.0001304724,0.00006194047,0.00071936235,0.000022093094,0.00010906044,0.000023309738,0.000405265,0.000011486004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010710931,0.005288074,0.009595405,0.004698997,0.000050654835,0.000046733265,0.07621678,0.08431405,0.462106,0.00018503392,0.34292728,0.013499922],"study_design_scores_gemma":[0.008136085,0.00041429792,0.4279472,0.00041344482,0.00025802426,0.000035250177,0.0052702376,0.038749073,0.49382296,0.0008887768,0.023248367,0.0008162932],"about_ca_topic_score_codex":0.000014057144,"about_ca_topic_score_gemma":0.000024348261,"teacher_disagreement_score":0.41835177,"about_ca_system_score_codex":0.000035957797,"about_ca_system_score_gemma":0.00021223842,"threshold_uncertainty_score":0.6981571},"labels":[],"label_agreement":null},{"id":"W6907820508","doi":"10.25384/sage.11865390","title":"Supplemental Material, Table_S1_FINAL - Pharmacogenetic Testing Options Relevant to Psychiatry in Canada","year":2020,"lang":"en","type":"article","venue":"Sage Journals Data","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; MEDLINE; Alternative medicine; Genetic testing; Mental illness","score_opus":0.21256082625237918,"score_gpt":0.4366587941689166,"score_spread":0.22409796791653744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6907820508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90033287,0.022281595,0.0003176886,0.03710309,0.0057356325,0.0010222653,0.032473747,0.00006313726,0.00066997076],"genre_scores_gemma":[0.9465381,0.008170863,0.00882846,0.033524346,0.0021812671,0.000049182498,0.00058586826,0.00007376546,0.000048166894],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673784,0.00048402636,0.00090264936,0.0006254788,0.00038631755,0.0008636769],"domain_scores_gemma":[0.9980898,0.00015164306,0.00022541218,0.00042804086,0.00007160056,0.0010335362],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010118464,0.00032886543,0.00041213888,0.0001349933,0.000279622,0.000084825224,0.0014541132,0.00009567345,0.023299344],"category_scores_gemma":[0.00018738442,0.00034209804,0.000044200944,0.0007303555,0.00003958938,0.00024054068,0.0008849562,0.0009751167,0.00012542677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003936643,0.0003143694,0.060850322,0.000097537326,0.00024690825,0.000564645,0.0003050263,0.0073271557,0.60594416,0.000010706674,0.18312012,0.14082539],"study_design_scores_gemma":[0.0053750556,0.00016187185,0.025330476,0.00025561647,0.0005452358,0.00025729876,0.00069590204,0.03502695,0.045017306,0.00020965989,0.88596845,0.0011562024],"about_ca_topic_score_codex":0.052027833,"about_ca_topic_score_gemma":0.12368858,"teacher_disagreement_score":0.7028483,"about_ca_system_score_codex":0.000174992,"about_ca_system_score_gemma":0.0020143017,"threshold_uncertainty_score":0.9999031},"labels":[],"label_agreement":null},{"id":"W6912556675","doi":"10.5281/zenodo.5787002","title":"GDSC2","year":2021,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Metadata; Software; Certification; Research data; Zhàng; Pharmacogenomics","score_opus":0.1550131002636586,"score_gpt":0.39878633716837814,"score_spread":0.24377323690471953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6912556675","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19595271,0.0024362463,0.0018376252,0.0038204305,0.0014907821,0.0004615896,0.0006298259,0.001198006,0.7921728],"genre_scores_gemma":[0.9870016,0.001194534,0.00037025427,0.0029078922,0.00063399813,6.9453804e-8,0.0014351271,0.0011667203,0.0052897874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798334,0.0007597818,0.00023200737,0.00037615272,0.00021766864,0.000431042],"domain_scores_gemma":[0.9986946,0.000043232518,0.000069747395,0.0003089202,0.0005637149,0.00031977333],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007348453,0.00013993999,0.00015188797,0.00011150634,0.0018864754,0.00024920187,0.000636628,0.00012254546,0.07400449],"category_scores_gemma":[0.00038134336,0.00015580097,0.000074379415,0.00045662167,0.00015056199,0.00010844196,0.0008655488,0.00053740415,0.0129603455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009774096,0.00041746438,0.000014964595,0.000048030746,0.00014853133,0.0001459557,0.0010069732,0.00021540007,0.22119337,0.011107058,0.35644406,0.40916044],"study_design_scores_gemma":[0.000851178,0.000038238955,0.00029187152,0.0000048050274,0.00004534961,0.00019777536,0.00012737559,0.00050083373,0.041115426,0.00045721757,0.9562012,0.0001687287],"about_ca_topic_score_codex":0.0000021320773,"about_ca_topic_score_gemma":1.18459e-7,"teacher_disagreement_score":0.7910489,"about_ca_system_score_codex":0.0000552865,"about_ca_system_score_gemma":0.000008364975,"threshold_uncertainty_score":0.99941295},"labels":[],"label_agreement":null},{"id":"W6920527541","doi":"10.60692/s3mhf-93n23","title":"The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"ADME; 1000 Genomes Project; Pharmacogenomics; Genetic variation; Gene; Population; Genome; Human genetics; Variation (astronomy)","score_opus":0.12294017799973875,"score_gpt":0.36941099452855947,"score_spread":0.24647081652882072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920527541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736553,0.00052383984,0.00030539665,0.00008902135,0.00046398767,0.0003038187,0.0001426758,0.0000174249,0.0007882878],"genre_scores_gemma":[0.9996864,0.00006296855,0.00004716288,0.00006255224,0.00004281425,0.00005190563,0.000019079382,0.000005719635,0.000021382717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985526,0.00034159952,0.00065088464,0.00010743661,0.00012717592,0.00022030211],"domain_scores_gemma":[0.99935985,0.00003751199,0.00023488706,0.00015363628,0.00013290918,0.000081233615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007551815,0.00012339574,0.00020012264,0.00020273842,0.00011256732,0.00004412292,0.000095219686,0.00011369367,0.000026406547],"category_scores_gemma":[0.000033573102,0.00009231982,0.00006259002,0.00036224868,0.000037338094,0.00020854213,0.000051121242,0.00017030296,0.000024552093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033322012,0.00003219539,0.9131116,0.0001965521,0.00013413321,0.000013754329,0.052105896,0.013908402,0.0039939857,0.0010715883,0.00009489085,0.015003775],"study_design_scores_gemma":[0.0016659679,0.000017711005,0.96755993,0.000027798947,0.000042330088,0.000022117436,0.0012769462,0.023887983,0.004238123,0.000021626474,0.001116167,0.00012328675],"about_ca_topic_score_codex":0.00004312159,"about_ca_topic_score_gemma":0.000010764826,"teacher_disagreement_score":0.054448333,"about_ca_system_score_codex":0.00008541054,"about_ca_system_score_gemma":0.00008793246,"threshold_uncertainty_score":0.37646928},"labels":[],"label_agreement":null},{"id":"W6920560985","doi":"10.60692/zmrpv-b4703","title":"Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"1000 Genomes Project; Allele; Pharmacogenetics; Allele frequency; CYP2A6; Genetic variation; Genome; Human genetic variation","score_opus":0.12961946722350667,"score_gpt":0.3467793525055919,"score_spread":0.2171598852820852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920560985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543977,0.000024999716,0.0012017831,0.00012408351,0.0010430769,0.0006573542,0.00052670855,0.00015646394,0.00082576723],"genre_scores_gemma":[0.9992221,0.000033666794,0.000048164246,0.0002142998,0.00010644665,0.00012122911,0.00019310955,0.000016497199,0.000044492088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981051,0.0002903763,0.00086866773,0.00018863588,0.00022215644,0.0003250526],"domain_scores_gemma":[0.99910474,0.000021917396,0.00041011433,0.00016862259,0.00014682338,0.00014777246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084390555,0.00020258833,0.00029820186,0.0007766661,0.0001384637,0.000041374165,0.00014784398,0.00015791661,0.00006145627],"category_scores_gemma":[0.000023342327,0.0002035095,0.000056530014,0.0008865376,0.000052821,0.00040307592,0.000072803945,0.00019907471,0.00028398383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070365105,0.000055414588,0.49094787,0.0014396396,0.00027102165,0.000020410673,0.14608881,0.0073501975,0.3321973,0.0011360326,0.00028955238,0.019500067],"study_design_scores_gemma":[0.0027927258,0.000026115302,0.88353604,0.000050889932,0.00013507545,0.000016451471,0.0007728659,0.06340583,0.0451565,0.000013030418,0.0037933765,0.0003011154],"about_ca_topic_score_codex":0.000009649821,"about_ca_topic_score_gemma":7.456646e-7,"teacher_disagreement_score":0.39258814,"about_ca_system_score_codex":0.000052283096,"about_ca_system_score_gemma":0.000044188804,"threshold_uncertainty_score":0.8298876},"labels":[],"label_agreement":null},{"id":"W6920575832","doi":"10.60692/271rm-kbs87","title":"Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Genotyping; CYP2D6; Allele; Context (archaeology); Pharmacogenetics; Allele frequency; Genotype; Gene","score_opus":0.11508791568029686,"score_gpt":0.33519760910665297,"score_spread":0.2201096934263561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920575832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917488,0.000031609517,0.0024174901,0.000102812286,0.0019198237,0.00084225717,0.0012501178,0.00009150855,0.0015955693],"genre_scores_gemma":[0.9986613,0.000005186323,0.00006422419,0.0004591169,0.00010674356,0.0003633161,0.00027394568,0.000018333612,0.000047833455],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973987,0.00064363726,0.0010579622,0.00019828044,0.00036855286,0.0003328785],"domain_scores_gemma":[0.9988279,0.000015907328,0.0006564734,0.00022007519,0.00014985021,0.00012980914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001014808,0.00021106446,0.00031453327,0.0006904658,0.00029743672,0.00002940318,0.00028029009,0.000093080016,0.000515022],"category_scores_gemma":[0.000014206423,0.00023041446,0.00009535777,0.0007861712,0.000037607228,0.00035010304,0.00013249063,0.00036598495,0.00012541079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018567339,0.0002217314,0.33153027,0.00088990247,0.00039244466,0.00002750282,0.23232375,0.07509548,0.34231558,0.0017429013,0.00040736215,0.013196307],"study_design_scores_gemma":[0.008463012,0.00012743197,0.73578084,0.000041443207,0.00038995701,0.000081547885,0.0037526414,0.11169206,0.10493633,0.000022290826,0.033852316,0.00086014165],"about_ca_topic_score_codex":0.0000141809,"about_ca_topic_score_gemma":4.893167e-7,"teacher_disagreement_score":0.40425053,"about_ca_system_score_codex":0.00018505646,"about_ca_system_score_gemma":0.00008727821,"threshold_uncertainty_score":0.9396029},"labels":[],"label_agreement":null},{"id":"W6920995309","doi":"10.6084/m9.figshare.18864874.v1","title":"Additional file 3 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Hematopoietic stem cell transplantation; Transplantation; Stem cell; Cell","score_opus":0.05745782231110878,"score_gpt":0.3331591838111815,"score_spread":0.2757013615000727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920995309","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47740552,0.00008525128,8.933402e-7,0.000043835087,0.000021131547,0.00038308857,0.5219895,0.000004814253,0.00006595118],"genre_scores_gemma":[0.70501834,0.00002073794,0.000031151398,0.000072803414,0.000026476637,0.0009498009,0.29386684,0.000009279044,0.000004563818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978312,0.0008783856,0.00063598447,0.00022132116,0.00026122812,0.0001718807],"domain_scores_gemma":[0.99837554,0.0010048202,0.00034841194,0.00014883566,0.000073621304,0.00004876068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037449083,0.00012329117,0.00019679894,0.0003270738,0.000054677486,0.0000042875563,0.00029753943,0.00010737096,0.30665877],"category_scores_gemma":[0.00005810523,0.0001304468,0.000061933846,0.0007192229,0.000022088907,0.00010904086,0.000023301129,0.00040521397,0.0000117121135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010640738,0.005230326,0.00955698,0.0046940115,0.000050303122,0.000046304118,0.07549277,0.08476127,0.46219808,0.00017747626,0.34332174,0.0134066725],"study_design_scores_gemma":[0.008130964,0.0004116375,0.4219375,0.00041107953,0.00025549944,0.00003485712,0.005229861,0.03889362,0.49919313,0.00087861513,0.023810279,0.0008129472],"about_ca_topic_score_codex":0.000013944438,"about_ca_topic_score_gemma":0.000023883029,"teacher_disagreement_score":0.41238052,"about_ca_system_score_codex":0.00003609498,"about_ca_system_score_gemma":0.00021264356,"threshold_uncertainty_score":0.69397503},"labels":[],"label_agreement":null},{"id":"W6921119853","doi":"10.6084/m9.figshare.18864892","title":"Additional file 8 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Identification (biology); Transplantation; Virtual screening; Cofactor; Stevia rebaudiana; Detoxification (alternative medicine)","score_opus":0.057475225775953966,"score_gpt":0.33328348761627896,"score_spread":0.275808261840325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921119853","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4782998,0.00008561514,8.9817297e-7,0.000044058786,0.000021010115,0.00038370877,0.5210939,0.0000048001366,0.000066188295],"genre_scores_gemma":[0.70570296,0.000020570638,0.000031213855,0.000072974915,0.000026291842,0.0009506797,0.29318154,0.000009277158,0.000004507697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978305,0.0008788846,0.0006361441,0.00022135557,0.00026118668,0.00017190937],"domain_scores_gemma":[0.99837536,0.0010055025,0.00034845062,0.00014887503,0.00007302896,0.000048767295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037487343,0.00012331133,0.0001968617,0.000327127,0.00005469921,0.0000042891224,0.0002976179,0.00010737868,0.30393305],"category_scores_gemma":[0.000057658883,0.00013047282,0.00006194098,0.00071900757,0.000022093047,0.00010904954,0.000023305976,0.00040525885,0.0000115384755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010677385,0.0052720434,0.009568348,0.004702626,0.00005069384,0.0000467856,0.07616366,0.08542478,0.46007228,0.00018305518,0.34377974,0.013668244],"study_design_scores_gemma":[0.008097603,0.0004131574,0.42269424,0.00041198224,0.0002569335,0.00003512475,0.00524003,0.038989294,0.49918076,0.0008849651,0.022983063,0.00081284164],"about_ca_topic_score_codex":0.000013932224,"about_ca_topic_score_gemma":0.000024012399,"teacher_disagreement_score":0.4131259,"about_ca_system_score_codex":0.000035996945,"about_ca_system_score_gemma":0.00021228114,"threshold_uncertainty_score":0.69670326},"labels":[],"label_agreement":null},{"id":"W6921559714","doi":"10.6084/m9.figshare.28637103","title":"Additional file 17 of Micro-CT imaging of live insects using carbon dioxide gas-induced hypoxia as anesthetic with minimal impact on certain subsequent life history traits","year":2025,"lang":"en","type":"other","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada; Western University","funders":"","keywords":"Anesthetic; Life history; Hypoxia (environmental); Carbon dioxide; Life saving; Voxel","score_opus":0.0869362611013834,"score_gpt":0.35324300689001814,"score_spread":0.2663067457886347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921559714","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016473774,0.004072096,2.8995789e-8,0.000021447326,0.00019373183,0.00063008047,0.8883529,0.00006176006,0.09019423],"genre_scores_gemma":[0.10671645,0.00013174457,0.00039724502,0.0035348712,0.0013848222,0.0010184605,0.8233011,0.0010189231,0.06249644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976466,0.0003885737,0.00049947144,0.000569147,0.0003577489,0.0005385125],"domain_scores_gemma":[0.9974343,0.00083283096,0.0008987517,0.00028533384,0.00020636553,0.00034238785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000085253356,0.0006467699,0.0008554485,0.00055818196,0.000056423163,0.000007586696,0.00044471773,0.00035669413,0.935777],"category_scores_gemma":[0.0004065302,0.0005969018,0.00032320607,0.00020863645,0.0000889659,0.000032976222,0.0000996029,0.0008587785,0.00018682214],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034580423,0.00031620875,0.000015304411,0.00045871342,0.0005828338,0.0002634887,0.0001567351,0.00017539207,0.016514556,0.000002248396,0.98038334,0.0007853898],"study_design_scores_gemma":[0.0016445847,0.0002242462,0.0010292513,0.0044068326,0.0004641025,0.000117880096,0.0000370402,0.00065765565,0.017358411,0.000010227134,0.9733081,0.0007416648],"about_ca_topic_score_codex":0.0002300438,"about_ca_topic_score_gemma":0.00002007408,"teacher_disagreement_score":0.9355902,"about_ca_system_score_codex":0.0003116169,"about_ca_system_score_gemma":0.002468416,"threshold_uncertainty_score":0.9996482},"labels":[],"label_agreement":null},{"id":"W6926951016","doi":"10.25384/sage.21637974","title":"sj-pdf-1-cpa-10.1177_07067437221140383 - Supplemental material for Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders","year":2022,"lang":"en","type":"article","venue":"Sage Journals Data","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Lived experience; Qualitative research; Perception; Pharmacogenomics; Qualitative analysis; Qualitative property","score_opus":0.3409892197344091,"score_gpt":0.5092634791460722,"score_spread":0.16827425941166307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6926951016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96275896,0.0009548547,0.000158282,0.00024044969,0.00082648743,0.0026012205,0.03242311,0.000009708812,0.000026941516],"genre_scores_gemma":[0.99662274,0.000096852826,0.001310152,0.00020041625,0.00018550007,0.0008275991,0.00041430336,0.000030479876,0.00031193002],"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","domain_scores_codex":[0.99717075,0.0009922095,0.0006776032,0.0004286444,0.00035911126,0.00037167672],"domain_scores_gemma":[0.9977935,0.00081688166,0.00068704266,0.00036835385,0.00018224127,0.00015197584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019911819,0.00022723214,0.00039707607,0.000102617894,0.0011947582,0.000026477346,0.0009345969,0.0000532305,0.016343389],"category_scores_gemma":[0.000110127854,0.00016745085,0.00006925173,0.00024923513,0.00019109342,0.00019650615,0.00105309,0.00040005188,8.037894e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036331185,0.0023816307,0.024666272,0.00014283611,0.0006409795,0.0000056890826,0.12679234,0.00033539525,0.8215394,0.0000027229728,0.012613738,0.007245871],"study_design_scores_gemma":[0.041620687,0.002515236,0.03186761,0.000223676,0.0029425914,0.00019161844,0.7733656,0.008369228,0.108179785,0.00026957504,0.029501462,0.0009529253],"about_ca_topic_score_codex":0.00006126148,"about_ca_topic_score_gemma":0.000029551999,"teacher_disagreement_score":0.71335965,"about_ca_system_score_codex":0.000039175084,"about_ca_system_score_gemma":0.0002472684,"threshold_uncertainty_score":0.9845558},"labels":[],"label_agreement":null},{"id":"W6929994867","doi":"10.5281/zenodo.11677387","title":"là où je me terre pdf gratuit","year":2024,"lang":"fr","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clan; Girl; Family life","score_opus":0.08867230062619322,"score_gpt":0.3661057492253912,"score_spread":0.27743344859919794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929994867","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062163355,0.010941654,0.00052364834,0.0034277923,0.0051325797,0.0011987191,0.0021741278,0.0010140397,0.9749658],"genre_scores_gemma":[0.026028339,0.0077037658,0.00025572866,0.0023668292,0.0038247867,4.5709555e-7,0.0032136422,0.011678861,0.9449276],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99415606,0.0019088002,0.0007190597,0.0012718854,0.0005602805,0.0013839371],"domain_scores_gemma":[0.9973404,0.00009103008,0.00031195302,0.0007471072,0.00053127244,0.0009782759],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016777226,0.00073063845,0.0006295118,0.0007032502,0.0020808273,0.0010219441,0.002259182,0.0008694412,0.7062674],"category_scores_gemma":[0.00045344178,0.0007936065,0.00031566207,0.00094994524,0.0007720525,0.00015222938,0.0025637075,0.0026700494,0.49467245],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012363319,0.00042402072,0.0000021185206,0.0005322421,0.0007291824,0.00021882825,0.0013518314,0.00010404365,0.014879029,0.009077389,0.780286,0.19227168],"study_design_scores_gemma":[0.0013125503,0.00020726868,0.000040407445,0.00016287818,0.0007087776,0.00031505572,0.00019819582,0.0017943023,0.0022167815,0.0011164085,0.99114794,0.00077943865],"about_ca_topic_score_codex":0.000022271168,"about_ca_topic_score_gemma":0.000002189415,"teacher_disagreement_score":0.21159495,"about_ca_system_score_codex":0.0003327371,"about_ca_system_score_gemma":0.000029066035,"threshold_uncertainty_score":0.9996308},"labels":[],"label_agreement":null},{"id":"W6930089775","doi":"10.5281/zenodo.10630689","title":"INSTAR's Kick-off meeting insights and aspirations: Discover how INSTAR aims to shape international standards for advanced technologies.","year":2024,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Commission","keywords":"Instar; Event (particle physics); Focus (optics); Key (lock); Information technology","score_opus":0.08846094087110204,"score_gpt":0.38221848164146854,"score_spread":0.29375754077036653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930089775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7466778,0.022088556,0.026417717,0.038294327,0.0053708665,0.005200226,0.01058588,0.0053465613,0.14001808],"genre_scores_gemma":[0.9935741,0.0024666712,0.00091057894,0.0008627066,0.0002993669,0.0000018311857,0.00066376006,0.0006030037,0.0006179831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830157,0.00019550732,0.00026301097,0.00053065276,0.00033134886,0.00037789997],"domain_scores_gemma":[0.99891204,0.00008934895,0.00006905076,0.00018589993,0.0005534498,0.00019019678],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008415521,0.0002020692,0.00017684906,0.00040806422,0.0013305465,0.00075157196,0.0006499289,0.00014365168,0.0016456605],"category_scores_gemma":[0.00077087653,0.00019781619,0.000060259074,0.0004937121,0.00018993924,0.00040212405,0.0009588975,0.000465419,0.0002924067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023006774,0.00009867414,0.0000049124665,0.0000980167,0.00016890257,0.000018773499,0.0014507909,0.00036370935,0.06877645,0.008591852,0.058614437,0.8615834],"study_design_scores_gemma":[0.00091870135,0.00017441445,0.000031239197,0.000048169106,0.000049292677,0.000022948298,0.0005103129,0.01054309,0.012571014,0.000726336,0.97417367,0.00023082132],"about_ca_topic_score_codex":0.0000013668559,"about_ca_topic_score_gemma":0.0000012137615,"teacher_disagreement_score":0.91555923,"about_ca_system_score_codex":0.00016211056,"about_ca_system_score_gemma":0.00002380051,"threshold_uncertainty_score":0.9999696},"labels":[],"label_agreement":null},{"id":"W6930320364","doi":"10.5281/zenodo.13243946","title":"Anaspis (Anaspis) flavipennis Haldeman 1848","year":2024,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"West virginia; Alien; Selection (genetic algorithm); Key (lock); Identification (biology)","score_opus":0.13645602111645913,"score_gpt":0.4053636163069848,"score_spread":0.26890759519052565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930320364","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21754612,0.009471812,0.0036254092,0.0075414334,0.0041520013,0.001495871,0.0013630796,0.004507554,0.7502967],"genre_scores_gemma":[0.9888591,0.0015643875,0.00015759894,0.0014195247,0.00088918384,2.2261986e-7,0.00090093707,0.001469774,0.004739233],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741244,0.0006806582,0.00035345095,0.00059682893,0.00032309038,0.00063353934],"domain_scores_gemma":[0.99873966,0.00007148875,0.00006745323,0.00037143577,0.0002985618,0.00045141368],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013143616,0.00024441368,0.00021817215,0.00035263275,0.0020285237,0.0006727684,0.0010590511,0.00018723159,0.0492872],"category_scores_gemma":[0.00020556421,0.00025228874,0.0001284292,0.000757133,0.00027714984,0.00024451024,0.0008566393,0.0008601729,0.025397329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009455462,0.00020333767,0.0000076276174,0.00014755948,0.00024460664,0.0001706763,0.0015005945,0.00019181352,0.083532244,0.015400534,0.46583426,0.4326722],"study_design_scores_gemma":[0.00056921126,0.00010504951,0.00018430021,0.000022007674,0.00010761926,0.00014892046,0.00011147635,0.0034465534,0.011672563,0.000691487,0.98265994,0.0002808636],"about_ca_topic_score_codex":0.000013542181,"about_ca_topic_score_gemma":4.1783818e-7,"teacher_disagreement_score":0.771313,"about_ca_system_score_codex":0.00011317309,"about_ca_system_score_gemma":0.000011045403,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W6930370647","doi":"10.5281/zenodo.12141046","title":"Tausch und tausch dimensionen pdf","year":2024,"lang":"de","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"History of medicine; Metabolic disease; Squire","score_opus":0.09182865612725744,"score_gpt":0.38098016651307776,"score_spread":0.2891515103858203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930370647","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016041729,0.033404637,0.00028295207,0.0019060532,0.0053540664,0.0016334504,0.002537215,0.0011024995,0.95217496],"genre_scores_gemma":[0.03280196,0.021462722,0.00032538624,0.0028710132,0.0055043665,6.7419563e-7,0.007772988,0.018789534,0.9104714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936054,0.0020198743,0.0008242115,0.0014996397,0.0007425092,0.0013084089],"domain_scores_gemma":[0.9969337,0.00009188595,0.00038702195,0.00092278776,0.0006788569,0.000985774],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019706904,0.0008072325,0.00072418567,0.0008867842,0.0025605005,0.0010693306,0.0022359085,0.00095026963,0.5843892],"category_scores_gemma":[0.00038160427,0.00086664443,0.00030466495,0.0010858155,0.00068920734,0.00014331998,0.0033458448,0.002888277,0.7016292],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020231795,0.0005322089,0.000001393551,0.0004953956,0.0016065312,0.00024932905,0.0009536602,0.00013663793,0.017632179,0.0032404193,0.90583956,0.06911037],"study_design_scores_gemma":[0.0016178245,0.00021822398,0.00002549787,0.00015499395,0.001331508,0.00011435297,0.00012039671,0.0013307524,0.0023726334,0.00072604,0.99112207,0.00086568214],"about_ca_topic_score_codex":0.000022072278,"about_ca_topic_score_gemma":4.9466934e-7,"teacher_disagreement_score":0.11724001,"about_ca_system_score_codex":0.00026448775,"about_ca_system_score_gemma":0.0000280686,"threshold_uncertainty_score":0.99996763},"labels":[],"label_agreement":null},{"id":"W6930750427","doi":"10.5281/zenodo.14981155","title":"Fig. 129 in A revision of the genus Sclerocoelus Marshall (Diptera: Sphaeroceridae)","year":2025,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Paratype; Aedeagus; Holotype; Genus; Male genitalia; Subgenus","score_opus":0.07647498326034988,"score_gpt":0.35450834241347623,"score_spread":0.2780333591531263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930750427","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023565083,0.004465522,0.00015767103,0.0006533858,0.00096919393,0.0012350738,0.001208467,0.00030829987,0.98864585],"genre_scores_gemma":[0.37707332,0.021212721,0.0004512279,0.0037536116,0.001532838,5.8048244e-7,0.0019122313,0.010833394,0.5832301],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99730647,0.0010296277,0.00044123453,0.00047889695,0.00031051415,0.00043327696],"domain_scores_gemma":[0.9987426,0.000040283347,0.00030350598,0.0005261595,0.00023414173,0.00015335003],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008333788,0.0002756627,0.0003700413,0.0004234602,0.00055075425,0.000091256734,0.001624709,0.00035610088,0.066075236],"category_scores_gemma":[0.0003253189,0.00024662382,0.00013054187,0.00068974635,0.00024215654,0.00004230177,0.0016749186,0.0009454614,0.0020550676],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009538829,0.00020374068,0.000014013591,0.0002877499,0.000109069086,0.000013647748,0.00031091901,0.00005325081,0.0024498147,0.0008739084,0.69636464,0.29922387],"study_design_scores_gemma":[0.0011537089,0.000038383532,0.00028411023,0.00022678022,0.00008698725,0.000014712152,0.000030198242,0.00019291992,0.0011782949,0.000058146918,0.9965234,0.00021236761],"about_ca_topic_score_codex":0.00004539831,"about_ca_topic_score_gemma":0.0000023934388,"teacher_disagreement_score":0.4054158,"about_ca_system_score_codex":0.00009702216,"about_ca_system_score_gemma":0.000021187981,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W6930896907","doi":"10.5281/zenodo.13335766","title":"♥╣[-_-]╠♥ +91-8094774404 ♥╣[-_-]╠♥ How To Win Back Your Ex Husband After Divorce","year":2024,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wife; Miracle; Caster; MAGIC (telescope); Happening","score_opus":0.12665139063124448,"score_gpt":0.3906243698042958,"score_spread":0.26397297917305135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930896907","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001686401,0.002049686,0.00009044154,0.003336213,0.0026789224,0.0013621624,0.97002286,0.000549037,0.01822427],"genre_scores_gemma":[0.0058899615,0.002599205,0.00011305824,0.0045629134,0.002716713,0.0000012875346,0.96927756,0.0028736652,0.011965647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950428,0.0012306544,0.0005753003,0.0013005189,0.000683648,0.0011670514],"domain_scores_gemma":[0.99701434,0.000083624065,0.00021111933,0.0010190385,0.0006054109,0.0010664881],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014511428,0.0006980012,0.00060333963,0.00075160613,0.0014550505,0.0014091571,0.0025463072,0.00066961057,0.11272049],"category_scores_gemma":[0.00042420308,0.0007220379,0.00024841804,0.0010026874,0.00032726716,0.00020428926,0.0037082415,0.0023533045,0.24820907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035608374,0.00027110966,7.1956356e-7,0.00043458497,0.00034629248,0.00019379062,0.0005246792,0.000049223538,0.0034544123,0.000047402318,0.9739959,0.020325791],"study_design_scores_gemma":[0.0009475551,0.00022405657,0.000033576784,0.000088758396,0.000424454,0.00012588341,0.00009233514,0.00008517962,0.0011306319,0.00009123523,0.9959772,0.0007791229],"about_ca_topic_score_codex":0.000018129942,"about_ca_topic_score_gemma":0.0000022355903,"teacher_disagreement_score":0.13548858,"about_ca_system_score_codex":0.00022542622,"about_ca_system_score_gemma":0.000024184166,"threshold_uncertainty_score":0.9999483},"labels":[],"label_agreement":null},{"id":"W6930957896","doi":"10.5281/zenodo.16750179","title":"Express Entry and Economic Migration Pathways to Canada: Opportunities and Barriers for South Asian Women","year":2020,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immigration; Family reunification; Context (archaeology); Human migration; South asia; Multiculturalism; Immigration policy; Economic restructuring","score_opus":0.12578631030112475,"score_gpt":0.3111413746716094,"score_spread":0.18535506437048466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930957896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755959,0.00031577083,0.0007744086,0.010934444,0.00027549049,0.00080632936,0.0027060495,0.00018848642,0.0084031],"genre_scores_gemma":[0.9947218,0.00036639383,0.00008383382,0.0038218615,0.00023294723,6.053573e-7,0.0002628071,0.00030349713,0.00020627043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886596,0.00022125633,0.00018599375,0.00030449254,0.000092479146,0.00032980015],"domain_scores_gemma":[0.998854,0.00003060436,0.00006352148,0.00009788346,0.000105453306,0.00084854086],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036669243,0.00012898543,0.00014671397,0.0000680121,0.001071472,0.00018035973,0.00027371824,0.00006277047,0.0026286226],"category_scores_gemma":[0.00018618042,0.00014476558,0.00001769759,0.00006775053,0.000091467766,0.0000763198,0.00037636535,0.00017437917,0.00006862275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013159786,0.000071647424,0.00012259971,0.00034459677,0.00034073734,0.000040391824,0.093665406,0.00081051426,0.095157385,0.008416698,0.43653432,0.36317974],"study_design_scores_gemma":[0.00082717085,0.00012692779,0.00018189191,0.0000032956405,0.00002590767,0.000010397345,0.0047705746,0.002207058,0.0033312722,0.00005593495,0.98829937,0.00016017426],"about_ca_topic_score_codex":0.00030924293,"about_ca_topic_score_gemma":0.000065035725,"teacher_disagreement_score":0.5517651,"about_ca_system_score_codex":0.000094153074,"about_ca_system_score_gemma":0.000033915352,"threshold_uncertainty_score":0.9982831},"labels":[],"label_agreement":null},{"id":"W6930972461","doi":"10.5281/zenodo.4298156","title":"Fig. 9 in The 'red-tailed' Lasioglossum (Dialictus) (Hymenoptera: Halictidae) of the western Nearctic","year":2020,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Nearctic ecozone; Scale (ratio); Dorsum; Taxonomy (biology)","score_opus":0.09487586672941159,"score_gpt":0.3551369093175219,"score_spread":0.26026104258811034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930972461","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025595443,0.0014210563,0.000046255765,0.0057891733,0.0009858023,0.0015358783,0.001120531,0.00034558342,0.98619616],"genre_scores_gemma":[0.80682045,0.0046908422,0.00009212244,0.012291842,0.002809996,0.0000016969929,0.0015996234,0.010263191,0.16143022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99621165,0.0020028432,0.00041409238,0.0004545045,0.00045296334,0.00046396235],"domain_scores_gemma":[0.9987091,0.000067956615,0.00031958742,0.0005993439,0.00012994216,0.00017405815],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009223817,0.00029891403,0.00034881168,0.00022180716,0.0007570568,0.00018894055,0.0024426286,0.00029210417,0.029741118],"category_scores_gemma":[0.00026677104,0.00021883438,0.00013991883,0.0007259862,0.00036913587,0.000051870473,0.0012118019,0.0012420345,0.0029850325],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000964562,0.0002707683,0.00012706178,0.00018232921,0.00019340329,0.000027267173,0.0027964553,0.00005703728,0.0028514059,0.00084007444,0.9708053,0.021752434],"study_design_scores_gemma":[0.0009967398,0.0000725807,0.00076774525,0.000050686533,0.00012634067,0.000035501795,0.00009450252,0.00012407456,0.00062278827,0.00006524631,0.9968313,0.0002125134],"about_ca_topic_score_codex":0.000057094156,"about_ca_topic_score_gemma":0.0000045143192,"teacher_disagreement_score":0.8247659,"about_ca_system_score_codex":0.00005536007,"about_ca_system_score_gemma":0.000013535225,"threshold_uncertainty_score":0.99779123},"labels":[],"label_agreement":null},{"id":"W6931566317","doi":"10.5281/zenodo.5068635","title":"Working# Download Justin Bieber Purpose mp3","year":2021,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nucleofection; Dysgeusia; Gestational period; Pretext; Hyporeflexia; TSG101","score_opus":0.15908524404698252,"score_gpt":0.38405640113003475,"score_spread":0.22497115708305224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931566317","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2390568,0.005008,0.0014090729,0.0054117916,0.0035379562,0.0009947183,0.0009209687,0.0018238587,0.74183685],"genre_scores_gemma":[0.98400784,0.0018121059,0.0003757952,0.003176571,0.0007997223,2.0394428e-7,0.0020848496,0.001021115,0.0067217904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972309,0.0009976926,0.00033542226,0.0005268735,0.00030084662,0.000608288],"domain_scores_gemma":[0.9984147,0.00006813241,0.00011187012,0.00040502066,0.0005778752,0.0004224211],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009719877,0.00021102876,0.0002187064,0.00017558289,0.00212924,0.00037323203,0.0008229125,0.0001812766,0.07253055],"category_scores_gemma":[0.0004678974,0.00023069516,0.00010093316,0.0007395248,0.00020816039,0.00011389524,0.001179008,0.00079397304,0.018488778],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014828051,0.00046967057,0.000034826062,0.000045142184,0.00015434013,0.00020064165,0.0011316082,0.00025193486,0.15070273,0.0035890439,0.40904057,0.4342312],"study_design_scores_gemma":[0.0011658093,0.000046041354,0.00024167441,0.000010893291,0.00008910101,0.00021578716,0.00015130217,0.00036674572,0.03606002,0.00022922478,0.9611713,0.00025208798],"about_ca_topic_score_codex":0.0000032396222,"about_ca_topic_score_gemma":3.444236e-7,"teacher_disagreement_score":0.74495107,"about_ca_system_score_codex":0.000076989265,"about_ca_system_score_gemma":0.000013904834,"threshold_uncertainty_score":0.9991698},"labels":[],"label_agreement":null},{"id":"W6931892810","doi":"10.5683/sp3/frjdhe","title":"Machine Learning Based Rapid Self-Assessment and Understanding of COVID-19 Disease Progression to Support Public Policy Decisions","year":2022,"lang":"en","type":"dataset","venue":"Borealis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University of Edmonton","funders":"Concordia University of Edmonton","keywords":"Action (physics); Big data; Public policy; Measure (data warehouse); Public health policy; Public health; Mental health","score_opus":0.1908353607798446,"score_gpt":0.4916216577200588,"score_spread":0.3007862969402142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931892810","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015113957,0.0018252668,0.0004953479,0.0052222046,0.00047819747,0.0011013083,0.9903274,0.000107508466,0.00029163802],"genre_scores_gemma":[0.007912708,0.00893029,0.00036634397,0.00803762,0.00026552615,0.00034701484,0.9740551,0.00006205311,0.000023303463],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549985,0.0016089124,0.00071902707,0.0007384754,0.0007158661,0.0007178868],"domain_scores_gemma":[0.9953071,0.0010541189,0.00052567327,0.00055968,0.0000969864,0.002456442],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021190783,0.0005261618,0.0006813062,0.0011330885,0.0009740021,0.00007700595,0.00071097957,0.0003348479,0.013726211],"category_scores_gemma":[0.00073993293,0.00050598016,0.00020574385,0.0006731216,0.00017779363,0.000075117816,0.00083272683,0.0014403124,0.0000037000607],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043686078,0.00077137473,0.0014503794,0.0002621565,0.00026504253,0.0002015773,0.00013870664,0.00090700004,0.00009507323,0.00062166346,0.9879943,0.006855875],"study_design_scores_gemma":[0.0023816694,0.000313284,0.00035713217,0.000020204077,0.0007258677,0.00001219809,0.0000745203,0.0017771294,0.0000385097,0.0003759616,0.99344087,0.00048266188],"about_ca_topic_score_codex":0.0014175398,"about_ca_topic_score_gemma":0.00028916818,"teacher_disagreement_score":0.016272249,"about_ca_system_score_codex":0.0008260574,"about_ca_system_score_gemma":0.004419572,"threshold_uncertainty_score":0.99973917},"labels":[],"label_agreement":null},{"id":"W6939349684","doi":"10.60692/ph6mz-d1132","title":"Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"1000 Genomes Project; Allele; Pharmacogenetics; Allele frequency; CYP2A6; Genetic variation; Genome; Human genetic variation","score_opus":0.12961946722350667,"score_gpt":0.3467793525055919,"score_spread":0.2171598852820852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939349684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543977,0.000024999716,0.0012017831,0.00012408351,0.0010430769,0.0006573542,0.00052670855,0.00015646394,0.00082576723],"genre_scores_gemma":[0.9992221,0.000033666794,0.000048164246,0.0002142998,0.00010644665,0.00012122911,0.00019310955,0.000016497199,0.000044492088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981051,0.0002903763,0.00086866773,0.00018863588,0.00022215644,0.0003250526],"domain_scores_gemma":[0.99910474,0.000021917396,0.00041011433,0.00016862259,0.00014682338,0.00014777246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084390555,0.00020258833,0.00029820186,0.0007766661,0.0001384637,0.000041374165,0.00014784398,0.00015791661,0.00006145627],"category_scores_gemma":[0.000023342327,0.0002035095,0.000056530014,0.0008865376,0.000052821,0.00040307592,0.000072803945,0.00019907471,0.00028398383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070365105,0.000055414588,0.49094787,0.0014396396,0.00027102165,0.000020410673,0.14608881,0.0073501975,0.3321973,0.0011360326,0.00028955238,0.019500067],"study_design_scores_gemma":[0.0027927258,0.000026115302,0.88353604,0.000050889932,0.00013507545,0.000016451471,0.0007728659,0.06340583,0.0451565,0.000013030418,0.0037933765,0.0003011154],"about_ca_topic_score_codex":0.000009649821,"about_ca_topic_score_gemma":7.456646e-7,"teacher_disagreement_score":0.39258814,"about_ca_system_score_codex":0.000052283096,"about_ca_system_score_gemma":0.000044188804,"threshold_uncertainty_score":0.8298876},"labels":[],"label_agreement":null},{"id":"W6939497478","doi":"10.6084/m9.figshare.18864886","title":"Additional file 7 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Amino acid; Detoxification (alternative medicine); Transplantation; Cell; Hematopoietic stem cell transplantation; Stem cell; Calcineurin","score_opus":0.057514645755624115,"score_gpt":0.33331185138226527,"score_spread":0.2757972056266412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939497478","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47800118,0.00008557213,8.9763085e-7,0.000044022745,0.000021015625,0.0003837283,0.52139294,0.0000048257452,0.00006581498],"genre_scores_gemma":[0.7046095,0.00002075527,0.000031152857,0.00007285911,0.000026261008,0.00094859925,0.2942771,0.000009273986,0.00000446496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978306,0.00087870855,0.0006361533,0.00022137832,0.00026123016,0.00017191672],"domain_scores_gemma":[0.9983761,0.0010048051,0.00034843394,0.00014888035,0.000073024494,0.00004876998],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003748641,0.00012331411,0.00019686285,0.0003271988,0.000054701493,0.000004289575,0.00029764746,0.000107379914,0.30152538],"category_scores_gemma":[0.000057188474,0.00013047774,0.00006194139,0.0007193355,0.00002209461,0.00010906354,0.000023310316,0.00040526828,0.0000114851555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010677676,0.0052732565,0.009615109,0.004734499,0.000050698338,0.000046789755,0.076183096,0.08540847,0.4638718,0.00018357892,0.33998853,0.013576396],"study_design_scores_gemma":[0.008132043,0.00041478025,0.42368135,0.00041669208,0.00025800115,0.00003526222,0.005260596,0.039127164,0.49784058,0.0008884158,0.023128869,0.0008162423],"about_ca_topic_score_codex":0.000013952474,"about_ca_topic_score_gemma":0.000024033849,"teacher_disagreement_score":0.41406626,"about_ca_system_score_codex":0.00003599833,"about_ca_system_score_gemma":0.00021226374,"threshold_uncertainty_score":0.69911313},"labels":[],"label_agreement":null},{"id":"W6939556771","doi":"10.6084/m9.figshare.18864880","title":"Additional file 5 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Stem cell","score_opus":0.05746518789926553,"score_gpt":0.3332821852662203,"score_spread":0.27581699736695475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939556771","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47803837,0.00008552132,8.966985e-7,0.000044011085,0.000021013022,0.00038376873,0.52135575,0.0000048257125,0.000065814005],"genre_scores_gemma":[0.7052704,0.000020744006,0.000031186755,0.00007292484,0.000026282392,0.0009501332,0.29361454,0.000009281438,0.0000044683807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978305,0.000878869,0.0006361447,0.0002213602,0.00026122737,0.00017189246],"domain_scores_gemma":[0.9983756,0.0010053234,0.00034844282,0.0001488748,0.000073015726,0.000048766167],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003748696,0.00012330725,0.00019686107,0.00032718136,0.0000547005,0.000004287856,0.00029762217,0.00010738202,0.3038432],"category_scores_gemma":[0.000057654335,0.00013046786,0.00006194403,0.0007193313,0.000022092063,0.00010905307,0.00002330892,0.00040524112,0.000011466523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010635378,0.005251601,0.009582465,0.0046834187,0.000050486025,0.000046594963,0.075793155,0.08495562,0.4611099,0.00018319675,0.34381676,0.013463268],"study_design_scores_gemma":[0.008095367,0.00041239624,0.42814282,0.00041171827,0.00025683822,0.00003510952,0.005239706,0.038751945,0.49408984,0.00088111334,0.02287068,0.0008124725],"about_ca_topic_score_codex":0.000013945803,"about_ca_topic_score_gemma":0.00002402547,"teacher_disagreement_score":0.41856033,"about_ca_system_score_codex":0.000035993515,"about_ca_system_score_gemma":0.00021221094,"threshold_uncertainty_score":0.6967932},"labels":[],"label_agreement":null},{"id":"W6939788826","doi":"10.6084/m9.figshare.18864895.v1","title":"Additional file 9 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Transplantation; Haematopoiesis; Cytotoxicity; Cell","score_opus":0.05748542301556154,"score_gpt":0.33329291555187474,"score_spread":0.2758074925363132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939788826","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4780996,0.00008564268,8.991975e-7,0.000044078464,0.00002101962,0.00038378715,0.52129424,0.000004826967,0.000065933644],"genre_scores_gemma":[0.7056759,0.000020761432,0.000031183503,0.00007297569,0.000026295911,0.000945528,0.29321358,0.00000928264,0.0000044825892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783057,0.00087885815,0.00063614105,0.00022133607,0.0002612128,0.0001718979],"domain_scores_gemma":[0.9983756,0.0010053829,0.00034841715,0.00014884154,0.000073025614,0.000048762344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037481473,0.0001233001,0.00019683782,0.00032718567,0.000054701526,0.0000042884685,0.00029745421,0.00010736521,0.3032028],"category_scores_gemma":[0.000057656638,0.00013046106,0.00006193984,0.0007193064,0.000022092661,0.00010906036,0.00002330114,0.0004051481,0.000011501761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010648756,0.005258164,0.009599333,0.004689742,0.00005055098,0.000046653317,0.07595853,0.08518619,0.46147987,0.00018063879,0.3431153,0.013370147],"study_design_scores_gemma":[0.008113897,0.00041351997,0.42606264,0.00041292564,0.0002575067,0.000035204408,0.0052531133,0.03908007,0.49560577,0.00088715093,0.023063587,0.00081460975],"about_ca_topic_score_codex":0.000013728823,"about_ca_topic_score_gemma":0.000023984128,"teacher_disagreement_score":0.41646332,"about_ca_system_score_codex":0.000035991285,"about_ca_system_score_gemma":0.00021218882,"threshold_uncertainty_score":0.6974342},"labels":[],"label_agreement":null},{"id":"W6939929994","doi":"10.6084/m9.figshare.18864862.v1","title":"Additional file 10 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Workflow; Docking (animal); Hematopoietic stem cell transplantation; Transplantation","score_opus":0.058926112205234624,"score_gpt":0.3351414189359377,"score_spread":0.27621530673070305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939929994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55196357,0.000105280255,9.926089e-7,0.000050752777,0.000022875043,0.00041636138,0.44735086,0.000005356212,0.000083965984],"genre_scores_gemma":[0.76224226,0.000023034694,0.000029257286,0.000071079245,0.000029424185,0.00085623073,0.23672988,0.00001032016,0.0000085203565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977824,0.00089518423,0.00065099046,0.0002278979,0.0002679167,0.0001755992],"domain_scores_gemma":[0.9985243,0.00083947135,0.00035056414,0.00015368847,0.00008154412,0.000050417708],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041828444,0.00012721587,0.00020182996,0.00033230768,0.00005624535,0.0000045455618,0.00030431905,0.00011198161,0.26948538],"category_scores_gemma":[0.00005407829,0.00013469555,0.00006366278,0.00071992946,0.00002283413,0.00011211919,0.000023946657,0.00038932226,0.000014837133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014501535,0.0058437684,0.009356708,0.005161831,0.000057049656,0.0000486299,0.076791845,0.08626004,0.52710074,0.00021731315,0.2734801,0.014231857],"study_design_scores_gemma":[0.0089754565,0.00045954587,0.3513688,0.00036000626,0.00028217406,0.000032754986,0.0046910658,0.040398583,0.56946653,0.0009674177,0.02217228,0.0008253302],"about_ca_topic_score_codex":0.000013653692,"about_ca_topic_score_gemma":0.00002383668,"teacher_disagreement_score":0.3420121,"about_ca_system_score_codex":0.000036803838,"about_ca_system_score_gemma":0.00021207014,"threshold_uncertainty_score":0.7311824},"labels":[],"label_agreement":null},{"id":"W6945142356","doi":"10.25384/sage.11865390.v1","title":"Supplemental Material, Table_S1_FINAL - Pharmacogenetic Testing Options Relevant to Psychiatry in Canada","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; MEDLINE; Alternative medicine; Genetic testing; Mental illness","score_opus":0.17160782194296742,"score_gpt":0.3928213312580935,"score_spread":0.22121350931512607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945142356","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4054134,0.001425804,0.000002246461,0.009356717,0.0020813083,0.0012263573,0.5779136,0.00011811182,0.0024625016],"genre_scores_gemma":[0.94208026,0.00004096403,0.0015038833,0.028916722,0.001145052,0.00047761473,0.025704848,0.00006986299,0.000060770595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977797,0.00021061448,0.0005213521,0.0004937347,0.00024590341,0.00074866787],"domain_scores_gemma":[0.9987422,0.00013941854,0.00011726358,0.00014707567,0.000089817215,0.00076419406],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011309389,0.00030801154,0.0003039731,0.000089264584,0.0001813693,0.000038503746,0.0004951059,0.00010280096,0.33902425],"category_scores_gemma":[0.00026233366,0.00034266274,0.000056635232,0.0006220244,0.00000901553,0.00007766475,0.00028526806,0.0005684612,0.0012948206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015727816,0.00011200331,0.0049082967,0.0001842989,0.000058802827,0.00016341906,0.00019156755,0.00824018,0.08666446,0.000015508294,0.8919131,0.007391064],"study_design_scores_gemma":[0.0016415451,0.000076967466,0.006752185,0.000120276185,0.00006440386,0.000025459722,0.0001302858,0.008461523,0.047577858,0.000024021321,0.9345926,0.0005328421],"about_ca_topic_score_codex":0.019498473,"about_ca_topic_score_gemma":0.06546614,"teacher_disagreement_score":0.5522087,"about_ca_system_score_codex":0.00019610257,"about_ca_system_score_gemma":0.0017006149,"threshold_uncertainty_score":0.99990255},"labels":[],"label_agreement":null},{"id":"W6949599471","doi":"10.5281/zenodo.14583873","title":"Pharmacogenetics in Oncology: Transforming Cancer Treatment - A review","year":2025,"lang":"en","type":"preprint","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Drug response; Drug; Personalized medicine; Precision medicine; Pharmacogenomics; Genetic testing; Cancer treatment","score_opus":0.22038495646921685,"score_gpt":0.4738355759385335,"score_spread":0.25345061946931663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6949599471","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07726152,0.30661702,0.0010658848,0.021339362,0.006951018,0.011968122,0.0154779665,0.0020202037,0.5572989],"genre_scores_gemma":[0.11349371,0.865827,0.00036566178,0.008406423,0.0010031507,0.000010026281,0.004914397,0.0017810385,0.0041985894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956628,0.0016828373,0.0007675396,0.00084859756,0.00029407605,0.00074412517],"domain_scores_gemma":[0.99831307,0.00009462246,0.00027231005,0.0004797965,0.0004642329,0.00037596712],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015063004,0.0004756136,0.0007205169,0.00047164326,0.0010803415,0.00015121631,0.0014705021,0.00048098317,0.02082109],"category_scores_gemma":[0.00015837632,0.00049763196,0.00023053086,0.00061020383,0.00021008517,0.000071931114,0.0016076962,0.0017090905,0.00084803376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021914877,0.0008292093,0.000014926911,0.0017008304,0.00043222337,0.000079671605,0.0016900278,0.0020990595,0.0058066403,0.0002801892,0.07449294,0.9123551],"study_design_scores_gemma":[0.0021091807,0.00013117747,0.000053590476,0.0006278723,0.0005737173,0.000032521508,0.000052109383,0.0016617543,0.0059206346,0.00017503912,0.988242,0.0004204531],"about_ca_topic_score_codex":0.00008091881,"about_ca_topic_score_gemma":0.000004983262,"teacher_disagreement_score":0.91374904,"about_ca_system_score_codex":0.0009084932,"about_ca_system_score_gemma":0.00010105547,"threshold_uncertainty_score":0.9999299},"labels":[],"label_agreement":null},{"id":"W6955155473","doi":"10.58066/shah-cx78","title":"Rocky Mountain bighorn sheep 01","year":2021,"lang":"en","type":"other","venue":"UVic’s Research and Learning Repository (University of Victoria)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovis canadensis; Wildlife refuge; Limpet; Current (fluid); Myotis lucifugus","score_opus":0.0803954990209709,"score_gpt":0.3843862036270558,"score_spread":0.3039907046060849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6955155473","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061843947,0.03768037,0.000081921105,0.00029224608,0.0034031456,0.00059700804,0.00006791159,0.0002221157,0.8958113],"genre_scores_gemma":[0.08293343,0.011757786,0.00027638872,0.0000440471,0.0018616169,0.0000027818942,0.0001008637,0.00020918065,0.9028139],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957772,0.0019372558,0.00022052517,0.00070794194,0.0006426775,0.0007143849],"domain_scores_gemma":[0.9980594,0.00044834247,0.00025166405,0.00034779488,0.00032015346,0.0005726765],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00124416,0.00032603316,0.00059492054,0.0005581008,0.000968293,0.000055579894,0.0005634623,0.0009451469,0.008851263],"category_scores_gemma":[0.000107975575,0.0004021633,0.00015723976,0.00049908546,0.00066663994,0.00005589819,0.00052432396,0.0033293026,0.00010403207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012151139,0.0011823971,0.021783149,0.001763825,0.0028303163,0.002574906,0.0059413686,0.00030895678,0.15494527,0.0009058743,0.7776333,0.028915519],"study_design_scores_gemma":[0.0012933931,0.00019254777,0.00086489675,0.00013370591,0.00014581408,0.000029685412,0.0012841377,0.00052887975,0.0015286263,0.00005711949,0.99358773,0.0003534433],"about_ca_topic_score_codex":0.0010933613,"about_ca_topic_score_gemma":0.00013049981,"teacher_disagreement_score":0.21595444,"about_ca_system_score_codex":0.00010261416,"about_ca_system_score_gemma":0.00034075006,"threshold_uncertainty_score":0.999843},"labels":[],"label_agreement":null},{"id":"W6957995327","doi":"10.6084/m9.figshare.18864874","title":"Additional file 3 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Hematopoietic stem cell transplantation; Transplantation; Stem cell; Cell","score_opus":0.05745782231110878,"score_gpt":0.3331591838111815,"score_spread":0.2757013615000727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957995327","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47740552,0.00008525128,8.933402e-7,0.000043835087,0.000021131547,0.00038308857,0.5219895,0.000004814253,0.00006595118],"genre_scores_gemma":[0.70501834,0.00002073794,0.000031151398,0.000072803414,0.000026476637,0.0009498009,0.29386684,0.000009279044,0.000004563818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978312,0.0008783856,0.00063598447,0.00022132116,0.00026122812,0.0001718807],"domain_scores_gemma":[0.99837554,0.0010048202,0.00034841194,0.00014883566,0.000073621304,0.00004876068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037449083,0.00012329117,0.00019679894,0.0003270738,0.000054677486,0.0000042875563,0.00029753943,0.00010737096,0.30665877],"category_scores_gemma":[0.00005810523,0.0001304468,0.000061933846,0.0007192229,0.000022088907,0.00010904086,0.000023301129,0.00040521397,0.0000117121135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010640738,0.005230326,0.00955698,0.0046940115,0.000050303122,0.000046304118,0.07549277,0.08476127,0.46219808,0.00017747626,0.34332174,0.0134066725],"study_design_scores_gemma":[0.008130964,0.0004116375,0.4219375,0.00041107953,0.00025549944,0.00003485712,0.005229861,0.03889362,0.49919313,0.00087861513,0.023810279,0.0008129472],"about_ca_topic_score_codex":0.000013944438,"about_ca_topic_score_gemma":0.000023883029,"teacher_disagreement_score":0.41238052,"about_ca_system_score_codex":0.00003609498,"about_ca_system_score_gemma":0.00021264356,"threshold_uncertainty_score":0.69397503},"labels":[],"label_agreement":null},{"id":"W6958121567","doi":"10.6084/m9.figshare.18864871.v1","title":"Additional file 2 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Ramachandran plot; Detoxification (alternative medicine); Haematopoiesis; Transplantation; Hematopoietic stem cell transplantation","score_opus":0.05670521650674531,"score_gpt":0.3330324615019495,"score_spread":0.27632724499520417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958121567","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47695136,0.0000860906,8.7623056e-7,0.000043893593,0.000021105292,0.00038320653,0.52244174,0.000004826104,0.00006690364],"genre_scores_gemma":[0.70291317,0.000020872669,0.000030830128,0.00007266986,0.00002647481,0.00094718015,0.29597503,0.000009246668,0.0000044961453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997831,0.00087881024,0.0006359835,0.00022126849,0.0002611368,0.00017184226],"domain_scores_gemma":[0.99837995,0.0010007808,0.00034874212,0.00014878904,0.00007299893,0.000048758353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037305555,0.00012327456,0.0001968203,0.00032699417,0.000054684187,0.000004287876,0.0002975572,0.00010737849,0.30765557],"category_scores_gemma":[0.000057579466,0.00013043983,0.00006192773,0.000719001,0.000022087459,0.00010903326,0.000023311637,0.00040520652,0.000011519136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010608989,0.005261462,0.009368812,0.004692399,0.000050629373,0.00004710875,0.07597882,0.08554614,0.4521308,0.00018179063,0.3520634,0.013617749],"study_design_scores_gemma":[0.008193699,0.0004175637,0.42434263,0.00041323062,0.0002599534,0.000035633395,0.00527664,0.03915676,0.4957276,0.0008935896,0.02446043,0.00082225987],"about_ca_topic_score_codex":0.0000139299145,"about_ca_topic_score_gemma":0.000023865994,"teacher_disagreement_score":0.41497383,"about_ca_system_score_codex":0.000035992638,"about_ca_system_score_gemma":0.0002118283,"threshold_uncertainty_score":0.6929773},"labels":[],"label_agreement":null},{"id":"W6968371761","doi":"10.5281/zenodo.15269494","title":"Megaselia nivizona Brown & Hartop & Wong 2022, New Species","year":2022,"lang":"de","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Holotype; Table (database); White (mutation); Range (aeronautics); Taxonomy (biology)","score_opus":0.11186373525043031,"score_gpt":0.3457574219271254,"score_spread":0.23389368667669508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6968371761","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09143047,0.07708819,0.0028326688,0.031499844,0.025439827,0.0052440544,0.015519358,0.0034533658,0.7474922],"genre_scores_gemma":[0.67428815,0.020377206,0.00040586578,0.011922735,0.01006015,0.0000012630488,0.013141176,0.007601928,0.26220152],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929593,0.0031216827,0.00071885245,0.0010136089,0.0009357809,0.0012507825],"domain_scores_gemma":[0.9972862,0.00012816797,0.0003578383,0.000721372,0.00048283883,0.0010235852],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0024975198,0.00048799964,0.00047699883,0.00052453164,0.009301932,0.0007495711,0.0026523813,0.00021300087,0.4168865],"category_scores_gemma":[0.00040784018,0.00060476863,0.0002495589,0.0013453087,0.0004394729,0.00025288534,0.0050719827,0.0025147335,0.027336903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046306895,0.0006568329,0.000012996921,0.0000661296,0.00046332588,0.00014289792,0.002647719,0.0011708309,0.04096934,0.0041605514,0.8176332,0.1316131],"study_design_scores_gemma":[0.002785811,0.00038342757,0.0002894336,0.000012538882,0.00040114037,0.00013569715,0.0006484019,0.0020005438,0.005627358,0.0004217041,0.98668605,0.0006079116],"about_ca_topic_score_codex":0.000030471434,"about_ca_topic_score_gemma":3.496266e-7,"teacher_disagreement_score":0.58285767,"about_ca_system_score_codex":0.0004066674,"about_ca_system_score_gemma":0.000056554487,"threshold_uncertainty_score":0.9997865},"labels":[],"label_agreement":null},{"id":"W6969520278","doi":"10.5441/001/1.f01v7r80/2","title":"Canadian Ringed Plover geolocation tracking, Bylot Island, Canada (data from Leandri-Breton et al. 2019)-tracks","year":2019,"lang":"en","type":"dataset","venue":"Movebank","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Flyway; Geolocation; Plover; Circumpolar star; Nearctic ecozone; Charadriiformes; Arctic; Charadrius; Glacier","score_opus":0.11811082296141487,"score_gpt":0.4131444478906195,"score_spread":0.2950336249292046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6969520278","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007239311,0.0064804303,0.000014832377,0.003864701,0.011638893,0.00083667814,0.9684019,0.00003966956,0.0014836006],"genre_scores_gemma":[0.0068631275,0.0043735374,0.000021656684,0.06307567,0.00095760927,0.00003667727,0.91990376,0.00009989756,0.0046680523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950015,0.00073463767,0.0008637411,0.00145757,0.0006686264,0.0012739014],"domain_scores_gemma":[0.9956792,0.0005547992,0.0005288872,0.0020511097,0.00023233752,0.0009536745],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011339654,0.0008887306,0.00091973576,0.00030942317,0.00033301915,0.00015272971,0.0025832227,0.0011407991,0.013867345],"category_scores_gemma":[0.00020328541,0.0009413365,0.00014865055,0.00024699786,0.00011983289,0.0002658788,0.0005190649,0.003208923,0.001817183],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001419788,0.00013070583,0.0013126465,0.000054233027,0.00060416036,0.00017396828,0.000050151873,0.0009848542,0.000306508,0.0000061172386,0.9945909,0.001643799],"study_design_scores_gemma":[0.0020875968,0.000027920853,0.0023197925,0.000041027153,0.0006547423,0.000013149006,0.00001213012,0.0019107346,0.00068332395,0.000047378115,0.99116176,0.00104047],"about_ca_topic_score_codex":0.9727868,"about_ca_topic_score_gemma":0.99568695,"teacher_disagreement_score":0.05921097,"about_ca_system_score_codex":0.00061722856,"about_ca_system_score_gemma":0.005013805,"threshold_uncertainty_score":0.9993037},"labels":[],"label_agreement":null},{"id":"W6976764132","doi":"10.6084/m9.figshare.18864865","title":"Additional file 11 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Docking (animal); Homology modeling; Sequence homology; Transplantation; Hematopoietic stem cell transplantation; Homology (biology); Detoxification (alternative medicine)","score_opus":0.058767790910192436,"score_gpt":0.3344986646976627,"score_spread":0.2757308737874703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976764132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5659743,0.00009313682,0.0000012348089,0.000053985095,0.00002475743,0.00041150206,0.4333875,0.000005183482,0.000048399284],"genre_scores_gemma":[0.77047044,0.000023998735,0.000031848176,0.00008124704,0.000029695702,0.0008665636,0.2284814,0.000010464066,0.0000043192376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776894,0.00090324355,0.00065431395,0.00022820874,0.00026800315,0.00017728875],"domain_scores_gemma":[0.99854696,0.00082266587,0.0003511244,0.00015320252,0.00007534497,0.00005069614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004187959,0.00012746532,0.0002030269,0.00033416407,0.00005678737,0.000004479834,0.00030478425,0.000110267996,0.16016985],"category_scores_gemma":[0.000048948772,0.00013495493,0.00006380055,0.00072375813,0.00002282005,0.00011340711,0.000023942766,0.0003776756,0.0000091019],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010113505,0.005962733,0.023586515,0.0053607584,0.00005041171,0.000052753483,0.087498635,0.10613607,0.56429815,0.00029544727,0.19452333,0.011223812],"study_design_scores_gemma":[0.007436621,0.00031314662,0.44710645,0.00030918655,0.00023443176,0.000029611114,0.0045138802,0.032397147,0.49223506,0.0007192168,0.014024172,0.00068109063],"about_ca_topic_score_codex":0.00002143675,"about_ca_topic_score_gemma":0.000045396322,"teacher_disagreement_score":0.4235199,"about_ca_system_score_codex":0.000036758665,"about_ca_system_score_gemma":0.0002078127,"threshold_uncertainty_score":0.84059787},"labels":[],"label_agreement":null},{"id":"W6976769252","doi":"10.6084/m9.figshare.18864880.v1","title":"Additional file 5 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Stem cell","score_opus":0.05746518789926553,"score_gpt":0.3332821852662203,"score_spread":0.27581699736695475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976769252","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47803837,0.00008552132,8.966985e-7,0.000044011085,0.000021013022,0.00038376873,0.52135575,0.0000048257125,0.000065814005],"genre_scores_gemma":[0.7052704,0.000020744006,0.000031186755,0.00007292484,0.000026282392,0.0009501332,0.29361454,0.000009281438,0.0000044683807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978305,0.000878869,0.0006361447,0.0002213602,0.00026122737,0.00017189246],"domain_scores_gemma":[0.9983756,0.0010053234,0.00034844282,0.0001488748,0.000073015726,0.000048766167],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003748696,0.00012330725,0.00019686107,0.00032718136,0.0000547005,0.000004287856,0.00029762217,0.00010738202,0.3038432],"category_scores_gemma":[0.000057654335,0.00013046786,0.00006194403,0.0007193313,0.000022092063,0.00010905307,0.00002330892,0.00040524112,0.000011466523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010635378,0.005251601,0.009582465,0.0046834187,0.000050486025,0.000046594963,0.075793155,0.08495562,0.4611099,0.00018319675,0.34381676,0.013463268],"study_design_scores_gemma":[0.008095367,0.00041239624,0.42814282,0.00041171827,0.00025683822,0.00003510952,0.005239706,0.038751945,0.49408984,0.00088111334,0.02287068,0.0008124725],"about_ca_topic_score_codex":0.000013945803,"about_ca_topic_score_gemma":0.00002402547,"teacher_disagreement_score":0.41856033,"about_ca_system_score_codex":0.000035993515,"about_ca_system_score_gemma":0.00021221094,"threshold_uncertainty_score":0.6967932},"labels":[],"label_agreement":null},{"id":"W6976814512","doi":"10.60692/2xy6e-k3h39","title":"The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"ADME; 1000 Genomes Project; Pharmacogenomics; Genetic variation; Gene; Population; Genome; Human genetics; Variation (astronomy)","score_opus":0.12294017799973875,"score_gpt":0.36941099452855947,"score_spread":0.24647081652882072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976814512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736553,0.00052383984,0.00030539665,0.00008902135,0.00046398767,0.0003038187,0.0001426758,0.0000174249,0.0007882878],"genre_scores_gemma":[0.9996864,0.00006296855,0.00004716288,0.00006255224,0.00004281425,0.00005190563,0.000019079382,0.000005719635,0.000021382717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985526,0.00034159952,0.00065088464,0.00010743661,0.00012717592,0.00022030211],"domain_scores_gemma":[0.99935985,0.00003751199,0.00023488706,0.00015363628,0.00013290918,0.000081233615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007551815,0.00012339574,0.00020012264,0.00020273842,0.00011256732,0.00004412292,0.000095219686,0.00011369367,0.000026406547],"category_scores_gemma":[0.000033573102,0.00009231982,0.00006259002,0.00036224868,0.000037338094,0.00020854213,0.000051121242,0.00017030296,0.000024552093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033322012,0.00003219539,0.9131116,0.0001965521,0.00013413321,0.000013754329,0.052105896,0.013908402,0.0039939857,0.0010715883,0.00009489085,0.015003775],"study_design_scores_gemma":[0.0016659679,0.000017711005,0.96755993,0.000027798947,0.000042330088,0.000022117436,0.0012769462,0.023887983,0.004238123,0.000021626474,0.001116167,0.00012328675],"about_ca_topic_score_codex":0.00004312159,"about_ca_topic_score_gemma":0.000010764826,"teacher_disagreement_score":0.054448333,"about_ca_system_score_codex":0.00008541054,"about_ca_system_score_gemma":0.00008793246,"threshold_uncertainty_score":0.37646928},"labels":[],"label_agreement":null},{"id":"W6977113418","doi":"10.6084/m9.figshare.16900743","title":"Additional file 2 of Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Degree (music); Airflow; Statistical analysis; Post hoc","score_opus":0.26837214078498695,"score_gpt":0.4103348117906738,"score_spread":0.14196267100568688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977113418","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23333973,0.00022609728,0.0000014390583,0.00011025334,0.00009210215,0.00037916217,0.76542777,0.000003861987,0.00041960733],"genre_scores_gemma":[0.80237067,0.000014393409,0.00023626376,0.00024293129,0.00009823827,0.00010384413,0.19675167,0.000011293977,0.0001706945],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794644,0.0005780459,0.00072407816,0.00023911912,0.0003381872,0.00017413731],"domain_scores_gemma":[0.9930857,0.0047341343,0.00085865526,0.0003986723,0.0008456467,0.00007718489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002963573,0.00014547246,0.00055423466,0.00015319187,0.000085929525,0.000003190899,0.00046214965,0.00015194279,0.7076637],"category_scores_gemma":[0.0051756096,0.00010820898,0.0006114554,0.0010532263,0.00006286517,0.00004227771,0.00036622092,0.00022532081,0.000021820915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006509292,0.0005700875,0.00039301158,0.00024502547,0.0017169797,0.0000024914061,0.000746415,0.0030408774,0.028929075,0.000006592636,0.9519267,0.005913426],"study_design_scores_gemma":[0.017399324,0.00057404203,0.10924617,0.0012348152,0.0040451847,0.0000072434073,0.00079825235,0.0072587496,0.48292288,0.000026854526,0.3761037,0.00038280062],"about_ca_topic_score_codex":0.0000066829098,"about_ca_topic_score_gemma":0.000048208727,"teacher_disagreement_score":0.7076419,"about_ca_system_score_codex":0.000020740592,"about_ca_system_score_gemma":0.0002065405,"threshold_uncertainty_score":0.6196062},"labels":[],"label_agreement":null},{"id":"W6977255997","doi":"10.6084/m9.figshare.18864877.v1","title":"Additional file 4 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; AutoDock; Docking (animal); Detoxification (alternative medicine); Transplantation; Ligand (biochemistry); Hematopoietic stem cell transplantation","score_opus":0.05780838960482853,"score_gpt":0.33353113093136527,"score_spread":0.27572274132653674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977255997","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47750482,0.00008558786,8.987127e-7,0.000043821918,0.000021008664,0.00038377038,0.5218894,0.0000048246507,0.00006589175],"genre_scores_gemma":[0.7049986,0.000020735462,0.000031173702,0.00007285602,0.000026267937,0.0009497431,0.2938869,0.000009276161,0.0000044406725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978311,0.0008782955,0.0006361597,0.000221338,0.00026121506,0.00017189556],"domain_scores_gemma":[0.998375,0.0010063101,0.00034845504,0.0001488955,0.000072560055,0.000048762307],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037472355,0.00012329781,0.00019683491,0.00032719155,0.00005469855,0.0000042893225,0.00029770884,0.000107377986,0.30388752],"category_scores_gemma":[0.000057475412,0.00013046598,0.00006193756,0.00071915175,0.00002209198,0.0001090532,0.000023308006,0.00040520425,0.000011526578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010821697,0.0052788947,0.009658623,0.0047070114,0.000050751143,0.000046841607,0.07622295,0.08459623,0.46096325,0.00018408362,0.34369144,0.013517752],"study_design_scores_gemma":[0.008160006,0.0004198349,0.4262318,0.00041458054,0.00025869728,0.000035370824,0.005277049,0.039257105,0.4950326,0.00089140615,0.023203047,0.0008184964],"about_ca_topic_score_codex":0.000013848502,"about_ca_topic_score_gemma":0.000023958843,"teacher_disagreement_score":0.4165732,"about_ca_system_score_codex":0.00003598742,"about_ca_system_score_gemma":0.00021202647,"threshold_uncertainty_score":0.69674885},"labels":[],"label_agreement":null},{"id":"W6979735805","doi":"","title":"Active site crowding of P450 3A4 as a strategy to alter its selectivity","year":2016,"lang":"en","type":"article","venue":"eScholarship@McGill (McGill)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de recherche du Québec – Nature et technologies; Centre in Green Chemistry and Catalysis; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Selectivity; Allosteric regulation; Macromolecular crowding; Ligand (biochemistry); Cell","score_opus":0.08266731052872751,"score_gpt":0.3883305993972025,"score_spread":0.305663288868475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6979735805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518254,0.0002737615,0.0000032974833,0.00015258596,0.0009775492,0.0007907756,0.0021171311,0.00015430026,0.04370524],"genre_scores_gemma":[0.99451673,0.00038751384,0.00016854129,0.0020901575,0.00015000353,0.000119811426,0.000010987076,0.00010492103,0.0024513565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954547,0.0011521402,0.0007576302,0.0009816351,0.00049780274,0.0011560374],"domain_scores_gemma":[0.99686563,0.0007944532,0.00037924715,0.0004680013,0.0005369488,0.00095573126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001540104,0.0006052712,0.00071835506,0.00038382658,0.0007170513,0.000028194687,0.00066911255,0.00054936786,0.0023888275],"category_scores_gemma":[0.0007079807,0.0005154121,0.0003017222,0.00073817157,0.00015419968,0.0006660327,0.000427256,0.0011371216,0.0015598589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006975196,0.0003385396,0.00016492693,0.000038515445,0.00027314387,0.00004461126,0.00002004087,0.00011497075,0.7347743,0.01627231,0.000024306013,0.24723682],"study_design_scores_gemma":[0.002320519,0.00038115922,0.001422715,0.00005019102,0.00022413403,0.000038327446,0.000020984047,0.00005545607,0.8419198,0.0057716467,0.14720157,0.0005935393],"about_ca_topic_score_codex":0.00006914129,"about_ca_topic_score_gemma":0.0000728366,"teacher_disagreement_score":0.24664328,"about_ca_system_score_codex":0.000322251,"about_ca_system_score_gemma":0.000100348916,"threshold_uncertainty_score":0.99972975},"labels":[],"label_agreement":null},{"id":"W6981676723","doi":"","title":"E.valdžios taikymas valstybės sienos apsaugoje","year":2006,"lang":"en","type":"dissertation","venue":"Laba (Lietuvos akademinių bibliotekų direktorių asociacija)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lithuanian; Work (physics); Government (linguistics); Politics; State (computer science); Subject (documents); Eu countries","score_opus":0.08601158229851781,"score_gpt":0.45152594653239264,"score_spread":0.36551436423387484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981676723","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52313626,0.049468085,0.000021022843,0.0009810727,0.038489968,0.0019640934,0.0024643089,0.0015469325,0.38192827],"genre_scores_gemma":[0.38881257,0.052904334,0.0010994321,0.0053222254,0.02006708,0.0016569556,0.012062636,0.001484929,0.5165898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98814046,0.0011875823,0.0029407637,0.002559072,0.002101605,0.0030705323],"domain_scores_gemma":[0.9924269,0.0015200377,0.002247169,0.0012917438,0.0010226121,0.0014915864],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0028807041,0.0024484573,0.0026891702,0.0041543506,0.0014097459,0.0005033444,0.002473073,0.0061732363,0.0056550456],"category_scores_gemma":[0.00065363327,0.0026514,0.0015149437,0.007027425,0.0004680457,0.000689139,0.00036512676,0.0069128624,0.0023839113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010830464,0.0024654095,0.0042094053,0.0018950491,0.0030688818,0.0005488752,0.004534781,0.00048315508,0.18719938,0.004878458,0.61598563,0.17364794],"study_design_scores_gemma":[0.0027191648,0.00013293905,0.0028166345,0.00022763634,0.0021127511,0.000029742843,0.00057942775,0.00032250097,0.09093673,0.0018823605,0.89552003,0.002720075],"about_ca_topic_score_codex":0.00028396843,"about_ca_topic_score_gemma":0.00018798192,"teacher_disagreement_score":0.27953443,"about_ca_system_score_codex":0.0004749364,"about_ca_system_score_gemma":0.0011858848,"threshold_uncertainty_score":0.99989027},"labels":[],"label_agreement":null},{"id":"W6981902823","doi":"","title":"Fuktindekser som hjelpemiddel i fuktprosjektering","year":2022,"lang":"no","type":"dissertation","venue":"Duo Research Archive (University of Oslo)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Product (mathematics); Work (physics); Gender relations","score_opus":0.1333754070085403,"score_gpt":0.42648433160736904,"score_spread":0.29310892459882876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981902823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150935,0.005638297,0.0003203067,0.00094757817,0.0034741613,0.0022649611,0.0043540425,0.00010143555,0.067805715],"genre_scores_gemma":[0.9202823,0.022212883,0.001593737,0.00031534405,0.0007947374,0.000032420347,0.0045468127,0.0002141025,0.05000763],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98852724,0.0052044466,0.00069254794,0.0015252028,0.0019573546,0.0020931847],"domain_scores_gemma":[0.99390656,0.002588946,0.0006898778,0.0008634819,0.0007823867,0.0011687747],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0050554075,0.0007612075,0.0012234786,0.001935743,0.0035649496,0.000062529194,0.0029203491,0.0007623241,0.04054121],"category_scores_gemma":[0.00032999404,0.0010427618,0.00077056524,0.0012599104,0.0015961626,0.00028459367,0.002198937,0.0075812605,0.00084031635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013675009,0.003575663,0.009465218,0.003123361,0.0037236835,0.0022334366,0.07355236,0.0015559151,0.7081172,0.005797619,0.050747033,0.12443351],"study_design_scores_gemma":[0.0069212527,0.00082061574,0.026602864,0.00023619644,0.0009221606,0.00003217242,0.044077568,0.009380521,0.011801575,0.005084651,0.89263356,0.0014868431],"about_ca_topic_score_codex":0.0014564929,"about_ca_topic_score_gemma":0.00071079505,"teacher_disagreement_score":0.8418865,"about_ca_system_score_codex":0.00030208047,"about_ca_system_score_gemma":0.0015618773,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W69827073","doi":"10.1007/978-1-4419-0840-7_28","title":"Drug–Drug Interactions: What Have We Learned and Where Are We Going?","year":2009,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Drug; Pharmacology; Drug repositioning; Medicine; Business; Risk analysis (engineering)","score_opus":0.12456421838485118,"score_gpt":0.41891046925073394,"score_spread":0.29434625086588273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W69827073","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006433862,0.25209528,0.000020374664,0.039123114,0.0050300574,0.0009699171,0.00018115187,0.00028155893,0.70165515],"genre_scores_gemma":[0.0028812406,0.37677407,0.00013927705,0.005206377,0.0009898198,0.00002439201,0.00003772304,0.000094367206,0.61385274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996914,0.0002623541,0.0008005565,0.000996106,0.00033683336,0.00069013686],"domain_scores_gemma":[0.9975664,0.00051376375,0.0005959961,0.00046289404,0.00021726846,0.00064364885],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005647883,0.0009425271,0.000983835,0.0004012479,0.00042420925,0.00024562606,0.00048076402,0.0005989454,0.015211884],"category_scores_gemma":[0.00001702252,0.00090224645,0.0003721565,0.000053754316,0.00032661544,0.0004521211,0.0002958636,0.0029909257,0.0010795349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004272659,0.000235931,0.00013454822,0.00029398338,0.0009646709,0.00027169517,0.0015010282,0.000092416936,0.0011691112,0.013346654,0.35142696,0.6301357],"study_design_scores_gemma":[0.0015386689,0.000028204568,0.000014417638,0.00049633824,0.0008394311,0.00009481698,0.0005135855,0.00069408334,0.0023830293,0.021214204,0.97124785,0.00093538733],"about_ca_topic_score_codex":0.0000137856505,"about_ca_topic_score_gemma":0.0004026624,"teacher_disagreement_score":0.62920034,"about_ca_system_score_codex":0.000096933545,"about_ca_system_score_gemma":0.00012556351,"threshold_uncertainty_score":0.9996982},"labels":[],"label_agreement":null},{"id":"W6990769860","doi":"","title":"The effects of paper structure on electrophotography /","year":2002,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Dielectric; Electric field; Coupling (piping); Field (mathematics); Permittivity; Finite element method; Constant (computer programming)","score_opus":0.022723538232751566,"score_gpt":0.32605421326598555,"score_spread":0.30333067503323397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990769860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91989106,0.00965934,1.33301725e-8,0.000024176737,0.008071328,0.0012990624,0.0013542454,0.00012440809,0.059576392],"genre_scores_gemma":[0.9744101,0.015963059,0.000038219234,0.0016697245,0.00020822037,0.00020599573,0.00036957304,0.00022447505,0.0069106203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994692,0.0013475742,0.0010187504,0.0009824682,0.00079593755,0.0011632693],"domain_scores_gemma":[0.9957729,0.0016387608,0.00087506097,0.00081926456,0.000401651,0.00049238495],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00070731,0.00103944,0.0009507511,0.00042110175,0.0018301258,0.000048202557,0.0012446552,0.0016484536,0.0012208936],"category_scores_gemma":[0.0005756735,0.00083426735,0.00072718214,0.0007809767,0.00020401465,0.00016624936,0.00009924947,0.0045335023,0.00016581114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083979825,0.0003518402,0.00001761656,0.00044218486,0.0009801365,0.00006056641,0.000016844046,0.00003189574,0.730527,0.02173173,0.00016464158,0.24483578],"study_design_scores_gemma":[0.0013818449,0.00025483998,0.0004303623,0.00008465324,0.0006946918,0.000008818474,0.000022821081,0.000015963435,0.57836586,0.009582455,0.40858898,0.00056875445],"about_ca_topic_score_codex":0.00003535089,"about_ca_topic_score_gemma":0.00016434414,"teacher_disagreement_score":0.40842432,"about_ca_system_score_codex":0.00015462257,"about_ca_system_score_gemma":0.000052355197,"threshold_uncertainty_score":0.99969214},"labels":[],"label_agreement":null},{"id":"W6991141598","doi":"","title":"Exploring the potential impact of collaborative medicines optimisation involving pharmacogenomic testing and general practice pharmacists in primary care in Ireland","year":2024,"lang":"en","type":"dissertation","venue":"Trinity's Access to Research Output (TARA) (Trinity College Dublin)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Polypharmacy; Pharmacogenomics; Psychological intervention; Population; Dosing; Health care; Pharmacotherapy; MEDLINE; Primary care; Precision medicine","score_opus":0.33353114083260177,"score_gpt":0.5318883995148753,"score_spread":0.19835725868227355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6991141598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698658,0.014876315,0.0000021260932,0.0007135804,0.002667799,0.0050430484,0.0016593153,0.00006693462,0.005105097],"genre_scores_gemma":[0.97679746,0.018493935,0.0002703619,0.00036460673,0.0011867711,0.001271728,0.00082912744,0.00014748322,0.0006384966],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98949164,0.004254558,0.0018491744,0.0013643319,0.0015470955,0.0014932049],"domain_scores_gemma":[0.9899494,0.005482569,0.00065425714,0.00050018344,0.0026952655,0.0007183216],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008190736,0.0009193583,0.0013978847,0.0036340526,0.0006897347,0.0004557787,0.0016263052,0.00058732537,0.00016312701],"category_scores_gemma":[0.003227758,0.00078914495,0.00025492674,0.006046352,0.00037486086,0.001447066,0.00097058236,0.005751072,0.00003312972],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.086134665,0.005646488,0.039457504,0.015414958,0.0053850613,0.0076441015,0.112613246,0.11013397,0.2560989,0.00076651183,0.016316308,0.34438828],"study_design_scores_gemma":[0.074257456,0.004675649,0.53003055,0.0048431684,0.0057954136,0.00048133906,0.052537028,0.11301683,0.13966689,0.0017563503,0.065009326,0.00793],"about_ca_topic_score_codex":0.002107378,"about_ca_topic_score_gemma":0.0011653366,"teacher_disagreement_score":0.49057305,"about_ca_system_score_codex":0.001338084,"about_ca_system_score_gemma":0.0038073882,"threshold_uncertainty_score":0.9994559},"labels":[],"label_agreement":null},{"id":"W6995700058","doi":"","title":"Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review","year":2025,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pace; Identification (biology); Public health; Precision medicine; Personalized medicine; Health care","score_opus":0.6265854639128405,"score_gpt":0.6788041960556664,"score_spread":0.05221873214282591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995700058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19684014,0.78225124,0.0027568184,0.008454979,0.0019175375,0.0063727186,0.0008888332,0.000041101972,0.00047664618],"genre_scores_gemma":[0.12815672,0.85247034,0.00089038344,0.017142735,0.0002578338,0.0007446914,0.00004929247,0.000058900016,0.00022909319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962202,0.00063296803,0.0014554936,0.00066228356,0.00026422492,0.0007648538],"domain_scores_gemma":[0.99427027,0.0030773785,0.0010502937,0.0003008824,0.00055663777,0.000744534],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0058636926,0.00043334687,0.0013847774,0.000611321,0.0008552779,0.00095260364,0.0014137785,0.00020499318,0.0009595719],"category_scores_gemma":[0.0011397381,0.00041568052,0.0002162068,0.00058670837,0.00025104533,0.0013310388,0.00087708666,0.0005144874,0.000002292391],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037220314,0.0012429822,0.041195154,0.09961529,0.0028173162,0.00001903428,0.0012007287,0.0001561126,0.05916956,0.0050779036,0.07448475,0.7112991],"study_design_scores_gemma":[0.011318353,0.000085724394,0.009643387,0.05394827,0.0014075012,0.00004005569,0.0001337598,0.002252787,0.047918808,0.009983246,0.8618552,0.0014128772],"about_ca_topic_score_codex":0.000020809857,"about_ca_topic_score_gemma":0.000012167442,"teacher_disagreement_score":0.7873705,"about_ca_system_score_codex":0.000108206,"about_ca_system_score_gemma":0.0010767926,"threshold_uncertainty_score":0.9999537},"labels":[],"label_agreement":null},{"id":"W6996405248","doi":"","title":"Seçici serotonin gerialım inhibitörü kullanan hastalarda cyp2c19 polimorfizmleri ile advers ilaç reaksiyonu ve hasta uyuncu ilişkisi","year":2013,"lang":"tr","type":"other","venue":"Dspace Repository (Marmara Üniversitesi)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Adverse effect; Hasta; Drug withdrawal","score_opus":0.03375035339542334,"score_gpt":0.3287204149397537,"score_spread":0.29497006154433036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6996405248","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26386008,0.019883037,0.0001066415,0.0018827533,0.021724468,0.0070383204,0.0028301051,0.001081552,0.68159306],"genre_scores_gemma":[0.13732761,0.012092413,0.001113213,0.0034162246,0.0073343064,0.00032734635,0.00083915197,0.001562325,0.8359874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9861857,0.0026158465,0.0020523337,0.0036011026,0.0016846717,0.0038603253],"domain_scores_gemma":[0.9905527,0.0006913374,0.0026727926,0.0020695115,0.0009137474,0.0030998983],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0013682882,0.0034131599,0.0032662598,0.0017211265,0.0021576772,0.00059231784,0.0027545802,0.0041576484,0.03367033],"category_scores_gemma":[0.00011291448,0.0038893046,0.0016800516,0.0014824943,0.0018122443,0.00077961833,0.001960296,0.004839253,0.008821461],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002473267,0.0018416293,0.007919437,0.0010918102,0.0056410977,0.004179894,0.0039590346,0.00087427185,0.23698771,0.00048686753,0.7289315,0.005613492],"study_design_scores_gemma":[0.008621823,0.00040026486,0.0014084978,0.00044146614,0.004008149,0.00054005114,0.0020481893,0.0023693668,0.061389156,0.000033654913,0.915081,0.0036583333],"about_ca_topic_score_codex":0.0012314428,"about_ca_topic_score_gemma":0.00007022941,"teacher_disagreement_score":0.18614957,"about_ca_system_score_codex":0.0013354555,"about_ca_system_score_gemma":0.0015955068,"threshold_uncertainty_score":0.9991414},"labels":[],"label_agreement":null},{"id":"W7008752584","doi":"","title":"CYP2D in the Brain Alters Response to Drugs and Neurotoxins","year":2021,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Canada Research Chairs; Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"Genetically modified mouse; Transgene; In vivo; Methamphetamine; Drug; Hypothermia; Human brain","score_opus":0.07343712034392316,"score_gpt":0.47987211672203617,"score_spread":0.406434996378113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7008752584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438834,0.009041043,0.000015904925,0.035559088,0.0039829,0.0024656446,0.00014919255,0.00003297577,0.004869856],"genre_scores_gemma":[0.9180123,0.0055439984,0.00011547831,0.053556427,0.0006397125,0.00054094783,0.0002321927,0.0001336109,0.02122529],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.987997,0.007930201,0.00091201713,0.0013203778,0.0005905347,0.0012498773],"domain_scores_gemma":[0.9940119,0.0039670835,0.00036598288,0.0007214486,0.00020600554,0.0007275786],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052652657,0.0009472745,0.00094473193,0.0006026155,0.0006099743,0.0002107114,0.001020204,0.0009139265,0.001522742],"category_scores_gemma":[0.0009174563,0.0008841775,0.0002690153,0.0013149665,0.00024327978,0.0000932498,0.00027484464,0.0031099624,0.00019285678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011540157,0.0008310294,0.0007599871,0.0003192753,0.00031062015,0.00086709345,0.35590658,0.00086689554,0.5858315,0.00028867618,0.015497374,0.026980797],"study_design_scores_gemma":[0.005047962,0.00035294445,0.034210123,0.00016233663,0.00070007995,0.00009080307,0.046309296,0.0014605502,0.077372745,0.000107273,0.8328909,0.0012949714],"about_ca_topic_score_codex":0.00014928466,"about_ca_topic_score_gemma":0.00018564338,"teacher_disagreement_score":0.81739354,"about_ca_system_score_codex":0.00008907662,"about_ca_system_score_gemma":0.00066420756,"threshold_uncertainty_score":0.99939},"labels":[],"label_agreement":null},{"id":"W7010145448","doi":"","title":"How community pharmacy pharmacogenomics testing services around the world can inform their design and delivery in the UK","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacy; Community pharmacy; Pharmacist; Service delivery framework; Service (business); Community pharmacist; Work (physics); Clinical pharmacy","score_opus":0.27101327059000685,"score_gpt":0.4099585461878017,"score_spread":0.13894527559779485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7010145448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9020208,0.017687356,0.000013711775,0.009655035,0.0010350541,0.0036815698,0.049037356,0.00020038552,0.016668743],"genre_scores_gemma":[0.97143996,0.00033950165,0.00009660256,0.024636112,0.00027769912,0.00046295064,0.0023094185,0.000026196476,0.00041155767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700075,0.0015857759,0.0003687551,0.000269704,0.00016972916,0.0006053061],"domain_scores_gemma":[0.99444157,0.004643353,0.00020321755,0.0003998287,0.00017233752,0.00013970768],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013296106,0.00039253352,0.0002984521,0.00021101898,0.0012197478,0.00033126885,0.001432388,0.00012284274,0.0024078062],"category_scores_gemma":[0.00022196565,0.0002570163,0.0000881527,0.0009249256,0.00009379497,0.00018280864,0.000547527,0.002140885,0.00003798524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012926585,0.0013008621,0.033399858,0.0022990787,0.0017002026,0.00020374505,0.03228121,0.012411551,0.05216036,0.00064066594,0.36336237,0.49894744],"study_design_scores_gemma":[0.0025572504,0.00002527827,0.0036349217,0.0002551987,0.0002195235,0.000031684784,0.002660801,0.04041446,0.030554334,0.0006746667,0.9185501,0.00042181436],"about_ca_topic_score_codex":0.00017559815,"about_ca_topic_score_gemma":0.0005876249,"teacher_disagreement_score":0.5551877,"about_ca_system_score_codex":0.00006494863,"about_ca_system_score_gemma":0.00022804509,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W7010550741","doi":"","title":"Investigations of the biocatalytic activity of human P450 2D6","year":2007,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; McGill University; University of Wisconsin-Madison; Vanderbilt University","keywords":"Enzyme; Limiting; Substrate (aquarium); Cytochrome P450; Drug; Oxygen atom","score_opus":0.09565551814055319,"score_gpt":0.41201519453783064,"score_spread":0.31635967639727747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7010550741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9242235,0.00070681,1.0793218e-7,0.000026865859,0.0026848135,0.0008886127,0.0024532215,0.000067118024,0.06894899],"genre_scores_gemma":[0.9930281,0.00033977456,0.00009208221,0.00040427432,0.000101550395,0.000068951296,0.000382195,0.00012952751,0.005453534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956463,0.0009318269,0.0012490256,0.0007355801,0.00072592264,0.00071134703],"domain_scores_gemma":[0.99601364,0.0004986635,0.001579992,0.00086852035,0.0006034025,0.00043577436],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018680746,0.000703595,0.0009670202,0.0004942203,0.0011207886,0.000015023154,0.001305086,0.0013593618,0.000591336],"category_scores_gemma":[0.00056222937,0.0006394277,0.0006425189,0.0010354586,0.00050736597,0.0002275784,0.00024995222,0.0029396538,0.00006510628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019155409,0.00059009774,0.00022426146,0.0004985119,0.0005132145,0.000007998095,0.000035870635,0.00008183271,0.92720956,0.027862659,0.000024723096,0.042759705],"study_design_scores_gemma":[0.0012114823,0.00007459116,0.007492147,0.00014866688,0.0011438822,0.0000071235595,0.000075914395,0.00003857851,0.933373,0.010652627,0.045226663,0.00055537],"about_ca_topic_score_codex":0.00024750244,"about_ca_topic_score_gemma":0.00054487784,"teacher_disagreement_score":0.06880465,"about_ca_system_score_codex":0.0002015392,"about_ca_system_score_gemma":0.00018898294,"threshold_uncertainty_score":0.99993706},"labels":[],"label_agreement":null},{"id":"W7017925180","doi":"","title":"Considerations for the implementation of pharmacogenomic (PGx) testing to guide antidepressant prescribing in primary care in Ontario, Canada","year":2024,"lang":"en","type":"dissertation","venue":"MacSphere (McMaster University)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Association of Physicists","funders":"McMaster University; Canadian Institutes of Health Research; Fondation Brocher","keywords":"Pharmacogenomics; Primary care; Equity (law); Genetic testing; Public health; Variety (cybernetics); Health care; MEDLINE; Feeling","score_opus":0.06927141617500784,"score_gpt":0.34479845397119446,"score_spread":0.2755270377961866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7017925180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8600265,0.0030773156,0.000023016628,0.00019938624,0.0028770186,0.003037426,0.0008680464,0.000029955918,0.12986137],"genre_scores_gemma":[0.9315393,0.00018181348,0.00080624537,0.00092323165,0.0001465538,0.00007245238,0.0005635665,0.00007922542,0.065687604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980963,0.00020110878,0.0005831724,0.00048994634,0.00018656021,0.00044291437],"domain_scores_gemma":[0.9986368,0.000649075,0.00022462978,0.00016180932,0.00020442744,0.0001232733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028474742,0.00032886286,0.00041555215,0.00031366153,0.00017972007,0.000033018172,0.00035353994,0.00019456004,0.010145636],"category_scores_gemma":[0.000028107961,0.00034261163,0.0001028127,0.00043380074,0.00003126075,0.00008814016,0.00012366935,0.00075977115,0.000003913076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019274448,0.00022509797,0.101833925,0.0025628353,0.0011792554,0.0006670736,0.0479273,0.039797455,0.13066061,0.0006218957,0.017092898,0.6555042],"study_design_scores_gemma":[0.00450197,0.000079117526,0.042353567,0.00030051183,0.0012399344,0.000006292956,0.025088524,0.0010271624,0.042064376,0.00009061576,0.8825559,0.0006920345],"about_ca_topic_score_codex":0.71470594,"about_ca_topic_score_gemma":0.9926898,"teacher_disagreement_score":0.865463,"about_ca_system_score_codex":0.0013184008,"about_ca_system_score_gemma":0.0036275007,"threshold_uncertainty_score":0.9999026},"labels":[],"label_agreement":null},{"id":"W7019888970","doi":"","title":"Inhibition of 17beta-estradiol activation by CYP1A1: Genotype- and regioselective inhibition by St. John's wort and several natural polyphenols","year":2011,"lang":"en","type":"article","venue":"MDC Repository (Max-Delbrueck-Center for Molecular Medicine)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Polyphenol; Quercetin; Enzyme; Myricetin; Hydroxytyrosol; Hydroxylation; Flavonols; Resveratrol; Phytoestrogens","score_opus":0.04126108276171334,"score_gpt":0.3254969816386821,"score_spread":0.28423589887696876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7019888970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984726,0.006930626,0.0037817748,0.00036615727,0.0010342445,0.001198391,0.0002082762,0.000065181106,0.0016893491],"genre_scores_gemma":[0.99591154,0.0005492164,0.00042220447,0.001922475,0.00029619053,0.000115502844,0.0004364043,0.000063813175,0.0002826519],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974071,0.00038512348,0.000703858,0.00066289527,0.0003324644,0.00050858594],"domain_scores_gemma":[0.99859864,0.0001052593,0.00045860725,0.00023814624,0.0002660903,0.00033326205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046598422,0.00044673626,0.00056138274,0.00020033152,0.00028121955,0.000021705,0.0001367268,0.0003702567,0.000047039262],"category_scores_gemma":[0.000053549116,0.00041880884,0.00012663694,0.0001979679,0.00049477036,0.00024529328,0.00007781778,0.00060587394,0.0000013875892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009407209,0.00033947284,0.0012432098,0.00012950003,0.00036426392,0.00003901474,0.002056295,0.000005079133,0.9808353,0.0001896001,0.009818005,0.0040395404],"study_design_scores_gemma":[0.0064142128,0.0005611836,0.0018736583,0.00011949272,0.00056806765,0.00016626716,0.00020360525,0.0009529793,0.972332,0.0006216975,0.015719026,0.0004677871],"about_ca_topic_score_codex":0.00011865694,"about_ca_topic_score_gemma":0.0000024224535,"teacher_disagreement_score":0.011185542,"about_ca_system_score_codex":0.00008490742,"about_ca_system_score_gemma":0.00006493392,"threshold_uncertainty_score":0.9998264},"labels":[],"label_agreement":null},{"id":"W7042486716","doi":"","title":"Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Dove Medical Press (Taylor and Francis Group)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pace; Identification (biology); Public health; Precision medicine; Personalized medicine; Health care","score_opus":0.1962153635122578,"score_gpt":0.4787068573117975,"score_spread":0.28249149379953975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7042486716","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010075367,0.7255862,0.23223498,0.022077799,0.0024262047,0.0060758865,0.0010703948,0.0000918212,0.00036137836],"genre_scores_gemma":[0.7805459,0.14127438,0.001483605,0.073363066,0.0008542992,0.0021617599,0.00020358186,0.0000764832,0.000036957692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699724,0.00034784438,0.000884607,0.00071385456,0.00027046254,0.00078598305],"domain_scores_gemma":[0.9952827,0.0029868227,0.00024170011,0.00021367274,0.00017313196,0.0011019508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035145734,0.00037392517,0.00092121644,0.00012295421,0.00060007704,0.00014206512,0.0003254231,0.00035173315,0.00013821117],"category_scores_gemma":[0.0014720781,0.00033028665,0.00013047006,0.00015546581,0.00044229414,0.00023850663,0.00028962974,0.00053757447,0.0000017523181],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005587979,0.00019732685,0.00030552218,0.02975773,0.0002841083,0.0000051604598,0.0005357548,0.000002235285,0.00030422187,0.007272414,0.00033162552,0.9604451],"study_design_scores_gemma":[0.027756318,0.0006098199,0.00031789785,0.0054728566,0.0013552972,0.00007063231,0.00019784465,0.2933688,0.0025391579,0.0048138835,0.66203517,0.001462314],"about_ca_topic_score_codex":0.000010869202,"about_ca_topic_score_gemma":0.000013377025,"teacher_disagreement_score":0.95898277,"about_ca_system_score_codex":0.000036521385,"about_ca_system_score_gemma":0.000051983265,"threshold_uncertainty_score":0.99991494},"labels":[],"label_agreement":null},{"id":"W7071720833","doi":"","title":"St. John's wort對大鼠腸道及肝臟Cytochrome P450活性之影響","year":2006,"lang":"en","type":"article","venue":"NTUR (臺灣機構典藏)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Process (computing); Identification (biology); Product (mathematics)","score_opus":0.07697392021927119,"score_gpt":0.4204090360956205,"score_spread":0.34343511587634934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071720833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8589178,0.006543139,0.0002635853,0.0013825384,0.00427862,0.00063917495,0.00034283032,0.00039519597,0.12723713],"genre_scores_gemma":[0.98141885,0.00059373776,0.000535375,0.004174745,0.002580875,0.00009966066,0.00014106458,0.00008132821,0.010374382],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970663,0.00026808717,0.0006193451,0.00063662545,0.00038130203,0.0010283197],"domain_scores_gemma":[0.998547,0.00022219495,0.0002113253,0.0004470058,0.00015431733,0.00041815822],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00073341903,0.00047148755,0.0004956531,0.00022238665,0.00041726025,0.000061920626,0.0006017995,0.00051282963,0.007453962],"category_scores_gemma":[0.00004347861,0.00045504153,0.00025989846,0.00046122816,0.00027002458,0.00015505374,0.00018946148,0.0010641463,0.0013735673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006646594,0.0020729434,0.018416278,0.00014326336,0.00058570266,0.00071211625,0.0006033473,0.0049182978,0.37858474,0.03529807,0.47897327,0.07902732],"study_design_scores_gemma":[0.0024583847,0.000058019697,0.013725856,0.000009111667,0.00023617568,0.00005348865,0.00002892549,0.0012876433,0.05122537,0.006695964,0.9236333,0.00058778963],"about_ca_topic_score_codex":0.00009440072,"about_ca_topic_score_gemma":0.000048912865,"teacher_disagreement_score":0.44466,"about_ca_system_score_codex":0.00008116546,"about_ca_system_score_gemma":0.00013861348,"threshold_uncertainty_score":0.99979013},"labels":[],"label_agreement":null},{"id":"W7074687273","doi":"","title":"Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape","year":2018,"lang":"en","type":"book","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; ADME; Drug; Bioequivalence; Drug metabolism; Pharmacy; Drug development","score_opus":0.05875969595178177,"score_gpt":0.37317114679606217,"score_spread":0.3144114508442804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7074687273","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022897568,0.22011642,0.000012404147,0.0034342906,0.018056141,0.0019613956,0.0010334668,0.0000977395,0.7323906],"genre_scores_gemma":[0.08527572,0.11635711,0.000102931794,0.017501857,0.0088096885,0.00028102042,0.00034277356,0.00031162985,0.77101725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964851,0.00061069784,0.0008142923,0.000722902,0.00048066347,0.00088634086],"domain_scores_gemma":[0.9979072,0.00068850024,0.0003259639,0.00042567318,0.00017206017,0.00048057784],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011783089,0.0007421254,0.00082076,0.00022164598,0.00025122127,0.000045786717,0.00084557396,0.00028534696,0.004217428],"category_scores_gemma":[0.000041982898,0.0005367351,0.00013246729,0.00019702277,0.00036878392,0.00005610303,0.0004869874,0.0029865233,0.00013370365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000938323,0.000068075155,0.0005529648,0.000100922734,0.00024031177,0.000049322225,0.00031999216,0.00006272416,0.00009968283,0.00168252,0.86969745,0.12703219],"study_design_scores_gemma":[0.0018195367,0.00000780159,0.000934485,0.0000308339,0.00069407094,0.000017318314,0.000030216,0.0019330289,0.00091423537,0.0021126296,0.99086726,0.00063860946],"about_ca_topic_score_codex":0.036358427,"about_ca_topic_score_gemma":0.42713907,"teacher_disagreement_score":0.39078066,"about_ca_system_score_codex":0.00027712874,"about_ca_system_score_gemma":0.0043011014,"threshold_uncertainty_score":0.9997084},"labels":[],"label_agreement":null},{"id":"W7094654196","doi":"","title":"Association of tardive dyskinesia with variation in CYP2D6:Is there a role for active metabolites?","year":2014,"lang":"en","type":"article","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Association (psychology); Tardive dyskinesia; Variation (astronomy); Disease; Action (physics)","score_opus":0.035765183948282486,"score_gpt":0.37283603540500626,"score_spread":0.3370708514567238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7094654196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97452676,0.00053507136,0.00445596,0.0015466709,0.00043239884,0.00094719126,0.00023133699,0.000039063998,0.01728552],"genre_scores_gemma":[0.9955861,0.00016764076,0.0014721119,0.0013454745,0.00020618948,0.00014294514,0.000024005358,0.00002226475,0.0010332646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985391,0.0003649076,0.0003215564,0.00026574815,0.00018066597,0.000328038],"domain_scores_gemma":[0.99858415,0.0005674011,0.00033069018,0.00012865434,0.0002953558,0.00009373294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001020553,0.00017982941,0.00036272468,0.00013250973,0.000070350725,0.000010687229,0.00015777067,0.00024462075,0.00057443517],"category_scores_gemma":[0.00012610288,0.00014718137,0.00009032361,0.00024953132,0.00003266063,0.000116561256,0.00003083155,0.00025563085,0.00001733004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042628897,0.0017502072,0.18144873,0.00019520402,0.0026134448,0.0000031457057,0.013357615,0.0044515166,0.66463494,0.040680278,0.0041425885,0.08245946],"study_design_scores_gemma":[0.008103289,0.00020110761,0.16061361,0.000011441678,0.00082364737,0.0000015911181,0.00021759215,0.030209085,0.5468667,0.008854752,0.24371819,0.00037894666],"about_ca_topic_score_codex":0.00006960848,"about_ca_topic_score_gemma":0.000060848484,"teacher_disagreement_score":0.23957561,"about_ca_system_score_codex":0.000061268314,"about_ca_system_score_gemma":0.000066686196,"threshold_uncertainty_score":0.6289662},"labels":[],"label_agreement":null},{"id":"W7104262049","doi":"10.71781/4834","title":"Identification de déterminants pharmacogénétiques prédictifs des concentrations des médicaments à l’aide de grandes cohortes observationnelles","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statistical analysis; Negative therapeutic reaction","score_opus":0.043698578052791565,"score_gpt":0.3170707835724838,"score_spread":0.2733722055196922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7104262049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91377467,0.07477551,0.0009011237,0.00036099405,0.0027580198,0.0009949089,0.00087587023,0.00017879717,0.0053801034],"genre_scores_gemma":[0.9273965,0.038047556,0.0015359233,0.00070816535,0.00045247603,0.0003613217,0.0015985634,0.00008555638,0.029813953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99446946,0.0016311643,0.0010305456,0.00093892094,0.0007076012,0.001222297],"domain_scores_gemma":[0.99662375,0.0005131747,0.0009337892,0.0003648995,0.00061199866,0.0009524005],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012451261,0.00077941845,0.00064135285,0.0004228472,0.019317795,0.0001678915,0.00091638375,0.0007459827,0.0012934654],"category_scores_gemma":[0.00020716747,0.0010077464,0.00048471495,0.0006486878,0.0014342453,0.00073032966,0.00025624828,0.0013545376,0.000058173977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015627652,0.001401992,0.31525493,0.0005464327,0.0016384344,0.001254266,0.081318006,0.016162353,0.55283326,0.0056749345,0.0017157748,0.020636832],"study_design_scores_gemma":[0.0042383918,0.00015753403,0.25486875,0.00028394003,0.0043461095,0.000980665,0.038195115,0.0287215,0.5192853,0.0031369678,0.14444815,0.0013375831],"about_ca_topic_score_codex":0.013048452,"about_ca_topic_score_gemma":0.0034526007,"teacher_disagreement_score":0.14273237,"about_ca_system_score_codex":0.00792089,"about_ca_system_score_gemma":0.004243853,"threshold_uncertainty_score":0.9996195},"labels":[],"label_agreement":null},{"id":"W7105695419","doi":"10.1136/bmjdhai-2025-000134","title":"Retrospective evaluation of a machine learning model to facilitate pharmacogenetic testing","year":2025,"lang":"en","type":"article","venue":"BMJ Digital Health & AI","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Pharmacogenetics; Logistic regression; Medical prescription; Epidemiology; Retrospective cohort study; Cohort; Gradient boosting","score_opus":0.3195143293878861,"score_gpt":0.5259982311863415,"score_spread":0.20648390179845538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7105695419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92311895,0.01107543,0.0060424055,0.008592243,0.0015537392,0.004439671,0.0011404052,0.0002349301,0.043802224],"genre_scores_gemma":[0.9899352,0.00017449373,0.00081038417,0.006916897,0.00012293515,0.00021884807,0.00005136677,0.000028645534,0.0017412392],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99681664,0.000584036,0.0008725676,0.00051941106,0.00054374494,0.00066358305],"domain_scores_gemma":[0.9979783,0.00024920268,0.00028535756,0.0002230092,0.00083929836,0.00042483205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030173173,0.00029788498,0.0005072621,0.0003310627,0.0003126476,0.000040478004,0.00028888884,0.0001336885,0.00012287594],"category_scores_gemma":[0.0009700279,0.00031182292,0.00011842363,0.0008616209,0.00010013291,0.00016249955,0.00020377256,0.0007418166,0.00007085801],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045383174,0.00034666847,0.01837206,0.000294786,0.00020104984,0.000003917029,0.0016149628,0.3080407,0.016464472,0.00062240753,0.00466164,0.6489235],"study_design_scores_gemma":[0.003041827,0.0002183802,0.0032892886,0.000083535706,0.00020250026,0.0000065675003,0.00006819222,0.9361272,0.007387252,0.0051678224,0.044095192,0.00031223954],"about_ca_topic_score_codex":0.000046357156,"about_ca_topic_score_gemma":0.000012965513,"teacher_disagreement_score":0.64861125,"about_ca_system_score_codex":0.00027966686,"about_ca_system_score_gemma":0.0011965057,"threshold_uncertainty_score":0.99993336},"labels":[],"label_agreement":null},{"id":"W7106551209","doi":"10.5281/zenodo.17693347","title":"Diverse Ligands for Mycobacterial CYP124 Identified from Plant and Marine Compounds","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Russian Science Foundation; Belarusian Republican Foundation for Fundamental Research","keywords":"Docking (animal); Molecular model; DNA; Genome","score_opus":0.09760576493939019,"score_gpt":0.36710833091511547,"score_spread":0.2695025659757253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7106551209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427109,0.00037466115,0.001038477,0.0010635074,0.0021916763,0.00088205806,0.004674595,0.0004423633,0.046621773],"genre_scores_gemma":[0.9911059,0.0006695847,0.00015447459,0.0009487006,0.0004964811,3.0012566e-7,0.004588019,0.00035126528,0.0016852741],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987,0.00019010714,0.00026051747,0.00038353718,0.00012974936,0.0003360448],"domain_scores_gemma":[0.9991598,0.00011201839,0.00008439962,0.00020236189,0.00024534308,0.00019604493],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006159489,0.0001607201,0.00020231733,0.00017648736,0.0017007894,0.00034277825,0.0005385845,0.00013242802,0.0065693753],"category_scores_gemma":[0.00018530402,0.00017114906,0.00005581965,0.00021383524,0.00018131008,0.00010541504,0.0012127544,0.00031088403,0.0004757994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018007136,0.00037686137,0.00018662632,0.00012447333,0.0004827462,0.00002176604,0.0011705995,0.000021847995,0.4658556,0.011139309,0.3595505,0.15926895],"study_design_scores_gemma":[0.0028263198,0.000069848946,0.0023709214,0.000011200731,0.00014763339,0.000012147282,0.00012955736,0.0013100457,0.023516217,0.0013844441,0.96805257,0.00016909766],"about_ca_topic_score_codex":0.000028182048,"about_ca_topic_score_gemma":0.000001462945,"teacher_disagreement_score":0.6085021,"about_ca_system_score_codex":0.000047898015,"about_ca_system_score_gemma":0.0000067319806,"threshold_uncertainty_score":0.99959886},"labels":[],"label_agreement":null},{"id":"W7106572479","doi":"10.5281/zenodo.17693346","title":"Diverse Ligands for Mycobacterial CYP124 Identified from Plant and Marine Compounds","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Russian Science Foundation; Belarusian Republican Foundation for Fundamental Research","keywords":"Docking (animal); Molecular model; Binding site; Sequence homology; File format","score_opus":0.09760576493939019,"score_gpt":0.36710833091511547,"score_spread":0.2695025659757253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7106572479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427109,0.00037466115,0.001038477,0.0010635074,0.0021916763,0.00088205806,0.004674595,0.0004423633,0.046621773],"genre_scores_gemma":[0.9911059,0.0006695847,0.00015447459,0.0009487006,0.0004964811,3.0012566e-7,0.004588019,0.00035126528,0.0016852741],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987,0.00019010714,0.00026051747,0.00038353718,0.00012974936,0.0003360448],"domain_scores_gemma":[0.9991598,0.00011201839,0.00008439962,0.00020236189,0.00024534308,0.00019604493],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006159489,0.0001607201,0.00020231733,0.00017648736,0.0017007894,0.00034277825,0.0005385845,0.00013242802,0.0065693753],"category_scores_gemma":[0.00018530402,0.00017114906,0.00005581965,0.00021383524,0.00018131008,0.00010541504,0.0012127544,0.00031088403,0.0004757994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018007136,0.00037686137,0.00018662632,0.00012447333,0.0004827462,0.00002176604,0.0011705995,0.000021847995,0.4658556,0.011139309,0.3595505,0.15926895],"study_design_scores_gemma":[0.0028263198,0.000069848946,0.0023709214,0.000011200731,0.00014763339,0.000012147282,0.00012955736,0.0013100457,0.023516217,0.0013844441,0.96805257,0.00016909766],"about_ca_topic_score_codex":0.000028182048,"about_ca_topic_score_gemma":0.000001462945,"teacher_disagreement_score":0.6085021,"about_ca_system_score_codex":0.000047898015,"about_ca_system_score_gemma":0.0000067319806,"threshold_uncertainty_score":0.99959886},"labels":[],"label_agreement":null},{"id":"W7116127768","doi":"10.5530/gjpb.2025.3.7","title":"Drug Repurposing in Personalized Medicine: Translational Pathways and Recommendations","year":2025,"lang":"en","type":"article","venue":"German Journal of Pharmaceuticals and Biomaterials","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"","keywords":"Repurposing; Drug repositioning; Personalized medicine; Translational medicine; Precision medicine; Translational research; Drug development; Big data; Psychological intervention","score_opus":0.10874218594624126,"score_gpt":0.4791589097608413,"score_spread":0.37041672381460006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116127768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95960367,0.022978162,0.00011356755,0.014235378,0.0018734691,0.00026054055,0.00006864396,0.000015178991,0.0008513972],"genre_scores_gemma":[0.9814375,0.014625181,0.0005261731,0.0029092568,0.0003463368,0.000009063013,0.0000102958265,0.00001259343,0.00012357952],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99753314,0.0007506599,0.001014407,0.00022519441,0.00016152427,0.00031504428],"domain_scores_gemma":[0.9987555,0.00047605185,0.00028953995,0.00007316144,0.00013580029,0.00026991774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028288127,0.00021866513,0.00053810596,0.00041177185,0.0001862943,0.00004583946,0.00016138257,0.00013960147,0.0009637572],"category_scores_gemma":[0.000086486405,0.0001766914,0.00006995401,0.00024533912,0.00042167472,0.00016539171,0.00006354829,0.00025612267,0.0000026551868],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005825127,0.00015569675,0.0021835982,0.00013541861,0.0001873477,0.000057769324,0.001996257,0.0000053225326,0.9229847,0.0067958888,0.0029404769,0.061975002],"study_design_scores_gemma":[0.012029186,0.0000865087,0.005945532,0.00036116794,0.0007259066,0.00034729898,0.00041320286,0.0010673901,0.3586516,0.017062766,0.6029126,0.0003968102],"about_ca_topic_score_codex":0.000004923497,"about_ca_topic_score_gemma":0.0000016558125,"teacher_disagreement_score":0.5999721,"about_ca_system_score_codex":0.000023059958,"about_ca_system_score_gemma":0.000100648984,"threshold_uncertainty_score":0.9999495},"labels":[],"label_agreement":null},{"id":"W7117141376","doi":"10.1111/cts.70458","title":"Tutorial Drug–Drug Interactions","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacodynamics; Population; Categorical variable; Drug; Variation (astronomy); Drug development; Socioeconomic status","score_opus":0.16183317808154946,"score_gpt":0.5523489411735696,"score_spread":0.39051576309202013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117141376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92143446,0.0013097422,0.0005369824,0.011610029,0.011899799,0.00022875016,0.000050145536,0.00005269265,0.05287741],"genre_scores_gemma":[0.99332446,0.00035102718,0.00045465358,0.0025154308,0.00068021874,0.000011404826,0.0000044296285,0.0000031473985,0.002655238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867773,0.00016096649,0.0003965219,0.00035058247,0.0001756012,0.00023861256],"domain_scores_gemma":[0.9986007,0.00090161216,0.000049367016,0.0000906141,0.00012320965,0.00023445497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017341824,0.0001016131,0.00015541671,0.000108633176,0.00052034314,0.000037703725,0.00025484464,0.0000464002,0.00050313794],"category_scores_gemma":[0.00014415829,0.000088107394,0.00008339235,0.00043779338,0.0013496083,0.00017194131,0.00005932906,0.0004957373,0.00004549431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005497686,0.00095796504,0.27846825,0.00003328719,0.00016293088,0.000010236611,0.0007223642,0.00048862153,0.018707192,0.23034987,0.014307507,0.455242],"study_design_scores_gemma":[0.0015320154,0.000006949549,0.13117927,0.00000916223,0.00009620647,0.000003105359,0.000020282907,0.0058869086,0.0036208902,0.025654813,0.83185315,0.00013722153],"about_ca_topic_score_codex":0.000011389764,"about_ca_topic_score_gemma":0.000019569301,"teacher_disagreement_score":0.81754565,"about_ca_system_score_codex":0.0000058254836,"about_ca_system_score_gemma":0.00030675143,"threshold_uncertainty_score":0.55090076},"labels":[],"label_agreement":null},{"id":"W7117709703","doi":"10.1016/j.athoracsur.2025.12.018","title":"Toward Personalized Neoadjuvant Strategies: Using Metabolic and Biological Response to Guide Treatment Deescalation or Intensification","year":2025,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"MEDLINE; Risk assessment; Neoadjuvant therapy; Precision medicine","score_opus":0.5424871994095962,"score_gpt":0.5634544153078072,"score_spread":0.020967215898210934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117709703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814507,0.008221104,0.001058679,0.007941918,0.0005579238,0.00042913452,0.0000523103,0.00003836613,0.00024986741],"genre_scores_gemma":[0.9871391,0.008300669,0.00034578278,0.003505851,0.00010544635,0.00004814934,0.000012266093,0.0000123865675,0.00053035875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969559,0.0017493604,0.0005410224,0.00029652027,0.00012399565,0.00033321878],"domain_scores_gemma":[0.9968066,0.0023378455,0.00019359209,0.00024383262,0.00026638276,0.00015171921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003395164,0.00022485381,0.00051095436,0.00028129242,0.00019912254,0.00003409594,0.00017684429,0.0001643039,0.00017788402],"category_scores_gemma":[0.00073880365,0.00013753599,0.00017106891,0.00048946793,0.00025077298,0.00008225245,0.00009096966,0.00016636013,0.000009962374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027384942,0.00041221952,0.004787155,0.00006549527,0.0007688393,0.000029199364,0.0036151328,0.0012930396,0.54650766,0.0016380479,0.0032369804,0.4102613],"study_design_scores_gemma":[0.0005819014,0.00014617592,0.023504319,0.0000893658,0.00057451695,0.00003720674,0.0028096735,0.006535114,0.5057773,0.0019046969,0.4576495,0.00039024418],"about_ca_topic_score_codex":0.00007518281,"about_ca_topic_score_gemma":0.0000042174674,"teacher_disagreement_score":0.45441252,"about_ca_system_score_codex":0.000023890287,"about_ca_system_score_gemma":0.00034264277,"threshold_uncertainty_score":0.5608555},"labels":[],"label_agreement":null},{"id":"W7128294010","doi":"10.33545/26174693.2024.v8.i7c.7431","title":"mRNA expression changes following drug treatment and pharmacogenomic responses","year":2024,"lang":"","type":"article","venue":"International Journal of Advanced Biochemistry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Pharmacogenetics; Drug; CYP2D6; Gene expression; Drug metabolism; Genotype; Gene; Messenger RNA; Peripheral blood mononuclear cell","score_opus":0.1543513701918684,"score_gpt":0.5402486620865178,"score_spread":0.3858972918946494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7128294010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8010926,0.18135157,0.000009672924,0.00735532,0.008597207,0.00028075557,0.00032544692,0.000022133907,0.00096524484],"genre_scores_gemma":[0.87108046,0.118004255,0.00037865003,0.00022519937,0.0040660193,0.000030544954,0.000018990977,0.00006233677,0.006133533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99525833,0.0010176413,0.00095920236,0.0006995384,0.0012221319,0.0008431483],"domain_scores_gemma":[0.9956005,0.001995459,0.00033321523,0.0002252599,0.0010500308,0.0007955106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036337778,0.00050098426,0.0005662374,0.0008556254,0.00037062695,0.00037971415,0.0010997913,0.00033214645,0.00085978454],"category_scores_gemma":[0.00032494805,0.00043830136,0.00043518058,0.00039175342,0.0005042314,0.00028767204,0.00050602795,0.002129326,0.000047289002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003437775,0.00043939298,0.00020933703,0.00014182381,0.001790412,0.0023986397,0.0013196226,0.00013113237,0.8273775,0.000025916277,0.0017067158,0.16102171],"study_design_scores_gemma":[0.0029186173,0.00023326895,0.000018109025,0.00052013184,0.0002665385,0.000495383,0.0007454264,0.00077327504,0.71400094,0.00045656346,0.2793013,0.0002704647],"about_ca_topic_score_codex":0.000007374399,"about_ca_topic_score_gemma":0.0000014260614,"teacher_disagreement_score":0.27759457,"about_ca_system_score_codex":0.00077248266,"about_ca_system_score_gemma":0.0011559386,"threshold_uncertainty_score":0.9998069},"labels":[],"label_agreement":null},{"id":"W7128309113","doi":"10.1093/jpp/rgaf132","title":"Observed tamoxifen drug interactions are dependent on both CYP2D6 phenotype and inhibitor potency","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmacy and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"CYP2D6; Tamoxifen; Potency; Drug; Phenotype; Clinical Practice","score_opus":0.09420184754445299,"score_gpt":0.4327028005211361,"score_spread":0.3385009529766831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7128309113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95871866,0.01576411,0.000102589285,0.008972625,0.011476071,0.00051287236,0.0001043889,0.00004867077,0.004300023],"genre_scores_gemma":[0.9709317,0.008802224,0.00019996354,0.01592766,0.0016226796,0.000032425094,0.000005672074,0.00003858542,0.0024390982],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99637824,0.0010866194,0.0011165064,0.00048814033,0.00028437088,0.00064610515],"domain_scores_gemma":[0.9970358,0.00097583985,0.00083300035,0.00015775798,0.00036019713,0.00063741545],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014533965,0.00050091493,0.0007973162,0.0006264123,0.0005055711,0.000062247214,0.0004614273,0.0001591468,0.0014241785],"category_scores_gemma":[0.0001052256,0.00045128993,0.00021571673,0.00037295112,0.00034224935,0.00034384354,0.00026606486,0.0022495354,0.000029412748],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008015367,0.0022934948,0.027345017,0.00041451486,0.0022337441,0.0007066165,0.001935871,0.00096242595,0.73202187,0.0013246826,0.10305264,0.11969376],"study_design_scores_gemma":[0.013548531,0.0001717653,0.0053204508,0.000080994105,0.0017575762,0.00024668197,0.00026969292,0.0024961547,0.26971763,0.0016704508,0.7042387,0.00048136577],"about_ca_topic_score_codex":0.000037131977,"about_ca_topic_score_gemma":0.00001639119,"teacher_disagreement_score":0.60118604,"about_ca_system_score_codex":0.00010555392,"about_ca_system_score_gemma":0.00026879425,"threshold_uncertainty_score":0.9997939},"labels":[],"label_agreement":null},{"id":"W7131959576","doi":"","title":"Pharmacogenetics in practice:Barriers and facilitators. Pharmacists take action in implementing pharmacogenetics","year":2024,"lang":"","type":"article","venue":"Pure Amsterdam UMC","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Pharmacogenetics; Action (physics); MEDLINE; Precision medicine; Genetic testing","score_opus":0.08252785550645766,"score_gpt":0.46974927788764886,"score_spread":0.38722142238119117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7131959576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81528544,0.15706466,0.00011437616,0.0031892613,0.013186847,0.0029757293,0.0015058041,0.00024031411,0.0064375596],"genre_scores_gemma":[0.8539458,0.13817678,0.0004455513,0.004110679,0.0017255935,0.00041254543,0.00011730056,0.00027528062,0.0007904494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9858694,0.003453817,0.0031979834,0.0027365098,0.001108005,0.0036342836],"domain_scores_gemma":[0.99473375,0.001699632,0.00063380896,0.00063025963,0.00032879712,0.001973722],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0061089797,0.0018799569,0.0015511004,0.0020363217,0.00069181225,0.000684203,0.0010509079,0.0011951935,0.004104002],"category_scores_gemma":[0.00033759308,0.002203041,0.00047825952,0.0026851324,0.00084007834,0.0011494152,0.0010689849,0.0053417473,0.00037078542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030192314,0.0015620763,0.05131493,0.0040764012,0.0029492786,0.00588793,0.016540755,0.00405297,0.2222008,0.0008895912,0.006303247,0.68120277],"study_design_scores_gemma":[0.011805826,0.0002615695,0.0014050831,0.000323674,0.0033997514,0.0006898504,0.003097423,0.11228476,0.06337581,0.00096956006,0.7999705,0.002416188],"about_ca_topic_score_codex":0.000090357935,"about_ca_topic_score_gemma":0.0001253079,"teacher_disagreement_score":0.79366726,"about_ca_system_score_codex":0.00068601925,"about_ca_system_score_gemma":0.001064758,"threshold_uncertainty_score":0.9993945},"labels":[],"label_agreement":null},{"id":"W7132895060","doi":"","title":"CYP2D in the Brain Impacts Response to Opioids","year":2025,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Opioid; Oxycodone; Endogeny; Agonist; Hormone; Endogenous opioid","score_opus":0.09348131980174242,"score_gpt":0.517528146086346,"score_spread":0.4240468262846036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132895060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9088859,0.011235445,0.00004644417,0.04005816,0.008007049,0.0031480966,0.00021656282,0.000060187096,0.02834215],"genre_scores_gemma":[0.874111,0.0038992383,0.00012509689,0.04777642,0.0008501209,0.000546708,0.00029874477,0.00010127129,0.0722914],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98725355,0.0077354014,0.0012528794,0.0012626494,0.000714579,0.0017809519],"domain_scores_gemma":[0.99199075,0.0054399027,0.00045620135,0.0010256281,0.0003187762,0.0007687582],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.008588668,0.0011783468,0.0011593861,0.0012243759,0.00071438326,0.00019007499,0.0021755747,0.0016235041,0.0024350279],"category_scores_gemma":[0.0022801582,0.0010389482,0.00045818303,0.0024780943,0.00015569934,0.00010193735,0.000276598,0.00405316,0.0008078661],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038188342,0.001966493,0.0012355715,0.000811582,0.00080190715,0.0006728847,0.21183413,0.003857981,0.5451785,0.0014004983,0.14752686,0.046525296],"study_design_scores_gemma":[0.004531484,0.00036500947,0.028235907,0.00028422297,0.0007895414,0.000020008702,0.015250879,0.0010984818,0.061343182,0.00030665597,0.8866374,0.0011372525],"about_ca_topic_score_codex":0.00035464915,"about_ca_topic_score_gemma":0.00068918883,"teacher_disagreement_score":0.7391105,"about_ca_system_score_codex":0.00026209827,"about_ca_system_score_gemma":0.002034321,"threshold_uncertainty_score":0.99997014},"labels":[],"label_agreement":null},{"id":"W7132978064","doi":"","title":"Meta-analysis of the data on differences in the exposure to psychiatric drugs between poor and normal cYP2C19/CYP2D6 metabolizers","year":2022,"lang":"sr","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Pharmacogenetics; Psychosis; Significant difference","score_opus":0.24703097666292717,"score_gpt":0.42380895361854004,"score_spread":0.17677797695561287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132978064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9136582,0.06426994,0.000009108057,0.0075172256,0.004474016,0.002007104,0.0059910812,0.000035345765,0.0020379678],"genre_scores_gemma":[0.98471755,0.0018010224,0.0000569849,0.011054857,0.00078652345,0.00036573157,0.0001494308,0.00006736574,0.0010005208],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9847421,0.009119282,0.001873735,0.0015537805,0.0016406538,0.001070462],"domain_scores_gemma":[0.99434936,0.0018306151,0.0011075266,0.0021029464,0.00014102517,0.00046855578],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005148015,0.0009114844,0.0023615938,0.0010496321,0.0018167631,0.00013003609,0.005321468,0.00020706849,0.0013787133],"category_scores_gemma":[0.000067105975,0.00061346445,0.0014268329,0.004184726,0.00047566186,0.0002214574,0.0027636893,0.0030529622,0.000014807324],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036464988,0.005763427,0.36114833,0.00039406115,0.47538477,0.00023982937,0.043484107,0.021712108,0.028318172,0.00090099813,0.037011135,0.021996548],"study_design_scores_gemma":[0.0044927387,0.00035714044,0.07409041,0.0000053959952,0.60758716,0.00004196377,0.0029307532,0.0051602772,0.015629621,0.0000674058,0.28847656,0.001160588],"about_ca_topic_score_codex":0.00080325245,"about_ca_topic_score_gemma":0.000050764862,"teacher_disagreement_score":0.2870579,"about_ca_system_score_codex":0.00008821855,"about_ca_system_score_gemma":0.00039207417,"threshold_uncertainty_score":0.99963164},"labels":[],"label_agreement":null},{"id":"W7132979001","doi":"","title":"Effects of human milk and formula on the transcriptional regulation of cytochrome P450 3A4 in HepG2 cells","year":2004,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heritage; Library and Archives Canada","funders":"","keywords":"CYP3A4; Pregnane X receptor; Transfection; Reporter gene; Transcriptional regulation; Caffeine; Messenger RNA; Gene expression","score_opus":0.05376511226784259,"score_gpt":0.42202314672170227,"score_spread":0.3682580344538597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132979001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867582,0.007387125,0.000025070818,0.00030969837,0.000965782,0.0021232348,0.00009092914,0.000012841267,0.002327136],"genre_scores_gemma":[0.99352026,0.0038543437,0.00006111464,0.00033242328,0.00019338833,0.000121143334,0.00016710254,0.00006367626,0.0016865721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964426,0.0008693941,0.0010555815,0.0005877408,0.00050250255,0.0005421912],"domain_scores_gemma":[0.99746907,0.0009644358,0.0008569241,0.0002879135,0.0002211945,0.00020048178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00100862,0.0006332381,0.0009659919,0.00046705926,0.00028989406,0.000017039976,0.0004074194,0.00092109374,0.0008659983],"category_scores_gemma":[0.000052192114,0.00056629966,0.00030076315,0.0004495127,0.0004367832,0.00008044616,0.000042121268,0.0013098215,0.000013757618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012883091,0.0010730271,0.000094448944,0.0020890008,0.00031757602,0.000011657838,0.018259183,0.0020939836,0.9605433,0.012815876,0.000076504395,0.0013371683],"study_design_scores_gemma":[0.0053815614,0.00043828975,0.09517614,0.00050841825,0.0008553005,0.000003437389,0.00070353155,0.0008417891,0.8912066,0.0030579567,0.0014001651,0.0004267846],"about_ca_topic_score_codex":0.00011696621,"about_ca_topic_score_gemma":0.000063465995,"teacher_disagreement_score":0.09508169,"about_ca_system_score_codex":0.00010022661,"about_ca_system_score_gemma":0.00027637597,"threshold_uncertainty_score":0.99967885},"labels":[],"label_agreement":null},{"id":"W7132990117","doi":"","title":"The Role of the Estrous Cycle on Human CYP2D6-mediated Harmine Response in CYP2D6-transgenic Mice","year":2022,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Estrous cycle; Harmine; Genetically modified mouse; Drug; Human brain; Menstrual cycle; Ratón; Transgene","score_opus":0.05413023961402391,"score_gpt":0.45801388230224255,"score_spread":0.40388364268821864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132990117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96337587,0.018018031,7.56465e-7,0.0021342798,0.0064036706,0.0023307859,0.0005327945,0.000047229987,0.007156601],"genre_scores_gemma":[0.98035765,0.0057019126,0.000009426417,0.0011379105,0.00041304374,0.00047810047,0.0003208522,0.00017568574,0.011405441],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9878331,0.007029843,0.0016157071,0.0010836766,0.0010038497,0.0014338448],"domain_scores_gemma":[0.9928525,0.003952189,0.0014103216,0.001118325,0.00027776495,0.0003889048],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004238089,0.001068952,0.0010877291,0.00045040651,0.0021136787,0.000064340755,0.002498984,0.0009781268,0.0035835325],"category_scores_gemma":[0.0005411045,0.00084307365,0.00073303544,0.0015169557,0.00067924557,0.00006896774,0.00034636108,0.0053801,0.00012378421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026068972,0.0017458108,0.0012980503,0.00012862244,0.0008014767,0.000039703926,0.033544503,0.008935313,0.9195898,0.0009233292,0.0007067792,0.006217625],"study_design_scores_gemma":[0.007193423,0.00084107014,0.025431292,0.00012100125,0.0014773618,0.000018533545,0.019056173,0.004191999,0.492837,0.0008687218,0.44679523,0.0011681772],"about_ca_topic_score_codex":0.0005183009,"about_ca_topic_score_gemma":0.0005292871,"teacher_disagreement_score":0.44608846,"about_ca_system_score_codex":0.00032855777,"about_ca_system_score_gemma":0.0010245827,"threshold_uncertainty_score":0.999402},"labels":[],"label_agreement":null},{"id":"W7133021441","doi":"","title":"Investigating the Involvement of the Sulfotransferase Pathway in Drug-induced Skin Rash","year":2021,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Covalent bond; Sulfotransferase; Covalent binding; Reactive intermediate; Drug; Plasma protein binding; Metabolism; Genipin","score_opus":0.09699687243208402,"score_gpt":0.4256327531972027,"score_spread":0.3286358807651186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133021441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96949327,0.011414743,0.000004743117,0.0032867293,0.0079817865,0.0022823547,0.000121512814,0.000022190907,0.005392672],"genre_scores_gemma":[0.98553354,0.003795667,0.00005059169,0.0037038664,0.0005756968,0.0003009289,0.00021807634,0.00011390995,0.0057077445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99069566,0.004562229,0.0017509329,0.0009995203,0.00086214644,0.0011295193],"domain_scores_gemma":[0.99587005,0.0011999285,0.0010431269,0.0010070805,0.0004897913,0.00039000713],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033775382,0.0009936943,0.0011645646,0.0002449723,0.00081756356,0.00008134887,0.0016958766,0.0009528998,0.0014869551],"category_scores_gemma":[0.0003584901,0.0007233454,0.00068868924,0.0016781883,0.00052784703,0.00008804165,0.00036329715,0.0042977785,0.000031726366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014286627,0.00091620523,0.0043712333,0.00078836764,0.0005665832,0.00003511987,0.12548135,0.001964388,0.84882724,0.0014520054,0.00080114766,0.014653512],"study_design_scores_gemma":[0.0035880802,0.000034550943,0.009524652,0.00046186158,0.0006838512,0.00000608377,0.028954051,0.0016038226,0.9208933,0.00040634267,0.03312153,0.0007218353],"about_ca_topic_score_codex":0.0015819523,"about_ca_topic_score_gemma":0.004765027,"teacher_disagreement_score":0.09652729,"about_ca_system_score_codex":0.00016108526,"about_ca_system_score_gemma":0.0020157923,"threshold_uncertainty_score":0.9995218},"labels":[],"label_agreement":null},{"id":"W7133046425","doi":"","title":"Characterizing Genotyping Methods for CYP2A6, Their Impacts on Prediction of Nicotine Metabolism, and Applications for the Discovery of Novel Associations","year":2025,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Common Fund; National Human Genome Research Institute; National Institute on Drug Abuse; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; NIH Office of the Director; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Alliance de recherche numérique du Canada","keywords":"Genotyping; Genotype; CYP2A6; 1000 Genomes Project; Amplicon; Genome-wide association study; Imputation (statistics); Nicotine","score_opus":0.1399656161753509,"score_gpt":0.5006515224826439,"score_spread":0.360685906307293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133046425","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24175186,0.053658616,0.6442215,0.0020564492,0.008225769,0.017434707,0.030970765,0.000078197816,0.0016021362],"genre_scores_gemma":[0.9127459,0.044280987,0.019998774,0.0015668869,0.0026633244,0.007065368,0.0057107373,0.0002457392,0.005722268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966729,0.0004998889,0.0013308714,0.00068762584,0.0001957254,0.0006129411],"domain_scores_gemma":[0.9883006,0.008008219,0.002163908,0.0004789403,0.00088723475,0.000161068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003017802,0.0006416614,0.0012897722,0.00039981317,0.00090947724,0.00006353834,0.00045525687,0.00078737305,0.000028210423],"category_scores_gemma":[0.000736725,0.00053841394,0.0006132869,0.00055800023,0.00019504977,0.0001652416,0.00011171601,0.00082558417,4.4810113e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013729624,0.00088717043,0.00008402473,0.0014362581,0.0027618133,2.2469553e-8,0.0074318955,0.00090370525,0.8931883,0.011786181,0.000096888034,0.080050774],"study_design_scores_gemma":[0.0045864084,0.00017213097,0.008889149,0.00019322691,0.0071615437,0.0000013580129,0.0027868736,0.036548465,0.7999817,0.0005479946,0.13870908,0.00042203045],"about_ca_topic_score_codex":0.000046147932,"about_ca_topic_score_gemma":0.000016258027,"teacher_disagreement_score":0.67099404,"about_ca_system_score_codex":0.0000793726,"about_ca_system_score_gemma":0.0005848817,"threshold_uncertainty_score":0.99970675},"labels":[],"label_agreement":null},{"id":"W7143507916","doi":"10.71465/ajpp.2268","title":"Impact of Nutraceuticals on Drug Efficacy and Metabolism","year":2022,"lang":"","type":"article","venue":"American Journal Of Pharmacy And Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nutraceutical; Drug; Pharmacodynamics; Clinical efficacy; Pharmacokinetics; Adverse effect; Efficacy; Drug development","score_opus":0.057446695774315173,"score_gpt":0.45070323153565417,"score_spread":0.393256535761339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7143507916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93232435,0.05581364,0.000012335411,0.002897411,0.0063187117,0.0009252221,0.0009856807,0.00002355655,0.0006990697],"genre_scores_gemma":[0.9529724,0.040220775,0.00018804839,0.004536896,0.0017162792,0.00004882309,0.000011472622,0.00012852269,0.00017674612],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9858477,0.007879276,0.002814447,0.00094670814,0.00094631047,0.0015655598],"domain_scores_gemma":[0.9894682,0.0036866162,0.0038937053,0.00033604246,0.0005794312,0.0020359831],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005315556,0.0011807892,0.0029406848,0.0013962617,0.0010494614,0.000051650957,0.0012629041,0.00015909699,0.010736586],"category_scores_gemma":[0.000107315645,0.0011154431,0.00094213494,0.0013758198,0.0034657335,0.00028453968,0.0009947384,0.0054869237,0.000015011503],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04855249,0.010696204,0.011349027,0.00032710173,0.012040391,0.0012476513,0.009589381,0.012306782,0.5746274,0.001227852,0.012873289,0.30516246],"study_design_scores_gemma":[0.092693485,0.016062962,0.021582622,0.00009705442,0.021891356,0.006821167,0.0031244936,0.014335469,0.17330009,0.0015337855,0.64540064,0.0031568557],"about_ca_topic_score_codex":0.00013353449,"about_ca_topic_score_gemma":6.647267e-7,"teacher_disagreement_score":0.63252735,"about_ca_system_score_codex":0.00023059137,"about_ca_system_score_gemma":0.0011256796,"threshold_uncertainty_score":0.99924624},"labels":[],"label_agreement":null},{"id":"W7162122644","doi":"10.82308/47540","title":"Barriers to personalized medicine in pediatrics: The implementation of a novel pharmacogenomic test for pediatric neuroblastoma","year":2015,"lang":"en","type":"dissertation","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Test (biology); Personalized medicine; Pediatric cancer; Palliative care; Deliberation; Genetic testing; Stakeholder","score_opus":0.08543492254270567,"score_gpt":0.47477359066425356,"score_spread":0.3893386681215479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7162122644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831981,0.003766593,0.0000660336,0.00125545,0.004485299,0.0036650407,0.0013820623,0.000046776353,0.0021346116],"genre_scores_gemma":[0.9801992,0.0036922507,0.0005255243,0.0053705466,0.0035244485,0.0014268117,0.001076132,0.00019132863,0.0039937613],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967539,0.00026364138,0.0011951593,0.00062271423,0.00046530223,0.00069932133],"domain_scores_gemma":[0.9965824,0.0012009076,0.00065913366,0.0002473232,0.0005888202,0.00072141964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022052985,0.0005485928,0.00076292054,0.0007977235,0.00021369521,0.000015655183,0.00074212626,0.00039679382,0.0024612544],"category_scores_gemma":[0.0006829063,0.00043294884,0.00021683636,0.00090835086,0.00009201465,0.00006792131,0.00006986772,0.0007557356,0.000023345932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005803966,0.0010263664,0.029381238,0.0019147205,0.0005416619,0.000022529126,0.04781975,0.0014396736,0.6599117,0.001054357,0.20762296,0.04346106],"study_design_scores_gemma":[0.09001286,0.002700723,0.020985229,0.00007842115,0.013467757,0.000037881815,0.053105235,0.007236062,0.15183327,0.0012550179,0.65558684,0.0037007113],"about_ca_topic_score_codex":0.00020256396,"about_ca_topic_score_gemma":0.00037324213,"teacher_disagreement_score":0.50807846,"about_ca_system_score_codex":0.00012145624,"about_ca_system_score_gemma":0.0012106415,"threshold_uncertainty_score":0.99981225},"labels":[],"label_agreement":null},{"id":"W7163132718","doi":"10.5281/zenodo.20507805","title":"Pharmacogenomics in Clinical Pharmacy","year":2025,"lang":"","type":"book-chapter","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Pharmacy; Accreditation; Precision medicine; Clinical pharmacy; Personalized medicine; Population","score_opus":0.20811212818754102,"score_gpt":0.43721074046860325,"score_spread":0.22909861228106224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7163132718","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007912909,0.007572127,0.00046479452,0.0024862706,0.0059943823,0.0031794335,0.0047378084,0.00075453834,0.9668977],"genre_scores_gemma":[0.49546832,0.25844762,0.0007317438,0.017497065,0.008362489,0.0000015171667,0.014878383,0.014975794,0.18963708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98920953,0.0031731215,0.002930037,0.0021967213,0.0007450681,0.0017455478],"domain_scores_gemma":[0.9944804,0.00048841914,0.0010240084,0.0011242076,0.0015510687,0.0013319385],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0067592505,0.001203337,0.0014714396,0.001543789,0.004071879,0.0008271896,0.0043239933,0.0011136812,0.15213615],"category_scores_gemma":[0.0009146725,0.0014999252,0.00074125757,0.0007295906,0.0014262358,0.00035542535,0.0052970373,0.0063763903,0.022782927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018144248,0.0012797111,0.00003105697,0.0004111036,0.001210912,0.00037263078,0.00070996035,0.00038826824,0.0064324844,0.026292095,0.17236374,0.7886936],"study_design_scores_gemma":[0.008446585,0.00023214404,0.00011926392,0.00017322705,0.0009133958,0.00016696598,0.00006898016,0.005280619,0.0019903725,0.0011548083,0.9802143,0.0012393536],"about_ca_topic_score_codex":0.000022446131,"about_ca_topic_score_gemma":9.156456e-7,"teacher_disagreement_score":0.80785054,"about_ca_system_score_codex":0.0005654915,"about_ca_system_score_gemma":0.00009701031,"threshold_uncertainty_score":0.99874496},"labels":[],"label_agreement":null},{"id":"W7163189178","doi":"10.5281/zenodo.20507806","title":"Pharmacogenomics in Clinical Pharmacy","year":2025,"lang":"","type":"book-chapter","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Pharmacy; Accreditation; Precision medicine; Clinical pharmacy; Personalized medicine; Population","score_opus":0.20811212818754102,"score_gpt":0.43721074046860325,"score_spread":0.22909861228106224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7163189178","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007912909,0.007572127,0.00046479452,0.0024862706,0.0059943823,0.0031794335,0.0047378084,0.00075453834,0.9668977],"genre_scores_gemma":[0.49546832,0.25844762,0.0007317438,0.017497065,0.008362489,0.0000015171667,0.014878383,0.014975794,0.18963708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98920953,0.0031731215,0.002930037,0.0021967213,0.0007450681,0.0017455478],"domain_scores_gemma":[0.9944804,0.00048841914,0.0010240084,0.0011242076,0.0015510687,0.0013319385],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0067592505,0.001203337,0.0014714396,0.001543789,0.004071879,0.0008271896,0.0043239933,0.0011136812,0.15213615],"category_scores_gemma":[0.0009146725,0.0014999252,0.00074125757,0.0007295906,0.0014262358,0.00035542535,0.0052970373,0.0063763903,0.022782927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018144248,0.0012797111,0.00003105697,0.0004111036,0.001210912,0.00037263078,0.00070996035,0.00038826824,0.0064324844,0.026292095,0.17236374,0.7886936],"study_design_scores_gemma":[0.008446585,0.00023214404,0.00011926392,0.00017322705,0.0009133958,0.00016696598,0.00006898016,0.005280619,0.0019903725,0.0011548083,0.9802143,0.0012393536],"about_ca_topic_score_codex":0.000022446131,"about_ca_topic_score_gemma":9.156456e-7,"teacher_disagreement_score":0.80785054,"about_ca_system_score_codex":0.0005654915,"about_ca_system_score_gemma":0.00009701031,"threshold_uncertainty_score":0.99874496},"labels":[],"label_agreement":null},{"id":"W7165991647","doi":"","title":"Farmakogenetik Testlerin Sağlık Ekonomisi Alanındaki Etkisinin Bibliyometrik Analizi","year":2025,"lang":"tr","type":"article","venue":"DergiPark (Istanbul University)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Bibliometrics; Health economics; Inclusion (mineral); Citation; Pharmacogenetics; Scientific literature; Value (mathematics)","score_opus":0.07182002256909965,"score_gpt":0.39090622865080266,"score_spread":0.319086206081703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7165991647","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47958604,0.021677643,0.000758416,0.0043919324,0.007610373,0.0013315327,0.0013723993,0.00037573278,0.48289594],"genre_scores_gemma":[0.8720742,0.03067136,0.0005803476,0.0064072586,0.00063956546,0.000009492994,0.00014794708,0.00011425119,0.0893556],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935464,0.0013265943,0.001068435,0.0016792238,0.000495849,0.0018834824],"domain_scores_gemma":[0.99562967,0.00109938,0.0005878785,0.00093934906,0.0006079918,0.0011357558],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012859612,0.001156725,0.0013082161,0.005773552,0.001227997,0.00024192948,0.0021605024,0.0013174494,0.005556697],"category_scores_gemma":[0.00020283,0.001464504,0.00071473484,0.010072344,0.00087935064,0.00036235774,0.0011324815,0.0021911706,0.0007771323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008329765,0.0052138297,0.09962687,0.0013024942,0.010374854,0.0038844654,0.0024552802,0.0072538434,0.06464404,0.11612853,0.61687243,0.063913606],"study_design_scores_gemma":[0.0075470675,0.000142996,0.012128227,0.0000943008,0.0022560044,0.000023338227,0.0011483754,0.0018535897,0.019822646,0.0004010906,0.9533359,0.0012464836],"about_ca_topic_score_codex":0.00014993917,"about_ca_topic_score_gemma":0.000088885616,"teacher_disagreement_score":0.39354032,"about_ca_system_score_codex":0.0006608384,"about_ca_system_score_gemma":0.001198569,"threshold_uncertainty_score":0.9999791},"labels":[],"label_agreement":null},{"id":"W74495713","doi":"10.1097/00008571-200007000-00001","title":"Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.","year":2000,"lang":"en","type":"review","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":397,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP3A4; Genetic variability; Pharmacology; Biology; Medicine; Internal medicine; Genetics; Cytochrome P450; Genotype; Metabolism","score_opus":0.28824948934828076,"score_gpt":0.5423411700006989,"score_spread":0.25409168065241816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W74495713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035261802,0.9556297,0.00014583606,0.000062176754,0.0018819117,0.0043103197,0.00084048475,0.000031809403,0.0018359576],"genre_scores_gemma":[0.08907802,0.90929097,0.00066755386,0.000085016654,0.00024552297,0.00038954438,0.00006678987,0.00009455706,0.0000819981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97145045,0.02311331,0.0024043235,0.0009384877,0.0014420424,0.0006514034],"domain_scores_gemma":[0.9946215,0.001636358,0.0018420527,0.0009972581,0.00063867855,0.0002641125],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015596975,0.0008269319,0.0022688694,0.00041716735,0.00013298023,0.000016507605,0.0011979735,0.00070122525,0.0014539735],"category_scores_gemma":[0.0004241795,0.0006807914,0.0009037577,0.0013203656,0.00037242565,0.000057201043,0.0003046894,0.0016309634,0.000019128083],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013411662,0.0012025342,0.00014784388,0.0034530226,0.0007008486,0.000006465953,0.00023717692,0.0036624735,0.0032353085,0.000015628155,0.0001662773,0.9870383],"study_design_scores_gemma":[0.002818421,0.000056559624,0.0004331076,0.0010825568,0.020320442,0.000059273432,0.000009747871,0.03672569,0.06702839,0.0004625631,0.870196,0.00080726884],"about_ca_topic_score_codex":0.000067550616,"about_ca_topic_score_gemma":0.000028602286,"teacher_disagreement_score":0.986231,"about_ca_system_score_codex":0.00031305695,"about_ca_system_score_gemma":0.0022980226,"threshold_uncertainty_score":0.99956435},"labels":[],"label_agreement":null},{"id":"W762497818","doi":"","title":"Advancements in the Field of Cardiovascular Disease Pharmacogenetics","year":2015,"lang":"en","type":"dissertation","venue":"MacSphere (McMaster University)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Cisco Systems; Sanofi; Eli Lilly Canada; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pharmacogenetics; Field (mathematics); Disease; Medicine; Data science; Intensive care medicine; Computer science; Internal medicine; Biology; Genetics; Genotype; Mathematics","score_opus":0.059891983149146094,"score_gpt":0.3694268530251954,"score_spread":0.3095348698760493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W762497818","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2141857,0.039403178,0.00008400906,0.00026823345,0.004164394,0.0017187871,0.00043144418,0.000054557157,0.7396897],"genre_scores_gemma":[0.6263512,0.02159438,0.00025273507,0.0029927809,0.0008809248,0.000038282582,0.00096291024,0.00016586235,0.34676093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973606,0.00077969756,0.00038732676,0.00048025322,0.00054043264,0.00045170792],"domain_scores_gemma":[0.9986308,0.00020406282,0.00024395142,0.00043472077,0.00020078692,0.000285672],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005901155,0.00040682268,0.0005393657,0.0002543246,0.00010826456,0.000016670232,0.0010312477,0.0003724551,0.022308609],"category_scores_gemma":[0.000051502397,0.0003837861,0.00041164082,0.000645286,0.000079804966,0.00009789309,0.00011201979,0.0009270367,0.000050509894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025470075,0.0006365216,0.0022659716,0.00047416077,0.0018418595,0.00065865985,0.00233242,0.00988937,0.0013009924,0.00032327886,0.008368057,0.9693617],"study_design_scores_gemma":[0.0028315762,0.000059941613,0.0004967621,0.000050559418,0.002246394,0.0000015073348,0.0015108135,0.0004617712,0.0038869428,0.00025627564,0.98781985,0.0003776201],"about_ca_topic_score_codex":0.00007805666,"about_ca_topic_score_gemma":0.000065857595,"teacher_disagreement_score":0.9794518,"about_ca_system_score_codex":0.00007606327,"about_ca_system_score_gemma":0.0002739887,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W821485509","doi":"10.71781/30250","title":"Les Déterminants Génétiques de la Pharmacocinétique du Busulfan et les Résultats de la Transplantation","year":2012,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondation Charles-Bruneau","keywords":"Philosophy","score_opus":0.020539569735155264,"score_gpt":0.3238571767413334,"score_spread":0.30331760700617816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W821485509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87450594,0.065646715,0.0009320146,0.00046202625,0.0019223997,0.00046132997,0.000486683,0.00013719445,0.055445727],"genre_scores_gemma":[0.9218797,0.064236626,0.001096947,0.00060785486,0.0007686503,0.0000866114,0.0008859999,0.000088848836,0.010348784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9918929,0.005242309,0.0006642658,0.00072159723,0.00046748496,0.0010114639],"domain_scores_gemma":[0.99630636,0.0015417704,0.0006060315,0.00024343163,0.00039208058,0.00091034936],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002053298,0.000828235,0.00066726655,0.00036487338,0.0061303875,0.00011585687,0.0006020039,0.001934394,0.0005041216],"category_scores_gemma":[0.00011608196,0.0010179485,0.0004966105,0.00030566077,0.00090202194,0.00044880126,0.000121653255,0.002423607,0.00003751309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027925046,0.0015764165,0.09629148,0.000891154,0.0013479341,0.009029908,0.11022716,0.0091801835,0.70240325,0.02542551,0.00097167405,0.039862853],"study_design_scores_gemma":[0.003995466,0.000061823426,0.25161928,0.00029468327,0.003282514,0.0051828986,0.008182207,0.004214265,0.47343636,0.00030377574,0.24836305,0.0010636677],"about_ca_topic_score_codex":0.022125749,"about_ca_topic_score_gemma":0.0017400905,"teacher_disagreement_score":0.24739137,"about_ca_system_score_codex":0.0024561305,"about_ca_system_score_gemma":0.0028341406,"threshold_uncertainty_score":0.99987787},"labels":[],"label_agreement":null},{"id":"W9251540","doi":"10.18553/jmcp.2014.20.4.376","title":"Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events","year":2014,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface","funders":"Ministério da Saúde; Universidade de São Paulo","keywords":"Amiodarone; Medicine; Warfarin; Adverse effect; Odds ratio; CYP2C9; Maintenance dose; VKORC1; Internal medicine; Atrial fibrillation; Prothrombin time; Loading dose; Anesthesia; Gastroenterology","score_opus":0.08974925117754175,"score_gpt":0.3912391506886126,"score_spread":0.30148989951107086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W9251540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956974,0.0008748791,0.00029724446,0.00058911234,0.0012809896,0.0003676921,0.00019124696,0.000035691985,0.0006657791],"genre_scores_gemma":[0.9919587,0.0016245111,0.0005663724,0.0047344887,0.00030186155,0.00000806381,0.0000111959525,0.000052580574,0.00074225845],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616694,0.0010427235,0.0010925407,0.00033593865,0.00072726386,0.0006346081],"domain_scores_gemma":[0.99530685,0.0012272457,0.0015683321,0.00027366335,0.0011570608,0.0004668266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001328952,0.00042688518,0.00080303464,0.00033157654,0.00021946816,0.000020745218,0.00073434913,0.0001680262,0.00031561166],"category_scores_gemma":[0.00062152854,0.0003438763,0.00032469333,0.0004163016,0.00027059033,0.00043020383,0.00015695777,0.0013225678,0.000023242545],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018508457,0.002868815,0.13913369,0.00078841473,0.0074203564,0.0023782582,0.010533786,0.19930674,0.3428561,0.00034226253,0.009677581,0.26618552],"study_design_scores_gemma":[0.037700783,0.0011133208,0.034070704,0.00048955233,0.004865496,0.0002941529,0.0013077764,0.030303068,0.339064,0.0003612016,0.54887867,0.001551255],"about_ca_topic_score_codex":0.000072516355,"about_ca_topic_score_gemma":0.000018957333,"teacher_disagreement_score":0.5392011,"about_ca_system_score_codex":0.00013194527,"about_ca_system_score_gemma":0.00018320778,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null},{"id":"W995787599","doi":"10.1007/978-3-319-16009-2","title":"Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450","year":2015,"lang":"en","type":"book","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Peroxidase; Chemistry; Monooxygenase; Cytochrome P450; Cytochrome c peroxidase; Biochemistry; Stereochemistry; Enzyme","score_opus":0.17305831116150946,"score_gpt":0.44657006518087206,"score_spread":0.27351175401936256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W995787599","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28717697,0.688759,0.000029351148,0.0006282556,0.0008699939,0.0009229098,0.0001547259,0.000032789558,0.02142599],"genre_scores_gemma":[0.9020987,0.08748454,0.00027479604,0.002813354,0.00051736675,0.00012950301,0.00011673063,0.000053818694,0.006511154],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807817,0.00024859436,0.0005807447,0.0005936609,0.0001163819,0.0003824567],"domain_scores_gemma":[0.99901634,0.00016218875,0.00025357743,0.00016006491,0.00007322838,0.00033458913],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005070876,0.00047355553,0.00095792447,0.0002598831,0.00008879363,0.000004861905,0.00016731991,0.00053066487,0.00015675715],"category_scores_gemma":[0.000056798614,0.0003508668,0.000038307157,0.00006680325,0.0018746484,0.00010957692,0.0002810411,0.00056904095,0.0000027821168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007308019,0.00020600174,0.0001674302,0.00035239,0.00014177023,0.00005835744,0.0028167705,0.0000038379835,0.9594301,0.010564156,0.001962118,0.023566255],"study_design_scores_gemma":[0.009279163,0.0031294755,0.00013132062,0.00042071939,0.00035073727,0.00023267808,0.002987301,0.00032169805,0.23168284,0.04122261,0.70923775,0.0010037274],"about_ca_topic_score_codex":0.000025277097,"about_ca_topic_score_gemma":0.000011848819,"teacher_disagreement_score":0.72774726,"about_ca_system_score_codex":0.00005136573,"about_ca_system_score_gemma":0.00009033279,"threshold_uncertainty_score":0.9998943},"labels":[],"label_agreement":null}]}